data_1r4y_residue save_MolProbity _Software.Sf_category software _Software.Sf_framecode MolProbity _Software.Entry_ID ? _Software.ID 1 _Software.Name MolProbity _Software.Version 4.0 _Software.Details . save_ save_CYRANGE _Software.Sf_category software _Software.Sf_framecode CYRANGE _Software.Entry_ID ? _Software.ID 2 _Software.Name CYRANGE _Software.Version 2.0 _Software.Details . save_ save_Structure_validation_residue _Structure_validation_residue.Sf_category structure_validation _Structure_validation_residue.Sf_framecode Structure_validation_residue _Structure_validation_residue.Entry_ID ? _Structure_validation_residue.List_ID 1 _Structure_validation_residue.PDB_accession_code 1r4y _Structure_validation_residue.Date_analyzed 2016-10-07 loop_ _Residue_analysis_software.Software_ID _Residue_analysis_software.Software_label _Residue_analysis_software.Method_ID _Residue_analysis_software.Method_label _Residue_analysis_software.Entry_ID _Residue_analysis_software.Structure_validation_oneline_list_ID 1 MolProbity . . ? 1 2 CYRANGE . . ? 1 stop_ loop_ _Residue_analysis.ID _Residue_analysis.PDB_model_num _Residue_analysis.Hydrogen_positions _Residue_analysis.MolProbity_flips _Residue_analysis.Cyrange_core_flag _Residue_analysis.Two_letter_chain_ID _Residue_analysis.PDB_strand_ID _Residue_analysis.PDB_residue_no _Residue_analysis.PDB_ins_code _Residue_analysis.PDB_residue_name _Residue_analysis.Assembly_ID _Residue_analysis.Entity_assembly_ID _Residue_analysis.Entity_ID _Residue_analysis.Comp_ID _Residue_analysis.Comp_index_ID _Residue_analysis.Clash_value _Residue_analysis.Clash_source_PDB_atom_name _Residue_analysis.Clash_destination_PDB_atom_name _Residue_analysis.Clash_destination_PDB_strand_ID _Residue_analysis.Clash_destination_PDB_residue_no _Residue_analysis.Clash_destination_PDB_ins_code _Residue_analysis.Clash_destination_PDB_residue_name _Residue_analysis.Cbeta_deviation_value _Residue_analysis.Rotamer_score _Residue_analysis.Rotamer_name _Residue_analysis.Ramachandran_phi _Residue_analysis.Ramachandran_psi _Residue_analysis.Ramachandran_score _Residue_analysis.Ramachandran_evaluation _Residue_analysis.Ramachandran_type _Residue_analysis.Bond_outlier_count _Residue_analysis.Worst_bond _Residue_analysis.Worst_bond_value _Residue_analysis.Worst_bond_sigma _Residue_analysis.Angle_outlier_count _Residue_analysis.Worst_angle _Residue_analysis.Worst_angle_value _Residue_analysis.Worst_angle_sigma _Residue_analysis.RNA_phosphate_perpendicular_outlier _Residue_analysis.RNA_suitness_score _Residue_analysis.RNA_suite_conformer _Residue_analysis.RNA_suite_triage _Residue_analysis.Max_b_factor _Residue_analysis.Tau_angle _Residue_analysis.Omega_dihedral _Residue_analysis.Disulfide_chi1 _Residue_analysis.Disulfide_chi2 _Residue_analysis.Disulfide_chi3 _Residue_analysis.Disulfide_ss_angle _Residue_analysis.Disulfide_ss _Residue_analysis.Disulfide_ss_angle_prime _Residue_analysis.Disulfide_chi2prime _Residue_analysis.Disulfide_chi1prime _Residue_analysis.Outlier_count_separate_geometry _Residue_analysis.Outlier_count _Residue_analysis.Entry_ID _Residue_analysis.Structure_validation_residue_list_ID . 001 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.529 0.158 0 CA-C-O 122.004 0.907 . . . . 0.0 110.708 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 91.4 m -83.96 111.22 19.06 Favored 'General case' 0 C--N 1.31 -1.119 0 O-C-N 121.742 -0.599 . . . . 0.0 111.046 177.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . 0.62 ' CZ2' ' CD2' ' A' ' 136' ' ' HIS . 16.9 m95 -79.7 142.44 35.48 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 177.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -138.51 141.09 39.38 Favored 'General case' 0 CA--C 1.498 -1.046 0 O-C-N 121.068 -1.02 . . . . 0.0 108.429 -178.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -122.81 61.08 1.01 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 118.612 -0.708 . . . . 0.0 110.502 177.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 39.0 78.69 0.05 OUTLIER Glycine 0 CA--C 1.532 1.114 0 O-C-N 124.207 0.942 . . . . 0.0 113.031 -177.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.01 -75.59 0.19 Allowed Glycine 0 C--O 1.224 -0.482 0 N-CA-C 111.189 -0.765 . . . . 0.0 111.189 -177.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.2 mt -128.33 163.2 25.32 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.593 0.711 . . . . 0.0 110.609 177.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.58 170.34 10.94 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.978 -177.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.511 ' CE2' ' CB ' ' A' ' 106' ' ' ALA . 70.6 m-85 -160.99 85.94 0.69 Allowed 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 122.278 1.037 . . . . 0.0 108.378 -171.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.432 ' ND2' ' H ' ' A' ' 14' ' ' ASN . 2.1 t-20 -54.11 122.98 11.34 Favored 'General case' 0 C--O 1.213 -0.864 0 CA-C-O 115.715 -2.088 . . . . 0.0 108.457 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.486 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 0.7 OUTLIER -46.49 -40.47 12.54 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 120.161 1.346 . . . . 0.0 112.543 175.716 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.432 ' H ' ' ND2' ' A' ' 12' ' ' ASN . 2.0 t-20 -57.75 -47.35 82.73 Favored 'General case' 0 C--O 1.199 -1.576 0 CA-C-O 118.573 -0.727 . . . . 0.0 111.093 176.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.3 mttt -70.52 -39.78 73.86 Favored 'General case' 0 C--O 1.203 -1.363 0 CA-C-N 120.912 1.687 . . . . 0.0 112.185 171.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -52.58 -41.01 63.23 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 121.55 1.977 . . . . 0.0 110.855 175.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -87.06 -47.0 9.28 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-O 117.393 -1.289 . . . . 0.0 109.64 177.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 39.3 t -67.49 -54.18 22.31 Favored 'General case' 0 CA--C 1.496 -1.108 0 C-N-CA 127.311 2.244 . . . . 0.0 107.597 -171.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.481 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 5.9 t-20 -42.32 -36.46 1.26 Allowed 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 119.862 1.21 . . . . 0.0 113.514 169.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.78 -33.97 27.19 Favored 'General case' 0 C--O 1.212 -0.906 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 172.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 14.9 m170 -44.96 -35.69 3.01 Favored 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 126.516 1.926 . . . . 0.0 110.33 177.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.481 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -74.3 -48.84 25.88 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-O 117.089 -1.434 . . . . 0.0 112.385 175.224 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -35.41 128.78 0.56 Allowed Pre-proline 0 CA--C 1.542 0.647 0 O-C-N 125.568 1.792 . . . . 0.0 112.51 172.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -73.98 123.04 8.1 Favored 'Trans proline' 0 N--CA 1.448 -1.189 0 C-N-CA 122.14 1.893 . . . . 0.0 108.661 -176.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.416 ' CD2' ' HE2' ' A' ' 115' ' ' LYS . 3.4 tp -59.47 102.86 0.16 Allowed 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.102 178.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 178.93 151.3 0.31 Allowed 'General case' 0 C--O 1.214 -0.795 0 CA-C-O 119.014 -0.517 . . . . 0.0 110.883 -176.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.428 ' HB3' ' CA ' ' A' ' 72' ' ' GLY . 0.9 OUTLIER -81.93 89.8 6.4 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 119.263 0.938 . . . . 0.0 109.571 -179.422 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 60.31 82.08 0.07 OUTLIER Glycine 0 C--O 1.226 -0.401 0 CA-C-O 121.617 0.565 . . . . 0.0 111.7 178.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.3 mttt -150.06 45.76 0.91 Allowed 'General case' 0 CA--C 1.511 -0.546 0 CA-C-O 122.521 1.153 . . . . 0.0 111.315 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 70.5 p -128.41 152.56 48.06 Favored 'General case' 0 CA--C 1.497 -1.076 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -175.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -42.77 -52.19 5.59 Favored Glycine 0 C--N 1.332 0.346 0 O-C-N 124.556 1.16 . . . . 0.0 112.139 -177.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.427 ' HG ' ' N ' ' A' ' 33' ' ' SER . 1.3 t -68.48 -77.98 0.07 Allowed 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 117.659 -1.162 . . . . 0.0 111.251 172.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 33' ' ' SER . . . . . 0.427 ' N ' ' HG ' ' A' ' 32' ' ' SER . 71.0 p -178.07 -61.73 0.01 OUTLIER 'General case' 0 C--O 1.218 -0.603 0 O-C-N 124.846 1.341 . . . . 0.0 110.888 -177.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -62.66 146.87 93.86 Favored Pre-proline 0 N--CA 1.428 -1.555 0 O-C-N 125.432 1.707 . . . . 0.0 112.714 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -78.19 -179.39 26.88 Favored 'Cis proline' 0 N--CA 1.439 -1.731 0 C-N-CA 121.856 -2.143 . . . . 0.0 111.785 1.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.411 ' CD2' ' N ' ' A' ' 36' ' ' HIS . 0.2 OUTLIER -152.69 164.1 38.39 Favored 'General case' 0 C--O 1.209 -1.063 0 O-C-N 118.913 -2.367 . . . . 0.0 111.251 -177.27 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.553 ' CH2' ' HA2' ' A' ' 44' ' ' GLY . 20.3 t90 -69.96 140.93 53.08 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 119.821 1.191 . . . . 0.0 108.422 176.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.445 ' CZ ' ' HA ' ' A' ' 40' ' ' ASN . 11.3 t80 -117.79 86.64 2.56 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 -177.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.457 ' CG2' ' CH2' ' A' ' 37' ' ' TRP . 70.4 p -38.91 -36.58 0.29 Allowed 'General case' 0 C--O 1.211 -0.965 0 C-N-CA 124.853 1.261 . . . . 0.0 111.185 175.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.445 ' HA ' ' CZ ' ' A' ' 38' ' ' PHE . 61.7 t30 73.49 4.94 4.91 Favored 'General case' 0 C--O 1.219 -0.52 0 C-N-CA 126.329 1.852 . . . . 0.0 109.36 176.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.416 ' CA ' ' HD3' ' A' ' 52' ' ' ARG . . . 120.04 -9.74 11.18 Favored Glycine 0 N--CA 1.427 -1.918 0 C-N-CA 125.221 1.391 . . . . 0.0 114.059 -172.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.567 ' CE2' ' HA ' ' A' ' 47' ' ' LYS . 17.3 m-85 -77.36 172.04 13.93 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.012 0.925 . . . . 0.0 110.489 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.04 -39.12 12.38 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.87 176.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.553 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . 174.27 -42.46 0.14 Allowed Glycine 0 C--N 1.334 0.439 0 C-N-CA 124.449 1.023 . . . . 0.0 112.73 -177.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -133.27 -63.87 0.75 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.519 0.676 . . . . 0.0 109.736 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.7 154.54 17.19 Favored Glycine 0 C--N 1.341 0.825 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.567 ' HA ' ' CE2' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -53.16 174.8 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.839 0.828 . . . . 0.0 112.775 175.721 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.424 ' CD1' ' CE1' ' A' ' 42' ' ' TYR . 5.6 mp -57.27 149.97 44.86 Favored Pre-proline 0 N--CA 1.445 -0.686 0 O-C-N 121.697 -0.627 . . . . 0.0 111.431 177.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -72.47 159.07 50.0 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 122.03 1.82 . . . . 0.0 109.474 -179.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 6.7 ttpt -54.65 97.76 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.147 0.579 . . . . 0.0 110.246 177.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.42 74.44 0.69 Allowed Glycine 0 N--CA 1.452 -0.26 0 CA-C-O 119.02 -0.878 . . . . 0.0 112.831 -175.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.416 ' HD3' ' CA ' ' A' ' 41' ' ' GLY . 7.1 ttm180 -173.69 164.28 4.37 Favored 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 123.966 0.906 . . . . 0.0 110.493 175.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.3 m -142.59 110.16 5.72 Favored Pre-proline 0 N--CA 1.448 -0.553 0 O-C-N 123.472 0.482 . . . . 0.0 110.563 178.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -73.15 178.7 6.23 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 122.286 1.991 . . . . 0.0 111.52 178.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.415 ' CG2' ' HB2' ' A' ' 133' ' ' LEU . 4.3 mt -88.63 119.07 35.27 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.552 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -179.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -82.65 134.96 35.16 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 120.85 -1.156 . . . . 0.0 109.076 176.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.535 ' CD1' ' HB3' ' A' ' 118' ' ' CYS . 6.9 m-85 -116.82 -44.33 2.83 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.575 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 122.5 -4.03 10.2 Favored Glycine 0 C--O 1.224 -0.508 0 CA-C-O 118.88 -0.956 . . . . 0.0 112.62 -176.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.7 mttt -101.49 139.15 37.54 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-N 118.307 1.054 . . . . 0.0 109.863 176.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.7 t -78.66 -1.0 32.25 Favored 'General case' 0 C--O 1.219 -0.507 0 O-C-N 125.097 1.498 . . . . 0.0 111.21 175.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -87.47 -51.22 6.04 Favored 'General case' 0 N--CA 1.451 -0.424 0 O-C-N 120.184 -1.572 . . . . 0.0 109.327 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 2.7 m -73.51 -35.55 65.62 Favored 'General case' 0 N--CA 1.451 -0.401 0 O-C-N 123.747 0.654 . . . . 0.0 109.624 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -63.05 -37.1 85.85 Favored 'General case' 0 C--O 1.225 -0.205 0 CA-C-O 121.531 0.681 . . . . 0.0 111.398 175.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.7 161.8 0.83 Allowed Pre-proline 0 N--CA 1.441 -0.908 0 CA-C-O 122.321 1.058 . . . . 0.0 112.642 177.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.413 ' HA ' ' CE2' ' A' ' 42' ' ' TYR . 27.5 Cg_endo -70.92 132.87 22.27 Favored 'Trans proline' 0 N--CA 1.438 -1.758 0 C-N-CA 120.72 0.947 . . . . 0.0 114.486 173.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.444 ' HD2' ' CD2' ' A' ' 42' ' ' TYR . 19.5 Cg_endo -72.04 168.01 25.15 Favored 'Trans proline' 0 N--CA 1.445 -1.37 0 C-N-CA 123.122 2.548 . . . . 0.0 110.905 177.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.6 tptt -126.92 52.98 1.73 Allowed 'General case' 0 C--O 1.203 -1.351 0 CA-C-N 115.136 -0.938 . . . . 0.0 108.51 178.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -75.52 164.88 25.9 Favored 'General case' 0 C--O 1.216 -0.692 0 O-C-N 120.411 -1.43 . . . . 0.0 111.347 178.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.4 p -157.87 -167.98 2.4 Favored 'General case' 0 C--N 1.322 -0.589 0 O-C-N 119.531 -1.98 . . . . 0.0 111.136 176.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.4 77.05 5.96 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 120.686 -1.259 . . . . 0.0 112.686 171.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -177.79 -44.86 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 O-C-N 123.694 0.621 . . . . 0.0 110.162 177.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.428 ' CA ' ' HB3' ' A' ' 27' ' ' ASP . . . 117.18 -69.24 0.3 Allowed Glycine 0 N--CA 1.439 -1.148 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.453 -178.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -128.84 60.95 1.52 Allowed 'General case' 0 CA--C 1.508 -0.67 0 C-N-CA 125.583 1.553 . . . . 0.0 107.367 -175.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.33 -106.45 0.01 OUTLIER Glycine 0 CA--C 1.535 1.292 0 CA-C-O 123.04 1.355 . . . . 0.0 112.862 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.8 mttm -73.11 -105.12 0.01 OUTLIER 'General case' 0 C--O 1.217 -0.608 0 O-C-N 119.699 -2.06 . . . . 0.0 110.621 177.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -106.47 16.8 24.21 Favored 'General case' 0 C--N 1.32 -0.711 0 O-C-N 121.486 -0.759 . . . . 0.0 111.116 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.425 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 10.0 m-20 -31.56 98.74 0.01 OUTLIER 'General case' 0 C--O 1.207 -1.132 0 C-N-CA 125.487 1.515 . . . . 0.0 111.856 -176.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.467 ' H ' ' CD2' ' A' ' 78' ' ' HIS . 4.4 p80 -85.11 44.41 1.08 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 119.752 -1.842 . . . . 0.0 107.745 -170.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.495 ' HB2' ' CD1' ' A' ' 37' ' ' TRP . 39.3 p90 -69.68 135.02 49.35 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 124.794 1.237 . . . . 0.0 111.011 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.1 mt -71.24 142.84 50.57 Favored 'General case' 0 C--O 1.216 -0.71 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 177.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.436 ' CD2' ' CZ ' ' A' ' 110' ' ' TYR . 0.3 OUTLIER -137.12 137.12 38.92 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 119.128 0.876 . . . . 0.0 108.864 177.059 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -99.78 168.66 9.76 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.649 176.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -157.04 130.02 4.42 Favored Pre-proline 0 C--N 1.327 -0.383 0 O-C-N 120.811 -1.181 . . . . 0.0 113.857 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.402 ' HA ' ' HG2' ' A' ' 107' ' ' ARG . 19.3 Cg_endo -72.6 98.76 0.98 Allowed 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 123.913 3.076 . . . . 0.0 109.713 -175.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 7.2 t -102.49 109.15 20.7 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.075 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -81.34 158.44 69.18 Favored Pre-proline 0 C--N 1.32 -0.696 0 O-C-N 121.607 -0.683 . . . . 0.0 112.112 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -78.12 -34.3 1.71 Allowed 'Trans proline' 0 CA--C 1.495 -1.473 0 C-N-CA 122.053 1.835 . . . . 0.0 112.802 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -43.83 -32.94 1.18 Allowed 'General case' 0 N--CA 1.474 0.77 0 O-C-N 125.537 1.773 . . . . 0.0 110.709 176.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.19 4.45 74.38 Favored Glycine 0 N--CA 1.431 -1.66 0 CA-C-O 118.586 -1.119 . . . . 0.0 111.268 177.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 4.5 p-80 -74.07 129.55 38.08 Favored 'General case' 0 N--CA 1.434 -1.253 0 O-C-N 125.669 1.452 . . . . 0.0 107.644 178.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -61.84 92.04 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 174.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.482 ' CD2' ' HB3' ' A' ' 94' ' ' PHE . 5.8 t80 -38.32 142.89 0.15 Allowed 'General case' 0 C--O 1.21 -0.99 0 CA-C-O 122.083 0.944 . . . . 0.0 110.382 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.46 58.73 1.03 Allowed 'General case' 0 C--N 1.312 -1.064 0 O-C-N 119.11 -2.244 . . . . 0.0 111.061 175.059 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.482 ' HB3' ' CD2' ' A' ' 92' ' ' TYR . 25.7 p90 -75.27 -18.3 60.1 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 123.925 0.89 . . . . 0.0 111.621 176.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -92.05 -22.39 19.97 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-O 122.21 1.005 . . . . 0.0 110.304 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.49 107.59 19.56 Favored 'General case' 0 CA--C 1.513 -0.459 0 O-C-N 120.369 -1.457 . . . . 0.0 109.001 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.23 -49.5 75.82 Favored 'General case' 0 C--N 1.33 -0.261 0 O-C-N 122.181 -0.325 . . . . 0.0 110.375 177.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -136.41 125.33 15.48 Favored Pre-proline 0 N--CA 1.44 -0.938 0 C-N-CA 124.338 1.055 . . . . 0.0 109.695 -175.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -71.94 176.12 39.81 Favored 'Cis proline' 0 C--N 1.349 0.601 0 O-C-N 124.94 2.021 . . . . 0.0 110.941 -2.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -138.07 124.0 20.1 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 124.059 0.943 . . . . 0.0 109.013 179.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.06 159.57 26.12 Favored 'General case' 0 C--N 1.322 -0.618 0 O-C-N 124.509 1.131 . . . . 0.0 111.399 177.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -60.06 138.97 91.11 Favored Pre-proline 0 N--CA 1.451 -0.403 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.32 177.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -72.25 -165.75 0.23 Allowed 'Trans proline' 0 N--CA 1.452 -0.971 0 C-N-CA 122.783 2.322 . . . . 0.0 111.725 176.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -131.58 155.7 21.51 Favored Glycine 0 CA--C 1.527 0.798 0 O-C-N 121.166 -0.959 . . . . 0.0 112.433 176.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -73.07 -17.46 24.81 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 122.389 2.059 . . . . 0.0 111.258 177.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.511 ' CB ' ' CE2' ' A' ' 11' ' ' TYR . . . -110.76 134.92 52.08 Favored 'General case' 0 CA--C 1.507 -0.711 0 C-N-CA 124.177 0.991 . . . . 0.0 110.094 177.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.402 ' HG2' ' HA ' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -138.37 151.04 47.15 Favored 'General case' 0 CA--C 1.5 -0.964 0 CA-C-O 116.489 -1.72 . . . . 0.0 111.41 176.964 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.3 p -82.39 122.24 36.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 124.77 1.228 . . . . 0.0 112.109 175.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 1.7 mp -110.71 120.46 61.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 -174.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.462 ' CD1' ' CG ' ' A' ' 115' ' ' LYS . 6.4 p90 -140.34 150.52 44.07 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 122.93 1.347 . . . . 0.0 109.958 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.6 p -82.32 160.58 22.85 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -178.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.476 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.0 OUTLIER -108.2 155.38 40.29 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 122.873 0.469 . . . . 0.0 110.568 179.203 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.476 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 14.7 Cg_endo -74.16 -51.21 0.16 OUTLIER 'Cis proline' 0 CA--C 1.501 -1.159 0 C-N-CA 123.343 -1.524 . . . . 0.0 109.596 -6.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -47.72 108.09 0.15 Allowed 'General case' 0 CA--C 1.505 -0.785 0 CA-C-O 116.101 -1.904 . . . . 0.0 108.919 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.462 ' CG ' ' CD1' ' A' ' 110' ' ' TYR . 0.1 OUTLIER -62.91 79.75 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.547 0 O-C-N 125.233 1.583 . . . . 0.0 109.014 -177.775 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.4 t -80.16 71.58 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 N-CA-C 103.965 -2.605 . . . . 0.0 103.965 -175.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.538 ' CE1' ' HA2' ' A' ' 119' ' ' GLY . 4.3 t80 -36.1 114.12 0.26 Allowed 'General case' 0 C--O 1.242 0.671 0 C-N-CA 124.049 0.94 . . . . 0.0 108.809 177.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . 0.535 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -97.03 -30.33 13.12 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.973 177.282 . . . . . . . . 3 3 . 1 . 001 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.538 ' HA2' ' CE1' ' A' ' 117' ' ' PHE . . . 144.12 -170.32 25.98 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 123.864 0.745 . . . . 0.0 112.027 -177.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.406 ' CG2' ' SG ' ' A' ' 134' ' ' CYS . 3.2 mp -111.61 142.84 22.77 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.395 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 -177.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 8.4 pt -114.83 155.19 16.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 119.822 1.192 . . . . 0.0 108.087 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.567 0 CA-C-O 122.9 1.333 . . . . 0.0 110.117 178.522 . . . . . . . . 0 0 . 1 . 001 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.502 -0.868 0 CA-C-O 118.313 -0.851 . . . . 0.0 109.256 . . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.415 ' HB2' ' CG2' ' A' ' 55' ' ' ILE . 9.4 tp -83.97 148.07 27.11 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 177.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . 0.406 ' SG ' ' CG2' ' A' ' 120' ' ' ILE . 90.8 m -58.59 -174.32 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.186 1.394 . . . . 0.0 110.608 175.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 61.3 m -131.22 93.28 3.34 Favored 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -177.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 0.62 ' CD2' ' CZ2' ' A' ' 4' ' ' TRP . 5.8 p-80 . . . . . 0 C--O 1.25 1.111 0 CA-C-O 114.957 -2.449 . . . . 0.0 113.427 173.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.452 ' CG1' ' CD2' ' A' ' 136' ' ' HIS . 14.4 p . . . . . 0 N--CA 1.449 -0.505 0 CA-C-O 121.666 0.745 . . . . 0.0 110.891 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.4 m -88.93 114.56 25.69 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 124.002 0.921 . . . . 0.0 109.47 -177.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . 0.454 ' CD1' ' HB2' ' A' ' 13' ' ' GLN . 31.8 m95 -79.33 150.18 31.52 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-O 118.88 -0.581 . . . . 0.0 110.421 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.5 m -144.52 131.62 20.51 Favored 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 -176.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -126.93 -80.4 0.6 Allowed 'General case' 0 C--O 1.217 -0.658 0 CA-C-O 117.708 -1.139 . . . . 0.0 110.742 176.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -56.89 -88.17 0.02 OUTLIER Glycine 0 C--N 1.344 1.018 0 O-C-N 124.395 1.059 . . . . 0.0 111.294 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -154.17 18.22 0.62 Allowed Glycine 0 C--O 1.223 -0.585 0 O-C-N 121.749 -0.853 . . . . 0.0 111.383 178.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 49.8 mt -129.98 158.79 38.6 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 123.511 0.724 . . . . 0.0 109.735 178.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.5 mp -96.6 134.42 39.86 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.228 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.471 ' CE2' ' CB ' ' A' ' 106' ' ' ALA . 76.2 m-85 -117.64 104.07 10.66 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 126.481 1.912 . . . . 0.0 108.267 -173.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -55.69 119.6 5.97 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.473 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 5.5 tp-100 -53.25 -41.42 65.44 Favored 'General case' 0 C--O 1.203 -1.344 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.91 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -49.78 -42.44 46.68 Favored 'General case' 0 C--O 1.197 -1.702 0 CA-C-O 119.544 -0.265 . . . . 0.0 111.377 175.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.3 mttp -70.86 -37.19 73.09 Favored 'General case' 0 C--O 1.202 -1.44 0 O-C-N 120.923 -1.111 . . . . 0.0 113.451 169.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.4 -38.44 66.22 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 122.353 2.342 . . . . 0.0 113.641 172.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -90.39 -39.63 12.55 Favored 'General case' 0 C--O 1.212 -0.877 0 CA-C-O 117.976 -1.012 . . . . 0.0 108.548 177.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 39.8 t -73.63 -59.79 2.55 Favored 'General case' 0 C--O 1.214 -0.806 0 C-N-CA 126.212 1.805 . . . . 0.0 109.911 -176.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.467 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 6.4 t-20 -41.0 -36.86 0.72 Allowed 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 119.72 1.145 . . . . 0.0 113.285 170.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -81.53 -36.79 28.75 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 115.035 1.495 . . . . 0.0 115.035 173.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 5.2 m170 -44.83 -38.68 4.72 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.382 1.873 . . . . 0.0 109.896 178.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.467 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -73.72 -47.01 42.52 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-O 117.88 -1.057 . . . . 0.0 112.732 175.064 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.405 ' HB1' ' CE1' ' A' ' 83' ' ' PHE . . . -35.74 127.59 0.61 Allowed Pre-proline 0 N--CA 1.439 -0.982 0 O-C-N 125.312 1.632 . . . . 0.0 112.885 173.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -73.63 125.87 10.39 Favored 'Trans proline' 0 N--CA 1.445 -1.369 0 C-N-CA 122.054 1.836 . . . . 0.0 108.576 -175.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.413 ' CD1' ' HE2' ' A' ' 115' ' ' LYS . 4.3 tp -60.6 93.92 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.472 0.709 . . . . 0.0 111.239 178.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 179.2 162.46 0.82 Allowed 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 123.102 0.561 . . . . 0.0 109.966 -176.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.2 118.44 34.85 Favored 'General case' 0 C--O 1.218 -0.595 0 C-N-CA 123.996 0.918 . . . . 0.0 110.344 177.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 46.71 64.72 2.51 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 120.048 -1.073 . . . . 0.0 112.7 177.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.9 ttpt -129.44 11.69 5.86 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 124.367 2.032 . . . . 0.0 111.079 178.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 25.9 p -112.71 150.53 31.4 Favored 'General case' 0 C--N 1.309 -1.165 0 O-C-N 119.27 -2.144 . . . . 0.0 107.233 -174.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -39.94 -51.13 3.4 Favored Glycine 0 C--N 1.335 0.474 0 O-C-N 124.404 1.065 . . . . 0.0 112.495 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.7 t -69.23 -78.09 0.07 Allowed 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 118.988 -0.53 . . . . 0.0 111.224 173.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.4 p -179.0 -63.75 0.01 OUTLIER 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 123.491 0.717 . . . . 0.0 110.202 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.588 ' CE2' ' CE1' ' A' ' 36' ' ' HIS . 65.6 m-85 -58.67 147.13 71.98 Favored Pre-proline 0 N--CA 1.426 -1.662 0 C-N-CA 124.708 1.203 . . . . 0.0 112.962 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -74.77 151.37 96.86 Favored 'Cis proline' 0 N--CA 1.45 -1.081 0 C-N-CA 123.088 -1.63 . . . . 0.0 110.734 -0.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.588 ' CE1' ' CE2' ' A' ' 34' ' ' TYR . 0.5 OUTLIER -129.39 166.38 19.66 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-O 117.474 -1.25 . . . . 0.0 110.347 -179.554 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.565 ' CH2' ' HA2' ' A' ' 44' ' ' GLY . 16.7 t90 -64.02 144.41 57.11 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 124.329 1.018 . . . . 0.0 108.586 178.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.554 ' CE1' ' CD1' ' A' ' 121' ' ' ILE . 16.3 t80 -117.4 82.51 1.83 Allowed 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 -174.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.435 ' CG2' ' CH2' ' A' ' 37' ' ' TRP . 73.1 p -40.38 -33.08 0.22 Allowed 'General case' 0 C--O 1.211 -0.948 0 C-N-CA 124.537 1.135 . . . . 0.0 110.459 174.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.446 ' HB2' ' CE2' ' A' ' 38' ' ' PHE . 46.3 t30 60.18 16.33 5.97 Favored 'General case' 0 C--O 1.214 -0.784 0 CA-C-O 122.877 1.323 . . . . 0.0 109.374 177.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 112.89 -38.39 3.25 Favored Glycine 0 N--CA 1.427 -1.905 0 O-C-N 119.469 -2.019 . . . . 0.0 113.367 -172.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.441 ' CD2' ' HA2' ' A' ' 46' ' ' GLY . 66.0 m-85 -50.64 170.53 0.03 OUTLIER 'General case' 0 C--O 1.231 0.081 0 CA-C-N 118.664 1.232 . . . . 0.0 111.695 178.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.44 -40.53 9.86 Favored 'General case' 0 C--N 1.32 -0.693 0 O-C-N 121.598 -0.689 . . . . 0.0 110.002 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.565 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -177.09 -53.31 0.06 OUTLIER Glycine 0 C--N 1.336 0.547 0 C-N-CA 123.855 0.74 . . . . 0.0 111.9 -178.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.76 -96.29 0.07 Allowed 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 -179.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.441 ' HA2' ' CD2' ' A' ' 42' ' ' TYR . . . -141.6 12.7 2.7 Favored Glycine 0 N--CA 1.438 -1.226 0 C-N-CA 125.306 1.432 . . . . 0.0 111.065 -176.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.2 pttt -112.06 146.41 38.0 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 117.991 -1.004 . . . . 0.0 108.804 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.06 159.01 34.23 Favored Pre-proline 0 C--N 1.323 -0.555 0 O-C-N 124.624 1.203 . . . . 0.0 108.676 -178.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -74.48 157.37 44.99 Favored 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 121.857 1.704 . . . . 0.0 109.925 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.2 ttpt -54.89 101.12 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.99 0.516 . . . . 0.0 109.859 177.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.77 88.4 1.77 Allowed Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 116.495 -0.321 . . . . 0.0 112.535 -176.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -169.97 161.28 8.74 Favored 'General case' 0 CA--C 1.513 -0.475 0 C-N-CA 123.415 0.686 . . . . 0.0 110.506 175.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.0 m -147.69 113.57 4.01 Favored Pre-proline 0 N--CA 1.447 -0.616 0 O-C-N 124.485 1.115 . . . . 0.0 110.412 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -72.28 166.92 28.32 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 122.621 2.214 . . . . 0.0 111.344 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.401 ' O ' ' CE1' ' A' ' 57' ' ' PHE . 6.0 mt -81.6 129.87 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 -178.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.71 136.93 35.49 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 177.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.488 ' CD1' ' SG ' ' A' ' 62' ' ' CYS . 3.0 m-85 -125.93 -53.87 1.52 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 -177.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 120.37 -5.51 11.98 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 123.852 0.739 . . . . 0.0 112.602 -176.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . 0.409 ' CB ' ' HB3' ' A' ' 62' ' ' CYS . 0.2 OUTLIER -65.75 177.5 1.25 Allowed 'General case' 0 C--O 1.207 -1.165 0 CA-C-N 118.251 1.026 . . . . 0.0 111.355 176.157 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.48 -45.13 4.73 Favored 'General case' 0 C--O 1.212 -0.885 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.55 -40.17 23.53 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.488 ' SG ' ' CD1' ' A' ' 57' ' ' PHE . 0.9 OUTLIER -71.43 -20.14 62.15 Favored 'General case' 0 C--N 1.342 0.253 0 O-C-N 123.871 0.732 . . . . 0.0 110.824 177.826 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -85.79 -42.24 14.36 Favored 'General case' 0 CA--C 1.509 -0.599 0 O-C-N 124.225 0.953 . . . . 0.0 112.196 174.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.75 165.38 0.46 Allowed Pre-proline 0 N--CA 1.44 -0.951 0 CA-C-O 121.437 0.637 . . . . 0.0 111.542 -179.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -71.82 139.16 32.95 Favored 'Trans proline' 0 N--CA 1.437 -1.8 0 N-CA-C 114.807 1.041 . . . . 0.0 114.807 173.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -70.51 174.28 10.39 Favored 'Trans proline' 0 N--CA 1.446 -1.286 0 C-N-CA 122.846 2.364 . . . . 0.0 111.09 178.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.4 mmtp -140.03 58.86 1.58 Allowed 'General case' 0 C--O 1.199 -1.569 0 CA-C-O 116.597 -1.668 . . . . 0.0 109.28 177.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.407 ' CE1' ' O ' ' A' ' 69' ' ' SER . 58.4 t-80 -75.4 164.02 26.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 119.534 1.061 . . . . 0.0 110.594 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.407 ' O ' ' CE1' ' A' ' 68' ' ' HIS . 0.3 OUTLIER -149.38 -168.66 3.17 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 123.574 0.75 . . . . 0.0 111.402 177.997 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.14 71.22 10.6 Favored 'General case' 0 C--O 1.216 -0.706 0 O-C-N 120.268 -1.52 . . . . 0.0 111.745 176.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -177.18 -42.4 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.418 ' O ' ' CE2' ' A' ' 79' ' ' TYR . . . 124.51 -46.69 1.07 Allowed Glycine 0 CA--C 1.487 -1.703 0 CA-C-O 117.757 -1.58 . . . . 0.0 112.469 -176.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -150.11 81.89 1.37 Allowed 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 177.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -61.42 -122.59 0.01 OUTLIER Glycine 0 C--O 1.219 -0.812 0 CA-C-O 121.197 0.332 . . . . 0.0 112.476 177.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.2 mttt -52.45 -89.34 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 O-C-N 120.411 -1.641 . . . . 0.0 112.086 178.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -119.62 17.01 12.85 Favored 'General case' 0 CA--C 1.508 -0.659 0 O-C-N 120.929 -1.107 . . . . 0.0 111.017 178.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.464 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 5.0 m-20 -27.05 105.08 0.02 OUTLIER 'General case' 0 C--O 1.203 -1.36 0 C-N-CA 125.44 1.496 . . . . 0.0 110.692 -177.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.503 ' H ' ' CD2' ' A' ' 78' ' ' HIS . 2.5 p80 -87.21 11.2 14.7 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 121.146 -0.971 . . . . 0.0 110.255 -176.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.493 ' CZ ' ' CD1' ' A' ' 81' ' ' LEU . 0.5 OUTLIER -33.96 132.95 0.22 Allowed 'General case' 0 N--CA 1.435 -1.206 0 C-N-CA 125.353 1.461 . . . . 0.0 113.205 172.37 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.19 151.98 38.44 Favored 'General case' 0 C--O 1.218 -0.587 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.493 ' CD1' ' CZ ' ' A' ' 79' ' ' TYR . 1.4 mp -135.87 139.94 43.75 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-N 119.081 0.855 . . . . 0.0 109.155 176.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -106.32 151.73 24.47 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-O 121.897 0.856 . . . . 0.0 110.793 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.405 ' CE1' ' HB1' ' A' ' 23' ' ' ALA . 55.4 t80 -140.1 130.61 14.0 Favored Pre-proline 0 N--CA 1.449 -0.506 0 O-C-N 121.727 -0.608 . . . . 0.0 111.979 -179.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.441 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 18.6 Cg_endo -72.34 108.88 2.61 Favored 'Trans proline' 0 N--CA 1.446 -1.272 0 C-N-CA 123.674 2.916 . . . . 0.0 110.632 -178.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.93 109.27 21.16 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.74 0.816 . . . . 0.0 109.752 -179.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -81.1 160.7 65.13 Favored Pre-proline 0 N--CA 1.446 -0.662 0 O-C-N 121.598 -0.689 . . . . 0.0 112.433 178.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -77.21 -41.66 0.34 Allowed 'Trans proline' 0 CA--C 1.494 -1.507 0 C-N-CA 122.395 2.063 . . . . 0.0 112.256 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -45.57 -30.61 1.53 Allowed 'General case' 0 C--N 1.35 0.622 0 O-C-N 125.275 1.609 . . . . 0.0 110.282 177.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.34 -4.9 85.87 Favored Glycine 0 N--CA 1.432 -1.573 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 176.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 4.3 p-80 -60.55 129.64 42.6 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -64.19 89.72 0.06 Allowed 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 177.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.483 ' CD2' ' HB3' ' A' ' 94' ' ' PHE . 6.2 t80 -36.41 142.91 0.08 Allowed 'General case' 0 C--O 1.211 -0.959 0 C-N-CA 124.041 0.937 . . . . 0.0 110.507 -178.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.06 58.07 1.47 Allowed 'General case' 0 C--N 1.313 -0.996 0 O-C-N 119.766 -1.834 . . . . 0.0 110.738 175.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.483 ' HB3' ' CD2' ' A' ' 92' ' ' TYR . 28.8 p90 -74.03 -14.88 61.08 Favored 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 123.524 0.73 . . . . 0.0 111.954 176.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.86 -33.63 17.28 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 124.584 1.154 . . . . 0.0 110.794 178.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 32.2 m -85.96 109.89 19.08 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -178.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.5 ptpt -58.17 -49.68 76.16 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 178.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -140.7 126.81 11.6 Favored Pre-proline 0 N--CA 1.43 -1.459 0 C-N-CA 124.416 1.086 . . . . 0.0 110.329 -175.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -71.95 175.98 40.44 Favored 'Cis proline' 0 C--N 1.35 0.606 0 O-C-N 124.909 2.005 . . . . 0.0 110.999 -2.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.2 tttp -141.09 130.23 23.42 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.773 0.829 . . . . 0.0 109.469 178.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -82.92 148.77 27.46 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.135 0.897 . . . . 0.0 110.372 176.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -43.86 137.94 3.31 Favored Pre-proline 0 N--CA 1.437 -1.116 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.021 173.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -73.18 -166.46 0.3 Allowed 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 122.449 2.1 . . . . 0.0 110.541 178.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -131.45 160.03 23.32 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-O 119.295 -0.725 . . . . 0.0 112.381 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -76.25 -65.84 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.778 2.319 . . . . 0.0 110.551 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.471 ' CB ' ' CE2' ' A' ' 11' ' ' TYR . . . -59.86 137.18 58.13 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 123.702 0.626 . . . . 0.0 110.996 177.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 5.1 mtm-85 -141.43 149.4 40.96 Favored 'General case' 0 CA--C 1.505 -0.767 0 O-C-N 124.211 0.944 . . . . 0.0 110.717 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.7 p -88.46 117.01 31.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.135 0.897 . . . . 0.0 111.862 178.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 1.2 mp -104.3 125.01 59.13 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.984 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 -171.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.435 ' CD1' ' C ' ' A' ' 110' ' ' TYR . 14.5 p90 -146.17 160.56 41.79 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.05 -178.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.0 p -93.86 166.0 12.4 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.867 -177.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.523 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -112.96 153.44 45.25 Favored Pre-proline 0 N--CA 1.44 -0.951 0 C-N-CA 122.478 0.311 . . . . 0.0 110.706 179.962 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.523 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 16.5 Cg_endo -74.46 -51.59 0.16 OUTLIER 'Cis proline' 0 CA--C 1.499 -1.253 0 C-N-CA 123.487 -1.464 . . . . 0.0 109.71 -5.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -45.44 111.99 0.4 Allowed 'General case' 0 CA--C 1.502 -0.901 0 CA-C-O 115.861 -2.019 . . . . 0.0 109.132 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.432 ' HG3' ' CD1' ' A' ' 110' ' ' TYR . 0.3 OUTLIER -64.87 74.81 0.04 OUTLIER 'General case' 0 CA--C 1.51 -0.593 0 O-C-N 125.787 1.929 . . . . 0.0 108.476 -178.383 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 9.5 t -73.45 72.16 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 105.696 -1.964 . . . . 0.0 105.696 -177.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.473 ' CZ ' ' NE2' ' A' ' 13' ' ' GLN . 17.2 t80 -46.93 107.98 0.13 Allowed 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 124.67 1.188 . . . . 0.0 108.881 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . 0.419 ' SG ' ' CG ' ' A' ' 57' ' ' PHE . 0.1 OUTLIER -83.75 -56.41 3.72 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 -179.853 . . . . . . . . 3 3 . 1 . 002 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -178.8 -145.09 5.97 Favored Glycine 0 N--CA 1.436 -1.357 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 1.2 mm -127.59 145.49 34.87 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.202 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 -175.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.554 ' CD1' ' CE1' ' A' ' 38' ' ' PHE . 3.1 pt -131.12 156.86 43.08 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.903 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.473 0 CA-C-O 121.781 0.8 . . . . 0.0 109.611 177.143 . . . . . . . . 0 0 . 1 . 002 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.514 -0.44 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 . . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.415 HD13 ' CE2' ' A' ' 57' ' ' PHE . 12.3 tp -82.94 136.0 34.71 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 83.7 m -63.43 -175.68 0.13 Allowed 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 124.082 0.953 . . . . 0.0 109.599 175.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 59.3 m -161.55 119.29 2.28 Favored 'General case' 0 CA--C 1.488 -1.427 0 N-CA-C 104.319 -2.474 . . . . 0.0 104.319 -177.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 0.452 ' CD2' ' CG1' ' A' ' 2' ' ' VAL . 3.2 m80 . . . . . 0 CA--C 1.558 1.254 0 CA-C-O 114.733 -2.556 . . . . 0.0 115.822 177.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.1 p . . . . . 0 N--CA 1.465 0.278 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 23.9 m -89.13 115.41 26.64 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 123.767 0.827 . . . . 0.0 109.625 -178.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . 0.409 ' CG ' HG13 ' A' ' 120' ' ' ILE . 23.7 m95 -77.71 142.06 38.98 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -133.86 138.76 45.8 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -178.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -129.59 49.98 2.21 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.868 0.842 . . . . 0.0 111.099 176.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 143.06 -99.45 0.23 Allowed Glycine 0 C--O 1.22 -0.778 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -129.32 5.38 6.32 Favored Glycine 0 N--CA 1.466 0.679 0 C-N-CA 123.676 0.655 . . . . 0.0 112.704 177.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.72 138.79 49.02 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 -175.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.5 mp -95.62 160.83 14.31 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 123.981 0.801 . . . . 0.0 109.468 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.505 ' CE2' ' CB ' ' A' ' 106' ' ' ALA . 65.9 m-85 -152.37 94.87 1.97 Allowed 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 122.182 0.992 . . . . 0.0 109.564 -173.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.27 120.63 7.91 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-O 117.427 -1.273 . . . . 0.0 108.038 -178.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.402 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 6.7 tp-100 -50.05 -43.24 50.96 Favored 'General case' 0 C--O 1.205 -1.266 0 O-C-N 124.655 1.222 . . . . 0.0 112.032 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -47.98 -48.84 32.16 Favored 'General case' 0 C--O 1.193 -1.897 0 CA-C-O 118.97 -0.538 . . . . 0.0 112.257 174.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.31 -38.13 84.45 Favored 'General case' 0 C--O 1.206 -1.214 0 CA-C-N 119.99 1.268 . . . . 0.0 114.2 168.019 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -49.96 -43.88 50.35 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 121.599 1.999 . . . . 0.0 114.455 170.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -88.59 -39.89 13.76 Favored 'General case' 0 C--O 1.206 -1.218 0 O-C-N 120.916 -1.115 . . . . 0.0 109.668 176.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 36.5 t -73.38 -60.2 2.36 Favored 'General case' 0 C--O 1.211 -0.942 0 C-N-CA 126.571 1.948 . . . . 0.0 109.896 -176.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.461 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 4.6 t-20 -40.26 -38.5 0.79 Allowed 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 120.268 1.394 . . . . 0.0 113.357 169.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.411 ' CB ' HG11 ' A' ' 108' ' ' VAL . 0.1 OUTLIER -81.81 -30.77 32.07 Favored 'General case' 0 C--O 1.217 -0.656 0 N-CA-C 116.11 1.892 . . . . 0.0 116.11 173.108 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 3.6 m170 -50.08 -35.35 25.03 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 125.733 1.613 . . . . 0.0 109.298 177.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.461 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.1 OUTLIER -73.9 -42.8 60.13 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 117.822 -1.085 . . . . 0.0 111.926 176.792 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.417 ' HB2' ' CE1' ' A' ' 83' ' ' PHE . . . -36.24 129.72 0.65 Allowed Pre-proline 0 N--CA 1.44 -0.974 0 O-C-N 125.233 1.583 . . . . 0.0 113.069 172.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -72.89 123.98 9.32 Favored 'Trans proline' 0 N--CA 1.444 -1.418 0 C-N-CA 122.053 1.835 . . . . 0.0 108.802 -176.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.417 ' CD2' ' HE2' ' A' ' 115' ' ' LYS . 2.1 tp -62.03 91.11 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.262 1.025 . . . . 0.0 110.668 178.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 179.78 157.8 0.67 Allowed 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 123.435 0.694 . . . . 0.0 109.427 -175.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.96 89.45 4.29 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 104.621 -2.362 . . . . 0.0 104.621 -164.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 63.2 75.48 0.34 Allowed Glycine 0 CA--C 1.529 0.943 0 C-N-CA 119.489 -1.338 . . . . 0.0 111.957 -176.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.8 ttpt -138.19 28.79 2.52 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 123.661 1.696 . . . . 0.0 111.825 176.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.7 p -118.39 146.76 44.17 Favored 'General case' 0 CA--C 1.492 -1.271 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 -172.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -42.43 -53.94 4.89 Favored Glycine 0 N--CA 1.452 -0.242 0 O-C-N 123.827 0.705 . . . . 0.0 111.561 -179.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.2 t -64.15 -62.43 1.62 Allowed 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 116.533 -1.698 . . . . 0.0 112.378 174.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 162.1 -59.11 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.475 0 C-N-CA 127.91 2.484 . . . . 0.0 111.396 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.577 ' CE1' ' CE1' ' A' ' 36' ' ' HIS . 70.8 m-85 -59.77 141.14 89.33 Favored Pre-proline 0 N--CA 1.446 -0.674 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 178.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -77.4 167.23 79.88 Favored 'Cis proline' 0 N--CA 1.436 -1.902 0 C-N-CA 121.833 -2.153 . . . . 0.0 112.721 3.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.577 ' CE1' ' CE1' ' A' ' 34' ' ' TYR . 2.5 p-80 -137.61 174.4 10.63 Favored 'General case' 0 C--O 1.205 -1.241 0 O-C-N 120.629 -1.294 . . . . 0.0 111.86 178.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.567 ' CH2' ' HA2' ' A' ' 44' ' ' GLY . 14.1 t90 -75.84 132.14 40.17 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 119.864 1.211 . . . . 0.0 110.726 173.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.438 ' CZ ' HD11 ' A' ' 121' ' ' ILE . 4.5 t80 -97.52 89.56 4.72 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 105.148 -2.167 . . . . 0.0 105.148 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.433 ' CG2' ' CH2' ' A' ' 37' ' ' TRP . 17.1 p -38.81 -36.01 0.24 Allowed 'General case' 0 C--O 1.203 -1.38 0 CA-C-O 117.733 -1.127 . . . . 0.0 110.286 169.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 50.4 t30 55.95 22.25 5.61 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 121.189 1.813 . . . . 0.0 109.973 176.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 101.37 -39.76 2.64 Favored Glycine 0 N--CA 1.425 -2.052 0 CA-C-O 116.726 -2.152 . . . . 0.0 116.587 -168.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.448 ' CE2' ' HD3' ' A' ' 66' ' ' PRO . 80.5 m-85 -46.58 152.65 0.44 Allowed 'General case' 0 C--O 1.233 0.202 0 C-N-CA 126.456 1.902 . . . . 0.0 110.695 177.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.82 -38.35 25.65 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.728 178.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.567 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -172.29 -59.07 0.04 OUTLIER Glycine 0 C--N 1.335 0.489 0 C-N-CA 124.689 1.138 . . . . 0.0 111.011 -178.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -125.16 -64.77 1.06 Allowed 'General case' 0 CA--C 1.507 -0.69 0 O-C-N 122.641 -0.329 . . . . 0.0 110.514 -176.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.99 -175.81 0.22 Allowed Glycine 0 C--N 1.342 0.872 0 C-N-CA 124.761 1.172 . . . . 0.0 110.988 178.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.54 -165.72 0.0 OUTLIER 'General case' 0 CA--C 1.551 0.987 0 CA-C-O 124.61 2.148 . . . . 0.0 112.623 175.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -96.35 169.02 9.54 Favored Pre-proline 0 C--N 1.306 -1.286 0 O-C-N 119.829 -1.794 . . . . 0.0 110.889 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -71.87 157.67 54.48 Favored 'Trans proline' 0 N--CA 1.441 -1.582 0 C-N-CA 121.888 1.725 . . . . 0.0 110.69 178.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.0 tttt -63.76 97.88 0.17 Allowed 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.713 -0.617 . . . . 0.0 110.205 176.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 123.62 40.0 0.48 Allowed Glycine 0 CA--C 1.52 0.351 0 N-CA-C 112.015 -0.434 . . . . 0.0 112.015 -176.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.96 161.35 34.54 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-N 117.325 0.562 . . . . 0.0 111.495 176.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.9 m -140.48 102.85 6.55 Favored Pre-proline 0 C--N 1.324 -0.527 0 O-C-N 124.045 0.841 . . . . 0.0 109.61 -178.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -72.08 175.78 9.37 Favored 'Trans proline' 0 N--CA 1.448 -1.183 0 C-N-CA 122.504 2.136 . . . . 0.0 111.418 178.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.8 mt -98.35 130.52 47.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 -178.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.34 135.37 33.72 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 177.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.447 ' CD1' ' HB3' ' A' ' 118' ' ' CYS . 17.3 m-85 -118.83 -45.37 2.59 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 124.078 0.951 . . . . 0.0 110.142 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 121.03 -2.31 11.68 Favored Glycine 0 C--O 1.222 -0.642 0 C-N-CA 123.885 0.755 . . . . 0.0 112.59 -175.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 18.0 mttm -105.33 137.82 42.51 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 118.222 1.011 . . . . 0.0 109.373 177.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.2 t -73.26 -4.64 34.41 Favored 'General case' 0 C--O 1.217 -0.642 0 O-C-N 125.182 1.551 . . . . 0.0 111.504 176.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -89.0 -50.59 6.08 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 124.654 1.182 . . . . 0.0 109.745 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 10.1 m -71.52 -22.55 61.76 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.46 0.648 . . . . 0.0 111.564 175.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -79.75 -35.87 38.14 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-O 118.892 -0.575 . . . . 0.0 111.143 174.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -52.35 160.79 1.19 Allowed Pre-proline 0 CA--C 1.539 0.542 0 CA-C-O 122.084 0.945 . . . . 0.0 111.67 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -71.94 144.14 42.39 Favored 'Trans proline' 0 N--CA 1.443 -1.492 0 C-N-CA 120.461 0.774 . . . . 0.0 113.573 175.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.448 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 19.8 Cg_endo -72.74 169.12 22.75 Favored 'Trans proline' 0 N--CA 1.444 -1.433 0 C-N-CA 124.151 3.234 . . . . 0.0 111.056 178.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.4 tptp -128.47 51.92 1.96 Allowed 'General case' 0 C--O 1.197 -1.675 0 CA-C-O 114.987 -2.435 . . . . 0.0 107.216 -179.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.42 ' CD2' ' O ' ' A' ' 72' ' ' GLY . 57.1 t-80 -74.79 144.56 43.49 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 121.212 1.824 . . . . 0.0 113.897 175.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.06 -91.17 0.5 Allowed 'General case' 0 N--CA 1.469 0.496 0 O-C-N 119.207 -2.183 . . . . 0.0 109.607 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.95 -174.94 0.38 Allowed 'General case' 0 C--O 1.215 -0.733 0 C-N-CA 123.713 0.805 . . . . 0.0 111.123 178.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -50.31 -27.02 5.47 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 173.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.42 ' O ' ' CD2' ' A' ' 68' ' ' HIS . . . -104.22 -118.54 4.49 Favored Glycine 0 C--O 1.214 -1.139 0 N-CA-C 106.583 -2.607 . . . . 0.0 106.583 178.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -121.75 -100.0 0.43 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 100.413 -3.921 . . . . 0.0 100.413 -167.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 144.75 -131.99 4.55 Favored Glycine 0 N--CA 1.439 -1.134 0 CA-C-N 115.232 -0.894 . . . . 0.0 113.32 -167.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.2 mttm -63.01 -104.41 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 122.049 0.928 . . . . 0.0 112.673 175.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -101.39 21.2 14.54 Favored 'General case' 0 CA--C 1.514 -0.423 0 O-C-N 120.785 -1.197 . . . . 0.0 111.588 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.455 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 1.1 m-20 -33.25 105.06 0.03 OUTLIER 'General case' 0 CA--C 1.49 -1.343 0 C-N-CA 126.181 1.792 . . . . 0.0 109.924 -176.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -83.8 16.44 2.76 Favored 'General case' 0 C--N 1.319 -0.74 0 O-C-N 120.683 -1.261 . . . . 0.0 110.5 -176.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.439 ' CE2' ' HB2' ' A' ' 81' ' ' LEU . 10.8 p90 -41.27 136.28 1.7 Allowed 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 125.607 1.563 . . . . 0.0 110.963 177.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.02 136.27 38.69 Favored 'General case' 0 C--O 1.215 -0.728 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.464 ' CD2' ' CZ ' ' A' ' 110' ' ' TYR . 0.5 OUTLIER -128.84 151.91 49.09 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.85 0.834 . . . . 0.0 109.1 175.442 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -121.81 163.33 19.34 Favored 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 124.242 1.017 . . . . 0.0 112.193 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.417 ' CE1' ' HB2' ' A' ' 23' ' ' ALA . 80.1 t80 -148.21 129.04 6.97 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -177.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.488 ' HD3' ' CD1' ' A' ' 34' ' ' TYR . 17.8 Cg_endo -72.0 109.61 2.73 Favored 'Trans proline' 0 N--CA 1.443 -1.477 0 C-N-CA 123.381 2.721 . . . . 0.0 110.887 -176.176 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.25 107.31 18.18 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-N 114.662 -1.154 . . . . 0.0 109.65 -178.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -80.01 160.17 69.23 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 177.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -76.4 -38.66 0.98 Allowed 'Trans proline' 0 CA--C 1.493 -1.564 0 C-N-CA 122.092 1.861 . . . . 0.0 112.896 178.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -44.67 -30.43 0.93 Allowed 'General case' 0 N--CA 1.474 0.766 0 O-C-N 125.644 1.84 . . . . 0.0 110.92 176.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.74 6.61 86.94 Favored Glycine 0 N--CA 1.437 -1.281 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 176.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -72.74 136.08 45.44 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -68.18 85.31 0.25 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 175.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.47 ' CD2' ' HB3' ' A' ' 94' ' ' PHE . 6.7 t80 -37.29 144.25 0.08 Allowed 'General case' 0 C--O 1.214 -0.769 0 C-N-CA 123.95 0.9 . . . . 0.0 110.659 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.3 55.91 0.8 Allowed 'General case' 0 C--N 1.313 -0.986 0 O-C-N 119.781 -1.825 . . . . 0.0 110.936 174.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.47 ' HB3' ' CD2' ' A' ' 92' ' ' TYR . 34.1 p90 -71.35 -24.17 62.04 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 124.099 0.959 . . . . 0.0 111.025 175.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -86.11 -27.66 24.52 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 123.973 0.909 . . . . 0.0 110.401 178.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -88.9 111.57 22.25 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -178.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.3 pttt -58.04 -49.75 75.81 Favored 'General case' 0 CA--C 1.511 -0.522 0 O-C-N 121.648 -0.658 . . . . 0.0 111.003 177.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.3 mtmm -138.07 126.08 14.03 Favored Pre-proline 0 N--CA 1.436 -1.155 0 CA-C-N 114.364 -1.289 . . . . 0.0 109.946 -175.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -69.55 176.65 31.16 Favored 'Cis proline' 0 N--CA 1.459 -0.558 0 O-C-N 124.35 1.71 . . . . 0.0 110.949 -3.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.99 123.16 16.84 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 124.845 1.258 . . . . 0.0 109.484 177.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.49 -179.37 7.14 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 125.309 1.63 . . . . 0.0 110.378 178.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -46.64 153.14 0.81 Allowed Pre-proline 0 CA--C 1.541 0.622 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.937 176.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.49 -70.62 0.02 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.576 0 C-N-CA 121.998 1.799 . . . . 0.0 110.626 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 125.14 129.42 3.36 Favored Glycine 0 CA--C 1.533 1.178 0 CA-C-N 118.885 0.766 . . . . 0.0 111.214 -178.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.93 -69.56 0.02 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 122.924 2.416 . . . . 0.0 110.477 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.505 ' CB ' ' CE2' ' A' ' 11' ' ' TYR . . . -66.94 132.87 48.85 Favored 'General case' 0 CA--C 1.512 -0.491 0 O-C-N 123.18 0.3 . . . . 0.0 110.732 179.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.42 ' HG2' ' HA ' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -139.76 152.15 46.38 Favored 'General case' 0 CA--C 1.497 -1.082 0 CA-C-O 117.719 -1.134 . . . . 0.0 110.737 -178.237 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.411 HG11 ' CB ' ' A' ' 20' ' ' SER . 3.3 p -87.32 114.17 25.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 O-C-N 124.153 0.908 . . . . 0.0 111.673 178.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 1.4 mp -98.7 118.07 44.69 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.236 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 -173.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.485 ' CD1' ' CG ' ' A' ' 115' ' ' LYS . 4.6 p90 -139.03 148.0 42.82 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-O 123.918 1.818 . . . . 0.0 108.616 -178.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.8 p -83.27 164.87 19.82 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.142 178.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.504 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -107.46 154.81 40.47 Favored Pre-proline 0 CA--C 1.55 0.959 0 CA-C-O 121.014 0.435 . . . . 0.0 111.072 178.495 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.504 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 15.9 Cg_endo -74.96 -53.29 0.16 OUTLIER 'Cis proline' 0 CA--C 1.498 -1.297 0 C-N-CA 124.158 -1.184 . . . . 0.0 110.071 -6.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -45.82 111.39 0.35 Allowed 'General case' 0 CA--C 1.509 -0.605 0 CA-C-O 117.174 -1.393 . . . . 0.0 108.783 177.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.485 ' CG ' ' CD1' ' A' ' 110' ' ' TYR . 0.1 OUTLIER -65.79 79.52 0.07 Allowed 'General case' 0 CA--C 1.507 -0.691 0 C-N-CA 125.008 1.323 . . . . 0.0 109.102 -179.905 . . . . . . . . 3 3 . 1 . 003 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 80.9 t -76.54 75.72 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.763 0 N-CA-C 105.558 -2.015 . . . . 0.0 105.558 -173.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.402 ' CZ ' ' NE2' ' A' ' 13' ' ' GLN . 57.3 t80 -37.68 101.92 0.02 OUTLIER 'General case' 0 C--O 1.237 0.397 0 C-N-CA 127.723 2.409 . . . . 0.0 108.822 -175.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . 0.447 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 16.0 m -85.4 -43.16 13.88 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 -176.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 156.79 -146.94 14.65 Favored Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.409 HG13 ' CG ' ' A' ' 4' ' ' TRP . 1.4 mm -129.5 139.24 52.22 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.403 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 -174.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.438 HD11 ' CZ ' ' A' ' 38' ' ' PHE . 4.3 pt -127.33 153.1 36.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 -177.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.569 0 CA-C-O 122.007 0.908 . . . . 0.0 109.711 175.665 . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 5.8 ptmt . . . . . 0 CA--C 1.506 -0.72 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 . . . . . . . . . 0 0 . 1 . 003 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 11.9 tp -81.99 138.85 34.84 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.557 1.161 . . . . 0.0 108.199 178.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 72.3 m -61.19 -176.57 0.07 Allowed 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 122.997 1.379 . . . . 0.0 111.133 174.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -158.69 112.88 2.46 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -178.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.255 1.354 0 CA-C-O 113.429 -3.177 . . . . 0.0 110.944 173.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 6.9 p . . . . . 0 CA--C 1.539 0.527 0 CA-C-O 122.556 1.169 . . . . 0.0 111.859 . . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 29.9 m -106.84 115.56 30.4 Favored 'General case' 0 C--N 1.315 -0.925 0 O-C-N 121.277 -0.889 . . . . 0.0 109.923 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . 0.681 ' CZ2' ' CD2' ' A' ' 136' ' ' HIS . 17.4 m95 -81.57 137.72 35.48 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -131.56 139.27 49.18 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -178.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -125.48 65.86 1.16 Allowed 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 177.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 40.39 70.72 0.35 Allowed Glycine 0 CA--C 1.529 0.91 0 O-C-N 123.876 0.735 . . . . 0.0 112.335 -178.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 177.69 -79.84 0.07 OUTLIER Glycine 0 C--O 1.227 -0.293 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 -178.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 25.8 mt -135.81 164.34 28.13 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 178.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.8 mp -83.41 139.87 32.72 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.194 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.446 ' CE2' ' CB ' ' A' ' 106' ' ' ALA . 78.5 m-85 -127.79 101.13 6.22 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 123.898 0.879 . . . . 0.0 109.643 -175.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -56.17 117.06 3.41 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-O 117.751 -1.119 . . . . 0.0 109.109 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.451 ' HB2' ' CD1' ' A' ' 4' ' ' TRP . 1.7 tp60 -43.67 -43.41 5.85 Favored 'General case' 0 C--O 1.221 -0.425 0 O-C-N 124.399 1.062 . . . . 0.0 111.533 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -48.77 -56.2 9.31 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 118.39 -0.814 . . . . 0.0 110.083 176.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.433 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 0.2 OUTLIER -53.45 -32.02 48.08 Favored 'General case' 0 C--O 1.204 -1.34 0 CA-C-O 117.147 -1.406 . . . . 0.0 111.395 174.45 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.4 -75.36 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 120.665 1.575 . . . . 0.0 111.784 174.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.405 ' O ' ' CD2' ' A' ' 21' ' ' HIS . 2.5 pt-20 -61.98 -37.42 84.75 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-O 117.936 -1.03 . . . . 0.0 109.913 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 34.5 t -64.24 -65.26 0.7 Allowed 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 126.212 1.805 . . . . 0.0 109.798 -179.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.496 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 10.2 t-20 -43.28 -32.51 0.8 Allowed 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 123.459 0.704 . . . . 0.0 111.959 174.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.58 -41.43 27.18 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 175.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.405 ' CD2' ' O ' ' A' ' 17' ' ' GLU . 10.1 m170 -41.93 -39.78 1.96 Allowed 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 125.594 1.557 . . . . 0.0 109.662 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.496 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -73.09 -51.21 18.9 Favored 'General case' 0 N--CA 1.439 -1.007 0 O-C-N 124.418 1.074 . . . . 0.0 111.561 176.513 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.415 ' HB2' ' CE1' ' A' ' 83' ' ' PHE . . . -37.03 130.76 0.74 Allowed Pre-proline 0 N--CA 1.442 -0.836 0 O-C-N 125.28 1.612 . . . . 0.0 111.873 175.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.404 ' HG2' ' CG2' ' A' ' 30' ' ' THR . 15.5 Cg_endo -74.11 124.33 8.99 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 121.662 1.574 . . . . 0.0 109.159 -177.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.9 tp -59.39 91.93 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.947 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 26' ' ' SER . . . . . 0.748 ' HG ' ' ND2' ' A' ' 73' ' ' ASN . 0.4 OUTLIER 178.47 159.57 0.55 Allowed 'General case' 0 N--CA 1.448 -0.565 0 O-C-N 124.264 0.977 . . . . 0.0 110.236 -176.531 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -101.95 131.05 48.58 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-O 118.238 -0.887 . . . . 0.0 109.972 178.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 41.88 71.77 0.33 Allowed Glycine 0 CA--C 1.522 0.491 0 O-C-N 124.912 1.382 . . . . 0.0 111.504 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.16 25.43 0.72 Allowed 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.413 0.625 . . . . 0.0 110.685 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.404 ' CG2' ' HG2' ' A' ' 24' ' ' PRO . 69.2 p -123.86 150.84 44.12 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-O 118.663 -0.684 . . . . 0.0 109.513 -178.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . 0.405 ' HA3' ' O ' ' A' ' 95' ' ' ASP . . . -39.0 -58.14 1.93 Allowed Glycine 0 N--CA 1.45 -0.42 0 O-C-N 124.853 1.345 . . . . 0.0 112.034 -178.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.6 t -70.28 -71.66 0.23 Allowed 'General case' 0 N--CA 1.443 -0.805 0 CA-C-O 118.621 -0.704 . . . . 0.0 110.648 176.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 58.6 p 178.91 -60.48 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.277 0 O-C-N 124.6 1.188 . . . . 0.0 111.531 -178.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.519 ' CD1' ' HD3' ' A' ' 84' ' ' PRO . 50.8 m-85 -62.48 149.1 89.04 Favored Pre-proline 0 N--CA 1.428 -1.542 0 C-N-CA 123.729 0.812 . . . . 0.0 111.85 178.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -75.39 164.08 89.01 Favored 'Cis proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.48 -1.883 . . . . 0.0 110.868 -1.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.431 ' CD2' ' CD1' ' A' ' 34' ' ' TYR . 0.6 OUTLIER -142.24 162.09 36.36 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.211 -178.3 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.621 ' CD2' ' CD2' ' A' ' 68' ' ' HIS . 21.5 t90 -61.58 132.01 51.92 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.503 ' CE2' HG21 ' A' ' 109' ' ' ILE . 8.2 t80 -104.07 78.01 1.48 Allowed 'General case' 0 N--CA 1.428 -1.569 0 C-N-CA 124.903 1.281 . . . . 0.0 108.157 -178.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.543 HG21 ' CE3' ' A' ' 37' ' ' TRP . 78.7 p -37.42 -38.67 0.25 Allowed 'General case' 0 CA--C 1.509 -0.62 0 O-C-N 124.167 0.917 . . . . 0.0 110.455 177.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.421 ' HA ' ' CE1' ' A' ' 38' ' ' PHE . 44.6 t30 62.8 12.63 5.84 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 122.747 1.26 . . . . 0.0 108.748 178.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 114.59 -35.49 4.4 Favored Glycine 0 N--CA 1.429 -1.797 0 O-C-N 119.666 -1.896 . . . . 0.0 112.309 -174.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.541 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 59.8 m-85 -50.48 162.27 0.25 Allowed 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 121.185 0.517 . . . . 0.0 111.807 178.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.21 -38.24 22.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.464 178.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 125.98 41.37 0.34 Allowed Glycine 0 N--CA 1.437 -1.251 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.634 -176.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -146.01 -70.07 0.26 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.16 -74.61 0.01 OUTLIER Glycine 0 N--CA 1.435 -1.408 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -177.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.8 pttt -98.29 178.57 5.02 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 118.257 1.029 . . . . 0.0 110.648 178.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.541 ' HG ' ' CD1' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -106.03 163.72 16.47 Favored Pre-proline 0 N--CA 1.444 -0.74 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.569 -179.548 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.63 163.11 36.61 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 121.762 1.641 . . . . 0.0 110.624 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.71 97.34 0.05 Allowed 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 125.06 54.59 0.17 Allowed Glycine 0 N--CA 1.447 -0.633 0 O-C-N 121.436 -0.79 . . . . 0.0 111.668 -179.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -150.95 145.9 25.9 Favored 'General case' 0 N--CA 1.452 -0.335 0 O-C-N 124.127 0.545 . . . . 0.0 110.963 177.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.3 m -139.01 98.99 8.31 Favored Pre-proline 0 N--CA 1.45 -0.457 0 O-C-N 124.407 1.067 . . . . 0.0 109.861 -178.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -73.56 166.93 28.56 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 121.626 1.55 . . . . 0.0 111.207 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.461 ' O ' ' CE2' ' A' ' 57' ' ' PHE . 5.6 mt -79.58 125.96 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -178.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.9 tppt? -81.69 155.71 25.42 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.125 0.488 . . . . 0.0 109.709 178.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.461 ' CE2' ' O ' ' A' ' 55' ' ' ILE . 21.6 m-85 -139.01 -46.88 0.48 Allowed 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.233 178.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 119.44 -2.35 14.0 Favored Glycine 0 CA--C 1.522 0.491 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.178 -176.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.2 mmtt -96.07 141.86 28.96 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-O 117.625 -1.179 . . . . 0.0 109.774 178.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.43 -7.1 58.17 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 124.832 1.333 . . . . 0.0 110.721 177.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -90.9 -53.06 4.55 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 123.71 0.804 . . . . 0.0 109.135 -179.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.448 ' SG ' ' CE2' ' A' ' 57' ' ' PHE . 4.9 t -72.18 -16.02 61.96 Favored 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 124.103 0.877 . . . . 0.0 110.672 176.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -86.68 -37.79 17.63 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 123.57 0.544 . . . . 0.0 111.043 177.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.17 165.15 0.28 Allowed Pre-proline 0 N--CA 1.441 -0.912 0 CA-C-O 121.991 0.9 . . . . 0.0 111.237 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -72.6 124.59 9.91 Favored 'Trans proline' 0 N--CA 1.441 -1.607 0 C-N-CA 120.927 1.084 . . . . 0.0 113.076 175.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.425 ' HD3' ' CZ ' ' A' ' 42' ' ' TYR . 19.0 Cg_endo -74.26 167.39 27.28 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 122.881 2.387 . . . . 0.0 110.253 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -127.54 104.03 7.66 Favored 'General case' 0 C--O 1.213 -0.82 0 CA-C-O 115.957 -1.973 . . . . 0.0 107.68 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.621 ' CD2' ' CD2' ' A' ' 37' ' ' TRP . 19.2 t-80 -93.55 161.92 14.17 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.47 1.106 . . . . 0.0 110.341 176.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.32 176.76 11.28 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.153 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.74 63.02 7.29 Favored 'General case' 0 C--O 1.224 -0.263 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.695 178.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -177.41 -39.0 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.885 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 122.59 -65.64 0.5 Allowed Glycine 0 N--CA 1.44 -1.056 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.515 -178.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.748 ' ND2' ' HG ' ' A' ' 26' ' ' SER . 1.6 p30 -120.51 62.03 0.86 Allowed 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -56.13 -105.61 0.01 OUTLIER Glycine 0 CA--C 1.532 1.149 0 CA-C-O 123.362 1.534 . . . . 0.0 112.236 -178.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 16.1 mttp -70.76 -104.59 0.0 OUTLIER 'General case' 0 C--O 1.218 -0.556 0 O-C-N 120.07 -1.841 . . . . 0.0 110.285 178.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.423 ' CG2' ' O ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -109.21 16.62 22.33 Favored 'General case' 0 N--CA 1.447 -0.607 0 O-C-N 121.553 -0.717 . . . . 0.0 110.65 179.45 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.47 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 5.4 m-20 -29.73 102.25 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 123.838 0.855 . . . . 0.0 111.651 -179.138 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.499 ' H ' ' CD2' ' A' ' 78' ' ' HIS . 4.9 p80 -87.88 28.13 1.07 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -175.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.534 ' CE1' ' CD1' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -54.46 168.16 0.28 Allowed 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 174.897 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.413 HD22 ' CG2' ' A' ' 109' ' ' ILE . 0.6 OUTLIER -98.26 158.05 15.8 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 118.477 -0.773 . . . . 0.0 109.758 176.947 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.534 ' CD1' ' CE1' ' A' ' 79' ' ' TYR . 1.4 mp -141.82 130.69 23.01 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 123.298 0.639 . . . . 0.0 109.511 178.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.471 ' CB ' ' CD1' ' A' ' 109' ' ' ILE . 0.4 OUTLIER -99.95 151.08 21.74 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 121.565 0.698 . . . . 0.0 110.995 179.138 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.415 ' CE1' ' HB2' ' A' ' 23' ' ' ALA . 28.7 t80 -142.0 121.01 7.85 Favored Pre-proline 0 N--CA 1.444 -0.774 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.273 -178.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.519 ' HD3' ' CD1' ' A' ' 34' ' ' TYR . 19.4 Cg_endo -72.9 111.73 3.34 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 122.886 2.391 . . . . 0.0 110.193 -177.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.55 125.54 51.94 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.125 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.485 ' CD2' ' NE2' ' A' ' 90' ' ' HIS . 63.5 m-85 -82.89 155.74 67.71 Favored Pre-proline 0 N--CA 1.443 -0.822 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.012 178.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -77.64 -42.12 0.29 Allowed 'Trans proline' 0 CA--C 1.505 -0.931 0 C-N-CA 122.104 1.869 . . . . 0.0 111.898 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -43.25 -30.88 0.54 Allowed 'General case' 0 C--N 1.346 0.426 0 O-C-N 125.078 1.486 . . . . 0.0 110.293 177.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 99.87 -12.48 60.86 Favored Glycine 0 N--CA 1.436 -1.364 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 177.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.485 ' NE2' ' CD2' ' A' ' 86' ' ' PHE . 4.8 p-80 -58.38 128.77 38.83 Favored 'General case' 0 N--CA 1.44 -0.925 0 O-C-N 124.325 0.662 . . . . 0.0 109.449 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -68.95 101.47 1.39 Allowed 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.488 ' O ' ' CD2' ' A' ' 94' ' ' PHE . 6.5 t80 -34.26 138.38 0.09 Allowed 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 122.028 0.918 . . . . 0.0 111.463 178.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.402 ' HE2' ' O ' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -78.96 60.08 2.81 Favored 'General case' 0 N--CA 1.442 -0.852 0 O-C-N 120.081 -1.637 . . . . 0.0 109.953 177.75 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.488 ' CD2' ' O ' ' A' ' 92' ' ' TYR . 30.4 p90 -75.55 1.7 13.61 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 123.269 0.628 . . . . 0.0 112.084 177.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . 0.405 ' O ' ' HA3' ' A' ' 31' ' ' GLY . 36.7 t0 -95.79 -38.8 10.16 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 122.394 1.092 . . . . 0.0 109.115 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -80.75 110.03 15.86 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 120.862 -1.149 . . . . 0.0 109.36 -178.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.8 pttt -57.86 -50.28 73.85 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.04 178.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.46 127.51 7.26 Favored Pre-proline 0 N--CA 1.431 -1.401 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.802 -176.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.402 ' O ' ' HE2' ' A' ' 93' ' ' LYS . 21.7 Cg_endo -73.05 178.04 34.09 Favored 'Cis proline' 0 N--CA 1.458 -0.596 0 O-C-N 125.093 2.102 . . . . 0.0 111.232 -2.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.0 132.39 25.11 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -72.67 145.02 47.53 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 124.244 0.965 . . . . 0.0 109.312 178.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -42.09 156.83 0.22 Allowed Pre-proline 0 N--CA 1.45 -0.448 0 O-C-N 123.74 0.65 . . . . 0.0 111.411 177.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -72.49 -163.13 0.14 Allowed 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 121.235 1.29 . . . . 0.0 111.142 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -139.85 154.33 23.73 Favored Glycine 0 N--CA 1.441 -0.988 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.04 178.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -75.52 -66.55 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.143 1.895 . . . . 0.0 110.131 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.446 ' CB ' ' CE2' ' A' ' 11' ' ' TYR . . . -69.19 135.75 51.07 Favored 'General case' 0 N--CA 1.443 -0.78 0 O-C-N 124.298 0.999 . . . . 0.0 110.907 178.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 4.3 mtt85 -141.47 146.02 35.94 Favored 'General case' 0 N--CA 1.448 -0.541 0 O-C-N 123.913 0.758 . . . . 0.0 110.716 -178.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.41 ' CG1' ' HB3' ' A' ' 83' ' ' PHE . 7.7 p -83.6 128.89 38.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 O-C-N 123.736 0.648 . . . . 0.0 109.869 178.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.503 HG21 ' CE2' ' A' ' 38' ' ' PHE . 9.1 mm -107.9 142.83 19.58 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.861 0 CA-C-O 118.571 -0.728 . . . . 0.0 109.938 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.49 ' CD1' ' HG3' ' A' ' 115' ' ' LYS . 12.4 p90 -167.15 155.45 9.67 Favored 'General case' 0 N--CA 1.442 -0.839 0 O-C-N 124.121 0.888 . . . . 0.0 111.14 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.0 p -91.83 164.71 13.59 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.476 -177.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.536 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -111.93 154.35 44.19 Favored Pre-proline 0 N--CA 1.442 -0.866 0 C-N-CA 122.45 0.3 . . . . 0.0 110.898 179.536 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.536 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 18.6 Cg_endo -74.52 -54.03 0.15 OUTLIER 'Cis proline' 0 CA--C 1.509 -0.748 0 C-N-CA 122.523 -1.865 . . . . 0.0 109.468 -4.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -42.92 111.49 0.27 Allowed 'General case' 0 CA--C 1.507 -0.692 0 CA-C-O 116.45 -1.738 . . . . 0.0 109.722 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.49 ' HG3' ' CD1' ' A' ' 110' ' ' TYR . 0.3 OUTLIER -63.09 76.35 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.375 0 O-C-N 125.77 1.919 . . . . 0.0 109.123 -178.44 . . . . . . . . 3 3 . 1 . 004 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 8.8 t -77.01 71.25 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 -176.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.595 ' CZ ' ' HA2' ' A' ' 119' ' ' GLY . 27.9 t80 -35.63 110.6 0.11 Allowed 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 123.16 0.584 . . . . 0.0 111.132 178.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . 0.448 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 6.2 m -82.61 -45.5 14.49 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.595 ' HA2' ' CZ ' ' A' ' 117' ' ' PHE . . . 161.93 -145.05 10.32 Favored Glycine 0 N--CA 1.443 -0.87 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.456 HG13 ' CD2' ' A' ' 4' ' ' TRP . 1.1 mm -127.63 136.97 59.01 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.82 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 -176.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 9.2 pt -127.36 156.06 38.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -177.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.558 0 CA-C-O 121.515 0.674 . . . . 0.0 109.82 178.053 . . . . . . . . 0 0 . 1 . 004 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.51 -0.577 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.411 ' HB2' ' CG2' ' A' ' 55' ' ' ILE . 5.2 tp -88.12 143.23 27.18 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 124.562 1.164 . . . . 0.0 109.135 178.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 76.0 m -62.04 -172.21 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 122.088 0.946 . . . . 0.0 109.707 177.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 19.5 m -133.04 92.46 3.03 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.469 -179.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 0.681 ' CD2' ' CZ2' ' A' ' 4' ' ' TRP . 2.1 p-80 . . . . . 0 C--O 1.25 1.097 0 CA-C-O 116.886 -1.531 . . . . 0.0 112.258 176.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.4 p . . . . . 0 N--CA 1.451 -0.39 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 . . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.2 m -89.52 109.05 20.02 Favored 'General case' 0 C--N 1.317 -0.818 0 O-C-N 121.488 -0.758 . . . . 0.0 109.553 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 39.7 m95 -77.32 140.0 39.9 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 124.065 0.946 . . . . 0.0 110.54 178.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.6 m -124.57 120.24 31.37 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 122.093 0.949 . . . . 0.0 109.045 -176.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 74.9 m -103.87 64.56 0.79 Allowed 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 34.65 60.14 0.65 Allowed Glycine 0 C--N 1.341 0.806 0 C-N-CA 124.992 1.282 . . . . 0.0 113.007 178.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 170.02 -80.97 0.09 OUTLIER Glycine 0 C--O 1.224 -0.491 0 N-CA-C 110.501 -1.039 . . . . 0.0 110.501 -175.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.66 159.05 20.94 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.488 1.115 . . . . 0.0 108.787 -176.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.74 125.33 53.4 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -172.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.499 ' CE2' ' CB ' ' A' ' 106' ' ' ALA . 89.5 m-85 -117.06 106.68 13.64 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 126.441 1.896 . . . . 0.0 108.537 -172.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -58.7 127.81 34.06 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.31 177.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.475 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 7.0 tp-100 -54.82 -44.49 73.9 Favored 'General case' 0 C--O 1.217 -0.626 0 O-C-N 121.373 -0.83 . . . . 0.0 112.773 178.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -51.71 -26.3 9.06 Favored 'General case' 0 C--O 1.213 -0.845 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 175.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.18 -41.66 15.43 Favored 'General case' 0 C--O 1.206 -1.217 0 CA-C-O 116.174 -1.87 . . . . 0.0 113.418 170.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.55 -62.91 1.35 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 121.705 2.048 . . . . 0.0 113.08 175.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -58.03 -43.61 86.87 Favored 'General case' 0 C--N 1.333 -0.137 0 O-C-N 121.543 -0.723 . . . . 0.0 110.73 174.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.5 t -61.93 -23.21 66.21 Favored 'General case' 0 C--O 1.222 -0.381 0 O-C-N 121.89 -0.506 . . . . 0.0 111.354 175.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -71.11 -63.89 1.02 Allowed 'General case' 0 N--CA 1.438 -1.059 0 O-C-N 120.603 -1.31 . . . . 0.0 108.439 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.39 -15.91 51.61 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 114.669 -1.151 . . . . 0.0 111.518 178.021 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 1.4 m170 -59.41 -51.86 68.08 Favored 'General case' 0 CA--C 1.517 -0.306 0 O-C-N 121.296 -0.878 . . . . 0.0 110.91 178.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -74.92 -41.02 60.51 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 123.811 0.694 . . . . 0.0 111.15 178.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.44 ' HB2' ' CE2' ' A' ' 83' ' ' PHE . . . -43.14 131.4 3.33 Favored Pre-proline 0 N--CA 1.447 -0.577 0 O-C-N 124.651 1.219 . . . . 0.0 112.441 177.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -71.18 123.65 9.8 Favored 'Trans proline' 0 N--CA 1.444 -1.414 0 C-N-CA 122.053 1.835 . . . . 0.0 109.54 -177.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.4 ' CD1' ' HE2' ' A' ' 115' ' ' LYS . 5.7 tp -61.48 96.66 0.06 Allowed 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.625 0.77 . . . . 0.0 110.94 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 178.2 165.21 0.74 Allowed 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 124.041 0.936 . . . . 0.0 109.728 -175.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.73 121.28 42.13 Favored 'General case' 0 CA--C 1.511 -0.525 0 C-N-CA 124.749 1.22 . . . . 0.0 109.688 177.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 48.77 67.9 1.51 Allowed Glycine 0 CA--C 1.525 0.707 0 CA-C-O 121.772 0.651 . . . . 0.0 112.636 174.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.05 28.47 1.01 Allowed 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.599 0.76 . . . . 0.0 112.759 -178.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 71.9 p -127.56 151.03 49.42 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -175.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -40.17 -58.22 2.42 Favored Glycine 0 C--O 1.228 -0.242 0 C-N-CA 123.655 0.645 . . . . 0.0 113.714 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 29.2 t -67.18 -72.64 0.16 Allowed 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 123.772 0.336 . . . . 0.0 111.623 173.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 47.8 p 177.96 -56.05 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 124.194 0.998 . . . . 0.0 112.827 -178.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.485 ' CD2' ' HD3' ' A' ' 84' ' ' PRO . 69.9 m-85 -68.87 147.36 97.84 Favored Pre-proline 0 N--CA 1.442 -0.857 0 C-N-CA 124.931 1.292 . . . . 0.0 113.286 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -75.49 165.53 85.46 Favored 'Cis proline' 0 N--CA 1.445 -1.353 0 C-N-CA 123.938 -1.276 . . . . 0.0 111.186 1.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.41 ' CD2' ' CD2' ' A' ' 34' ' ' TYR . 1.1 p80 -141.47 171.8 13.56 Favored 'General case' 0 CA--C 1.504 -0.797 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.574 -177.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.486 ' CH2' ' HA2' ' A' ' 44' ' ' GLY . 22.0 t90 -72.17 128.08 34.58 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 122.687 1.232 . . . . 0.0 109.726 175.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.479 ' CZ ' ' HA ' ' A' ' 40' ' ' ASN . 19.3 t80 -98.29 86.15 3.59 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 126.674 1.989 . . . . 0.0 107.041 176.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 69.0 p -40.36 -33.43 0.25 Allowed 'General case' 0 C--O 1.217 -0.645 0 CA-C-N 114.656 -1.156 . . . . 0.0 111.105 172.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.479 ' HA ' ' CZ ' ' A' ' 38' ' ' PHE . 57.1 t30 68.56 5.92 5.13 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.519 1.128 . . . . 0.0 110.878 -178.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 115.96 -26.41 8.85 Favored Glycine 0 N--CA 1.432 -1.59 0 C-N-CA 125.066 1.317 . . . . 0.0 116.095 -171.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.431 ' CD2' ' HA2' ' A' ' 46' ' ' GLY . 58.4 m-85 -54.57 -178.16 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 122.365 1.079 . . . . 0.0 110.299 176.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -103.87 -40.7 6.14 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 124.462 1.105 . . . . 0.0 110.763 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.486 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -174.05 -61.55 0.05 OUTLIER Glycine 0 C--N 1.336 0.549 0 C-N-CA 123.751 0.691 . . . . 0.0 112.641 -178.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -82.92 -98.62 0.05 OUTLIER 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.431 ' HA2' ' CD2' ' A' ' 42' ' ' TYR . . . -138.84 29.76 2.53 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 125.048 1.308 . . . . 0.0 111.674 -174.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.9 mttt -126.87 149.19 49.88 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 118.144 -0.931 . . . . 0.0 108.737 -178.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.38 160.51 34.11 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.406 1.066 . . . . 0.0 109.187 -178.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -69.02 157.54 61.43 Favored 'Trans proline' 0 N--CA 1.443 -1.459 0 C-N-CA 121.884 1.723 . . . . 0.0 110.161 177.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -49.27 104.41 0.06 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.094 0.958 . . . . 0.0 110.352 176.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.74 87.98 0.59 Allowed Glycine 0 CA--C 1.524 0.601 0 O-C-N 123.572 0.545 . . . . 0.0 111.851 -174.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.83 155.53 39.4 Favored 'General case' 0 CA--C 1.516 -0.365 0 C-N-CA 123.164 0.586 . . . . 0.0 110.552 174.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.0 m -138.92 101.59 7.78 Favored Pre-proline 0 C--N 1.329 -0.305 0 O-C-N 124.014 0.821 . . . . 0.0 111.439 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -66.4 153.74 76.87 Favored 'Trans proline' 0 N--CA 1.448 -1.148 0 C-N-CA 123.856 3.038 . . . . 0.0 112.073 177.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.8 mt -66.74 127.33 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -95.39 134.45 38.18 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 176.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.477 ' CD1' ' SG ' ' A' ' 62' ' ' CYS . 1.7 m-85 -119.62 -55.31 2.12 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 124.213 1.005 . . . . 0.0 110.623 -179.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 120.42 -2.9 12.49 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 124.88 1.228 . . . . 0.0 113.469 -176.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.8 mmtp -66.46 177.66 1.46 Allowed 'General case' 0 C--O 1.215 -0.735 0 O-C-N 122.065 -0.667 . . . . 0.0 111.364 173.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.0 p -104.23 -47.17 4.22 Favored 'General case' 0 C--O 1.216 -0.679 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.153 177.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.45 -41.03 41.21 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 123.097 0.559 . . . . 0.0 110.892 177.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.477 ' SG ' ' CD1' ' A' ' 57' ' ' PHE . 1.5 t -74.25 -17.37 60.88 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 122.786 0.434 . . . . 0.0 110.736 178.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -87.58 -38.31 16.08 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 123.115 0.566 . . . . 0.0 112.31 171.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.78 163.8 1.92 Allowed Pre-proline 0 N--CA 1.448 -0.57 0 CA-C-O 121.785 0.803 . . . . 0.0 111.491 -178.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -70.54 138.75 36.01 Favored 'Trans proline' 0 N--CA 1.439 -1.69 0 C-N-CA 120.401 0.734 . . . . 0.0 112.232 175.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -68.21 175.29 6.89 Favored 'Trans proline' 0 N--CA 1.448 -1.2 0 C-N-CA 122.952 2.435 . . . . 0.0 111.965 175.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.8 tptt -136.98 56.27 1.8 Allowed 'General case' 0 C--O 1.209 -1.041 0 O-C-N 120.835 -1.165 . . . . 0.0 108.685 174.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -77.54 165.05 24.82 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 119.16 -1.016 . . . . 0.0 110.488 177.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.57 -165.62 2.03 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.908 0.883 . . . . 0.0 111.241 178.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.11 73.69 10.36 Favored 'General case' 0 C--O 1.219 -0.509 0 O-C-N 121.322 -0.862 . . . . 0.0 111.146 175.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -176.89 -43.35 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.507 0 O-C-N 124.419 1.074 . . . . 0.0 111.367 178.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.452 ' O ' ' CE2' ' A' ' 79' ' ' TYR . . . 122.53 -52.65 0.75 Allowed Glycine 0 C--O 1.217 -0.918 0 CA-C-N 114.693 -1.139 . . . . 0.0 111.208 -177.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -148.59 86.18 1.52 Allowed 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.25 -112.2 0.01 OUTLIER Glycine 0 CA--C 1.525 0.66 0 CA-C-O 122.331 0.962 . . . . 0.0 113.037 176.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -64.58 -96.73 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 O-C-N 120.427 -1.631 . . . . 0.0 112.436 176.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -110.55 16.27 21.6 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 121.379 -0.826 . . . . 0.0 110.272 178.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.459 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 8.6 m-20 -29.24 104.93 0.03 OUTLIER 'General case' 0 C--O 1.207 -1.141 0 C-N-CA 125.792 1.637 . . . . 0.0 109.94 -176.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.523 ' H ' ' CD2' ' A' ' 78' ' ' HIS . 2.5 p80 -87.17 16.31 5.28 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 118.968 0.803 . . . . 0.0 110.268 -175.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.452 ' CE2' ' O ' ' A' ' 72' ' ' GLY . 0.3 OUTLIER -36.19 134.27 0.43 Allowed 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 126.156 1.782 . . . . 0.0 111.311 172.148 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.68 153.65 34.95 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.797 176.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.418 ' CD1' ' CZ ' ' A' ' 79' ' ' TYR . 1.7 mp -140.27 139.06 35.44 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 123.191 0.596 . . . . 0.0 109.659 177.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.459 ' CB ' ' CD1' ' A' ' 109' ' ' ILE . 0.5 OUTLIER -105.81 154.2 20.85 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.593 0.711 . . . . 0.0 111.284 179.261 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.44 ' CE2' ' HB2' ' A' ' 23' ' ' ALA . 5.7 t80 -141.79 126.35 10.32 Favored Pre-proline 0 CA--C 1.537 0.452 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.748 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.485 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 19.6 Cg_endo -73.87 104.44 1.83 Allowed 'Trans proline' 0 N--CA 1.448 -1.148 0 C-N-CA 124.789 3.659 . . . . 0.0 110.615 -177.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.8 t -104.38 119.66 39.46 Favored 'General case' 0 N--CA 1.446 -0.67 0 O-C-N 124.675 1.234 . . . . 0.0 109.963 -179.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.434 ' CD2' ' NE2' ' A' ' 90' ' ' HIS . 64.7 m-85 -81.17 158.8 69.2 Favored Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 176.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -74.78 -42.54 0.55 Allowed 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 122.504 2.136 . . . . 0.0 113.409 178.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -40.42 -37.03 0.62 Allowed 'General case' 0 N--CA 1.478 0.94 0 CA-C-O 123.529 1.633 . . . . 0.0 109.803 174.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 97.45 -1.88 60.54 Favored Glycine 0 N--CA 1.442 -0.931 0 O-C-N 121.053 -1.03 . . . . 0.0 112.248 -178.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.434 ' NE2' ' CD2' ' A' ' 86' ' ' PHE . 5.9 p-80 -65.39 126.74 29.18 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 176.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -59.62 106.07 0.43 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 171.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.44 ' O ' ' CD2' ' A' ' 94' ' ' PHE . 7.1 t80 -38.98 139.93 0.42 Allowed 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 121.684 0.754 . . . . 0.0 110.166 173.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 7.5 ptpt -75.68 58.44 1.08 Allowed 'General case' 0 C--N 1.326 -0.416 0 O-C-N 120.42 -1.425 . . . . 0.0 111.818 173.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.44 ' CD2' ' O ' ' A' ' 92' ' ' TYR . 34.2 p90 -73.08 -14.63 61.43 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 123.856 0.862 . . . . 0.0 112.327 176.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -88.8 -37.23 15.57 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 123.329 1.537 . . . . 0.0 111.298 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -79.9 106.9 12.26 Favored 'General case' 0 N--CA 1.455 -0.179 0 O-C-N 120.926 -1.109 . . . . 0.0 109.162 177.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt -57.99 -48.4 80.1 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.739 0.78 . . . . 0.0 111.713 176.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.7 tmtt? -137.49 130.66 17.04 Favored Pre-proline 0 N--CA 1.445 -0.701 0 C-N-CA 124.828 1.251 . . . . 0.0 110.199 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -68.57 174.53 35.9 Favored 'Cis proline' 0 N--CA 1.453 -0.873 0 C-N-CA 123.181 -1.591 . . . . 0.0 110.415 -9.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 22.0 tttm -139.03 116.95 11.6 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 29.4 tp10 -69.96 167.2 17.99 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 123.981 0.801 . . . . 0.0 110.639 174.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -42.68 153.28 0.32 Allowed Pre-proline 0 CA--C 1.536 0.41 0 C-N-CA 124.228 1.011 . . . . 0.0 112.064 173.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -72.85 -84.02 0.0 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 122.829 2.353 . . . . 0.0 112.547 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 146.58 142.4 3.73 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -74.75 -68.85 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 123.325 2.683 . . . . 0.0 110.71 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.499 ' CB ' ' CE2' ' A' ' 11' ' ' TYR . . . -68.3 139.67 55.94 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 121.735 0.779 . . . . 0.0 111.165 178.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.87 144.3 33.77 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.011 -178.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.3 p -81.58 124.81 39.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 O-C-N 124.341 1.025 . . . . 0.0 109.139 178.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.459 ' CD1' ' CB ' ' A' ' 82' ' ' GLU . 5.8 mm -105.54 141.16 21.51 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.701 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.061 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.435 ' CD1' ' HG3' ' A' ' 115' ' ' LYS . 10.4 p90 -165.17 152.92 11.24 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-O 121.952 0.882 . . . . 0.0 111.294 -176.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.0 p -88.66 165.82 14.52 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.852 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.535 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.3 OUTLIER -108.21 156.84 37.73 Favored Pre-proline 0 CA--C 1.547 0.841 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 176.107 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.535 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 17.7 Cg_endo -72.07 -53.4 0.16 OUTLIER 'Cis proline' 0 CA--C 1.51 -0.683 0 C-N-CA 124.216 -1.16 . . . . 0.0 111.064 -10.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -45.61 111.43 0.34 Allowed 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 118.685 -0.674 . . . . 0.0 109.92 177.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.435 ' HG3' ' CD1' ' A' ' 110' ' ' TYR . 0.2 OUTLIER -62.69 79.86 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.349 0 C-N-CA 124.911 1.285 . . . . 0.0 108.098 -178.262 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.2 t -77.43 73.06 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 105.311 -2.107 . . . . 0.0 105.311 -178.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.475 ' CZ ' ' NE2' ' A' ' 13' ' ' GLN . 20.7 t80 -46.63 108.16 0.13 Allowed 'General case' 0 N--CA 1.44 -0.95 0 C-N-CA 124.918 1.287 . . . . 0.0 109.008 177.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . 0.424 ' SG ' ' CG ' ' A' ' 57' ' ' PHE . 0.1 OUTLIER -83.45 -53.0 6.03 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 121.952 0.882 . . . . 0.0 110.031 179.448 . . . . . . . . 3 3 . 1 . 005 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 177.18 -146.09 7.58 Favored Glycine 0 N--CA 1.437 -1.252 0 CA-C-N 114.464 -1.244 . . . . 0.0 110.43 179.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 1.2 mm -126.61 146.85 31.77 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 -177.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 8.0 pt -132.7 151.79 35.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.495 0 C-N-CA 122.807 0.443 . . . . 0.0 110.863 178.223 . . . . . . . . 0 0 . 1 . 005 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.514 -0.415 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 . . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 10.0 tp -84.51 137.61 33.24 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.127 0.892 . . . . 0.0 108.746 178.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 35.0 m -70.71 -178.75 1.94 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 122.865 1.317 . . . . 0.0 109.821 174.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 13.7 p -160.24 100.01 1.35 Allowed 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 105.148 -2.167 . . . . 0.0 105.148 -178.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.242 0.674 0 CA-C-O 115.921 -1.99 . . . . 0.0 112.441 168.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.3 p . . . . . 0 C--O 1.238 0.494 0 CA-C-O 121.43 0.633 . . . . 0.0 109.654 . . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 48.9 m -85.78 119.67 26.36 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.148 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . 0.528 ' CE2' ' CD2' ' A' ' 136' ' ' HIS . 19.8 m95 -80.44 141.42 35.28 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -141.02 142.51 34.22 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -120.42 50.38 1.32 Allowed 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.896 177.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 48.06 73.75 0.31 Allowed Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 -178.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 166.55 -74.95 0.15 Allowed Glycine 0 C--N 1.333 0.395 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 54.9 mt -123.82 158.18 32.42 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.401 ' O ' ' CD1' ' A' ' 11' ' ' TYR . 3.9 mp -83.02 165.64 19.46 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.049 179.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.595 ' CE2' ' CB ' ' A' ' 106' ' ' ALA . 50.2 m-85 -159.12 85.56 0.81 Allowed 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 121.872 0.844 . . . . 0.0 109.981 -175.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -57.43 121.45 10.27 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 117.656 -1.164 . . . . 0.0 108.602 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.563 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 0.6 OUTLIER -43.33 -57.93 2.79 Favored 'General case' 0 C--O 1.207 -1.167 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.386 -179.892 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.445 ' O ' ' CB ' ' A' ' 18' ' ' SER . 19.7 t-20 -44.98 -46.9 11.4 Favored 'General case' 0 C--O 1.198 -1.647 0 O-C-N 124.065 0.853 . . . . 0.0 109.766 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . 0.431 ' CE ' ' HA3' ' A' ' 89' ' ' GLY . 0.0 OUTLIER -62.35 -48.23 80.74 Favored 'General case' 0 C--O 1.204 -1.307 0 CA-C-O 117.376 -1.297 . . . . 0.0 111.267 174.954 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -51.04 -68.19 0.19 Allowed 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 120.091 1.314 . . . . 0.0 111.685 175.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.431 ' O ' ' CD2' ' A' ' 21' ' ' HIS . 1.5 pt-20 -55.99 -32.94 64.4 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.206 177.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.445 ' CB ' ' O ' ' A' ' 14' ' ' ASN . 12.6 t -68.05 -53.78 23.15 Favored 'General case' 0 C--O 1.216 -0.708 0 C-N-CA 123.949 0.9 . . . . 0.0 109.46 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.414 ' OD1' ' CD2' ' A' ' 83' ' ' PHE . 6.7 t-20 -49.37 -30.62 7.97 Favored 'General case' 0 N--CA 1.434 -1.266 0 O-C-N 120.443 -1.41 . . . . 0.0 109.291 178.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.99 -29.36 22.05 Favored 'General case' 0 N--CA 1.442 -0.873 0 O-C-N 123.521 0.513 . . . . 0.0 111.642 176.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.431 ' CD2' ' O ' ' A' ' 17' ' ' GLU . 7.7 m170 -54.19 -42.93 70.27 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 124.029 0.931 . . . . 0.0 109.38 179.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.429 ' CD2' ' N ' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -79.59 -48.89 13.03 Favored 'General case' 0 N--CA 1.443 -0.78 0 O-C-N 123.769 0.668 . . . . 0.0 109.562 -179.892 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.488 ' HB2' ' CE1' ' A' ' 83' ' ' PHE . . . -40.35 136.09 1.41 Allowed Pre-proline 0 N--CA 1.442 -0.871 0 O-C-N 125.187 1.554 . . . . 0.0 110.831 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.418 ' HG2' ' CG2' ' A' ' 30' ' ' THR . 18.6 Cg_endo -73.14 122.22 7.88 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 122.032 1.821 . . . . 0.0 110.631 -178.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.452 ' CD1' ' HE2' ' A' ' 115' ' ' LYS . 3.0 tp -60.23 95.5 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 123.597 0.56 . . . . 0.0 110.059 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 179.3 162.42 0.84 Allowed 'General case' 0 N--CA 1.448 -0.566 0 O-C-N 123.643 0.59 . . . . 0.0 109.883 -178.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -103.55 112.54 25.51 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 123.927 0.767 . . . . 0.0 109.083 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.01 64.69 4.12 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 177.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . 0.418 ' O ' ' CG ' ' A' ' 29' ' ' LYS . 12.7 tttt -134.47 12.92 3.8 Favored 'General case' 0 C--N 1.334 -0.074 0 CA-C-O 123.003 1.382 . . . . 0.0 110.024 178.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.418 ' CG2' ' HG2' ' A' ' 24' ' ' PRO . 22.8 p -112.92 145.8 40.11 Favored 'General case' 0 C--N 1.315 -0.898 0 O-C-N 120.501 -1.374 . . . . 0.0 108.481 -176.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -38.42 -49.57 2.31 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.8 t -74.2 -60.69 2.15 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-O 117.177 -1.392 . . . . 0.0 110.165 177.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 162.2 -59.92 0.0 OUTLIER 'General case' 0 C--O 1.222 -0.344 0 O-C-N 125.256 1.597 . . . . 0.0 110.555 179.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.692 ' CE2' ' CE1' ' A' ' 36' ' ' HIS . 60.3 m-85 -58.83 145.78 77.7 Favored Pre-proline 0 N--CA 1.434 -1.256 0 CA-C-O 117.676 -1.154 . . . . 0.0 112.522 178.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.401 ' C ' ' HA ' ' A' ' 34' ' ' TYR . 22.2 Cg_endo -74.23 153.41 99.14 Favored 'Cis proline' 0 N--CA 1.454 -0.82 0 C-N-CA 121.578 -2.259 . . . . 0.0 111.855 -1.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.692 ' CE1' ' CE2' ' A' ' 34' ' ' TYR . 0.5 OUTLIER -131.8 154.91 48.63 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-O 117.782 -1.104 . . . . 0.0 110.509 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.539 ' CH2' ' CG2' ' A' ' 39' ' ' THR . 13.4 t90 -48.98 144.78 4.42 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.227 0.954 . . . . 0.0 109.143 178.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.496 ' CE1' ' CD1' ' A' ' 121' ' ' ILE . 24.6 t80 -114.93 80.96 1.49 Allowed 'General case' 0 N--CA 1.425 -1.717 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 -176.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.539 ' CG2' ' CH2' ' A' ' 37' ' ' TRP . 4.3 p -38.46 -32.86 0.08 Allowed 'General case' 0 C--O 1.21 -1.012 0 O-C-N 124.114 0.884 . . . . 0.0 109.933 176.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.476 ' HB2' ' CD2' ' A' ' 38' ' ' PHE . 51.0 t30 52.18 22.24 1.87 Allowed 'General case' 0 N--CA 1.447 -0.603 0 O-C-N 121.154 -0.966 . . . . 0.0 108.69 175.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.447 ' CA ' ' HD3' ' A' ' 52' ' ' ARG . . . 107.71 -41.42 2.21 Favored Glycine 0 N--CA 1.422 -2.263 0 CA-C-O 118.697 -1.057 . . . . 0.0 114.886 -173.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.509 ' CE2' ' HD3' ' A' ' 66' ' ' PRO . 62.4 m-85 -45.72 153.78 0.25 Allowed 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 123.721 0.808 . . . . 0.0 112.126 175.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.48 -40.32 16.51 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.708 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.505 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -164.97 -65.46 0.02 OUTLIER Glycine 0 C--N 1.339 0.717 0 N-CA-C 111.356 -0.698 . . . . 0.0 111.356 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.456 ' OD2' ' CE ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -121.08 -61.19 1.57 Allowed 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -179.708 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -50.47 179.24 0.03 OUTLIER Glycine 0 C--N 1.348 1.244 0 CA-C-O 123.598 1.666 . . . . 0.0 111.217 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.8 -171.06 0.26 Allowed 'General case' 0 C--N 1.326 -0.437 0 O-C-N 121.059 -1.259 . . . . 0.0 109.832 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.416 ' CD2' ' HA3' ' A' ' 41' ' ' GLY . 5.2 mp -69.96 154.52 94.59 Favored Pre-proline 0 N--CA 1.441 -0.914 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.213 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.09 156.53 47.13 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 122.114 1.876 . . . . 0.0 111.044 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.07 98.03 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.08 75.8 0.64 Allowed Glycine 0 N--CA 1.444 -0.775 0 CA-C-O 119.777 -0.457 . . . . 0.0 112.096 -178.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.447 ' HD3' ' CA ' ' A' ' 41' ' ' GLY . 6.9 ttt180 -177.22 163.85 2.12 Favored 'General case' 0 CA--C 1.517 -0.32 0 O-C-N 124.075 0.514 . . . . 0.0 110.419 177.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.2 m -137.05 111.81 9.41 Favored Pre-proline 0 N--CA 1.444 -0.774 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.972 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . 0.405 ' HG3' ' CD1' ' A' ' 48' ' ' LEU . 23.0 Cg_endo -72.98 165.79 31.82 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 122.02 1.813 . . . . 0.0 112.01 178.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.483 ' O ' ' CE2' ' A' ' 57' ' ' PHE . 4.3 mt -88.81 119.51 36.08 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.471 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -179.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 15.8 tptt -82.82 132.41 35.17 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.553 ' CD1' ' HB3' ' A' ' 118' ' ' CYS . 19.9 m-85 -117.56 -49.78 2.55 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.633 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 124.02 -1.63 9.13 Favored Glycine 0 CA--C 1.521 0.434 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.685 -178.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.4 mmtp -102.68 143.32 32.5 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 36.5 t -78.86 -1.26 34.16 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 124.315 1.01 . . . . 0.0 110.664 178.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -88.2 -57.48 2.91 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -178.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.9 m -72.44 -26.41 61.82 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 -179.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -71.37 -34.38 70.39 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 123.665 0.603 . . . . 0.0 110.154 177.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.99 160.81 14.37 Favored Pre-proline 0 N--CA 1.439 -0.995 0 CA-C-O 121.119 0.485 . . . . 0.0 110.354 179.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -74.48 141.3 28.13 Favored 'Trans proline' 0 N--CA 1.445 -1.36 0 C-N-CA 121.713 1.608 . . . . 0.0 113.555 175.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.509 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 20.8 Cg_endo -73.66 167.93 26.04 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 122.43 2.087 . . . . 0.0 111.671 179.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.456 ' CE ' ' OD2' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -133.13 60.61 1.7 Allowed 'General case' 0 C--O 1.239 0.543 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.236 179.417 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.493 ' CE1' ' O ' ' A' ' 70' ' ' LYS . 57.0 t-80 -74.79 145.6 42.78 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-O 123.995 1.855 . . . . 0.0 112.01 178.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -133.12 -85.27 0.46 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 119.49 -2.006 . . . . 0.0 109.796 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.493 ' O ' ' CE1' ' A' ' 68' ' ' HIS . 0.2 OUTLIER -72.64 -171.07 0.76 Allowed 'General case' 0 C--O 1.203 -1.379 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.166 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -77.97 41.65 0.36 Allowed 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.664 0.745 . . . . 0.0 111.415 178.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -169.51 -105.58 0.18 Allowed Glycine 0 C--O 1.21 -1.368 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -178.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -113.44 -87.99 0.56 Allowed 'General case' 0 C--N 1.317 -0.847 0 O-C-N 120.968 -1.313 . . . . 0.0 107.567 -177.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 117.46 -141.73 16.74 Favored Glycine 0 N--CA 1.443 -0.896 0 CA-C-O 118.525 -1.153 . . . . 0.0 111.211 -178.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 36.8 mttt -49.01 -89.57 0.0 OUTLIER 'General case' 0 C--O 1.223 -0.308 0 O-C-N 125.21 1.182 . . . . 0.0 110.233 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.497 ' CG2' ' O ' ' A' ' 76' ' ' THR . 0.6 OUTLIER -127.23 28.51 5.72 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.868 179.331 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.549 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 41.0 t0 -30.01 97.78 0.01 OUTLIER 'General case' 0 C--O 1.214 -0.8 0 C-N-CA 122.93 0.492 . . . . 0.0 111.795 -178.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -86.91 15.2 6.13 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -176.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.524 ' CE1' ' CD1' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -52.95 174.07 0.04 OUTLIER 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 174.484 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.13 157.65 15.8 Favored 'General case' 0 C--O 1.218 -0.596 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.324 177.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.524 ' CD1' ' CE1' ' A' ' 79' ' ' TYR . 2.8 mp -143.03 108.55 5.07 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.533 0.682 . . . . 0.0 109.161 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.52 ' CB ' ' CD1' ' A' ' 109' ' ' ILE . 7.2 pm0 -80.9 150.58 28.98 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 122.148 0.975 . . . . 0.0 110.205 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.488 ' CE1' ' HB2' ' A' ' 23' ' ' ALA . 15.8 t80 -141.16 137.03 16.39 Favored Pre-proline 0 N--CA 1.442 -0.87 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.161 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.484 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 19.4 Cg_endo -74.01 91.78 0.92 Allowed 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 123.293 2.662 . . . . 0.0 110.914 -178.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.0 t -95.48 109.1 21.35 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 122.194 0.997 . . . . 0.0 111.118 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -82.42 159.08 65.25 Favored Pre-proline 0 N--CA 1.443 -0.821 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.692 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -76.57 -40.78 0.51 Allowed 'Trans proline' 0 CA--C 1.501 -1.132 0 C-N-CA 122.324 2.016 . . . . 0.0 112.453 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -42.36 -32.2 0.49 Allowed 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 125.123 1.515 . . . . 0.0 109.854 178.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . 0.431 ' HA3' ' CE ' ' A' ' 15' ' ' LYS . . . 87.14 10.0 72.36 Favored Glycine 0 N--CA 1.438 -1.169 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 177.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.419 ' CD2' ' O ' ' A' ' 90' ' ' HIS . 3.8 p-80 -80.82 130.33 35.0 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -62.21 88.45 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.526 ' O ' ' CD2' ' A' ' 94' ' ' PHE . 7.7 t80 -36.42 146.72 0.03 OUTLIER 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 122.362 1.077 . . . . 0.0 110.809 -178.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -78.8 58.81 2.41 Favored 'General case' 0 C--N 1.317 -0.814 0 O-C-N 120.19 -1.569 . . . . 0.0 110.072 177.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.526 ' CD2' ' O ' ' A' ' 92' ' ' TYR . 29.6 p90 -79.45 -8.9 59.44 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 122.837 0.455 . . . . 0.0 111.544 178.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -92.47 -33.16 14.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 49.3 m -79.82 110.54 15.28 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . 0.41 ' CG ' ' N ' ' A' ' 98' ' ' LYS . 0.1 OUTLIER -58.86 -50.09 75.29 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.157 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.41 ' N ' ' CG ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -146.4 129.55 8.14 Favored Pre-proline 0 N--CA 1.432 -1.346 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -177.245 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -72.15 177.66 33.85 Favored 'Cis proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.135 -2.027 . . . . 0.0 111.967 -2.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.17 135.82 21.99 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 123.789 0.68 . . . . 0.0 109.731 178.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.93 172.71 13.42 Favored 'General case' 0 C--O 1.245 0.856 0 O-C-N 124.27 0.981 . . . . 0.0 111.246 178.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -57.3 158.74 9.75 Favored Pre-proline 0 N--CA 1.438 -1.033 0 CA-C-O 121.604 0.716 . . . . 0.0 112.193 175.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -75.78 -89.87 0.0 OUTLIER 'Trans proline' 0 C--O 1.205 -1.14 0 C-N-CA 122.212 1.942 . . . . 0.0 111.115 179.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 151.77 148.68 4.89 Favored Glycine 0 N--CA 1.438 -1.214 0 O-C-N 120.983 -1.073 . . . . 0.0 111.358 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -74.45 -35.47 3.72 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.149 1.9 . . . . 0.0 111.779 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.595 ' CB ' ' CE2' ' A' ' 11' ' ' TYR . . . -102.85 146.72 27.85 Favored 'General case' 0 N--CA 1.437 -1.078 0 O-C-N 124.232 0.958 . . . . 0.0 109.914 178.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.408 ' HG2' ' HA ' ' A' ' 84' ' ' PRO . 2.2 mtm-85 -146.44 148.82 32.67 Favored 'General case' 0 N--CA 1.445 -0.705 0 O-C-N 123.833 0.708 . . . . 0.0 111.417 179.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.442 ' CG1' ' HB3' ' A' ' 83' ' ' PHE . 3.8 p -82.63 117.71 29.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 123.19 0.596 . . . . 0.0 110.23 178.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.52 ' CD1' ' CB ' ' A' ' 82' ' ' GLU . 6.1 mm -96.01 140.71 16.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.511 ' CD1' ' HG3' ' A' ' 115' ' ' LYS . 9.0 p90 -167.18 152.25 7.33 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.789 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.6 p -87.76 163.86 16.26 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.715 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.562 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.2 OUTLIER -112.94 152.62 45.04 Favored Pre-proline 0 N--CA 1.434 -1.231 0 C-N-CA 123.209 0.604 . . . . 0.0 110.842 -179.783 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.562 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 17.8 Cg_endo -73.56 -55.46 0.14 OUTLIER 'Cis proline' 0 CA--C 1.512 -0.601 0 C-N-CA 122.0 -2.083 . . . . 0.0 110.64 -4.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -41.65 111.18 0.21 Allowed 'General case' 0 N--CA 1.438 -1.057 0 CA-C-O 116.093 -1.908 . . . . 0.0 110.342 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.511 ' HG3' ' CD1' ' A' ' 110' ' ' TYR . 0.1 OUTLIER -64.39 74.41 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.7 0 O-C-N 126.03 2.081 . . . . 0.0 108.755 -178.604 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . 0.411 ' O ' ' CG1' ' A' ' 116' ' ' VAL . 13.3 t -71.47 69.81 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 -178.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.564 ' CE1' ' HA2' ' A' ' 119' ' ' GLY . 9.8 t80 -36.48 111.06 0.13 Allowed 'General case' 0 N--CA 1.437 -1.078 0 C-N-CA 124.074 0.949 . . . . 0.0 109.849 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . 0.553 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 0.1 OUTLIER -94.28 -26.69 16.5 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.258 . . . . . . . . 3 3 . 1 . 006 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.564 ' HA2' ' CE1' ' A' ' 117' ' ' PHE . . . 137.39 -166.58 24.98 Favored Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 -178.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.449 ' CG2' ' SG ' ' A' ' 134' ' ' CYS . 3.5 mp -111.6 146.1 16.96 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.369 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 -177.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.496 ' CD1' ' CE1' ' A' ' 38' ' ' PHE . 6.2 pt -116.77 157.11 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 CA-C-N 119.237 0.926 . . . . 0.0 108.836 178.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.449 -0.511 0 CA-C-O 121.561 0.696 . . . . 0.0 110.126 177.965 . . . . . . . . 0 0 . 1 . 006 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.513 -0.477 0 CA-C-O 118.941 -0.552 . . . . 0.0 109.606 . . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.444 ' HB2' ' CG2' ' A' ' 55' ' ' ILE . 10.4 tp -89.6 136.47 33.02 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.396 1.06 . . . . 0.0 108.504 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . 0.449 ' SG ' ' CG2' ' A' ' 120' ' ' ILE . 70.7 m -56.97 -176.44 0.02 OUTLIER 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 124.793 1.237 . . . . 0.0 108.308 178.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 6.8 m -161.16 83.99 0.65 Allowed 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 0.528 ' CD2' ' CE2' ' A' ' 4' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--O 1.258 1.527 0 CA-C-O 116.11 -1.9 . . . . 0.0 112.143 175.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.9 p . . . . . 0 C--O 1.233 0.206 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 . . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.1 m -85.61 123.73 31.35 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 177.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . 0.421 ' CD1' ' HB2' ' A' ' 13' ' ' GLN . 35.0 m95 -86.18 142.58 28.52 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 122.913 0.485 . . . . 0.0 110.059 177.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -127.21 125.84 41.74 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 -176.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 7.2 m -120.7 53.75 1.1 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.691 178.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 132.68 -95.95 0.3 Allowed Glycine 0 C--O 1.223 -0.565 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -132.33 8.84 5.35 Favored Glycine 0 N--CA 1.469 0.897 0 C-N-CA 123.881 0.753 . . . . 0.0 113.624 177.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.52 140.28 49.3 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 124.85 1.26 . . . . 0.0 108.858 -176.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -105.24 116.5 32.05 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 124.509 1.131 . . . . 0.0 108.099 -170.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.424 ' CE2' ' CB ' ' A' ' 106' ' ' ALA . 73.8 m-85 -108.55 98.5 8.01 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 -172.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -55.14 117.87 3.86 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 177.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.457 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 6.4 tp-100 -51.0 -44.42 60.96 Favored 'General case' 0 C--O 1.214 -0.796 0 C-N-CA 119.814 -0.754 . . . . 0.0 112.853 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -48.42 -42.91 33.54 Favored 'General case' 0 C--O 1.201 -1.479 0 O-C-N 123.771 0.67 . . . . 0.0 112.217 175.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.9 mttt -69.52 -40.8 76.73 Favored 'General case' 0 C--O 1.212 -0.879 0 CA-C-N 120.068 1.304 . . . . 0.0 113.454 168.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -52.5 -40.38 62.33 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 121.688 2.04 . . . . 0.0 113.82 173.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -85.66 -43.83 13.09 Favored 'General case' 0 C--O 1.217 -0.616 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.603 173.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 41.0 t -71.36 -62.88 1.24 Allowed 'General case' 0 C--O 1.217 -0.62 0 C-N-CA 126.914 2.086 . . . . 0.0 110.839 -176.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -39.55 -38.16 0.57 Allowed 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 120.262 1.392 . . . . 0.0 111.673 168.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.1 p -83.51 -26.67 29.98 Favored 'General case' 0 C--O 1.218 -0.598 0 N-CA-C 116.464 2.024 . . . . 0.0 116.464 175.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 2.9 m170 -54.25 -32.99 57.44 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 125.186 1.394 . . . . 0.0 109.088 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -75.48 -41.39 55.6 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 125.086 1.355 . . . . 0.0 111.208 177.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.405 ' HB1' ' CZ ' ' A' ' 83' ' ' PHE . . . -39.04 125.47 1.25 Allowed Pre-proline 0 CA--C 1.539 0.526 0 C-N-CA 125.39 1.476 . . . . 0.0 111.503 174.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -71.02 123.2 9.47 Favored 'Trans proline' 0 N--CA 1.439 -1.68 0 C-N-CA 122.71 2.274 . . . . 0.0 109.101 -177.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.7 tp -60.41 97.17 0.05 OUTLIER 'General case' 0 C--O 1.222 -0.394 0 C-N-CA 124.18 0.992 . . . . 0.0 111.043 177.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -175.25 149.05 1.02 Allowed 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 123.729 0.812 . . . . 0.0 110.928 -176.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.439 ' HB3' ' CA ' ' A' ' 72' ' ' GLY . 3.6 t0 -82.02 82.74 7.51 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -178.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 68.22 81.29 0.19 Allowed Glycine 0 C--O 1.227 -0.317 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 175.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.35 47.3 0.97 Allowed 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 122.748 1.261 . . . . 0.0 112.778 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 68.2 p -134.14 154.85 50.96 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.286 -175.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -41.6 -61.4 2.19 Favored Glycine 0 C--O 1.228 -0.243 0 C-N-CA 124.189 0.899 . . . . 0.0 112.704 -178.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.9 t -65.0 -72.35 0.15 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 118.103 -0.951 . . . . 0.0 112.186 173.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 60.7 p 179.74 -55.2 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.955 0.902 . . . . 0.0 112.278 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.455 ' CD1' ' HD3' ' A' ' 84' ' ' PRO . 80.9 m-85 -71.34 142.93 87.38 Favored Pre-proline 0 N--CA 1.437 -1.083 0 O-C-N 124.821 1.325 . . . . 0.0 112.04 -178.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.409 ' HB2' ' CD1' ' A' ' 81' ' ' LEU . 27.8 Cg_endo -79.04 158.81 91.22 Favored 'Cis proline' 0 N--CA 1.442 -1.552 0 C-N-CA 122.159 -2.017 . . . . 0.0 110.713 6.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -140.91 157.72 44.97 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-O 118.582 -0.723 . . . . 0.0 111.944 178.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.513 ' CD1' ' HB2' ' A' ' 79' ' ' TYR . 21.5 t90 -58.4 149.7 24.2 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 122.943 1.354 . . . . 0.0 110.879 172.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.451 ' CZ ' ' CD1' ' A' ' 121' ' ' ILE . 8.1 t80 -123.69 83.87 2.2 Favored 'General case' 0 N--CA 1.434 -1.25 0 C-N-CA 127.515 2.326 . . . . 0.0 105.779 -174.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 71.1 p -36.46 -41.93 0.31 Allowed 'General case' 0 C--O 1.213 -0.849 0 CA-C-N 114.464 -1.244 . . . . 0.0 110.819 171.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 55.4 t30 57.05 20.08 5.2 Favored 'General case' 0 CA--C 1.55 0.965 0 CA-C-O 122.413 1.102 . . . . 0.0 111.028 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.84 -33.13 6.64 Favored Glycine 0 C--O 1.222 -0.626 0 CA-C-O 117.655 -1.636 . . . . 0.0 113.558 -171.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.58 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 84.3 m-85 -52.76 157.04 1.74 Allowed 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.328 1.451 . . . . 0.0 111.339 177.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.72 -31.2 46.29 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.635 0.731 . . . . 0.0 112.061 176.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.451 ' HA2' ' CZ2' ' A' ' 37' ' ' TRP . . . 114.83 34.47 1.52 Allowed Glycine 0 C--O 1.221 -0.699 0 CA-C-O 117.28 -1.845 . . . . 0.0 114.779 -174.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -147.54 -64.88 0.27 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.483 1.113 . . . . 0.0 112.219 -178.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -135.47 -100.81 0.64 Allowed Glycine 0 C--O 1.219 -0.804 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.88 -174.39 5.24 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.348 0.594 . . . . 0.0 109.79 178.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.58 ' HG ' ' CD1' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -101.47 168.87 8.47 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.507 -178.725 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -71.29 -179.13 3.34 Favored 'Trans proline' 0 N--CA 1.442 -1.53 0 C-N-CA 123.003 2.468 . . . . 0.0 112.166 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.15 104.0 11.33 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 119.98 -1.7 . . . . 0.0 110.014 174.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.43 71.21 0.52 Allowed Glycine 0 N--CA 1.469 0.863 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 177.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.66 169.29 21.83 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 124.013 0.925 . . . . 0.0 109.637 178.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.9 m -155.23 107.96 2.25 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 173.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -71.76 172.87 13.6 Favored 'Trans proline' 0 N--CA 1.444 -1.4 0 C-N-CA 122.817 2.345 . . . . 0.0 111.246 177.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.8 mt -85.82 132.9 30.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.92 149.28 25.76 Favored 'General case' 0 C--N 1.33 -0.265 0 O-C-N 121.499 -0.75 . . . . 0.0 109.87 175.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.465 ' CE2' ' SG ' ' A' ' 62' ' ' CYS . 21.0 m-85 -132.67 -49.48 0.9 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.616 1.167 . . . . 0.0 110.856 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 111.33 -3.32 28.12 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 125.008 1.29 . . . . 0.0 113.249 -174.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.87 128.9 40.39 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-O 117.724 -1.131 . . . . 0.0 109.728 176.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 22.5 p -61.82 -10.62 9.55 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 125.617 1.823 . . . . 0.0 112.718 176.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.14 -54.21 4.33 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 126.181 1.792 . . . . 0.0 110.505 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.465 ' SG ' ' CE2' ' A' ' 57' ' ' PHE . 2.6 t -73.34 -15.2 61.39 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 124.275 0.985 . . . . 0.0 113.092 174.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -84.68 -40.5 17.31 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.383 1.473 . . . . 0.0 110.259 173.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.63 155.41 3.9 Favored Pre-proline 0 CA--C 1.539 0.529 0 CA-C-O 122.636 1.208 . . . . 0.0 111.566 -178.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -69.02 138.02 39.1 Favored 'Trans proline' 0 N--CA 1.439 -1.689 0 C-N-CA 120.344 0.696 . . . . 0.0 112.411 175.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.412 ' HD2' ' CD1' ' A' ' 42' ' ' TYR . 27.9 Cg_endo -66.17 172.24 9.04 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 124.118 3.212 . . . . 0.0 110.713 173.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.7 mmtt -140.94 63.0 1.46 Allowed 'General case' 0 C--O 1.207 -1.133 0 CA-C-O 118.287 -0.863 . . . . 0.0 109.508 177.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 31.1 t-80 -74.29 163.86 27.3 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 123.433 0.458 . . . . 0.0 110.382 177.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 21.1 p -148.63 -173.37 4.32 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.483 1.113 . . . . 0.0 110.976 176.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.75 74.19 10.2 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 120.734 -1.229 . . . . 0.0 111.706 176.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -177.05 -46.46 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 124.281 1.033 . . . . 0.0 109.68 -179.255 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.439 ' CA ' ' HB3' ' A' ' 27' ' ' ASP . . . 120.66 -78.12 0.32 Allowed Glycine 0 N--CA 1.441 -1.017 0 O-C-N 124.441 1.088 . . . . 0.0 112.677 -174.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -119.99 61.61 0.85 Allowed 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 128.874 2.869 . . . . 0.0 109.003 -178.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -70.56 -106.36 0.04 OUTLIER Glycine 0 CA--C 1.526 0.725 0 CA-C-O 123.088 1.382 . . . . 0.0 111.506 -175.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.0 mttt -61.35 -90.05 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.68 0 O-C-N 120.201 -1.764 . . . . 0.0 113.353 174.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -128.77 15.37 6.42 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.641 177.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -29.38 97.33 0.01 OUTLIER 'General case' 0 C--O 1.214 -0.806 0 C-N-CA 126.126 1.77 . . . . 0.0 112.349 -175.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -88.53 58.0 4.48 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 119.866 -1.771 . . . . 0.0 107.527 -169.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.513 ' HB2' ' CD1' ' A' ' 37' ' ' TRP . 46.7 p90 -80.85 133.55 35.61 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 125.08 1.352 . . . . 0.0 108.885 -177.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.3 mt -71.2 126.33 29.32 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 176.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.431 HD21 ' CZ ' ' A' ' 110' ' ' TYR . 0.4 OUTLIER -120.23 141.79 49.62 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 177.962 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -103.84 166.14 10.6 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 175.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.444 ' CD1' ' HD2' ' A' ' 84' ' ' PRO . 7.6 t80 -152.85 127.04 4.47 Favored Pre-proline 0 CA--C 1.538 0.511 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.455 ' HD3' ' CD1' ' A' ' 34' ' ' TYR . 17.8 Cg_endo -71.66 118.39 5.63 Favored 'Trans proline' 0 N--CA 1.444 -1.416 0 C-N-CA 124.755 3.637 . . . . 0.0 110.312 -176.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.99 111.29 17.72 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.742 -1.117 . . . . 0.0 108.61 -177.118 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -79.31 157.64 75.13 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 177.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -73.52 -36.1 4.19 Favored 'Trans proline' 0 N--CA 1.448 -1.18 0 C-N-CA 122.636 2.224 . . . . 0.0 113.321 178.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -46.74 -29.93 2.16 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 126.911 2.084 . . . . 0.0 110.044 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.93 6.08 76.37 Favored Glycine 0 N--CA 1.44 -1.099 0 C-N-CA 125.367 1.46 . . . . 0.0 112.344 178.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.1 p-80 -76.56 128.7 35.24 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 177.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -56.82 106.79 0.33 Allowed 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 171.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.441 ' CD2' ' HG2' ' A' ' 84' ' ' PRO . 3.0 t80 -37.08 131.96 0.74 Allowed 'General case' 0 C--O 1.215 -0.715 0 C-N-CA 123.833 0.853 . . . . 0.0 108.852 176.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.27 59.68 0.08 Allowed 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.385 -0.822 . . . . 0.0 112.162 173.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.419 ' CD2' ' O ' ' A' ' 92' ' ' TYR . 6.5 p90 -72.92 -5.09 36.17 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 127.347 2.259 . . . . 0.0 112.196 174.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.68 -40.6 10.16 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 123.652 1.691 . . . . 0.0 110.166 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 74.9 m -76.93 97.72 4.69 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 120.348 -1.47 . . . . 0.0 108.393 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.6 pttm -59.16 -46.71 87.67 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.955 0.883 . . . . 0.0 111.81 177.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.46 126.35 8.12 Favored Pre-proline 0 CA--C 1.54 0.576 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.909 -179.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -69.47 171.75 51.01 Favored 'Cis proline' 0 N--CA 1.454 -0.842 0 C-N-CA 123.183 -1.591 . . . . 0.0 111.184 -5.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -128.77 146.05 51.01 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 123.612 0.765 . . . . 0.0 109.107 177.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -95.19 165.96 12.14 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 173.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -36.02 138.48 0.44 Allowed Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 125.034 1.334 . . . . 0.0 110.954 170.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -71.88 -68.43 0.02 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 123.174 2.583 . . . . 0.0 114.259 176.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 130.82 142.09 5.01 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -75.3 -66.62 0.02 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 123.468 2.778 . . . . 0.0 110.951 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.424 ' CB ' ' CE2' ' A' ' 11' ' ' TYR . . . -64.74 131.8 47.85 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.789 0.804 . . . . 0.0 111.356 178.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.75 150.61 44.99 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-N 114.63 -1.168 . . . . 0.0 110.057 -178.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.6 p -88.36 119.19 35.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 O-C-N 124.58 1.175 . . . . 0.0 110.454 178.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 1.2 mp -107.25 117.8 53.74 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.011 0 N-CA-C 105.847 -1.908 . . . . 0.0 105.847 -173.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.431 ' CZ ' HD21 ' A' ' 81' ' ' LEU . 5.9 p90 -136.06 151.53 49.94 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-O 122.732 1.253 . . . . 0.0 108.213 -178.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.8 p -83.46 157.23 22.51 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.142 177.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.458 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -105.47 157.16 35.12 Favored Pre-proline 0 CA--C 1.552 1.022 0 O-C-N 121.966 -0.459 . . . . 0.0 111.317 178.188 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.458 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 19.1 Cg_endo -72.35 -49.77 0.21 Allowed 'Cis proline' 0 N--CA 1.454 -0.807 0 C-N-CA 124.412 -1.078 . . . . 0.0 111.375 -11.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -48.06 105.14 0.07 Allowed 'General case' 0 C--O 1.224 -0.268 0 C-N-CA 124.113 0.965 . . . . 0.0 109.24 176.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.404 ' CG ' ' CD1' ' A' ' 110' ' ' TYR . 0.1 OUTLIER -61.85 79.87 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 126.113 1.765 . . . . 0.0 108.695 -178.152 . . . . . . . . 3 3 . 1 . 007 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 39.4 t -81.41 72.8 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 104.271 -2.492 . . . . 0.0 104.271 -177.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.457 ' CZ ' ' NE2' ' A' ' 13' ' ' GLN . 47.6 t80 -36.87 106.63 0.05 OUTLIER 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 125.864 1.665 . . . . 0.0 109.827 176.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 7.8 m -84.79 -45.51 12.28 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 -177.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 163.7 -146.78 11.96 Favored Glycine 0 N--CA 1.439 -1.149 0 CA-C-N 114.75 -1.113 . . . . 0.0 110.682 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 1.3 mm -127.5 141.1 47.27 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.925 0 N-CA-C 104.93 -2.248 . . . . 0.0 104.93 -177.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.451 ' CD1' ' CZ ' ' A' ' 38' ' ' PHE . 5.7 pt -130.51 150.44 34.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -178.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.321 -0.633 0 CA-C-O 121.439 0.638 . . . . 0.0 110.344 178.537 . . . . . . . . 0 0 . 1 . 007 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.513 -0.446 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 . . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 12.4 tp -82.24 136.2 35.11 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.606 -0.886 . . . . 0.0 108.606 178.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 64.1 m -67.08 -177.31 0.63 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 123.066 1.412 . . . . 0.0 109.979 173.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 2.1 m -158.72 124.6 4.48 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 104.836 -2.283 . . . . 0.0 104.836 -177.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 3.0 m80 . . . . . 0 C--N 1.324 -0.503 0 CA-C-O 117.228 -1.367 . . . . 0.0 113.238 175.039 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.7 p . . . . . 0 CA--C 1.531 0.228 0 CA-C-O 121.297 0.57 . . . . 0.0 111.271 . . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.58 114.59 21.63 Favored 'General case' 0 C--N 1.319 -0.723 0 O-C-N 122.092 -0.38 . . . . 0.0 110.538 178.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 23.0 m95 -81.17 139.57 35.48 Favored 'General case' 0 C--O 1.215 -0.721 0 O-C-N 121.994 -0.441 . . . . 0.0 110.345 177.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -130.69 138.5 50.06 Favored 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -178.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -122.85 61.71 1.0 Allowed 'General case' 0 N--CA 1.442 -0.852 0 O-C-N 124.092 0.87 . . . . 0.0 108.755 175.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 43.7 52.22 6.58 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 123.133 0.396 . . . . 0.0 112.115 179.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -164.29 -85.3 0.06 OUTLIER Glycine 0 C--O 1.224 -0.476 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -177.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -127.19 164.0 22.64 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 121.749 0.785 . . . . 0.0 110.098 177.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.9 mp -88.69 126.09 35.15 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -177.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.469 ' CZ ' ' CB ' ' A' ' 106' ' ' ALA . 70.2 m-85 -111.3 89.73 3.13 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 126.695 1.998 . . . . 0.0 108.586 -174.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -54.71 125.39 19.73 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.544 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 7.5 tp-100 -60.59 -21.66 62.87 Favored 'General case' 0 C--O 1.213 -0.838 0 C-N-CA 119.028 -1.069 . . . . 0.0 113.249 176.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -64.64 -23.46 67.27 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 172.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.2 mtmt -103.73 -36.65 7.79 Favored 'General case' 0 C--O 1.202 -1.424 0 C-N-CA 126.492 1.917 . . . . 0.0 109.782 175.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.27 -42.53 70.09 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 121.307 1.867 . . . . 0.0 111.736 177.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -84.13 -47.56 10.76 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-O 117.598 -1.191 . . . . 0.0 108.809 177.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.7 t -66.64 -53.01 38.62 Favored 'General case' 0 C--O 1.212 -0.884 0 CA-C-N 120.326 1.421 . . . . 0.0 109.514 -172.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.476 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 6.4 t-20 -42.78 -36.52 1.49 Allowed 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 123.946 0.898 . . . . 0.0 113.396 169.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.01 -33.95 29.82 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 172.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -46.2 -37.01 6.57 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 126.469 1.908 . . . . 0.0 109.925 178.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.476 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -73.13 -48.8 32.48 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 117.635 -1.174 . . . . 0.0 112.698 175.182 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.418 ' HB3' ' CE1' ' A' ' 83' ' ' PHE . . . -36.59 128.38 0.71 Allowed Pre-proline 0 N--CA 1.442 -0.873 0 O-C-N 125.487 1.742 . . . . 0.0 112.226 173.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -73.69 125.96 10.42 Favored 'Trans proline' 0 N--CA 1.444 -1.417 0 C-N-CA 121.979 1.786 . . . . 0.0 107.573 -175.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.442 ' CD1' ' HE2' ' A' ' 115' ' ' LYS . 3.4 tp -61.77 84.98 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 124.552 1.141 . . . . 0.0 111.911 177.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.4 m -174.43 155.12 2.24 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.165 0.986 . . . . 0.0 110.047 -173.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.434 ' HA ' ' HA ' ' A' ' 36' ' ' HIS . 0.2 OUTLIER -96.31 137.45 35.36 Favored 'General case' 0 CA--C 1.503 -0.849 0 CA-C-O 117.566 -1.207 . . . . 0.0 110.784 175.239 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 37.21 70.58 0.24 Allowed Glycine 0 C--N 1.338 0.673 0 O-C-N 125.008 1.442 . . . . 0.0 111.897 177.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -148.6 24.15 0.99 Allowed 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 121.997 0.903 . . . . 0.0 111.824 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 50.1 p -130.2 151.8 50.33 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -175.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -40.7 -64.98 1.1 Allowed Glycine 0 CA--C 1.505 -0.536 0 O-C-N 124.25 0.969 . . . . 0.0 112.764 -177.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 40.5 t -60.15 -60.99 2.94 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-O 115.809 -2.043 . . . . 0.0 112.641 174.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 161.16 -53.32 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.706 0 O-C-N 125.777 1.923 . . . . 0.0 111.863 176.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.46 ' CD2' ' HD3' ' A' ' 84' ' ' PRO . 62.2 m-85 -63.38 146.86 95.96 Favored Pre-proline 0 N--CA 1.438 -1.065 0 N-CA-C 114.757 1.392 . . . . 0.0 114.757 177.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -75.41 166.32 83.44 Favored 'Cis proline' 0 N--CA 1.446 -1.308 0 C-N-CA 123.442 -1.483 . . . . 0.0 110.862 0.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.454 ' CD2' ' CD2' ' A' ' 34' ' ' TYR . 0.8 OUTLIER -139.61 172.41 12.84 Favored 'General case' 0 CA--C 1.502 -0.884 0 O-C-N 120.867 -1.146 . . . . 0.0 109.89 -176.895 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.475 ' CH2' ' HA2' ' A' ' 44' ' ' GLY . 21.3 t90 -71.4 141.4 50.32 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.889 0.852 . . . . 0.0 108.825 177.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -121.05 83.0 2.0 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 -176.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.426 ' CG2' ' CH2' ' A' ' 37' ' ' TRP . 44.2 p -40.32 -31.23 0.13 Allowed 'General case' 0 C--O 1.212 -0.886 0 C-N-CA 124.512 1.125 . . . . 0.0 111.255 174.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.4 t30 71.32 7.67 6.14 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.039 1.735 . . . . 0.0 109.405 178.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 117.58 -11.32 14.02 Favored Glycine 0 N--CA 1.434 -1.481 0 O-C-N 120.592 -1.318 . . . . 0.0 113.169 -170.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.565 ' CE2' ' HA ' ' A' ' 47' ' ' LYS . 4.9 m-85 -75.93 176.26 8.04 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 118.364 1.082 . . . . 0.0 109.852 -176.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.62 -39.11 9.26 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.563 174.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.475 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -172.49 -82.55 0.05 OUTLIER Glycine 0 C--N 1.333 0.406 0 C-N-CA 123.571 0.605 . . . . 0.0 111.983 -178.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.83 -63.1 1.15 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 122.021 0.915 . . . . 0.0 110.438 178.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.97 166.49 12.88 Favored Glycine 0 C--N 1.34 0.751 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.565 ' HA ' ' CE2' ' A' ' 42' ' ' TYR . 1.2 pttt -53.91 -176.25 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 123.13 1.443 . . . . 0.0 113.095 174.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.07 156.77 79.63 Favored Pre-proline 0 C--N 1.313 -1.007 0 O-C-N 121.23 -0.919 . . . . 0.0 111.313 178.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -72.5 175.21 10.44 Favored 'Trans proline' 0 N--CA 1.447 -1.263 0 C-N-CA 122.225 1.95 . . . . 0.0 110.556 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.52 96.44 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.481 0 O-C-N 121.651 -0.656 . . . . 0.0 110.611 176.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.7 90.51 2.14 Favored Glycine 0 C--O 1.226 -0.4 0 CA-C-N 116.295 -0.412 . . . . 0.0 112.168 -176.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.18 162.63 4.51 Favored 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 123.808 0.843 . . . . 0.0 110.583 175.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 48.1 m -142.56 95.64 6.43 Favored Pre-proline 0 C--O 1.234 0.248 0 O-C-N 124.961 1.413 . . . . 0.0 110.132 -177.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -73.31 146.84 40.9 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.531 2.154 . . . . 0.0 110.071 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.3 mt -68.18 116.81 8.95 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.531 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -178.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.12 136.88 35.11 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 177.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.562 ' CD2' ' HB3' ' A' ' 118' ' ' CYS . 8.7 m-85 -114.96 -53.35 2.65 Favored 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 123.752 0.821 . . . . 0.0 110.128 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 128.99 -11.46 6.2 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 123.896 0.76 . . . . 0.0 112.845 -176.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.0 132.21 35.48 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-N 117.27 0.535 . . . . 0.0 110.739 176.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -73.32 0.78 11.05 Favored 'General case' 0 C--O 1.223 -0.297 0 O-C-N 124.875 1.36 . . . . 0.0 111.946 175.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.28 -54.37 4.34 Favored 'General case' 0 N--CA 1.446 -0.645 0 O-C-N 120.638 -1.289 . . . . 0.0 109.004 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.8 m -75.66 -35.17 60.48 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 124.617 1.198 . . . . 0.0 109.013 -179.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -59.73 -39.97 86.5 Favored 'General case' 0 C--N 1.343 0.324 0 O-C-N 124.362 1.039 . . . . 0.0 111.286 175.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.0 159.02 0.5 Allowed Pre-proline 0 N--CA 1.446 -0.648 0 CA-C-O 122.94 1.352 . . . . 0.0 111.536 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -70.55 133.18 23.55 Favored 'Trans proline' 0 N--CA 1.437 -1.8 0 C-N-CA 120.212 0.608 . . . . 0.0 112.573 175.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.464 ' CD ' ' CE2' ' A' ' 42' ' ' TYR . 22.3 Cg_endo -72.51 170.36 19.56 Favored 'Trans proline' 0 N--CA 1.446 -1.32 0 C-N-CA 125.103 3.868 . . . . 0.0 111.239 176.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -136.85 53.0 1.92 Allowed 'General case' 0 CA--C 1.497 -1.075 0 CA-C-O 116.835 -1.555 . . . . 0.0 108.123 -177.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 21.5 t-80 -75.62 167.38 22.0 Favored 'General case' 0 C--O 1.216 -0.676 0 O-C-N 123.971 0.795 . . . . 0.0 110.933 178.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -154.18 -166.62 2.41 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 121.383 -0.823 . . . . 0.0 111.4 176.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.25 70.54 10.14 Favored 'General case' 0 C--O 1.212 -0.878 0 O-C-N 120.001 -1.687 . . . . 0.0 111.81 175.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -177.08 -41.27 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 123.33 0.652 . . . . 0.0 109.73 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.412 ' O ' ' CE2' ' A' ' 79' ' ' TYR . . . 120.81 -76.31 0.32 Allowed Glycine 0 N--CA 1.442 -0.914 0 N-CA-C 109.839 -1.305 . . . . 0.0 109.839 -177.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -124.59 61.56 1.14 Allowed 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 -175.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -53.31 -102.94 0.01 OUTLIER Glycine 0 CA--C 1.535 1.33 0 CA-C-O 122.533 1.074 . . . . 0.0 113.855 178.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.7 mttm -72.3 -105.74 0.01 OUTLIER 'General case' 0 C--O 1.221 -0.442 0 O-C-N 120.51 -1.583 . . . . 0.0 110.916 175.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -105.36 19.04 21.26 Favored 'General case' 0 C--N 1.322 -0.597 0 O-C-N 121.05 -1.031 . . . . 0.0 110.782 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.43 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 1.2 m-20 -30.64 99.63 0.02 OUTLIER 'General case' 0 C--O 1.208 -1.117 0 C-N-CA 125.357 1.463 . . . . 0.0 110.665 -177.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -81.76 11.71 4.61 Favored 'General case' 0 C--O 1.221 -0.41 0 O-C-N 121.072 -1.017 . . . . 0.0 111.023 -176.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.486 ' CE2' HD23 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -38.6 141.46 0.26 Allowed 'General case' 0 N--CA 1.426 -1.653 0 CA-C-O 122.903 1.335 . . . . 0.0 114.559 170.625 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.86 157.96 29.65 Favored 'General case' 0 CA--C 1.509 -0.611 0 O-C-N 120.448 -1.407 . . . . 0.0 109.412 177.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.486 HD23 ' CE2' ' A' ' 79' ' ' TYR . 1.1 mt -143.95 129.43 19.01 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 178.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.484 ' CB ' ' CD1' ' A' ' 109' ' ' ILE . 1.1 pm0 -97.17 151.54 19.71 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-O 122.917 1.342 . . . . 0.0 111.382 178.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.418 ' CE1' ' HB3' ' A' ' 23' ' ' ALA . 74.4 t80 -141.42 130.75 12.61 Favored Pre-proline 0 N--CA 1.448 -0.57 0 CA-C-N 114.801 -1.09 . . . . 0.0 111.504 -178.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.46 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 18.1 Cg_endo -75.74 97.02 1.07 Allowed 'Trans proline' 0 N--CA 1.443 -1.468 0 C-N-CA 123.995 3.13 . . . . 0.0 109.516 -177.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.5 t -101.18 116.28 32.46 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 122.233 1.016 . . . . 0.0 111.06 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.429 ' CD2' ' NE2' ' A' ' 90' ' ' HIS . 57.4 m-85 -82.31 159.77 63.95 Favored Pre-proline 0 N--CA 1.445 -0.676 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.101 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -77.24 -39.36 0.59 Allowed 'Trans proline' 0 N--CA 1.444 -1.398 0 C-N-CA 122.374 2.049 . . . . 0.0 112.613 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -43.58 -31.03 0.66 Allowed 'General case' 0 N--CA 1.476 0.857 0 O-C-N 125.11 1.506 . . . . 0.0 110.773 175.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.18 13.63 68.26 Favored Glycine 0 N--CA 1.436 -1.337 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 176.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.429 ' NE2' ' CD2' ' A' ' 86' ' ' PHE . 7.7 p-80 -77.93 130.06 36.1 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -59.12 90.91 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 123.801 0.84 . . . . 0.0 109.748 175.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.468 ' CD2' ' HB3' ' A' ' 94' ' ' PHE . 3.8 t80 -38.51 139.71 0.38 Allowed 'General case' 0 C--O 1.217 -0.644 0 C-N-CA 124.385 1.074 . . . . 0.0 109.295 -177.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 8.2 ptpt -77.41 64.25 2.74 Favored 'General case' 0 C--N 1.315 -0.927 0 O-C-N 119.582 -1.949 . . . . 0.0 110.359 175.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.468 ' HB3' ' CD2' ' A' ' 92' ' ' TYR . 23.1 p90 -80.09 -12.89 59.63 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 123.518 0.727 . . . . 0.0 112.544 176.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.1 -33.13 14.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 122.313 1.054 . . . . 0.0 109.888 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.1 m -82.12 110.32 17.23 Favored 'General case' 0 CA--C 1.514 -0.439 0 O-C-N 120.73 -1.231 . . . . 0.0 109.598 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.9 pttt -58.17 -49.51 76.79 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-O 121.587 0.708 . . . . 0.0 110.096 178.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.3 tttm -140.87 126.68 11.36 Favored Pre-proline 0 N--CA 1.436 -1.149 0 C-N-CA 124.313 1.045 . . . . 0.0 110.0 -176.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -71.68 176.42 37.91 Favored 'Cis proline' 0 C--N 1.352 0.711 0 O-C-N 124.545 1.813 . . . . 0.0 110.665 -3.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 20.8 tttm -141.93 135.82 29.79 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -85.02 147.76 26.52 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.153 0.908 . . . . 0.0 109.396 176.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -43.9 152.13 0.48 Allowed Pre-proline 0 C--O 1.219 -0.539 0 C-N-CA 123.325 0.65 . . . . 0.0 112.438 176.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -71.83 -86.59 0.0 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.46 0 C-N-CA 121.214 1.276 . . . . 0.0 110.861 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 128.96 153.46 7.98 Favored Glycine 0 CA--C 1.529 0.925 0 O-C-N 120.84 -1.163 . . . . 0.0 111.835 -176.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -75.63 -61.15 0.04 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.404 0 C-N-CA 122.471 2.114 . . . . 0.0 110.102 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.469 ' CB ' ' CZ ' ' A' ' 11' ' ' TYR . . . -60.87 132.0 52.48 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 109.794 -0.446 . . . . 0.0 109.794 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.427 ' HG2' ' HA ' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -146.29 146.44 30.72 Favored 'General case' 0 CA--C 1.503 -0.843 0 O-C-N 124.109 0.881 . . . . 0.0 110.864 178.683 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.404 ' CG1' ' HB3' ' A' ' 83' ' ' PHE . 7.6 p -79.84 119.64 29.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.512 1.133 . . . . 0.0 110.243 177.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.484 ' CD1' ' CB ' ' A' ' 82' ' ' GLU . 7.0 mm -100.6 142.14 16.19 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.964 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.103 178.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.421 ' CD1' ' HG3' ' A' ' 115' ' ' LYS . 10.8 p90 -164.91 153.66 12.42 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-O 122.537 1.16 . . . . 0.0 110.278 -178.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.6 p -87.18 168.6 13.09 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.47 -178.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.522 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.4 OUTLIER -114.49 152.04 45.77 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 122.124 0.17 . . . . 0.0 111.302 177.763 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.522 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 14.3 Cg_endo -75.21 -51.56 0.16 OUTLIER 'Cis proline' 0 CA--C 1.494 -1.493 0 N-CA-C 108.48 -1.392 . . . . 0.0 108.48 -4.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -43.28 111.12 0.24 Allowed 'General case' 0 CA--C 1.5 -0.953 0 CA-C-O 116.59 -1.672 . . . . 0.0 109.912 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.442 ' HE2' ' CD1' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -68.66 67.96 0.14 Allowed 'General case' 0 CA--C 1.508 -0.646 0 O-C-N 125.944 2.027 . . . . 0.0 108.495 -177.989 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.6 t -73.15 72.65 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 -178.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.601 ' CZ ' ' HA2' ' A' ' 119' ' ' GLY . 41.5 t80 -41.72 116.61 0.81 Allowed 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 124.701 1.2 . . . . 0.0 109.22 179.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . 0.562 ' HB3' ' CD2' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -90.91 -41.55 11.09 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-O 121.637 0.732 . . . . 0.0 109.79 178.582 . . . . . . . . 3 3 . 1 . 008 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.601 ' HA2' ' CZ ' ' A' ' 117' ' ' PHE . . . 157.65 -171.65 34.83 Favored Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 111.569 -0.612 . . . . 0.0 111.569 -178.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 3.2 mp -109.71 147.06 14.37 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.983 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 7.0 pt -119.76 155.47 22.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 177.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.322 -0.598 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.572 . . . . . . . . 0 0 . 1 . 008 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.509 -0.613 0 CA-C-O 118.736 -0.649 . . . . 0.0 109.592 . . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 10.9 tp -66.34 133.11 49.85 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 71.3 m -57.83 -178.34 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 124.94 1.4 . . . . 0.0 110.34 176.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.2 m -161.34 112.63 1.76 Allowed 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 -178.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.241 0.636 0 CA-C-O 116.106 -1.902 . . . . 0.0 113.626 172.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.4 p . . . . . 0 N--CA 1.465 0.309 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.2 m -90.05 113.31 24.99 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -178.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . 0.548 ' CH2' ' CE1' ' A' ' 136' ' ' HIS . 33.1 m95 -82.61 141.06 32.84 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.038 177.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -130.65 138.23 49.97 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -177.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -133.33 -77.67 0.48 Allowed 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 176.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -75.54 34.96 1.16 Allowed Glycine 0 CA--C 1.533 1.209 0 CA-C-O 119.606 -0.552 . . . . 0.0 113.478 -179.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 72.3 5.05 61.83 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-N 118.453 1.126 . . . . 0.0 113.911 -170.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.48 139.29 42.21 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 -174.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.6 mp -94.26 129.19 41.0 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 124.256 0.973 . . . . 0.0 108.655 -174.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.46 ' CE2' ' CB ' ' A' ' 106' ' ' ALA . 77.6 m-85 -125.2 98.01 5.47 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 -170.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -52.77 122.81 9.85 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.485 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 6.6 tp-100 -54.7 -41.49 70.32 Favored 'General case' 0 C--O 1.21 -1.022 0 C-N-CA 119.089 -1.044 . . . . 0.0 111.781 -179.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -48.3 -44.19 33.69 Favored 'General case' 0 C--O 1.205 -1.287 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 173.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.6 mttt -69.93 -38.14 76.13 Favored 'General case' 0 C--O 1.211 -0.96 0 CA-C-O 117.03 -1.462 . . . . 0.0 114.295 167.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -52.9 -41.31 64.26 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 122.484 2.402 . . . . 0.0 114.081 170.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -85.98 -41.57 14.76 Favored 'General case' 0 C--O 1.214 -0.797 0 O-C-N 120.554 -1.341 . . . . 0.0 109.858 175.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 43.4 t -72.7 -59.13 2.87 Favored 'General case' 0 C--O 1.212 -0.882 0 C-N-CA 126.627 1.971 . . . . 0.0 109.665 -175.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.435 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 4.4 t-20 -39.39 -39.7 0.71 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 120.107 1.321 . . . . 0.0 113.773 168.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.8 -33.72 40.24 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 172.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 6.6 m170 -48.22 -36.46 13.89 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 126.334 1.854 . . . . 0.0 110.152 178.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.435 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -73.49 -45.94 50.97 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 125.119 1.368 . . . . 0.0 111.702 176.076 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -39.13 130.03 1.24 Allowed Pre-proline 0 CA--C 1.539 0.552 0 O-C-N 125.411 1.694 . . . . 0.0 111.871 173.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -72.56 129.71 15.03 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 N-CA-C 107.296 -1.848 . . . . 0.0 107.296 -176.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.8 tp -63.3 83.86 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 125.265 1.426 . . . . 0.0 111.693 178.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 179.15 144.92 0.15 Allowed 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.044 0.938 . . . . 0.0 109.456 -172.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.424 ' HA ' ' HA ' ' A' ' 36' ' ' HIS . 1.4 t0 -86.93 118.7 26.48 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.816 0.847 . . . . 0.0 110.134 179.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 54.16 63.65 4.98 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 175.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -127.83 11.48 6.65 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 123.412 1.577 . . . . 0.0 112.499 176.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.0 p -118.49 150.94 38.77 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 -171.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -44.04 -61.41 3.09 Favored Glycine 0 CA--C 1.506 -0.472 0 CA-C-O 119.142 -0.81 . . . . 0.0 111.959 -179.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.409 ' CA ' ' HE2' ' A' ' 100' ' ' LYS . 58.5 m -52.39 -66.96 0.29 Allowed 'General case' 0 CA--C 1.489 -1.396 0 CA-C-O 116.325 -1.798 . . . . 0.0 111.984 175.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.1 p 164.2 -64.4 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.655 0 O-C-N 126.712 2.507 . . . . 0.0 110.642 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.429 ' CD1' ' HD3' ' A' ' 84' ' ' PRO . 98.1 m-85 -59.6 149.1 72.49 Favored Pre-proline 0 N--CA 1.436 -1.172 0 CA-C-N 114.403 -1.272 . . . . 0.0 113.249 -177.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -74.29 166.23 83.17 Favored 'Cis proline' 0 N--CA 1.435 -1.951 0 C-N-CA 122.405 -1.915 . . . . 0.0 111.775 -2.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 27' ' ' ASP . 0.5 OUTLIER -140.94 170.78 15.1 Favored 'General case' 0 C--O 1.214 -0.787 0 O-C-N 121.105 -0.997 . . . . 0.0 110.984 -177.891 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.486 ' CD1' ' CD2' ' A' ' 79' ' ' TYR . 18.2 t90 -66.68 148.85 51.35 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 120.812 1.642 . . . . 0.0 109.539 173.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.46 ' CZ ' HD13 ' A' ' 121' ' ' ILE . 11.7 t80 -120.74 86.92 2.66 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 104.079 -2.563 . . . . 0.0 104.079 -175.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 71.6 p -41.68 -35.77 0.84 Allowed 'General case' 0 C--O 1.214 -0.792 0 CA-C-N 114.308 -1.315 . . . . 0.0 110.252 171.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.43 ' HB2' ' CE2' ' A' ' 38' ' ' PHE . 56.3 t30 56.04 20.36 4.29 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 120.337 1.426 . . . . 0.0 111.916 178.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.3 -41.17 2.23 Favored Glycine 0 N--CA 1.43 -1.728 0 CA-C-O 115.413 -2.882 . . . . 0.0 115.459 -167.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.401 ' CE2' ' HD3' ' A' ' 66' ' ' PRO . 83.6 m-85 -44.52 153.85 0.15 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 120.216 2.008 . . . . 0.0 112.558 174.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.59 -37.51 21.06 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 176.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.47 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -169.1 -72.58 0.04 OUTLIER Glycine 0 C--N 1.334 0.434 0 C-N-CA 124.529 1.061 . . . . 0.0 111.374 -178.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -113.59 -63.73 1.41 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.223 1.009 . . . . 0.0 110.669 -178.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.45 -173.32 0.62 Allowed Glycine 0 C--N 1.339 0.714 0 CA-C-O 122.299 0.944 . . . . 0.0 111.605 178.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.7 mttt -58.28 -171.46 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 124.555 2.121 . . . . 0.0 112.289 175.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -81.25 159.31 68.01 Favored Pre-proline 0 C--N 1.311 -1.086 0 O-C-N 120.102 -1.624 . . . . 0.0 110.232 -178.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -70.28 161.97 44.04 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 121.357 1.371 . . . . 0.0 109.481 177.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.47 100.26 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.993 0.917 . . . . 0.0 110.825 176.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.41 83.15 1.69 Allowed Glycine 0 N--CA 1.462 0.402 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.148 -174.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.7 mmt-85 -165.35 165.27 19.5 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 124.542 1.137 . . . . 0.0 110.993 173.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 87.6 m -140.69 96.8 7.46 Favored Pre-proline 0 N--CA 1.465 0.291 0 O-C-N 124.91 1.381 . . . . 0.0 109.538 -176.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -72.72 145.37 41.12 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.572 2.181 . . . . 0.0 110.291 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.3 mt -69.98 120.52 17.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.4 tmtt? -81.9 136.33 35.34 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 176.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -119.75 -48.7 2.36 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 123.808 0.843 . . . . 0.0 110.39 178.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 120.78 -2.92 11.98 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 125.053 1.311 . . . . 0.0 113.246 -175.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.46 134.65 39.38 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-N 118.459 1.129 . . . . 0.0 109.854 175.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.7 t -73.49 -2.05 20.99 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 125.427 1.704 . . . . 0.0 112.141 175.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -89.47 -51.42 5.55 Favored 'General case' 0 CA--C 1.509 -0.604 0 C-N-CA 124.936 1.294 . . . . 0.0 109.305 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.8 m -74.99 -35.4 62.04 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 124.5 1.125 . . . . 0.0 111.667 177.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -64.22 -30.24 71.31 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 124.086 0.866 . . . . 0.0 112.114 172.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.54 159.21 25.65 Favored Pre-proline 0 N--CA 1.449 -0.486 0 CA-C-O 121.739 0.78 . . . . 0.0 111.751 176.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -70.38 139.41 38.04 Favored 'Trans proline' 0 CA--C 1.546 1.12 0 C-N-CA 120.45 0.767 . . . . 0.0 113.202 174.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.401 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 19.7 Cg_endo -71.85 173.37 12.84 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 124.968 3.779 . . . . 0.0 111.671 178.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -134.99 47.92 2.32 Favored 'General case' 0 C--O 1.241 0.625 0 O-C-N 120.214 -1.554 . . . . 0.0 110.981 -177.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.458 ' HA ' ' OD2' ' A' ' 77' ' ' ASP . 56.5 t-80 -65.04 130.0 41.78 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 176.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.6 t -111.74 -93.7 0.45 Allowed 'General case' 0 N--CA 1.486 1.361 0 O-C-N 119.224 -2.173 . . . . 0.0 110.384 177.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.9 mptt -68.92 -175.01 0.66 Allowed 'General case' 0 C--O 1.219 -0.539 0 C-N-CA 124.93 1.292 . . . . 0.0 110.629 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -68.81 38.93 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 173.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.54 -105.89 0.19 Allowed Glycine 0 C--O 1.217 -0.955 0 N-CA-C 107.701 -2.159 . . . . 0.0 107.701 -177.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -110.2 -89.92 0.48 Allowed 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 125.928 2.775 . . . . 0.0 106.19 -175.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 119.62 -135.27 11.09 Favored Glycine 0 N--CA 1.448 -0.565 0 O-C-N 119.294 -2.128 . . . . 0.0 110.296 -174.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 72.8 mttt -66.32 -78.69 0.05 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.2 1.0 . . . . 0.0 110.017 -176.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -128.17 31.44 5.06 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 118.454 -0.784 . . . . 0.0 111.635 178.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.458 ' OD2' ' HA ' ' A' ' 68' ' ' HIS . 20.3 t0 -30.51 89.33 0.0 OUTLIER 'General case' 0 C--O 1.221 -0.438 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -177.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -85.52 11.92 9.59 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 119.681 -1.887 . . . . 0.0 109.322 -169.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.486 ' CD2' ' CD1' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -49.71 170.03 0.03 OUTLIER 'General case' 0 N--CA 1.438 -1.053 0 CA-C-O 123.463 1.601 . . . . 0.0 112.316 173.378 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.14 141.5 28.68 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 113.634 -1.621 . . . . 0.0 109.996 172.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.518 HD22 ' CZ ' ' A' ' 110' ' ' TYR . 0.2 OUTLIER -123.96 129.8 51.54 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 174.492 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.401 ' CD ' ' HE2' ' A' ' 36' ' ' HIS . 2.2 pm0 -91.47 164.25 13.87 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 122.689 1.233 . . . . 0.0 113.26 172.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.429 ' CD1' ' HD2' ' A' ' 84' ' ' PRO . 84.1 t80 -152.04 132.42 7.36 Favored Pre-proline 0 CA--C 1.533 0.321 0 O-C-N 120.319 -1.488 . . . . 0.0 112.836 179.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.429 ' HD3' ' CD1' ' A' ' 34' ' ' TYR . 19.3 Cg_endo -73.96 108.53 2.68 Favored 'Trans proline' 0 CA--C 1.506 -0.88 1 C-N-CA 125.498 4.132 . . . . 0.0 109.632 -176.794 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -109.03 110.12 21.32 Favored 'General case' 0 CA--C 1.509 -0.627 0 O-C-N 125.435 1.709 . . . . 0.0 109.638 -178.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -81.58 158.02 69.08 Favored Pre-proline 0 C--O 1.238 0.494 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.114 178.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -75.58 -38.21 1.45 Allowed 'Trans proline' 0 CA--C 1.507 -0.829 0 C-N-CA 122.172 1.915 . . . . 0.0 112.224 179.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -45.73 -30.98 1.78 Allowed 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 123.977 1.846 . . . . 0.0 110.534 177.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.63 -0.44 89.21 Favored Glycine 0 N--CA 1.435 -1.368 0 CA-C-N 114.733 -1.121 . . . . 0.0 112.875 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -62.7 131.14 47.94 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 175.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -57.08 96.41 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 170.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.493 ' CD2' ' HB3' ' A' ' 94' ' ' PHE . 6.1 t80 -41.65 143.88 0.45 Allowed 'General case' 0 C--O 1.217 -0.633 0 C-N-CA 123.584 0.754 . . . . 0.0 109.532 178.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 12.5 ptpt -75.18 61.36 1.13 Allowed 'General case' 0 C--N 1.316 -0.88 0 O-C-N 119.696 -1.877 . . . . 0.0 109.096 173.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.493 ' HB3' ' CD2' ' A' ' 92' ' ' TYR . 36.3 p90 -75.8 -4.1 38.75 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 115.999 -1.953 . . . . 0.0 112.061 173.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -105.71 -26.1 11.95 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 120.417 1.462 . . . . 0.0 111.154 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 6.0 m -102.1 106.59 17.48 Favored 'General case' 0 CA--C 1.503 -0.839 0 O-C-N 120.574 -1.329 . . . . 0.0 108.8 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.8 ptpt -70.75 -32.74 70.0 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.424 0.631 . . . . 0.0 112.3 175.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 29.7 tttt -129.5 113.82 18.09 Favored Pre-proline 0 CA--C 1.538 0.5 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -178.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -71.4 174.09 47.4 Favored 'Cis proline' 0 C--O 1.221 -0.331 0 C-N-CA 123.82 -1.325 . . . . 0.0 111.066 -3.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.409 ' HE2' ' CA ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -133.63 128.38 34.98 Favored 'General case' 0 CA--C 1.502 -0.891 0 C-N-CA 124.6 1.16 . . . . 0.0 109.694 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -98.96 134.14 42.23 Favored 'General case' 0 C--O 1.244 0.769 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 -178.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -43.42 132.22 3.61 Favored Pre-proline 0 CA--C 1.534 0.354 0 O-C-N 124.264 0.977 . . . . 0.0 110.615 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -68.39 -163.94 0.1 OUTLIER 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 122.761 2.307 . . . . 0.0 111.623 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -123.48 161.18 17.89 Favored Glycine 0 CA--C 1.525 0.663 0 O-C-N 121.128 -0.982 . . . . 0.0 111.992 176.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -73.22 -43.28 0.74 Allowed 'Trans proline' 0 N--CA 1.449 -1.122 0 C-N-CA 121.711 1.608 . . . . 0.0 109.433 177.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.46 ' CB ' ' CE2' ' A' ' 11' ' ' TYR . . . -80.38 134.07 35.98 Favored 'General case' 0 N--CA 1.448 -0.555 0 O-C-N 124.329 1.018 . . . . 0.0 110.849 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 4.9 mtm-85 -140.35 150.22 43.68 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.569 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.6 p -89.15 118.78 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 O-C-N 124.527 1.142 . . . . 0.0 111.469 177.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 1.4 mp -107.3 118.16 54.49 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.809 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 -172.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.518 ' CZ ' HD22 ' A' ' 81' ' ' LEU . 5.1 p90 -138.3 151.43 47.58 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-O 122.482 1.134 . . . . 0.0 108.032 -178.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.6 p -84.16 160.74 20.8 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.79 -1.095 . . . . 0.0 109.709 177.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.47 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -107.47 155.8 38.94 Favored Pre-proline 0 CA--C 1.555 1.14 0 CA-C-O 121.515 0.674 . . . . 0.0 110.639 178.956 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.47 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 14.9 Cg_endo -74.5 -48.94 0.25 Allowed 'Cis proline' 0 CA--C 1.506 -0.878 0 C-N-CA 124.475 -1.052 . . . . 0.0 110.574 -8.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -49.09 107.67 0.15 Allowed 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 117.171 -1.395 . . . . 0.0 108.96 177.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.416 ' CG ' ' CD1' ' A' ' 110' ' ' TYR . 0.1 OUTLIER -64.02 78.38 0.03 OUTLIER 'General case' 0 CA--C 1.508 -0.673 0 C-N-CA 125.724 1.61 . . . . 0.0 108.274 -177.965 . . . . . . . . 3 3 . 1 . 009 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.8 t -79.6 71.97 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 104.19 -2.522 . . . . 0.0 104.19 -176.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.485 ' CZ ' ' NE2' ' A' ' 13' ' ' GLN . 46.0 t80 -40.42 105.14 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.561 1.544 . . . . 0.0 109.036 177.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -82.86 -40.46 20.26 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-O 122.417 1.103 . . . . 0.0 109.204 -179.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.427 ' HA2' ' CZ ' ' A' ' 117' ' ' PHE . . . 162.56 -148.3 15.16 Favored Glycine 0 N--CA 1.435 -1.378 0 N-CA-C 109.811 -1.315 . . . . 0.0 109.811 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.418 HG13 ' CG ' ' A' ' 4' ' ' TRP . 1.3 mm -129.57 141.98 45.09 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.382 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 -175.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.46 HD13 ' CZ ' ' A' ' 38' ' ' PHE . 4.7 pt -127.96 154.77 38.93 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 -175.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.491 0 CA-C-O 121.397 0.617 . . . . 0.0 109.342 178.764 . . . . . . . . 0 0 . 1 . 009 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.506 -0.739 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 . . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 12.0 tp -83.45 143.93 29.93 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 124.474 1.109 . . . . 0.0 108.577 178.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 71.5 m -65.68 -175.13 0.25 Allowed 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 122.888 1.327 . . . . 0.0 111.165 173.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 18.6 p -131.78 96.33 3.92 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -177.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 0.548 ' CE1' ' CH2' ' A' ' 4' ' ' TRP . 27.9 p-80 . . . . . 0 C--O 1.246 0.913 0 CA-C-O 115.346 -2.264 . . . . 0.0 112.86 172.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 N--CA 1.447 -0.619 0 CA-C-O 120.687 0.28 . . . . 0.0 110.791 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.8 m -87.36 115.45 24.78 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 123.148 0.579 . . . . 0.0 111.071 178.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 14.5 m95 -83.1 140.58 32.56 Favored 'General case' 0 C--O 1.213 -0.858 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 m -124.55 133.84 53.17 Favored 'General case' 0 C--N 1.309 -1.155 0 O-C-N 120.478 -1.389 . . . . 0.0 108.787 -177.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . 0.402 ' HB3' ' CB ' ' A' ' 122' ' ' ALA . 3.7 m -120.79 56.89 0.99 Allowed 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 118.215 -0.898 . . . . 0.0 109.273 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 39.64 60.62 1.73 Allowed Glycine 0 C--N 1.345 1.043 0 O-C-N 124.648 1.218 . . . . 0.0 112.088 -178.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 178.74 -81.57 0.06 OUTLIER Glycine 0 C--N 1.334 0.467 0 N-CA-C 110.881 -0.887 . . . . 0.0 110.881 -177.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.9 mt -123.97 160.11 28.32 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.45 0.643 . . . . 0.0 109.827 178.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.0 mp -90.47 132.78 35.47 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 -177.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.537 ' CE2' ' CB ' ' A' ' 106' ' ' ALA . 65.4 m-85 -116.43 91.08 3.48 Favored 'General case' 0 N--CA 1.433 -1.279 0 C-N-CA 127.826 2.45 . . . . 0.0 109.213 -175.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.01 127.02 28.42 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-O 117.52 -1.229 . . . . 0.0 108.514 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.605 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 0.0 OUTLIER -50.38 -50.58 51.05 Favored 'General case' 0 C--O 1.209 -1.063 0 CA-C-O 116.752 -1.594 . . . . 0.0 110.682 -179.227 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.418 ' O ' ' CB ' ' A' ' 18' ' ' SER . 11.2 t-20 -47.45 -38.48 13.66 Favored 'General case' 0 C--O 1.191 -2.011 0 O-C-N 124.633 1.208 . . . . 0.0 110.232 177.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.25 -51.43 24.62 Favored 'General case' 0 C--O 1.2 -1.52 0 CA-C-O 116.687 -1.625 . . . . 0.0 113.376 170.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.59 -34.63 11.91 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 121.583 1.992 . . . . 0.0 112.687 173.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -89.91 -44.04 10.17 Favored 'General case' 0 N--CA 1.435 -1.183 0 C-N-CA 123.659 0.784 . . . . 0.0 109.68 177.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.418 ' CB ' ' O ' ' A' ' 14' ' ' ASN . 30.8 t -64.58 -25.65 68.06 Favored 'General case' 0 C--O 1.205 -1.242 0 C-N-CA 126.492 1.917 . . . . 0.0 106.787 -177.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -73.6 -53.37 10.64 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 119.153 -2.217 . . . . 0.0 108.711 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.26 -12.47 61.17 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 122.08 0.943 . . . . 0.0 111.626 177.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 1.4 m170 -62.28 -50.76 70.4 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 -176.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -74.03 -41.28 62.05 Favored 'General case' 0 N--CA 1.443 -0.8 0 O-C-N 124.418 1.074 . . . . 0.0 110.091 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.433 ' HB3' ' CE2' ' A' ' 83' ' ' PHE . . . -41.64 129.54 2.38 Favored Pre-proline 0 N--CA 1.445 -0.699 0 O-C-N 125.644 1.84 . . . . 0.0 111.332 178.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.417 ' HG2' ' CG2' ' A' ' 30' ' ' THR . 18.2 Cg_endo -73.03 126.57 11.33 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 121.923 1.748 . . . . 0.0 109.573 -177.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.461 ' CD1' ' HE3' ' A' ' 115' ' ' LYS . 4.1 tp -59.79 88.65 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.434 0 O-C-N 124.143 0.902 . . . . 0.0 111.19 178.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -175.88 167.12 3.08 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -176.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -115.19 132.34 56.64 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 117.704 -1.141 . . . . 0.0 109.579 177.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 50.71 62.0 5.59 Favored Glycine 0 C--N 1.34 0.796 0 N-CA-C 108.254 -1.938 . . . . 0.0 108.254 172.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -151.55 35.68 0.57 Allowed 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 122.304 1.05 . . . . 0.0 110.685 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 30' ' ' THR . . . . . 0.417 ' CG2' ' HG2' ' A' ' 24' ' ' PRO . 9.2 p -144.23 153.06 41.67 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -175.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -36.64 -78.33 0.04 OUTLIER Glycine 0 C--N 1.34 0.776 0 O-C-N 124.307 1.005 . . . . 0.0 111.314 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.462 ' O ' ' HE3' ' A' ' 100' ' ' LYS . 30.8 t -52.41 -61.52 2.23 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-O 117.681 -1.152 . . . . 0.0 110.669 177.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 162.04 -51.86 0.0 OUTLIER 'General case' 0 C--O 1.218 -0.592 0 O-C-N 125.521 1.763 . . . . 0.0 110.421 179.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.51 ' CD2' ' HD3' ' A' ' 84' ' ' PRO . 61.6 m-85 -61.82 151.33 79.73 Favored Pre-proline 0 N--CA 1.43 -1.474 0 CA-C-O 117.13 -1.414 . . . . 0.0 111.511 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -73.76 164.41 87.48 Favored 'Cis proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.032 -2.07 . . . . 0.0 111.931 -3.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -140.95 162.87 34.45 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-O 116.897 -1.525 . . . . 0.0 110.6 -178.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.493 ' CD1' ' HB2' ' A' ' 79' ' ' TYR . 18.2 t90 -60.69 139.26 57.93 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 124.143 0.902 . . . . 0.0 108.772 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.513 ' CD2' ' HB2' ' A' ' 40' ' ' ASN . 25.7 t80 -110.98 79.02 1.16 Allowed 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 -176.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 23.6 p -37.79 -34.57 0.11 Allowed 'General case' 0 C--O 1.214 -0.782 0 C-N-CA 124.265 1.026 . . . . 0.0 110.778 175.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.513 ' HB2' ' CD2' ' A' ' 38' ' ' PHE . 43.4 t30 57.63 19.25 5.28 Favored 'General case' 0 C--O 1.209 -1.068 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 174.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.443 ' CA ' ' HD2' ' A' ' 52' ' ' ARG . . . 112.49 -46.94 1.1 Allowed Glycine 0 N--CA 1.421 -2.364 0 O-C-N 118.682 -2.511 . . . . 0.0 112.353 -171.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.465 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 58.2 m-85 -49.63 144.87 5.55 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 124.285 1.034 . . . . 0.0 110.372 -177.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.78 -35.79 26.21 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.214 178.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -164.13 -100.32 0.15 Allowed Glycine 0 N--CA 1.442 -0.906 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.89 175.98 8.33 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 118.111 -0.947 . . . . 0.0 109.778 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.401 ' O ' ' HD2' ' A' ' 66' ' ' PRO . . . 38.51 -156.93 0.01 OUTLIER Glycine 0 C--N 1.349 1.264 0 CA-C-O 123.14 1.411 . . . . 0.0 112.08 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.45 ' HA ' ' CE1' ' A' ' 42' ' ' TYR . 0.8 OUTLIER -65.11 -172.17 0.09 Allowed 'General case' 0 N--CA 1.444 -0.737 0 O-C-N 120.267 -1.726 . . . . 0.0 111.727 174.869 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.465 ' HG ' ' CD1' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -87.93 174.76 4.84 Favored Pre-proline 0 N--CA 1.441 -0.924 0 O-C-N 120.51 -1.369 . . . . 0.0 109.109 -178.774 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -73.92 -175.7 2.26 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 122.335 2.023 . . . . 0.0 111.734 178.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.4 tttt -67.47 94.89 0.43 Allowed 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 121.134 -0.979 . . . . 0.0 109.751 177.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.47 91.3 1.73 Allowed Glycine 0 CA--C 1.5 -0.866 0 CA-C-O 118.807 -0.996 . . . . 0.0 110.885 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.443 ' HD2' ' CA ' ' A' ' 41' ' ' GLY . 0.1 OUTLIER -177.11 155.94 1.22 Allowed 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 123.767 0.827 . . . . 0.0 110.58 177.661 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.1 m -141.33 98.31 6.66 Favored Pre-proline 0 C--N 1.327 -0.39 0 O-C-N 124.374 1.046 . . . . 0.0 110.763 -178.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -71.23 177.46 6.57 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 122.24 1.96 . . . . 0.0 112.024 179.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.405 ' O ' ' CE1' ' A' ' 57' ' ' PHE . 5.4 mt -97.96 136.64 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -179.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.43 155.25 18.59 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 177.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.541 ' CD2' ' HB3' ' A' ' 118' ' ' CYS . 9.4 m-85 -140.26 -47.72 0.44 Allowed 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 123.765 0.826 . . . . 0.0 111.046 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 119.73 -3.72 13.27 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 116.284 -0.416 . . . . 0.0 112.148 -177.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -95.73 134.73 38.32 Favored 'General case' 0 CA--C 1.501 -0.925 0 CA-C-O 118.096 -0.954 . . . . 0.0 108.708 -179.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.7 t -72.15 -5.33 34.77 Favored 'General case' 0 C--O 1.221 -0.428 0 O-C-N 124.971 1.419 . . . . 0.0 111.581 177.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -91.92 -51.0 5.42 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 -177.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.9 m -75.15 -37.52 61.32 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -178.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -59.91 -41.63 92.13 Favored 'General case' 0 C--N 1.343 0.305 0 CA-C-O 121.927 0.87 . . . . 0.0 109.857 176.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -49.41 160.69 0.53 Allowed Pre-proline 0 N--CA 1.439 -1.024 0 CA-C-O 122.672 1.225 . . . . 0.0 110.177 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -75.21 144.84 30.04 Favored 'Trans proline' 0 N--CA 1.441 -1.592 0 C-N-CA 120.99 1.126 . . . . 0.0 113.231 175.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.459 ' HG3' ' CD2' ' A' ' 42' ' ' TYR . 21.0 Cg_endo -75.25 168.75 23.97 Favored 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 123.584 2.856 . . . . 0.0 111.443 178.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.1 tptt -132.22 52.18 2.09 Favored 'General case' 0 C--O 1.207 -1.17 0 CA-C-O 117.683 -1.151 . . . . 0.0 108.899 -178.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.454 ' CE1' ' O ' ' A' ' 70' ' ' LYS . 49.0 t-80 -83.84 158.56 21.63 Favored 'General case' 0 C--O 1.216 -0.672 0 CA-C-N 119.048 0.84 . . . . 0.0 110.011 179.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -175.71 -36.23 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.6 0.76 . . . . 0.0 109.658 173.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . 0.454 ' O ' ' CE1' ' A' ' 68' ' ' HIS . 0.0 OUTLIER -81.39 -171.51 3.32 Favored 'General case' 0 C--O 1.212 -0.909 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 178.389 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -82.69 36.34 0.49 Allowed 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 122.038 0.923 . . . . 0.0 111.827 177.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.427 ' O ' ' CE2' ' A' ' 79' ' ' TYR . . . 159.82 -83.67 0.13 Allowed Glycine 0 N--CA 1.44 -1.06 0 O-C-N 120.009 -1.682 . . . . 0.0 111.051 -177.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.442 ' OD1' ' CE1' ' A' ' 79' ' ' TYR . 0.5 OUTLIER -143.73 75.89 1.49 Allowed 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 117.436 -1.269 . . . . 0.0 108.548 179.366 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -33.52 -94.89 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 119.517 1.053 . . . . 0.0 114.719 176.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.2 mttm -85.16 -108.88 0.05 OUTLIER 'General case' 0 C--O 1.216 -0.685 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.436 176.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.422 ' O ' ' CG2' ' A' ' 76' ' ' THR . 0.5 OUTLIER -101.55 21.8 13.72 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 123.892 0.877 . . . . 0.0 111.046 -179.949 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.435 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 5.6 m-20 -30.25 104.56 0.03 OUTLIER 'General case' 0 C--O 1.19 -2.035 0 C-N-CA 124.292 1.037 . . . . 0.0 111.576 -177.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -80.76 10.69 4.59 Favored 'General case' 0 C--N 1.314 -0.951 0 O-C-N 118.081 -2.887 . . . . 0.0 110.824 -177.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.526 ' CE2' HD23 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -38.37 141.01 0.27 Allowed 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 115.65 1.722 . . . . 0.0 115.65 172.948 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.68 158.49 30.98 Favored 'General case' 0 C--N 1.317 -0.811 0 O-C-N 120.101 -1.624 . . . . 0.0 110.237 178.291 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.526 HD23 ' CE2' ' A' ' 79' ' ' TYR . 1.3 mt -140.31 133.75 29.98 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.3 pm0 -101.65 151.69 21.71 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-O 122.489 1.138 . . . . 0.0 108.906 -178.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.433 ' CE2' ' HB3' ' A' ' 23' ' ' ALA . 7.8 t80 -141.84 132.44 12.92 Favored Pre-proline 0 N--CA 1.44 -0.969 0 O-C-N 121.33 -0.856 . . . . 0.0 111.989 -179.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.51 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 18.6 Cg_endo -74.47 93.74 0.92 Allowed 'Trans proline' 0 N--CA 1.449 -1.145 0 C-N-CA 123.657 2.905 . . . . 0.0 110.264 -177.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.3 t -93.34 119.33 32.35 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 122.437 1.113 . . . . 0.0 111.028 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.645 ' CD2' ' CE1' ' A' ' 90' ' ' HIS . 25.1 m-85 -84.43 151.83 59.82 Favored Pre-proline 0 N--CA 1.438 -1.067 0 O-C-N 121.005 -1.059 . . . . 0.0 111.029 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -78.06 -42.46 0.24 Allowed 'Trans proline' 0 CA--C 1.503 -1.073 0 C-N-CA 122.291 1.994 . . . . 0.0 112.718 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -42.9 -33.33 0.76 Allowed 'General case' 0 C--N 1.348 0.533 0 O-C-N 126.032 2.082 . . . . 0.0 110.161 176.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 99.92 16.34 28.56 Favored Glycine 0 N--CA 1.432 -1.6 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 178.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.645 ' CE1' ' CD2' ' A' ' 86' ' ' PHE . 2.0 p-80 -87.93 131.16 34.7 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.82 100.67 1.96 Allowed 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 176.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.483 ' O ' ' CD2' ' A' ' 94' ' ' PHE . 19.9 t80 -35.77 140.74 0.1 Allowed 'General case' 0 C--O 1.205 -1.271 0 CA-C-O 122.051 0.929 . . . . 0.0 112.172 177.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.91 61.69 2.57 Favored 'General case' 0 C--N 1.315 -0.892 0 O-C-N 119.032 -2.293 . . . . 0.0 109.418 178.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.483 ' CD2' ' O ' ' A' ' 92' ' ' TYR . 30.4 p90 -76.07 4.13 9.08 Favored 'General case' 0 N--CA 1.439 -1.025 0 C-N-CA 124.077 0.951 . . . . 0.0 111.832 177.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -104.45 -33.3 8.64 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-O 122.578 1.18 . . . . 0.0 109.242 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 14.3 m -98.54 95.79 7.53 Favored 'General case' 0 CA--C 1.506 -0.725 0 O-C-N 120.554 -1.341 . . . . 0.0 107.915 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.48 -35.39 65.67 Favored 'General case' 0 C--O 1.22 -0.448 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 177.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.56 105.77 43.21 Favored Pre-proline 0 N--CA 1.437 -1.121 0 O-C-N 120.006 -1.684 . . . . 0.0 109.451 -179.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -73.88 172.14 63.0 Favored 'Cis proline' 0 C--O 1.213 -0.737 0 O-C-N 124.416 1.745 . . . . 0.0 112.039 -1.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.462 ' HE3' ' O ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -118.2 127.32 53.64 Favored 'General case' 0 CA--C 1.511 -0.54 0 C-N-CA 123.408 0.683 . . . . 0.0 109.544 -178.798 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -82.34 149.76 27.57 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.857 1.348 . . . . 0.0 110.218 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -51.31 139.25 26.57 Favored Pre-proline 0 N--CA 1.43 -1.448 0 CA-C-O 122.364 1.078 . . . . 0.0 112.546 172.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -73.61 -164.22 0.19 Allowed 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 121.689 1.593 . . . . 0.0 111.885 177.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -140.14 158.94 26.02 Favored Glycine 0 N--CA 1.441 -0.986 0 O-C-N 121.338 -0.851 . . . . 0.0 112.368 177.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -74.88 -62.56 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.471 2.114 . . . . 0.0 110.867 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.537 ' CB ' ' CE2' ' A' ' 11' ' ' TYR . . . -67.57 133.88 50.23 Favored 'General case' 0 N--CA 1.436 -1.174 0 O-C-N 123.868 0.73 . . . . 0.0 110.488 179.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.33 147.03 39.25 Favored 'General case' 0 CA--C 1.498 -1.039 0 CA-C-O 117.206 -1.378 . . . . 0.0 111.51 178.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . 0.45 HG23 ' CE2' ' A' ' 117' ' ' PHE . 3.2 p -83.24 120.14 33.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 C-N-CA 124.221 1.008 . . . . 0.0 110.985 177.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.5 HG23 ' CE2' ' A' ' 38' ' ' PHE . 1.7 mp -105.84 124.35 60.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 -175.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.462 ' CD1' ' HG3' ' A' ' 115' ' ' LYS . 19.3 p90 -142.27 164.2 30.78 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-O 121.661 0.743 . . . . 0.0 111.074 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.6 p -91.88 163.67 13.95 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -177.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.54 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.2 OUTLIER -117.04 152.22 48.52 Favored Pre-proline 0 N--CA 1.434 -1.226 0 C-N-CA 123.292 0.637 . . . . 0.0 110.646 -179.72 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.54 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 19.1 Cg_endo -73.48 -51.68 0.16 OUTLIER 'Cis proline' 0 CA--C 1.51 -0.717 0 C-N-CA 122.252 -1.978 . . . . 0.0 109.484 -5.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -41.64 111.69 0.25 Allowed 'General case' 0 N--CA 1.438 -1.064 0 CA-C-O 113.612 -3.089 . . . . 0.0 110.012 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.462 ' HG3' ' CD1' ' A' ' 110' ' ' TYR . 0.1 OUTLIER -65.76 68.89 0.05 OUTLIER 'General case' 0 CA--C 1.508 -0.669 0 O-C-N 127.12 2.763 . . . . 0.0 108.562 -178.707 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 24.2 t -74.29 64.28 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 106.028 -1.842 . . . . 0.0 106.028 -177.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.605 ' CZ ' ' NE2' ' A' ' 13' ' ' GLN . 2.0 t80 -36.71 124.65 0.85 Allowed 'General case' 0 N--CA 1.432 -1.347 0 O-C-N 120.61 -1.306 . . . . 0.0 108.946 178.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . 0.541 ' HB3' ' CD2' ' A' ' 57' ' ' PHE . 0.1 OUTLIER -101.41 -38.23 8.1 Favored 'General case' 0 N--CA 1.439 -1.008 0 O-C-N 123.836 0.71 . . . . 0.0 109.383 177.29 . . . . . . . . 3 3 . 1 . 010 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.547 ' HA2' ' CZ ' ' A' ' 117' ' ' PHE . . . 158.68 -159.9 30.61 Favored Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 -178.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 3.4 mp -117.91 145.4 23.86 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.349 0 CA-C-O 117.383 -1.294 . . . . 0.0 107.947 -178.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.414 HD13 ' CE1' ' A' ' 38' ' ' PHE . 6.6 pt -110.27 158.5 10.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-N 120.959 1.708 . . . . 0.0 109.101 178.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . 0.402 ' CB ' ' HB3' ' A' ' 6' ' ' CYS . . . . . . . . 0 N--CA 1.44 -0.946 0 C-N-CA 124.063 0.945 . . . . 0.0 109.648 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 11.4 ptpt . . . . . 0 CA--C 1.505 -0.786 0 CA-C-O 118.521 -0.752 . . . . 0.0 109.975 . . . . . . . . . 0 0 . 1 . 010 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.447 HD21 ' CD2' ' A' ' 57' ' ' PHE . 9.7 tp -83.99 139.71 32.37 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 72.1 m -58.98 -174.37 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.913 0 CA-C-O 124.124 1.916 . . . . 0.0 108.594 177.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.38 120.85 0.96 Allowed 'General case' 0 C--N 1.314 -0.949 0 O-C-N 120.057 -1.652 . . . . 0.0 108.575 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 1.8 m80 . . . . . 0 C--O 1.253 1.255 0 CA-C-O 115.143 -2.36 . . . . 0.0 111.847 177.212 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.2 p . . . . . 0 C--O 1.234 0.237 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -85.65 117.54 24.6 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.693 177.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . 0.601 ' CH2' ' CE1' ' A' ' 136' ' ' HIS . 26.9 m95 -85.02 140.76 30.78 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.036 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -136.05 132.87 36.78 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -176.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -119.05 69.39 0.81 Allowed 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 34.79 86.65 0.01 OUTLIER Glycine 0 CA--C 1.53 0.983 0 C-N-CA 124.037 0.827 . . . . 0.0 113.648 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 147.78 -74.05 0.29 Allowed Glycine 0 N--CA 1.462 0.403 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 -176.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.7 mt -131.16 160.18 35.53 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -102.27 154.74 18.76 Favored 'General case' 0 C--O 1.218 -0.597 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.442 178.116 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.476 ' CE1' ' CB ' ' A' ' 106' ' ' ALA . 30.6 m-85 -134.59 108.84 8.28 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -178.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -55.89 120.2 7.02 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 177.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.497 ' HB2' ' CD1' ' A' ' 4' ' ' TRP . 8.4 tp-100 -54.8 -42.01 71.28 Favored 'General case' 0 CA--C 1.503 -0.846 0 C-N-CA 119.959 -0.697 . . . . 0.0 112.387 178.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -50.35 -26.05 4.49 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 124.029 0.831 . . . . 0.0 112.306 177.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.2 mttp -96.36 -34.25 11.63 Favored 'General case' 0 C--O 1.219 -0.503 0 C-N-CA 124.569 1.148 . . . . 0.0 112.49 170.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.02 -39.52 69.2 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 120.406 1.457 . . . . 0.0 111.851 176.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -87.38 -44.56 11.27 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 122.962 0.505 . . . . 0.0 110.204 175.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.2 t -69.21 -57.67 5.06 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 118.959 0.799 . . . . 0.0 112.292 -177.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.496 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 3.9 t-20 -44.89 -30.97 1.1 Allowed 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 170.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 p -83.64 -33.34 25.3 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 175.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -47.84 -36.79 12.53 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.037 0.935 . . . . 0.0 109.919 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.496 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.1 OUTLIER -70.17 -47.96 59.36 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 124.577 1.151 . . . . 0.0 110.573 177.87 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.407 ' HB1' ' CE1' ' A' ' 83' ' ' PHE . . . -39.61 127.21 1.46 Allowed Pre-proline 0 CA--C 1.537 0.447 0 O-C-N 124.602 1.189 . . . . 0.0 110.606 176.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -72.79 124.69 9.9 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 121.546 1.497 . . . . 0.0 109.096 -177.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.8 tp -60.78 94.36 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 123.542 0.737 . . . . 0.0 111.291 178.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 179.89 160.35 0.84 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.35 -174.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -99.86 116.18 31.33 Favored 'General case' 0 CA--C 1.51 -0.567 0 C-N-CA 123.826 0.85 . . . . 0.0 108.898 177.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 50.51 72.47 0.49 Allowed Glycine 0 CA--C 1.528 0.873 0 O-C-N 124.394 1.059 . . . . 0.0 112.426 176.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.17 22.03 1.55 Allowed 'General case' 0 N--CA 1.473 0.708 0 O-C-N 122.429 -0.453 . . . . 0.0 112.033 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 33.5 p -121.91 156.8 32.58 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -176.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -43.68 -52.01 6.63 Favored Glycine 0 C--N 1.332 0.337 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.989 -178.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 12.2 t -68.03 -79.48 0.05 Allowed 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 119.306 -0.378 . . . . 0.0 111.235 173.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 89.1 p -178.42 -59.05 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 124.803 1.241 . . . . 0.0 109.83 -178.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.479 ' CE1' ' HB3' ' A' ' 103' ' ' PRO . 81.6 m-85 -63.57 148.95 93.22 Favored Pre-proline 0 CA--C 1.552 1.022 0 C-N-CA 123.303 0.641 . . . . 0.0 112.375 -176.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -74.9 169.77 73.56 Favored 'Cis proline' 0 N--CA 1.455 -0.736 0 O-C-N 123.524 1.276 . . . . 0.0 112.116 1.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.427 ' CD2' ' CD2' ' A' ' 34' ' ' TYR . 1.4 p80 -142.5 169.22 17.98 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 -177.29 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.47 ' CD1' ' HB2' ' A' ' 79' ' ' TYR . 20.5 t90 -71.65 129.22 38.16 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.549 ' CD2' HG21 ' A' ' 109' ' ' ILE . 33.9 t80 -99.48 82.74 2.7 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 105.869 -1.901 . . . . 0.0 105.869 179.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.41 ' CG2' ' CZ3' ' A' ' 37' ' ' TRP . 41.6 p -39.51 -33.5 0.17 Allowed 'General case' 0 CA--C 1.503 -0.845 0 CA-C-N 114.337 -1.301 . . . . 0.0 110.815 170.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.472 ' HB2' ' CD2' ' A' ' 38' ' ' PHE . 59.0 t30 55.63 20.13 3.7 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 123.558 1.646 . . . . 0.0 112.125 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.403 ' HA2' ' NE ' ' A' ' 52' ' ' ARG . . . 110.08 -44.52 1.48 Allowed Glycine 0 N--CA 1.436 -1.331 0 CA-C-O 116.039 -2.534 . . . . 0.0 113.661 -170.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.473 ' CE2' ' HD3' ' A' ' 66' ' ' PRO . 76.9 m-85 -45.94 150.99 0.5 Allowed 'General case' 0 C--N 1.343 0.296 0 C-N-CA 125.779 1.631 . . . . 0.0 110.666 -178.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.4 -37.73 27.67 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.049 178.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.433 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -164.29 -77.66 0.03 OUTLIER Glycine 0 C--N 1.335 0.503 0 N-CA-C 111.189 -0.765 . . . . 0.0 111.189 -178.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -113.22 -62.78 1.54 Allowed 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 123.289 0.636 . . . . 0.0 111.377 -178.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.6 -169.85 0.11 Allowed Glycine 0 C--N 1.342 0.892 0 C-N-CA 124.408 1.004 . . . . 0.0 111.135 177.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.9 mtpt -59.53 -169.49 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 123.279 1.514 . . . . 0.0 111.701 176.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -93.18 176.58 2.44 Favored Pre-proline 0 C--N 1.318 -0.783 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.309 -178.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -70.83 158.85 54.43 Favored 'Trans proline' 0 N--CA 1.444 -1.386 0 O-C-N 123.807 1.425 . . . . 0.0 110.967 178.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.4 ttpp -64.71 97.23 0.21 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.263 176.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 119.19 40.12 0.65 Allowed Glycine 0 N--CA 1.464 0.509 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.853 -177.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.403 ' NE ' ' HA2' ' A' ' 41' ' ' GLY . 0.2 OUTLIER -122.07 159.79 26.34 Favored 'General case' 0 CA--C 1.513 -0.471 0 C-N-CA 122.837 0.455 . . . . 0.0 110.703 175.761 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 53.3 m -136.03 98.9 11.42 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.621 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -72.37 179.19 5.28 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.668 2.245 . . . . 0.0 111.275 177.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.8 mt -107.17 140.48 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -95.89 146.45 24.57 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 121.533 0.682 . . . . 0.0 109.621 176.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.506 ' CD1' ' HB3' ' A' ' 118' ' ' CYS . 24.0 m-85 -128.59 -50.14 1.27 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.263 1.025 . . . . 0.0 110.77 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 117.28 -3.18 18.57 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 123.742 0.687 . . . . 0.0 112.657 -175.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.98 133.33 42.6 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-N 117.759 0.779 . . . . 0.0 109.818 177.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 46.3 t -69.4 -6.09 27.79 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 124.749 1.281 . . . . 0.0 111.551 176.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.48 -57.16 2.98 Favored 'General case' 0 CA--C 1.517 -0.318 0 O-C-N 120.651 -1.28 . . . . 0.0 109.367 -178.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 2.1 t -68.9 -25.91 64.83 Favored 'General case' 0 N--CA 1.457 -0.107 0 O-C-N 124.492 1.12 . . . . 0.0 110.806 176.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -70.86 -38.45 73.14 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.367 0.603 . . . . 0.0 110.618 174.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.44 158.16 6.05 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-O 122.163 0.982 . . . . 0.0 111.745 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -70.78 140.85 39.74 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 120.309 0.673 . . . . 0.0 113.029 175.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.473 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 19.3 Cg_endo -71.77 172.26 14.83 Favored 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 122.73 2.287 . . . . 0.0 111.514 177.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -134.18 54.67 1.93 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.899 178.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.441 ' CE1' ' O ' ' A' ' 69' ' ' SER . 49.9 t-80 -77.95 156.44 30.24 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 121.669 0.747 . . . . 0.0 110.249 -178.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.441 ' O ' ' CE1' ' A' ' 68' ' ' HIS . 0.2 OUTLIER -142.95 -166.02 2.2 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 121.251 -0.906 . . . . 0.0 110.568 179.047 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.6 72.51 10.3 Favored 'General case' 0 C--O 1.219 -0.535 0 O-C-N 121.894 -0.504 . . . . 0.0 110.647 176.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -178.58 -41.37 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.61 0.719 . . . . 0.0 110.563 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.409 ' O ' ' CE2' ' A' ' 79' ' ' TYR . . . 118.73 -48.18 0.96 Allowed Glycine 0 CA--C 1.499 -0.948 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.206 -177.149 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.426 ' ND2' ' CZ ' ' A' ' 112' ' ' TYR . 2.0 t-20 -147.56 85.17 1.57 Allowed 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 179.083 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -71.07 -119.35 0.05 OUTLIER Glycine 0 CA--C 1.529 0.909 0 CA-C-O 122.036 0.798 . . . . 0.0 111.807 177.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -52.79 -87.77 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.675 0 O-C-N 121.066 -1.255 . . . . 0.0 112.717 178.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -123.54 19.05 9.63 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.014 177.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.496 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 6.5 m-20 -32.18 105.18 0.03 OUTLIER 'General case' 0 CA--C 1.504 -0.815 0 C-N-CA 124.898 1.279 . . . . 0.0 109.15 -176.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.453 ' H ' ' CD2' ' A' ' 78' ' ' HIS . 3.2 p80 -88.42 18.43 4.51 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -175.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.47 ' HB2' ' CD1' ' A' ' 37' ' ' TRP . 0.4 OUTLIER -40.15 135.25 1.42 Allowed 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 125.419 1.488 . . . . 0.0 110.948 173.804 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.45 155.37 36.34 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.851 176.113 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.456 ' CD1' ' CZ ' ' A' ' 79' ' ' TYR . 1.7 mp -140.69 150.49 43.54 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.883 0.373 . . . . 0.0 110.147 176.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.485 ' CB ' ' CD1' ' A' ' 109' ' ' ILE . 0.4 OUTLIER -115.76 157.53 24.2 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 122.009 0.909 . . . . 0.0 110.627 -179.699 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.425 ' CE2' ' CE2' ' A' ' 92' ' ' TYR . 30.3 t80 -139.99 133.76 15.46 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-O 118.698 -0.668 . . . . 0.0 112.204 -178.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.522 ' HA ' ' HG2' ' A' ' 107' ' ' ARG . 17.8 Cg_endo -70.03 87.71 0.58 Allowed 'Trans proline' 0 CA--C 1.505 -0.956 0 C-N-CA 123.937 3.091 . . . . 0.0 110.72 -174.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.484 ' HA ' ' CZ ' ' A' ' 92' ' ' TYR . 2.7 t -83.5 129.02 34.96 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 124.237 0.961 . . . . 0.0 110.902 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.648 ' CD1' ' CD1' ' A' ' 92' ' ' TYR . 4.6 m-85 -96.54 152.34 38.55 Favored Pre-proline 0 C--O 1.237 0.395 0 C-N-CA 122.796 0.439 . . . . 0.0 110.203 -178.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -73.07 -47.74 0.31 Allowed 'Trans proline' 0 N--CA 1.447 -1.213 0 O-C-N 124.047 1.551 . . . . 0.0 112.266 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -42.74 -41.08 3.05 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 123.07 1.414 . . . . 0.0 110.278 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 94.85 18.0 36.17 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.146 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.437 ' O ' ' CE1' ' A' ' 92' ' ' TYR . 1.8 p-80 -86.69 147.48 25.86 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-N 118.061 0.931 . . . . 0.0 109.601 176.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -63.92 139.82 58.81 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 118.642 0.655 . . . . 0.0 111.902 174.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.648 ' CD1' ' CD1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -96.18 146.97 24.23 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -174.608 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.21 69.05 9.85 Favored 'General case' 0 C--N 1.32 -0.696 0 O-C-N 121.371 -0.83 . . . . 0.0 110.08 175.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.404 ' CD2' ' HZ ' ' A' ' 83' ' ' PHE . 25.7 p90 -83.55 -23.58 31.96 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.113 177.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -91.17 -23.74 20.15 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 123.012 1.387 . . . . 0.0 110.924 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.15 108.9 18.53 Favored 'General case' 0 CA--C 1.517 -0.325 0 O-C-N 120.61 -1.306 . . . . 0.0 108.575 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.97 -48.2 82.69 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 121.609 0.719 . . . . 0.0 111.067 178.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.03 128.39 14.24 Favored Pre-proline 0 CA--C 1.543 0.7 0 CA-C-N 114.508 -1.223 . . . . 0.0 110.233 -178.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -69.78 176.3 33.19 Favored 'Cis proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.789 -1.754 . . . . 0.0 111.527 -5.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -140.72 122.83 15.68 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 124.005 0.922 . . . . 0.0 109.092 178.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -87.6 162.32 17.22 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 125.47 1.731 . . . . 0.0 110.006 178.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -50.53 154.49 2.22 Favored Pre-proline 0 C--O 1.222 -0.382 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.116 177.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.479 ' HB3' ' CE1' ' A' ' 34' ' ' TYR . 20.5 Cg_endo -73.7 -87.39 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 121.096 1.197 . . . . 0.0 111.912 178.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 148.7 159.9 8.78 Favored Glycine 0 CA--C 1.524 0.654 0 O-C-N 121.146 -0.971 . . . . 0.0 110.905 -178.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -76.64 -73.17 0.01 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.725 2.284 . . . . 0.0 110.949 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.476 ' CB ' ' CE1' ' A' ' 11' ' ' TYR . . . -62.26 151.42 36.39 Favored 'General case' 0 N--CA 1.442 -0.865 0 O-C-N 123.915 0.759 . . . . 0.0 110.105 178.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.522 ' HG2' ' HA ' ' A' ' 84' ' ' PRO . 7.8 mtm-85 -152.7 142.74 22.27 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.983 -178.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.8 p -82.09 124.61 39.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 O-C-N 124.207 0.942 . . . . 0.0 109.477 178.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.549 HG21 ' CD2' ' A' ' 38' ' ' PHE . 6.1 mm -104.65 142.0 18.92 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.722 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.87 -179.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.469 ' CD1' ' HG3' ' A' ' 115' ' ' LYS . 9.6 p90 -163.73 147.71 10.3 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 122.271 1.034 . . . . 0.0 111.711 -178.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 9.6 p -83.6 169.74 15.07 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.388 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.57 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.6 OUTLIER -111.37 154.61 43.65 Favored Pre-proline 0 CA--C 1.552 1.035 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.295 177.812 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.57 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 18.8 Cg_endo -73.65 -56.92 0.14 OUTLIER 'Cis proline' 0 CA--C 1.504 -1.012 0 C-N-CA 123.724 -1.365 . . . . 0.0 110.466 -6.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -43.79 116.62 1.0 Allowed 'General case' 0 N--CA 1.448 -0.551 0 O-C-N 123.812 0.695 . . . . 0.0 109.352 178.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.469 ' HG3' ' CD1' ' A' ' 110' ' ' TYR . 0.0 OUTLIER -65.39 79.67 0.06 Allowed 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -179.001 . . . . . . . . 3 3 . 1 . 011 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 91.7 t -73.63 75.95 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 -177.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.436 ' CZ ' ' NE2' ' A' ' 13' ' ' GLN . 40.4 t80 -37.91 103.91 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 125.808 1.643 . . . . 0.0 109.432 -179.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . 0.506 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 10.9 m -83.25 -44.61 14.78 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -178.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 157.12 -147.71 16.36 Favored Glycine 0 N--CA 1.442 -0.906 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.433 HG13 ' CG ' ' A' ' 4' ' ' TRP . 1.2 mm -127.88 140.45 49.11 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.803 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -176.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.488 ' CD1' ' CE1' ' A' ' 38' ' ' PHE . 8.9 pt -129.05 155.24 40.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -177.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.329 -0.306 0 CA-C-O 122.407 1.098 . . . . 0.0 109.255 178.242 . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 4.2 ptpt . . . . . 0 CA--C 1.514 -0.419 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 . . . . . . . . . 0 0 . 1 . 011 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.0 tp -84.14 148.14 26.95 Favored 'General case' 0 C--O 1.235 0.296 0 O-C-N 124.31 1.007 . . . . 0.0 109.167 178.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 72.2 m -67.26 -174.54 0.38 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 122.316 1.055 . . . . 0.0 109.95 175.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 15.2 m -129.04 95.29 4.03 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -177.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 0.601 ' CE1' ' CH2' ' A' ' 4' ' ' TRP . 24.5 p-80 . . . . . 0 C--N 1.328 -0.337 0 O-C-N 123.711 0.632 . . . . 0.0 110.928 176.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.0 p . . . . . 0 CA--C 1.533 0.302 0 CA-C-O 121.864 0.84 . . . . 0.0 110.791 . . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.42 ' CG2' ' HB3' ' A' ' 10' ' ' LEU . 3.7 m -86.71 111.56 20.81 Favored 'General case' 0 CA--C 1.505 -0.782 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -176.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 24.8 m95 -77.29 142.7 39.32 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 123.247 0.619 . . . . 0.0 110.011 178.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -140.01 135.82 33.08 Favored 'General case' 0 CA--C 1.496 -1.114 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -179.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -116.24 60.76 0.72 Allowed 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.594 177.114 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 39.22 72.27 0.22 Allowed Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.018 0.824 . . . . 0.0 112.688 -178.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 168.38 -77.46 0.11 Allowed Glycine 0 C--O 1.224 -0.49 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 -177.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 16.9 mt -126.17 162.43 25.4 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 121.749 0.785 . . . . 0.0 109.908 178.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.42 ' HB3' ' CG2' ' A' ' 3' ' ' THR . 0.2 OUTLIER -89.91 165.23 14.21 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.086 -177.242 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.431 ' CZ ' ' HB3' ' A' ' 106' ' ' ALA . 46.6 m-85 -156.1 82.95 1.0 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 -171.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -53.46 125.76 19.1 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.546 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 7.2 tp-100 -59.43 -21.4 59.96 Favored 'General case' 0 C--O 1.217 -0.656 0 C-N-CA 118.996 -1.081 . . . . 0.0 113.776 176.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -63.16 -24.67 67.99 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 172.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.8 mttp -101.53 -30.46 11.38 Favored 'General case' 0 C--O 1.201 -1.467 0 CA-C-O 114.038 -2.887 . . . . 0.0 111.023 174.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.42 -66.0 0.48 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 122.212 2.278 . . . . 0.0 112.204 176.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 26.4 pt-20 -61.27 -44.98 96.35 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-O 117.88 -1.057 . . . . 0.0 109.449 176.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 46.0 t -57.54 -47.86 80.88 Favored 'General case' 0 C--O 1.212 -0.909 0 CA-C-N 119.801 1.182 . . . . 0.0 109.003 -176.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.424 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 5.0 t-20 -47.7 -37.1 12.36 Favored 'General case' 0 N--CA 1.442 -0.834 0 O-C-N 121.064 -1.023 . . . . 0.0 112.302 174.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.99 -29.46 39.49 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 172.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 17.9 m170 -53.19 -39.91 64.01 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 125.696 1.598 . . . . 0.0 110.539 176.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.424 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -82.16 -49.92 9.6 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-O 117.733 -1.127 . . . . 0.0 110.232 178.922 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.416 ' HB1' ' CE1' ' A' ' 83' ' ' PHE . . . -42.15 136.63 2.23 Favored Pre-proline 0 N--CA 1.448 -0.57 0 O-C-N 125.504 1.753 . . . . 0.0 112.446 177.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -73.01 123.3 8.78 Favored 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 121.722 1.615 . . . . 0.0 109.228 -176.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.0 tp -59.62 103.07 0.17 Allowed 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.853 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.83 176.96 0.72 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.803 0.811 . . . . 0.0 110.5 -175.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.487 ' HB2' ' CE1' ' A' ' 79' ' ' TYR . 1.3 t0 -110.94 83.87 1.83 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.38 81.18 0.26 Allowed Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 173.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -149.47 40.3 0.84 Allowed 'General case' 0 CA--C 1.509 -0.62 0 O-C-N 121.852 -0.793 . . . . 0.0 111.972 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.7 p -128.2 152.22 48.32 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 -175.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -42.45 -49.25 5.76 Favored Glycine 0 C--N 1.334 0.47 0 CA-C-O 119.629 -0.539 . . . . 0.0 112.562 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.81 -78.31 0.06 Allowed 'General case' 0 N--CA 1.452 -0.357 0 O-C-N 123.792 0.348 . . . . 0.0 111.478 174.014 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 79.3 p -177.06 -65.77 0.01 OUTLIER 'General case' 0 C--O 1.22 -0.466 0 C-N-CA 125.121 1.368 . . . . 0.0 110.161 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -63.3 150.9 88.35 Favored Pre-proline 0 N--CA 1.43 -1.46 0 C-N-CA 125.498 1.519 . . . . 0.0 111.95 -176.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -75.98 160.31 95.86 Favored 'Cis proline' 0 N--CA 1.449 -1.108 0 C-N-CA 122.621 -1.824 . . . . 0.0 110.957 2.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -135.75 166.12 24.0 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 118.197 -0.906 . . . . 0.0 109.181 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.523 ' CH2' ' HA2' ' A' ' 44' ' ' GLY . 21.8 t90 -62.66 152.09 36.34 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 175.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.437 ' CZ ' HD12 ' A' ' 121' ' ' ILE . 18.5 t80 -128.78 78.27 1.84 Allowed 'General case' 0 N--CA 1.425 -1.7 0 N-CA-C 105.169 -2.16 . . . . 0.0 105.169 -173.204 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 73.1 p -39.24 -35.68 0.27 Allowed 'General case' 0 C--O 1.212 -0.899 0 C-N-CA 124.25 1.02 . . . . 0.0 110.179 173.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.408 ' HB2' ' CD2' ' A' ' 38' ' ' PHE . 44.6 t30 57.04 19.6 4.81 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 123.306 1.527 . . . . 0.0 110.023 176.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 107.68 -40.8 2.39 Favored Glycine 0 N--CA 1.428 -1.846 0 CA-C-O 116.194 -2.448 . . . . 0.0 115.208 -169.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.453 ' CE2' ' HD3' ' A' ' 66' ' ' PRO . 77.0 m-85 -45.85 153.75 0.27 Allowed 'General case' 0 C--N 1.339 0.145 0 CA-C-N 119.385 1.592 . . . . 0.0 112.18 176.338 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.98 -36.38 27.95 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.764 0.792 . . . . 0.0 111.496 177.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.523 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -175.18 -63.6 0.05 OUTLIER Glycine 0 C--N 1.337 0.595 0 C-N-CA 124.513 1.054 . . . . 0.0 111.337 -178.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -117.88 -68.15 0.94 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.373 0.606 . . . . 0.0 111.277 -179.075 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.13 -173.86 0.25 Allowed Glycine 0 C--N 1.341 0.839 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 178.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.97 -174.04 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 124.874 2.273 . . . . 0.0 113.336 174.108 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.6 163.58 55.73 Favored Pre-proline 0 C--N 1.313 -1.016 0 O-C-N 119.837 -1.789 . . . . 0.0 110.723 -179.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -71.18 160.14 49.95 Favored 'Trans proline' 0 N--CA 1.446 -1.27 0 C-N-CA 122.06 1.84 . . . . 0.0 109.764 178.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.5 ttpt -50.95 99.04 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.987 0.915 . . . . 0.0 110.324 177.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.92 85.64 1.86 Allowed Glycine 0 C--O 1.227 -0.316 0 CA-C-N 116.387 -0.37 . . . . 0.0 112.652 -174.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.02 165.21 18.09 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 124.205 1.002 . . . . 0.0 111.361 174.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 93.5 m -138.46 96.05 9.93 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.023 -177.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -72.49 145.6 42.72 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 122.355 2.036 . . . . 0.0 110.672 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.1 mt -73.94 119.74 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -179.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.6 tppt? -81.5 135.36 35.6 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 177.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.492 ' CD1' ' HB3' ' A' ' 118' ' ' CYS . 28.6 m-85 -113.55 -52.09 2.77 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.276 1.031 . . . . 0.0 110.587 179.119 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 121.16 -3.1 11.5 Favored Glycine 0 C--O 1.223 -0.554 0 C-N-CA 123.642 0.639 . . . . 0.0 112.85 -175.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 16.2 mttt -101.87 130.37 48.33 Favored 'General case' 0 CA--C 1.502 -0.903 0 CA-C-N 118.173 0.987 . . . . 0.0 109.26 177.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 28.1 t -63.55 -12.2 30.61 Favored 'General case' 0 C--O 1.223 -0.307 0 O-C-N 124.665 1.228 . . . . 0.0 111.581 175.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -86.99 -47.79 8.66 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.867 1.267 . . . . 0.0 110.615 178.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 71.6 m -74.68 -10.59 59.68 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 123.967 0.792 . . . . 0.0 112.731 173.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -93.24 -40.12 10.61 Favored 'General case' 0 CA--C 1.507 -0.674 0 C-N-CA 124.795 1.238 . . . . 0.0 110.151 176.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.48 158.77 0.58 Allowed Pre-proline 0 CA--C 1.539 0.53 0 CA-C-O 121.827 0.822 . . . . 0.0 111.825 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -70.76 132.94 22.69 Favored 'Trans proline' 0 N--CA 1.442 -1.534 0 C-N-CA 120.823 1.015 . . . . 0.0 113.336 174.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.453 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 17.8 Cg_endo -71.45 170.78 17.61 Favored 'Trans proline' 0 N--CA 1.446 -1.301 0 C-N-CA 123.404 2.736 . . . . 0.0 111.057 178.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.8 tptt -124.46 53.0 1.47 Allowed 'General case' 0 C--O 1.205 -1.243 0 O-C-N 121.417 -0.802 . . . . 0.0 108.954 178.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.475 ' CD2' ' CG ' ' A' ' 37' ' ' TRP . 52.3 t-80 -78.89 161.0 27.03 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 119.333 -2.104 . . . . 0.0 111.744 178.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -171.78 -163.93 0.29 Allowed 'General case' 0 CA--C 1.504 -0.812 0 O-C-N 117.813 -3.054 . . . . 0.0 109.396 175.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.31 53.66 0.14 Allowed 'General case' 0 C--O 1.215 -0.723 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 172.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . 0.402 ' O ' ' C ' ' A' ' 72' ' ' GLY . 3.5 m-20 -177.49 74.48 0.02 OUTLIER 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 -178.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.424 ' O ' ' CE2' ' A' ' 79' ' ' TYR . . . -11.68 -70.27 0.01 OUTLIER Glycine 0 C--O 1.219 -0.79 0 C-N-CA 125.175 1.369 . . . . 0.0 114.305 178.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 18.3 t30 -121.96 78.61 1.49 Allowed 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 124.924 1.29 . . . . 0.0 112.68 165.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.13 -98.8 0.04 OUTLIER Glycine 0 CA--C 1.521 0.436 0 CA-C-O 122.74 1.189 . . . . 0.0 111.546 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.0 mttt -72.12 -102.57 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.38 0 CA-C-O 122.827 1.299 . . . . 0.0 111.059 176.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -112.29 14.75 20.51 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 121.104 -0.997 . . . . 0.0 110.844 178.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -31.72 100.21 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.561 0 C-N-CA 124.514 1.126 . . . . 0.0 112.202 -178.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -87.7 45.45 1.28 Allowed 'General case' 0 CA--C 1.516 -0.329 0 O-C-N 119.942 -1.724 . . . . 0.0 108.174 -172.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.487 ' CE1' ' HB2' ' A' ' 27' ' ' ASP . 40.7 p90 -71.07 135.52 47.78 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 124.42 1.088 . . . . 0.0 110.398 -178.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.5 138.2 48.75 Favored 'General case' 0 C--O 1.218 -0.57 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 176.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.443 ' HG ' ' CE1' ' A' ' 110' ' ' TYR . 0.4 OUTLIER -130.54 141.92 50.47 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 176.432 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -104.03 167.69 9.6 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-O 121.974 0.893 . . . . 0.0 112.628 174.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.483 ' CD1' ' HD2' ' A' ' 84' ' ' PRO . 31.9 t80 -154.31 139.33 11.83 Favored Pre-proline 0 C--O 1.225 -0.209 0 O-C-N 120.974 -1.079 . . . . 0.0 113.368 178.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.483 ' HD2' ' CD1' ' A' ' 83' ' ' PHE . 19.3 Cg_endo -74.49 94.89 0.92 Allowed 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 124.346 3.364 . . . . 0.0 110.832 -175.321 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.415 ' HA ' ' OD1' ' A' ' 19' ' ' ASN . 6.3 t -98.86 105.24 17.37 Favored 'General case' 0 CA--C 1.508 -0.64 0 O-C-N 124.879 1.362 . . . . 0.0 112.577 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.526 ' CE1' ' CD1' ' A' ' 92' ' ' TYR . 56.4 m-85 -82.35 159.55 64.38 Favored Pre-proline 0 N--CA 1.446 -0.632 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.321 -179.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -76.55 -36.28 1.75 Allowed 'Trans proline' 0 CA--C 1.498 -1.309 0 C-N-CA 122.283 1.989 . . . . 0.0 112.973 178.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -45.87 -31.14 1.98 Allowed 'General case' 0 N--CA 1.468 0.439 0 O-C-N 125.016 1.448 . . . . 0.0 110.406 176.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.15 17.69 68.87 Favored Glycine 0 N--CA 1.438 -1.193 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 177.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -82.66 140.99 32.83 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 178.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -72.33 85.63 1.09 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 175.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.526 ' CD1' ' CE1' ' A' ' 86' ' ' PHE . 70.8 t80 -40.82 151.91 0.05 Allowed 'General case' 0 C--O 1.22 -0.472 0 CA-C-O 122.655 1.217 . . . . 0.0 111.57 -179.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.71 64.99 5.69 Favored 'General case' 0 C--N 1.314 -0.972 0 O-C-N 119.153 -2.217 . . . . 0.0 110.541 177.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.447 ' CD2' ' O ' ' A' ' 92' ' ' TYR . 33.2 p90 -82.2 -12.27 58.21 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 118.17 -0.919 . . . . 0.0 110.732 178.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -97.88 -30.91 12.48 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 123.782 1.753 . . . . 0.0 110.485 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 69.2 m -80.3 108.92 14.31 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 119.662 -1.899 . . . . 0.0 109.492 178.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.25 -48.56 80.04 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.611 0.72 . . . . 0.0 111.135 178.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.81 125.25 13.81 Favored Pre-proline 0 N--CA 1.438 -1.058 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.105 -175.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -71.75 175.02 44.07 Favored 'Cis proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.819 -1.742 . . . . 0.0 110.84 -3.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.85 130.12 31.29 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 123.919 0.888 . . . . 0.0 109.49 178.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.432 ' HB3' ' CE1' ' A' ' 92' ' ' TYR . 0.4 OUTLIER -78.86 -177.99 5.79 Favored 'General case' 0 C--O 1.238 0.479 0 O-C-N 125.59 1.806 . . . . 0.0 112.863 177.061 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -76.74 152.36 82.91 Favored Pre-proline 0 N--CA 1.451 -0.425 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 172.18 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -69.92 -165.07 0.15 Allowed 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.372 2.048 . . . . 0.0 112.688 175.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -131.52 158.19 22.67 Favored Glycine 0 CA--C 1.526 0.772 0 O-C-N 121.43 -0.794 . . . . 0.0 112.799 176.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -76.02 -42.78 0.37 Allowed 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.394 2.063 . . . . 0.0 111.313 178.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.431 ' HB3' ' CZ ' ' A' ' 11' ' ' TYR . . . -92.72 145.56 24.32 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 123.23 0.612 . . . . 0.0 110.709 177.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.433 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 4.4 mtm-85 -145.4 149.5 34.85 Favored 'General case' 0 CA--C 1.495 -1.136 0 CA-C-O 117.104 -1.427 . . . . 0.0 111.597 177.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.3 p -83.65 110.43 18.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 O-C-N 124.136 0.898 . . . . 0.0 110.434 178.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 1.7 mp -95.93 125.06 48.83 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.104 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 -174.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.443 ' CE1' ' HG ' ' A' ' 81' ' ' LEU . 8.6 p90 -146.23 154.97 42.34 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.782 0.801 . . . . 0.0 109.061 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.8 p -91.79 164.8 13.57 Favored 'General case' 0 C--N 1.317 -0.817 0 O-C-N 121.931 -0.48 . . . . 0.0 109.734 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.47 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -110.88 155.77 41.84 Favored Pre-proline 0 CA--C 1.544 0.729 0 O-C-N 121.759 -0.588 . . . . 0.0 110.911 179.18 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.47 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 19.3 Cg_endo -73.18 -50.17 0.2 OUTLIER 'Cis proline' 0 CA--C 1.5 -1.188 0 C-N-CA 123.544 -1.44 . . . . 0.0 111.099 -8.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -46.32 110.51 0.28 Allowed 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 115.999 -1.953 . . . . 0.0 108.846 178.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.428 ' HG3' ' CD1' ' A' ' 110' ' ' TYR . 0.3 OUTLIER -67.71 68.36 0.1 Allowed 'General case' 0 CA--C 1.511 -0.549 0 O-C-N 125.904 2.003 . . . . 0.0 108.154 -178.49 . . . . . . . . 3 3 . 1 . 012 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 72.0 t -73.66 71.43 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 105.358 -2.089 . . . . 0.0 105.358 -177.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.596 ' CZ ' ' HA2' ' A' ' 119' ' ' GLY . 29.9 t80 -39.44 116.44 0.61 Allowed 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 125.832 1.653 . . . . 0.0 109.352 179.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . 0.492 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 4.6 m -89.09 -46.55 8.75 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -178.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.596 ' HA2' ' CZ ' ' A' ' 117' ' ' PHE . . . 155.08 -171.62 33.34 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 -179.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.433 ' HA ' ' O ' ' A' ' 107' ' ' ARG . 2.8 mp -109.65 129.69 64.06 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.269 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 -177.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.437 HD12 ' CZ ' ' A' ' 38' ' ' PHE . 8.9 pt -102.55 155.42 5.09 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 CA-C-N 119.535 1.061 . . . . 0.0 108.318 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.518 0 CA-C-O 122.879 1.324 . . . . 0.0 110.07 175.561 . . . . . . . . 0 0 . 1 . 012 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.507 -0.684 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 . . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 7.2 tp -83.8 147.46 27.57 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 176.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 99.5 m -60.18 -177.67 0.07 Allowed 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 123.708 1.718 . . . . 0.0 109.985 176.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -162.96 109.43 1.18 Allowed 'General case' 0 C--N 1.319 -0.746 0 O-C-N 120.588 -1.32 . . . . 0.0 107.475 -177.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.254 1.303 0 CA-C-O 115.335 -2.269 . . . . 0.0 111.438 174.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.1 p . . . . . 0 C--O 1.237 0.425 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 . . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.5 m -98.78 118.34 35.3 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 124.26 1.024 . . . . 0.0 108.944 -176.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . 0.413 ' CE2' ' ND1' ' A' ' 136' ' ' HIS . 28.6 m95 -82.35 137.07 34.87 Favored 'General case' 0 CA--C 1.506 -0.716 0 O-C-N 120.851 -1.156 . . . . 0.0 109.024 -172.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -127.14 132.12 50.62 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 122.115 0.959 . . . . 0.0 108.43 -176.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -121.6 66.68 0.89 Allowed 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.707 176.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 42.44 56.2 4.21 Favored Glycine 0 N--CA 1.471 1.019 0 O-C-N 124.061 0.851 . . . . 0.0 113.28 -176.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -168.36 -88.69 0.07 OUTLIER Glycine 0 C--O 1.226 -0.387 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 -175.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 32.5 mt -132.14 165.16 24.7 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.304 1.441 . . . . 0.0 109.983 177.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -90.83 111.04 22.27 Favored 'General case' 0 C--O 1.223 -0.336 0 C-N-CA 124.48 1.112 . . . . 0.0 110.137 179.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -89.64 111.2 22.09 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 130.635 3.574 . . . . 0.0 109.067 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -54.6 122.16 10.0 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 176.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.447 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 6.9 tp-100 -55.12 -48.33 73.78 Favored 'General case' 0 C--O 1.215 -0.739 0 C-N-CA 118.754 -1.178 . . . . 0.0 113.227 177.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -48.94 -37.21 19.33 Favored 'General case' 0 C--O 1.204 -1.301 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 173.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.5 mttp -71.61 -42.08 68.11 Favored 'General case' 0 C--O 1.21 -1.021 0 CA-C-O 116.369 -1.777 . . . . 0.0 113.132 167.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -51.98 -48.27 64.45 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 122.828 2.558 . . . . 0.0 113.475 172.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -74.5 -47.79 31.06 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 119.0 0.818 . . . . 0.0 111.753 172.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 38.0 t -66.55 -55.73 14.09 Favored 'General case' 0 N--CA 1.481 1.098 0 O-C-N 119.738 -1.851 . . . . 0.0 112.301 -175.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -40.5 -46.15 2.4 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.711 1.205 . . . . 0.0 110.894 169.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.16 -28.87 57.54 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 126.976 2.11 . . . . 0.0 116.437 174.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -54.68 -35.6 63.74 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 127.802 2.441 . . . . 0.0 111.037 177.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -75.91 -42.6 48.51 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 126.569 1.948 . . . . 0.0 112.506 174.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -45.65 127.6 6.54 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 127.318 2.247 . . . . 0.0 111.844 175.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -66.28 146.66 81.7 Favored 'Trans proline' 0 N--CA 1.445 -1.346 0 C-N-CA 122.833 2.355 . . . . 0.0 111.272 -175.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.72 94.57 5.76 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.613 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.6 m 179.78 167.96 1.2 Allowed 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.711 1.604 . . . . 0.0 110.665 -174.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.458 ' HA ' ' HA ' ' A' ' 36' ' ' HIS . 0.3 OUTLIER -108.71 118.29 36.41 Favored 'General case' 0 CA--C 1.51 -0.594 0 C-N-CA 125.988 1.715 . . . . 0.0 109.169 175.12 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 55.27 62.39 6.34 Favored Glycine 0 CA--C 1.522 0.495 0 O-C-N 123.663 0.602 . . . . 0.0 112.713 171.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt -145.73 20.68 1.48 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.755 1.622 . . . . 0.0 115.243 -176.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 45.2 p -118.42 158.3 25.56 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 125.715 1.606 . . . . 0.0 108.513 179.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -50.52 -55.01 18.46 Favored Glycine 0 CA--C 1.504 -0.596 0 N-CA-C 116.222 1.249 . . . . 0.0 116.222 -177.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.5 t -62.72 -62.06 1.99 Allowed 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 116.695 -1.621 . . . . 0.0 112.896 171.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 160.22 -42.15 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 131.427 3.891 . . . . 0.0 115.963 178.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.475 ' CD2' ' HD3' ' A' ' 84' ' ' PRO . 86.0 m-85 -78.47 147.32 71.67 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 125.182 1.393 . . . . 0.0 113.999 -177.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -71.84 162.28 89.64 Favored 'Cis proline' 0 N--CA 1.441 -1.603 0 CA-C-N 120.626 1.259 . . . . 0.0 110.609 -2.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.458 ' HA ' ' HA ' ' A' ' 27' ' ' ASP . 1.6 p80 -139.36 173.65 11.33 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 113.16 -1.836 . . . . 0.0 108.068 -177.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.526 ' CH2' ' HA2' ' A' ' 44' ' ' GLY . 19.7 t90 -75.96 138.47 40.99 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 123.222 1.487 . . . . 0.0 110.78 173.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.431 ' CZ ' ' HA ' ' A' ' 40' ' ' ASN . 28.4 t80 -106.89 91.83 3.83 Favored 'General case' 0 N--CA 1.419 -1.994 0 C-N-CA 130.297 3.439 . . . . 0.0 104.688 177.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 80.4 p -41.47 -37.98 1.18 Allowed 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 112.794 -2.003 . . . . 0.0 111.851 164.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.431 ' HA ' ' CZ ' ' A' ' 38' ' ' PHE . 65.8 t30 59.31 17.12 5.53 Favored 'General case' 0 C--O 1.213 -0.842 0 CA-C-N 118.901 0.773 . . . . 0.0 111.995 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.437 ' HA2' ' NE ' ' A' ' 52' ' ' ARG . . . 107.38 -43.3 1.72 Allowed Glycine 0 N--CA 1.44 -1.085 0 CA-C-O 115.132 -3.038 . . . . 0.0 114.62 -166.01 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -45.94 154.85 0.21 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 128.789 2.836 . . . . 0.0 111.667 178.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -82.04 -34.7 29.39 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 178.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.526 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -175.95 -68.38 0.06 OUTLIER Glycine 0 CA--C 1.528 0.848 0 C-N-CA 126.199 1.856 . . . . 0.0 113.036 -175.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . 0.461 ' OD2' ' HE2' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -118.78 -62.73 1.49 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 127.188 2.195 . . . . 0.0 113.955 -176.322 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.39 -168.54 1.59 Allowed Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 125.732 1.635 . . . . 0.0 111.021 178.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 43.8 pttt -59.06 -172.15 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 124.696 2.189 . . . . 0.0 113.631 173.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -87.41 170.02 12.97 Favored Pre-proline 0 C--N 1.316 -0.852 0 CA-C-N 114.333 -1.303 . . . . 0.0 111.947 -177.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -62.59 164.68 17.59 Favored 'Trans proline' 0 N--CA 1.44 -1.662 0 CA-C-O 123.093 1.205 . . . . 0.0 109.955 177.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.13 102.06 0.12 Allowed 'General case' 0 C--O 1.218 -0.58 0 O-C-N 120.307 -1.495 . . . . 0.0 110.695 170.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.08 78.35 1.4 Allowed Glycine 0 N--CA 1.466 0.638 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -176.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.437 ' NE ' ' HA2' ' A' ' 41' ' ' GLY . 0.4 OUTLIER -148.93 154.48 39.48 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 124.303 1.041 . . . . 0.0 109.96 170.974 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.9 m -124.72 101.46 33.2 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 125.087 1.355 . . . . 0.0 108.882 175.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -69.22 148.9 69.6 Favored 'Trans proline' 0 N--CA 1.444 -1.437 0 C-N-CA 123.316 2.677 . . . . 0.0 111.078 172.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.5 mt -61.19 118.38 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 175.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.0 tppt? -86.52 132.29 33.96 Favored 'General case' 0 C--N 1.332 -0.179 0 O-C-N 121.611 -0.681 . . . . 0.0 109.516 174.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.513 ' CD1' ' HB3' ' A' ' 118' ' ' CYS . 7.9 m-85 -114.84 -36.32 4.52 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.518 1.927 . . . . 0.0 112.495 178.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.47 0.42 55.59 Favored Glycine 0 N--CA 1.474 1.221 0 C-N-CA 125.494 1.521 . . . . 0.0 114.114 -172.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.45 134.78 42.88 Favored 'General case' 0 CA--C 1.506 -0.726 0 C-N-CA 123.939 0.896 . . . . 0.0 111.299 175.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 79.6 p -68.91 -8.78 47.43 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.092 0.957 . . . . 0.0 113.502 176.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.03 -52.3 6.42 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 126.926 2.09 . . . . 0.0 108.977 176.091 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 3.7 m -78.75 -15.49 58.38 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -179.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -86.05 -30.8 22.35 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 127.212 2.205 . . . . 0.0 111.977 167.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.43 153.86 13.3 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 119.463 1.029 . . . . 0.0 113.76 179.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -67.11 136.85 42.21 Favored 'Trans proline' 0 CA--C 1.553 1.43 0 C-N-CA 120.363 0.709 . . . . 0.0 111.789 173.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -67.09 174.76 6.46 Favored 'Trans proline' 0 N--CA 1.459 -0.539 1 C-N-CA 125.428 4.085 . . . . 0.0 113.225 175.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . 0.461 ' HE2' ' OD2' ' A' ' 45' ' ' ASP 0.355 4.2 mmtt -133.9 41.21 3.03 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 116.073 1.879 . . . . 0.0 116.073 178.35 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.496 ' HA ' ' OD2' ' A' ' 77' ' ' ASP 0.312 56.3 t-80 -58.32 152.3 17.8 Favored 'General case' 0 C--O 1.218 -0.564 0 CA-C-O 124.798 2.237 . . . . 0.0 114.284 -177.527 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -148.56 -172.13 4.02 Favored 'General case' 0 CA--C 1.512 -0.51 0 O-C-N 119.777 -1.827 . . . . 0.0 111.026 179.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.02 69.79 5.25 Favored 'General case' 0 C--O 1.213 -0.821 0 O-C-N 121.151 -0.968 . . . . 0.0 112.002 172.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -170.03 -45.43 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 124.158 0.983 . . . . 0.0 111.887 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 133.98 -66.75 0.56 Allowed Glycine 0 C--O 1.204 -1.738 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 -179.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.49 ' ND2' ' H ' ' A' ' 73' ' ' ASN . 0.1 OUTLIER -107.48 -3.24 19.65 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 130.311 3.444 . . . . 0.0 113.417 -176.411 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 34.4 -122.13 0.42 Allowed Glycine 0 C--O 1.221 -0.712 0 C-N-CA 128.282 2.849 . . . . 0.0 113.783 -176.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 24.4 mttt -69.72 -79.02 0.06 Allowed 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 115.209 1.559 . . . . 0.0 115.209 167.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -123.45 11.22 9.26 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-O 116.676 -1.63 . . . . 0.0 111.957 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.496 ' OD2' ' HA ' ' A' ' 68' ' ' HIS . 58.1 t0 -17.78 94.53 0.01 OUTLIER 'General case' 0 C--O 1.214 -0.792 0 C-N-CA 126.689 1.996 . . . . 0.0 114.293 -171.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 19.2 p80 -84.32 11.47 8.32 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -172.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.432 ' CD2' ' CD1' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -43.87 162.42 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 126.684 1.994 . . . . 0.0 113.223 169.372 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -83.02 150.45 26.34 Favored 'General case' 0 N--CA 1.427 -1.585 0 CA-C-N 113.236 -1.802 . . . . 0.0 110.441 169.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.6 mt -132.42 130.47 40.65 Favored 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 123.743 0.817 . . . . 0.0 109.218 173.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.06 155.19 17.23 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 123.734 0.814 . . . . 0.0 112.088 176.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.413 ' HZ ' ' CE2' ' A' ' 94' ' ' PHE . 59.8 t80 -149.05 127.16 5.82 Favored Pre-proline 0 CA--C 1.551 1.004 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 179.146 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.475 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 23.4 Cg_endo -71.59 94.78 0.69 Allowed 'Trans proline' 0 N--CA 1.45 -1.065 1 C-N-CA 126.062 4.508 . . . . 0.0 110.119 -176.093 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 6.2 t -94.49 114.3 26.28 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 113.233 -1.803 . . . . 0.0 110.127 178.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -82.31 154.25 69.15 Favored Pre-proline 0 CA--C 1.54 0.581 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.136 178.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -73.31 -35.12 5.28 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.953 2.435 . . . . 0.0 115.204 177.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -50.79 -30.95 15.47 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 128.182 2.593 . . . . 0.0 110.983 175.082 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.27 11.53 82.08 Favored Glycine 0 CA--C 1.499 -0.955 0 CA-C-N 114.568 -1.197 . . . . 0.0 115.067 177.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . 0.255 5.2 p-80 -62.36 132.37 52.38 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 171.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -56.76 99.51 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 157.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -47.07 137.02 8.06 Favored 'General case' 0 N--CA 1.436 -1.153 0 O-C-N 118.823 -2.423 . . . . 0.0 108.484 169.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.36 59.01 1.02 Allowed 'General case' 0 C--N 1.324 -0.536 0 O-C-N 120.786 -1.196 . . . . 0.0 112.326 171.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.413 ' CE2' ' HZ ' ' A' ' 83' ' ' PHE . 32.6 p90 -71.72 -29.43 64.54 Favored 'General case' 0 C--O 1.219 -0.506 0 C-N-CA 124.794 1.237 . . . . 0.0 112.644 173.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -75.65 -38.9 58.46 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.527 1.931 . . . . 0.0 111.402 175.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.3 t -77.75 107.76 10.49 Favored 'General case' 0 C--N 1.33 -0.248 0 O-C-N 121.33 -0.856 . . . . 0.0 109.046 -176.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.5 pttt -60.35 -41.17 93.09 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 122.593 1.187 . . . . 0.0 114.109 178.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -145.24 131.13 9.54 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 114.174 -1.376 . . . . 0.0 110.837 178.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.67 165.21 70.39 Favored 'Cis proline' 0 N--CA 1.455 -0.771 0 O-C-N 123.283 1.149 . . . . 0.0 110.349 -11.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.37 148.5 47.49 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 125.484 1.513 . . . . 0.0 107.712 177.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -96.14 171.0 8.88 Favored 'General case' 0 C--N 1.319 -0.761 0 O-C-N 124.014 0.821 . . . . 0.0 109.577 169.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -46.5 152.17 0.91 Allowed Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 127.424 2.29 . . . . 0.0 111.865 168.038 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -72.74 -84.77 0.0 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.336 0 C-N-CA 123.107 2.538 . . . . 0.0 112.284 176.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 138.48 146.07 4.93 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.069 -1.213 . . . . 0.0 110.069 -178.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -76.62 -67.5 0.02 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 124.062 3.175 . . . . 0.0 112.162 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.99 132.16 46.23 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 123.125 1.44 . . . . 0.0 111.658 176.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.68 152.12 48.95 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 113.615 -1.63 . . . . 0.0 110.194 -177.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.5 p -87.54 116.62 30.04 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.642 0 C-N-CA 125.247 1.419 . . . . 0.0 109.438 175.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.404 HG22 ' CE2' ' A' ' 38' ' ' PHE . 1.6 mp -104.22 115.64 46.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 104.877 -2.268 . . . . 0.0 104.877 -178.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -126.81 156.22 41.63 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 114.48 -1.236 . . . . 0.0 108.467 177.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.2 p -82.98 166.48 18.79 Favored 'General case' 0 CA--C 1.505 -0.783 0 C-N-CA 124.844 1.258 . . . . 0.0 111.277 177.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.468 ' CG ' ' HA ' ' A' ' 113' ' ' PRO 0.276 8.7 t80 -109.94 158.49 34.86 Favored Pre-proline 0 CA--C 1.544 0.748 0 O-C-N 120.962 -1.086 . . . . 0.0 112.33 176.333 . . . . . . . . 3 3 . 1 . 013 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.468 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 18.9 Cg_endo -69.01 -41.9 0.81 Allowed 'Cis proline' 0 C--N 1.348 0.516 0 N-CA-C 114.794 1.036 . . . . 0.0 114.794 -21.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -50.37 106.48 0.12 Allowed 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 125.528 1.531 . . . . 0.0 108.92 170.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.3 mtmt -67.12 65.41 0.06 Allowed 'General case' 0 C--N 1.339 0.111 0 C-N-CA 127.959 2.503 . . . . 0.0 108.792 177.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 47.3 t -72.93 86.54 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.586 0 N-CA-C 103.254 -2.869 . . . . 0.0 103.254 175.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.485 ' CZ ' ' HA2' ' A' ' 119' ' ' GLY . 37.8 t80 -46.12 103.8 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 129.142 2.977 . . . . 0.0 109.427 176.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . 0.513 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 22.4 m -80.21 -41.7 24.68 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 122.884 1.326 . . . . 0.0 110.447 -176.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.485 ' HA2' ' CZ ' ' A' ' 117' ' ' PHE . . . 159.44 -154.22 25.28 Favored Glycine 0 N--CA 1.433 -1.552 0 CA-C-N 113.651 -1.613 . . . . 0.0 110.09 -178.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.404 HG13 ' CB ' ' A' ' 4' ' ' TRP . 1.3 mm -123.08 147.99 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 N-CA-C 105.208 -2.145 . . . . 0.0 105.208 -179.092 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.415 ' CD1' ' CE1' ' A' ' 38' ' ' PHE . 4.3 pt -136.99 151.65 27.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 O-C-N 119.851 -1.781 . . . . 0.0 109.175 179.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.5 0 CA-C-O 121.742 0.782 . . . . 0.0 110.355 176.747 . . . . . . . . 0 0 . 1 . 013 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.513 -0.448 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 . . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 14.7 tp -77.4 141.67 39.67 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.036 173.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 34.9 m -70.56 176.78 3.86 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 126.448 1.899 . . . . 0.0 111.243 169.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 92.5 p -142.37 100.45 3.7 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 105.284 -2.117 . . . . 0.0 105.284 -177.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 0.413 ' ND1' ' CE2' ' A' ' 4' ' ' TRP . 0.5 OUTLIER . . . . . 0 C--O 1.246 0.921 0 CA-C-O 114.972 -2.442 . . . . 0.0 114.671 165.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.0 p . . . . . 0 N--CA 1.449 -0.485 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.1 m -84.46 112.38 20.33 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-O 121.546 0.688 . . . . 0.0 110.008 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . 0.457 ' CG ' HG13 ' A' ' 120' ' ' ILE . 27.5 m95 -78.44 138.08 38.3 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 123.877 0.871 . . . . 0.0 111.248 175.089 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 m -120.16 120.52 36.43 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -177.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 55.6 m -106.88 51.89 0.73 Allowed 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.581 178.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 45.46 48.06 11.79 Favored Glycine 0 C--O 1.218 -0.863 0 O-C-N 123.951 0.782 . . . . 0.0 111.974 -176.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -162.2 -80.97 0.04 OUTLIER Glycine 0 C--O 1.225 -0.407 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 -177.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.6 mt -127.39 163.91 23.01 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.148 0.499 . . . . 0.0 110.008 177.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.2 mp -85.55 133.78 34.05 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.144 -179.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.504 ' CE2' ' CB ' ' A' ' 106' ' ' ALA . 64.5 m-85 -122.89 110.37 15.34 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 124.41 1.084 . . . . 0.0 110.17 -175.321 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -65.74 119.16 10.7 Favored 'General case' 0 N--CA 1.444 -0.751 0 O-C-N 120.335 -1.478 . . . . 0.0 108.517 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.462 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 7.0 tp-100 -48.47 -42.46 32.77 Favored 'General case' 0 C--O 1.197 -1.687 0 CA-C-N 118.542 0.61 . . . . 0.0 111.518 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.4 ' O ' ' CB ' ' A' ' 18' ' ' SER . 21.2 t30 -48.8 -48.36 41.43 Favored 'General case' 0 C--O 1.189 -2.087 0 CA-C-N 117.785 0.266 . . . . 0.0 111.106 175.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -67.28 -34.94 78.45 Favored 'General case' 0 C--O 1.196 -1.742 0 O-C-N 120.641 -1.287 . . . . 0.0 112.502 171.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.37 -45.1 80.68 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 121.337 1.88 . . . . 0.0 113.106 172.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.401 ' O ' ' CD2' ' A' ' 21' ' ' HIS . 4.2 pt-20 -85.94 -37.8 18.67 Favored 'General case' 0 C--O 1.206 -1.197 0 CA-C-O 118.575 -0.726 . . . . 0.0 109.14 178.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.4 ' CB ' ' O ' ' A' ' 14' ' ' ASN . 47.8 t -71.75 -61.29 1.83 Allowed 'General case' 0 CA--C 1.5 -0.947 0 C-N-CA 126.6 1.96 . . . . 0.0 108.819 -177.037 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.485 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 8.7 t-20 -40.97 -35.93 0.59 Allowed 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 119.285 0.948 . . . . 0.0 112.555 173.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.61 -37.96 26.77 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 174.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.401 ' CD2' ' O ' ' A' ' 17' ' ' GLU . 5.5 m170 -44.09 -39.2 4.07 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 126.436 1.894 . . . . 0.0 109.518 178.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.485 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -73.41 -49.09 28.9 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-O 118.435 -0.793 . . . . 0.0 112.1 175.77 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.476 ' HB3' ' CE1' ' A' ' 83' ' ' PHE . . . -35.64 129.77 0.57 Allowed Pre-proline 0 N--CA 1.439 -1.006 0 O-C-N 124.634 1.209 . . . . 0.0 112.566 174.076 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -73.4 124.23 9.26 Favored 'Trans proline' 0 N--CA 1.442 -1.54 0 C-N-CA 121.898 1.732 . . . . 0.0 109.707 -176.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.448 ' CD1' ' HE2' ' A' ' 115' ' ' LYS . 5.4 tp -60.44 95.45 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.103 0.561 . . . . 0.0 110.925 179.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 179.13 173.07 0.8 Allowed 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 123.322 0.649 . . . . 0.0 110.445 -176.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -109.25 119.37 39.28 Favored 'General case' 0 CA--C 1.511 -0.53 0 C-N-CA 124.101 0.961 . . . . 0.0 109.934 179.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 45.98 64.06 2.62 Favored Glycine 0 C--O 1.225 -0.413 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.209 177.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.0 ptmt -127.5 8.51 6.47 Favored 'General case' 0 CA--C 1.511 -0.543 0 O-C-N 122.247 -0.56 . . . . 0.0 111.463 179.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.1 p -115.06 152.45 32.47 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -174.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -39.37 -59.16 1.92 Allowed Glycine 0 C--N 1.335 0.493 0 O-C-N 124.001 0.813 . . . . 0.0 112.544 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 29.7 t -62.46 -63.3 1.27 Allowed 'General case' 0 N--CA 1.441 -0.895 0 CA-C-O 116.273 -1.822 . . . . 0.0 111.166 176.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 159.63 -57.85 0.0 OUTLIER 'General case' 0 C--O 1.221 -0.418 0 O-C-N 126.085 2.115 . . . . 0.0 109.537 179.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.508 ' CD2' ' HD3' ' A' ' 84' ' ' PRO . 55.3 m-85 -55.8 145.09 53.8 Favored Pre-proline 0 N--CA 1.434 -1.229 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 179.234 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -74.4 163.4 90.4 Favored 'Cis proline' 0 N--CA 1.447 -1.221 0 C-N-CA 122.822 -1.741 . . . . 0.0 111.428 -1.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.484 ' CD2' ' CD2' ' A' ' 34' ' ' TYR . 1.5 p80 -137.22 175.1 9.91 Favored 'General case' 0 C--O 1.212 -0.914 0 O-C-N 120.981 -1.074 . . . . 0.0 110.339 -177.148 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.469 ' CD1' ' HB2' ' A' ' 79' ' ' TYR . 21.0 t90 -75.15 130.83 39.87 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.545 ' CE1' ' CD1' ' A' ' 121' ' ' ILE . 42.2 t80 -101.81 77.74 1.75 Allowed 'General case' 0 N--CA 1.427 -1.608 0 C-N-CA 126.009 1.724 . . . . 0.0 107.309 -178.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.457 HG21 ' CE3' ' A' ' 37' ' ' TRP . 64.0 p -39.63 -31.78 0.11 Allowed 'General case' 0 C--O 1.215 -0.716 0 C-N-CA 124.297 1.039 . . . . 0.0 110.694 175.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 43.7 t30 60.47 14.08 4.57 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 122.861 1.315 . . . . 0.0 109.147 177.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 116.3 -40.3 2.44 Favored Glycine 0 N--CA 1.423 -2.178 0 O-C-N 119.556 -1.965 . . . . 0.0 111.875 -174.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.491 ' CE2' ' HD3' ' A' ' 66' ' ' PRO . 65.0 m-85 -49.54 156.12 0.69 Allowed 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.732 1.213 . . . . 0.0 110.392 -178.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.37 -39.4 20.74 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.576 178.08 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.42 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -162.41 -76.67 0.03 OUTLIER Glycine 0 C--N 1.339 0.741 0 C-N-CA 123.715 0.674 . . . . 0.0 111.623 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -114.0 -63.81 1.4 Allowed 'General case' 0 CA--C 1.509 -0.62 0 C-N-CA 122.514 0.326 . . . . 0.0 110.959 -179.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.12 -168.25 0.07 OUTLIER Glycine 0 C--N 1.353 1.513 0 O-C-N 124.274 0.983 . . . . 0.0 111.119 178.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.1 -164.43 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 124.62 2.152 . . . . 0.0 111.987 176.101 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.403 ' CB ' ' CD ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -105.9 178.04 1.21 Allowed Pre-proline 0 N--CA 1.433 -1.311 0 O-C-N 119.647 -1.908 . . . . 0.0 110.568 -179.478 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . 0.403 ' CD ' ' CB ' ' A' ' 48' ' ' LEU . 23.9 Cg_endo -73.01 177.61 7.54 Favored 'Trans proline' 0 N--CA 1.444 -1.416 0 C-N-CA 122.138 1.892 . . . . 0.0 111.685 178.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.8 tttm -83.83 102.0 12.03 Favored 'General case' 0 N--CA 1.444 -0.767 0 O-C-N 120.955 -1.091 . . . . 0.0 109.87 177.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 117.96 65.12 0.32 Allowed Glycine 0 C--O 1.223 -0.577 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.23 176.3 12.11 Favored 'General case' 0 CA--C 1.51 -0.574 0 C-N-CA 123.066 0.547 . . . . 0.0 110.625 178.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.9 m -154.24 107.0 2.43 Favored Pre-proline 0 C--O 1.215 -0.711 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.786 173.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -71.26 174.4 10.82 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 121.879 1.719 . . . . 0.0 111.783 178.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.452 ' CG2' ' HB2' ' A' ' 133' ' ' LEU . 4.1 mt -95.11 132.95 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.2 136.68 39.72 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -121.94 -52.99 1.97 Allowed 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 123.098 0.559 . . . . 0.0 109.959 -179.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 126.45 -6.37 7.57 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 123.654 0.645 . . . . 0.0 112.285 -176.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.73 131.52 37.05 Favored 'General case' 0 CA--C 1.5 -0.975 0 CA-C-O 118.087 -0.958 . . . . 0.0 109.207 178.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 87.5 p -67.05 -7.53 23.48 Favored 'General case' 0 C--O 1.22 -0.496 0 O-C-N 125.056 1.473 . . . . 0.0 111.532 176.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -89.64 -56.88 3.07 Favored 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 124.42 1.088 . . . . 0.0 109.629 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 68.6 m -69.64 -20.29 63.6 Favored 'General case' 0 N--CA 1.448 -0.569 0 O-C-N 123.859 0.724 . . . . 0.0 110.364 177.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -78.46 -41.77 31.79 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.321 0.648 . . . . 0.0 110.674 176.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.7 159.8 0.87 Allowed Pre-proline 0 N--CA 1.443 -0.809 0 CA-C-O 121.503 0.668 . . . . 0.0 110.832 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -72.01 136.88 28.14 Favored 'Trans proline' 0 N--CA 1.439 -1.695 0 C-N-CA 121.521 1.481 . . . . 0.0 114.264 173.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.491 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 19.0 Cg_endo -72.29 170.06 20.08 Favored 'Trans proline' 0 N--CA 1.445 -1.379 0 C-N-CA 122.786 2.324 . . . . 0.0 111.236 178.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -128.87 53.28 1.87 Allowed 'General case' 0 C--O 1.2 -1.514 0 CA-C-O 118.166 -0.921 . . . . 0.0 110.596 178.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.432 ' CE1' ' O ' ' A' ' 69' ' ' SER . 46.7 t-80 -76.87 165.72 24.31 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 119.468 1.031 . . . . 0.0 111.061 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.432 ' O ' ' CE1' ' A' ' 68' ' ' HIS . 0.2 OUTLIER -157.55 -165.29 1.74 Allowed 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 121.17 -0.956 . . . . 0.0 110.962 177.194 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.85 75.01 10.4 Favored 'General case' 0 N--CA 1.445 -0.676 0 O-C-N 120.174 -1.579 . . . . 0.0 111.332 176.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -177.46 -45.25 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 123.291 0.636 . . . . 0.0 109.881 179.124 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.482 ' O ' ' CE2' ' A' ' 79' ' ' TYR . . . 122.92 -50.89 0.82 Allowed Glycine 0 N--CA 1.438 -1.203 0 CA-C-O 118.636 -1.091 . . . . 0.0 111.632 -176.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -151.54 82.97 1.3 Allowed 'General case' 0 N--CA 1.438 -1.075 0 CA-C-N 118.603 1.202 . . . . 0.0 107.962 178.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.03 -115.96 0.01 OUTLIER Glycine 0 C--O 1.222 -0.616 0 CA-C-O 123.083 1.38 . . . . 0.0 111.451 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.0 mttp -60.39 -98.37 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.46 0 O-C-N 119.681 -2.07 . . . . 0.0 110.648 178.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -109.37 16.1 22.59 Favored 'General case' 0 N--CA 1.447 -0.581 0 O-C-N 120.633 -1.292 . . . . 0.0 110.833 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.488 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 5.7 m-20 -29.31 103.44 0.02 OUTLIER 'General case' 0 C--O 1.203 -1.364 0 C-N-CA 124.807 1.243 . . . . 0.0 110.85 -177.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.495 ' H ' ' CD2' ' A' ' 78' ' ' HIS . 3.5 p80 -85.74 14.19 6.19 Favored 'General case' 0 CA--C 1.513 -0.447 0 O-C-N 121.39 -0.819 . . . . 0.0 110.209 -176.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.508 ' CE2' ' CD2' ' A' ' 81' ' ' LEU . 0.3 OUTLIER -35.84 132.29 0.49 Allowed 'General case' 0 N--CA 1.426 -1.645 0 C-N-CA 124.911 1.285 . . . . 0.0 113.795 173.071 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.05 154.99 38.99 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 118.346 -0.835 . . . . 0.0 109.034 179.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.508 ' CD2' ' CE2' ' A' ' 79' ' ' TYR . 1.2 mp -142.34 143.34 32.7 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 123.956 0.902 . . . . 0.0 109.647 178.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.495 ' CB ' ' CD1' ' A' ' 109' ' ' ILE . 0.2 OUTLIER -108.93 162.78 13.89 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-O 122.186 0.994 . . . . 0.0 111.233 179.464 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.476 ' CE1' ' HB3' ' A' ' 23' ' ' ALA . 38.0 t80 -150.64 126.33 4.95 Favored Pre-proline 0 N--CA 1.443 -0.801 0 CA-C-N 115.626 -0.716 . . . . 0.0 112.312 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.508 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 21.5 Cg_endo -71.98 101.35 1.19 Allowed 'Trans proline' 0 N--CA 1.446 -1.292 0 C-N-CA 123.764 2.976 . . . . 0.0 111.01 -179.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -101.01 114.88 29.21 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 121.943 0.877 . . . . 0.0 110.661 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -81.4 160.96 63.69 Favored Pre-proline 0 N--CA 1.442 -0.868 0 O-C-N 121.423 -0.798 . . . . 0.0 112.483 178.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -76.67 -41.61 0.41 Allowed 'Trans proline' 0 CA--C 1.497 -1.358 0 C-N-CA 122.496 2.131 . . . . 0.0 112.962 179.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -45.09 -30.99 1.21 Allowed 'General case' 0 C--N 1.349 0.574 0 O-C-N 125.052 1.47 . . . . 0.0 110.021 177.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.66 -4.08 83.57 Favored Glycine 0 N--CA 1.427 -1.964 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 177.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -61.53 127.73 32.9 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -61.02 93.29 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 176.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.491 ' O ' ' CD2' ' A' ' 94' ' ' PHE . 7.1 t80 -38.32 143.3 0.14 Allowed 'General case' 0 C--O 1.212 -0.92 0 CA-C-O 121.994 0.902 . . . . 0.0 110.813 179.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 12.2 ptpt -78.49 62.04 3.01 Favored 'General case' 0 C--N 1.318 -0.796 0 O-C-N 119.712 -1.867 . . . . 0.0 110.368 176.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.491 ' CD2' ' O ' ' A' ' 92' ' ' TYR . 30.6 p90 -80.84 -8.34 59.68 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 123.372 0.669 . . . . 0.0 111.299 177.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -97.21 -32.63 11.83 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 122.095 0.95 . . . . 0.0 110.179 178.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.8 m -81.85 107.1 14.3 Favored 'General case' 0 N--CA 1.443 -0.8 0 O-C-N 121.181 -0.95 . . . . 0.0 108.731 -178.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.5 ptpt -59.31 -48.8 80.26 Favored 'General case' 0 C--O 1.224 -0.286 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.6 pttt -142.66 128.42 10.42 Favored Pre-proline 0 N--CA 1.431 -1.415 0 C-N-CA 124.208 1.003 . . . . 0.0 109.64 -176.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -71.25 176.92 34.72 Favored 'Cis proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.682 -1.799 . . . . 0.0 111.421 -3.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.4 146.52 38.46 Favored 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 122.953 0.501 . . . . 0.0 110.172 177.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -99.62 165.06 11.8 Favored 'General case' 0 C--N 1.319 -0.76 0 O-C-N 123.939 0.774 . . . . 0.0 110.776 178.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -57.45 153.42 28.4 Favored Pre-proline 0 N--CA 1.439 -1.013 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.528 177.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -74.12 -164.69 0.22 Allowed 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 122.453 2.102 . . . . 0.0 111.468 177.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -132.89 157.8 22.8 Favored Glycine 0 N--CA 1.444 -0.782 0 O-C-N 121.342 -0.848 . . . . 0.0 112.643 178.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -74.92 -64.36 0.03 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 122.474 2.116 . . . . 0.0 110.101 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.504 ' CB ' ' CE2' ' A' ' 11' ' ' TYR . . . -69.39 141.43 54.14 Favored 'General case' 0 N--CA 1.441 -0.883 0 O-C-N 123.502 0.501 . . . . 0.0 111.017 179.212 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 5.2 mtm-85 -142.86 143.86 32.26 Favored 'General case' 0 N--CA 1.442 -0.852 0 O-C-N 124.257 0.973 . . . . 0.0 111.204 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.8 p -83.39 124.67 39.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 O-C-N 124.016 0.823 . . . . 0.0 110.377 178.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.521 HG23 ' CD2' ' A' ' 38' ' ' PHE . 6.2 mm -103.91 140.44 22.05 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.914 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -179.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.491 ' CD1' ' HG3' ' A' ' 115' ' ' LYS . 9.9 p90 -164.21 152.05 12.43 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-O 122.53 1.157 . . . . 0.0 111.287 -178.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.6 p -89.64 166.76 13.41 Favored 'General case' 0 C--N 1.319 -0.725 0 O-C-N 121.593 -0.692 . . . . 0.0 109.204 -178.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.556 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -110.95 153.8 43.65 Favored Pre-proline 0 N--CA 1.438 -1.029 0 C-N-CA 122.971 0.508 . . . . 0.0 111.168 179.263 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.556 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 19.5 Cg_endo -73.78 -55.28 0.14 OUTLIER 'Cis proline' 0 CA--C 1.501 -1.134 0 C-N-CA 123.001 -1.666 . . . . 0.0 109.759 -5.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -44.18 113.67 0.56 Allowed 'General case' 0 CA--C 1.5 -0.976 0 CA-C-O 115.653 -2.117 . . . . 0.0 109.823 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.491 ' HG3' ' CD1' ' A' ' 110' ' ' TYR . 0.1 OUTLIER -63.24 78.61 0.02 OUTLIER 'General case' 0 CA--C 1.508 -0.663 0 O-C-N 125.529 1.768 . . . . 0.0 108.64 -178.3 . . . . . . . . 3 3 . 1 . 014 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 77.6 t -73.54 72.11 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 -176.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.462 ' CZ ' ' NE2' ' A' ' 13' ' ' GLN . 42.0 t80 -37.46 104.96 0.03 OUTLIER 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 125.647 1.579 . . . . 0.0 110.15 -178.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 5.7 m -82.72 -44.68 15.35 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 -178.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 158.03 -145.71 12.22 Favored Glycine 0 N--CA 1.44 -1.09 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.457 HG13 ' CG ' ' A' ' 4' ' ' TRP . 1.1 mm -127.43 145.7 34.43 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.212 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 -175.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.545 ' CD1' ' CE1' ' A' ' 38' ' ' PHE . 5.7 pt -137.39 151.93 27.01 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.937 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 -177.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.447 -0.605 0 CA-C-O 122.088 0.947 . . . . 0.0 109.711 -178.719 . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.2 pttt . . . . . 0 CA--C 1.501 -0.924 0 CA-C-O 118.263 -0.875 . . . . 0.0 108.779 . . . . . . . . . 0 0 . 1 . 014 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.452 ' HB2' ' CG2' ' A' ' 55' ' ' ILE . 9.0 tp -61.56 127.7 32.71 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 124.798 1.311 . . . . 0.0 109.1 179.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 35.2 m -67.19 -174.36 0.36 Allowed 'General case' 0 N--CA 1.436 -1.156 0 CA-C-O 122.707 1.242 . . . . 0.0 109.39 177.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 66.3 m -151.1 101.33 2.86 Favored 'General case' 0 C--N 1.322 -0.613 0 O-C-N 121.468 -0.77 . . . . 0.0 109.354 -179.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 0.452 ' CD2' ' H ' ' A' ' 136' ' ' HIS . 0.4 OUTLIER . . . . . 0 C--O 1.247 0.969 0 CA-C-O 116.527 -1.702 . . . . 0.0 113.313 175.131 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.1 p . . . . . 0 C--O 1.237 0.441 0 CA-C-O 121.922 0.867 . . . . 0.0 109.564 . . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.9 m -90.09 115.38 27.31 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -176.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . 0.509 ' CE2' ' CD2' ' A' ' 136' ' ' HIS . 23.3 m95 -78.23 142.28 38.0 Favored 'General case' 0 C--O 1.215 -0.725 0 O-C-N 121.676 -0.64 . . . . 0.0 110.671 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -140.66 141.74 35.01 Favored 'General case' 0 CA--C 1.499 -1.008 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 -177.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -119.67 -79.14 0.6 Allowed 'General case' 0 C--O 1.218 -0.598 0 O-C-N 124.467 1.104 . . . . 0.0 111.034 176.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -74.32 -87.45 0.23 Allowed Glycine 0 C--O 1.219 -0.804 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -179.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -143.67 12.61 2.2 Favored Glycine 0 C--O 1.221 -0.662 0 O-C-N 121.573 -0.957 . . . . 0.0 111.704 178.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 22.4 mt -113.9 155.49 25.68 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 117.824 0.812 . . . . 0.0 109.581 178.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.4 mp -106.78 133.37 51.54 Favored 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -175.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.472 ' CE2' ' CB ' ' A' ' 106' ' ' ALA . 60.8 m-85 -124.58 91.4 3.44 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 125.749 1.62 . . . . 0.0 106.992 -170.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -53.48 121.07 6.95 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 117.708 -1.139 . . . . 0.0 108.745 179.095 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.498 ' NE2' ' CE1' ' A' ' 117' ' ' PHE . 1.2 tt0 -52.24 -50.78 61.35 Favored 'General case' 0 CA--C 1.498 -1.029 0 CA-C-O 117.243 -1.361 . . . . 0.0 111.173 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -50.42 -36.84 34.87 Favored 'General case' 0 C--O 1.194 -1.825 0 O-C-N 125.42 1.7 . . . . 0.0 110.615 178.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.4 mttp -71.59 -51.01 25.61 Favored 'General case' 0 C--O 1.212 -0.917 0 CA-C-O 116.526 -1.702 . . . . 0.0 115.428 166.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.86 -35.11 9.79 Favored 'General case' 0 C--O 1.211 -0.936 0 CA-C-N 121.653 2.024 . . . . 0.0 113.024 171.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.443 ' O ' ' CD2' ' A' ' 21' ' ' HIS . 16.0 pt-20 -88.32 -40.81 13.31 Favored 'General case' 0 C--O 1.205 -1.285 0 C-N-CA 125.76 1.624 . . . . 0.0 110.471 172.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.4 t -77.0 -59.12 2.91 Favored 'General case' 0 CA--C 1.501 -0.912 0 O-C-N 117.217 -3.427 . . . . 0.0 108.123 -172.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.476 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -45.38 -32.31 2.03 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 167.215 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.5 p -83.74 -24.56 31.1 Favored 'General case' 0 C--O 1.216 -0.691 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 173.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.443 ' CD2' ' O ' ' A' ' 17' ' ' GLU . 10.0 m170 -55.98 -37.91 69.72 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 126.504 1.922 . . . . 0.0 108.701 178.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.476 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.1 OUTLIER -71.02 -44.45 65.85 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 117.15 -1.405 . . . . 0.0 110.178 178.899 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -39.99 126.04 1.62 Allowed Pre-proline 0 CA--C 1.549 0.934 0 O-C-N 126.058 2.099 . . . . 0.0 111.287 176.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -72.67 123.41 9.0 Favored 'Trans proline' 0 N--CA 1.445 -1.38 0 C-N-CA 122.433 2.089 . . . . 0.0 107.804 -175.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.421 ' CD1' ' HE2' ' A' ' 115' ' ' LYS . 3.4 tp -60.51 87.85 0.02 OUTLIER 'General case' 0 CA--C 1.507 -0.704 0 C-N-CA 124.514 1.126 . . . . 0.0 112.414 178.39 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.4 m -174.53 148.96 1.23 Allowed 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.993 1.317 . . . . 0.0 109.95 -171.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.406 ' HA ' ' HA ' ' A' ' 36' ' ' HIS . 0.0 OUTLIER -86.81 113.71 22.86 Favored 'General case' 0 CA--C 1.508 -0.655 0 C-N-CA 124.136 0.974 . . . . 0.0 110.176 176.362 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 54.03 72.41 0.55 Allowed Glycine 0 CA--C 1.525 0.669 0 C-N-CA 119.402 -1.38 . . . . 0.0 111.996 177.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.04 21.41 2.27 Favored 'General case' 0 CA--C 1.504 -0.813 0 O-C-N 121.438 -1.036 . . . . 0.0 112.724 177.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.7 p -129.57 152.07 49.49 Favored 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 -171.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -38.43 -66.87 0.58 Allowed Glycine 0 N--CA 1.442 -0.919 0 O-C-N 124.502 1.126 . . . . 0.0 112.858 178.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.409 ' HA ' ' CE ' ' A' ' 100' ' ' LYS . 24.2 t -52.77 -65.46 0.55 Allowed 'General case' 0 CA--C 1.492 -1.28 0 CA-C-O 114.994 -2.431 . . . . 0.0 113.07 173.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 160.87 -53.18 0.0 OUTLIER 'General case' 0 C--O 1.219 -0.552 0 O-C-N 127.626 3.079 . . . . 0.0 109.507 178.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.533 ' CE2' ' CE1' ' A' ' 36' ' ' HIS . 50.9 m-85 -61.46 147.05 88.61 Favored Pre-proline 0 N--CA 1.439 -1.008 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -74.55 150.53 95.66 Favored 'Cis proline' 0 N--CA 1.443 -1.477 0 C-N-CA 123.457 -1.476 . . . . 0.0 109.6 0.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.533 ' CE1' ' CE2' ' A' ' 34' ' ' TYR . 0.4 OUTLIER -126.72 160.64 30.21 Favored 'General case' 0 CA--C 1.499 -1.008 0 CA-C-O 117.062 -1.447 . . . . 0.0 109.003 179.242 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.542 ' CH2' ' HA2' ' A' ' 44' ' ' GLY . 22.1 t90 -58.45 148.8 26.92 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 124.763 1.289 . . . . 0.0 109.184 177.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.472 ' CZ ' HD13 ' A' ' 121' ' ' ILE . 10.8 t80 -129.22 78.36 1.85 Allowed 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 103.711 -2.7 . . . . 0.0 103.711 -170.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 44.7 p -39.15 -34.96 0.2 Allowed 'General case' 0 C--O 1.204 -1.31 0 C-N-CA 124.81 1.244 . . . . 0.0 110.117 173.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 56.7 t30 66.86 11.98 8.62 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.683 1.593 . . . . 0.0 110.523 178.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 108.15 -6.83 34.76 Favored Glycine 0 CA--C 1.537 1.451 0 O-C-N 120.96 -1.088 . . . . 0.0 114.687 -170.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.541 ' CE2' ' HA ' ' A' ' 47' ' ' LYS . 6.1 m-85 -78.26 168.51 19.73 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 124.472 1.109 . . . . 0.0 109.782 -178.298 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.11 -37.36 17.46 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.748 175.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.542 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . 176.43 -60.31 0.1 Allowed Glycine 0 CA--C 1.506 -0.469 0 C-N-CA 124.179 0.895 . . . . 0.0 112.881 -177.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -115.85 -63.11 1.5 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 122.716 1.246 . . . . 0.0 110.819 179.125 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.24 165.89 8.95 Favored Glycine 0 C--N 1.339 0.728 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 177.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.541 ' HA ' ' CE2' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -59.2 -168.97 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 123.288 1.518 . . . . 0.0 111.325 178.082 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.428 HD13 ' CE1' ' A' ' 42' ' ' TYR . 4.7 mp -77.14 152.12 81.85 Favored Pre-proline 0 N--CA 1.43 -1.458 0 O-C-N 120.472 -1.392 . . . . 0.0 110.833 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -72.17 170.43 19.1 Favored 'Trans proline' 0 N--CA 1.445 -1.336 0 C-N-CA 122.539 2.159 . . . . 0.0 110.792 179.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.92 100.43 0.07 Allowed 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.619 -0.676 . . . . 0.0 109.378 176.338 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.75 56.48 0.37 Allowed Glycine 0 CA--C 1.51 -0.252 0 O-C-N 121.684 -0.635 . . . . 0.0 111.552 -177.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.36 165.52 32.82 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 118.573 -0.727 . . . . 0.0 112.454 174.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 54.1 m -145.02 97.29 4.86 Favored Pre-proline 0 C--O 1.233 0.21 0 O-C-N 125.338 1.649 . . . . 0.0 110.276 -176.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -72.47 148.09 47.65 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.878 2.385 . . . . 0.0 110.88 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.7 mt -69.18 120.97 17.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -177.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.6 tppt? -83.03 135.24 34.92 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 120.897 -1.127 . . . . 0.0 108.652 177.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.522 ' CD1' ' HB3' ' A' ' 118' ' ' CYS . 7.9 m-85 -118.44 -51.61 2.4 Favored 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 123.786 0.834 . . . . 0.0 109.858 -178.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 122.32 -4.51 10.3 Favored Glycine 0 C--O 1.222 -0.613 0 CA-C-O 119.35 -0.695 . . . . 0.0 112.831 -175.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.6 mtpt -96.5 139.03 33.2 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-N 118.399 1.1 . . . . 0.0 110.553 175.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 23.2 t -74.77 -1.71 23.27 Favored 'General case' 0 C--O 1.222 -0.351 0 O-C-N 124.771 1.294 . . . . 0.0 111.961 175.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -87.95 -54.16 4.37 Favored 'General case' 0 CA--C 1.516 -0.364 0 O-C-N 120.793 -1.192 . . . . 0.0 108.709 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 2.7 m -75.47 -32.38 60.57 Favored 'General case' 0 N--CA 1.45 -0.438 0 O-C-N 124.028 0.83 . . . . 0.0 109.426 -178.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -62.88 -39.17 93.66 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 122.556 1.169 . . . . 0.0 110.811 173.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.421 ' HD3' ' CE1' ' A' ' 78' ' ' HIS . 0.0 OUTLIER -53.64 160.01 2.21 Favored Pre-proline 0 N--CA 1.444 -0.749 0 O-C-N 120.973 -1.079 . . . . 0.0 112.621 178.78 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -70.32 133.87 25.53 Favored 'Trans proline' 0 N--CA 1.438 -1.79 0 N-CA-C 114.697 0.999 . . . . 0.0 114.697 172.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.433 ' CD ' ' CD2' ' A' ' 42' ' ' TYR . 21.1 Cg_endo -70.46 168.92 21.07 Favored 'Trans proline' 0 N--CA 1.439 -1.685 0 C-N-CA 124.115 3.21 . . . . 0.0 111.238 176.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.9 tptt -128.05 51.75 1.94 Allowed 'General case' 0 C--O 1.199 -1.583 0 CA-C-N 115.02 -0.991 . . . . 0.0 108.826 177.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -75.66 168.82 19.3 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 119.921 -1.737 . . . . 0.0 110.972 178.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 24.0 p -161.67 -156.82 0.45 Allowed 'General case' 0 C--O 1.222 -0.375 0 O-C-N 120.994 -1.066 . . . . 0.0 111.846 174.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.11 70.88 9.13 Favored 'General case' 0 C--O 1.215 -0.719 0 O-C-N 120.67 -1.269 . . . . 0.0 112.739 172.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -176.08 -40.78 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.88 0.848 . . . . 0.0 109.701 177.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 108.67 -57.82 0.42 Allowed Glycine 0 C--O 1.212 -1.219 0 CA-C-O 118.389 -1.228 . . . . 0.0 111.761 -175.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -135.05 67.92 1.48 Allowed 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 105.529 -2.026 . . . . 0.0 105.529 -173.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.47 -119.24 0.01 OUTLIER Glycine 0 CA--C 1.529 0.93 0 CA-C-O 122.411 1.006 . . . . 0.0 113.001 177.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.7 mttt -63.79 -99.3 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.528 0 O-C-N 119.32 -2.282 . . . . 0.0 112.156 176.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -105.46 12.45 31.43 Favored 'General case' 0 C--N 1.317 -0.841 0 O-C-N 119.453 -2.03 . . . . 0.0 110.547 178.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.463 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 21.1 m-20 -29.66 105.83 0.03 OUTLIER 'General case' 0 C--O 1.201 -1.498 0 C-N-CA 126.234 1.813 . . . . 0.0 110.41 -176.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.544 ' H ' ' CD2' ' A' ' 78' ' ' HIS . 2.3 p80 -86.21 14.02 7.07 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 120.144 1.338 . . . . 0.0 110.082 -175.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -32.55 132.2 0.14 Allowed 'General case' 0 N--CA 1.439 -1.018 0 C-N-CA 126.015 1.726 . . . . 0.0 112.887 170.428 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.61 155.53 35.8 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 121.015 -1.053 . . . . 0.0 109.067 178.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.7 mp -141.81 134.36 28.28 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 118.874 0.761 . . . . 0.0 109.354 176.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.451 ' CB ' ' CD1' ' A' ' 109' ' ' ILE . 1.7 pm0 -103.13 154.56 19.17 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 122.842 1.306 . . . . 0.0 110.78 179.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.442 ' HZ ' ' CD2' ' A' ' 94' ' ' PHE . 37.8 t80 -141.79 138.82 17.5 Favored Pre-proline 0 C--O 1.218 -0.559 0 O-C-N 121.265 -0.897 . . . . 0.0 112.853 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.494 ' O ' ' CE2' ' A' ' 92' ' ' TYR . 14.6 Cg_endo -72.15 88.35 0.84 Allowed 'Trans proline' 0 CA--C 1.485 -1.942 0 C-N-CA 124.658 3.572 . . . . 0.0 109.341 -173.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.7 t -80.11 116.62 20.32 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.674 0.789 . . . . 0.0 111.769 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.506 ' CD1' ' CE1' ' A' ' 92' ' ' TYR . 7.8 m-85 -84.65 159.09 58.88 Favored Pre-proline 0 C--N 1.318 -0.777 0 O-C-N 120.406 -1.434 . . . . 0.0 110.701 -179.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -76.42 -45.29 0.21 Allowed 'Trans proline' 0 N--CA 1.446 -1.291 0 C-N-CA 122.252 1.968 . . . . 0.0 111.544 178.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -53.62 -28.75 34.47 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 124.108 1.909 . . . . 0.0 110.229 177.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.73 -9.5 51.1 Favored Glycine 0 N--CA 1.436 -1.354 0 CA-C-O 116.458 -2.301 . . . . 0.0 112.133 -177.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -50.53 138.91 16.74 Favored 'General case' 0 C--O 1.209 -1.041 0 CA-C-O 116.805 -1.569 . . . . 0.0 107.887 178.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -62.1 143.51 56.57 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 120.88 1.673 . . . . 0.0 111.644 175.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.506 ' CE1' ' CD1' ' A' ' 86' ' ' PHE . 0.1 OUTLIER -98.01 155.08 17.28 Favored 'General case' 0 C--O 1.215 -0.756 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -174.159 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.73 55.11 2.59 Favored 'General case' 0 C--N 1.314 -0.935 0 O-C-N 118.515 -2.615 . . . . 0.0 111.053 172.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.442 ' CD2' ' HZ ' ' A' ' 83' ' ' PHE . 40.0 p90 -69.24 -26.74 64.94 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-O 117.828 -1.082 . . . . 0.0 110.877 175.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -90.09 -21.05 22.48 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 119.956 1.253 . . . . 0.0 111.442 179.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.7 m -108.77 101.05 10.21 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 -178.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.26 -29.57 67.5 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.896 0.855 . . . . 0.0 110.234 175.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.6 mttm -125.75 113.38 24.85 Favored Pre-proline 0 N--CA 1.444 -0.745 0 CA-C-O 117.654 -1.165 . . . . 0.0 109.276 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -70.29 173.36 46.84 Favored 'Cis proline' 0 C--N 1.356 0.926 0 O-C-N 124.44 1.758 . . . . 0.0 110.521 -3.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.409 ' CE ' ' HA ' ' A' ' 32' ' ' SER . 0.5 OUTLIER -130.39 145.99 51.89 Favored 'General case' 0 CA--C 1.507 -0.705 0 C-N-CA 125.293 1.437 . . . . 0.0 110.021 177.863 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.07 175.19 5.53 Favored 'General case' 0 C--O 1.243 0.733 0 O-C-N 125.751 1.907 . . . . 0.0 109.122 -177.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -76.49 139.83 67.9 Favored Pre-proline 0 N--CA 1.442 -0.849 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.916 176.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -72.74 -165.61 0.24 Allowed 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 122.523 2.149 . . . . 0.0 111.899 175.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -136.3 163.89 25.11 Favored Glycine 0 CA--C 1.525 0.679 0 O-C-N 120.853 -1.154 . . . . 0.0 112.891 176.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -76.62 -50.12 0.11 Allowed 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.464 2.109 . . . . 0.0 110.898 178.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.472 ' CB ' ' CE2' ' A' ' 11' ' ' TYR . . . -75.29 142.51 43.27 Favored 'General case' 0 CA--C 1.51 -0.563 0 O-C-N 121.903 -0.498 . . . . 0.0 110.465 177.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.456 ' HG2' ' HA ' ' A' ' 84' ' ' PRO . 3.6 mtm-85 -143.81 145.69 32.53 Favored 'General case' 0 CA--C 1.5 -0.968 0 CA-C-O 117.721 -1.133 . . . . 0.0 112.415 178.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 5.3 p -79.15 124.98 38.2 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.476 0 O-C-N 124.176 0.922 . . . . 0.0 110.62 177.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.451 ' CD1' ' CB ' ' A' ' 82' ' ' GLU . 4.4 mm -103.99 141.38 19.74 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 C-N-CA 123.914 0.886 . . . . 0.0 109.718 -179.086 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.412 ' CD1' ' HG3' ' A' ' 115' ' ' LYS . 10.4 p90 -166.01 152.48 9.41 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 122.891 1.329 . . . . 0.0 110.034 -178.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.7 p -89.79 167.68 12.68 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.062 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.543 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.3 OUTLIER -108.46 153.83 41.86 Favored Pre-proline 0 CA--C 1.552 1.031 0 O-C-N 123.534 0.521 . . . . 0.0 111.341 177.182 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.543 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 14.1 Cg_endo -75.81 -55.27 0.14 OUTLIER 'Cis proline' 0 CA--C 1.49 -1.706 0 N-CA-C 107.998 -1.578 . . . . 0.0 107.998 -5.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -44.17 112.24 0.38 Allowed 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 116.279 -1.82 . . . . 0.0 109.713 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.421 ' HE2' ' CD1' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -66.44 76.17 0.1 Allowed 'General case' 0 CA--C 1.505 -0.755 0 C-N-CA 124.797 1.239 . . . . 0.0 107.985 -177.666 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 54.8 t -75.83 72.03 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 -176.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.536 ' CE1' ' HA2' ' A' ' 119' ' ' GLY . 7.6 t80 -39.08 111.17 0.17 Allowed 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 126.321 1.848 . . . . 0.0 106.84 -178.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . 0.522 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 0.1 OUTLIER -91.25 -22.78 20.41 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 121.126 -0.23 . . . . 0.0 110.405 175.974 . . . . . . . . 3 3 . 1 . 015 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.536 ' HA2' ' CE1' ' A' ' 117' ' ' PHE . . . 134.82 -170.31 22.86 Favored Glycine 0 CA--C 1.496 -1.148 0 C-N-CA 123.621 0.629 . . . . 0.0 112.1 -176.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 3.4 mp -107.67 151.53 9.66 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 -179.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.472 HD13 ' CZ ' ' A' ' 38' ' ' PHE . 9.9 pt -120.94 154.72 24.5 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.621 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 177.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.325 -0.475 0 CA-C-O 123.644 1.688 . . . . 0.0 110.069 175.117 . . . . . . . . 0 0 . 1 . 015 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.509 -0.631 0 CA-C-O 118.715 -0.66 . . . . 0.0 109.759 . . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 10.4 tp -84.41 141.44 30.83 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.656 1.223 . . . . 0.0 108.387 177.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 79.4 m -60.64 -179.42 0.12 Allowed 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 123.264 1.507 . . . . 0.0 110.312 174.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 13.2 m -159.06 87.79 0.87 Allowed 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 104.002 -2.592 . . . . 0.0 104.002 -176.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 0.509 ' CD2' ' CE2' ' A' ' 4' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--O 1.257 1.48 0 CA-C-O 114.024 -2.893 . . . . 0.0 114.756 167.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.7 p . . . . . 0 C--O 1.234 0.285 0 CA-C-O 121.611 0.719 . . . . 0.0 109.974 . . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.9 m -88.04 114.49 24.71 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 123.665 0.786 . . . . 0.0 109.368 -178.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . 0.515 ' CE2' ' CD2' ' A' ' 136' ' ' HIS . 19.5 m95 -79.01 144.32 34.81 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.052 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -138.61 134.35 33.65 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -178.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -118.78 -84.19 0.65 Allowed 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.42 0.628 . . . . 0.0 110.374 176.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -92.85 75.1 1.26 Allowed Glycine 0 C--O 1.217 -0.927 0 CA-C-O 117.564 -1.687 . . . . 0.0 111.813 -177.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 45.9 27.5 2.4 Favored Glycine 0 N--CA 1.473 1.145 0 CA-C-N 118.96 1.38 . . . . 0.0 113.948 -175.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.6 mt -129.98 149.17 51.82 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -174.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.42 155.15 17.98 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 124.487 1.117 . . . . 0.0 108.102 -173.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.541 ' CE2' ' CB ' ' A' ' 106' ' ' ALA . 50.7 m-85 -158.72 86.03 0.84 Allowed 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 122.181 0.991 . . . . 0.0 108.872 -172.463 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -54.99 125.22 19.5 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-O 117.058 -1.449 . . . . 0.0 108.727 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.54 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 0.8 OUTLIER -49.74 -35.07 20.88 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-N 119.106 0.866 . . . . 0.0 111.271 178.585 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.404 ' O ' ' CB ' ' A' ' 18' ' ' SER . 8.4 t-20 -61.07 -44.91 96.65 Favored 'General case' 0 C--O 1.204 -1.317 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.41 175.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.4 -42.88 64.67 Favored 'General case' 0 C--O 1.207 -1.15 0 CA-C-O 117.736 -1.126 . . . . 0.0 111.899 173.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -52.09 -39.8 60.3 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 119.893 1.224 . . . . 0.0 111.422 176.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -85.81 -47.91 9.27 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-O 117.907 -1.044 . . . . 0.0 110.387 176.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.404 ' CB ' ' O ' ' A' ' 14' ' ' ASN . 29.0 t -64.39 -59.42 4.38 Favored 'General case' 0 CA--C 1.499 -0.992 0 C-N-CA 125.982 1.713 . . . . 0.0 107.948 -173.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.447 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 13.4 t-20 -38.07 -40.51 0.49 Allowed 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 118.919 0.782 . . . . 0.0 112.362 172.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.6 -38.2 40.53 Favored 'General case' 0 C--O 1.218 -0.602 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 174.52 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 10.3 m170 -43.55 -36.04 1.93 Allowed 'General case' 0 C--N 1.34 0.191 0 C-N-CA 126.25 1.82 . . . . 0.0 109.87 178.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.447 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.1 OUTLIER -74.8 -52.0 12.59 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 124.318 1.047 . . . . 0.0 111.105 177.226 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -37.58 126.08 0.92 Allowed Pre-proline 0 CA--C 1.544 0.722 0 O-C-N 124.967 1.417 . . . . 0.0 111.629 174.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -73.09 132.18 17.77 Favored 'Trans proline' 0 N--CA 1.445 -1.343 0 C-N-CA 122.033 1.822 . . . . 0.0 110.125 -178.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.3 tp -59.79 112.42 1.83 Allowed 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.561 179.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 179.71 149.98 0.33 Allowed 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 122.617 0.367 . . . . 0.0 111.193 -178.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.493 ' HB2' ' CE2' ' A' ' 79' ' ' TYR . 4.2 t0 -86.86 78.99 8.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 122.024 0.916 . . . . 0.0 108.62 -179.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . 0.411 ' N ' ' HA ' ' A' ' 36' ' ' HIS . . . 68.38 76.93 0.4 Allowed Glycine 0 N--CA 1.451 -0.333 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 177.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -152.13 40.55 0.63 Allowed 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 122.342 1.068 . . . . 0.0 111.876 178.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.4 p -121.32 159.1 26.76 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 -176.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -37.66 -77.81 0.05 OUTLIER Glycine 0 C--N 1.333 0.407 0 C-N-CA 125.145 1.355 . . . . 0.0 111.846 -178.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 32' ' ' SER . . . . . 0.403 ' OG ' ' HE2' ' A' ' 100' ' ' LYS . 18.0 t -55.24 -57.11 13.15 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.137 177.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 161.1 -51.16 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.568 0 O-C-N 124.859 1.35 . . . . 0.0 111.44 178.191 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.416 ' CD1' ' HD3' ' A' ' 84' ' ' PRO . 90.2 m-85 -69.53 147.36 96.71 Favored Pre-proline 0 N--CA 1.444 -0.775 0 O-C-N 124.089 0.868 . . . . 0.0 112.915 178.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.436 ' HB2' ' CG ' ' A' ' 81' ' ' LEU . 28.4 Cg_endo -77.42 179.3 31.66 Favored 'Cis proline' 0 N--CA 1.446 -1.314 0 C-N-CA 122.359 -1.934 . . . . 0.0 112.426 2.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.411 ' HA ' ' N ' ' A' ' 28' ' ' GLY . 0.5 OUTLIER -154.29 167.58 29.47 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-O 118.322 -0.847 . . . . 0.0 110.972 -179.87 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.503 ' CH2' ' HA2' ' A' ' 44' ' ' GLY . 17.9 t90 -61.74 152.23 31.76 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 122.183 0.992 . . . . 0.0 109.546 175.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.455 ' CE2' ' HB2' ' A' ' 40' ' ' ASN . 8.7 t80 -125.27 84.46 2.28 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 -175.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 62.3 p -38.67 -36.4 0.25 Allowed 'General case' 0 C--O 1.214 -0.784 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.234 173.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.455 ' HB2' ' CE2' ' A' ' 38' ' ' PHE . 51.3 t30 55.07 21.15 3.65 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-O 122.697 1.237 . . . . 0.0 110.849 177.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.431 ' CA ' ' HG2' ' A' ' 52' ' ' ARG . . . 106.9 -40.08 2.64 Favored Glycine 0 N--CA 1.423 -2.186 0 CA-C-O 118.504 -1.164 . . . . 0.0 114.431 -171.038 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.471 ' CE2' ' HD3' ' A' ' 66' ' ' PRO . 76.1 m-85 -48.72 155.42 0.57 Allowed 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 118.998 1.399 . . . . 0.0 111.761 177.492 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.44 -36.29 22.45 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.376 0.608 . . . . 0.0 110.796 178.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.503 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -172.21 -61.87 0.04 OUTLIER Glycine 0 C--N 1.335 0.498 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -178.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -123.33 -64.19 1.18 Allowed 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 122.542 0.337 . . . . 0.0 110.891 -178.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.64 -174.13 0.14 Allowed Glycine 0 C--N 1.345 1.043 0 C-N-CA 124.435 1.016 . . . . 0.0 110.676 178.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -59.99 -166.28 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 123.793 1.759 . . . . 0.0 110.687 178.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -94.31 170.17 8.65 Favored Pre-proline 0 C--N 1.312 -1.034 0 O-C-N 120.995 -1.066 . . . . 0.0 110.217 -178.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -71.64 158.18 54.12 Favored 'Trans proline' 0 N--CA 1.441 -1.582 0 C-N-CA 121.913 1.742 . . . . 0.0 111.062 178.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.28 97.59 0.09 Allowed 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.983 177.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 119.85 39.31 0.66 Allowed Glycine 0 C--O 1.227 -0.283 0 CA-C-O 119.476 -0.624 . . . . 0.0 111.952 -176.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.431 ' HG2' ' CA ' ' A' ' 41' ' ' GLY . 0.0 OUTLIER -122.63 161.81 23.09 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 117.759 0.779 . . . . 0.0 111.283 177.103 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 26.0 m -139.74 98.32 7.91 Favored Pre-proline 0 C--N 1.328 -0.357 0 O-C-N 124.265 0.978 . . . . 0.0 110.054 -178.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -72.06 161.19 45.47 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 122.052 1.835 . . . . 0.0 111.674 178.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.422 ' O ' ' CE2' ' A' ' 57' ' ' PHE . 6.9 mt -85.43 121.47 37.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 -178.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.66 135.07 35.13 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 177.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.545 ' CD1' ' HB3' ' A' ' 118' ' ' CYS . 15.1 m-85 -118.3 -51.87 2.4 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 123.354 0.661 . . . . 0.0 110.617 179.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 122.42 -2.09 10.4 Favored Glycine 0 C--O 1.226 -0.366 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.302 -176.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 33.9 mmtt -100.0 141.61 32.58 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-N 117.567 0.683 . . . . 0.0 110.195 177.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 44.9 t -76.22 -2.06 29.48 Favored 'General case' 0 C--O 1.221 -0.429 0 O-C-N 124.66 1.225 . . . . 0.0 111.226 176.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.83 -55.56 3.72 Favored 'General case' 0 CA--C 1.512 -0.511 0 O-C-N 120.876 -1.14 . . . . 0.0 109.075 -179.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 2.0 m -74.38 -31.77 62.49 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 124.586 1.179 . . . . 0.0 109.383 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -64.89 -38.24 90.3 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 122.279 1.037 . . . . 0.0 110.586 175.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.12 160.1 2.57 Favored Pre-proline 0 N--CA 1.445 -0.676 0 O-C-N 121.179 -0.95 . . . . 0.0 112.251 179.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -71.2 140.62 37.73 Favored 'Trans proline' 0 N--CA 1.441 -1.586 0 C-N-CA 120.326 0.684 . . . . 0.0 113.422 175.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.471 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 22.9 Cg_endo -73.1 170.3 20.14 Favored 'Trans proline' 0 N--CA 1.446 -1.307 0 C-N-CA 123.542 2.828 . . . . 0.0 111.415 177.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.9 tptp -136.15 57.38 1.78 Allowed 'General case' 0 C--O 1.214 -0.789 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -178.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 43.8 t-80 -74.0 154.95 39.07 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 124.486 2.089 . . . . 0.0 113.09 175.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.07 -172.08 3.5 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 118.677 -2.514 . . . . 0.0 110.411 178.2 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -85.26 69.48 10.74 Favored 'General case' 0 N--CA 1.45 -0.44 0 O-C-N 121.947 -0.471 . . . . 0.0 111.042 176.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -177.76 -42.68 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 123.555 0.535 . . . . 0.0 110.112 179.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.446 ' CA ' ' HB3' ' A' ' 27' ' ' ASP . . . 124.98 -78.95 0.37 Allowed Glycine 0 N--CA 1.441 -0.967 0 CA-C-N 115.189 -0.914 . . . . 0.0 112.727 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -118.86 58.66 0.84 Allowed 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.236 1.015 . . . . 0.0 108.956 178.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -57.28 -105.58 0.01 OUTLIER Glycine 0 CA--C 1.525 0.701 0 CA-C-O 121.661 0.589 . . . . 0.0 112.695 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 22.1 mttt -60.97 -96.32 0.0 OUTLIER 'General case' 0 C--O 1.222 -0.384 0 O-C-N 121.197 -1.178 . . . . 0.0 111.259 177.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -126.63 26.88 6.2 Favored 'General case' 0 CA--C 1.511 -0.527 0 O-C-N 121.645 -0.659 . . . . 0.0 111.086 178.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.476 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 1.9 m-20 -34.49 106.23 0.04 OUTLIER 'General case' 0 C--O 1.216 -0.689 0 C-N-CA 124.597 1.159 . . . . 0.0 109.91 -176.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -84.19 19.49 1.83 Allowed 'General case' 0 C--N 1.328 -0.354 0 O-C-N 121.142 -0.974 . . . . 0.0 110.63 -177.37 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.493 ' CE2' ' HB2' ' A' ' 27' ' ' ASP . 22.9 p90 -48.49 135.46 14.19 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 124.695 1.198 . . . . 0.0 110.818 177.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.07 137.24 40.05 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.475 HD23 ' CZ ' ' A' ' 110' ' ' TYR . 0.3 OUTLIER -123.91 148.76 46.58 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.132 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -115.16 163.45 15.63 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.725 -0.671 . . . . 0.0 112.134 176.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.489 ' CD1' ' HD2' ' A' ' 84' ' ' PRO . 40.2 t80 -152.61 133.93 8.19 Favored Pre-proline 0 CA--C 1.534 0.352 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -178.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.489 ' HD2' ' CD1' ' A' ' 83' ' ' PHE . 17.8 Cg_endo -72.27 104.3 1.66 Allowed 'Trans proline' 0 N--CA 1.446 -1.299 0 C-N-CA 123.345 2.697 . . . . 0.0 110.626 -176.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.6 t -105.92 108.36 19.83 Favored 'General case' 0 CA--C 1.5 -0.947 0 O-C-N 124.356 1.035 . . . . 0.0 110.136 -178.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.438 ' CD2' ' NE2' ' A' ' 90' ' ' HIS . 1.4 m-85 -85.29 161.25 52.45 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-O 121.138 0.494 . . . . 0.0 111.372 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -76.33 -41.23 0.49 Allowed 'Trans proline' 0 CA--C 1.496 -1.395 0 C-N-CA 121.871 1.714 . . . . 0.0 112.711 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -39.54 -31.13 0.08 Allowed 'General case' 0 N--CA 1.469 0.497 0 O-C-N 124.989 1.431 . . . . 0.0 111.363 175.176 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 91.58 -9.96 75.85 Favored Glycine 0 N--CA 1.43 -1.76 0 C-N-CA 124.749 1.166 . . . . 0.0 111.892 179.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.438 ' NE2' ' CD2' ' A' ' 86' ' ' PHE . 0.5 OUTLIER -57.63 143.8 39.97 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 122.712 1.244 . . . . 0.0 109.089 177.447 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -88.6 122.54 32.16 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 174.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -48.11 170.02 0.02 OUTLIER 'General case' 0 C--O 1.214 -0.78 0 CA-C-O 123.213 1.482 . . . . 0.0 113.614 175.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.86 60.83 1.1 Allowed 'General case' 0 C--N 1.321 -0.634 0 O-C-N 119.371 -2.081 . . . . 0.0 107.33 -176.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -81.12 14.91 2.09 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 121.742 -0.599 . . . . 0.0 112.1 177.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -108.46 -31.41 7.82 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.458 0.647 . . . . 0.0 109.982 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.8 m -113.87 116.09 28.75 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 123.175 0.59 . . . . 0.0 109.474 -179.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.8 pttm -58.33 -45.48 88.02 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.058 177.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 9.7 ttmt -142.07 131.9 12.47 Favored Pre-proline 0 N--CA 1.442 -0.87 0 CA-C-O 118.424 -0.798 . . . . 0.0 109.948 -179.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -70.25 175.37 38.41 Favored 'Cis proline' 0 N--CA 1.456 -0.724 0 O-C-N 124.769 1.931 . . . . 0.0 112.256 -4.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . 0.403 ' HE2' ' OG ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -145.18 147.54 32.58 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 177.765 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -84.86 175.87 8.85 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.24 0.543 . . . . 0.0 111.276 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -73.13 140.67 80.36 Favored Pre-proline 0 CA--C 1.545 0.754 0 O-C-N 121.469 -0.769 . . . . 0.0 111.361 175.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -70.26 -161.85 0.09 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.47 2.114 . . . . 0.0 113.356 175.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -137.83 158.08 24.49 Favored Glycine 0 CA--C 1.523 0.592 0 O-C-N 120.948 -1.095 . . . . 0.0 111.625 176.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -74.4 -41.03 0.95 Allowed 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 122.242 1.962 . . . . 0.0 111.374 179.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.541 ' CB ' ' CE2' ' A' ' 11' ' ' TYR . . . -90.28 138.23 31.7 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 121.082 0.467 . . . . 0.0 110.03 177.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.414 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 0.0 OUTLIER -139.32 151.82 46.71 Favored 'General case' 0 C--O 1.213 -0.845 0 CA-C-O 117.916 -1.04 . . . . 0.0 111.483 177.753 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.3 p -82.62 120.71 34.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 123.958 0.903 . . . . 0.0 110.584 177.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 1.7 mp -108.16 120.49 59.61 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.628 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 -176.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.475 ' CZ ' HD23 ' A' ' 81' ' ' LEU . 5.8 p90 -140.92 152.42 45.01 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 122.733 1.254 . . . . 0.0 110.149 -178.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.0 p -84.33 160.88 20.6 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.788 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.526 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.3 OUTLIER -113.01 152.83 45.26 Favored Pre-proline 0 CA--C 1.545 0.758 0 CA-C-O 120.464 0.173 . . . . 0.0 110.927 179.506 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.526 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 19.3 Cg_endo -74.25 -50.03 0.2 Allowed 'Cis proline' 0 CA--C 1.499 -1.261 0 C-N-CA 123.462 -1.474 . . . . 0.0 111.043 -5.021 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 32.6 t-20 -44.39 106.57 0.07 Allowed 'General case' 0 CA--C 1.512 -0.516 0 O-C-N 125.03 1.456 . . . . 0.0 108.801 178.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.453 ' HG3' ' CD1' ' A' ' 110' ' ' TYR . 0.4 OUTLIER -67.88 68.56 0.11 Allowed 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 124.322 1.049 . . . . 0.0 108.811 -178.828 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 24.2 t -73.87 73.32 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 -177.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.547 ' CE1' ' HA2' ' A' ' 119' ' ' GLY . 4.6 t80 -37.26 117.1 0.51 Allowed 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 124.65 1.18 . . . . 0.0 108.139 179.132 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . 0.545 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -97.15 -34.08 11.26 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.744 177.328 . . . . . . . . 3 3 . 1 . 016 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.547 ' HA2' ' CE1' ' A' ' 117' ' ' PHE . . . 146.25 -175.09 25.9 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 123.484 0.564 . . . . 0.0 111.708 -178.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.419 ' CG2' ' SG ' ' A' ' 134' ' ' CYS . 3.3 mp -103.66 149.38 7.63 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.745 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -179.185 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.3 pt -122.16 151.85 26.03 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 178.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.418 0 CA-C-O 122.558 1.171 . . . . 0.0 109.504 178.204 . . . . . . . . 0 0 . 1 . 016 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.502 -0.885 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 . . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 9.9 tp -59.63 129.64 42.9 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 125.141 1.526 . . . . 0.0 107.42 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . 0.419 ' SG ' ' CG2' ' A' ' 120' ' ' ILE . 79.9 m -58.64 -177.22 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 125.031 1.457 . . . . 0.0 109.313 178.204 . . . . . . . . 2 2 . 1 . 016 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.2 m -152.22 81.6 1.25 Allowed 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 -176.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 0.515 ' CD2' ' CE2' ' A' ' 4' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--O 1.242 0.692 0 CA-C-O 116.021 -1.942 . . . . 0.0 112.546 173.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.459 ' CG1' ' CD2' ' A' ' 136' ' ' HIS . 0.4 OUTLIER . . . . . 0 N--CA 1.465 0.294 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 . . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.3 m -101.9 105.14 15.91 Favored 'General case' 0 C--N 1.313 -1.013 0 O-C-N 121.584 -0.698 . . . . 0.0 109.373 -176.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 20.3 m95 -73.81 141.97 46.17 Favored 'General case' 0 C--O 1.217 -0.615 0 C-N-CA 124.202 1.001 . . . . 0.0 108.628 -178.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -135.23 144.33 46.84 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -179.339 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -124.47 30.68 5.94 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 123.324 0.65 . . . . 0.0 112.571 175.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 153.08 -96.78 0.17 Allowed Glycine 0 C--O 1.223 -0.539 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -118.45 -4.48 13.58 Favored Glycine 0 N--CA 1.468 0.802 0 C-N-CA 123.649 0.642 . . . . 0.0 113.862 176.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -104.53 133.38 49.49 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 -176.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.8 mp -94.25 164.81 12.88 Favored 'General case' 0 C--O 1.221 -0.426 0 O-C-N 125.373 1.67 . . . . 0.0 110.4 -179.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.459 ' CE2' ' CB ' ' A' ' 106' ' ' ALA . 41.3 m-85 -157.62 84.19 0.9 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 125.086 1.354 . . . . 0.0 108.548 -170.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -54.33 122.85 11.25 Favored 'General case' 0 C--O 1.218 -0.57 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -179.129 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.544 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 0.7 OUTLIER -52.08 -48.56 64.62 Favored 'General case' 0 C--O 1.212 -0.915 0 CA-C-N 119.753 1.16 . . . . 0.0 111.876 -179.163 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -48.0 -34.98 10.16 Favored 'General case' 0 C--O 1.207 -1.169 0 O-C-N 124.455 1.097 . . . . 0.0 111.548 176.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -76.38 -55.7 5.31 Favored 'General case' 0 C--O 1.202 -1.429 0 CA-C-O 114.991 -2.433 . . . . 0.0 114.262 168.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -43.38 -37.96 2.53 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 122.274 2.306 . . . . 0.0 113.89 173.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -82.16 -53.11 6.34 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 117.136 -1.411 . . . . 0.0 110.54 172.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 34.8 t -57.77 -22.3 46.25 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-N 119.923 1.238 . . . . 0.0 109.466 -177.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.451 ' ND2' ' CE1' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -75.39 -46.31 33.71 Favored 'General case' 0 N--CA 1.433 -1.304 0 O-C-N 120.277 -1.514 . . . . 0.0 110.596 176.351 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.38 -6.31 34.54 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.311 1.044 . . . . 0.0 112.405 173.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 20.0 m170 -73.55 -43.32 60.17 Favored 'General case' 0 C--O 1.222 -0.379 0 O-C-N 120.017 -1.677 . . . . 0.0 110.758 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -81.89 -35.17 29.51 Favored 'General case' 0 C--O 1.22 -0.5 0 C-N-CA 123.636 0.775 . . . . 0.0 111.304 178.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -42.92 125.65 3.2 Favored Pre-proline 0 N--CA 1.442 -0.833 0 O-C-N 125.11 1.506 . . . . 0.0 112.706 177.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -72.87 127.01 11.81 Favored 'Trans proline' 0 N--CA 1.446 -1.322 0 C-N-CA 122.327 2.018 . . . . 0.0 108.589 -175.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.49 111.15 2.21 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.519 0.728 . . . . 0.0 109.244 178.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -176.46 175.29 1.79 Allowed 'General case' 0 C--O 1.209 -1.034 0 C-N-CA 123.815 0.846 . . . . 0.0 111.552 -179.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.427 ' HB3' ' CA ' ' A' ' 72' ' ' GLY . 3.5 t0 -115.54 85.55 2.3 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 176.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.68 71.42 1.13 Allowed Glycine 0 C--O 1.226 -0.381 0 N-CA-C 110.146 -1.181 . . . . 0.0 110.146 174.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.79 51.42 0.86 Allowed 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 122.942 1.353 . . . . 0.0 112.583 179.139 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.5 149.02 46.48 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -173.356 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -41.07 -69.93 0.46 Allowed Glycine 0 CA--C 1.509 -0.33 0 O-C-N 124.829 1.331 . . . . 0.0 113.59 -175.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 47.2 t -56.65 -53.29 59.4 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 116.344 -1.788 . . . . 0.0 111.727 175.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 155.65 -34.91 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 127.653 2.381 . . . . 0.0 112.178 177.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.462 ' CE1' ' CZ ' ' A' ' 107' ' ' ARG . 92.7 m-85 -85.24 144.16 40.49 Favored Pre-proline 0 CA--C 1.544 0.713 0 N-CA-C 115.027 1.491 . . . . 0.0 115.027 178.203 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.417 ' HB2' ' CD1' ' A' ' 81' ' ' LEU . 40.8 Cg_endo -80.95 174.93 44.88 Favored 'Cis proline' 0 N--CA 1.435 -1.914 0 C-N-CA 122.628 -1.822 . . . . 0.0 112.199 5.149 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -149.89 165.76 31.61 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 117.587 -1.197 . . . . 0.0 110.694 -175.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.404 ' CD1' ' HB2' ' A' ' 79' ' ' TYR . 19.9 t90 -70.87 146.06 49.86 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 118.686 -1.205 . . . . 0.0 111.107 173.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -114.46 85.73 2.29 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 104.026 -2.583 . . . . 0.0 104.026 -176.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 60.5 p -36.63 -41.39 0.3 Allowed 'General case' 0 C--O 1.212 -0.892 0 CA-C-N 114.275 -1.33 . . . . 0.0 110.914 169.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 57.4 t30 58.31 20.19 7.02 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 122.972 1.368 . . . . 0.0 111.224 178.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 107.37 -39.81 2.75 Favored Glycine 0 N--CA 1.436 -1.345 0 CA-C-O 118.425 -1.208 . . . . 0.0 114.181 -168.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -53.85 147.4 12.09 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 118.574 1.187 . . . . 0.0 110.392 -178.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -82.04 -36.77 27.39 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 122.216 1.008 . . . . 0.0 111.516 179.065 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 179.59 -56.89 0.08 OUTLIER Glycine 0 C--N 1.332 0.36 0 C-N-CA 124.995 1.284 . . . . 0.0 110.833 -178.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -78.84 -156.93 0.11 Allowed 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 123.434 1.587 . . . . 0.0 110.861 179.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.42 ' CA ' ' HB2' ' A' ' 65' ' ' PRO . . . -88.59 44.26 3.15 Favored Glycine 0 N--CA 1.442 -0.934 0 CA-C-O 118.347 -1.252 . . . . 0.0 114.562 174.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.2 mtpt -146.21 160.62 41.73 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.12 1.368 . . . . 0.0 110.233 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.1 mp -125.99 155.8 72.68 Favored Pre-proline 0 C--O 1.241 0.621 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.931 -177.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -71.2 158.22 55.32 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.045 1.83 . . . . 0.0 110.011 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.81 105.79 0.14 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.536 0.734 . . . . 0.0 109.214 176.161 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.32 61.09 0.98 Allowed Glycine 0 N--CA 1.465 0.585 0 O-C-N 121.574 -0.704 . . . . 0.0 112.237 -176.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.8 tpm_? -134.79 151.61 51.09 Favored 'General case' 0 CA--C 1.51 -0.588 0 O-C-N 122.083 -0.657 . . . . 0.0 111.117 174.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.6 m -147.97 103.98 3.62 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.181 0.926 . . . . 0.0 109.285 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -71.16 154.82 61.91 Favored 'Trans proline' 0 N--CA 1.445 -1.33 0 C-N-CA 122.459 2.106 . . . . 0.0 110.867 176.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.0 mt -63.91 123.83 17.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 178.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.06 135.25 34.91 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.486 ' CD1' ' HB3' ' A' ' 118' ' ' CYS . 21.7 m-85 -116.27 -33.58 4.93 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 124.458 1.103 . . . . 0.0 110.754 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.06 -2.38 56.65 Favored Glycine 0 CA--C 1.525 0.707 0 O-C-N 121.558 -0.713 . . . . 0.0 113.406 -174.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.65 132.95 43.64 Favored 'General case' 0 CA--C 1.498 -1.056 0 CA-C-N 118.086 0.943 . . . . 0.0 109.875 176.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.82 -13.94 57.57 Favored 'General case' 0 C--O 1.217 -0.645 0 O-C-N 124.535 1.147 . . . . 0.0 112.222 177.191 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -86.88 -49.67 7.23 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 125.295 1.438 . . . . 0.0 110.106 178.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.401 ' HB3' ' CD2' ' A' ' 57' ' ' PHE . 79.4 m -74.89 -9.9 58.98 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 124.015 0.822 . . . . 0.0 112.906 174.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -92.67 -41.39 10.2 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.308 1.443 . . . . 0.0 109.224 176.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.14 157.26 1.55 Allowed Pre-proline 0 N--CA 1.45 -0.462 0 CA-C-O 122.189 0.995 . . . . 0.0 111.552 -177.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.42 ' HB2' ' CA ' ' A' ' 46' ' ' GLY . 26.7 Cg_endo -69.75 132.44 23.36 Favored 'Trans proline' 0 N--CA 1.43 -2.224 0 N-CA-C 114.193 0.805 . . . . 0.0 114.193 174.354 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -69.39 168.11 22.01 Favored 'Trans proline' 0 N--CA 1.433 -2.066 0 C-N-CA 123.691 2.928 . . . . 0.0 111.129 175.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.4 tptt -127.99 123.31 34.46 Favored 'General case' 0 CA--C 1.507 -0.675 0 CA-C-O 115.472 -2.204 . . . . 0.0 105.101 176.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 14.1 t-80 -107.37 164.18 12.41 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 127.528 3.017 . . . . 0.0 110.888 171.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.06 175.53 13.31 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 122.406 1.098 . . . . 0.0 109.633 -178.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.21 48.7 1.52 Allowed 'General case' 0 C--O 1.218 -0.594 0 O-C-N 121.568 -0.707 . . . . 0.0 112.3 175.19 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -161.64 22.14 0.12 Allowed 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 122.614 1.197 . . . . 0.0 112.23 -178.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.427 ' CA ' ' HB3' ' A' ' 27' ' ' ASP . . . 73.92 -63.73 1.98 Allowed Glycine 0 CA--C 1.538 1.48 0 O-C-N 120.793 -1.192 . . . . 0.0 112.897 -169.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -108.08 -98.65 0.37 Allowed 'General case' 0 C--O 1.207 -1.145 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 175.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 123.52 -157.93 18.04 Favored Glycine 0 C--O 1.222 -0.65 0 O-C-N 119.795 -1.815 . . . . 0.0 110.644 -168.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.9 mttp -50.54 -84.29 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.919 0.888 . . . . 0.0 113.268 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -117.61 9.55 13.16 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 118.554 -0.736 . . . . 0.0 111.879 175.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.422 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 0.4 OUTLIER -26.2 97.95 0.01 OUTLIER 'General case' 0 C--O 1.211 -0.958 0 C-N-CA 126.671 1.988 . . . . 0.0 112.1 -179.325 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.4 ' H ' ' CD2' ' A' ' 78' ' ' HIS . 6.0 p80 -89.12 69.4 8.34 Favored 'General case' 0 CA--C 1.506 -0.721 0 O-C-N 119.446 -2.034 . . . . 0.0 107.326 -170.076 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.404 ' HB2' ' CD1' ' A' ' 37' ' ' TRP . 35.9 p90 -92.84 135.55 34.03 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 124.674 1.189 . . . . 0.0 109.575 -177.274 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.47 127.96 34.15 Favored 'General case' 0 C--O 1.213 -0.86 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 175.292 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.481 HD22 ' CZ ' ' A' ' 110' ' ' TYR . 0.1 OUTLIER -115.08 146.08 41.67 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 174.965 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -106.83 161.73 14.43 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 122.355 1.074 . . . . 0.0 112.214 173.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.451 ' CE1' ' ND2' ' A' ' 19' ' ' ASN . 9.1 t80 -153.95 140.23 12.68 Favored Pre-proline 0 C--N 1.328 -0.368 0 O-C-N 121.444 -0.785 . . . . 0.0 112.715 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.425 ' HA ' ' HG2' ' A' ' 107' ' ' ARG . 20.1 Cg_endo -70.99 95.72 0.67 Allowed 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 124.366 3.378 . . . . 0.0 112.844 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.8 t -101.54 104.49 15.39 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 122.436 1.112 . . . . 0.0 110.347 -177.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -80.61 160.87 66.07 Favored Pre-proline 0 C--N 1.32 -0.681 0 O-C-N 121.099 -1.001 . . . . 0.0 111.932 -179.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -76.39 -35.05 2.38 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.194 1.929 . . . . 0.0 113.664 177.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -43.02 -31.61 0.55 Allowed 'General case' 0 N--CA 1.475 0.781 0 O-C-N 125.213 1.57 . . . . 0.0 110.868 174.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.71 15.81 76.91 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.5 178.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -81.62 160.74 23.7 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 121.36 0.6 . . . . 0.0 109.824 177.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -97.11 92.28 5.97 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 174.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.477 ' CE2' ' HB3' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -47.57 162.52 0.07 Allowed 'General case' 0 C--O 1.223 -0.303 0 CA-C-O 123.105 1.431 . . . . 0.0 113.194 175.68 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.18 59.1 5.39 Favored 'General case' 0 C--N 1.319 -0.759 0 O-C-N 120.026 -1.671 . . . . 0.0 110.899 177.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -75.09 -16.47 60.56 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.755 175.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -92.66 -23.25 19.03 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 123.873 1.797 . . . . 0.0 111.478 179.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.51 109.82 19.88 Favored 'General case' 0 CA--C 1.513 -0.458 0 O-C-N 119.892 -1.755 . . . . 0.0 109.131 177.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.2 ptpt -59.45 -46.55 88.45 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 121.354 0.597 . . . . 0.0 112.109 176.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -141.52 127.22 11.0 Favored Pre-proline 0 N--CA 1.444 -0.75 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.107 -178.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -70.5 173.04 48.9 Favored 'Cis proline' 0 N--CA 1.456 -0.714 0 C-N-CA 123.288 -1.547 . . . . 0.0 110.951 -5.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.47 149.62 52.06 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 123.526 0.73 . . . . 0.0 109.243 177.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . 0.477 ' HB3' ' CE2' ' A' ' 92' ' ' TYR . 2.9 tt0 -100.91 176.72 5.18 Favored 'General case' 0 C--N 1.316 -0.889 0 O-C-N 123.938 0.774 . . . . 0.0 111.773 176.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -83.14 126.34 72.47 Favored Pre-proline 0 CA--C 1.541 0.631 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 179.059 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -67.6 -166.32 0.13 Allowed 'Trans proline' 0 N--CA 1.452 -0.94 0 CA-C-O 123.371 1.321 . . . . 0.0 113.226 176.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -139.42 173.04 22.97 Favored Glycine 0 CA--C 1.523 0.558 0 O-C-N 121.02 -1.05 . . . . 0.0 112.679 176.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -75.05 -57.92 0.05 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 123.017 2.478 . . . . 0.0 111.101 178.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.459 ' CB ' ' CE2' ' A' ' 11' ' ' TYR . . . -60.87 133.38 56.04 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-O 120.979 0.419 . . . . 0.0 111.155 177.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.462 ' CZ ' ' CE1' ' A' ' 34' ' ' TYR . 6.8 mtm-85 -147.35 149.48 32.88 Favored 'General case' 0 CA--C 1.497 -1.084 0 CA-C-O 117.194 -1.384 . . . . 0.0 110.522 179.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.8 p -81.86 118.92 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 O-C-N 124.434 1.084 . . . . 0.0 110.493 175.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 1.8 mp -108.07 117.51 53.81 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.662 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 -177.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.481 ' CZ ' HD22 ' A' ' 81' ' ' LEU . 8.0 p90 -134.1 153.21 51.96 Favored 'General case' 0 N--CA 1.447 -0.621 0 O-C-N 124.252 0.97 . . . . 0.0 109.56 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.8 p -84.28 162.72 20.01 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.231 178.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.467 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -110.06 154.87 42.52 Favored Pre-proline 0 CA--C 1.548 0.884 0 O-C-N 122.014 -0.429 . . . . 0.0 110.61 178.747 . . . . . . . . 3 3 . 1 . 017 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.467 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 17.9 Cg_endo -74.15 -48.81 0.25 Allowed 'Cis proline' 0 CA--C 1.509 -0.749 0 C-N-CA 123.934 -1.278 . . . . 0.0 111.515 -8.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -45.8 107.77 0.11 Allowed 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 117.62 -1.181 . . . . 0.0 108.895 175.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.84 68.46 0.11 Allowed 'General case' 0 CA--C 1.512 -0.509 0 C-N-CA 125.711 1.604 . . . . 0.0 108.09 -179.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.0 t -73.19 78.89 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 N-CA-C 102.992 -2.966 . . . . 0.0 102.992 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.544 ' CZ ' ' NE2' ' A' ' 13' ' ' GLN . 5.2 t80 -37.82 118.9 0.71 Allowed 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 125.339 1.456 . . . . 0.0 108.93 176.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . 0.486 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 7.3 m -95.22 -45.31 7.23 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 121.763 0.792 . . . . 0.0 109.304 179.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.508 ' HA2' ' CE1' ' A' ' 117' ' ' PHE . . . 156.16 -166.55 33.13 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 -178.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.427 ' HA ' ' O ' ' A' ' 107' ' ' ARG . 3.0 mp -117.03 132.67 66.12 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.343 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 -178.275 . . . . . . . . 2 2 . 1 . 017 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 10.2 pt -108.44 154.62 9.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.564 0 CA-C-O 121.733 0.778 . . . . 0.0 110.637 175.449 . . . . . . . . 0 0 . 1 . 017 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.512 -0.482 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 . . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 6.0 tp -81.33 146.18 30.49 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 175.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 87.2 m -61.4 175.01 0.63 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 123.488 1.613 . . . . 0.0 109.614 172.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 72.0 m -161.4 90.99 0.83 Allowed 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 104.198 -2.519 . . . . 0.0 104.198 -175.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 0.459 ' CD2' ' CG1' ' A' ' 2' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.474 0.726 0 CA-C-O 115.656 -2.116 . . . . 0.0 115.305 169.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.6 p . . . . . 0 CA--C 1.518 -0.285 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 . . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -85.59 112.25 20.8 Favored 'General case' 0 C--N 1.32 -0.698 0 O-C-N 121.907 -0.496 . . . . 0.0 110.469 178.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . 0.42 ' CG ' HG13 ' A' ' 120' ' ' ILE . 29.9 m95 -79.13 139.16 38.11 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 123.091 0.556 . . . . 0.0 110.951 176.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -121.36 124.66 45.07 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -177.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 13.6 m -113.65 40.68 2.35 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.267 0.556 . . . . 0.0 110.912 177.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 138.05 -94.84 0.22 Allowed Glycine 0 C--O 1.223 -0.574 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 -179.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -123.79 1.62 9.3 Favored Glycine 0 N--CA 1.463 0.434 0 C-N-CA 123.074 0.369 . . . . 0.0 112.803 177.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.492 ' HB2' ' CZ ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -107.8 140.44 40.88 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 -173.428 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 17.1 mt -106.07 121.01 43.27 Favored 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 124.258 0.974 . . . . 0.0 109.311 -177.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.526 ' CE2' ' CB ' ' A' ' 106' ' ' ALA . 61.2 m-85 -116.06 99.94 7.61 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 124.966 1.307 . . . . 0.0 108.968 -175.137 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -56.26 122.28 11.42 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-O 118.234 -0.889 . . . . 0.0 108.982 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.495 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 6.1 tp-100 -50.09 -46.97 53.92 Favored 'General case' 0 C--O 1.21 -0.987 0 O-C-N 123.978 0.799 . . . . 0.0 112.105 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . 0.402 ' O ' ' CB ' ' A' ' 18' ' ' SER . 5.5 t-20 -50.07 -41.54 48.22 Favored 'General case' 0 C--O 1.201 -1.482 0 O-C-N 123.211 0.319 . . . . 0.0 110.975 176.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.12 -37.12 75.23 Favored 'General case' 0 C--O 1.204 -1.302 0 CA-C-O 116.916 -1.516 . . . . 0.0 113.076 170.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.04 -44.95 79.28 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 121.813 2.097 . . . . 0.0 113.151 172.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.434 ' O ' ' CD2' ' A' ' 21' ' ' HIS . 5.1 pt-20 -82.52 -37.67 24.9 Favored 'General case' 0 C--O 1.211 -0.927 0 C-N-CA 123.203 0.601 . . . . 0.0 109.715 176.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 18' ' ' SER . . . . . 0.402 ' CB ' ' O ' ' A' ' 14' ' ' ASN . 28.8 t -73.98 -60.02 2.45 Favored 'General case' 0 CA--C 1.505 -0.777 0 O-C-N 119.751 -1.843 . . . . 0.0 109.521 -176.422 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.452 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 12.1 t-20 -40.75 -37.4 0.75 Allowed 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 124.543 1.137 . . . . 0.0 112.359 172.127 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -82.52 -36.45 26.36 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 174.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.434 ' CD2' ' O ' ' A' ' 17' ' ' GLU . 4.4 m170 -45.76 -38.56 7.19 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 126.288 1.835 . . . . 0.0 110.133 178.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.452 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -72.05 -47.43 51.65 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 123.826 0.85 . . . . 0.0 112.145 175.793 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -37.88 130.25 0.94 Allowed Pre-proline 0 N--CA 1.443 -0.785 0 O-C-N 124.762 1.289 . . . . 0.0 112.079 174.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -73.31 124.48 9.49 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 121.836 1.691 . . . . 0.0 108.939 -176.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.434 ' CD1' ' HE2' ' A' ' 115' ' ' LYS . 3.9 tp -60.94 93.27 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 123.635 0.774 . . . . 0.0 111.227 179.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 178.55 155.0 0.4 Allowed 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 122.957 0.503 . . . . 0.0 110.092 -174.032 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.4 ' HA ' ' HA ' ' A' ' 36' ' ' HIS . 0.0 OUTLIER -95.77 123.18 39.22 Favored 'General case' 0 CA--C 1.508 -0.642 0 C-N-CA 123.973 0.909 . . . . 0.0 109.006 178.825 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 48.04 70.25 0.78 Allowed Glycine 0 C--N 1.335 0.482 0 CA-C-O 122.104 0.835 . . . . 0.0 111.895 176.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -149.09 30.18 0.79 Allowed 'General case' 0 CA--C 1.51 -0.58 0 O-C-N 121.831 -0.805 . . . . 0.0 111.962 179.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 36.4 p -127.52 147.23 50.32 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -175.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -41.23 -55.35 3.62 Favored Glycine 0 N--CA 1.448 -0.556 0 O-C-N 123.981 0.8 . . . . 0.0 112.082 -178.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 29.2 t -67.37 -70.64 0.24 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 118.803 -0.618 . . . . 0.0 111.474 175.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.1 p 176.03 -57.66 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 124.306 1.042 . . . . 0.0 112.85 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -67.48 151.55 97.05 Favored Pre-proline 0 N--CA 1.427 -1.609 0 C-N-CA 124.131 0.972 . . . . 0.0 112.066 178.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -74.62 164.06 89.0 Favored 'Cis proline' 0 N--CA 1.455 -0.74 0 C-N-CA 123.144 -1.607 . . . . 0.0 111.103 -1.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 27' ' ' ASP . 0.3 OUTLIER -143.17 161.4 38.32 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 117.474 -1.251 . . . . 0.0 109.662 -179.034 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.521 ' CH2' ' HA2' ' A' ' 44' ' ' GLY . 13.7 t90 -59.33 138.67 57.55 Favored 'General case' 0 N--CA 1.446 -0.629 0 O-C-N 124.937 1.398 . . . . 0.0 110.137 177.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.443 ' CE2' ' HB2' ' A' ' 40' ' ' ASN . 9.8 t80 -109.13 85.83 2.17 Favored 'General case' 0 N--CA 1.423 -1.782 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 -176.018 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.445 ' CG2' ' CH2' ' A' ' 37' ' ' TRP . 20.1 p -38.69 -34.6 0.15 Allowed 'General case' 0 CA--C 1.495 -1.138 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.653 170.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.443 ' HB2' ' CE2' ' A' ' 38' ' ' PHE . 62.9 t30 53.8 22.58 3.29 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 120.854 1.661 . . . . 0.0 111.625 177.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.403 ' HA3' ' CD2' ' A' ' 48' ' ' LEU . . . 104.27 -44.28 1.51 Allowed Glycine 0 N--CA 1.419 -2.488 0 CA-C-O 117.26 -1.855 . . . . 0.0 115.218 -168.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.466 ' CE2' ' HD3' ' A' ' 66' ' ' PRO . 84.8 m-85 -43.34 151.1 0.17 Allowed 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.691 1.597 . . . . 0.0 112.279 176.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.82 -36.39 25.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.326 0.584 . . . . 0.0 111.884 177.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.521 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -165.3 -77.63 0.03 OUTLIER Glycine 0 C--N 1.34 0.794 0 C-N-CA 124.459 1.028 . . . . 0.0 111.846 -179.078 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -109.41 -67.98 0.95 Allowed 'General case' 0 CA--C 1.513 -0.459 0 C-N-CA 123.521 0.728 . . . . 0.0 111.029 -179.245 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.23 -170.71 0.11 Allowed Glycine 0 C--N 1.348 1.233 0 C-N-CA 124.436 1.017 . . . . 0.0 110.967 178.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -58.77 -167.64 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 124.296 1.998 . . . . 0.0 111.703 177.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.403 ' CD2' ' HA3' ' A' ' 41' ' ' GLY . 0.0 OUTLIER -86.78 163.47 40.96 Favored Pre-proline 0 N--CA 1.44 -0.968 0 O-C-N 120.139 -1.601 . . . . 0.0 110.566 -179.354 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -71.83 171.51 16.39 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 122.067 1.844 . . . . 0.0 111.077 178.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -58.79 96.44 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.196 177.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.33 88.4 1.97 Allowed Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 111.895 -0.482 . . . . 0.0 111.895 -177.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.55 163.75 17.02 Favored 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 123.795 0.838 . . . . 0.0 111.557 176.283 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 97.7 m -143.6 95.07 5.94 Favored Pre-proline 0 C--O 1.236 0.389 0 O-C-N 124.33 1.019 . . . . 0.0 109.604 -176.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -72.98 169.75 21.43 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.529 2.153 . . . . 0.0 110.901 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.4 ' CG2' ' HB2' ' A' ' 133' ' ' LEU . 6.4 mt -99.58 134.22 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -178.2 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -86.09 157.6 20.01 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 121.107 0.479 . . . . 0.0 110.182 176.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -140.65 -46.85 0.41 Allowed 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 123.805 0.842 . . . . 0.0 111.036 178.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 112.57 -4.42 26.29 Favored Glycine 0 C--N 1.338 0.664 0 C-N-CA 123.523 0.582 . . . . 0.0 113.057 -175.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.91 134.84 38.42 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-O 117.859 -1.067 . . . . 0.0 110.388 176.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 20.1 t -69.23 -6.36 28.68 Favored 'General case' 0 C--O 1.225 -0.222 0 O-C-N 125.127 1.517 . . . . 0.0 111.538 176.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.69 -56.88 3.07 Favored 'General case' 0 N--CA 1.446 -0.674 0 O-C-N 120.289 -1.507 . . . . 0.0 109.614 -179.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 27.7 m -70.99 -18.06 62.62 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 123.789 0.68 . . . . 0.0 110.688 177.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -80.28 -41.0 25.79 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 123.678 0.791 . . . . 0.0 111.515 174.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.04 158.97 1.57 Allowed Pre-proline 0 N--CA 1.444 -0.766 0 CA-C-O 122.282 1.039 . . . . 0.0 111.033 179.404 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -71.02 136.21 29.17 Favored 'Trans proline' 0 N--CA 1.444 -1.395 0 C-N-CA 121.003 1.135 . . . . 0.0 113.673 174.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.466 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 19.2 Cg_endo -72.54 171.34 17.35 Favored 'Trans proline' 0 N--CA 1.446 -1.287 0 C-N-CA 122.957 2.438 . . . . 0.0 111.015 178.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.4 tptt -128.41 49.93 2.14 Favored 'General case' 0 C--O 1.212 -0.9 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.936 178.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.442 ' CE1' ' CE3' ' A' ' 37' ' ' TRP . 56.2 t-80 -77.13 161.25 28.39 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 120.132 -1.605 . . . . 0.0 112.126 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -161.56 177.89 9.6 Favored 'General case' 0 CA--C 1.502 -0.896 0 O-C-N 118.787 -2.445 . . . . 0.0 108.178 176.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.2 pttp -64.68 74.22 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 124.858 1.263 . . . . 0.0 111.724 175.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 179.56 -47.58 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 125.524 1.53 . . . . 0.0 110.294 -176.322 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 113.31 -71.89 0.22 Allowed Glycine 0 CA--C 1.488 -1.621 0 CA-C-O 118.805 -0.997 . . . . 0.0 112.157 -177.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -128.81 64.33 1.45 Allowed 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 125.934 1.694 . . . . 0.0 107.803 -177.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.56 -110.63 0.01 OUTLIER Glycine 0 C--N 1.334 0.454 0 CA-C-O 122.391 0.995 . . . . 0.0 112.543 178.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.5 mttp -63.22 -98.4 0.0 OUTLIER 'General case' 0 C--O 1.222 -0.372 0 O-C-N 119.792 -2.005 . . . . 0.0 111.75 177.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -114.23 15.93 18.06 Favored 'General case' 0 CA--C 1.51 -0.593 0 O-C-N 120.608 -1.307 . . . . 0.0 111.082 178.239 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.475 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 29.0 m-20 -30.5 107.5 0.04 OUTLIER 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 124.787 1.235 . . . . 0.0 110.16 -177.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.49 ' H ' ' CD2' ' A' ' 78' ' ' HIS . 2.8 p80 -87.43 14.52 7.94 Favored 'General case' 0 CA--C 1.511 -0.524 0 O-C-N 121.654 -0.654 . . . . 0.0 110.561 -177.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.518 ' HB2' ' CD1' ' A' ' 37' ' ' TRP . 14.9 p90 -39.51 137.34 0.83 Allowed 'General case' 0 N--CA 1.429 -1.514 0 C-N-CA 125.592 1.557 . . . . 0.0 110.715 176.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.88 157.87 37.07 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.622 177.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.437 HD12 ' CE2' ' A' ' 79' ' ' TYR . 5.5 mp -139.67 120.77 14.7 Favored 'General case' 0 CA--C 1.501 -0.925 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 -177.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.497 ' CB ' ' CD1' ' A' ' 109' ' ' ILE . 0.5 OUTLIER -92.36 152.68 19.63 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-O 122.259 1.028 . . . . 0.0 111.585 178.723 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.423 ' HZ ' ' CD2' ' A' ' 94' ' ' PHE . 12.6 t80 -145.23 134.05 11.04 Favored Pre-proline 0 N--CA 1.444 -0.762 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.583 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -74.62 112.92 3.67 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.959 2.44 . . . . 0.0 110.188 -177.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.6 t -104.73 110.45 22.78 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 124.323 1.014 . . . . 0.0 110.079 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.408 ' CE1' ' HB2' ' A' ' 92' ' ' TYR . 70.1 m-85 -82.02 157.92 68.05 Favored Pre-proline 0 N--CA 1.445 -0.69 0 O-C-N 121.424 -0.797 . . . . 0.0 112.25 178.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -76.63 -42.25 0.36 Allowed 'Trans proline' 0 CA--C 1.501 -1.15 0 C-N-CA 122.555 2.17 . . . . 0.0 112.332 179.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -44.69 -30.92 1.02 Allowed 'General case' 0 C--N 1.353 0.731 0 CA-C-O 122.159 0.98 . . . . 0.0 110.855 176.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 85.23 8.77 81.06 Favored Glycine 0 N--CA 1.434 -1.47 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 177.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 4.2 p-80 -73.84 128.38 35.36 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.36 93.15 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 123.601 0.76 . . . . 0.0 109.76 173.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.47 ' O ' ' CD2' ' A' ' 94' ' ' PHE . 12.9 t80 -39.7 144.58 0.17 Allowed 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 121.967 0.889 . . . . 0.0 111.19 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.38 57.31 1.49 Allowed 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 120.011 -1.68 . . . . 0.0 109.988 176.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.47 ' CD2' ' O ' ' A' ' 92' ' ' TYR . 34.3 p90 -71.19 -9.91 58.88 Favored 'General case' 0 N--CA 1.439 -1.018 0 C-N-CA 124.085 0.954 . . . . 0.0 112.168 175.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -89.7 -36.41 15.23 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 123.131 1.443 . . . . 0.0 110.451 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.9 m -84.46 111.29 19.34 Favored 'General case' 0 N--CA 1.441 -0.904 0 O-C-N 120.341 -1.474 . . . . 0.0 109.394 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.0 ptpt -58.75 -47.92 82.99 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-O 120.945 0.403 . . . . 0.0 111.235 178.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.18 130.51 10.84 Favored Pre-proline 0 N--CA 1.432 -1.346 0 C-N-CA 123.78 0.832 . . . . 0.0 109.378 -177.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -70.1 175.44 37.65 Favored 'Cis proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.284 -1.965 . . . . 0.0 111.007 -6.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.43 147.03 42.86 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.902 178.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -87.94 173.41 8.93 Favored 'General case' 0 C--O 1.24 0.591 0 O-C-N 123.837 0.711 . . . . 0.0 112.133 177.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -72.5 143.03 84.73 Favored Pre-proline 0 N--CA 1.442 -0.853 0 CA-C-O 118.117 -0.944 . . . . 0.0 111.165 177.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -73.15 -164.8 0.21 Allowed 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.266 2.644 . . . . 0.0 111.739 176.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -140.97 164.5 26.44 Favored Glycine 0 N--CA 1.44 -1.046 0 O-C-N 121.581 -0.7 . . . . 0.0 112.478 177.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -75.39 -60.24 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.692 2.262 . . . . 0.0 110.481 179.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.526 ' CB ' ' CE2' ' A' ' 11' ' ' TYR . . . -63.31 139.83 58.81 Favored 'General case' 0 N--CA 1.438 -1.031 0 O-C-N 123.689 0.618 . . . . 0.0 111.62 178.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 1.5 mtm-85 -143.14 143.48 31.83 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.307 -179.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.0 p -83.14 124.13 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 O-C-N 123.92 0.762 . . . . 0.0 110.479 178.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.497 ' CD1' ' CB ' ' A' ' 82' ' ' GLU . 6.3 mm -106.23 140.91 22.8 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.892 0 C-N-CA 122.823 0.449 . . . . 0.0 110.157 -179.231 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.428 ' CD1' ' HG3' ' A' ' 115' ' ' LYS . 9.7 p90 -165.48 153.1 10.83 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-O 122.042 0.925 . . . . 0.0 110.483 -177.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.4 p -88.8 165.53 14.62 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.776 -178.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.519 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.2 OUTLIER -111.29 154.09 43.79 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 122.184 0.193 . . . . 0.0 111.368 178.761 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.519 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 19.0 Cg_endo -73.87 -52.85 0.16 OUTLIER 'Cis proline' 0 CA--C 1.499 -1.256 0 C-N-CA 123.525 -1.448 . . . . 0.0 109.708 -6.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -43.24 110.93 0.22 Allowed 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 117.628 -1.177 . . . . 0.0 109.914 178.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.434 ' HE2' ' CD1' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -66.96 72.45 0.1 Allowed 'General case' 0 CA--C 1.51 -0.585 0 C-N-CA 124.429 1.092 . . . . 0.0 108.519 -178.116 . . . . . . . . 3 3 . 1 . 018 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 36.9 t -72.32 77.4 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 N-CA-C 105.596 -2.001 . . . . 0.0 105.596 -176.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.495 ' CZ ' ' NE2' ' A' ' 13' ' ' GLN . 41.5 t80 -39.57 107.1 0.06 Allowed 'General case' 0 N--CA 1.435 -1.219 0 C-N-CA 126.002 1.721 . . . . 0.0 110.034 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 10.2 m -81.94 -46.13 14.47 Favored 'General case' 0 N--CA 1.436 -1.175 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 -178.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.441 ' HA2' ' CZ ' ' A' ' 117' ' ' PHE . . . 160.4 -147.73 15.03 Favored Glycine 0 N--CA 1.441 -0.998 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.42 HG13 ' CG ' ' A' ' 4' ' ' TRP . 1.2 mm -128.64 138.94 53.23 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.929 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 -175.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 7.6 pt -130.0 154.94 41.13 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -177.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.445 -0.72 0 CA-C-O 121.794 0.807 . . . . 0.0 109.714 179.109 . . . . . . . . 0 0 . 1 . 018 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . 0.409 ' HE3' ' O ' ' A' ' 133' ' ' LEU . 2.5 ptmt . . . . . 0 CA--C 1.509 -0.615 0 CA-C-O 119.094 -0.479 . . . . 0.0 109.712 . . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.409 ' O ' ' HE3' ' A' ' 132' ' ' LYS . 11.6 tp -86.76 136.25 33.07 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-O 121.646 0.736 . . . . 0.0 109.448 177.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 50.7 m -66.02 -179.61 0.76 Allowed 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 124.152 0.981 . . . . 0.0 109.389 175.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 68.4 m -159.44 92.08 1.04 Allowed 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 -178.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.257 1.496 0 CA-C-O 113.965 -2.921 . . . . 0.0 113.682 170.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.5 p . . . . . 0 C--O 1.235 0.29 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 . . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.9 m -94.79 107.78 19.8 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 123.634 0.774 . . . . 0.0 110.62 178.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 20.4 m95 -78.57 141.42 38.11 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.005 0.922 . . . . 0.0 108.879 179.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -132.63 138.09 47.24 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -121.63 64.53 0.9 Allowed 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 114.838 -1.073 . . . . 0.0 108.674 177.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 37.6 75.03 0.09 OUTLIER Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.851 1.215 . . . . 0.0 114.104 178.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 159.87 -75.03 0.2 Allowed Glycine 0 C--O 1.226 -0.404 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 -175.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 74.2 mt -126.69 159.91 32.3 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 122.12 0.962 . . . . 0.0 110.34 177.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.9 mp -87.96 167.48 13.68 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.143 179.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.478 ' CE2' ' CB ' ' A' ' 106' ' ' ALA . 65.4 m-85 -156.09 87.17 1.05 Allowed 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 125.276 1.43 . . . . 0.0 108.386 -173.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -53.47 120.11 5.69 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-O 117.832 -1.08 . . . . 0.0 108.457 177.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.533 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 0.9 OUTLIER -49.27 -43.77 43.31 Favored 'General case' 0 C--O 1.212 -0.876 0 CA-C-N 119.865 1.211 . . . . 0.0 111.629 178.842 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -48.89 -42.37 36.57 Favored 'General case' 0 C--O 1.201 -1.462 0 CA-C-N 117.779 0.263 . . . . 0.0 111.187 176.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.47 -44.36 62.42 Favored 'General case' 0 C--O 1.21 -1.026 0 O-C-N 120.416 -1.427 . . . . 0.0 112.644 169.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -52.11 -38.49 57.58 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 121.4 1.909 . . . . 0.0 112.907 175.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -86.06 -48.89 8.23 Favored 'General case' 0 C--O 1.21 -1.022 0 CA-C-O 117.51 -1.234 . . . . 0.0 108.971 175.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.2 t -69.45 -57.88 4.69 Favored 'General case' 0 CA--C 1.504 -0.797 0 C-N-CA 126.599 1.96 . . . . 0.0 109.483 -173.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.427 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 0.5 OUTLIER -42.17 -36.6 1.23 Allowed 'General case' 0 C--O 1.217 -0.627 0 CA-C-N 119.536 1.062 . . . . 0.0 110.745 169.664 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 p -83.53 -29.74 27.66 Favored 'General case' 0 C--O 1.218 -0.564 0 N-CA-C 114.911 1.449 . . . . 0.0 114.911 176.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -50.31 -35.67 28.47 Favored 'General case' 0 C--O 1.222 -0.351 0 C-N-CA 126.696 1.999 . . . . 0.0 109.826 178.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.427 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.1 OUTLIER -71.59 -49.54 39.37 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 125.43 1.492 . . . . 0.0 111.193 175.946 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -39.39 123.15 1.38 Allowed Pre-proline 0 C--O 1.239 0.529 0 O-C-N 124.867 1.355 . . . . 0.0 111.807 174.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -70.76 126.37 12.57 Favored 'Trans proline' 0 N--CA 1.445 -1.366 0 C-N-CA 122.083 1.855 . . . . 0.0 108.868 -177.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.9 tp -62.91 94.54 0.07 Allowed 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.449 0.7 . . . . 0.0 112.219 178.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.1 m 179.98 153.64 0.52 Allowed 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 125.082 1.353 . . . . 0.0 110.163 -173.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.61 119.16 31.77 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.436 1.494 . . . . 0.0 109.367 176.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 49.86 69.69 0.99 Allowed Glycine 0 CA--C 1.525 0.708 0 CA-C-O 122.189 0.883 . . . . 0.0 112.476 174.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.5 mtpt -145.95 22.89 1.39 Allowed 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -178.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 33.6 p -123.45 150.97 43.18 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 124.398 1.079 . . . . 0.0 108.693 -177.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -38.65 -63.44 1.01 Allowed Glycine 0 CA--C 1.522 0.477 0 C-N-CA 124.705 1.145 . . . . 0.0 113.712 178.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 44.1 t -63.64 -59.4 4.65 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 118.312 -0.851 . . . . 0.0 112.071 174.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.0 m 158.9 -48.61 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.872 2.069 . . . . 0.0 112.17 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.513 ' CD2' ' HD3' ' A' ' 84' ' ' PRO . 63.3 m-85 -64.48 145.54 98.43 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-O 117.801 -1.095 . . . . 0.0 112.909 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -73.35 158.53 98.38 Favored 'Cis proline' 0 N--CA 1.448 -1.198 0 C-N-CA 123.577 -1.426 . . . . 0.0 111.137 -4.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.442 ' CD2' ' CD2' ' A' ' 34' ' ' TYR . 2.1 p80 -137.19 170.56 15.88 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-N 114.713 -1.131 . . . . 0.0 109.565 -176.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.529 ' CD1' ' HB2' ' A' ' 79' ' ' TYR . 22.7 t90 -71.56 148.03 47.07 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.99 0.9 . . . . 0.0 109.243 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.488 ' CE2' ' HB2' ' A' ' 40' ' ' ASN . 27.5 t80 -124.31 78.24 1.64 Allowed 'General case' 0 N--CA 1.435 -1.182 0 C-N-CA 127.11 2.164 . . . . 0.0 106.003 -177.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 77.0 p -37.04 -39.91 0.26 Allowed 'General case' 0 C--O 1.218 -0.571 0 C-N-CA 124.421 1.088 . . . . 0.0 111.6 171.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.488 ' HB2' ' CE2' ' A' ' 38' ' ' PHE . 46.0 t30 59.69 16.06 5.19 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 122.428 1.109 . . . . 0.0 110.907 178.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 115.11 -40.89 2.31 Favored Glycine 0 N--CA 1.44 -1.049 0 CA-C-O 117.435 -1.758 . . . . 0.0 111.619 -172.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -49.34 159.53 0.31 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.202 1.501 . . . . 0.0 112.295 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.25 -35.82 23.14 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 122.589 1.185 . . . . 0.0 111.317 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.444 ' HA2' ' CZ2' ' A' ' 37' ' ' TRP . . . 145.04 -31.44 1.73 Allowed Glycine 0 C--O 1.218 -0.863 0 C-N-CA 125.185 1.374 . . . . 0.0 111.586 -176.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.9 -54.28 5.72 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 119.049 1.425 . . . . 0.0 111.575 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 157.23 33.13 0.02 OUTLIER Glycine 0 C--N 1.336 0.541 0 O-C-N 124.309 1.006 . . . . 0.0 112.748 -177.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 29.2 mttt -142.07 159.8 41.51 Favored 'General case' 0 CA--C 1.507 -0.7 0 C-N-CA 124.36 1.064 . . . . 0.0 109.088 178.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.8 mt -108.01 147.96 36.52 Favored Pre-proline 0 N--CA 1.446 -0.657 0 O-C-N 124.429 1.081 . . . . 0.0 110.613 -179.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -72.62 177.66 7.23 Favored 'Trans proline' 0 N--CA 1.446 -1.3 0 C-N-CA 124.251 3.301 . . . . 0.0 111.278 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.9 ttpt -76.94 102.69 6.5 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 120.575 -1.328 . . . . 0.0 109.938 175.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.3 83.69 1.75 Allowed Glycine 0 C--O 1.222 -0.653 0 O-C-N 124.216 0.948 . . . . 0.0 110.945 177.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.2 172.91 14.09 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 124.444 1.097 . . . . 0.0 110.056 178.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.9 m -152.79 107.93 2.7 Favored Pre-proline 0 C--N 1.327 -0.384 0 O-C-N 123.635 0.585 . . . . 0.0 110.77 174.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -70.79 145.89 52.36 Favored 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 122.288 1.992 . . . . 0.0 111.166 177.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 16.9 mt -70.42 119.96 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 3.8 tttt -84.01 132.67 34.72 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 176.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.554 ' CD1' ' HB3' ' A' ' 118' ' ' CYS . 10.9 m-85 -114.54 -53.51 2.65 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 124.818 1.247 . . . . 0.0 111.273 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 121.28 -6.31 10.84 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.587 1.089 . . . . 0.0 113.21 -176.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -91.92 131.07 37.51 Favored 'General case' 0 CA--C 1.509 -0.621 0 O-C-N 121.606 -0.938 . . . . 0.0 110.233 177.188 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 32.3 t -68.77 -2.43 9.38 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 124.891 1.369 . . . . 0.0 111.802 176.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.21 -54.06 4.39 Favored 'General case' 0 CA--C 1.518 -0.284 0 O-C-N 120.252 -1.53 . . . . 0.0 108.967 178.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.9 m -77.11 -34.27 56.81 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 123.814 0.696 . . . . 0.0 110.422 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -62.27 -37.66 86.34 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.322 0.649 . . . . 0.0 111.186 173.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.35 159.6 1.11 Allowed Pre-proline 0 N--CA 1.448 -0.557 0 CA-C-O 121.485 0.659 . . . . 0.0 112.123 178.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -68.73 120.62 7.52 Favored 'Trans proline' 0 N--CA 1.444 -1.392 0 C-N-CA 120.742 0.961 . . . . 0.0 111.573 174.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -69.19 168.53 20.55 Favored 'Trans proline' 0 N--CA 1.447 -1.262 0 C-N-CA 124.233 3.289 . . . . 0.0 111.261 175.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.7 tptp -131.12 136.46 48.39 Favored 'General case' 0 C--O 1.211 -0.967 0 CA-C-O 118.042 -0.98 . . . . 0.0 108.43 176.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -115.32 160.52 19.7 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 125.516 1.527 . . . . 0.0 108.593 177.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -150.59 170.63 18.7 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.735 179.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.93 60.61 6.32 Favored 'General case' 0 C--O 1.217 -0.613 0 C-N-CA 123.068 0.547 . . . . 0.0 111.406 177.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -175.16 -38.4 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.299 0.64 . . . . 0.0 110.967 -179.07 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 125.48 -67.18 0.53 Allowed Glycine 0 C--N 1.336 0.573 0 C-N-CA 125.071 1.319 . . . . 0.0 109.929 -178.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -128.48 62.14 1.46 Allowed 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 127.905 2.482 . . . . 0.0 107.925 -174.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -61.64 -104.35 0.01 OUTLIER Glycine 0 CA--C 1.529 0.926 0 CA-C-O 121.706 0.615 . . . . 0.0 112.299 176.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.2 mttt -65.42 -92.92 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 O-C-N 120.736 -1.449 . . . . 0.0 112.009 177.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -128.62 14.4 6.49 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 121.553 -0.717 . . . . 0.0 110.877 178.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.448 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 47.1 m-20 -27.95 102.83 0.02 OUTLIER 'General case' 0 C--O 1.208 -1.098 0 C-N-CA 125.491 1.516 . . . . 0.0 111.564 -178.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.463 ' H ' ' CD2' ' A' ' 78' ' ' HIS . 5.6 p80 -94.59 65.34 3.13 Favored 'General case' 0 CA--C 1.505 -0.766 0 O-C-N 120.214 -1.554 . . . . 0.0 108.432 -170.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.529 ' HB2' ' CD1' ' A' ' 37' ' ' TRP . 13.7 p90 -93.97 141.75 28.16 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 124.523 1.129 . . . . 0.0 110.574 -176.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.29 141.38 54.34 Favored 'General case' 0 C--O 1.216 -0.673 0 C-N-CA 119.694 -0.802 . . . . 0.0 110.496 173.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.46 ' CD1' ' CE2' ' A' ' 79' ' ' TYR . 0.8 OUTLIER -128.75 143.51 50.94 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 124.69 1.196 . . . . 0.0 110.339 176.236 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -106.41 153.93 21.53 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 122.717 1.246 . . . . 0.0 111.426 177.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -142.94 128.99 10.4 Favored Pre-proline 0 N--CA 1.45 -0.459 0 O-C-N 121.379 -0.826 . . . . 0.0 112.506 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.513 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 23.7 Cg_endo -72.45 93.94 0.76 Allowed 'Trans proline' 0 N--CA 1.446 -1.277 0 C-N-CA 124.091 3.194 . . . . 0.0 110.612 179.037 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.2 t -99.95 113.23 25.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 122.503 1.145 . . . . 0.0 109.939 179.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.433 ' CD2' ' NE2' ' A' ' 90' ' ' HIS . 43.6 m-85 -81.51 158.5 68.64 Favored Pre-proline 0 C--N 1.324 -0.517 0 O-C-N 121.466 -0.772 . . . . 0.0 111.996 179.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -76.16 -39.27 0.89 Allowed 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.257 1.971 . . . . 0.0 113.87 178.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -40.43 -38.18 0.79 Allowed 'General case' 0 N--CA 1.471 0.603 0 O-C-N 125.145 1.528 . . . . 0.0 110.287 174.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 102.01 -7.58 55.03 Favored Glycine 0 N--CA 1.44 -1.062 0 C-N-CA 124.762 1.172 . . . . 0.0 112.716 -178.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.433 ' NE2' ' CD2' ' A' ' 86' ' ' PHE . 9.2 p-80 -62.75 123.56 18.75 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 177.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -62.64 117.04 5.72 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 171.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -44.16 154.44 0.11 Allowed 'General case' 0 C--O 1.21 -0.994 0 CA-C-O 123.018 1.389 . . . . 0.0 112.689 172.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.51 66.53 6.34 Favored 'General case' 0 C--N 1.32 -0.693 0 O-C-N 119.149 -2.219 . . . . 0.0 109.926 177.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -80.79 -6.46 58.56 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 174.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -91.0 -38.35 12.88 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 122.677 1.227 . . . . 0.0 110.696 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 52.4 m -88.41 106.88 18.54 Favored 'General case' 0 CA--C 1.519 -0.243 0 O-C-N 121.346 -0.846 . . . . 0.0 109.202 179.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 9.7 ptpt -58.23 -46.48 85.84 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.16 0.505 . . . . 0.0 111.309 177.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.21 132.08 12.42 Favored Pre-proline 0 N--CA 1.444 -0.726 0 C-N-CA 125.065 1.346 . . . . 0.0 109.787 -178.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -68.27 173.39 39.03 Favored 'Cis proline' 0 N--CA 1.459 -0.519 0 C-N-CA 123.06 -1.642 . . . . 0.0 110.505 -9.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.3 ptmm? -137.85 154.76 49.46 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 123.56 0.744 . . . . 0.0 109.563 178.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -98.11 171.07 8.47 Favored 'General case' 0 C--O 1.244 0.778 0 CA-C-O 122.159 0.981 . . . . 0.0 110.177 178.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -53.66 143.56 38.09 Favored Pre-proline 0 N--CA 1.443 -0.777 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.106 172.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -73.88 -68.58 0.02 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.344 0 C-N-CA 122.311 2.007 . . . . 0.0 110.688 176.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 124.63 152.81 8.41 Favored Glycine 0 CA--C 1.524 0.611 0 O-C-N 120.388 -1.445 . . . . 0.0 111.251 -178.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -75.78 -56.52 0.06 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.85 2.367 . . . . 0.0 111.115 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.478 ' CB ' ' CE2' ' A' ' 11' ' ' TYR . . . -72.09 138.47 47.81 Favored 'General case' 0 N--CA 1.438 -1.049 0 O-C-N 123.369 0.418 . . . . 0.0 110.4 177.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 10.0 mtm-85 -144.43 149.28 35.77 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-O 118.073 -0.965 . . . . 0.0 110.429 177.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.1 p -83.92 114.26 24.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 125.145 1.378 . . . . 0.0 111.017 175.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.408 HG22 ' CE2' ' A' ' 38' ' ' PHE . 1.8 mp -101.43 120.68 51.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 -176.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 17.6 p90 -138.19 162.47 34.18 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.459 -178.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.5 p -91.52 161.94 14.75 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 122.755 0.422 . . . . 0.0 110.886 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.487 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.2 OUTLIER -110.64 154.96 42.93 Favored Pre-proline 0 CA--C 1.546 0.818 0 CA-C-N 118.216 0.462 . . . . 0.0 111.275 177.946 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.487 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 18.9 Cg_endo -72.37 -54.28 0.15 OUTLIER 'Cis proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.689 -1.379 . . . . 0.0 108.771 -9.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 41.3 t-20 -40.18 108.45 0.09 Allowed 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 116.511 -1.709 . . . . 0.0 110.507 178.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.5 63.84 0.07 Allowed 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 126.455 1.902 . . . . 0.0 108.119 -178.223 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 35.9 t -73.34 75.52 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 103.712 -2.699 . . . . 0.0 103.712 178.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.533 ' CZ ' ' NE2' ' A' ' 13' ' ' GLN . 2.2 t80 -40.87 124.21 2.08 Favored 'General case' 0 N--CA 1.437 -1.111 0 C-N-CA 125.182 1.393 . . . . 0.0 107.714 174.361 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . 0.554 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 0.1 OUTLIER -100.64 -40.84 7.19 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.227 175.768 . . . . . . . . 3 3 . 1 . 019 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.491 ' HA2' ' CZ ' ' A' ' 117' ' ' PHE . . . 160.31 -174.79 37.09 Favored Glycine 0 CA--C 1.505 -0.589 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 -178.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 3.2 mp -106.06 145.34 14.1 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.004 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 178.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 8.5 pt -119.78 152.71 22.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.445 0 CA-C-O 122.964 1.364 . . . . 0.0 109.741 179.508 . . . . . . . . 0 0 . 1 . 019 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.504 -0.796 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 . . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 9.7 tp -56.75 131.85 50.43 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 125.415 1.697 . . . . 0.0 107.842 179.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 71.3 m -58.54 178.0 0.12 Allowed 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 124.38 1.072 . . . . 0.0 109.554 174.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 38.3 m -154.23 112.09 3.5 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 -176.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.255 1.343 0 CA-C-O 115.519 -2.182 . . . . 0.0 110.943 172.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.45 HG11 ' CD2' ' A' ' 136' ' ' HIS . 3.5 p . . . . . 0 C--O 1.236 0.376 0 CA-C-O 121.858 0.837 . . . . 0.0 109.487 . . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.2 m -90.56 120.0 31.28 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -176.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . 0.403 ' CG ' HG13 ' A' ' 120' ' ' ILE . 31.9 m95 -79.75 141.34 36.42 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 -179.263 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -134.01 129.6 36.36 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-O 122.366 1.079 . . . . 0.0 108.669 -176.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -125.96 67.24 1.19 Allowed 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 177.064 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 130.38 -98.36 0.41 Allowed Glycine 0 C--O 1.22 -0.741 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 178.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -133.32 8.42 5.04 Favored Glycine 0 N--CA 1.464 0.512 0 C-N-CA 123.416 0.532 . . . . 0.0 112.4 178.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.85 142.36 46.87 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -176.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.6 mp -110.21 125.92 53.58 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -175.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.455 ' CE2' ' CB ' ' A' ' 106' ' ' ALA . 77.5 m-85 -117.04 103.5 10.31 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 126.327 1.851 . . . . 0.0 108.2 -173.094 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -55.18 121.47 8.9 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 118.113 -0.946 . . . . 0.0 108.991 178.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.533 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 5.9 tp-100 -51.33 -45.28 62.23 Favored 'General case' 0 C--O 1.206 -1.211 0 O-C-N 124.023 0.827 . . . . 0.0 111.881 179.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -51.02 -40.83 59.13 Favored 'General case' 0 C--O 1.197 -1.697 0 CA-C-N 117.801 0.273 . . . . 0.0 111.309 176.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.86 -36.78 72.98 Favored 'General case' 0 C--O 1.199 -1.604 0 O-C-N 120.1 -1.625 . . . . 0.0 113.395 168.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.61 -40.96 72.78 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 123.04 2.654 . . . . 0.0 113.871 171.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -86.45 -38.75 17.0 Favored 'General case' 0 C--O 1.206 -1.186 0 C-N-CA 123.622 0.769 . . . . 0.0 108.999 176.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.7 t -73.42 -58.74 3.1 Favored 'General case' 0 CA--C 1.502 -0.879 0 O-C-N 119.889 -1.757 . . . . 0.0 108.771 -176.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.451 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 7.6 t-20 -42.62 -36.13 1.3 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 119.624 1.102 . . . . 0.0 112.977 171.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -82.27 -31.95 29.86 Favored 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 174.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 5.0 m170 -50.8 -39.33 52.57 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 126.204 1.802 . . . . 0.0 109.162 178.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.451 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -75.38 -45.7 37.56 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-O 117.388 -1.291 . . . . 0.0 110.689 177.844 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -40.4 135.15 1.49 Allowed Pre-proline 0 CA--C 1.543 0.706 0 O-C-N 125.609 1.818 . . . . 0.0 111.966 176.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -72.65 122.02 7.88 Favored 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 122.067 1.845 . . . . 0.0 109.319 -176.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.2 tp -59.88 94.39 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.311 0.644 . . . . 0.0 111.17 178.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -171.58 178.71 3.07 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 123.312 0.645 . . . . 0.0 109.673 -176.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -116.45 89.25 3.07 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 124.211 1.004 . . . . 0.0 109.673 177.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 71.86 78.69 0.46 Allowed Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 176.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.1 mmtp -149.77 30.24 0.73 Allowed 'General case' 0 CA--C 1.513 -0.46 0 C-N-CA 123.355 0.662 . . . . 0.0 111.723 178.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.8 p -122.02 149.37 43.6 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -175.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -42.11 -52.62 4.94 Favored Glycine 0 C--N 1.332 0.353 0 O-C-N 123.814 0.696 . . . . 0.0 111.905 -179.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.5 t -67.75 -64.53 0.84 Allowed 'General case' 0 CA--C 1.503 -0.847 0 CA-C-O 116.266 -1.826 . . . . 0.0 112.303 174.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 166.24 -59.39 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 126.334 1.854 . . . . 0.0 111.423 177.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.493 ' CD2' ' HD3' ' A' ' 84' ' ' PRO . 60.5 m-85 -62.99 147.52 94.17 Favored Pre-proline 0 N--CA 1.436 -1.162 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 179.119 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -75.6 164.56 87.79 Favored 'Cis proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.232 -1.57 . . . . 0.0 111.6 0.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.466 ' CD2' ' CD2' ' A' ' 34' ' ' TYR . 1.3 p80 -140.08 173.64 11.31 Favored 'General case' 0 C--O 1.21 -1.012 0 CA-C-O 117.865 -1.064 . . . . 0.0 110.305 -177.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.578 ' CD1' ' CD2' ' A' ' 79' ' ' TYR . 19.6 t90 -75.95 127.1 32.28 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 119.441 1.018 . . . . 0.0 109.226 175.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.55 ' CZ ' ' HA ' ' A' ' 40' ' ' ASN . 34.6 t80 -97.38 86.69 3.94 Favored 'General case' 0 N--CA 1.427 -1.62 0 C-N-CA 125.928 1.691 . . . . 0.0 107.303 177.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.416 ' CG2' ' CH2' ' A' ' 37' ' ' TRP . 61.8 p -39.87 -35.1 0.32 Allowed 'General case' 0 CA--C 1.508 -0.67 0 C-N-CA 124.774 1.23 . . . . 0.0 111.042 173.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.55 ' HA ' ' CZ ' ' A' ' 38' ' ' PHE . 65.1 t30 69.19 8.77 7.01 Favored 'General case' 0 C--O 1.222 -0.381 0 C-N-CA 124.614 1.165 . . . . 0.0 110.376 177.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.424 ' CA ' ' HD3' ' A' ' 52' ' ' ARG . . . 112.7 -13.78 24.8 Favored Glycine 0 N--CA 1.428 -1.843 0 C-N-CA 124.741 1.162 . . . . 0.0 114.206 -172.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.566 ' CE2' ' HA ' ' A' ' 47' ' ' LYS . 16.0 m-85 -70.61 166.55 20.44 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.095 0.958 . . . . 0.0 110.682 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.01 -40.44 16.87 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.992 176.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.546 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . 174.84 -49.63 0.13 Allowed Glycine 0 C--N 1.335 0.484 0 C-N-CA 124.354 0.978 . . . . 0.0 111.794 -178.013 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -125.01 -63.24 1.17 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 122.026 0.917 . . . . 0.0 109.505 -179.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.48 161.38 21.76 Favored Glycine 0 C--N 1.341 0.823 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.566 ' HA ' ' CE2' ' A' ' 42' ' ' TYR . 19.5 mtmt -54.74 175.15 0.06 Allowed 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 122.303 1.049 . . . . 0.0 112.339 176.188 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.433 ' CD1' ' CE1' ' A' ' 42' ' ' TYR . 5.8 mp -56.76 153.72 21.01 Favored Pre-proline 0 N--CA 1.447 -0.618 0 O-C-N 121.658 -0.651 . . . . 0.0 111.381 178.296 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -71.72 158.99 52.07 Favored 'Trans proline' 0 N--CA 1.448 -1.19 0 C-N-CA 121.88 1.72 . . . . 0.0 110.092 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.9 tttt -55.52 98.35 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.145 0.578 . . . . 0.0 109.921 177.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.8 72.89 0.62 Allowed Glycine 0 C--O 1.228 -0.226 0 CA-C-O 119.503 -0.609 . . . . 0.0 112.686 -176.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.424 ' HD3' ' CA ' ' A' ' 41' ' ' GLY . 12.3 ttm180 -174.42 162.8 3.59 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 124.175 0.99 . . . . 0.0 110.448 175.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.3 m -136.52 110.34 9.6 Favored Pre-proline 0 C--O 1.208 -1.089 0 O-C-N 123.909 0.756 . . . . 0.0 110.87 178.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -71.98 -178.72 3.33 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 121.698 1.599 . . . . 0.0 112.232 177.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.406 ' CG2' ' HB2' ' A' ' 133' ' ' LEU . 6.6 mt -95.42 114.17 31.45 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 -178.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.61 135.46 35.55 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 120.954 -1.091 . . . . 0.0 108.635 177.277 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.481 ' CD2' ' HB3' ' A' ' 118' ' ' CYS . 4.7 m-85 -117.67 -52.4 2.45 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 123.234 0.614 . . . . 0.0 109.795 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 134.15 -12.26 4.71 Favored Glycine 0 C--O 1.224 -0.513 0 C-N-CA 123.92 0.772 . . . . 0.0 112.418 -176.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.51 134.33 34.44 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 117.43 0.615 . . . . 0.0 109.481 177.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 87.8 p -75.93 2.72 11.79 Favored 'General case' 0 C--O 1.222 -0.372 0 O-C-N 124.362 1.039 . . . . 0.0 111.713 176.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -89.11 -56.14 3.4 Favored 'General case' 0 C--O 1.217 -0.619 0 C-N-CA 124.867 1.267 . . . . 0.0 109.047 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 2.1 m -71.57 -29.97 65.33 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 178.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -66.66 -38.16 86.27 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-O 121.091 0.472 . . . . 0.0 110.909 175.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.84 164.18 0.58 Allowed Pre-proline 0 N--CA 1.447 -0.598 0 CA-C-O 122.156 0.979 . . . . 0.0 111.692 178.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -69.85 126.54 13.37 Favored 'Trans proline' 0 N--CA 1.443 -1.48 0 C-N-CA 121.239 1.293 . . . . 0.0 114.499 172.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.463 ' CD ' ' CD2' ' A' ' 42' ' ' TYR . 21.5 Cg_endo -70.64 168.16 23.51 Favored 'Trans proline' 0 N--CA 1.444 -1.44 0 C-N-CA 124.099 3.2 . . . . 0.0 111.48 177.171 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.2 tptt -130.61 61.22 1.62 Allowed 'General case' 0 C--O 1.202 -1.397 0 CA-C-O 116.95 -1.5 . . . . 0.0 108.854 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 40.6 t-80 -75.58 164.97 25.78 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 120.291 1.405 . . . . 0.0 111.029 178.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.9 -179.71 7.21 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 120.869 -1.144 . . . . 0.0 110.841 178.093 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.34 69.23 10.46 Favored 'General case' 0 C--O 1.211 -0.928 0 O-C-N 120.29 -1.506 . . . . 0.0 111.34 177.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -176.76 -41.98 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 O-C-N 123.772 0.67 . . . . 0.0 109.707 179.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.449 ' O ' ' CE2' ' A' ' 79' ' ' TYR . . . 138.11 -72.5 0.44 Allowed Glycine 0 C--O 1.21 -1.361 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 -178.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -140.72 72.85 1.4 Allowed 'General case' 0 N--CA 1.438 -1.064 0 O-C-N 121.872 -0.781 . . . . 0.0 109.865 179.24 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.47 -101.98 0.01 OUTLIER Glycine 0 C--O 1.221 -0.717 0 CA-C-O 119.736 -0.48 . . . . 0.0 112.47 178.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -52.42 -90.29 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.457 0 CA-C-O 122.152 0.977 . . . . 0.0 111.25 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -134.47 20.66 3.64 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-O 117.765 -1.112 . . . . 0.0 111.192 178.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -20.54 90.1 0.01 OUTLIER 'General case' 0 C--O 1.211 -0.938 0 C-N-CA 125.424 1.49 . . . . 0.0 114.089 -177.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 28.4 p80 -92.22 29.45 1.66 Allowed 'General case' 0 N--CA 1.467 0.383 0 O-C-N 119.097 -2.252 . . . . 0.0 108.196 -170.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.578 ' CD2' ' CD1' ' A' ' 37' ' ' TRP . 0.1 OUTLIER -57.37 176.29 0.13 Allowed 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 115.073 1.508 . . . . 0.0 115.073 174.161 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.6 mt -95.84 154.99 16.94 Favored 'General case' 0 C--O 1.215 -0.758 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.371 173.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.411 ' CD2' ' CZ ' ' A' ' 79' ' ' TYR . 2.1 mt -141.14 129.28 22.12 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -177.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.495 ' CB ' ' CD1' ' A' ' 109' ' ' ILE . 0.2 OUTLIER -98.92 155.72 17.26 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 122.832 1.301 . . . . 0.0 111.543 178.66 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.435 ' CD1' ' HD2' ' A' ' 84' ' ' PRO . 47.7 t80 -146.27 129.8 8.34 Favored Pre-proline 0 N--CA 1.452 -0.332 0 O-C-N 121.221 -0.924 . . . . 0.0 112.2 179.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.493 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 21.5 Cg_endo -71.96 106.02 1.93 Allowed 'Trans proline' 0 N--CA 1.445 -1.324 0 C-N-CA 124.531 3.487 . . . . 0.0 110.801 -179.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.94 114.99 29.46 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.937 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -82.17 158.02 67.52 Favored Pre-proline 0 N--CA 1.449 -0.515 0 O-C-N 121.775 -0.578 . . . . 0.0 111.818 178.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -76.8 -38.88 0.77 Allowed 'Trans proline' 0 CA--C 1.498 -1.288 0 C-N-CA 122.467 2.112 . . . . 0.0 112.713 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -44.92 -30.7 1.06 Allowed 'General case' 0 N--CA 1.469 0.497 0 O-C-N 125.342 1.651 . . . . 0.0 110.98 176.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 90.42 -8.48 79.73 Favored Glycine 0 N--CA 1.438 -1.216 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 176.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.6 p-80 -59.71 129.25 41.0 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 178.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -62.68 96.58 0.09 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 175.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.481 ' CD2' ' HB3' ' A' ' 94' ' ' PHE . 7.0 t80 -37.82 142.34 0.16 Allowed 'General case' 0 C--O 1.212 -0.904 0 CA-C-O 121.843 0.83 . . . . 0.0 110.92 178.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . 0.409 ' HE2' ' O ' ' A' ' 99' ' ' PRO . 0.1 OUTLIER -77.43 57.29 1.5 Allowed 'General case' 0 C--N 1.314 -0.947 0 O-C-N 119.584 -1.947 . . . . 0.0 110.779 175.972 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.481 ' HB3' ' CD2' ' A' ' 92' ' ' TYR . 33.2 p90 -71.25 -9.26 57.82 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 124.319 1.048 . . . . 0.0 112.23 175.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -92.19 -37.27 12.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 122.223 1.011 . . . . 0.0 109.709 -179.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.9 m -75.41 106.15 6.8 Favored 'General case' 0 CA--C 1.513 -0.464 0 O-C-N 121.266 -0.896 . . . . 0.0 108.968 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.1 pttp -58.59 -49.91 75.76 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 121.882 0.848 . . . . 0.0 110.362 178.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -145.54 126.06 7.27 Favored Pre-proline 0 N--CA 1.436 -1.146 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.244 -176.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.409 ' O ' ' HE2' ' A' ' 93' ' ' LYS . 29.7 Cg_endo -70.11 175.96 35.58 Favored 'Cis proline' 0 N--CA 1.461 -0.397 0 O-C-N 124.419 1.747 . . . . 0.0 111.797 -4.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 15.3 tttm -141.95 132.34 25.12 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 123.526 0.73 . . . . 0.0 109.069 178.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -72.14 170.81 13.18 Favored 'General case' 0 C--O 1.237 0.442 0 O-C-N 124.747 1.279 . . . . 0.0 111.881 177.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -65.13 152.1 92.25 Favored Pre-proline 0 N--CA 1.445 -0.699 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.442 177.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -73.3 -164.83 0.21 Allowed 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.734 2.289 . . . . 0.0 112.139 175.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -141.4 157.43 26.14 Favored Glycine 0 CA--C 1.522 0.494 0 O-C-N 121.353 -0.842 . . . . 0.0 112.438 177.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -75.76 -67.56 0.02 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.868 2.379 . . . . 0.0 110.43 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.455 ' CB ' ' CE2' ' A' ' 11' ' ' TYR . . . -60.73 138.78 58.06 Favored 'General case' 0 N--CA 1.446 -0.634 0 O-C-N 123.9 0.75 . . . . 0.0 110.452 179.038 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 6.0 mtm-85 -144.1 144.07 31.43 Favored 'General case' 0 CA--C 1.508 -0.656 0 O-C-N 124.529 1.143 . . . . 0.0 111.148 -179.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.3 p -82.52 123.95 38.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 123.907 0.754 . . . . 0.0 110.595 179.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.504 HG21 ' CD2' ' A' ' 38' ' ' PHE . 7.0 mm -104.67 138.68 28.34 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.903 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -178.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.474 ' C ' ' CD1' ' A' ' 110' ' ' TYR . 12.6 p90 -165.52 155.19 12.62 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-O 121.801 0.81 . . . . 0.0 111.517 -178.188 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 16.9 p -91.2 160.86 15.33 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -175.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.497 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -107.79 155.79 39.23 Favored Pre-proline 0 C--N 1.318 -0.776 0 O-C-N 122.029 -0.419 . . . . 0.0 110.694 179.905 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.497 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 17.8 Cg_endo -73.32 -53.87 0.15 OUTLIER 'Cis proline' 0 CA--C 1.5 -1.176 0 C-N-CA 123.351 -1.521 . . . . 0.0 109.399 -7.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -44.17 107.38 0.09 Allowed 'General case' 0 C--O 1.217 -0.642 0 CA-C-O 116.187 -1.864 . . . . 0.0 109.632 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.404 ' HG2' ' CG ' ' A' ' 110' ' ' TYR . 0.3 OUTLIER -62.35 85.37 0.02 OUTLIER 'General case' 0 CA--C 1.509 -0.627 0 O-C-N 124.568 1.168 . . . . 0.0 108.737 -176.099 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 81.0 t -84.31 67.67 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.756 0 N-CA-C 104.964 -2.235 . . . . 0.0 104.964 -173.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.585 ' CZ ' ' HA2' ' A' ' 119' ' ' GLY . 47.1 t80 -37.13 101.98 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.225 1.41 . . . . 0.0 109.759 178.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . 0.481 ' HB3' ' CD2' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -81.79 -24.62 35.86 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 178.997 . . . . . . . . 3 3 . 1 . 020 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.585 ' HA2' ' CZ ' ' A' ' 117' ' ' PHE . . . 144.99 -147.42 18.58 Favored Glycine 0 N--CA 1.434 -1.435 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 -178.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.403 HG13 ' CG ' ' A' ' 4' ' ' TRP . 1.1 mm -127.31 148.27 32.08 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.273 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 -175.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.525 ' CD1' ' CE1' ' A' ' 38' ' ' PHE . 8.2 pt -136.23 154.99 34.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 108.139 -1.059 . . . . 0.0 108.139 -178.253 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.575 0 CA-C-O 122.145 0.974 . . . . 0.0 109.502 -179.976 . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 3.8 ptmt . . . . . 0 CA--C 1.498 -1.021 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 . . . . . . . . . 0 0 . 1 . 020 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.406 ' HB2' ' CG2' ' A' ' 55' ' ' ILE . 13.4 tp -54.32 129.71 36.39 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 125.11 1.507 . . . . 0.0 108.339 -179.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 76.4 m -66.57 -173.78 0.25 Allowed 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 124.363 2.03 . . . . 0.0 108.237 177.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 39.3 m -157.94 125.52 5.19 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 102.819 -3.03 . . . . 0.0 102.819 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 0.45 ' CD2' HG11 ' A' ' 2' ' ' VAL . 2.4 m80 . . . . . 0 CA--C 1.575 1.923 0 N-CA-C 118.489 2.774 . . . . 0.0 118.489 175.091 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.3 p . . . . . 0 N--CA 1.48 1.066 0 CA-C-O 123.12 1.438 . . . . 0.0 112.774 . . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 3' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 12' ' ' ASN . 6.4 m -93.37 111.25 22.85 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 -173.089 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . 0.414 ' CZ2' ' CD2' ' A' ' 136' ' ' HIS . 18.0 m95 -75.59 143.77 42.16 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 -178.557 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.9 m -145.88 153.25 40.65 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 -179.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -125.65 -84.64 0.63 Allowed 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 172.448 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -102.0 58.38 0.61 Allowed Glycine 0 N--CA 1.473 1.101 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 -178.032 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 72.92 -3.31 29.02 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 117.681 1.832 . . . . 0.0 117.681 -171.331 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.351 5.1 mt -94.73 132.61 39.3 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.087 1.755 . . . . 0.0 108.405 -177.438 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.409 ' O ' ' CD1' ' A' ' 11' ' ' TYR . 4.4 mm? -99.29 151.86 20.57 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.316 1.446 . . . . 0.0 110.102 -170.861 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.446 ' CZ ' ' CB ' ' A' ' 106' ' ' ALA . 40.9 m-85 -157.85 74.65 0.74 Allowed 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 -168.017 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . 0.414 ' HA ' ' HA ' ' A' ' 3' ' ' THR . 0.2 OUTLIER -50.67 128.0 19.47 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 120.053 -1.655 . . . . 0.0 108.606 178.251 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.486 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 0.2 OUTLIER -44.66 -54.7 5.91 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-O 117.682 -1.151 . . . . 0.0 111.841 178.179 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -48.27 -51.2 26.76 Favored 'General case' 0 C--O 1.202 -1.403 0 O-C-N 124.235 0.959 . . . . 0.0 112.449 176.193 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.41 -35.64 74.36 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 114.329 -2.748 . . . . 0.0 117.491 169.981 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.13 -68.33 0.35 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 127.518 2.327 . . . . 0.0 115.487 169.537 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -48.35 -42.0 30.17 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 117.714 -1.136 . . . . 0.0 110.739 167.836 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 41.5 t -64.84 -53.09 52.25 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 126.687 1.995 . . . . 0.0 110.418 -179.702 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -44.98 -49.12 11.37 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 119.189 0.904 . . . . 0.0 111.247 173.152 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 20' ' ' SER . . . . . 0.471 ' HB2' ' CE2' ' A' ' 110' ' ' TYR . 1.7 p -67.72 -32.65 73.42 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 118.133 2.642 . . . . 0.0 118.133 172.933 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 11.0 m170 -58.64 -40.24 82.84 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 127.535 2.334 . . . . 0.0 110.73 174.38 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -80.6 -44.76 18.41 Favored 'General case' 0 CA--C 1.511 -0.521 0 C-N-CA 125.28 1.432 . . . . 0.0 111.658 176.407 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -47.35 126.45 9.67 Favored Pre-proline 0 CA--C 1.552 1.041 0 O-C-N 125.527 1.767 . . . . 0.0 112.76 177.457 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -68.28 128.96 18.28 Favored 'Trans proline' 0 N--CA 1.439 -1.718 0 N-CA-C 107.596 -1.732 . . . . 0.0 107.596 -176.272 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.6 tp -65.31 90.65 0.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 126.397 1.879 . . . . 0.0 112.505 178.138 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 174.21 161.95 0.19 Allowed 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 125.84 1.656 . . . . 0.0 108.786 -172.148 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.482 ' HA ' ' HA ' ' A' ' 36' ' ' HIS . 2.9 t70 -104.74 119.17 38.36 Favored 'General case' 0 CA--C 1.495 -1.171 0 C-N-CA 128.558 2.743 . . . . 0.0 108.425 -179.062 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 56.76 50.02 66.47 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 119.69 -1.243 . . . . 0.0 112.069 172.407 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.81 -3.57 14.89 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 125.382 1.473 . . . . 0.0 114.344 176.119 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.2 p -114.27 158.42 21.44 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 -170.895 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -45.89 -55.08 7.55 Favored Glycine 0 N--CA 1.467 0.736 0 C-N-CA 124.331 0.967 . . . . 0.0 115.039 -178.745 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 30.4 t -57.52 -71.8 0.1 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 114.266 1.209 . . . . 0.0 114.266 165.64 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.5 m 161.44 -51.03 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 131.338 3.855 . . . . 0.0 110.929 -176.507 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.46 ' CD2' ' HD3' ' A' ' 84' ' ' PRO . 90.8 m-85 -57.38 147.72 57.36 Favored Pre-proline 0 CA--C 1.569 1.694 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -174.038 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -66.79 148.31 78.21 Favored 'Cis proline' 0 N--CA 1.428 -2.324 0 N-CA-C 106.784 -2.045 . . . . 0.0 106.784 -7.467 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 27' ' ' ASP 0.27 0.3 OUTLIER -117.3 167.08 11.55 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 113.736 -1.574 . . . . 0.0 107.393 174.927 . . . . . . . . 4 4 . 1 . 021 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.459 ' CD1' ' HB2' ' A' ' 79' ' ' TYR . 11.1 t90 -64.03 133.17 52.6 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 123.274 1.511 . . . . 0.0 112.329 168.768 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.496 ' CD2' ' HB2' ' A' ' 40' ' ' ASN . 18.0 t80 -98.7 89.98 4.55 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 102.995 -2.965 . . . . 0.0 102.995 -179.742 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 82.8 p -38.86 -41.52 0.75 Allowed 'General case' 0 CA--C 1.502 -0.887 0 CA-C-N 111.329 -2.669 . . . . 0.0 110.421 160.923 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.496 ' HB2' ' CD2' ' A' ' 38' ' ' PHE . 63.2 t30 57.36 25.09 10.84 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 120.625 1.557 . . . . 0.0 112.09 178.316 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.418 ' HA2' ' CD ' ' A' ' 52' ' ' ARG . . . 94.4 -39.35 2.92 Favored Glycine 0 CA--C 1.542 1.779 0 CA-C-O 113.723 -3.82 . . . . 0.0 117.846 -163.92 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -45.14 148.72 0.56 Allowed 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 130.203 3.401 . . . . 0.0 111.687 173.853 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.68 -32.56 25.52 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 115.34 1.607 . . . . 0.0 115.34 177.363 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.412 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -168.79 -81.95 0.05 OUTLIER Glycine 0 CA--C 1.527 0.841 0 C-N-CA 126.133 1.825 . . . . 0.0 111.82 -176.647 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -108.26 -63.95 1.27 Allowed 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 127.337 2.255 . . . . 0.0 114.226 -178.307 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.52 -171.37 0.66 Allowed Glycine 0 C--O 1.222 -0.599 0 CA-C-N 114.54 -1.209 . . . . 0.0 111.989 177.012 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.55 -175.29 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.838 0 CA-C-O 124.375 2.036 . . . . 0.0 115.151 170.441 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.7 160.04 81.84 Favored Pre-proline 0 C--N 1.312 -1.044 0 CA-C-N 114.338 -1.301 . . . . 0.0 110.56 -177.889 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -62.03 168.72 8.58 Favored 'Trans proline' 0 N--CA 1.435 -1.967 0 CA-C-O 123.88 1.534 . . . . 0.0 110.119 171.306 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 6.5 ttpt -55.1 101.35 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.624 1.57 . . . . 0.0 111.665 170.222 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.37 90.24 1.67 Allowed Glycine 0 N--CA 1.474 1.203 0 N-CA-C 111.553 -0.619 . . . . 0.0 111.553 -173.822 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.418 ' CD ' ' HA2' ' A' ' 41' ' ' GLY . 0.0 OUTLIER -167.01 163.89 15.96 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 126.463 1.905 . . . . 0.0 111.148 171.98 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 42.4 m -134.89 101.93 11.37 Favored Pre-proline 0 N--CA 1.478 0.972 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -178.325 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -71.46 140.71 37.05 Favored 'Trans proline' 0 N--CA 1.43 -2.247 0 C-N-CA 122.155 1.903 . . . . 0.0 109.911 176.472 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.0 mt -61.8 119.52 5.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 172.294 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.65 143.88 28.16 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.284 169.821 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.529 ' CD1' ' HB3' ' A' ' 118' ' ' CYS . 7.0 m-85 -124.68 -53.24 1.68 Allowed 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 126.308 1.843 . . . . 0.0 111.044 179.514 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 122.43 -5.62 10.05 Favored Glycine 0 N--CA 1.476 1.345 0 C-N-CA 126.735 2.112 . . . . 0.0 114.929 -172.982 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.79 131.48 39.12 Favored 'General case' 0 CA--C 1.503 -0.865 0 C-N-CA 125.013 1.325 . . . . 0.0 110.765 172.622 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 92.0 p -67.89 2.78 1.8 Allowed 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 174.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.38 -55.19 3.25 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 128.608 2.763 . . . . 0.0 108.201 -173.839 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.8 m -77.31 -26.32 52.12 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.528 1.131 . . . . 0.0 113.077 175.148 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -72.32 -26.74 62.06 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 126.274 1.829 . . . . 0.0 114.043 166.881 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.07 155.06 74.99 Favored Pre-proline 0 CA--C 1.539 0.52 0 O-C-N 120.247 -1.533 . . . . 0.0 114.32 175.412 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -63.85 129.55 25.04 Favored 'Trans proline' 0 CA--C 1.568 2.207 0 O-C-N 119.336 -0.929 . . . . 0.0 112.063 174.582 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -65.75 177.43 2.87 Favored 'Trans proline' 0 N--CA 1.447 -1.253 1 C-N-CA 125.448 4.099 . . . . 0.0 111.146 176.587 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.4 tptt -132.75 53.0 2.04 Favored 'General case' 0 C--O 1.214 -0.767 0 O-C-N 120.331 -1.481 . . . . 0.0 110.309 170.649 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 46.3 t-80 -76.04 160.94 29.31 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-O 123.315 1.531 . . . . 0.0 112.978 -178.819 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.74 -171.48 3.87 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 117.949 -2.969 . . . . 0.0 110.947 177.116 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.76 79.94 7.32 Favored 'General case' 0 C--O 1.213 -0.832 0 O-C-N 120.736 -1.227 . . . . 0.0 110.043 170.113 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -175.25 -44.21 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 126.022 1.729 . . . . 0.0 111.766 176.218 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 123.8 -63.61 0.55 Allowed Glycine 0 C--O 1.221 -0.691 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 -176.287 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -140.28 96.84 3.11 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 128.165 2.586 . . . . 0.0 106.251 177.097 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.46 -99.21 0.08 OUTLIER Glycine 0 CA--C 1.536 1.353 0 N-CA-C 116.365 1.306 . . . . 0.0 116.365 170.444 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 23.9 mttt -75.33 -97.94 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.164 -1.786 . . . . 0.0 114.313 172.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -109.52 12.8 24.28 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.838 -1.164 . . . . 0.0 111.025 178.518 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -23.16 95.06 0.01 OUTLIER 'General case' 0 C--O 1.215 -0.718 0 C-N-CA 129.449 3.099 . . . . 0.0 111.51 -171.783 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 5.7 p80 -91.13 54.67 2.66 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 118.048 -2.907 . . . . 0.0 106.529 -163.172 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.459 ' HB2' ' CD1' ' A' ' 37' ' ' TRP . 39.8 p90 -85.53 148.33 26.0 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 -172.439 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.79 162.29 29.29 Favored 'General case' 0 C--O 1.217 -0.634 0 C-N-CA 116.817 -1.953 . . . . 0.0 112.951 168.455 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.431 ' HB2' ' CE1' ' A' ' 110' ' ' TYR . 4.1 mp -141.65 111.23 6.52 Favored 'General case' 0 CA--C 1.498 -1.04 0 CA-C-N 119.921 1.237 . . . . 0.0 111.701 179.003 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -80.2 152.69 29.03 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 119.243 -0.983 . . . . 0.0 111.291 -178.145 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.47 ' CZ ' ' CD1' ' A' ' 94' ' ' PHE . 3.0 t80 -142.02 133.86 13.44 Favored Pre-proline 0 CA--C 1.544 0.741 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 179.073 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.506 ' HG2' ' CD2' ' A' ' 92' ' ' TYR . 30.9 Cg_endo -71.9 87.37 0.85 Allowed 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 124.633 3.555 . . . . 0.0 112.009 -177.29 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 6.4 t -89.89 96.73 10.82 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-N 114.316 -1.311 . . . . 0.0 110.592 -179.837 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -80.58 157.5 72.28 Favored Pre-proline 0 CA--C 1.552 1.052 0 O-C-N 120.963 -1.085 . . . . 0.0 112.407 179.695 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . 0.267 9.3 Cg_endo -71.59 -30.96 14.17 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 122.171 1.914 . . . . 0.0 115.711 175.107 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -43.74 -35.81 2.0 Favored 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 128.353 2.661 . . . . 0.0 109.899 174.931 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.71 7.85 70.86 Favored Glycine 0 C--N 1.328 0.106 0 N-CA-C 116.432 1.333 . . . . 0.0 116.432 -178.404 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -71.59 128.52 36.08 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 174.442 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -64.54 110.4 2.3 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 104.965 -2.235 . . . . 0.0 104.965 163.033 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.506 ' CD2' ' HG2' ' A' ' 84' ' ' PRO . 9.3 t80 -39.3 142.15 0.28 Allowed 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 126.735 2.014 . . . . 0.0 109.756 171.052 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.76 61.94 3.15 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 118.098 -2.877 . . . . 0.0 111.664 169.906 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.47 ' CD1' ' CZ ' ' A' ' 83' ' ' PHE . 11.9 p90 -70.93 -27.58 63.87 Favored 'General case' 0 C--O 1.221 -0.442 0 C-N-CA 124.775 1.23 . . . . 0.0 113.447 170.134 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -76.53 -42.47 42.97 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 125.728 1.611 . . . . 0.0 111.633 -179.256 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.1 m -76.51 116.39 17.15 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 119.807 -1.808 . . . . 0.0 109.316 -179.935 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.1 pttt -56.81 -44.22 81.76 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 123.534 1.635 . . . . 0.0 113.945 176.634 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.3 tttt -151.26 133.96 8.61 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 126.0 1.72 . . . . 0.0 111.938 179.831 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -66.63 165.4 64.79 Favored 'Cis proline' 0 N--CA 1.45 -1.045 0 C-N-CA 124.013 -1.244 . . . . 0.0 110.022 -9.862 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.6 pttm -142.11 145.94 34.83 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 105.62 -1.992 . . . . 0.0 105.62 176.265 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -69.17 173.01 6.03 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.205 1.002 . . . . 0.0 111.797 172.797 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -113.28 127.08 27.24 Favored Pre-proline 0 CA--C 1.556 1.175 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -178.258 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . 0.403 ' HG3' ' CE1' ' A' ' 34' ' ' TYR . 70.1 Cg_endo -74.35 -160.87 0.11 Allowed 'Trans proline' 0 CA--C 1.554 1.522 0 C-N-CA 125.217 3.945 . . . . 0.0 109.787 167.953 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 112.49 -39.61 2.81 Favored Glycine 0 CA--C 1.545 1.96 0 CA-C-O 114.797 -3.224 . . . . 0.0 112.505 -162.344 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -70.93 -163.67 0.13 Allowed 'Trans proline' 0 C--N 1.366 1.488 1 CA-C-N 125.577 4.689 . . . . 0.0 112.469 177.736 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.446 ' CB ' ' CZ ' ' A' ' 11' ' ' TYR . . . -63.95 160.77 17.07 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 124.757 2.218 . . . . 0.0 113.052 169.451 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.418 ' HG2' ' HA ' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -144.74 151.95 39.65 Favored 'General case' 0 C--O 1.214 -0.799 0 CA-C-N 111.832 -2.44 . . . . 0.0 110.8 179.613 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.7 p -87.8 120.84 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 C-N-CA 127.13 2.172 . . . . 0.0 112.003 173.292 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 1.7 mp -112.1 127.32 69.36 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.886 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 -171.644 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.471 ' CE2' ' HB2' ' A' ' 20' ' ' SER . 14.1 p90 -145.98 156.24 43.37 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 -177.029 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.7 p -81.79 164.91 21.35 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.196 0.999 . . . . 0.0 112.187 176.306 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.437 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.4 OUTLIER -109.8 158.89 33.63 Favored Pre-proline 0 CA--C 1.556 1.185 0 N-CA-C 112.667 0.618 . . . . 0.0 112.667 175.415 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.437 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 19.8 Cg_endo -69.45 -52.73 0.16 OUTLIER 'Cis proline' 0 CA--C 1.501 -1.167 0 N-CA-C 108.915 -1.225 . . . . 0.0 108.915 -15.837 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 28.6 t30 -43.69 108.88 0.12 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.931 0.892 . . . . 0.0 110.098 177.004 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.54 75.05 0.17 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 127.99 2.516 . . . . 0.0 107.615 -179.344 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 72.0 t -85.06 78.45 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 101.112 -3.662 . . . . 0.0 101.112 -175.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.486 ' CZ ' ' NE2' ' A' ' 13' ' ' GLN . 5.9 t80 -41.29 113.51 0.41 Allowed 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 129.071 2.948 . . . . 0.0 104.944 176.5 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . 0.529 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 0.1 OUTLIER -93.89 -37.95 11.46 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 122.101 0.953 . . . . 0.0 112.963 174.967 . . . . . . . . 3 3 . 1 . 021 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 163.72 -168.92 38.51 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 125.32 1.438 . . . . 0.0 111.648 -179.601 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 1.3 mp -114.72 120.39 64.24 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.356 0 N-CA-C 103.119 -2.919 . . . . 0.0 103.119 176.411 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.419 ' HA ' ' HA ' ' A' ' 133' ' ' LEU . 8.4 pt -89.52 153.5 3.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-O 117.707 -1.139 . . . . 0.0 109.333 172.427 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.491 1.579 0 CA-C-N 121.484 1.947 . . . . 0.0 113.25 172.062 . . . . . . . . 0 0 . 1 . 021 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.879 0 CA-C-O 118.469 -0.777 . . . . 0.0 110.531 . . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.419 ' HA ' ' HA ' ' A' ' 121' ' ' ILE . 14.3 tp -71.99 142.67 49.37 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 118.82 0.736 . . . . 0.0 110.325 175.668 . . . . . . . . 2 2 . 1 . 021 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 75.1 m -69.27 179.52 1.95 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 124.764 2.221 . . . . 0.0 113.05 165.875 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 96.9 p -146.01 89.15 1.86 Allowed 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 -179.103 . . . . . . . . 1 1 . 1 . 021 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 0.414 ' CD2' ' CZ2' ' A' ' 4' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 113.814 -2.993 . . . . 0.0 116.852 163.596 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.534 0.349 0 CA-C-O 124.337 2.017 . . . . 0.0 109.825 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -92.65 113.05 25.21 Favored 'General case' 0 C--N 1.312 -1.031 0 O-C-N 119.046 -2.284 . . . . 0.0 110.27 179.323 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 25.6 m95 -77.93 141.04 39.27 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 177.345 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -130.88 119.91 22.88 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -178.695 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -98.33 52.31 1.03 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.593 176.49 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 42.88 49.73 6.13 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 123.395 0.521 . . . . 0.0 112.619 -175.478 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -167.39 -82.89 0.05 OUTLIER Glycine 0 C--O 1.226 -0.396 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 -176.804 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 85.3 mt -119.41 159.33 24.43 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.546 0.689 . . . . 0.0 110.205 177.617 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.5 mt -82.99 165.47 19.64 Favored 'General case' 0 C--O 1.219 -0.544 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.613 179.499 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -157.78 85.72 0.9 Allowed 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 -174.337 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -54.51 114.46 1.68 Allowed 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 177.231 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.51 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 8.1 tp-100 -51.16 -34.17 30.21 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -179.797 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -43.26 -34.28 1.14 Allowed 'General case' 0 C--O 1.22 -0.472 0 O-C-N 124.969 1.418 . . . . 0.0 112.137 174.406 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.92 -51.32 4.51 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 116.182 -1.866 . . . . 0.0 113.341 171.843 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -42.42 -33.39 0.66 Allowed 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 123.041 2.655 . . . . 0.0 114.021 174.863 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -85.06 -49.25 8.44 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 124.49 1.116 . . . . 0.0 109.537 172.5 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 36.8 t -62.42 -43.62 98.39 Favored 'General case' 0 C--O 1.217 -0.656 0 O-C-N 119.796 -1.815 . . . . 0.0 110.482 -174.553 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -46.03 -38.66 8.11 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 125.901 1.68 . . . . 0.0 110.713 171.111 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.9 p -79.32 -28.97 42.14 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.697 0.799 . . . . 0.0 112.554 176.25 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.6 m170 -57.16 -44.11 83.14 Favored 'General case' 0 C--O 1.225 -0.222 0 C-N-CA 124.251 1.021 . . . . 0.0 110.886 176.866 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -78.77 -46.13 19.51 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 118.392 -0.814 . . . . 0.0 110.719 178.583 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -43.38 130.72 3.62 Favored Pre-proline 0 N--CA 1.447 -0.596 0 O-C-N 125.312 1.632 . . . . 0.0 111.434 178.611 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -71.08 122.87 9.16 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.242 1.961 . . . . 0.0 108.908 -177.362 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.0 tp -61.15 88.94 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.425 1.09 . . . . 0.0 111.77 177.744 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -177.77 167.65 2.13 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.448 -175.172 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.416 ' HA ' ' HA ' ' A' ' 36' ' ' HIS . 1.3 t70 -114.89 126.88 55.31 Favored 'General case' 0 CA--C 1.512 -0.494 0 C-N-CA 124.295 1.038 . . . . 0.0 110.112 179.756 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 56.09 55.51 28.9 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-O 122.348 0.971 . . . . 0.0 111.145 176.189 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.2 tttt -141.01 28.56 1.9 Allowed 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 124.197 1.951 . . . . 0.0 112.068 -179.386 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 34.6 p -134.74 143.31 47.08 Favored 'General case' 0 C--N 1.309 -1.157 0 O-C-N 119.854 -1.779 . . . . 0.0 108.506 -174.836 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -40.03 -65.8 0.88 Allowed Glycine 0 C--N 1.332 0.349 0 C-N-CA 124.223 0.916 . . . . 0.0 113.543 -177.794 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 25.3 t -54.65 -61.56 2.23 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 117.567 -1.206 . . . . 0.0 111.281 172.914 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.0 p 159.45 -43.02 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 O-C-N 125.637 1.836 . . . . 0.0 113.091 -178.584 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.589 ' CE2' ' CE1' ' A' ' 36' ' ' HIS . 62.2 m-85 -79.34 149.67 72.7 Favored Pre-proline 0 N--CA 1.442 -0.86 0 C-N-CA 124.88 1.272 . . . . 0.0 113.258 178.286 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -74.26 157.93 99.09 Favored 'Cis proline' 0 N--CA 1.45 -1.037 0 C-N-CA 123.476 -1.468 . . . . 0.0 110.351 -1.118 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.589 ' CE1' ' CE2' ' A' ' 34' ' ' TYR . 0.3 OUTLIER -134.6 155.85 49.73 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 113.649 -1.614 . . . . 0.0 109.01 179.125 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.561 ' CD1' ' CD2' ' A' ' 79' ' ' TYR . 25.2 t90 -55.49 121.6 9.37 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-O 122.158 0.98 . . . . 0.0 110.724 174.134 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.463 ' CZ ' ' HA ' ' A' ' 40' ' ' ASN . 41.7 t80 -92.77 85.86 5.34 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 126.997 2.119 . . . . 0.0 106.343 177.929 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 43.8 p -38.98 -36.45 0.28 Allowed 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.505 171.533 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.463 ' HA ' ' CZ ' ' A' ' 38' ' ' PHE . 63.9 t30 66.45 9.93 6.89 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 122.402 1.096 . . . . 0.0 111.687 -179.261 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 113.21 -18.93 20.71 Favored Glycine 0 N--CA 1.433 -1.519 0 C-N-CA 124.874 1.226 . . . . 0.0 113.226 -171.824 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.551 ' CE2' ' HA ' ' A' ' 47' ' ' LYS . 11.4 m-85 -63.98 161.53 15.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 118.647 1.223 . . . . 0.0 110.993 179.983 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.41 -41.88 19.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.373 0.606 . . . . 0.0 111.287 176.047 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.552 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -173.33 -67.4 0.05 OUTLIER Glycine 0 C--N 1.339 0.696 0 C-N-CA 124.094 0.854 . . . . 0.0 112.497 -177.755 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -115.77 -63.21 1.48 Allowed 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 124.003 0.921 . . . . 0.0 110.045 -179.782 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -58.12 162.49 9.74 Favored Glycine 0 C--N 1.341 0.827 0 N-CA-C 110.971 -0.851 . . . . 0.0 110.971 178.454 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.551 ' HA ' ' CE2' ' A' ' 42' ' ' TYR . 11.8 mtmt -56.6 173.36 0.19 Allowed 'General case' 0 C--N 1.334 -0.089 0 CA-C-O 121.59 0.709 . . . . 0.0 111.152 179.097 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.7 mp -57.63 154.17 26.76 Favored Pre-proline 0 N--CA 1.446 -0.667 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.708 -179.421 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -70.74 159.15 53.63 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 121.692 1.595 . . . . 0.0 110.066 179.919 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.6 tttt -56.45 97.68 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.247 0.619 . . . . 0.0 110.081 176.137 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 117.83 60.26 0.29 Allowed Glycine 0 C--N 1.329 0.172 0 CA-C-N 116.443 -0.344 . . . . 0.0 112.629 -176.343 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -164.06 162.56 23.13 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 123.287 0.635 . . . . 0.0 110.606 175.194 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.9 m -139.08 109.33 7.62 Favored Pre-proline 0 C--N 1.326 -0.449 0 C-N-CA 123.196 0.598 . . . . 0.0 109.584 179.641 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -72.86 177.16 8.01 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 123.126 2.551 . . . . 0.0 111.129 177.287 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.424 ' O ' ' CE2' ' A' ' 57' ' ' PHE . 6.5 mt -94.89 124.57 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -179.383 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.09 136.42 35.93 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 175.123 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.459 ' CD1' ' HB3' ' A' ' 118' ' ' CYS . 10.8 m-85 -118.89 -28.54 5.53 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.717 0.807 . . . . 0.0 111.027 177.747 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.66 -3.66 56.23 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 123.883 0.754 . . . . 0.0 113.209 -175.046 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.3 mmpt? -97.88 127.82 44.07 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-N 117.695 0.748 . . . . 0.0 109.414 176.868 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -66.35 -11.69 52.54 Favored 'General case' 0 C--O 1.219 -0.51 0 O-C-N 124.893 1.371 . . . . 0.0 111.819 175.854 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.15 -46.87 10.69 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 125.637 1.575 . . . . 0.0 111.049 175.806 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.459 ' SG ' ' CE2' ' A' ' 57' ' ' PHE . 2.0 t -73.1 -16.63 61.46 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 123.956 0.785 . . . . 0.0 112.071 176.688 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -90.04 -34.66 15.87 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.387 1.075 . . . . 0.0 110.812 175.246 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.21 163.1 0.97 Allowed Pre-proline 0 N--CA 1.446 -0.629 0 CA-C-O 121.538 0.685 . . . . 0.0 112.157 179.838 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . 0.447 ' HA ' ' CE2' ' A' ' 42' ' ' TYR . 24.6 Cg_endo -71.74 129.45 15.54 Favored 'Trans proline' 0 N--CA 1.44 -1.651 0 C-N-CA 121.144 1.229 . . . . 0.0 113.093 174.605 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.465 ' CD ' ' CD2' ' A' ' 42' ' ' TYR . 20.4 Cg_endo -68.46 167.59 22.05 Favored 'Trans proline' 0 N--CA 1.443 -1.498 0 C-N-CA 123.713 2.942 . . . . 0.0 111.206 176.701 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 10.3 tptt -126.75 66.16 1.26 Allowed 'General case' 0 C--O 1.223 -0.328 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.787 177.423 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.409 ' CE1' ' O ' ' A' ' 69' ' ' SER . 41.7 t-80 -77.92 168.07 20.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.498 0.666 . . . . 0.0 110.932 177.39 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.409 ' O ' ' CE1' ' A' ' 68' ' ' HIS . 1.5 p -141.47 173.79 11.17 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 121.232 -0.918 . . . . 0.0 111.429 176.782 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.5 mtpt -84.77 71.97 10.79 Favored 'General case' 0 C--O 1.219 -0.521 0 O-C-N 120.495 -1.378 . . . . 0.0 110.993 175.338 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -177.29 -43.07 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 O-C-N 124.54 1.15 . . . . 0.0 111.014 178.509 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 161.71 -85.08 0.11 Allowed Glycine 0 N--CA 1.442 -0.912 0 N-CA-C 108.626 -1.79 . . . . 0.0 108.626 -178.801 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -94.14 -98.27 0.15 Allowed 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 124.424 1.089 . . . . 0.0 108.465 -178.171 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 125.9 -162.92 20.02 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 125.781 1.658 . . . . 0.0 110.614 -175.503 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.3 mttt -43.65 -81.49 0.01 OUTLIER 'General case' 0 C--O 1.218 -0.554 0 C-N-CA 125.118 1.367 . . . . 0.0 112.942 -179.678 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -117.96 14.53 14.17 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 116.062 -1.923 . . . . 0.0 111.856 176.01 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.471 ' OD2' ' CE1' ' A' ' 79' ' ' TYR . 11.6 p-10 -11.77 83.08 0.0 OUTLIER 'General case' 0 C--O 1.214 -0.793 0 CA-C-O 124.469 2.08 . . . . 0.0 115.685 179.08 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 33.6 p80 -91.88 19.41 6.63 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 118.361 -2.712 . . . . 0.0 109.485 -170.531 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.561 ' CD2' ' CD1' ' A' ' 37' ' ' TRP . 0.1 OUTLIER -52.91 179.12 0.02 OUTLIER 'General case' 0 N--CA 1.428 -1.542 0 C-N-CA 125.329 1.452 . . . . 0.0 113.987 175.229 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.405 ' CD2' ' SG ' ' A' ' 62' ' ' CYS . 2.0 mt -100.63 154.34 18.67 Favored 'General case' 0 CA--C 1.504 -0.812 0 CA-C-O 118.444 -0.789 . . . . 0.0 110.869 173.871 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.465 ' CD1' ' CE1' ' A' ' 79' ' ' TYR . 2.6 mp -142.02 125.89 17.13 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 123.901 0.881 . . . . 0.0 109.803 179.175 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -92.34 154.24 18.69 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 121.386 0.613 . . . . 0.0 109.832 -179.125 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.49 ' CD1' ' HD2' ' A' ' 84' ' ' PRO . 6.4 t80 -143.68 135.13 12.73 Favored Pre-proline 0 N--CA 1.45 -0.449 0 O-C-N 121.538 -0.726 . . . . 0.0 112.65 179.078 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.49 ' HD2' ' CD1' ' A' ' 83' ' ' PHE . 18.2 Cg_endo -73.33 99.72 1.15 Allowed 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 123.988 3.125 . . . . 0.0 110.236 -177.374 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.4 t -95.93 108.12 20.46 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.743 -179.912 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -83.36 150.82 61.31 Favored Pre-proline 0 C--O 1.241 0.638 0 CA-C-O 118.804 -0.617 . . . . 0.0 110.953 178.964 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -75.72 -36.55 2.09 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 123.311 2.674 . . . . 0.0 113.209 178.352 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -41.42 -34.4 0.53 Allowed 'General case' 0 C--N 1.351 0.669 0 O-C-N 125.53 1.769 . . . . 0.0 111.079 176.186 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 98.03 -4.91 61.13 Favored Glycine 0 N--CA 1.439 -1.143 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 178.25 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -71.92 136.55 46.91 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 122.107 0.956 . . . . 0.0 108.813 177.501 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -75.45 104.2 5.91 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 173.432 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.417 ' O ' ' CD2' ' A' ' 94' ' ' PHE . 8.3 t80 -37.84 145.41 0.07 Allowed 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.991 0.9 . . . . 0.0 111.884 177.131 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.87 61.3 3.75 Favored 'General case' 0 C--N 1.322 -0.591 0 O-C-N 119.902 -1.749 . . . . 0.0 110.679 176.004 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.417 ' CD2' ' O ' ' A' ' 92' ' ' TYR . 43.6 p90 -75.56 1.88 13.16 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.325 1.05 . . . . 0.0 113.144 175.253 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -98.11 -41.16 8.06 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.407 1.083 . . . . 0.0 110.305 178.853 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 18.8 m -87.09 110.61 20.22 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -178.965 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 12.7 pttt -57.62 -49.13 77.46 Favored 'General case' 0 C--O 1.241 0.609 0 O-C-N 121.872 -0.518 . . . . 0.0 110.724 177.372 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 13.1 mtmt -141.56 128.54 11.54 Favored Pre-proline 0 N--CA 1.444 -0.758 0 C-N-CA 125.383 1.473 . . . . 0.0 110.765 -177.265 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -71.34 173.57 49.49 Favored 'Cis proline' 0 CA--C 1.54 0.821 0 C-N-CA 122.934 -1.694 . . . . 0.0 110.955 -4.891 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -141.99 142.4 32.94 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 123.895 0.878 . . . . 0.0 109.674 179.365 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -80.82 175.59 10.55 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.613 1.195 . . . . 0.0 111.557 179.061 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -73.61 140.39 78.51 Favored Pre-proline 0 N--CA 1.449 -0.522 0 CA-C-O 118.567 -0.73 . . . . 0.0 110.846 175.717 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -70.23 -163.14 0.11 Allowed 'Trans proline' 0 CA--C 1.548 1.188 0 C-N-CA 124.001 3.134 . . . . 0.0 112.687 175.375 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -145.37 163.44 28.15 Favored Glycine 0 N--CA 1.446 -0.693 0 O-C-N 120.487 -1.383 . . . . 0.0 111.707 174.747 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.43 -57.73 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.244 2.629 . . . . 0.0 110.829 178.689 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.64 135.72 56.97 Favored 'General case' 0 N--CA 1.438 -1.026 0 O-C-N 123.586 0.554 . . . . 0.0 110.589 178.045 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.434 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 3.1 mtm-85 -141.7 143.94 33.82 Favored 'General case' 0 C--O 1.211 -0.95 0 CA-C-O 117.225 -1.369 . . . . 0.0 110.807 178.578 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.8 p -81.98 119.2 31.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 C-N-CA 124.702 1.201 . . . . 0.0 110.104 176.904 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.46 HG23 ' CE2' ' A' ' 38' ' ' PHE . 1.8 mp -105.39 124.5 60.33 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.786 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 -177.113 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.406 ' CD1' ' HG3' ' A' ' 115' ' ' LYS . 15.3 p90 -141.33 162.73 34.79 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 123.192 0.597 . . . . 0.0 109.931 -179.42 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.2 p -95.34 165.11 12.54 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -177.83 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.554 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.6 OUTLIER -108.96 153.41 42.49 Favored Pre-proline 0 CA--C 1.54 0.593 0 O-C-N 122.121 -0.362 . . . . 0.0 111.442 177.454 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.554 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 18.8 Cg_endo -74.44 -54.31 0.15 OUTLIER 'Cis proline' 0 N--CA 1.455 -0.769 0 C-N-CA 123.491 -1.462 . . . . 0.0 110.427 -7.803 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -42.6 112.57 0.36 Allowed 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 116.544 -1.693 . . . . 0.0 110.061 175.89 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.406 ' HG3' ' CD1' ' A' ' 110' ' ' TYR . 0.1 OUTLIER -64.93 71.42 0.03 OUTLIER 'General case' 0 CA--C 1.514 -0.423 0 O-C-N 125.621 1.825 . . . . 0.0 108.357 179.529 . . . . . . . . 3 3 . 1 . 022 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.0 t -74.55 75.67 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 -179.299 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.572 ' CZ ' ' HA2' ' A' ' 119' ' ' GLY . 27.6 t80 -41.08 119.39 1.16 Allowed 'General case' 0 N--CA 1.437 -1.122 0 C-N-CA 125.217 1.407 . . . . 0.0 110.063 176.798 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . 0.459 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 5.5 m -95.15 -45.48 7.18 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.837 -178.937 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . 0.572 ' HA2' ' CZ ' ' A' ' 117' ' ' PHE . . . 157.64 177.95 31.23 Favored Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.48 -179.841 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.434 ' HA ' ' O ' ' A' ' 107' ' ' ARG . 2.7 mp -101.23 124.37 54.89 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.289 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -178.586 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.448 HD12 ' CE1' ' A' ' 38' ' ' PHE . 7.5 pt -97.15 154.22 3.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 CA-C-N 120.232 1.378 . . . . 0.0 109.024 -179.598 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.326 -0.444 0 CA-C-O 122.468 1.128 . . . . 0.0 110.762 176.057 . . . . . . . . 0 0 . 1 . 022 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.513 -0.467 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 . . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 7.4 tp -82.29 149.82 27.59 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.47 1.106 . . . . 0.0 108.728 175.243 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 8.3 m -63.11 -175.72 0.11 Allowed 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 124.01 1.862 . . . . 0.0 108.525 176.096 . . . . . . . . 1 1 . 1 . 022 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -172.01 121.87 0.47 Allowed 'General case' 0 C--N 1.316 -0.868 0 O-C-N 120.482 -1.386 . . . . 0.0 107.601 -176.925 . . . . . . . . 2 2 . 1 . 022 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.258 1.5 0 CA-C-O 113.472 -3.156 . . . . 0.0 110.493 172.617 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.8 p . . . . . 0 N--CA 1.45 -0.47 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.9 m -86.83 119.75 27.39 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.467 -177.434 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . 0.434 ' CG ' HG13 ' A' ' 120' ' ' ILE . 28.8 m95 -79.98 139.63 36.93 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.956 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -133.5 132.81 41.43 Favored 'General case' 0 CA--C 1.501 -0.905 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -178.36 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -120.56 41.65 3.2 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.284 177.732 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 148.31 -96.26 0.17 Allowed Glycine 0 C--O 1.222 -0.637 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 -179.36 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -127.07 4.37 7.34 Favored Glycine 0 C--O 1.223 -0.593 0 N-CA-C 112.061 -0.416 . . . . 0.0 112.061 178.585 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . 0.499 ' HB2' ' CZ ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -111.13 141.29 44.82 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 -173.083 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . 0.4 ' CD2' ' N ' ' A' ' 10' ' ' LEU . 1.2 mm? -113.42 120.23 40.33 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -171.808 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.575 ' CE2' ' CB ' ' A' ' 106' ' ' ALA . 63.4 m-85 -115.18 101.41 8.94 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 125.065 1.346 . . . . 0.0 109.595 -175.653 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -57.62 120.94 9.21 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.984 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.513 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 6.8 tp-100 -46.49 -43.58 16.9 Favored 'General case' 0 C--O 1.2 -1.547 0 O-C-N 124.246 0.967 . . . . 0.0 111.498 179.591 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -48.22 -49.22 33.89 Favored 'General case' 0 C--O 1.194 -1.821 0 CA-C-N 117.693 0.224 . . . . 0.0 110.768 176.474 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.46 -34.58 77.48 Favored 'General case' 0 C--O 1.195 -1.779 0 O-C-N 120.712 -1.242 . . . . 0.0 111.922 172.985 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.0 -50.59 72.9 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 121.1 1.773 . . . . 0.0 112.067 174.269 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.434 ' O ' ' CD2' ' A' ' 21' ' ' HIS . 3.6 pt-20 -78.5 -36.94 44.36 Favored 'General case' 0 C--O 1.207 -1.145 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.754 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 43.2 t -71.37 -63.25 1.15 Allowed 'General case' 0 CA--C 1.503 -0.833 0 C-N-CA 125.463 1.505 . . . . 0.0 108.981 -177.863 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.49 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 10.4 t-20 -39.54 -37.92 0.54 Allowed 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 123.942 0.897 . . . . 0.0 111.768 174.771 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.2 -40.35 27.36 Favored 'General case' 0 N--CA 1.443 -0.801 0 O-C-N 124.757 1.286 . . . . 0.0 113.342 175.229 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.434 ' CD2' ' O ' ' A' ' 17' ' ' GLU . 4.6 m170 -42.44 -40.38 2.55 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.467 1.507 . . . . 0.0 109.611 178.442 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.49 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -71.16 -49.46 43.63 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-O 118.162 -0.923 . . . . 0.0 111.279 177.036 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . 0.491 ' HB2' ' CE1' ' A' ' 83' ' ' PHE . . . -35.56 131.76 0.53 Allowed Pre-proline 0 N--CA 1.441 -0.902 0 O-C-N 125.067 1.479 . . . . 0.0 112.054 174.656 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -73.01 122.1 7.83 Favored 'Trans proline' 0 N--CA 1.446 -1.319 0 C-N-CA 122.24 1.96 . . . . 0.0 110.292 -178.115 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.441 ' CD1' ' HE2' ' A' ' 115' ' ' LYS . 3.3 tp -59.51 97.84 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.658 179.057 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -179.98 166.02 1.25 Allowed 'General case' 0 C--N 1.324 -0.516 0 O-C-N 123.548 0.53 . . . . 0.0 109.943 -177.699 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -103.46 98.46 8.36 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.531 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 66.83 79.19 0.22 Allowed Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 177.714 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -151.44 27.99 0.65 Allowed 'General case' 0 CA--C 1.513 -0.443 0 O-C-N 122.012 -0.699 . . . . 0.0 110.964 178.533 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.8 p -122.47 148.62 44.92 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -175.753 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -39.72 -56.14 2.6 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 111.752 -0.539 . . . . 0.0 111.752 -179.517 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 29.4 t -69.35 -60.14 2.54 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 116.909 -1.519 . . . . 0.0 111.354 176.958 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 163.04 -56.7 0.0 OUTLIER 'General case' 0 C--O 1.223 -0.329 0 O-C-N 125.603 1.814 . . . . 0.0 110.77 178.136 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.536 ' CD1' ' HD3' ' A' ' 84' ' ' PRO . 69.1 m-85 -60.25 144.7 87.22 Favored Pre-proline 0 N--CA 1.437 -1.08 0 CA-C-O 118.051 -0.976 . . . . 0.0 113.127 178.849 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -74.92 165.05 86.91 Favored 'Cis proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.361 -1.933 . . . . 0.0 112.027 -0.53 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.445 ' CD2' ' CD1' ' A' ' 34' ' ' TYR . 1.0 OUTLIER -139.42 168.21 20.33 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 121.546 -0.721 . . . . 0.0 110.308 -178.343 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.635 ' CD1' ' CD2' ' A' ' 79' ' ' TYR . 22.7 t90 -70.31 113.72 7.74 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 179.094 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.445 ' CE1' ' HA ' ' A' ' 40' ' ' ASN . 8.5 t80 -84.71 79.44 9.6 Favored 'General case' 0 N--CA 1.427 -1.596 0 C-N-CA 124.888 1.275 . . . . 0.0 108.872 178.234 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.476 HG21 ' CE3' ' A' ' 37' ' ' TRP . 60.6 p -36.51 -38.07 0.15 Allowed 'General case' 0 C--O 1.216 -0.677 0 C-N-CA 124.439 1.095 . . . . 0.0 110.596 176.9 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.445 ' HA ' ' CE1' ' A' ' 38' ' ' PHE . 65.2 t30 69.83 7.47 6.24 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 124.099 0.959 . . . . 0.0 108.599 176.992 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 120.81 -35.37 3.72 Favored Glycine 0 N--CA 1.429 -1.811 0 CA-C-O 117.293 -1.837 . . . . 0.0 111.796 -175.705 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.41 ' CD2' ' HA2' ' A' ' 46' ' ' GLY . 60.4 m-85 -51.42 173.13 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 118.066 0.933 . . . . 0.0 110.424 -178.354 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.66 -43.01 8.11 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -179.169 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.523 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -178.29 -52.2 0.07 OUTLIER Glycine 0 C--N 1.338 0.682 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 -179.657 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.5 -90.74 0.09 Allowed 'General case' 0 C--O 1.217 -0.647 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -179.86 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . 0.41 ' HA2' ' CD2' ' A' ' 42' ' ' TYR . . . -148.93 28.75 1.27 Allowed Glycine 0 N--CA 1.443 -0.862 0 O-C-N 120.898 -1.126 . . . . 0.0 110.616 -176.362 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.3 mttp -126.06 144.28 50.79 Favored 'General case' 0 CA--C 1.501 -0.92 0 CA-C-O 117.703 -1.141 . . . . 0.0 109.115 -177.695 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.5 mt -106.46 159.12 30.91 Favored Pre-proline 0 C--N 1.319 -0.738 0 O-C-N 124.151 0.907 . . . . 0.0 109.26 -179.232 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -73.54 -175.61 2.13 Favored 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 122.954 2.436 . . . . 0.0 111.564 179.05 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.7 tptp -68.35 98.38 0.83 Allowed 'General case' 0 N--CA 1.445 -0.691 0 O-C-N 121.35 -0.844 . . . . 0.0 109.259 177.185 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.23 88.3 1.07 Allowed Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 179.042 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.32 137.93 18.75 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 119.286 -0.387 . . . . 0.0 111.294 177.347 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.9 m -128.95 103.36 18.76 Favored Pre-proline 0 C--N 1.327 -0.392 0 O-C-N 124.629 1.206 . . . . 0.0 110.225 -178.56 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -72.42 158.28 51.58 Favored 'Trans proline' 0 N--CA 1.448 -1.194 0 C-N-CA 122.226 1.95 . . . . 0.0 111.762 178.916 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.43 ' CG2' ' HB2' ' A' ' 133' ' ' LEU . 5.4 mt -77.41 123.41 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.023 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -91.12 135.69 33.6 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 179.01 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.488 ' CE2' ' SG ' ' A' ' 62' ' ' CYS . 15.3 m-85 -114.74 -52.48 2.7 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.225 179.91 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 126.9 -5.57 7.4 Favored Glycine 0 C--O 1.223 -0.585 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.853 -177.232 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.95 132.1 36.76 Favored 'General case' 0 CA--C 1.5 -0.978 0 CA-C-O 117.651 -1.166 . . . . 0.0 109.393 178.891 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 31.1 t -67.09 -9.78 43.07 Favored 'General case' 0 C--O 1.221 -0.439 0 O-C-N 125.034 1.459 . . . . 0.0 111.036 177.481 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -92.15 -49.77 6.02 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 124.032 0.933 . . . . 0.0 108.887 -179.193 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.488 ' SG ' ' CE2' ' A' ' 57' ' ' PHE . 3.9 t -75.89 -6.61 51.65 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 123.766 0.666 . . . . 0.0 111.214 175.988 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -99.94 -32.58 10.9 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.571 0.749 . . . . 0.0 110.165 177.987 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.483 ' HD3' ' CE1' ' A' ' 78' ' ' HIS . 0.0 OUTLIER -51.5 166.03 0.39 Allowed Pre-proline 0 N--CA 1.441 -0.89 0 CA-C-O 121.725 0.774 . . . . 0.0 111.018 179.913 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -72.11 135.24 24.7 Favored 'Trans proline' 0 N--CA 1.44 -1.645 0 C-N-CA 121.291 1.327 . . . . 0.0 113.865 174.959 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -71.72 171.31 16.69 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 122.529 2.153 . . . . 0.0 112.095 178.217 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.8 tptt -138.48 72.18 1.4 Allowed 'General case' 0 C--O 1.195 -1.813 0 CA-C-O 116.385 -1.769 . . . . 0.0 108.287 178.185 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.458 ' CD2' ' CD2' ' A' ' 37' ' ' TRP . 53.2 t-80 -79.4 159.36 27.11 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 119.463 1.029 . . . . 0.0 110.603 178.207 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.31 -178.35 6.02 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.78 0.8 . . . . 0.0 110.011 -179.681 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -86.37 62.98 7.75 Favored 'General case' 0 C--O 1.209 -1.039 0 O-C-N 121.299 -0.875 . . . . 0.0 110.926 178.08 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -177.6 -39.27 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.831 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 129.82 -82.88 0.33 Allowed Glycine 0 C--O 1.207 -1.573 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 -179.301 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 -115.88 53.17 0.86 Allowed 'General case' 0 C--N 1.313 -0.979 0 O-C-N 120.744 -1.445 . . . . 0.0 107.978 -177.762 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -55.8 -115.94 0.01 OUTLIER Glycine 0 C--O 1.217 -0.93 0 O-C-N 123.879 0.737 . . . . 0.0 111.9 178.172 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.9 mttm -42.73 -82.92 0.01 OUTLIER 'General case' 0 C--O 1.223 -0.311 0 O-C-N 121.443 -1.034 . . . . 0.0 110.894 179.946 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.455 ' CG2' ' O ' ' A' ' 76' ' ' THR . 0.6 OUTLIER -146.43 26.77 1.15 Allowed 'General case' 0 CA--C 1.507 -0.682 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.164 178.203 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.475 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 0.8 OUTLIER -26.54 96.52 0.01 OUTLIER 'General case' 0 C--O 1.213 -0.827 0 C-N-CA 124.231 1.012 . . . . 0.0 112.331 -178.688 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.483 ' CE1' ' HD3' ' A' ' 64' ' ' ARG . 16.5 p80 -94.71 23.77 5.17 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -173.756 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.635 ' CD2' ' CD1' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -57.51 -177.25 0.02 OUTLIER 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 174.889 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . 0.402 ' CD2' ' CG2' ' A' ' 109' ' ' ILE . 0.4 OUTLIER -100.48 149.4 23.72 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.371 175.42 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -138.42 118.92 13.83 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 124.021 0.825 . . . . 0.0 108.873 -179.027 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.511 ' CB ' ' CD1' ' A' ' 109' ' ' ILE . 0.2 OUTLIER -87.68 163.12 16.71 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-O 122.238 1.018 . . . . 0.0 111.581 178.702 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.491 ' CE1' ' HB2' ' A' ' 23' ' ' ALA . 50.9 t80 -153.11 122.13 3.22 Favored Pre-proline 0 N--CA 1.446 -0.634 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.876 -179.424 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.536 ' HD3' ' CD1' ' A' ' 34' ' ' TYR . 18.2 Cg_endo -71.93 112.09 3.32 Favored 'Trans proline' 0 N--CA 1.447 -1.21 0 C-N-CA 123.506 2.804 . . . . 0.0 110.792 -177.946 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.78 121.22 43.39 Favored 'General case' 0 CA--C 1.51 -0.574 0 O-C-N 124.139 0.899 . . . . 0.0 110.268 -179.319 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -82.11 157.7 68.13 Favored Pre-proline 0 N--CA 1.444 -0.76 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 178.725 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -75.52 -37.95 1.58 Allowed 'Trans proline' 0 CA--C 1.5 -1.176 0 C-N-CA 122.392 2.061 . . . . 0.0 112.84 179.542 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.35 -30.82 2.26 Favored 'General case' 0 C--O 1.224 -0.285 0 C-N-CA 124.902 1.281 . . . . 0.0 108.786 -179.648 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 95.91 -9.94 68.2 Favored Glycine 0 N--CA 1.431 -1.662 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 176.443 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.403 ' O ' ' CD2' ' A' ' 90' ' ' HIS . 4.1 p-80 -61.92 125.91 25.49 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.064 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.98 97.22 0.06 Allowed 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 123.12 0.568 . . . . 0.0 110.234 176.121 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.517 ' CD2' ' HB3' ' A' ' 94' ' ' PHE . 6.2 t80 -36.25 140.49 0.13 Allowed 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 121.919 0.866 . . . . 0.0 111.285 179.541 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.51 59.79 1.98 Allowed 'General case' 0 N--CA 1.444 -0.772 0 O-C-N 120.227 -1.546 . . . . 0.0 110.156 177.465 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.517 ' HB3' ' CD2' ' A' ' 92' ' ' TYR . 28.2 p90 -77.27 -8.12 57.08 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 123.443 0.697 . . . . 0.0 111.633 177.67 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.87 -33.33 13.56 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 122.166 0.984 . . . . 0.0 109.679 -179.624 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.87 104.08 11.99 Favored 'General case' 0 N--CA 1.443 -0.812 0 O-C-N 121.236 -0.915 . . . . 0.0 108.987 179.907 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.7 -49.38 77.96 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.724 178.818 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 39.1 pttt -139.22 125.79 12.56 Favored Pre-proline 0 N--CA 1.435 -1.18 0 C-N-CA 123.633 0.773 . . . . 0.0 108.975 -176.833 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -71.14 177.34 32.85 Favored 'Cis proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.376 -1.927 . . . . 0.0 111.469 -4.057 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -132.9 144.88 50.46 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 122.724 0.41 . . . . 0.0 109.988 177.48 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -95.9 152.64 18.32 Favored 'General case' 0 C--N 1.319 -0.747 0 O-C-N 124.338 1.024 . . . . 0.0 110.366 177.53 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -44.66 149.01 0.83 Allowed Pre-proline 0 N--CA 1.44 -0.948 0 O-C-N 123.926 0.766 . . . . 0.0 111.694 174.025 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -73.14 -164.88 0.21 Allowed 'Trans proline' 0 N--CA 1.446 -1.317 0 C-N-CA 122.394 2.063 . . . . 0.0 111.557 178.155 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -139.12 157.18 24.8 Favored Glycine 0 N--CA 1.443 -0.9 0 O-C-N 121.955 -0.465 . . . . 0.0 112.206 177.856 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -75.09 -75.91 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 122.806 2.338 . . . . 0.0 110.956 179.659 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.575 ' CB ' ' CE2' ' A' ' 11' ' ' TYR . . . -60.4 136.54 58.07 Favored 'General case' 0 N--CA 1.441 -0.922 0 O-C-N 123.434 0.459 . . . . 0.0 110.573 178.747 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -141.71 146.98 36.71 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.853 -178.607 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 6.6 p -83.03 125.76 40.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 O-C-N 123.719 0.637 . . . . 0.0 110.119 178.589 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.511 ' CD1' ' CB ' ' A' ' 82' ' ' GLU . 9.4 mm -104.62 140.87 21.43 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.92 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.063 179.614 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.452 ' CD1' ' HG3' ' A' ' 115' ' ' LYS . 9.7 p90 -166.12 155.48 11.69 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 121.841 0.829 . . . . 0.0 110.38 -178.944 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.4 p -90.86 160.96 15.45 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.93 -179.977 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.529 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -109.48 153.95 42.56 Favored Pre-proline 0 N--CA 1.44 -0.969 0 C-N-CA 123.055 0.542 . . . . 0.0 111.367 179.149 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.529 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 19.1 Cg_endo -73.29 -54.05 0.15 OUTLIER 'Cis proline' 0 CA--C 1.504 -1.007 0 C-N-CA 122.538 -1.859 . . . . 0.0 110.18 -5.434 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -42.36 107.36 0.08 Allowed 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 116.961 -1.495 . . . . 0.0 110.237 179.803 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.452 ' HG3' ' CD1' ' A' ' 110' ' ' TYR . 0.2 OUTLIER -64.44 76.6 0.04 OUTLIER 'General case' 0 CA--C 1.512 -0.493 0 O-C-N 125.061 1.476 . . . . 0.0 108.802 -177.621 . . . . . . . . 3 3 . 1 . 023 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 38.1 t -75.95 74.23 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 -176.516 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.513 ' CZ ' ' NE2' ' A' ' 13' ' ' GLN . 39.1 t80 -36.35 105.97 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 124.629 1.171 . . . . 0.0 110.55 179.606 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . 0.459 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 8.7 m -83.52 -46.27 12.63 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -178.771 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 162.34 -144.96 10.15 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 179.727 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.434 HG13 ' CG ' ' A' ' 4' ' ' TRP . 1.2 mm -128.72 144.67 37.34 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.091 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -176.519 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 8.6 pt -133.64 155.46 40.21 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.722 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -178.561 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.324 -0.524 0 CA-C-O 121.69 0.757 . . . . 0.0 109.953 177.711 . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 6.9 ptmm? . . . . . 0 CA--C 1.512 -0.484 0 CA-C-O 118.997 -0.525 . . . . 0.0 109.74 . . . . . . . . . 0 0 . 1 . 023 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.43 ' HB2' ' CG2' ' A' ' 55' ' ' ILE . 6.0 tp -88.39 141.77 28.27 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.237 0.96 . . . . 0.0 109.244 178.866 . . . . . . . . 2 2 . 1 . 023 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 57.5 m -67.57 -176.1 0.58 Allowed 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 121.862 0.839 . . . . 0.0 109.307 177.494 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 2.1 m -156.27 84.92 0.99 Allowed 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -178.855 . . . . . . . . 1 1 . 1 . 023 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.258 1.543 0 CA-C-O 115.151 -2.357 . . . . 0.0 112.528 173.957 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . 0.468 ' CG1' ' CD2' ' A' ' 136' ' ' HIS . 7.6 p . . . . . 0 N--CA 1.455 -0.219 0 CA-C-O 120.758 0.314 . . . . 0.0 110.257 . . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.4 m -85.94 109.13 18.54 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 125.936 1.695 . . . . 0.0 110.962 -179.493 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . 0.448 ' CD1' ' HB2' ' A' ' 13' ' ' GLN . 25.5 m95 -77.67 142.4 38.84 Favored 'General case' 0 N--CA 1.442 -0.863 0 O-C-N 121.709 -0.619 . . . . 0.0 110.164 179.546 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -131.97 134.36 45.53 Favored 'General case' 0 CA--C 1.5 -0.943 0 C-N-CA 123.204 0.602 . . . . 0.0 110.117 -176.957 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -134.07 -73.46 0.48 Allowed 'General case' 0 C--O 1.222 -0.393 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 177.367 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -80.44 42.5 2.61 Favored Glycine 0 C--O 1.211 -1.281 0 CA-C-O 117.844 -1.531 . . . . 0.0 111.373 179.905 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 64.04 12.78 50.69 Favored Glycine 0 C--O 1.22 -0.751 0 CA-C-N 119.361 1.581 . . . . 0.0 111.756 -175.067 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -114.33 149.45 36.01 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -176.119 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -105.18 125.5 51.05 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 -172.169 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.512 ' CE2' ' CB ' ' A' ' 106' ' ' ALA . 90.5 m-85 -120.27 106.96 12.41 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 124.509 1.124 . . . . 0.0 108.015 -174.076 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -54.19 116.28 2.52 Favored 'General case' 0 C--O 1.206 -1.187 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.724 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.449 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 6.3 tp-100 -54.79 -45.46 74.32 Favored 'General case' 0 C--O 1.196 -1.757 0 CA-C-O 116.429 -1.748 . . . . 0.0 111.993 178.881 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -51.0 -36.28 38.49 Favored 'General case' 0 C--O 1.189 -2.126 0 O-C-N 124.117 0.886 . . . . 0.0 110.242 175.843 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -75.59 -40.85 55.9 Favored 'General case' 0 C--O 1.197 -1.696 0 CA-C-N 121.765 2.075 . . . . 0.0 112.177 170.039 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -52.1 -35.9 49.26 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 117.463 -3.273 . . . . 0.0 113.406 171.018 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.428 ' O ' ' CD2' ' A' ' 21' ' ' HIS . 0.9 OUTLIER -94.5 -38.43 10.91 Favored 'General case' 0 C--O 1.2 -1.506 0 CA-C-O 122.657 1.218 . . . . 0.0 108.009 178.275 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 26.1 t -73.22 -58.49 3.27 Favored 'General case' 0 C--O 1.201 -1.467 1 O-C-N 115.447 -4.533 . . . . 0.0 106.838 -177.306 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.501 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 1.3 t-20 -50.46 -27.92 7.37 Favored 'General case' 0 C--N 1.311 -1.076 0 O-C-N 117.733 -3.104 . . . . 0.0 113.391 173.167 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.0 p -86.98 -16.95 34.26 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 123.629 0.581 . . . . 0.0 112.527 175.191 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.428 ' CD2' ' O ' ' A' ' 17' ' ' GLU . 7.5 m170 -66.19 -39.5 89.73 Favored 'General case' 0 C--O 1.215 -0.719 0 C-N-CA 124.973 1.309 . . . . 0.0 107.881 179.773 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.501 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -75.47 -41.78 54.75 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 116.647 -1.644 . . . . 0.0 109.269 -178.519 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -40.31 130.07 1.7 Allowed Pre-proline 0 N--CA 1.443 -0.778 0 O-C-N 126.649 2.468 . . . . 0.0 111.943 177.764 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . 0.435 ' HD2' ' CD ' ' A' ' 35' ' ' PRO . 14.5 Cg_endo -72.73 115.02 4.18 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 122.103 1.868 . . . . 0.0 109.83 -176.133 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.476 ' CD1' ' HE2' ' A' ' 115' ' ' LYS . 2.5 tp -56.14 100.28 0.04 OUTLIER 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 123.272 0.629 . . . . 0.0 111.225 178.711 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -167.72 166.27 13.86 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.788 0.804 . . . . 0.0 109.453 -177.195 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.451 ' HB2' ' CE1' ' A' ' 79' ' ' TYR . 5.8 t0 -100.42 73.3 1.65 Allowed 'General case' 0 CA--C 1.548 0.87 0 CA-C-O 124.048 1.88 . . . . 0.0 107.104 179.014 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.58 86.03 0.57 Allowed Glycine 0 N--CA 1.448 -0.503 0 O-C-N 118.816 -2.427 . . . . 0.0 109.36 176.504 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.14 33.52 0.58 Allowed 'General case' 0 CA--C 1.514 -0.425 0 O-C-N 121.205 -1.174 . . . . 0.0 111.23 177.204 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 55.3 p -129.73 143.85 51.01 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -175.927 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -38.08 -67.79 0.48 Allowed Glycine 0 C--N 1.338 0.642 0 O-C-N 124.117 0.885 . . . . 0.0 112.979 -178.552 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 32.2 t -51.86 -66.38 0.39 Allowed 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 115.744 -2.074 . . . . 0.0 110.554 174.328 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.2 p 167.44 -56.42 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.418 0 O-C-N 126.927 2.642 . . . . 0.0 111.256 179.895 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.488 ' CD2' ' HD3' ' A' ' 84' ' ' PRO . 32.3 m-85 -69.27 150.03 97.32 Favored Pre-proline 0 N--CA 1.429 -1.478 0 CA-C-O 116.494 -1.717 . . . . 0.0 112.708 178.995 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.435 ' CD ' ' HD2' ' A' ' 24' ' ' PRO . 37.5 Cg_endo -72.24 138.56 55.03 Favored 'Cis proline' 0 N--CA 1.442 -1.519 0 C-N-CA 121.281 -2.383 . . . . 0.0 112.264 -4.602 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.415 ' O ' HD11 ' A' ' 81' ' ' LEU . 0.7 OUTLIER -128.94 150.6 50.31 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-O 116.91 -1.519 . . . . 0.0 113.781 173.44 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.531 ' CD1' ' HB2' ' A' ' 79' ' ' TYR . 19.1 t90 -44.42 151.85 0.23 Allowed 'General case' 0 C--O 1.237 0.428 0 CA-C-O 122.577 1.179 . . . . 0.0 110.872 176.305 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.518 ' CZ ' ' CD1' ' A' ' 121' ' ' ILE . 3.0 t80 -127.87 79.64 1.91 Allowed 'General case' 0 N--CA 1.417 -2.089 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 -172.921 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.422 ' CG2' ' CH2' ' A' ' 37' ' ' TRP . 38.1 p -36.96 -39.51 0.23 Allowed 'General case' 0 C--O 1.205 -1.288 0 C-N-CA 125.388 1.475 . . . . 0.0 110.506 173.773 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.504 ' HA ' ' CE1' ' A' ' 38' ' ' PHE . 43.5 t30 59.14 17.42 5.58 Favored 'General case' 0 C--O 1.206 -1.211 0 CA-C-N 120.426 1.466 . . . . 0.0 107.39 173.154 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 113.09 -45.84 1.26 Allowed Glycine 0 N--CA 1.428 -1.851 0 O-C-N 118.716 -2.49 . . . . 0.0 113.321 -170.639 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.404 ' CZ ' ' HD3' ' A' ' 66' ' ' PRO . 83.3 m-85 -45.21 153.61 0.2 Allowed 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.318 1.047 . . . . 0.0 111.942 178.097 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.09 -36.38 24.92 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.14 178.593 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 126.56 42.16 0.3 Allowed Glycine 0 C--N 1.341 0.819 0 C-N-CA 123.922 0.773 . . . . 0.0 111.299 -177.296 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -146.64 -69.64 0.25 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.294 179.707 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -146.43 -73.49 0.02 OUTLIER Glycine 0 C--O 1.195 -2.287 0 N-CA-C 107.591 -2.204 . . . . 0.0 107.591 -176.192 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.5 ptpt -100.96 -165.33 1.19 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 120.468 2.134 . . . . 0.0 110.35 178.638 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -113.35 174.12 2.49 Favored Pre-proline 0 N--CA 1.438 -1.041 0 C-N-CA 123.623 0.769 . . . . 0.0 110.028 -178.93 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.27 156.91 46.22 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.362 2.041 . . . . 0.0 110.855 179.426 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.71 98.1 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.301 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.31 55.83 0.24 Allowed Glycine 0 CA--C 1.507 -0.442 0 CA-C-O 118.345 -1.253 . . . . 0.0 111.889 -178.318 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.3 mmt180 -149.79 143.07 25.15 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-N 117.671 0.735 . . . . 0.0 110.811 177.055 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.1 m -131.45 96.74 20.67 Favored Pre-proline 0 C--N 1.324 -0.531 0 O-C-N 124.318 1.011 . . . . 0.0 110.352 -178.628 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -72.36 173.23 13.44 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 122.022 1.814 . . . . 0.0 111.723 179.267 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.423 ' O ' ' CE1' ' A' ' 57' ' ' PHE . 8.4 mt -86.53 111.62 21.69 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.076 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 -176.348 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.23 137.49 36.66 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 120.617 -1.302 . . . . 0.0 108.703 178.922 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.491 ' CG ' ' SG ' ' A' ' 118' ' ' CYS . 3.0 m-85 -118.5 -52.79 2.35 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.628 -179.999 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 128.73 -9.95 6.39 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 123.48 0.562 . . . . 0.0 111.722 -176.74 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 15.2 mmtt -69.08 170.57 9.71 Favored 'General case' 0 C--O 1.197 -1.692 0 CA-C-O 118.217 -0.897 . . . . 0.0 111.127 177.16 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.4 m -101.69 -47.54 4.59 Favored 'General case' 0 C--O 1.19 -2.027 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.596 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.29 -40.92 64.17 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-N 120.888 1.676 . . . . 0.0 108.974 178.698 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.488 ' SG ' ' CD1' ' A' ' 57' ' ' PHE . 11.0 t -71.84 -14.58 62.0 Favored 'General case' 0 C--N 1.348 0.533 0 O-C-N 123.468 0.48 . . . . 0.0 110.138 178.198 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -95.62 -32.75 12.65 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 174.693 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.94 168.36 0.43 Allowed Pre-proline 0 N--CA 1.429 -1.493 0 CA-C-O 122.349 1.071 . . . . 0.0 108.674 -177.635 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -72.71 124.7 9.94 Favored 'Trans proline' 0 N--CA 1.438 -1.768 0 C-N-CA 121.068 1.179 . . . . 0.0 115.13 172.123 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.404 ' HD3' ' CZ ' ' A' ' 42' ' ' TYR . 18.6 Cg_endo -72.04 164.15 36.55 Favored 'Trans proline' 0 CA--C 1.502 -1.111 0 C-N-CA 123.595 2.863 . . . . 0.0 111.802 179.614 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 8.2 tptt -126.06 130.38 51.02 Favored 'General case' 0 C--O 1.205 -1.273 0 CA-C-O 117.329 -1.319 . . . . 0.0 108.382 178.951 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 41.4 t-80 -122.6 161.5 23.62 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 119.226 0.921 . . . . 0.0 110.214 174.612 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.6 179.08 8.92 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.2 179.223 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.8 mptt -84.82 69.18 10.69 Favored 'General case' 0 C--O 1.215 -0.757 0 O-C-N 121.828 -0.545 . . . . 0.0 111.422 177.146 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -176.94 -41.36 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.223 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.443 ' CA ' ' HB3' ' A' ' 27' ' ' ASP . . . 122.07 -63.9 0.51 Allowed Glycine 0 N--CA 1.442 -0.958 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -179.061 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . 0.408 ' ND2' ' N ' ' A' ' 73' ' ' ASN . 0.1 OUTLIER -133.98 56.74 1.83 Allowed 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 -173.06 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.96 -109.73 0.01 OUTLIER Glycine 0 C--O 1.215 -1.035 0 CA-C-O 121.998 0.777 . . . . 0.0 111.583 179.412 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 19.8 mttt -60.98 -98.82 0.0 OUTLIER 'General case' 0 C--O 1.214 -0.794 0 O-C-N 120.017 -1.872 . . . . 0.0 109.941 179.374 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.449 ' CG2' ' O ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -120.94 15.66 11.67 Favored 'General case' 0 CA--C 1.493 -1.226 0 O-C-N 119.331 -2.105 . . . . 0.0 110.611 -179.241 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.433 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 1.3 m-20 -24.3 95.56 0.01 OUTLIER 'General case' 0 C--O 1.197 -1.689 0 C-N-CA 126.768 2.027 . . . . 0.0 112.948 -176.615 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.455 ' H ' ' CD2' ' A' ' 78' ' ' HIS . 6.4 p80 -88.98 60.45 5.46 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 -167.929 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.531 ' HB2' ' CD1' ' A' ' 37' ' ' TRP . 52.0 p90 -91.11 136.78 32.85 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 124.672 1.189 . . . . 0.0 111.602 -178.446 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.5 mt -67.31 128.88 38.06 Favored 'General case' 0 C--O 1.205 -1.281 0 CA-C-O 117.481 -1.247 . . . . 0.0 109.271 178.811 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.415 HD11 ' O ' ' A' ' 36' ' ' HIS . 0.2 OUTLIER -121.28 135.03 55.17 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 121.025 1.739 . . . . 0.0 107.329 178.608 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.432 ' CB ' ' CD1' ' A' ' 109' ' ' ILE . 0.1 OUTLIER -101.56 166.09 10.89 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-O 123.168 1.461 . . . . 0.0 114.503 171.218 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.478 ' CD1' ' HD2' ' A' ' 84' ' ' PRO . 52.2 t80 -146.3 131.82 9.26 Favored Pre-proline 0 CA--C 1.498 -1.024 0 O-C-N 117.823 -3.048 . . . . 0.0 113.115 179.462 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.5 ' O ' ' CE2' ' A' ' 92' ' ' TYR . 19.3 Cg_endo -72.98 106.18 2.1 Favored 'Trans proline' 0 CA--C 1.473 -2.554 0 C-N-CA 124.645 3.563 . . . . 0.0 110.583 -175.698 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.497 ' HA ' ' CZ ' ' A' ' 92' ' ' TYR . 0.6 OUTLIER -100.73 121.01 40.94 Favored 'General case' 0 CA--C 1.49 -1.332 0 O-C-N 125.613 1.82 . . . . 0.0 112.36 -179.306 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.597 ' CD1' ' CD1' ' A' ' 92' ' ' TYR . 13.8 m-85 -85.19 162.66 48.3 Favored Pre-proline 0 N--CA 1.44 -0.963 0 CA-C-N 120.475 1.489 . . . . 0.0 111.179 -179.423 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -77.77 -44.34 0.18 Allowed 'Trans proline' 0 CA--C 1.516 -0.386 0 C-N-CA 122.161 1.907 . . . . 0.0 112.431 179.605 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -48.62 -26.4 2.23 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 125.279 1.612 . . . . 0.0 110.913 174.446 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.92 17.64 80.2 Favored Glycine 0 N--CA 1.431 -1.676 0 CA-C-O 117.39 -1.783 . . . . 0.0 109.706 179.592 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.419 ' O ' ' CE1' ' A' ' 92' ' ' TYR . 1.0 OUTLIER -82.74 147.52 28.39 Favored 'General case' 0 C--O 1.182 -2.454 0 CA-C-O 116.929 -1.51 . . . . 0.0 110.359 -179.593 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -62.09 134.39 56.54 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 123.54 2.882 . . . . 0.0 111.831 176.173 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.597 ' CD1' ' CD1' ' A' ' 86' ' ' PHE . 0.2 OUTLIER -93.6 136.48 33.83 Favored 'General case' 0 C--O 1.202 -1.399 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 -173.21 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.39 61.24 0.47 Allowed 'General case' 0 C--N 1.318 -0.778 0 O-C-N 119.769 -1.832 . . . . 0.0 111.029 175.075 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.428 ' CD2' ' HZ ' ' A' ' 83' ' ' PHE . 1.5 p90 -74.95 -23.96 58.39 Favored 'General case' 0 N--CA 1.426 -1.651 0 C-N-CA 126.401 1.88 . . . . 0.0 109.581 179.749 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.56 -31.49 21.19 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 -178.844 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.9 t -82.38 104.74 12.9 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 -177.61 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 32.6 pttt -58.27 -50.71 72.63 Favored 'General case' 0 C--O 1.227 -0.126 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 179.241 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.4 mttp -137.41 124.88 14.04 Favored Pre-proline 0 N--CA 1.438 -1.027 0 C-N-CA 124.787 1.235 . . . . 0.0 109.095 -173.719 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -73.26 175.01 47.31 Favored 'Cis proline' 0 CA--C 1.54 0.822 0 O-C-N 124.934 2.018 . . . . 0.0 111.564 -2.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.6 tttp -137.6 117.5 13.26 Favored 'General case' 0 C--O 1.22 -0.467 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.152 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -72.54 154.3 40.88 Favored 'General case' 0 C--O 1.253 1.243 0 O-C-N 124.62 1.2 . . . . 0.0 110.32 176.918 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -48.43 124.55 11.73 Favored Pre-proline 0 N--CA 1.438 -1.07 0 C-N-CA 125.113 1.365 . . . . 0.0 112.105 172.758 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -70.3 -164.95 0.15 Allowed 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 122.691 2.261 . . . . 0.0 112.125 177.681 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -134.73 158.66 23.59 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.561 177.288 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -76.07 -61.76 0.03 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.72 2.28 . . . . 0.0 110.109 179.9 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.512 ' CB ' ' CE2' ' A' ' 11' ' ' TYR . . . -58.78 133.34 55.88 Favored 'General case' 0 N--CA 1.432 -1.328 0 O-C-N 124.653 1.22 . . . . 0.0 111.938 178.015 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.434 ' HG2' ' HA ' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -141.23 146.9 37.46 Favored 'General case' 0 CA--C 1.496 -1.11 0 O-C-N 124.632 1.208 . . . . 0.0 111.817 -178.489 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.7 p -80.5 126.1 39.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.423 0.63 . . . . 0.0 110.407 178.839 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . 0.432 ' CD1' ' CB ' ' A' ' 82' ' ' GLU . 24.5 mm -100.28 147.24 7.86 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.229 0 O-C-N 121.227 -0.921 . . . . 0.0 110.361 179.008 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.472 ' CD1' ' HG3' ' A' ' 115' ' ' LYS . 11.4 p90 -176.76 148.14 0.66 Allowed 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 124.408 2.052 . . . . 0.0 110.131 -177.624 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 7.0 p -81.55 167.69 19.02 Favored 'General case' 0 C--N 1.311 -1.075 0 O-C-N 120.207 -1.558 . . . . 0.0 108.947 -177.612 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.464 ' C ' ' CD1' ' A' ' 112' ' ' TYR . 0.1 OUTLIER -116.2 152.56 47.99 Favored Pre-proline 0 N--CA 1.432 -1.34 0 C-N-CA 123.938 0.895 . . . . 0.0 109.892 179.875 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.422 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 15.6 Cg_endo -72.7 -44.03 0.61 Allowed 'Cis proline' 0 CA--C 1.516 -0.413 0 C-N-CA 122.076 -2.052 . . . . 0.0 109.378 -9.213 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 43.4 m-20 -46.84 106.98 0.09 Allowed 'General case' 0 CA--C 1.49 -1.337 0 CA-C-O 113.631 -3.08 . . . . 0.0 109.816 -179.382 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.476 ' HE2' ' CD1' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -68.31 72.27 0.2 Allowed 'General case' 0 CA--C 1.501 -0.918 0 O-C-N 127.457 2.973 . . . . 0.0 107.03 -175.787 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.6 t -74.08 70.16 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 -177.133 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.449 ' CZ ' ' NE2' ' A' ' 13' ' ' GLN . 54.6 t80 -37.17 100.8 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 126.064 1.746 . . . . 0.0 110.732 178.831 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . 0.491 ' SG ' ' CG ' ' A' ' 57' ' ' PHE . 0.1 OUTLIER -81.43 -39.53 24.76 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 -178.235 . . . . . . . . 3 3 . 1 . 024 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 159.82 -146.86 13.36 Favored Glycine 0 N--CA 1.441 -1.02 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 -179.734 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -129.61 149.0 33.22 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.672 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 -172.923 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . 0.518 ' CD1' ' CZ ' ' A' ' 38' ' ' PHE . 7.2 pt -138.23 154.69 28.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 120.304 1.411 . . . . 0.0 108.293 -178.177 . . . . . . . . 2 2 . 1 . 024 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.32 -0.685 0 CA-C-O 122.338 1.066 . . . . 0.0 110.021 176.867 . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 9.2 ptpt . . . . . 0 CA--C 1.511 -0.529 0 CA-C-O 117.448 -1.263 . . . . 0.0 110.608 . . . . . . . . . 0 0 . 1 . 024 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 12.2 tp -82.28 139.71 34.03 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.807 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 73.3 m -67.28 -172.83 0.24 Allowed 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 124.072 0.949 . . . . 0.0 109.363 176.833 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 61.1 m -162.05 114.33 1.72 Allowed 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 117.056 -1.449 . . . . 0.0 107.835 -179.624 . . . . . . . . 1 1 . 1 . 024 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 0.468 ' CD2' ' CG1' ' A' ' 2' ' ' VAL . 2.4 m80 . . . . . 0 C--O 1.277 2.515 0 CA-C-O 113.525 -3.131 . . . . 0.0 113.22 176.206 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.1 p . . . . . 0 C--O 1.24 0.565 0 CA-C-O 121.271 0.557 . . . . 0.0 110.188 . . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.2 m -94.51 121.34 35.95 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -174.581 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 4' ' ' TRP . . . . . 0.436 ' CD1' ' HB2' ' A' ' 13' ' ' GLN . 24.2 m95 -79.36 140.53 37.45 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.271 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -128.56 134.48 48.64 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -178.079 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 8.4 m -123.1 -71.46 0.72 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.689 178.868 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -86.27 32.26 3.9 Favored Glycine 0 C--O 1.221 -0.685 0 CA-C-O 119.773 -0.459 . . . . 0.0 111.996 176.906 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 82.53 -13.03 43.53 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-N 117.491 0.646 . . . . 0.0 112.854 -175.164 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.66 139.99 29.97 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -177.685 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.0 mp -86.22 135.09 33.7 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 124.032 0.832 . . . . 0.0 109.455 -178.589 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 11' ' ' TYR . . . . . 0.533 ' CE2' ' CB ' ' A' ' 106' ' ' ALA . 60.4 m-85 -124.06 105.84 9.88 Favored 'General case' 0 CA--C 1.506 -0.717 0 C-N-CA 125.539 1.536 . . . . 0.0 109.554 -175.14 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.79 112.97 1.46 Allowed 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -179.328 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 13' ' ' GLN . . . . . 0.455 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 6.1 tp-100 -51.2 -48.68 61.94 Favored 'General case' 0 C--O 1.214 -0.792 0 C-N-CA 119.586 -0.846 . . . . 0.0 111.91 -179.024 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -49.2 -39.8 31.09 Favored 'General case' 0 C--O 1.197 -1.669 0 O-C-N 124.162 0.913 . . . . 0.0 111.263 176.862 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -71.59 -38.89 70.84 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-N 118.755 0.707 . . . . 0.0 112.904 171.217 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -53.67 -39.14 64.85 Favored 'General case' 0 C--O 1.215 -0.741 0 CA-C-N 119.87 1.213 . . . . 0.0 111.99 173.409 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 17' ' ' GLU . . . . . 0.456 ' O ' ' CD2' ' A' ' 21' ' ' HIS . 6.0 pt-20 -90.38 -38.78 13.09 Favored 'General case' 0 C--O 1.221 -0.431 0 C-N-CA 123.802 0.841 . . . . 0.0 110.809 176.228 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.7 t -75.05 -60.12 2.43 Favored 'General case' 0 CA--C 1.506 -0.747 0 O-C-N 119.716 -1.865 . . . . 0.0 109.557 -176.508 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 19' ' ' ASN . . . . . 0.502 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -48.39 -29.45 4.02 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 171.062 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 31.7 p -85.19 -24.66 27.8 Favored 'General case' 0 C--O 1.221 -0.432 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 175.413 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 21' ' ' HIS . . . . . 0.456 ' CD2' ' O ' ' A' ' 17' ' ' GLU . 10.2 m170 -57.13 -35.97 70.12 Favored 'General case' 0 C--O 1.222 -0.351 0 C-N-CA 124.156 0.982 . . . . 0.0 109.217 178.061 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 22' ' ' HIS . . . . . 0.502 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.1 OUTLIER -71.69 -42.13 67.8 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 118.566 -0.731 . . . . 0.0 110.138 179.901 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -39.99 133.77 1.43 Allowed Pre-proline 0 N--CA 1.443 -0.793 0 O-C-N 125.189 1.555 . . . . 0.0 111.124 176.505 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -72.61 119.36 6.06 Favored 'Trans proline' 0 N--CA 1.443 -1.442 0 C-N-CA 122.1 1.867 . . . . 0.0 108.55 -177.8 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 25' ' ' LEU . . . . . 0.43 ' CD2' ' HE2' ' A' ' 115' ' ' LYS . 3.4 tp -60.58 84.19 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.284 1.033 . . . . 0.0 111.266 177.885 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.4 m -165.89 147.24 6.94 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.291 -174.682 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 27' ' ' ASP . . . . . 0.433 ' HB3' ' CA ' ' A' ' 72' ' ' GLY . 2.7 t0 -78.89 85.66 4.84 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 -178.843 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.68 86.31 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 177.812 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.2 mmtt -150.49 44.68 0.86 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.934 0.873 . . . . 0.0 111.615 178.749 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.2 p -130.64 -170.77 2.41 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.55 -174.695 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -83.82 -55.23 2.86 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.706 177.446 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -76.05 9.56 2.4 Favored 'General case' 0 CA--C 1.514 -0.415 0 O-C-N 122.136 -0.626 . . . . 0.0 112.336 177.854 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.1 p 89.83 -58.45 0.02 OUTLIER 'General case' 0 CA--C 1.503 -0.855 0 C-N-CA 127.17 2.188 . . . . 0.0 109.258 -179.782 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 34' ' ' TYR . . . . . 0.471 ' CG ' ' HG3' ' A' ' 84' ' ' PRO . 85.9 m-85 -59.38 142.82 86.38 Favored Pre-proline 0 N--CA 1.437 -1.08 0 O-C-N 125.826 1.953 . . . . 0.0 112.768 -176.914 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 35' ' ' PRO . . . . . 0.428 ' HB2' ' CG ' ' A' ' 81' ' ' LEU . 36.0 Cg_endo -76.48 -172.69 11.47 Favored 'Cis proline' 0 N--CA 1.438 -1.764 0 C-N-CA 122.66 -1.808 . . . . 0.0 111.521 0.577 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 36' ' ' HIS . . . . . 0.429 ' CD2' ' N ' ' A' ' 36' ' ' HIS . 0.3 OUTLIER -159.62 159.75 33.5 Favored 'General case' 0 CA--C 1.502 -0.886 0 O-C-N 120.774 -1.204 . . . . 0.0 110.101 -178.68 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 37' ' ' TRP . . . . . 0.563 ' CD1' ' HB2' ' A' ' 79' ' ' TYR . 10.3 t90 -69.6 134.35 48.67 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-O 122.796 1.284 . . . . 0.0 110.044 175.458 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 38' ' ' PHE . . . . . 0.456 ' CZ ' ' HA ' ' A' ' 40' ' ' ASN . 14.0 t80 -97.63 97.59 9.16 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 178.939 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 39' ' ' THR . . . . . 0.412 ' HA ' ' CZ2' ' A' ' 37' ' ' TRP . 77.4 p -36.14 -35.18 0.07 Allowed 'General case' 0 C--O 1.208 -1.124 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.873 173.489 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 40' ' ' ASN . . . . . 0.456 ' HA ' ' CZ ' ' A' ' 38' ' ' PHE . 4.1 t-20 65.97 11.65 7.87 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 123.926 0.89 . . . . 0.0 110.631 179.717 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 41' ' ' GLY . . . . . 0.464 ' CA ' ' HD3' ' A' ' 52' ' ' ARG . . . 97.7 4.08 58.12 Favored Glycine 0 CA--C 1.536 1.384 0 N-CA-C 114.364 0.506 . . . . 0.0 114.364 -169.939 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 42' ' ' TYR . . . . . 0.52 ' CD2' ' HA ' ' A' ' 47' ' ' LYS . 2.6 m-85 -99.0 165.61 11.67 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 124.103 0.961 . . . . 0.0 109.339 -177.456 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.3 -34.88 25.62 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.625 176.911 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 44' ' ' GLY . . . . . 0.513 ' HA2' ' CZ2' ' A' ' 37' ' ' TRP . . . 173.24 -62.3 0.13 Allowed Glycine 0 C--N 1.335 0.489 0 C-N-CA 124.008 0.813 . . . . 0.0 112.06 -178.285 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -111.42 -61.81 1.64 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 122.607 1.194 . . . . 0.0 110.356 179.671 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.16 161.12 6.91 Favored Glycine 0 C--N 1.34 0.797 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.228 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 47' ' ' LYS . . . . . 0.52 ' HA ' ' CD2' ' A' ' 42' ' ' TYR . 8.5 ptpt -56.98 -163.14 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 122.998 1.38 . . . . 0.0 112.033 175.732 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 48' ' ' LEU . . . . . 0.475 HD13 ' CE1' ' A' ' 42' ' ' TYR . 4.0 mp -81.35 155.25 71.87 Favored Pre-proline 0 N--CA 1.44 -0.931 0 O-C-N 121.068 -1.02 . . . . 0.0 111.041 178.107 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -71.2 159.4 52.14 Favored 'Trans proline' 0 N--CA 1.444 -1.394 0 C-N-CA 121.947 1.765 . . . . 0.0 110.266 178.45 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -53.11 97.77 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.263 0.625 . . . . 0.0 110.083 177.274 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.26 79.19 0.95 Allowed Glycine 0 CA--C 1.517 0.191 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.184 -176.146 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 52' ' ' ARG . . . . . 0.464 ' HD3' ' CA ' ' A' ' 41' ' ' GLY . 0.0 OUTLIER -174.83 157.31 2.42 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 123.891 0.876 . . . . 0.0 110.733 175.547 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.2 m -141.47 108.76 6.15 Favored Pre-proline 0 C--N 1.328 -0.347 0 O-C-N 123.972 0.795 . . . . 0.0 109.829 -179.91 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -72.53 179.12 5.43 Favored 'Trans proline' 0 N--CA 1.447 -1.226 0 C-N-CA 122.479 2.119 . . . . 0.0 111.619 177.338 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 55' ' ' ILE . . . . . 0.411 ' CG2' ' HB2' ' A' ' 133' ' ' LEU . 5.2 mt -90.16 124.76 42.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.788 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.18 134.65 35.66 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.675 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 57' ' ' PHE . . . . . 0.459 ' CD1' ' HB3' ' A' ' 118' ' ' CYS . 40.1 m-85 -114.33 -47.83 2.91 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 123.494 0.718 . . . . 0.0 110.642 179.43 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 121.66 -1.81 11.12 Favored Glycine 0 C--O 1.223 -0.54 0 C-N-CA 123.767 0.698 . . . . 0.0 112.514 -176.36 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.5 mttm -103.24 145.53 29.8 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 117.74 0.77 . . . . 0.0 109.588 177.537 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 30.4 t -79.13 -9.16 59.48 Favored 'General case' 0 C--O 1.222 -0.374 0 O-C-N 124.794 1.309 . . . . 0.0 111.309 176.784 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -89.04 -48.99 7.03 Favored 'General case' 0 CA--C 1.515 -0.375 0 C-N-CA 123.788 0.835 . . . . 0.0 109.797 179.995 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 62' ' ' CYS . . . . . 0.442 ' SG ' ' CE2' ' A' ' 57' ' ' PHE . 1.4 t -72.91 -17.04 61.54 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 123.739 0.649 . . . . 0.0 111.814 175.871 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -86.43 -33.13 20.52 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-O 122.009 0.909 . . . . 0.0 111.295 174.422 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 64' ' ' ARG . . . . . 0.505 ' HD3' ' CE1' ' A' ' 78' ' ' HIS . 0.0 OUTLIER -57.27 158.99 9.09 Favored Pre-proline 0 N--CA 1.445 -0.691 0 O-C-N 121.369 -0.832 . . . . 0.0 111.343 179.492 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -71.14 140.09 36.86 Favored 'Trans proline' 0 N--CA 1.442 -1.5 0 C-N-CA 120.763 0.975 . . . . 0.0 113.74 174.365 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 66' ' ' PRO . . . . . 0.477 ' HD2' ' CD2' ' A' ' 42' ' ' TYR . 22.8 Cg_endo -70.77 169.88 19.13 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 123.482 2.788 . . . . 0.0 112.238 177.058 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -133.37 49.95 2.26 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 179.224 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 68' ' ' HIS . . . . . 0.454 ' HA ' ' OD2' ' A' ' 77' ' ' ASP . 25.1 t-80 -73.92 156.97 37.09 Favored 'General case' 0 C--O 1.22 -0.459 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.588 -177.536 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 69' ' ' SER . . . . . 0.443 ' O ' ' CE1' ' A' ' 68' ' ' HIS . 1.5 p -148.22 -160.05 1.12 Allowed 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 122.287 1.041 . . . . 0.0 111.3 177.169 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.59 75.64 9.49 Favored 'General case' 0 C--O 1.217 -0.625 0 O-C-N 120.259 -1.526 . . . . 0.0 111.722 172.148 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -177.22 -44.59 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.271 0.628 . . . . 0.0 109.958 177.6 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 72' ' ' GLY . . . . . 0.433 ' CA ' ' HB3' ' A' ' 27' ' ' ASP . . . 109.17 -54.46 0.55 Allowed Glycine 0 C--O 1.212 -1.239 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.912 -178.458 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -133.87 65.65 1.57 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 -179.574 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.44 -126.63 0.01 OUTLIER Glycine 0 CA--C 1.525 0.718 0 CA-C-O 121.94 0.745 . . . . 0.0 111.492 179.447 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.8 mttt -58.2 -92.66 0.0 OUTLIER 'General case' 0 C--O 1.221 -0.444 0 O-C-N 120.738 -1.448 . . . . 0.0 112.311 178.132 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 76' ' ' THR . . . . . 0.415 ' O ' ' C ' ' A' ' 77' ' ' ASP . 0.5 OUTLIER -115.86 15.99 16.27 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-O 118.307 -0.854 . . . . 0.0 110.427 177.473 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 77' ' ' ASP . . . . . 0.505 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 20.1 t0 -29.11 102.06 0.02 OUTLIER 'General case' 0 C--O 1.212 -0.897 0 O-C-N 123.979 0.799 . . . . 0.0 110.99 -179.566 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 78' ' ' HIS . . . . . 0.505 ' CE1' ' HD3' ' A' ' 64' ' ' ARG . 5.7 p80 -87.55 64.18 7.98 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -176.016 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 79' ' ' TYR . . . . . 0.563 ' HB2' ' CD1' ' A' ' 37' ' ' TRP . 34.4 p90 -90.29 136.56 32.98 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 124.242 1.017 . . . . 0.0 109.527 -178.128 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.44 142.51 44.92 Favored 'General case' 0 C--O 1.216 -0.697 0 C-N-CA 119.758 -0.777 . . . . 0.0 109.225 176.22 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 81' ' ' LEU . . . . . 0.497 HD21 ' CZ ' ' A' ' 110' ' ' TYR . 1.1 tt -134.66 144.07 47.62 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 176.338 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 82' ' ' GLU . . . . . 0.409 ' CG ' ' HE2' ' A' ' 36' ' ' HIS . 6.1 pm0 -109.35 165.62 11.49 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 123.547 0.739 . . . . 0.0 111.429 -179.694 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 83' ' ' PHE . . . . . 0.524 ' CD1' ' HD2' ' A' ' 84' ' ' PRO . 36.7 t80 -148.93 135.23 10.12 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 117.795 -1.098 . . . . 0.0 112.444 -179.186 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 84' ' ' PRO . . . . . 0.524 ' HD2' ' CD1' ' A' ' 83' ' ' PHE . 19.1 Cg_endo -70.73 88.67 0.64 Allowed 'Trans proline' 0 CA--C 1.501 -1.152 0 C-N-CA 124.513 3.475 . . . . 0.0 110.679 -176.015 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 85' ' ' THR . . . . . 0.463 ' HA ' ' CZ ' ' A' ' 92' ' ' TYR . 1.2 t -86.71 115.92 24.47 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 124.411 1.07 . . . . 0.0 111.958 179.741 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 86' ' ' PHE . . . . . 0.617 ' CD1' ' CD1' ' A' ' 92' ' ' TYR . 18.2 m-85 -83.67 160.42 58.78 Favored Pre-proline 0 N--CA 1.45 -0.473 0 C-N-CA 123.193 0.597 . . . . 0.0 111.525 -179.877 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.05 -44.54 0.33 Allowed 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 122.189 1.926 . . . . 0.0 111.748 179.041 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -52.21 -28.38 18.22 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 122.992 1.377 . . . . 0.0 110.031 177.89 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.1 -14.14 40.53 Favored Glycine 0 N--CA 1.438 -1.227 0 CA-C-O 118.23 -1.317 . . . . 0.0 111.809 -179.023 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 90' ' ' HIS . . . . . 0.425 ' O ' ' CE1' ' A' ' 92' ' ' TYR . 1.6 p-80 -48.69 143.22 5.36 Favored 'General case' 0 C--O 1.213 -0.838 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.425 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -63.64 137.66 58.18 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.793 0.806 . . . . 0.0 111.736 177.32 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 92' ' ' TYR . . . . . 0.617 ' CD1' ' CD1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -94.86 148.5 22.24 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 -174.876 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -84.4 68.62 10.31 Favored 'General case' 0 C--N 1.321 -0.649 0 O-C-N 121.272 -0.893 . . . . 0.0 109.564 176.079 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 94' ' ' PHE . . . . . 0.422 ' CD2' ' O ' ' A' ' 92' ' ' TYR . 30.7 p90 -83.4 -16.15 46.99 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.583 177.465 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.8 -30.87 17.68 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 123.82 0.848 . . . . 0.0 110.448 178.55 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.0 t -90.91 110.29 21.52 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -177.014 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.52 -46.1 91.38 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-O 120.958 0.409 . . . . 0.0 110.347 179.723 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 98' ' ' LYS . . . . . 0.403 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 6.6 mttm -141.07 128.46 11.98 Favored Pre-proline 0 N--CA 1.438 -1.04 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.962 -178.251 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 99' ' ' PRO . . . . . 0.403 ' C ' ' HA ' ' A' ' 98' ' ' LYS . 20.0 Cg_endo -70.05 176.86 31.71 Favored 'Cis proline' 0 N--CA 1.458 -0.602 0 O-C-N 124.579 1.831 . . . . 0.0 111.472 -3.802 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.03 152.34 48.76 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 123.515 0.726 . . . . 0.0 109.891 177.731 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -104.13 146.37 28.84 Favored 'General case' 0 C--N 1.321 -0.656 0 O-C-N 124.327 1.017 . . . . 0.0 108.767 -179.875 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -56.23 120.26 33.64 Favored Pre-proline 0 N--CA 1.445 -0.706 0 CA-C-O 118.095 -0.955 . . . . 0.0 110.792 177.353 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -71.6 -163.22 0.13 Allowed 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 122.723 2.282 . . . . 0.0 111.753 178.303 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -142.5 172.29 24.38 Favored Glycine 0 CA--C 1.524 0.645 0 O-C-N 121.414 -0.804 . . . . 0.0 112.113 177.187 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -74.03 -50.88 0.15 Allowed 'Trans proline' 0 N--CA 1.447 -1.26 0 C-N-CA 122.112 1.875 . . . . 0.0 110.542 178.925 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 106' ' ' ALA . . . . . 0.533 ' CB ' ' CE2' ' A' ' 11' ' ' TYR . . . -61.24 135.74 57.83 Favored 'General case' 0 CA--C 1.507 -0.704 0 O-C-N 123.645 0.591 . . . . 0.0 109.892 -179.155 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 107' ' ' ARG . . . . . 0.5 ' HG2' ' HA ' ' A' ' 84' ' ' PRO . 9.4 mtm-85 -151.39 148.1 27.71 Favored 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 124.224 0.952 . . . . 0.0 110.456 -179.085 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.8 p -87.99 116.01 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 O-C-N 124.354 1.034 . . . . 0.0 111.525 178.584 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 1.4 mp -107.39 122.05 61.08 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.885 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 -173.09 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 110' ' ' TYR . . . . . 0.497 ' CZ ' HD21 ' A' ' 81' ' ' LEU . 6.3 p90 -141.46 151.73 43.62 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 121.836 0.827 . . . . 0.0 109.711 -179.388 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.3 p -80.64 163.23 23.78 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.639 178.421 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 112' ' ' TYR . . . . . 0.505 ' CD1' ' O ' ' A' ' 77' ' ' ASP . 0.1 OUTLIER -111.9 154.73 44.04 Favored Pre-proline 0 CA--C 1.546 0.808 0 O-C-N 123.353 0.408 . . . . 0.0 110.893 178.86 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 113' ' ' PRO . . . . . 0.494 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 19.0 Cg_endo -74.16 -51.08 0.16 OUTLIER 'Cis proline' 0 CA--C 1.502 -1.094 0 C-N-CA 123.533 -1.444 . . . . 0.0 110.529 -5.956 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 -45.23 109.96 0.21 Allowed 'General case' 0 C--O 1.219 -0.549 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.971 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 115' ' ' LYS . . . . . 0.463 ' CG ' ' CD1' ' A' ' 110' ' ' TYR . 0.1 OUTLIER -66.39 76.63 0.1 Allowed 'General case' 0 CA--C 1.512 -0.497 0 C-N-CA 123.675 0.79 . . . . 0.0 109.016 179.547 . . . . . . . . 3 3 . 1 . 025 nuclear orig core ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 57.3 t -74.84 72.51 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 -176.188 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 117' ' ' PHE . . . . . 0.455 ' CZ ' ' NE2' ' A' ' 13' ' ' GLN . 59.8 t80 -34.02 104.95 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 126.752 2.021 . . . . 0.0 109.22 -178.378 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 118' ' ' CYS . . . . . 0.459 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 14.6 m -84.84 -44.81 12.9 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -177.683 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 158.89 -151.03 21.94 Favored Glycine 0 N--CA 1.441 -1.02 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 179.657 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 120' ' ' ILE . . . . . 0.404 HG13 ' CG ' ' A' ' 4' ' ' TRP . 1.1 mm -127.44 133.14 68.51 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.806 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 -176.45 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 6.4 pt -119.72 155.14 22.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -177.327 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--N 1.323 -0.545 0 CA-C-O 120.817 0.342 . . . . 0.0 110.249 178.635 . . . . . . . . 0 0 . 1 . 025 nuclear orig core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.514 -0.42 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 133' ' ' LEU . . . . . 0.411 ' HB2' ' CG2' ' A' ' 55' ' ' ILE . 14.9 tp -85.62 140.64 30.41 Favored 'General case' 0 C--O 1.244 0.765 0 O-C-N 123.886 0.741 . . . . 0.0 109.375 177.633 . . . . . . . . 2 2 . 1 . 025 nuclear orig core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 60.8 m -68.71 -178.47 1.18 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.786 175.954 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 73.6 m -148.62 100.27 3.09 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 -178.787 . . . . . . . . 1 1 . 1 . 025 nuclear orig core ' A' A ' 136' ' ' HIS . . . . . 0.406 ' ND1' ' CE2' ' A' ' 4' ' ' TRP . 0.3 OUTLIER . . . . . 0 C--O 1.248 0.981 0 CA-C-O 117.892 -1.051 . . . . 0.0 113.268 173.312 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.346 0 CA-C-O 117.578 -1.201 . . . . 0.0 110.465 . . . . . . . . . 0 0 . 1 . 001 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -43.63 156.54 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.549 0 C-N-CA 125.347 1.459 . . . . 0.0 110.708 174.247 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 91.4 m -83.96 111.22 19.06 Favored 'General case' 0 C--N 1.31 -1.119 0 O-C-N 121.742 -0.599 . . . . 0.0 111.046 177.736 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.62 ' CZ2' ' CD2' ' A' ' 136' ' ' HIS . 16.9 m95 -79.7 142.44 35.48 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 177.983 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -138.51 141.09 39.38 Favored 'General case' 0 CA--C 1.498 -1.046 0 O-C-N 121.068 -1.02 . . . . 0.0 108.429 -178.588 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -122.81 61.08 1.01 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 118.612 -0.708 . . . . 0.0 110.502 177.54 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 39.0 78.69 0.05 OUTLIER Glycine 0 CA--C 1.532 1.114 0 O-C-N 124.207 0.942 . . . . 0.0 113.031 -177.828 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.01 -75.59 0.19 Allowed Glycine 0 C--O 1.224 -0.482 0 N-CA-C 111.189 -0.765 . . . . 0.0 111.189 -177.439 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.2 mt -128.33 163.2 25.32 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.593 0.711 . . . . 0.0 110.609 177.15 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -88.58 170.34 10.94 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.978 -177.202 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.511 ' CE2' ' CB ' ' A' ' 106' ' ' ALA . 70.6 m-85 -160.99 85.94 0.69 Allowed 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 122.278 1.037 . . . . 0.0 108.378 -171.254 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.432 ' ND2' ' H ' ' A' ' 14' ' ' ASN . 2.1 t-20 -54.11 122.98 11.34 Favored 'General case' 0 C--O 1.213 -0.864 0 CA-C-O 115.715 -2.088 . . . . 0.0 108.457 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.486 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 0.7 OUTLIER -46.49 -40.47 12.54 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 120.161 1.346 . . . . 0.0 112.543 175.716 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.432 ' H ' ' ND2' ' A' ' 12' ' ' ASN . 2.0 t-20 -57.75 -47.35 82.73 Favored 'General case' 0 C--O 1.199 -1.576 0 CA-C-O 118.573 -0.727 . . . . 0.0 111.093 176.195 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.3 mttt -70.52 -39.78 73.86 Favored 'General case' 0 C--O 1.203 -1.363 0 CA-C-N 120.912 1.687 . . . . 0.0 112.185 171.877 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -52.58 -41.01 63.23 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 121.55 1.977 . . . . 0.0 110.855 175.937 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -87.06 -47.0 9.28 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-O 117.393 -1.289 . . . . 0.0 109.64 177.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 39.3 t -67.49 -54.18 22.31 Favored 'General case' 0 CA--C 1.496 -1.108 0 C-N-CA 127.311 2.244 . . . . 0.0 107.597 -171.499 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.481 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 5.9 t-20 -42.32 -36.46 1.26 Allowed 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 119.862 1.21 . . . . 0.0 113.514 169.319 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.78 -33.97 27.19 Favored 'General case' 0 C--O 1.212 -0.906 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 172.813 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 14.9 m170 -44.96 -35.69 3.01 Favored 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 126.516 1.926 . . . . 0.0 110.33 177.476 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.481 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -74.3 -48.84 25.88 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-O 117.089 -1.434 . . . . 0.0 112.385 175.224 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -35.41 128.78 0.56 Allowed Pre-proline 0 CA--C 1.542 0.647 0 O-C-N 125.568 1.792 . . . . 0.0 112.51 172.569 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 14.9 Cg_endo -73.98 123.04 8.1 Favored 'Trans proline' 0 N--CA 1.448 -1.189 0 C-N-CA 122.14 1.893 . . . . 0.0 108.661 -176.062 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.416 ' CD2' ' HE2' ' A' ' 115' ' ' LYS . 3.4 tp -59.47 102.86 0.16 Allowed 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.102 178.654 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 178.93 151.3 0.31 Allowed 'General case' 0 C--O 1.214 -0.795 0 CA-C-O 119.014 -0.517 . . . . 0.0 110.883 -176.674 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.428 ' HB3' ' CA ' ' A' ' 72' ' ' GLY . 0.9 OUTLIER -81.93 89.8 6.4 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 119.263 0.938 . . . . 0.0 109.571 -179.422 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 60.31 82.08 0.07 OUTLIER Glycine 0 C--O 1.226 -0.401 0 CA-C-O 121.617 0.565 . . . . 0.0 111.7 178.379 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.3 mttt -150.06 45.76 0.91 Allowed 'General case' 0 CA--C 1.511 -0.546 0 CA-C-O 122.521 1.153 . . . . 0.0 111.315 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 70.5 p -128.41 152.56 48.06 Favored 'General case' 0 CA--C 1.497 -1.076 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -175.251 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -42.77 -52.19 5.59 Favored Glycine 0 C--N 1.332 0.346 0 O-C-N 124.556 1.16 . . . . 0.0 112.139 -177.728 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.427 ' HG ' ' N ' ' A' ' 33' ' ' SER . 1.3 t -68.48 -77.98 0.07 Allowed 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 117.659 -1.162 . . . . 0.0 111.251 172.939 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 33' ' ' SER . . . . . 0.427 ' N ' ' HG ' ' A' ' 32' ' ' SER . 71.0 p -178.07 -61.73 0.01 OUTLIER 'General case' 0 C--O 1.218 -0.603 0 O-C-N 124.846 1.341 . . . . 0.0 110.888 -177.042 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -62.66 146.87 93.86 Favored Pre-proline 0 N--CA 1.428 -1.555 0 O-C-N 125.432 1.707 . . . . 0.0 112.714 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 29.3 Cg_endo -78.19 -179.39 26.88 Favored 'Cis proline' 0 N--CA 1.439 -1.731 0 C-N-CA 121.856 -2.143 . . . . 0.0 111.785 1.452 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.411 ' CD2' ' N ' ' A' ' 36' ' ' HIS . 0.2 OUTLIER -152.69 164.1 38.39 Favored 'General case' 0 C--O 1.209 -1.063 0 O-C-N 118.913 -2.367 . . . . 0.0 111.251 -177.27 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.553 ' CH2' ' HA2' ' A' ' 44' ' ' GLY . 20.3 t90 -69.96 140.93 53.08 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 119.821 1.191 . . . . 0.0 108.422 176.826 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.445 ' CZ ' ' HA ' ' A' ' 40' ' ' ASN . 11.3 t80 -117.79 86.64 2.56 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 -177.766 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.457 ' CG2' ' CH2' ' A' ' 37' ' ' TRP . 70.4 p -38.91 -36.58 0.29 Allowed 'General case' 0 C--O 1.211 -0.965 0 C-N-CA 124.853 1.261 . . . . 0.0 111.185 175.007 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.445 ' HA ' ' CZ ' ' A' ' 38' ' ' PHE . 61.7 t30 73.49 4.94 4.91 Favored 'General case' 0 C--O 1.219 -0.52 0 C-N-CA 126.329 1.852 . . . . 0.0 109.36 176.815 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.416 ' CA ' ' HD3' ' A' ' 52' ' ' ARG . . . 120.04 -9.74 11.18 Favored Glycine 0 N--CA 1.427 -1.918 0 C-N-CA 125.221 1.391 . . . . 0.0 114.059 -172.553 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.567 ' CE2' ' HA ' ' A' ' 47' ' ' LYS . 17.3 m-85 -77.36 172.04 13.93 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.012 0.925 . . . . 0.0 110.489 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.04 -39.12 12.38 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.87 176.382 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.553 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . 174.27 -42.46 0.14 Allowed Glycine 0 C--N 1.334 0.439 0 C-N-CA 124.449 1.023 . . . . 0.0 112.73 -177.996 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -133.27 -63.87 0.75 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.519 0.676 . . . . 0.0 109.736 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.7 154.54 17.19 Favored Glycine 0 C--N 1.341 0.825 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.567 ' HA ' ' CE2' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -53.16 174.8 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.839 0.828 . . . . 0.0 112.775 175.721 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.424 ' CD1' ' CE1' ' A' ' 42' ' ' TYR . 5.6 mp -57.27 149.97 44.86 Favored Pre-proline 0 N--CA 1.445 -0.686 0 O-C-N 121.697 -0.627 . . . . 0.0 111.431 177.888 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -72.47 159.07 50.0 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 122.03 1.82 . . . . 0.0 109.474 -179.011 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 6.7 ttpt -54.65 97.76 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.147 0.579 . . . . 0.0 110.246 177.36 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.42 74.44 0.69 Allowed Glycine 0 N--CA 1.452 -0.26 0 CA-C-O 119.02 -0.878 . . . . 0.0 112.831 -175.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.416 ' HD3' ' CA ' ' A' ' 41' ' ' GLY . 7.1 ttm180 -173.69 164.28 4.37 Favored 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 123.966 0.906 . . . . 0.0 110.493 175.327 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.3 m -142.59 110.16 5.72 Favored Pre-proline 0 N--CA 1.448 -0.553 0 O-C-N 123.472 0.482 . . . . 0.0 110.563 178.6 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 23.6 Cg_endo -73.15 178.7 6.23 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 122.286 1.991 . . . . 0.0 111.52 178.32 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.415 ' CG2' ' HB2' ' A' ' 133' ' ' LEU . 4.3 mt -88.63 119.07 35.27 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.552 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -179.131 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -82.65 134.96 35.16 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 120.85 -1.156 . . . . 0.0 109.076 176.884 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.535 ' CD1' ' HB3' ' A' ' 118' ' ' CYS . 6.9 m-85 -116.82 -44.33 2.83 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.575 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 122.5 -4.03 10.2 Favored Glycine 0 C--O 1.224 -0.508 0 CA-C-O 118.88 -0.956 . . . . 0.0 112.62 -176.203 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.7 mttt -101.49 139.15 37.54 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-N 118.307 1.054 . . . . 0.0 109.863 176.843 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.7 t -78.66 -1.0 32.25 Favored 'General case' 0 C--O 1.219 -0.507 0 O-C-N 125.097 1.498 . . . . 0.0 111.21 175.642 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -87.47 -51.22 6.04 Favored 'General case' 0 N--CA 1.451 -0.424 0 O-C-N 120.184 -1.572 . . . . 0.0 109.327 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 2.7 m -73.51 -35.55 65.62 Favored 'General case' 0 N--CA 1.451 -0.401 0 O-C-N 123.747 0.654 . . . . 0.0 109.624 179.342 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -63.05 -37.1 85.85 Favored 'General case' 0 C--O 1.225 -0.205 0 CA-C-O 121.531 0.681 . . . . 0.0 111.398 175.505 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.7 161.8 0.83 Allowed Pre-proline 0 N--CA 1.441 -0.908 0 CA-C-O 122.321 1.058 . . . . 0.0 112.642 177.781 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.413 ' HA ' ' CE2' ' A' ' 42' ' ' TYR . 27.5 Cg_endo -70.92 132.87 22.27 Favored 'Trans proline' 0 N--CA 1.438 -1.758 0 C-N-CA 120.72 0.947 . . . . 0.0 114.486 173.343 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.444 ' HD2' ' CD2' ' A' ' 42' ' ' TYR . 19.5 Cg_endo -72.04 168.01 25.15 Favored 'Trans proline' 0 N--CA 1.445 -1.37 0 C-N-CA 123.122 2.548 . . . . 0.0 110.905 177.736 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.6 tptt -126.92 52.98 1.73 Allowed 'General case' 0 C--O 1.203 -1.351 0 CA-C-N 115.136 -0.938 . . . . 0.0 108.51 178.892 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -75.52 164.88 25.9 Favored 'General case' 0 C--O 1.216 -0.692 0 O-C-N 120.411 -1.43 . . . . 0.0 111.347 178.404 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.4 p -157.87 -167.98 2.4 Favored 'General case' 0 C--N 1.322 -0.589 0 O-C-N 119.531 -1.98 . . . . 0.0 111.136 176.473 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.4 77.05 5.96 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 120.686 -1.259 . . . . 0.0 112.686 171.975 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -177.79 -44.86 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 O-C-N 123.694 0.621 . . . . 0.0 110.162 177.887 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.428 ' CA ' ' HB3' ' A' ' 27' ' ' ASP . . . 117.18 -69.24 0.3 Allowed Glycine 0 N--CA 1.439 -1.148 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.453 -178.986 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -128.84 60.95 1.52 Allowed 'General case' 0 CA--C 1.508 -0.67 0 C-N-CA 125.583 1.553 . . . . 0.0 107.367 -175.71 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.33 -106.45 0.01 OUTLIER Glycine 0 CA--C 1.535 1.292 0 CA-C-O 123.04 1.355 . . . . 0.0 112.862 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.8 mttm -73.11 -105.12 0.01 OUTLIER 'General case' 0 C--O 1.217 -0.608 0 O-C-N 119.699 -2.06 . . . . 0.0 110.621 177.121 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -106.47 16.8 24.21 Favored 'General case' 0 C--N 1.32 -0.711 0 O-C-N 121.486 -0.759 . . . . 0.0 111.116 179.329 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.425 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 10.0 m-20 -31.56 98.74 0.01 OUTLIER 'General case' 0 C--O 1.207 -1.132 0 C-N-CA 125.487 1.515 . . . . 0.0 111.856 -176.725 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.467 ' H ' ' CD2' ' A' ' 78' ' ' HIS . 4.4 p80 -85.11 44.41 1.08 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 119.752 -1.842 . . . . 0.0 107.745 -170.67 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.495 ' HB2' ' CD1' ' A' ' 37' ' ' TRP . 39.3 p90 -69.68 135.02 49.35 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 124.794 1.237 . . . . 0.0 111.011 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.1 mt -71.24 142.84 50.57 Favored 'General case' 0 C--O 1.216 -0.71 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 177.83 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.436 ' CD2' ' CZ ' ' A' ' 110' ' ' TYR . 0.3 OUTLIER -137.12 137.12 38.92 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 119.128 0.876 . . . . 0.0 108.864 177.059 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -99.78 168.66 9.76 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.649 176.432 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 78.6 t80 -157.04 130.02 4.42 Favored Pre-proline 0 C--N 1.327 -0.383 0 O-C-N 120.811 -1.181 . . . . 0.0 113.857 -179.932 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.402 ' HA ' ' HG2' ' A' ' 107' ' ' ARG . 19.3 Cg_endo -72.6 98.76 0.98 Allowed 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 123.913 3.076 . . . . 0.0 109.713 -175.554 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 7.2 t -102.49 109.15 20.7 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.075 -179.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -81.34 158.44 69.18 Favored Pre-proline 0 C--N 1.32 -0.696 0 O-C-N 121.607 -0.683 . . . . 0.0 112.112 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -78.12 -34.3 1.71 Allowed 'Trans proline' 0 CA--C 1.495 -1.473 0 C-N-CA 122.053 1.835 . . . . 0.0 112.802 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -43.83 -32.94 1.18 Allowed 'General case' 0 N--CA 1.474 0.77 0 O-C-N 125.537 1.773 . . . . 0.0 110.709 176.285 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.19 4.45 74.38 Favored Glycine 0 N--CA 1.431 -1.66 0 CA-C-O 118.586 -1.119 . . . . 0.0 111.268 177.191 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 4.5 p-80 -74.07 129.55 38.08 Favored 'General case' 0 N--CA 1.434 -1.253 0 O-C-N 125.669 1.452 . . . . 0.0 107.644 178.306 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -61.84 92.04 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 174.325 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.482 ' CD2' ' HB3' ' A' ' 94' ' ' PHE . 5.8 t80 -38.32 142.89 0.15 Allowed 'General case' 0 C--O 1.21 -0.99 0 CA-C-O 122.083 0.944 . . . . 0.0 110.382 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.46 58.73 1.03 Allowed 'General case' 0 C--N 1.312 -1.064 0 O-C-N 119.11 -2.244 . . . . 0.0 111.061 175.059 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.482 ' HB3' ' CD2' ' A' ' 92' ' ' TYR . 25.7 p90 -75.27 -18.3 60.1 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 123.925 0.89 . . . . 0.0 111.621 176.802 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -92.05 -22.39 19.97 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-O 122.21 1.005 . . . . 0.0 110.304 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.49 107.59 19.56 Favored 'General case' 0 CA--C 1.513 -0.459 0 O-C-N 120.369 -1.457 . . . . 0.0 109.001 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.23 -49.5 75.82 Favored 'General case' 0 C--N 1.33 -0.261 0 O-C-N 122.181 -0.325 . . . . 0.0 110.375 177.368 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -136.41 125.33 15.48 Favored Pre-proline 0 N--CA 1.44 -0.938 0 C-N-CA 124.338 1.055 . . . . 0.0 109.695 -175.2 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -71.94 176.12 39.81 Favored 'Cis proline' 0 C--N 1.349 0.601 0 O-C-N 124.94 2.021 . . . . 0.0 110.941 -2.661 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -138.07 124.0 20.1 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 124.059 0.943 . . . . 0.0 109.013 179.013 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.06 159.57 26.12 Favored 'General case' 0 C--N 1.322 -0.618 0 O-C-N 124.509 1.131 . . . . 0.0 111.399 177.483 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -60.06 138.97 91.11 Favored Pre-proline 0 N--CA 1.451 -0.403 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.32 177.707 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -72.25 -165.75 0.23 Allowed 'Trans proline' 0 N--CA 1.452 -0.971 0 C-N-CA 122.783 2.322 . . . . 0.0 111.725 176.907 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -131.58 155.7 21.51 Favored Glycine 0 CA--C 1.527 0.798 0 O-C-N 121.166 -0.959 . . . . 0.0 112.433 176.614 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -73.07 -17.46 24.81 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 122.389 2.059 . . . . 0.0 111.258 177.429 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.511 ' CB ' ' CE2' ' A' ' 11' ' ' TYR . . . -110.76 134.92 52.08 Favored 'General case' 0 CA--C 1.507 -0.711 0 C-N-CA 124.177 0.991 . . . . 0.0 110.094 177.811 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.402 ' HG2' ' HA ' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -138.37 151.04 47.15 Favored 'General case' 0 CA--C 1.5 -0.964 0 CA-C-O 116.489 -1.72 . . . . 0.0 111.41 176.964 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.3 p -82.39 122.24 36.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 124.77 1.228 . . . . 0.0 112.109 175.942 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 1.7 mp -110.71 120.46 61.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 -174.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.462 ' CD1' ' CG ' ' A' ' 115' ' ' LYS . 6.4 p90 -140.34 150.52 44.07 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 122.93 1.347 . . . . 0.0 109.958 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.6 p -82.32 160.58 22.85 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -178.647 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.476 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.0 OUTLIER -108.2 155.38 40.29 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 122.873 0.469 . . . . 0.0 110.568 179.203 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.476 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 14.7 Cg_endo -74.16 -51.21 0.16 OUTLIER 'Cis proline' 0 CA--C 1.501 -1.159 0 C-N-CA 123.343 -1.524 . . . . 0.0 109.596 -6.87 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -47.72 108.09 0.15 Allowed 'General case' 0 CA--C 1.505 -0.785 0 CA-C-O 116.101 -1.904 . . . . 0.0 108.919 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.462 ' CG ' ' CD1' ' A' ' 110' ' ' TYR . 0.1 OUTLIER -62.91 79.75 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.547 0 O-C-N 125.233 1.583 . . . . 0.0 109.014 -177.775 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 15.4 t -80.16 71.58 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 N-CA-C 103.965 -2.605 . . . . 0.0 103.965 -175.319 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.538 ' CE1' ' HA2' ' A' ' 119' ' ' GLY . 4.3 t80 -36.1 114.12 0.26 Allowed 'General case' 0 C--O 1.242 0.671 0 C-N-CA 124.049 0.94 . . . . 0.0 108.809 177.854 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . 0.535 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -97.03 -30.33 13.12 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.973 177.282 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.538 ' HA2' ' CE1' ' A' ' 117' ' ' PHE . . . 144.12 -170.32 25.98 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 123.864 0.745 . . . . 0.0 112.027 -177.274 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.406 ' CG2' ' SG ' ' A' ' 134' ' ' CYS . 3.2 mp -111.61 142.84 22.77 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.395 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 -177.077 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 8.4 pt -114.83 155.19 16.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 119.822 1.192 . . . . 0.0 108.087 -179.879 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -177.96 161.04 1.51 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 122.9 1.333 . . . . 0.0 110.117 178.522 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.487 ' CE1' ' HG ' ' A' ' 131' ' ' LEU . 1.5 m-70 -90.61 93.23 9.18 Favored 'General case' 0 C--N 1.32 -0.707 0 O-C-N 121.26 -0.9 . . . . 0.0 109.04 -178.532 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 2.0 t -98.16 36.53 1.57 Allowed 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 124.689 2.185 . . . . 0.0 111.419 -179.336 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 25.9 tptt -100.43 -27.87 13.22 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 118.324 -2.735 . . . . 0.0 110.972 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -169.09 -63.14 0.02 OUTLIER 'General case' 0 C--O 1.219 -0.537 0 O-C-N 124.117 0.886 . . . . 0.0 110.298 178.36 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -155.5 -45.28 0.08 Allowed 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 122.567 1.175 . . . . 0.0 110.901 178.867 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.45 75.43 0.72 Allowed 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 122.052 0.93 . . . . 0.0 111.152 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -119.57 -104.55 2.09 Favored Glycine 0 N--CA 1.46 0.259 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -88.24 155.3 19.81 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 121.387 -1.067 . . . . 0.0 111.349 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.487 ' HG ' ' CE1' ' A' ' 123' ' ' HIS . 0.5 OUTLIER -99.8 138.2 37.21 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 121.663 -0.648 . . . . 0.0 110.133 178.57 . . . . . . . . 3 3 . 1 . 001 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -150.16 167.09 27.89 Favored 'General case' 0 CA--C 1.502 -0.868 0 C-N-CA 123.984 0.914 . . . . 0.0 109.256 -177.827 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.415 ' HB2' ' CG2' ' A' ' 55' ' ' ILE . 9.4 tp -83.97 148.07 27.11 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 177.783 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . 0.406 ' SG ' ' CG2' ' A' ' 120' ' ' ILE . 90.8 m -58.59 -174.32 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.186 1.394 . . . . 0.0 110.608 175.995 . . . . . . . . 2 2 . 1 . 001 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 61.3 m -131.22 93.28 3.34 Favored 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -177.58 . . . . . . . . 1 1 . 1 . 001 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 0.62 ' CD2' ' CZ2' ' A' ' 4' ' ' TRP . 5.8 p-80 . . . . . 0 C--O 1.25 1.111 0 CA-C-O 114.957 -2.449 . . . . 0.0 113.427 173.515 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.456 0 CA-C-O 118.316 -0.85 . . . . 0.0 108.78 . . . . . . . . . 0 0 . 1 . 002 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.452 ' CG1' ' CD2' ' A' ' 136' ' ' HIS . 14.4 p -72.79 146.68 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 O-C-N 123.98 0.8 . . . . 0.0 110.891 175.334 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.4 m -88.93 114.56 25.69 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 124.002 0.921 . . . . 0.0 109.47 -177.724 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.454 ' CD1' ' HB2' ' A' ' 13' ' ' GLN . 31.8 m95 -79.33 150.18 31.52 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-O 118.88 -0.581 . . . . 0.0 110.421 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.5 m -144.52 131.62 20.51 Favored 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 -176.035 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -126.93 -80.4 0.6 Allowed 'General case' 0 C--O 1.217 -0.658 0 CA-C-O 117.708 -1.139 . . . . 0.0 110.742 176.911 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -56.89 -88.17 0.02 OUTLIER Glycine 0 C--N 1.344 1.018 0 O-C-N 124.395 1.059 . . . . 0.0 111.294 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -154.17 18.22 0.62 Allowed Glycine 0 C--O 1.223 -0.585 0 O-C-N 121.749 -0.853 . . . . 0.0 111.383 178.226 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 49.8 mt -129.98 158.79 38.6 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 123.511 0.724 . . . . 0.0 109.735 178.816 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.5 mp -96.6 134.42 39.86 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.228 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.471 ' CE2' ' CB ' ' A' ' 106' ' ' ALA . 76.2 m-85 -117.64 104.07 10.66 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 126.481 1.912 . . . . 0.0 108.267 -173.944 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -55.69 119.6 5.97 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.473 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 5.5 tp-100 -53.25 -41.42 65.44 Favored 'General case' 0 C--O 1.203 -1.344 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.91 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -49.78 -42.44 46.68 Favored 'General case' 0 C--O 1.197 -1.702 0 CA-C-O 119.544 -0.265 . . . . 0.0 111.377 175.781 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.3 mttp -70.86 -37.19 73.09 Favored 'General case' 0 C--O 1.202 -1.44 0 O-C-N 120.923 -1.111 . . . . 0.0 113.451 169.274 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.4 -38.44 66.22 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 122.353 2.342 . . . . 0.0 113.641 172.158 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -90.39 -39.63 12.55 Favored 'General case' 0 C--O 1.212 -0.877 0 CA-C-O 117.976 -1.012 . . . . 0.0 108.548 177.286 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 39.8 t -73.63 -59.79 2.55 Favored 'General case' 0 C--O 1.214 -0.806 0 C-N-CA 126.212 1.805 . . . . 0.0 109.911 -176.45 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.467 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 6.4 t-20 -41.0 -36.86 0.72 Allowed 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 119.72 1.145 . . . . 0.0 113.285 170.709 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -81.53 -36.79 28.75 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 115.035 1.495 . . . . 0.0 115.035 173.434 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 5.2 m170 -44.83 -38.68 4.72 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.382 1.873 . . . . 0.0 109.896 178.102 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.467 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -73.72 -47.01 42.52 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-O 117.88 -1.057 . . . . 0.0 112.732 175.064 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.405 ' HB1' ' CE1' ' A' ' 83' ' ' PHE . . . -35.74 127.59 0.61 Allowed Pre-proline 0 N--CA 1.439 -0.982 0 O-C-N 125.312 1.632 . . . . 0.0 112.885 173.011 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 14.2 Cg_endo -73.63 125.87 10.39 Favored 'Trans proline' 0 N--CA 1.445 -1.369 0 C-N-CA 122.054 1.836 . . . . 0.0 108.576 -175.758 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.413 ' CD1' ' HE2' ' A' ' 115' ' ' LYS . 4.3 tp -60.6 93.92 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.472 0.709 . . . . 0.0 111.239 178.658 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 179.2 162.46 0.82 Allowed 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 123.102 0.561 . . . . 0.0 109.966 -176.079 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.2 118.44 34.85 Favored 'General case' 0 C--O 1.218 -0.595 0 C-N-CA 123.996 0.918 . . . . 0.0 110.344 177.648 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 46.71 64.72 2.51 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 120.048 -1.073 . . . . 0.0 112.7 177.469 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.9 ttpt -129.44 11.69 5.86 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 124.367 2.032 . . . . 0.0 111.079 178.024 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 25.9 p -112.71 150.53 31.4 Favored 'General case' 0 C--N 1.309 -1.165 0 O-C-N 119.27 -2.144 . . . . 0.0 107.233 -174.485 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -39.94 -51.13 3.4 Favored Glycine 0 C--N 1.335 0.474 0 O-C-N 124.404 1.065 . . . . 0.0 112.495 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.7 t -69.23 -78.09 0.07 Allowed 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 118.988 -0.53 . . . . 0.0 111.224 173.423 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.4 p -179.0 -63.75 0.01 OUTLIER 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 123.491 0.717 . . . . 0.0 110.202 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.588 ' CE2' ' CE1' ' A' ' 36' ' ' HIS . 65.6 m-85 -58.67 147.13 71.98 Favored Pre-proline 0 N--CA 1.426 -1.662 0 C-N-CA 124.708 1.203 . . . . 0.0 112.962 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -74.77 151.37 96.86 Favored 'Cis proline' 0 N--CA 1.45 -1.081 0 C-N-CA 123.088 -1.63 . . . . 0.0 110.734 -0.738 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.588 ' CE1' ' CE2' ' A' ' 34' ' ' TYR . 0.5 OUTLIER -129.39 166.38 19.66 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-O 117.474 -1.25 . . . . 0.0 110.347 -179.554 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.565 ' CH2' ' HA2' ' A' ' 44' ' ' GLY . 16.7 t90 -64.02 144.41 57.11 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 124.329 1.018 . . . . 0.0 108.586 178.026 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.554 ' CE1' ' CD1' ' A' ' 121' ' ' ILE . 16.3 t80 -117.4 82.51 1.83 Allowed 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 -174.785 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.435 ' CG2' ' CH2' ' A' ' 37' ' ' TRP . 73.1 p -40.38 -33.08 0.22 Allowed 'General case' 0 C--O 1.211 -0.948 0 C-N-CA 124.537 1.135 . . . . 0.0 110.459 174.01 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.446 ' HB2' ' CE2' ' A' ' 38' ' ' PHE . 46.3 t30 60.18 16.33 5.97 Favored 'General case' 0 C--O 1.214 -0.784 0 CA-C-O 122.877 1.323 . . . . 0.0 109.374 177.704 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 112.89 -38.39 3.25 Favored Glycine 0 N--CA 1.427 -1.905 0 O-C-N 119.469 -2.019 . . . . 0.0 113.367 -172.197 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.441 ' CD2' ' HA2' ' A' ' 46' ' ' GLY . 66.0 m-85 -50.64 170.53 0.03 OUTLIER 'General case' 0 C--O 1.231 0.081 0 CA-C-N 118.664 1.232 . . . . 0.0 111.695 178.849 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.44 -40.53 9.86 Favored 'General case' 0 C--N 1.32 -0.693 0 O-C-N 121.598 -0.689 . . . . 0.0 110.002 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.565 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -177.09 -53.31 0.06 OUTLIER Glycine 0 C--N 1.336 0.547 0 C-N-CA 123.855 0.74 . . . . 0.0 111.9 -178.439 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.76 -96.29 0.07 Allowed 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 -179.456 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.441 ' HA2' ' CD2' ' A' ' 42' ' ' TYR . . . -141.6 12.7 2.7 Favored Glycine 0 N--CA 1.438 -1.226 0 C-N-CA 125.306 1.432 . . . . 0.0 111.065 -176.328 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.2 pttt -112.06 146.41 38.0 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 117.991 -1.004 . . . . 0.0 108.804 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -111.06 159.01 34.23 Favored Pre-proline 0 C--N 1.323 -0.555 0 O-C-N 124.624 1.203 . . . . 0.0 108.676 -178.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -74.48 157.37 44.99 Favored 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 121.857 1.704 . . . . 0.0 109.925 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.2 ttpt -54.89 101.12 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.99 0.516 . . . . 0.0 109.859 177.887 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.77 88.4 1.77 Allowed Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 116.495 -0.321 . . . . 0.0 112.535 -176.438 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -169.97 161.28 8.74 Favored 'General case' 0 CA--C 1.513 -0.475 0 C-N-CA 123.415 0.686 . . . . 0.0 110.506 175.683 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.0 m -147.69 113.57 4.01 Favored Pre-proline 0 N--CA 1.447 -0.616 0 O-C-N 124.485 1.115 . . . . 0.0 110.412 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -72.28 166.92 28.32 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 122.621 2.214 . . . . 0.0 111.344 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.401 ' O ' ' CE1' ' A' ' 57' ' ' PHE . 6.0 mt -81.6 129.87 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 -178.077 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.71 136.93 35.49 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 177.729 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.488 ' CD1' ' SG ' ' A' ' 62' ' ' CYS . 3.0 m-85 -125.93 -53.87 1.52 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 -177.436 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 120.37 -5.51 11.98 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 123.852 0.739 . . . . 0.0 112.602 -176.467 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . 0.409 ' CB ' ' HB3' ' A' ' 62' ' ' CYS . 0.2 OUTLIER -65.75 177.5 1.25 Allowed 'General case' 0 C--O 1.207 -1.165 0 CA-C-N 118.251 1.026 . . . . 0.0 111.355 176.157 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.48 -45.13 4.73 Favored 'General case' 0 C--O 1.212 -0.885 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.404 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.55 -40.17 23.53 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.488 ' SG ' ' CD1' ' A' ' 57' ' ' PHE . 0.9 OUTLIER -71.43 -20.14 62.15 Favored 'General case' 0 C--N 1.342 0.253 0 O-C-N 123.871 0.732 . . . . 0.0 110.824 177.826 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -85.79 -42.24 14.36 Favored 'General case' 0 CA--C 1.509 -0.599 0 O-C-N 124.225 0.953 . . . . 0.0 112.196 174.714 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.75 165.38 0.46 Allowed Pre-proline 0 N--CA 1.44 -0.951 0 CA-C-O 121.437 0.637 . . . . 0.0 111.542 -179.155 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -71.82 139.16 32.95 Favored 'Trans proline' 0 N--CA 1.437 -1.8 0 N-CA-C 114.807 1.041 . . . . 0.0 114.807 173.436 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -70.51 174.28 10.39 Favored 'Trans proline' 0 N--CA 1.446 -1.286 0 C-N-CA 122.846 2.364 . . . . 0.0 111.09 178.424 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.4 mmtp -140.03 58.86 1.58 Allowed 'General case' 0 C--O 1.199 -1.569 0 CA-C-O 116.597 -1.668 . . . . 0.0 109.28 177.246 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.407 ' CE1' ' O ' ' A' ' 69' ' ' SER . 58.4 t-80 -75.4 164.02 26.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 119.534 1.061 . . . . 0.0 110.594 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.407 ' O ' ' CE1' ' A' ' 68' ' ' HIS . 0.3 OUTLIER -149.38 -168.66 3.17 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 123.574 0.75 . . . . 0.0 111.402 177.997 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.14 71.22 10.6 Favored 'General case' 0 C--O 1.216 -0.706 0 O-C-N 120.268 -1.52 . . . . 0.0 111.745 176.433 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -177.18 -42.4 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.103 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.418 ' O ' ' CE2' ' A' ' 79' ' ' TYR . . . 124.51 -46.69 1.07 Allowed Glycine 0 CA--C 1.487 -1.703 0 CA-C-O 117.757 -1.58 . . . . 0.0 112.469 -176.84 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -150.11 81.89 1.37 Allowed 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 177.829 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -61.42 -122.59 0.01 OUTLIER Glycine 0 C--O 1.219 -0.812 0 CA-C-O 121.197 0.332 . . . . 0.0 112.476 177.129 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.2 mttt -52.45 -89.34 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 O-C-N 120.411 -1.641 . . . . 0.0 112.086 178.298 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -119.62 17.01 12.85 Favored 'General case' 0 CA--C 1.508 -0.659 0 O-C-N 120.929 -1.107 . . . . 0.0 111.017 178.143 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.464 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 5.0 m-20 -27.05 105.08 0.02 OUTLIER 'General case' 0 C--O 1.203 -1.36 0 C-N-CA 125.44 1.496 . . . . 0.0 110.692 -177.075 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.503 ' H ' ' CD2' ' A' ' 78' ' ' HIS . 2.5 p80 -87.21 11.2 14.7 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 121.146 -0.971 . . . . 0.0 110.255 -176.072 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.493 ' CZ ' ' CD1' ' A' ' 81' ' ' LEU . 0.5 OUTLIER -33.96 132.95 0.22 Allowed 'General case' 0 N--CA 1.435 -1.206 0 C-N-CA 125.353 1.461 . . . . 0.0 113.205 172.37 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.19 151.98 38.44 Favored 'General case' 0 C--O 1.218 -0.587 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.883 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.493 ' CD1' ' CZ ' ' A' ' 79' ' ' TYR . 1.4 mp -135.87 139.94 43.75 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-N 119.081 0.855 . . . . 0.0 109.155 176.744 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.8 pm0 -106.32 151.73 24.47 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-O 121.897 0.856 . . . . 0.0 110.793 179.757 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.405 ' CE1' ' HB1' ' A' ' 23' ' ' ALA . 55.4 t80 -140.1 130.61 14.0 Favored Pre-proline 0 N--CA 1.449 -0.506 0 O-C-N 121.727 -0.608 . . . . 0.0 111.979 -179.11 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.441 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 18.6 Cg_endo -72.34 108.88 2.61 Favored 'Trans proline' 0 N--CA 1.446 -1.272 0 C-N-CA 123.674 2.916 . . . . 0.0 110.632 -178.935 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.93 109.27 21.16 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.74 0.816 . . . . 0.0 109.752 -179.259 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -81.1 160.7 65.13 Favored Pre-proline 0 N--CA 1.446 -0.662 0 O-C-N 121.598 -0.689 . . . . 0.0 112.433 178.195 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -77.21 -41.66 0.34 Allowed 'Trans proline' 0 CA--C 1.494 -1.507 0 C-N-CA 122.395 2.063 . . . . 0.0 112.256 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -45.57 -30.61 1.53 Allowed 'General case' 0 C--N 1.35 0.622 0 O-C-N 125.275 1.609 . . . . 0.0 110.282 177.473 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.34 -4.9 85.87 Favored Glycine 0 N--CA 1.432 -1.573 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 176.791 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 4.3 p-80 -60.55 129.64 42.6 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -64.19 89.72 0.06 Allowed 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 177.265 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.483 ' CD2' ' HB3' ' A' ' 94' ' ' PHE . 6.2 t80 -36.41 142.91 0.08 Allowed 'General case' 0 C--O 1.211 -0.959 0 C-N-CA 124.041 0.937 . . . . 0.0 110.507 -178.858 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.06 58.07 1.47 Allowed 'General case' 0 C--N 1.313 -0.996 0 O-C-N 119.766 -1.834 . . . . 0.0 110.738 175.969 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.483 ' HB3' ' CD2' ' A' ' 92' ' ' TYR . 28.8 p90 -74.03 -14.88 61.08 Favored 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 123.524 0.73 . . . . 0.0 111.954 176.679 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.86 -33.63 17.28 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 124.584 1.154 . . . . 0.0 110.794 178.732 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 32.2 m -85.96 109.89 19.08 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -178.558 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.5 ptpt -58.17 -49.68 76.16 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 178.623 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -140.7 126.81 11.6 Favored Pre-proline 0 N--CA 1.43 -1.459 0 C-N-CA 124.416 1.086 . . . . 0.0 110.329 -175.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 24.6 Cg_endo -71.95 175.98 40.44 Favored 'Cis proline' 0 C--N 1.35 0.606 0 O-C-N 124.909 2.005 . . . . 0.0 110.999 -2.925 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.2 tttp -141.09 130.23 23.42 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.773 0.829 . . . . 0.0 109.469 178.822 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -82.92 148.77 27.46 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.135 0.897 . . . . 0.0 110.372 176.687 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -43.86 137.94 3.31 Favored Pre-proline 0 N--CA 1.437 -1.116 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.021 173.489 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -73.18 -166.46 0.3 Allowed 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 122.449 2.1 . . . . 0.0 110.541 178.413 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -131.45 160.03 23.32 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-O 119.295 -0.725 . . . . 0.0 112.381 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -76.25 -65.84 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.778 2.319 . . . . 0.0 110.551 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.471 ' CB ' ' CE2' ' A' ' 11' ' ' TYR . . . -59.86 137.18 58.13 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 123.702 0.626 . . . . 0.0 110.996 177.991 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 5.1 mtm-85 -141.43 149.4 40.96 Favored 'General case' 0 CA--C 1.505 -0.767 0 O-C-N 124.211 0.944 . . . . 0.0 110.717 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.7 p -88.46 117.01 31.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.135 0.897 . . . . 0.0 111.862 178.772 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 1.2 mp -104.3 125.01 59.13 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.984 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 -171.847 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.435 ' CD1' ' C ' ' A' ' 110' ' ' TYR . 14.5 p90 -146.17 160.56 41.79 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.05 -178.939 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.0 p -93.86 166.0 12.4 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.867 -177.867 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.523 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -112.96 153.44 45.25 Favored Pre-proline 0 N--CA 1.44 -0.951 0 C-N-CA 122.478 0.311 . . . . 0.0 110.706 179.962 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.523 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 16.5 Cg_endo -74.46 -51.59 0.16 OUTLIER 'Cis proline' 0 CA--C 1.499 -1.253 0 C-N-CA 123.487 -1.464 . . . . 0.0 109.71 -5.864 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -45.44 111.99 0.4 Allowed 'General case' 0 CA--C 1.502 -0.901 0 CA-C-O 115.861 -2.019 . . . . 0.0 109.132 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.432 ' HG3' ' CD1' ' A' ' 110' ' ' TYR . 0.3 OUTLIER -64.87 74.81 0.04 OUTLIER 'General case' 0 CA--C 1.51 -0.593 0 O-C-N 125.787 1.929 . . . . 0.0 108.476 -178.383 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 9.5 t -73.45 72.16 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 105.696 -1.964 . . . . 0.0 105.696 -177.08 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.473 ' CZ ' ' NE2' ' A' ' 13' ' ' GLN . 17.2 t80 -46.93 107.98 0.13 Allowed 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 124.67 1.188 . . . . 0.0 108.881 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . 0.419 ' SG ' ' CG ' ' A' ' 57' ' ' PHE . 0.1 OUTLIER -83.75 -56.41 3.72 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 -179.853 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . -178.8 -145.09 5.97 Favored Glycine 0 N--CA 1.436 -1.357 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 179.67 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 1.2 mm -127.59 145.49 34.87 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.202 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 -175.088 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.554 ' CD1' ' CE1' ' A' ' 38' ' ' PHE . 3.1 pt -131.12 156.86 43.08 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.903 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -176.14 162.61 2.52 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.781 0.8 . . . . 0.0 109.611 177.143 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.467 ' CE1' ' HG ' ' A' ' 131' ' ' LEU . 2.7 m-70 -91.66 93.88 9.12 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 108.858 -0.794 . . . . 0.0 108.858 -178.187 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 2.4 t -97.63 38.55 1.27 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 123.176 1.465 . . . . 0.0 111.554 179.608 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 9.8 tttm -104.13 -27.83 11.84 Favored 'General case' 0 C--N 1.322 -0.601 0 O-C-N 120.493 -1.38 . . . . 0.0 111.014 178.339 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -171.03 -63.07 0.02 OUTLIER 'General case' 0 C--O 1.22 -0.453 0 O-C-N 123.546 0.529 . . . . 0.0 110.518 177.866 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -154.87 -46.02 0.08 Allowed 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.535 0.734 . . . . 0.0 110.664 178.64 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -157.08 75.01 0.81 Allowed 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 123.477 0.711 . . . . 0.0 110.988 -179.132 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -122.0 -102.1 1.71 Allowed Glycine 0 C--N 1.331 0.274 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.48 159.85 17.78 Favored 'General case' 0 CA--C 1.508 -0.645 0 O-C-N 121.816 -0.814 . . . . 0.0 110.303 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.467 ' HG ' ' CE1' ' A' ' 123' ' ' HIS . 0.8 OUTLIER -112.69 141.56 46.33 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.643 0.735 . . . . 0.0 109.864 177.811 . . . . . . . . 3 3 . 1 . 002 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.25 172.75 14.36 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 123.884 0.873 . . . . 0.0 109.725 -178.614 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.415 HD13 ' CE2' ' A' ' 57' ' ' PHE . 12.3 tp -82.94 136.0 34.71 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 83.7 m -63.43 -175.68 0.13 Allowed 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 124.082 0.953 . . . . 0.0 109.599 175.576 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 59.3 m -161.55 119.29 2.28 Favored 'General case' 0 CA--C 1.488 -1.427 0 N-CA-C 104.319 -2.474 . . . . 0.0 104.319 -177.479 . . . . . . . . 1 1 . 1 . 002 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 0.452 ' CD2' ' CG1' ' A' ' 2' ' ' VAL . 3.2 m80 . . . . . 0 CA--C 1.558 1.254 0 CA-C-O 114.733 -2.556 . . . . 0.0 115.822 177.184 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.71 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 . . . . . . . . . 0 0 . 1 . 003 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.1 p -104.19 148.47 8.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 23.9 m -89.13 115.41 26.64 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 123.767 0.827 . . . . 0.0 109.625 -178.158 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.409 ' CG ' HG13 ' A' ' 120' ' ' ILE . 23.7 m95 -77.71 142.06 38.98 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -133.86 138.76 45.8 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -178.316 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -129.59 49.98 2.21 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.868 0.842 . . . . 0.0 111.099 176.865 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 143.06 -99.45 0.23 Allowed Glycine 0 C--O 1.22 -0.778 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -129.32 5.38 6.32 Favored Glycine 0 N--CA 1.466 0.679 0 C-N-CA 123.676 0.655 . . . . 0.0 112.704 177.834 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -112.72 138.79 49.02 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 -175.69 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.5 mp -95.62 160.83 14.31 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 123.981 0.801 . . . . 0.0 109.468 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.505 ' CE2' ' CB ' ' A' ' 106' ' ' ALA . 65.9 m-85 -152.37 94.87 1.97 Allowed 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 122.182 0.992 . . . . 0.0 109.564 -173.968 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.27 120.63 7.91 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-O 117.427 -1.273 . . . . 0.0 108.038 -178.315 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.402 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 6.7 tp-100 -50.05 -43.24 50.96 Favored 'General case' 0 C--O 1.205 -1.266 0 O-C-N 124.655 1.222 . . . . 0.0 112.032 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -47.98 -48.84 32.16 Favored 'General case' 0 C--O 1.193 -1.897 0 CA-C-O 118.97 -0.538 . . . . 0.0 112.257 174.59 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.31 -38.13 84.45 Favored 'General case' 0 C--O 1.206 -1.214 0 CA-C-N 119.99 1.268 . . . . 0.0 114.2 168.019 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -49.96 -43.88 50.35 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 121.599 1.999 . . . . 0.0 114.455 170.758 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -88.59 -39.89 13.76 Favored 'General case' 0 C--O 1.206 -1.218 0 O-C-N 120.916 -1.115 . . . . 0.0 109.668 176.359 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 36.5 t -73.38 -60.2 2.36 Favored 'General case' 0 C--O 1.211 -0.942 0 C-N-CA 126.571 1.948 . . . . 0.0 109.896 -176.102 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.461 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 4.6 t-20 -40.26 -38.5 0.79 Allowed 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 120.268 1.394 . . . . 0.0 113.357 169.239 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.411 ' CB ' HG11 ' A' ' 108' ' ' VAL . 0.1 OUTLIER -81.81 -30.77 32.07 Favored 'General case' 0 C--O 1.217 -0.656 0 N-CA-C 116.11 1.892 . . . . 0.0 116.11 173.108 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 3.6 m170 -50.08 -35.35 25.03 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 125.733 1.613 . . . . 0.0 109.298 177.958 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.461 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.1 OUTLIER -73.9 -42.8 60.13 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 117.822 -1.085 . . . . 0.0 111.926 176.792 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.417 ' HB2' ' CE1' ' A' ' 83' ' ' PHE . . . -36.24 129.72 0.65 Allowed Pre-proline 0 N--CA 1.44 -0.974 0 O-C-N 125.233 1.583 . . . . 0.0 113.069 172.027 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 17.4 Cg_endo -72.89 123.98 9.32 Favored 'Trans proline' 0 N--CA 1.444 -1.418 0 C-N-CA 122.053 1.835 . . . . 0.0 108.802 -176.439 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.417 ' CD2' ' HE2' ' A' ' 115' ' ' LYS . 2.1 tp -62.03 91.11 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.262 1.025 . . . . 0.0 110.668 178.769 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 179.78 157.8 0.67 Allowed 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 123.435 0.694 . . . . 0.0 109.427 -175.408 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.96 89.45 4.29 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 104.621 -2.362 . . . . 0.0 104.621 -164.281 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 63.2 75.48 0.34 Allowed Glycine 0 CA--C 1.529 0.943 0 C-N-CA 119.489 -1.338 . . . . 0.0 111.957 -176.266 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.8 ttpt -138.19 28.79 2.52 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 123.661 1.696 . . . . 0.0 111.825 176.224 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 7.7 p -118.39 146.76 44.17 Favored 'General case' 0 CA--C 1.492 -1.271 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 -172.643 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -42.43 -53.94 4.89 Favored Glycine 0 N--CA 1.452 -0.242 0 O-C-N 123.827 0.705 . . . . 0.0 111.561 -179.156 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.2 t -64.15 -62.43 1.62 Allowed 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 116.533 -1.698 . . . . 0.0 112.378 174.182 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 162.1 -59.11 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.475 0 C-N-CA 127.91 2.484 . . . . 0.0 111.396 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.577 ' CE1' ' CE1' ' A' ' 36' ' ' HIS . 70.8 m-85 -59.77 141.14 89.33 Favored Pre-proline 0 N--CA 1.446 -0.674 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 178.191 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 36.7 Cg_endo -77.4 167.23 79.88 Favored 'Cis proline' 0 N--CA 1.436 -1.902 0 C-N-CA 121.833 -2.153 . . . . 0.0 112.721 3.512 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.577 ' CE1' ' CE1' ' A' ' 34' ' ' TYR . 2.5 p-80 -137.61 174.4 10.63 Favored 'General case' 0 C--O 1.205 -1.241 0 O-C-N 120.629 -1.294 . . . . 0.0 111.86 178.192 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.567 ' CH2' ' HA2' ' A' ' 44' ' ' GLY . 14.1 t90 -75.84 132.14 40.17 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 119.864 1.211 . . . . 0.0 110.726 173.515 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.438 ' CZ ' HD11 ' A' ' 121' ' ' ILE . 4.5 t80 -97.52 89.56 4.72 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 105.148 -2.167 . . . . 0.0 105.148 -179.382 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.433 ' CG2' ' CH2' ' A' ' 37' ' ' TRP . 17.1 p -38.81 -36.01 0.24 Allowed 'General case' 0 C--O 1.203 -1.38 0 CA-C-O 117.733 -1.127 . . . . 0.0 110.286 169.989 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 50.4 t30 55.95 22.25 5.61 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 121.189 1.813 . . . . 0.0 109.973 176.499 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 101.37 -39.76 2.64 Favored Glycine 0 N--CA 1.425 -2.052 0 CA-C-O 116.726 -2.152 . . . . 0.0 116.587 -168.249 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.448 ' CE2' ' HD3' ' A' ' 66' ' ' PRO . 80.5 m-85 -46.58 152.65 0.44 Allowed 'General case' 0 C--O 1.233 0.202 0 C-N-CA 126.456 1.902 . . . . 0.0 110.695 177.348 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.82 -38.35 25.65 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.728 178.644 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.567 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -172.29 -59.07 0.04 OUTLIER Glycine 0 C--N 1.335 0.489 0 C-N-CA 124.689 1.138 . . . . 0.0 111.011 -178.173 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -125.16 -64.77 1.06 Allowed 'General case' 0 CA--C 1.507 -0.69 0 O-C-N 122.641 -0.329 . . . . 0.0 110.514 -176.802 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.99 -175.81 0.22 Allowed Glycine 0 C--N 1.342 0.872 0 C-N-CA 124.761 1.172 . . . . 0.0 110.988 178.835 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.54 -165.72 0.0 OUTLIER 'General case' 0 CA--C 1.551 0.987 0 CA-C-O 124.61 2.148 . . . . 0.0 112.623 175.697 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -96.35 169.02 9.54 Favored Pre-proline 0 C--N 1.306 -1.286 0 O-C-N 119.829 -1.794 . . . . 0.0 110.889 -179.96 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -71.87 157.67 54.48 Favored 'Trans proline' 0 N--CA 1.441 -1.582 0 C-N-CA 121.888 1.725 . . . . 0.0 110.69 178.23 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.0 tttt -63.76 97.88 0.17 Allowed 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.713 -0.617 . . . . 0.0 110.205 176.685 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 123.62 40.0 0.48 Allowed Glycine 0 CA--C 1.52 0.351 0 N-CA-C 112.015 -0.434 . . . . 0.0 112.015 -176.528 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -132.96 161.35 34.54 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-N 117.325 0.562 . . . . 0.0 111.495 176.85 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.9 m -140.48 102.85 6.55 Favored Pre-proline 0 C--N 1.324 -0.527 0 O-C-N 124.045 0.841 . . . . 0.0 109.61 -178.484 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -72.08 175.78 9.37 Favored 'Trans proline' 0 N--CA 1.448 -1.183 0 C-N-CA 122.504 2.136 . . . . 0.0 111.418 178.208 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.8 mt -98.35 130.52 47.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 -178.297 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.34 135.37 33.72 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 177.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.447 ' CD1' ' HB3' ' A' ' 118' ' ' CYS . 17.3 m-85 -118.83 -45.37 2.59 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 124.078 0.951 . . . . 0.0 110.142 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 121.03 -2.31 11.68 Favored Glycine 0 C--O 1.222 -0.642 0 C-N-CA 123.885 0.755 . . . . 0.0 112.59 -175.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 18.0 mttm -105.33 137.82 42.51 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 118.222 1.011 . . . . 0.0 109.373 177.507 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.2 t -73.26 -4.64 34.41 Favored 'General case' 0 C--O 1.217 -0.642 0 O-C-N 125.182 1.551 . . . . 0.0 111.504 176.157 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -89.0 -50.59 6.08 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 124.654 1.182 . . . . 0.0 109.745 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 10.1 m -71.52 -22.55 61.76 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.46 0.648 . . . . 0.0 111.564 175.41 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -79.75 -35.87 38.14 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-O 118.892 -0.575 . . . . 0.0 111.143 174.023 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -52.35 160.79 1.19 Allowed Pre-proline 0 CA--C 1.539 0.542 0 CA-C-O 122.084 0.945 . . . . 0.0 111.67 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -71.94 144.14 42.39 Favored 'Trans proline' 0 N--CA 1.443 -1.492 0 C-N-CA 120.461 0.774 . . . . 0.0 113.573 175.037 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.448 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 19.8 Cg_endo -72.74 169.12 22.75 Favored 'Trans proline' 0 N--CA 1.444 -1.433 0 C-N-CA 124.151 3.234 . . . . 0.0 111.056 178.513 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.4 tptp -128.47 51.92 1.96 Allowed 'General case' 0 C--O 1.197 -1.675 0 CA-C-O 114.987 -2.435 . . . . 0.0 107.216 -179.016 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.42 ' CD2' ' O ' ' A' ' 72' ' ' GLY . 57.1 t-80 -74.79 144.56 43.49 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 121.212 1.824 . . . . 0.0 113.897 175.011 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.06 -91.17 0.5 Allowed 'General case' 0 N--CA 1.469 0.496 0 O-C-N 119.207 -2.183 . . . . 0.0 109.607 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.95 -174.94 0.38 Allowed 'General case' 0 C--O 1.215 -0.733 0 C-N-CA 123.713 0.805 . . . . 0.0 111.123 178.974 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -50.31 -27.02 5.47 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 173.39 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.42 ' O ' ' CD2' ' A' ' 68' ' ' HIS . . . -104.22 -118.54 4.49 Favored Glycine 0 C--O 1.214 -1.139 0 N-CA-C 106.583 -2.607 . . . . 0.0 106.583 178.01 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -121.75 -100.0 0.43 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 100.413 -3.921 . . . . 0.0 100.413 -167.542 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 144.75 -131.99 4.55 Favored Glycine 0 N--CA 1.439 -1.134 0 CA-C-N 115.232 -0.894 . . . . 0.0 113.32 -167.678 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.2 mttm -63.01 -104.41 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 122.049 0.928 . . . . 0.0 112.673 175.986 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -101.39 21.2 14.54 Favored 'General case' 0 CA--C 1.514 -0.423 0 O-C-N 120.785 -1.197 . . . . 0.0 111.588 -179.685 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.455 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 1.1 m-20 -33.25 105.06 0.03 OUTLIER 'General case' 0 CA--C 1.49 -1.343 0 C-N-CA 126.181 1.792 . . . . 0.0 109.924 -176.238 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -83.8 16.44 2.76 Favored 'General case' 0 C--N 1.319 -0.74 0 O-C-N 120.683 -1.261 . . . . 0.0 110.5 -176.759 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.439 ' CE2' ' HB2' ' A' ' 81' ' ' LEU . 10.8 p90 -41.27 136.28 1.7 Allowed 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 125.607 1.563 . . . . 0.0 110.963 177.495 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -77.02 136.27 38.69 Favored 'General case' 0 C--O 1.215 -0.728 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.08 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.464 ' CD2' ' CZ ' ' A' ' 110' ' ' TYR . 0.5 OUTLIER -128.84 151.91 49.09 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.85 0.834 . . . . 0.0 109.1 175.442 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -121.81 163.33 19.34 Favored 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 124.242 1.017 . . . . 0.0 112.193 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.417 ' CE1' ' HB2' ' A' ' 23' ' ' ALA . 80.1 t80 -148.21 129.04 6.97 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -177.629 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.488 ' HD3' ' CD1' ' A' ' 34' ' ' TYR . 17.8 Cg_endo -72.0 109.61 2.73 Favored 'Trans proline' 0 N--CA 1.443 -1.477 0 C-N-CA 123.381 2.721 . . . . 0.0 110.887 -176.176 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -107.25 107.31 18.18 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-N 114.662 -1.154 . . . . 0.0 109.65 -178.062 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -80.01 160.17 69.23 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 177.414 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -76.4 -38.66 0.98 Allowed 'Trans proline' 0 CA--C 1.493 -1.564 0 C-N-CA 122.092 1.861 . . . . 0.0 112.896 178.472 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -44.67 -30.43 0.93 Allowed 'General case' 0 N--CA 1.474 0.766 0 O-C-N 125.644 1.84 . . . . 0.0 110.92 176.874 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.74 6.61 86.94 Favored Glycine 0 N--CA 1.437 -1.281 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 176.799 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -72.74 136.08 45.44 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -68.18 85.31 0.25 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 175.304 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.47 ' CD2' ' HB3' ' A' ' 94' ' ' PHE . 6.7 t80 -37.29 144.25 0.08 Allowed 'General case' 0 C--O 1.214 -0.769 0 C-N-CA 123.95 0.9 . . . . 0.0 110.659 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.3 55.91 0.8 Allowed 'General case' 0 C--N 1.313 -0.986 0 O-C-N 119.781 -1.825 . . . . 0.0 110.936 174.687 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.47 ' HB3' ' CD2' ' A' ' 92' ' ' TYR . 34.1 p90 -71.35 -24.17 62.04 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 124.099 0.959 . . . . 0.0 111.025 175.884 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -86.11 -27.66 24.52 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 123.973 0.909 . . . . 0.0 110.401 178.103 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -88.9 111.57 22.25 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -178.872 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.3 pttt -58.04 -49.75 75.81 Favored 'General case' 0 CA--C 1.511 -0.522 0 O-C-N 121.648 -0.658 . . . . 0.0 111.003 177.471 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 2.3 mtmm -138.07 126.08 14.03 Favored Pre-proline 0 N--CA 1.436 -1.155 0 CA-C-N 114.364 -1.289 . . . . 0.0 109.946 -175.826 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 22.9 Cg_endo -69.55 176.65 31.16 Favored 'Cis proline' 0 N--CA 1.459 -0.558 0 O-C-N 124.35 1.71 . . . . 0.0 110.949 -3.965 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.99 123.16 16.84 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 124.845 1.258 . . . . 0.0 109.484 177.345 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.49 -179.37 7.14 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 125.309 1.63 . . . . 0.0 110.378 178.677 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -46.64 153.14 0.81 Allowed Pre-proline 0 CA--C 1.541 0.622 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.937 176.462 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.49 -70.62 0.02 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.576 0 C-N-CA 121.998 1.799 . . . . 0.0 110.626 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 125.14 129.42 3.36 Favored Glycine 0 CA--C 1.533 1.178 0 CA-C-N 118.885 0.766 . . . . 0.0 111.214 -178.511 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.93 -69.56 0.02 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 122.924 2.416 . . . . 0.0 110.477 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.505 ' CB ' ' CE2' ' A' ' 11' ' ' TYR . . . -66.94 132.87 48.85 Favored 'General case' 0 CA--C 1.512 -0.491 0 O-C-N 123.18 0.3 . . . . 0.0 110.732 179.105 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.42 ' HG2' ' HA ' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -139.76 152.15 46.38 Favored 'General case' 0 CA--C 1.497 -1.082 0 CA-C-O 117.719 -1.134 . . . . 0.0 110.737 -178.237 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.411 HG11 ' CB ' ' A' ' 20' ' ' SER . 3.3 p -87.32 114.17 25.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 O-C-N 124.153 0.908 . . . . 0.0 111.673 178.246 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 1.4 mp -98.7 118.07 44.69 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.236 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 -173.312 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.485 ' CD1' ' CG ' ' A' ' 115' ' ' LYS . 4.6 p90 -139.03 148.0 42.82 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-O 123.918 1.818 . . . . 0.0 108.616 -178.897 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.8 p -83.27 164.87 19.82 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.142 178.444 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.504 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -107.46 154.81 40.47 Favored Pre-proline 0 CA--C 1.55 0.959 0 CA-C-O 121.014 0.435 . . . . 0.0 111.072 178.495 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.504 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 15.9 Cg_endo -74.96 -53.29 0.16 OUTLIER 'Cis proline' 0 CA--C 1.498 -1.297 0 C-N-CA 124.158 -1.184 . . . . 0.0 110.071 -6.622 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 32.7 t30 -45.82 111.39 0.35 Allowed 'General case' 0 CA--C 1.509 -0.605 0 CA-C-O 117.174 -1.393 . . . . 0.0 108.783 177.29 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.485 ' CG ' ' CD1' ' A' ' 110' ' ' TYR . 0.1 OUTLIER -65.79 79.52 0.07 Allowed 'General case' 0 CA--C 1.507 -0.691 0 C-N-CA 125.008 1.323 . . . . 0.0 109.102 -179.905 . . . . . . . . 3 3 . 1 . 003 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 80.9 t -76.54 75.72 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.763 0 N-CA-C 105.558 -2.015 . . . . 0.0 105.558 -173.248 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.402 ' CZ ' ' NE2' ' A' ' 13' ' ' GLN . 57.3 t80 -37.68 101.92 0.02 OUTLIER 'General case' 0 C--O 1.237 0.397 0 C-N-CA 127.723 2.409 . . . . 0.0 108.822 -175.898 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . 0.447 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 16.0 m -85.4 -43.16 13.88 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 -176.156 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 156.79 -146.94 14.65 Favored Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.194 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.409 HG13 ' CG ' ' A' ' 4' ' ' TRP . 1.4 mm -129.5 139.24 52.22 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.403 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 -174.792 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.438 HD11 ' CZ ' ' A' ' 38' ' ' PHE . 4.3 pt -127.33 153.1 36.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 -177.321 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -167.38 158.89 12.02 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 122.007 0.908 . . . . 0.0 109.711 175.665 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -91.51 93.04 8.79 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -177.482 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.7 t -97.63 37.63 1.36 Allowed 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 123.682 1.706 . . . . 0.0 111.871 -179.5 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.0 tptm -102.98 -29.12 11.59 Favored 'General case' 0 C--O 1.218 -0.605 0 O-C-N 120.775 -1.203 . . . . 0.0 111.071 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -174.43 -65.01 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.373 0 O-C-N 124.22 0.95 . . . . 0.0 110.307 177.409 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -150.6 -46.52 0.12 Allowed 'General case' 0 N--CA 1.456 -0.137 0 CA-C-O 123.027 1.394 . . . . 0.0 110.709 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.07 76.45 0.85 Allowed 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 122.496 1.141 . . . . 0.0 111.072 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -127.03 -106.53 1.42 Allowed Glycine 0 N--CA 1.461 0.302 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.49 152.94 27.09 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 122.227 -0.573 . . . . 0.0 111.01 178.467 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -114.58 144.68 42.99 Favored 'General case' 0 C--O 1.221 -0.417 0 C-N-CA 123.666 0.786 . . . . 0.0 110.027 177.652 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 5.8 ptmt -150.78 169.87 20.61 Favored 'General case' 0 CA--C 1.506 -0.72 0 C-N-CA 124.335 1.054 . . . . 0.0 109.261 -177.841 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 11.9 tp -81.99 138.85 34.84 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.557 1.161 . . . . 0.0 108.199 178.569 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 72.3 m -61.19 -176.57 0.07 Allowed 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 122.997 1.379 . . . . 0.0 111.133 174.716 . . . . . . . . 1 1 . 1 . 003 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -158.69 112.88 2.46 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -178.469 . . . . . . . . 2 2 . 1 . 003 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.255 1.354 0 CA-C-O 113.429 -3.177 . . . . 0.0 110.944 173.777 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.483 -1.598 0 CA-C-O 114.195 -2.812 . . . . 0.0 106.842 . . . . . . . . . 0 0 . 1 . 004 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 6.9 p 49.79 176.71 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 O-C-N 127.062 2.726 . . . . 0.0 111.859 -176.658 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 29.9 m -106.84 115.56 30.4 Favored 'General case' 0 C--N 1.315 -0.925 0 O-C-N 121.277 -0.889 . . . . 0.0 109.923 179.422 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.681 ' CZ2' ' CD2' ' A' ' 136' ' ' HIS . 17.4 m95 -81.57 137.72 35.48 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -131.56 139.27 49.18 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -178.197 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -125.48 65.86 1.16 Allowed 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 177.643 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 40.39 70.72 0.35 Allowed Glycine 0 CA--C 1.529 0.91 0 O-C-N 123.876 0.735 . . . . 0.0 112.335 -178.707 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 177.69 -79.84 0.07 OUTLIER Glycine 0 C--O 1.227 -0.293 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 -178.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 25.8 mt -135.81 164.34 28.13 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 178.364 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.8 mp -83.41 139.87 32.72 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.194 179.133 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.446 ' CE2' ' CB ' ' A' ' 106' ' ' ALA . 78.5 m-85 -127.79 101.13 6.22 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 123.898 0.879 . . . . 0.0 109.643 -175.235 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -56.17 117.06 3.41 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-O 117.751 -1.119 . . . . 0.0 109.109 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.451 ' HB2' ' CD1' ' A' ' 4' ' ' TRP . 1.7 tp60 -43.67 -43.41 5.85 Favored 'General case' 0 C--O 1.221 -0.425 0 O-C-N 124.399 1.062 . . . . 0.0 111.533 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -48.77 -56.2 9.31 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 118.39 -0.814 . . . . 0.0 110.083 176.455 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.433 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 0.2 OUTLIER -53.45 -32.02 48.08 Favored 'General case' 0 C--O 1.204 -1.34 0 CA-C-O 117.147 -1.406 . . . . 0.0 111.395 174.45 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.4 -75.36 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 120.665 1.575 . . . . 0.0 111.784 174.013 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.405 ' O ' ' CD2' ' A' ' 21' ' ' HIS . 2.5 pt-20 -61.98 -37.42 84.75 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-O 117.936 -1.03 . . . . 0.0 109.913 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 34.5 t -64.24 -65.26 0.7 Allowed 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 126.212 1.805 . . . . 0.0 109.798 -179.315 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.496 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 10.2 t-20 -43.28 -32.51 0.8 Allowed 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 123.459 0.704 . . . . 0.0 111.959 174.309 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.58 -41.43 27.18 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 175.237 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.405 ' CD2' ' O ' ' A' ' 17' ' ' GLU . 10.1 m170 -41.93 -39.78 1.96 Allowed 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 125.594 1.557 . . . . 0.0 109.662 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.496 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -73.09 -51.21 18.9 Favored 'General case' 0 N--CA 1.439 -1.007 0 O-C-N 124.418 1.074 . . . . 0.0 111.561 176.513 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.415 ' HB2' ' CE1' ' A' ' 83' ' ' PHE . . . -37.03 130.76 0.74 Allowed Pre-proline 0 N--CA 1.442 -0.836 0 O-C-N 125.28 1.612 . . . . 0.0 111.873 175.628 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.404 ' HG2' ' CG2' ' A' ' 30' ' ' THR . 15.5 Cg_endo -74.11 124.33 8.99 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 121.662 1.574 . . . . 0.0 109.159 -177.031 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.9 tp -59.39 91.93 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.947 178.986 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 26' ' ' SER . . . . . 0.748 ' HG ' ' ND2' ' A' ' 73' ' ' ASN . 0.4 OUTLIER 178.47 159.57 0.55 Allowed 'General case' 0 N--CA 1.448 -0.565 0 O-C-N 124.264 0.977 . . . . 0.0 110.236 -176.531 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -101.95 131.05 48.58 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-O 118.238 -0.887 . . . . 0.0 109.972 178.978 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 41.88 71.77 0.33 Allowed Glycine 0 CA--C 1.522 0.491 0 O-C-N 124.912 1.382 . . . . 0.0 111.504 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.16 25.43 0.72 Allowed 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.413 0.625 . . . . 0.0 110.685 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.404 ' CG2' ' HG2' ' A' ' 24' ' ' PRO . 69.2 p -123.86 150.84 44.12 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-O 118.663 -0.684 . . . . 0.0 109.513 -178.058 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . 0.405 ' HA3' ' O ' ' A' ' 95' ' ' ASP . . . -39.0 -58.14 1.93 Allowed Glycine 0 N--CA 1.45 -0.42 0 O-C-N 124.853 1.345 . . . . 0.0 112.034 -178.792 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.6 t -70.28 -71.66 0.23 Allowed 'General case' 0 N--CA 1.443 -0.805 0 CA-C-O 118.621 -0.704 . . . . 0.0 110.648 176.509 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 58.6 p 178.91 -60.48 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.277 0 O-C-N 124.6 1.188 . . . . 0.0 111.531 -178.74 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.519 ' CD1' ' HD3' ' A' ' 84' ' ' PRO . 50.8 m-85 -62.48 149.1 89.04 Favored Pre-proline 0 N--CA 1.428 -1.542 0 C-N-CA 123.729 0.812 . . . . 0.0 111.85 178.776 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -75.39 164.08 89.01 Favored 'Cis proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.48 -1.883 . . . . 0.0 110.868 -1.001 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.431 ' CD2' ' CD1' ' A' ' 34' ' ' TYR . 0.6 OUTLIER -142.24 162.09 36.36 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.211 -178.3 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.621 ' CD2' ' CD2' ' A' ' 68' ' ' HIS . 21.5 t90 -61.58 132.01 51.92 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.503 ' CE2' HG21 ' A' ' 109' ' ' ILE . 8.2 t80 -104.07 78.01 1.48 Allowed 'General case' 0 N--CA 1.428 -1.569 0 C-N-CA 124.903 1.281 . . . . 0.0 108.157 -178.388 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.543 HG21 ' CE3' ' A' ' 37' ' ' TRP . 78.7 p -37.42 -38.67 0.25 Allowed 'General case' 0 CA--C 1.509 -0.62 0 O-C-N 124.167 0.917 . . . . 0.0 110.455 177.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.421 ' HA ' ' CE1' ' A' ' 38' ' ' PHE . 44.6 t30 62.8 12.63 5.84 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 122.747 1.26 . . . . 0.0 108.748 178.322 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 114.59 -35.49 4.4 Favored Glycine 0 N--CA 1.429 -1.797 0 O-C-N 119.666 -1.896 . . . . 0.0 112.309 -174.992 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.541 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 59.8 m-85 -50.48 162.27 0.25 Allowed 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 121.185 0.517 . . . . 0.0 111.807 178.225 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.21 -38.24 22.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.464 178.654 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 125.98 41.37 0.34 Allowed Glycine 0 N--CA 1.437 -1.251 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.634 -176.923 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -146.01 -70.07 0.26 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.16 -74.61 0.01 OUTLIER Glycine 0 N--CA 1.435 -1.408 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -177.759 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.8 pttt -98.29 178.57 5.02 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 118.257 1.029 . . . . 0.0 110.648 178.311 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.541 ' HG ' ' CD1' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -106.03 163.72 16.47 Favored Pre-proline 0 N--CA 1.444 -0.74 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.569 -179.548 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.63 163.11 36.61 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 121.762 1.641 . . . . 0.0 110.624 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.71 97.34 0.05 Allowed 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 125.06 54.59 0.17 Allowed Glycine 0 N--CA 1.447 -0.633 0 O-C-N 121.436 -0.79 . . . . 0.0 111.668 -179.032 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -150.95 145.9 25.9 Favored 'General case' 0 N--CA 1.452 -0.335 0 O-C-N 124.127 0.545 . . . . 0.0 110.963 177.864 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.3 m -139.01 98.99 8.31 Favored Pre-proline 0 N--CA 1.45 -0.457 0 O-C-N 124.407 1.067 . . . . 0.0 109.861 -178.702 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -73.56 166.93 28.56 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 121.626 1.55 . . . . 0.0 111.207 179.112 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.461 ' O ' ' CE2' ' A' ' 57' ' ' PHE . 5.6 mt -79.58 125.96 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -178.228 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.9 tppt? -81.69 155.71 25.42 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.125 0.488 . . . . 0.0 109.709 178.142 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.461 ' CE2' ' O ' ' A' ' 55' ' ' ILE . 21.6 m-85 -139.01 -46.88 0.48 Allowed 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.233 178.314 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 119.44 -2.35 14.0 Favored Glycine 0 CA--C 1.522 0.491 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.178 -176.824 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.2 mmtt -96.07 141.86 28.96 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-O 117.625 -1.179 . . . . 0.0 109.774 178.847 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.43 -7.1 58.17 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 124.832 1.333 . . . . 0.0 110.721 177.926 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -90.9 -53.06 4.55 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 123.71 0.804 . . . . 0.0 109.135 -179.004 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.448 ' SG ' ' CE2' ' A' ' 57' ' ' PHE . 4.9 t -72.18 -16.02 61.96 Favored 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 124.103 0.877 . . . . 0.0 110.672 176.606 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -86.68 -37.79 17.63 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 123.57 0.544 . . . . 0.0 111.043 177.158 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.17 165.15 0.28 Allowed Pre-proline 0 N--CA 1.441 -0.912 0 CA-C-O 121.991 0.9 . . . . 0.0 111.237 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -72.6 124.59 9.91 Favored 'Trans proline' 0 N--CA 1.441 -1.607 0 C-N-CA 120.927 1.084 . . . . 0.0 113.076 175.705 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.425 ' HD3' ' CZ ' ' A' ' 42' ' ' TYR . 19.0 Cg_endo -74.26 167.39 27.28 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 122.881 2.387 . . . . 0.0 110.253 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -127.54 104.03 7.66 Favored 'General case' 0 C--O 1.213 -0.82 0 CA-C-O 115.957 -1.973 . . . . 0.0 107.68 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.621 ' CD2' ' CD2' ' A' ' 37' ' ' TRP . 19.2 t-80 -93.55 161.92 14.17 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.47 1.106 . . . . 0.0 110.341 176.587 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.32 176.76 11.28 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.153 179.478 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.74 63.02 7.29 Favored 'General case' 0 C--O 1.224 -0.263 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.695 178.0 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -177.41 -39.0 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.885 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 122.59 -65.64 0.5 Allowed Glycine 0 N--CA 1.44 -1.056 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.515 -178.549 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.748 ' ND2' ' HG ' ' A' ' 26' ' ' SER . 1.6 p30 -120.51 62.03 0.86 Allowed 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.041 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -56.13 -105.61 0.01 OUTLIER Glycine 0 CA--C 1.532 1.149 0 CA-C-O 123.362 1.534 . . . . 0.0 112.236 -178.749 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 16.1 mttp -70.76 -104.59 0.0 OUTLIER 'General case' 0 C--O 1.218 -0.556 0 O-C-N 120.07 -1.841 . . . . 0.0 110.285 178.438 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.423 ' CG2' ' O ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -109.21 16.62 22.33 Favored 'General case' 0 N--CA 1.447 -0.607 0 O-C-N 121.553 -0.717 . . . . 0.0 110.65 179.45 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.47 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 5.4 m-20 -29.73 102.25 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 123.838 0.855 . . . . 0.0 111.651 -179.138 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.499 ' H ' ' CD2' ' A' ' 78' ' ' HIS . 4.9 p80 -87.88 28.13 1.07 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -175.908 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.534 ' CE1' ' CD1' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -54.46 168.16 0.28 Allowed 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 174.897 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.413 HD22 ' CG2' ' A' ' 109' ' ' ILE . 0.6 OUTLIER -98.26 158.05 15.8 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 118.477 -0.773 . . . . 0.0 109.758 176.947 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.534 ' CD1' ' CE1' ' A' ' 79' ' ' TYR . 1.4 mp -141.82 130.69 23.01 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 123.298 0.639 . . . . 0.0 109.511 178.863 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.471 ' CB ' ' CD1' ' A' ' 109' ' ' ILE . 0.4 OUTLIER -99.95 151.08 21.74 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 121.565 0.698 . . . . 0.0 110.995 179.138 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.415 ' CE1' ' HB2' ' A' ' 23' ' ' ALA . 28.7 t80 -142.0 121.01 7.85 Favored Pre-proline 0 N--CA 1.444 -0.774 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.273 -178.853 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.519 ' HD3' ' CD1' ' A' ' 34' ' ' TYR . 19.4 Cg_endo -72.9 111.73 3.34 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 122.886 2.391 . . . . 0.0 110.193 -177.191 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.55 125.54 51.94 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.125 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.485 ' CD2' ' NE2' ' A' ' 90' ' ' HIS . 63.5 m-85 -82.89 155.74 67.71 Favored Pre-proline 0 N--CA 1.443 -0.822 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.012 178.836 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -77.64 -42.12 0.29 Allowed 'Trans proline' 0 CA--C 1.505 -0.931 0 C-N-CA 122.104 1.869 . . . . 0.0 111.898 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -43.25 -30.88 0.54 Allowed 'General case' 0 C--N 1.346 0.426 0 O-C-N 125.078 1.486 . . . . 0.0 110.293 177.428 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 99.87 -12.48 60.86 Favored Glycine 0 N--CA 1.436 -1.364 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 177.151 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.485 ' NE2' ' CD2' ' A' ' 86' ' ' PHE . 4.8 p-80 -58.38 128.77 38.83 Favored 'General case' 0 N--CA 1.44 -0.925 0 O-C-N 124.325 0.662 . . . . 0.0 109.449 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -68.95 101.47 1.39 Allowed 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.086 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.488 ' O ' ' CD2' ' A' ' 94' ' ' PHE . 6.5 t80 -34.26 138.38 0.09 Allowed 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 122.028 0.918 . . . . 0.0 111.463 178.858 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.402 ' HE2' ' O ' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -78.96 60.08 2.81 Favored 'General case' 0 N--CA 1.442 -0.852 0 O-C-N 120.081 -1.637 . . . . 0.0 109.953 177.75 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.488 ' CD2' ' O ' ' A' ' 92' ' ' TYR . 30.4 p90 -75.55 1.7 13.61 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 123.269 0.628 . . . . 0.0 112.084 177.207 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . 0.405 ' O ' ' HA3' ' A' ' 31' ' ' GLY . 36.7 t0 -95.79 -38.8 10.16 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 122.394 1.092 . . . . 0.0 109.115 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -80.75 110.03 15.86 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 120.862 -1.149 . . . . 0.0 109.36 -178.883 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.8 pttt -57.86 -50.28 73.85 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.04 178.51 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.46 127.51 7.26 Favored Pre-proline 0 N--CA 1.431 -1.401 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.802 -176.734 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.402 ' O ' ' HE2' ' A' ' 93' ' ' LYS . 21.7 Cg_endo -73.05 178.04 34.09 Favored 'Cis proline' 0 N--CA 1.458 -0.596 0 O-C-N 125.093 2.102 . . . . 0.0 111.232 -2.354 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.0 132.39 25.11 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.14 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -72.67 145.02 47.53 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 124.244 0.965 . . . . 0.0 109.312 178.922 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -42.09 156.83 0.22 Allowed Pre-proline 0 N--CA 1.45 -0.448 0 O-C-N 123.74 0.65 . . . . 0.0 111.411 177.709 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -72.49 -163.13 0.14 Allowed 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 121.235 1.29 . . . . 0.0 111.142 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -139.85 154.33 23.73 Favored Glycine 0 N--CA 1.441 -0.988 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.04 178.523 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -75.52 -66.55 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.143 1.895 . . . . 0.0 110.131 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.446 ' CB ' ' CE2' ' A' ' 11' ' ' TYR . . . -69.19 135.75 51.07 Favored 'General case' 0 N--CA 1.443 -0.78 0 O-C-N 124.298 0.999 . . . . 0.0 110.907 178.551 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 4.3 mtt85 -141.47 146.02 35.94 Favored 'General case' 0 N--CA 1.448 -0.541 0 O-C-N 123.913 0.758 . . . . 0.0 110.716 -178.848 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.41 ' CG1' ' HB3' ' A' ' 83' ' ' PHE . 7.7 p -83.6 128.89 38.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 O-C-N 123.736 0.648 . . . . 0.0 109.869 178.865 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.503 HG21 ' CE2' ' A' ' 38' ' ' PHE . 9.1 mm -107.9 142.83 19.58 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.861 0 CA-C-O 118.571 -0.728 . . . . 0.0 109.938 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.49 ' CD1' ' HG3' ' A' ' 115' ' ' LYS . 12.4 p90 -167.15 155.45 9.67 Favored 'General case' 0 N--CA 1.442 -0.839 0 O-C-N 124.121 0.888 . . . . 0.0 111.14 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.0 p -91.83 164.71 13.59 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.476 -177.91 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.536 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -111.93 154.35 44.19 Favored Pre-proline 0 N--CA 1.442 -0.866 0 C-N-CA 122.45 0.3 . . . . 0.0 110.898 179.536 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.536 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 18.6 Cg_endo -74.52 -54.03 0.15 OUTLIER 'Cis proline' 0 CA--C 1.509 -0.748 0 C-N-CA 122.523 -1.865 . . . . 0.0 109.468 -4.345 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -42.92 111.49 0.27 Allowed 'General case' 0 CA--C 1.507 -0.692 0 CA-C-O 116.45 -1.738 . . . . 0.0 109.722 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.49 ' HG3' ' CD1' ' A' ' 110' ' ' TYR . 0.3 OUTLIER -63.09 76.35 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.375 0 O-C-N 125.77 1.919 . . . . 0.0 109.123 -178.44 . . . . . . . . 3 3 . 1 . 004 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 8.8 t -77.01 71.25 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 -176.972 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.595 ' CZ ' ' HA2' ' A' ' 119' ' ' GLY . 27.9 t80 -35.63 110.6 0.11 Allowed 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 123.16 0.584 . . . . 0.0 111.132 178.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . 0.448 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 6.2 m -82.61 -45.5 14.49 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.595 ' HA2' ' CZ ' ' A' ' 117' ' ' PHE . . . 161.93 -145.05 10.32 Favored Glycine 0 N--CA 1.443 -0.87 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.456 HG13 ' CD2' ' A' ' 4' ' ' TRP . 1.1 mm -127.63 136.97 59.01 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.82 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 -176.45 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 9.2 pt -127.36 156.06 38.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -177.69 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -173.9 145.9 1.17 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.515 0.674 . . . . 0.0 109.82 178.053 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.451 ' CE1' ' HB2' ' A' ' 131' ' ' LEU . 3.9 m-70 -90.37 93.59 9.39 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.038 -177.483 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.9 p -103.15 46.18 0.93 Allowed 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 -177.198 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -108.36 -23.68 11.79 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.833 177.493 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -174.25 -64.02 0.01 OUTLIER 'General case' 0 C--O 1.223 -0.314 0 O-C-N 123.72 0.638 . . . . 0.0 110.801 178.064 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -155.31 -46.03 0.08 Allowed 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 122.146 0.974 . . . . 0.0 110.028 179.076 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -159.57 76.89 0.68 Allowed 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.93 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -127.92 -104.3 1.23 Allowed Glycine 0 N--CA 1.452 -0.239 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.71 144.98 36.85 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 122.444 -0.445 . . . . 0.0 111.086 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.451 ' HB2' ' CE1' ' A' ' 123' ' ' HIS . 4.4 tp -109.77 136.79 48.54 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 122.475 0.31 . . . . 0.0 110.896 178.346 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.03 171.73 13.67 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -178.745 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.411 ' HB2' ' CG2' ' A' ' 55' ' ' ILE . 5.2 tp -88.12 143.23 27.18 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 124.562 1.164 . . . . 0.0 109.135 178.766 . . . . . . . . 2 2 . 1 . 004 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 76.0 m -62.04 -172.21 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 122.088 0.946 . . . . 0.0 109.707 177.302 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 19.5 m -133.04 92.46 3.03 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.469 -179.006 . . . . . . . . 1 1 . 1 . 004 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 0.681 ' CD2' ' CZ2' ' A' ' 4' ' ' TRP . 2.1 p-80 . . . . . 0 C--O 1.25 1.097 0 CA-C-O 116.886 -1.531 . . . . 0.0 112.258 176.35 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.534 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 . . . . . . . . . 0 0 . 1 . 005 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.4 p -119.94 132.29 70.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -178.055 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.2 m -89.52 109.05 20.02 Favored 'General case' 0 C--N 1.317 -0.818 0 O-C-N 121.488 -0.758 . . . . 0.0 109.553 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 39.7 m95 -77.32 140.0 39.9 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 124.065 0.946 . . . . 0.0 110.54 178.549 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.6 m -124.57 120.24 31.37 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 122.093 0.949 . . . . 0.0 109.045 -176.118 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 74.9 m -103.87 64.56 0.79 Allowed 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -179.943 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 34.65 60.14 0.65 Allowed Glycine 0 C--N 1.341 0.806 0 C-N-CA 124.992 1.282 . . . . 0.0 113.007 178.95 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 170.02 -80.97 0.09 OUTLIER Glycine 0 C--O 1.224 -0.491 0 N-CA-C 110.501 -1.039 . . . . 0.0 110.501 -175.21 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -114.66 159.05 20.94 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.488 1.115 . . . . 0.0 108.787 -176.198 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -110.74 125.33 53.4 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -172.019 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.499 ' CE2' ' CB ' ' A' ' 106' ' ' ALA . 89.5 m-85 -117.06 106.68 13.64 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 126.441 1.896 . . . . 0.0 108.537 -172.043 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -58.7 127.81 34.06 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.31 177.171 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.475 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 7.0 tp-100 -54.82 -44.49 73.9 Favored 'General case' 0 C--O 1.217 -0.626 0 O-C-N 121.373 -0.83 . . . . 0.0 112.773 178.311 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -51.71 -26.3 9.06 Favored 'General case' 0 C--O 1.213 -0.845 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 175.874 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.18 -41.66 15.43 Favored 'General case' 0 C--O 1.206 -1.217 0 CA-C-O 116.174 -1.87 . . . . 0.0 113.418 170.235 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.55 -62.91 1.35 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 121.705 2.048 . . . . 0.0 113.08 175.167 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -58.03 -43.61 86.87 Favored 'General case' 0 C--N 1.333 -0.137 0 O-C-N 121.543 -0.723 . . . . 0.0 110.73 174.214 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.5 t -61.93 -23.21 66.21 Favored 'General case' 0 C--O 1.222 -0.381 0 O-C-N 121.89 -0.506 . . . . 0.0 111.354 175.595 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -71.11 -63.89 1.02 Allowed 'General case' 0 N--CA 1.438 -1.059 0 O-C-N 120.603 -1.31 . . . . 0.0 108.439 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.39 -15.91 51.61 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 114.669 -1.151 . . . . 0.0 111.518 178.021 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 1.4 m170 -59.41 -51.86 68.08 Favored 'General case' 0 CA--C 1.517 -0.306 0 O-C-N 121.296 -0.878 . . . . 0.0 110.91 178.284 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -74.92 -41.02 60.51 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 123.811 0.694 . . . . 0.0 111.15 178.212 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.44 ' HB2' ' CE2' ' A' ' 83' ' ' PHE . . . -43.14 131.4 3.33 Favored Pre-proline 0 N--CA 1.447 -0.577 0 O-C-N 124.651 1.219 . . . . 0.0 112.441 177.801 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -71.18 123.65 9.8 Favored 'Trans proline' 0 N--CA 1.444 -1.414 0 C-N-CA 122.053 1.835 . . . . 0.0 109.54 -177.195 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.4 ' CD1' ' HE2' ' A' ' 115' ' ' LYS . 5.7 tp -61.48 96.66 0.06 Allowed 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.625 0.77 . . . . 0.0 110.94 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 178.2 165.21 0.74 Allowed 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 124.041 0.936 . . . . 0.0 109.728 -175.118 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.73 121.28 42.13 Favored 'General case' 0 CA--C 1.511 -0.525 0 C-N-CA 124.749 1.22 . . . . 0.0 109.688 177.041 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 48.77 67.9 1.51 Allowed Glycine 0 CA--C 1.525 0.707 0 CA-C-O 121.772 0.651 . . . . 0.0 112.636 174.802 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.05 28.47 1.01 Allowed 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.599 0.76 . . . . 0.0 112.759 -178.233 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 71.9 p -127.56 151.03 49.42 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -175.442 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -40.17 -58.22 2.42 Favored Glycine 0 C--O 1.228 -0.242 0 C-N-CA 123.655 0.645 . . . . 0.0 113.714 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 29.2 t -67.18 -72.64 0.16 Allowed 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 123.772 0.336 . . . . 0.0 111.623 173.535 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 47.8 p 177.96 -56.05 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 124.194 0.998 . . . . 0.0 112.827 -178.474 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.485 ' CD2' ' HD3' ' A' ' 84' ' ' PRO . 69.9 m-85 -68.87 147.36 97.84 Favored Pre-proline 0 N--CA 1.442 -0.857 0 C-N-CA 124.931 1.292 . . . . 0.0 113.286 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 26.1 Cg_endo -75.49 165.53 85.46 Favored 'Cis proline' 0 N--CA 1.445 -1.353 0 C-N-CA 123.938 -1.276 . . . . 0.0 111.186 1.567 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.41 ' CD2' ' CD2' ' A' ' 34' ' ' TYR . 1.1 p80 -141.47 171.8 13.56 Favored 'General case' 0 CA--C 1.504 -0.797 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.574 -177.987 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.486 ' CH2' ' HA2' ' A' ' 44' ' ' GLY . 22.0 t90 -72.17 128.08 34.58 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 122.687 1.232 . . . . 0.0 109.726 175.564 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.479 ' CZ ' ' HA ' ' A' ' 40' ' ' ASN . 19.3 t80 -98.29 86.15 3.59 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 126.674 1.989 . . . . 0.0 107.041 176.612 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 69.0 p -40.36 -33.43 0.25 Allowed 'General case' 0 C--O 1.217 -0.645 0 CA-C-N 114.656 -1.156 . . . . 0.0 111.105 172.062 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.479 ' HA ' ' CZ ' ' A' ' 38' ' ' PHE . 57.1 t30 68.56 5.92 5.13 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.519 1.128 . . . . 0.0 110.878 -178.516 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 115.96 -26.41 8.85 Favored Glycine 0 N--CA 1.432 -1.59 0 C-N-CA 125.066 1.317 . . . . 0.0 116.095 -171.427 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.431 ' CD2' ' HA2' ' A' ' 46' ' ' GLY . 58.4 m-85 -54.57 -178.16 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 122.365 1.079 . . . . 0.0 110.299 176.755 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -103.87 -40.7 6.14 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 124.462 1.105 . . . . 0.0 110.763 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.486 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -174.05 -61.55 0.05 OUTLIER Glycine 0 C--N 1.336 0.549 0 C-N-CA 123.751 0.691 . . . . 0.0 112.641 -178.038 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -82.92 -98.62 0.05 OUTLIER 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.424 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.431 ' HA2' ' CD2' ' A' ' 42' ' ' TYR . . . -138.84 29.76 2.53 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 125.048 1.308 . . . . 0.0 111.674 -174.359 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.9 mttt -126.87 149.19 49.88 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 118.144 -0.931 . . . . 0.0 108.737 -178.718 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -115.38 160.51 34.11 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.406 1.066 . . . . 0.0 109.187 -178.11 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -69.02 157.54 61.43 Favored 'Trans proline' 0 N--CA 1.443 -1.459 0 C-N-CA 121.884 1.723 . . . . 0.0 110.161 177.671 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -49.27 104.41 0.06 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.094 0.958 . . . . 0.0 110.352 176.317 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.74 87.98 0.59 Allowed Glycine 0 CA--C 1.524 0.601 0 O-C-N 123.572 0.545 . . . . 0.0 111.851 -174.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -150.83 155.53 39.4 Favored 'General case' 0 CA--C 1.516 -0.365 0 C-N-CA 123.164 0.586 . . . . 0.0 110.552 174.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.0 m -138.92 101.59 7.78 Favored Pre-proline 0 C--N 1.329 -0.305 0 O-C-N 124.014 0.821 . . . . 0.0 111.439 178.925 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -66.4 153.74 76.87 Favored 'Trans proline' 0 N--CA 1.448 -1.148 0 C-N-CA 123.856 3.038 . . . . 0.0 112.073 177.518 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.8 mt -66.74 127.33 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -95.39 134.45 38.18 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 176.029 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.477 ' CD1' ' SG ' ' A' ' 62' ' ' CYS . 1.7 m-85 -119.62 -55.31 2.12 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 124.213 1.005 . . . . 0.0 110.623 -179.445 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 120.42 -2.9 12.49 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 124.88 1.228 . . . . 0.0 113.469 -176.058 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.8 mmtp -66.46 177.66 1.46 Allowed 'General case' 0 C--O 1.215 -0.735 0 O-C-N 122.065 -0.667 . . . . 0.0 111.364 173.481 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.0 p -104.23 -47.17 4.22 Favored 'General case' 0 C--O 1.216 -0.679 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.153 177.324 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.45 -41.03 41.21 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 123.097 0.559 . . . . 0.0 110.892 177.542 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.477 ' SG ' ' CD1' ' A' ' 57' ' ' PHE . 1.5 t -74.25 -17.37 60.88 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 122.786 0.434 . . . . 0.0 110.736 178.61 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -87.58 -38.31 16.08 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 123.115 0.566 . . . . 0.0 112.31 171.456 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.78 163.8 1.92 Allowed Pre-proline 0 N--CA 1.448 -0.57 0 CA-C-O 121.785 0.803 . . . . 0.0 111.491 -178.247 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -70.54 138.75 36.01 Favored 'Trans proline' 0 N--CA 1.439 -1.69 0 C-N-CA 120.401 0.734 . . . . 0.0 112.232 175.735 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -68.21 175.29 6.89 Favored 'Trans proline' 0 N--CA 1.448 -1.2 0 C-N-CA 122.952 2.435 . . . . 0.0 111.965 175.817 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.8 tptt -136.98 56.27 1.8 Allowed 'General case' 0 C--O 1.209 -1.041 0 O-C-N 120.835 -1.165 . . . . 0.0 108.685 174.159 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -77.54 165.05 24.82 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 119.16 -1.016 . . . . 0.0 110.488 177.693 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.57 -165.62 2.03 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.908 0.883 . . . . 0.0 111.241 178.197 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.11 73.69 10.36 Favored 'General case' 0 C--O 1.219 -0.509 0 O-C-N 121.322 -0.862 . . . . 0.0 111.146 175.602 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -176.89 -43.35 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.507 0 O-C-N 124.419 1.074 . . . . 0.0 111.367 178.637 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.452 ' O ' ' CE2' ' A' ' 79' ' ' TYR . . . 122.53 -52.65 0.75 Allowed Glycine 0 C--O 1.217 -0.918 0 CA-C-N 114.693 -1.139 . . . . 0.0 111.208 -177.79 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -148.59 86.18 1.52 Allowed 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.25 -112.2 0.01 OUTLIER Glycine 0 CA--C 1.525 0.66 0 CA-C-O 122.331 0.962 . . . . 0.0 113.037 176.714 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -64.58 -96.73 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 O-C-N 120.427 -1.631 . . . . 0.0 112.436 176.582 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -110.55 16.27 21.6 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 121.379 -0.826 . . . . 0.0 110.272 178.46 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.459 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 8.6 m-20 -29.24 104.93 0.03 OUTLIER 'General case' 0 C--O 1.207 -1.141 0 C-N-CA 125.792 1.637 . . . . 0.0 109.94 -176.868 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.523 ' H ' ' CD2' ' A' ' 78' ' ' HIS . 2.5 p80 -87.17 16.31 5.28 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 118.968 0.803 . . . . 0.0 110.268 -175.421 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.452 ' CE2' ' O ' ' A' ' 72' ' ' GLY . 0.3 OUTLIER -36.19 134.27 0.43 Allowed 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 126.156 1.782 . . . . 0.0 111.311 172.148 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -76.68 153.65 34.95 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.797 176.648 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.418 ' CD1' ' CZ ' ' A' ' 79' ' ' TYR . 1.7 mp -140.27 139.06 35.44 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 123.191 0.596 . . . . 0.0 109.659 177.658 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.459 ' CB ' ' CD1' ' A' ' 109' ' ' ILE . 0.5 OUTLIER -105.81 154.2 20.85 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.593 0.711 . . . . 0.0 111.284 179.261 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.44 ' CE2' ' HB2' ' A' ' 23' ' ' ALA . 5.7 t80 -141.79 126.35 10.32 Favored Pre-proline 0 CA--C 1.537 0.452 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.748 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.485 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 19.6 Cg_endo -73.87 104.44 1.83 Allowed 'Trans proline' 0 N--CA 1.448 -1.148 0 C-N-CA 124.789 3.659 . . . . 0.0 110.615 -177.56 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.8 t -104.38 119.66 39.46 Favored 'General case' 0 N--CA 1.446 -0.67 0 O-C-N 124.675 1.234 . . . . 0.0 109.963 -179.045 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.434 ' CD2' ' NE2' ' A' ' 90' ' ' HIS . 64.7 m-85 -81.17 158.8 69.2 Favored Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 176.505 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -74.78 -42.54 0.55 Allowed 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 122.504 2.136 . . . . 0.0 113.409 178.295 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -40.42 -37.03 0.62 Allowed 'General case' 0 N--CA 1.478 0.94 0 CA-C-O 123.529 1.633 . . . . 0.0 109.803 174.972 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 97.45 -1.88 60.54 Favored Glycine 0 N--CA 1.442 -0.931 0 O-C-N 121.053 -1.03 . . . . 0.0 112.248 -178.87 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.434 ' NE2' ' CD2' ' A' ' 86' ' ' PHE . 5.9 p-80 -65.39 126.74 29.18 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 176.589 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -59.62 106.07 0.43 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 171.049 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.44 ' O ' ' CD2' ' A' ' 94' ' ' PHE . 7.1 t80 -38.98 139.93 0.42 Allowed 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 121.684 0.754 . . . . 0.0 110.166 173.723 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 7.5 ptpt -75.68 58.44 1.08 Allowed 'General case' 0 C--N 1.326 -0.416 0 O-C-N 120.42 -1.425 . . . . 0.0 111.818 173.304 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.44 ' CD2' ' O ' ' A' ' 92' ' ' TYR . 34.2 p90 -73.08 -14.63 61.43 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 123.856 0.862 . . . . 0.0 112.327 176.143 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -88.8 -37.23 15.57 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 123.329 1.537 . . . . 0.0 111.298 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -79.9 106.9 12.26 Favored 'General case' 0 N--CA 1.455 -0.179 0 O-C-N 120.926 -1.109 . . . . 0.0 109.162 177.152 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt -57.99 -48.4 80.1 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.739 0.78 . . . . 0.0 111.713 176.652 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.7 tmtt? -137.49 130.66 17.04 Favored Pre-proline 0 N--CA 1.445 -0.701 0 C-N-CA 124.828 1.251 . . . . 0.0 110.199 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -68.57 174.53 35.9 Favored 'Cis proline' 0 N--CA 1.453 -0.873 0 C-N-CA 123.181 -1.591 . . . . 0.0 110.415 -9.179 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 22.0 tttm -139.03 116.95 11.6 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 29.4 tp10 -69.96 167.2 17.99 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 123.981 0.801 . . . . 0.0 110.639 174.401 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -42.68 153.28 0.32 Allowed Pre-proline 0 CA--C 1.536 0.41 0 C-N-CA 124.228 1.011 . . . . 0.0 112.064 173.377 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -72.85 -84.02 0.0 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 122.829 2.353 . . . . 0.0 112.547 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 146.58 142.4 3.73 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -74.75 -68.85 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 123.325 2.683 . . . . 0.0 110.71 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.499 ' CB ' ' CE2' ' A' ' 11' ' ' TYR . . . -68.3 139.67 55.94 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 121.735 0.779 . . . . 0.0 111.165 178.583 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.87 144.3 33.77 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.011 -178.651 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.3 p -81.58 124.81 39.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 O-C-N 124.341 1.025 . . . . 0.0 109.139 178.687 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.459 ' CD1' ' CB ' ' A' ' 82' ' ' GLU . 5.8 mm -105.54 141.16 21.51 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.701 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.061 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.435 ' CD1' ' HG3' ' A' ' 115' ' ' LYS . 10.4 p90 -165.17 152.92 11.24 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-O 121.952 0.882 . . . . 0.0 111.294 -176.501 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.0 p -88.66 165.82 14.52 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.852 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.535 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.3 OUTLIER -108.21 156.84 37.73 Favored Pre-proline 0 CA--C 1.547 0.841 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 176.107 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.535 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 17.7 Cg_endo -72.07 -53.4 0.16 OUTLIER 'Cis proline' 0 CA--C 1.51 -0.683 0 C-N-CA 124.216 -1.16 . . . . 0.0 111.064 -10.27 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -45.61 111.43 0.34 Allowed 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 118.685 -0.674 . . . . 0.0 109.92 177.267 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.435 ' HG3' ' CD1' ' A' ' 110' ' ' TYR . 0.2 OUTLIER -62.69 79.86 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.349 0 C-N-CA 124.911 1.285 . . . . 0.0 108.098 -178.262 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 16.2 t -77.43 73.06 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 105.311 -2.107 . . . . 0.0 105.311 -178.263 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.475 ' CZ ' ' NE2' ' A' ' 13' ' ' GLN . 20.7 t80 -46.63 108.16 0.13 Allowed 'General case' 0 N--CA 1.44 -0.95 0 C-N-CA 124.918 1.287 . . . . 0.0 109.008 177.455 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . 0.424 ' SG ' ' CG ' ' A' ' 57' ' ' PHE . 0.1 OUTLIER -83.45 -53.0 6.03 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 121.952 0.882 . . . . 0.0 110.031 179.448 . . . . . . . . 3 3 . 1 . 005 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 177.18 -146.09 7.58 Favored Glycine 0 N--CA 1.437 -1.252 0 CA-C-N 114.464 -1.244 . . . . 0.0 110.43 179.242 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 1.2 mm -126.61 146.85 31.77 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 -177.136 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 8.0 pt -132.7 151.79 35.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -178.891 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -174.95 149.42 1.12 Allowed 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 122.807 0.443 . . . . 0.0 110.863 178.223 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 3.8 m-70 -89.91 96.57 10.74 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -177.005 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 4.3 p -101.59 46.18 0.94 Allowed 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 124.498 1.119 . . . . 0.0 109.816 -177.361 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.7 tttm -107.98 -24.59 11.55 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.543 175.896 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -174.12 -77.25 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 122.202 1.001 . . . . 0.0 109.808 177.954 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -140.63 -47.47 0.42 Allowed 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 125.83 1.652 . . . . 0.0 110.447 -177.025 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -160.0 82.41 0.72 Allowed 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 125.073 1.349 . . . . 0.0 108.995 -177.793 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -123.44 -108.95 1.9 Allowed Glycine 0 CA--C 1.518 0.236 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 175.146 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -87.72 141.2 28.79 Favored 'General case' 0 C--N 1.322 -0.622 0 O-C-N 121.555 -0.968 . . . . 0.0 111.187 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 4.9 tp -94.5 142.6 27.24 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 120.544 0.211 . . . . 0.0 110.819 177.733 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.44 167.55 23.35 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 124.442 1.097 . . . . 0.0 109.626 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 10.0 tp -84.51 137.61 33.24 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.127 0.892 . . . . 0.0 108.746 178.065 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 35.0 m -70.71 -178.75 1.94 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 122.865 1.317 . . . . 0.0 109.821 174.252 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 13.7 p -160.24 100.01 1.35 Allowed 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 105.148 -2.167 . . . . 0.0 105.148 -178.15 . . . . . . . . 1 1 . 1 . 005 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.242 0.674 0 CA-C-O 115.921 -1.99 . . . . 0.0 112.441 168.141 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.513 -0.477 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 . . . . . . . . . 0 0 . 1 . 006 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.3 p -93.52 128.49 44.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 O-C-N 124.372 1.045 . . . . 0.0 109.654 179.788 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 48.9 m -85.78 119.67 26.36 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.148 -179.105 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.528 ' CE2' ' CD2' ' A' ' 136' ' ' HIS . 19.8 m95 -80.44 141.42 35.28 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -141.02 142.51 34.22 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -120.42 50.38 1.32 Allowed 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.896 177.921 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 48.06 73.75 0.31 Allowed Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 -178.925 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 166.55 -74.95 0.15 Allowed Glycine 0 C--N 1.333 0.395 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 54.9 mt -123.82 158.18 32.42 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.401 ' O ' ' CD1' ' A' ' 11' ' ' TYR . 3.9 mp -83.02 165.64 19.46 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.049 179.266 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.595 ' CE2' ' CB ' ' A' ' 106' ' ' ALA . 50.2 m-85 -159.12 85.56 0.81 Allowed 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 121.872 0.844 . . . . 0.0 109.981 -175.319 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -57.43 121.45 10.27 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 117.656 -1.164 . . . . 0.0 108.602 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.563 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 0.6 OUTLIER -43.33 -57.93 2.79 Favored 'General case' 0 C--O 1.207 -1.167 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.386 -179.892 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.445 ' O ' ' CB ' ' A' ' 18' ' ' SER . 19.7 t-20 -44.98 -46.9 11.4 Favored 'General case' 0 C--O 1.198 -1.647 0 O-C-N 124.065 0.853 . . . . 0.0 109.766 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . 0.431 ' CE ' ' HA3' ' A' ' 89' ' ' GLY . 0.0 OUTLIER -62.35 -48.23 80.74 Favored 'General case' 0 C--O 1.204 -1.307 0 CA-C-O 117.376 -1.297 . . . . 0.0 111.267 174.954 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -51.04 -68.19 0.19 Allowed 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 120.091 1.314 . . . . 0.0 111.685 175.501 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.431 ' O ' ' CD2' ' A' ' 21' ' ' HIS . 1.5 pt-20 -55.99 -32.94 64.4 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.206 177.968 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.445 ' CB ' ' O ' ' A' ' 14' ' ' ASN . 12.6 t -68.05 -53.78 23.15 Favored 'General case' 0 C--O 1.216 -0.708 0 C-N-CA 123.949 0.9 . . . . 0.0 109.46 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.414 ' OD1' ' CD2' ' A' ' 83' ' ' PHE . 6.7 t-20 -49.37 -30.62 7.97 Favored 'General case' 0 N--CA 1.434 -1.266 0 O-C-N 120.443 -1.41 . . . . 0.0 109.291 178.415 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.99 -29.36 22.05 Favored 'General case' 0 N--CA 1.442 -0.873 0 O-C-N 123.521 0.513 . . . . 0.0 111.642 176.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.431 ' CD2' ' O ' ' A' ' 17' ' ' GLU . 7.7 m170 -54.19 -42.93 70.27 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 124.029 0.931 . . . . 0.0 109.38 179.099 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.429 ' CD2' ' N ' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -79.59 -48.89 13.03 Favored 'General case' 0 N--CA 1.443 -0.78 0 O-C-N 123.769 0.668 . . . . 0.0 109.562 -179.892 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.488 ' HB2' ' CE1' ' A' ' 83' ' ' PHE . . . -40.35 136.09 1.41 Allowed Pre-proline 0 N--CA 1.442 -0.871 0 O-C-N 125.187 1.554 . . . . 0.0 110.831 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.418 ' HG2' ' CG2' ' A' ' 30' ' ' THR . 18.6 Cg_endo -73.14 122.22 7.88 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 122.032 1.821 . . . . 0.0 110.631 -178.756 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.452 ' CD1' ' HE2' ' A' ' 115' ' ' LYS . 3.0 tp -60.23 95.5 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 123.597 0.56 . . . . 0.0 110.059 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 179.3 162.42 0.84 Allowed 'General case' 0 N--CA 1.448 -0.566 0 O-C-N 123.643 0.59 . . . . 0.0 109.883 -178.21 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -103.55 112.54 25.51 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 123.927 0.767 . . . . 0.0 109.083 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.01 64.69 4.12 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 177.845 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . 0.418 ' O ' ' CG ' ' A' ' 29' ' ' LYS . 12.7 tttt -134.47 12.92 3.8 Favored 'General case' 0 C--N 1.334 -0.074 0 CA-C-O 123.003 1.382 . . . . 0.0 110.024 178.111 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.418 ' CG2' ' HG2' ' A' ' 24' ' ' PRO . 22.8 p -112.92 145.8 40.11 Favored 'General case' 0 C--N 1.315 -0.898 0 O-C-N 120.501 -1.374 . . . . 0.0 108.481 -176.604 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -38.42 -49.57 2.31 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.8 t -74.2 -60.69 2.15 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-O 117.177 -1.392 . . . . 0.0 110.165 177.594 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 162.2 -59.92 0.0 OUTLIER 'General case' 0 C--O 1.222 -0.344 0 O-C-N 125.256 1.597 . . . . 0.0 110.555 179.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.692 ' CE2' ' CE1' ' A' ' 36' ' ' HIS . 60.3 m-85 -58.83 145.78 77.7 Favored Pre-proline 0 N--CA 1.434 -1.256 0 CA-C-O 117.676 -1.154 . . . . 0.0 112.522 178.77 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.401 ' C ' ' HA ' ' A' ' 34' ' ' TYR . 22.2 Cg_endo -74.23 153.41 99.14 Favored 'Cis proline' 0 N--CA 1.454 -0.82 0 C-N-CA 121.578 -2.259 . . . . 0.0 111.855 -1.523 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.692 ' CE1' ' CE2' ' A' ' 34' ' ' TYR . 0.5 OUTLIER -131.8 154.91 48.63 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-O 117.782 -1.104 . . . . 0.0 110.509 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.539 ' CH2' ' CG2' ' A' ' 39' ' ' THR . 13.4 t90 -48.98 144.78 4.42 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.227 0.954 . . . . 0.0 109.143 178.699 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.496 ' CE1' ' CD1' ' A' ' 121' ' ' ILE . 24.6 t80 -114.93 80.96 1.49 Allowed 'General case' 0 N--CA 1.425 -1.717 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 -176.281 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.539 ' CG2' ' CH2' ' A' ' 37' ' ' TRP . 4.3 p -38.46 -32.86 0.08 Allowed 'General case' 0 C--O 1.21 -1.012 0 O-C-N 124.114 0.884 . . . . 0.0 109.933 176.404 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.476 ' HB2' ' CD2' ' A' ' 38' ' ' PHE . 51.0 t30 52.18 22.24 1.87 Allowed 'General case' 0 N--CA 1.447 -0.603 0 O-C-N 121.154 -0.966 . . . . 0.0 108.69 175.967 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.447 ' CA ' ' HD3' ' A' ' 52' ' ' ARG . . . 107.71 -41.42 2.21 Favored Glycine 0 N--CA 1.422 -2.263 0 CA-C-O 118.697 -1.057 . . . . 0.0 114.886 -173.605 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.509 ' CE2' ' HD3' ' A' ' 66' ' ' PRO . 62.4 m-85 -45.72 153.78 0.25 Allowed 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 123.721 0.808 . . . . 0.0 112.126 175.918 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.48 -40.32 16.51 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.708 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.505 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -164.97 -65.46 0.02 OUTLIER Glycine 0 C--N 1.339 0.717 0 N-CA-C 111.356 -0.698 . . . . 0.0 111.356 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.456 ' OD2' ' CE ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -121.08 -61.19 1.57 Allowed 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -179.708 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -50.47 179.24 0.03 OUTLIER Glycine 0 C--N 1.348 1.244 0 CA-C-O 123.598 1.666 . . . . 0.0 111.217 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -68.8 -171.06 0.26 Allowed 'General case' 0 C--N 1.326 -0.437 0 O-C-N 121.059 -1.259 . . . . 0.0 109.832 179.906 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.416 ' CD2' ' HA3' ' A' ' 41' ' ' GLY . 5.2 mp -69.96 154.52 94.59 Favored Pre-proline 0 N--CA 1.441 -0.914 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.213 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.09 156.53 47.13 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 122.114 1.876 . . . . 0.0 111.044 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.07 98.03 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.08 75.8 0.64 Allowed Glycine 0 N--CA 1.444 -0.775 0 CA-C-O 119.777 -0.457 . . . . 0.0 112.096 -178.348 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.447 ' HD3' ' CA ' ' A' ' 41' ' ' GLY . 6.9 ttt180 -177.22 163.85 2.12 Favored 'General case' 0 CA--C 1.517 -0.32 0 O-C-N 124.075 0.514 . . . . 0.0 110.419 177.914 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.2 m -137.05 111.81 9.41 Favored Pre-proline 0 N--CA 1.444 -0.774 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.972 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . 0.405 ' HG3' ' CD1' ' A' ' 48' ' ' LEU . 23.0 Cg_endo -72.98 165.79 31.82 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 122.02 1.813 . . . . 0.0 112.01 178.733 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.483 ' O ' ' CE2' ' A' ' 57' ' ' PHE . 4.3 mt -88.81 119.51 36.08 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.471 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -179.333 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 15.8 tptt -82.82 132.41 35.17 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.239 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.553 ' CD1' ' HB3' ' A' ' 118' ' ' CYS . 19.9 m-85 -117.56 -49.78 2.55 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.633 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 124.02 -1.63 9.13 Favored Glycine 0 CA--C 1.521 0.434 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.685 -178.381 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.4 mmtp -102.68 143.32 32.5 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 36.5 t -78.86 -1.26 34.16 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 124.315 1.01 . . . . 0.0 110.664 178.053 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -88.2 -57.48 2.91 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -178.995 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.9 m -72.44 -26.41 61.82 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 -179.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -71.37 -34.38 70.39 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 123.665 0.603 . . . . 0.0 110.154 177.763 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.99 160.81 14.37 Favored Pre-proline 0 N--CA 1.439 -0.995 0 CA-C-O 121.119 0.485 . . . . 0.0 110.354 179.286 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 26.5 Cg_endo -74.48 141.3 28.13 Favored 'Trans proline' 0 N--CA 1.445 -1.36 0 C-N-CA 121.713 1.608 . . . . 0.0 113.555 175.183 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.509 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 20.8 Cg_endo -73.66 167.93 26.04 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 122.43 2.087 . . . . 0.0 111.671 179.002 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.456 ' CE ' ' OD2' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -133.13 60.61 1.7 Allowed 'General case' 0 C--O 1.239 0.543 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.236 179.417 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.493 ' CE1' ' O ' ' A' ' 70' ' ' LYS . 57.0 t-80 -74.79 145.6 42.78 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-O 123.995 1.855 . . . . 0.0 112.01 178.144 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -133.12 -85.27 0.46 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 119.49 -2.006 . . . . 0.0 109.796 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.493 ' O ' ' CE1' ' A' ' 68' ' ' HIS . 0.2 OUTLIER -72.64 -171.07 0.76 Allowed 'General case' 0 C--O 1.203 -1.379 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.166 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -77.97 41.65 0.36 Allowed 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.664 0.745 . . . . 0.0 111.415 178.016 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -169.51 -105.58 0.18 Allowed Glycine 0 C--O 1.21 -1.368 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -178.36 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -113.44 -87.99 0.56 Allowed 'General case' 0 C--N 1.317 -0.847 0 O-C-N 120.968 -1.313 . . . . 0.0 107.567 -177.024 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 117.46 -141.73 16.74 Favored Glycine 0 N--CA 1.443 -0.896 0 CA-C-O 118.525 -1.153 . . . . 0.0 111.211 -178.515 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 36.8 mttt -49.01 -89.57 0.0 OUTLIER 'General case' 0 C--O 1.223 -0.308 0 O-C-N 125.21 1.182 . . . . 0.0 110.233 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.497 ' CG2' ' O ' ' A' ' 76' ' ' THR . 0.6 OUTLIER -127.23 28.51 5.72 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.868 179.331 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.549 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 41.0 t0 -30.01 97.78 0.01 OUTLIER 'General case' 0 C--O 1.214 -0.8 0 C-N-CA 122.93 0.492 . . . . 0.0 111.795 -178.863 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 7.1 p80 -86.91 15.2 6.13 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -176.242 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.524 ' CE1' ' CD1' ' A' ' 81' ' ' LEU . 0.0 OUTLIER -52.95 174.07 0.04 OUTLIER 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 174.484 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -95.13 157.65 15.8 Favored 'General case' 0 C--O 1.218 -0.596 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.324 177.624 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.524 ' CD1' ' CE1' ' A' ' 79' ' ' TYR . 2.8 mp -143.03 108.55 5.07 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.533 0.682 . . . . 0.0 109.161 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.52 ' CB ' ' CD1' ' A' ' 109' ' ' ILE . 7.2 pm0 -80.9 150.58 28.98 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 122.148 0.975 . . . . 0.0 110.205 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.488 ' CE1' ' HB2' ' A' ' 23' ' ' ALA . 15.8 t80 -141.16 137.03 16.39 Favored Pre-proline 0 N--CA 1.442 -0.87 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.161 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.484 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 19.4 Cg_endo -74.01 91.78 0.92 Allowed 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 123.293 2.662 . . . . 0.0 110.914 -178.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.0 t -95.48 109.1 21.35 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 122.194 0.997 . . . . 0.0 111.118 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -82.42 159.08 65.25 Favored Pre-proline 0 N--CA 1.443 -0.821 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.692 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -76.57 -40.78 0.51 Allowed 'Trans proline' 0 CA--C 1.501 -1.132 0 C-N-CA 122.324 2.016 . . . . 0.0 112.453 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -42.36 -32.2 0.49 Allowed 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 125.123 1.515 . . . . 0.0 109.854 178.312 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . 0.431 ' HA3' ' CE ' ' A' ' 15' ' ' LYS . . . 87.14 10.0 72.36 Favored Glycine 0 N--CA 1.438 -1.169 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 177.252 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.419 ' CD2' ' O ' ' A' ' 90' ' ' HIS . 3.8 p-80 -80.82 130.33 35.0 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -62.21 88.45 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.779 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.526 ' O ' ' CD2' ' A' ' 94' ' ' PHE . 7.7 t80 -36.42 146.72 0.03 OUTLIER 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 122.362 1.077 . . . . 0.0 110.809 -178.935 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -78.8 58.81 2.41 Favored 'General case' 0 C--N 1.317 -0.814 0 O-C-N 120.19 -1.569 . . . . 0.0 110.072 177.958 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.526 ' CD2' ' O ' ' A' ' 92' ' ' TYR . 29.6 p90 -79.45 -8.9 59.44 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 122.837 0.455 . . . . 0.0 111.544 178.216 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -92.47 -33.16 14.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 49.3 m -79.82 110.54 15.28 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.234 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . 0.41 ' CG ' ' N ' ' A' ' 98' ' ' LYS . 0.1 OUTLIER -58.86 -50.09 75.29 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.157 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.41 ' N ' ' CG ' ' A' ' 97' ' ' LYS . 0.0 OUTLIER -146.4 129.55 8.14 Favored Pre-proline 0 N--CA 1.432 -1.346 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -177.245 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 26.4 Cg_endo -72.15 177.66 33.85 Favored 'Cis proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.135 -2.027 . . . . 0.0 111.967 -2.87 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.17 135.82 21.99 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 123.789 0.68 . . . . 0.0 109.731 178.059 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.93 172.71 13.42 Favored 'General case' 0 C--O 1.245 0.856 0 O-C-N 124.27 0.981 . . . . 0.0 111.246 178.155 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -57.3 158.74 9.75 Favored Pre-proline 0 N--CA 1.438 -1.033 0 CA-C-O 121.604 0.716 . . . . 0.0 112.193 175.072 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -75.78 -89.87 0.0 OUTLIER 'Trans proline' 0 C--O 1.205 -1.14 0 C-N-CA 122.212 1.942 . . . . 0.0 111.115 179.014 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 151.77 148.68 4.89 Favored Glycine 0 N--CA 1.438 -1.214 0 O-C-N 120.983 -1.073 . . . . 0.0 111.358 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -74.45 -35.47 3.72 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.149 1.9 . . . . 0.0 111.779 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.595 ' CB ' ' CE2' ' A' ' 11' ' ' TYR . . . -102.85 146.72 27.85 Favored 'General case' 0 N--CA 1.437 -1.078 0 O-C-N 124.232 0.958 . . . . 0.0 109.914 178.413 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.408 ' HG2' ' HA ' ' A' ' 84' ' ' PRO . 2.2 mtm-85 -146.44 148.82 32.67 Favored 'General case' 0 N--CA 1.445 -0.705 0 O-C-N 123.833 0.708 . . . . 0.0 111.417 179.173 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.442 ' CG1' ' HB3' ' A' ' 83' ' ' PHE . 3.8 p -82.63 117.71 29.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 123.19 0.596 . . . . 0.0 110.23 178.713 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.52 ' CD1' ' CB ' ' A' ' 82' ' ' GLU . 6.1 mm -96.01 140.71 16.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.511 ' CD1' ' HG3' ' A' ' 115' ' ' LYS . 9.0 p90 -167.18 152.25 7.33 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.789 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.6 p -87.76 163.86 16.26 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.715 -178.863 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.562 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.2 OUTLIER -112.94 152.62 45.04 Favored Pre-proline 0 N--CA 1.434 -1.231 0 C-N-CA 123.209 0.604 . . . . 0.0 110.842 -179.783 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.562 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 17.8 Cg_endo -73.56 -55.46 0.14 OUTLIER 'Cis proline' 0 CA--C 1.512 -0.601 0 C-N-CA 122.0 -2.083 . . . . 0.0 110.64 -4.14 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -41.65 111.18 0.21 Allowed 'General case' 0 N--CA 1.438 -1.057 0 CA-C-O 116.093 -1.908 . . . . 0.0 110.342 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.511 ' HG3' ' CD1' ' A' ' 110' ' ' TYR . 0.1 OUTLIER -64.39 74.41 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.7 0 O-C-N 126.03 2.081 . . . . 0.0 108.755 -178.604 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . 0.411 ' O ' ' CG1' ' A' ' 116' ' ' VAL . 13.3 t -71.47 69.81 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 -178.139 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.564 ' CE1' ' HA2' ' A' ' 119' ' ' GLY . 9.8 t80 -36.48 111.06 0.13 Allowed 'General case' 0 N--CA 1.437 -1.078 0 C-N-CA 124.074 0.949 . . . . 0.0 109.849 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . 0.553 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 0.1 OUTLIER -94.28 -26.69 16.5 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.258 . . . . . . . . 3 3 . 1 . 006 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.564 ' HA2' ' CE1' ' A' ' 117' ' ' PHE . . . 137.39 -166.58 24.98 Favored Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 -178.749 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.449 ' CG2' ' SG ' ' A' ' 134' ' ' CYS . 3.5 mp -111.6 146.1 16.96 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.369 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 -177.612 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.496 ' CD1' ' CE1' ' A' ' 38' ' ' PHE . 6.2 pt -116.77 157.11 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 CA-C-N 119.237 0.926 . . . . 0.0 108.836 178.663 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -176.73 147.15 0.6 Allowed 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.561 0.696 . . . . 0.0 110.126 177.965 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 1.4 m-70 -89.25 94.26 9.85 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 -177.873 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 3.9 t -99.53 44.65 1.01 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 123.315 1.531 . . . . 0.0 110.961 -179.706 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 11.1 tttt -105.86 -26.73 11.61 Favored 'General case' 0 C--O 1.222 -0.391 0 O-C-N 120.664 -1.272 . . . . 0.0 110.395 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -171.17 -63.91 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 124.419 1.074 . . . . 0.0 110.957 178.417 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -155.16 -45.96 0.08 Allowed 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 121.998 0.904 . . . . 0.0 110.041 178.903 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -158.18 76.04 0.76 Allowed 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.59 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -120.47 -103.49 1.94 Allowed Glycine 0 C--N 1.331 0.289 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.09 143.61 26.52 Favored 'General case' 0 CA--C 1.513 -0.459 0 O-C-N 122.333 -0.51 . . . . 0.0 110.872 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 6.0 tp -96.62 138.27 34.44 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 121.057 0.456 . . . . 0.0 110.176 179.149 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -140.67 169.0 18.47 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.606 -178.954 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.444 ' HB2' ' CG2' ' A' ' 55' ' ' ILE . 10.4 tp -89.6 136.47 33.02 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.396 1.06 . . . . 0.0 108.504 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . 0.449 ' SG ' ' CG2' ' A' ' 120' ' ' ILE . 70.7 m -56.97 -176.44 0.02 OUTLIER 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 124.793 1.237 . . . . 0.0 108.308 178.478 . . . . . . . . 2 2 . 1 . 006 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 6.8 m -161.16 83.99 0.65 Allowed 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 0.528 ' CD2' ' CE2' ' A' ' 4' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--O 1.258 1.527 0 CA-C-O 116.11 -1.9 . . . . 0.0 112.143 175.19 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.835 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 . . . . . . . . . 0 0 . 1 . 007 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.9 p -100.98 136.2 33.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 179.543 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.1 m -85.61 123.73 31.35 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 177.158 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.421 ' CD1' ' HB2' ' A' ' 13' ' ' GLN . 35.0 m95 -86.18 142.58 28.52 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 122.913 0.485 . . . . 0.0 110.059 177.13 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -127.21 125.84 41.74 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 -176.751 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 7.2 m -120.7 53.75 1.1 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.691 178.541 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 132.68 -95.95 0.3 Allowed Glycine 0 C--O 1.223 -0.565 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -132.33 8.84 5.35 Favored Glycine 0 N--CA 1.469 0.897 0 C-N-CA 123.881 0.753 . . . . 0.0 113.624 177.995 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.52 140.28 49.3 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 124.85 1.26 . . . . 0.0 108.858 -176.632 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.7 mm? -105.24 116.5 32.05 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 124.509 1.131 . . . . 0.0 108.099 -170.451 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.424 ' CE2' ' CB ' ' A' ' 106' ' ' ALA . 73.8 m-85 -108.55 98.5 8.01 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 -172.119 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -55.14 117.87 3.86 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 177.557 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.457 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 6.4 tp-100 -51.0 -44.42 60.96 Favored 'General case' 0 C--O 1.214 -0.796 0 C-N-CA 119.814 -0.754 . . . . 0.0 112.853 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -48.42 -42.91 33.54 Favored 'General case' 0 C--O 1.201 -1.479 0 O-C-N 123.771 0.67 . . . . 0.0 112.217 175.49 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.9 mttt -69.52 -40.8 76.73 Favored 'General case' 0 C--O 1.212 -0.879 0 CA-C-N 120.068 1.304 . . . . 0.0 113.454 168.623 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -52.5 -40.38 62.33 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 121.688 2.04 . . . . 0.0 113.82 173.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -85.66 -43.83 13.09 Favored 'General case' 0 C--O 1.217 -0.616 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.603 173.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 41.0 t -71.36 -62.88 1.24 Allowed 'General case' 0 C--O 1.217 -0.62 0 C-N-CA 126.914 2.086 . . . . 0.0 110.839 -176.315 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -39.55 -38.16 0.57 Allowed 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 120.262 1.392 . . . . 0.0 111.673 168.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.1 p -83.51 -26.67 29.98 Favored 'General case' 0 C--O 1.218 -0.598 0 N-CA-C 116.464 2.024 . . . . 0.0 116.464 175.364 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 2.9 m170 -54.25 -32.99 57.44 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 125.186 1.394 . . . . 0.0 109.088 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -75.48 -41.39 55.6 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 125.086 1.355 . . . . 0.0 111.208 177.111 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.405 ' HB1' ' CZ ' ' A' ' 83' ' ' PHE . . . -39.04 125.47 1.25 Allowed Pre-proline 0 CA--C 1.539 0.526 0 C-N-CA 125.39 1.476 . . . . 0.0 111.503 174.44 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 19.0 Cg_endo -71.02 123.2 9.47 Favored 'Trans proline' 0 N--CA 1.439 -1.68 0 C-N-CA 122.71 2.274 . . . . 0.0 109.101 -177.494 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.7 tp -60.41 97.17 0.05 OUTLIER 'General case' 0 C--O 1.222 -0.394 0 C-N-CA 124.18 0.992 . . . . 0.0 111.043 177.706 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -175.25 149.05 1.02 Allowed 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 123.729 0.812 . . . . 0.0 110.928 -176.324 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.439 ' HB3' ' CA ' ' A' ' 72' ' ' GLY . 3.6 t0 -82.02 82.74 7.51 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -178.521 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 68.22 81.29 0.19 Allowed Glycine 0 C--O 1.227 -0.317 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 175.291 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.35 47.3 0.97 Allowed 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 122.748 1.261 . . . . 0.0 112.778 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 68.2 p -134.14 154.85 50.96 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.286 -175.111 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -41.6 -61.4 2.19 Favored Glycine 0 C--O 1.228 -0.243 0 C-N-CA 124.189 0.899 . . . . 0.0 112.704 -178.417 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.9 t -65.0 -72.35 0.15 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 118.103 -0.951 . . . . 0.0 112.186 173.434 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 60.7 p 179.74 -55.2 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.955 0.902 . . . . 0.0 112.278 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.455 ' CD1' ' HD3' ' A' ' 84' ' ' PRO . 80.9 m-85 -71.34 142.93 87.38 Favored Pre-proline 0 N--CA 1.437 -1.083 0 O-C-N 124.821 1.325 . . . . 0.0 112.04 -178.644 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.409 ' HB2' ' CD1' ' A' ' 81' ' ' LEU . 27.8 Cg_endo -79.04 158.81 91.22 Favored 'Cis proline' 0 N--CA 1.442 -1.552 0 C-N-CA 122.159 -2.017 . . . . 0.0 110.713 6.574 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -140.91 157.72 44.97 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-O 118.582 -0.723 . . . . 0.0 111.944 178.275 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.513 ' CD1' ' HB2' ' A' ' 79' ' ' TYR . 21.5 t90 -58.4 149.7 24.2 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 122.943 1.354 . . . . 0.0 110.879 172.948 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.451 ' CZ ' ' CD1' ' A' ' 121' ' ' ILE . 8.1 t80 -123.69 83.87 2.2 Favored 'General case' 0 N--CA 1.434 -1.25 0 C-N-CA 127.515 2.326 . . . . 0.0 105.779 -174.993 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 71.1 p -36.46 -41.93 0.31 Allowed 'General case' 0 C--O 1.213 -0.849 0 CA-C-N 114.464 -1.244 . . . . 0.0 110.819 171.682 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 55.4 t30 57.05 20.08 5.2 Favored 'General case' 0 CA--C 1.55 0.965 0 CA-C-O 122.413 1.102 . . . . 0.0 111.028 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.84 -33.13 6.64 Favored Glycine 0 C--O 1.222 -0.626 0 CA-C-O 117.655 -1.636 . . . . 0.0 113.558 -171.896 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.58 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 84.3 m-85 -52.76 157.04 1.74 Allowed 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.328 1.451 . . . . 0.0 111.339 177.734 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.72 -31.2 46.29 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.635 0.731 . . . . 0.0 112.061 176.902 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.451 ' HA2' ' CZ2' ' A' ' 37' ' ' TRP . . . 114.83 34.47 1.52 Allowed Glycine 0 C--O 1.221 -0.699 0 CA-C-O 117.28 -1.845 . . . . 0.0 114.779 -174.56 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -147.54 -64.88 0.27 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.483 1.113 . . . . 0.0 112.219 -178.9 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -135.47 -100.81 0.64 Allowed Glycine 0 C--O 1.219 -0.804 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.88 -174.39 5.24 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.348 0.594 . . . . 0.0 109.79 178.232 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.58 ' HG ' ' CD1' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -101.47 168.87 8.47 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.507 -178.725 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -71.29 -179.13 3.34 Favored 'Trans proline' 0 N--CA 1.442 -1.53 0 C-N-CA 123.003 2.468 . . . . 0.0 112.166 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.15 104.0 11.33 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 119.98 -1.7 . . . . 0.0 110.014 174.304 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.43 71.21 0.52 Allowed Glycine 0 N--CA 1.469 0.863 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 177.662 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -161.66 169.29 21.83 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 124.013 0.925 . . . . 0.0 109.637 178.797 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.9 m -155.23 107.96 2.25 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 173.898 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -71.76 172.87 13.6 Favored 'Trans proline' 0 N--CA 1.444 -1.4 0 C-N-CA 122.817 2.345 . . . . 0.0 111.246 177.03 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.8 mt -85.82 132.9 30.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.92 149.28 25.76 Favored 'General case' 0 C--N 1.33 -0.265 0 O-C-N 121.499 -0.75 . . . . 0.0 109.87 175.552 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.465 ' CE2' ' SG ' ' A' ' 62' ' ' CYS . 21.0 m-85 -132.67 -49.48 0.9 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.616 1.167 . . . . 0.0 110.856 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 111.33 -3.32 28.12 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 125.008 1.29 . . . . 0.0 113.249 -174.671 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.87 128.9 40.39 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-O 117.724 -1.131 . . . . 0.0 109.728 176.046 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 22.5 p -61.82 -10.62 9.55 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 125.617 1.823 . . . . 0.0 112.718 176.783 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.14 -54.21 4.33 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 126.181 1.792 . . . . 0.0 110.505 179.329 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.465 ' SG ' ' CE2' ' A' ' 57' ' ' PHE . 2.6 t -73.34 -15.2 61.39 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 124.275 0.985 . . . . 0.0 113.092 174.91 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -84.68 -40.5 17.31 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.383 1.473 . . . . 0.0 110.259 173.471 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.63 155.41 3.9 Favored Pre-proline 0 CA--C 1.539 0.529 0 CA-C-O 122.636 1.208 . . . . 0.0 111.566 -178.683 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -69.02 138.02 39.1 Favored 'Trans proline' 0 N--CA 1.439 -1.689 0 C-N-CA 120.344 0.696 . . . . 0.0 112.411 175.093 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.412 ' HD2' ' CD1' ' A' ' 42' ' ' TYR . 27.9 Cg_endo -66.17 172.24 9.04 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 124.118 3.212 . . . . 0.0 110.713 173.93 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.7 mmtt -140.94 63.0 1.46 Allowed 'General case' 0 C--O 1.207 -1.133 0 CA-C-O 118.287 -0.863 . . . . 0.0 109.508 177.388 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 31.1 t-80 -74.29 163.86 27.3 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 123.433 0.458 . . . . 0.0 110.382 177.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 21.1 p -148.63 -173.37 4.32 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.483 1.113 . . . . 0.0 110.976 176.186 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.75 74.19 10.2 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 120.734 -1.229 . . . . 0.0 111.706 176.359 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -177.05 -46.46 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 124.281 1.033 . . . . 0.0 109.68 -179.255 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.439 ' CA ' ' HB3' ' A' ' 27' ' ' ASP . . . 120.66 -78.12 0.32 Allowed Glycine 0 N--CA 1.441 -1.017 0 O-C-N 124.441 1.088 . . . . 0.0 112.677 -174.766 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -119.99 61.61 0.85 Allowed 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 128.874 2.869 . . . . 0.0 109.003 -178.079 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -70.56 -106.36 0.04 OUTLIER Glycine 0 CA--C 1.526 0.725 0 CA-C-O 123.088 1.382 . . . . 0.0 111.506 -175.239 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.0 mttt -61.35 -90.05 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.68 0 O-C-N 120.201 -1.764 . . . . 0.0 113.353 174.36 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -128.77 15.37 6.42 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.641 177.437 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -29.38 97.33 0.01 OUTLIER 'General case' 0 C--O 1.214 -0.806 0 C-N-CA 126.126 1.77 . . . . 0.0 112.349 -175.733 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -88.53 58.0 4.48 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 119.866 -1.771 . . . . 0.0 107.527 -169.232 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.513 ' HB2' ' CD1' ' A' ' 37' ' ' TRP . 46.7 p90 -80.85 133.55 35.61 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 125.08 1.352 . . . . 0.0 108.885 -177.189 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 5.3 mt -71.2 126.33 29.32 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 176.804 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.431 HD21 ' CZ ' ' A' ' 110' ' ' TYR . 0.4 OUTLIER -120.23 141.79 49.62 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 177.962 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -103.84 166.14 10.6 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 175.784 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.444 ' CD1' ' HD2' ' A' ' 84' ' ' PRO . 7.6 t80 -152.85 127.04 4.47 Favored Pre-proline 0 CA--C 1.538 0.511 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.455 ' HD3' ' CD1' ' A' ' 34' ' ' TYR . 17.8 Cg_endo -71.66 118.39 5.63 Favored 'Trans proline' 0 N--CA 1.444 -1.416 0 C-N-CA 124.755 3.637 . . . . 0.0 110.312 -176.871 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.99 111.29 17.72 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.742 -1.117 . . . . 0.0 108.61 -177.118 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -79.31 157.64 75.13 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 177.133 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -73.52 -36.1 4.19 Favored 'Trans proline' 0 N--CA 1.448 -1.18 0 C-N-CA 122.636 2.224 . . . . 0.0 113.321 178.694 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -46.74 -29.93 2.16 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 126.911 2.084 . . . . 0.0 110.044 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.93 6.08 76.37 Favored Glycine 0 N--CA 1.44 -1.099 0 C-N-CA 125.367 1.46 . . . . 0.0 112.344 178.599 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.1 p-80 -76.56 128.7 35.24 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 177.104 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -56.82 106.79 0.33 Allowed 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 171.485 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.441 ' CD2' ' HG2' ' A' ' 84' ' ' PRO . 3.0 t80 -37.08 131.96 0.74 Allowed 'General case' 0 C--O 1.215 -0.715 0 C-N-CA 123.833 0.853 . . . . 0.0 108.852 176.667 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.27 59.68 0.08 Allowed 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.385 -0.822 . . . . 0.0 112.162 173.361 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.419 ' CD2' ' O ' ' A' ' 92' ' ' TYR . 6.5 p90 -72.92 -5.09 36.17 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 127.347 2.259 . . . . 0.0 112.196 174.937 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.68 -40.6 10.16 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 123.652 1.691 . . . . 0.0 110.166 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 74.9 m -76.93 97.72 4.69 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 120.348 -1.47 . . . . 0.0 108.393 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.6 pttm -59.16 -46.71 87.67 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.955 0.883 . . . . 0.0 111.81 177.225 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.46 126.35 8.12 Favored Pre-proline 0 CA--C 1.54 0.576 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.909 -179.149 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -69.47 171.75 51.01 Favored 'Cis proline' 0 N--CA 1.454 -0.842 0 C-N-CA 123.183 -1.591 . . . . 0.0 111.184 -5.48 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -128.77 146.05 51.01 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 123.612 0.765 . . . . 0.0 109.107 177.004 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -95.19 165.96 12.14 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 173.935 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -36.02 138.48 0.44 Allowed Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 125.034 1.334 . . . . 0.0 110.954 170.579 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -71.88 -68.43 0.02 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 123.174 2.583 . . . . 0.0 114.259 176.423 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 130.82 142.09 5.01 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -75.3 -66.62 0.02 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 123.468 2.778 . . . . 0.0 110.951 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.424 ' CB ' ' CE2' ' A' ' 11' ' ' TYR . . . -64.74 131.8 47.85 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.789 0.804 . . . . 0.0 111.356 178.652 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -139.75 150.61 44.99 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-N 114.63 -1.168 . . . . 0.0 110.057 -178.443 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.6 p -88.36 119.19 35.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 O-C-N 124.58 1.175 . . . . 0.0 110.454 178.377 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 1.2 mp -107.25 117.8 53.74 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.011 0 N-CA-C 105.847 -1.908 . . . . 0.0 105.847 -173.975 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.431 ' CZ ' HD21 ' A' ' 81' ' ' LEU . 5.9 p90 -136.06 151.53 49.94 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-O 122.732 1.253 . . . . 0.0 108.213 -178.941 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.8 p -83.46 157.23 22.51 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.142 177.492 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.458 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -105.47 157.16 35.12 Favored Pre-proline 0 CA--C 1.552 1.022 0 O-C-N 121.966 -0.459 . . . . 0.0 111.317 178.188 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.458 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 19.1 Cg_endo -72.35 -49.77 0.21 Allowed 'Cis proline' 0 N--CA 1.454 -0.807 0 C-N-CA 124.412 -1.078 . . . . 0.0 111.375 -11.072 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -48.06 105.14 0.07 Allowed 'General case' 0 C--O 1.224 -0.268 0 C-N-CA 124.113 0.965 . . . . 0.0 109.24 176.55 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.404 ' CG ' ' CD1' ' A' ' 110' ' ' TYR . 0.1 OUTLIER -61.85 79.87 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 126.113 1.765 . . . . 0.0 108.695 -178.152 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 39.4 t -81.41 72.8 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 104.271 -2.492 . . . . 0.0 104.271 -177.256 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.457 ' CZ ' ' NE2' ' A' ' 13' ' ' GLN . 47.6 t80 -36.87 106.63 0.05 OUTLIER 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 125.864 1.665 . . . . 0.0 109.827 176.112 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 7.8 m -84.79 -45.51 12.28 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 -177.912 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 163.7 -146.78 11.96 Favored Glycine 0 N--CA 1.439 -1.149 0 CA-C-N 114.75 -1.113 . . . . 0.0 110.682 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 1.3 mm -127.5 141.1 47.27 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.925 0 N-CA-C 104.93 -2.248 . . . . 0.0 104.93 -177.892 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.451 ' CD1' ' CZ ' ' A' ' 38' ' ' PHE . 5.7 pt -130.51 150.44 34.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -178.74 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -169.19 162.22 10.59 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.439 0.638 . . . . 0.0 110.344 178.537 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.437 ' CE1' ' HG ' ' A' ' 131' ' ' LEU . 2.1 m-70 -92.7 90.62 7.15 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-O 121.357 0.598 . . . . 0.0 109.515 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 8.4 p -101.79 43.21 1.08 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 122.056 0.932 . . . . 0.0 109.952 -177.274 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.65 -23.31 11.52 Favored 'General case' 0 C--O 1.217 -0.636 0 CA-C-N 114.77 -1.105 . . . . 0.0 111.855 175.455 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -171.45 -70.4 0.02 OUTLIER 'General case' 0 C--O 1.22 -0.485 0 O-C-N 123.971 0.794 . . . . 0.0 110.032 176.502 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -154.6 -45.47 0.09 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.316 1.447 . . . . 0.0 111.158 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -154.17 81.4 1.13 Allowed 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.838 1.255 . . . . 0.0 108.8 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -128.62 -108.2 1.38 Allowed Glycine 0 N--CA 1.464 0.5 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 175.119 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.53 159.84 19.16 Favored 'General case' 0 C--N 1.32 -0.679 0 O-C-N 122.237 -0.567 . . . . 0.0 111.328 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.437 ' HG ' ' CE1' ' A' ' 123' ' ' HIS . 0.6 OUTLIER -108.79 148.07 31.09 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 122.961 0.504 . . . . 0.0 109.956 177.577 . . . . . . . . 3 3 . 1 . 007 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.1 171.43 18.45 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 124.122 0.969 . . . . 0.0 109.104 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 12.4 tp -82.24 136.2 35.11 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.606 -0.886 . . . . 0.0 108.606 178.006 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 64.1 m -67.08 -177.31 0.63 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 123.066 1.412 . . . . 0.0 109.979 173.126 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 2.1 m -158.72 124.6 4.48 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 104.836 -2.283 . . . . 0.0 104.836 -177.989 . . . . . . . . 1 1 . 1 . 007 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 3.0 m80 . . . . . 0 C--N 1.324 -0.503 0 CA-C-O 117.228 -1.367 . . . . 0.0 113.238 175.039 . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.848 0 CA-C-O 117.892 -1.052 . . . . 0.0 109.172 . . . . . . . . . 0 0 . 1 . 008 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.7 p -51.6 153.45 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 O-C-N 124.153 0.908 . . . . 0.0 111.271 174.424 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -83.58 114.59 21.63 Favored 'General case' 0 C--N 1.319 -0.723 0 O-C-N 122.092 -0.38 . . . . 0.0 110.538 178.354 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 23.0 m95 -81.17 139.57 35.48 Favored 'General case' 0 C--O 1.215 -0.721 0 O-C-N 121.994 -0.441 . . . . 0.0 110.345 177.609 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -130.69 138.5 50.06 Favored 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -178.809 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -122.85 61.71 1.0 Allowed 'General case' 0 N--CA 1.442 -0.852 0 O-C-N 124.092 0.87 . . . . 0.0 108.755 175.553 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 43.7 52.22 6.58 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 123.133 0.396 . . . . 0.0 112.115 179.041 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -164.29 -85.3 0.06 OUTLIER Glycine 0 C--O 1.224 -0.476 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -177.967 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -127.19 164.0 22.64 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 121.749 0.785 . . . . 0.0 110.098 177.414 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.9 mp -88.69 126.09 35.15 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -177.256 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.469 ' CZ ' ' CB ' ' A' ' 106' ' ' ALA . 70.2 m-85 -111.3 89.73 3.13 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 126.695 1.998 . . . . 0.0 108.586 -174.27 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -54.71 125.39 19.73 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.265 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.544 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 7.5 tp-100 -60.59 -21.66 62.87 Favored 'General case' 0 C--O 1.213 -0.838 0 C-N-CA 119.028 -1.069 . . . . 0.0 113.249 176.793 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -64.64 -23.46 67.27 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 172.673 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.2 mtmt -103.73 -36.65 7.79 Favored 'General case' 0 C--O 1.202 -1.424 0 C-N-CA 126.492 1.917 . . . . 0.0 109.782 175.135 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.27 -42.53 70.09 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 121.307 1.867 . . . . 0.0 111.736 177.112 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -84.13 -47.56 10.76 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-O 117.598 -1.191 . . . . 0.0 108.809 177.034 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.7 t -66.64 -53.01 38.62 Favored 'General case' 0 C--O 1.212 -0.884 0 CA-C-N 120.326 1.421 . . . . 0.0 109.514 -172.212 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.476 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 6.4 t-20 -42.78 -36.52 1.49 Allowed 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 123.946 0.898 . . . . 0.0 113.396 169.639 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -82.01 -33.95 29.82 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 172.548 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -46.2 -37.01 6.57 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 126.469 1.908 . . . . 0.0 109.925 178.071 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.476 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -73.13 -48.8 32.48 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 117.635 -1.174 . . . . 0.0 112.698 175.182 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.418 ' HB3' ' CE1' ' A' ' 83' ' ' PHE . . . -36.59 128.38 0.71 Allowed Pre-proline 0 N--CA 1.442 -0.873 0 O-C-N 125.487 1.742 . . . . 0.0 112.226 173.153 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -73.69 125.96 10.42 Favored 'Trans proline' 0 N--CA 1.444 -1.417 0 C-N-CA 121.979 1.786 . . . . 0.0 107.573 -175.817 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.442 ' CD1' ' HE2' ' A' ' 115' ' ' LYS . 3.4 tp -61.77 84.98 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 124.552 1.141 . . . . 0.0 111.911 177.998 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.4 m -174.43 155.12 2.24 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.165 0.986 . . . . 0.0 110.047 -173.291 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.434 ' HA ' ' HA ' ' A' ' 36' ' ' HIS . 0.2 OUTLIER -96.31 137.45 35.36 Favored 'General case' 0 CA--C 1.503 -0.849 0 CA-C-O 117.566 -1.207 . . . . 0.0 110.784 175.239 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 37.21 70.58 0.24 Allowed Glycine 0 C--N 1.338 0.673 0 O-C-N 125.008 1.442 . . . . 0.0 111.897 177.032 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -148.6 24.15 0.99 Allowed 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 121.997 0.903 . . . . 0.0 111.824 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 50.1 p -130.2 151.8 50.33 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -175.956 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -40.7 -64.98 1.1 Allowed Glycine 0 CA--C 1.505 -0.536 0 O-C-N 124.25 0.969 . . . . 0.0 112.764 -177.517 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 40.5 t -60.15 -60.99 2.94 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-O 115.809 -2.043 . . . . 0.0 112.641 174.691 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 161.16 -53.32 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.706 0 O-C-N 125.777 1.923 . . . . 0.0 111.863 176.705 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.46 ' CD2' ' HD3' ' A' ' 84' ' ' PRO . 62.2 m-85 -63.38 146.86 95.96 Favored Pre-proline 0 N--CA 1.438 -1.065 0 N-CA-C 114.757 1.392 . . . . 0.0 114.757 177.41 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -75.41 166.32 83.44 Favored 'Cis proline' 0 N--CA 1.446 -1.308 0 C-N-CA 123.442 -1.483 . . . . 0.0 110.862 0.711 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.454 ' CD2' ' CD2' ' A' ' 34' ' ' TYR . 0.8 OUTLIER -139.61 172.41 12.84 Favored 'General case' 0 CA--C 1.502 -0.884 0 O-C-N 120.867 -1.146 . . . . 0.0 109.89 -176.895 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.475 ' CH2' ' HA2' ' A' ' 44' ' ' GLY . 21.3 t90 -71.4 141.4 50.32 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.889 0.852 . . . . 0.0 108.825 177.303 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 55.4 t80 -121.05 83.0 2.0 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 -176.379 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.426 ' CG2' ' CH2' ' A' ' 37' ' ' TRP . 44.2 p -40.32 -31.23 0.13 Allowed 'General case' 0 C--O 1.212 -0.886 0 C-N-CA 124.512 1.125 . . . . 0.0 111.255 174.229 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.4 t30 71.32 7.67 6.14 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.039 1.735 . . . . 0.0 109.405 178.014 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 117.58 -11.32 14.02 Favored Glycine 0 N--CA 1.434 -1.481 0 O-C-N 120.592 -1.318 . . . . 0.0 113.169 -170.9 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.565 ' CE2' ' HA ' ' A' ' 47' ' ' LYS . 4.9 m-85 -75.93 176.26 8.04 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 118.364 1.082 . . . . 0.0 109.852 -176.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.62 -39.11 9.26 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.563 174.993 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.475 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -172.49 -82.55 0.05 OUTLIER Glycine 0 C--N 1.333 0.406 0 C-N-CA 123.571 0.605 . . . . 0.0 111.983 -178.209 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.83 -63.1 1.15 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 122.021 0.915 . . . . 0.0 110.438 178.399 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.97 166.49 12.88 Favored Glycine 0 C--N 1.34 0.751 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.565 ' HA ' ' CE2' ' A' ' 42' ' ' TYR . 1.2 pttt -53.91 -176.25 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 123.13 1.443 . . . . 0.0 113.095 174.559 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -65.07 156.77 79.63 Favored Pre-proline 0 C--N 1.313 -1.007 0 O-C-N 121.23 -0.919 . . . . 0.0 111.313 178.324 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -72.5 175.21 10.44 Favored 'Trans proline' 0 N--CA 1.447 -1.263 0 C-N-CA 122.225 1.95 . . . . 0.0 110.556 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.52 96.44 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.481 0 O-C-N 121.651 -0.656 . . . . 0.0 110.611 176.358 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.7 90.51 2.14 Favored Glycine 0 C--O 1.226 -0.4 0 CA-C-N 116.295 -0.412 . . . . 0.0 112.168 -176.559 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -173.18 162.63 4.51 Favored 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 123.808 0.843 . . . . 0.0 110.583 175.876 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 48.1 m -142.56 95.64 6.43 Favored Pre-proline 0 C--O 1.234 0.248 0 O-C-N 124.961 1.413 . . . . 0.0 110.132 -177.332 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -73.31 146.84 40.9 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.531 2.154 . . . . 0.0 110.071 -179.234 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.3 mt -68.18 116.81 8.95 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.531 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -178.664 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.12 136.88 35.11 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 177.873 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.562 ' CD2' ' HB3' ' A' ' 118' ' ' CYS . 8.7 m-85 -114.96 -53.35 2.65 Favored 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 123.752 0.821 . . . . 0.0 110.128 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 128.99 -11.46 6.2 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 123.896 0.76 . . . . 0.0 112.845 -176.16 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -90.0 132.21 35.48 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-N 117.27 0.535 . . . . 0.0 110.739 176.321 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -73.32 0.78 11.05 Favored 'General case' 0 C--O 1.223 -0.297 0 O-C-N 124.875 1.36 . . . . 0.0 111.946 175.835 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.28 -54.37 4.34 Favored 'General case' 0 N--CA 1.446 -0.645 0 O-C-N 120.638 -1.289 . . . . 0.0 109.004 -179.948 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.8 m -75.66 -35.17 60.48 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 124.617 1.198 . . . . 0.0 109.013 -179.146 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -59.73 -39.97 86.5 Favored 'General case' 0 C--N 1.343 0.324 0 O-C-N 124.362 1.039 . . . . 0.0 111.286 175.496 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.0 159.02 0.5 Allowed Pre-proline 0 N--CA 1.446 -0.648 0 CA-C-O 122.94 1.352 . . . . 0.0 111.536 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -70.55 133.18 23.55 Favored 'Trans proline' 0 N--CA 1.437 -1.8 0 C-N-CA 120.212 0.608 . . . . 0.0 112.573 175.395 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.464 ' CD ' ' CE2' ' A' ' 42' ' ' TYR . 22.3 Cg_endo -72.51 170.36 19.56 Favored 'Trans proline' 0 N--CA 1.446 -1.32 0 C-N-CA 125.103 3.868 . . . . 0.0 111.239 176.904 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -136.85 53.0 1.92 Allowed 'General case' 0 CA--C 1.497 -1.075 0 CA-C-O 116.835 -1.555 . . . . 0.0 108.123 -177.54 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 21.5 t-80 -75.62 167.38 22.0 Favored 'General case' 0 C--O 1.216 -0.676 0 O-C-N 123.971 0.795 . . . . 0.0 110.933 178.529 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -154.18 -166.62 2.41 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 121.383 -0.823 . . . . 0.0 111.4 176.421 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.25 70.54 10.14 Favored 'General case' 0 C--O 1.212 -0.878 0 O-C-N 120.001 -1.687 . . . . 0.0 111.81 175.733 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -177.08 -41.27 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 123.33 0.652 . . . . 0.0 109.73 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.412 ' O ' ' CE2' ' A' ' 79' ' ' TYR . . . 120.81 -76.31 0.32 Allowed Glycine 0 N--CA 1.442 -0.914 0 N-CA-C 109.839 -1.305 . . . . 0.0 109.839 -177.836 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.9 p-10 -124.59 61.56 1.14 Allowed 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 -175.241 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -53.31 -102.94 0.01 OUTLIER Glycine 0 CA--C 1.535 1.33 0 CA-C-O 122.533 1.074 . . . . 0.0 113.855 178.286 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.7 mttm -72.3 -105.74 0.01 OUTLIER 'General case' 0 C--O 1.221 -0.442 0 O-C-N 120.51 -1.583 . . . . 0.0 110.916 175.836 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -105.36 19.04 21.26 Favored 'General case' 0 C--N 1.322 -0.597 0 O-C-N 121.05 -1.031 . . . . 0.0 110.782 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.43 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 1.2 m-20 -30.64 99.63 0.02 OUTLIER 'General case' 0 C--O 1.208 -1.117 0 C-N-CA 125.357 1.463 . . . . 0.0 110.665 -177.406 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -81.76 11.71 4.61 Favored 'General case' 0 C--O 1.221 -0.41 0 O-C-N 121.072 -1.017 . . . . 0.0 111.023 -176.703 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.486 ' CE2' HD23 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -38.6 141.46 0.26 Allowed 'General case' 0 N--CA 1.426 -1.653 0 CA-C-O 122.903 1.335 . . . . 0.0 114.559 170.625 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -77.86 157.96 29.65 Favored 'General case' 0 CA--C 1.509 -0.611 0 O-C-N 120.448 -1.407 . . . . 0.0 109.412 177.409 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.486 HD23 ' CE2' ' A' ' 79' ' ' TYR . 1.1 mt -143.95 129.43 19.01 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 178.988 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.484 ' CB ' ' CD1' ' A' ' 109' ' ' ILE . 1.1 pm0 -97.17 151.54 19.71 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-O 122.917 1.342 . . . . 0.0 111.382 178.645 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.418 ' CE1' ' HB3' ' A' ' 23' ' ' ALA . 74.4 t80 -141.42 130.75 12.61 Favored Pre-proline 0 N--CA 1.448 -0.57 0 CA-C-N 114.801 -1.09 . . . . 0.0 111.504 -178.655 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.46 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 18.1 Cg_endo -75.74 97.02 1.07 Allowed 'Trans proline' 0 N--CA 1.443 -1.468 0 C-N-CA 123.995 3.13 . . . . 0.0 109.516 -177.728 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 10.5 t -101.18 116.28 32.46 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 122.233 1.016 . . . . 0.0 111.06 179.533 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.429 ' CD2' ' NE2' ' A' ' 90' ' ' HIS . 57.4 m-85 -82.31 159.77 63.95 Favored Pre-proline 0 N--CA 1.445 -0.676 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.101 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -77.24 -39.36 0.59 Allowed 'Trans proline' 0 N--CA 1.444 -1.398 0 C-N-CA 122.374 2.049 . . . . 0.0 112.613 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -43.58 -31.03 0.66 Allowed 'General case' 0 N--CA 1.476 0.857 0 O-C-N 125.11 1.506 . . . . 0.0 110.773 175.754 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.18 13.63 68.26 Favored Glycine 0 N--CA 1.436 -1.337 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 176.695 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.429 ' NE2' ' CD2' ' A' ' 86' ' ' PHE . 7.7 p-80 -77.93 130.06 36.1 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -59.12 90.91 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 123.801 0.84 . . . . 0.0 109.748 175.994 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.468 ' CD2' ' HB3' ' A' ' 94' ' ' PHE . 3.8 t80 -38.51 139.71 0.38 Allowed 'General case' 0 C--O 1.217 -0.644 0 C-N-CA 124.385 1.074 . . . . 0.0 109.295 -177.473 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 8.2 ptpt -77.41 64.25 2.74 Favored 'General case' 0 C--N 1.315 -0.927 0 O-C-N 119.582 -1.949 . . . . 0.0 110.359 175.119 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.468 ' HB3' ' CD2' ' A' ' 92' ' ' TYR . 23.1 p90 -80.09 -12.89 59.63 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 123.518 0.727 . . . . 0.0 112.544 176.135 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.1 -33.13 14.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 122.313 1.054 . . . . 0.0 109.888 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.1 m -82.12 110.32 17.23 Favored 'General case' 0 CA--C 1.514 -0.439 0 O-C-N 120.73 -1.231 . . . . 0.0 109.598 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.9 pttt -58.17 -49.51 76.79 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-O 121.587 0.708 . . . . 0.0 110.096 178.122 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 6.3 tttm -140.87 126.68 11.36 Favored Pre-proline 0 N--CA 1.436 -1.149 0 C-N-CA 124.313 1.045 . . . . 0.0 110.0 -176.499 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -71.68 176.42 37.91 Favored 'Cis proline' 0 C--N 1.352 0.711 0 O-C-N 124.545 1.813 . . . . 0.0 110.665 -3.34 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 20.8 tttm -141.93 135.82 29.79 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.431 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -85.02 147.76 26.52 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.153 0.908 . . . . 0.0 109.396 176.616 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -43.9 152.13 0.48 Allowed Pre-proline 0 C--O 1.219 -0.539 0 C-N-CA 123.325 0.65 . . . . 0.0 112.438 176.829 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -71.83 -86.59 0.0 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.46 0 C-N-CA 121.214 1.276 . . . . 0.0 110.861 -179.744 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 128.96 153.46 7.98 Favored Glycine 0 CA--C 1.529 0.925 0 O-C-N 120.84 -1.163 . . . . 0.0 111.835 -176.681 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -75.63 -61.15 0.04 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.404 0 C-N-CA 122.471 2.114 . . . . 0.0 110.102 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.469 ' CB ' ' CZ ' ' A' ' 11' ' ' TYR . . . -60.87 132.0 52.48 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 109.794 -0.446 . . . . 0.0 109.794 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.427 ' HG2' ' HA ' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -146.29 146.44 30.72 Favored 'General case' 0 CA--C 1.503 -0.843 0 O-C-N 124.109 0.881 . . . . 0.0 110.864 178.683 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.404 ' CG1' ' HB3' ' A' ' 83' ' ' PHE . 7.6 p -79.84 119.64 29.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.512 1.133 . . . . 0.0 110.243 177.274 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.484 ' CD1' ' CB ' ' A' ' 82' ' ' GLU . 7.0 mm -100.6 142.14 16.19 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.964 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.103 178.908 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.421 ' CD1' ' HG3' ' A' ' 115' ' ' LYS . 10.8 p90 -164.91 153.66 12.42 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-O 122.537 1.16 . . . . 0.0 110.278 -178.664 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.6 p -87.18 168.6 13.09 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.47 -178.62 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.522 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.4 OUTLIER -114.49 152.04 45.77 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 122.124 0.17 . . . . 0.0 111.302 177.763 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.522 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 14.3 Cg_endo -75.21 -51.56 0.16 OUTLIER 'Cis proline' 0 CA--C 1.494 -1.493 0 N-CA-C 108.48 -1.392 . . . . 0.0 108.48 -4.977 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 3.0 m-20 -43.28 111.12 0.24 Allowed 'General case' 0 CA--C 1.5 -0.953 0 CA-C-O 116.59 -1.672 . . . . 0.0 109.912 179.013 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.442 ' HE2' ' CD1' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -68.66 67.96 0.14 Allowed 'General case' 0 CA--C 1.508 -0.646 0 O-C-N 125.944 2.027 . . . . 0.0 108.495 -177.989 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.6 t -73.15 72.65 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 -178.343 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.601 ' CZ ' ' HA2' ' A' ' 119' ' ' GLY . 41.5 t80 -41.72 116.61 0.81 Allowed 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 124.701 1.2 . . . . 0.0 109.22 179.384 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . 0.562 ' HB3' ' CD2' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -90.91 -41.55 11.09 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-O 121.637 0.732 . . . . 0.0 109.79 178.582 . . . . . . . . 3 3 . 1 . 008 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.601 ' HA2' ' CZ ' ' A' ' 117' ' ' PHE . . . 157.65 -171.65 34.83 Favored Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 111.569 -0.612 . . . . 0.0 111.569 -178.431 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 3.2 mp -109.71 147.06 14.37 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.983 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 -178.803 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 7.0 pt -119.76 155.47 22.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 177.891 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -173.99 160.49 3.51 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.572 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 1.6 m-70 -90.52 89.0 7.37 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.165 -177.913 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 2.9 p -103.85 43.4 1.09 Allowed 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 123.496 0.718 . . . . 0.0 109.66 -176.98 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -105.52 -24.79 12.53 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.146 176.041 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -169.42 -65.37 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.323 0 CA-C-O 121.061 0.458 . . . . 0.0 110.534 177.601 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -155.76 -44.59 0.08 Allowed 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.929 0.891 . . . . 0.0 110.612 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -156.12 81.03 0.99 Allowed 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 124.155 0.982 . . . . 0.0 109.24 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -131.77 -107.57 1.12 Allowed Glycine 0 N--CA 1.46 0.288 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 176.556 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -94.08 129.62 40.55 Favored 'General case' 0 C--N 1.322 -0.589 0 O-C-N 121.365 -1.079 . . . . 0.0 109.416 -178.893 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.53 149.23 22.98 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 121.728 0.775 . . . . 0.0 111.584 176.067 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.41 166.95 29.48 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 118.736 -0.649 . . . . 0.0 109.592 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 10.9 tp -66.34 133.11 49.85 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 179.46 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 71.3 m -57.83 -178.34 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 124.94 1.4 . . . . 0.0 110.34 176.249 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.2 m -161.34 112.63 1.76 Allowed 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 -178.239 . . . . . . . . 1 1 . 1 . 008 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.241 0.636 0 CA-C-O 116.106 -1.902 . . . . 0.0 113.626 172.486 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.653 ' H1 ' ' HB3' ' A' ' 13' ' ' GLN . . . . . . . . 0 CA--C 1.5 -0.955 0 CA-C-O 115.284 -2.293 . . . . 0.0 109.346 . . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.4 p -41.91 132.53 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 O-C-N 126.332 2.27 . . . . 0.0 109.499 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.2 m -90.05 113.31 24.99 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -178.309 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.548 ' CH2' ' CE1' ' A' ' 136' ' ' HIS . 33.1 m95 -82.61 141.06 32.84 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.038 177.779 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -130.65 138.23 49.97 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -177.142 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -133.33 -77.67 0.48 Allowed 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 176.433 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -75.54 34.96 1.16 Allowed Glycine 0 CA--C 1.533 1.209 0 CA-C-O 119.606 -0.552 . . . . 0.0 113.478 -179.284 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 72.3 5.05 61.83 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-N 118.453 1.126 . . . . 0.0 113.911 -170.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -107.48 139.29 42.21 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 -174.996 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.6 mp -94.26 129.19 41.0 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 124.256 0.973 . . . . 0.0 108.655 -174.388 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.46 ' CE2' ' CB ' ' A' ' 106' ' ' ALA . 77.6 m-85 -125.2 98.01 5.47 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 -170.501 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -52.77 122.81 9.85 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.805 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.653 ' HB3' ' H1 ' ' A' ' 1' ' ' ALA . 6.6 tp-100 -54.7 -41.49 70.32 Favored 'General case' 0 C--O 1.21 -1.022 0 C-N-CA 119.089 -1.044 . . . . 0.0 111.781 -179.04 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -48.3 -44.19 33.69 Favored 'General case' 0 C--O 1.205 -1.287 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 173.211 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.6 mttt -69.93 -38.14 76.13 Favored 'General case' 0 C--O 1.211 -0.96 0 CA-C-O 117.03 -1.462 . . . . 0.0 114.295 167.208 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -52.9 -41.31 64.26 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 122.484 2.402 . . . . 0.0 114.081 170.913 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -85.98 -41.57 14.76 Favored 'General case' 0 C--O 1.214 -0.797 0 O-C-N 120.554 -1.341 . . . . 0.0 109.858 175.357 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 43.4 t -72.7 -59.13 2.87 Favored 'General case' 0 C--O 1.212 -0.882 0 C-N-CA 126.627 1.971 . . . . 0.0 109.665 -175.054 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.435 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 4.4 t-20 -39.39 -39.7 0.71 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 120.107 1.321 . . . . 0.0 113.773 168.687 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.8 -33.72 40.24 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 172.965 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 6.6 m170 -48.22 -36.46 13.89 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 126.334 1.854 . . . . 0.0 110.152 178.23 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.435 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -73.49 -45.94 50.97 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 125.119 1.368 . . . . 0.0 111.702 176.076 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -39.13 130.03 1.24 Allowed Pre-proline 0 CA--C 1.539 0.552 0 O-C-N 125.411 1.694 . . . . 0.0 111.871 173.861 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -72.56 129.71 15.03 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 N-CA-C 107.296 -1.848 . . . . 0.0 107.296 -176.041 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.8 tp -63.3 83.86 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 125.265 1.426 . . . . 0.0 111.693 178.635 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 179.15 144.92 0.15 Allowed 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.044 0.938 . . . . 0.0 109.456 -172.887 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.424 ' HA ' ' HA ' ' A' ' 36' ' ' HIS . 1.4 t0 -86.93 118.7 26.48 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.816 0.847 . . . . 0.0 110.134 179.045 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 54.16 63.65 4.98 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 175.595 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -127.83 11.48 6.65 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 123.412 1.577 . . . . 0.0 112.499 176.818 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.0 p -118.49 150.94 38.77 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 -171.173 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -44.04 -61.41 3.09 Favored Glycine 0 CA--C 1.506 -0.472 0 CA-C-O 119.142 -0.81 . . . . 0.0 111.959 -179.043 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.409 ' CA ' ' HE2' ' A' ' 100' ' ' LYS . 58.5 m -52.39 -66.96 0.29 Allowed 'General case' 0 CA--C 1.489 -1.396 0 CA-C-O 116.325 -1.798 . . . . 0.0 111.984 175.504 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.1 p 164.2 -64.4 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.655 0 O-C-N 126.712 2.507 . . . . 0.0 110.642 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.429 ' CD1' ' HD3' ' A' ' 84' ' ' PRO . 98.1 m-85 -59.6 149.1 72.49 Favored Pre-proline 0 N--CA 1.436 -1.172 0 CA-C-N 114.403 -1.272 . . . . 0.0 113.249 -177.877 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 28.7 Cg_endo -74.29 166.23 83.17 Favored 'Cis proline' 0 N--CA 1.435 -1.951 0 C-N-CA 122.405 -1.915 . . . . 0.0 111.775 -2.446 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.424 ' HA ' ' HA ' ' A' ' 27' ' ' ASP . 0.5 OUTLIER -140.94 170.78 15.1 Favored 'General case' 0 C--O 1.214 -0.787 0 O-C-N 121.105 -0.997 . . . . 0.0 110.984 -177.891 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.486 ' CD1' ' CD2' ' A' ' 79' ' ' TYR . 18.2 t90 -66.68 148.85 51.35 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 120.812 1.642 . . . . 0.0 109.539 173.894 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.46 ' CZ ' HD13 ' A' ' 121' ' ' ILE . 11.7 t80 -120.74 86.92 2.66 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 104.079 -2.563 . . . . 0.0 104.079 -175.371 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 71.6 p -41.68 -35.77 0.84 Allowed 'General case' 0 C--O 1.214 -0.792 0 CA-C-N 114.308 -1.315 . . . . 0.0 110.252 171.52 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.43 ' HB2' ' CE2' ' A' ' 38' ' ' PHE . 56.3 t30 56.04 20.36 4.29 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 120.337 1.426 . . . . 0.0 111.916 178.36 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 105.3 -41.17 2.23 Favored Glycine 0 N--CA 1.43 -1.728 0 CA-C-O 115.413 -2.882 . . . . 0.0 115.459 -167.955 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.401 ' CE2' ' HD3' ' A' ' 66' ' ' PRO . 83.6 m-85 -44.52 153.85 0.15 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 120.216 2.008 . . . . 0.0 112.558 174.734 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.59 -37.51 21.06 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 176.964 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.47 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -169.1 -72.58 0.04 OUTLIER Glycine 0 C--N 1.334 0.434 0 C-N-CA 124.529 1.061 . . . . 0.0 111.374 -178.523 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -113.59 -63.73 1.41 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.223 1.009 . . . . 0.0 110.669 -178.869 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.45 -173.32 0.62 Allowed Glycine 0 C--N 1.339 0.714 0 CA-C-O 122.299 0.944 . . . . 0.0 111.605 178.215 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.7 mttt -58.28 -171.46 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 124.555 2.121 . . . . 0.0 112.289 175.276 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -81.25 159.31 68.01 Favored Pre-proline 0 C--N 1.311 -1.086 0 O-C-N 120.102 -1.624 . . . . 0.0 110.232 -178.788 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -70.28 161.97 44.04 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 121.357 1.371 . . . . 0.0 109.481 177.733 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.47 100.26 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.993 0.917 . . . . 0.0 110.825 176.305 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.41 83.15 1.69 Allowed Glycine 0 N--CA 1.462 0.402 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.148 -174.224 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.7 mmt-85 -165.35 165.27 19.5 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 124.542 1.137 . . . . 0.0 110.993 173.502 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 87.6 m -140.69 96.8 7.46 Favored Pre-proline 0 N--CA 1.465 0.291 0 O-C-N 124.91 1.381 . . . . 0.0 109.538 -176.836 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -72.72 145.37 41.12 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.572 2.181 . . . . 0.0 110.291 179.923 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.3 mt -69.98 120.52 17.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.4 tmtt? -81.9 136.33 35.34 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 176.519 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -119.75 -48.7 2.36 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 123.808 0.843 . . . . 0.0 110.39 178.408 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 120.78 -2.92 11.98 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 125.053 1.311 . . . . 0.0 113.246 -175.123 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.46 134.65 39.38 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-N 118.459 1.129 . . . . 0.0 109.854 175.815 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.7 t -73.49 -2.05 20.99 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 125.427 1.704 . . . . 0.0 112.141 175.574 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -89.47 -51.42 5.55 Favored 'General case' 0 CA--C 1.509 -0.604 0 C-N-CA 124.936 1.294 . . . . 0.0 109.305 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.8 m -74.99 -35.4 62.04 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 124.5 1.125 . . . . 0.0 111.667 177.871 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -64.22 -30.24 71.31 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 124.086 0.866 . . . . 0.0 112.114 172.996 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.54 159.21 25.65 Favored Pre-proline 0 N--CA 1.449 -0.486 0 CA-C-O 121.739 0.78 . . . . 0.0 111.751 176.334 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -70.38 139.41 38.04 Favored 'Trans proline' 0 CA--C 1.546 1.12 0 C-N-CA 120.45 0.767 . . . . 0.0 113.202 174.692 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.401 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 19.7 Cg_endo -71.85 173.37 12.84 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 124.968 3.779 . . . . 0.0 111.671 178.252 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -134.99 47.92 2.32 Favored 'General case' 0 C--O 1.241 0.625 0 O-C-N 120.214 -1.554 . . . . 0.0 110.981 -177.908 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.458 ' HA ' ' OD2' ' A' ' 77' ' ' ASP . 56.5 t-80 -65.04 130.0 41.78 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 176.474 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.6 t -111.74 -93.7 0.45 Allowed 'General case' 0 N--CA 1.486 1.361 0 O-C-N 119.224 -2.173 . . . . 0.0 110.384 177.636 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.9 mptt -68.92 -175.01 0.66 Allowed 'General case' 0 C--O 1.219 -0.539 0 C-N-CA 124.93 1.292 . . . . 0.0 110.629 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -68.81 38.93 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 173.13 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.54 -105.89 0.19 Allowed Glycine 0 C--O 1.217 -0.955 0 N-CA-C 107.701 -2.159 . . . . 0.0 107.701 -177.979 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -110.2 -89.92 0.48 Allowed 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 125.928 2.775 . . . . 0.0 106.19 -175.435 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 119.62 -135.27 11.09 Favored Glycine 0 N--CA 1.448 -0.565 0 O-C-N 119.294 -2.128 . . . . 0.0 110.296 -174.932 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 72.8 mttt -66.32 -78.69 0.05 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.2 1.0 . . . . 0.0 110.017 -176.843 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.7 OUTLIER -128.17 31.44 5.06 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 118.454 -0.784 . . . . 0.0 111.635 178.726 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.458 ' OD2' ' HA ' ' A' ' 68' ' ' HIS . 20.3 t0 -30.51 89.33 0.0 OUTLIER 'General case' 0 C--O 1.221 -0.438 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -177.084 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -85.52 11.92 9.59 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 119.681 -1.887 . . . . 0.0 109.322 -169.898 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.486 ' CD2' ' CD1' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -49.71 170.03 0.03 OUTLIER 'General case' 0 N--CA 1.438 -1.053 0 CA-C-O 123.463 1.601 . . . . 0.0 112.316 173.378 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.5 OUTLIER -95.14 141.5 28.68 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 113.634 -1.621 . . . . 0.0 109.996 172.203 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.518 HD22 ' CZ ' ' A' ' 110' ' ' TYR . 0.2 OUTLIER -123.96 129.8 51.54 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 174.492 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.401 ' CD ' ' HE2' ' A' ' 36' ' ' HIS . 2.2 pm0 -91.47 164.25 13.87 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 122.689 1.233 . . . . 0.0 113.26 172.418 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.429 ' CD1' ' HD2' ' A' ' 84' ' ' PRO . 84.1 t80 -152.04 132.42 7.36 Favored Pre-proline 0 CA--C 1.533 0.321 0 O-C-N 120.319 -1.488 . . . . 0.0 112.836 179.275 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.429 ' HD3' ' CD1' ' A' ' 34' ' ' TYR . 19.3 Cg_endo -73.96 108.53 2.68 Favored 'Trans proline' 0 CA--C 1.506 -0.88 1 C-N-CA 125.498 4.132 . . . . 0.0 109.632 -176.794 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -109.03 110.12 21.32 Favored 'General case' 0 CA--C 1.509 -0.627 0 O-C-N 125.435 1.709 . . . . 0.0 109.638 -178.632 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -81.58 158.02 69.08 Favored Pre-proline 0 C--O 1.238 0.494 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.114 178.565 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -75.58 -38.21 1.45 Allowed 'Trans proline' 0 CA--C 1.507 -0.829 0 C-N-CA 122.172 1.915 . . . . 0.0 112.224 179.29 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -45.73 -30.98 1.78 Allowed 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 123.977 1.846 . . . . 0.0 110.534 177.496 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 84.63 -0.44 89.21 Favored Glycine 0 N--CA 1.435 -1.368 0 CA-C-N 114.733 -1.121 . . . . 0.0 112.875 179.071 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -62.7 131.14 47.94 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 175.853 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -57.08 96.41 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 170.696 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.493 ' CD2' ' HB3' ' A' ' 94' ' ' PHE . 6.1 t80 -41.65 143.88 0.45 Allowed 'General case' 0 C--O 1.217 -0.633 0 C-N-CA 123.584 0.754 . . . . 0.0 109.532 178.736 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 12.5 ptpt -75.18 61.36 1.13 Allowed 'General case' 0 C--N 1.316 -0.88 0 O-C-N 119.696 -1.877 . . . . 0.0 109.096 173.528 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.493 ' HB3' ' CD2' ' A' ' 92' ' ' TYR . 36.3 p90 -75.8 -4.1 38.75 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 115.999 -1.953 . . . . 0.0 112.061 173.838 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -105.71 -26.1 11.95 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 120.417 1.462 . . . . 0.0 111.154 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 6.0 m -102.1 106.59 17.48 Favored 'General case' 0 CA--C 1.503 -0.839 0 O-C-N 120.574 -1.329 . . . . 0.0 108.8 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.8 ptpt -70.75 -32.74 70.0 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.424 0.631 . . . . 0.0 112.3 175.152 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 29.7 tttt -129.5 113.82 18.09 Favored Pre-proline 0 CA--C 1.538 0.5 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -178.477 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -71.4 174.09 47.4 Favored 'Cis proline' 0 C--O 1.221 -0.331 0 C-N-CA 123.82 -1.325 . . . . 0.0 111.066 -3.798 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.409 ' HE2' ' CA ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -133.63 128.38 34.98 Favored 'General case' 0 CA--C 1.502 -0.891 0 C-N-CA 124.6 1.16 . . . . 0.0 109.694 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -98.96 134.14 42.23 Favored 'General case' 0 C--O 1.244 0.769 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 -178.434 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -43.42 132.22 3.61 Favored Pre-proline 0 CA--C 1.534 0.354 0 O-C-N 124.264 0.977 . . . . 0.0 110.615 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -68.39 -163.94 0.1 OUTLIER 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 122.761 2.307 . . . . 0.0 111.623 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -123.48 161.18 17.89 Favored Glycine 0 CA--C 1.525 0.663 0 O-C-N 121.128 -0.982 . . . . 0.0 111.992 176.651 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -73.22 -43.28 0.74 Allowed 'Trans proline' 0 N--CA 1.449 -1.122 0 C-N-CA 121.711 1.608 . . . . 0.0 109.433 177.199 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.46 ' CB ' ' CE2' ' A' ' 11' ' ' TYR . . . -80.38 134.07 35.98 Favored 'General case' 0 N--CA 1.448 -0.555 0 O-C-N 124.329 1.018 . . . . 0.0 110.849 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 4.9 mtm-85 -140.35 150.22 43.68 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.569 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.6 p -89.15 118.78 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 O-C-N 124.527 1.142 . . . . 0.0 111.469 177.893 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 1.4 mp -107.3 118.16 54.49 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.809 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 -172.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.518 ' CZ ' HD22 ' A' ' 81' ' ' LEU . 5.1 p90 -138.3 151.43 47.58 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-O 122.482 1.134 . . . . 0.0 108.032 -178.32 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.6 p -84.16 160.74 20.8 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.79 -1.095 . . . . 0.0 109.709 177.925 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.47 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -107.47 155.8 38.94 Favored Pre-proline 0 CA--C 1.555 1.14 0 CA-C-O 121.515 0.674 . . . . 0.0 110.639 178.956 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.47 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 14.9 Cg_endo -74.5 -48.94 0.25 Allowed 'Cis proline' 0 CA--C 1.506 -0.878 0 C-N-CA 124.475 -1.052 . . . . 0.0 110.574 -8.407 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -49.09 107.67 0.15 Allowed 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 117.171 -1.395 . . . . 0.0 108.96 177.578 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.416 ' CG ' ' CD1' ' A' ' 110' ' ' TYR . 0.1 OUTLIER -64.02 78.38 0.03 OUTLIER 'General case' 0 CA--C 1.508 -0.673 0 C-N-CA 125.724 1.61 . . . . 0.0 108.274 -177.965 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.8 t -79.6 71.97 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 104.19 -2.522 . . . . 0.0 104.19 -176.869 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.485 ' CZ ' ' NE2' ' A' ' 13' ' ' GLN . 46.0 t80 -40.42 105.14 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.561 1.544 . . . . 0.0 109.036 177.588 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -82.86 -40.46 20.26 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-O 122.417 1.103 . . . . 0.0 109.204 -179.471 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.427 ' HA2' ' CZ ' ' A' ' 117' ' ' PHE . . . 162.56 -148.3 15.16 Favored Glycine 0 N--CA 1.435 -1.378 0 N-CA-C 109.811 -1.315 . . . . 0.0 109.811 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.418 HG13 ' CG ' ' A' ' 4' ' ' TRP . 1.3 mm -129.57 141.98 45.09 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.382 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 -175.023 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.46 HD13 ' CZ ' ' A' ' 38' ' ' PHE . 4.7 pt -127.96 154.77 38.93 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 -175.445 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -175.79 164.02 2.89 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.397 0.617 . . . . 0.0 109.342 178.764 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.47 ' CE1' ' HG ' ' A' ' 131' ' ' LEU . 2.6 m-70 -93.55 91.8 7.27 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -177.391 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.4 p -102.68 43.64 1.06 Allowed 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 123.909 0.884 . . . . 0.0 109.196 -176.56 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 7.1 tptm -107.41 -25.01 11.62 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.577 174.316 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -169.52 -65.46 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.15 0.5 . . . . 0.0 110.06 177.26 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -152.95 -46.91 0.1 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-O 122.581 1.182 . . . . 0.0 110.648 179.399 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.55 76.03 0.66 Allowed 'General case' 0 C--O 1.221 -0.446 0 C-N-CA 125.009 1.324 . . . . 0.0 111.103 -177.195 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -123.77 -107.16 1.78 Allowed Glycine 0 N--CA 1.465 0.63 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 178.834 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -80.31 158.29 26.15 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 121.532 -0.981 . . . . 0.0 111.642 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.47 ' HG ' ' CE1' ' A' ' 123' ' ' HIS . 0.9 OUTLIER -101.24 147.84 25.81 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 121.339 -0.85 . . . . 0.0 110.342 176.839 . . . . . . . . 3 3 . 1 . 009 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -158.14 167.41 29.9 Favored 'General case' 0 CA--C 1.506 -0.739 0 C-N-CA 124.438 1.095 . . . . 0.0 109.055 -177.284 . . . . . . . . 2 2 . 1 . 009 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 12.0 tp -83.45 143.93 29.93 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 124.474 1.109 . . . . 0.0 108.577 178.558 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 71.5 m -65.68 -175.13 0.25 Allowed 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 122.888 1.327 . . . . 0.0 111.165 173.189 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 18.6 p -131.78 96.33 3.92 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -177.905 . . . . . . . . 1 1 . 1 . 009 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 0.548 ' CE1' ' CH2' ' A' ' 4' ' ' TRP . 27.9 p-80 . . . . . 0 C--O 1.246 0.913 0 CA-C-O 115.346 -2.264 . . . . 0.0 112.86 172.697 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.514 -0.423 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 . . . . . . . . . 0 0 . 1 . 010 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.5 p -67.15 152.21 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 O-C-N 124.204 0.94 . . . . 0.0 110.791 176.546 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.8 m -87.36 115.45 24.78 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 123.148 0.579 . . . . 0.0 111.071 178.935 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 14.5 m95 -83.1 140.58 32.56 Favored 'General case' 0 C--O 1.213 -0.858 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 m -124.55 133.84 53.17 Favored 'General case' 0 C--N 1.309 -1.155 0 O-C-N 120.478 -1.389 . . . . 0.0 108.787 -177.993 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . 0.402 ' HB3' ' CB ' ' A' ' 122' ' ' ALA . 3.7 m -120.79 56.89 0.99 Allowed 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 118.215 -0.898 . . . . 0.0 109.273 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 39.64 60.62 1.73 Allowed Glycine 0 C--N 1.345 1.043 0 O-C-N 124.648 1.218 . . . . 0.0 112.088 -178.533 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 178.74 -81.57 0.06 OUTLIER Glycine 0 C--N 1.334 0.467 0 N-CA-C 110.881 -0.887 . . . . 0.0 110.881 -177.96 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.9 mt -123.97 160.11 28.32 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.45 0.643 . . . . 0.0 109.827 178.602 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.0 mp -90.47 132.78 35.47 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 -177.78 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.537 ' CE2' ' CB ' ' A' ' 106' ' ' ALA . 65.4 m-85 -116.43 91.08 3.48 Favored 'General case' 0 N--CA 1.433 -1.279 0 C-N-CA 127.826 2.45 . . . . 0.0 109.213 -175.838 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.01 127.02 28.42 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-O 117.52 -1.229 . . . . 0.0 108.514 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.605 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 0.0 OUTLIER -50.38 -50.58 51.05 Favored 'General case' 0 C--O 1.209 -1.063 0 CA-C-O 116.752 -1.594 . . . . 0.0 110.682 -179.227 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.418 ' O ' ' CB ' ' A' ' 18' ' ' SER . 11.2 t-20 -47.45 -38.48 13.66 Favored 'General case' 0 C--O 1.191 -2.011 0 O-C-N 124.633 1.208 . . . . 0.0 110.232 177.771 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.25 -51.43 24.62 Favored 'General case' 0 C--O 1.2 -1.52 0 CA-C-O 116.687 -1.625 . . . . 0.0 113.376 170.25 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -48.59 -34.63 11.91 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 121.583 1.992 . . . . 0.0 112.687 173.677 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -89.91 -44.04 10.17 Favored 'General case' 0 N--CA 1.435 -1.183 0 C-N-CA 123.659 0.784 . . . . 0.0 109.68 177.737 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.418 ' CB ' ' O ' ' A' ' 14' ' ' ASN . 30.8 t -64.58 -25.65 68.06 Favored 'General case' 0 C--O 1.205 -1.242 0 C-N-CA 126.492 1.917 . . . . 0.0 106.787 -177.438 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -73.6 -53.37 10.64 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 119.153 -2.217 . . . . 0.0 108.711 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.26 -12.47 61.17 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 122.08 0.943 . . . . 0.0 111.626 177.803 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 1.4 m170 -62.28 -50.76 70.4 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 -176.412 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -74.03 -41.28 62.05 Favored 'General case' 0 N--CA 1.443 -0.8 0 O-C-N 124.418 1.074 . . . . 0.0 110.091 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.433 ' HB3' ' CE2' ' A' ' 83' ' ' PHE . . . -41.64 129.54 2.38 Favored Pre-proline 0 N--CA 1.445 -0.699 0 O-C-N 125.644 1.84 . . . . 0.0 111.332 178.384 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.417 ' HG2' ' CG2' ' A' ' 30' ' ' THR . 18.2 Cg_endo -73.03 126.57 11.33 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 121.923 1.748 . . . . 0.0 109.573 -177.161 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.461 ' CD1' ' HE3' ' A' ' 115' ' ' LYS . 4.1 tp -59.79 88.65 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.434 0 O-C-N 124.143 0.902 . . . . 0.0 111.19 178.861 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -175.88 167.12 3.08 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -176.163 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -115.19 132.34 56.64 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 117.704 -1.141 . . . . 0.0 109.579 177.612 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 50.71 62.0 5.59 Favored Glycine 0 C--N 1.34 0.796 0 N-CA-C 108.254 -1.938 . . . . 0.0 108.254 172.136 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -151.55 35.68 0.57 Allowed 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 122.304 1.05 . . . . 0.0 110.685 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 30' ' ' THR . . . . . 0.417 ' CG2' ' HG2' ' A' ' 24' ' ' PRO . 9.2 p -144.23 153.06 41.67 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -175.65 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -36.64 -78.33 0.04 OUTLIER Glycine 0 C--N 1.34 0.776 0 O-C-N 124.307 1.005 . . . . 0.0 111.314 -178.92 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.462 ' O ' ' HE3' ' A' ' 100' ' ' LYS . 30.8 t -52.41 -61.52 2.23 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-O 117.681 -1.152 . . . . 0.0 110.669 177.921 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 162.04 -51.86 0.0 OUTLIER 'General case' 0 C--O 1.218 -0.592 0 O-C-N 125.521 1.763 . . . . 0.0 110.421 179.124 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.51 ' CD2' ' HD3' ' A' ' 84' ' ' PRO . 61.6 m-85 -61.82 151.33 79.73 Favored Pre-proline 0 N--CA 1.43 -1.474 0 CA-C-O 117.13 -1.414 . . . . 0.0 111.511 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 22.7 Cg_endo -73.76 164.41 87.48 Favored 'Cis proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.032 -2.07 . . . . 0.0 111.931 -3.453 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -140.95 162.87 34.45 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-O 116.897 -1.525 . . . . 0.0 110.6 -178.345 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.493 ' CD1' ' HB2' ' A' ' 79' ' ' TYR . 18.2 t90 -60.69 139.26 57.93 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 124.143 0.902 . . . . 0.0 108.772 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.513 ' CD2' ' HB2' ' A' ' 40' ' ' ASN . 25.7 t80 -110.98 79.02 1.16 Allowed 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 -176.123 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 23.6 p -37.79 -34.57 0.11 Allowed 'General case' 0 C--O 1.214 -0.782 0 C-N-CA 124.265 1.026 . . . . 0.0 110.778 175.171 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.513 ' HB2' ' CD2' ' A' ' 38' ' ' PHE . 43.4 t30 57.63 19.25 5.28 Favored 'General case' 0 C--O 1.209 -1.068 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 174.688 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.443 ' CA ' ' HD2' ' A' ' 52' ' ' ARG . . . 112.49 -46.94 1.1 Allowed Glycine 0 N--CA 1.421 -2.364 0 O-C-N 118.682 -2.511 . . . . 0.0 112.353 -171.808 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.465 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 58.2 m-85 -49.63 144.87 5.55 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 124.285 1.034 . . . . 0.0 110.372 -177.314 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.78 -35.79 26.21 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.214 178.362 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -164.13 -100.32 0.15 Allowed Glycine 0 N--CA 1.442 -0.906 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.89 175.98 8.33 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 118.111 -0.947 . . . . 0.0 109.778 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.401 ' O ' ' HD2' ' A' ' 66' ' ' PRO . . . 38.51 -156.93 0.01 OUTLIER Glycine 0 C--N 1.349 1.264 0 CA-C-O 123.14 1.411 . . . . 0.0 112.08 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.45 ' HA ' ' CE1' ' A' ' 42' ' ' TYR . 0.8 OUTLIER -65.11 -172.17 0.09 Allowed 'General case' 0 N--CA 1.444 -0.737 0 O-C-N 120.267 -1.726 . . . . 0.0 111.727 174.869 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.465 ' HG ' ' CD1' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -87.93 174.76 4.84 Favored Pre-proline 0 N--CA 1.441 -0.924 0 O-C-N 120.51 -1.369 . . . . 0.0 109.109 -178.774 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -73.92 -175.7 2.26 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 122.335 2.023 . . . . 0.0 111.734 178.305 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.4 tttt -67.47 94.89 0.43 Allowed 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 121.134 -0.979 . . . . 0.0 109.751 177.57 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.47 91.3 1.73 Allowed Glycine 0 CA--C 1.5 -0.866 0 CA-C-O 118.807 -0.996 . . . . 0.0 110.885 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.443 ' HD2' ' CA ' ' A' ' 41' ' ' GLY . 0.1 OUTLIER -177.11 155.94 1.22 Allowed 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 123.767 0.827 . . . . 0.0 110.58 177.661 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.1 m -141.33 98.31 6.66 Favored Pre-proline 0 C--N 1.327 -0.39 0 O-C-N 124.374 1.046 . . . . 0.0 110.763 -178.536 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -71.23 177.46 6.57 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 122.24 1.96 . . . . 0.0 112.024 179.061 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.405 ' O ' ' CE1' ' A' ' 57' ' ' PHE . 5.4 mt -97.96 136.64 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -179.228 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -91.43 155.25 18.59 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 177.697 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.541 ' CD2' ' HB3' ' A' ' 118' ' ' CYS . 9.4 m-85 -140.26 -47.72 0.44 Allowed 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 123.765 0.826 . . . . 0.0 111.046 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 119.73 -3.72 13.27 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 116.284 -0.416 . . . . 0.0 112.148 -177.852 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -95.73 134.73 38.32 Favored 'General case' 0 CA--C 1.501 -0.925 0 CA-C-O 118.096 -0.954 . . . . 0.0 108.708 -179.138 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.7 t -72.15 -5.33 34.77 Favored 'General case' 0 C--O 1.221 -0.428 0 O-C-N 124.971 1.419 . . . . 0.0 111.581 177.21 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -91.92 -51.0 5.42 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 -177.398 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.9 m -75.15 -37.52 61.32 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -178.423 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -59.91 -41.63 92.13 Favored 'General case' 0 C--N 1.343 0.305 0 CA-C-O 121.927 0.87 . . . . 0.0 109.857 176.861 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -49.41 160.69 0.53 Allowed Pre-proline 0 N--CA 1.439 -1.024 0 CA-C-O 122.672 1.225 . . . . 0.0 110.177 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -75.21 144.84 30.04 Favored 'Trans proline' 0 N--CA 1.441 -1.592 0 C-N-CA 120.99 1.126 . . . . 0.0 113.231 175.115 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.459 ' HG3' ' CD2' ' A' ' 42' ' ' TYR . 21.0 Cg_endo -75.25 168.75 23.97 Favored 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 123.584 2.856 . . . . 0.0 111.443 178.786 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.1 tptt -132.22 52.18 2.09 Favored 'General case' 0 C--O 1.207 -1.17 0 CA-C-O 117.683 -1.151 . . . . 0.0 108.899 -178.419 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.454 ' CE1' ' O ' ' A' ' 70' ' ' LYS . 49.0 t-80 -83.84 158.56 21.63 Favored 'General case' 0 C--O 1.216 -0.672 0 CA-C-N 119.048 0.84 . . . . 0.0 110.011 179.074 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -175.71 -36.23 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.6 0.76 . . . . 0.0 109.658 173.455 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . 0.454 ' O ' ' CE1' ' A' ' 68' ' ' HIS . 0.0 OUTLIER -81.39 -171.51 3.32 Favored 'General case' 0 C--O 1.212 -0.909 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 178.389 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -82.69 36.34 0.49 Allowed 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 122.038 0.923 . . . . 0.0 111.827 177.067 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.427 ' O ' ' CE2' ' A' ' 79' ' ' TYR . . . 159.82 -83.67 0.13 Allowed Glycine 0 N--CA 1.44 -1.06 0 O-C-N 120.009 -1.682 . . . . 0.0 111.051 -177.045 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.442 ' OD1' ' CE1' ' A' ' 79' ' ' TYR . 0.5 OUTLIER -143.73 75.89 1.49 Allowed 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 117.436 -1.269 . . . . 0.0 108.548 179.366 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -33.52 -94.89 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 119.517 1.053 . . . . 0.0 114.719 176.168 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.2 mttm -85.16 -108.88 0.05 OUTLIER 'General case' 0 C--O 1.216 -0.685 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.436 176.795 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.422 ' O ' ' CG2' ' A' ' 76' ' ' THR . 0.5 OUTLIER -101.55 21.8 13.72 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 123.892 0.877 . . . . 0.0 111.046 -179.949 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.435 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 5.6 m-20 -30.25 104.56 0.03 OUTLIER 'General case' 0 C--O 1.19 -2.035 0 C-N-CA 124.292 1.037 . . . . 0.0 111.576 -177.529 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -80.76 10.69 4.59 Favored 'General case' 0 C--N 1.314 -0.951 0 O-C-N 118.081 -2.887 . . . . 0.0 110.824 -177.206 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.526 ' CE2' HD23 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -38.37 141.01 0.27 Allowed 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 115.65 1.722 . . . . 0.0 115.65 172.948 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.68 158.49 30.98 Favored 'General case' 0 C--N 1.317 -0.811 0 O-C-N 120.101 -1.624 . . . . 0.0 110.237 178.291 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.526 HD23 ' CE2' ' A' ' 79' ' ' TYR . 1.3 mt -140.31 133.75 29.98 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.3 pm0 -101.65 151.69 21.71 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-O 122.489 1.138 . . . . 0.0 108.906 -178.549 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.433 ' CE2' ' HB3' ' A' ' 23' ' ' ALA . 7.8 t80 -141.84 132.44 12.92 Favored Pre-proline 0 N--CA 1.44 -0.969 0 O-C-N 121.33 -0.856 . . . . 0.0 111.989 -179.11 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.51 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 18.6 Cg_endo -74.47 93.74 0.92 Allowed 'Trans proline' 0 N--CA 1.449 -1.145 0 C-N-CA 123.657 2.905 . . . . 0.0 110.264 -177.933 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.3 t -93.34 119.33 32.35 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 122.437 1.113 . . . . 0.0 111.028 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.645 ' CD2' ' CE1' ' A' ' 90' ' ' HIS . 25.1 m-85 -84.43 151.83 59.82 Favored Pre-proline 0 N--CA 1.438 -1.067 0 O-C-N 121.005 -1.059 . . . . 0.0 111.029 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -78.06 -42.46 0.24 Allowed 'Trans proline' 0 CA--C 1.503 -1.073 0 C-N-CA 122.291 1.994 . . . . 0.0 112.718 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -42.9 -33.33 0.76 Allowed 'General case' 0 C--N 1.348 0.533 0 O-C-N 126.032 2.082 . . . . 0.0 110.161 176.273 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 99.92 16.34 28.56 Favored Glycine 0 N--CA 1.432 -1.6 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 178.541 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.645 ' CE1' ' CD2' ' A' ' 86' ' ' PHE . 2.0 p-80 -87.93 131.16 34.7 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.82 100.67 1.96 Allowed 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 176.18 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.483 ' O ' ' CD2' ' A' ' 94' ' ' PHE . 19.9 t80 -35.77 140.74 0.1 Allowed 'General case' 0 C--O 1.205 -1.271 0 CA-C-O 122.051 0.929 . . . . 0.0 112.172 177.473 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.91 61.69 2.57 Favored 'General case' 0 C--N 1.315 -0.892 0 O-C-N 119.032 -2.293 . . . . 0.0 109.418 178.648 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.483 ' CD2' ' O ' ' A' ' 92' ' ' TYR . 30.4 p90 -76.07 4.13 9.08 Favored 'General case' 0 N--CA 1.439 -1.025 0 C-N-CA 124.077 0.951 . . . . 0.0 111.832 177.016 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -104.45 -33.3 8.64 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-O 122.578 1.18 . . . . 0.0 109.242 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 14.3 m -98.54 95.79 7.53 Favored 'General case' 0 CA--C 1.506 -0.725 0 O-C-N 120.554 -1.341 . . . . 0.0 107.915 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -73.48 -35.39 65.67 Favored 'General case' 0 C--O 1.22 -0.448 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 177.27 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -119.56 105.77 43.21 Favored Pre-proline 0 N--CA 1.437 -1.121 0 O-C-N 120.006 -1.684 . . . . 0.0 109.451 -179.355 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -73.88 172.14 63.0 Favored 'Cis proline' 0 C--O 1.213 -0.737 0 O-C-N 124.416 1.745 . . . . 0.0 112.039 -1.84 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.462 ' HE3' ' O ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -118.2 127.32 53.64 Favored 'General case' 0 CA--C 1.511 -0.54 0 C-N-CA 123.408 0.683 . . . . 0.0 109.544 -178.798 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 9.2 tp10 -82.34 149.76 27.57 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.857 1.348 . . . . 0.0 110.218 178.927 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -51.31 139.25 26.57 Favored Pre-proline 0 N--CA 1.43 -1.448 0 CA-C-O 122.364 1.078 . . . . 0.0 112.546 172.258 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -73.61 -164.22 0.19 Allowed 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 121.689 1.593 . . . . 0.0 111.885 177.741 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -140.14 158.94 26.02 Favored Glycine 0 N--CA 1.441 -0.986 0 O-C-N 121.338 -0.851 . . . . 0.0 112.368 177.038 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -74.88 -62.56 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.471 2.114 . . . . 0.0 110.867 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.537 ' CB ' ' CE2' ' A' ' 11' ' ' TYR . . . -67.57 133.88 50.23 Favored 'General case' 0 N--CA 1.436 -1.174 0 O-C-N 123.868 0.73 . . . . 0.0 110.488 179.017 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -140.33 147.03 39.25 Favored 'General case' 0 CA--C 1.498 -1.039 0 CA-C-O 117.206 -1.378 . . . . 0.0 111.51 178.766 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . 0.45 HG23 ' CE2' ' A' ' 117' ' ' PHE . 3.2 p -83.24 120.14 33.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 C-N-CA 124.221 1.008 . . . . 0.0 110.985 177.775 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.5 HG23 ' CE2' ' A' ' 38' ' ' PHE . 1.7 mp -105.84 124.35 60.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 -175.975 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.462 ' CD1' ' HG3' ' A' ' 115' ' ' LYS . 19.3 p90 -142.27 164.2 30.78 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-O 121.661 0.743 . . . . 0.0 111.074 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.6 p -91.88 163.67 13.95 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -177.804 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.54 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.2 OUTLIER -117.04 152.22 48.52 Favored Pre-proline 0 N--CA 1.434 -1.226 0 C-N-CA 123.292 0.637 . . . . 0.0 110.646 -179.72 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.54 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 19.1 Cg_endo -73.48 -51.68 0.16 OUTLIER 'Cis proline' 0 CA--C 1.51 -0.717 0 C-N-CA 122.252 -1.978 . . . . 0.0 109.484 -5.441 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -41.64 111.69 0.25 Allowed 'General case' 0 N--CA 1.438 -1.064 0 CA-C-O 113.612 -3.089 . . . . 0.0 110.012 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.462 ' HG3' ' CD1' ' A' ' 110' ' ' TYR . 0.1 OUTLIER -65.76 68.89 0.05 OUTLIER 'General case' 0 CA--C 1.508 -0.669 0 O-C-N 127.12 2.763 . . . . 0.0 108.562 -178.707 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 24.2 t -74.29 64.28 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 106.028 -1.842 . . . . 0.0 106.028 -177.623 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.605 ' CZ ' ' NE2' ' A' ' 13' ' ' GLN . 2.0 t80 -36.71 124.65 0.85 Allowed 'General case' 0 N--CA 1.432 -1.347 0 O-C-N 120.61 -1.306 . . . . 0.0 108.946 178.949 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . 0.541 ' HB3' ' CD2' ' A' ' 57' ' ' PHE . 0.1 OUTLIER -101.41 -38.23 8.1 Favored 'General case' 0 N--CA 1.439 -1.008 0 O-C-N 123.836 0.71 . . . . 0.0 109.383 177.29 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.547 ' HA2' ' CZ ' ' A' ' 117' ' ' PHE . . . 158.68 -159.9 30.61 Favored Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 -178.602 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 3.4 mp -117.91 145.4 23.86 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.349 0 CA-C-O 117.383 -1.294 . . . . 0.0 107.947 -178.12 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.414 HD13 ' CE1' ' A' ' 38' ' ' PHE . 6.6 pt -110.27 158.5 10.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-N 120.959 1.708 . . . . 0.0 109.101 178.008 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . 0.402 ' CB ' ' HB3' ' A' ' 6' ' ' CYS . . . 177.89 159.01 0.46 Allowed 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 124.063 0.945 . . . . 0.0 109.648 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.503 ' CE1' ' CD2' ' A' ' 131' ' ' LEU . 0.3 OUTLIER -91.11 96.04 10.39 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -178.407 . . . . . . . . 3 3 . 1 . 010 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.2 p -103.32 43.98 1.05 Allowed 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.706 0.765 . . . . 0.0 109.027 -177.008 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.6 tptt -105.78 -24.13 12.56 Favored 'General case' 0 C--O 1.221 -0.423 0 O-C-N 121.387 -0.821 . . . . 0.0 110.831 177.312 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -175.34 -70.95 0.01 OUTLIER 'General case' 0 C--O 1.223 -0.32 0 O-C-N 124.152 0.908 . . . . 0.0 110.831 178.404 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -136.38 -55.87 0.75 Allowed 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -177.426 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -163.67 77.85 0.4 Allowed 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 121.859 0.837 . . . . 0.0 110.796 -178.191 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -112.17 -102.66 2.63 Favored Glycine 0 C--N 1.332 0.324 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -91.99 147.76 22.72 Favored 'General case' 0 CA--C 1.511 -0.546 0 O-C-N 121.251 -1.146 . . . . 0.0 110.844 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.503 ' CD2' ' CE1' ' A' ' 123' ' ' HIS . 17.2 mt -83.43 145.77 28.79 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 121.989 0.899 . . . . 0.0 110.975 178.007 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 11.4 ptpt -157.09 169.57 24.49 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-O 118.521 -0.752 . . . . 0.0 109.975 -177.091 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.447 HD21 ' CD2' ' A' ' 57' ' ' PHE . 9.7 tp -83.99 139.71 32.37 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.17 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 72.1 m -58.98 -174.37 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.913 0 CA-C-O 124.124 1.916 . . . . 0.0 108.594 177.389 . . . . . . . . 1 1 . 1 . 010 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.38 120.85 0.96 Allowed 'General case' 0 C--N 1.314 -0.949 0 O-C-N 120.057 -1.652 . . . . 0.0 108.575 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 1.8 m80 . . . . . 0 C--O 1.253 1.255 0 CA-C-O 115.143 -2.36 . . . . 0.0 111.847 177.212 . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.7 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 . . . . . . . . . 0 0 . 1 . 011 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.2 p -169.91 131.22 0.23 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 179.088 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -85.65 117.54 24.6 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.693 177.468 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.601 ' CH2' ' CE1' ' A' ' 136' ' ' HIS . 26.9 m95 -85.02 140.76 30.78 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.036 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -136.05 132.87 36.78 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -176.908 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -119.05 69.39 0.81 Allowed 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.651 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 34.79 86.65 0.01 OUTLIER Glycine 0 CA--C 1.53 0.983 0 C-N-CA 124.037 0.827 . . . . 0.0 113.648 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 147.78 -74.05 0.29 Allowed Glycine 0 N--CA 1.462 0.403 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 -176.855 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 5.7 mt -131.16 160.18 35.53 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.243 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -102.27 154.74 18.76 Favored 'General case' 0 C--O 1.218 -0.597 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.442 178.116 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.476 ' CE1' ' CB ' ' A' ' 106' ' ' ALA . 30.6 m-85 -134.59 108.84 8.28 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -178.277 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -55.89 120.2 7.02 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 177.649 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.497 ' HB2' ' CD1' ' A' ' 4' ' ' TRP . 8.4 tp-100 -54.8 -42.01 71.28 Favored 'General case' 0 CA--C 1.503 -0.846 0 C-N-CA 119.959 -0.697 . . . . 0.0 112.387 178.822 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -50.35 -26.05 4.49 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 124.029 0.831 . . . . 0.0 112.306 177.379 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.2 mttp -96.36 -34.25 11.63 Favored 'General case' 0 C--O 1.219 -0.503 0 C-N-CA 124.569 1.148 . . . . 0.0 112.49 170.957 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.02 -39.52 69.2 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 120.406 1.457 . . . . 0.0 111.851 176.31 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -87.38 -44.56 11.27 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 122.962 0.505 . . . . 0.0 110.204 175.125 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.2 t -69.21 -57.67 5.06 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 118.959 0.799 . . . . 0.0 112.292 -177.982 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.496 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 3.9 t-20 -44.89 -30.97 1.1 Allowed 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 170.939 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.5 p -83.64 -33.34 25.3 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 175.56 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -47.84 -36.79 12.53 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.037 0.935 . . . . 0.0 109.919 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.496 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.1 OUTLIER -70.17 -47.96 59.36 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 124.577 1.151 . . . . 0.0 110.573 177.87 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.407 ' HB1' ' CE1' ' A' ' 83' ' ' PHE . . . -39.61 127.21 1.46 Allowed Pre-proline 0 CA--C 1.537 0.447 0 O-C-N 124.602 1.189 . . . . 0.0 110.606 176.364 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -72.79 124.69 9.9 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 121.546 1.497 . . . . 0.0 109.096 -177.774 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 3.8 tp -60.78 94.36 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 123.542 0.737 . . . . 0.0 111.291 178.416 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 179.89 160.35 0.84 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.35 -174.949 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -99.86 116.18 31.33 Favored 'General case' 0 CA--C 1.51 -0.567 0 C-N-CA 123.826 0.85 . . . . 0.0 108.898 177.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 50.51 72.47 0.49 Allowed Glycine 0 CA--C 1.528 0.873 0 O-C-N 124.394 1.059 . . . . 0.0 112.426 176.481 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.17 22.03 1.55 Allowed 'General case' 0 N--CA 1.473 0.708 0 O-C-N 122.429 -0.453 . . . . 0.0 112.033 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 33.5 p -121.91 156.8 32.58 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -176.471 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -43.68 -52.01 6.63 Favored Glycine 0 C--N 1.332 0.337 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.989 -178.792 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 12.2 t -68.03 -79.48 0.05 Allowed 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 119.306 -0.378 . . . . 0.0 111.235 173.726 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 89.1 p -178.42 -59.05 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 124.803 1.241 . . . . 0.0 109.83 -178.863 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.479 ' CE1' ' HB3' ' A' ' 103' ' ' PRO . 81.6 m-85 -63.57 148.95 93.22 Favored Pre-proline 0 CA--C 1.552 1.022 0 C-N-CA 123.303 0.641 . . . . 0.0 112.375 -176.54 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -74.9 169.77 73.56 Favored 'Cis proline' 0 N--CA 1.455 -0.736 0 O-C-N 123.524 1.276 . . . . 0.0 112.116 1.347 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.427 ' CD2' ' CD2' ' A' ' 34' ' ' TYR . 1.4 p80 -142.5 169.22 17.98 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 -177.29 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.47 ' CD1' ' HB2' ' A' ' 79' ' ' TYR . 20.5 t90 -71.65 129.22 38.16 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.399 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.549 ' CD2' HG21 ' A' ' 109' ' ' ILE . 33.9 t80 -99.48 82.74 2.7 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 105.869 -1.901 . . . . 0.0 105.869 179.331 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.41 ' CG2' ' CZ3' ' A' ' 37' ' ' TRP . 41.6 p -39.51 -33.5 0.17 Allowed 'General case' 0 CA--C 1.503 -0.845 0 CA-C-N 114.337 -1.301 . . . . 0.0 110.815 170.905 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.472 ' HB2' ' CD2' ' A' ' 38' ' ' PHE . 59.0 t30 55.63 20.13 3.7 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 123.558 1.646 . . . . 0.0 112.125 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.403 ' HA2' ' NE ' ' A' ' 52' ' ' ARG . . . 110.08 -44.52 1.48 Allowed Glycine 0 N--CA 1.436 -1.331 0 CA-C-O 116.039 -2.534 . . . . 0.0 113.661 -170.959 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.473 ' CE2' ' HD3' ' A' ' 66' ' ' PRO . 76.9 m-85 -45.94 150.99 0.5 Allowed 'General case' 0 C--N 1.343 0.296 0 C-N-CA 125.779 1.631 . . . . 0.0 110.666 -178.728 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.4 -37.73 27.67 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.049 178.052 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.433 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -164.29 -77.66 0.03 OUTLIER Glycine 0 C--N 1.335 0.503 0 N-CA-C 111.189 -0.765 . . . . 0.0 111.189 -178.38 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -113.22 -62.78 1.54 Allowed 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 123.289 0.636 . . . . 0.0 111.377 -178.303 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.6 -169.85 0.11 Allowed Glycine 0 C--N 1.342 0.892 0 C-N-CA 124.408 1.004 . . . . 0.0 111.135 177.809 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.9 mtpt -59.53 -169.49 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 123.279 1.514 . . . . 0.0 111.701 176.728 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -93.18 176.58 2.44 Favored Pre-proline 0 C--N 1.318 -0.783 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.309 -178.091 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -70.83 158.85 54.43 Favored 'Trans proline' 0 N--CA 1.444 -1.386 0 O-C-N 123.807 1.425 . . . . 0.0 110.967 178.276 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.4 ttpp -64.71 97.23 0.21 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.263 176.39 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 119.19 40.12 0.65 Allowed Glycine 0 N--CA 1.464 0.509 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.853 -177.208 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.403 ' NE ' ' HA2' ' A' ' 41' ' ' GLY . 0.2 OUTLIER -122.07 159.79 26.34 Favored 'General case' 0 CA--C 1.513 -0.471 0 C-N-CA 122.837 0.455 . . . . 0.0 110.703 175.761 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 53.3 m -136.03 98.9 11.42 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.621 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -72.37 179.19 5.28 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.668 2.245 . . . . 0.0 111.275 177.191 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.8 mt -107.17 140.48 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -95.89 146.45 24.57 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 121.533 0.682 . . . . 0.0 109.621 176.669 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.506 ' CD1' ' HB3' ' A' ' 118' ' ' CYS . 24.0 m-85 -128.59 -50.14 1.27 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.263 1.025 . . . . 0.0 110.77 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 117.28 -3.18 18.57 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 123.742 0.687 . . . . 0.0 112.657 -175.135 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.98 133.33 42.6 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-N 117.759 0.779 . . . . 0.0 109.818 177.381 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 46.3 t -69.4 -6.09 27.79 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 124.749 1.281 . . . . 0.0 111.551 176.773 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.48 -57.16 2.98 Favored 'General case' 0 CA--C 1.517 -0.318 0 O-C-N 120.651 -1.28 . . . . 0.0 109.367 -178.58 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 2.1 t -68.9 -25.91 64.83 Favored 'General case' 0 N--CA 1.457 -0.107 0 O-C-N 124.492 1.12 . . . . 0.0 110.806 176.522 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -70.86 -38.45 73.14 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.367 0.603 . . . . 0.0 110.618 174.576 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.44 158.16 6.05 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-O 122.163 0.982 . . . . 0.0 111.745 179.787 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -70.78 140.85 39.74 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 120.309 0.673 . . . . 0.0 113.029 175.751 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.473 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 19.3 Cg_endo -71.77 172.26 14.83 Favored 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 122.73 2.287 . . . . 0.0 111.514 177.896 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -134.18 54.67 1.93 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.899 178.721 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.441 ' CE1' ' O ' ' A' ' 69' ' ' SER . 49.9 t-80 -77.95 156.44 30.24 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 121.669 0.747 . . . . 0.0 110.249 -178.804 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.441 ' O ' ' CE1' ' A' ' 68' ' ' HIS . 0.2 OUTLIER -142.95 -166.02 2.2 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 121.251 -0.906 . . . . 0.0 110.568 179.047 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.6 72.51 10.3 Favored 'General case' 0 C--O 1.219 -0.535 0 O-C-N 121.894 -0.504 . . . . 0.0 110.647 176.619 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -178.58 -41.37 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.61 0.719 . . . . 0.0 110.563 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.409 ' O ' ' CE2' ' A' ' 79' ' ' TYR . . . 118.73 -48.18 0.96 Allowed Glycine 0 CA--C 1.499 -0.948 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.206 -177.149 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.426 ' ND2' ' CZ ' ' A' ' 112' ' ' TYR . 2.0 t-20 -147.56 85.17 1.57 Allowed 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 179.083 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -71.07 -119.35 0.05 OUTLIER Glycine 0 CA--C 1.529 0.909 0 CA-C-O 122.036 0.798 . . . . 0.0 111.807 177.119 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -52.79 -87.77 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.675 0 O-C-N 121.066 -1.255 . . . . 0.0 112.717 178.211 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -123.54 19.05 9.63 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.014 177.623 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.496 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 6.5 m-20 -32.18 105.18 0.03 OUTLIER 'General case' 0 CA--C 1.504 -0.815 0 C-N-CA 124.898 1.279 . . . . 0.0 109.15 -176.123 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.453 ' H ' ' CD2' ' A' ' 78' ' ' HIS . 3.2 p80 -88.42 18.43 4.51 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -175.987 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.47 ' HB2' ' CD1' ' A' ' 37' ' ' TRP . 0.4 OUTLIER -40.15 135.25 1.42 Allowed 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 125.419 1.488 . . . . 0.0 110.948 173.804 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -75.45 155.37 36.34 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.851 176.113 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.456 ' CD1' ' CZ ' ' A' ' 79' ' ' TYR . 1.7 mp -140.69 150.49 43.54 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.883 0.373 . . . . 0.0 110.147 176.484 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.485 ' CB ' ' CD1' ' A' ' 109' ' ' ILE . 0.4 OUTLIER -115.76 157.53 24.2 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 122.009 0.909 . . . . 0.0 110.627 -179.699 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.425 ' CE2' ' CE2' ' A' ' 92' ' ' TYR . 30.3 t80 -139.99 133.76 15.46 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-O 118.698 -0.668 . . . . 0.0 112.204 -178.452 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.522 ' HA ' ' HG2' ' A' ' 107' ' ' ARG . 17.8 Cg_endo -70.03 87.71 0.58 Allowed 'Trans proline' 0 CA--C 1.505 -0.956 0 C-N-CA 123.937 3.091 . . . . 0.0 110.72 -174.706 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.484 ' HA ' ' CZ ' ' A' ' 92' ' ' TYR . 2.7 t -83.5 129.02 34.96 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 124.237 0.961 . . . . 0.0 110.902 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.648 ' CD1' ' CD1' ' A' ' 92' ' ' TYR . 4.6 m-85 -96.54 152.34 38.55 Favored Pre-proline 0 C--O 1.237 0.395 0 C-N-CA 122.796 0.439 . . . . 0.0 110.203 -178.95 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -73.07 -47.74 0.31 Allowed 'Trans proline' 0 N--CA 1.447 -1.213 0 O-C-N 124.047 1.551 . . . . 0.0 112.266 179.426 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -42.74 -41.08 3.05 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 123.07 1.414 . . . . 0.0 110.278 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 94.85 18.0 36.17 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.146 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.437 ' O ' ' CE1' ' A' ' 92' ' ' TYR . 1.8 p-80 -86.69 147.48 25.86 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-N 118.061 0.931 . . . . 0.0 109.601 176.526 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -63.92 139.82 58.81 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 118.642 0.655 . . . . 0.0 111.902 174.525 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.648 ' CD1' ' CD1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -96.18 146.97 24.23 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -174.608 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.21 69.05 9.85 Favored 'General case' 0 C--N 1.32 -0.696 0 O-C-N 121.371 -0.83 . . . . 0.0 110.08 175.478 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.404 ' CD2' ' HZ ' ' A' ' 83' ' ' PHE . 25.7 p90 -83.55 -23.58 31.96 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.113 177.743 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -91.17 -23.74 20.15 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 123.012 1.387 . . . . 0.0 110.924 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.15 108.9 18.53 Favored 'General case' 0 CA--C 1.517 -0.325 0 O-C-N 120.61 -1.306 . . . . 0.0 108.575 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.97 -48.2 82.69 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 121.609 0.719 . . . . 0.0 111.067 178.602 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -139.03 128.39 14.24 Favored Pre-proline 0 CA--C 1.543 0.7 0 CA-C-N 114.508 -1.223 . . . . 0.0 110.233 -178.995 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -69.78 176.3 33.19 Favored 'Cis proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.789 -1.754 . . . . 0.0 111.527 -5.126 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -140.72 122.83 15.68 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 124.005 0.922 . . . . 0.0 109.092 178.803 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -87.6 162.32 17.22 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 125.47 1.731 . . . . 0.0 110.006 178.17 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -50.53 154.49 2.22 Favored Pre-proline 0 C--O 1.222 -0.382 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.116 177.646 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.479 ' HB3' ' CE1' ' A' ' 34' ' ' TYR . 20.5 Cg_endo -73.7 -87.39 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 121.096 1.197 . . . . 0.0 111.912 178.227 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 148.7 159.9 8.78 Favored Glycine 0 CA--C 1.524 0.654 0 O-C-N 121.146 -0.971 . . . . 0.0 110.905 -178.815 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -76.64 -73.17 0.01 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.725 2.284 . . . . 0.0 110.949 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.476 ' CB ' ' CE1' ' A' ' 11' ' ' TYR . . . -62.26 151.42 36.39 Favored 'General case' 0 N--CA 1.442 -0.865 0 O-C-N 123.915 0.759 . . . . 0.0 110.105 178.969 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.522 ' HG2' ' HA ' ' A' ' 84' ' ' PRO . 7.8 mtm-85 -152.7 142.74 22.27 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.983 -178.769 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.8 p -82.09 124.61 39.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 O-C-N 124.207 0.942 . . . . 0.0 109.477 178.725 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.549 HG21 ' CD2' ' A' ' 38' ' ' PHE . 6.1 mm -104.65 142.0 18.92 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.722 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.87 -179.444 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.469 ' CD1' ' HG3' ' A' ' 115' ' ' LYS . 9.6 p90 -163.73 147.71 10.3 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 122.271 1.034 . . . . 0.0 111.711 -178.386 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 9.6 p -83.6 169.74 15.07 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.388 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.57 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.6 OUTLIER -111.37 154.61 43.65 Favored Pre-proline 0 CA--C 1.552 1.035 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.295 177.812 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.57 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 18.8 Cg_endo -73.65 -56.92 0.14 OUTLIER 'Cis proline' 0 CA--C 1.504 -1.012 0 C-N-CA 123.724 -1.365 . . . . 0.0 110.466 -6.746 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -43.79 116.62 1.0 Allowed 'General case' 0 N--CA 1.448 -0.551 0 O-C-N 123.812 0.695 . . . . 0.0 109.352 178.233 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.469 ' HG3' ' CD1' ' A' ' 110' ' ' TYR . 0.0 OUTLIER -65.39 79.67 0.06 Allowed 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -179.001 . . . . . . . . 3 3 . 1 . 011 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 91.7 t -73.63 75.95 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 -177.039 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.436 ' CZ ' ' NE2' ' A' ' 13' ' ' GLN . 40.4 t80 -37.91 103.91 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 125.808 1.643 . . . . 0.0 109.432 -179.199 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . 0.506 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 10.9 m -83.25 -44.61 14.78 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -178.188 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 157.12 -147.71 16.36 Favored Glycine 0 N--CA 1.442 -0.906 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.433 HG13 ' CG ' ' A' ' 4' ' ' TRP . 1.2 mm -127.88 140.45 49.11 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.803 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -176.889 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.488 ' CD1' ' CE1' ' A' ' 38' ' ' PHE . 8.9 pt -129.05 155.24 40.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -177.952 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -174.91 153.21 1.65 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 122.407 1.098 . . . . 0.0 109.255 178.242 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 3.7 m-70 -90.57 92.46 8.86 Favored 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -177.743 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 2.0 t -97.55 43.32 1.07 Allowed 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 122.661 1.22 . . . . 0.0 110.829 -179.705 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 7.5 ttpt -104.89 -27.42 11.73 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.534 178.413 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -172.09 -65.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 O-C-N 124.281 0.988 . . . . 0.0 110.683 179.37 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 24.1 t30 -153.95 -47.56 0.09 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-O 122.354 1.074 . . . . 0.0 109.864 178.991 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.4 76.23 0.82 Allowed 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.539 -177.974 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -125.39 -106.21 1.57 Allowed Glycine 0 CA--C 1.519 0.328 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 179.054 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -81.94 143.41 31.66 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 122.084 -0.656 . . . . 0.0 110.727 -179.301 . . . . . . . . 2 2 . 1 . 011 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 5.2 tp -100.0 139.29 35.88 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 120.861 0.362 . . . . 0.0 110.503 177.999 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 4.2 ptpt -148.04 169.75 19.27 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -179.929 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 4.0 tp -84.14 148.14 26.95 Favored 'General case' 0 C--O 1.235 0.296 0 O-C-N 124.31 1.007 . . . . 0.0 109.167 178.286 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 72.2 m -67.26 -174.54 0.38 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 122.316 1.055 . . . . 0.0 109.95 175.131 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 15.2 m -129.04 95.29 4.03 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -177.971 . . . . . . . . 1 1 . 1 . 011 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 0.601 ' CE1' ' CH2' ' A' ' 4' ' ' TRP . 24.5 p-80 . . . . . 0 C--N 1.328 -0.337 0 O-C-N 123.711 0.632 . . . . 0.0 110.928 176.814 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.799 0 CA-C-O 116.48 -1.724 . . . . 0.0 107.786 . . . . . . . . . 0 0 . 1 . 012 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.0 p -40.25 119.87 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 O-C-N 125.439 1.712 . . . . 0.0 110.791 178.637 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.42 ' CG2' ' HB3' ' A' ' 10' ' ' LEU . 3.7 m -86.71 111.56 20.81 Favored 'General case' 0 CA--C 1.505 -0.782 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -176.283 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 24.8 m95 -77.29 142.7 39.32 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 123.247 0.619 . . . . 0.0 110.011 178.114 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -140.01 135.82 33.08 Favored 'General case' 0 CA--C 1.496 -1.114 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -179.007 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -116.24 60.76 0.72 Allowed 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.594 177.114 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 39.22 72.27 0.22 Allowed Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.018 0.824 . . . . 0.0 112.688 -178.346 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 168.38 -77.46 0.11 Allowed Glycine 0 C--O 1.224 -0.49 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 -177.206 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 16.9 mt -126.17 162.43 25.4 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 121.749 0.785 . . . . 0.0 109.908 178.177 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.42 ' HB3' ' CG2' ' A' ' 3' ' ' THR . 0.2 OUTLIER -89.91 165.23 14.21 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.086 -177.242 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.431 ' CZ ' ' HB3' ' A' ' 106' ' ' ALA . 46.6 m-85 -156.1 82.95 1.0 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 -171.362 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -53.46 125.76 19.1 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.324 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.546 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 7.2 tp-100 -59.43 -21.4 59.96 Favored 'General case' 0 C--O 1.217 -0.656 0 C-N-CA 118.996 -1.081 . . . . 0.0 113.776 176.528 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -63.16 -24.67 67.99 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 172.81 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 6.8 mttp -101.53 -30.46 11.38 Favored 'General case' 0 C--O 1.201 -1.467 0 CA-C-O 114.038 -2.887 . . . . 0.0 111.023 174.998 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.42 -66.0 0.48 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 122.212 2.278 . . . . 0.0 112.204 176.477 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 26.4 pt-20 -61.27 -44.98 96.35 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-O 117.88 -1.057 . . . . 0.0 109.449 176.683 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 46.0 t -57.54 -47.86 80.88 Favored 'General case' 0 C--O 1.212 -0.909 0 CA-C-N 119.801 1.182 . . . . 0.0 109.003 -176.437 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.424 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 5.0 t-20 -47.7 -37.1 12.36 Favored 'General case' 0 N--CA 1.442 -0.834 0 O-C-N 121.064 -1.023 . . . . 0.0 112.302 174.333 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.99 -29.46 39.49 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 172.736 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 17.9 m170 -53.19 -39.91 64.01 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 125.696 1.598 . . . . 0.0 110.539 176.403 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.424 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -82.16 -49.92 9.6 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-O 117.733 -1.127 . . . . 0.0 110.232 178.922 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.416 ' HB1' ' CE1' ' A' ' 83' ' ' PHE . . . -42.15 136.63 2.23 Favored Pre-proline 0 N--CA 1.448 -0.57 0 O-C-N 125.504 1.753 . . . . 0.0 112.446 177.511 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -73.01 123.3 8.78 Favored 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 121.722 1.615 . . . . 0.0 109.228 -176.709 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.0 tp -59.62 103.07 0.17 Allowed 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.853 179.55 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -179.83 176.96 0.72 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.803 0.811 . . . . 0.0 110.5 -175.577 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.487 ' HB2' ' CE1' ' A' ' 79' ' ' TYR . 1.3 t0 -110.94 83.87 1.83 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.38 81.18 0.26 Allowed Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 173.547 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -149.47 40.3 0.84 Allowed 'General case' 0 CA--C 1.509 -0.62 0 O-C-N 121.852 -0.793 . . . . 0.0 111.972 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 17.7 p -128.2 152.22 48.32 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 -175.01 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -42.45 -49.25 5.76 Favored Glycine 0 C--N 1.334 0.47 0 CA-C-O 119.629 -0.539 . . . . 0.0 112.562 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.81 -78.31 0.06 Allowed 'General case' 0 N--CA 1.452 -0.357 0 O-C-N 123.792 0.348 . . . . 0.0 111.478 174.014 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 79.3 p -177.06 -65.77 0.01 OUTLIER 'General case' 0 C--O 1.22 -0.466 0 C-N-CA 125.121 1.368 . . . . 0.0 110.161 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 90.7 m-85 -63.3 150.9 88.35 Favored Pre-proline 0 N--CA 1.43 -1.46 0 C-N-CA 125.498 1.519 . . . . 0.0 111.95 -176.771 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 17.2 Cg_endo -75.98 160.31 95.86 Favored 'Cis proline' 0 N--CA 1.449 -1.108 0 C-N-CA 122.621 -1.824 . . . . 0.0 110.957 2.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -135.75 166.12 24.0 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 118.197 -0.906 . . . . 0.0 109.181 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.523 ' CH2' ' HA2' ' A' ' 44' ' ' GLY . 21.8 t90 -62.66 152.09 36.34 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 175.882 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.437 ' CZ ' HD12 ' A' ' 121' ' ' ILE . 18.5 t80 -128.78 78.27 1.84 Allowed 'General case' 0 N--CA 1.425 -1.7 0 N-CA-C 105.169 -2.16 . . . . 0.0 105.169 -173.204 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 73.1 p -39.24 -35.68 0.27 Allowed 'General case' 0 C--O 1.212 -0.899 0 C-N-CA 124.25 1.02 . . . . 0.0 110.179 173.3 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.408 ' HB2' ' CD2' ' A' ' 38' ' ' PHE . 44.6 t30 57.04 19.6 4.81 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 123.306 1.527 . . . . 0.0 110.023 176.929 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 107.68 -40.8 2.39 Favored Glycine 0 N--CA 1.428 -1.846 0 CA-C-O 116.194 -2.448 . . . . 0.0 115.208 -169.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.453 ' CE2' ' HD3' ' A' ' 66' ' ' PRO . 77.0 m-85 -45.85 153.75 0.27 Allowed 'General case' 0 C--N 1.339 0.145 0 CA-C-N 119.385 1.592 . . . . 0.0 112.18 176.338 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.98 -36.38 27.95 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.764 0.792 . . . . 0.0 111.496 177.909 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.523 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -175.18 -63.6 0.05 OUTLIER Glycine 0 C--N 1.337 0.595 0 C-N-CA 124.513 1.054 . . . . 0.0 111.337 -178.584 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -117.88 -68.15 0.94 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.373 0.606 . . . . 0.0 111.277 -179.075 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.13 -173.86 0.25 Allowed Glycine 0 C--N 1.341 0.839 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 178.764 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -55.97 -174.04 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 124.874 2.273 . . . . 0.0 113.336 174.108 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -80.6 163.58 55.73 Favored Pre-proline 0 C--N 1.313 -1.016 0 O-C-N 119.837 -1.789 . . . . 0.0 110.723 -179.66 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -71.18 160.14 49.95 Favored 'Trans proline' 0 N--CA 1.446 -1.27 0 C-N-CA 122.06 1.84 . . . . 0.0 109.764 178.38 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.5 ttpt -50.95 99.04 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.987 0.915 . . . . 0.0 110.324 177.082 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.92 85.64 1.86 Allowed Glycine 0 C--O 1.227 -0.316 0 CA-C-N 116.387 -0.37 . . . . 0.0 112.652 -174.569 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.02 165.21 18.09 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 124.205 1.002 . . . . 0.0 111.361 174.82 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 93.5 m -138.46 96.05 9.93 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.023 -177.944 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -72.49 145.6 42.72 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 122.355 2.036 . . . . 0.0 110.672 -179.883 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 7.1 mt -73.94 119.74 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -179.258 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.6 tppt? -81.5 135.36 35.6 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 177.819 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.492 ' CD1' ' HB3' ' A' ' 118' ' ' CYS . 28.6 m-85 -113.55 -52.09 2.77 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.276 1.031 . . . . 0.0 110.587 179.119 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 121.16 -3.1 11.5 Favored Glycine 0 C--O 1.223 -0.554 0 C-N-CA 123.642 0.639 . . . . 0.0 112.85 -175.07 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 16.2 mttt -101.87 130.37 48.33 Favored 'General case' 0 CA--C 1.502 -0.903 0 CA-C-N 118.173 0.987 . . . . 0.0 109.26 177.169 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 28.1 t -63.55 -12.2 30.61 Favored 'General case' 0 C--O 1.223 -0.307 0 O-C-N 124.665 1.228 . . . . 0.0 111.581 175.292 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -86.99 -47.79 8.66 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.867 1.267 . . . . 0.0 110.615 178.697 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 71.6 m -74.68 -10.59 59.68 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 123.967 0.792 . . . . 0.0 112.731 173.984 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -93.24 -40.12 10.61 Favored 'General case' 0 CA--C 1.507 -0.674 0 C-N-CA 124.795 1.238 . . . . 0.0 110.151 176.513 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.48 158.77 0.58 Allowed Pre-proline 0 CA--C 1.539 0.53 0 CA-C-O 121.827 0.822 . . . . 0.0 111.825 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -70.76 132.94 22.69 Favored 'Trans proline' 0 N--CA 1.442 -1.534 0 C-N-CA 120.823 1.015 . . . . 0.0 113.336 174.802 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.453 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 17.8 Cg_endo -71.45 170.78 17.61 Favored 'Trans proline' 0 N--CA 1.446 -1.301 0 C-N-CA 123.404 2.736 . . . . 0.0 111.057 178.709 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.8 tptt -124.46 53.0 1.47 Allowed 'General case' 0 C--O 1.205 -1.243 0 O-C-N 121.417 -0.802 . . . . 0.0 108.954 178.061 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.475 ' CD2' ' CG ' ' A' ' 37' ' ' TRP . 52.3 t-80 -78.89 161.0 27.03 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 119.333 -2.104 . . . . 0.0 111.744 178.869 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -171.78 -163.93 0.29 Allowed 'General case' 0 CA--C 1.504 -0.812 0 O-C-N 117.813 -3.054 . . . . 0.0 109.396 175.292 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.31 53.66 0.14 Allowed 'General case' 0 C--O 1.215 -0.723 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 172.164 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . 0.402 ' O ' ' C ' ' A' ' 72' ' ' GLY . 3.5 m-20 -177.49 74.48 0.02 OUTLIER 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 -178.634 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.424 ' O ' ' CE2' ' A' ' 79' ' ' TYR . . . -11.68 -70.27 0.01 OUTLIER Glycine 0 C--O 1.219 -0.79 0 C-N-CA 125.175 1.369 . . . . 0.0 114.305 178.827 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 18.3 t30 -121.96 78.61 1.49 Allowed 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 124.924 1.29 . . . . 0.0 112.68 165.192 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.13 -98.8 0.04 OUTLIER Glycine 0 CA--C 1.521 0.436 0 CA-C-O 122.74 1.189 . . . . 0.0 111.546 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.0 mttt -72.12 -102.57 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.38 0 CA-C-O 122.827 1.299 . . . . 0.0 111.059 176.779 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -112.29 14.75 20.51 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 121.104 -0.997 . . . . 0.0 110.844 178.87 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -31.72 100.21 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.561 0 C-N-CA 124.514 1.126 . . . . 0.0 112.202 -178.04 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 6.1 p80 -87.7 45.45 1.28 Allowed 'General case' 0 CA--C 1.516 -0.329 0 O-C-N 119.942 -1.724 . . . . 0.0 108.174 -172.388 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.487 ' CE1' ' HB2' ' A' ' 27' ' ' ASP . 40.7 p90 -71.07 135.52 47.78 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 124.42 1.088 . . . . 0.0 110.398 -178.922 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.5 138.2 48.75 Favored 'General case' 0 C--O 1.218 -0.57 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 176.327 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.443 ' HG ' ' CE1' ' A' ' 110' ' ' TYR . 0.4 OUTLIER -130.54 141.92 50.47 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 176.432 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -104.03 167.69 9.6 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-O 121.974 0.893 . . . . 0.0 112.628 174.563 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.483 ' CD1' ' HD2' ' A' ' 84' ' ' PRO . 31.9 t80 -154.31 139.33 11.83 Favored Pre-proline 0 C--O 1.225 -0.209 0 O-C-N 120.974 -1.079 . . . . 0.0 113.368 178.636 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.483 ' HD2' ' CD1' ' A' ' 83' ' ' PHE . 19.3 Cg_endo -74.49 94.89 0.92 Allowed 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 124.346 3.364 . . . . 0.0 110.832 -175.321 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.415 ' HA ' ' OD1' ' A' ' 19' ' ' ASN . 6.3 t -98.86 105.24 17.37 Favored 'General case' 0 CA--C 1.508 -0.64 0 O-C-N 124.879 1.362 . . . . 0.0 112.577 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.526 ' CE1' ' CD1' ' A' ' 92' ' ' TYR . 56.4 m-85 -82.35 159.55 64.38 Favored Pre-proline 0 N--CA 1.446 -0.632 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.321 -179.414 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -76.55 -36.28 1.75 Allowed 'Trans proline' 0 CA--C 1.498 -1.309 0 C-N-CA 122.283 1.989 . . . . 0.0 112.973 178.438 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -45.87 -31.14 1.98 Allowed 'General case' 0 N--CA 1.468 0.439 0 O-C-N 125.016 1.448 . . . . 0.0 110.406 176.974 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.15 17.69 68.87 Favored Glycine 0 N--CA 1.438 -1.193 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 177.374 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -82.66 140.99 32.83 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 178.399 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -72.33 85.63 1.09 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 175.369 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.526 ' CD1' ' CE1' ' A' ' 86' ' ' PHE . 70.8 t80 -40.82 151.91 0.05 Allowed 'General case' 0 C--O 1.22 -0.472 0 CA-C-O 122.655 1.217 . . . . 0.0 111.57 -179.357 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.71 64.99 5.69 Favored 'General case' 0 C--N 1.314 -0.972 0 O-C-N 119.153 -2.217 . . . . 0.0 110.541 177.211 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.447 ' CD2' ' O ' ' A' ' 92' ' ' TYR . 33.2 p90 -82.2 -12.27 58.21 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 118.17 -0.919 . . . . 0.0 110.732 178.678 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -97.88 -30.91 12.48 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 123.782 1.753 . . . . 0.0 110.485 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 69.2 m -80.3 108.92 14.31 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 119.662 -1.899 . . . . 0.0 109.492 178.917 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.25 -48.56 80.04 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.611 0.72 . . . . 0.0 111.135 178.231 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -137.81 125.25 13.81 Favored Pre-proline 0 N--CA 1.438 -1.058 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.105 -175.729 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 25.3 Cg_endo -71.75 175.02 44.07 Favored 'Cis proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.819 -1.742 . . . . 0.0 110.84 -3.471 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.85 130.12 31.29 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 123.919 0.888 . . . . 0.0 109.49 178.409 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.432 ' HB3' ' CE1' ' A' ' 92' ' ' TYR . 0.4 OUTLIER -78.86 -177.99 5.79 Favored 'General case' 0 C--O 1.238 0.479 0 O-C-N 125.59 1.806 . . . . 0.0 112.863 177.061 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -76.74 152.36 82.91 Favored Pre-proline 0 N--CA 1.451 -0.425 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 172.18 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -69.92 -165.07 0.15 Allowed 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.372 2.048 . . . . 0.0 112.688 175.568 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -131.52 158.19 22.67 Favored Glycine 0 CA--C 1.526 0.772 0 O-C-N 121.43 -0.794 . . . . 0.0 112.799 176.565 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -76.02 -42.78 0.37 Allowed 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.394 2.063 . . . . 0.0 111.313 178.244 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.431 ' HB3' ' CZ ' ' A' ' 11' ' ' TYR . . . -92.72 145.56 24.32 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 123.23 0.612 . . . . 0.0 110.709 177.069 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.433 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 4.4 mtm-85 -145.4 149.5 34.85 Favored 'General case' 0 CA--C 1.495 -1.136 0 CA-C-O 117.104 -1.427 . . . . 0.0 111.597 177.875 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.3 p -83.65 110.43 18.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 O-C-N 124.136 0.898 . . . . 0.0 110.434 178.641 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 1.7 mp -95.93 125.06 48.83 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.104 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 -174.735 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.443 ' CE1' ' HG ' ' A' ' 81' ' ' LEU . 8.6 p90 -146.23 154.97 42.34 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.782 0.801 . . . . 0.0 109.061 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.8 p -91.79 164.8 13.57 Favored 'General case' 0 C--N 1.317 -0.817 0 O-C-N 121.931 -0.48 . . . . 0.0 109.734 -179.88 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.47 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -110.88 155.77 41.84 Favored Pre-proline 0 CA--C 1.544 0.729 0 O-C-N 121.759 -0.588 . . . . 0.0 110.911 179.18 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.47 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 19.3 Cg_endo -73.18 -50.17 0.2 OUTLIER 'Cis proline' 0 CA--C 1.5 -1.188 0 C-N-CA 123.544 -1.44 . . . . 0.0 111.099 -8.249 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.4 m-20 -46.32 110.51 0.28 Allowed 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 115.999 -1.953 . . . . 0.0 108.846 178.295 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.428 ' HG3' ' CD1' ' A' ' 110' ' ' TYR . 0.3 OUTLIER -67.71 68.36 0.1 Allowed 'General case' 0 CA--C 1.511 -0.549 0 O-C-N 125.904 2.003 . . . . 0.0 108.154 -178.49 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 72.0 t -73.66 71.43 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 105.358 -2.089 . . . . 0.0 105.358 -177.763 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.596 ' CZ ' ' HA2' ' A' ' 119' ' ' GLY . 29.9 t80 -39.44 116.44 0.61 Allowed 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 125.832 1.653 . . . . 0.0 109.352 179.597 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . 0.492 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 4.6 m -89.09 -46.55 8.75 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -178.978 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.596 ' HA2' ' CZ ' ' A' ' 117' ' ' PHE . . . 155.08 -171.62 33.34 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 -179.235 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.433 ' HA ' ' O ' ' A' ' 107' ' ' ARG . 2.8 mp -109.65 129.69 64.06 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.269 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 -177.847 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.437 HD12 ' CZ ' ' A' ' 38' ' ' PHE . 8.9 pt -102.55 155.42 5.09 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 CA-C-N 119.535 1.061 . . . . 0.0 108.318 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -175.51 157.98 2.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 122.879 1.324 . . . . 0.0 110.07 175.561 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.455 ' CE1' ' HG ' ' A' ' 131' ' ' LEU . 4.0 m-70 -89.8 94.31 9.78 Favored 'General case' 0 N--CA 1.447 -0.579 0 O-C-N 121.31 -0.869 . . . . 0.0 108.69 -177.221 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.4 t -97.06 37.87 1.28 Allowed 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 123.643 1.687 . . . . 0.0 111.808 179.993 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.5 ttpp -102.86 -28.21 12.19 Favored 'General case' 0 C--O 1.219 -0.517 0 O-C-N 120.519 -1.363 . . . . 0.0 111.313 179.024 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -172.35 -68.1 0.02 OUTLIER 'General case' 0 C--O 1.219 -0.517 0 O-C-N 124.145 0.903 . . . . 0.0 109.954 178.084 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -155.3 -44.85 0.08 Allowed 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.056 0.942 . . . . 0.0 110.649 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -153.3 79.56 1.18 Allowed 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 124.671 1.189 . . . . 0.0 109.106 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -129.58 -104.8 1.13 Allowed Glycine 0 N--CA 1.459 0.212 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 176.496 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -89.14 150.92 22.48 Favored 'General case' 0 CA--C 1.509 -0.61 0 O-C-N 121.845 -0.797 . . . . 0.0 111.055 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.455 ' HG ' ' CE1' ' A' ' 123' ' ' HIS . 0.5 OUTLIER -103.23 145.91 29.23 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.226 0.536 . . . . 0.0 109.633 178.051 . . . . . . . . 3 3 . 1 . 012 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -154.65 169.84 22.94 Favored 'General case' 0 CA--C 1.507 -0.684 0 C-N-CA 125.318 1.447 . . . . 0.0 109.931 179.464 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 7.2 tp -83.8 147.46 27.57 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 176.612 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 99.5 m -60.18 -177.67 0.07 Allowed 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 123.708 1.718 . . . . 0.0 109.985 176.219 . . . . . . . . 1 1 . 1 . 012 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -162.96 109.43 1.18 Allowed 'General case' 0 C--N 1.319 -0.746 0 O-C-N 120.588 -1.32 . . . . 0.0 107.475 -177.916 . . . . . . . . 2 2 . 1 . 012 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.254 1.303 0 CA-C-O 115.335 -2.269 . . . . 0.0 111.438 174.227 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.473 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 . . . . . . . . . 0 0 . 1 . 013 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.1 p -67.26 139.94 20.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.5 m -98.78 118.34 35.3 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 124.26 1.024 . . . . 0.0 108.944 -176.219 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.413 ' CE2' ' ND1' ' A' ' 136' ' ' HIS . 28.6 m95 -82.35 137.07 34.87 Favored 'General case' 0 CA--C 1.506 -0.716 0 O-C-N 120.851 -1.156 . . . . 0.0 109.024 -172.833 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -127.14 132.12 50.62 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 122.115 0.959 . . . . 0.0 108.43 -176.265 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -121.6 66.68 0.89 Allowed 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.707 176.919 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 42.44 56.2 4.21 Favored Glycine 0 N--CA 1.471 1.019 0 O-C-N 124.061 0.851 . . . . 0.0 113.28 -176.673 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -168.36 -88.69 0.07 OUTLIER Glycine 0 C--O 1.226 -0.387 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 -175.607 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 32.5 mt -132.14 165.16 24.7 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.304 1.441 . . . . 0.0 109.983 177.592 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -90.83 111.04 22.27 Favored 'General case' 0 C--O 1.223 -0.336 0 C-N-CA 124.48 1.112 . . . . 0.0 110.137 179.197 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -89.64 111.2 22.09 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 130.635 3.574 . . . . 0.0 109.067 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -54.6 122.16 10.0 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 176.374 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.447 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 6.9 tp-100 -55.12 -48.33 73.78 Favored 'General case' 0 C--O 1.215 -0.739 0 C-N-CA 118.754 -1.178 . . . . 0.0 113.227 177.482 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -48.94 -37.21 19.33 Favored 'General case' 0 C--O 1.204 -1.301 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 173.903 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.5 mttp -71.61 -42.08 68.11 Favored 'General case' 0 C--O 1.21 -1.021 0 CA-C-O 116.369 -1.777 . . . . 0.0 113.132 167.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -51.98 -48.27 64.45 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 122.828 2.558 . . . . 0.0 113.475 172.984 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -74.5 -47.79 31.06 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 119.0 0.818 . . . . 0.0 111.753 172.048 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 38.0 t -66.55 -55.73 14.09 Favored 'General case' 0 N--CA 1.481 1.098 0 O-C-N 119.738 -1.851 . . . . 0.0 112.301 -175.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -40.5 -46.15 2.4 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.711 1.205 . . . . 0.0 110.894 169.474 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -76.16 -28.87 57.54 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 126.976 2.11 . . . . 0.0 116.437 174.981 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -54.68 -35.6 63.74 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 127.802 2.441 . . . . 0.0 111.037 177.572 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -75.91 -42.6 48.51 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 126.569 1.948 . . . . 0.0 112.506 174.325 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -45.65 127.6 6.54 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 127.318 2.247 . . . . 0.0 111.844 175.037 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -66.28 146.66 81.7 Favored 'Trans proline' 0 N--CA 1.445 -1.346 0 C-N-CA 122.833 2.355 . . . . 0.0 111.272 -175.44 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -79.72 94.57 5.76 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.613 -179.781 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.6 m 179.78 167.96 1.2 Allowed 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.711 1.604 . . . . 0.0 110.665 -174.926 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.458 ' HA ' ' HA ' ' A' ' 36' ' ' HIS . 0.3 OUTLIER -108.71 118.29 36.41 Favored 'General case' 0 CA--C 1.51 -0.594 0 C-N-CA 125.988 1.715 . . . . 0.0 109.169 175.12 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 55.27 62.39 6.34 Favored Glycine 0 CA--C 1.522 0.495 0 O-C-N 123.663 0.602 . . . . 0.0 112.713 171.233 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt -145.73 20.68 1.48 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.755 1.622 . . . . 0.0 115.243 -176.306 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 45.2 p -118.42 158.3 25.56 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 125.715 1.606 . . . . 0.0 108.513 179.335 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -50.52 -55.01 18.46 Favored Glycine 0 CA--C 1.504 -0.596 0 N-CA-C 116.222 1.249 . . . . 0.0 116.222 -177.02 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.5 t -62.72 -62.06 1.99 Allowed 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 116.695 -1.621 . . . . 0.0 112.896 171.057 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 160.22 -42.15 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 131.427 3.891 . . . . 0.0 115.963 178.478 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.475 ' CD2' ' HD3' ' A' ' 84' ' ' PRO . 86.0 m-85 -78.47 147.32 71.67 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 125.182 1.393 . . . . 0.0 113.999 -177.954 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 35.1 Cg_endo -71.84 162.28 89.64 Favored 'Cis proline' 0 N--CA 1.441 -1.603 0 CA-C-N 120.626 1.259 . . . . 0.0 110.609 -2.725 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.458 ' HA ' ' HA ' ' A' ' 27' ' ' ASP . 1.6 p80 -139.36 173.65 11.33 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 113.16 -1.836 . . . . 0.0 108.068 -177.14 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.526 ' CH2' ' HA2' ' A' ' 44' ' ' GLY . 19.7 t90 -75.96 138.47 40.99 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 123.222 1.487 . . . . 0.0 110.78 173.298 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.431 ' CZ ' ' HA ' ' A' ' 40' ' ' ASN . 28.4 t80 -106.89 91.83 3.83 Favored 'General case' 0 N--CA 1.419 -1.994 0 C-N-CA 130.297 3.439 . . . . 0.0 104.688 177.712 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 80.4 p -41.47 -37.98 1.18 Allowed 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 112.794 -2.003 . . . . 0.0 111.851 164.162 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.431 ' HA ' ' CZ ' ' A' ' 38' ' ' PHE . 65.8 t30 59.31 17.12 5.53 Favored 'General case' 0 C--O 1.213 -0.842 0 CA-C-N 118.901 0.773 . . . . 0.0 111.995 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.437 ' HA2' ' NE ' ' A' ' 52' ' ' ARG . . . 107.38 -43.3 1.72 Allowed Glycine 0 N--CA 1.44 -1.085 0 CA-C-O 115.132 -3.038 . . . . 0.0 114.62 -166.01 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -45.94 154.85 0.21 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 128.789 2.836 . . . . 0.0 111.667 178.032 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -82.04 -34.7 29.39 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 178.282 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.526 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -175.95 -68.38 0.06 OUTLIER Glycine 0 CA--C 1.528 0.848 0 C-N-CA 126.199 1.856 . . . . 0.0 113.036 -175.815 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . 0.461 ' OD2' ' HE2' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -118.78 -62.73 1.49 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 127.188 2.195 . . . . 0.0 113.955 -176.322 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.39 -168.54 1.59 Allowed Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 125.732 1.635 . . . . 0.0 111.021 178.12 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 43.8 pttt -59.06 -172.15 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 124.696 2.189 . . . . 0.0 113.631 173.342 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -87.41 170.02 12.97 Favored Pre-proline 0 C--N 1.316 -0.852 0 CA-C-N 114.333 -1.303 . . . . 0.0 111.947 -177.755 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -62.59 164.68 17.59 Favored 'Trans proline' 0 N--CA 1.44 -1.662 0 CA-C-O 123.093 1.205 . . . . 0.0 109.955 177.26 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.13 102.06 0.12 Allowed 'General case' 0 C--O 1.218 -0.58 0 O-C-N 120.307 -1.495 . . . . 0.0 110.695 170.333 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.08 78.35 1.4 Allowed Glycine 0 N--CA 1.466 0.638 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -176.756 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.437 ' NE ' ' HA2' ' A' ' 41' ' ' GLY . 0.4 OUTLIER -148.93 154.48 39.48 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 124.303 1.041 . . . . 0.0 109.96 170.974 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.9 m -124.72 101.46 33.2 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 125.087 1.355 . . . . 0.0 108.882 175.829 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 32.5 Cg_endo -69.22 148.9 69.6 Favored 'Trans proline' 0 N--CA 1.444 -1.437 0 C-N-CA 123.316 2.677 . . . . 0.0 111.078 172.518 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.5 mt -61.19 118.38 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 175.378 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.0 tppt? -86.52 132.29 33.96 Favored 'General case' 0 C--N 1.332 -0.179 0 O-C-N 121.611 -0.681 . . . . 0.0 109.516 174.111 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.513 ' CD1' ' HB3' ' A' ' 118' ' ' CYS . 7.9 m-85 -114.84 -36.32 4.52 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.518 1.927 . . . . 0.0 112.495 178.409 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.47 0.42 55.59 Favored Glycine 0 N--CA 1.474 1.221 0 C-N-CA 125.494 1.521 . . . . 0.0 114.114 -172.847 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.45 134.78 42.88 Favored 'General case' 0 CA--C 1.506 -0.726 0 C-N-CA 123.939 0.896 . . . . 0.0 111.299 175.315 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 79.6 p -68.91 -8.78 47.43 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.092 0.957 . . . . 0.0 113.502 176.939 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -84.03 -52.3 6.42 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 126.926 2.09 . . . . 0.0 108.977 176.091 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 3.7 m -78.75 -15.49 58.38 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -179.28 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -86.05 -30.8 22.35 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 127.212 2.205 . . . . 0.0 111.977 167.888 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.43 153.86 13.3 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 119.463 1.029 . . . . 0.0 113.76 179.111 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -67.11 136.85 42.21 Favored 'Trans proline' 0 CA--C 1.553 1.43 0 C-N-CA 120.363 0.709 . . . . 0.0 111.789 173.628 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -67.09 174.76 6.46 Favored 'Trans proline' 0 N--CA 1.459 -0.539 1 C-N-CA 125.428 4.085 . . . . 0.0 113.225 175.421 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . 0.461 ' HE2' ' OD2' ' A' ' 45' ' ' ASP 0.355 4.2 mmtt -133.9 41.21 3.03 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 116.073 1.879 . . . . 0.0 116.073 178.35 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.496 ' HA ' ' OD2' ' A' ' 77' ' ' ASP 0.312 56.3 t-80 -58.32 152.3 17.8 Favored 'General case' 0 C--O 1.218 -0.564 0 CA-C-O 124.798 2.237 . . . . 0.0 114.284 -177.527 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -148.56 -172.13 4.02 Favored 'General case' 0 CA--C 1.512 -0.51 0 O-C-N 119.777 -1.827 . . . . 0.0 111.026 179.147 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.02 69.79 5.25 Favored 'General case' 0 C--O 1.213 -0.821 0 O-C-N 121.151 -0.968 . . . . 0.0 112.002 172.626 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -170.03 -45.43 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 124.158 0.983 . . . . 0.0 111.887 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 133.98 -66.75 0.56 Allowed Glycine 0 C--O 1.204 -1.738 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 -179.148 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.49 ' ND2' ' H ' ' A' ' 73' ' ' ASN . 0.1 OUTLIER -107.48 -3.24 19.65 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 130.311 3.444 . . . . 0.0 113.417 -176.411 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 34.4 -122.13 0.42 Allowed Glycine 0 C--O 1.221 -0.712 0 C-N-CA 128.282 2.849 . . . . 0.0 113.783 -176.63 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 24.4 mttt -69.72 -79.02 0.06 Allowed 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 115.209 1.559 . . . . 0.0 115.209 167.716 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -123.45 11.22 9.26 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-O 116.676 -1.63 . . . . 0.0 111.957 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.496 ' OD2' ' HA ' ' A' ' 68' ' ' HIS . 58.1 t0 -17.78 94.53 0.01 OUTLIER 'General case' 0 C--O 1.214 -0.792 0 C-N-CA 126.689 1.996 . . . . 0.0 114.293 -171.867 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 19.2 p80 -84.32 11.47 8.32 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -172.87 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.432 ' CD2' ' CD1' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -43.87 162.42 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 126.684 1.994 . . . . 0.0 113.223 169.372 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -83.02 150.45 26.34 Favored 'General case' 0 N--CA 1.427 -1.585 0 CA-C-N 113.236 -1.802 . . . . 0.0 110.441 169.641 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.6 mt -132.42 130.47 40.65 Favored 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 123.743 0.817 . . . . 0.0 109.218 173.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.06 155.19 17.23 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 123.734 0.814 . . . . 0.0 112.088 176.955 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.413 ' HZ ' ' CE2' ' A' ' 94' ' ' PHE . 59.8 t80 -149.05 127.16 5.82 Favored Pre-proline 0 CA--C 1.551 1.004 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 179.146 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.475 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 23.4 Cg_endo -71.59 94.78 0.69 Allowed 'Trans proline' 0 N--CA 1.45 -1.065 1 C-N-CA 126.062 4.508 . . . . 0.0 110.119 -176.093 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 6.2 t -94.49 114.3 26.28 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 113.233 -1.803 . . . . 0.0 110.127 178.719 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -82.31 154.25 69.15 Favored Pre-proline 0 CA--C 1.54 0.581 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.136 178.268 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -73.31 -35.12 5.28 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.953 2.435 . . . . 0.0 115.204 177.943 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -50.79 -30.95 15.47 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 128.182 2.593 . . . . 0.0 110.983 175.082 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.27 11.53 82.08 Favored Glycine 0 CA--C 1.499 -0.955 0 CA-C-N 114.568 -1.197 . . . . 0.0 115.067 177.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . 0.255 5.2 p-80 -62.36 132.37 52.38 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 171.834 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -56.76 99.51 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 157.359 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -47.07 137.02 8.06 Favored 'General case' 0 N--CA 1.436 -1.153 0 O-C-N 118.823 -2.423 . . . . 0.0 108.484 169.021 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.36 59.01 1.02 Allowed 'General case' 0 C--N 1.324 -0.536 0 O-C-N 120.786 -1.196 . . . . 0.0 112.326 171.26 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.413 ' CE2' ' HZ ' ' A' ' 83' ' ' PHE . 32.6 p90 -71.72 -29.43 64.54 Favored 'General case' 0 C--O 1.219 -0.506 0 C-N-CA 124.794 1.237 . . . . 0.0 112.644 173.884 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -75.65 -38.9 58.46 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.527 1.931 . . . . 0.0 111.402 175.764 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.3 t -77.75 107.76 10.49 Favored 'General case' 0 C--N 1.33 -0.248 0 O-C-N 121.33 -0.856 . . . . 0.0 109.046 -176.315 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.5 pttt -60.35 -41.17 93.09 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 122.593 1.187 . . . . 0.0 114.109 178.655 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -145.24 131.13 9.54 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 114.174 -1.376 . . . . 0.0 110.837 178.913 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.67 165.21 70.39 Favored 'Cis proline' 0 N--CA 1.455 -0.771 0 O-C-N 123.283 1.149 . . . . 0.0 110.349 -11.102 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.37 148.5 47.49 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 125.484 1.513 . . . . 0.0 107.712 177.681 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -96.14 171.0 8.88 Favored 'General case' 0 C--N 1.319 -0.761 0 O-C-N 124.014 0.821 . . . . 0.0 109.577 169.2 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -46.5 152.17 0.91 Allowed Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 127.424 2.29 . . . . 0.0 111.865 168.038 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -72.74 -84.77 0.0 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.336 0 C-N-CA 123.107 2.538 . . . . 0.0 112.284 176.972 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 138.48 146.07 4.93 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.069 -1.213 . . . . 0.0 110.069 -178.605 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -76.62 -67.5 0.02 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 124.062 3.175 . . . . 0.0 112.162 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -68.99 132.16 46.23 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 123.125 1.44 . . . . 0.0 111.658 176.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.68 152.12 48.95 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 113.615 -1.63 . . . . 0.0 110.194 -177.99 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.5 p -87.54 116.62 30.04 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.642 0 C-N-CA 125.247 1.419 . . . . 0.0 109.438 175.928 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.404 HG22 ' CE2' ' A' ' 38' ' ' PHE . 1.6 mp -104.22 115.64 46.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 104.877 -2.268 . . . . 0.0 104.877 -178.582 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -126.81 156.22 41.63 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 114.48 -1.236 . . . . 0.0 108.467 177.245 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.2 p -82.98 166.48 18.79 Favored 'General case' 0 CA--C 1.505 -0.783 0 C-N-CA 124.844 1.258 . . . . 0.0 111.277 177.225 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.468 ' CG ' ' HA ' ' A' ' 113' ' ' PRO 0.276 8.7 t80 -109.94 158.49 34.86 Favored Pre-proline 0 CA--C 1.544 0.748 0 O-C-N 120.962 -1.086 . . . . 0.0 112.33 176.333 . . . . . . . . 3 3 . 1 . 013 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.468 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 18.9 Cg_endo -69.01 -41.9 0.81 Allowed 'Cis proline' 0 C--N 1.348 0.516 0 N-CA-C 114.794 1.036 . . . . 0.0 114.794 -21.544 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -50.37 106.48 0.12 Allowed 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 125.528 1.531 . . . . 0.0 108.92 170.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 2.3 mtmt -67.12 65.41 0.06 Allowed 'General case' 0 C--N 1.339 0.111 0 C-N-CA 127.959 2.503 . . . . 0.0 108.792 177.431 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 47.3 t -72.93 86.54 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.586 0 N-CA-C 103.254 -2.869 . . . . 0.0 103.254 175.951 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.485 ' CZ ' ' HA2' ' A' ' 119' ' ' GLY . 37.8 t80 -46.12 103.8 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 129.142 2.977 . . . . 0.0 109.427 176.933 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . 0.513 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 22.4 m -80.21 -41.7 24.68 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 122.884 1.326 . . . . 0.0 110.447 -176.056 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.485 ' HA2' ' CZ ' ' A' ' 117' ' ' PHE . . . 159.44 -154.22 25.28 Favored Glycine 0 N--CA 1.433 -1.552 0 CA-C-N 113.651 -1.613 . . . . 0.0 110.09 -178.555 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.404 HG13 ' CB ' ' A' ' 4' ' ' TRP . 1.3 mm -123.08 147.99 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 N-CA-C 105.208 -2.145 . . . . 0.0 105.208 -179.092 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.415 ' CD1' ' CE1' ' A' ' 38' ' ' PHE . 4.3 pt -136.99 151.65 27.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 O-C-N 119.851 -1.781 . . . . 0.0 109.175 179.397 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -166.14 159.68 15.5 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.742 0.782 . . . . 0.0 110.355 176.747 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 32.9 m-70 -90.09 91.2 8.45 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.673 -178.46 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 2.0 t -92.29 33.33 1.1 Allowed 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 123.25 1.5 . . . . 0.0 112.944 -179.079 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.93 -33.95 12.58 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 120.905 -1.122 . . . . 0.0 112.019 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -170.73 -78.86 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.628 1.571 . . . . 0.0 109.566 -178.393 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -127.59 -58.65 1.24 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 129.28 3.032 . . . . 0.0 110.435 -176.9 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -160.95 74.73 0.51 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.671 1.988 . . . . 0.0 112.176 -176.226 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -122.4 -106.92 1.91 Allowed Glycine 0 N--CA 1.468 0.783 0 O-C-N 121.346 -0.846 . . . . 0.0 112.369 177.172 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.99 154.66 33.44 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 121.735 -0.862 . . . . 0.0 112.235 177.362 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 7.4 tp -125.59 135.06 51.79 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.925 1.29 . . . . 0.0 110.532 -178.271 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -147.35 166.42 27.18 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.48 -1.236 . . . . 0.0 109.057 -177.416 . . . . . . . . 2 2 . 1 . 013 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 14.7 tp -77.4 141.67 39.67 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.036 173.946 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 34.9 m -70.56 176.78 3.86 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 126.448 1.899 . . . . 0.0 111.243 169.686 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 92.5 p -142.37 100.45 3.7 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 105.284 -2.117 . . . . 0.0 105.284 -177.866 . . . . . . . . 1 1 . 1 . 013 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 0.413 ' ND1' ' CE2' ' A' ' 4' ' ' TRP . 0.5 OUTLIER . . . . . 0 C--O 1.246 0.921 0 CA-C-O 114.972 -2.442 . . . . 0.0 114.671 165.022 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . 0.637 ' H1 ' ' HB3' ' A' ' 13' ' ' GLN . . . . . . . . 0 CA--C 1.51 -0.561 0 CA-C-O 118.061 -0.971 . . . . 0.0 109.214 . . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.0 p -51.56 136.64 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 O-C-N 124.583 1.177 . . . . 0.0 109.145 -178.871 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.1 m -84.46 112.38 20.33 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-O 121.546 0.688 . . . . 0.0 110.008 179.926 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.457 ' CG ' HG13 ' A' ' 120' ' ' ILE . 27.5 m95 -78.44 138.08 38.3 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 123.877 0.871 . . . . 0.0 111.248 175.089 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 m -120.16 120.52 36.43 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -177.679 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 55.6 m -106.88 51.89 0.73 Allowed 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.581 178.916 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 45.46 48.06 11.79 Favored Glycine 0 C--O 1.218 -0.863 0 O-C-N 123.951 0.782 . . . . 0.0 111.974 -176.964 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -162.2 -80.97 0.04 OUTLIER Glycine 0 C--O 1.225 -0.407 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 -177.52 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.6 mt -127.39 163.91 23.01 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.148 0.499 . . . . 0.0 110.008 177.684 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.2 mp -85.55 133.78 34.05 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.144 -179.353 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.504 ' CE2' ' CB ' ' A' ' 106' ' ' ALA . 64.5 m-85 -122.89 110.37 15.34 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 124.41 1.084 . . . . 0.0 110.17 -175.321 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -65.74 119.16 10.7 Favored 'General case' 0 N--CA 1.444 -0.751 0 O-C-N 120.335 -1.478 . . . . 0.0 108.517 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.637 ' HB3' ' H1 ' ' A' ' 1' ' ' ALA . 7.0 tp-100 -48.47 -42.46 32.77 Favored 'General case' 0 C--O 1.197 -1.687 0 CA-C-N 118.542 0.61 . . . . 0.0 111.518 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.4 ' O ' ' CB ' ' A' ' 18' ' ' SER . 21.2 t30 -48.8 -48.36 41.43 Favored 'General case' 0 C--O 1.189 -2.087 0 CA-C-N 117.785 0.266 . . . . 0.0 111.106 175.875 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -67.28 -34.94 78.45 Favored 'General case' 0 C--O 1.196 -1.742 0 O-C-N 120.641 -1.287 . . . . 0.0 112.502 171.277 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.37 -45.1 80.68 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 121.337 1.88 . . . . 0.0 113.106 172.904 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.401 ' O ' ' CD2' ' A' ' 21' ' ' HIS . 4.2 pt-20 -85.94 -37.8 18.67 Favored 'General case' 0 C--O 1.206 -1.197 0 CA-C-O 118.575 -0.726 . . . . 0.0 109.14 178.733 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.4 ' CB ' ' O ' ' A' ' 14' ' ' ASN . 47.8 t -71.75 -61.29 1.83 Allowed 'General case' 0 CA--C 1.5 -0.947 0 C-N-CA 126.6 1.96 . . . . 0.0 108.819 -177.037 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.485 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 8.7 t-20 -40.97 -35.93 0.59 Allowed 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 119.285 0.948 . . . . 0.0 112.555 173.311 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -81.61 -37.96 26.77 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 174.228 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.401 ' CD2' ' O ' ' A' ' 17' ' ' GLU . 5.5 m170 -44.09 -39.2 4.07 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 126.436 1.894 . . . . 0.0 109.518 178.652 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.485 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -73.41 -49.09 28.9 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-O 118.435 -0.793 . . . . 0.0 112.1 175.77 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.476 ' HB3' ' CE1' ' A' ' 83' ' ' PHE . . . -35.64 129.77 0.57 Allowed Pre-proline 0 N--CA 1.439 -1.006 0 O-C-N 124.634 1.209 . . . . 0.0 112.566 174.076 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -73.4 124.23 9.26 Favored 'Trans proline' 0 N--CA 1.442 -1.54 0 C-N-CA 121.898 1.732 . . . . 0.0 109.707 -176.86 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.448 ' CD1' ' HE2' ' A' ' 115' ' ' LYS . 5.4 tp -60.44 95.45 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.103 0.561 . . . . 0.0 110.925 179.48 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 179.13 173.07 0.8 Allowed 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 123.322 0.649 . . . . 0.0 110.445 -176.745 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -109.25 119.37 39.28 Favored 'General case' 0 CA--C 1.511 -0.53 0 C-N-CA 124.101 0.961 . . . . 0.0 109.934 179.095 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 45.98 64.06 2.62 Favored Glycine 0 C--O 1.225 -0.413 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.209 177.94 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.0 ptmt -127.5 8.51 6.47 Favored 'General case' 0 CA--C 1.511 -0.543 0 O-C-N 122.247 -0.56 . . . . 0.0 111.463 179.102 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.1 p -115.06 152.45 32.47 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -174.055 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -39.37 -59.16 1.92 Allowed Glycine 0 C--N 1.335 0.493 0 O-C-N 124.001 0.813 . . . . 0.0 112.544 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 29.7 t -62.46 -63.3 1.27 Allowed 'General case' 0 N--CA 1.441 -0.895 0 CA-C-O 116.273 -1.822 . . . . 0.0 111.166 176.042 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 159.63 -57.85 0.0 OUTLIER 'General case' 0 C--O 1.221 -0.418 0 O-C-N 126.085 2.115 . . . . 0.0 109.537 179.099 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.508 ' CD2' ' HD3' ' A' ' 84' ' ' PRO . 55.3 m-85 -55.8 145.09 53.8 Favored Pre-proline 0 N--CA 1.434 -1.229 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 179.234 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 22.5 Cg_endo -74.4 163.4 90.4 Favored 'Cis proline' 0 N--CA 1.447 -1.221 0 C-N-CA 122.822 -1.741 . . . . 0.0 111.428 -1.87 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.484 ' CD2' ' CD2' ' A' ' 34' ' ' TYR . 1.5 p80 -137.22 175.1 9.91 Favored 'General case' 0 C--O 1.212 -0.914 0 O-C-N 120.981 -1.074 . . . . 0.0 110.339 -177.148 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.469 ' CD1' ' HB2' ' A' ' 79' ' ' TYR . 21.0 t90 -75.15 130.83 39.87 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.486 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.545 ' CE1' ' CD1' ' A' ' 121' ' ' ILE . 42.2 t80 -101.81 77.74 1.75 Allowed 'General case' 0 N--CA 1.427 -1.608 0 C-N-CA 126.009 1.724 . . . . 0.0 107.309 -178.975 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.457 HG21 ' CE3' ' A' ' 37' ' ' TRP . 64.0 p -39.63 -31.78 0.11 Allowed 'General case' 0 C--O 1.215 -0.716 0 C-N-CA 124.297 1.039 . . . . 0.0 110.694 175.458 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 43.7 t30 60.47 14.08 4.57 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 122.861 1.315 . . . . 0.0 109.147 177.693 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 116.3 -40.3 2.44 Favored Glycine 0 N--CA 1.423 -2.178 0 O-C-N 119.556 -1.965 . . . . 0.0 111.875 -174.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.491 ' CE2' ' HD3' ' A' ' 66' ' ' PRO . 65.0 m-85 -49.54 156.12 0.69 Allowed 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.732 1.213 . . . . 0.0 110.392 -178.214 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.37 -39.4 20.74 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.576 178.08 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.42 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -162.41 -76.67 0.03 OUTLIER Glycine 0 C--N 1.339 0.741 0 C-N-CA 123.715 0.674 . . . . 0.0 111.623 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -114.0 -63.81 1.4 Allowed 'General case' 0 CA--C 1.509 -0.62 0 C-N-CA 122.514 0.326 . . . . 0.0 110.959 -179.598 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.12 -168.25 0.07 OUTLIER Glycine 0 C--N 1.353 1.513 0 O-C-N 124.274 0.983 . . . . 0.0 111.119 178.588 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.1 -164.43 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 124.62 2.152 . . . . 0.0 111.987 176.101 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.403 ' CB ' ' CD ' ' A' ' 49' ' ' PRO . 0.0 OUTLIER -105.9 178.04 1.21 Allowed Pre-proline 0 N--CA 1.433 -1.311 0 O-C-N 119.647 -1.908 . . . . 0.0 110.568 -179.478 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . 0.403 ' CD ' ' CB ' ' A' ' 48' ' ' LEU . 23.9 Cg_endo -73.01 177.61 7.54 Favored 'Trans proline' 0 N--CA 1.444 -1.416 0 C-N-CA 122.138 1.892 . . . . 0.0 111.685 178.396 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.8 tttm -83.83 102.0 12.03 Favored 'General case' 0 N--CA 1.444 -0.767 0 O-C-N 120.955 -1.091 . . . . 0.0 109.87 177.74 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 117.96 65.12 0.32 Allowed Glycine 0 C--O 1.223 -0.577 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -153.23 176.3 12.11 Favored 'General case' 0 CA--C 1.51 -0.574 0 C-N-CA 123.066 0.547 . . . . 0.0 110.625 178.72 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.9 m -154.24 107.0 2.43 Favored Pre-proline 0 C--O 1.215 -0.711 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.786 173.75 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -71.26 174.4 10.82 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 121.879 1.719 . . . . 0.0 111.783 178.809 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.452 ' CG2' ' HB2' ' A' ' 133' ' ' LEU . 4.1 mt -95.11 132.95 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.2 136.68 39.72 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.227 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 8.2 m-85 -121.94 -52.99 1.97 Allowed 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 123.098 0.559 . . . . 0.0 109.959 -179.273 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 126.45 -6.37 7.57 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 123.654 0.645 . . . . 0.0 112.285 -176.884 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.73 131.52 37.05 Favored 'General case' 0 CA--C 1.5 -0.975 0 CA-C-O 118.087 -0.958 . . . . 0.0 109.207 178.749 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 87.5 p -67.05 -7.53 23.48 Favored 'General case' 0 C--O 1.22 -0.496 0 O-C-N 125.056 1.473 . . . . 0.0 111.532 176.984 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 9.5 m-20 -89.64 -56.88 3.07 Favored 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 124.42 1.088 . . . . 0.0 109.629 179.341 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 68.6 m -69.64 -20.29 63.6 Favored 'General case' 0 N--CA 1.448 -0.569 0 O-C-N 123.859 0.724 . . . . 0.0 110.364 177.522 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -78.46 -41.77 31.79 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.321 0.648 . . . . 0.0 110.674 176.599 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -50.7 159.8 0.87 Allowed Pre-proline 0 N--CA 1.443 -0.809 0 CA-C-O 121.503 0.668 . . . . 0.0 110.832 179.699 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -72.01 136.88 28.14 Favored 'Trans proline' 0 N--CA 1.439 -1.695 0 C-N-CA 121.521 1.481 . . . . 0.0 114.264 173.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.491 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 19.0 Cg_endo -72.29 170.06 20.08 Favored 'Trans proline' 0 N--CA 1.445 -1.379 0 C-N-CA 122.786 2.324 . . . . 0.0 111.236 178.943 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -128.87 53.28 1.87 Allowed 'General case' 0 C--O 1.2 -1.514 0 CA-C-O 118.166 -0.921 . . . . 0.0 110.596 178.468 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.432 ' CE1' ' O ' ' A' ' 69' ' ' SER . 46.7 t-80 -76.87 165.72 24.31 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 119.468 1.031 . . . . 0.0 111.061 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.432 ' O ' ' CE1' ' A' ' 68' ' ' HIS . 0.2 OUTLIER -157.55 -165.29 1.74 Allowed 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 121.17 -0.956 . . . . 0.0 110.962 177.194 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.85 75.01 10.4 Favored 'General case' 0 N--CA 1.445 -0.676 0 O-C-N 120.174 -1.579 . . . . 0.0 111.332 176.67 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -177.46 -45.25 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 123.291 0.636 . . . . 0.0 109.881 179.124 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.482 ' O ' ' CE2' ' A' ' 79' ' ' TYR . . . 122.92 -50.89 0.82 Allowed Glycine 0 N--CA 1.438 -1.203 0 CA-C-O 118.636 -1.091 . . . . 0.0 111.632 -176.888 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -151.54 82.97 1.3 Allowed 'General case' 0 N--CA 1.438 -1.075 0 CA-C-N 118.603 1.202 . . . . 0.0 107.962 178.116 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.03 -115.96 0.01 OUTLIER Glycine 0 C--O 1.222 -0.616 0 CA-C-O 123.083 1.38 . . . . 0.0 111.451 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.0 mttp -60.39 -98.37 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.46 0 O-C-N 119.681 -2.07 . . . . 0.0 110.648 178.052 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -109.37 16.1 22.59 Favored 'General case' 0 N--CA 1.447 -0.581 0 O-C-N 120.633 -1.292 . . . . 0.0 110.833 179.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.488 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 5.7 m-20 -29.31 103.44 0.02 OUTLIER 'General case' 0 C--O 1.203 -1.364 0 C-N-CA 124.807 1.243 . . . . 0.0 110.85 -177.958 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.495 ' H ' ' CD2' ' A' ' 78' ' ' HIS . 3.5 p80 -85.74 14.19 6.19 Favored 'General case' 0 CA--C 1.513 -0.447 0 O-C-N 121.39 -0.819 . . . . 0.0 110.209 -176.9 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.508 ' CE2' ' CD2' ' A' ' 81' ' ' LEU . 0.3 OUTLIER -35.84 132.29 0.49 Allowed 'General case' 0 N--CA 1.426 -1.645 0 C-N-CA 124.911 1.285 . . . . 0.0 113.795 173.071 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -74.05 154.99 38.99 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 118.346 -0.835 . . . . 0.0 109.034 179.376 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.508 ' CD2' ' CE2' ' A' ' 79' ' ' TYR . 1.2 mp -142.34 143.34 32.7 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 123.956 0.902 . . . . 0.0 109.647 178.322 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.495 ' CB ' ' CD1' ' A' ' 109' ' ' ILE . 0.2 OUTLIER -108.93 162.78 13.89 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-O 122.186 0.994 . . . . 0.0 111.233 179.464 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.476 ' CE1' ' HB3' ' A' ' 23' ' ' ALA . 38.0 t80 -150.64 126.33 4.95 Favored Pre-proline 0 N--CA 1.443 -0.801 0 CA-C-N 115.626 -0.716 . . . . 0.0 112.312 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.508 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 21.5 Cg_endo -71.98 101.35 1.19 Allowed 'Trans proline' 0 N--CA 1.446 -1.292 0 C-N-CA 123.764 2.976 . . . . 0.0 111.01 -179.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -101.01 114.88 29.21 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 121.943 0.877 . . . . 0.0 110.661 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -81.4 160.96 63.69 Favored Pre-proline 0 N--CA 1.442 -0.868 0 O-C-N 121.423 -0.798 . . . . 0.0 112.483 178.478 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -76.67 -41.61 0.41 Allowed 'Trans proline' 0 CA--C 1.497 -1.358 0 C-N-CA 122.496 2.131 . . . . 0.0 112.962 179.071 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -45.09 -30.99 1.21 Allowed 'General case' 0 C--N 1.349 0.574 0 O-C-N 125.052 1.47 . . . . 0.0 110.021 177.895 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.66 -4.08 83.57 Favored Glycine 0 N--CA 1.427 -1.964 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 177.228 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -61.53 127.73 32.9 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.733 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -61.02 93.29 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 176.879 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.491 ' O ' ' CD2' ' A' ' 94' ' ' PHE . 7.1 t80 -38.32 143.3 0.14 Allowed 'General case' 0 C--O 1.212 -0.92 0 CA-C-O 121.994 0.902 . . . . 0.0 110.813 179.572 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 12.2 ptpt -78.49 62.04 3.01 Favored 'General case' 0 C--N 1.318 -0.796 0 O-C-N 119.712 -1.867 . . . . 0.0 110.368 176.911 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.491 ' CD2' ' O ' ' A' ' 92' ' ' TYR . 30.6 p90 -80.84 -8.34 59.68 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 123.372 0.669 . . . . 0.0 111.299 177.641 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -97.21 -32.63 11.83 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 122.095 0.95 . . . . 0.0 110.179 178.972 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.8 m -81.85 107.1 14.3 Favored 'General case' 0 N--CA 1.443 -0.8 0 O-C-N 121.181 -0.95 . . . . 0.0 108.731 -178.485 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.5 ptpt -59.31 -48.8 80.26 Favored 'General case' 0 C--O 1.224 -0.286 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.312 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.6 pttt -142.66 128.42 10.42 Favored Pre-proline 0 N--CA 1.431 -1.415 0 C-N-CA 124.208 1.003 . . . . 0.0 109.64 -176.371 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -71.25 176.92 34.72 Favored 'Cis proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.682 -1.799 . . . . 0.0 111.421 -3.827 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.4 146.52 38.46 Favored 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 122.953 0.501 . . . . 0.0 110.172 177.985 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -99.62 165.06 11.8 Favored 'General case' 0 C--N 1.319 -0.76 0 O-C-N 123.939 0.774 . . . . 0.0 110.776 178.725 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -57.45 153.42 28.4 Favored Pre-proline 0 N--CA 1.439 -1.013 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.528 177.595 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -74.12 -164.69 0.22 Allowed 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 122.453 2.102 . . . . 0.0 111.468 177.413 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -132.89 157.8 22.8 Favored Glycine 0 N--CA 1.444 -0.782 0 O-C-N 121.342 -0.848 . . . . 0.0 112.643 178.241 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -74.92 -64.36 0.03 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 122.474 2.116 . . . . 0.0 110.101 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.504 ' CB ' ' CE2' ' A' ' 11' ' ' TYR . . . -69.39 141.43 54.14 Favored 'General case' 0 N--CA 1.441 -0.883 0 O-C-N 123.502 0.501 . . . . 0.0 111.017 179.212 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 5.2 mtm-85 -142.86 143.86 32.26 Favored 'General case' 0 N--CA 1.442 -0.852 0 O-C-N 124.257 0.973 . . . . 0.0 111.204 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.8 p -83.39 124.67 39.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 O-C-N 124.016 0.823 . . . . 0.0 110.377 178.823 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.521 HG23 ' CD2' ' A' ' 38' ' ' PHE . 6.2 mm -103.91 140.44 22.05 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.914 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -179.336 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.491 ' CD1' ' HG3' ' A' ' 115' ' ' LYS . 9.9 p90 -164.21 152.05 12.43 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-O 122.53 1.157 . . . . 0.0 111.287 -178.543 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.6 p -89.64 166.76 13.41 Favored 'General case' 0 C--N 1.319 -0.725 0 O-C-N 121.593 -0.692 . . . . 0.0 109.204 -178.255 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.556 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -110.95 153.8 43.65 Favored Pre-proline 0 N--CA 1.438 -1.029 0 C-N-CA 122.971 0.508 . . . . 0.0 111.168 179.263 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.556 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 19.5 Cg_endo -73.78 -55.28 0.14 OUTLIER 'Cis proline' 0 CA--C 1.501 -1.134 0 C-N-CA 123.001 -1.666 . . . . 0.0 109.759 -5.677 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.3 t-20 -44.18 113.67 0.56 Allowed 'General case' 0 CA--C 1.5 -0.976 0 CA-C-O 115.653 -2.117 . . . . 0.0 109.823 179.88 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.491 ' HG3' ' CD1' ' A' ' 110' ' ' TYR . 0.1 OUTLIER -63.24 78.61 0.02 OUTLIER 'General case' 0 CA--C 1.508 -0.663 0 O-C-N 125.529 1.768 . . . . 0.0 108.64 -178.3 . . . . . . . . 3 3 . 1 . 014 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 77.6 t -73.54 72.11 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 -176.011 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.462 ' CZ ' ' NE2' ' A' ' 13' ' ' GLN . 42.0 t80 -37.46 104.96 0.03 OUTLIER 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 125.647 1.579 . . . . 0.0 110.15 -178.791 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 5.7 m -82.72 -44.68 15.35 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 -178.184 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 158.03 -145.71 12.22 Favored Glycine 0 N--CA 1.44 -1.09 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.457 HG13 ' CG ' ' A' ' 4' ' ' TRP . 1.1 mm -127.43 145.7 34.43 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.212 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 -175.528 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.545 ' CD1' ' CE1' ' A' ' 38' ' ' PHE . 5.7 pt -137.39 151.93 27.01 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.937 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 -177.717 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 177.87 129.55 0.06 Allowed 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 122.088 0.947 . . . . 0.0 109.711 -178.719 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -88.75 95.35 10.24 Favored 'General case' 0 N--CA 1.441 -0.881 0 O-C-N 121.431 -0.793 . . . . 0.0 110.583 179.594 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.1 t -98.19 31.82 2.64 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 123.729 1.728 . . . . 0.0 112.221 179.678 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 70.1 tttt -84.32 -44.56 13.69 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 116.688 -1.625 . . . . 0.0 110.063 -178.642 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 169.86 -81.49 0.0 OUTLIER 'General case' 0 C--O 1.223 -0.313 0 O-C-N 126.013 2.071 . . . . 0.0 110.889 178.99 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -159.81 29.85 0.18 Allowed 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 124.387 1.075 . . . . 0.0 110.665 -178.344 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -171.8 89.72 0.11 Allowed 'General case' 0 N--CA 1.444 -0.744 0 CA-C-O 122.671 1.224 . . . . 0.0 110.267 -177.953 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 166.8 105.48 0.18 Allowed Glycine 0 CA--C 1.483 -1.933 0 CA-C-O 115.254 -2.97 . . . . 0.0 107.902 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -35.99 146.32 0.03 OUTLIER 'General case' 0 C--O 1.24 0.558 0 CA-C-N 119.494 1.647 . . . . 0.0 112.659 177.419 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 8.4 mp -57.45 148.25 24.0 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -175.704 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.2 pttt -123.56 149.96 44.63 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-O 118.263 -0.875 . . . . 0.0 108.779 -177.764 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.452 ' HB2' ' CG2' ' A' ' 55' ' ' ILE . 9.0 tp -61.56 127.7 32.71 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 124.798 1.311 . . . . 0.0 109.1 179.613 . . . . . . . . 2 2 . 1 . 014 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 35.2 m -67.19 -174.36 0.36 Allowed 'General case' 0 N--CA 1.436 -1.156 0 CA-C-O 122.707 1.242 . . . . 0.0 109.39 177.612 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 66.3 m -151.1 101.33 2.86 Favored 'General case' 0 C--N 1.322 -0.613 0 O-C-N 121.468 -0.77 . . . . 0.0 109.354 -179.35 . . . . . . . . 1 1 . 1 . 014 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 0.452 ' CD2' ' H ' ' A' ' 136' ' ' HIS . 0.4 OUTLIER . . . . . 0 C--O 1.247 0.969 0 CA-C-O 116.527 -1.702 . . . . 0.0 113.313 175.131 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.945 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 . . . . . . . . . 0 0 . 1 . 015 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 9.1 p -119.66 135.52 59.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 C-N-CA 124.2 1.0 . . . . 0.0 109.564 177.037 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.9 m -90.09 115.38 27.31 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -176.537 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.509 ' CE2' ' CD2' ' A' ' 136' ' ' HIS . 23.3 m95 -78.23 142.28 38.0 Favored 'General case' 0 C--O 1.215 -0.725 0 O-C-N 121.676 -0.64 . . . . 0.0 110.671 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -140.66 141.74 35.01 Favored 'General case' 0 CA--C 1.499 -1.008 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 -177.361 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -119.67 -79.14 0.6 Allowed 'General case' 0 C--O 1.218 -0.598 0 O-C-N 124.467 1.104 . . . . 0.0 111.034 176.916 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -74.32 -87.45 0.23 Allowed Glycine 0 C--O 1.219 -0.804 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -179.125 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -143.67 12.61 2.2 Favored Glycine 0 C--O 1.221 -0.662 0 O-C-N 121.573 -0.957 . . . . 0.0 111.704 178.293 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 22.4 mt -113.9 155.49 25.68 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 117.824 0.812 . . . . 0.0 109.581 178.925 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.4 mp -106.78 133.37 51.54 Favored 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -175.668 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.472 ' CE2' ' CB ' ' A' ' 106' ' ' ALA . 60.8 m-85 -124.58 91.4 3.44 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 125.749 1.62 . . . . 0.0 106.992 -170.349 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -53.48 121.07 6.95 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 117.708 -1.139 . . . . 0.0 108.745 179.095 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.498 ' NE2' ' CE1' ' A' ' 117' ' ' PHE . 1.2 tt0 -52.24 -50.78 61.35 Favored 'General case' 0 CA--C 1.498 -1.029 0 CA-C-O 117.243 -1.361 . . . . 0.0 111.173 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -50.42 -36.84 34.87 Favored 'General case' 0 C--O 1.194 -1.825 0 O-C-N 125.42 1.7 . . . . 0.0 110.615 178.75 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.4 mttp -71.59 -51.01 25.61 Favored 'General case' 0 C--O 1.212 -0.917 0 CA-C-O 116.526 -1.702 . . . . 0.0 115.428 166.893 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.86 -35.11 9.79 Favored 'General case' 0 C--O 1.211 -0.936 0 CA-C-N 121.653 2.024 . . . . 0.0 113.024 171.949 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.443 ' O ' ' CD2' ' A' ' 21' ' ' HIS . 16.0 pt-20 -88.32 -40.81 13.31 Favored 'General case' 0 C--O 1.205 -1.285 0 C-N-CA 125.76 1.624 . . . . 0.0 110.471 172.139 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.4 t -77.0 -59.12 2.91 Favored 'General case' 0 CA--C 1.501 -0.912 0 O-C-N 117.217 -3.427 . . . . 0.0 108.123 -172.488 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.476 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -45.38 -32.31 2.03 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 167.215 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 54.5 p -83.74 -24.56 31.1 Favored 'General case' 0 C--O 1.216 -0.691 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 173.049 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.443 ' CD2' ' O ' ' A' ' 17' ' ' GLU . 10.0 m170 -55.98 -37.91 69.72 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 126.504 1.922 . . . . 0.0 108.701 178.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.476 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.1 OUTLIER -71.02 -44.45 65.85 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 117.15 -1.405 . . . . 0.0 110.178 178.899 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -39.99 126.04 1.62 Allowed Pre-proline 0 CA--C 1.549 0.934 0 O-C-N 126.058 2.099 . . . . 0.0 111.287 176.098 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 13.5 Cg_endo -72.67 123.41 9.0 Favored 'Trans proline' 0 N--CA 1.445 -1.38 0 C-N-CA 122.433 2.089 . . . . 0.0 107.804 -175.972 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.421 ' CD1' ' HE2' ' A' ' 115' ' ' LYS . 3.4 tp -60.51 87.85 0.02 OUTLIER 'General case' 0 CA--C 1.507 -0.704 0 C-N-CA 124.514 1.126 . . . . 0.0 112.414 178.39 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.4 m -174.53 148.96 1.23 Allowed 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.993 1.317 . . . . 0.0 109.95 -171.581 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.406 ' HA ' ' HA ' ' A' ' 36' ' ' HIS . 0.0 OUTLIER -86.81 113.71 22.86 Favored 'General case' 0 CA--C 1.508 -0.655 0 C-N-CA 124.136 0.974 . . . . 0.0 110.176 176.362 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 54.03 72.41 0.55 Allowed Glycine 0 CA--C 1.525 0.669 0 C-N-CA 119.402 -1.38 . . . . 0.0 111.996 177.189 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.04 21.41 2.27 Favored 'General case' 0 CA--C 1.504 -0.813 0 O-C-N 121.438 -1.036 . . . . 0.0 112.724 177.951 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.7 p -129.57 152.07 49.49 Favored 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 -171.693 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -38.43 -66.87 0.58 Allowed Glycine 0 N--CA 1.442 -0.919 0 O-C-N 124.502 1.126 . . . . 0.0 112.858 178.392 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.409 ' HA ' ' CE ' ' A' ' 100' ' ' LYS . 24.2 t -52.77 -65.46 0.55 Allowed 'General case' 0 CA--C 1.492 -1.28 0 CA-C-O 114.994 -2.431 . . . . 0.0 113.07 173.803 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 160.87 -53.18 0.0 OUTLIER 'General case' 0 C--O 1.219 -0.552 0 O-C-N 127.626 3.079 . . . . 0.0 109.507 178.611 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.533 ' CE2' ' CE1' ' A' ' 36' ' ' HIS . 50.9 m-85 -61.46 147.05 88.61 Favored Pre-proline 0 N--CA 1.439 -1.008 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 23.2 Cg_endo -74.55 150.53 95.66 Favored 'Cis proline' 0 N--CA 1.443 -1.477 0 C-N-CA 123.457 -1.476 . . . . 0.0 109.6 0.772 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.533 ' CE1' ' CE2' ' A' ' 34' ' ' TYR . 0.4 OUTLIER -126.72 160.64 30.21 Favored 'General case' 0 CA--C 1.499 -1.008 0 CA-C-O 117.062 -1.447 . . . . 0.0 109.003 179.242 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.542 ' CH2' ' HA2' ' A' ' 44' ' ' GLY . 22.1 t90 -58.45 148.8 26.92 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 124.763 1.289 . . . . 0.0 109.184 177.527 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.472 ' CZ ' HD13 ' A' ' 121' ' ' ILE . 10.8 t80 -129.22 78.36 1.85 Allowed 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 103.711 -2.7 . . . . 0.0 103.711 -170.711 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 44.7 p -39.15 -34.96 0.2 Allowed 'General case' 0 C--O 1.204 -1.31 0 C-N-CA 124.81 1.244 . . . . 0.0 110.117 173.855 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 56.7 t30 66.86 11.98 8.62 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.683 1.593 . . . . 0.0 110.523 178.799 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 108.15 -6.83 34.76 Favored Glycine 0 CA--C 1.537 1.451 0 O-C-N 120.96 -1.088 . . . . 0.0 114.687 -170.066 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.541 ' CE2' ' HA ' ' A' ' 47' ' ' LYS . 6.1 m-85 -78.26 168.51 19.73 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 124.472 1.109 . . . . 0.0 109.782 -178.298 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.11 -37.36 17.46 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.748 175.973 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.542 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . 176.43 -60.31 0.1 Allowed Glycine 0 CA--C 1.506 -0.469 0 C-N-CA 124.179 0.895 . . . . 0.0 112.881 -177.784 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -115.85 -63.11 1.5 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 122.716 1.246 . . . . 0.0 110.819 179.125 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.24 165.89 8.95 Favored Glycine 0 C--N 1.339 0.728 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 177.872 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.541 ' HA ' ' CE2' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -59.2 -168.97 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 123.288 1.518 . . . . 0.0 111.325 178.082 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.428 HD13 ' CE1' ' A' ' 42' ' ' TYR . 4.7 mp -77.14 152.12 81.85 Favored Pre-proline 0 N--CA 1.43 -1.458 0 O-C-N 120.472 -1.392 . . . . 0.0 110.833 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -72.17 170.43 19.1 Favored 'Trans proline' 0 N--CA 1.445 -1.336 0 C-N-CA 122.539 2.159 . . . . 0.0 110.792 179.0 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.92 100.43 0.07 Allowed 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.619 -0.676 . . . . 0.0 109.378 176.338 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.75 56.48 0.37 Allowed Glycine 0 CA--C 1.51 -0.252 0 O-C-N 121.684 -0.635 . . . . 0.0 111.552 -177.844 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.1 OUTLIER -150.36 165.52 32.82 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 118.573 -0.727 . . . . 0.0 112.454 174.214 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 54.1 m -145.02 97.29 4.86 Favored Pre-proline 0 C--O 1.233 0.21 0 O-C-N 125.338 1.649 . . . . 0.0 110.276 -176.807 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -72.47 148.09 47.65 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.878 2.385 . . . . 0.0 110.88 179.764 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.7 mt -69.18 120.97 17.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -177.877 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.6 tppt? -83.03 135.24 34.92 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 120.897 -1.127 . . . . 0.0 108.652 177.805 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.522 ' CD1' ' HB3' ' A' ' 118' ' ' CYS . 7.9 m-85 -118.44 -51.61 2.4 Favored 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 123.786 0.834 . . . . 0.0 109.858 -178.982 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 122.32 -4.51 10.3 Favored Glycine 0 C--O 1.222 -0.613 0 CA-C-O 119.35 -0.695 . . . . 0.0 112.831 -175.282 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.6 mtpt -96.5 139.03 33.2 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-N 118.399 1.1 . . . . 0.0 110.553 175.832 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 23.2 t -74.77 -1.71 23.27 Favored 'General case' 0 C--O 1.222 -0.351 0 O-C-N 124.771 1.294 . . . . 0.0 111.961 175.027 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -87.95 -54.16 4.37 Favored 'General case' 0 CA--C 1.516 -0.364 0 O-C-N 120.793 -1.192 . . . . 0.0 108.709 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 2.7 m -75.47 -32.38 60.57 Favored 'General case' 0 N--CA 1.45 -0.438 0 O-C-N 124.028 0.83 . . . . 0.0 109.426 -178.845 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -62.88 -39.17 93.66 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 122.556 1.169 . . . . 0.0 110.811 173.056 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.421 ' HD3' ' CE1' ' A' ' 78' ' ' HIS . 0.0 OUTLIER -53.64 160.01 2.21 Favored Pre-proline 0 N--CA 1.444 -0.749 0 O-C-N 120.973 -1.079 . . . . 0.0 112.621 178.78 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -70.32 133.87 25.53 Favored 'Trans proline' 0 N--CA 1.438 -1.79 0 N-CA-C 114.697 0.999 . . . . 0.0 114.697 172.202 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.433 ' CD ' ' CD2' ' A' ' 42' ' ' TYR . 21.1 Cg_endo -70.46 168.92 21.07 Favored 'Trans proline' 0 N--CA 1.439 -1.685 0 C-N-CA 124.115 3.21 . . . . 0.0 111.238 176.665 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.9 tptt -128.05 51.75 1.94 Allowed 'General case' 0 C--O 1.199 -1.583 0 CA-C-N 115.02 -0.991 . . . . 0.0 108.826 177.808 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -75.66 168.82 19.3 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 119.921 -1.737 . . . . 0.0 110.972 178.395 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 24.0 p -161.67 -156.82 0.45 Allowed 'General case' 0 C--O 1.222 -0.375 0 O-C-N 120.994 -1.066 . . . . 0.0 111.846 174.317 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.11 70.88 9.13 Favored 'General case' 0 C--O 1.215 -0.719 0 O-C-N 120.67 -1.269 . . . . 0.0 112.739 172.315 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -176.08 -40.78 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.88 0.848 . . . . 0.0 109.701 177.483 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 108.67 -57.82 0.42 Allowed Glycine 0 C--O 1.212 -1.219 0 CA-C-O 118.389 -1.228 . . . . 0.0 111.761 -175.658 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -135.05 67.92 1.48 Allowed 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 105.529 -2.026 . . . . 0.0 105.529 -173.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.47 -119.24 0.01 OUTLIER Glycine 0 CA--C 1.529 0.93 0 CA-C-O 122.411 1.006 . . . . 0.0 113.001 177.801 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.7 mttt -63.79 -99.3 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.528 0 O-C-N 119.32 -2.282 . . . . 0.0 112.156 176.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -105.46 12.45 31.43 Favored 'General case' 0 C--N 1.317 -0.841 0 O-C-N 119.453 -2.03 . . . . 0.0 110.547 178.433 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.463 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 21.1 m-20 -29.66 105.83 0.03 OUTLIER 'General case' 0 C--O 1.201 -1.498 0 C-N-CA 126.234 1.813 . . . . 0.0 110.41 -176.479 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.544 ' H ' ' CD2' ' A' ' 78' ' ' HIS . 2.3 p80 -86.21 14.02 7.07 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 120.144 1.338 . . . . 0.0 110.082 -175.357 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . . . . . . . . . 0.4 OUTLIER -32.55 132.2 0.14 Allowed 'General case' 0 N--CA 1.439 -1.018 0 C-N-CA 126.015 1.726 . . . . 0.0 112.887 170.428 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -75.61 155.53 35.8 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 121.015 -1.053 . . . . 0.0 109.067 178.238 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.7 mp -141.81 134.36 28.28 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 118.874 0.761 . . . . 0.0 109.354 176.835 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.451 ' CB ' ' CD1' ' A' ' 109' ' ' ILE . 1.7 pm0 -103.13 154.56 19.17 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 122.842 1.306 . . . . 0.0 110.78 179.396 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.442 ' HZ ' ' CD2' ' A' ' 94' ' ' PHE . 37.8 t80 -141.79 138.82 17.5 Favored Pre-proline 0 C--O 1.218 -0.559 0 O-C-N 121.265 -0.897 . . . . 0.0 112.853 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.494 ' O ' ' CE2' ' A' ' 92' ' ' TYR . 14.6 Cg_endo -72.15 88.35 0.84 Allowed 'Trans proline' 0 CA--C 1.485 -1.942 0 C-N-CA 124.658 3.572 . . . . 0.0 109.341 -173.29 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.7 t -80.11 116.62 20.32 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.674 0.789 . . . . 0.0 111.769 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.506 ' CD1' ' CE1' ' A' ' 92' ' ' TYR . 7.8 m-85 -84.65 159.09 58.88 Favored Pre-proline 0 C--N 1.318 -0.777 0 O-C-N 120.406 -1.434 . . . . 0.0 110.701 -179.556 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -76.42 -45.29 0.21 Allowed 'Trans proline' 0 N--CA 1.446 -1.291 0 C-N-CA 122.252 1.968 . . . . 0.0 111.544 178.766 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -53.62 -28.75 34.47 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 124.108 1.909 . . . . 0.0 110.229 177.275 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.73 -9.5 51.1 Favored Glycine 0 N--CA 1.436 -1.354 0 CA-C-O 116.458 -2.301 . . . . 0.0 112.133 -177.434 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -50.53 138.91 16.74 Favored 'General case' 0 C--O 1.209 -1.041 0 CA-C-O 116.805 -1.569 . . . . 0.0 107.887 178.609 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -62.1 143.51 56.57 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 120.88 1.673 . . . . 0.0 111.644 175.782 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.506 ' CE1' ' CD1' ' A' ' 86' ' ' PHE . 0.1 OUTLIER -98.01 155.08 17.28 Favored 'General case' 0 C--O 1.215 -0.756 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -174.159 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.73 55.11 2.59 Favored 'General case' 0 C--N 1.314 -0.935 0 O-C-N 118.515 -2.615 . . . . 0.0 111.053 172.18 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.442 ' CD2' ' HZ ' ' A' ' 83' ' ' PHE . 40.0 p90 -69.24 -26.74 64.94 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-O 117.828 -1.082 . . . . 0.0 110.877 175.412 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -90.09 -21.05 22.48 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 119.956 1.253 . . . . 0.0 111.442 179.234 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.7 m -108.77 101.05 10.21 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 -178.747 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.26 -29.57 67.5 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.896 0.855 . . . . 0.0 110.234 175.969 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.6 mttm -125.75 113.38 24.85 Favored Pre-proline 0 N--CA 1.444 -0.745 0 CA-C-O 117.654 -1.165 . . . . 0.0 109.276 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -70.29 173.36 46.84 Favored 'Cis proline' 0 C--N 1.356 0.926 0 O-C-N 124.44 1.758 . . . . 0.0 110.521 -3.556 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.409 ' CE ' ' HA ' ' A' ' 32' ' ' SER . 0.5 OUTLIER -130.39 145.99 51.89 Favored 'General case' 0 CA--C 1.507 -0.705 0 C-N-CA 125.293 1.437 . . . . 0.0 110.021 177.863 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.07 175.19 5.53 Favored 'General case' 0 C--O 1.243 0.733 0 O-C-N 125.751 1.907 . . . . 0.0 109.122 -177.869 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -76.49 139.83 67.9 Favored Pre-proline 0 N--CA 1.442 -0.849 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.916 176.626 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -72.74 -165.61 0.24 Allowed 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 122.523 2.149 . . . . 0.0 111.899 175.612 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -136.3 163.89 25.11 Favored Glycine 0 CA--C 1.525 0.679 0 O-C-N 120.853 -1.154 . . . . 0.0 112.891 176.236 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -76.62 -50.12 0.11 Allowed 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.464 2.109 . . . . 0.0 110.898 178.846 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.472 ' CB ' ' CE2' ' A' ' 11' ' ' TYR . . . -75.29 142.51 43.27 Favored 'General case' 0 CA--C 1.51 -0.563 0 O-C-N 121.903 -0.498 . . . . 0.0 110.465 177.331 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.456 ' HG2' ' HA ' ' A' ' 84' ' ' PRO . 3.6 mtm-85 -143.81 145.69 32.53 Favored 'General case' 0 CA--C 1.5 -0.968 0 CA-C-O 117.721 -1.133 . . . . 0.0 112.415 178.32 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 5.3 p -79.15 124.98 38.2 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.476 0 O-C-N 124.176 0.922 . . . . 0.0 110.62 177.769 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.451 ' CD1' ' CB ' ' A' ' 82' ' ' GLU . 4.4 mm -103.99 141.38 19.74 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 C-N-CA 123.914 0.886 . . . . 0.0 109.718 -179.086 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.412 ' CD1' ' HG3' ' A' ' 115' ' ' LYS . 10.4 p90 -166.01 152.48 9.41 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 122.891 1.329 . . . . 0.0 110.034 -178.161 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.7 p -89.79 167.68 12.68 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.062 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.543 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.3 OUTLIER -108.46 153.83 41.86 Favored Pre-proline 0 CA--C 1.552 1.031 0 O-C-N 123.534 0.521 . . . . 0.0 111.341 177.182 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.543 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 14.1 Cg_endo -75.81 -55.27 0.14 OUTLIER 'Cis proline' 0 CA--C 1.49 -1.706 0 N-CA-C 107.998 -1.578 . . . . 0.0 107.998 -5.681 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -44.17 112.24 0.38 Allowed 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 116.279 -1.82 . . . . 0.0 109.713 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.421 ' HE2' ' CD1' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -66.44 76.17 0.1 Allowed 'General case' 0 CA--C 1.505 -0.755 0 C-N-CA 124.797 1.239 . . . . 0.0 107.985 -177.666 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 54.8 t -75.83 72.03 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 -176.255 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.536 ' CE1' ' HA2' ' A' ' 119' ' ' GLY . 7.6 t80 -39.08 111.17 0.17 Allowed 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 126.321 1.848 . . . . 0.0 106.84 -178.819 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . 0.522 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 0.1 OUTLIER -91.25 -22.78 20.41 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 121.126 -0.23 . . . . 0.0 110.405 175.974 . . . . . . . . 3 3 . 1 . 015 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.536 ' HA2' ' CE1' ' A' ' 117' ' ' PHE . . . 134.82 -170.31 22.86 Favored Glycine 0 CA--C 1.496 -1.148 0 C-N-CA 123.621 0.629 . . . . 0.0 112.1 -176.636 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 3.4 mp -107.67 151.53 9.66 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 -179.274 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.472 HD13 ' CZ ' ' A' ' 38' ' ' PHE . 9.9 pt -120.94 154.72 24.5 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.621 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 177.327 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -174.34 157.97 2.83 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 123.644 1.688 . . . . 0.0 110.069 175.117 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 7.2 m-70 -90.57 95.78 10.33 Favored 'General case' 0 C--O 1.219 -0.547 0 O-C-N 120.717 -1.239 . . . . 0.0 108.457 -176.339 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.3 t -96.85 36.53 1.39 Allowed 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 124.391 2.043 . . . . 0.0 111.328 -179.492 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.5 tptt -101.53 -28.69 12.4 Favored 'General case' 0 C--O 1.217 -0.632 0 O-C-N 119.153 -2.217 . . . . 0.0 111.214 178.075 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -171.06 -66.18 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.57 0 O-C-N 123.62 0.575 . . . . 0.0 110.079 177.671 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -155.59 -44.77 0.08 Allowed 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 122.096 0.951 . . . . 0.0 110.194 179.348 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -153.55 79.1 1.15 Allowed 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 125.167 1.387 . . . . 0.0 109.269 -178.936 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -130.49 -103.54 1.0 Allowed Glycine 0 N--CA 1.463 0.486 0 O-C-N 120.399 -1.438 . . . . 0.0 109.723 176.814 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.25 150.57 21.9 Favored 'General case' 0 C--N 1.323 -0.577 0 O-C-N 120.99 -1.3 . . . . 0.0 110.701 -178.812 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -104.96 146.46 29.0 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 118.941 0.791 . . . . 0.0 109.246 179.445 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.96 168.35 25.49 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 125.412 1.485 . . . . 0.0 109.759 -179.9 . . . . . . . . 2 2 . 1 . 015 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 10.4 tp -84.41 141.44 30.83 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.656 1.223 . . . . 0.0 108.387 177.245 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 79.4 m -60.64 -179.42 0.12 Allowed 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 123.264 1.507 . . . . 0.0 110.312 174.889 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 13.2 m -159.06 87.79 0.87 Allowed 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 104.002 -2.592 . . . . 0.0 104.002 -176.993 . . . . . . . . 1 1 . 1 . 015 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 0.509 ' CD2' ' CE2' ' A' ' 4' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--O 1.257 1.48 0 CA-C-O 114.024 -2.893 . . . . 0.0 114.756 167.939 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.514 -0.412 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 . . . . . . . . . 0 0 . 1 . 016 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.7 p -84.19 146.73 6.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.611 0.719 . . . . 0.0 109.974 177.733 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.9 m -88.04 114.49 24.71 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 123.665 0.786 . . . . 0.0 109.368 -178.927 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.515 ' CE2' ' CD2' ' A' ' 136' ' ' HIS . 19.5 m95 -79.01 144.32 34.81 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.052 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -138.61 134.35 33.65 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -178.426 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -118.78 -84.19 0.65 Allowed 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.42 0.628 . . . . 0.0 110.374 176.911 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -92.85 75.1 1.26 Allowed Glycine 0 C--O 1.217 -0.927 0 CA-C-O 117.564 -1.687 . . . . 0.0 111.813 -177.447 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 45.9 27.5 2.4 Favored Glycine 0 N--CA 1.473 1.145 0 CA-C-N 118.96 1.38 . . . . 0.0 113.948 -175.885 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 2.6 mt -129.98 149.17 51.82 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -174.912 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.1 OUTLIER -100.42 155.15 17.98 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 124.487 1.117 . . . . 0.0 108.102 -173.826 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.541 ' CE2' ' CB ' ' A' ' 106' ' ' ALA . 50.7 m-85 -158.72 86.03 0.84 Allowed 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 122.181 0.991 . . . . 0.0 108.872 -172.463 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -54.99 125.22 19.5 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-O 117.058 -1.449 . . . . 0.0 108.727 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.54 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 0.8 OUTLIER -49.74 -35.07 20.88 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-N 119.106 0.866 . . . . 0.0 111.271 178.585 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.404 ' O ' ' CB ' ' A' ' 18' ' ' SER . 8.4 t-20 -61.07 -44.91 96.65 Favored 'General case' 0 C--O 1.204 -1.317 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.41 175.95 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.4 -42.88 64.67 Favored 'General case' 0 C--O 1.207 -1.15 0 CA-C-O 117.736 -1.126 . . . . 0.0 111.899 173.73 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -52.09 -39.8 60.3 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 119.893 1.224 . . . . 0.0 111.422 176.521 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -85.81 -47.91 9.27 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-O 117.907 -1.044 . . . . 0.0 110.387 176.099 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.404 ' CB ' ' O ' ' A' ' 14' ' ' ASN . 29.0 t -64.39 -59.42 4.38 Favored 'General case' 0 CA--C 1.499 -0.992 0 C-N-CA 125.982 1.713 . . . . 0.0 107.948 -173.368 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.447 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 13.4 t-20 -38.07 -40.51 0.49 Allowed 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 118.919 0.782 . . . . 0.0 112.362 172.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.6 -38.2 40.53 Favored 'General case' 0 C--O 1.218 -0.602 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 174.52 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 10.3 m170 -43.55 -36.04 1.93 Allowed 'General case' 0 C--N 1.34 0.191 0 C-N-CA 126.25 1.82 . . . . 0.0 109.87 178.037 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.447 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.1 OUTLIER -74.8 -52.0 12.59 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 124.318 1.047 . . . . 0.0 111.105 177.226 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -37.58 126.08 0.92 Allowed Pre-proline 0 CA--C 1.544 0.722 0 O-C-N 124.967 1.417 . . . . 0.0 111.629 174.826 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -73.09 132.18 17.77 Favored 'Trans proline' 0 N--CA 1.445 -1.343 0 C-N-CA 122.033 1.822 . . . . 0.0 110.125 -178.088 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 7.3 tp -59.79 112.42 1.83 Allowed 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.561 179.017 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 179.71 149.98 0.33 Allowed 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 122.617 0.367 . . . . 0.0 111.193 -178.715 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.493 ' HB2' ' CE2' ' A' ' 79' ' ' TYR . 4.2 t0 -86.86 78.99 8.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 122.024 0.916 . . . . 0.0 108.62 -179.378 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . 0.411 ' N ' ' HA ' ' A' ' 36' ' ' HIS . . . 68.38 76.93 0.4 Allowed Glycine 0 N--CA 1.451 -0.333 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 177.019 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -152.13 40.55 0.63 Allowed 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 122.342 1.068 . . . . 0.0 111.876 178.503 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 8.4 p -121.32 159.1 26.76 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 -176.665 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -37.66 -77.81 0.05 OUTLIER Glycine 0 C--N 1.333 0.407 0 C-N-CA 125.145 1.355 . . . . 0.0 111.846 -178.607 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 32' ' ' SER . . . . . 0.403 ' OG ' ' HE2' ' A' ' 100' ' ' LYS . 18.0 t -55.24 -57.11 13.15 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.137 177.493 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 161.1 -51.16 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.568 0 O-C-N 124.859 1.35 . . . . 0.0 111.44 178.191 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.416 ' CD1' ' HD3' ' A' ' 84' ' ' PRO . 90.2 m-85 -69.53 147.36 96.71 Favored Pre-proline 0 N--CA 1.444 -0.775 0 O-C-N 124.089 0.868 . . . . 0.0 112.915 178.591 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.436 ' HB2' ' CG ' ' A' ' 81' ' ' LEU . 28.4 Cg_endo -77.42 179.3 31.66 Favored 'Cis proline' 0 N--CA 1.446 -1.314 0 C-N-CA 122.359 -1.934 . . . . 0.0 112.426 2.572 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.411 ' HA ' ' N ' ' A' ' 28' ' ' GLY . 0.5 OUTLIER -154.29 167.58 29.47 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-O 118.322 -0.847 . . . . 0.0 110.972 -179.87 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.503 ' CH2' ' HA2' ' A' ' 44' ' ' GLY . 17.9 t90 -61.74 152.23 31.76 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 122.183 0.992 . . . . 0.0 109.546 175.638 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.455 ' CE2' ' HB2' ' A' ' 40' ' ' ASN . 8.7 t80 -125.27 84.46 2.28 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 -175.411 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 62.3 p -38.67 -36.4 0.25 Allowed 'General case' 0 C--O 1.214 -0.784 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.234 173.372 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.455 ' HB2' ' CE2' ' A' ' 38' ' ' PHE . 51.3 t30 55.07 21.15 3.65 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-O 122.697 1.237 . . . . 0.0 110.849 177.816 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.431 ' CA ' ' HG2' ' A' ' 52' ' ' ARG . . . 106.9 -40.08 2.64 Favored Glycine 0 N--CA 1.423 -2.186 0 CA-C-O 118.504 -1.164 . . . . 0.0 114.431 -171.038 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.471 ' CE2' ' HD3' ' A' ' 66' ' ' PRO . 76.1 m-85 -48.72 155.42 0.57 Allowed 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 118.998 1.399 . . . . 0.0 111.761 177.492 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.44 -36.29 22.45 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.376 0.608 . . . . 0.0 110.796 178.428 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.503 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -172.21 -61.87 0.04 OUTLIER Glycine 0 C--N 1.335 0.498 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -178.864 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -123.33 -64.19 1.18 Allowed 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 122.542 0.337 . . . . 0.0 110.891 -178.515 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.64 -174.13 0.14 Allowed Glycine 0 C--N 1.345 1.043 0 C-N-CA 124.435 1.016 . . . . 0.0 110.676 178.703 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -59.99 -166.28 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 123.793 1.759 . . . . 0.0 110.687 178.581 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -94.31 170.17 8.65 Favored Pre-proline 0 C--N 1.312 -1.034 0 O-C-N 120.995 -1.066 . . . . 0.0 110.217 -178.518 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -71.64 158.18 54.12 Favored 'Trans proline' 0 N--CA 1.441 -1.582 0 C-N-CA 121.913 1.742 . . . . 0.0 111.062 178.539 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.28 97.59 0.09 Allowed 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.983 177.459 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 119.85 39.31 0.66 Allowed Glycine 0 C--O 1.227 -0.283 0 CA-C-O 119.476 -0.624 . . . . 0.0 111.952 -176.914 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.431 ' HG2' ' CA ' ' A' ' 41' ' ' GLY . 0.0 OUTLIER -122.63 161.81 23.09 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 117.759 0.779 . . . . 0.0 111.283 177.103 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 26.0 m -139.74 98.32 7.91 Favored Pre-proline 0 C--N 1.328 -0.357 0 O-C-N 124.265 0.978 . . . . 0.0 110.054 -178.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -72.06 161.19 45.47 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 122.052 1.835 . . . . 0.0 111.674 178.747 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.422 ' O ' ' CE2' ' A' ' 57' ' ' PHE . 6.9 mt -85.43 121.47 37.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 -178.81 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.66 135.07 35.13 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 177.542 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.545 ' CD1' ' HB3' ' A' ' 118' ' ' CYS . 15.1 m-85 -118.3 -51.87 2.4 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 123.354 0.661 . . . . 0.0 110.617 179.361 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 122.42 -2.09 10.4 Favored Glycine 0 C--O 1.226 -0.366 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.302 -176.938 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 33.9 mmtt -100.0 141.61 32.58 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-N 117.567 0.683 . . . . 0.0 110.195 177.241 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 44.9 t -76.22 -2.06 29.48 Favored 'General case' 0 C--O 1.221 -0.429 0 O-C-N 124.66 1.225 . . . . 0.0 111.226 176.522 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -87.83 -55.56 3.72 Favored 'General case' 0 CA--C 1.512 -0.511 0 O-C-N 120.876 -1.14 . . . . 0.0 109.075 -179.196 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 2.0 m -74.38 -31.77 62.49 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 124.586 1.179 . . . . 0.0 109.383 -179.57 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -64.89 -38.24 90.3 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 122.279 1.037 . . . . 0.0 110.586 175.053 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.12 160.1 2.57 Favored Pre-proline 0 N--CA 1.445 -0.676 0 O-C-N 121.179 -0.95 . . . . 0.0 112.251 179.304 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -71.2 140.62 37.73 Favored 'Trans proline' 0 N--CA 1.441 -1.586 0 C-N-CA 120.326 0.684 . . . . 0.0 113.422 175.629 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.471 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 22.9 Cg_endo -73.1 170.3 20.14 Favored 'Trans proline' 0 N--CA 1.446 -1.307 0 C-N-CA 123.542 2.828 . . . . 0.0 111.415 177.949 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.9 tptp -136.15 57.38 1.78 Allowed 'General case' 0 C--O 1.214 -0.789 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -178.913 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 43.8 t-80 -74.0 154.95 39.07 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 124.486 2.089 . . . . 0.0 113.09 175.285 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.07 -172.08 3.5 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 118.677 -2.514 . . . . 0.0 110.411 178.2 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -85.26 69.48 10.74 Favored 'General case' 0 N--CA 1.45 -0.44 0 O-C-N 121.947 -0.471 . . . . 0.0 111.042 176.717 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -177.76 -42.68 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 123.555 0.535 . . . . 0.0 110.112 179.365 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.446 ' CA ' ' HB3' ' A' ' 27' ' ' ASP . . . 124.98 -78.95 0.37 Allowed Glycine 0 N--CA 1.441 -0.967 0 CA-C-N 115.189 -0.914 . . . . 0.0 112.727 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -118.86 58.66 0.84 Allowed 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.236 1.015 . . . . 0.0 108.956 178.353 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -57.28 -105.58 0.01 OUTLIER Glycine 0 CA--C 1.525 0.701 0 CA-C-O 121.661 0.589 . . . . 0.0 112.695 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 22.1 mttt -60.97 -96.32 0.0 OUTLIER 'General case' 0 C--O 1.222 -0.384 0 O-C-N 121.197 -1.178 . . . . 0.0 111.259 177.393 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -126.63 26.88 6.2 Favored 'General case' 0 CA--C 1.511 -0.527 0 O-C-N 121.645 -0.659 . . . . 0.0 111.086 178.902 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.476 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 1.9 m-20 -34.49 106.23 0.04 OUTLIER 'General case' 0 C--O 1.216 -0.689 0 C-N-CA 124.597 1.159 . . . . 0.0 109.91 -176.732 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -84.19 19.49 1.83 Allowed 'General case' 0 C--N 1.328 -0.354 0 O-C-N 121.142 -0.974 . . . . 0.0 110.63 -177.37 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.493 ' CE2' ' HB2' ' A' ' 27' ' ' ASP . 22.9 p90 -48.49 135.46 14.19 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 124.695 1.198 . . . . 0.0 110.818 177.933 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -76.07 137.24 40.05 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.431 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.475 HD23 ' CZ ' ' A' ' 110' ' ' TYR . 0.3 OUTLIER -123.91 148.76 46.58 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.132 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -115.16 163.45 15.63 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.725 -0.671 . . . . 0.0 112.134 176.965 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.489 ' CD1' ' HD2' ' A' ' 84' ' ' PRO . 40.2 t80 -152.61 133.93 8.19 Favored Pre-proline 0 CA--C 1.534 0.352 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -178.981 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.489 ' HD2' ' CD1' ' A' ' 83' ' ' PHE . 17.8 Cg_endo -72.27 104.3 1.66 Allowed 'Trans proline' 0 N--CA 1.446 -1.299 0 C-N-CA 123.345 2.697 . . . . 0.0 110.626 -176.573 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.6 t -105.92 108.36 19.83 Favored 'General case' 0 CA--C 1.5 -0.947 0 O-C-N 124.356 1.035 . . . . 0.0 110.136 -178.773 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.438 ' CD2' ' NE2' ' A' ' 90' ' ' HIS . 1.4 m-85 -85.29 161.25 52.45 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-O 121.138 0.494 . . . . 0.0 111.372 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -76.33 -41.23 0.49 Allowed 'Trans proline' 0 CA--C 1.496 -1.395 0 C-N-CA 121.871 1.714 . . . . 0.0 112.711 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -39.54 -31.13 0.08 Allowed 'General case' 0 N--CA 1.469 0.497 0 O-C-N 124.989 1.431 . . . . 0.0 111.363 175.176 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 91.58 -9.96 75.85 Favored Glycine 0 N--CA 1.43 -1.76 0 C-N-CA 124.749 1.166 . . . . 0.0 111.892 179.234 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.438 ' NE2' ' CD2' ' A' ' 86' ' ' PHE . 0.5 OUTLIER -57.63 143.8 39.97 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 122.712 1.244 . . . . 0.0 109.089 177.447 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -88.6 122.54 32.16 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 174.827 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -48.11 170.02 0.02 OUTLIER 'General case' 0 C--O 1.214 -0.78 0 CA-C-O 123.213 1.482 . . . . 0.0 113.614 175.761 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.86 60.83 1.1 Allowed 'General case' 0 C--N 1.321 -0.634 0 O-C-N 119.371 -2.081 . . . . 0.0 107.33 -176.937 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 7.3 p90 -81.12 14.91 2.09 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 121.742 -0.599 . . . . 0.0 112.1 177.417 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -108.46 -31.41 7.82 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.458 0.647 . . . . 0.0 109.982 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.8 m -113.87 116.09 28.75 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 123.175 0.59 . . . . 0.0 109.474 -179.589 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.8 pttm -58.33 -45.48 88.02 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.058 177.741 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 9.7 ttmt -142.07 131.9 12.47 Favored Pre-proline 0 N--CA 1.442 -0.87 0 CA-C-O 118.424 -0.798 . . . . 0.0 109.948 -179.138 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 30.9 Cg_endo -70.25 175.37 38.41 Favored 'Cis proline' 0 N--CA 1.456 -0.724 0 O-C-N 124.769 1.931 . . . . 0.0 112.256 -4.437 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . 0.403 ' HE2' ' OG ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -145.18 147.54 32.58 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 177.765 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -84.86 175.87 8.85 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.24 0.543 . . . . 0.0 111.276 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -73.13 140.67 80.36 Favored Pre-proline 0 CA--C 1.545 0.754 0 O-C-N 121.469 -0.769 . . . . 0.0 111.361 175.258 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -70.26 -161.85 0.09 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.47 2.114 . . . . 0.0 113.356 175.431 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -137.83 158.08 24.49 Favored Glycine 0 CA--C 1.523 0.592 0 O-C-N 120.948 -1.095 . . . . 0.0 111.625 176.485 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -74.4 -41.03 0.95 Allowed 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 122.242 1.962 . . . . 0.0 111.374 179.184 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.541 ' CB ' ' CE2' ' A' ' 11' ' ' TYR . . . -90.28 138.23 31.7 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 121.082 0.467 . . . . 0.0 110.03 177.739 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.414 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 0.0 OUTLIER -139.32 151.82 46.71 Favored 'General case' 0 C--O 1.213 -0.845 0 CA-C-O 117.916 -1.04 . . . . 0.0 111.483 177.753 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.3 p -82.62 120.71 34.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 123.958 0.903 . . . . 0.0 110.584 177.403 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 1.7 mp -108.16 120.49 59.61 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.628 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 -176.756 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.475 ' CZ ' HD23 ' A' ' 81' ' ' LEU . 5.8 p90 -140.92 152.42 45.01 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 122.733 1.254 . . . . 0.0 110.149 -178.853 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 3.0 p -84.33 160.88 20.6 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.788 -179.547 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.526 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.3 OUTLIER -113.01 152.83 45.26 Favored Pre-proline 0 CA--C 1.545 0.758 0 CA-C-O 120.464 0.173 . . . . 0.0 110.927 179.506 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.526 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 19.3 Cg_endo -74.25 -50.03 0.2 Allowed 'Cis proline' 0 CA--C 1.499 -1.261 0 C-N-CA 123.462 -1.474 . . . . 0.0 111.043 -5.021 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 32.6 t-20 -44.39 106.57 0.07 Allowed 'General case' 0 CA--C 1.512 -0.516 0 O-C-N 125.03 1.456 . . . . 0.0 108.801 178.582 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.453 ' HG3' ' CD1' ' A' ' 110' ' ' TYR . 0.4 OUTLIER -67.88 68.56 0.11 Allowed 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 124.322 1.049 . . . . 0.0 108.811 -178.828 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 24.2 t -73.87 73.32 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 -177.787 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.547 ' CE1' ' HA2' ' A' ' 119' ' ' GLY . 4.6 t80 -37.26 117.1 0.51 Allowed 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 124.65 1.18 . . . . 0.0 108.139 179.132 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . 0.545 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -97.15 -34.08 11.26 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.744 177.328 . . . . . . . . 3 3 . 1 . 016 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.547 ' HA2' ' CE1' ' A' ' 117' ' ' PHE . . . 146.25 -175.09 25.9 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 123.484 0.564 . . . . 0.0 111.708 -178.375 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.419 ' CG2' ' SG ' ' A' ' 134' ' ' CYS . 3.3 mp -103.66 149.38 7.63 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.745 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -179.185 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 5.3 pt -122.16 151.85 26.03 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 178.873 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -176.65 132.55 0.21 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 122.558 1.171 . . . . 0.0 109.504 178.204 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -88.17 94.83 9.94 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 121.079 -1.013 . . . . 0.0 110.687 179.188 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.1 t -98.48 33.19 2.3 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 123.154 1.454 . . . . 0.0 111.306 179.71 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.4 tttt -84.32 -46.42 11.8 Favored 'General case' 0 C--O 1.215 -0.728 0 CA-C-O 117.866 -1.064 . . . . 0.0 109.709 179.168 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 172.74 -82.39 0.0 OUTLIER 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 124.592 1.157 . . . . 0.0 110.371 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -157.99 25.64 0.26 Allowed 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.483 1.113 . . . . 0.0 110.704 -178.568 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -170.82 88.56 0.12 Allowed 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 122.069 0.938 . . . . 0.0 110.599 -177.631 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 167.94 104.15 0.17 Allowed Glycine 0 CA--C 1.491 -1.421 0 CA-C-O 116.04 -2.533 . . . . 0.0 107.134 179.266 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -33.02 139.23 0.05 Allowed 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.686 1.595 . . . . 0.0 112.35 177.878 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -56.94 156.01 7.32 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.185 -177.632 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -132.87 153.37 51.39 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -176.905 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 9.9 tp -59.63 129.64 42.9 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 125.141 1.526 . . . . 0.0 107.42 -179.77 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . 0.419 ' SG ' ' CG2' ' A' ' 120' ' ' ILE . 79.9 m -58.64 -177.22 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 125.031 1.457 . . . . 0.0 109.313 178.204 . . . . . . . . 2 2 . 1 . 016 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.2 m -152.22 81.6 1.25 Allowed 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 -176.8 . . . . . . . . 1 1 . 1 . 016 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 0.515 ' CD2' ' CE2' ' A' ' 4' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--O 1.242 0.692 0 CA-C-O 116.021 -1.942 . . . . 0.0 112.546 173.35 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 116.258 -1.829 . . . . 0.0 107.827 . . . . . . . . . 0 0 . 1 . 017 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.459 ' CG1' ' CD2' ' A' ' 136' ' ' HIS . 0.4 OUTLIER 77.87 148.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 C-N-CA 125.191 1.396 . . . . 0.0 109.155 -177.185 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 9.3 m -101.9 105.14 15.91 Favored 'General case' 0 C--N 1.313 -1.013 0 O-C-N 121.584 -0.698 . . . . 0.0 109.373 -176.864 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 20.3 m95 -73.81 141.97 46.17 Favored 'General case' 0 C--O 1.217 -0.615 0 C-N-CA 124.202 1.001 . . . . 0.0 108.628 -178.258 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -135.23 144.33 46.84 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -179.339 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -124.47 30.68 5.94 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 123.324 0.65 . . . . 0.0 112.571 175.404 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 153.08 -96.78 0.17 Allowed Glycine 0 C--O 1.223 -0.539 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -118.45 -4.48 13.58 Favored Glycine 0 N--CA 1.468 0.802 0 C-N-CA 123.649 0.642 . . . . 0.0 113.862 176.135 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -104.53 133.38 49.49 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 -176.894 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 4.8 mp -94.25 164.81 12.88 Favored 'General case' 0 C--O 1.221 -0.426 0 O-C-N 125.373 1.67 . . . . 0.0 110.4 -179.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.459 ' CE2' ' CB ' ' A' ' 106' ' ' ALA . 41.3 m-85 -157.62 84.19 0.9 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 125.086 1.354 . . . . 0.0 108.548 -170.956 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -54.33 122.85 11.25 Favored 'General case' 0 C--O 1.218 -0.57 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -179.129 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.544 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 0.7 OUTLIER -52.08 -48.56 64.62 Favored 'General case' 0 C--O 1.212 -0.915 0 CA-C-N 119.753 1.16 . . . . 0.0 111.876 -179.163 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -48.0 -34.98 10.16 Favored 'General case' 0 C--O 1.207 -1.169 0 O-C-N 124.455 1.097 . . . . 0.0 111.548 176.331 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -76.38 -55.7 5.31 Favored 'General case' 0 C--O 1.202 -1.429 0 CA-C-O 114.991 -2.433 . . . . 0.0 114.262 168.187 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -43.38 -37.96 2.53 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 122.274 2.306 . . . . 0.0 113.89 173.264 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -82.16 -53.11 6.34 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 117.136 -1.411 . . . . 0.0 110.54 172.999 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 34.8 t -57.77 -22.3 46.25 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-N 119.923 1.238 . . . . 0.0 109.466 -177.787 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.451 ' ND2' ' CE1' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -75.39 -46.31 33.71 Favored 'General case' 0 N--CA 1.433 -1.304 0 O-C-N 120.277 -1.514 . . . . 0.0 110.596 176.351 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.38 -6.31 34.54 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.311 1.044 . . . . 0.0 112.405 173.854 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 20.0 m170 -73.55 -43.32 60.17 Favored 'General case' 0 C--O 1.222 -0.379 0 O-C-N 120.017 -1.677 . . . . 0.0 110.758 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -81.89 -35.17 29.51 Favored 'General case' 0 C--O 1.22 -0.5 0 C-N-CA 123.636 0.775 . . . . 0.0 111.304 178.862 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -42.92 125.65 3.2 Favored Pre-proline 0 N--CA 1.442 -0.833 0 O-C-N 125.11 1.506 . . . . 0.0 112.706 177.463 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -72.87 127.01 11.81 Favored 'Trans proline' 0 N--CA 1.446 -1.322 0 C-N-CA 122.327 2.018 . . . . 0.0 108.589 -175.419 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -63.49 111.15 2.21 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.519 0.728 . . . . 0.0 109.244 178.877 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -176.46 175.29 1.79 Allowed 'General case' 0 C--O 1.209 -1.034 0 C-N-CA 123.815 0.846 . . . . 0.0 111.552 -179.421 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.427 ' HB3' ' CA ' ' A' ' 72' ' ' GLY . 3.5 t0 -115.54 85.55 2.3 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 176.799 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.68 71.42 1.13 Allowed Glycine 0 C--O 1.226 -0.381 0 N-CA-C 110.146 -1.181 . . . . 0.0 110.146 174.261 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.79 51.42 0.86 Allowed 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 122.942 1.353 . . . . 0.0 112.583 179.139 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -137.5 149.02 46.48 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -173.356 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -41.07 -69.93 0.46 Allowed Glycine 0 CA--C 1.509 -0.33 0 O-C-N 124.829 1.331 . . . . 0.0 113.59 -175.826 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 47.2 t -56.65 -53.29 59.4 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 116.344 -1.788 . . . . 0.0 111.727 175.306 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 155.65 -34.91 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 127.653 2.381 . . . . 0.0 112.178 177.318 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.462 ' CE1' ' CZ ' ' A' ' 107' ' ' ARG . 92.7 m-85 -85.24 144.16 40.49 Favored Pre-proline 0 CA--C 1.544 0.713 0 N-CA-C 115.027 1.491 . . . . 0.0 115.027 178.203 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.417 ' HB2' ' CD1' ' A' ' 81' ' ' LEU . 40.8 Cg_endo -80.95 174.93 44.88 Favored 'Cis proline' 0 N--CA 1.435 -1.914 0 C-N-CA 122.628 -1.822 . . . . 0.0 112.199 5.149 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -149.89 165.76 31.61 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 117.587 -1.197 . . . . 0.0 110.694 -175.585 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.404 ' CD1' ' HB2' ' A' ' 79' ' ' TYR . 19.9 t90 -70.87 146.06 49.86 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 118.686 -1.205 . . . . 0.0 111.107 173.349 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -114.46 85.73 2.29 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 104.026 -2.583 . . . . 0.0 104.026 -176.845 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 60.5 p -36.63 -41.39 0.3 Allowed 'General case' 0 C--O 1.212 -0.892 0 CA-C-N 114.275 -1.33 . . . . 0.0 110.914 169.701 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 57.4 t30 58.31 20.19 7.02 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 122.972 1.368 . . . . 0.0 111.224 178.514 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 107.37 -39.81 2.75 Favored Glycine 0 N--CA 1.436 -1.345 0 CA-C-O 118.425 -1.208 . . . . 0.0 114.181 -168.988 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 86.9 m-85 -53.85 147.4 12.09 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 118.574 1.187 . . . . 0.0 110.392 -178.966 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -82.04 -36.77 27.39 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 122.216 1.008 . . . . 0.0 111.516 179.065 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 179.59 -56.89 0.08 OUTLIER Glycine 0 C--N 1.332 0.36 0 C-N-CA 124.995 1.284 . . . . 0.0 110.833 -178.722 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -78.84 -156.93 0.11 Allowed 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 123.434 1.587 . . . . 0.0 110.861 179.504 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.42 ' CA ' ' HB2' ' A' ' 65' ' ' PRO . . . -88.59 44.26 3.15 Favored Glycine 0 N--CA 1.442 -0.934 0 CA-C-O 118.347 -1.252 . . . . 0.0 114.562 174.344 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.2 mtpt -146.21 160.62 41.73 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.12 1.368 . . . . 0.0 110.233 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.1 mp -125.99 155.8 72.68 Favored Pre-proline 0 C--O 1.241 0.621 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.931 -177.911 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -71.2 158.22 55.32 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.045 1.83 . . . . 0.0 110.011 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.81 105.79 0.14 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.536 0.734 . . . . 0.0 109.214 176.161 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.32 61.09 0.98 Allowed Glycine 0 N--CA 1.465 0.585 0 O-C-N 121.574 -0.704 . . . . 0.0 112.237 -176.643 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.8 tpm_? -134.79 151.61 51.09 Favored 'General case' 0 CA--C 1.51 -0.588 0 O-C-N 122.083 -0.657 . . . . 0.0 111.117 174.396 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.6 m -147.97 103.98 3.62 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.181 0.926 . . . . 0.0 109.285 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -71.16 154.82 61.91 Favored 'Trans proline' 0 N--CA 1.445 -1.33 0 C-N-CA 122.459 2.106 . . . . 0.0 110.867 176.262 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 12.0 mt -63.91 123.83 17.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 178.734 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.06 135.25 34.91 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.949 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.486 ' CD1' ' HB3' ' A' ' 118' ' ' CYS . 21.7 m-85 -116.27 -33.58 4.93 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 124.458 1.103 . . . . 0.0 110.754 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.06 -2.38 56.65 Favored Glycine 0 CA--C 1.525 0.707 0 O-C-N 121.558 -0.713 . . . . 0.0 113.406 -174.583 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.65 132.95 43.64 Favored 'General case' 0 CA--C 1.498 -1.056 0 CA-C-N 118.086 0.943 . . . . 0.0 109.875 176.923 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.82 -13.94 57.57 Favored 'General case' 0 C--O 1.217 -0.645 0 O-C-N 124.535 1.147 . . . . 0.0 112.222 177.191 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -86.88 -49.67 7.23 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 125.295 1.438 . . . . 0.0 110.106 178.438 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.401 ' HB3' ' CD2' ' A' ' 57' ' ' PHE . 79.4 m -74.89 -9.9 58.98 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 124.015 0.822 . . . . 0.0 112.906 174.711 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -92.67 -41.39 10.2 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.308 1.443 . . . . 0.0 109.224 176.468 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.14 157.26 1.55 Allowed Pre-proline 0 N--CA 1.45 -0.462 0 CA-C-O 122.189 0.995 . . . . 0.0 111.552 -177.738 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.42 ' HB2' ' CA ' ' A' ' 46' ' ' GLY . 26.7 Cg_endo -69.75 132.44 23.36 Favored 'Trans proline' 0 N--CA 1.43 -2.224 0 N-CA-C 114.193 0.805 . . . . 0.0 114.193 174.354 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 29.1 Cg_endo -69.39 168.11 22.01 Favored 'Trans proline' 0 N--CA 1.433 -2.066 0 C-N-CA 123.691 2.928 . . . . 0.0 111.129 175.814 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.4 tptt -127.99 123.31 34.46 Favored 'General case' 0 CA--C 1.507 -0.675 0 CA-C-O 115.472 -2.204 . . . . 0.0 105.101 176.148 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 14.1 t-80 -107.37 164.18 12.41 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 127.528 3.017 . . . . 0.0 110.888 171.92 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.06 175.53 13.31 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 122.406 1.098 . . . . 0.0 109.633 -178.982 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.21 48.7 1.52 Allowed 'General case' 0 C--O 1.218 -0.594 0 O-C-N 121.568 -0.707 . . . . 0.0 112.3 175.19 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -161.64 22.14 0.12 Allowed 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 122.614 1.197 . . . . 0.0 112.23 -178.691 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.427 ' CA ' ' HB3' ' A' ' 27' ' ' ASP . . . 73.92 -63.73 1.98 Allowed Glycine 0 CA--C 1.538 1.48 0 O-C-N 120.793 -1.192 . . . . 0.0 112.897 -169.911 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -108.08 -98.65 0.37 Allowed 'General case' 0 C--O 1.207 -1.145 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 175.001 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 123.52 -157.93 18.04 Favored Glycine 0 C--O 1.222 -0.65 0 O-C-N 119.795 -1.815 . . . . 0.0 110.644 -168.154 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.9 mttp -50.54 -84.29 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.919 0.888 . . . . 0.0 113.268 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -117.61 9.55 13.16 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 118.554 -0.736 . . . . 0.0 111.879 175.6 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.422 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 0.4 OUTLIER -26.2 97.95 0.01 OUTLIER 'General case' 0 C--O 1.211 -0.958 0 C-N-CA 126.671 1.988 . . . . 0.0 112.1 -179.325 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.4 ' H ' ' CD2' ' A' ' 78' ' ' HIS . 6.0 p80 -89.12 69.4 8.34 Favored 'General case' 0 CA--C 1.506 -0.721 0 O-C-N 119.446 -2.034 . . . . 0.0 107.326 -170.076 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.404 ' HB2' ' CD1' ' A' ' 37' ' ' TRP . 35.9 p90 -92.84 135.55 34.03 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 124.674 1.189 . . . . 0.0 109.575 -177.274 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.47 127.96 34.15 Favored 'General case' 0 C--O 1.213 -0.86 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 175.292 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.481 HD22 ' CZ ' ' A' ' 110' ' ' TYR . 0.1 OUTLIER -115.08 146.08 41.67 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 174.965 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -106.83 161.73 14.43 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 122.355 1.074 . . . . 0.0 112.214 173.995 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.451 ' CE1' ' ND2' ' A' ' 19' ' ' ASN . 9.1 t80 -153.95 140.23 12.68 Favored Pre-proline 0 C--N 1.328 -0.368 0 O-C-N 121.444 -0.785 . . . . 0.0 112.715 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.425 ' HA ' ' HG2' ' A' ' 107' ' ' ARG . 20.1 Cg_endo -70.99 95.72 0.67 Allowed 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 124.366 3.378 . . . . 0.0 112.844 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.8 t -101.54 104.49 15.39 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 122.436 1.112 . . . . 0.0 110.347 -177.169 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -80.61 160.87 66.07 Favored Pre-proline 0 C--N 1.32 -0.681 0 O-C-N 121.099 -1.001 . . . . 0.0 111.932 -179.569 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -76.39 -35.05 2.38 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.194 1.929 . . . . 0.0 113.664 177.098 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -43.02 -31.61 0.55 Allowed 'General case' 0 N--CA 1.475 0.781 0 O-C-N 125.213 1.57 . . . . 0.0 110.868 174.589 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.71 15.81 76.91 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.5 178.379 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -81.62 160.74 23.7 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 121.36 0.6 . . . . 0.0 109.824 177.42 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -97.11 92.28 5.97 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 174.223 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.477 ' CE2' ' HB3' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -47.57 162.52 0.07 Allowed 'General case' 0 C--O 1.223 -0.303 0 CA-C-O 123.105 1.431 . . . . 0.0 113.194 175.68 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.18 59.1 5.39 Favored 'General case' 0 C--N 1.319 -0.759 0 O-C-N 120.026 -1.671 . . . . 0.0 110.899 177.531 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -75.09 -16.47 60.56 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.755 175.303 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -92.66 -23.25 19.03 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 123.873 1.797 . . . . 0.0 111.478 179.355 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.51 109.82 19.88 Favored 'General case' 0 CA--C 1.513 -0.458 0 O-C-N 119.892 -1.755 . . . . 0.0 109.131 177.871 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.2 ptpt -59.45 -46.55 88.45 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 121.354 0.597 . . . . 0.0 112.109 176.932 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.1 mtmt -141.52 127.22 11.0 Favored Pre-proline 0 N--CA 1.444 -0.75 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.107 -178.151 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -70.5 173.04 48.9 Favored 'Cis proline' 0 N--CA 1.456 -0.714 0 C-N-CA 123.288 -1.547 . . . . 0.0 110.951 -5.018 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.47 149.62 52.06 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 123.526 0.73 . . . . 0.0 109.243 177.443 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . 0.477 ' HB3' ' CE2' ' A' ' 92' ' ' TYR . 2.9 tt0 -100.91 176.72 5.18 Favored 'General case' 0 C--N 1.316 -0.889 0 O-C-N 123.938 0.774 . . . . 0.0 111.773 176.437 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -83.14 126.34 72.47 Favored Pre-proline 0 CA--C 1.541 0.631 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 179.059 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 31.7 Cg_endo -67.6 -166.32 0.13 Allowed 'Trans proline' 0 N--CA 1.452 -0.94 0 CA-C-O 123.371 1.321 . . . . 0.0 113.226 176.407 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -139.42 173.04 22.97 Favored Glycine 0 CA--C 1.523 0.558 0 O-C-N 121.02 -1.05 . . . . 0.0 112.679 176.277 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -75.05 -57.92 0.05 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 123.017 2.478 . . . . 0.0 111.101 178.786 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.459 ' CB ' ' CE2' ' A' ' 11' ' ' TYR . . . -60.87 133.38 56.04 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-O 120.979 0.419 . . . . 0.0 111.155 177.879 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.462 ' CZ ' ' CE1' ' A' ' 34' ' ' TYR . 6.8 mtm-85 -147.35 149.48 32.88 Favored 'General case' 0 CA--C 1.497 -1.084 0 CA-C-O 117.194 -1.384 . . . . 0.0 110.522 179.5 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.8 p -81.86 118.92 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 O-C-N 124.434 1.084 . . . . 0.0 110.493 175.414 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 1.8 mp -108.07 117.51 53.81 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.662 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 -177.656 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.481 ' CZ ' HD22 ' A' ' 81' ' ' LEU . 8.0 p90 -134.1 153.21 51.96 Favored 'General case' 0 N--CA 1.447 -0.621 0 O-C-N 124.252 0.97 . . . . 0.0 109.56 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.8 p -84.28 162.72 20.01 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.231 178.195 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.467 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -110.06 154.87 42.52 Favored Pre-proline 0 CA--C 1.548 0.884 0 O-C-N 122.014 -0.429 . . . . 0.0 110.61 178.747 . . . . . . . . 3 3 . 1 . 017 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.467 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 17.9 Cg_endo -74.15 -48.81 0.25 Allowed 'Cis proline' 0 CA--C 1.509 -0.749 0 C-N-CA 123.934 -1.278 . . . . 0.0 111.515 -8.987 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -45.8 107.77 0.11 Allowed 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 117.62 -1.181 . . . . 0.0 108.895 175.496 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.84 68.46 0.11 Allowed 'General case' 0 CA--C 1.512 -0.509 0 C-N-CA 125.711 1.604 . . . . 0.0 108.09 -179.4 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.0 t -73.19 78.89 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 N-CA-C 102.992 -2.966 . . . . 0.0 102.992 -179.934 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.544 ' CZ ' ' NE2' ' A' ' 13' ' ' GLN . 5.2 t80 -37.82 118.9 0.71 Allowed 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 125.339 1.456 . . . . 0.0 108.93 176.548 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . 0.486 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 7.3 m -95.22 -45.31 7.23 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 121.763 0.792 . . . . 0.0 109.304 179.367 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.508 ' HA2' ' CE1' ' A' ' 117' ' ' PHE . . . 156.16 -166.55 33.13 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 -178.713 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.427 ' HA ' ' O ' ' A' ' 107' ' ' ARG . 3.0 mp -117.03 132.67 66.12 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.343 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 -178.275 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 10.2 pt -108.44 154.62 9.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.947 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -170.75 157.1 5.44 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.733 0.778 . . . . 0.0 110.637 175.449 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 8.3 m-70 -90.42 89.88 7.79 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -175.756 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.5 t -95.6 40.16 1.12 Allowed 'General case' 0 N--CA 1.483 1.22 0 CA-C-O 124.032 1.873 . . . . 0.0 111.02 -179.21 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 7.6 tptm -103.09 -28.47 11.94 Favored 'General case' 0 C--O 1.221 -0.432 0 O-C-N 120.193 -1.567 . . . . 0.0 111.358 177.998 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -171.45 -65.75 0.02 OUTLIER 'General case' 0 C--O 1.222 -0.369 0 O-C-N 124.076 0.86 . . . . 0.0 110.57 177.665 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -152.8 -46.01 0.1 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 122.985 1.374 . . . . 0.0 110.87 178.571 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -157.0 75.56 0.83 Allowed 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.986 0.898 . . . . 0.0 110.835 -178.431 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -129.73 -107.26 1.24 Allowed Glycine 0 N--CA 1.462 0.398 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 178.691 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.57 151.37 36.32 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 122.23 -0.571 . . . . 0.0 111.296 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -110.87 146.09 37.1 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 177.689 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -154.2 170.06 22.13 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 125.196 1.398 . . . . 0.0 110.093 177.743 . . . . . . . . 2 2 . 1 . 017 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 6.0 tp -81.33 146.18 30.49 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 175.894 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 87.2 m -61.4 175.01 0.63 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 123.488 1.613 . . . . 0.0 109.614 172.241 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 72.0 m -161.4 90.99 0.83 Allowed 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 104.198 -2.519 . . . . 0.0 104.198 -175.188 . . . . . . . . 1 1 . 1 . 017 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 0.459 ' CD2' ' CG1' ' A' ' 2' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.474 0.726 0 CA-C-O 115.656 -2.116 . . . . 0.0 115.305 169.631 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.657 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 . . . . . . . . . 0 0 . 1 . 018 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.6 p -106.8 141.94 20.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -179.256 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -85.59 112.25 20.8 Favored 'General case' 0 C--N 1.32 -0.698 0 O-C-N 121.907 -0.496 . . . . 0.0 110.469 178.504 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.42 ' CG ' HG13 ' A' ' 120' ' ' ILE . 29.9 m95 -79.13 139.16 38.11 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 123.091 0.556 . . . . 0.0 110.951 176.54 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -121.36 124.66 45.07 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -177.81 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 13.6 m -113.65 40.68 2.35 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.267 0.556 . . . . 0.0 110.912 177.598 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 138.05 -94.84 0.22 Allowed Glycine 0 C--O 1.223 -0.574 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 -179.138 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -123.79 1.62 9.3 Favored Glycine 0 N--CA 1.463 0.434 0 C-N-CA 123.074 0.369 . . . . 0.0 112.803 177.393 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.492 ' HB2' ' CZ ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -107.8 140.44 40.88 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 -173.428 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 17.1 mt -106.07 121.01 43.27 Favored 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 124.258 0.974 . . . . 0.0 109.311 -177.48 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.526 ' CE2' ' CB ' ' A' ' 106' ' ' ALA . 61.2 m-85 -116.06 99.94 7.61 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 124.966 1.307 . . . . 0.0 108.968 -175.137 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -56.26 122.28 11.42 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-O 118.234 -0.889 . . . . 0.0 108.982 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.495 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 6.1 tp-100 -50.09 -46.97 53.92 Favored 'General case' 0 C--O 1.21 -0.987 0 O-C-N 123.978 0.799 . . . . 0.0 112.105 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . 0.402 ' O ' ' CB ' ' A' ' 18' ' ' SER . 5.5 t-20 -50.07 -41.54 48.22 Favored 'General case' 0 C--O 1.201 -1.482 0 O-C-N 123.211 0.319 . . . . 0.0 110.975 176.541 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.12 -37.12 75.23 Favored 'General case' 0 C--O 1.204 -1.302 0 CA-C-O 116.916 -1.516 . . . . 0.0 113.076 170.429 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.04 -44.95 79.28 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 121.813 2.097 . . . . 0.0 113.151 172.847 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.434 ' O ' ' CD2' ' A' ' 21' ' ' HIS . 5.1 pt-20 -82.52 -37.67 24.9 Favored 'General case' 0 C--O 1.211 -0.927 0 C-N-CA 123.203 0.601 . . . . 0.0 109.715 176.836 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 18' ' ' SER . . . . . 0.402 ' CB ' ' O ' ' A' ' 14' ' ' ASN . 28.8 t -73.98 -60.02 2.45 Favored 'General case' 0 CA--C 1.505 -0.777 0 O-C-N 119.751 -1.843 . . . . 0.0 109.521 -176.422 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.452 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 12.1 t-20 -40.75 -37.4 0.75 Allowed 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 124.543 1.137 . . . . 0.0 112.359 172.127 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -82.52 -36.45 26.36 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 174.561 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.434 ' CD2' ' O ' ' A' ' 17' ' ' GLU . 4.4 m170 -45.76 -38.56 7.19 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 126.288 1.835 . . . . 0.0 110.133 178.563 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.452 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -72.05 -47.43 51.65 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 123.826 0.85 . . . . 0.0 112.145 175.793 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -37.88 130.25 0.94 Allowed Pre-proline 0 N--CA 1.443 -0.785 0 O-C-N 124.762 1.289 . . . . 0.0 112.079 174.165 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -73.31 124.48 9.49 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 121.836 1.691 . . . . 0.0 108.939 -176.381 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.434 ' CD1' ' HE2' ' A' ' 115' ' ' LYS . 3.9 tp -60.94 93.27 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 123.635 0.774 . . . . 0.0 111.227 179.367 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 178.55 155.0 0.4 Allowed 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 122.957 0.503 . . . . 0.0 110.092 -174.032 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.4 ' HA ' ' HA ' ' A' ' 36' ' ' HIS . 0.0 OUTLIER -95.77 123.18 39.22 Favored 'General case' 0 CA--C 1.508 -0.642 0 C-N-CA 123.973 0.909 . . . . 0.0 109.006 178.825 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 48.04 70.25 0.78 Allowed Glycine 0 C--N 1.335 0.482 0 CA-C-O 122.104 0.835 . . . . 0.0 111.895 176.602 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -149.09 30.18 0.79 Allowed 'General case' 0 CA--C 1.51 -0.58 0 O-C-N 121.831 -0.805 . . . . 0.0 111.962 179.562 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 36.4 p -127.52 147.23 50.32 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -175.859 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -41.23 -55.35 3.62 Favored Glycine 0 N--CA 1.448 -0.556 0 O-C-N 123.981 0.8 . . . . 0.0 112.082 -178.928 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 29.2 t -67.37 -70.64 0.24 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 118.803 -0.618 . . . . 0.0 111.474 175.183 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.1 p 176.03 -57.66 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 124.306 1.042 . . . . 0.0 112.85 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -67.48 151.55 97.05 Favored Pre-proline 0 N--CA 1.427 -1.609 0 C-N-CA 124.131 0.972 . . . . 0.0 112.066 178.583 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 24.5 Cg_endo -74.62 164.06 89.0 Favored 'Cis proline' 0 N--CA 1.455 -0.74 0 C-N-CA 123.144 -1.607 . . . . 0.0 111.103 -1.536 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.4 ' HA ' ' HA ' ' A' ' 27' ' ' ASP . 0.3 OUTLIER -143.17 161.4 38.32 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 117.474 -1.251 . . . . 0.0 109.662 -179.034 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.521 ' CH2' ' HA2' ' A' ' 44' ' ' GLY . 13.7 t90 -59.33 138.67 57.55 Favored 'General case' 0 N--CA 1.446 -0.629 0 O-C-N 124.937 1.398 . . . . 0.0 110.137 177.827 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.443 ' CE2' ' HB2' ' A' ' 40' ' ' ASN . 9.8 t80 -109.13 85.83 2.17 Favored 'General case' 0 N--CA 1.423 -1.782 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 -176.018 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.445 ' CG2' ' CH2' ' A' ' 37' ' ' TRP . 20.1 p -38.69 -34.6 0.15 Allowed 'General case' 0 CA--C 1.495 -1.138 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.653 170.745 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.443 ' HB2' ' CE2' ' A' ' 38' ' ' PHE . 62.9 t30 53.8 22.58 3.29 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 120.854 1.661 . . . . 0.0 111.625 177.675 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.403 ' HA3' ' CD2' ' A' ' 48' ' ' LEU . . . 104.27 -44.28 1.51 Allowed Glycine 0 N--CA 1.419 -2.488 0 CA-C-O 117.26 -1.855 . . . . 0.0 115.218 -168.578 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.466 ' CE2' ' HD3' ' A' ' 66' ' ' PRO . 84.8 m-85 -43.34 151.1 0.17 Allowed 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.691 1.597 . . . . 0.0 112.279 176.294 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.82 -36.39 25.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.326 0.584 . . . . 0.0 111.884 177.894 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.521 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -165.3 -77.63 0.03 OUTLIER Glycine 0 C--N 1.34 0.794 0 C-N-CA 124.459 1.028 . . . . 0.0 111.846 -179.078 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -109.41 -67.98 0.95 Allowed 'General case' 0 CA--C 1.513 -0.459 0 C-N-CA 123.521 0.728 . . . . 0.0 111.029 -179.245 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.23 -170.71 0.11 Allowed Glycine 0 C--N 1.348 1.233 0 C-N-CA 124.436 1.017 . . . . 0.0 110.967 178.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -58.77 -167.64 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 124.296 1.998 . . . . 0.0 111.703 177.356 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.403 ' CD2' ' HA3' ' A' ' 41' ' ' GLY . 0.0 OUTLIER -86.78 163.47 40.96 Favored Pre-proline 0 N--CA 1.44 -0.968 0 O-C-N 120.139 -1.601 . . . . 0.0 110.566 -179.354 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -71.83 171.51 16.39 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 122.067 1.844 . . . . 0.0 111.077 178.056 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -58.79 96.44 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.196 177.131 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.33 88.4 1.97 Allowed Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 111.895 -0.482 . . . . 0.0 111.895 -177.533 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.55 163.75 17.02 Favored 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 123.795 0.838 . . . . 0.0 111.557 176.283 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 97.7 m -143.6 95.07 5.94 Favored Pre-proline 0 C--O 1.236 0.389 0 O-C-N 124.33 1.019 . . . . 0.0 109.604 -176.882 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -72.98 169.75 21.43 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.529 2.153 . . . . 0.0 110.901 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.4 ' CG2' ' HB2' ' A' ' 133' ' ' LEU . 6.4 mt -99.58 134.22 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -178.2 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -86.09 157.6 20.01 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 121.107 0.479 . . . . 0.0 110.182 176.7 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 26.2 m-85 -140.65 -46.85 0.41 Allowed 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 123.805 0.842 . . . . 0.0 111.036 178.233 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 112.57 -4.42 26.29 Favored Glycine 0 C--N 1.338 0.664 0 C-N-CA 123.523 0.582 . . . . 0.0 113.057 -175.104 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.91 134.84 38.42 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-O 117.859 -1.067 . . . . 0.0 110.388 176.982 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 20.1 t -69.23 -6.36 28.68 Favored 'General case' 0 C--O 1.225 -0.222 0 O-C-N 125.127 1.517 . . . . 0.0 111.538 176.617 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.69 -56.88 3.07 Favored 'General case' 0 N--CA 1.446 -0.674 0 O-C-N 120.289 -1.507 . . . . 0.0 109.614 -179.45 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 27.7 m -70.99 -18.06 62.62 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 123.789 0.68 . . . . 0.0 110.688 177.218 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -80.28 -41.0 25.79 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 123.678 0.791 . . . . 0.0 111.515 174.806 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.04 158.97 1.57 Allowed Pre-proline 0 N--CA 1.444 -0.766 0 CA-C-O 122.282 1.039 . . . . 0.0 111.033 179.404 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -71.02 136.21 29.17 Favored 'Trans proline' 0 N--CA 1.444 -1.395 0 C-N-CA 121.003 1.135 . . . . 0.0 113.673 174.149 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.466 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 19.2 Cg_endo -72.54 171.34 17.35 Favored 'Trans proline' 0 N--CA 1.446 -1.287 0 C-N-CA 122.957 2.438 . . . . 0.0 111.015 178.581 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.4 tptt -128.41 49.93 2.14 Favored 'General case' 0 C--O 1.212 -0.9 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.936 178.545 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.442 ' CE1' ' CE3' ' A' ' 37' ' ' TRP . 56.2 t-80 -77.13 161.25 28.39 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 120.132 -1.605 . . . . 0.0 112.126 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -161.56 177.89 9.6 Favored 'General case' 0 CA--C 1.502 -0.896 0 O-C-N 118.787 -2.445 . . . . 0.0 108.178 176.878 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.2 pttp -64.68 74.22 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 124.858 1.263 . . . . 0.0 111.724 175.379 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 179.56 -47.58 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 125.524 1.53 . . . . 0.0 110.294 -176.322 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 113.31 -71.89 0.22 Allowed Glycine 0 CA--C 1.488 -1.621 0 CA-C-O 118.805 -0.997 . . . . 0.0 112.157 -177.541 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -128.81 64.33 1.45 Allowed 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 125.934 1.694 . . . . 0.0 107.803 -177.731 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.56 -110.63 0.01 OUTLIER Glycine 0 C--N 1.334 0.454 0 CA-C-O 122.391 0.995 . . . . 0.0 112.543 178.817 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.5 mttp -63.22 -98.4 0.0 OUTLIER 'General case' 0 C--O 1.222 -0.372 0 O-C-N 119.792 -2.005 . . . . 0.0 111.75 177.562 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -114.23 15.93 18.06 Favored 'General case' 0 CA--C 1.51 -0.593 0 O-C-N 120.608 -1.307 . . . . 0.0 111.082 178.239 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.475 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 29.0 m-20 -30.5 107.5 0.04 OUTLIER 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 124.787 1.235 . . . . 0.0 110.16 -177.236 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.49 ' H ' ' CD2' ' A' ' 78' ' ' HIS . 2.8 p80 -87.43 14.52 7.94 Favored 'General case' 0 CA--C 1.511 -0.524 0 O-C-N 121.654 -0.654 . . . . 0.0 110.561 -177.068 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.518 ' HB2' ' CD1' ' A' ' 37' ' ' TRP . 14.9 p90 -39.51 137.34 0.83 Allowed 'General case' 0 N--CA 1.429 -1.514 0 C-N-CA 125.592 1.557 . . . . 0.0 110.715 176.973 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -71.88 157.87 37.07 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.622 177.244 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.437 HD12 ' CE2' ' A' ' 79' ' ' TYR . 5.5 mp -139.67 120.77 14.7 Favored 'General case' 0 CA--C 1.501 -0.925 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 -177.903 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.497 ' CB ' ' CD1' ' A' ' 109' ' ' ILE . 0.5 OUTLIER -92.36 152.68 19.63 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-O 122.259 1.028 . . . . 0.0 111.585 178.723 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.423 ' HZ ' ' CD2' ' A' ' 94' ' ' PHE . 12.6 t80 -145.23 134.05 11.04 Favored Pre-proline 0 N--CA 1.444 -0.762 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.583 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -74.62 112.92 3.67 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.959 2.44 . . . . 0.0 110.188 -177.672 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.6 t -104.73 110.45 22.78 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 124.323 1.014 . . . . 0.0 110.079 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.408 ' CE1' ' HB2' ' A' ' 92' ' ' TYR . 70.1 m-85 -82.02 157.92 68.05 Favored Pre-proline 0 N--CA 1.445 -0.69 0 O-C-N 121.424 -0.797 . . . . 0.0 112.25 178.85 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -76.63 -42.25 0.36 Allowed 'Trans proline' 0 CA--C 1.501 -1.15 0 C-N-CA 122.555 2.17 . . . . 0.0 112.332 179.561 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -44.69 -30.92 1.02 Allowed 'General case' 0 C--N 1.353 0.731 0 CA-C-O 122.159 0.98 . . . . 0.0 110.855 176.688 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 85.23 8.77 81.06 Favored Glycine 0 N--CA 1.434 -1.47 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 177.279 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 4.2 p-80 -73.84 128.38 35.36 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.58 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.36 93.15 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 123.601 0.76 . . . . 0.0 109.76 173.286 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.47 ' O ' ' CD2' ' A' ' 94' ' ' PHE . 12.9 t80 -39.7 144.58 0.17 Allowed 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 121.967 0.889 . . . . 0.0 111.19 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.38 57.31 1.49 Allowed 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 120.011 -1.68 . . . . 0.0 109.988 176.666 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.47 ' CD2' ' O ' ' A' ' 92' ' ' TYR . 34.3 p90 -71.19 -9.91 58.88 Favored 'General case' 0 N--CA 1.439 -1.018 0 C-N-CA 124.085 0.954 . . . . 0.0 112.168 175.711 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -89.7 -36.41 15.23 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 123.131 1.443 . . . . 0.0 110.451 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.9 m -84.46 111.29 19.34 Favored 'General case' 0 N--CA 1.441 -0.904 0 O-C-N 120.341 -1.474 . . . . 0.0 109.394 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.0 ptpt -58.75 -47.92 82.99 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-O 120.945 0.403 . . . . 0.0 111.235 178.3 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -143.18 130.51 10.84 Favored Pre-proline 0 N--CA 1.432 -1.346 0 C-N-CA 123.78 0.832 . . . . 0.0 109.378 -177.312 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -70.1 175.44 37.65 Favored 'Cis proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.284 -1.965 . . . . 0.0 111.007 -6.484 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.43 147.03 42.86 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.902 178.313 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -87.94 173.41 8.93 Favored 'General case' 0 C--O 1.24 0.591 0 O-C-N 123.837 0.711 . . . . 0.0 112.133 177.211 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -72.5 143.03 84.73 Favored Pre-proline 0 N--CA 1.442 -0.853 0 CA-C-O 118.117 -0.944 . . . . 0.0 111.165 177.295 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -73.15 -164.8 0.21 Allowed 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.266 2.644 . . . . 0.0 111.739 176.327 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -140.97 164.5 26.44 Favored Glycine 0 N--CA 1.44 -1.046 0 O-C-N 121.581 -0.7 . . . . 0.0 112.478 177.359 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -75.39 -60.24 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.692 2.262 . . . . 0.0 110.481 179.127 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.526 ' CB ' ' CE2' ' A' ' 11' ' ' TYR . . . -63.31 139.83 58.81 Favored 'General case' 0 N--CA 1.438 -1.031 0 O-C-N 123.689 0.618 . . . . 0.0 111.62 178.206 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 1.5 mtm-85 -143.14 143.48 31.83 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.307 -179.503 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.0 p -83.14 124.13 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 O-C-N 123.92 0.762 . . . . 0.0 110.479 178.789 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.497 ' CD1' ' CB ' ' A' ' 82' ' ' GLU . 6.3 mm -106.23 140.91 22.8 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.892 0 C-N-CA 122.823 0.449 . . . . 0.0 110.157 -179.231 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.428 ' CD1' ' HG3' ' A' ' 115' ' ' LYS . 9.7 p90 -165.48 153.1 10.83 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-O 122.042 0.925 . . . . 0.0 110.483 -177.413 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.4 p -88.8 165.53 14.62 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.776 -178.907 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.519 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.2 OUTLIER -111.29 154.09 43.79 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 122.184 0.193 . . . . 0.0 111.368 178.761 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.519 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 19.0 Cg_endo -73.87 -52.85 0.16 OUTLIER 'Cis proline' 0 CA--C 1.499 -1.256 0 C-N-CA 123.525 -1.448 . . . . 0.0 109.708 -6.883 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -43.24 110.93 0.22 Allowed 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 117.628 -1.177 . . . . 0.0 109.914 178.761 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.434 ' HE2' ' CD1' ' A' ' 25' ' ' LEU . 0.2 OUTLIER -66.96 72.45 0.1 Allowed 'General case' 0 CA--C 1.51 -0.585 0 C-N-CA 124.429 1.092 . . . . 0.0 108.519 -178.116 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 36.9 t -72.32 77.4 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 N-CA-C 105.596 -2.001 . . . . 0.0 105.596 -176.919 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.495 ' CZ ' ' NE2' ' A' ' 13' ' ' GLN . 41.5 t80 -39.57 107.1 0.06 Allowed 'General case' 0 N--CA 1.435 -1.219 0 C-N-CA 126.002 1.721 . . . . 0.0 110.034 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 10.2 m -81.94 -46.13 14.47 Favored 'General case' 0 N--CA 1.436 -1.175 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 -178.113 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.441 ' HA2' ' CZ ' ' A' ' 117' ' ' PHE . . . 160.4 -147.73 15.03 Favored Glycine 0 N--CA 1.441 -0.998 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.42 HG13 ' CG ' ' A' ' 4' ' ' TRP . 1.2 mm -128.64 138.94 53.23 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.929 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 -175.682 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 7.6 pt -130.0 154.94 41.13 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -177.922 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -178.89 159.68 1.05 Allowed 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 121.794 0.807 . . . . 0.0 109.714 179.109 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.472 ' CE1' ' HG ' ' A' ' 131' ' ' LEU . 1.4 m-70 -91.2 93.05 8.93 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -178.867 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.8 t -97.71 39.97 1.19 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 123.376 1.56 . . . . 0.0 111.395 -179.924 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 8.0 tttm -103.75 -26.97 12.53 Favored 'General case' 0 C--O 1.221 -0.412 0 O-C-N 120.812 -1.18 . . . . 0.0 111.432 178.597 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -169.53 -64.06 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.292 0 O-C-N 124.296 0.998 . . . . 0.0 110.853 177.838 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -153.62 -46.84 0.09 Allowed 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 123.303 1.525 . . . . 0.0 110.586 178.454 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -157.58 75.59 0.79 Allowed 'General case' 0 N--CA 1.442 -0.853 0 CA-C-O 122.381 1.086 . . . . 0.0 110.913 -178.679 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -118.98 -105.89 2.21 Favored Glycine 0 C--N 1.334 0.425 0 O-C-N 121.186 -0.946 . . . . 0.0 110.982 178.84 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -85.59 156.78 20.58 Favored 'General case' 0 CA--C 1.516 -0.341 0 O-C-N 122.157 -0.613 . . . . 0.0 111.648 179.245 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.472 ' HG ' ' CE1' ' A' ' 123' ' ' HIS . 0.5 OUTLIER -105.95 141.99 36.42 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 178.208 . . . . . . . . 3 3 . 1 . 018 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . 0.409 ' HE3' ' O ' ' A' ' 133' ' ' LEU . 2.5 ptmt -149.13 172.54 14.64 Favored 'General case' 0 CA--C 1.509 -0.615 0 C-N-CA 123.466 0.707 . . . . 0.0 109.712 179.173 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.409 ' O ' ' HE3' ' A' ' 132' ' ' LYS . 11.6 tp -86.76 136.25 33.07 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-O 121.646 0.736 . . . . 0.0 109.448 177.678 . . . . . . . . 2 2 . 1 . 018 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 50.7 m -66.02 -179.61 0.76 Allowed 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 124.152 0.981 . . . . 0.0 109.389 175.627 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 68.4 m -159.44 92.08 1.04 Allowed 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 -178.17 . . . . . . . . 1 1 . 1 . 018 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.257 1.496 0 CA-C-O 113.965 -2.921 . . . . 0.0 113.682 170.493 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.474 0.761 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 . . . . . . . . . 0 0 . 1 . 019 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.5 p -89.69 159.06 2.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 O-C-N 123.85 0.719 . . . . 0.0 109.92 178.209 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.9 m -94.79 107.78 19.8 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 123.634 0.774 . . . . 0.0 110.62 178.984 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 20.4 m95 -78.57 141.42 38.11 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.005 0.922 . . . . 0.0 108.879 179.416 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -132.63 138.09 47.24 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.5 OUTLIER -121.63 64.53 0.9 Allowed 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 114.838 -1.073 . . . . 0.0 108.674 177.834 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 37.6 75.03 0.09 OUTLIER Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.851 1.215 . . . . 0.0 114.104 178.803 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 159.87 -75.03 0.2 Allowed Glycine 0 C--O 1.226 -0.404 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 -175.346 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 74.2 mt -126.69 159.91 32.3 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 122.12 0.962 . . . . 0.0 110.34 177.337 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 9.9 mp -87.96 167.48 13.68 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.143 179.284 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.478 ' CE2' ' CB ' ' A' ' 106' ' ' ALA . 65.4 m-85 -156.09 87.17 1.05 Allowed 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 125.276 1.43 . . . . 0.0 108.386 -173.175 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -53.47 120.11 5.69 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-O 117.832 -1.08 . . . . 0.0 108.457 177.814 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.533 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 0.9 OUTLIER -49.27 -43.77 43.31 Favored 'General case' 0 C--O 1.212 -0.876 0 CA-C-N 119.865 1.211 . . . . 0.0 111.629 178.842 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -48.89 -42.37 36.57 Favored 'General case' 0 C--O 1.201 -1.462 0 CA-C-N 117.779 0.263 . . . . 0.0 111.187 176.087 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.47 -44.36 62.42 Favored 'General case' 0 C--O 1.21 -1.026 0 O-C-N 120.416 -1.427 . . . . 0.0 112.644 169.602 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -52.11 -38.49 57.58 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 121.4 1.909 . . . . 0.0 112.907 175.379 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -86.06 -48.89 8.23 Favored 'General case' 0 C--O 1.21 -1.022 0 CA-C-O 117.51 -1.234 . . . . 0.0 108.971 175.66 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.2 t -69.45 -57.88 4.69 Favored 'General case' 0 CA--C 1.504 -0.797 0 C-N-CA 126.599 1.96 . . . . 0.0 109.483 -173.173 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.427 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 0.5 OUTLIER -42.17 -36.6 1.23 Allowed 'General case' 0 C--O 1.217 -0.627 0 CA-C-N 119.536 1.062 . . . . 0.0 110.745 169.664 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.4 p -83.53 -29.74 27.66 Favored 'General case' 0 C--O 1.218 -0.564 0 N-CA-C 114.911 1.449 . . . . 0.0 114.911 176.161 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -50.31 -35.67 28.47 Favored 'General case' 0 C--O 1.222 -0.351 0 C-N-CA 126.696 1.999 . . . . 0.0 109.826 178.532 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.427 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.1 OUTLIER -71.59 -49.54 39.37 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 125.43 1.492 . . . . 0.0 111.193 175.946 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -39.39 123.15 1.38 Allowed Pre-proline 0 C--O 1.239 0.529 0 O-C-N 124.867 1.355 . . . . 0.0 111.807 174.852 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -70.76 126.37 12.57 Favored 'Trans proline' 0 N--CA 1.445 -1.366 0 C-N-CA 122.083 1.855 . . . . 0.0 108.868 -177.044 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.9 tp -62.91 94.54 0.07 Allowed 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.449 0.7 . . . . 0.0 112.219 178.959 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.1 m 179.98 153.64 0.52 Allowed 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 125.082 1.353 . . . . 0.0 110.163 -173.022 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.61 119.16 31.77 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.436 1.494 . . . . 0.0 109.367 176.235 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 49.86 69.69 0.99 Allowed Glycine 0 CA--C 1.525 0.708 0 CA-C-O 122.189 0.883 . . . . 0.0 112.476 174.347 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.5 mtpt -145.95 22.89 1.39 Allowed 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -178.549 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 33.6 p -123.45 150.97 43.18 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 124.398 1.079 . . . . 0.0 108.693 -177.169 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -38.65 -63.44 1.01 Allowed Glycine 0 CA--C 1.522 0.477 0 C-N-CA 124.705 1.145 . . . . 0.0 113.712 178.448 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 44.1 t -63.64 -59.4 4.65 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 118.312 -0.851 . . . . 0.0 112.071 174.497 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.0 m 158.9 -48.61 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.872 2.069 . . . . 0.0 112.17 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.513 ' CD2' ' HD3' ' A' ' 84' ' ' PRO . 63.3 m-85 -64.48 145.54 98.43 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-O 117.801 -1.095 . . . . 0.0 112.909 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 28.6 Cg_endo -73.35 158.53 98.38 Favored 'Cis proline' 0 N--CA 1.448 -1.198 0 C-N-CA 123.577 -1.426 . . . . 0.0 111.137 -4.132 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.442 ' CD2' ' CD2' ' A' ' 34' ' ' TYR . 2.1 p80 -137.19 170.56 15.88 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-N 114.713 -1.131 . . . . 0.0 109.565 -176.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.529 ' CD1' ' HB2' ' A' ' 79' ' ' TYR . 22.7 t90 -71.56 148.03 47.07 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.99 0.9 . . . . 0.0 109.243 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.488 ' CE2' ' HB2' ' A' ' 40' ' ' ASN . 27.5 t80 -124.31 78.24 1.64 Allowed 'General case' 0 N--CA 1.435 -1.182 0 C-N-CA 127.11 2.164 . . . . 0.0 106.003 -177.71 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 77.0 p -37.04 -39.91 0.26 Allowed 'General case' 0 C--O 1.218 -0.571 0 C-N-CA 124.421 1.088 . . . . 0.0 111.6 171.911 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.488 ' HB2' ' CE2' ' A' ' 38' ' ' PHE . 46.0 t30 59.69 16.06 5.19 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 122.428 1.109 . . . . 0.0 110.907 178.678 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 115.11 -40.89 2.31 Favored Glycine 0 N--CA 1.44 -1.049 0 CA-C-O 117.435 -1.758 . . . . 0.0 111.619 -172.7 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 76.2 m-85 -49.34 159.53 0.31 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.202 1.501 . . . . 0.0 112.295 -179.627 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.25 -35.82 23.14 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 122.589 1.185 . . . . 0.0 111.317 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.444 ' HA2' ' CZ2' ' A' ' 37' ' ' TRP . . . 145.04 -31.44 1.73 Allowed Glycine 0 C--O 1.218 -0.863 0 C-N-CA 125.185 1.374 . . . . 0.0 111.586 -176.701 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.9 -54.28 5.72 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 119.049 1.425 . . . . 0.0 111.575 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 157.23 33.13 0.02 OUTLIER Glycine 0 C--N 1.336 0.541 0 O-C-N 124.309 1.006 . . . . 0.0 112.748 -177.642 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 29.2 mttt -142.07 159.8 41.51 Favored 'General case' 0 CA--C 1.507 -0.7 0 C-N-CA 124.36 1.064 . . . . 0.0 109.088 178.846 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 3.8 mt -108.01 147.96 36.52 Favored Pre-proline 0 N--CA 1.446 -0.657 0 O-C-N 124.429 1.081 . . . . 0.0 110.613 -179.406 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -72.62 177.66 7.23 Favored 'Trans proline' 0 N--CA 1.446 -1.3 0 C-N-CA 124.251 3.301 . . . . 0.0 111.278 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.9 ttpt -76.94 102.69 6.5 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 120.575 -1.328 . . . . 0.0 109.938 175.05 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.3 83.69 1.75 Allowed Glycine 0 C--O 1.222 -0.653 0 O-C-N 124.216 0.948 . . . . 0.0 110.945 177.55 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -163.2 172.91 14.09 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 124.444 1.097 . . . . 0.0 110.056 178.803 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.9 m -152.79 107.93 2.7 Favored Pre-proline 0 C--N 1.327 -0.384 0 O-C-N 123.635 0.585 . . . . 0.0 110.77 174.0 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -70.79 145.89 52.36 Favored 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 122.288 1.992 . . . . 0.0 111.166 177.012 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 16.9 mt -70.42 119.96 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.147 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 3.8 tttt -84.01 132.67 34.72 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 176.574 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.554 ' CD1' ' HB3' ' A' ' 118' ' ' CYS . 10.9 m-85 -114.54 -53.51 2.65 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 124.818 1.247 . . . . 0.0 111.273 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 121.28 -6.31 10.84 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.587 1.089 . . . . 0.0 113.21 -176.444 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -91.92 131.07 37.51 Favored 'General case' 0 CA--C 1.509 -0.621 0 O-C-N 121.606 -0.938 . . . . 0.0 110.233 177.188 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 32.3 t -68.77 -2.43 9.38 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 124.891 1.369 . . . . 0.0 111.802 176.456 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -88.21 -54.06 4.39 Favored 'General case' 0 CA--C 1.518 -0.284 0 O-C-N 120.252 -1.53 . . . . 0.0 108.967 178.587 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.9 m -77.11 -34.27 56.81 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 123.814 0.696 . . . . 0.0 110.422 -178.954 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -62.27 -37.66 86.34 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.322 0.649 . . . . 0.0 111.186 173.874 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.35 159.6 1.11 Allowed Pre-proline 0 N--CA 1.448 -0.557 0 CA-C-O 121.485 0.659 . . . . 0.0 112.123 178.77 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -68.73 120.62 7.52 Favored 'Trans proline' 0 N--CA 1.444 -1.392 0 C-N-CA 120.742 0.961 . . . . 0.0 111.573 174.455 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 25.4 Cg_endo -69.19 168.53 20.55 Favored 'Trans proline' 0 N--CA 1.447 -1.262 0 C-N-CA 124.233 3.289 . . . . 0.0 111.261 175.116 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.7 tptp -131.12 136.46 48.39 Favored 'General case' 0 C--O 1.211 -0.967 0 CA-C-O 118.042 -0.98 . . . . 0.0 108.43 176.902 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -115.32 160.52 19.7 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 125.516 1.527 . . . . 0.0 108.593 177.744 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -150.59 170.63 18.7 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.735 179.359 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.93 60.61 6.32 Favored 'General case' 0 C--O 1.217 -0.613 0 C-N-CA 123.068 0.547 . . . . 0.0 111.406 177.639 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -175.16 -38.4 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.299 0.64 . . . . 0.0 110.967 -179.07 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 125.48 -67.18 0.53 Allowed Glycine 0 C--N 1.336 0.573 0 C-N-CA 125.071 1.319 . . . . 0.0 109.929 -178.106 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -128.48 62.14 1.46 Allowed 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 127.905 2.482 . . . . 0.0 107.925 -174.501 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -61.64 -104.35 0.01 OUTLIER Glycine 0 CA--C 1.529 0.926 0 CA-C-O 121.706 0.615 . . . . 0.0 112.299 176.99 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.2 mttt -65.42 -92.92 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 O-C-N 120.736 -1.449 . . . . 0.0 112.009 177.763 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -128.62 14.4 6.49 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 121.553 -0.717 . . . . 0.0 110.877 178.282 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.448 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 47.1 m-20 -27.95 102.83 0.02 OUTLIER 'General case' 0 C--O 1.208 -1.098 0 C-N-CA 125.491 1.516 . . . . 0.0 111.564 -178.255 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.463 ' H ' ' CD2' ' A' ' 78' ' ' HIS . 5.6 p80 -94.59 65.34 3.13 Favored 'General case' 0 CA--C 1.505 -0.766 0 O-C-N 120.214 -1.554 . . . . 0.0 108.432 -170.268 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.529 ' HB2' ' CD1' ' A' ' 37' ' ' TRP . 13.7 p90 -93.97 141.75 28.16 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 124.523 1.129 . . . . 0.0 110.574 -176.471 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -69.29 141.38 54.34 Favored 'General case' 0 C--O 1.216 -0.673 0 C-N-CA 119.694 -0.802 . . . . 0.0 110.496 173.895 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.46 ' CD1' ' CE2' ' A' ' 79' ' ' TYR . 0.8 OUTLIER -128.75 143.51 50.94 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 124.69 1.196 . . . . 0.0 110.339 176.236 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -106.41 153.93 21.53 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 122.717 1.246 . . . . 0.0 111.426 177.874 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 6.9 t80 -142.94 128.99 10.4 Favored Pre-proline 0 N--CA 1.45 -0.459 0 O-C-N 121.379 -0.826 . . . . 0.0 112.506 179.963 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.513 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 23.7 Cg_endo -72.45 93.94 0.76 Allowed 'Trans proline' 0 N--CA 1.446 -1.277 0 C-N-CA 124.091 3.194 . . . . 0.0 110.612 179.037 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.2 t -99.95 113.23 25.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 122.503 1.145 . . . . 0.0 109.939 179.242 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.433 ' CD2' ' NE2' ' A' ' 90' ' ' HIS . 43.6 m-85 -81.51 158.5 68.64 Favored Pre-proline 0 C--N 1.324 -0.517 0 O-C-N 121.466 -0.772 . . . . 0.0 111.996 179.177 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -76.16 -39.27 0.89 Allowed 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.257 1.971 . . . . 0.0 113.87 178.321 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -40.43 -38.18 0.79 Allowed 'General case' 0 N--CA 1.471 0.603 0 O-C-N 125.145 1.528 . . . . 0.0 110.287 174.88 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 102.01 -7.58 55.03 Favored Glycine 0 N--CA 1.44 -1.062 0 C-N-CA 124.762 1.172 . . . . 0.0 112.716 -178.483 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.433 ' NE2' ' CD2' ' A' ' 86' ' ' PHE . 9.2 p-80 -62.75 123.56 18.75 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 177.75 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -62.64 117.04 5.72 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 171.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -44.16 154.44 0.11 Allowed 'General case' 0 C--O 1.21 -0.994 0 CA-C-O 123.018 1.389 . . . . 0.0 112.689 172.489 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.51 66.53 6.34 Favored 'General case' 0 C--N 1.32 -0.693 0 O-C-N 119.149 -2.219 . . . . 0.0 109.926 177.896 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 15.7 p90 -80.79 -6.46 58.56 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 174.705 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -91.0 -38.35 12.88 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 122.677 1.227 . . . . 0.0 110.696 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 52.4 m -88.41 106.88 18.54 Favored 'General case' 0 CA--C 1.519 -0.243 0 O-C-N 121.346 -0.846 . . . . 0.0 109.202 179.141 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 9.7 ptpt -58.23 -46.48 85.84 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.16 0.505 . . . . 0.0 111.309 177.487 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -142.21 132.08 12.42 Favored Pre-proline 0 N--CA 1.444 -0.726 0 C-N-CA 125.065 1.346 . . . . 0.0 109.787 -178.858 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 29.0 Cg_endo -68.27 173.39 39.03 Favored 'Cis proline' 0 N--CA 1.459 -0.519 0 C-N-CA 123.06 -1.642 . . . . 0.0 110.505 -9.093 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.3 ptmm? -137.85 154.76 49.46 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 123.56 0.744 . . . . 0.0 109.563 178.345 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -98.11 171.07 8.47 Favored 'General case' 0 C--O 1.244 0.778 0 CA-C-O 122.159 0.981 . . . . 0.0 110.177 178.681 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -53.66 143.56 38.09 Favored Pre-proline 0 N--CA 1.443 -0.777 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.106 172.897 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -73.88 -68.58 0.02 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.344 0 C-N-CA 122.311 2.007 . . . . 0.0 110.688 176.496 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 124.63 152.81 8.41 Favored Glycine 0 CA--C 1.524 0.611 0 O-C-N 120.388 -1.445 . . . . 0.0 111.251 -178.661 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -75.78 -56.52 0.06 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.85 2.367 . . . . 0.0 111.115 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.478 ' CB ' ' CE2' ' A' ' 11' ' ' TYR . . . -72.09 138.47 47.81 Favored 'General case' 0 N--CA 1.438 -1.049 0 O-C-N 123.369 0.418 . . . . 0.0 110.4 177.337 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 10.0 mtm-85 -144.43 149.28 35.77 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-O 118.073 -0.965 . . . . 0.0 110.429 177.864 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.1 p -83.92 114.26 24.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 125.145 1.378 . . . . 0.0 111.017 175.925 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.408 HG22 ' CE2' ' A' ' 38' ' ' PHE . 1.8 mp -101.43 120.68 51.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 -176.973 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 17.6 p90 -138.19 162.47 34.18 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.459 -178.849 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.5 p -91.52 161.94 14.75 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 122.755 0.422 . . . . 0.0 110.886 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.487 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.2 OUTLIER -110.64 154.96 42.93 Favored Pre-proline 0 CA--C 1.546 0.818 0 CA-C-N 118.216 0.462 . . . . 0.0 111.275 177.946 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.487 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 18.9 Cg_endo -72.37 -54.28 0.15 OUTLIER 'Cis proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.689 -1.379 . . . . 0.0 108.771 -9.95 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 41.3 t-20 -40.18 108.45 0.09 Allowed 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 116.511 -1.709 . . . . 0.0 110.507 178.658 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -67.5 63.84 0.07 Allowed 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 126.455 1.902 . . . . 0.0 108.119 -178.223 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 35.9 t -73.34 75.52 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 103.712 -2.699 . . . . 0.0 103.712 178.937 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.533 ' CZ ' ' NE2' ' A' ' 13' ' ' GLN . 2.2 t80 -40.87 124.21 2.08 Favored 'General case' 0 N--CA 1.437 -1.111 0 C-N-CA 125.182 1.393 . . . . 0.0 107.714 174.361 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . 0.554 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 0.1 OUTLIER -100.64 -40.84 7.19 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.227 175.768 . . . . . . . . 3 3 . 1 . 019 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.491 ' HA2' ' CZ ' ' A' ' 117' ' ' PHE . . . 160.31 -174.79 37.09 Favored Glycine 0 CA--C 1.505 -0.589 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 -178.692 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 3.2 mp -106.06 145.34 14.1 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.004 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 178.065 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 8.5 pt -119.78 152.71 22.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 179.936 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -174.99 125.54 0.27 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 122.964 1.364 . . . . 0.0 109.741 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -88.09 89.89 8.17 Favored 'General case' 0 C--N 1.322 -0.591 0 O-C-N 120.86 -1.15 . . . . 0.0 111.734 178.193 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 3.5 p -102.06 41.44 1.22 Allowed 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 123.86 0.864 . . . . 0.0 109.83 -177.908 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 9.2 ttpt -93.02 -41.11 10.17 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-O 116.638 -1.649 . . . . 0.0 111.559 177.277 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 170.64 -85.28 0.0 OUTLIER 'General case' 0 C--O 1.223 -0.307 0 C-N-CA 126.758 2.023 . . . . 0.0 109.168 178.886 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -158.48 26.12 0.24 Allowed 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 125.334 1.454 . . . . 0.0 111.768 -175.676 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -170.11 92.98 0.22 Allowed 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 123.095 1.426 . . . . 0.0 110.629 -175.104 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 163.54 109.73 0.23 Allowed Glycine 0 CA--C 1.494 -1.222 0 N-CA-C 106.442 -2.663 . . . . 0.0 106.442 178.659 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -37.49 143.89 0.09 Allowed 'General case' 0 C--O 1.24 0.581 0 CA-C-N 119.053 1.426 . . . . 0.0 112.465 175.078 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 6.6 mp -54.41 144.54 20.54 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -179.322 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.15 148.42 45.76 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -178.979 . . . . . . . . 2 2 . 1 . 019 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 9.7 tp -56.75 131.85 50.43 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 125.415 1.697 . . . . 0.0 107.842 179.002 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 71.3 m -58.54 178.0 0.12 Allowed 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 124.38 1.072 . . . . 0.0 109.554 174.585 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 38.3 m -154.23 112.09 3.5 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 -176.287 . . . . . . . . 1 1 . 1 . 019 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.255 1.343 0 CA-C-O 115.519 -2.182 . . . . 0.0 110.943 172.035 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.51 -0.581 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 . . . . . . . . . 0 0 . 1 . 020 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.45 HG11 ' CD2' ' A' ' 136' ' ' HIS . 3.5 p -74.24 134.79 28.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.858 0.837 . . . . 0.0 109.487 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.2 m -90.56 120.0 31.28 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -176.908 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.403 ' CG ' HG13 ' A' ' 120' ' ' ILE . 31.9 m95 -79.75 141.34 36.42 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 -179.263 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -134.01 129.6 36.36 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-O 122.366 1.079 . . . . 0.0 108.669 -176.856 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -125.96 67.24 1.19 Allowed 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 177.064 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 130.38 -98.36 0.41 Allowed Glycine 0 C--O 1.22 -0.741 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 178.899 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -133.32 8.42 5.04 Favored Glycine 0 N--CA 1.464 0.512 0 C-N-CA 123.416 0.532 . . . . 0.0 112.4 178.101 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -115.85 142.36 46.87 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -176.754 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.6 mp -110.21 125.92 53.58 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -175.07 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.455 ' CE2' ' CB ' ' A' ' 106' ' ' ALA . 77.5 m-85 -117.04 103.5 10.31 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 126.327 1.851 . . . . 0.0 108.2 -173.094 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -55.18 121.47 8.9 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 118.113 -0.946 . . . . 0.0 108.991 178.809 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.533 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 5.9 tp-100 -51.33 -45.28 62.23 Favored 'General case' 0 C--O 1.206 -1.211 0 O-C-N 124.023 0.827 . . . . 0.0 111.881 179.672 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -51.02 -40.83 59.13 Favored 'General case' 0 C--O 1.197 -1.697 0 CA-C-N 117.801 0.273 . . . . 0.0 111.309 176.102 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.86 -36.78 72.98 Favored 'General case' 0 C--O 1.199 -1.604 0 O-C-N 120.1 -1.625 . . . . 0.0 113.395 168.979 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.61 -40.96 72.78 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 123.04 2.654 . . . . 0.0 113.871 171.705 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -86.45 -38.75 17.0 Favored 'General case' 0 C--O 1.206 -1.186 0 C-N-CA 123.622 0.769 . . . . 0.0 108.999 176.655 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.7 t -73.42 -58.74 3.1 Favored 'General case' 0 CA--C 1.502 -0.879 0 O-C-N 119.889 -1.757 . . . . 0.0 108.771 -176.469 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.451 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 7.6 t-20 -42.62 -36.13 1.3 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 119.624 1.102 . . . . 0.0 112.977 171.823 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -82.27 -31.95 29.86 Favored 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 174.149 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 5.0 m170 -50.8 -39.33 52.57 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 126.204 1.802 . . . . 0.0 109.162 178.475 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.451 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -75.38 -45.7 37.56 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-O 117.388 -1.291 . . . . 0.0 110.689 177.844 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -40.4 135.15 1.49 Allowed Pre-proline 0 CA--C 1.543 0.706 0 O-C-N 125.609 1.818 . . . . 0.0 111.966 176.574 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -72.65 122.02 7.88 Favored 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 122.067 1.845 . . . . 0.0 109.319 -176.953 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 5.2 tp -59.88 94.39 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.311 0.644 . . . . 0.0 111.17 178.717 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -171.58 178.71 3.07 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 123.312 0.645 . . . . 0.0 109.673 -176.444 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 2.7 t0 -116.45 89.25 3.07 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 124.211 1.004 . . . . 0.0 109.673 177.413 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 71.86 78.69 0.46 Allowed Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 176.397 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.1 mmtp -149.77 30.24 0.73 Allowed 'General case' 0 CA--C 1.513 -0.46 0 C-N-CA 123.355 0.662 . . . . 0.0 111.723 178.094 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 11.8 p -122.02 149.37 43.6 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -175.116 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -42.11 -52.62 4.94 Favored Glycine 0 C--N 1.332 0.353 0 O-C-N 123.814 0.696 . . . . 0.0 111.905 -179.181 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.5 t -67.75 -64.53 0.84 Allowed 'General case' 0 CA--C 1.503 -0.847 0 CA-C-O 116.266 -1.826 . . . . 0.0 112.303 174.237 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 166.24 -59.39 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 126.334 1.854 . . . . 0.0 111.423 177.723 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.493 ' CD2' ' HD3' ' A' ' 84' ' ' PRO . 60.5 m-85 -62.99 147.52 94.17 Favored Pre-proline 0 N--CA 1.436 -1.162 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 179.119 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -75.6 164.56 87.79 Favored 'Cis proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.232 -1.57 . . . . 0.0 111.6 0.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.466 ' CD2' ' CD2' ' A' ' 34' ' ' TYR . 1.3 p80 -140.08 173.64 11.31 Favored 'General case' 0 C--O 1.21 -1.012 0 CA-C-O 117.865 -1.064 . . . . 0.0 110.305 -177.491 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.578 ' CD1' ' CD2' ' A' ' 79' ' ' TYR . 19.6 t90 -75.95 127.1 32.28 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 119.441 1.018 . . . . 0.0 109.226 175.964 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.55 ' CZ ' ' HA ' ' A' ' 40' ' ' ASN . 34.6 t80 -97.38 86.69 3.94 Favored 'General case' 0 N--CA 1.427 -1.62 0 C-N-CA 125.928 1.691 . . . . 0.0 107.303 177.766 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.416 ' CG2' ' CH2' ' A' ' 37' ' ' TRP . 61.8 p -39.87 -35.1 0.32 Allowed 'General case' 0 CA--C 1.508 -0.67 0 C-N-CA 124.774 1.23 . . . . 0.0 111.042 173.603 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.55 ' HA ' ' CZ ' ' A' ' 38' ' ' PHE . 65.1 t30 69.19 8.77 7.01 Favored 'General case' 0 C--O 1.222 -0.381 0 C-N-CA 124.614 1.165 . . . . 0.0 110.376 177.757 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.424 ' CA ' ' HD3' ' A' ' 52' ' ' ARG . . . 112.7 -13.78 24.8 Favored Glycine 0 N--CA 1.428 -1.843 0 C-N-CA 124.741 1.162 . . . . 0.0 114.206 -172.563 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.566 ' CE2' ' HA ' ' A' ' 47' ' ' LYS . 16.0 m-85 -70.61 166.55 20.44 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.095 0.958 . . . . 0.0 110.682 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.01 -40.44 16.87 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.992 176.671 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.546 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . 174.84 -49.63 0.13 Allowed Glycine 0 C--N 1.335 0.484 0 C-N-CA 124.354 0.978 . . . . 0.0 111.794 -178.013 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -125.01 -63.24 1.17 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 122.026 0.917 . . . . 0.0 109.505 -179.652 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.48 161.38 21.76 Favored Glycine 0 C--N 1.341 0.823 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.566 ' HA ' ' CE2' ' A' ' 42' ' ' TYR . 19.5 mtmt -54.74 175.15 0.06 Allowed 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 122.303 1.049 . . . . 0.0 112.339 176.188 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.433 ' CD1' ' CE1' ' A' ' 42' ' ' TYR . 5.8 mp -56.76 153.72 21.01 Favored Pre-proline 0 N--CA 1.447 -0.618 0 O-C-N 121.658 -0.651 . . . . 0.0 111.381 178.296 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -71.72 158.99 52.07 Favored 'Trans proline' 0 N--CA 1.448 -1.19 0 C-N-CA 121.88 1.72 . . . . 0.0 110.092 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.9 tttt -55.52 98.35 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.145 0.578 . . . . 0.0 109.921 177.133 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.8 72.89 0.62 Allowed Glycine 0 C--O 1.228 -0.226 0 CA-C-O 119.503 -0.609 . . . . 0.0 112.686 -176.15 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.424 ' HD3' ' CA ' ' A' ' 41' ' ' GLY . 12.3 ttm180 -174.42 162.8 3.59 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 124.175 0.99 . . . . 0.0 110.448 175.786 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.3 m -136.52 110.34 9.6 Favored Pre-proline 0 C--O 1.208 -1.089 0 O-C-N 123.909 0.756 . . . . 0.0 110.87 178.625 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -71.98 -178.72 3.33 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 121.698 1.599 . . . . 0.0 112.232 177.592 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.406 ' CG2' ' HB2' ' A' ' 133' ' ' LEU . 6.6 mt -95.42 114.17 31.45 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 -178.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.61 135.46 35.55 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 120.954 -1.091 . . . . 0.0 108.635 177.277 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.481 ' CD2' ' HB3' ' A' ' 118' ' ' CYS . 4.7 m-85 -117.67 -52.4 2.45 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 123.234 0.614 . . . . 0.0 109.795 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 134.15 -12.26 4.71 Favored Glycine 0 C--O 1.224 -0.513 0 C-N-CA 123.92 0.772 . . . . 0.0 112.418 -176.785 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.51 134.33 34.44 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 117.43 0.615 . . . . 0.0 109.481 177.816 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 87.8 p -75.93 2.72 11.79 Favored 'General case' 0 C--O 1.222 -0.372 0 O-C-N 124.362 1.039 . . . . 0.0 111.713 176.084 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -89.11 -56.14 3.4 Favored 'General case' 0 C--O 1.217 -0.619 0 C-N-CA 124.867 1.267 . . . . 0.0 109.047 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 2.1 m -71.57 -29.97 65.33 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 178.849 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -66.66 -38.16 86.27 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-O 121.091 0.472 . . . . 0.0 110.909 175.259 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.84 164.18 0.58 Allowed Pre-proline 0 N--CA 1.447 -0.598 0 CA-C-O 122.156 0.979 . . . . 0.0 111.692 178.493 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -69.85 126.54 13.37 Favored 'Trans proline' 0 N--CA 1.443 -1.48 0 C-N-CA 121.239 1.293 . . . . 0.0 114.499 172.594 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.463 ' CD ' ' CD2' ' A' ' 42' ' ' TYR . 21.5 Cg_endo -70.64 168.16 23.51 Favored 'Trans proline' 0 N--CA 1.444 -1.44 0 C-N-CA 124.099 3.2 . . . . 0.0 111.48 177.171 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.2 tptt -130.61 61.22 1.62 Allowed 'General case' 0 C--O 1.202 -1.397 0 CA-C-O 116.95 -1.5 . . . . 0.0 108.854 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 40.6 t-80 -75.58 164.97 25.78 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 120.291 1.405 . . . . 0.0 111.029 178.737 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.9 -179.71 7.21 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 120.869 -1.144 . . . . 0.0 110.841 178.093 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.34 69.23 10.46 Favored 'General case' 0 C--O 1.211 -0.928 0 O-C-N 120.29 -1.506 . . . . 0.0 111.34 177.453 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -176.76 -41.98 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 O-C-N 123.772 0.67 . . . . 0.0 109.707 179.385 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.449 ' O ' ' CE2' ' A' ' 79' ' ' TYR . . . 138.11 -72.5 0.44 Allowed Glycine 0 C--O 1.21 -1.361 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 -178.749 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -140.72 72.85 1.4 Allowed 'General case' 0 N--CA 1.438 -1.064 0 O-C-N 121.872 -0.781 . . . . 0.0 109.865 179.24 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.47 -101.98 0.01 OUTLIER Glycine 0 C--O 1.221 -0.717 0 CA-C-O 119.736 -0.48 . . . . 0.0 112.47 178.353 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -52.42 -90.29 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.457 0 CA-C-O 122.152 0.977 . . . . 0.0 111.25 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -134.47 20.66 3.64 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-O 117.765 -1.112 . . . . 0.0 111.192 178.586 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -20.54 90.1 0.01 OUTLIER 'General case' 0 C--O 1.211 -0.938 0 C-N-CA 125.424 1.49 . . . . 0.0 114.089 -177.461 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 28.4 p80 -92.22 29.45 1.66 Allowed 'General case' 0 N--CA 1.467 0.383 0 O-C-N 119.097 -2.252 . . . . 0.0 108.196 -170.1 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.578 ' CD2' ' CD1' ' A' ' 37' ' ' TRP . 0.1 OUTLIER -57.37 176.29 0.13 Allowed 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 115.073 1.508 . . . . 0.0 115.073 174.161 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 3.6 mt -95.84 154.99 16.94 Favored 'General case' 0 C--O 1.215 -0.758 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.371 173.946 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.411 ' CD2' ' CZ ' ' A' ' 79' ' ' TYR . 2.1 mt -141.14 129.28 22.12 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -177.96 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.495 ' CB ' ' CD1' ' A' ' 109' ' ' ILE . 0.2 OUTLIER -98.92 155.72 17.26 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 122.832 1.301 . . . . 0.0 111.543 178.66 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.435 ' CD1' ' HD2' ' A' ' 84' ' ' PRO . 47.7 t80 -146.27 129.8 8.34 Favored Pre-proline 0 N--CA 1.452 -0.332 0 O-C-N 121.221 -0.924 . . . . 0.0 112.2 179.422 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.493 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 21.5 Cg_endo -71.96 106.02 1.93 Allowed 'Trans proline' 0 N--CA 1.445 -1.324 0 C-N-CA 124.531 3.487 . . . . 0.0 110.801 -179.462 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.94 114.99 29.46 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.937 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 70.7 m-85 -82.17 158.02 67.52 Favored Pre-proline 0 N--CA 1.449 -0.515 0 O-C-N 121.775 -0.578 . . . . 0.0 111.818 178.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -76.8 -38.88 0.77 Allowed 'Trans proline' 0 CA--C 1.498 -1.288 0 C-N-CA 122.467 2.112 . . . . 0.0 112.713 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -44.92 -30.7 1.06 Allowed 'General case' 0 N--CA 1.469 0.497 0 O-C-N 125.342 1.651 . . . . 0.0 110.98 176.674 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 90.42 -8.48 79.73 Favored Glycine 0 N--CA 1.438 -1.216 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 176.349 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.6 p-80 -59.71 129.25 41.0 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 178.072 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -62.68 96.58 0.09 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 175.483 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.481 ' CD2' ' HB3' ' A' ' 94' ' ' PHE . 7.0 t80 -37.82 142.34 0.16 Allowed 'General case' 0 C--O 1.212 -0.904 0 CA-C-O 121.843 0.83 . . . . 0.0 110.92 178.865 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . 0.409 ' HE2' ' O ' ' A' ' 99' ' ' PRO . 0.1 OUTLIER -77.43 57.29 1.5 Allowed 'General case' 0 C--N 1.314 -0.947 0 O-C-N 119.584 -1.947 . . . . 0.0 110.779 175.972 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.481 ' HB3' ' CD2' ' A' ' 92' ' ' TYR . 33.2 p90 -71.25 -9.26 57.82 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 124.319 1.048 . . . . 0.0 112.23 175.892 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -92.19 -37.27 12.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 122.223 1.011 . . . . 0.0 109.709 -179.456 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.9 m -75.41 106.15 6.8 Favored 'General case' 0 CA--C 1.513 -0.464 0 O-C-N 121.266 -0.896 . . . . 0.0 108.968 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.1 pttp -58.59 -49.91 75.76 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 121.882 0.848 . . . . 0.0 110.362 178.163 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -145.54 126.06 7.27 Favored Pre-proline 0 N--CA 1.436 -1.146 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.244 -176.612 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.409 ' O ' ' HE2' ' A' ' 93' ' ' LYS . 29.7 Cg_endo -70.11 175.96 35.58 Favored 'Cis proline' 0 N--CA 1.461 -0.397 0 O-C-N 124.419 1.747 . . . . 0.0 111.797 -4.686 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 15.3 tttm -141.95 132.34 25.12 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 123.526 0.73 . . . . 0.0 109.069 178.252 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -72.14 170.81 13.18 Favored 'General case' 0 C--O 1.237 0.442 0 O-C-N 124.747 1.279 . . . . 0.0 111.881 177.141 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -65.13 152.1 92.25 Favored Pre-proline 0 N--CA 1.445 -0.699 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.442 177.863 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -73.3 -164.83 0.21 Allowed 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.734 2.289 . . . . 0.0 112.139 175.983 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -141.4 157.43 26.14 Favored Glycine 0 CA--C 1.522 0.494 0 O-C-N 121.353 -0.842 . . . . 0.0 112.438 177.403 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -75.76 -67.56 0.02 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.868 2.379 . . . . 0.0 110.43 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.455 ' CB ' ' CE2' ' A' ' 11' ' ' TYR . . . -60.73 138.78 58.06 Favored 'General case' 0 N--CA 1.446 -0.634 0 O-C-N 123.9 0.75 . . . . 0.0 110.452 179.038 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 6.0 mtm-85 -144.1 144.07 31.43 Favored 'General case' 0 CA--C 1.508 -0.656 0 O-C-N 124.529 1.143 . . . . 0.0 111.148 -179.051 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 4.3 p -82.52 123.95 38.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 123.907 0.754 . . . . 0.0 110.595 179.032 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.504 HG21 ' CD2' ' A' ' 38' ' ' PHE . 7.0 mm -104.67 138.68 28.34 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.903 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -178.923 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.474 ' C ' ' CD1' ' A' ' 110' ' ' TYR . 12.6 p90 -165.52 155.19 12.62 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-O 121.801 0.81 . . . . 0.0 111.517 -178.188 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 16.9 p -91.2 160.86 15.33 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -175.918 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.497 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -107.79 155.79 39.23 Favored Pre-proline 0 C--N 1.318 -0.776 0 O-C-N 122.029 -0.419 . . . . 0.0 110.694 179.905 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.497 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 17.8 Cg_endo -73.32 -53.87 0.15 OUTLIER 'Cis proline' 0 CA--C 1.5 -1.176 0 C-N-CA 123.351 -1.521 . . . . 0.0 109.399 -7.429 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 11.6 t30 -44.17 107.38 0.09 Allowed 'General case' 0 C--O 1.217 -0.642 0 CA-C-O 116.187 -1.864 . . . . 0.0 109.632 179.886 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.404 ' HG2' ' CG ' ' A' ' 110' ' ' TYR . 0.3 OUTLIER -62.35 85.37 0.02 OUTLIER 'General case' 0 CA--C 1.509 -0.627 0 O-C-N 124.568 1.168 . . . . 0.0 108.737 -176.099 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 81.0 t -84.31 67.67 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.756 0 N-CA-C 104.964 -2.235 . . . . 0.0 104.964 -173.692 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.585 ' CZ ' ' HA2' ' A' ' 119' ' ' GLY . 47.1 t80 -37.13 101.98 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.225 1.41 . . . . 0.0 109.759 178.549 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . 0.481 ' HB3' ' CD2' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -81.79 -24.62 35.86 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 178.997 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.585 ' HA2' ' CZ ' ' A' ' 117' ' ' PHE . . . 144.99 -147.42 18.58 Favored Glycine 0 N--CA 1.434 -1.435 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 -178.724 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.403 HG13 ' CG ' ' A' ' 4' ' ' TRP . 1.1 mm -127.31 148.27 32.08 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.273 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 -175.428 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.525 ' CD1' ' CE1' ' A' ' 38' ' ' PHE . 8.2 pt -136.23 154.99 34.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 108.139 -1.059 . . . . 0.0 108.139 -178.253 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . 179.25 131.43 0.08 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 122.145 0.974 . . . . 0.0 109.502 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.45 ' CG ' HD12 ' A' ' 131' ' ' LEU . 0.5 OUTLIER -88.05 94.61 9.85 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 122.372 1.082 . . . . 0.0 111.927 179.212 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.3 p -103.84 42.21 1.21 Allowed 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.304 -0.872 . . . . 0.0 109.184 -176.7 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 15.0 tttt -95.72 -39.54 9.83 Favored 'General case' 0 C--O 1.211 -0.937 0 CA-C-O 115.328 -2.272 . . . . 0.0 111.117 178.009 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 169.89 -86.38 0.0 OUTLIER 'General case' 0 C--O 1.218 -0.568 0 O-C-N 126.136 2.148 . . . . 0.0 108.749 178.606 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -158.76 28.7 0.22 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.055 2.142 . . . . 0.0 110.384 -176.633 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -169.34 91.72 0.24 Allowed 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 122.829 1.3 . . . . 0.0 110.034 -177.646 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 163.31 109.62 0.23 Allowed Glycine 0 CA--C 1.483 -1.965 0 CA-C-O 115.245 -2.975 . . . . 0.0 106.146 179.077 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -35.44 151.73 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 119.877 1.839 . . . . 0.0 112.76 175.322 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.45 HD12 ' CG ' ' A' ' 123' ' ' HIS . 0.0 OUTLIER -59.79 154.93 17.14 Favored 'General case' 0 C--N 1.32 -0.713 0 O-C-N 121.037 -1.039 . . . . 0.0 108.642 -176.504 . . . . . . . . 3 3 . 1 . 020 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 3.8 ptmt -132.64 151.39 51.97 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 -178.248 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.406 ' HB2' ' CG2' ' A' ' 55' ' ' ILE . 13.4 tp -54.32 129.71 36.39 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 125.11 1.507 . . . . 0.0 108.339 -179.569 . . . . . . . . 2 2 . 1 . 020 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 76.4 m -66.57 -173.78 0.25 Allowed 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 124.363 2.03 . . . . 0.0 108.237 177.291 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 39.3 m -157.94 125.52 5.19 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 102.819 -3.03 . . . . 0.0 102.819 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 0.45 ' CD2' HG11 ' A' ' 2' ' ' VAL . 2.4 m80 . . . . . 0 CA--C 1.575 1.923 0 N-CA-C 118.489 2.774 . . . . 0.0 118.489 175.091 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.498 1.96 0 CA-C-O 116.669 -1.634 . . . . 0.0 107.644 . . . . . . . . . 0 0 . 1 . 021 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.3 p -41.51 142.82 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 CA-C-O 123.12 1.438 . . . . 0.0 112.774 169.752 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 3' ' ' THR . . . . . 0.414 ' HA ' ' HA ' ' A' ' 12' ' ' ASN . 6.4 m -93.37 111.25 22.85 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 -173.089 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.414 ' CZ2' ' CD2' ' A' ' 136' ' ' HIS . 18.0 m95 -75.59 143.77 42.16 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 -178.557 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.9 m -145.88 153.25 40.65 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 -179.975 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -125.65 -84.64 0.63 Allowed 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 172.448 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -102.0 58.38 0.61 Allowed Glycine 0 N--CA 1.473 1.101 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 -178.032 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 72.92 -3.31 29.02 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 117.681 1.832 . . . . 0.0 117.681 -171.331 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.351 5.1 mt -94.73 132.61 39.3 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.087 1.755 . . . . 0.0 108.405 -177.438 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.409 ' O ' ' CD1' ' A' ' 11' ' ' TYR . 4.4 mm? -99.29 151.86 20.57 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.316 1.446 . . . . 0.0 110.102 -170.861 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.446 ' CZ ' ' CB ' ' A' ' 106' ' ' ALA . 40.9 m-85 -157.85 74.65 0.74 Allowed 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 -168.017 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . 0.414 ' HA ' ' HA ' ' A' ' 3' ' ' THR . 0.2 OUTLIER -50.67 128.0 19.47 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 120.053 -1.655 . . . . 0.0 108.606 178.251 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.486 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 0.2 OUTLIER -44.66 -54.7 5.91 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-O 117.682 -1.151 . . . . 0.0 111.841 178.179 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -48.27 -51.2 26.76 Favored 'General case' 0 C--O 1.202 -1.403 0 O-C-N 124.235 0.959 . . . . 0.0 112.449 176.193 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.41 -35.64 74.36 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 114.329 -2.748 . . . . 0.0 117.491 169.981 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -63.13 -68.33 0.35 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 127.518 2.327 . . . . 0.0 115.487 169.537 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -48.35 -42.0 30.17 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 117.714 -1.136 . . . . 0.0 110.739 167.836 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 41.5 t -64.84 -53.09 52.25 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 126.687 1.995 . . . . 0.0 110.418 -179.702 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -44.98 -49.12 11.37 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 119.189 0.904 . . . . 0.0 111.247 173.152 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 20' ' ' SER . . . . . 0.471 ' HB2' ' CE2' ' A' ' 110' ' ' TYR . 1.7 p -67.72 -32.65 73.42 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 118.133 2.642 . . . . 0.0 118.133 172.933 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 11.0 m170 -58.64 -40.24 82.84 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 127.535 2.334 . . . . 0.0 110.73 174.38 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -80.6 -44.76 18.41 Favored 'General case' 0 CA--C 1.511 -0.521 0 C-N-CA 125.28 1.432 . . . . 0.0 111.658 176.407 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -47.35 126.45 9.67 Favored Pre-proline 0 CA--C 1.552 1.041 0 O-C-N 125.527 1.767 . . . . 0.0 112.76 177.457 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -68.28 128.96 18.28 Favored 'Trans proline' 0 N--CA 1.439 -1.718 0 N-CA-C 107.596 -1.732 . . . . 0.0 107.596 -176.272 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 4.6 tp -65.31 90.65 0.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 126.397 1.879 . . . . 0.0 112.505 178.138 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 174.21 161.95 0.19 Allowed 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 125.84 1.656 . . . . 0.0 108.786 -172.148 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.482 ' HA ' ' HA ' ' A' ' 36' ' ' HIS . 2.9 t70 -104.74 119.17 38.36 Favored 'General case' 0 CA--C 1.495 -1.171 0 C-N-CA 128.558 2.743 . . . . 0.0 108.425 -179.062 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 56.76 50.02 66.47 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 119.69 -1.243 . . . . 0.0 112.069 172.407 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.81 -3.57 14.89 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 125.382 1.473 . . . . 0.0 114.344 176.119 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.2 p -114.27 158.42 21.44 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 -170.895 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -45.89 -55.08 7.55 Favored Glycine 0 N--CA 1.467 0.736 0 C-N-CA 124.331 0.967 . . . . 0.0 115.039 -178.745 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 30.4 t -57.52 -71.8 0.1 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 114.266 1.209 . . . . 0.0 114.266 165.64 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.5 m 161.44 -51.03 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 131.338 3.855 . . . . 0.0 110.929 -176.507 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.46 ' CD2' ' HD3' ' A' ' 84' ' ' PRO . 90.8 m-85 -57.38 147.72 57.36 Favored Pre-proline 0 CA--C 1.569 1.694 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -174.038 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -66.79 148.31 78.21 Favored 'Cis proline' 0 N--CA 1.428 -2.324 0 N-CA-C 106.784 -2.045 . . . . 0.0 106.784 -7.467 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.482 ' HA ' ' HA ' ' A' ' 27' ' ' ASP 0.27 0.3 OUTLIER -117.3 167.08 11.55 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 113.736 -1.574 . . . . 0.0 107.393 174.927 . . . . . . . . 4 4 . 1 . 021 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.459 ' CD1' ' HB2' ' A' ' 79' ' ' TYR . 11.1 t90 -64.03 133.17 52.6 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 123.274 1.511 . . . . 0.0 112.329 168.768 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.496 ' CD2' ' HB2' ' A' ' 40' ' ' ASN . 18.0 t80 -98.7 89.98 4.55 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 102.995 -2.965 . . . . 0.0 102.995 -179.742 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 82.8 p -38.86 -41.52 0.75 Allowed 'General case' 0 CA--C 1.502 -0.887 0 CA-C-N 111.329 -2.669 . . . . 0.0 110.421 160.923 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.496 ' HB2' ' CD2' ' A' ' 38' ' ' PHE . 63.2 t30 57.36 25.09 10.84 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 120.625 1.557 . . . . 0.0 112.09 178.316 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.418 ' HA2' ' CD ' ' A' ' 52' ' ' ARG . . . 94.4 -39.35 2.92 Favored Glycine 0 CA--C 1.542 1.779 0 CA-C-O 113.723 -3.82 . . . . 0.0 117.846 -163.92 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -45.14 148.72 0.56 Allowed 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 130.203 3.401 . . . . 0.0 111.687 173.853 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.68 -32.56 25.52 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 115.34 1.607 . . . . 0.0 115.34 177.363 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.412 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -168.79 -81.95 0.05 OUTLIER Glycine 0 CA--C 1.527 0.841 0 C-N-CA 126.133 1.825 . . . . 0.0 111.82 -176.647 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -108.26 -63.95 1.27 Allowed 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 127.337 2.255 . . . . 0.0 114.226 -178.307 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.52 -171.37 0.66 Allowed Glycine 0 C--O 1.222 -0.599 0 CA-C-N 114.54 -1.209 . . . . 0.0 111.989 177.012 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.55 -175.29 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.838 0 CA-C-O 124.375 2.036 . . . . 0.0 115.151 170.441 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -74.7 160.04 81.84 Favored Pre-proline 0 C--N 1.312 -1.044 0 CA-C-N 114.338 -1.301 . . . . 0.0 110.56 -177.889 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -62.03 168.72 8.58 Favored 'Trans proline' 0 N--CA 1.435 -1.967 0 CA-C-O 123.88 1.534 . . . . 0.0 110.119 171.306 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 6.5 ttpt -55.1 101.35 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.624 1.57 . . . . 0.0 111.665 170.222 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.37 90.24 1.67 Allowed Glycine 0 N--CA 1.474 1.203 0 N-CA-C 111.553 -0.619 . . . . 0.0 111.553 -173.822 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.418 ' CD ' ' HA2' ' A' ' 41' ' ' GLY . 0.0 OUTLIER -167.01 163.89 15.96 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 126.463 1.905 . . . . 0.0 111.148 171.98 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 42.4 m -134.89 101.93 11.37 Favored Pre-proline 0 N--CA 1.478 0.972 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -178.325 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 29.8 Cg_endo -71.46 140.71 37.05 Favored 'Trans proline' 0 N--CA 1.43 -2.247 0 C-N-CA 122.155 1.903 . . . . 0.0 109.911 176.472 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.0 mt -61.8 119.52 5.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 172.294 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.65 143.88 28.16 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.284 169.821 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.529 ' CD1' ' HB3' ' A' ' 118' ' ' CYS . 7.0 m-85 -124.68 -53.24 1.68 Allowed 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 126.308 1.843 . . . . 0.0 111.044 179.514 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 122.43 -5.62 10.05 Favored Glycine 0 N--CA 1.476 1.345 0 C-N-CA 126.735 2.112 . . . . 0.0 114.929 -172.982 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.79 131.48 39.12 Favored 'General case' 0 CA--C 1.503 -0.865 0 C-N-CA 125.013 1.325 . . . . 0.0 110.765 172.622 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 92.0 p -67.89 2.78 1.8 Allowed 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 174.976 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.38 -55.19 3.25 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 128.608 2.763 . . . . 0.0 108.201 -173.839 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.8 m -77.31 -26.32 52.12 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.528 1.131 . . . . 0.0 113.077 175.148 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -72.32 -26.74 62.06 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 126.274 1.829 . . . . 0.0 114.043 166.881 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.07 155.06 74.99 Favored Pre-proline 0 CA--C 1.539 0.52 0 O-C-N 120.247 -1.533 . . . . 0.0 114.32 175.412 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -63.85 129.55 25.04 Favored 'Trans proline' 0 CA--C 1.568 2.207 0 O-C-N 119.336 -0.929 . . . . 0.0 112.063 174.582 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.4 Cg_endo -65.75 177.43 2.87 Favored 'Trans proline' 0 N--CA 1.447 -1.253 1 C-N-CA 125.448 4.099 . . . . 0.0 111.146 176.587 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.4 tptt -132.75 53.0 2.04 Favored 'General case' 0 C--O 1.214 -0.767 0 O-C-N 120.331 -1.481 . . . . 0.0 110.309 170.649 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 46.3 t-80 -76.04 160.94 29.31 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-O 123.315 1.531 . . . . 0.0 112.978 -178.819 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.74 -171.48 3.87 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 117.949 -2.969 . . . . 0.0 110.947 177.116 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.76 79.94 7.32 Favored 'General case' 0 C--O 1.213 -0.832 0 O-C-N 120.736 -1.227 . . . . 0.0 110.043 170.113 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -175.25 -44.21 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 126.022 1.729 . . . . 0.0 111.766 176.218 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 123.8 -63.61 0.55 Allowed Glycine 0 C--O 1.221 -0.691 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 -176.287 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -140.28 96.84 3.11 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 128.165 2.586 . . . . 0.0 106.251 177.097 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.46 -99.21 0.08 OUTLIER Glycine 0 CA--C 1.536 1.353 0 N-CA-C 116.365 1.306 . . . . 0.0 116.365 170.444 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 23.9 mttt -75.33 -97.94 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.164 -1.786 . . . . 0.0 114.313 172.913 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -109.52 12.8 24.28 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.838 -1.164 . . . . 0.0 111.025 178.518 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -23.16 95.06 0.01 OUTLIER 'General case' 0 C--O 1.215 -0.718 0 C-N-CA 129.449 3.099 . . . . 0.0 111.51 -171.783 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 5.7 p80 -91.13 54.67 2.66 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 118.048 -2.907 . . . . 0.0 106.529 -163.172 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.459 ' HB2' ' CD1' ' A' ' 37' ' ' TRP . 39.8 p90 -85.53 148.33 26.0 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 -172.439 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -73.79 162.29 29.29 Favored 'General case' 0 C--O 1.217 -0.634 0 C-N-CA 116.817 -1.953 . . . . 0.0 112.951 168.455 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.431 ' HB2' ' CE1' ' A' ' 110' ' ' TYR . 4.1 mp -141.65 111.23 6.52 Favored 'General case' 0 CA--C 1.498 -1.04 0 CA-C-N 119.921 1.237 . . . . 0.0 111.701 179.003 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -80.2 152.69 29.03 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 119.243 -0.983 . . . . 0.0 111.291 -178.145 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.47 ' CZ ' ' CD1' ' A' ' 94' ' ' PHE . 3.0 t80 -142.02 133.86 13.44 Favored Pre-proline 0 CA--C 1.544 0.741 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 179.073 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.506 ' HG2' ' CD2' ' A' ' 92' ' ' TYR . 30.9 Cg_endo -71.9 87.37 0.85 Allowed 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 124.633 3.555 . . . . 0.0 112.009 -177.29 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 6.4 t -89.89 96.73 10.82 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-N 114.316 -1.311 . . . . 0.0 110.592 -179.837 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -80.58 157.5 72.28 Favored Pre-proline 0 CA--C 1.552 1.052 0 O-C-N 120.963 -1.085 . . . . 0.0 112.407 179.695 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . 0.267 9.3 Cg_endo -71.59 -30.96 14.17 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 122.171 1.914 . . . . 0.0 115.711 175.107 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -43.74 -35.81 2.0 Favored 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 128.353 2.661 . . . . 0.0 109.899 174.931 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.71 7.85 70.86 Favored Glycine 0 C--N 1.328 0.106 0 N-CA-C 116.432 1.333 . . . . 0.0 116.432 -178.404 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -71.59 128.52 36.08 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 174.442 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -64.54 110.4 2.3 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 104.965 -2.235 . . . . 0.0 104.965 163.033 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.506 ' CD2' ' HG2' ' A' ' 84' ' ' PRO . 9.3 t80 -39.3 142.15 0.28 Allowed 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 126.735 2.014 . . . . 0.0 109.756 171.052 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.76 61.94 3.15 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 118.098 -2.877 . . . . 0.0 111.664 169.906 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.47 ' CD1' ' CZ ' ' A' ' 83' ' ' PHE . 11.9 p90 -70.93 -27.58 63.87 Favored 'General case' 0 C--O 1.221 -0.442 0 C-N-CA 124.775 1.23 . . . . 0.0 113.447 170.134 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -76.53 -42.47 42.97 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 125.728 1.611 . . . . 0.0 111.633 -179.256 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.1 m -76.51 116.39 17.15 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 119.807 -1.808 . . . . 0.0 109.316 -179.935 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.1 pttt -56.81 -44.22 81.76 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 123.534 1.635 . . . . 0.0 113.945 176.634 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.3 tttt -151.26 133.96 8.61 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 126.0 1.72 . . . . 0.0 111.938 179.831 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -66.63 165.4 64.79 Favored 'Cis proline' 0 N--CA 1.45 -1.045 0 C-N-CA 124.013 -1.244 . . . . 0.0 110.022 -9.862 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.6 pttm -142.11 145.94 34.83 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 105.62 -1.992 . . . . 0.0 105.62 176.265 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -69.17 173.01 6.03 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.205 1.002 . . . . 0.0 111.797 172.797 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -113.28 127.08 27.24 Favored Pre-proline 0 CA--C 1.556 1.175 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -178.258 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . 0.403 ' HG3' ' CE1' ' A' ' 34' ' ' TYR . 70.1 Cg_endo -74.35 -160.87 0.11 Allowed 'Trans proline' 0 CA--C 1.554 1.522 0 C-N-CA 125.217 3.945 . . . . 0.0 109.787 167.953 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 112.49 -39.61 2.81 Favored Glycine 0 CA--C 1.545 1.96 0 CA-C-O 114.797 -3.224 . . . . 0.0 112.505 -162.344 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -70.93 -163.67 0.13 Allowed 'Trans proline' 0 C--N 1.366 1.488 1 CA-C-N 125.577 4.689 . . . . 0.0 112.469 177.736 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.446 ' CB ' ' CZ ' ' A' ' 11' ' ' TYR . . . -63.95 160.77 17.07 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 124.757 2.218 . . . . 0.0 113.052 169.451 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.418 ' HG2' ' HA ' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -144.74 151.95 39.65 Favored 'General case' 0 C--O 1.214 -0.799 0 CA-C-N 111.832 -2.44 . . . . 0.0 110.8 179.613 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.7 p -87.8 120.84 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 C-N-CA 127.13 2.172 . . . . 0.0 112.003 173.292 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 1.7 mp -112.1 127.32 69.36 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.886 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 -171.644 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.471 ' CE2' ' HB2' ' A' ' 20' ' ' SER . 14.1 p90 -145.98 156.24 43.37 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 -177.029 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.7 p -81.79 164.91 21.35 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.196 0.999 . . . . 0.0 112.187 176.306 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.437 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.4 OUTLIER -109.8 158.89 33.63 Favored Pre-proline 0 CA--C 1.556 1.185 0 N-CA-C 112.667 0.618 . . . . 0.0 112.667 175.415 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.437 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 19.8 Cg_endo -69.45 -52.73 0.16 OUTLIER 'Cis proline' 0 CA--C 1.501 -1.167 0 N-CA-C 108.915 -1.225 . . . . 0.0 108.915 -15.837 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 28.6 t30 -43.69 108.88 0.12 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.931 0.892 . . . . 0.0 110.098 177.004 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -67.54 75.05 0.17 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 127.99 2.516 . . . . 0.0 107.615 -179.344 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 72.0 t -85.06 78.45 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 101.112 -3.662 . . . . 0.0 101.112 -175.983 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.486 ' CZ ' ' NE2' ' A' ' 13' ' ' GLN . 5.9 t80 -41.29 113.51 0.41 Allowed 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 129.071 2.948 . . . . 0.0 104.944 176.5 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . 0.529 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 0.1 OUTLIER -93.89 -37.95 11.46 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 122.101 0.953 . . . . 0.0 112.963 174.967 . . . . . . . . 3 3 . 1 . 021 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 163.72 -168.92 38.51 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 125.32 1.438 . . . . 0.0 111.648 -179.601 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 1.3 mp -114.72 120.39 64.24 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.356 0 N-CA-C 103.119 -2.919 . . . . 0.0 103.119 176.411 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.419 ' HA ' ' HA ' ' A' ' 133' ' ' LEU . 8.4 pt -89.52 153.5 3.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-O 117.707 -1.139 . . . . 0.0 109.333 172.427 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -161.64 164.07 29.49 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 121.484 1.947 . . . . 0.0 113.25 172.062 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 39.2 m-70 -89.33 91.68 8.85 Favored 'General case' 0 C--O 1.217 -0.656 0 C-N-CA 119.168 -1.013 . . . . 0.0 109.404 -176.001 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.1 t -94.1 32.35 1.51 Allowed 'General case' 0 N--CA 1.502 2.148 0 CA-C-O 124.413 2.054 . . . . 0.0 112.661 -179.828 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.0 tptm -97.77 -33.53 11.24 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-O 117.154 -1.403 . . . . 0.0 112.225 178.465 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.25 -68.45 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.655 1.582 . . . . 0.0 110.629 178.991 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -150.91 -49.3 0.12 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 127.354 2.262 . . . . 0.0 111.908 -179.121 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -149.22 82.23 1.42 Allowed 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 127.984 2.514 . . . . 0.0 108.314 -177.763 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -130.95 -114.43 1.64 Allowed Glycine 0 N--CA 1.473 1.155 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 171.019 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -79.27 145.2 33.67 Favored 'General case' 0 C--N 1.308 -1.224 0 O-C-N 121.078 -1.248 . . . . 0.0 111.105 178.495 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 3.7 tp -104.89 126.34 51.86 Favored 'General case' 0 C--O 1.217 -0.605 0 C-N-CA 123.468 0.707 . . . . 0.0 110.999 175.479 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.65 168.54 19.3 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.052 1.741 . . . . 0.0 110.531 -179.488 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.419 ' HA ' ' HA ' ' A' ' 121' ' ' ILE . 14.3 tp -71.99 142.67 49.37 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 118.82 0.736 . . . . 0.0 110.325 175.668 . . . . . . . . 2 2 . 1 . 021 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 75.1 m -69.27 179.52 1.95 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 124.764 2.221 . . . . 0.0 113.05 165.875 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 96.9 p -146.01 89.15 1.86 Allowed 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 -179.103 . . . . . . . . 1 1 . 1 . 021 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 0.414 ' CD2' ' CZ2' ' A' ' 4' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 113.814 -2.993 . . . . 0.0 116.852 163.596 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 114.717 -2.563 . . . . 0.0 108.642 . . . . . . . . . 0 0 . 1 . 022 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER 61.71 110.27 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-O 124.337 2.017 . . . . 0.0 109.825 177.985 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -92.65 113.05 25.21 Favored 'General case' 0 C--N 1.312 -1.031 0 O-C-N 119.046 -2.284 . . . . 0.0 110.27 179.323 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 25.6 m95 -77.93 141.04 39.27 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 177.345 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -130.88 119.91 22.88 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -178.695 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.8 OUTLIER -98.33 52.31 1.03 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.593 176.49 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 42.88 49.73 6.13 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 123.395 0.521 . . . . 0.0 112.619 -175.478 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -167.39 -82.89 0.05 OUTLIER Glycine 0 C--O 1.226 -0.396 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 -176.804 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 85.3 mt -119.41 159.33 24.43 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.546 0.689 . . . . 0.0 110.205 177.617 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 3.5 mt -82.99 165.47 19.64 Favored 'General case' 0 C--O 1.219 -0.544 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.613 179.499 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 55.7 m-85 -157.78 85.72 0.9 Allowed 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 -174.337 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -54.51 114.46 1.68 Allowed 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 177.231 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.51 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 8.1 tp-100 -51.16 -34.17 30.21 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -179.797 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -43.26 -34.28 1.14 Allowed 'General case' 0 C--O 1.22 -0.472 0 O-C-N 124.969 1.418 . . . . 0.0 112.137 174.406 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.92 -51.32 4.51 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 116.182 -1.866 . . . . 0.0 113.341 171.843 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -42.42 -33.39 0.66 Allowed 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 123.041 2.655 . . . . 0.0 114.021 174.863 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -85.06 -49.25 8.44 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 124.49 1.116 . . . . 0.0 109.537 172.5 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 36.8 t -62.42 -43.62 98.39 Favored 'General case' 0 C--O 1.217 -0.656 0 O-C-N 119.796 -1.815 . . . . 0.0 110.482 -174.553 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -46.03 -38.66 8.11 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 125.901 1.68 . . . . 0.0 110.713 171.111 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.9 p -79.32 -28.97 42.14 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.697 0.799 . . . . 0.0 112.554 176.25 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.6 m170 -57.16 -44.11 83.14 Favored 'General case' 0 C--O 1.225 -0.222 0 C-N-CA 124.251 1.021 . . . . 0.0 110.886 176.866 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -78.77 -46.13 19.51 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 118.392 -0.814 . . . . 0.0 110.719 178.583 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -43.38 130.72 3.62 Favored Pre-proline 0 N--CA 1.447 -0.596 0 O-C-N 125.312 1.632 . . . . 0.0 111.434 178.611 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -71.08 122.87 9.16 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.242 1.961 . . . . 0.0 108.908 -177.362 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . . . . . . . . . 2.0 tp -61.15 88.94 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.425 1.09 . . . . 0.0 111.77 177.744 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -177.77 167.65 2.13 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.448 -175.172 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.416 ' HA ' ' HA ' ' A' ' 36' ' ' HIS . 1.3 t70 -114.89 126.88 55.31 Favored 'General case' 0 CA--C 1.512 -0.494 0 C-N-CA 124.295 1.038 . . . . 0.0 110.112 179.756 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 56.09 55.51 28.9 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-O 122.348 0.971 . . . . 0.0 111.145 176.189 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.2 tttt -141.01 28.56 1.9 Allowed 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 124.197 1.951 . . . . 0.0 112.068 -179.386 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 34.6 p -134.74 143.31 47.08 Favored 'General case' 0 C--N 1.309 -1.157 0 O-C-N 119.854 -1.779 . . . . 0.0 108.506 -174.836 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -40.03 -65.8 0.88 Allowed Glycine 0 C--N 1.332 0.349 0 C-N-CA 124.223 0.916 . . . . 0.0 113.543 -177.794 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 25.3 t -54.65 -61.56 2.23 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 117.567 -1.206 . . . . 0.0 111.281 172.914 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.0 p 159.45 -43.02 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 O-C-N 125.637 1.836 . . . . 0.0 113.091 -178.584 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.589 ' CE2' ' CE1' ' A' ' 36' ' ' HIS . 62.2 m-85 -79.34 149.67 72.7 Favored Pre-proline 0 N--CA 1.442 -0.86 0 C-N-CA 124.88 1.272 . . . . 0.0 113.258 178.286 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -74.26 157.93 99.09 Favored 'Cis proline' 0 N--CA 1.45 -1.037 0 C-N-CA 123.476 -1.468 . . . . 0.0 110.351 -1.118 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.589 ' CE1' ' CE2' ' A' ' 34' ' ' TYR . 0.3 OUTLIER -134.6 155.85 49.73 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 113.649 -1.614 . . . . 0.0 109.01 179.125 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.561 ' CD1' ' CD2' ' A' ' 79' ' ' TYR . 25.2 t90 -55.49 121.6 9.37 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-O 122.158 0.98 . . . . 0.0 110.724 174.134 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.463 ' CZ ' ' HA ' ' A' ' 40' ' ' ASN . 41.7 t80 -92.77 85.86 5.34 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 126.997 2.119 . . . . 0.0 106.343 177.929 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 39' ' ' THR . . . . . . . . . . . . . 43.8 p -38.98 -36.45 0.28 Allowed 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.505 171.533 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.463 ' HA ' ' CZ ' ' A' ' 38' ' ' PHE . 63.9 t30 66.45 9.93 6.89 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 122.402 1.096 . . . . 0.0 111.687 -179.261 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 113.21 -18.93 20.71 Favored Glycine 0 N--CA 1.433 -1.519 0 C-N-CA 124.874 1.226 . . . . 0.0 113.226 -171.824 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.551 ' CE2' ' HA ' ' A' ' 47' ' ' LYS . 11.4 m-85 -63.98 161.53 15.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 118.647 1.223 . . . . 0.0 110.993 179.983 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.41 -41.88 19.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.373 0.606 . . . . 0.0 111.287 176.047 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.552 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -173.33 -67.4 0.05 OUTLIER Glycine 0 C--N 1.339 0.696 0 C-N-CA 124.094 0.854 . . . . 0.0 112.497 -177.755 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -115.77 -63.21 1.48 Allowed 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 124.003 0.921 . . . . 0.0 110.045 -179.782 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -58.12 162.49 9.74 Favored Glycine 0 C--N 1.341 0.827 0 N-CA-C 110.971 -0.851 . . . . 0.0 110.971 178.454 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.551 ' HA ' ' CE2' ' A' ' 42' ' ' TYR . 11.8 mtmt -56.6 173.36 0.19 Allowed 'General case' 0 C--N 1.334 -0.089 0 CA-C-O 121.59 0.709 . . . . 0.0 111.152 179.097 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 5.7 mp -57.63 154.17 26.76 Favored Pre-proline 0 N--CA 1.446 -0.667 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.708 -179.421 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -70.74 159.15 53.63 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 121.692 1.595 . . . . 0.0 110.066 179.919 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.6 tttt -56.45 97.68 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.247 0.619 . . . . 0.0 110.081 176.137 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 117.83 60.26 0.29 Allowed Glycine 0 C--N 1.329 0.172 0 CA-C-N 116.443 -0.344 . . . . 0.0 112.629 -176.343 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 14.0 ttm180 -164.06 162.56 23.13 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 123.287 0.635 . . . . 0.0 110.606 175.194 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.9 m -139.08 109.33 7.62 Favored Pre-proline 0 C--N 1.326 -0.449 0 C-N-CA 123.196 0.598 . . . . 0.0 109.584 179.641 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 26.3 Cg_endo -72.86 177.16 8.01 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 123.126 2.551 . . . . 0.0 111.129 177.287 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.424 ' O ' ' CE2' ' A' ' 57' ' ' PHE . 6.5 mt -94.89 124.57 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -179.383 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.09 136.42 35.93 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 175.123 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.459 ' CD1' ' HB3' ' A' ' 118' ' ' CYS . 10.8 m-85 -118.89 -28.54 5.53 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.717 0.807 . . . . 0.0 111.027 177.747 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.66 -3.66 56.23 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 123.883 0.754 . . . . 0.0 113.209 -175.046 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.3 mmpt? -97.88 127.82 44.07 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-N 117.695 0.748 . . . . 0.0 109.414 176.868 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -66.35 -11.69 52.54 Favored 'General case' 0 C--O 1.219 -0.51 0 O-C-N 124.893 1.371 . . . . 0.0 111.819 175.854 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.15 -46.87 10.69 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 125.637 1.575 . . . . 0.0 111.049 175.806 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.459 ' SG ' ' CE2' ' A' ' 57' ' ' PHE . 2.0 t -73.1 -16.63 61.46 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 123.956 0.785 . . . . 0.0 112.071 176.688 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -90.04 -34.66 15.87 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.387 1.075 . . . . 0.0 110.812 175.246 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.21 163.1 0.97 Allowed Pre-proline 0 N--CA 1.446 -0.629 0 CA-C-O 121.538 0.685 . . . . 0.0 112.157 179.838 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . 0.447 ' HA ' ' CE2' ' A' ' 42' ' ' TYR . 24.6 Cg_endo -71.74 129.45 15.54 Favored 'Trans proline' 0 N--CA 1.44 -1.651 0 C-N-CA 121.144 1.229 . . . . 0.0 113.093 174.605 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.465 ' CD ' ' CD2' ' A' ' 42' ' ' TYR . 20.4 Cg_endo -68.46 167.59 22.05 Favored 'Trans proline' 0 N--CA 1.443 -1.498 0 C-N-CA 123.713 2.942 . . . . 0.0 111.206 176.701 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 10.3 tptt -126.75 66.16 1.26 Allowed 'General case' 0 C--O 1.223 -0.328 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.787 177.423 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.409 ' CE1' ' O ' ' A' ' 69' ' ' SER . 41.7 t-80 -77.92 168.07 20.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.498 0.666 . . . . 0.0 110.932 177.39 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.409 ' O ' ' CE1' ' A' ' 68' ' ' HIS . 1.5 p -141.47 173.79 11.17 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 121.232 -0.918 . . . . 0.0 111.429 176.782 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.5 mtpt -84.77 71.97 10.79 Favored 'General case' 0 C--O 1.219 -0.521 0 O-C-N 120.495 -1.378 . . . . 0.0 110.993 175.338 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -177.29 -43.07 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 O-C-N 124.54 1.15 . . . . 0.0 111.014 178.509 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 161.71 -85.08 0.11 Allowed Glycine 0 N--CA 1.442 -0.912 0 N-CA-C 108.626 -1.79 . . . . 0.0 108.626 -178.801 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -94.14 -98.27 0.15 Allowed 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 124.424 1.089 . . . . 0.0 108.465 -178.171 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 125.9 -162.92 20.02 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 125.781 1.658 . . . . 0.0 110.614 -175.503 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.3 mttt -43.65 -81.49 0.01 OUTLIER 'General case' 0 C--O 1.218 -0.554 0 C-N-CA 125.118 1.367 . . . . 0.0 112.942 -179.678 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -117.96 14.53 14.17 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 116.062 -1.923 . . . . 0.0 111.856 176.01 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.471 ' OD2' ' CE1' ' A' ' 79' ' ' TYR . 11.6 p-10 -11.77 83.08 0.0 OUTLIER 'General case' 0 C--O 1.214 -0.793 0 CA-C-O 124.469 2.08 . . . . 0.0 115.685 179.08 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 33.6 p80 -91.88 19.41 6.63 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 118.361 -2.712 . . . . 0.0 109.485 -170.531 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.561 ' CD2' ' CD1' ' A' ' 37' ' ' TRP . 0.1 OUTLIER -52.91 179.12 0.02 OUTLIER 'General case' 0 N--CA 1.428 -1.542 0 C-N-CA 125.329 1.452 . . . . 0.0 113.987 175.229 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.405 ' CD2' ' SG ' ' A' ' 62' ' ' CYS . 2.0 mt -100.63 154.34 18.67 Favored 'General case' 0 CA--C 1.504 -0.812 0 CA-C-O 118.444 -0.789 . . . . 0.0 110.869 173.871 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.465 ' CD1' ' CE1' ' A' ' 79' ' ' TYR . 2.6 mp -142.02 125.89 17.13 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 123.901 0.881 . . . . 0.0 109.803 179.175 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -92.34 154.24 18.69 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 121.386 0.613 . . . . 0.0 109.832 -179.125 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.49 ' CD1' ' HD2' ' A' ' 84' ' ' PRO . 6.4 t80 -143.68 135.13 12.73 Favored Pre-proline 0 N--CA 1.45 -0.449 0 O-C-N 121.538 -0.726 . . . . 0.0 112.65 179.078 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.49 ' HD2' ' CD1' ' A' ' 83' ' ' PHE . 18.2 Cg_endo -73.33 99.72 1.15 Allowed 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 123.988 3.125 . . . . 0.0 110.236 -177.374 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.4 t -95.93 108.12 20.46 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.743 -179.912 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 59.0 m-85 -83.36 150.82 61.31 Favored Pre-proline 0 C--O 1.241 0.638 0 CA-C-O 118.804 -0.617 . . . . 0.0 110.953 178.964 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -75.72 -36.55 2.09 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 123.311 2.674 . . . . 0.0 113.209 178.352 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -41.42 -34.4 0.53 Allowed 'General case' 0 C--N 1.351 0.669 0 O-C-N 125.53 1.769 . . . . 0.0 111.079 176.186 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 98.03 -4.91 61.13 Favored Glycine 0 N--CA 1.439 -1.143 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 178.25 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -71.92 136.55 46.91 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 122.107 0.956 . . . . 0.0 108.813 177.501 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -75.45 104.2 5.91 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 173.432 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.417 ' O ' ' CD2' ' A' ' 94' ' ' PHE . 8.3 t80 -37.84 145.41 0.07 Allowed 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.991 0.9 . . . . 0.0 111.884 177.131 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.87 61.3 3.75 Favored 'General case' 0 C--N 1.322 -0.591 0 O-C-N 119.902 -1.749 . . . . 0.0 110.679 176.004 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.417 ' CD2' ' O ' ' A' ' 92' ' ' TYR . 43.6 p90 -75.56 1.88 13.16 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.325 1.05 . . . . 0.0 113.144 175.253 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -98.11 -41.16 8.06 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.407 1.083 . . . . 0.0 110.305 178.853 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 18.8 m -87.09 110.61 20.22 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -178.965 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 12.7 pttt -57.62 -49.13 77.46 Favored 'General case' 0 C--O 1.241 0.609 0 O-C-N 121.872 -0.518 . . . . 0.0 110.724 177.372 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 13.1 mtmt -141.56 128.54 11.54 Favored Pre-proline 0 N--CA 1.444 -0.758 0 C-N-CA 125.383 1.473 . . . . 0.0 110.765 -177.265 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -71.34 173.57 49.49 Favored 'Cis proline' 0 CA--C 1.54 0.821 0 C-N-CA 122.934 -1.694 . . . . 0.0 110.955 -4.891 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -141.99 142.4 32.94 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 123.895 0.878 . . . . 0.0 109.674 179.365 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -80.82 175.59 10.55 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.613 1.195 . . . . 0.0 111.557 179.061 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -73.61 140.39 78.51 Favored Pre-proline 0 N--CA 1.449 -0.522 0 CA-C-O 118.567 -0.73 . . . . 0.0 110.846 175.717 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -70.23 -163.14 0.11 Allowed 'Trans proline' 0 CA--C 1.548 1.188 0 C-N-CA 124.001 3.134 . . . . 0.0 112.687 175.375 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -145.37 163.44 28.15 Favored Glycine 0 N--CA 1.446 -0.693 0 O-C-N 120.487 -1.383 . . . . 0.0 111.707 174.747 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.43 -57.73 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.244 2.629 . . . . 0.0 110.829 178.689 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . . . . . . . . . . . -63.64 135.72 56.97 Favored 'General case' 0 N--CA 1.438 -1.026 0 O-C-N 123.586 0.554 . . . . 0.0 110.589 178.045 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.434 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 3.1 mtm-85 -141.7 143.94 33.82 Favored 'General case' 0 C--O 1.211 -0.95 0 CA-C-O 117.225 -1.369 . . . . 0.0 110.807 178.578 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 2.8 p -81.98 119.2 31.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 C-N-CA 124.702 1.201 . . . . 0.0 110.104 176.904 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.46 HG23 ' CE2' ' A' ' 38' ' ' PHE . 1.8 mp -105.39 124.5 60.33 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.786 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 -177.113 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.406 ' CD1' ' HG3' ' A' ' 115' ' ' LYS . 15.3 p90 -141.33 162.73 34.79 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 123.192 0.597 . . . . 0.0 109.931 -179.42 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.2 p -95.34 165.11 12.54 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -177.83 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.554 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.6 OUTLIER -108.96 153.41 42.49 Favored Pre-proline 0 CA--C 1.54 0.593 0 O-C-N 122.121 -0.362 . . . . 0.0 111.442 177.454 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.554 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 18.8 Cg_endo -74.44 -54.31 0.15 OUTLIER 'Cis proline' 0 N--CA 1.455 -0.769 0 C-N-CA 123.491 -1.462 . . . . 0.0 110.427 -7.803 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -42.6 112.57 0.36 Allowed 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 116.544 -1.693 . . . . 0.0 110.061 175.89 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.406 ' HG3' ' CD1' ' A' ' 110' ' ' TYR . 0.1 OUTLIER -64.93 71.42 0.03 OUTLIER 'General case' 0 CA--C 1.514 -0.423 0 O-C-N 125.621 1.825 . . . . 0.0 108.357 179.529 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 18.0 t -74.55 75.67 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 -179.299 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.572 ' CZ ' ' HA2' ' A' ' 119' ' ' GLY . 27.6 t80 -41.08 119.39 1.16 Allowed 'General case' 0 N--CA 1.437 -1.122 0 C-N-CA 125.217 1.407 . . . . 0.0 110.063 176.798 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . 0.459 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 5.5 m -95.15 -45.48 7.18 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.837 -178.937 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . 0.572 ' HA2' ' CZ ' ' A' ' 117' ' ' PHE . . . 157.64 177.95 31.23 Favored Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.48 -179.841 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.434 ' HA ' ' O ' ' A' ' 107' ' ' ARG . 2.7 mp -101.23 124.37 54.89 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.289 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -178.586 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.448 HD12 ' CE1' ' A' ' 38' ' ' PHE . 7.5 pt -97.15 154.22 3.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 CA-C-N 120.232 1.378 . . . . 0.0 109.024 -179.598 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -173.8 156.25 2.8 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 122.468 1.128 . . . . 0.0 110.762 176.057 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.425 ' CE1' ' HG ' ' A' ' 131' ' ' LEU . 6.1 m-70 -90.03 93.0 9.22 Favored 'General case' 0 C--O 1.221 -0.445 0 O-C-N 121.338 -0.851 . . . . 0.0 109.095 -177.24 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.8 t -96.89 38.18 1.25 Allowed 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 124.014 1.864 . . . . 0.0 110.995 -178.804 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.8 tptt -101.72 -30.32 11.39 Favored 'General case' 0 C--O 1.221 -0.414 0 O-C-N 119.739 -1.85 . . . . 0.0 110.919 178.5 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -170.8 -68.61 0.02 OUTLIER 'General case' 0 C--O 1.222 -0.384 0 O-C-N 124.593 1.183 . . . . 0.0 110.419 -179.907 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -154.9 -44.53 0.08 Allowed 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 122.855 1.312 . . . . 0.0 111.001 179.304 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -154.77 79.66 1.08 Allowed 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 124.526 1.13 . . . . 0.0 109.01 -179.219 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -131.31 -106.55 1.09 Allowed Glycine 0 N--CA 1.459 0.176 0 N-CA-C 110.459 -1.057 . . . . 0.0 110.459 175.865 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.37 150.43 24.74 Favored 'General case' 0 C--N 1.322 -0.627 0 O-C-N 121.435 -1.038 . . . . 0.0 111.18 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.425 ' HG ' ' CE1' ' A' ' 123' ' ' HIS . 0.6 OUTLIER -105.27 145.65 30.39 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.657 . . . . . . . . 3 3 . 1 . 022 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.14 168.54 24.98 Favored 'General case' 0 CA--C 1.513 -0.467 0 C-N-CA 125.535 1.534 . . . . 0.0 109.82 179.922 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 7.4 tp -82.29 149.82 27.59 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.47 1.106 . . . . 0.0 108.728 175.243 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 8.3 m -63.11 -175.72 0.11 Allowed 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 124.01 1.862 . . . . 0.0 108.525 176.096 . . . . . . . . 1 1 . 1 . 022 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -172.01 121.87 0.47 Allowed 'General case' 0 C--N 1.316 -0.868 0 O-C-N 120.482 -1.386 . . . . 0.0 107.601 -176.925 . . . . . . . . 2 2 . 1 . 022 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.258 1.5 0 CA-C-O 113.472 -3.156 . . . . 0.0 110.493 172.617 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.538 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 . . . . . . . . . 0 0 . 1 . 023 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 1.8 p -123.85 122.73 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.093 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.9 m -86.83 119.75 27.39 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.467 -177.434 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.434 ' CG ' HG13 ' A' ' 120' ' ' ILE . 28.8 m95 -79.98 139.63 36.93 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.956 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -133.5 132.81 41.43 Favored 'General case' 0 CA--C 1.501 -0.905 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -178.36 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.1 OUTLIER -120.56 41.65 3.2 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.284 177.732 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 148.31 -96.26 0.17 Allowed Glycine 0 C--O 1.222 -0.637 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 -179.36 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -127.07 4.37 7.34 Favored Glycine 0 C--O 1.223 -0.593 0 N-CA-C 112.061 -0.416 . . . . 0.0 112.061 178.585 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . 0.499 ' HB2' ' CZ ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -111.13 141.29 44.82 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 -173.083 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . 0.4 ' CD2' ' N ' ' A' ' 10' ' ' LEU . 1.2 mm? -113.42 120.23 40.33 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -171.808 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.575 ' CE2' ' CB ' ' A' ' 106' ' ' ALA . 63.4 m-85 -115.18 101.41 8.94 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 125.065 1.346 . . . . 0.0 109.595 -175.653 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -57.62 120.94 9.21 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.984 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.513 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 6.8 tp-100 -46.49 -43.58 16.9 Favored 'General case' 0 C--O 1.2 -1.547 0 O-C-N 124.246 0.967 . . . . 0.0 111.498 179.591 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -48.22 -49.22 33.89 Favored 'General case' 0 C--O 1.194 -1.821 0 CA-C-N 117.693 0.224 . . . . 0.0 110.768 176.474 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.46 -34.58 77.48 Favored 'General case' 0 C--O 1.195 -1.779 0 O-C-N 120.712 -1.242 . . . . 0.0 111.922 172.985 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.0 -50.59 72.9 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 121.1 1.773 . . . . 0.0 112.067 174.269 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.434 ' O ' ' CD2' ' A' ' 21' ' ' HIS . 3.6 pt-20 -78.5 -36.94 44.36 Favored 'General case' 0 C--O 1.207 -1.145 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.754 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 43.2 t -71.37 -63.25 1.15 Allowed 'General case' 0 CA--C 1.503 -0.833 0 C-N-CA 125.463 1.505 . . . . 0.0 108.981 -177.863 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.49 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 10.4 t-20 -39.54 -37.92 0.54 Allowed 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 123.942 0.897 . . . . 0.0 111.768 174.771 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -80.2 -40.35 27.36 Favored 'General case' 0 N--CA 1.443 -0.801 0 O-C-N 124.757 1.286 . . . . 0.0 113.342 175.229 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.434 ' CD2' ' O ' ' A' ' 17' ' ' GLU . 4.6 m170 -42.44 -40.38 2.55 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.467 1.507 . . . . 0.0 109.611 178.442 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.49 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -71.16 -49.46 43.63 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-O 118.162 -0.923 . . . . 0.0 111.279 177.036 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . 0.491 ' HB2' ' CE1' ' A' ' 83' ' ' PHE . . . -35.56 131.76 0.53 Allowed Pre-proline 0 N--CA 1.441 -0.902 0 O-C-N 125.067 1.479 . . . . 0.0 112.054 174.656 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -73.01 122.1 7.83 Favored 'Trans proline' 0 N--CA 1.446 -1.319 0 C-N-CA 122.24 1.96 . . . . 0.0 110.292 -178.115 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.441 ' CD1' ' HE2' ' A' ' 115' ' ' LYS . 3.3 tp -59.51 97.84 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.658 179.057 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -179.98 166.02 1.25 Allowed 'General case' 0 C--N 1.324 -0.516 0 O-C-N 123.548 0.53 . . . . 0.0 109.943 -177.699 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -103.46 98.46 8.36 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.531 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 66.83 79.19 0.22 Allowed Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 177.714 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -151.44 27.99 0.65 Allowed 'General case' 0 CA--C 1.513 -0.443 0 O-C-N 122.012 -0.699 . . . . 0.0 110.964 178.533 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 10.8 p -122.47 148.62 44.92 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -175.753 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -39.72 -56.14 2.6 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 111.752 -0.539 . . . . 0.0 111.752 -179.517 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 29.4 t -69.35 -60.14 2.54 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 116.909 -1.519 . . . . 0.0 111.354 176.958 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 163.04 -56.7 0.0 OUTLIER 'General case' 0 C--O 1.223 -0.329 0 O-C-N 125.603 1.814 . . . . 0.0 110.77 178.136 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.536 ' CD1' ' HD3' ' A' ' 84' ' ' PRO . 69.1 m-85 -60.25 144.7 87.22 Favored Pre-proline 0 N--CA 1.437 -1.08 0 CA-C-O 118.051 -0.976 . . . . 0.0 113.127 178.849 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . . . . . . . . . 25.0 Cg_endo -74.92 165.05 86.91 Favored 'Cis proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.361 -1.933 . . . . 0.0 112.027 -0.53 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.445 ' CD2' ' CD1' ' A' ' 34' ' ' TYR . 1.0 OUTLIER -139.42 168.21 20.33 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 121.546 -0.721 . . . . 0.0 110.308 -178.343 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.635 ' CD1' ' CD2' ' A' ' 79' ' ' TYR . 22.7 t90 -70.31 113.72 7.74 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 179.094 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.445 ' CE1' ' HA ' ' A' ' 40' ' ' ASN . 8.5 t80 -84.71 79.44 9.6 Favored 'General case' 0 N--CA 1.427 -1.596 0 C-N-CA 124.888 1.275 . . . . 0.0 108.872 178.234 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.476 HG21 ' CE3' ' A' ' 37' ' ' TRP . 60.6 p -36.51 -38.07 0.15 Allowed 'General case' 0 C--O 1.216 -0.677 0 C-N-CA 124.439 1.095 . . . . 0.0 110.596 176.9 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.445 ' HA ' ' CE1' ' A' ' 38' ' ' PHE . 65.2 t30 69.83 7.47 6.24 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 124.099 0.959 . . . . 0.0 108.599 176.992 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 120.81 -35.37 3.72 Favored Glycine 0 N--CA 1.429 -1.811 0 CA-C-O 117.293 -1.837 . . . . 0.0 111.796 -175.705 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.41 ' CD2' ' HA2' ' A' ' 46' ' ' GLY . 60.4 m-85 -51.42 173.13 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 118.066 0.933 . . . . 0.0 110.424 -178.354 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.66 -43.01 8.11 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -179.169 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.523 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -178.29 -52.2 0.07 OUTLIER Glycine 0 C--N 1.338 0.682 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 -179.657 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.5 -90.74 0.09 Allowed 'General case' 0 C--O 1.217 -0.647 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -179.86 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . 0.41 ' HA2' ' CD2' ' A' ' 42' ' ' TYR . . . -148.93 28.75 1.27 Allowed Glycine 0 N--CA 1.443 -0.862 0 O-C-N 120.898 -1.126 . . . . 0.0 110.616 -176.362 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.3 mttp -126.06 144.28 50.79 Favored 'General case' 0 CA--C 1.501 -0.92 0 CA-C-O 117.703 -1.141 . . . . 0.0 109.115 -177.695 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.5 mt -106.46 159.12 30.91 Favored Pre-proline 0 C--N 1.319 -0.738 0 O-C-N 124.151 0.907 . . . . 0.0 109.26 -179.232 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -73.54 -175.61 2.13 Favored 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 122.954 2.436 . . . . 0.0 111.564 179.05 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.7 tptp -68.35 98.38 0.83 Allowed 'General case' 0 N--CA 1.445 -0.691 0 O-C-N 121.35 -0.844 . . . . 0.0 109.259 177.185 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.23 88.3 1.07 Allowed Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 179.042 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -151.32 137.93 18.75 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 119.286 -0.387 . . . . 0.0 111.294 177.347 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.9 m -128.95 103.36 18.76 Favored Pre-proline 0 C--N 1.327 -0.392 0 O-C-N 124.629 1.206 . . . . 0.0 110.225 -178.56 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -72.42 158.28 51.58 Favored 'Trans proline' 0 N--CA 1.448 -1.194 0 C-N-CA 122.226 1.95 . . . . 0.0 111.762 178.916 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.43 ' CG2' ' HB2' ' A' ' 133' ' ' LEU . 5.4 mt -77.41 123.41 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.023 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -91.12 135.69 33.6 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 179.01 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.488 ' CE2' ' SG ' ' A' ' 62' ' ' CYS . 15.3 m-85 -114.74 -52.48 2.7 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.225 179.91 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 126.9 -5.57 7.4 Favored Glycine 0 C--O 1.223 -0.585 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.853 -177.232 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.95 132.1 36.76 Favored 'General case' 0 CA--C 1.5 -0.978 0 CA-C-O 117.651 -1.166 . . . . 0.0 109.393 178.891 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 31.1 t -67.09 -9.78 43.07 Favored 'General case' 0 C--O 1.221 -0.439 0 O-C-N 125.034 1.459 . . . . 0.0 111.036 177.481 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -92.15 -49.77 6.02 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 124.032 0.933 . . . . 0.0 108.887 -179.193 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.488 ' SG ' ' CE2' ' A' ' 57' ' ' PHE . 3.9 t -75.89 -6.61 51.65 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 123.766 0.666 . . . . 0.0 111.214 175.988 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -99.94 -32.58 10.9 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.571 0.749 . . . . 0.0 110.165 177.987 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.483 ' HD3' ' CE1' ' A' ' 78' ' ' HIS . 0.0 OUTLIER -51.5 166.03 0.39 Allowed Pre-proline 0 N--CA 1.441 -0.89 0 CA-C-O 121.725 0.774 . . . . 0.0 111.018 179.913 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 26.6 Cg_endo -72.11 135.24 24.7 Favored 'Trans proline' 0 N--CA 1.44 -1.645 0 C-N-CA 121.291 1.327 . . . . 0.0 113.865 174.959 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -71.72 171.31 16.69 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 122.529 2.153 . . . . 0.0 112.095 178.217 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.8 tptt -138.48 72.18 1.4 Allowed 'General case' 0 C--O 1.195 -1.813 0 CA-C-O 116.385 -1.769 . . . . 0.0 108.287 178.185 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.458 ' CD2' ' CD2' ' A' ' 37' ' ' TRP . 53.2 t-80 -79.4 159.36 27.11 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 119.463 1.029 . . . . 0.0 110.603 178.207 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.31 -178.35 6.02 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.78 0.8 . . . . 0.0 110.011 -179.681 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -86.37 62.98 7.75 Favored 'General case' 0 C--O 1.209 -1.039 0 O-C-N 121.299 -0.875 . . . . 0.0 110.926 178.08 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -177.6 -39.27 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.831 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 129.82 -82.88 0.33 Allowed Glycine 0 C--O 1.207 -1.573 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 -179.301 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.1 p-10 -115.88 53.17 0.86 Allowed 'General case' 0 C--N 1.313 -0.979 0 O-C-N 120.744 -1.445 . . . . 0.0 107.978 -177.762 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -55.8 -115.94 0.01 OUTLIER Glycine 0 C--O 1.217 -0.93 0 O-C-N 123.879 0.737 . . . . 0.0 111.9 178.172 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.9 mttm -42.73 -82.92 0.01 OUTLIER 'General case' 0 C--O 1.223 -0.311 0 O-C-N 121.443 -1.034 . . . . 0.0 110.894 179.946 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.455 ' CG2' ' O ' ' A' ' 76' ' ' THR . 0.6 OUTLIER -146.43 26.77 1.15 Allowed 'General case' 0 CA--C 1.507 -0.682 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.164 178.203 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.475 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 0.8 OUTLIER -26.54 96.52 0.01 OUTLIER 'General case' 0 C--O 1.213 -0.827 0 C-N-CA 124.231 1.012 . . . . 0.0 112.331 -178.688 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.483 ' CE1' ' HD3' ' A' ' 64' ' ' ARG . 16.5 p80 -94.71 23.77 5.17 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -173.756 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.635 ' CD2' ' CD1' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -57.51 -177.25 0.02 OUTLIER 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 174.889 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . 0.402 ' CD2' ' CG2' ' A' ' 109' ' ' ILE . 0.4 OUTLIER -100.48 149.4 23.72 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.371 175.42 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -138.42 118.92 13.83 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 124.021 0.825 . . . . 0.0 108.873 -179.027 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.511 ' CB ' ' CD1' ' A' ' 109' ' ' ILE . 0.2 OUTLIER -87.68 163.12 16.71 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-O 122.238 1.018 . . . . 0.0 111.581 178.702 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.491 ' CE1' ' HB2' ' A' ' 23' ' ' ALA . 50.9 t80 -153.11 122.13 3.22 Favored Pre-proline 0 N--CA 1.446 -0.634 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.876 -179.424 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.536 ' HD3' ' CD1' ' A' ' 34' ' ' TYR . 18.2 Cg_endo -71.93 112.09 3.32 Favored 'Trans proline' 0 N--CA 1.447 -1.21 0 C-N-CA 123.506 2.804 . . . . 0.0 110.792 -177.946 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.78 121.22 43.39 Favored 'General case' 0 CA--C 1.51 -0.574 0 O-C-N 124.139 0.899 . . . . 0.0 110.268 -179.319 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 58.4 m-85 -82.11 157.7 68.13 Favored Pre-proline 0 N--CA 1.444 -0.76 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 178.725 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -75.52 -37.95 1.58 Allowed 'Trans proline' 0 CA--C 1.5 -1.176 0 C-N-CA 122.392 2.061 . . . . 0.0 112.84 179.542 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.35 -30.82 2.26 Favored 'General case' 0 C--O 1.224 -0.285 0 C-N-CA 124.902 1.281 . . . . 0.0 108.786 -179.648 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 95.91 -9.94 68.2 Favored Glycine 0 N--CA 1.431 -1.662 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 176.443 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.403 ' O ' ' CD2' ' A' ' 90' ' ' HIS . 4.1 p-80 -61.92 125.91 25.49 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.064 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.98 97.22 0.06 Allowed 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 123.12 0.568 . . . . 0.0 110.234 176.121 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.517 ' CD2' ' HB3' ' A' ' 94' ' ' PHE . 6.2 t80 -36.25 140.49 0.13 Allowed 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 121.919 0.866 . . . . 0.0 111.285 179.541 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.51 59.79 1.98 Allowed 'General case' 0 N--CA 1.444 -0.772 0 O-C-N 120.227 -1.546 . . . . 0.0 110.156 177.465 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.517 ' HB3' ' CD2' ' A' ' 92' ' ' TYR . 28.2 p90 -77.27 -8.12 57.08 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 123.443 0.697 . . . . 0.0 111.633 177.67 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.87 -33.33 13.56 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 122.166 0.984 . . . . 0.0 109.679 -179.624 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.87 104.08 11.99 Favored 'General case' 0 N--CA 1.443 -0.812 0 O-C-N 121.236 -0.915 . . . . 0.0 108.987 179.907 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.7 -49.38 77.96 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.724 178.818 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 39.1 pttt -139.22 125.79 12.56 Favored Pre-proline 0 N--CA 1.435 -1.18 0 C-N-CA 123.633 0.773 . . . . 0.0 108.975 -176.833 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -71.14 177.34 32.85 Favored 'Cis proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.376 -1.927 . . . . 0.0 111.469 -4.057 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -132.9 144.88 50.46 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 122.724 0.41 . . . . 0.0 109.988 177.48 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -95.9 152.64 18.32 Favored 'General case' 0 C--N 1.319 -0.747 0 O-C-N 124.338 1.024 . . . . 0.0 110.366 177.53 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -44.66 149.01 0.83 Allowed Pre-proline 0 N--CA 1.44 -0.948 0 O-C-N 123.926 0.766 . . . . 0.0 111.694 174.025 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -73.14 -164.88 0.21 Allowed 'Trans proline' 0 N--CA 1.446 -1.317 0 C-N-CA 122.394 2.063 . . . . 0.0 111.557 178.155 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -139.12 157.18 24.8 Favored Glycine 0 N--CA 1.443 -0.9 0 O-C-N 121.955 -0.465 . . . . 0.0 112.206 177.856 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -75.09 -75.91 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 122.806 2.338 . . . . 0.0 110.956 179.659 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.575 ' CB ' ' CE2' ' A' ' 11' ' ' TYR . . . -60.4 136.54 58.07 Favored 'General case' 0 N--CA 1.441 -0.922 0 O-C-N 123.434 0.459 . . . . 0.0 110.573 178.747 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -141.71 146.98 36.71 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.853 -178.607 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 6.6 p -83.03 125.76 40.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 O-C-N 123.719 0.637 . . . . 0.0 110.119 178.589 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.511 ' CD1' ' CB ' ' A' ' 82' ' ' GLU . 9.4 mm -104.62 140.87 21.43 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.92 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.063 179.614 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.452 ' CD1' ' HG3' ' A' ' 115' ' ' LYS . 9.7 p90 -166.12 155.48 11.69 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 121.841 0.829 . . . . 0.0 110.38 -178.944 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.4 p -90.86 160.96 15.45 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.93 -179.977 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.529 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -109.48 153.95 42.56 Favored Pre-proline 0 N--CA 1.44 -0.969 0 C-N-CA 123.055 0.542 . . . . 0.0 111.367 179.149 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.529 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 19.1 Cg_endo -73.29 -54.05 0.15 OUTLIER 'Cis proline' 0 CA--C 1.504 -1.007 0 C-N-CA 122.538 -1.859 . . . . 0.0 110.18 -5.434 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -42.36 107.36 0.08 Allowed 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 116.961 -1.495 . . . . 0.0 110.237 179.803 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.452 ' HG3' ' CD1' ' A' ' 110' ' ' TYR . 0.2 OUTLIER -64.44 76.6 0.04 OUTLIER 'General case' 0 CA--C 1.512 -0.493 0 O-C-N 125.061 1.476 . . . . 0.0 108.802 -177.621 . . . . . . . . 3 3 . 1 . 023 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 38.1 t -75.95 74.23 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 -176.516 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.513 ' CZ ' ' NE2' ' A' ' 13' ' ' GLN . 39.1 t80 -36.35 105.97 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 124.629 1.171 . . . . 0.0 110.55 179.606 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . 0.459 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 8.7 m -83.52 -46.27 12.63 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -178.771 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 162.34 -144.96 10.15 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 179.727 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.434 HG13 ' CG ' ' A' ' 4' ' ' TRP . 1.2 mm -128.72 144.67 37.34 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.091 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -176.519 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 8.6 pt -133.64 155.46 40.21 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.722 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -178.561 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -171.93 148.83 2.35 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.69 0.757 . . . . 0.0 109.953 177.711 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . 0.44 ' CG ' HD12 ' A' ' 131' ' ' LEU . 5.1 m-70 -89.81 95.95 10.47 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 -176.922 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 3.0 t -98.16 41.13 1.14 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 122.349 1.071 . . . . 0.0 111.466 179.904 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.4 tptt -106.09 -27.55 11.04 Favored 'General case' 0 C--O 1.221 -0.42 0 O-C-N 121.563 -0.71 . . . . 0.0 110.477 178.921 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -173.07 -67.82 0.02 OUTLIER 'General case' 0 C--O 1.221 -0.408 0 CA-C-O 121.625 0.726 . . . . 0.0 110.617 178.39 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -155.54 -43.61 0.08 Allowed 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 122.64 1.21 . . . . 0.0 110.271 178.812 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -154.41 78.59 1.09 Allowed 'General case' 0 N--CA 1.443 -0.805 0 CA-C-O 122.582 1.182 . . . . 0.0 109.45 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -130.65 -104.19 1.02 Allowed Glycine 0 N--CA 1.452 -0.243 0 O-C-N 120.954 -1.091 . . . . 0.0 110.503 178.106 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -84.0 146.16 28.13 Favored 'General case' 0 CA--C 1.513 -0.473 0 O-C-N 122.197 -0.59 . . . . 0.0 110.871 -179.843 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.44 HD12 ' CG ' ' A' ' 123' ' ' HIS . 5.0 tp -111.33 137.32 49.23 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 122.826 0.451 . . . . 0.0 110.585 178.178 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 6.9 ptmm? -140.34 171.94 13.44 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.74 -179.527 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.43 ' HB2' ' CG2' ' A' ' 55' ' ' ILE . 6.0 tp -88.39 141.77 28.27 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.237 0.96 . . . . 0.0 109.244 178.866 . . . . . . . . 2 2 . 1 . 023 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 57.5 m -67.57 -176.1 0.58 Allowed 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 121.862 0.839 . . . . 0.0 109.307 177.494 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 2.1 m -156.27 84.92 0.99 Allowed 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -178.855 . . . . . . . . 1 1 . 1 . 023 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.258 1.543 0 CA-C-O 115.151 -2.357 . . . . 0.0 112.528 173.957 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.771 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 . . . . . . . . . 0 0 . 1 . 024 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . 0.468 ' CG1' ' CD2' ' A' ' 136' ' ' HIS . 7.6 p -104.44 167.99 2.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 O-C-N 123.973 0.796 . . . . 0.0 110.257 177.995 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.4 m -85.94 109.13 18.54 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 125.936 1.695 . . . . 0.0 110.962 -179.493 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.448 ' CD1' ' HB2' ' A' ' 13' ' ' GLN . 25.5 m95 -77.67 142.4 38.84 Favored 'General case' 0 N--CA 1.442 -0.863 0 O-C-N 121.709 -0.619 . . . . 0.0 110.164 179.546 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -131.97 134.36 45.53 Favored 'General case' 0 CA--C 1.5 -0.943 0 C-N-CA 123.204 0.602 . . . . 0.0 110.117 -176.957 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -134.07 -73.46 0.48 Allowed 'General case' 0 C--O 1.222 -0.393 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 177.367 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -80.44 42.5 2.61 Favored Glycine 0 C--O 1.211 -1.281 0 CA-C-O 117.844 -1.531 . . . . 0.0 111.373 179.905 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 64.04 12.78 50.69 Favored Glycine 0 C--O 1.22 -0.751 0 CA-C-N 119.361 1.581 . . . . 0.0 111.756 -175.067 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -114.33 149.45 36.01 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -176.119 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 2.1 mm? -105.18 125.5 51.05 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 -172.169 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.512 ' CE2' ' CB ' ' A' ' 106' ' ' ALA . 90.5 m-85 -120.27 106.96 12.41 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 124.509 1.124 . . . . 0.0 108.015 -174.076 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -54.19 116.28 2.52 Favored 'General case' 0 C--O 1.206 -1.187 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.724 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.449 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 6.3 tp-100 -54.79 -45.46 74.32 Favored 'General case' 0 C--O 1.196 -1.757 0 CA-C-O 116.429 -1.748 . . . . 0.0 111.993 178.881 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -51.0 -36.28 38.49 Favored 'General case' 0 C--O 1.189 -2.126 0 O-C-N 124.117 0.886 . . . . 0.0 110.242 175.843 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -75.59 -40.85 55.9 Favored 'General case' 0 C--O 1.197 -1.696 0 CA-C-N 121.765 2.075 . . . . 0.0 112.177 170.039 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -52.1 -35.9 49.26 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 117.463 -3.273 . . . . 0.0 113.406 171.018 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.428 ' O ' ' CD2' ' A' ' 21' ' ' HIS . 0.9 OUTLIER -94.5 -38.43 10.91 Favored 'General case' 0 C--O 1.2 -1.506 0 CA-C-O 122.657 1.218 . . . . 0.0 108.009 178.275 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 26.1 t -73.22 -58.49 3.27 Favored 'General case' 0 C--O 1.201 -1.467 1 O-C-N 115.447 -4.533 . . . . 0.0 106.838 -177.306 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.501 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 1.3 t-20 -50.46 -27.92 7.37 Favored 'General case' 0 C--N 1.311 -1.076 0 O-C-N 117.733 -3.104 . . . . 0.0 113.391 173.167 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 24.0 p -86.98 -16.95 34.26 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 123.629 0.581 . . . . 0.0 112.527 175.191 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.428 ' CD2' ' O ' ' A' ' 17' ' ' GLU . 7.5 m170 -66.19 -39.5 89.73 Favored 'General case' 0 C--O 1.215 -0.719 0 C-N-CA 124.973 1.309 . . . . 0.0 107.881 179.773 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.501 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -75.47 -41.78 54.75 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 116.647 -1.644 . . . . 0.0 109.269 -178.519 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -40.31 130.07 1.7 Allowed Pre-proline 0 N--CA 1.443 -0.778 0 O-C-N 126.649 2.468 . . . . 0.0 111.943 177.764 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . 0.435 ' HD2' ' CD ' ' A' ' 35' ' ' PRO . 14.5 Cg_endo -72.73 115.02 4.18 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 122.103 1.868 . . . . 0.0 109.83 -176.133 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.476 ' CD1' ' HE2' ' A' ' 115' ' ' LYS . 2.5 tp -56.14 100.28 0.04 OUTLIER 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 123.272 0.629 . . . . 0.0 111.225 178.711 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -167.72 166.27 13.86 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.788 0.804 . . . . 0.0 109.453 -177.195 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.451 ' HB2' ' CE1' ' A' ' 79' ' ' TYR . 5.8 t0 -100.42 73.3 1.65 Allowed 'General case' 0 CA--C 1.548 0.87 0 CA-C-O 124.048 1.88 . . . . 0.0 107.104 179.014 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.58 86.03 0.57 Allowed Glycine 0 N--CA 1.448 -0.503 0 O-C-N 118.816 -2.427 . . . . 0.0 109.36 176.504 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.14 33.52 0.58 Allowed 'General case' 0 CA--C 1.514 -0.425 0 O-C-N 121.205 -1.174 . . . . 0.0 111.23 177.204 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 55.3 p -129.73 143.85 51.01 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -175.927 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -38.08 -67.79 0.48 Allowed Glycine 0 C--N 1.338 0.642 0 O-C-N 124.117 0.885 . . . . 0.0 112.979 -178.552 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 32.2 t -51.86 -66.38 0.39 Allowed 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 115.744 -2.074 . . . . 0.0 110.554 174.328 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.2 p 167.44 -56.42 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.418 0 O-C-N 126.927 2.642 . . . . 0.0 111.256 179.895 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.488 ' CD2' ' HD3' ' A' ' 84' ' ' PRO . 32.3 m-85 -69.27 150.03 97.32 Favored Pre-proline 0 N--CA 1.429 -1.478 0 CA-C-O 116.494 -1.717 . . . . 0.0 112.708 178.995 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.435 ' CD ' ' HD2' ' A' ' 24' ' ' PRO . 37.5 Cg_endo -72.24 138.56 55.03 Favored 'Cis proline' 0 N--CA 1.442 -1.519 0 C-N-CA 121.281 -2.383 . . . . 0.0 112.264 -4.602 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.415 ' O ' HD11 ' A' ' 81' ' ' LEU . 0.7 OUTLIER -128.94 150.6 50.31 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-O 116.91 -1.519 . . . . 0.0 113.781 173.44 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.531 ' CD1' ' HB2' ' A' ' 79' ' ' TYR . 19.1 t90 -44.42 151.85 0.23 Allowed 'General case' 0 C--O 1.237 0.428 0 CA-C-O 122.577 1.179 . . . . 0.0 110.872 176.305 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.518 ' CZ ' ' CD1' ' A' ' 121' ' ' ILE . 3.0 t80 -127.87 79.64 1.91 Allowed 'General case' 0 N--CA 1.417 -2.089 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 -172.921 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.422 ' CG2' ' CH2' ' A' ' 37' ' ' TRP . 38.1 p -36.96 -39.51 0.23 Allowed 'General case' 0 C--O 1.205 -1.288 0 C-N-CA 125.388 1.475 . . . . 0.0 110.506 173.773 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.504 ' HA ' ' CE1' ' A' ' 38' ' ' PHE . 43.5 t30 59.14 17.42 5.58 Favored 'General case' 0 C--O 1.206 -1.211 0 CA-C-N 120.426 1.466 . . . . 0.0 107.39 173.154 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 113.09 -45.84 1.26 Allowed Glycine 0 N--CA 1.428 -1.851 0 O-C-N 118.716 -2.49 . . . . 0.0 113.321 -170.639 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.404 ' CZ ' ' HD3' ' A' ' 66' ' ' PRO . 83.3 m-85 -45.21 153.61 0.2 Allowed 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.318 1.047 . . . . 0.0 111.942 178.097 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.09 -36.38 24.92 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.14 178.593 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 126.56 42.16 0.3 Allowed Glycine 0 C--N 1.341 0.819 0 C-N-CA 123.922 0.773 . . . . 0.0 111.299 -177.296 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -146.64 -69.64 0.25 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.294 179.707 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -146.43 -73.49 0.02 OUTLIER Glycine 0 C--O 1.195 -2.287 0 N-CA-C 107.591 -2.204 . . . . 0.0 107.591 -176.192 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.5 ptpt -100.96 -165.33 1.19 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 120.468 2.134 . . . . 0.0 110.35 178.638 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 0.0 OUTLIER -113.35 174.12 2.49 Favored Pre-proline 0 N--CA 1.438 -1.041 0 C-N-CA 123.623 0.769 . . . . 0.0 110.028 -178.93 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.27 156.91 46.22 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.362 2.041 . . . . 0.0 110.855 179.426 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.71 98.1 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.301 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.31 55.83 0.24 Allowed Glycine 0 CA--C 1.507 -0.442 0 CA-C-O 118.345 -1.253 . . . . 0.0 111.889 -178.318 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 1.3 mmt180 -149.79 143.07 25.15 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-N 117.671 0.735 . . . . 0.0 110.811 177.055 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.1 m -131.45 96.74 20.67 Favored Pre-proline 0 C--N 1.324 -0.531 0 O-C-N 124.318 1.011 . . . . 0.0 110.352 -178.628 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -72.36 173.23 13.44 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 122.022 1.814 . . . . 0.0 111.723 179.267 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.423 ' O ' ' CE1' ' A' ' 57' ' ' PHE . 8.4 mt -86.53 111.62 21.69 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.076 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 -176.348 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.23 137.49 36.66 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 120.617 -1.302 . . . . 0.0 108.703 178.922 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.491 ' CG ' ' SG ' ' A' ' 118' ' ' CYS . 3.0 m-85 -118.5 -52.79 2.35 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.628 -179.999 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 128.73 -9.95 6.39 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 123.48 0.562 . . . . 0.0 111.722 -176.74 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 15.2 mmtt -69.08 170.57 9.71 Favored 'General case' 0 C--O 1.197 -1.692 0 CA-C-O 118.217 -0.897 . . . . 0.0 111.127 177.16 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.4 m -101.69 -47.54 4.59 Favored 'General case' 0 C--O 1.19 -2.027 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.596 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.29 -40.92 64.17 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-N 120.888 1.676 . . . . 0.0 108.974 178.698 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.488 ' SG ' ' CD1' ' A' ' 57' ' ' PHE . 11.0 t -71.84 -14.58 62.0 Favored 'General case' 0 C--N 1.348 0.533 0 O-C-N 123.468 0.48 . . . . 0.0 110.138 178.198 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -95.62 -32.75 12.65 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 174.693 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.94 168.36 0.43 Allowed Pre-proline 0 N--CA 1.429 -1.493 0 CA-C-O 122.349 1.071 . . . . 0.0 108.674 -177.635 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -72.71 124.7 9.94 Favored 'Trans proline' 0 N--CA 1.438 -1.768 0 C-N-CA 121.068 1.179 . . . . 0.0 115.13 172.123 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.404 ' HD3' ' CZ ' ' A' ' 42' ' ' TYR . 18.6 Cg_endo -72.04 164.15 36.55 Favored 'Trans proline' 0 CA--C 1.502 -1.111 0 C-N-CA 123.595 2.863 . . . . 0.0 111.802 179.614 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 8.2 tptt -126.06 130.38 51.02 Favored 'General case' 0 C--O 1.205 -1.273 0 CA-C-O 117.329 -1.319 . . . . 0.0 108.382 178.951 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 41.4 t-80 -122.6 161.5 23.62 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 119.226 0.921 . . . . 0.0 110.214 174.612 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.6 179.08 8.92 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.2 179.223 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.8 mptt -84.82 69.18 10.69 Favored 'General case' 0 C--O 1.215 -0.757 0 O-C-N 121.828 -0.545 . . . . 0.0 111.422 177.146 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -176.94 -41.36 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.223 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.443 ' CA ' ' HB3' ' A' ' 27' ' ' ASP . . . 122.07 -63.9 0.51 Allowed Glycine 0 N--CA 1.442 -0.958 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -179.061 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . 0.408 ' ND2' ' N ' ' A' ' 73' ' ' ASN . 0.1 OUTLIER -133.98 56.74 1.83 Allowed 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 -173.06 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.96 -109.73 0.01 OUTLIER Glycine 0 C--O 1.215 -1.035 0 CA-C-O 121.998 0.777 . . . . 0.0 111.583 179.412 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 19.8 mttt -60.98 -98.82 0.0 OUTLIER 'General case' 0 C--O 1.214 -0.794 0 O-C-N 120.017 -1.872 . . . . 0.0 109.941 179.374 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.449 ' CG2' ' O ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -120.94 15.66 11.67 Favored 'General case' 0 CA--C 1.493 -1.226 0 O-C-N 119.331 -2.105 . . . . 0.0 110.611 -179.241 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.433 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 1.3 m-20 -24.3 95.56 0.01 OUTLIER 'General case' 0 C--O 1.197 -1.689 0 C-N-CA 126.768 2.027 . . . . 0.0 112.948 -176.615 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.455 ' H ' ' CD2' ' A' ' 78' ' ' HIS . 6.4 p80 -88.98 60.45 5.46 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 -167.929 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.531 ' HB2' ' CD1' ' A' ' 37' ' ' TRP . 52.0 p90 -91.11 136.78 32.85 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 124.672 1.189 . . . . 0.0 111.602 -178.446 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 2.5 mt -67.31 128.88 38.06 Favored 'General case' 0 C--O 1.205 -1.281 0 CA-C-O 117.481 -1.247 . . . . 0.0 109.271 178.811 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.415 HD11 ' O ' ' A' ' 36' ' ' HIS . 0.2 OUTLIER -121.28 135.03 55.17 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 121.025 1.739 . . . . 0.0 107.329 178.608 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.432 ' CB ' ' CD1' ' A' ' 109' ' ' ILE . 0.1 OUTLIER -101.56 166.09 10.89 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-O 123.168 1.461 . . . . 0.0 114.503 171.218 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.478 ' CD1' ' HD2' ' A' ' 84' ' ' PRO . 52.2 t80 -146.3 131.82 9.26 Favored Pre-proline 0 CA--C 1.498 -1.024 0 O-C-N 117.823 -3.048 . . . . 0.0 113.115 179.462 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.5 ' O ' ' CE2' ' A' ' 92' ' ' TYR . 19.3 Cg_endo -72.98 106.18 2.1 Favored 'Trans proline' 0 CA--C 1.473 -2.554 0 C-N-CA 124.645 3.563 . . . . 0.0 110.583 -175.698 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.497 ' HA ' ' CZ ' ' A' ' 92' ' ' TYR . 0.6 OUTLIER -100.73 121.01 40.94 Favored 'General case' 0 CA--C 1.49 -1.332 0 O-C-N 125.613 1.82 . . . . 0.0 112.36 -179.306 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.597 ' CD1' ' CD1' ' A' ' 92' ' ' TYR . 13.8 m-85 -85.19 162.66 48.3 Favored Pre-proline 0 N--CA 1.44 -0.963 0 CA-C-N 120.475 1.489 . . . . 0.0 111.179 -179.423 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -77.77 -44.34 0.18 Allowed 'Trans proline' 0 CA--C 1.516 -0.386 0 C-N-CA 122.161 1.907 . . . . 0.0 112.431 179.605 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -48.62 -26.4 2.23 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 125.279 1.612 . . . . 0.0 110.913 174.446 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.92 17.64 80.2 Favored Glycine 0 N--CA 1.431 -1.676 0 CA-C-O 117.39 -1.783 . . . . 0.0 109.706 179.592 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.419 ' O ' ' CE1' ' A' ' 92' ' ' TYR . 1.0 OUTLIER -82.74 147.52 28.39 Favored 'General case' 0 C--O 1.182 -2.454 0 CA-C-O 116.929 -1.51 . . . . 0.0 110.359 -179.593 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -62.09 134.39 56.54 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 123.54 2.882 . . . . 0.0 111.831 176.173 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.597 ' CD1' ' CD1' ' A' ' 86' ' ' PHE . 0.2 OUTLIER -93.6 136.48 33.83 Favored 'General case' 0 C--O 1.202 -1.399 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 -173.21 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.39 61.24 0.47 Allowed 'General case' 0 C--N 1.318 -0.778 0 O-C-N 119.769 -1.832 . . . . 0.0 111.029 175.075 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.428 ' CD2' ' HZ ' ' A' ' 83' ' ' PHE . 1.5 p90 -74.95 -23.96 58.39 Favored 'General case' 0 N--CA 1.426 -1.651 0 C-N-CA 126.401 1.88 . . . . 0.0 109.581 179.749 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.56 -31.49 21.19 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 -178.844 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.9 t -82.38 104.74 12.9 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 -177.61 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 32.6 pttt -58.27 -50.71 72.63 Favored 'General case' 0 C--O 1.227 -0.126 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 179.241 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.4 mttp -137.41 124.88 14.04 Favored Pre-proline 0 N--CA 1.438 -1.027 0 C-N-CA 124.787 1.235 . . . . 0.0 109.095 -173.719 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -73.26 175.01 47.31 Favored 'Cis proline' 0 CA--C 1.54 0.822 0 O-C-N 124.934 2.018 . . . . 0.0 111.564 -2.913 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 9.6 tttp -137.6 117.5 13.26 Favored 'General case' 0 C--O 1.22 -0.467 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.152 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -72.54 154.3 40.88 Favored 'General case' 0 C--O 1.253 1.243 0 O-C-N 124.62 1.2 . . . . 0.0 110.32 176.918 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -48.43 124.55 11.73 Favored Pre-proline 0 N--CA 1.438 -1.07 0 C-N-CA 125.113 1.365 . . . . 0.0 112.105 172.758 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -70.3 -164.95 0.15 Allowed 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 122.691 2.261 . . . . 0.0 112.125 177.681 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -134.73 158.66 23.59 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.561 177.288 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -76.07 -61.76 0.03 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.72 2.28 . . . . 0.0 110.109 179.9 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.512 ' CB ' ' CE2' ' A' ' 11' ' ' TYR . . . -58.78 133.34 55.88 Favored 'General case' 0 N--CA 1.432 -1.328 0 O-C-N 124.653 1.22 . . . . 0.0 111.938 178.015 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.434 ' HG2' ' HA ' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -141.23 146.9 37.46 Favored 'General case' 0 CA--C 1.496 -1.11 0 O-C-N 124.632 1.208 . . . . 0.0 111.817 -178.489 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 7.7 p -80.5 126.1 39.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.423 0.63 . . . . 0.0 110.407 178.839 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . 0.432 ' CD1' ' CB ' ' A' ' 82' ' ' GLU . 24.5 mm -100.28 147.24 7.86 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.229 0 O-C-N 121.227 -0.921 . . . . 0.0 110.361 179.008 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.472 ' CD1' ' HG3' ' A' ' 115' ' ' LYS . 11.4 p90 -176.76 148.14 0.66 Allowed 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 124.408 2.052 . . . . 0.0 110.131 -177.624 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 7.0 p -81.55 167.69 19.02 Favored 'General case' 0 C--N 1.311 -1.075 0 O-C-N 120.207 -1.558 . . . . 0.0 108.947 -177.612 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.464 ' C ' ' CD1' ' A' ' 112' ' ' TYR . 0.1 OUTLIER -116.2 152.56 47.99 Favored Pre-proline 0 N--CA 1.432 -1.34 0 C-N-CA 123.938 0.895 . . . . 0.0 109.892 179.875 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.422 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 15.6 Cg_endo -72.7 -44.03 0.61 Allowed 'Cis proline' 0 CA--C 1.516 -0.413 0 C-N-CA 122.076 -2.052 . . . . 0.0 109.378 -9.213 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 43.4 m-20 -46.84 106.98 0.09 Allowed 'General case' 0 CA--C 1.49 -1.337 0 CA-C-O 113.631 -3.08 . . . . 0.0 109.816 -179.382 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.476 ' HE2' ' CD1' ' A' ' 25' ' ' LEU . 0.1 OUTLIER -68.31 72.27 0.2 Allowed 'General case' 0 CA--C 1.501 -0.918 0 O-C-N 127.457 2.973 . . . . 0.0 107.03 -175.787 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 14.6 t -74.08 70.16 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 -177.133 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.449 ' CZ ' ' NE2' ' A' ' 13' ' ' GLN . 54.6 t80 -37.17 100.8 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 126.064 1.746 . . . . 0.0 110.732 178.831 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . 0.491 ' SG ' ' CG ' ' A' ' 57' ' ' PHE . 0.1 OUTLIER -81.43 -39.53 24.76 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 -178.235 . . . . . . . . 3 3 . 1 . 024 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 159.82 -146.86 13.36 Favored Glycine 0 N--CA 1.441 -1.02 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 -179.734 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . . . . . . . . . 1.0 OUTLIER -129.61 149.0 33.22 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.672 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 -172.923 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . 0.518 ' CD1' ' CZ ' ' A' ' 38' ' ' PHE . 7.2 pt -138.23 154.69 28.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 120.304 1.411 . . . . 0.0 108.293 -178.177 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -172.31 151.77 2.61 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 122.338 1.066 . . . . 0.0 110.021 176.867 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 2.2 m-70 -89.46 94.96 10.07 Favored 'General case' 0 N--CA 1.445 -0.681 0 O-C-N 120.996 -1.065 . . . . 0.0 108.278 -176.89 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 3.4 t -98.17 41.27 1.14 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 123.798 1.761 . . . . 0.0 110.611 -179.544 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.6 tttt -103.04 -26.44 13.06 Favored 'General case' 0 C--N 1.321 -0.662 0 O-C-N 119.072 -2.267 . . . . 0.0 111.183 177.866 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -170.28 -61.38 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.593 0 O-C-N 123.633 0.583 . . . . 0.0 110.524 177.493 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -156.03 -45.29 0.08 Allowed 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 122.499 1.142 . . . . 0.0 110.108 178.995 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -159.46 75.54 0.65 Allowed 'General case' 0 C--O 1.218 -0.575 0 CA-C-O 122.173 0.987 . . . . 0.0 110.523 -179.017 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -119.1 -101.89 2.01 Favored Glycine 0 N--CA 1.459 0.214 0 CA-C-O 122.578 1.099 . . . . 0.0 110.863 179.816 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.84 140.45 29.49 Favored 'General case' 0 CA--C 1.506 -0.719 0 O-C-N 120.934 -1.333 . . . . 0.0 111.035 -179.317 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . 0.408 HD22 ' CE1' ' A' ' 38' ' ' PHE . 6.0 tp -92.49 145.32 24.55 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 121.519 -0.738 . . . . 0.0 111.484 177.847 . . . . . . . . 2 2 . 1 . 024 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 9.2 ptpt -150.02 173.92 13.3 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 117.448 -1.263 . . . . 0.0 110.608 179.111 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 12.2 tp -82.28 139.71 34.03 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.807 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 73.3 m -67.28 -172.83 0.24 Allowed 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 124.072 0.949 . . . . 0.0 109.363 176.833 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 61.1 m -162.05 114.33 1.72 Allowed 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 117.056 -1.449 . . . . 0.0 107.835 -179.624 . . . . . . . . 1 1 . 1 . 024 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 0.468 ' CD2' ' CG1' ' A' ' 2' ' ' VAL . 2.4 m80 . . . . . 0 C--O 1.277 2.515 0 CA-C-O 113.525 -3.131 . . . . 0.0 113.22 176.206 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.701 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 025 nuclear orig full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.1 p -50.46 149.57 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-O 121.271 0.557 . . . . 0.0 110.188 179.542 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.2 m -94.51 121.34 35.95 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -174.581 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 4' ' ' TRP . . . . . 0.436 ' CD1' ' HB2' ' A' ' 13' ' ' GLN . 24.2 m95 -79.36 140.53 37.45 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.271 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -128.56 134.48 48.64 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -178.079 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 6' ' ' CYS . . . . . . . . . . . . . 8.4 m -123.1 -71.46 0.72 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.689 178.868 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -86.27 32.26 3.9 Favored Glycine 0 C--O 1.221 -0.685 0 CA-C-O 119.773 -0.459 . . . . 0.0 111.996 176.906 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 82.53 -13.03 43.53 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-N 117.491 0.646 . . . . 0.0 112.854 -175.164 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.2 OUTLIER -87.66 139.99 29.97 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -177.685 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 5.0 mp -86.22 135.09 33.7 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 124.032 0.832 . . . . 0.0 109.455 -178.589 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 11' ' ' TYR . . . . . 0.533 ' CE2' ' CB ' ' A' ' 106' ' ' ALA . 60.4 m-85 -124.06 105.84 9.88 Favored 'General case' 0 CA--C 1.506 -0.717 0 C-N-CA 125.539 1.536 . . . . 0.0 109.554 -175.14 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.79 112.97 1.46 Allowed 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -179.328 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 13' ' ' GLN . . . . . 0.455 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 6.1 tp-100 -51.2 -48.68 61.94 Favored 'General case' 0 C--O 1.214 -0.792 0 C-N-CA 119.586 -0.846 . . . . 0.0 111.91 -179.024 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -49.2 -39.8 31.09 Favored 'General case' 0 C--O 1.197 -1.669 0 O-C-N 124.162 0.913 . . . . 0.0 111.263 176.862 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -71.59 -38.89 70.84 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-N 118.755 0.707 . . . . 0.0 112.904 171.217 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -53.67 -39.14 64.85 Favored 'General case' 0 C--O 1.215 -0.741 0 CA-C-N 119.87 1.213 . . . . 0.0 111.99 173.409 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 17' ' ' GLU . . . . . 0.456 ' O ' ' CD2' ' A' ' 21' ' ' HIS . 6.0 pt-20 -90.38 -38.78 13.09 Favored 'General case' 0 C--O 1.221 -0.431 0 C-N-CA 123.802 0.841 . . . . 0.0 110.809 176.228 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.7 t -75.05 -60.12 2.43 Favored 'General case' 0 CA--C 1.506 -0.747 0 O-C-N 119.716 -1.865 . . . . 0.0 109.557 -176.508 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 19' ' ' ASN . . . . . 0.502 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -48.39 -29.45 4.02 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 171.062 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 31.7 p -85.19 -24.66 27.8 Favored 'General case' 0 C--O 1.221 -0.432 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 175.413 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 21' ' ' HIS . . . . . 0.456 ' CD2' ' O ' ' A' ' 17' ' ' GLU . 10.2 m170 -57.13 -35.97 70.12 Favored 'General case' 0 C--O 1.222 -0.351 0 C-N-CA 124.156 0.982 . . . . 0.0 109.217 178.061 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 22' ' ' HIS . . . . . 0.502 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.1 OUTLIER -71.69 -42.13 67.8 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 118.566 -0.731 . . . . 0.0 110.138 179.901 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 23' ' ' ALA . . . . . . . . . . . . . . . -39.99 133.77 1.43 Allowed Pre-proline 0 N--CA 1.443 -0.793 0 O-C-N 125.189 1.555 . . . . 0.0 111.124 176.505 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -72.61 119.36 6.06 Favored 'Trans proline' 0 N--CA 1.443 -1.442 0 C-N-CA 122.1 1.867 . . . . 0.0 108.55 -177.8 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 25' ' ' LEU . . . . . 0.43 ' CD2' ' HE2' ' A' ' 115' ' ' LYS . 3.4 tp -60.58 84.19 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.284 1.033 . . . . 0.0 111.266 177.885 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.4 m -165.89 147.24 6.94 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.291 -174.682 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 27' ' ' ASP . . . . . 0.433 ' HB3' ' CA ' ' A' ' 72' ' ' GLY . 2.7 t0 -78.89 85.66 4.84 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 -178.843 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.68 86.31 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 177.812 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.2 mmtt -150.49 44.68 0.86 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.934 0.873 . . . . 0.0 111.615 178.749 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 12.2 p -130.64 -170.77 2.41 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.55 -174.695 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -83.82 -55.23 2.86 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.706 177.446 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -76.05 9.56 2.4 Favored 'General case' 0 CA--C 1.514 -0.415 0 O-C-N 122.136 -0.626 . . . . 0.0 112.336 177.854 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.1 p 89.83 -58.45 0.02 OUTLIER 'General case' 0 CA--C 1.503 -0.855 0 C-N-CA 127.17 2.188 . . . . 0.0 109.258 -179.782 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 34' ' ' TYR . . . . . 0.471 ' CG ' ' HG3' ' A' ' 84' ' ' PRO . 85.9 m-85 -59.38 142.82 86.38 Favored Pre-proline 0 N--CA 1.437 -1.08 0 O-C-N 125.826 1.953 . . . . 0.0 112.768 -176.914 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 35' ' ' PRO . . . . . 0.428 ' HB2' ' CG ' ' A' ' 81' ' ' LEU . 36.0 Cg_endo -76.48 -172.69 11.47 Favored 'Cis proline' 0 N--CA 1.438 -1.764 0 C-N-CA 122.66 -1.808 . . . . 0.0 111.521 0.577 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 36' ' ' HIS . . . . . 0.429 ' CD2' ' N ' ' A' ' 36' ' ' HIS . 0.3 OUTLIER -159.62 159.75 33.5 Favored 'General case' 0 CA--C 1.502 -0.886 0 O-C-N 120.774 -1.204 . . . . 0.0 110.101 -178.68 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 37' ' ' TRP . . . . . 0.563 ' CD1' ' HB2' ' A' ' 79' ' ' TYR . 10.3 t90 -69.6 134.35 48.67 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-O 122.796 1.284 . . . . 0.0 110.044 175.458 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 38' ' ' PHE . . . . . 0.456 ' CZ ' ' HA ' ' A' ' 40' ' ' ASN . 14.0 t80 -97.63 97.59 9.16 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 178.939 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 39' ' ' THR . . . . . 0.412 ' HA ' ' CZ2' ' A' ' 37' ' ' TRP . 77.4 p -36.14 -35.18 0.07 Allowed 'General case' 0 C--O 1.208 -1.124 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.873 173.489 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 40' ' ' ASN . . . . . 0.456 ' HA ' ' CZ ' ' A' ' 38' ' ' PHE . 4.1 t-20 65.97 11.65 7.87 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 123.926 0.89 . . . . 0.0 110.631 179.717 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 41' ' ' GLY . . . . . 0.464 ' CA ' ' HD3' ' A' ' 52' ' ' ARG . . . 97.7 4.08 58.12 Favored Glycine 0 CA--C 1.536 1.384 0 N-CA-C 114.364 0.506 . . . . 0.0 114.364 -169.939 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 42' ' ' TYR . . . . . 0.52 ' CD2' ' HA ' ' A' ' 47' ' ' LYS . 2.6 m-85 -99.0 165.61 11.67 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 124.103 0.961 . . . . 0.0 109.339 -177.456 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.3 -34.88 25.62 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.625 176.911 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 44' ' ' GLY . . . . . 0.513 ' HA2' ' CZ2' ' A' ' 37' ' ' TRP . . . 173.24 -62.3 0.13 Allowed Glycine 0 C--N 1.335 0.489 0 C-N-CA 124.008 0.813 . . . . 0.0 112.06 -178.285 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -111.42 -61.81 1.64 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 122.607 1.194 . . . . 0.0 110.356 179.671 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.16 161.12 6.91 Favored Glycine 0 C--N 1.34 0.797 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.228 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 47' ' ' LYS . . . . . 0.52 ' HA ' ' CD2' ' A' ' 42' ' ' TYR . 8.5 ptpt -56.98 -163.14 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 122.998 1.38 . . . . 0.0 112.033 175.732 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 48' ' ' LEU . . . . . 0.475 HD13 ' CE1' ' A' ' 42' ' ' TYR . 4.0 mp -81.35 155.25 71.87 Favored Pre-proline 0 N--CA 1.44 -0.931 0 O-C-N 121.068 -1.02 . . . . 0.0 111.041 178.107 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -71.2 159.4 52.14 Favored 'Trans proline' 0 N--CA 1.444 -1.394 0 C-N-CA 121.947 1.765 . . . . 0.0 110.266 178.45 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -53.11 97.77 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.263 0.625 . . . . 0.0 110.083 177.274 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.26 79.19 0.95 Allowed Glycine 0 CA--C 1.517 0.191 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.184 -176.146 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 52' ' ' ARG . . . . . 0.464 ' HD3' ' CA ' ' A' ' 41' ' ' GLY . 0.0 OUTLIER -174.83 157.31 2.42 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 123.891 0.876 . . . . 0.0 110.733 175.547 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.2 m -141.47 108.76 6.15 Favored Pre-proline 0 C--N 1.328 -0.347 0 O-C-N 123.972 0.795 . . . . 0.0 109.829 -179.91 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -72.53 179.12 5.43 Favored 'Trans proline' 0 N--CA 1.447 -1.226 0 C-N-CA 122.479 2.119 . . . . 0.0 111.619 177.338 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 55' ' ' ILE . . . . . 0.411 ' CG2' ' HB2' ' A' ' 133' ' ' LEU . 5.2 mt -90.16 124.76 42.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.788 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.18 134.65 35.66 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.675 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 57' ' ' PHE . . . . . 0.459 ' CD1' ' HB3' ' A' ' 118' ' ' CYS . 40.1 m-85 -114.33 -47.83 2.91 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 123.494 0.718 . . . . 0.0 110.642 179.43 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 121.66 -1.81 11.12 Favored Glycine 0 C--O 1.223 -0.54 0 C-N-CA 123.767 0.698 . . . . 0.0 112.514 -176.36 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.5 mttm -103.24 145.53 29.8 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 117.74 0.77 . . . . 0.0 109.588 177.537 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 30.4 t -79.13 -9.16 59.48 Favored 'General case' 0 C--O 1.222 -0.374 0 O-C-N 124.794 1.309 . . . . 0.0 111.309 176.784 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -89.04 -48.99 7.03 Favored 'General case' 0 CA--C 1.515 -0.375 0 C-N-CA 123.788 0.835 . . . . 0.0 109.797 179.995 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 62' ' ' CYS . . . . . 0.442 ' SG ' ' CE2' ' A' ' 57' ' ' PHE . 1.4 t -72.91 -17.04 61.54 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 123.739 0.649 . . . . 0.0 111.814 175.871 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -86.43 -33.13 20.52 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-O 122.009 0.909 . . . . 0.0 111.295 174.422 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 64' ' ' ARG . . . . . 0.505 ' HD3' ' CE1' ' A' ' 78' ' ' HIS . 0.0 OUTLIER -57.27 158.99 9.09 Favored Pre-proline 0 N--CA 1.445 -0.691 0 O-C-N 121.369 -0.832 . . . . 0.0 111.343 179.492 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -71.14 140.09 36.86 Favored 'Trans proline' 0 N--CA 1.442 -1.5 0 C-N-CA 120.763 0.975 . . . . 0.0 113.74 174.365 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 66' ' ' PRO . . . . . 0.477 ' HD2' ' CD2' ' A' ' 42' ' ' TYR . 22.8 Cg_endo -70.77 169.88 19.13 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 123.482 2.788 . . . . 0.0 112.238 177.058 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -133.37 49.95 2.26 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 179.224 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 68' ' ' HIS . . . . . 0.454 ' HA ' ' OD2' ' A' ' 77' ' ' ASP . 25.1 t-80 -73.92 156.97 37.09 Favored 'General case' 0 C--O 1.22 -0.459 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.588 -177.536 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 69' ' ' SER . . . . . 0.443 ' O ' ' CE1' ' A' ' 68' ' ' HIS . 1.5 p -148.22 -160.05 1.12 Allowed 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 122.287 1.041 . . . . 0.0 111.3 177.169 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.59 75.64 9.49 Favored 'General case' 0 C--O 1.217 -0.625 0 O-C-N 120.259 -1.526 . . . . 0.0 111.722 172.148 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -177.22 -44.59 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.271 0.628 . . . . 0.0 109.958 177.6 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 72' ' ' GLY . . . . . 0.433 ' CA ' ' HB3' ' A' ' 27' ' ' ASP . . . 109.17 -54.46 0.55 Allowed Glycine 0 C--O 1.212 -1.239 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.912 -178.458 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -133.87 65.65 1.57 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 -179.574 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.44 -126.63 0.01 OUTLIER Glycine 0 CA--C 1.525 0.718 0 CA-C-O 121.94 0.745 . . . . 0.0 111.492 179.447 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.8 mttt -58.2 -92.66 0.0 OUTLIER 'General case' 0 C--O 1.221 -0.444 0 O-C-N 120.738 -1.448 . . . . 0.0 112.311 178.132 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 76' ' ' THR . . . . . 0.415 ' O ' ' C ' ' A' ' 77' ' ' ASP . 0.5 OUTLIER -115.86 15.99 16.27 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-O 118.307 -0.854 . . . . 0.0 110.427 177.473 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 77' ' ' ASP . . . . . 0.505 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 20.1 t0 -29.11 102.06 0.02 OUTLIER 'General case' 0 C--O 1.212 -0.897 0 O-C-N 123.979 0.799 . . . . 0.0 110.99 -179.566 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 78' ' ' HIS . . . . . 0.505 ' CE1' ' HD3' ' A' ' 64' ' ' ARG . 5.7 p80 -87.55 64.18 7.98 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -176.016 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 79' ' ' TYR . . . . . 0.563 ' HB2' ' CD1' ' A' ' 37' ' ' TRP . 34.4 p90 -90.29 136.56 32.98 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 124.242 1.017 . . . . 0.0 109.527 -178.128 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.3 OUTLIER -74.44 142.51 44.92 Favored 'General case' 0 C--O 1.216 -0.697 0 C-N-CA 119.758 -0.777 . . . . 0.0 109.225 176.22 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 81' ' ' LEU . . . . . 0.497 HD21 ' CZ ' ' A' ' 110' ' ' TYR . 1.1 tt -134.66 144.07 47.62 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 176.338 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 82' ' ' GLU . . . . . 0.409 ' CG ' ' HE2' ' A' ' 36' ' ' HIS . 6.1 pm0 -109.35 165.62 11.49 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 123.547 0.739 . . . . 0.0 111.429 -179.694 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 83' ' ' PHE . . . . . 0.524 ' CD1' ' HD2' ' A' ' 84' ' ' PRO . 36.7 t80 -148.93 135.23 10.12 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 117.795 -1.098 . . . . 0.0 112.444 -179.186 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 84' ' ' PRO . . . . . 0.524 ' HD2' ' CD1' ' A' ' 83' ' ' PHE . 19.1 Cg_endo -70.73 88.67 0.64 Allowed 'Trans proline' 0 CA--C 1.501 -1.152 0 C-N-CA 124.513 3.475 . . . . 0.0 110.679 -176.015 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 85' ' ' THR . . . . . 0.463 ' HA ' ' CZ ' ' A' ' 92' ' ' TYR . 1.2 t -86.71 115.92 24.47 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 124.411 1.07 . . . . 0.0 111.958 179.741 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 86' ' ' PHE . . . . . 0.617 ' CD1' ' CD1' ' A' ' 92' ' ' TYR . 18.2 m-85 -83.67 160.42 58.78 Favored Pre-proline 0 N--CA 1.45 -0.473 0 C-N-CA 123.193 0.597 . . . . 0.0 111.525 -179.877 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.05 -44.54 0.33 Allowed 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 122.189 1.926 . . . . 0.0 111.748 179.041 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -52.21 -28.38 18.22 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 122.992 1.377 . . . . 0.0 110.031 177.89 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.1 -14.14 40.53 Favored Glycine 0 N--CA 1.438 -1.227 0 CA-C-O 118.23 -1.317 . . . . 0.0 111.809 -179.023 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 90' ' ' HIS . . . . . 0.425 ' O ' ' CE1' ' A' ' 92' ' ' TYR . 1.6 p-80 -48.69 143.22 5.36 Favored 'General case' 0 C--O 1.213 -0.838 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.425 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -63.64 137.66 58.18 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.793 0.806 . . . . 0.0 111.736 177.32 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 92' ' ' TYR . . . . . 0.617 ' CD1' ' CD1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -94.86 148.5 22.24 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 -174.876 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -84.4 68.62 10.31 Favored 'General case' 0 C--N 1.321 -0.649 0 O-C-N 121.272 -0.893 . . . . 0.0 109.564 176.079 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 94' ' ' PHE . . . . . 0.422 ' CD2' ' O ' ' A' ' 92' ' ' TYR . 30.7 p90 -83.4 -16.15 46.99 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.583 177.465 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -89.8 -30.87 17.68 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 123.82 0.848 . . . . 0.0 110.448 178.55 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.0 t -90.91 110.29 21.52 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -177.014 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.52 -46.1 91.38 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-O 120.958 0.409 . . . . 0.0 110.347 179.723 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 98' ' ' LYS . . . . . 0.403 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 6.6 mttm -141.07 128.46 11.98 Favored Pre-proline 0 N--CA 1.438 -1.04 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.962 -178.251 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 99' ' ' PRO . . . . . 0.403 ' C ' ' HA ' ' A' ' 98' ' ' LYS . 20.0 Cg_endo -70.05 176.86 31.71 Favored 'Cis proline' 0 N--CA 1.458 -0.602 0 O-C-N 124.579 1.831 . . . . 0.0 111.472 -3.802 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.03 152.34 48.76 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 123.515 0.726 . . . . 0.0 109.891 177.731 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -104.13 146.37 28.84 Favored 'General case' 0 C--N 1.321 -0.656 0 O-C-N 124.327 1.017 . . . . 0.0 108.767 -179.875 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -56.23 120.26 33.64 Favored Pre-proline 0 N--CA 1.445 -0.706 0 CA-C-O 118.095 -0.955 . . . . 0.0 110.792 177.353 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -71.6 -163.22 0.13 Allowed 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 122.723 2.282 . . . . 0.0 111.753 178.303 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -142.5 172.29 24.38 Favored Glycine 0 CA--C 1.524 0.645 0 O-C-N 121.414 -0.804 . . . . 0.0 112.113 177.187 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -74.03 -50.88 0.15 Allowed 'Trans proline' 0 N--CA 1.447 -1.26 0 C-N-CA 122.112 1.875 . . . . 0.0 110.542 178.925 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 106' ' ' ALA . . . . . 0.533 ' CB ' ' CE2' ' A' ' 11' ' ' TYR . . . -61.24 135.74 57.83 Favored 'General case' 0 CA--C 1.507 -0.704 0 O-C-N 123.645 0.591 . . . . 0.0 109.892 -179.155 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 107' ' ' ARG . . . . . 0.5 ' HG2' ' HA ' ' A' ' 84' ' ' PRO . 9.4 mtm-85 -151.39 148.1 27.71 Favored 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 124.224 0.952 . . . . 0.0 110.456 -179.085 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 12.8 p -87.99 116.01 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 O-C-N 124.354 1.034 . . . . 0.0 111.525 178.584 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 109' ' ' ILE . . . . . . . . . . . . . 1.4 mp -107.39 122.05 61.08 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.885 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 -173.09 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 110' ' ' TYR . . . . . 0.497 ' CZ ' HD21 ' A' ' 81' ' ' LEU . 6.3 p90 -141.46 151.73 43.62 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 121.836 0.827 . . . . 0.0 109.711 -179.388 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.3 p -80.64 163.23 23.78 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.639 178.421 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 112' ' ' TYR . . . . . 0.505 ' CD1' ' O ' ' A' ' 77' ' ' ASP . 0.1 OUTLIER -111.9 154.73 44.04 Favored Pre-proline 0 CA--C 1.546 0.808 0 O-C-N 123.353 0.408 . . . . 0.0 110.893 178.86 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 113' ' ' PRO . . . . . 0.494 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 19.0 Cg_endo -74.16 -51.08 0.16 OUTLIER 'Cis proline' 0 CA--C 1.502 -1.094 0 C-N-CA 123.533 -1.444 . . . . 0.0 110.529 -5.956 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 43.8 t-20 -45.23 109.96 0.21 Allowed 'General case' 0 C--O 1.219 -0.549 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.971 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 115' ' ' LYS . . . . . 0.463 ' CG ' ' CD1' ' A' ' 110' ' ' TYR . 0.1 OUTLIER -66.39 76.63 0.1 Allowed 'General case' 0 CA--C 1.512 -0.497 0 C-N-CA 123.675 0.79 . . . . 0.0 109.016 179.547 . . . . . . . . 3 3 . 1 . 025 nuclear orig full ' A' A ' 116' ' ' VAL . . . . . . . . . . . . . 57.3 t -74.84 72.51 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 -176.188 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 117' ' ' PHE . . . . . 0.455 ' CZ ' ' NE2' ' A' ' 13' ' ' GLN . 59.8 t80 -34.02 104.95 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 126.752 2.021 . . . . 0.0 109.22 -178.378 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 118' ' ' CYS . . . . . 0.459 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 14.6 m -84.84 -44.81 12.9 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -177.683 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 158.89 -151.03 21.94 Favored Glycine 0 N--CA 1.441 -1.02 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 179.657 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 120' ' ' ILE . . . . . 0.404 HG13 ' CG ' ' A' ' 4' ' ' TRP . 1.1 mm -127.44 133.14 68.51 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.806 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 -176.45 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 6.4 pt -119.72 155.14 22.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -177.327 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 122' ' ' ALA . . . . . . . . . . . . . . . -176.11 153.75 1.32 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.817 0.342 . . . . 0.0 110.249 178.635 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 5.6 m-70 -90.23 97.56 11.26 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -176.922 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.7 t -97.27 40.84 1.13 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 123.169 1.462 . . . . 0.0 111.47 179.595 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 12.7 tttm -105.02 -27.05 11.89 Favored 'General case' 0 C--O 1.219 -0.515 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.118 178.229 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -172.82 -66.59 0.02 OUTLIER 'General case' 0 C--O 1.22 -0.469 0 O-C-N 123.934 0.771 . . . . 0.0 110.234 178.265 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -155.34 -44.22 0.08 Allowed 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 122.241 1.02 . . . . 0.0 110.782 179.514 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -155.39 79.64 1.03 Allowed 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 124.159 0.984 . . . . 0.0 109.414 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -130.06 -105.67 1.14 Allowed Glycine 0 C--N 1.329 0.193 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 176.821 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -83.66 143.07 30.32 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 122.439 -0.447 . . . . 0.0 111.352 179.774 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 5.7 tp -99.12 145.75 26.84 Favored 'General case' 0 C--O 1.22 -0.448 0 CA-C-O 120.769 0.319 . . . . 0.0 111.066 177.506 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -152.79 172.26 16.99 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -179.743 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 133' ' ' LEU . . . . . 0.411 ' HB2' ' CG2' ' A' ' 55' ' ' ILE . 14.9 tp -85.62 140.64 30.41 Favored 'General case' 0 C--O 1.244 0.765 0 O-C-N 123.886 0.741 . . . . 0.0 109.375 177.633 . . . . . . . . 2 2 . 1 . 025 nuclear orig full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 60.8 m -68.71 -178.47 1.18 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.786 175.954 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 73.6 m -148.62 100.27 3.09 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 -178.787 . . . . . . . . 1 1 . 1 . 025 nuclear orig full ' A' A ' 136' ' ' HIS . . . . . 0.406 ' ND1' ' CE2' ' A' ' 4' ' ' TRP . 0.3 OUTLIER . . . . . 0 C--O 1.248 0.981 0 CA-C-O 117.892 -1.051 . . . . 0.0 113.268 173.312 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.529 0.158 0 CA-C-O 122.004 0.907 . . . . 0.0 110.708 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 91.4 m -83.96 111.22 19.06 Favored 'General case' 0 C--N 1.31 -1.119 0 O-C-N 121.742 -0.599 . . . . 0.0 111.046 177.736 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 4' ' ' TRP . . . . . 0.465 ' CD2' ' HB3' ' A' ' 136' ' ' HIS . 16.9 m95 -79.7 142.44 35.48 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 177.983 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -138.51 141.09 39.38 Favored 'General case' 0 CA--C 1.498 -1.046 0 O-C-N 121.068 -1.02 . . . . 0.0 108.429 -178.588 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.635 ' SG ' ' HB3' ' A' ' 122' ' ' ALA . 0.5 OUTLIER -122.81 61.08 1.01 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 118.612 -0.708 . . . . 0.0 110.502 177.54 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 39.0 78.69 0.05 OUTLIER Glycine 0 CA--C 1.532 1.114 0 O-C-N 124.207 0.942 . . . . 0.0 113.031 -177.828 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.01 -75.59 0.19 Allowed Glycine 0 C--O 1.224 -0.482 0 N-CA-C 111.189 -0.765 . . . . 0.0 111.189 -177.439 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.2 mt -128.33 163.2 25.32 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.593 0.711 . . . . 0.0 110.609 177.15 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.62 HD22 ' H ' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -88.58 170.34 10.94 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.978 -177.202 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.798 ' CZ ' ' HB3' ' A' ' 106' ' ' ALA . 70.6 m-85 -160.99 85.94 0.69 Allowed 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 122.278 1.037 . . . . 0.0 108.378 -171.254 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -54.11 122.98 11.34 Favored 'General case' 0 C--O 1.213 -0.864 0 CA-C-O 115.715 -2.088 . . . . 0.0 108.457 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -46.49 -40.47 12.54 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 120.161 1.346 . . . . 0.0 112.543 175.716 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -57.75 -47.35 82.73 Favored 'General case' 0 C--O 1.199 -1.576 0 CA-C-O 118.573 -0.727 . . . . 0.0 111.093 176.195 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.423 ' CE ' ' HA3' ' A' ' 89' ' ' GLY . 6.3 mttt -70.52 -39.78 73.86 Favored 'General case' 0 C--O 1.203 -1.363 0 CA-C-N 120.912 1.687 . . . . 0.0 112.185 171.877 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.589 ' HA ' HG21 ' A' ' 85' ' ' THR . . . -52.58 -41.01 63.23 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 121.55 1.977 . . . . 0.0 110.855 175.937 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -87.06 -47.0 9.28 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-O 117.393 -1.289 . . . . 0.0 109.64 177.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 39.3 t -67.49 -54.18 22.31 Favored 'General case' 0 CA--C 1.496 -1.108 0 C-N-CA 127.311 2.244 . . . . 0.0 107.597 -171.499 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.519 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 5.9 t-20 -42.32 -36.46 1.26 Allowed 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 119.862 1.21 . . . . 0.0 113.514 169.319 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.422 ' O ' ' HB3' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -82.78 -33.97 27.19 Favored 'General case' 0 C--O 1.212 -0.906 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 172.813 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -44.96 -35.69 3.01 Favored 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 126.516 1.926 . . . . 0.0 110.33 177.476 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.519 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -74.3 -48.84 25.88 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-O 117.089 -1.434 . . . . 0.0 112.385 175.224 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.547 ' HB2' ' CE1' ' A' ' 83' ' ' PHE . . . -35.41 128.78 0.56 Allowed Pre-proline 0 CA--C 1.542 0.647 0 O-C-N 125.568 1.792 . . . . 0.0 112.51 172.569 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.759 ' HG2' HG22 ' A' ' 30' ' ' THR . 14.9 Cg_endo -73.98 123.04 8.1 Favored 'Trans proline' 0 N--CA 1.448 -1.189 0 C-N-CA 122.14 1.893 . . . . 0.0 108.661 -176.062 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.521 HD22 ' HE2' ' A' ' 115' ' ' LYS . 3.4 tp -59.47 102.86 0.16 Allowed 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.102 178.654 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 178.93 151.3 0.31 Allowed 'General case' 0 C--O 1.214 -0.795 0 CA-C-O 119.014 -0.517 . . . . 0.0 110.883 -176.674 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.48 ' HB3' ' CA ' ' A' ' 72' ' ' GLY . 0.9 OUTLIER -81.93 89.8 6.4 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 119.263 0.938 . . . . 0.0 109.571 -179.422 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 60.31 82.08 0.07 OUTLIER Glycine 0 C--O 1.226 -0.401 0 CA-C-O 121.617 0.565 . . . . 0.0 111.7 178.379 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.3 mttt -150.06 45.76 0.91 Allowed 'General case' 0 CA--C 1.511 -0.546 0 CA-C-O 122.521 1.153 . . . . 0.0 111.315 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.759 HG22 ' HG2' ' A' ' 24' ' ' PRO . 70.5 p -128.41 152.56 48.06 Favored 'General case' 0 CA--C 1.497 -1.076 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -175.251 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -42.77 -52.19 5.59 Favored Glycine 0 C--N 1.332 0.346 0 O-C-N 124.556 1.16 . . . . 0.0 112.139 -177.728 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.3 t -68.48 -77.98 0.07 Allowed 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 117.659 -1.162 . . . . 0.0 111.251 172.939 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 71.0 p -178.07 -61.73 0.01 OUTLIER 'General case' 0 C--O 1.218 -0.603 0 O-C-N 124.846 1.341 . . . . 0.0 110.888 -177.042 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -62.66 146.87 93.86 Favored Pre-proline 0 N--CA 1.428 -1.555 0 O-C-N 125.432 1.707 . . . . 0.0 112.714 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.599 ' HB2' HD21 ' A' ' 81' ' ' LEU . 29.3 Cg_endo -78.19 -179.39 26.88 Favored 'Cis proline' 0 N--CA 1.439 -1.731 0 C-N-CA 121.856 -2.143 . . . . 0.0 111.785 1.452 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.411 ' CD2' ' N ' ' A' ' 36' ' ' HIS . 0.2 OUTLIER -152.69 164.1 38.39 Favored 'General case' 0 C--O 1.209 -1.063 0 O-C-N 118.913 -2.367 . . . . 0.0 111.251 -177.27 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.986 ' CH2' HG22 ' A' ' 39' ' ' THR . 20.3 t90 -69.96 140.93 53.08 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 119.821 1.191 . . . . 0.0 108.422 176.826 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.463 ' CZ ' ' HA ' ' A' ' 40' ' ' ASN . 11.3 t80 -117.79 86.64 2.56 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 -177.766 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.986 HG22 ' CH2' ' A' ' 37' ' ' TRP . 70.4 p -38.91 -36.58 0.29 Allowed 'General case' 0 C--O 1.211 -0.965 0 C-N-CA 124.853 1.261 . . . . 0.0 111.185 175.007 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.463 ' HA ' ' CZ ' ' A' ' 38' ' ' PHE . 9.6 t-20 73.49 4.94 4.91 Favored 'General case' 0 C--O 1.219 -0.52 0 C-N-CA 126.329 1.852 . . . . 0.0 109.36 176.815 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.441 ' CA ' ' HD3' ' A' ' 52' ' ' ARG . . . 120.04 -9.74 11.18 Favored Glycine 0 N--CA 1.427 -1.918 0 C-N-CA 125.221 1.391 . . . . 0.0 114.059 -172.553 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.592 ' CE1' HD11 ' A' ' 48' ' ' LEU . 17.3 m-85 -77.36 172.04 13.93 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.012 0.925 . . . . 0.0 110.489 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.04 -39.12 12.38 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.87 176.382 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.583 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . 174.27 -42.46 0.14 Allowed Glycine 0 C--N 1.334 0.439 0 C-N-CA 124.449 1.023 . . . . 0.0 112.73 -177.996 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -133.27 -63.87 0.75 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.519 0.676 . . . . 0.0 109.736 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.7 154.54 17.19 Favored Glycine 0 C--N 1.341 0.825 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.589 ' HA ' ' CE2' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -53.16 174.8 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.839 0.828 . . . . 0.0 112.775 175.721 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.592 HD11 ' CE1' ' A' ' 42' ' ' TYR . 5.6 mp -57.27 149.97 44.86 Favored Pre-proline 0 N--CA 1.445 -0.686 0 O-C-N 121.697 -0.627 . . . . 0.0 111.431 177.888 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -72.47 159.07 50.0 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 122.03 1.82 . . . . 0.0 109.474 -179.011 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 6.7 ttpt -54.65 97.76 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.147 0.579 . . . . 0.0 110.246 177.36 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.42 74.44 0.69 Allowed Glycine 0 N--CA 1.452 -0.26 0 CA-C-O 119.02 -0.878 . . . . 0.0 112.831 -175.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.441 ' HD3' ' CA ' ' A' ' 41' ' ' GLY . 7.1 ttm180 -173.69 164.28 4.37 Favored 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 123.966 0.906 . . . . 0.0 110.493 175.327 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.3 m -142.59 110.16 5.72 Favored Pre-proline 0 N--CA 1.448 -0.553 0 O-C-N 123.472 0.482 . . . . 0.0 110.563 178.6 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.409 ' HG3' HD13 ' A' ' 48' ' ' LEU . 23.6 Cg_endo -73.15 178.7 6.23 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 122.286 1.991 . . . . 0.0 111.52 178.32 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.416 ' CG2' ' HB2' ' A' ' 133' ' ' LEU . 4.3 mt -88.63 119.07 35.27 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.552 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -179.131 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -82.65 134.96 35.16 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 120.85 -1.156 . . . . 0.0 109.076 176.884 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.598 ' CE1' HD13 ' A' ' 133' ' ' LEU . 6.9 m-85 -116.82 -44.33 2.83 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.575 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 122.5 -4.03 10.2 Favored Glycine 0 C--O 1.224 -0.508 0 CA-C-O 118.88 -0.956 . . . . 0.0 112.62 -176.203 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.7 mttt -101.49 139.15 37.54 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-N 118.307 1.054 . . . . 0.0 109.863 176.843 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.7 t -78.66 -1.0 32.25 Favored 'General case' 0 C--O 1.219 -0.507 0 O-C-N 125.097 1.498 . . . . 0.0 111.21 175.642 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -87.47 -51.22 6.04 Favored 'General case' 0 N--CA 1.451 -0.424 0 O-C-N 120.184 -1.572 . . . . 0.0 109.327 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.739 ' HB3' HD11 ' A' ' 80' ' ' LEU . 2.7 m -73.51 -35.55 65.62 Favored 'General case' 0 N--CA 1.451 -0.401 0 O-C-N 123.747 0.654 . . . . 0.0 109.624 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -63.05 -37.1 85.85 Favored 'General case' 0 C--O 1.225 -0.205 0 CA-C-O 121.531 0.681 . . . . 0.0 111.398 175.505 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.7 161.8 0.83 Allowed Pre-proline 0 N--CA 1.441 -0.908 0 CA-C-O 122.321 1.058 . . . . 0.0 112.642 177.781 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.424 ' HA ' ' CE2' ' A' ' 42' ' ' TYR . 27.5 Cg_endo -70.92 132.87 22.27 Favored 'Trans proline' 0 N--CA 1.438 -1.758 0 C-N-CA 120.72 0.947 . . . . 0.0 114.486 173.343 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.507 ' HD2' ' CD2' ' A' ' 42' ' ' TYR . 19.5 Cg_endo -72.04 168.01 25.15 Favored 'Trans proline' 0 N--CA 1.445 -1.37 0 C-N-CA 123.122 2.548 . . . . 0.0 110.905 177.736 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.6 tptt -126.92 52.98 1.73 Allowed 'General case' 0 C--O 1.203 -1.351 0 CA-C-N 115.136 -0.938 . . . . 0.0 108.51 178.892 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -75.52 164.88 25.9 Favored 'General case' 0 C--O 1.216 -0.692 0 O-C-N 120.411 -1.43 . . . . 0.0 111.347 178.404 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.4 p -157.87 -167.98 2.4 Favored 'General case' 0 C--N 1.322 -0.589 0 O-C-N 119.531 -1.98 . . . . 0.0 111.136 176.473 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.4 77.05 5.96 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 120.686 -1.259 . . . . 0.0 112.686 171.975 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -177.79 -44.86 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 O-C-N 123.694 0.621 . . . . 0.0 110.162 177.887 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.48 ' CA ' ' HB3' ' A' ' 27' ' ' ASP . . . 117.18 -69.24 0.3 Allowed Glycine 0 N--CA 1.439 -1.148 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.453 -178.986 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -128.84 60.95 1.52 Allowed 'General case' 0 CA--C 1.508 -0.67 0 C-N-CA 125.583 1.553 . . . . 0.0 107.367 -175.71 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.33 -106.45 0.01 OUTLIER Glycine 0 CA--C 1.535 1.292 0 CA-C-O 123.04 1.355 . . . . 0.0 112.862 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.8 mttm -73.11 -105.12 0.01 OUTLIER 'General case' 0 C--O 1.217 -0.608 0 O-C-N 119.699 -2.06 . . . . 0.0 110.621 177.121 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.519 HG23 ' O ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -106.47 16.8 24.21 Favored 'General case' 0 C--N 1.32 -0.711 0 O-C-N 121.486 -0.759 . . . . 0.0 111.116 179.329 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.425 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 10.0 m-20 -31.56 98.74 0.01 OUTLIER 'General case' 0 C--O 1.207 -1.132 0 C-N-CA 125.487 1.515 . . . . 0.0 111.856 -176.725 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 8.2 p-80 -85.11 44.41 1.08 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 119.752 -1.842 . . . . 0.0 107.745 -170.67 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.508 ' HB2' ' CD1' ' A' ' 37' ' ' TRP . 39.3 p90 -69.68 135.02 49.35 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 124.794 1.237 . . . . 0.0 111.011 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.817 HD22 HG23 ' A' ' 109' ' ' ILE . 2.1 mt -71.24 142.84 50.57 Favored 'General case' 0 C--O 1.216 -0.71 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 177.83 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.599 HD21 ' HB2' ' A' ' 35' ' ' PRO . 0.3 OUTLIER -137.12 137.12 38.92 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 119.128 0.876 . . . . 0.0 108.864 177.059 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.463 ' HB2' HD11 ' A' ' 109' ' ' ILE . 0.5 OUTLIER -99.78 168.66 9.76 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.649 176.432 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.547 ' CE1' ' HB2' ' A' ' 23' ' ' ALA . 78.6 t80 -157.04 130.02 4.42 Favored Pre-proline 0 C--N 1.327 -0.383 0 O-C-N 120.811 -1.181 . . . . 0.0 113.857 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.426 ' HA ' ' HG2' ' A' ' 107' ' ' ARG . 19.3 Cg_endo -72.6 98.76 0.98 Allowed 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 123.913 3.076 . . . . 0.0 109.713 -175.554 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.589 HG21 ' HA ' ' A' ' 16' ' ' ALA . 7.2 t -102.49 109.15 20.7 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.075 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -81.34 158.44 69.18 Favored Pre-proline 0 C--N 1.32 -0.696 0 O-C-N 121.607 -0.683 . . . . 0.0 112.112 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -78.12 -34.3 1.71 Allowed 'Trans proline' 0 CA--C 1.495 -1.473 0 C-N-CA 122.053 1.835 . . . . 0.0 112.802 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -43.83 -32.94 1.18 Allowed 'General case' 0 N--CA 1.474 0.77 0 O-C-N 125.537 1.773 . . . . 0.0 110.709 176.285 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.423 ' HA3' ' CE ' ' A' ' 15' ' ' LYS . . . 89.19 4.45 74.38 Favored Glycine 0 N--CA 1.431 -1.66 0 CA-C-O 118.586 -1.119 . . . . 0.0 111.268 177.191 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 4.5 p-80 -74.07 129.55 38.08 Favored 'General case' 0 N--CA 1.434 -1.253 0 O-C-N 125.669 1.452 . . . . 0.0 107.644 178.306 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -61.84 92.04 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 174.325 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.497 ' CD2' ' HB3' ' A' ' 94' ' ' PHE . 5.8 t80 -38.32 142.89 0.15 Allowed 'General case' 0 C--O 1.21 -0.99 0 CA-C-O 122.083 0.944 . . . . 0.0 110.382 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.46 58.73 1.03 Allowed 'General case' 0 C--N 1.312 -1.064 0 O-C-N 119.11 -2.244 . . . . 0.0 111.061 175.059 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.497 ' HB3' ' CD2' ' A' ' 92' ' ' TYR . 25.7 p90 -75.27 -18.3 60.1 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 123.925 0.89 . . . . 0.0 111.621 176.802 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -92.05 -22.39 19.97 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-O 122.21 1.005 . . . . 0.0 110.304 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.49 107.59 19.56 Favored 'General case' 0 CA--C 1.513 -0.459 0 O-C-N 120.369 -1.457 . . . . 0.0 109.001 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.23 -49.5 75.82 Favored 'General case' 0 C--N 1.33 -0.261 0 O-C-N 122.181 -0.325 . . . . 0.0 110.375 177.368 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -136.41 125.33 15.48 Favored Pre-proline 0 N--CA 1.44 -0.938 0 C-N-CA 124.338 1.055 . . . . 0.0 109.695 -175.2 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -71.94 176.12 39.81 Favored 'Cis proline' 0 C--N 1.349 0.601 0 O-C-N 124.94 2.021 . . . . 0.0 110.941 -2.661 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -138.07 124.0 20.1 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 124.059 0.943 . . . . 0.0 109.013 179.013 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.06 159.57 26.12 Favored 'General case' 0 C--N 1.322 -0.618 0 O-C-N 124.509 1.131 . . . . 0.0 111.399 177.483 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -60.06 138.97 91.11 Favored Pre-proline 0 N--CA 1.451 -0.403 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.32 177.707 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -72.25 -165.75 0.23 Allowed 'Trans proline' 0 N--CA 1.452 -0.971 0 C-N-CA 122.783 2.322 . . . . 0.0 111.725 176.907 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -131.58 155.7 21.51 Favored Glycine 0 CA--C 1.527 0.798 0 O-C-N 121.166 -0.959 . . . . 0.0 112.433 176.614 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -73.07 -17.46 24.81 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 122.389 2.059 . . . . 0.0 111.258 177.429 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.798 ' HB3' ' CZ ' ' A' ' 11' ' ' TYR . . . -110.76 134.92 52.08 Favored 'General case' 0 CA--C 1.507 -0.711 0 C-N-CA 124.177 0.991 . . . . 0.0 110.094 177.811 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.427 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 0.0 OUTLIER -138.37 151.04 47.15 Favored 'General case' 0 CA--C 1.5 -0.964 0 CA-C-O 116.489 -1.72 . . . . 0.0 111.41 176.964 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.513 ' C ' HD12 ' A' ' 109' ' ' ILE . 7.3 p -82.39 122.24 36.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 124.77 1.228 . . . . 0.0 112.109 175.942 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.817 HG23 HD22 ' A' ' 80' ' ' LEU . 1.7 mp -110.71 120.46 61.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 -174.522 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.498 ' O ' HD23 ' A' ' 80' ' ' LEU . 6.4 p90 -140.34 150.52 44.07 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 122.93 1.347 . . . . 0.0 109.958 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.6 p -82.32 160.58 22.85 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -178.647 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.52 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.0 OUTLIER -108.2 155.38 40.29 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 122.873 0.469 . . . . 0.0 110.568 179.203 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.52 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 14.7 Cg_endo -74.16 -51.21 0.16 OUTLIER 'Cis proline' 0 CA--C 1.501 -1.159 0 C-N-CA 123.343 -1.524 . . . . 0.0 109.596 -6.87 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -47.72 108.09 0.15 Allowed 'General case' 0 CA--C 1.505 -0.785 0 CA-C-O 116.101 -1.904 . . . . 0.0 108.919 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.521 ' HE2' HD22 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -62.91 79.75 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.547 0 O-C-N 125.233 1.583 . . . . 0.0 109.014 -177.775 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.481 ' O ' HG12 ' A' ' 116' ' ' VAL . 15.4 t -80.16 71.58 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 N-CA-C 103.965 -2.605 . . . . 0.0 103.965 -175.319 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.547 ' CE1' ' HA2' ' A' ' 119' ' ' GLY . 4.3 t80 -36.1 114.12 0.26 Allowed 'General case' 0 C--O 1.242 0.671 0 C-N-CA 124.049 0.94 . . . . 0.0 108.809 177.854 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 118' ' ' CYS . . . . . 0.546 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -97.03 -30.33 13.12 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.973 177.282 . . . . . . . . 3 3 . 1 . 001 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.547 ' HA2' ' CE1' ' A' ' 117' ' ' PHE . . . 144.12 -170.32 25.98 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 123.864 0.745 . . . . 0.0 112.027 -177.274 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.679 HG21 ' HB1' ' A' ' 106' ' ' ALA . 3.2 mp -111.61 142.84 22.77 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.395 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 -177.077 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.72 HG22 HD12 ' A' ' 133' ' ' LEU . 8.4 pt -114.83 155.19 16.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 119.822 1.192 . . . . 0.0 108.087 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.635 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . . . . . . . . 0 C--N 1.323 -0.567 0 CA-C-O 122.9 1.333 . . . . 0.0 110.117 178.522 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.502 -0.868 0 CA-C-O 118.313 -0.851 . . . . 0.0 109.256 . . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.72 HD12 HG22 ' A' ' 121' ' ' ILE . 9.4 tp -83.97 148.07 27.11 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 177.783 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 134' ' ' CYS . . . . . 0.533 ' SG ' HG22 ' A' ' 120' ' ' ILE . 90.8 m -58.59 -174.32 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.186 1.394 . . . . 0.0 110.608 175.995 . . . . . . . . 2 2 . 1 . 001 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 61.3 m -131.22 93.28 3.34 Favored 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -177.58 . . . . . . . . 1 1 . 1 . 001 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.465 ' HB3' ' CD2' ' A' ' 4' ' ' TRP . 1.1 p80 . . . . . 0 C--O 1.25 1.111 0 CA-C-O 114.957 -2.449 . . . . 0.0 113.427 173.515 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.545 HG22 ' HB3' ' A' ' 136' ' ' HIS . 14.4 p . . . . . 0 N--CA 1.449 -0.505 0 CA-C-O 121.666 0.745 . . . . 0.0 110.891 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.4 m -88.93 114.56 25.69 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 124.002 0.921 . . . . 0.0 109.47 -177.724 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 4' ' ' TRP . . . . . 0.47 ' CD1' ' HB2' ' A' ' 13' ' ' GLN . 31.8 m95 -79.33 150.18 31.52 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-O 118.88 -0.581 . . . . 0.0 110.421 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.5 m -144.52 131.62 20.51 Favored 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 -176.035 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.736 ' SG ' ' HB3' ' A' ' 122' ' ' ALA . 0.0 OUTLIER -126.93 -80.4 0.6 Allowed 'General case' 0 C--O 1.217 -0.658 0 CA-C-O 117.708 -1.139 . . . . 0.0 110.742 176.911 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -56.89 -88.17 0.02 OUTLIER Glycine 0 C--N 1.344 1.018 0 O-C-N 124.395 1.059 . . . . 0.0 111.294 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -154.17 18.22 0.62 Allowed Glycine 0 C--O 1.223 -0.585 0 O-C-N 121.749 -0.853 . . . . 0.0 111.383 178.226 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 49.8 mt -129.98 158.79 38.6 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 123.511 0.724 . . . . 0.0 109.735 178.816 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.5 mp -96.6 134.42 39.86 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.228 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.471 ' CE2' ' CB ' ' A' ' 106' ' ' ALA . 76.2 m-85 -117.64 104.07 10.66 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 126.481 1.912 . . . . 0.0 108.267 -173.944 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -55.69 119.6 5.97 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.986 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.47 ' HB2' ' CD1' ' A' ' 4' ' ' TRP . 22.1 tp60 -53.25 -41.42 65.44 Favored 'General case' 0 C--O 1.203 -1.344 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.91 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -49.78 -42.44 46.68 Favored 'General case' 0 C--O 1.197 -1.702 0 CA-C-O 119.544 -0.265 . . . . 0.0 111.377 175.781 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.3 mttp -70.86 -37.19 73.09 Favored 'General case' 0 C--O 1.202 -1.44 0 O-C-N 120.923 -1.111 . . . . 0.0 113.451 169.274 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.4 -38.44 66.22 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 122.353 2.342 . . . . 0.0 113.641 172.158 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -90.39 -39.63 12.55 Favored 'General case' 0 C--O 1.212 -0.877 0 CA-C-O 117.976 -1.012 . . . . 0.0 108.548 177.286 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 39.8 t -73.63 -59.79 2.55 Favored 'General case' 0 C--O 1.214 -0.806 0 C-N-CA 126.212 1.805 . . . . 0.0 109.911 -176.45 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.498 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 6.4 t-20 -41.0 -36.86 0.72 Allowed 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 119.72 1.145 . . . . 0.0 113.285 170.709 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.477 ' O ' ' HB3' ' A' ' 23' ' ' ALA . 0.5 OUTLIER -81.53 -36.79 28.75 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 115.035 1.495 . . . . 0.0 115.035 173.434 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -44.83 -38.68 4.72 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.382 1.873 . . . . 0.0 109.896 178.102 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.498 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -73.72 -47.01 42.52 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-O 117.88 -1.057 . . . . 0.0 112.732 175.064 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.831 ' HB1' ' HG3' ' A' ' 35' ' ' PRO . . . -35.74 127.59 0.61 Allowed Pre-proline 0 N--CA 1.439 -0.982 0 O-C-N 125.312 1.632 . . . . 0.0 112.885 173.011 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.719 ' HG2' HG22 ' A' ' 30' ' ' THR . 14.2 Cg_endo -73.63 125.87 10.39 Favored 'Trans proline' 0 N--CA 1.445 -1.369 0 C-N-CA 122.054 1.836 . . . . 0.0 108.576 -175.758 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.818 HD13 ' HE2' ' A' ' 115' ' ' LYS . 4.3 tp -60.6 93.92 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.472 0.709 . . . . 0.0 111.239 178.658 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 179.2 162.46 0.82 Allowed 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 123.102 0.561 . . . . 0.0 109.966 -176.079 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.2 118.44 34.85 Favored 'General case' 0 C--O 1.218 -0.595 0 C-N-CA 123.996 0.918 . . . . 0.0 110.344 177.648 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 46.71 64.72 2.51 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 120.048 -1.073 . . . . 0.0 112.7 177.469 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.9 ttpt -129.44 11.69 5.86 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 124.367 2.032 . . . . 0.0 111.079 178.024 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.719 HG22 ' HG2' ' A' ' 24' ' ' PRO . 25.9 p -112.71 150.53 31.4 Favored 'General case' 0 C--N 1.309 -1.165 0 O-C-N 119.27 -2.144 . . . . 0.0 107.233 -174.485 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -39.94 -51.13 3.4 Favored Glycine 0 C--N 1.335 0.474 0 O-C-N 124.404 1.065 . . . . 0.0 112.495 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.7 t -69.23 -78.09 0.07 Allowed 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 118.988 -0.53 . . . . 0.0 111.224 173.423 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.4 p -179.0 -63.75 0.01 OUTLIER 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 123.491 0.717 . . . . 0.0 110.202 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.588 ' CE2' ' CE1' ' A' ' 36' ' ' HIS . 65.6 m-85 -58.67 147.13 71.98 Favored Pre-proline 0 N--CA 1.426 -1.662 0 C-N-CA 124.708 1.203 . . . . 0.0 112.962 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.831 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 20.7 Cg_endo -74.77 151.37 96.86 Favored 'Cis proline' 0 N--CA 1.45 -1.081 0 C-N-CA 123.088 -1.63 . . . . 0.0 110.734 -0.738 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.614 ' C ' HD23 ' A' ' 81' ' ' LEU . 0.5 OUTLIER -129.39 166.38 19.66 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-O 117.474 -1.25 . . . . 0.0 110.347 -179.554 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.961 ' CH2' HG22 ' A' ' 39' ' ' THR . 16.7 t90 -64.02 144.41 57.11 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 124.329 1.018 . . . . 0.0 108.586 178.026 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.554 ' CE1' ' CD1' ' A' ' 121' ' ' ILE . 16.3 t80 -117.4 82.51 1.83 Allowed 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 -174.785 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.961 HG22 ' CH2' ' A' ' 37' ' ' TRP . 73.1 p -40.38 -33.08 0.22 Allowed 'General case' 0 C--O 1.211 -0.948 0 C-N-CA 124.537 1.135 . . . . 0.0 110.459 174.01 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.485 ' HB2' ' CE2' ' A' ' 38' ' ' PHE . 46.3 t30 60.18 16.33 5.97 Favored 'General case' 0 C--O 1.214 -0.784 0 CA-C-O 122.877 1.323 . . . . 0.0 109.374 177.704 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.434 ' O ' ' HD3' ' A' ' 52' ' ' ARG . . . 112.89 -38.39 3.25 Favored Glycine 0 N--CA 1.427 -1.905 0 O-C-N 119.469 -2.019 . . . . 0.0 113.367 -172.197 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.7 ' HA ' HD23 ' A' ' 48' ' ' LEU . 66.0 m-85 -50.64 170.53 0.03 OUTLIER 'General case' 0 C--O 1.231 0.081 0 CA-C-N 118.664 1.232 . . . . 0.0 111.695 178.849 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.44 -40.53 9.86 Favored 'General case' 0 C--N 1.32 -0.693 0 O-C-N 121.598 -0.689 . . . . 0.0 110.002 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.576 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -177.09 -53.31 0.06 OUTLIER Glycine 0 C--N 1.336 0.547 0 C-N-CA 123.855 0.74 . . . . 0.0 111.9 -178.439 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.76 -96.29 0.07 Allowed 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 -179.456 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.445 ' HA2' ' CD2' ' A' ' 42' ' ' TYR . . . -141.6 12.7 2.7 Favored Glycine 0 N--CA 1.438 -1.226 0 C-N-CA 125.306 1.432 . . . . 0.0 111.065 -176.328 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.2 pttt -112.06 146.41 38.0 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 117.991 -1.004 . . . . 0.0 108.804 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.7 HD23 ' HA ' ' A' ' 42' ' ' TYR . 0.4 OUTLIER -111.06 159.01 34.23 Favored Pre-proline 0 C--N 1.323 -0.555 0 O-C-N 124.624 1.203 . . . . 0.0 108.676 -178.473 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -74.48 157.37 44.99 Favored 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 121.857 1.704 . . . . 0.0 109.925 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.2 ttpt -54.89 101.12 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.99 0.516 . . . . 0.0 109.859 177.887 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.77 88.4 1.77 Allowed Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 116.495 -0.321 . . . . 0.0 112.535 -176.438 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.434 ' HD3' ' O ' ' A' ' 41' ' ' GLY . 0.9 OUTLIER -169.97 161.28 8.74 Favored 'General case' 0 CA--C 1.513 -0.475 0 C-N-CA 123.415 0.686 . . . . 0.0 110.506 175.683 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.0 m -147.69 113.57 4.01 Favored Pre-proline 0 N--CA 1.447 -0.616 0 O-C-N 124.485 1.115 . . . . 0.0 110.412 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -72.28 166.92 28.32 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 122.621 2.214 . . . . 0.0 111.344 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.401 ' O ' ' CE1' ' A' ' 57' ' ' PHE . 6.0 mt -81.6 129.87 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 -178.077 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.71 136.93 35.49 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 177.729 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.528 ' CE2' HD13 ' A' ' 133' ' ' LEU . 3.0 m-85 -125.93 -53.87 1.52 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 -177.436 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 120.37 -5.51 11.98 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 123.852 0.739 . . . . 0.0 112.602 -176.467 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.409 ' CB ' ' HB3' ' A' ' 62' ' ' CYS . 0.2 OUTLIER -65.75 177.5 1.25 Allowed 'General case' 0 C--O 1.207 -1.165 0 CA-C-N 118.251 1.026 . . . . 0.0 111.355 176.157 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.48 -45.13 4.73 Favored 'General case' 0 C--O 1.212 -0.885 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.404 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.55 -40.17 23.53 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.11 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.57 ' HA ' HD11 ' A' ' 80' ' ' LEU . 0.9 OUTLIER -71.43 -20.14 62.15 Favored 'General case' 0 C--N 1.342 0.253 0 O-C-N 123.871 0.732 . . . . 0.0 110.824 177.826 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -85.79 -42.24 14.36 Favored 'General case' 0 CA--C 1.509 -0.599 0 O-C-N 124.225 0.953 . . . . 0.0 112.196 174.714 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.419 ' HD2' ' CD2' ' A' ' 78' ' ' HIS . 0.0 OUTLIER -51.75 165.38 0.46 Allowed Pre-proline 0 N--CA 1.44 -0.951 0 CA-C-O 121.437 0.637 . . . . 0.0 111.542 -179.155 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -71.82 139.16 32.95 Favored 'Trans proline' 0 N--CA 1.437 -1.8 0 N-CA-C 114.807 1.041 . . . . 0.0 114.807 173.436 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.44 ' HD2' ' CE2' ' A' ' 42' ' ' TYR . 18.5 Cg_endo -70.51 174.28 10.39 Favored 'Trans proline' 0 N--CA 1.446 -1.286 0 C-N-CA 122.846 2.364 . . . . 0.0 111.09 178.424 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.417 ' HG3' ' CE1' ' A' ' 78' ' ' HIS . 1.4 mmtp -140.03 58.86 1.58 Allowed 'General case' 0 C--O 1.199 -1.569 0 CA-C-O 116.597 -1.668 . . . . 0.0 109.28 177.246 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.407 ' CE1' ' O ' ' A' ' 69' ' ' SER . 58.4 t-80 -75.4 164.02 26.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 119.534 1.061 . . . . 0.0 110.594 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.407 ' O ' ' CE1' ' A' ' 68' ' ' HIS . 0.3 OUTLIER -149.38 -168.66 3.17 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 123.574 0.75 . . . . 0.0 111.402 177.997 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.14 71.22 10.6 Favored 'General case' 0 C--O 1.216 -0.706 0 O-C-N 120.268 -1.52 . . . . 0.0 111.745 176.433 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -177.18 -42.4 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.103 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.418 ' O ' ' CE2' ' A' ' 79' ' ' TYR . . . 124.51 -46.69 1.07 Allowed Glycine 0 CA--C 1.487 -1.703 0 CA-C-O 117.757 -1.58 . . . . 0.0 112.469 -176.84 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -150.11 81.89 1.37 Allowed 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 177.829 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -61.42 -122.59 0.01 OUTLIER Glycine 0 C--O 1.219 -0.812 0 CA-C-O 121.197 0.332 . . . . 0.0 112.476 177.129 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.2 mttt -52.45 -89.34 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 O-C-N 120.411 -1.641 . . . . 0.0 112.086 178.298 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.561 HG23 ' O ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -119.62 17.01 12.85 Favored 'General case' 0 CA--C 1.508 -0.659 0 O-C-N 120.929 -1.107 . . . . 0.0 111.017 178.143 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.464 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 5.0 m-20 -27.05 105.08 0.02 OUTLIER 'General case' 0 C--O 1.203 -1.36 0 C-N-CA 125.44 1.496 . . . . 0.0 110.692 -177.075 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.419 ' CD2' ' HD2' ' A' ' 64' ' ' ARG . 3.5 p-80 -87.21 11.2 14.7 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 121.146 -0.971 . . . . 0.0 110.255 -176.072 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.996 ' CZ ' HD11 ' A' ' 81' ' ' LEU . 0.5 OUTLIER -33.96 132.95 0.22 Allowed 'General case' 0 N--CA 1.435 -1.206 0 C-N-CA 125.353 1.461 . . . . 0.0 113.205 172.37 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.662 HD22 ' CG2' ' A' ' 109' ' ' ILE . 0.2 OUTLIER -75.19 151.98 38.44 Favored 'General case' 0 C--O 1.218 -0.587 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.883 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.996 HD11 ' CZ ' ' A' ' 79' ' ' TYR . 1.4 mp -135.87 139.94 43.75 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-N 119.081 0.855 . . . . 0.0 109.155 176.744 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.452 ' HB2' HD11 ' A' ' 109' ' ' ILE . 1.8 pm0 -106.32 151.73 24.47 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-O 121.897 0.856 . . . . 0.0 110.793 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.424 ' CZ ' ' HB2' ' A' ' 23' ' ' ALA . 55.4 t80 -140.1 130.61 14.0 Favored Pre-proline 0 N--CA 1.449 -0.506 0 O-C-N 121.727 -0.608 . . . . 0.0 111.979 -179.11 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.455 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 18.6 Cg_endo -72.34 108.88 2.61 Favored 'Trans proline' 0 N--CA 1.446 -1.272 0 C-N-CA 123.674 2.916 . . . . 0.0 110.632 -178.935 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.93 109.27 21.16 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.74 0.816 . . . . 0.0 109.752 -179.259 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -81.1 160.7 65.13 Favored Pre-proline 0 N--CA 1.446 -0.662 0 O-C-N 121.598 -0.689 . . . . 0.0 112.433 178.195 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -77.21 -41.66 0.34 Allowed 'Trans proline' 0 CA--C 1.494 -1.507 0 C-N-CA 122.395 2.063 . . . . 0.0 112.256 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -45.57 -30.61 1.53 Allowed 'General case' 0 C--N 1.35 0.622 0 O-C-N 125.275 1.609 . . . . 0.0 110.282 177.473 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.34 -4.9 85.87 Favored Glycine 0 N--CA 1.432 -1.573 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 176.791 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 4.3 p-80 -60.55 129.64 42.6 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -64.19 89.72 0.06 Allowed 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 177.265 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.493 ' CD2' ' HB3' ' A' ' 94' ' ' PHE . 6.2 t80 -36.41 142.91 0.08 Allowed 'General case' 0 C--O 1.211 -0.959 0 C-N-CA 124.041 0.937 . . . . 0.0 110.507 -178.858 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.06 58.07 1.47 Allowed 'General case' 0 C--N 1.313 -0.996 0 O-C-N 119.766 -1.834 . . . . 0.0 110.738 175.969 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.493 ' HB3' ' CD2' ' A' ' 92' ' ' TYR . 28.8 p90 -74.03 -14.88 61.08 Favored 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 123.524 0.73 . . . . 0.0 111.954 176.679 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.86 -33.63 17.28 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 124.584 1.154 . . . . 0.0 110.794 178.732 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 32.2 m -85.96 109.89 19.08 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -178.558 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.5 ptpt -58.17 -49.68 76.16 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 178.623 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 99' ' ' PRO . 0.7 OUTLIER -140.7 126.81 11.6 Favored Pre-proline 0 N--CA 1.43 -1.459 0 C-N-CA 124.416 1.086 . . . . 0.0 110.329 -175.939 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' A' ' 98' ' ' LYS . 24.6 Cg_endo -71.95 175.98 40.44 Favored 'Cis proline' 0 C--N 1.35 0.606 0 O-C-N 124.909 2.005 . . . . 0.0 110.999 -2.925 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.2 tttp -141.09 130.23 23.42 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.773 0.829 . . . . 0.0 109.469 178.822 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -82.92 148.77 27.46 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.135 0.897 . . . . 0.0 110.372 176.687 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -43.86 137.94 3.31 Favored Pre-proline 0 N--CA 1.437 -1.116 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.021 173.489 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -73.18 -166.46 0.3 Allowed 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 122.449 2.1 . . . . 0.0 110.541 178.413 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -131.45 160.03 23.32 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-O 119.295 -0.725 . . . . 0.0 112.381 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -76.25 -65.84 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.778 2.319 . . . . 0.0 110.551 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.581 ' HA ' ' HB2' ' A' ' 122' ' ' ALA . . . -59.86 137.18 58.13 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 123.702 0.626 . . . . 0.0 110.996 177.991 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 5.1 mtm-85 -141.43 149.4 40.96 Favored 'General case' 0 CA--C 1.505 -0.767 0 O-C-N 124.211 0.944 . . . . 0.0 110.717 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.425 HG23 ' HD1' ' A' ' 117' ' ' PHE . 2.7 p -88.46 117.01 31.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.135 0.897 . . . . 0.0 111.862 178.772 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.714 HG12 HD13 ' A' ' 121' ' ' ILE . 1.2 mp -104.3 125.01 59.13 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.984 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 -171.847 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.621 ' C ' HD23 ' A' ' 80' ' ' LEU . 14.5 p90 -146.17 160.56 41.79 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.05 -178.939 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.0 p -93.86 166.0 12.4 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.867 -177.867 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.56 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -112.96 153.44 45.25 Favored Pre-proline 0 N--CA 1.44 -0.951 0 C-N-CA 122.478 0.311 . . . . 0.0 110.706 179.962 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.56 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 16.5 Cg_endo -74.46 -51.59 0.16 OUTLIER 'Cis proline' 0 CA--C 1.499 -1.253 0 C-N-CA 123.487 -1.464 . . . . 0.0 109.71 -5.864 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -45.44 111.99 0.4 Allowed 'General case' 0 CA--C 1.502 -0.901 0 CA-C-O 115.861 -2.019 . . . . 0.0 109.132 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.818 ' HE2' HD13 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -64.87 74.81 0.04 OUTLIER 'General case' 0 CA--C 1.51 -0.593 0 O-C-N 125.787 1.929 . . . . 0.0 108.476 -178.383 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.502 ' O ' HG12 ' A' ' 116' ' ' VAL . 9.5 t -73.45 72.16 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 105.696 -1.964 . . . . 0.0 105.696 -177.08 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.425 ' HD1' HG23 ' A' ' 108' ' ' VAL . 17.2 t80 -46.93 107.98 0.13 Allowed 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 124.67 1.188 . . . . 0.0 108.881 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 118' ' ' CYS . . . . . 0.419 ' SG ' ' CG ' ' A' ' 57' ' ' PHE . 0.1 OUTLIER -83.75 -56.41 3.72 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 -179.853 . . . . . . . . 3 3 . 1 . 002 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.428 ' HA2' ' CH2' ' A' ' 4' ' ' TRP . . . -178.8 -145.09 5.97 Favored Glycine 0 N--CA 1.436 -1.357 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.451 HG13 ' CG ' ' A' ' 4' ' ' TRP . 1.2 mm -127.59 145.49 34.87 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.202 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 -175.088 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.714 HD13 HG12 ' A' ' 109' ' ' ILE . 3.1 pt -131.12 156.86 43.08 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.903 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.736 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . . . . . . . . 0 C--N 1.325 -0.473 0 CA-C-O 121.781 0.8 . . . . 0.0 109.611 177.143 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.514 -0.44 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 . . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.528 HD13 ' CE2' ' A' ' 57' ' ' PHE . 12.3 tp -82.94 136.0 34.71 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear build core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 83.7 m -63.43 -175.68 0.13 Allowed 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 124.082 0.953 . . . . 0.0 109.599 175.576 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 59.3 m -161.55 119.29 2.28 Favored 'General case' 0 CA--C 1.488 -1.427 0 N-CA-C 104.319 -2.474 . . . . 0.0 104.319 -177.479 . . . . . . . . 1 1 . 1 . 002 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.545 ' HB3' HG22 ' A' ' 2' ' ' VAL . 3.2 m80 . . . . . 0 CA--C 1.558 1.254 0 CA-C-O 114.733 -2.556 . . . . 0.0 115.822 177.184 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.1 p . . . . . 0 N--CA 1.465 0.278 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.583 HG22 ' H ' ' A' ' 11' ' ' TYR . 23.9 m -89.13 115.41 26.64 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 123.767 0.827 . . . . 0.0 109.625 -178.158 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 4' ' ' TRP . . . . . 0.47 ' CG ' HG13 ' A' ' 120' ' ' ILE . 23.7 m95 -77.71 142.06 38.98 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -133.86 138.76 45.8 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -178.316 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.662 ' SG ' ' HB3' ' A' ' 122' ' ' ALA . 0.1 OUTLIER -129.59 49.98 2.21 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.868 0.842 . . . . 0.0 111.099 176.865 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 143.06 -99.45 0.23 Allowed Glycine 0 C--O 1.22 -0.778 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -129.32 5.38 6.32 Favored Glycine 0 N--CA 1.466 0.679 0 C-N-CA 123.676 0.655 . . . . 0.0 112.704 177.834 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.499 HD12 ' OH ' ' A' ' 11' ' ' TYR . 0.3 OUTLIER -112.72 138.79 49.02 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 -175.69 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.5 mp -95.62 160.83 14.31 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 123.981 0.801 . . . . 0.0 109.468 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.583 ' H ' HG22 ' A' ' 3' ' ' THR . 65.9 m-85 -152.37 94.87 1.97 Allowed 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 122.182 0.992 . . . . 0.0 109.564 -173.968 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.27 120.63 7.91 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-O 117.427 -1.273 . . . . 0.0 108.038 -178.315 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.402 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 6.7 tp-100 -50.05 -43.24 50.96 Favored 'General case' 0 C--O 1.205 -1.266 0 O-C-N 124.655 1.222 . . . . 0.0 112.032 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -47.98 -48.84 32.16 Favored 'General case' 0 C--O 1.193 -1.897 0 CA-C-O 118.97 -0.538 . . . . 0.0 112.257 174.59 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.31 -38.13 84.45 Favored 'General case' 0 C--O 1.206 -1.214 0 CA-C-N 119.99 1.268 . . . . 0.0 114.2 168.019 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.549 ' O ' HG11 ' A' ' 108' ' ' VAL . . . -49.96 -43.88 50.35 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 121.599 1.999 . . . . 0.0 114.455 170.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -88.59 -39.89 13.76 Favored 'General case' 0 C--O 1.206 -1.218 0 O-C-N 120.916 -1.115 . . . . 0.0 109.668 176.359 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 36.5 t -73.38 -60.2 2.36 Favored 'General case' 0 C--O 1.211 -0.942 0 C-N-CA 126.571 1.948 . . . . 0.0 109.896 -176.102 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.489 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 4.6 t-20 -40.26 -38.5 0.79 Allowed 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 120.268 1.394 . . . . 0.0 113.357 169.239 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.634 ' HB3' HG11 ' A' ' 108' ' ' VAL . 0.1 OUTLIER -81.81 -30.77 32.07 Favored 'General case' 0 C--O 1.217 -0.656 0 N-CA-C 116.11 1.892 . . . . 0.0 116.11 173.108 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -50.08 -35.35 25.03 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 125.733 1.613 . . . . 0.0 109.298 177.958 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.489 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.1 OUTLIER -73.9 -42.8 60.13 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 117.822 -1.085 . . . . 0.0 111.926 176.792 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.841 ' HB1' ' HG3' ' A' ' 35' ' ' PRO . . . -36.24 129.72 0.65 Allowed Pre-proline 0 N--CA 1.44 -0.974 0 O-C-N 125.233 1.583 . . . . 0.0 113.069 172.027 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.873 ' HG2' HG22 ' A' ' 30' ' ' THR . 17.4 Cg_endo -72.89 123.98 9.32 Favored 'Trans proline' 0 N--CA 1.444 -1.418 0 C-N-CA 122.053 1.835 . . . . 0.0 108.802 -176.439 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.489 ' HA ' HD12 ' A' ' 25' ' ' LEU . 2.1 tp -62.03 91.11 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.262 1.025 . . . . 0.0 110.668 178.769 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 179.78 157.8 0.67 Allowed 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 123.435 0.694 . . . . 0.0 109.427 -175.408 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.416 ' OD1' ' N ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -98.96 89.45 4.29 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 104.621 -2.362 . . . . 0.0 104.621 -164.281 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 63.2 75.48 0.34 Allowed Glycine 0 CA--C 1.529 0.943 0 C-N-CA 119.489 -1.338 . . . . 0.0 111.957 -176.266 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.8 ttpt -138.19 28.79 2.52 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 123.661 1.696 . . . . 0.0 111.825 176.224 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.873 HG22 ' HG2' ' A' ' 24' ' ' PRO . 7.7 p -118.39 146.76 44.17 Favored 'General case' 0 CA--C 1.492 -1.271 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 -172.643 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -42.43 -53.94 4.89 Favored Glycine 0 N--CA 1.452 -0.242 0 O-C-N 123.827 0.705 . . . . 0.0 111.561 -179.156 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.2 t -64.15 -62.43 1.62 Allowed 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 116.533 -1.698 . . . . 0.0 112.378 174.182 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 162.1 -59.11 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.475 0 C-N-CA 127.91 2.484 . . . . 0.0 111.396 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.577 ' CE1' ' CE1' ' A' ' 36' ' ' HIS . 70.8 m-85 -59.77 141.14 89.33 Favored Pre-proline 0 N--CA 1.446 -0.674 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 178.191 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.841 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 36.7 Cg_endo -77.4 167.23 79.88 Favored 'Cis proline' 0 N--CA 1.436 -1.902 0 C-N-CA 121.833 -2.153 . . . . 0.0 112.721 3.512 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.577 ' CE1' ' CE1' ' A' ' 34' ' ' TYR . 2.5 p-80 -137.61 174.4 10.63 Favored 'General case' 0 C--O 1.205 -1.241 0 O-C-N 120.629 -1.294 . . . . 0.0 111.86 178.192 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.93 ' CH2' HG22 ' A' ' 39' ' ' THR . 14.1 t90 -75.84 132.14 40.17 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 119.864 1.211 . . . . 0.0 110.726 173.515 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -97.52 89.56 4.72 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 105.148 -2.167 . . . . 0.0 105.148 -179.382 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.93 HG22 ' CH2' ' A' ' 37' ' ' TRP . 17.1 p -38.81 -36.01 0.24 Allowed 'General case' 0 C--O 1.203 -1.38 0 CA-C-O 117.733 -1.127 . . . . 0.0 110.286 169.989 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 50.4 t30 55.95 22.25 5.61 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 121.189 1.813 . . . . 0.0 109.973 176.499 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.559 ' HA3' HD23 ' A' ' 48' ' ' LEU . . . 101.37 -39.76 2.64 Favored Glycine 0 N--CA 1.425 -2.052 0 CA-C-O 116.726 -2.152 . . . . 0.0 116.587 -168.249 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.479 ' CE2' ' HD3' ' A' ' 66' ' ' PRO . 80.5 m-85 -46.58 152.65 0.44 Allowed 'General case' 0 C--O 1.233 0.202 0 C-N-CA 126.456 1.902 . . . . 0.0 110.695 177.348 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.82 -38.35 25.65 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.728 178.644 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.574 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -172.29 -59.07 0.04 OUTLIER Glycine 0 C--N 1.335 0.489 0 C-N-CA 124.689 1.138 . . . . 0.0 111.011 -178.173 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -125.16 -64.77 1.06 Allowed 'General case' 0 CA--C 1.507 -0.69 0 O-C-N 122.641 -0.329 . . . . 0.0 110.514 -176.802 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.99 -175.81 0.22 Allowed Glycine 0 C--N 1.342 0.872 0 C-N-CA 124.761 1.172 . . . . 0.0 110.988 178.835 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.54 -165.72 0.0 OUTLIER 'General case' 0 CA--C 1.551 0.987 0 CA-C-O 124.61 2.148 . . . . 0.0 112.623 175.697 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.723 ' H ' HD12 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -96.35 169.02 9.54 Favored Pre-proline 0 C--N 1.306 -1.286 0 O-C-N 119.829 -1.794 . . . . 0.0 110.889 -179.96 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -71.87 157.67 54.48 Favored 'Trans proline' 0 N--CA 1.441 -1.582 0 C-N-CA 121.888 1.725 . . . . 0.0 110.69 178.23 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.0 tttt -63.76 97.88 0.17 Allowed 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.713 -0.617 . . . . 0.0 110.205 176.685 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 123.62 40.0 0.48 Allowed Glycine 0 CA--C 1.52 0.351 0 N-CA-C 112.015 -0.434 . . . . 0.0 112.015 -176.528 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.443 ' HD3' ' HA2' ' A' ' 41' ' ' GLY . 0.0 OUTLIER -132.96 161.35 34.54 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-N 117.325 0.562 . . . . 0.0 111.495 176.85 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.9 m -140.48 102.85 6.55 Favored Pre-proline 0 C--N 1.324 -0.527 0 O-C-N 124.045 0.841 . . . . 0.0 109.61 -178.484 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -72.08 175.78 9.37 Favored 'Trans proline' 0 N--CA 1.448 -1.183 0 C-N-CA 122.504 2.136 . . . . 0.0 111.418 178.208 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.8 mt -98.35 130.52 47.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 -178.297 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.34 135.37 33.72 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 177.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.508 ' CD1' ' HB3' ' A' ' 118' ' ' CYS . 17.3 m-85 -118.83 -45.37 2.59 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 124.078 0.951 . . . . 0.0 110.142 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 121.03 -2.31 11.68 Favored Glycine 0 C--O 1.222 -0.642 0 C-N-CA 123.885 0.755 . . . . 0.0 112.59 -175.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 18.0 mttm -105.33 137.82 42.51 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 118.222 1.011 . . . . 0.0 109.373 177.507 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.2 t -73.26 -4.64 34.41 Favored 'General case' 0 C--O 1.217 -0.642 0 O-C-N 125.182 1.551 . . . . 0.0 111.504 176.157 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -89.0 -50.59 6.08 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 124.654 1.182 . . . . 0.0 109.745 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 10.1 m -71.52 -22.55 61.76 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.46 0.648 . . . . 0.0 111.564 175.41 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -79.75 -35.87 38.14 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-O 118.892 -0.575 . . . . 0.0 111.143 174.023 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -52.35 160.79 1.19 Allowed Pre-proline 0 CA--C 1.539 0.542 0 CA-C-O 122.084 0.945 . . . . 0.0 111.67 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -71.94 144.14 42.39 Favored 'Trans proline' 0 N--CA 1.443 -1.492 0 C-N-CA 120.461 0.774 . . . . 0.0 113.573 175.037 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.479 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 19.8 Cg_endo -72.74 169.12 22.75 Favored 'Trans proline' 0 N--CA 1.444 -1.433 0 C-N-CA 124.151 3.234 . . . . 0.0 111.056 178.513 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.4 tptp -128.47 51.92 1.96 Allowed 'General case' 0 C--O 1.197 -1.675 0 CA-C-O 114.987 -2.435 . . . . 0.0 107.216 -179.016 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.42 ' CD2' ' O ' ' A' ' 72' ' ' GLY . 57.1 t-80 -74.79 144.56 43.49 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 121.212 1.824 . . . . 0.0 113.897 175.011 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.06 -91.17 0.5 Allowed 'General case' 0 N--CA 1.469 0.496 0 O-C-N 119.207 -2.183 . . . . 0.0 109.607 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.95 -174.94 0.38 Allowed 'General case' 0 C--O 1.215 -0.733 0 C-N-CA 123.713 0.805 . . . . 0.0 111.123 178.974 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -50.31 -27.02 5.47 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 173.39 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.42 ' O ' ' CD2' ' A' ' 68' ' ' HIS . . . -104.22 -118.54 4.49 Favored Glycine 0 C--O 1.214 -1.139 0 N-CA-C 106.583 -2.607 . . . . 0.0 106.583 178.01 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -121.75 -100.0 0.43 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 100.413 -3.921 . . . . 0.0 100.413 -167.542 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 144.75 -131.99 4.55 Favored Glycine 0 N--CA 1.439 -1.134 0 CA-C-N 115.232 -0.894 . . . . 0.0 113.32 -167.678 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.2 mttm -63.01 -104.41 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 122.049 0.928 . . . . 0.0 112.673 175.986 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.534 HG23 ' O ' ' A' ' 76' ' ' THR . 0.6 OUTLIER -101.39 21.2 14.54 Favored 'General case' 0 CA--C 1.514 -0.423 0 O-C-N 120.785 -1.197 . . . . 0.0 111.588 -179.685 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.455 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 1.1 m-20 -33.25 105.06 0.03 OUTLIER 'General case' 0 CA--C 1.49 -1.343 0 C-N-CA 126.181 1.792 . . . . 0.0 109.924 -176.238 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -83.8 16.44 2.76 Favored 'General case' 0 C--N 1.319 -0.74 0 O-C-N 120.683 -1.261 . . . . 0.0 110.5 -176.759 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.487 ' CE2' ' HB2' ' A' ' 81' ' ' LEU . 10.8 p90 -41.27 136.28 1.7 Allowed 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 125.607 1.563 . . . . 0.0 110.963 177.495 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.446 HD21 HG22 ' A' ' 111' ' ' THR . 0.3 OUTLIER -77.02 136.27 38.69 Favored 'General case' 0 C--O 1.215 -0.728 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.08 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.578 HD21 ' HB2' ' A' ' 35' ' ' PRO . 0.5 OUTLIER -128.84 151.91 49.09 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.85 0.834 . . . . 0.0 109.1 175.442 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -121.81 163.33 19.34 Favored 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 124.242 1.017 . . . . 0.0 112.193 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.602 ' CE1' ' HB2' ' A' ' 23' ' ' ALA . 80.1 t80 -148.21 129.04 6.97 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -177.629 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.5 ' HD3' ' CD1' ' A' ' 34' ' ' TYR . 17.8 Cg_endo -72.0 109.61 2.73 Favored 'Trans proline' 0 N--CA 1.443 -1.477 0 C-N-CA 123.381 2.721 . . . . 0.0 110.887 -176.176 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.469 HG21 ' HA ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -107.25 107.31 18.18 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-N 114.662 -1.154 . . . . 0.0 109.65 -178.062 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -80.01 160.17 69.23 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 177.414 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -76.4 -38.66 0.98 Allowed 'Trans proline' 0 CA--C 1.493 -1.564 0 C-N-CA 122.092 1.861 . . . . 0.0 112.896 178.472 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -44.67 -30.43 0.93 Allowed 'General case' 0 N--CA 1.474 0.766 0 O-C-N 125.644 1.84 . . . . 0.0 110.92 176.874 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.74 6.61 86.94 Favored Glycine 0 N--CA 1.437 -1.281 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 176.799 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -72.74 136.08 45.44 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -68.18 85.31 0.25 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 175.304 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.494 ' CD2' ' HB3' ' A' ' 94' ' ' PHE . 6.7 t80 -37.29 144.25 0.08 Allowed 'General case' 0 C--O 1.214 -0.769 0 C-N-CA 123.95 0.9 . . . . 0.0 110.659 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.3 55.91 0.8 Allowed 'General case' 0 C--N 1.313 -0.986 0 O-C-N 119.781 -1.825 . . . . 0.0 110.936 174.687 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.494 ' HB3' ' CD2' ' A' ' 92' ' ' TYR . 34.1 p90 -71.35 -24.17 62.04 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 124.099 0.959 . . . . 0.0 111.025 175.884 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -86.11 -27.66 24.52 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 123.973 0.909 . . . . 0.0 110.401 178.103 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -88.9 111.57 22.25 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -178.872 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.3 pttt -58.04 -49.75 75.81 Favored 'General case' 0 CA--C 1.511 -0.522 0 O-C-N 121.648 -0.658 . . . . 0.0 111.003 177.471 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 99' ' ' PRO . 2.3 mtmm -138.07 126.08 14.03 Favored Pre-proline 0 N--CA 1.436 -1.155 0 CA-C-N 114.364 -1.289 . . . . 0.0 109.946 -175.826 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.409 ' HA ' ' HA ' ' A' ' 98' ' ' LYS . 22.9 Cg_endo -69.55 176.65 31.16 Favored 'Cis proline' 0 N--CA 1.459 -0.558 0 O-C-N 124.35 1.71 . . . . 0.0 110.949 -3.965 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.99 123.16 16.84 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 124.845 1.258 . . . . 0.0 109.484 177.345 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.49 -179.37 7.14 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 125.309 1.63 . . . . 0.0 110.378 178.677 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -46.64 153.14 0.81 Allowed Pre-proline 0 CA--C 1.541 0.622 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.937 176.462 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.49 -70.62 0.02 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.576 0 C-N-CA 121.998 1.799 . . . . 0.0 110.626 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 125.14 129.42 3.36 Favored Glycine 0 CA--C 1.533 1.178 0 CA-C-N 118.885 0.766 . . . . 0.0 111.214 -178.511 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.93 -69.56 0.02 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 122.924 2.416 . . . . 0.0 110.477 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.505 ' CB ' ' CE2' ' A' ' 11' ' ' TYR . . . -66.94 132.87 48.85 Favored 'General case' 0 CA--C 1.512 -0.491 0 O-C-N 123.18 0.3 . . . . 0.0 110.732 179.105 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.446 ' HG2' ' HA ' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -139.76 152.15 46.38 Favored 'General case' 0 CA--C 1.497 -1.082 0 CA-C-O 117.719 -1.134 . . . . 0.0 110.737 -178.237 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.634 HG11 ' HB3' ' A' ' 20' ' ' SER . 3.3 p -87.32 114.17 25.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 O-C-N 124.153 0.908 . . . . 0.0 111.673 178.246 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.641 HG12 HD13 ' A' ' 121' ' ' ILE . 1.4 mp -98.7 118.07 44.69 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.236 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 -173.312 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.485 ' CD1' ' CG ' ' A' ' 115' ' ' LYS . 4.6 p90 -139.03 148.0 42.82 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-O 123.918 1.818 . . . . 0.0 108.616 -178.897 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.446 HG22 HD21 ' A' ' 80' ' ' LEU . 4.8 p -83.27 164.87 19.82 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.142 178.444 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.543 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -107.46 154.81 40.47 Favored Pre-proline 0 CA--C 1.55 0.959 0 CA-C-O 121.014 0.435 . . . . 0.0 111.072 178.495 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.543 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 15.9 Cg_endo -74.96 -53.29 0.16 OUTLIER 'Cis proline' 0 CA--C 1.498 -1.297 0 C-N-CA 124.158 -1.184 . . . . 0.0 110.071 -6.622 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.539 ' O ' HG23 ' A' ' 116' ' ' VAL . 32.7 t30 -45.82 111.39 0.35 Allowed 'General case' 0 CA--C 1.509 -0.605 0 CA-C-O 117.174 -1.393 . . . . 0.0 108.783 177.29 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.485 ' CG ' ' CD1' ' A' ' 110' ' ' TYR . 0.1 OUTLIER -65.79 79.52 0.07 Allowed 'General case' 0 CA--C 1.507 -0.691 0 C-N-CA 125.008 1.323 . . . . 0.0 109.102 -179.905 . . . . . . . . 3 3 . 1 . 003 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 114' ' ' ASN . 80.9 t -76.54 75.72 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.763 0 N-CA-C 105.558 -2.015 . . . . 0.0 105.558 -173.248 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.402 ' CZ ' ' NE2' ' A' ' 13' ' ' GLN . 57.3 t80 -37.68 101.92 0.02 OUTLIER 'General case' 0 C--O 1.237 0.397 0 C-N-CA 127.723 2.409 . . . . 0.0 108.822 -175.898 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 118' ' ' CYS . . . . . 0.508 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 16.0 m -85.4 -43.16 13.88 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 -176.156 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 156.79 -146.94 14.65 Favored Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.194 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.47 HG13 ' CG ' ' A' ' 4' ' ' TRP . 1.4 mm -129.5 139.24 52.22 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.403 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 -174.792 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.641 HD13 HG12 ' A' ' 109' ' ' ILE . 4.3 pt -127.33 153.1 36.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 -177.321 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.662 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . . . . . . . . 0 C--N 1.323 -0.569 0 CA-C-O 122.007 0.908 . . . . 0.0 109.711 175.665 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 5.8 ptmt . . . . . 0 CA--C 1.506 -0.72 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 . . . . . . . . . 0 0 . 1 . 003 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 11.9 tp -81.99 138.85 34.84 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.557 1.161 . . . . 0.0 108.199 178.569 . . . . . . . . 1 1 . 1 . 003 nuclear build core ' A' A ' 134' ' ' CYS . . . . . 0.448 ' SG ' HG22 ' A' ' 120' ' ' ILE . 72.3 m -61.19 -176.57 0.07 Allowed 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 122.997 1.379 . . . . 0.0 111.133 174.716 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -158.69 112.88 2.46 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -178.469 . . . . . . . . 2 2 . 1 . 003 nuclear build core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.255 1.354 0 CA-C-O 113.429 -3.177 . . . . 0.0 110.944 173.777 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.61 HG22 ' H ' ' A' ' 3' ' ' THR . 6.9 p . . . . . 0 CA--C 1.539 0.527 0 CA-C-O 122.556 1.169 . . . . 0.0 111.859 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.706 HG21 HD23 ' A' ' 10' ' ' LEU . 29.9 m -106.84 115.56 30.4 Favored 'General case' 0 C--N 1.315 -0.925 0 O-C-N 121.277 -0.889 . . . . 0.0 109.923 179.422 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 4' ' ' TRP . . . . . 0.543 ' CZ2' ' CE1' ' A' ' 136' ' ' HIS . 17.4 m95 -81.57 137.72 35.48 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -131.56 139.27 49.18 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -178.197 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.71 ' SG ' ' HB3' ' A' ' 122' ' ' ALA . 0.5 OUTLIER -125.48 65.86 1.16 Allowed 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 177.643 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 40.39 70.72 0.35 Allowed Glycine 0 CA--C 1.529 0.91 0 O-C-N 123.876 0.735 . . . . 0.0 112.335 -178.707 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 177.69 -79.84 0.07 OUTLIER Glycine 0 C--O 1.227 -0.293 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 -178.923 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 25.8 mt -135.81 164.34 28.13 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 178.364 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.706 HD23 HG21 ' A' ' 3' ' ' THR . 2.8 mp -83.41 139.87 32.72 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.194 179.133 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.446 ' CE2' ' CB ' ' A' ' 106' ' ' ALA . 78.5 m-85 -127.79 101.13 6.22 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 123.898 0.879 . . . . 0.0 109.643 -175.235 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -56.17 117.06 3.41 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-O 117.751 -1.119 . . . . 0.0 109.109 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.685 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 3.5 tp-100 -43.67 -43.41 5.85 Favored 'General case' 0 C--O 1.221 -0.425 0 O-C-N 124.399 1.062 . . . . 0.0 111.533 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -48.77 -56.2 9.31 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 118.39 -0.814 . . . . 0.0 110.083 176.455 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.433 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 0.2 OUTLIER -53.45 -32.02 48.08 Favored 'General case' 0 C--O 1.204 -1.34 0 CA-C-O 117.147 -1.406 . . . . 0.0 111.395 174.45 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.685 ' HB3' ' O ' ' A' ' 13' ' ' GLN . . . -55.4 -75.36 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 120.665 1.575 . . . . 0.0 111.784 174.013 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -61.98 -37.42 84.75 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-O 117.936 -1.03 . . . . 0.0 109.913 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 34.5 t -64.24 -65.26 0.7 Allowed 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 126.212 1.805 . . . . 0.0 109.798 -179.315 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.513 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 10.2 t-20 -43.28 -32.51 0.8 Allowed 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 123.459 0.704 . . . . 0.0 111.959 174.309 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.58 -41.43 27.18 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 175.237 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -41.93 -39.78 1.96 Allowed 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 125.594 1.557 . . . . 0.0 109.662 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.513 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -73.09 -51.21 18.9 Favored 'General case' 0 N--CA 1.439 -1.007 0 O-C-N 124.418 1.074 . . . . 0.0 111.561 176.513 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.698 ' HB1' ' HG3' ' A' ' 35' ' ' PRO . . . -37.03 130.76 0.74 Allowed Pre-proline 0 N--CA 1.442 -0.836 0 O-C-N 125.28 1.612 . . . . 0.0 111.873 175.628 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.679 ' HG2' HG22 ' A' ' 30' ' ' THR . 15.5 Cg_endo -74.11 124.33 8.99 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 121.662 1.574 . . . . 0.0 109.159 -177.031 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.712 HD13 ' HE2' ' A' ' 115' ' ' LYS . 5.9 tp -59.39 91.93 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.947 178.986 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 178.47 159.57 0.55 Allowed 'General case' 0 N--CA 1.448 -0.565 0 O-C-N 124.264 0.977 . . . . 0.0 110.236 -176.531 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -101.95 131.05 48.58 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-O 118.238 -0.887 . . . . 0.0 109.972 178.978 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 41.88 71.77 0.33 Allowed Glycine 0 CA--C 1.522 0.491 0 O-C-N 124.912 1.382 . . . . 0.0 111.504 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.16 25.43 0.72 Allowed 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.413 0.625 . . . . 0.0 110.685 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.679 HG22 ' HG2' ' A' ' 24' ' ' PRO . 69.2 p -123.86 150.84 44.12 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-O 118.663 -0.684 . . . . 0.0 109.513 -178.058 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.432 ' HA3' ' O ' ' A' ' 95' ' ' ASP . . . -39.0 -58.14 1.93 Allowed Glycine 0 N--CA 1.45 -0.42 0 O-C-N 124.853 1.345 . . . . 0.0 112.034 -178.792 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.6 t -70.28 -71.66 0.23 Allowed 'General case' 0 N--CA 1.443 -0.805 0 CA-C-O 118.621 -0.704 . . . . 0.0 110.648 176.509 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 58.6 p 178.91 -60.48 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.277 0 O-C-N 124.6 1.188 . . . . 0.0 111.531 -178.74 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.541 ' CD1' ' HD3' ' A' ' 84' ' ' PRO . 50.8 m-85 -62.48 149.1 89.04 Favored Pre-proline 0 N--CA 1.428 -1.542 0 C-N-CA 123.729 0.812 . . . . 0.0 111.85 178.776 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.698 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 18.5 Cg_endo -75.39 164.08 89.01 Favored 'Cis proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.48 -1.883 . . . . 0.0 110.868 -1.001 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.431 ' CD2' ' CD1' ' A' ' 34' ' ' TYR . 0.6 OUTLIER -142.24 162.09 36.36 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.211 -178.3 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.93 ' CZ3' HG22 ' A' ' 39' ' ' THR . 21.5 t90 -61.58 132.01 51.92 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -104.07 78.01 1.48 Allowed 'General case' 0 N--CA 1.428 -1.569 0 C-N-CA 124.903 1.281 . . . . 0.0 108.157 -178.388 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.93 HG22 ' CZ3' ' A' ' 37' ' ' TRP . 78.7 p -37.42 -38.67 0.25 Allowed 'General case' 0 CA--C 1.509 -0.62 0 O-C-N 124.167 0.917 . . . . 0.0 110.455 177.483 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 44.6 t30 62.8 12.63 5.84 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 122.747 1.26 . . . . 0.0 108.748 178.322 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 114.59 -35.49 4.4 Favored Glycine 0 N--CA 1.429 -1.797 0 O-C-N 119.666 -1.896 . . . . 0.0 112.309 -174.992 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.658 ' N ' HD23 ' A' ' 48' ' ' LEU . 59.8 m-85 -50.48 162.27 0.25 Allowed 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 121.185 0.517 . . . . 0.0 111.807 178.225 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.21 -38.24 22.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.464 178.654 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.445 ' CA ' ' HB3' ' A' ' 68' ' ' HIS . . . 125.98 41.37 0.34 Allowed Glycine 0 N--CA 1.437 -1.251 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.634 -176.923 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -146.01 -70.07 0.26 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.16 -74.61 0.01 OUTLIER Glycine 0 N--CA 1.435 -1.408 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -177.759 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.8 pttt -98.29 178.57 5.02 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 118.257 1.029 . . . . 0.0 110.648 178.311 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.697 ' H ' HD12 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -106.03 163.72 16.47 Favored Pre-proline 0 N--CA 1.444 -0.74 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.569 -179.548 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.63 163.11 36.61 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 121.762 1.641 . . . . 0.0 110.624 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.71 97.34 0.05 Allowed 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 125.06 54.59 0.17 Allowed Glycine 0 N--CA 1.447 -0.633 0 O-C-N 121.436 -0.79 . . . . 0.0 111.668 -179.032 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -150.95 145.9 25.9 Favored 'General case' 0 N--CA 1.452 -0.335 0 O-C-N 124.127 0.545 . . . . 0.0 110.963 177.864 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.3 m -139.01 98.99 8.31 Favored Pre-proline 0 N--CA 1.45 -0.457 0 O-C-N 124.407 1.067 . . . . 0.0 109.861 -178.702 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.509 ' HG3' HD21 ' A' ' 48' ' ' LEU . 19.1 Cg_endo -73.56 166.93 28.56 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 121.626 1.55 . . . . 0.0 111.207 179.112 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.461 ' O ' ' CE2' ' A' ' 57' ' ' PHE . 5.6 mt -79.58 125.96 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -178.228 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.9 tppt? -81.69 155.71 25.42 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.125 0.488 . . . . 0.0 109.709 178.142 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.505 ' CD1' ' HB3' ' A' ' 118' ' ' CYS . 21.6 m-85 -139.01 -46.88 0.48 Allowed 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.233 178.314 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 119.44 -2.35 14.0 Favored Glycine 0 CA--C 1.522 0.491 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.178 -176.824 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.2 mmtt -96.07 141.86 28.96 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-O 117.625 -1.179 . . . . 0.0 109.774 178.847 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.43 -7.1 58.17 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 124.832 1.333 . . . . 0.0 110.721 177.926 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -90.9 -53.06 4.55 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 123.71 0.804 . . . . 0.0 109.135 -179.004 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.593 ' SG ' HD21 ' A' ' 80' ' ' LEU . 4.9 t -72.18 -16.02 61.96 Favored 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 124.103 0.877 . . . . 0.0 110.672 176.606 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -86.68 -37.79 17.63 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 123.57 0.544 . . . . 0.0 111.043 177.158 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.527 ' HD3' ' CD2' ' A' ' 78' ' ' HIS . 0.0 OUTLIER -49.17 165.15 0.28 Allowed Pre-proline 0 N--CA 1.441 -0.912 0 CA-C-O 121.991 0.9 . . . . 0.0 111.237 179.625 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -72.6 124.59 9.91 Favored 'Trans proline' 0 N--CA 1.441 -1.607 0 C-N-CA 120.927 1.084 . . . . 0.0 113.076 175.705 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.45 ' HD3' ' CZ ' ' A' ' 42' ' ' TYR . 19.0 Cg_endo -74.26 167.39 27.28 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 122.881 2.387 . . . . 0.0 110.253 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -127.54 104.03 7.66 Favored 'General case' 0 C--O 1.213 -0.82 0 CA-C-O 115.957 -1.973 . . . . 0.0 107.68 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.66 ' CE1' ' CE3' ' A' ' 37' ' ' TRP . 66.2 t60 -93.55 161.92 14.17 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.47 1.106 . . . . 0.0 110.341 176.587 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.405 ' HB2' ' OD2' ' A' ' 77' ' ' ASP . 0.3 OUTLIER -152.32 176.76 11.28 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.153 179.478 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.74 63.02 7.29 Favored 'General case' 0 C--O 1.224 -0.263 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.695 178.0 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -177.41 -39.0 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.885 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 122.59 -65.64 0.5 Allowed Glycine 0 N--CA 1.44 -1.056 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.515 -178.549 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 10.0 p-10 -120.51 62.03 0.86 Allowed 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -56.13 -105.61 0.01 OUTLIER Glycine 0 CA--C 1.532 1.149 0 CA-C-O 123.362 1.534 . . . . 0.0 112.236 -178.749 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 16.1 mttp -70.76 -104.59 0.0 OUTLIER 'General case' 0 C--O 1.218 -0.556 0 O-C-N 120.07 -1.841 . . . . 0.0 110.285 178.438 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.581 HG23 ' O ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -109.21 16.62 22.33 Favored 'General case' 0 N--CA 1.447 -0.607 0 O-C-N 121.553 -0.717 . . . . 0.0 110.65 179.45 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.47 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 5.4 m-20 -29.73 102.25 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 123.838 0.855 . . . . 0.0 111.651 -179.138 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.527 ' CD2' ' HD3' ' A' ' 64' ' ' ARG . 9.5 p-80 -87.88 28.13 1.07 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -175.908 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 1.062 ' CE1' HD11 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -54.46 168.16 0.28 Allowed 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 174.897 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.699 HD23 ' O ' ' A' ' 110' ' ' TYR . 0.6 OUTLIER -98.26 158.05 15.8 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 118.477 -0.773 . . . . 0.0 109.758 176.947 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 1.062 HD11 ' CE1' ' A' ' 79' ' ' TYR . 1.4 mp -141.82 130.69 23.01 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 123.298 0.639 . . . . 0.0 109.511 178.863 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.471 ' CB ' ' CD1' ' A' ' 109' ' ' ILE . 0.4 OUTLIER -99.95 151.08 21.74 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 121.565 0.698 . . . . 0.0 110.995 179.138 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.598 ' CZ ' ' HB2' ' A' ' 23' ' ' ALA . 28.7 t80 -142.0 121.01 7.85 Favored Pre-proline 0 N--CA 1.444 -0.774 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.273 -178.853 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.541 ' HD3' ' CD1' ' A' ' 34' ' ' TYR . 19.4 Cg_endo -72.9 111.73 3.34 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 122.886 2.391 . . . . 0.0 110.193 -177.191 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.55 125.54 51.94 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.125 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.485 ' CD2' ' NE2' ' A' ' 90' ' ' HIS . 63.5 m-85 -82.89 155.74 67.71 Favored Pre-proline 0 N--CA 1.443 -0.822 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.012 178.836 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -77.64 -42.12 0.29 Allowed 'Trans proline' 0 CA--C 1.505 -0.931 0 C-N-CA 122.104 1.869 . . . . 0.0 111.898 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -43.25 -30.88 0.54 Allowed 'General case' 0 C--N 1.346 0.426 0 O-C-N 125.078 1.486 . . . . 0.0 110.293 177.428 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 99.87 -12.48 60.86 Favored Glycine 0 N--CA 1.436 -1.364 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 177.151 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.485 ' NE2' ' CD2' ' A' ' 86' ' ' PHE . 4.8 p-80 -58.38 128.77 38.83 Favored 'General case' 0 N--CA 1.44 -0.925 0 O-C-N 124.325 0.662 . . . . 0.0 109.449 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -68.95 101.47 1.39 Allowed 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.086 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.488 ' O ' ' CD2' ' A' ' 94' ' ' PHE . 6.5 t80 -34.26 138.38 0.09 Allowed 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 122.028 0.918 . . . . 0.0 111.463 178.858 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.407 ' HE2' ' O ' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -78.96 60.08 2.81 Favored 'General case' 0 N--CA 1.442 -0.852 0 O-C-N 120.081 -1.637 . . . . 0.0 109.953 177.75 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.488 ' CD2' ' O ' ' A' ' 92' ' ' TYR . 30.4 p90 -75.55 1.7 13.61 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 123.269 0.628 . . . . 0.0 112.084 177.207 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.432 ' O ' ' HA3' ' A' ' 31' ' ' GLY . 36.7 t0 -95.79 -38.8 10.16 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 122.394 1.092 . . . . 0.0 109.115 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -80.75 110.03 15.86 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 120.862 -1.149 . . . . 0.0 109.36 -178.883 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.8 pttt -57.86 -50.28 73.85 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.04 178.51 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.46 127.51 7.26 Favored Pre-proline 0 N--CA 1.431 -1.401 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.802 -176.734 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.407 ' O ' ' HE2' ' A' ' 93' ' ' LYS . 21.7 Cg_endo -73.05 178.04 34.09 Favored 'Cis proline' 0 N--CA 1.458 -0.596 0 O-C-N 125.093 2.102 . . . . 0.0 111.232 -2.354 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.0 132.39 25.11 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.14 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -72.67 145.02 47.53 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 124.244 0.965 . . . . 0.0 109.312 178.922 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -42.09 156.83 0.22 Allowed Pre-proline 0 N--CA 1.45 -0.448 0 O-C-N 123.74 0.65 . . . . 0.0 111.411 177.709 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -72.49 -163.13 0.14 Allowed 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 121.235 1.29 . . . . 0.0 111.142 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -139.85 154.33 23.73 Favored Glycine 0 N--CA 1.441 -0.988 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.04 178.523 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -75.52 -66.55 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.143 1.895 . . . . 0.0 110.131 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.563 ' HA ' ' HB2' ' A' ' 122' ' ' ALA . . . -69.19 135.75 51.07 Favored 'General case' 0 N--CA 1.443 -0.78 0 O-C-N 124.298 0.999 . . . . 0.0 110.907 178.551 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.425 ' HG2' ' HA ' ' A' ' 84' ' ' PRO . 4.3 mtt85 -141.47 146.02 35.94 Favored 'General case' 0 N--CA 1.448 -0.541 0 O-C-N 123.913 0.758 . . . . 0.0 110.716 -178.848 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.452 ' O ' HD13 ' A' ' 109' ' ' ILE . 7.7 p -83.6 128.89 38.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 O-C-N 123.736 0.648 . . . . 0.0 109.869 178.865 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.656 ' CG2' HD22 ' A' ' 80' ' ' LEU . 9.1 mm -107.9 142.83 19.58 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.861 0 CA-C-O 118.571 -0.728 . . . . 0.0 109.938 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.699 ' O ' HD23 ' A' ' 80' ' ' LEU . 12.4 p90 -167.15 155.45 9.67 Favored 'General case' 0 N--CA 1.442 -0.839 0 O-C-N 124.121 0.888 . . . . 0.0 111.14 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.0 p -91.83 164.71 13.59 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.476 -177.91 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.568 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -111.93 154.35 44.19 Favored Pre-proline 0 N--CA 1.442 -0.866 0 C-N-CA 122.45 0.3 . . . . 0.0 110.898 179.536 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.568 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 18.6 Cg_endo -74.52 -54.03 0.15 OUTLIER 'Cis proline' 0 CA--C 1.509 -0.748 0 C-N-CA 122.523 -1.865 . . . . 0.0 109.468 -4.345 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -42.92 111.49 0.27 Allowed 'General case' 0 CA--C 1.507 -0.692 0 CA-C-O 116.45 -1.738 . . . . 0.0 109.722 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.712 ' HE2' HD13 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -63.09 76.35 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.375 0 O-C-N 125.77 1.919 . . . . 0.0 109.123 -178.44 . . . . . . . . 3 3 . 1 . 004 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.591 ' O ' HG12 ' A' ' 116' ' ' VAL . 8.8 t -77.01 71.25 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 -176.972 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.594 ' CZ ' ' HA2' ' A' ' 119' ' ' GLY . 27.9 t80 -35.63 110.6 0.11 Allowed 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 123.16 0.584 . . . . 0.0 111.132 178.493 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 118' ' ' CYS . . . . . 0.63 ' SG ' HD21 ' A' ' 80' ' ' LEU . 6.2 m -82.61 -45.5 14.49 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.594 ' HA2' ' CZ ' ' A' ' 117' ' ' PHE . . . 161.93 -145.05 10.32 Favored Glycine 0 N--CA 1.443 -0.87 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.511 HG13 ' CD2' ' A' ' 4' ' ' TRP . 1.1 mm -127.63 136.97 59.01 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.82 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 -176.45 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.721 HG22 HD12 ' A' ' 133' ' ' LEU . 9.2 pt -127.36 156.06 38.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -177.69 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.71 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . . . . . . . . 0 C--N 1.323 -0.558 0 CA-C-O 121.515 0.674 . . . . 0.0 109.82 178.053 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.51 -0.577 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.721 HD12 HG22 ' A' ' 121' ' ' ILE . 5.2 tp -88.12 143.23 27.18 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 124.562 1.164 . . . . 0.0 109.135 178.766 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 134' ' ' CYS . . . . . 0.47 ' SG ' HG22 ' A' ' 120' ' ' ILE . 76.0 m -62.04 -172.21 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 122.088 0.946 . . . . 0.0 109.707 177.302 . . . . . . . . 2 2 . 1 . 004 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 19.5 m -133.04 92.46 3.03 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.469 -179.006 . . . . . . . . 1 1 . 1 . 004 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.543 ' CE1' ' CZ2' ' A' ' 4' ' ' TRP . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.097 0 CA-C-O 116.886 -1.531 . . . . 0.0 112.258 176.35 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.4 p . . . . . 0 N--CA 1.451 -0.39 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 . . . . . . . . . 0 0 . 1 . 005 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.2 m -89.52 109.05 20.02 Favored 'General case' 0 C--N 1.317 -0.818 0 O-C-N 121.488 -0.758 . . . . 0.0 109.553 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 4' ' ' TRP . . . . . 0.418 ' CG ' HG13 ' A' ' 120' ' ' ILE . 39.7 m95 -77.32 140.0 39.9 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 124.065 0.946 . . . . 0.0 110.54 178.549 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.6 m -124.57 120.24 31.37 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 122.093 0.949 . . . . 0.0 109.045 -176.118 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.555 ' HB3' ' HB3' ' A' ' 122' ' ' ALA . 74.9 m -103.87 64.56 0.79 Allowed 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 34.65 60.14 0.65 Allowed Glycine 0 C--N 1.341 0.806 0 C-N-CA 124.992 1.282 . . . . 0.0 113.007 178.95 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.599 ' C ' HD13 ' A' ' 9' ' ' LEU . . . 170.02 -80.97 0.09 OUTLIER Glycine 0 C--O 1.224 -0.491 0 N-CA-C 110.501 -1.039 . . . . 0.0 110.501 -175.21 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.707 HD23 ' OH ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -114.66 159.05 20.94 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.488 1.115 . . . . 0.0 108.787 -176.198 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.534 HD13 ' C ' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -110.74 125.33 53.4 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -172.019 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.707 ' OH ' HD23 ' A' ' 9' ' ' LEU . 89.5 m-85 -117.06 106.68 13.64 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 126.441 1.896 . . . . 0.0 108.537 -172.043 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -58.7 127.81 34.06 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.31 177.171 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.475 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 7.0 tp-100 -54.82 -44.49 73.9 Favored 'General case' 0 C--O 1.217 -0.626 0 O-C-N 121.373 -0.83 . . . . 0.0 112.773 178.311 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -51.71 -26.3 9.06 Favored 'General case' 0 C--O 1.213 -0.845 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 175.874 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.18 -41.66 15.43 Favored 'General case' 0 C--O 1.206 -1.217 0 CA-C-O 116.174 -1.87 . . . . 0.0 113.418 170.235 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.55 -62.91 1.35 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 121.705 2.048 . . . . 0.0 113.08 175.167 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -58.03 -43.61 86.87 Favored 'General case' 0 C--N 1.333 -0.137 0 O-C-N 121.543 -0.723 . . . . 0.0 110.73 174.214 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.5 t -61.93 -23.21 66.21 Favored 'General case' 0 C--O 1.222 -0.381 0 O-C-N 121.89 -0.506 . . . . 0.0 111.354 175.595 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -71.11 -63.89 1.02 Allowed 'General case' 0 N--CA 1.438 -1.059 0 O-C-N 120.603 -1.31 . . . . 0.0 108.439 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.39 -15.91 51.61 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 114.669 -1.151 . . . . 0.0 111.518 178.021 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -59.41 -51.86 68.08 Favored 'General case' 0 CA--C 1.517 -0.306 0 O-C-N 121.296 -0.878 . . . . 0.0 110.91 178.284 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -74.92 -41.02 60.51 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 123.811 0.694 . . . . 0.0 111.15 178.212 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.752 ' HB2' ' CZ ' ' A' ' 83' ' ' PHE . . . -43.14 131.4 3.33 Favored Pre-proline 0 N--CA 1.447 -0.577 0 O-C-N 124.651 1.219 . . . . 0.0 112.441 177.801 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.616 ' HG2' HG22 ' A' ' 30' ' ' THR . 19.2 Cg_endo -71.18 123.65 9.8 Favored 'Trans proline' 0 N--CA 1.444 -1.414 0 C-N-CA 122.053 1.835 . . . . 0.0 109.54 -177.195 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.75 HD13 ' HE2' ' A' ' 115' ' ' LYS . 5.7 tp -61.48 96.66 0.06 Allowed 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.625 0.77 . . . . 0.0 110.94 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 178.2 165.21 0.74 Allowed 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 124.041 0.936 . . . . 0.0 109.728 -175.118 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.73 121.28 42.13 Favored 'General case' 0 CA--C 1.511 -0.525 0 C-N-CA 124.749 1.22 . . . . 0.0 109.688 177.041 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 48.77 67.9 1.51 Allowed Glycine 0 CA--C 1.525 0.707 0 CA-C-O 121.772 0.651 . . . . 0.0 112.636 174.802 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.05 28.47 1.01 Allowed 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.599 0.76 . . . . 0.0 112.759 -178.233 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.616 HG22 ' HG2' ' A' ' 24' ' ' PRO . 71.9 p -127.56 151.03 49.42 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -175.442 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -40.17 -58.22 2.42 Favored Glycine 0 C--O 1.228 -0.242 0 C-N-CA 123.655 0.645 . . . . 0.0 113.714 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.444 ' HB3' ' HA ' ' A' ' 94' ' ' PHE . 29.2 t -67.18 -72.64 0.16 Allowed 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 123.772 0.336 . . . . 0.0 111.623 173.535 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 47.8 p 177.96 -56.05 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 124.194 0.998 . . . . 0.0 112.827 -178.474 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.509 ' CD2' ' HD3' ' A' ' 84' ' ' PRO . 69.9 m-85 -68.87 147.36 97.84 Favored Pre-proline 0 N--CA 1.442 -0.857 0 C-N-CA 124.931 1.292 . . . . 0.0 113.286 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.726 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 26.1 Cg_endo -75.49 165.53 85.46 Favored 'Cis proline' 0 N--CA 1.445 -1.353 0 C-N-CA 123.938 -1.276 . . . . 0.0 111.186 1.567 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.661 ' C ' HD23 ' A' ' 81' ' ' LEU . 1.1 p80 -141.47 171.8 13.56 Favored 'General case' 0 CA--C 1.504 -0.797 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.574 -177.987 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.885 ' CH2' HG22 ' A' ' 39' ' ' THR . 22.0 t90 -72.17 128.08 34.58 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 122.687 1.232 . . . . 0.0 109.726 175.564 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.497 ' CZ ' ' HA ' ' A' ' 40' ' ' ASN . 19.3 t80 -98.29 86.15 3.59 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 126.674 1.989 . . . . 0.0 107.041 176.612 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.885 HG22 ' CH2' ' A' ' 37' ' ' TRP . 69.0 p -40.36 -33.43 0.25 Allowed 'General case' 0 C--O 1.217 -0.645 0 CA-C-N 114.656 -1.156 . . . . 0.0 111.105 172.062 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.497 ' HA ' ' CZ ' ' A' ' 38' ' ' PHE . 11.7 t-20 68.56 5.92 5.13 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.519 1.128 . . . . 0.0 110.878 -178.516 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.4 ' CA ' ' HD2' ' A' ' 52' ' ' ARG . . . 115.96 -26.41 8.85 Favored Glycine 0 N--CA 1.432 -1.59 0 C-N-CA 125.066 1.317 . . . . 0.0 116.095 -171.427 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.517 ' N ' HD23 ' A' ' 48' ' ' LEU . 58.4 m-85 -54.57 -178.16 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 122.365 1.079 . . . . 0.0 110.299 176.755 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -103.87 -40.7 6.14 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 124.462 1.105 . . . . 0.0 110.763 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.493 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -174.05 -61.55 0.05 OUTLIER Glycine 0 C--N 1.336 0.549 0 C-N-CA 123.751 0.691 . . . . 0.0 112.641 -178.038 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -82.92 -98.62 0.05 OUTLIER 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.424 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.434 ' HA2' ' CD2' ' A' ' 42' ' ' TYR . . . -138.84 29.76 2.53 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 125.048 1.308 . . . . 0.0 111.674 -174.359 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.9 mttt -126.87 149.19 49.88 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 118.144 -0.931 . . . . 0.0 108.737 -178.718 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.517 HD23 ' N ' ' A' ' 42' ' ' TYR . 0.3 OUTLIER -115.38 160.51 34.11 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.406 1.066 . . . . 0.0 109.187 -178.11 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -69.02 157.54 61.43 Favored 'Trans proline' 0 N--CA 1.443 -1.459 0 C-N-CA 121.884 1.723 . . . . 0.0 110.161 177.671 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -49.27 104.41 0.06 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.094 0.958 . . . . 0.0 110.352 176.317 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.74 87.98 0.59 Allowed Glycine 0 CA--C 1.524 0.601 0 O-C-N 123.572 0.545 . . . . 0.0 111.851 -174.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.445 ' HD3' ' N ' ' A' ' 53' ' ' THR . 0.0 OUTLIER -150.83 155.53 39.4 Favored 'General case' 0 CA--C 1.516 -0.365 0 C-N-CA 123.164 0.586 . . . . 0.0 110.552 174.648 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 53' ' ' THR . . . . . 0.445 ' N ' ' HD3' ' A' ' 52' ' ' ARG . 4.0 m -138.92 101.59 7.78 Favored Pre-proline 0 C--N 1.329 -0.305 0 O-C-N 124.014 0.821 . . . . 0.0 111.439 178.925 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -66.4 153.74 76.87 Favored 'Trans proline' 0 N--CA 1.448 -1.148 0 C-N-CA 123.856 3.038 . . . . 0.0 112.073 177.518 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.8 mt -66.74 127.33 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -95.39 134.45 38.18 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 176.029 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.484 ' CE2' HD13 ' A' ' 133' ' ' LEU . 1.7 m-85 -119.62 -55.31 2.12 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 124.213 1.005 . . . . 0.0 110.623 -179.445 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 120.42 -2.9 12.49 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 124.88 1.228 . . . . 0.0 113.469 -176.058 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.413 ' HD2' ' CG1' ' A' ' 116' ' ' VAL . 1.8 mmtp -66.46 177.66 1.46 Allowed 'General case' 0 C--O 1.215 -0.735 0 O-C-N 122.065 -0.667 . . . . 0.0 111.364 173.481 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.0 p -104.23 -47.17 4.22 Favored 'General case' 0 C--O 1.216 -0.679 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.153 177.324 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.45 -41.03 41.21 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 123.097 0.559 . . . . 0.0 110.892 177.542 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.477 ' SG ' ' CD1' ' A' ' 57' ' ' PHE . 1.5 t -74.25 -17.37 60.88 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 122.786 0.434 . . . . 0.0 110.736 178.61 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -87.58 -38.31 16.08 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 123.115 0.566 . . . . 0.0 112.31 171.456 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.582 ' HD3' ' CD2' ' A' ' 78' ' ' HIS . 0.0 OUTLIER -55.78 163.8 1.92 Allowed Pre-proline 0 N--CA 1.448 -0.57 0 CA-C-O 121.785 0.803 . . . . 0.0 111.491 -178.247 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -70.54 138.75 36.01 Favored 'Trans proline' 0 N--CA 1.439 -1.69 0 C-N-CA 120.401 0.734 . . . . 0.0 112.232 175.735 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -68.21 175.29 6.89 Favored 'Trans proline' 0 N--CA 1.448 -1.2 0 C-N-CA 122.952 2.435 . . . . 0.0 111.965 175.817 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.8 tptt -136.98 56.27 1.8 Allowed 'General case' 0 C--O 1.209 -1.041 0 O-C-N 120.835 -1.165 . . . . 0.0 108.685 174.159 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -77.54 165.05 24.82 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 119.16 -1.016 . . . . 0.0 110.488 177.693 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.57 -165.62 2.03 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.908 0.883 . . . . 0.0 111.241 178.197 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.11 73.69 10.36 Favored 'General case' 0 C--O 1.219 -0.509 0 O-C-N 121.322 -0.862 . . . . 0.0 111.146 175.602 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -176.89 -43.35 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.507 0 O-C-N 124.419 1.074 . . . . 0.0 111.367 178.637 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.452 ' O ' ' CE2' ' A' ' 79' ' ' TYR . . . 122.53 -52.65 0.75 Allowed Glycine 0 C--O 1.217 -0.918 0 CA-C-N 114.693 -1.139 . . . . 0.0 111.208 -177.79 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -148.59 86.18 1.52 Allowed 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.25 -112.2 0.01 OUTLIER Glycine 0 CA--C 1.525 0.66 0 CA-C-O 122.331 0.962 . . . . 0.0 113.037 176.714 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -64.58 -96.73 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 O-C-N 120.427 -1.631 . . . . 0.0 112.436 176.582 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.486 HG23 ' O ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -110.55 16.27 21.6 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 121.379 -0.826 . . . . 0.0 110.272 178.46 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.459 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 8.6 m-20 -29.24 104.93 0.03 OUTLIER 'General case' 0 C--O 1.207 -1.141 0 C-N-CA 125.792 1.637 . . . . 0.0 109.94 -176.868 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.582 ' CD2' ' HD3' ' A' ' 64' ' ' ARG . 3.6 p-80 -87.17 16.31 5.28 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 118.968 0.803 . . . . 0.0 110.268 -175.421 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.926 ' CZ ' HD11 ' A' ' 81' ' ' LEU . 0.3 OUTLIER -36.19 134.27 0.43 Allowed 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 126.156 1.782 . . . . 0.0 111.311 172.148 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.622 HD23 ' O ' ' A' ' 110' ' ' TYR . 0.3 OUTLIER -76.68 153.65 34.95 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.797 176.648 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.926 HD11 ' CZ ' ' A' ' 79' ' ' TYR . 1.7 mp -140.27 139.06 35.44 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 123.191 0.596 . . . . 0.0 109.659 177.658 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.459 ' CB ' ' CD1' ' A' ' 109' ' ' ILE . 0.5 OUTLIER -105.81 154.2 20.85 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.593 0.711 . . . . 0.0 111.284 179.261 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.752 ' CZ ' ' HB2' ' A' ' 23' ' ' ALA . 5.7 t80 -141.79 126.35 10.32 Favored Pre-proline 0 CA--C 1.537 0.452 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.748 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.509 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 19.6 Cg_endo -73.87 104.44 1.83 Allowed 'Trans proline' 0 N--CA 1.448 -1.148 0 C-N-CA 124.789 3.659 . . . . 0.0 110.615 -177.56 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.8 t -104.38 119.66 39.46 Favored 'General case' 0 N--CA 1.446 -0.67 0 O-C-N 124.675 1.234 . . . . 0.0 109.963 -179.045 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.434 ' CD2' ' NE2' ' A' ' 90' ' ' HIS . 64.7 m-85 -81.17 158.8 69.2 Favored Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 176.505 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -74.78 -42.54 0.55 Allowed 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 122.504 2.136 . . . . 0.0 113.409 178.295 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -40.42 -37.03 0.62 Allowed 'General case' 0 N--CA 1.478 0.94 0 CA-C-O 123.529 1.633 . . . . 0.0 109.803 174.972 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 97.45 -1.88 60.54 Favored Glycine 0 N--CA 1.442 -0.931 0 O-C-N 121.053 -1.03 . . . . 0.0 112.248 -178.87 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.434 ' NE2' ' CD2' ' A' ' 86' ' ' PHE . 5.9 p-80 -65.39 126.74 29.18 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 176.589 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -59.62 106.07 0.43 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 171.049 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.44 ' O ' ' CD2' ' A' ' 94' ' ' PHE . 7.1 t80 -38.98 139.93 0.42 Allowed 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 121.684 0.754 . . . . 0.0 110.166 173.723 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 7.5 ptpt -75.68 58.44 1.08 Allowed 'General case' 0 C--N 1.326 -0.416 0 O-C-N 120.42 -1.425 . . . . 0.0 111.818 173.304 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.498 ' CD2' ' HZ ' ' A' ' 83' ' ' PHE . 34.2 p90 -73.08 -14.63 61.43 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 123.856 0.862 . . . . 0.0 112.327 176.143 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -88.8 -37.23 15.57 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 123.329 1.537 . . . . 0.0 111.298 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -79.9 106.9 12.26 Favored 'General case' 0 N--CA 1.455 -0.179 0 O-C-N 120.926 -1.109 . . . . 0.0 109.162 177.152 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt -57.99 -48.4 80.1 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.739 0.78 . . . . 0.0 111.713 176.652 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.7 tmtt? -137.49 130.66 17.04 Favored Pre-proline 0 N--CA 1.445 -0.701 0 C-N-CA 124.828 1.251 . . . . 0.0 110.199 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -68.57 174.53 35.9 Favored 'Cis proline' 0 N--CA 1.453 -0.873 0 C-N-CA 123.181 -1.591 . . . . 0.0 110.415 -9.179 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 22.0 tttm -139.03 116.95 11.6 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 29.4 tp10 -69.96 167.2 17.99 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 123.981 0.801 . . . . 0.0 110.639 174.401 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -42.68 153.28 0.32 Allowed Pre-proline 0 CA--C 1.536 0.41 0 C-N-CA 124.228 1.011 . . . . 0.0 112.064 173.377 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -72.85 -84.02 0.0 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 122.829 2.353 . . . . 0.0 112.547 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 146.58 142.4 3.73 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -74.75 -68.85 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 123.325 2.683 . . . . 0.0 110.71 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.679 ' HA ' ' HB2' ' A' ' 122' ' ' ALA . . . -68.3 139.67 55.94 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 121.735 0.779 . . . . 0.0 111.165 178.583 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.87 144.3 33.77 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.011 -178.651 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.436 ' CG1' ' HB3' ' A' ' 83' ' ' PHE . 4.3 p -81.58 124.81 39.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 O-C-N 124.341 1.025 . . . . 0.0 109.139 178.687 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.566 ' CG2' HD22 ' A' ' 80' ' ' LEU . 5.8 mm -105.54 141.16 21.51 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.701 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.061 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.622 ' O ' HD23 ' A' ' 80' ' ' LEU . 10.4 p90 -165.17 152.92 11.24 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-O 121.952 0.882 . . . . 0.0 111.294 -176.501 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.0 p -88.66 165.82 14.52 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.852 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.561 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.3 OUTLIER -108.21 156.84 37.73 Favored Pre-proline 0 CA--C 1.547 0.841 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 176.107 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.561 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 17.7 Cg_endo -72.07 -53.4 0.16 OUTLIER 'Cis proline' 0 CA--C 1.51 -0.683 0 C-N-CA 124.216 -1.16 . . . . 0.0 111.064 -10.27 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -45.61 111.43 0.34 Allowed 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 118.685 -0.674 . . . . 0.0 109.92 177.267 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.75 ' HE2' HD13 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -62.69 79.86 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.349 0 C-N-CA 124.911 1.285 . . . . 0.0 108.098 -178.262 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.461 ' O ' HG12 ' A' ' 116' ' ' VAL . 16.2 t -77.43 73.06 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 105.311 -2.107 . . . . 0.0 105.311 -178.263 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.475 ' CZ ' ' NE2' ' A' ' 13' ' ' GLN . 20.7 t80 -46.63 108.16 0.13 Allowed 'General case' 0 N--CA 1.44 -0.95 0 C-N-CA 124.918 1.287 . . . . 0.0 109.008 177.455 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 118' ' ' CYS . . . . . 0.424 ' SG ' ' CG ' ' A' ' 57' ' ' PHE . 0.1 OUTLIER -83.45 -53.0 6.03 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 121.952 0.882 . . . . 0.0 110.031 179.448 . . . . . . . . 3 3 . 1 . 005 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 177.18 -146.09 7.58 Favored Glycine 0 N--CA 1.437 -1.252 0 CA-C-N 114.464 -1.244 . . . . 0.0 110.43 179.242 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.418 HG13 ' CG ' ' A' ' 4' ' ' TRP . 1.2 mm -126.61 146.85 31.77 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 -177.136 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.561 HG22 HD12 ' A' ' 133' ' ' LEU . 8.0 pt -132.7 151.79 35.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -178.891 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.679 ' HB2' ' HA ' ' A' ' 106' ' ' ALA . . . . . . . . 0 C--N 1.325 -0.495 0 C-N-CA 122.807 0.443 . . . . 0.0 110.863 178.223 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.514 -0.415 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 . . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.561 HD12 HG22 ' A' ' 121' ' ' ILE . 10.0 tp -84.51 137.61 33.24 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.127 0.892 . . . . 0.0 108.746 178.065 . . . . . . . . 2 2 . 1 . 005 nuclear build core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 35.0 m -70.71 -178.75 1.94 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 122.865 1.317 . . . . 0.0 109.821 174.252 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 13.7 p -160.24 100.01 1.35 Allowed 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 105.148 -2.167 . . . . 0.0 105.148 -178.15 . . . . . . . . 1 1 . 1 . 005 nuclear build core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.242 0.674 0 CA-C-O 115.921 -1.99 . . . . 0.0 112.441 168.141 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.724 HG22 ' HB2' ' A' ' 136' ' ' HIS . 9.3 p . . . . . 0 C--O 1.238 0.494 0 CA-C-O 121.43 0.633 . . . . 0.0 109.654 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.924 HG21 HD23 ' A' ' 10' ' ' LEU . 48.9 m -85.78 119.67 26.36 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.148 -179.105 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 19.8 m95 -80.44 141.42 35.28 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.274 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -141.02 142.51 34.22 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.728 ' SG ' ' HB3' ' A' ' 122' ' ' ALA . 0.1 OUTLIER -120.42 50.38 1.32 Allowed 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.896 177.921 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 48.06 73.75 0.31 Allowed Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 -178.925 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 166.55 -74.95 0.15 Allowed Glycine 0 C--N 1.333 0.395 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 54.9 mt -123.82 158.18 32.42 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.924 HD23 HG21 ' A' ' 3' ' ' THR . 3.9 mp -83.02 165.64 19.46 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.049 179.266 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.763 ' CZ ' ' HB3' ' A' ' 106' ' ' ALA . 50.2 m-85 -159.12 85.56 0.81 Allowed 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 121.872 0.844 . . . . 0.0 109.981 -175.319 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -57.43 121.45 10.27 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 117.656 -1.164 . . . . 0.0 108.602 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.407 ' OE1' ' CZ ' ' A' ' 117' ' ' PHE . 1.2 tt0 -43.33 -57.93 2.79 Favored 'General case' 0 C--O 1.207 -1.167 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.386 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.445 ' O ' ' CB ' ' A' ' 18' ' ' SER . 19.7 t-20 -44.98 -46.9 11.4 Favored 'General case' 0 C--O 1.198 -1.647 0 O-C-N 124.065 0.853 . . . . 0.0 109.766 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.442 ' CE ' ' HA3' ' A' ' 89' ' ' GLY . 0.0 OUTLIER -62.35 -48.23 80.74 Favored 'General case' 0 C--O 1.204 -1.307 0 CA-C-O 117.376 -1.297 . . . . 0.0 111.267 174.954 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -51.04 -68.19 0.19 Allowed 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 120.091 1.314 . . . . 0.0 111.685 175.501 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -55.99 -32.94 64.4 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.206 177.968 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.445 ' CB ' ' O ' ' A' ' 14' ' ' ASN . 12.6 t -68.05 -53.78 23.15 Favored 'General case' 0 C--O 1.216 -0.708 0 C-N-CA 123.949 0.9 . . . . 0.0 109.46 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.414 ' OD1' ' CD2' ' A' ' 83' ' ' PHE . 6.7 t-20 -49.37 -30.62 7.97 Favored 'General case' 0 N--CA 1.434 -1.266 0 O-C-N 120.443 -1.41 . . . . 0.0 109.291 178.415 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.99 -29.36 22.05 Favored 'General case' 0 N--CA 1.442 -0.873 0 O-C-N 123.521 0.513 . . . . 0.0 111.642 176.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -54.19 -42.93 70.27 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 124.029 0.931 . . . . 0.0 109.38 179.099 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.429 ' CD2' ' N ' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -79.59 -48.89 13.03 Favored 'General case' 0 N--CA 1.443 -0.78 0 O-C-N 123.769 0.668 . . . . 0.0 109.562 -179.892 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.571 ' HB2' ' CZ ' ' A' ' 83' ' ' PHE . . . -40.35 136.09 1.41 Allowed Pre-proline 0 N--CA 1.442 -0.871 0 O-C-N 125.187 1.554 . . . . 0.0 110.831 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.819 ' HG2' HG22 ' A' ' 30' ' ' THR . 18.6 Cg_endo -73.14 122.22 7.88 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 122.032 1.821 . . . . 0.0 110.631 -178.756 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.676 HD13 ' HE2' ' A' ' 115' ' ' LYS . 3.0 tp -60.23 95.5 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 123.597 0.56 . . . . 0.0 110.059 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 179.3 162.42 0.84 Allowed 'General case' 0 N--CA 1.448 -0.566 0 O-C-N 123.643 0.59 . . . . 0.0 109.883 -178.21 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -103.55 112.54 25.51 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 123.927 0.767 . . . . 0.0 109.083 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.01 64.69 4.12 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 177.845 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.418 ' O ' ' CG ' ' A' ' 29' ' ' LYS . 12.7 tttt -134.47 12.92 3.8 Favored 'General case' 0 C--N 1.334 -0.074 0 CA-C-O 123.003 1.382 . . . . 0.0 110.024 178.111 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.819 HG22 ' HG2' ' A' ' 24' ' ' PRO . 22.8 p -112.92 145.8 40.11 Favored 'General case' 0 C--N 1.315 -0.898 0 O-C-N 120.501 -1.374 . . . . 0.0 108.481 -176.604 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -38.42 -49.57 2.31 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.8 t -74.2 -60.69 2.15 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-O 117.177 -1.392 . . . . 0.0 110.165 177.594 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 162.2 -59.92 0.0 OUTLIER 'General case' 0 C--O 1.222 -0.344 0 O-C-N 125.256 1.597 . . . . 0.0 110.555 179.139 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.692 ' CE2' ' CE1' ' A' ' 36' ' ' HIS . 60.3 m-85 -58.83 145.78 77.7 Favored Pre-proline 0 N--CA 1.434 -1.256 0 CA-C-O 117.676 -1.154 . . . . 0.0 112.522 178.77 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.554 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 22.2 Cg_endo -74.23 153.41 99.14 Favored 'Cis proline' 0 N--CA 1.454 -0.82 0 C-N-CA 121.578 -2.259 . . . . 0.0 111.855 -1.523 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.692 ' CE1' ' CE2' ' A' ' 34' ' ' TYR . 0.5 OUTLIER -131.8 154.91 48.63 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-O 117.782 -1.104 . . . . 0.0 110.509 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 1.001 ' CH2' HG22 ' A' ' 39' ' ' THR . 13.4 t90 -48.98 144.78 4.42 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.227 0.954 . . . . 0.0 109.143 178.699 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.577 ' CZ ' HD13 ' A' ' 121' ' ' ILE . 24.6 t80 -114.93 80.96 1.49 Allowed 'General case' 0 N--CA 1.425 -1.717 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 -176.281 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 39' ' ' THR . . . . . 1.001 HG22 ' CH2' ' A' ' 37' ' ' TRP . 4.3 p -38.46 -32.86 0.08 Allowed 'General case' 0 C--O 1.21 -1.012 0 O-C-N 124.114 0.884 . . . . 0.0 109.933 176.404 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.498 ' HB2' ' CD2' ' A' ' 38' ' ' PHE . 51.0 t30 52.18 22.24 1.87 Allowed 'General case' 0 N--CA 1.447 -0.603 0 O-C-N 121.154 -0.966 . . . . 0.0 108.69 175.967 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.47 ' HA3' HD23 ' A' ' 48' ' ' LEU . . . 107.71 -41.42 2.21 Favored Glycine 0 N--CA 1.422 -2.263 0 CA-C-O 118.697 -1.057 . . . . 0.0 114.886 -173.605 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.529 ' CD2' ' HG3' ' A' ' 66' ' ' PRO . 62.4 m-85 -45.72 153.78 0.25 Allowed 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 123.721 0.808 . . . . 0.0 112.126 175.918 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.48 -40.32 16.51 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.708 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.512 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -164.97 -65.46 0.02 OUTLIER Glycine 0 C--N 1.339 0.717 0 N-CA-C 111.356 -0.698 . . . . 0.0 111.356 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.456 ' OD2' ' CE ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -121.08 -61.19 1.57 Allowed 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -179.708 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -50.47 179.24 0.03 OUTLIER Glycine 0 C--N 1.348 1.244 0 CA-C-O 123.598 1.666 . . . . 0.0 111.217 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.409 ' HA ' ' CE1' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -68.8 -171.06 0.26 Allowed 'General case' 0 C--N 1.326 -0.437 0 O-C-N 121.059 -1.259 . . . . 0.0 109.832 179.906 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.553 HD13 ' HG3' ' A' ' 54' ' ' PRO . 5.2 mp -69.96 154.52 94.59 Favored Pre-proline 0 N--CA 1.441 -0.914 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.213 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.09 156.53 47.13 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 122.114 1.876 . . . . 0.0 111.044 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.07 98.03 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.08 75.8 0.64 Allowed Glycine 0 N--CA 1.444 -0.775 0 CA-C-O 119.777 -0.457 . . . . 0.0 112.096 -178.348 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.46 ' HD3' ' CA ' ' A' ' 41' ' ' GLY . 6.9 ttt180 -177.22 163.85 2.12 Favored 'General case' 0 CA--C 1.517 -0.32 0 O-C-N 124.075 0.514 . . . . 0.0 110.419 177.914 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.2 m -137.05 111.81 9.41 Favored Pre-proline 0 N--CA 1.444 -0.774 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.972 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.553 ' HG3' HD13 ' A' ' 48' ' ' LEU . 23.0 Cg_endo -72.98 165.79 31.82 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 122.02 1.813 . . . . 0.0 112.01 178.733 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.483 ' O ' ' CE2' ' A' ' 57' ' ' PHE . 4.3 mt -88.81 119.51 36.08 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.471 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -179.333 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 15.8 tptt -82.82 132.41 35.17 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.239 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.673 ' CE1' HD13 ' A' ' 133' ' ' LEU . 19.9 m-85 -117.56 -49.78 2.55 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.633 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 124.02 -1.63 9.13 Favored Glycine 0 CA--C 1.521 0.434 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.685 -178.381 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.4 mmtp -102.68 143.32 32.5 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 36.5 t -78.86 -1.26 34.16 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 124.315 1.01 . . . . 0.0 110.664 178.053 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.549 ' HB2' HG21 ' A' ' 111' ' ' THR . 0.9 OUTLIER -88.2 -57.48 2.91 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -178.995 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.9 m -72.44 -26.41 61.82 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 -179.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -71.37 -34.38 70.39 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 123.665 0.603 . . . . 0.0 110.154 177.763 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.99 160.81 14.37 Favored Pre-proline 0 N--CA 1.439 -0.995 0 CA-C-O 121.119 0.485 . . . . 0.0 110.354 179.286 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.438 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 26.5 Cg_endo -74.48 141.3 28.13 Favored 'Trans proline' 0 N--CA 1.445 -1.36 0 C-N-CA 121.713 1.608 . . . . 0.0 113.555 175.183 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.529 ' HG3' ' CD2' ' A' ' 42' ' ' TYR . 20.8 Cg_endo -73.66 167.93 26.04 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 122.43 2.087 . . . . 0.0 111.671 179.002 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.456 ' CE ' ' OD2' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -133.13 60.61 1.7 Allowed 'General case' 0 C--O 1.239 0.543 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.236 179.417 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.493 ' CE1' ' O ' ' A' ' 70' ' ' LYS . 57.0 t-80 -74.79 145.6 42.78 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-O 123.995 1.855 . . . . 0.0 112.01 178.144 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -133.12 -85.27 0.46 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 119.49 -2.006 . . . . 0.0 109.796 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.493 ' O ' ' CE1' ' A' ' 68' ' ' HIS . 0.2 OUTLIER -72.64 -171.07 0.76 Allowed 'General case' 0 C--O 1.203 -1.379 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.166 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -77.97 41.65 0.36 Allowed 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.664 0.745 . . . . 0.0 111.415 178.016 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -169.51 -105.58 0.18 Allowed Glycine 0 C--O 1.21 -1.368 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -178.36 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -113.44 -87.99 0.56 Allowed 'General case' 0 C--N 1.317 -0.847 0 O-C-N 120.968 -1.313 . . . . 0.0 107.567 -177.024 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 117.46 -141.73 16.74 Favored Glycine 0 N--CA 1.443 -0.896 0 CA-C-O 118.525 -1.153 . . . . 0.0 111.211 -178.515 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 36.8 mttt -49.01 -89.57 0.0 OUTLIER 'General case' 0 C--O 1.223 -0.308 0 O-C-N 125.21 1.182 . . . . 0.0 110.233 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.69 HG23 ' O ' ' A' ' 76' ' ' THR . 0.6 OUTLIER -127.23 28.51 5.72 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.868 179.331 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.549 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 41.0 t0 -30.01 97.78 0.01 OUTLIER 'General case' 0 C--O 1.214 -0.8 0 C-N-CA 122.93 0.492 . . . . 0.0 111.795 -178.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.404 ' CD2' ' H ' ' A' ' 78' ' ' HIS . 7.1 p80 -86.91 15.2 6.13 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -176.242 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 1.052 ' CE1' HD11 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -52.95 174.07 0.04 OUTLIER 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 174.484 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.769 HD22 ' CG2' ' A' ' 109' ' ' ILE . 0.6 OUTLIER -95.13 157.65 15.8 Favored 'General case' 0 C--O 1.218 -0.596 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.324 177.624 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 1.052 HD11 ' CE1' ' A' ' 79' ' ' TYR . 2.8 mp -143.03 108.55 5.07 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.533 0.682 . . . . 0.0 109.161 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.52 ' CB ' ' CD1' ' A' ' 109' ' ' ILE . 7.2 pm0 -80.9 150.58 28.98 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 122.148 0.975 . . . . 0.0 110.205 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.571 ' CZ ' ' HB2' ' A' ' 23' ' ' ALA . 15.8 t80 -141.16 137.03 16.39 Favored Pre-proline 0 N--CA 1.442 -0.87 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.161 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.484 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 19.4 Cg_endo -74.01 91.78 0.92 Allowed 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 123.293 2.662 . . . . 0.0 110.914 -178.572 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.0 t -95.48 109.1 21.35 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 122.194 0.997 . . . . 0.0 111.118 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -82.42 159.08 65.25 Favored Pre-proline 0 N--CA 1.443 -0.821 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.692 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -76.57 -40.78 0.51 Allowed 'Trans proline' 0 CA--C 1.501 -1.132 0 C-N-CA 122.324 2.016 . . . . 0.0 112.453 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -42.36 -32.2 0.49 Allowed 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 125.123 1.515 . . . . 0.0 109.854 178.312 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.442 ' HA3' ' CE ' ' A' ' 15' ' ' LYS . . . 87.14 10.0 72.36 Favored Glycine 0 N--CA 1.438 -1.169 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 177.252 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.419 ' O ' ' CD2' ' A' ' 90' ' ' HIS . 3.8 p-80 -80.82 130.33 35.0 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -62.21 88.45 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.779 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.533 ' CD2' ' HB3' ' A' ' 94' ' ' PHE . 7.7 t80 -36.42 146.72 0.03 OUTLIER 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 122.362 1.077 . . . . 0.0 110.809 -178.935 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -78.8 58.81 2.41 Favored 'General case' 0 C--N 1.317 -0.814 0 O-C-N 120.19 -1.569 . . . . 0.0 110.072 177.958 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.533 ' HB3' ' CD2' ' A' ' 92' ' ' TYR . 29.6 p90 -79.45 -8.9 59.44 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 122.837 0.455 . . . . 0.0 111.544 178.216 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -92.47 -33.16 14.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 49.3 m -79.82 110.54 15.28 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.234 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.41 ' CG ' ' N ' ' A' ' 98' ' ' LYS . 0.1 OUTLIER -58.86 -50.09 75.29 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.157 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -146.4 129.55 8.14 Favored Pre-proline 0 N--CA 1.432 -1.346 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -177.245 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.439 ' HA ' ' HA ' ' A' ' 98' ' ' LYS . 26.4 Cg_endo -72.15 177.66 33.85 Favored 'Cis proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.135 -2.027 . . . . 0.0 111.967 -2.87 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.17 135.82 21.99 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 123.789 0.68 . . . . 0.0 109.731 178.059 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.93 172.71 13.42 Favored 'General case' 0 C--O 1.245 0.856 0 O-C-N 124.27 0.981 . . . . 0.0 111.246 178.155 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -57.3 158.74 9.75 Favored Pre-proline 0 N--CA 1.438 -1.033 0 CA-C-O 121.604 0.716 . . . . 0.0 112.193 175.072 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -75.78 -89.87 0.0 OUTLIER 'Trans proline' 0 C--O 1.205 -1.14 0 C-N-CA 122.212 1.942 . . . . 0.0 111.115 179.014 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 151.77 148.68 4.89 Favored Glycine 0 N--CA 1.438 -1.214 0 O-C-N 120.983 -1.073 . . . . 0.0 111.358 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -74.45 -35.47 3.72 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.149 1.9 . . . . 0.0 111.779 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.763 ' HB3' ' CZ ' ' A' ' 11' ' ' TYR . . . -102.85 146.72 27.85 Favored 'General case' 0 N--CA 1.437 -1.078 0 O-C-N 124.232 0.958 . . . . 0.0 109.914 178.413 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.422 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 2.2 mtm-85 -146.44 148.82 32.67 Favored 'General case' 0 N--CA 1.445 -0.705 0 O-C-N 123.833 0.708 . . . . 0.0 111.417 179.173 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.474 ' CG1' ' HB3' ' A' ' 83' ' ' PHE . 3.8 p -82.63 117.71 29.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 123.19 0.596 . . . . 0.0 110.23 178.713 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.769 ' CG2' HD22 ' A' ' 80' ' ' LEU . 6.1 mm -96.01 140.71 16.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.631 ' C ' HD23 ' A' ' 80' ' ' LEU . 9.0 p90 -167.18 152.25 7.33 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.789 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.549 HG21 ' HB2' ' A' ' 61' ' ' ASP . 1.6 p -87.76 163.86 16.26 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.715 -178.863 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.572 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.2 OUTLIER -112.94 152.62 45.04 Favored Pre-proline 0 N--CA 1.434 -1.231 0 C-N-CA 123.209 0.604 . . . . 0.0 110.842 -179.783 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.608 ' O ' HD21 ' A' ' 25' ' ' LEU . 17.8 Cg_endo -73.56 -55.46 0.14 OUTLIER 'Cis proline' 0 CA--C 1.512 -0.601 0 C-N-CA 122.0 -2.083 . . . . 0.0 110.64 -4.14 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -41.65 111.18 0.21 Allowed 'General case' 0 N--CA 1.438 -1.057 0 CA-C-O 116.093 -1.908 . . . . 0.0 110.342 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.676 ' HE2' HD13 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -64.39 74.41 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.7 0 O-C-N 126.03 2.081 . . . . 0.0 108.755 -178.604 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.64 ' O ' HG12 ' A' ' 116' ' ' VAL . 13.3 t -71.47 69.81 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 -178.139 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.572 ' CE1' ' HA2' ' A' ' 119' ' ' GLY . 9.8 t80 -36.48 111.06 0.13 Allowed 'General case' 0 N--CA 1.437 -1.078 0 C-N-CA 124.074 0.949 . . . . 0.0 109.849 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 118' ' ' CYS . . . . . 0.577 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 0.1 OUTLIER -94.28 -26.69 16.5 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.258 . . . . . . . . 3 3 . 1 . 006 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.572 ' HA2' ' CE1' ' A' ' 117' ' ' PHE . . . 137.39 -166.58 24.98 Favored Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 -178.749 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.665 HG22 ' SG ' ' A' ' 134' ' ' CYS . 3.5 mp -111.6 146.1 16.96 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.369 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 -177.612 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.654 HG22 HD12 ' A' ' 133' ' ' LEU . 6.2 pt -116.77 157.11 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 CA-C-N 119.237 0.926 . . . . 0.0 108.836 178.663 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.728 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . . . . . . . . 0 N--CA 1.449 -0.511 0 CA-C-O 121.561 0.696 . . . . 0.0 110.126 177.965 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.513 -0.477 0 CA-C-O 118.941 -0.552 . . . . 0.0 109.606 . . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.673 HD13 ' CE1' ' A' ' 57' ' ' PHE . 10.4 tp -89.6 136.47 33.02 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.396 1.06 . . . . 0.0 108.504 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 134' ' ' CYS . . . . . 0.665 ' SG ' HG22 ' A' ' 120' ' ' ILE . 70.7 m -56.97 -176.44 0.02 OUTLIER 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 124.793 1.237 . . . . 0.0 108.308 178.478 . . . . . . . . 2 2 . 1 . 006 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 6.8 m -161.16 83.99 0.65 Allowed 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.724 ' HB2' HG22 ' A' ' 2' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--O 1.258 1.527 0 CA-C-O 116.11 -1.9 . . . . 0.0 112.143 175.19 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.473 HG22 ' HB3' ' A' ' 136' ' ' HIS . 9.9 p . . . . . 0 C--O 1.233 0.206 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.552 ' CG2' HD12 ' A' ' 10' ' ' LEU . 1.1 m -85.61 123.73 31.35 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 177.158 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 4' ' ' TRP . . . . . 0.44 ' CG ' HG13 ' A' ' 120' ' ' ILE . 35.0 m95 -86.18 142.58 28.52 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 122.913 0.485 . . . . 0.0 110.059 177.13 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.574 ' OG1' HD13 ' A' ' 10' ' ' LEU . 0.8 OUTLIER -127.21 125.84 41.74 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 -176.751 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.548 ' HB3' ' HB3' ' A' ' 122' ' ' ALA . 7.2 m -120.7 53.75 1.1 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.691 178.541 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 132.68 -95.95 0.3 Allowed Glycine 0 C--O 1.223 -0.565 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -132.33 8.84 5.35 Favored Glycine 0 N--CA 1.469 0.897 0 C-N-CA 123.881 0.753 . . . . 0.0 113.624 177.995 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.454 HD13 ' OH ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -115.52 140.28 49.3 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 124.85 1.26 . . . . 0.0 108.858 -176.632 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.574 HD13 ' OG1' ' A' ' 5' ' ' THR . 2.7 mm? -105.24 116.5 32.05 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 124.509 1.131 . . . . 0.0 108.099 -170.451 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.454 ' OH ' HD13 ' A' ' 9' ' ' LEU . 73.8 m-85 -108.55 98.5 8.01 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 -172.119 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -55.14 117.87 3.86 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 177.557 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.431 ' HB2' ' CD1' ' A' ' 4' ' ' TRP . 28.3 tp60 -51.0 -44.42 60.96 Favored 'General case' 0 C--O 1.214 -0.796 0 C-N-CA 119.814 -0.754 . . . . 0.0 112.853 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -48.42 -42.91 33.54 Favored 'General case' 0 C--O 1.201 -1.479 0 O-C-N 123.771 0.67 . . . . 0.0 112.217 175.49 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.9 mttt -69.52 -40.8 76.73 Favored 'General case' 0 C--O 1.212 -0.879 0 CA-C-N 120.068 1.304 . . . . 0.0 113.454 168.623 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -52.5 -40.38 62.33 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 121.688 2.04 . . . . 0.0 113.82 173.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -85.66 -43.83 13.09 Favored 'General case' 0 C--O 1.217 -0.616 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.603 173.86 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 41.0 t -71.36 -62.88 1.24 Allowed 'General case' 0 C--O 1.217 -0.62 0 C-N-CA 126.914 2.086 . . . . 0.0 110.839 -176.315 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.421 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 8.3 t-20 -39.55 -38.16 0.57 Allowed 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 120.262 1.392 . . . . 0.0 111.673 168.942 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.576 ' HB3' HG11 ' A' ' 108' ' ' VAL . 1.1 p -83.51 -26.67 29.98 Favored 'General case' 0 C--O 1.218 -0.598 0 N-CA-C 116.464 2.024 . . . . 0.0 116.464 175.364 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -54.25 -32.99 57.44 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 125.186 1.394 . . . . 0.0 109.088 178.994 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.421 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.1 OUTLIER -75.48 -41.39 55.6 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 125.086 1.355 . . . . 0.0 111.208 177.111 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.861 ' HB1' ' HG3' ' A' ' 35' ' ' PRO . . . -39.04 125.47 1.25 Allowed Pre-proline 0 CA--C 1.539 0.526 0 C-N-CA 125.39 1.476 . . . . 0.0 111.503 174.44 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.403 ' HG2' ' CG2' ' A' ' 30' ' ' THR . 19.0 Cg_endo -71.02 123.2 9.47 Favored 'Trans proline' 0 N--CA 1.439 -1.68 0 C-N-CA 122.71 2.274 . . . . 0.0 109.101 -177.494 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.451 HD22 ' HE2' ' A' ' 115' ' ' LYS . 2.7 tp -60.41 97.17 0.05 OUTLIER 'General case' 0 C--O 1.222 -0.394 0 C-N-CA 124.18 0.992 . . . . 0.0 111.043 177.706 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -175.25 149.05 1.02 Allowed 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 123.729 0.812 . . . . 0.0 110.928 -176.324 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.508 ' HB3' ' CA ' ' A' ' 72' ' ' GLY . 3.6 t0 -82.02 82.74 7.51 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -178.521 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.415 ' N ' ' HA ' ' A' ' 36' ' ' HIS . . . 68.22 81.29 0.19 Allowed Glycine 0 C--O 1.227 -0.317 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 175.291 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.35 47.3 0.97 Allowed 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 122.748 1.261 . . . . 0.0 112.778 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.403 ' CG2' ' HG2' ' A' ' 24' ' ' PRO . 68.2 p -134.14 154.85 50.96 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.286 -175.111 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -41.6 -61.4 2.19 Favored Glycine 0 C--O 1.228 -0.243 0 C-N-CA 124.189 0.899 . . . . 0.0 112.704 -178.417 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.9 t -65.0 -72.35 0.15 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 118.103 -0.951 . . . . 0.0 112.186 173.434 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 60.7 p 179.74 -55.2 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.955 0.902 . . . . 0.0 112.278 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.475 ' CD1' ' HD3' ' A' ' 84' ' ' PRO . 80.9 m-85 -71.34 142.93 87.38 Favored Pre-proline 0 N--CA 1.437 -1.083 0 O-C-N 124.821 1.325 . . . . 0.0 112.04 -178.644 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.861 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 27.8 Cg_endo -79.04 158.81 91.22 Favored 'Cis proline' 0 N--CA 1.442 -1.552 0 C-N-CA 122.159 -2.017 . . . . 0.0 110.713 6.574 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.421 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 0.6 OUTLIER -140.91 157.72 44.97 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-O 118.582 -0.723 . . . . 0.0 111.944 178.275 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.939 ' CH2' HG22 ' A' ' 39' ' ' THR . 21.5 t90 -58.4 149.7 24.2 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 122.943 1.354 . . . . 0.0 110.879 172.948 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.496 ' CE2' HD13 ' A' ' 121' ' ' ILE . 8.1 t80 -123.69 83.87 2.2 Favored 'General case' 0 N--CA 1.434 -1.25 0 C-N-CA 127.515 2.326 . . . . 0.0 105.779 -174.993 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.939 HG22 ' CH2' ' A' ' 37' ' ' TRP . 71.1 p -36.46 -41.93 0.31 Allowed 'General case' 0 C--O 1.213 -0.849 0 CA-C-N 114.464 -1.244 . . . . 0.0 110.819 171.682 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 55.4 t30 57.05 20.08 5.2 Favored 'General case' 0 CA--C 1.55 0.965 0 CA-C-O 122.413 1.102 . . . . 0.0 111.028 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.84 -33.13 6.64 Favored Glycine 0 C--O 1.222 -0.626 0 CA-C-O 117.655 -1.636 . . . . 0.0 113.558 -171.896 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.604 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 84.3 m-85 -52.76 157.04 1.74 Allowed 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.328 1.451 . . . . 0.0 111.339 177.734 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.72 -31.2 46.29 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.635 0.731 . . . . 0.0 112.061 176.902 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.509 ' HA2' ' CZ2' ' A' ' 37' ' ' TRP . . . 114.83 34.47 1.52 Allowed Glycine 0 C--O 1.221 -0.699 0 CA-C-O 117.28 -1.845 . . . . 0.0 114.779 -174.56 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -147.54 -64.88 0.27 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.483 1.113 . . . . 0.0 112.219 -178.9 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -135.47 -100.81 0.64 Allowed Glycine 0 C--O 1.219 -0.804 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.88 -174.39 5.24 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.348 0.594 . . . . 0.0 109.79 178.232 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.72 HD13 ' NE ' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -101.47 168.87 8.47 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.507 -178.725 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -71.29 -179.13 3.34 Favored 'Trans proline' 0 N--CA 1.442 -1.53 0 C-N-CA 123.003 2.468 . . . . 0.0 112.166 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.15 104.0 11.33 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 119.98 -1.7 . . . . 0.0 110.014 174.304 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.43 71.21 0.52 Allowed Glycine 0 N--CA 1.469 0.863 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 177.662 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.72 ' NE ' HD13 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -161.66 169.29 21.83 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 124.013 0.925 . . . . 0.0 109.637 178.797 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.9 m -155.23 107.96 2.25 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 173.898 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.508 ' HG3' HD21 ' A' ' 48' ' ' LEU . 24.4 Cg_endo -71.76 172.87 13.6 Favored 'Trans proline' 0 N--CA 1.444 -1.4 0 C-N-CA 122.817 2.345 . . . . 0.0 111.246 177.03 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.8 mt -85.82 132.9 30.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.92 149.28 25.76 Favored 'General case' 0 C--N 1.33 -0.265 0 O-C-N 121.499 -0.75 . . . . 0.0 109.87 175.552 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.465 ' CE2' ' SG ' ' A' ' 62' ' ' CYS . 21.0 m-85 -132.67 -49.48 0.9 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.616 1.167 . . . . 0.0 110.856 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 111.33 -3.32 28.12 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 125.008 1.29 . . . . 0.0 113.249 -174.671 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.87 128.9 40.39 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-O 117.724 -1.131 . . . . 0.0 109.728 176.046 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 22.5 p -61.82 -10.62 9.55 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 125.617 1.823 . . . . 0.0 112.718 176.783 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.586 ' HB2' HG11 ' A' ' 116' ' ' VAL . 0.4 OUTLIER -88.14 -54.21 4.33 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 126.181 1.792 . . . . 0.0 110.505 179.329 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.465 ' SG ' ' CE2' ' A' ' 57' ' ' PHE . 2.6 t -73.34 -15.2 61.39 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 124.275 0.985 . . . . 0.0 113.092 174.91 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -84.68 -40.5 17.31 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.383 1.473 . . . . 0.0 110.259 173.471 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.63 155.41 3.9 Favored Pre-proline 0 CA--C 1.539 0.529 0 CA-C-O 122.636 1.208 . . . . 0.0 111.566 -178.683 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -69.02 138.02 39.1 Favored 'Trans proline' 0 N--CA 1.439 -1.689 0 C-N-CA 120.344 0.696 . . . . 0.0 112.411 175.093 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.454 ' HD2' ' CD1' ' A' ' 42' ' ' TYR . 27.9 Cg_endo -66.17 172.24 9.04 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 124.118 3.212 . . . . 0.0 110.713 173.93 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.7 mmtt -140.94 63.0 1.46 Allowed 'General case' 0 C--O 1.207 -1.133 0 CA-C-O 118.287 -0.863 . . . . 0.0 109.508 177.388 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 31.1 t-80 -74.29 163.86 27.3 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 123.433 0.458 . . . . 0.0 110.382 177.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 21.1 p -148.63 -173.37 4.32 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.483 1.113 . . . . 0.0 110.976 176.186 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.75 74.19 10.2 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 120.734 -1.229 . . . . 0.0 111.706 176.359 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -177.05 -46.46 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 124.281 1.033 . . . . 0.0 109.68 -179.255 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.508 ' CA ' ' HB3' ' A' ' 27' ' ' ASP . . . 120.66 -78.12 0.32 Allowed Glycine 0 N--CA 1.441 -1.017 0 O-C-N 124.441 1.088 . . . . 0.0 112.677 -174.766 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -119.99 61.61 0.85 Allowed 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 128.874 2.869 . . . . 0.0 109.003 -178.079 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -70.56 -106.36 0.04 OUTLIER Glycine 0 CA--C 1.526 0.725 0 CA-C-O 123.088 1.382 . . . . 0.0 111.506 -175.239 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.0 mttt -61.35 -90.05 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.68 0 O-C-N 120.201 -1.764 . . . . 0.0 113.353 174.36 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.42 HG23 ' O ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -128.77 15.37 6.42 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.641 177.437 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -29.38 97.33 0.01 OUTLIER 'General case' 0 C--O 1.214 -0.806 0 C-N-CA 126.126 1.77 . . . . 0.0 112.349 -175.733 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.403 ' CD2' ' H ' ' A' ' 78' ' ' HIS . 6.1 p80 -88.53 58.0 4.48 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 119.866 -1.771 . . . . 0.0 107.527 -169.232 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.528 ' HB2' ' CD1' ' A' ' 37' ' ' TRP . 46.7 p90 -80.85 133.55 35.61 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 125.08 1.352 . . . . 0.0 108.885 -177.189 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.611 HD21 HG22 ' A' ' 111' ' ' THR . 5.3 mt -71.2 126.33 29.32 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 176.804 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.727 HD21 ' HB2' ' A' ' 35' ' ' PRO . 0.4 OUTLIER -120.23 141.79 49.62 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 177.962 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.407 ' HB2' HD11 ' A' ' 109' ' ' ILE . 0.6 OUTLIER -103.84 166.14 10.6 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 175.784 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.723 ' CE2' ' HB2' ' A' ' 23' ' ' ALA . 7.6 t80 -152.85 127.04 4.47 Favored Pre-proline 0 CA--C 1.538 0.511 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.475 ' HD3' ' CD1' ' A' ' 34' ' ' TYR . 17.8 Cg_endo -71.66 118.39 5.63 Favored 'Trans proline' 0 N--CA 1.444 -1.416 0 C-N-CA 124.755 3.637 . . . . 0.0 110.312 -176.871 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.99 111.29 17.72 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.742 -1.117 . . . . 0.0 108.61 -177.118 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -79.31 157.64 75.13 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 177.133 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -73.52 -36.1 4.19 Favored 'Trans proline' 0 N--CA 1.448 -1.18 0 C-N-CA 122.636 2.224 . . . . 0.0 113.321 178.694 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -46.74 -29.93 2.16 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 126.911 2.084 . . . . 0.0 110.044 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.93 6.08 76.37 Favored Glycine 0 N--CA 1.44 -1.099 0 C-N-CA 125.367 1.46 . . . . 0.0 112.344 178.599 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.1 p-80 -76.56 128.7 35.24 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 177.104 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -56.82 106.79 0.33 Allowed 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 171.485 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.46 ' CD2' ' HG2' ' A' ' 84' ' ' PRO . 3.0 t80 -37.08 131.96 0.74 Allowed 'General case' 0 C--O 1.215 -0.715 0 C-N-CA 123.833 0.853 . . . . 0.0 108.852 176.667 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.27 59.68 0.08 Allowed 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.385 -0.822 . . . . 0.0 112.162 173.361 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.482 ' CD2' ' HZ ' ' A' ' 83' ' ' PHE . 6.5 p90 -72.92 -5.09 36.17 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 127.347 2.259 . . . . 0.0 112.196 174.937 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.68 -40.6 10.16 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 123.652 1.691 . . . . 0.0 110.166 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 74.9 m -76.93 97.72 4.69 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 120.348 -1.47 . . . . 0.0 108.393 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.6 pttm -59.16 -46.71 87.67 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.955 0.883 . . . . 0.0 111.81 177.225 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.46 126.35 8.12 Favored Pre-proline 0 CA--C 1.54 0.576 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.909 -179.149 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -69.47 171.75 51.01 Favored 'Cis proline' 0 N--CA 1.454 -0.842 0 C-N-CA 123.183 -1.591 . . . . 0.0 111.184 -5.48 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -128.77 146.05 51.01 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 123.612 0.765 . . . . 0.0 109.107 177.004 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -95.19 165.96 12.14 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 173.935 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -36.02 138.48 0.44 Allowed Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 125.034 1.334 . . . . 0.0 110.954 170.579 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -71.88 -68.43 0.02 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 123.174 2.583 . . . . 0.0 114.259 176.423 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 130.82 142.09 5.01 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -75.3 -66.62 0.02 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 123.468 2.778 . . . . 0.0 110.951 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.589 ' HA ' ' HB2' ' A' ' 122' ' ' ALA . . . -64.74 131.8 47.85 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.789 0.804 . . . . 0.0 111.356 178.652 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.406 ' HG2' ' HA ' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -139.75 150.61 44.99 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-N 114.63 -1.168 . . . . 0.0 110.057 -178.443 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.576 HG11 ' HB3' ' A' ' 20' ' ' SER . 3.6 p -88.36 119.19 35.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 O-C-N 124.58 1.175 . . . . 0.0 110.454 178.377 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.534 HG12 HD13 ' A' ' 121' ' ' ILE . 1.2 mp -107.25 117.8 53.74 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.011 0 N-CA-C 105.847 -1.908 . . . . 0.0 105.847 -173.975 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.649 ' CZ ' HD22 ' A' ' 81' ' ' LEU . 5.9 p90 -136.06 151.53 49.94 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-O 122.732 1.253 . . . . 0.0 108.213 -178.941 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.611 HG22 HD21 ' A' ' 80' ' ' LEU . 1.8 p -83.46 157.23 22.51 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.142 177.492 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.484 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -105.47 157.16 35.12 Favored Pre-proline 0 CA--C 1.552 1.022 0 O-C-N 121.966 -0.459 . . . . 0.0 111.317 178.188 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.484 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 19.1 Cg_endo -72.35 -49.77 0.21 Allowed 'Cis proline' 0 N--CA 1.454 -0.807 0 C-N-CA 124.412 -1.078 . . . . 0.0 111.375 -11.072 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -48.06 105.14 0.07 Allowed 'General case' 0 C--O 1.224 -0.268 0 C-N-CA 124.113 0.965 . . . . 0.0 109.24 176.55 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.451 ' HE2' HD22 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -61.85 79.87 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 126.113 1.765 . . . . 0.0 108.695 -178.152 . . . . . . . . 3 3 . 1 . 007 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.586 HG11 ' HB2' ' A' ' 61' ' ' ASP . 39.4 t -81.41 72.8 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 104.271 -2.492 . . . . 0.0 104.271 -177.256 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -36.87 106.63 0.05 OUTLIER 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 125.864 1.665 . . . . 0.0 109.827 176.112 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 118' ' ' CYS . . . . . 0.421 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 7.8 m -84.79 -45.51 12.28 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 -177.912 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 163.7 -146.78 11.96 Favored Glycine 0 N--CA 1.439 -1.149 0 CA-C-N 114.75 -1.113 . . . . 0.0 110.682 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.44 HG13 ' CG ' ' A' ' 4' ' ' TRP . 1.3 mm -127.5 141.1 47.27 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.925 0 N-CA-C 104.93 -2.248 . . . . 0.0 104.93 -177.892 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.534 HD13 HG12 ' A' ' 109' ' ' ILE . 5.7 pt -130.51 150.44 34.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -178.74 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.589 ' HB2' ' HA ' ' A' ' 106' ' ' ALA . . . . . . . . 0 C--N 1.321 -0.633 0 CA-C-O 121.439 0.638 . . . . 0.0 110.344 178.537 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.513 -0.446 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 . . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.401 HD12 HG22 ' A' ' 121' ' ' ILE . 12.4 tp -82.24 136.2 35.11 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.606 -0.886 . . . . 0.0 108.606 178.006 . . . . . . . . 2 2 . 1 . 007 nuclear build core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 64.1 m -67.08 -177.31 0.63 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 123.066 1.412 . . . . 0.0 109.979 173.126 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 2.1 m -158.72 124.6 4.48 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 104.836 -2.283 . . . . 0.0 104.836 -177.989 . . . . . . . . 1 1 . 1 . 007 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.473 ' HB3' HG22 ' A' ' 2' ' ' VAL . 3.0 m80 . . . . . 0 C--N 1.324 -0.503 0 CA-C-O 117.228 -1.367 . . . . 0.0 113.238 175.039 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.41 HG13 ' CD2' ' A' ' 136' ' ' HIS . 7.7 p . . . . . 0 CA--C 1.531 0.228 0 CA-C-O 121.297 0.57 . . . . 0.0 111.271 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.528 HG21 HD23 ' A' ' 10' ' ' LEU . 0.9 OUTLIER -83.58 114.59 21.63 Favored 'General case' 0 C--N 1.319 -0.723 0 O-C-N 122.092 -0.38 . . . . 0.0 110.538 178.354 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 23.0 m95 -81.17 139.57 35.48 Favored 'General case' 0 C--O 1.215 -0.721 0 O-C-N 121.994 -0.441 . . . . 0.0 110.345 177.609 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -130.69 138.5 50.06 Favored 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -178.809 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.645 ' SG ' ' HB3' ' A' ' 122' ' ' ALA . 0.1 OUTLIER -122.85 61.71 1.0 Allowed 'General case' 0 N--CA 1.442 -0.852 0 O-C-N 124.092 0.87 . . . . 0.0 108.755 175.553 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 43.7 52.22 6.58 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 123.133 0.396 . . . . 0.0 112.115 179.041 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -164.29 -85.3 0.06 OUTLIER Glycine 0 C--O 1.224 -0.476 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -177.967 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -127.19 164.0 22.64 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 121.749 0.785 . . . . 0.0 110.098 177.414 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.528 HD23 HG21 ' A' ' 3' ' ' THR . 10.9 mp -88.69 126.09 35.15 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -177.256 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.495 ' CZ ' ' HB3' ' A' ' 106' ' ' ALA . 70.2 m-85 -111.3 89.73 3.13 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 126.695 1.998 . . . . 0.0 108.586 -174.27 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -54.71 125.39 19.73 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.544 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 7.5 tp-100 -60.59 -21.66 62.87 Favored 'General case' 0 C--O 1.213 -0.838 0 C-N-CA 119.028 -1.069 . . . . 0.0 113.249 176.793 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -64.64 -23.46 67.27 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 172.673 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.2 mtmt -103.73 -36.65 7.79 Favored 'General case' 0 C--O 1.202 -1.424 0 C-N-CA 126.492 1.917 . . . . 0.0 109.782 175.135 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.629 ' HA ' HG21 ' A' ' 85' ' ' THR . . . -54.27 -42.53 70.09 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 121.307 1.867 . . . . 0.0 111.736 177.112 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -84.13 -47.56 10.76 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-O 117.598 -1.191 . . . . 0.0 108.809 177.034 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.7 t -66.64 -53.01 38.62 Favored 'General case' 0 C--O 1.212 -0.884 0 CA-C-N 120.326 1.421 . . . . 0.0 109.514 -172.212 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.518 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 6.4 t-20 -42.78 -36.52 1.49 Allowed 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 123.946 0.898 . . . . 0.0 113.396 169.639 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.456 ' O ' ' HB3' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -82.01 -33.95 29.82 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 172.548 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -46.2 -37.01 6.57 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 126.469 1.908 . . . . 0.0 109.925 178.071 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.518 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -73.13 -48.8 32.48 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 117.635 -1.174 . . . . 0.0 112.698 175.182 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.769 ' HB1' ' HG3' ' A' ' 35' ' ' PRO . . . -36.59 128.38 0.71 Allowed Pre-proline 0 N--CA 1.442 -0.873 0 O-C-N 125.487 1.742 . . . . 0.0 112.226 173.153 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.552 ' HG2' HG22 ' A' ' 30' ' ' THR . 13.8 Cg_endo -73.69 125.96 10.42 Favored 'Trans proline' 0 N--CA 1.444 -1.417 0 C-N-CA 121.979 1.786 . . . . 0.0 107.573 -175.817 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.672 HD13 ' HE2' ' A' ' 115' ' ' LYS . 3.4 tp -61.77 84.98 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 124.552 1.141 . . . . 0.0 111.911 177.998 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.4 m -174.43 155.12 2.24 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.165 0.986 . . . . 0.0 110.047 -173.291 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -96.31 137.45 35.36 Favored 'General case' 0 CA--C 1.503 -0.849 0 CA-C-O 117.566 -1.207 . . . . 0.0 110.784 175.239 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 37.21 70.58 0.24 Allowed Glycine 0 C--N 1.338 0.673 0 O-C-N 125.008 1.442 . . . . 0.0 111.897 177.032 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -148.6 24.15 0.99 Allowed 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 121.997 0.903 . . . . 0.0 111.824 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.552 HG22 ' HG2' ' A' ' 24' ' ' PRO . 50.1 p -130.2 151.8 50.33 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -175.956 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -40.7 -64.98 1.1 Allowed Glycine 0 CA--C 1.505 -0.536 0 O-C-N 124.25 0.969 . . . . 0.0 112.764 -177.517 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 40.5 t -60.15 -60.99 2.94 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-O 115.809 -2.043 . . . . 0.0 112.641 174.691 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 161.16 -53.32 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.706 0 O-C-N 125.777 1.923 . . . . 0.0 111.863 176.705 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.485 ' CD2' ' HD3' ' A' ' 84' ' ' PRO . 62.2 m-85 -63.38 146.86 95.96 Favored Pre-proline 0 N--CA 1.438 -1.065 0 N-CA-C 114.757 1.392 . . . . 0.0 114.757 177.41 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.769 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 20.7 Cg_endo -75.41 166.32 83.44 Favored 'Cis proline' 0 N--CA 1.446 -1.308 0 C-N-CA 123.442 -1.483 . . . . 0.0 110.862 0.711 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.465 ' C ' HD23 ' A' ' 81' ' ' LEU . 0.8 OUTLIER -139.61 172.41 12.84 Favored 'General case' 0 CA--C 1.502 -0.884 0 O-C-N 120.867 -1.146 . . . . 0.0 109.89 -176.895 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.943 ' CH2' HG22 ' A' ' 39' ' ' THR . 21.3 t90 -71.4 141.4 50.32 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.889 0.852 . . . . 0.0 108.825 177.303 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.598 ' CZ ' HD13 ' A' ' 121' ' ' ILE . 55.4 t80 -121.05 83.0 2.0 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 -176.379 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.943 HG22 ' CH2' ' A' ' 37' ' ' TRP . 44.2 p -40.32 -31.23 0.13 Allowed 'General case' 0 C--O 1.212 -0.886 0 C-N-CA 124.512 1.125 . . . . 0.0 111.255 174.229 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.4 t30 71.32 7.67 6.14 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.039 1.735 . . . . 0.0 109.405 178.014 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.71 ' C ' HD23 ' A' ' 48' ' ' LEU . . . 117.58 -11.32 14.02 Favored Glycine 0 N--CA 1.434 -1.481 0 O-C-N 120.592 -1.318 . . . . 0.0 113.169 -170.9 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.579 ' CE2' ' HA ' ' A' ' 47' ' ' LYS . 4.9 m-85 -75.93 176.26 8.04 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 118.364 1.082 . . . . 0.0 109.852 -176.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.62 -39.11 9.26 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.563 174.993 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.485 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -172.49 -82.55 0.05 OUTLIER Glycine 0 C--N 1.333 0.406 0 C-N-CA 123.571 0.605 . . . . 0.0 111.983 -178.209 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.83 -63.1 1.15 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 122.021 0.915 . . . . 0.0 110.438 178.399 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.97 166.49 12.88 Favored Glycine 0 C--N 1.34 0.751 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.579 ' HA ' ' CE2' ' A' ' 42' ' ' TYR . 1.2 pttt -53.91 -176.25 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 123.13 1.443 . . . . 0.0 113.095 174.559 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.729 HD11 ' HG3' ' A' ' 54' ' ' PRO . 0.1 OUTLIER -65.07 156.77 79.63 Favored Pre-proline 0 C--N 1.313 -1.007 0 O-C-N 121.23 -0.919 . . . . 0.0 111.313 178.324 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -72.5 175.21 10.44 Favored 'Trans proline' 0 N--CA 1.447 -1.263 0 C-N-CA 122.225 1.95 . . . . 0.0 110.556 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.52 96.44 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.481 0 O-C-N 121.651 -0.656 . . . . 0.0 110.611 176.358 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.7 90.51 2.14 Favored Glycine 0 C--O 1.226 -0.4 0 CA-C-N 116.295 -0.412 . . . . 0.0 112.168 -176.559 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.461 ' HB3' HD22 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -173.18 162.63 4.51 Favored 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 123.808 0.843 . . . . 0.0 110.583 175.876 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 48.1 m -142.56 95.64 6.43 Favored Pre-proline 0 C--O 1.234 0.248 0 O-C-N 124.961 1.413 . . . . 0.0 110.132 -177.332 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.729 ' HG3' HD11 ' A' ' 48' ' ' LEU . 19.5 Cg_endo -73.31 146.84 40.9 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.531 2.154 . . . . 0.0 110.071 -179.234 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.413 HD12 HG21 ' A' ' 121' ' ' ILE . 5.3 mt -68.18 116.81 8.95 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.531 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -178.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.12 136.88 35.11 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 177.873 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.576 ' CD2' ' HB3' ' A' ' 118' ' ' CYS . 8.7 m-85 -114.96 -53.35 2.65 Favored 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 123.752 0.821 . . . . 0.0 110.128 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 128.99 -11.46 6.2 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 123.896 0.76 . . . . 0.0 112.845 -176.16 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.405 ' HA ' ' CE ' ' A' ' 59' ' ' LYS . 0.3 OUTLIER -90.0 132.21 35.48 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-N 117.27 0.535 . . . . 0.0 110.739 176.321 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -73.32 0.78 11.05 Favored 'General case' 0 C--O 1.223 -0.297 0 O-C-N 124.875 1.36 . . . . 0.0 111.946 175.835 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.428 ' OD2' HG11 ' A' ' 116' ' ' VAL . 0.6 OUTLIER -87.28 -54.37 4.34 Favored 'General case' 0 N--CA 1.446 -0.645 0 O-C-N 120.638 -1.289 . . . . 0.0 109.004 -179.948 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.442 ' HA ' HD11 ' A' ' 80' ' ' LEU . 1.8 m -75.66 -35.17 60.48 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 124.617 1.198 . . . . 0.0 109.013 -179.146 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -59.73 -39.97 86.5 Favored 'General case' 0 C--N 1.343 0.324 0 O-C-N 124.362 1.039 . . . . 0.0 111.286 175.496 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.0 159.02 0.5 Allowed Pre-proline 0 N--CA 1.446 -0.648 0 CA-C-O 122.94 1.352 . . . . 0.0 111.536 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -70.55 133.18 23.55 Favored 'Trans proline' 0 N--CA 1.437 -1.8 0 C-N-CA 120.212 0.608 . . . . 0.0 112.573 175.395 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.476 ' HD2' ' CD2' ' A' ' 42' ' ' TYR . 22.3 Cg_endo -72.51 170.36 19.56 Favored 'Trans proline' 0 N--CA 1.446 -1.32 0 C-N-CA 125.103 3.868 . . . . 0.0 111.239 176.904 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -136.85 53.0 1.92 Allowed 'General case' 0 CA--C 1.497 -1.075 0 CA-C-O 116.835 -1.555 . . . . 0.0 108.123 -177.54 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 21.5 t-80 -75.62 167.38 22.0 Favored 'General case' 0 C--O 1.216 -0.676 0 O-C-N 123.971 0.795 . . . . 0.0 110.933 178.529 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -154.18 -166.62 2.41 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 121.383 -0.823 . . . . 0.0 111.4 176.421 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.25 70.54 10.14 Favored 'General case' 0 C--O 1.212 -0.878 0 O-C-N 120.001 -1.687 . . . . 0.0 111.81 175.733 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -177.08 -41.27 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 123.33 0.652 . . . . 0.0 109.73 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.412 ' O ' ' CE2' ' A' ' 79' ' ' TYR . . . 120.81 -76.31 0.32 Allowed Glycine 0 N--CA 1.442 -0.914 0 N-CA-C 109.839 -1.305 . . . . 0.0 109.839 -177.836 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.414 ' HB3' ' OH ' ' A' ' 79' ' ' TYR . 2.9 p-10 -124.59 61.56 1.14 Allowed 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 -175.241 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -53.31 -102.94 0.01 OUTLIER Glycine 0 CA--C 1.535 1.33 0 CA-C-O 122.533 1.074 . . . . 0.0 113.855 178.286 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.7 mttm -72.3 -105.74 0.01 OUTLIER 'General case' 0 C--O 1.221 -0.442 0 O-C-N 120.51 -1.583 . . . . 0.0 110.916 175.836 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.538 HG23 ' O ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -105.36 19.04 21.26 Favored 'General case' 0 C--N 1.322 -0.597 0 O-C-N 121.05 -1.031 . . . . 0.0 110.782 179.623 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.43 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 1.2 m-20 -30.64 99.63 0.02 OUTLIER 'General case' 0 C--O 1.208 -1.117 0 C-N-CA 125.357 1.463 . . . . 0.0 110.665 -177.406 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.452 ' CD2' ' H ' ' A' ' 78' ' ' HIS . 0.5 OUTLIER -81.76 11.71 4.61 Favored 'General case' 0 C--O 1.221 -0.41 0 O-C-N 121.072 -1.017 . . . . 0.0 111.023 -176.703 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.872 ' CE1' HD11 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -38.6 141.46 0.26 Allowed 'General case' 0 N--CA 1.426 -1.653 0 CA-C-O 122.903 1.335 . . . . 0.0 114.559 170.625 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.586 HD22 ' CG2' ' A' ' 109' ' ' ILE . 0.2 OUTLIER -77.86 157.96 29.65 Favored 'General case' 0 CA--C 1.509 -0.611 0 O-C-N 120.448 -1.407 . . . . 0.0 109.412 177.409 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.872 HD11 ' CE1' ' A' ' 79' ' ' TYR . 1.1 mt -143.95 129.43 19.01 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 178.988 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.484 ' CB ' ' CD1' ' A' ' 109' ' ' ILE . 1.1 pm0 -97.17 151.54 19.71 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-O 122.917 1.342 . . . . 0.0 111.382 178.645 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.464 ' CE1' ' HB2' ' A' ' 23' ' ' ALA . 74.4 t80 -141.42 130.75 12.61 Favored Pre-proline 0 N--CA 1.448 -0.57 0 CA-C-N 114.801 -1.09 . . . . 0.0 111.504 -178.655 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.485 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 18.1 Cg_endo -75.74 97.02 1.07 Allowed 'Trans proline' 0 N--CA 1.443 -1.468 0 C-N-CA 123.995 3.13 . . . . 0.0 109.516 -177.728 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.629 HG21 ' HA ' ' A' ' 16' ' ' ALA . 10.5 t -101.18 116.28 32.46 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 122.233 1.016 . . . . 0.0 111.06 179.533 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.429 ' CD2' ' NE2' ' A' ' 90' ' ' HIS . 57.4 m-85 -82.31 159.77 63.95 Favored Pre-proline 0 N--CA 1.445 -0.676 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.101 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -77.24 -39.36 0.59 Allowed 'Trans proline' 0 N--CA 1.444 -1.398 0 C-N-CA 122.374 2.049 . . . . 0.0 112.613 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -43.58 -31.03 0.66 Allowed 'General case' 0 N--CA 1.476 0.857 0 O-C-N 125.11 1.506 . . . . 0.0 110.773 175.754 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.18 13.63 68.26 Favored Glycine 0 N--CA 1.436 -1.337 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 176.695 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.429 ' NE2' ' CD2' ' A' ' 86' ' ' PHE . 7.7 p-80 -77.93 130.06 36.1 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -59.12 90.91 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 123.801 0.84 . . . . 0.0 109.748 175.994 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.485 ' CD2' ' HB3' ' A' ' 94' ' ' PHE . 3.8 t80 -38.51 139.71 0.38 Allowed 'General case' 0 C--O 1.217 -0.644 0 C-N-CA 124.385 1.074 . . . . 0.0 109.295 -177.473 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 8.2 ptpt -77.41 64.25 2.74 Favored 'General case' 0 C--N 1.315 -0.927 0 O-C-N 119.582 -1.949 . . . . 0.0 110.359 175.119 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.485 ' HB3' ' CD2' ' A' ' 92' ' ' TYR . 23.1 p90 -80.09 -12.89 59.63 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 123.518 0.727 . . . . 0.0 112.544 176.135 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.1 -33.13 14.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 122.313 1.054 . . . . 0.0 109.888 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.1 m -82.12 110.32 17.23 Favored 'General case' 0 CA--C 1.514 -0.439 0 O-C-N 120.73 -1.231 . . . . 0.0 109.598 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.9 pttt -58.17 -49.51 76.79 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-O 121.587 0.708 . . . . 0.0 110.096 178.122 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 99' ' ' PRO . 6.3 tttm -140.87 126.68 11.36 Favored Pre-proline 0 N--CA 1.436 -1.149 0 C-N-CA 124.313 1.045 . . . . 0.0 110.0 -176.499 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.414 ' HA ' ' HA ' ' A' ' 98' ' ' LYS . 18.1 Cg_endo -71.68 176.42 37.91 Favored 'Cis proline' 0 C--N 1.352 0.711 0 O-C-N 124.545 1.813 . . . . 0.0 110.665 -3.34 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 20.8 tttm -141.93 135.82 29.79 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.431 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -85.02 147.76 26.52 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.153 0.908 . . . . 0.0 109.396 176.616 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -43.9 152.13 0.48 Allowed Pre-proline 0 C--O 1.219 -0.539 0 C-N-CA 123.325 0.65 . . . . 0.0 112.438 176.829 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.43 ' HB3' ' CE1' ' A' ' 34' ' ' TYR . 18.2 Cg_endo -71.83 -86.59 0.0 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.46 0 C-N-CA 121.214 1.276 . . . . 0.0 110.861 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 128.96 153.46 7.98 Favored Glycine 0 CA--C 1.529 0.925 0 O-C-N 120.84 -1.163 . . . . 0.0 111.835 -176.681 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -75.63 -61.15 0.04 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.404 0 C-N-CA 122.471 2.114 . . . . 0.0 110.102 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.495 ' HB3' ' CZ ' ' A' ' 11' ' ' TYR . . . -60.87 132.0 52.48 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 109.794 -0.446 . . . . 0.0 109.794 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.422 ' HG2' ' HA ' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -146.29 146.44 30.72 Favored 'General case' 0 CA--C 1.503 -0.843 0 O-C-N 124.109 0.881 . . . . 0.0 110.864 178.683 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.575 HG23 ' CD1' ' A' ' 117' ' ' PHE . 7.6 p -79.84 119.64 29.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.512 1.133 . . . . 0.0 110.243 177.274 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.586 ' CG2' HD22 ' A' ' 80' ' ' LEU . 7.0 mm -100.6 142.14 16.19 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.964 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.103 178.908 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.553 ' O ' HD23 ' A' ' 80' ' ' LEU . 10.8 p90 -164.91 153.66 12.42 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-O 122.537 1.16 . . . . 0.0 110.278 -178.664 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.6 p -87.18 168.6 13.09 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.47 -178.62 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.563 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.4 OUTLIER -114.49 152.04 45.77 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 122.124 0.17 . . . . 0.0 111.302 177.763 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.563 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 14.3 Cg_endo -75.21 -51.56 0.16 OUTLIER 'Cis proline' 0 CA--C 1.494 -1.493 0 N-CA-C 108.48 -1.392 . . . . 0.0 108.48 -4.977 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.482 ' HB3' HG23 ' A' ' 116' ' ' VAL . 3.0 m-20 -43.28 111.12 0.24 Allowed 'General case' 0 CA--C 1.5 -0.953 0 CA-C-O 116.59 -1.672 . . . . 0.0 109.912 179.013 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.672 ' HE2' HD13 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -68.66 67.96 0.14 Allowed 'General case' 0 CA--C 1.508 -0.646 0 O-C-N 125.944 2.027 . . . . 0.0 108.495 -177.989 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.483 ' O ' HG12 ' A' ' 116' ' ' VAL . 14.6 t -73.15 72.65 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 -178.343 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.594 ' CZ ' ' HA2' ' A' ' 119' ' ' GLY . 41.5 t80 -41.72 116.61 0.81 Allowed 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 124.701 1.2 . . . . 0.0 109.22 179.384 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 118' ' ' CYS . . . . . 0.576 ' HB3' ' CD2' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -90.91 -41.55 11.09 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-O 121.637 0.732 . . . . 0.0 109.79 178.582 . . . . . . . . 3 3 . 1 . 008 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.594 ' HA2' ' CZ ' ' A' ' 117' ' ' PHE . . . 157.65 -171.65 34.83 Favored Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 111.569 -0.612 . . . . 0.0 111.569 -178.431 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.649 HG22 ' SG ' ' A' ' 134' ' ' CYS . 3.2 mp -109.71 147.06 14.37 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.983 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 -178.803 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.598 HD13 ' CZ ' ' A' ' 38' ' ' PHE . 7.0 pt -119.76 155.47 22.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 177.891 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.645 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . . . . . . . . 0 C--N 1.322 -0.598 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.572 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.509 -0.613 0 CA-C-O 118.736 -0.649 . . . . 0.0 109.592 . . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.56 HD13 ' CE2' ' A' ' 57' ' ' PHE . 10.9 tp -66.34 133.11 49.85 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 134' ' ' CYS . . . . . 0.649 ' SG ' HG22 ' A' ' 120' ' ' ILE . 71.3 m -57.83 -178.34 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 124.94 1.4 . . . . 0.0 110.34 176.249 . . . . . . . . 2 2 . 1 . 008 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.2 m -161.34 112.63 1.76 Allowed 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 -178.239 . . . . . . . . 1 1 . 1 . 008 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.41 ' CD2' HG13 ' A' ' 2' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--O 1.241 0.636 0 CA-C-O 116.106 -1.902 . . . . 0.0 113.626 172.486 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.4 p . . . . . 0 N--CA 1.465 0.309 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 009 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.2 m -90.05 113.31 24.99 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -178.309 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 4' ' ' TRP . . . . . 0.548 ' CH2' ' CE1' ' A' ' 136' ' ' HIS . 33.1 m95 -82.61 141.06 32.84 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.038 177.779 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -130.65 138.23 49.97 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -177.142 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.729 ' SG ' ' HB3' ' A' ' 122' ' ' ALA . 0.1 OUTLIER -133.33 -77.67 0.48 Allowed 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 176.433 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -75.54 34.96 1.16 Allowed Glycine 0 CA--C 1.533 1.209 0 CA-C-O 119.606 -0.552 . . . . 0.0 113.478 -179.284 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 72.3 5.05 61.83 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-N 118.453 1.126 . . . . 0.0 113.911 -170.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.573 HD13 ' OH ' ' A' ' 11' ' ' TYR . 0.4 OUTLIER -107.48 139.29 42.21 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 -174.996 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.6 mp -94.26 129.19 41.0 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 124.256 0.973 . . . . 0.0 108.655 -174.388 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.573 ' OH ' HD13 ' A' ' 9' ' ' LEU . 77.6 m-85 -125.2 98.01 5.47 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 -170.501 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -52.77 122.81 9.85 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.805 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 29.8 tp60 -54.7 -41.49 70.32 Favored 'General case' 0 C--O 1.21 -1.022 0 C-N-CA 119.089 -1.044 . . . . 0.0 111.781 -179.04 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -48.3 -44.19 33.69 Favored 'General case' 0 C--O 1.205 -1.287 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 173.211 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.448 ' CE ' ' HA3' ' A' ' 89' ' ' GLY . 6.6 mttt -69.93 -38.14 76.13 Favored 'General case' 0 C--O 1.211 -0.96 0 CA-C-O 117.03 -1.462 . . . . 0.0 114.295 167.208 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -52.9 -41.31 64.26 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 122.484 2.402 . . . . 0.0 114.081 170.913 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -85.98 -41.57 14.76 Favored 'General case' 0 C--O 1.214 -0.797 0 O-C-N 120.554 -1.341 . . . . 0.0 109.858 175.357 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 43.4 t -72.7 -59.13 2.87 Favored 'General case' 0 C--O 1.212 -0.882 0 C-N-CA 126.627 1.971 . . . . 0.0 109.665 -175.054 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.46 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 4.4 t-20 -39.39 -39.7 0.71 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 120.107 1.321 . . . . 0.0 113.773 168.687 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.501 ' O ' ' HB3' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -79.8 -33.72 40.24 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 172.965 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -48.22 -36.46 13.89 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 126.334 1.854 . . . . 0.0 110.152 178.23 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.46 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -73.49 -45.94 50.97 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 125.119 1.368 . . . . 0.0 111.702 176.076 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.801 ' HB1' ' HG3' ' A' ' 35' ' ' PRO . . . -39.13 130.03 1.24 Allowed Pre-proline 0 CA--C 1.539 0.552 0 O-C-N 125.411 1.694 . . . . 0.0 111.871 173.861 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.637 ' HG2' HG22 ' A' ' 30' ' ' THR . 17.0 Cg_endo -72.56 129.71 15.03 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 N-CA-C 107.296 -1.848 . . . . 0.0 107.296 -176.041 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.472 HD12 ' HA ' ' A' ' 25' ' ' LEU . 3.8 tp -63.3 83.86 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 125.265 1.426 . . . . 0.0 111.693 178.635 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 179.15 144.92 0.15 Allowed 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.044 0.938 . . . . 0.0 109.456 -172.887 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.448 ' CG ' ' H ' ' A' ' 37' ' ' TRP . 1.4 t0 -86.93 118.7 26.48 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.816 0.847 . . . . 0.0 110.134 179.045 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 54.16 63.65 4.98 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 175.595 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -127.83 11.48 6.65 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 123.412 1.577 . . . . 0.0 112.499 176.818 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.637 HG22 ' HG2' ' A' ' 24' ' ' PRO . 10.0 p -118.49 150.94 38.77 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 -171.173 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -44.04 -61.41 3.09 Favored Glycine 0 CA--C 1.506 -0.472 0 CA-C-O 119.142 -0.81 . . . . 0.0 111.959 -179.043 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.415 ' CA ' ' HE2' ' A' ' 100' ' ' LYS . 58.5 m -52.39 -66.96 0.29 Allowed 'General case' 0 CA--C 1.489 -1.396 0 CA-C-O 116.325 -1.798 . . . . 0.0 111.984 175.504 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.1 p 164.2 -64.4 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.655 0 O-C-N 126.712 2.507 . . . . 0.0 110.642 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.448 ' CD1' ' HD3' ' A' ' 84' ' ' PRO . 98.1 m-85 -59.6 149.1 72.49 Favored Pre-proline 0 N--CA 1.436 -1.172 0 CA-C-N 114.403 -1.272 . . . . 0.0 113.249 -177.877 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.801 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 28.7 Cg_endo -74.29 166.23 83.17 Favored 'Cis proline' 0 N--CA 1.435 -1.951 0 C-N-CA 122.405 -1.915 . . . . 0.0 111.775 -2.446 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 27' ' ' ASP . 0.5 OUTLIER -140.94 170.78 15.1 Favored 'General case' 0 C--O 1.214 -0.787 0 O-C-N 121.105 -0.997 . . . . 0.0 110.984 -177.891 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.856 ' CH2' HG22 ' A' ' 39' ' ' THR . 18.2 t90 -66.68 148.85 51.35 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 120.812 1.642 . . . . 0.0 109.539 173.894 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.477 ' CE2' ' HB2' ' A' ' 40' ' ' ASN . 11.7 t80 -120.74 86.92 2.66 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 104.079 -2.563 . . . . 0.0 104.079 -175.371 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.856 HG22 ' CH2' ' A' ' 37' ' ' TRP . 71.6 p -41.68 -35.77 0.84 Allowed 'General case' 0 C--O 1.214 -0.792 0 CA-C-N 114.308 -1.315 . . . . 0.0 110.252 171.52 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.477 ' HB2' ' CE2' ' A' ' 38' ' ' PHE . 56.3 t30 56.04 20.36 4.29 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 120.337 1.426 . . . . 0.0 111.916 178.36 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.72 ' C ' HD23 ' A' ' 48' ' ' LEU . . . 105.3 -41.17 2.23 Favored Glycine 0 N--CA 1.43 -1.728 0 CA-C-O 115.413 -2.882 . . . . 0.0 115.459 -167.955 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.425 ' CE2' ' HD3' ' A' ' 66' ' ' PRO . 83.6 m-85 -44.52 153.85 0.15 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 120.216 2.008 . . . . 0.0 112.558 174.734 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.59 -37.51 21.06 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 176.964 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.462 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -169.1 -72.58 0.04 OUTLIER Glycine 0 C--N 1.334 0.434 0 C-N-CA 124.529 1.061 . . . . 0.0 111.374 -178.523 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -113.59 -63.73 1.41 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.223 1.009 . . . . 0.0 110.669 -178.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.45 -173.32 0.62 Allowed Glycine 0 C--N 1.339 0.714 0 CA-C-O 122.299 0.944 . . . . 0.0 111.605 178.215 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.7 mttt -58.28 -171.46 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 124.555 2.121 . . . . 0.0 112.289 175.276 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.72 HD23 ' C ' ' A' ' 41' ' ' GLY . 0.0 OUTLIER -81.25 159.31 68.01 Favored Pre-proline 0 C--N 1.311 -1.086 0 O-C-N 120.102 -1.624 . . . . 0.0 110.232 -178.788 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -70.28 161.97 44.04 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 121.357 1.371 . . . . 0.0 109.481 177.733 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.47 100.26 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.993 0.917 . . . . 0.0 110.825 176.305 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.41 83.15 1.69 Allowed Glycine 0 N--CA 1.462 0.402 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.148 -174.224 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.7 mmt-85 -165.35 165.27 19.5 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 124.542 1.137 . . . . 0.0 110.993 173.502 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 87.6 m -140.69 96.8 7.46 Favored Pre-proline 0 N--CA 1.465 0.291 0 O-C-N 124.91 1.381 . . . . 0.0 109.538 -176.836 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.505 ' HB3' HD21 ' A' ' 48' ' ' LEU . 19.5 Cg_endo -72.72 145.37 41.12 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.572 2.181 . . . . 0.0 110.291 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.3 mt -69.98 120.52 17.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.4 tmtt? -81.9 136.33 35.34 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 176.519 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -119.75 -48.7 2.36 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 123.808 0.843 . . . . 0.0 110.39 178.408 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 120.78 -2.92 11.98 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 125.053 1.311 . . . . 0.0 113.246 -175.123 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.46 134.65 39.38 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-N 118.459 1.129 . . . . 0.0 109.854 175.815 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.7 t -73.49 -2.05 20.99 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 125.427 1.704 . . . . 0.0 112.141 175.574 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -89.47 -51.42 5.55 Favored 'General case' 0 CA--C 1.509 -0.604 0 C-N-CA 124.936 1.294 . . . . 0.0 109.305 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.882 ' HA ' HD11 ' A' ' 80' ' ' LEU . 1.8 m -74.99 -35.4 62.04 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 124.5 1.125 . . . . 0.0 111.667 177.871 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -64.22 -30.24 71.31 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 124.086 0.866 . . . . 0.0 112.114 172.996 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.54 159.21 25.65 Favored Pre-proline 0 N--CA 1.449 -0.486 0 CA-C-O 121.739 0.78 . . . . 0.0 111.751 176.334 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -70.38 139.41 38.04 Favored 'Trans proline' 0 CA--C 1.546 1.12 0 C-N-CA 120.45 0.767 . . . . 0.0 113.202 174.692 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.425 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 19.7 Cg_endo -71.85 173.37 12.84 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 124.968 3.779 . . . . 0.0 111.671 178.252 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -134.99 47.92 2.32 Favored 'General case' 0 C--O 1.241 0.625 0 O-C-N 120.214 -1.554 . . . . 0.0 110.981 -177.908 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.465 ' HA ' ' OD2' ' A' ' 77' ' ' ASP . 56.5 t-80 -65.04 130.0 41.78 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 176.474 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.6 t -111.74 -93.7 0.45 Allowed 'General case' 0 N--CA 1.486 1.361 0 O-C-N 119.224 -2.173 . . . . 0.0 110.384 177.636 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.9 mptt -68.92 -175.01 0.66 Allowed 'General case' 0 C--O 1.219 -0.539 0 C-N-CA 124.93 1.292 . . . . 0.0 110.629 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -68.81 38.93 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 173.13 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.54 -105.89 0.19 Allowed Glycine 0 C--O 1.217 -0.955 0 N-CA-C 107.701 -2.159 . . . . 0.0 107.701 -177.979 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -110.2 -89.92 0.48 Allowed 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 125.928 2.775 . . . . 0.0 106.19 -175.435 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 119.62 -135.27 11.09 Favored Glycine 0 N--CA 1.448 -0.565 0 O-C-N 119.294 -2.128 . . . . 0.0 110.296 -174.932 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 72.8 mttt -66.32 -78.69 0.05 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.2 1.0 . . . . 0.0 110.017 -176.843 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.514 HG23 ' O ' ' A' ' 76' ' ' THR . 0.7 OUTLIER -128.17 31.44 5.06 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 118.454 -0.784 . . . . 0.0 111.635 178.726 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.465 ' OD2' ' HA ' ' A' ' 68' ' ' HIS . 20.3 t0 -30.51 89.33 0.0 OUTLIER 'General case' 0 C--O 1.221 -0.438 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -177.084 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -85.52 11.92 9.59 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 119.681 -1.887 . . . . 0.0 109.322 -169.898 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.486 ' CD2' ' CD1' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -49.71 170.03 0.03 OUTLIER 'General case' 0 N--CA 1.438 -1.053 0 CA-C-O 123.463 1.601 . . . . 0.0 112.316 173.378 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.882 HD11 ' HA ' ' A' ' 62' ' ' CYS . 0.5 OUTLIER -95.14 141.5 28.68 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 113.634 -1.621 . . . . 0.0 109.996 172.203 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.755 HD22 ' CZ ' ' A' ' 110' ' ' TYR . 0.2 OUTLIER -123.96 129.8 51.54 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 174.492 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.425 ' HB2' HD11 ' A' ' 109' ' ' ILE . 2.2 pm0 -91.47 164.25 13.87 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 122.689 1.233 . . . . 0.0 113.26 172.418 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.453 ' CE1' ' HB2' ' A' ' 23' ' ' ALA . 84.1 t80 -152.04 132.42 7.36 Favored Pre-proline 0 CA--C 1.533 0.321 0 O-C-N 120.319 -1.488 . . . . 0.0 112.836 179.275 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.448 ' HD3' ' CD1' ' A' ' 34' ' ' TYR . 19.3 Cg_endo -73.96 108.53 2.68 Favored 'Trans proline' 0 CA--C 1.506 -0.88 1 C-N-CA 125.498 4.132 . . . . 0.0 109.632 -176.794 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -109.03 110.12 21.32 Favored 'General case' 0 CA--C 1.509 -0.627 0 O-C-N 125.435 1.709 . . . . 0.0 109.638 -178.632 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -81.58 158.02 69.08 Favored Pre-proline 0 C--O 1.238 0.494 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.114 178.565 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -75.58 -38.21 1.45 Allowed 'Trans proline' 0 CA--C 1.507 -0.829 0 C-N-CA 122.172 1.915 . . . . 0.0 112.224 179.29 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -45.73 -30.98 1.78 Allowed 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 123.977 1.846 . . . . 0.0 110.534 177.496 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.448 ' HA3' ' CE ' ' A' ' 15' ' ' LYS . . . 84.63 -0.44 89.21 Favored Glycine 0 N--CA 1.435 -1.368 0 CA-C-N 114.733 -1.121 . . . . 0.0 112.875 179.071 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -62.7 131.14 47.94 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 175.853 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -57.08 96.41 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 170.696 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.523 ' CD2' ' HB3' ' A' ' 94' ' ' PHE . 6.1 t80 -41.65 143.88 0.45 Allowed 'General case' 0 C--O 1.217 -0.633 0 C-N-CA 123.584 0.754 . . . . 0.0 109.532 178.736 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 12.5 ptpt -75.18 61.36 1.13 Allowed 'General case' 0 C--N 1.316 -0.88 0 O-C-N 119.696 -1.877 . . . . 0.0 109.096 173.528 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.523 ' HB3' ' CD2' ' A' ' 92' ' ' TYR . 36.3 p90 -75.8 -4.1 38.75 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 115.999 -1.953 . . . . 0.0 112.061 173.838 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -105.71 -26.1 11.95 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 120.417 1.462 . . . . 0.0 111.154 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 6.0 m -102.1 106.59 17.48 Favored 'General case' 0 CA--C 1.503 -0.839 0 O-C-N 120.574 -1.329 . . . . 0.0 108.8 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.8 ptpt -70.75 -32.74 70.0 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.424 0.631 . . . . 0.0 112.3 175.152 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 99' ' ' PRO . 29.7 tttt -129.5 113.82 18.09 Favored Pre-proline 0 CA--C 1.538 0.5 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -178.477 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.431 ' HA ' ' HA ' ' A' ' 98' ' ' LYS . 18.4 Cg_endo -71.4 174.09 47.4 Favored 'Cis proline' 0 C--O 1.221 -0.331 0 C-N-CA 123.82 -1.325 . . . . 0.0 111.066 -3.798 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.415 ' HE2' ' CA ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -133.63 128.38 34.98 Favored 'General case' 0 CA--C 1.502 -0.891 0 C-N-CA 124.6 1.16 . . . . 0.0 109.694 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -98.96 134.14 42.23 Favored 'General case' 0 C--O 1.244 0.769 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 -178.434 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -43.42 132.22 3.61 Favored Pre-proline 0 CA--C 1.534 0.354 0 O-C-N 124.264 0.977 . . . . 0.0 110.615 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -68.39 -163.94 0.1 OUTLIER 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 122.761 2.307 . . . . 0.0 111.623 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -123.48 161.18 17.89 Favored Glycine 0 CA--C 1.525 0.663 0 O-C-N 121.128 -0.982 . . . . 0.0 111.992 176.651 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -73.22 -43.28 0.74 Allowed 'Trans proline' 0 N--CA 1.449 -1.122 0 C-N-CA 121.711 1.608 . . . . 0.0 109.433 177.199 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.519 ' HA ' ' HB2' ' A' ' 122' ' ' ALA . . . -80.38 134.07 35.98 Favored 'General case' 0 N--CA 1.448 -0.555 0 O-C-N 124.329 1.018 . . . . 0.0 110.849 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 4.9 mtm-85 -140.35 150.22 43.68 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.569 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.441 ' C ' HD12 ' A' ' 109' ' ' ILE . 2.6 p -89.15 118.78 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 O-C-N 124.527 1.142 . . . . 0.0 111.469 177.893 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.59 HG12 HD13 ' A' ' 121' ' ' ILE . 1.4 mp -107.3 118.16 54.49 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.809 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 -172.399 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.755 ' CZ ' HD22 ' A' ' 81' ' ' LEU . 5.1 p90 -138.3 151.43 47.58 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-O 122.482 1.134 . . . . 0.0 108.032 -178.32 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.6 p -84.16 160.74 20.8 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.79 -1.095 . . . . 0.0 109.709 177.925 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.519 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -107.47 155.8 38.94 Favored Pre-proline 0 CA--C 1.555 1.14 0 CA-C-O 121.515 0.674 . . . . 0.0 110.639 178.956 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.519 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 14.9 Cg_endo -74.5 -48.94 0.25 Allowed 'Cis proline' 0 CA--C 1.506 -0.878 0 C-N-CA 124.475 -1.052 . . . . 0.0 110.574 -8.407 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -49.09 107.67 0.15 Allowed 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 117.171 -1.395 . . . . 0.0 108.96 177.578 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.416 ' CG ' ' CD1' ' A' ' 110' ' ' TYR . 0.1 OUTLIER -64.02 78.38 0.03 OUTLIER 'General case' 0 CA--C 1.508 -0.673 0 C-N-CA 125.724 1.61 . . . . 0.0 108.274 -177.965 . . . . . . . . 3 3 . 1 . 009 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.436 ' O ' HG12 ' A' ' 116' ' ' VAL . 18.8 t -79.6 71.97 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 104.19 -2.522 . . . . 0.0 104.19 -176.869 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -40.42 105.14 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.561 1.544 . . . . 0.0 109.036 177.588 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -82.86 -40.46 20.26 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-O 122.417 1.103 . . . . 0.0 109.204 -179.471 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.438 ' HA2' ' CH2' ' A' ' 4' ' ' TRP . . . 162.56 -148.3 15.16 Favored Glycine 0 N--CA 1.435 -1.378 0 N-CA-C 109.811 -1.315 . . . . 0.0 109.811 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.498 HG13 ' CG ' ' A' ' 4' ' ' TRP . 1.3 mm -129.57 141.98 45.09 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.382 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 -175.023 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.59 HD13 HG12 ' A' ' 109' ' ' ILE . 4.7 pt -127.96 154.77 38.93 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 -175.445 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.729 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . . . . . . . . 0 C--N 1.325 -0.491 0 CA-C-O 121.397 0.617 . . . . 0.0 109.342 178.764 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.506 -0.739 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 . . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.426 HD12 HG22 ' A' ' 121' ' ' ILE . 12.0 tp -83.45 143.93 29.93 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 124.474 1.109 . . . . 0.0 108.577 178.558 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 134' ' ' CYS . . . . . 0.415 ' SG ' HG22 ' A' ' 120' ' ' ILE . 71.5 m -65.68 -175.13 0.25 Allowed 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 122.888 1.327 . . . . 0.0 111.165 173.189 . . . . . . . . 2 2 . 1 . 009 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 18.6 p -131.78 96.33 3.92 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -177.905 . . . . . . . . 1 1 . 1 . 009 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.548 ' CE1' ' CH2' ' A' ' 4' ' ' TRP . 27.9 p-80 . . . . . 0 C--O 1.246 0.913 0 CA-C-O 115.346 -2.264 . . . . 0.0 112.86 172.697 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 N--CA 1.447 -0.619 0 CA-C-O 120.687 0.28 . . . . 0.0 110.791 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.862 HG21 HD23 ' A' ' 10' ' ' LEU . 1.8 m -87.36 115.45 24.78 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 123.148 0.579 . . . . 0.0 111.071 178.935 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 14.5 m95 -83.1 140.58 32.56 Favored 'General case' 0 C--O 1.213 -0.858 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 m -124.55 133.84 53.17 Favored 'General case' 0 C--N 1.309 -1.155 0 O-C-N 120.478 -1.389 . . . . 0.0 108.787 -177.993 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.618 ' HB3' ' HB3' ' A' ' 122' ' ' ALA . 3.7 m -120.79 56.89 0.99 Allowed 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 118.215 -0.898 . . . . 0.0 109.273 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 39.64 60.62 1.73 Allowed Glycine 0 C--N 1.345 1.043 0 O-C-N 124.648 1.218 . . . . 0.0 112.088 -178.533 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 178.74 -81.57 0.06 OUTLIER Glycine 0 C--N 1.334 0.467 0 N-CA-C 110.881 -0.887 . . . . 0.0 110.881 -177.96 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.9 mt -123.97 160.11 28.32 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.45 0.643 . . . . 0.0 109.827 178.602 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.862 HD23 HG21 ' A' ' 3' ' ' THR . 9.0 mp -90.47 132.78 35.47 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 -177.78 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.669 ' CZ ' ' HB3' ' A' ' 106' ' ' ALA . 65.4 m-85 -116.43 91.08 3.48 Favored 'General case' 0 N--CA 1.433 -1.279 0 C-N-CA 127.826 2.45 . . . . 0.0 109.213 -175.838 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -56.01 127.02 28.42 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-O 117.52 -1.229 . . . . 0.0 108.514 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.456 ' OE1' ' CZ ' ' A' ' 117' ' ' PHE . 2.1 tp60 -50.38 -50.58 51.05 Favored 'General case' 0 C--O 1.209 -1.063 0 CA-C-O 116.752 -1.594 . . . . 0.0 110.682 -179.227 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.418 ' O ' ' CB ' ' A' ' 18' ' ' SER . 11.2 t-20 -47.45 -38.48 13.66 Favored 'General case' 0 C--O 1.191 -2.011 0 O-C-N 124.633 1.208 . . . . 0.0 110.232 177.771 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.25 -51.43 24.62 Favored 'General case' 0 C--O 1.2 -1.52 0 CA-C-O 116.687 -1.625 . . . . 0.0 113.376 170.25 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.597 ' HB1' HD11 ' A' ' 120' ' ' ILE . . . -48.59 -34.63 11.91 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 121.583 1.992 . . . . 0.0 112.687 173.677 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -89.91 -44.04 10.17 Favored 'General case' 0 N--CA 1.435 -1.183 0 C-N-CA 123.659 0.784 . . . . 0.0 109.68 177.737 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.418 ' CB ' ' O ' ' A' ' 14' ' ' ASN . 30.8 t -64.58 -25.65 68.06 Favored 'General case' 0 C--O 1.205 -1.242 0 C-N-CA 126.492 1.917 . . . . 0.0 106.787 -177.438 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -73.6 -53.37 10.64 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 119.153 -2.217 . . . . 0.0 108.711 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.26 -12.47 61.17 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 122.08 0.943 . . . . 0.0 111.626 177.803 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -62.28 -50.76 70.4 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 -176.412 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -74.03 -41.28 62.05 Favored 'General case' 0 N--CA 1.443 -0.8 0 O-C-N 124.418 1.074 . . . . 0.0 110.091 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.706 ' HB2' ' CZ ' ' A' ' 83' ' ' PHE . . . -41.64 129.54 2.38 Favored Pre-proline 0 N--CA 1.445 -0.699 0 O-C-N 125.644 1.84 . . . . 0.0 111.332 178.384 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.486 ' HG2' ' CG2' ' A' ' 30' ' ' THR . 18.2 Cg_endo -73.03 126.57 11.33 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 121.923 1.748 . . . . 0.0 109.573 -177.161 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.876 HD21 ' O ' ' A' ' 113' ' ' PRO . 4.1 tp -59.79 88.65 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.434 0 O-C-N 124.143 0.902 . . . . 0.0 111.19 178.861 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -175.88 167.12 3.08 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -176.163 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -115.19 132.34 56.64 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 117.704 -1.141 . . . . 0.0 109.579 177.612 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 50.71 62.0 5.59 Favored Glycine 0 C--N 1.34 0.796 0 N-CA-C 108.254 -1.938 . . . . 0.0 108.254 172.136 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -151.55 35.68 0.57 Allowed 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 122.304 1.05 . . . . 0.0 110.685 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.486 ' CG2' ' HG2' ' A' ' 24' ' ' PRO . 9.2 p -144.23 153.06 41.67 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -175.65 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.425 ' CA ' ' HB3' ' A' ' 97' ' ' LYS . . . -36.64 -78.33 0.04 OUTLIER Glycine 0 C--N 1.34 0.776 0 O-C-N 124.307 1.005 . . . . 0.0 111.314 -178.92 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.462 ' O ' ' HE3' ' A' ' 100' ' ' LYS . 30.8 t -52.41 -61.52 2.23 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-O 117.681 -1.152 . . . . 0.0 110.669 177.921 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 162.04 -51.86 0.0 OUTLIER 'General case' 0 C--O 1.218 -0.592 0 O-C-N 125.521 1.763 . . . . 0.0 110.421 179.124 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.518 ' CD2' ' HD3' ' A' ' 84' ' ' PRO . 61.6 m-85 -61.82 151.33 79.73 Favored Pre-proline 0 N--CA 1.43 -1.474 0 CA-C-O 117.13 -1.414 . . . . 0.0 111.511 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.489 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 22.7 Cg_endo -73.76 164.41 87.48 Favored 'Cis proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.032 -2.07 . . . . 0.0 111.931 -3.453 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -140.95 162.87 34.45 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-O 116.897 -1.525 . . . . 0.0 110.6 -178.345 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.728 ' CH2' HG22 ' A' ' 39' ' ' THR . 18.2 t90 -60.69 139.26 57.93 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 124.143 0.902 . . . . 0.0 108.772 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.665 ' CE2' HG21 ' A' ' 109' ' ' ILE . 25.7 t80 -110.98 79.02 1.16 Allowed 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 -176.123 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.728 HG22 ' CH2' ' A' ' 37' ' ' TRP . 23.6 p -37.79 -34.57 0.11 Allowed 'General case' 0 C--O 1.214 -0.782 0 C-N-CA 124.265 1.026 . . . . 0.0 110.778 175.171 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.55 ' HB2' ' CD2' ' A' ' 38' ' ' PHE . 43.4 t30 57.63 19.25 5.28 Favored 'General case' 0 C--O 1.209 -1.068 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 174.688 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.805 ' C ' HD23 ' A' ' 48' ' ' LEU . . . 112.49 -46.94 1.1 Allowed Glycine 0 N--CA 1.421 -2.364 0 O-C-N 118.682 -2.511 . . . . 0.0 112.353 -171.808 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.659 ' N ' HD23 ' A' ' 48' ' ' LEU . 58.2 m-85 -49.63 144.87 5.55 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 124.285 1.034 . . . . 0.0 110.372 -177.314 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.78 -35.79 26.21 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.214 178.362 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -164.13 -100.32 0.15 Allowed Glycine 0 N--CA 1.442 -0.906 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.89 175.98 8.33 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 118.111 -0.947 . . . . 0.0 109.778 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.422 ' O ' ' HD2' ' A' ' 66' ' ' PRO . . . 38.51 -156.93 0.01 OUTLIER Glycine 0 C--N 1.349 1.264 0 CA-C-O 123.14 1.411 . . . . 0.0 112.08 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.487 ' HA ' ' CE1' ' A' ' 42' ' ' TYR . 0.8 OUTLIER -65.11 -172.17 0.09 Allowed 'General case' 0 N--CA 1.444 -0.737 0 O-C-N 120.267 -1.726 . . . . 0.0 111.727 174.869 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.88 HD22 ' HB3' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -87.93 174.76 4.84 Favored Pre-proline 0 N--CA 1.441 -0.924 0 O-C-N 120.51 -1.369 . . . . 0.0 109.109 -178.774 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -73.92 -175.7 2.26 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 122.335 2.023 . . . . 0.0 111.734 178.305 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.4 tttt -67.47 94.89 0.43 Allowed 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 121.134 -0.979 . . . . 0.0 109.751 177.57 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.47 91.3 1.73 Allowed Glycine 0 CA--C 1.5 -0.866 0 CA-C-O 118.807 -0.996 . . . . 0.0 110.885 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.88 ' HB3' HD22 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -177.11 155.94 1.22 Allowed 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 123.767 0.827 . . . . 0.0 110.58 177.661 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.1 m -141.33 98.31 6.66 Favored Pre-proline 0 C--N 1.327 -0.39 0 O-C-N 124.374 1.046 . . . . 0.0 110.763 -178.536 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -71.23 177.46 6.57 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 122.24 1.96 . . . . 0.0 112.024 179.061 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.41 ' CG2' ' HB2' ' A' ' 133' ' ' LEU . 5.4 mt -97.96 136.64 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -179.228 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 56' ' ' LYS . . . . . 0.543 ' O ' HD22 ' A' ' 133' ' ' LEU . 0.1 OUTLIER -91.43 155.25 18.59 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 177.697 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.606 ' CE2' HD13 ' A' ' 133' ' ' LEU . 9.4 m-85 -140.26 -47.72 0.44 Allowed 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 123.765 0.826 . . . . 0.0 111.046 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 119.73 -3.72 13.27 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 116.284 -0.416 . . . . 0.0 112.148 -177.852 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -95.73 134.73 38.32 Favored 'General case' 0 CA--C 1.501 -0.925 0 CA-C-O 118.096 -0.954 . . . . 0.0 108.708 -179.138 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.7 t -72.15 -5.33 34.77 Favored 'General case' 0 C--O 1.221 -0.428 0 O-C-N 124.971 1.419 . . . . 0.0 111.581 177.21 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.683 ' HB2' HG21 ' A' ' 111' ' ' THR . 0.0 OUTLIER -91.92 -51.0 5.42 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 -177.398 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.812 ' HA ' HD11 ' A' ' 80' ' ' LEU . 1.9 m -75.15 -37.52 61.32 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -178.423 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -59.91 -41.63 92.13 Favored 'General case' 0 C--N 1.343 0.305 0 CA-C-O 121.927 0.87 . . . . 0.0 109.857 176.861 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -49.41 160.69 0.53 Allowed Pre-proline 0 N--CA 1.439 -1.024 0 CA-C-O 122.672 1.225 . . . . 0.0 110.177 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -75.21 144.84 30.04 Favored 'Trans proline' 0 N--CA 1.441 -1.592 0 C-N-CA 120.99 1.126 . . . . 0.0 113.231 175.115 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.514 ' HG3' ' CD2' ' A' ' 42' ' ' TYR . 21.0 Cg_endo -75.25 168.75 23.97 Favored 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 123.584 2.856 . . . . 0.0 111.443 178.786 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.1 tptt -132.22 52.18 2.09 Favored 'General case' 0 C--O 1.207 -1.17 0 CA-C-O 117.683 -1.151 . . . . 0.0 108.899 -178.419 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.454 ' CE1' ' O ' ' A' ' 70' ' ' LYS . 49.0 t-80 -83.84 158.56 21.63 Favored 'General case' 0 C--O 1.216 -0.672 0 CA-C-N 119.048 0.84 . . . . 0.0 110.011 179.074 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -175.71 -36.23 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.6 0.76 . . . . 0.0 109.658 173.455 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 70' ' ' LYS . . . . . 0.454 ' O ' ' CE1' ' A' ' 68' ' ' HIS . 0.0 OUTLIER -81.39 -171.51 3.32 Favored 'General case' 0 C--O 1.212 -0.909 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 178.389 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -82.69 36.34 0.49 Allowed 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 122.038 0.923 . . . . 0.0 111.827 177.067 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.427 ' O ' ' CE2' ' A' ' 79' ' ' TYR . . . 159.82 -83.67 0.13 Allowed Glycine 0 N--CA 1.44 -1.06 0 O-C-N 120.009 -1.682 . . . . 0.0 111.051 -177.045 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.54 ' ND2' ' CE1' ' A' ' 79' ' ' TYR . 17.2 t-20 -143.73 75.89 1.49 Allowed 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 117.436 -1.269 . . . . 0.0 108.548 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 74' ' ' GLY . . . . . 0.414 ' CA ' ' HB2' ' A' ' 70' ' ' LYS . . . -33.52 -94.89 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 119.517 1.053 . . . . 0.0 114.719 176.168 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.2 mttm -85.16 -108.88 0.05 OUTLIER 'General case' 0 C--O 1.216 -0.685 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.436 176.795 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.605 HG23 ' O ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -101.55 21.8 13.72 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 123.892 0.877 . . . . 0.0 111.046 -179.949 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.435 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 5.6 m-20 -30.25 104.56 0.03 OUTLIER 'General case' 0 C--O 1.19 -2.035 0 C-N-CA 124.292 1.037 . . . . 0.0 111.576 -177.529 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.456 ' CD2' ' H ' ' A' ' 78' ' ' HIS . 0.5 OUTLIER -80.76 10.69 4.59 Favored 'General case' 0 C--N 1.314 -0.951 0 O-C-N 118.081 -2.887 . . . . 0.0 110.824 -177.206 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.862 ' CZ ' HD21 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -38.37 141.01 0.27 Allowed 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 115.65 1.722 . . . . 0.0 115.65 172.948 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.812 HD11 ' HA ' ' A' ' 62' ' ' CYS . 0.2 OUTLIER -76.68 158.49 30.98 Favored 'General case' 0 C--N 1.317 -0.811 0 O-C-N 120.101 -1.624 . . . . 0.0 110.237 178.291 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.862 HD21 ' CZ ' ' A' ' 79' ' ' TYR . 1.3 mt -140.31 133.75 29.98 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.3 pm0 -101.65 151.69 21.71 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-O 122.489 1.138 . . . . 0.0 108.906 -178.549 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.706 ' CZ ' ' HB2' ' A' ' 23' ' ' ALA . 7.8 t80 -141.84 132.44 12.92 Favored Pre-proline 0 N--CA 1.44 -0.969 0 O-C-N 121.33 -0.856 . . . . 0.0 111.989 -179.11 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.518 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 18.6 Cg_endo -74.47 93.74 0.92 Allowed 'Trans proline' 0 N--CA 1.449 -1.145 0 C-N-CA 123.657 2.905 . . . . 0.0 110.264 -177.933 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.3 t -93.34 119.33 32.35 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 122.437 1.113 . . . . 0.0 111.028 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.645 ' CD2' ' CE1' ' A' ' 90' ' ' HIS . 25.1 m-85 -84.43 151.83 59.82 Favored Pre-proline 0 N--CA 1.438 -1.067 0 O-C-N 121.005 -1.059 . . . . 0.0 111.029 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -78.06 -42.46 0.24 Allowed 'Trans proline' 0 CA--C 1.503 -1.073 0 C-N-CA 122.291 1.994 . . . . 0.0 112.718 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -42.9 -33.33 0.76 Allowed 'General case' 0 C--N 1.348 0.533 0 O-C-N 126.032 2.082 . . . . 0.0 110.161 176.273 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 99.92 16.34 28.56 Favored Glycine 0 N--CA 1.432 -1.6 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 178.541 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.645 ' CE1' ' CD2' ' A' ' 86' ' ' PHE . 2.0 p-80 -87.93 131.16 34.7 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.82 100.67 1.96 Allowed 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 176.18 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.483 ' O ' ' CD2' ' A' ' 94' ' ' PHE . 19.9 t80 -35.77 140.74 0.1 Allowed 'General case' 0 C--O 1.205 -1.271 0 CA-C-O 122.051 0.929 . . . . 0.0 112.172 177.473 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.406 ' CE ' ' HB2' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -77.91 61.69 2.57 Favored 'General case' 0 C--N 1.315 -0.892 0 O-C-N 119.032 -2.293 . . . . 0.0 109.418 178.648 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.483 ' CD2' ' O ' ' A' ' 92' ' ' TYR . 30.4 p90 -76.07 4.13 9.08 Favored 'General case' 0 N--CA 1.439 -1.025 0 C-N-CA 124.077 0.951 . . . . 0.0 111.832 177.016 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -104.45 -33.3 8.64 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-O 122.578 1.18 . . . . 0.0 109.242 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 14.3 m -98.54 95.79 7.53 Favored 'General case' 0 CA--C 1.506 -0.725 0 O-C-N 120.554 -1.341 . . . . 0.0 107.915 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.425 ' HB3' ' CA ' ' A' ' 31' ' ' GLY . 0.1 OUTLIER -73.48 -35.39 65.67 Favored 'General case' 0 C--O 1.22 -0.448 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 177.27 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -119.56 105.77 43.21 Favored Pre-proline 0 N--CA 1.437 -1.121 0 O-C-N 120.006 -1.684 . . . . 0.0 109.451 -179.355 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.415 ' HA ' ' HA ' ' A' ' 98' ' ' LYS . 24.1 Cg_endo -73.88 172.14 63.0 Favored 'Cis proline' 0 C--O 1.213 -0.737 0 O-C-N 124.416 1.745 . . . . 0.0 112.039 -1.84 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.462 ' HE3' ' O ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -118.2 127.32 53.64 Favored 'General case' 0 CA--C 1.511 -0.54 0 C-N-CA 123.408 0.683 . . . . 0.0 109.544 -178.798 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.406 ' HB2' ' CE ' ' A' ' 93' ' ' LYS . 9.2 tp10 -82.34 149.76 27.57 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.857 1.348 . . . . 0.0 110.218 178.927 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -51.31 139.25 26.57 Favored Pre-proline 0 N--CA 1.43 -1.448 0 CA-C-O 122.364 1.078 . . . . 0.0 112.546 172.258 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -73.61 -164.22 0.19 Allowed 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 121.689 1.593 . . . . 0.0 111.885 177.741 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -140.14 158.94 26.02 Favored Glycine 0 N--CA 1.441 -0.986 0 O-C-N 121.338 -0.851 . . . . 0.0 112.368 177.038 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -74.88 -62.56 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.471 2.114 . . . . 0.0 110.867 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.669 ' HB3' ' CZ ' ' A' ' 11' ' ' TYR . . . -67.57 133.88 50.23 Favored 'General case' 0 N--CA 1.436 -1.174 0 O-C-N 123.868 0.73 . . . . 0.0 110.488 179.017 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.42 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 0.0 OUTLIER -140.33 147.03 39.25 Favored 'General case' 0 CA--C 1.498 -1.039 0 CA-C-O 117.206 -1.378 . . . . 0.0 111.51 178.766 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.525 ' C ' HD12 ' A' ' 109' ' ' ILE . 3.2 p -83.24 120.14 33.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 C-N-CA 124.221 1.008 . . . . 0.0 110.985 177.775 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.665 HG21 ' CE2' ' A' ' 38' ' ' PHE . 1.7 mp -105.84 124.35 60.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 -175.975 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.553 ' C ' HD23 ' A' ' 80' ' ' LEU . 19.3 p90 -142.27 164.2 30.78 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-O 121.661 0.743 . . . . 0.0 111.074 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.683 HG21 ' HB2' ' A' ' 61' ' ' ASP . 1.6 p -91.88 163.67 13.95 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -177.804 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.553 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.2 OUTLIER -117.04 152.22 48.52 Favored Pre-proline 0 N--CA 1.434 -1.226 0 C-N-CA 123.292 0.637 . . . . 0.0 110.646 -179.72 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.876 ' O ' HD21 ' A' ' 25' ' ' LEU . 19.1 Cg_endo -73.48 -51.68 0.16 OUTLIER 'Cis proline' 0 CA--C 1.51 -0.717 0 C-N-CA 122.252 -1.978 . . . . 0.0 109.484 -5.441 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -41.64 111.69 0.25 Allowed 'General case' 0 N--CA 1.438 -1.064 0 CA-C-O 113.612 -3.089 . . . . 0.0 110.012 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.733 ' CE ' HD13 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -65.76 68.89 0.05 OUTLIER 'General case' 0 CA--C 1.508 -0.669 0 O-C-N 127.12 2.763 . . . . 0.0 108.562 -178.707 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.578 ' O ' HG12 ' A' ' 116' ' ' VAL . 24.2 t -74.29 64.28 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 106.028 -1.842 . . . . 0.0 106.028 -177.623 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.551 ' CZ ' ' HA2' ' A' ' 119' ' ' GLY . 2.0 t80 -36.71 124.65 0.85 Allowed 'General case' 0 N--CA 1.432 -1.347 0 O-C-N 120.61 -1.306 . . . . 0.0 108.946 178.949 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 118' ' ' CYS . . . . . 0.568 ' HB3' ' CD2' ' A' ' 57' ' ' PHE . 0.1 OUTLIER -101.41 -38.23 8.1 Favored 'General case' 0 N--CA 1.439 -1.008 0 O-C-N 123.836 0.71 . . . . 0.0 109.383 177.29 . . . . . . . . 3 3 . 1 . 010 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.551 ' HA2' ' CZ ' ' A' ' 117' ' ' PHE . . . 158.68 -159.9 30.61 Favored Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 -178.602 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.634 HG22 ' SG ' ' A' ' 134' ' ' CYS . 3.4 mp -117.91 145.4 23.86 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.349 0 CA-C-O 117.383 -1.294 . . . . 0.0 107.947 -178.12 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.537 HD13 ' CE1' ' A' ' 38' ' ' PHE . 6.6 pt -110.27 158.5 10.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-N 120.959 1.708 . . . . 0.0 109.101 178.008 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.618 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . . . . . . . . 0 N--CA 1.44 -0.946 0 C-N-CA 124.063 0.945 . . . . 0.0 109.648 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 11.4 ptpt . . . . . 0 CA--C 1.505 -0.786 0 CA-C-O 118.521 -0.752 . . . . 0.0 109.975 . . . . . . . . . 0 0 . 1 . 010 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.606 HD13 ' CE2' ' A' ' 57' ' ' PHE . 9.7 tp -83.99 139.71 32.37 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.17 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 134' ' ' CYS . . . . . 0.634 ' SG ' HG22 ' A' ' 120' ' ' ILE . 72.1 m -58.98 -174.37 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.913 0 CA-C-O 124.124 1.916 . . . . 0.0 108.594 177.389 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.38 120.85 0.96 Allowed 'General case' 0 C--N 1.314 -0.949 0 O-C-N 120.057 -1.652 . . . . 0.0 108.575 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 1.8 m80 . . . . . 0 C--O 1.253 1.255 0 CA-C-O 115.143 -2.36 . . . . 0.0 111.847 177.212 . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.446 HG11 ' HD2' ' A' ' 136' ' ' HIS . 5.2 p . . . . . 0 C--O 1.234 0.237 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 . . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.811 HG23 HD23 ' A' ' 10' ' ' LEU . 0.9 OUTLIER -85.65 117.54 24.6 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.693 177.468 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 4' ' ' TRP . . . . . 0.601 ' CH2' ' CE1' ' A' ' 136' ' ' HIS . 26.9 m95 -85.02 140.76 30.78 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.036 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -136.05 132.87 36.78 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -176.908 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.676 ' SG ' ' HB3' ' A' ' 122' ' ' ALA . 0.5 OUTLIER -119.05 69.39 0.81 Allowed 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.651 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 34.79 86.65 0.01 OUTLIER Glycine 0 CA--C 1.53 0.983 0 C-N-CA 124.037 0.827 . . . . 0.0 113.648 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 147.78 -74.05 0.29 Allowed Glycine 0 N--CA 1.462 0.403 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 -176.855 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.441 HD13 ' HG3' ' A' ' 87' ' ' PRO . 5.7 mt -131.16 160.18 35.53 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.243 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.811 HD23 HG23 ' A' ' 3' ' ' THR . 0.0 OUTLIER -102.27 154.74 18.76 Favored 'General case' 0 C--O 1.218 -0.597 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.442 178.116 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.638 ' CZ ' ' HB3' ' A' ' 106' ' ' ALA . 30.6 m-85 -134.59 108.84 8.28 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -178.277 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -55.89 120.2 7.02 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 177.649 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.493 ' HB2' ' CD1' ' A' ' 4' ' ' TRP . 8.4 tp-100 -54.8 -42.01 71.28 Favored 'General case' 0 CA--C 1.503 -0.846 0 C-N-CA 119.959 -0.697 . . . . 0.0 112.387 178.822 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -50.35 -26.05 4.49 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 124.029 0.831 . . . . 0.0 112.306 177.379 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.2 mttp -96.36 -34.25 11.63 Favored 'General case' 0 C--O 1.219 -0.503 0 C-N-CA 124.569 1.148 . . . . 0.0 112.49 170.957 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.02 -39.52 69.2 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 120.406 1.457 . . . . 0.0 111.851 176.31 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -87.38 -44.56 11.27 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 122.962 0.505 . . . . 0.0 110.204 175.125 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.2 t -69.21 -57.67 5.06 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 118.959 0.799 . . . . 0.0 112.292 -177.982 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.529 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 0.2 OUTLIER -44.89 -30.97 1.1 Allowed 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 170.939 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.432 ' O ' ' HB3' ' A' ' 23' ' ' ALA . 1.5 p -83.64 -33.34 25.3 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 175.56 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -47.84 -36.79 12.53 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.037 0.935 . . . . 0.0 109.919 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.529 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.1 OUTLIER -70.17 -47.96 59.36 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 124.577 1.151 . . . . 0.0 110.573 177.87 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.507 ' HB1' ' HG3' ' A' ' 35' ' ' PRO . . . -39.61 127.21 1.46 Allowed Pre-proline 0 CA--C 1.537 0.447 0 O-C-N 124.602 1.189 . . . . 0.0 110.606 176.364 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.568 ' HG2' HG22 ' A' ' 30' ' ' THR . 18.7 Cg_endo -72.79 124.69 9.9 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 121.546 1.497 . . . . 0.0 109.096 -177.774 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.726 HD21 ' O ' ' A' ' 113' ' ' PRO . 3.8 tp -60.78 94.36 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 123.542 0.737 . . . . 0.0 111.291 178.416 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 179.89 160.35 0.84 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.35 -174.949 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -99.86 116.18 31.33 Favored 'General case' 0 CA--C 1.51 -0.567 0 C-N-CA 123.826 0.85 . . . . 0.0 108.898 177.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 50.51 72.47 0.49 Allowed Glycine 0 CA--C 1.528 0.873 0 O-C-N 124.394 1.059 . . . . 0.0 112.426 176.481 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.17 22.03 1.55 Allowed 'General case' 0 N--CA 1.473 0.708 0 O-C-N 122.429 -0.453 . . . . 0.0 112.033 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.568 HG22 ' HG2' ' A' ' 24' ' ' PRO . 33.5 p -121.91 156.8 32.58 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -176.471 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -43.68 -52.01 6.63 Favored Glycine 0 C--N 1.332 0.337 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.989 -178.792 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 12.2 t -68.03 -79.48 0.05 Allowed 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 119.306 -0.378 . . . . 0.0 111.235 173.726 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 89.1 p -178.42 -59.05 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 124.803 1.241 . . . . 0.0 109.83 -178.863 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.534 ' CE1' ' HB3' ' A' ' 103' ' ' PRO . 81.6 m-85 -63.57 148.95 93.22 Favored Pre-proline 0 CA--C 1.552 1.022 0 C-N-CA 123.303 0.641 . . . . 0.0 112.375 -176.54 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.507 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 25.2 Cg_endo -74.9 169.77 73.56 Favored 'Cis proline' 0 N--CA 1.455 -0.736 0 O-C-N 123.524 1.276 . . . . 0.0 112.116 1.347 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.753 ' C ' HD23 ' A' ' 81' ' ' LEU . 1.4 p80 -142.5 169.22 17.98 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 -177.29 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.899 ' CH2' HG22 ' A' ' 39' ' ' THR . 20.5 t90 -71.65 129.22 38.16 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.399 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.517 ' CZ ' HD13 ' A' ' 121' ' ' ILE . 33.9 t80 -99.48 82.74 2.7 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 105.869 -1.901 . . . . 0.0 105.869 179.331 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.899 HG22 ' CH2' ' A' ' 37' ' ' TRP . 41.6 p -39.51 -33.5 0.17 Allowed 'General case' 0 CA--C 1.503 -0.845 0 CA-C-N 114.337 -1.301 . . . . 0.0 110.815 170.905 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.499 ' HB2' ' CE2' ' A' ' 38' ' ' PHE . 59.0 t30 55.63 20.13 3.7 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 123.558 1.646 . . . . 0.0 112.125 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.464 ' C ' HD23 ' A' ' 48' ' ' LEU . . . 110.08 -44.52 1.48 Allowed Glycine 0 N--CA 1.436 -1.331 0 CA-C-O 116.039 -2.534 . . . . 0.0 113.661 -170.959 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.518 ' CE2' ' HD3' ' A' ' 66' ' ' PRO . 76.9 m-85 -45.94 150.99 0.5 Allowed 'General case' 0 C--N 1.343 0.296 0 C-N-CA 125.779 1.631 . . . . 0.0 110.666 -178.728 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.4 -37.73 27.67 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.049 178.052 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.436 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -164.29 -77.66 0.03 OUTLIER Glycine 0 C--N 1.335 0.503 0 N-CA-C 111.189 -0.765 . . . . 0.0 111.189 -178.38 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -113.22 -62.78 1.54 Allowed 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 123.289 0.636 . . . . 0.0 111.377 -178.303 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.6 -169.85 0.11 Allowed Glycine 0 C--N 1.342 0.892 0 C-N-CA 124.408 1.004 . . . . 0.0 111.135 177.809 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.9 mtpt -59.53 -169.49 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 123.279 1.514 . . . . 0.0 111.701 176.728 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.631 ' H ' HD12 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -93.18 176.58 2.44 Favored Pre-proline 0 C--N 1.318 -0.783 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.309 -178.091 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -70.83 158.85 54.43 Favored 'Trans proline' 0 N--CA 1.444 -1.386 0 O-C-N 123.807 1.425 . . . . 0.0 110.967 178.276 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.4 ttpp -64.71 97.23 0.21 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.263 176.39 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 119.19 40.12 0.65 Allowed Glycine 0 N--CA 1.464 0.509 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.853 -177.208 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.451 ' NE ' ' HA2' ' A' ' 41' ' ' GLY . 0.2 OUTLIER -122.07 159.79 26.34 Favored 'General case' 0 CA--C 1.513 -0.471 0 C-N-CA 122.837 0.455 . . . . 0.0 110.703 175.761 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 53.3 m -136.03 98.9 11.42 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.621 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -72.37 179.19 5.28 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.668 2.245 . . . . 0.0 111.275 177.191 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.8 mt -107.17 140.48 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -95.89 146.45 24.57 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 121.533 0.682 . . . . 0.0 109.621 176.669 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.568 ' CD1' ' HB3' ' A' ' 118' ' ' CYS . 24.0 m-85 -128.59 -50.14 1.27 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.263 1.025 . . . . 0.0 110.77 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 117.28 -3.18 18.57 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 123.742 0.687 . . . . 0.0 112.657 -175.135 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.98 133.33 42.6 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-N 117.759 0.779 . . . . 0.0 109.818 177.381 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 46.3 t -69.4 -6.09 27.79 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 124.749 1.281 . . . . 0.0 111.551 176.773 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.48 -57.16 2.98 Favored 'General case' 0 CA--C 1.517 -0.318 0 O-C-N 120.651 -1.28 . . . . 0.0 109.367 -178.58 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.502 ' SG ' HD21 ' A' ' 80' ' ' LEU . 2.1 t -68.9 -25.91 64.83 Favored 'General case' 0 N--CA 1.457 -0.107 0 O-C-N 124.492 1.12 . . . . 0.0 110.806 176.522 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -70.86 -38.45 73.14 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.367 0.603 . . . . 0.0 110.618 174.576 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.408 ' HD2' ' ND1' ' A' ' 78' ' ' HIS . 0.0 OUTLIER -55.44 158.16 6.05 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-O 122.163 0.982 . . . . 0.0 111.745 179.787 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -70.78 140.85 39.74 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 120.309 0.673 . . . . 0.0 113.029 175.751 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.518 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 19.3 Cg_endo -71.77 172.26 14.83 Favored 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 122.73 2.287 . . . . 0.0 111.514 177.896 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -134.18 54.67 1.93 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.899 178.721 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.441 ' CE1' ' O ' ' A' ' 69' ' ' SER . 49.9 t-80 -77.95 156.44 30.24 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 121.669 0.747 . . . . 0.0 110.249 -178.804 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.441 ' O ' ' CE1' ' A' ' 68' ' ' HIS . 0.2 OUTLIER -142.95 -166.02 2.2 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 121.251 -0.906 . . . . 0.0 110.568 179.047 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.6 72.51 10.3 Favored 'General case' 0 C--O 1.219 -0.535 0 O-C-N 121.894 -0.504 . . . . 0.0 110.647 176.619 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -178.58 -41.37 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.61 0.719 . . . . 0.0 110.563 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.409 ' O ' ' CE2' ' A' ' 79' ' ' TYR . . . 118.73 -48.18 0.96 Allowed Glycine 0 CA--C 1.499 -0.948 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.206 -177.149 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -147.56 85.17 1.57 Allowed 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 179.083 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -71.07 -119.35 0.05 OUTLIER Glycine 0 CA--C 1.529 0.909 0 CA-C-O 122.036 0.798 . . . . 0.0 111.807 177.119 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -52.79 -87.77 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.675 0 O-C-N 121.066 -1.255 . . . . 0.0 112.717 178.211 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.531 HG23 ' O ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -123.54 19.05 9.63 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.014 177.623 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.496 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 6.5 m-20 -32.18 105.18 0.03 OUTLIER 'General case' 0 CA--C 1.504 -0.815 0 C-N-CA 124.898 1.279 . . . . 0.0 109.15 -176.123 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.503 ' CD2' ' H ' ' A' ' 78' ' ' HIS . 3.2 p80 -88.42 18.43 4.51 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -175.987 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.964 ' CZ ' HD11 ' A' ' 81' ' ' LEU . 0.4 OUTLIER -40.15 135.25 1.42 Allowed 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 125.419 1.488 . . . . 0.0 110.948 173.804 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.687 HD23 ' C ' ' A' ' 110' ' ' TYR . 0.4 OUTLIER -75.45 155.37 36.34 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.851 176.113 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.964 HD11 ' CZ ' ' A' ' 79' ' ' TYR . 1.7 mp -140.69 150.49 43.54 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.883 0.373 . . . . 0.0 110.147 176.484 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.485 ' CB ' ' CD1' ' A' ' 109' ' ' ILE . 0.4 OUTLIER -115.76 157.53 24.2 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 122.009 0.909 . . . . 0.0 110.627 -179.699 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.493 ' HB3' HG12 ' A' ' 108' ' ' VAL . 30.3 t80 -139.99 133.76 15.46 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-O 118.698 -0.668 . . . . 0.0 112.204 -178.452 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.555 ' HA ' ' HG2' ' A' ' 107' ' ' ARG . 17.8 Cg_endo -70.03 87.71 0.58 Allowed 'Trans proline' 0 CA--C 1.505 -0.956 0 C-N-CA 123.937 3.091 . . . . 0.0 110.72 -174.706 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.64 HG22 ' HA ' ' A' ' 107' ' ' ARG . 2.7 t -83.5 129.02 34.96 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 124.237 0.961 . . . . 0.0 110.902 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.648 ' CD1' ' CD1' ' A' ' 92' ' ' TYR . 4.6 m-85 -96.54 152.34 38.55 Favored Pre-proline 0 C--O 1.237 0.395 0 C-N-CA 122.796 0.439 . . . . 0.0 110.203 -178.95 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 87' ' ' PRO . . . . . 0.441 ' HG3' HD13 ' A' ' 9' ' ' LEU . 18.8 Cg_endo -73.07 -47.74 0.31 Allowed 'Trans proline' 0 N--CA 1.447 -1.213 0 O-C-N 124.047 1.551 . . . . 0.0 112.266 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -42.74 -41.08 3.05 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 123.07 1.414 . . . . 0.0 110.278 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 94.85 18.0 36.17 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.146 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.437 ' O ' ' CE1' ' A' ' 92' ' ' TYR . 1.5 p80 -86.69 147.48 25.86 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-N 118.061 0.931 . . . . 0.0 109.601 176.526 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -63.92 139.82 58.81 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 118.642 0.655 . . . . 0.0 111.902 174.525 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.648 ' CD1' ' CD1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -96.18 146.97 24.23 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -174.608 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.21 69.05 9.85 Favored 'General case' 0 C--N 1.32 -0.696 0 O-C-N 121.371 -0.83 . . . . 0.0 110.08 175.478 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.441 ' CD2' ' HZ ' ' A' ' 83' ' ' PHE . 25.7 p90 -83.55 -23.58 31.96 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.113 177.743 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -91.17 -23.74 20.15 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 123.012 1.387 . . . . 0.0 110.924 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.15 108.9 18.53 Favored 'General case' 0 CA--C 1.517 -0.325 0 O-C-N 120.61 -1.306 . . . . 0.0 108.575 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.97 -48.2 82.69 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 121.609 0.719 . . . . 0.0 111.067 178.602 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 99' ' ' PRO . 0.3 OUTLIER -139.03 128.39 14.24 Favored Pre-proline 0 CA--C 1.543 0.7 0 CA-C-N 114.508 -1.223 . . . . 0.0 110.233 -178.995 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.438 ' HA ' ' HA ' ' A' ' 98' ' ' LYS . 25.9 Cg_endo -69.78 176.3 33.19 Favored 'Cis proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.789 -1.754 . . . . 0.0 111.527 -5.126 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -140.72 122.83 15.68 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 124.005 0.922 . . . . 0.0 109.092 178.803 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -87.6 162.32 17.22 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 125.47 1.731 . . . . 0.0 110.006 178.17 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -50.53 154.49 2.22 Favored Pre-proline 0 C--O 1.222 -0.382 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.116 177.646 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.534 ' HB3' ' CE1' ' A' ' 34' ' ' TYR . 20.5 Cg_endo -73.7 -87.39 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 121.096 1.197 . . . . 0.0 111.912 178.227 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 148.7 159.9 8.78 Favored Glycine 0 CA--C 1.524 0.654 0 O-C-N 121.146 -0.971 . . . . 0.0 110.905 -178.815 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -76.64 -73.17 0.01 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.725 2.284 . . . . 0.0 110.949 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.638 ' HB3' ' CZ ' ' A' ' 11' ' ' TYR . . . -62.26 151.42 36.39 Favored 'General case' 0 N--CA 1.442 -0.865 0 O-C-N 123.915 0.759 . . . . 0.0 110.105 178.969 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.64 ' HA ' HG22 ' A' ' 85' ' ' THR . 7.8 mtm-85 -152.7 142.74 22.27 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.983 -178.769 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.493 HG12 ' HB3' ' A' ' 83' ' ' PHE . 4.8 p -82.09 124.61 39.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 O-C-N 124.207 0.942 . . . . 0.0 109.477 178.725 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.616 ' CG2' HD22 ' A' ' 80' ' ' LEU . 6.1 mm -104.65 142.0 18.92 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.722 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.87 -179.444 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.687 ' C ' HD23 ' A' ' 80' ' ' LEU . 9.6 p90 -163.73 147.71 10.3 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 122.271 1.034 . . . . 0.0 111.711 -178.386 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 9.6 p -83.6 169.74 15.07 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.388 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.588 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.6 OUTLIER -111.37 154.61 43.65 Favored Pre-proline 0 CA--C 1.552 1.035 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.295 177.812 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.726 ' O ' HD21 ' A' ' 25' ' ' LEU . 18.8 Cg_endo -73.65 -56.92 0.14 OUTLIER 'Cis proline' 0 CA--C 1.504 -1.012 0 C-N-CA 123.724 -1.365 . . . . 0.0 110.466 -6.746 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.512 ' O ' HG23 ' A' ' 116' ' ' VAL . 1.1 m-20 -43.79 116.62 1.0 Allowed 'General case' 0 N--CA 1.448 -0.551 0 O-C-N 123.812 0.695 . . . . 0.0 109.352 178.233 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.561 ' HE2' HD22 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -65.39 79.67 0.06 Allowed 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -179.001 . . . . . . . . 3 3 . 1 . 011 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 114' ' ' ASN . 91.7 t -73.63 75.95 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 -177.039 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.436 ' CZ ' ' NE2' ' A' ' 13' ' ' GLN . 40.4 t80 -37.91 103.91 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 125.808 1.643 . . . . 0.0 109.432 -179.199 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 118' ' ' CYS . . . . . 0.568 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 10.9 m -83.25 -44.61 14.78 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -178.188 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 157.12 -147.71 16.36 Favored Glycine 0 N--CA 1.442 -0.906 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.49 HG13 ' CG ' ' A' ' 4' ' ' TRP . 1.2 mm -127.88 140.45 49.11 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.803 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -176.889 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.93 HG22 HD12 ' A' ' 133' ' ' LEU . 8.9 pt -129.05 155.24 40.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -177.952 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.676 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . . . . . . . . 0 C--N 1.329 -0.306 0 CA-C-O 122.407 1.098 . . . . 0.0 109.255 178.242 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 4.2 ptpt . . . . . 0 CA--C 1.514 -0.419 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 . . . . . . . . . 0 0 . 1 . 011 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.93 HD12 HG22 ' A' ' 121' ' ' ILE . 4.0 tp -84.14 148.14 26.95 Favored 'General case' 0 C--O 1.235 0.296 0 O-C-N 124.31 1.007 . . . . 0.0 109.167 178.286 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 134' ' ' CYS . . . . . 0.459 ' SG ' HG22 ' A' ' 120' ' ' ILE . 72.2 m -67.26 -174.54 0.38 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 122.316 1.055 . . . . 0.0 109.95 175.131 . . . . . . . . 2 2 . 1 . 011 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 15.2 m -129.04 95.29 4.03 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -177.971 . . . . . . . . 1 1 . 1 . 011 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.601 ' CE1' ' CH2' ' A' ' 4' ' ' TRP . 24.5 p-80 . . . . . 0 C--N 1.328 -0.337 0 O-C-N 123.711 0.632 . . . . 0.0 110.928 176.814 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.0 p . . . . . 0 CA--C 1.533 0.302 0 CA-C-O 121.864 0.84 . . . . 0.0 110.791 . . . . . . . . . 0 0 . 1 . 012 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.45 ' CG2' ' HB3' ' A' ' 10' ' ' LEU . 3.7 m -86.71 111.56 20.81 Favored 'General case' 0 CA--C 1.505 -0.782 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -176.283 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 24.8 m95 -77.29 142.7 39.32 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 123.247 0.619 . . . . 0.0 110.011 178.114 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -140.01 135.82 33.08 Favored 'General case' 0 CA--C 1.496 -1.114 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -179.007 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.665 ' SG ' ' HB3' ' A' ' 122' ' ' ALA . 0.8 OUTLIER -116.24 60.76 0.72 Allowed 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.594 177.114 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 39.22 72.27 0.22 Allowed Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.018 0.824 . . . . 0.0 112.688 -178.346 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 168.38 -77.46 0.11 Allowed Glycine 0 C--O 1.224 -0.49 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 -177.206 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 16.9 mt -126.17 162.43 25.4 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 121.749 0.785 . . . . 0.0 109.908 178.177 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.617 HD22 ' H ' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -89.91 165.23 14.21 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.086 -177.242 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -156.1 82.95 1.0 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 -171.362 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -53.46 125.76 19.1 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.324 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.421 ' NE2' ' HB3' ' A' ' 16' ' ' ALA . 30.7 tp60 -59.43 -21.4 59.96 Favored 'General case' 0 C--O 1.217 -0.656 0 C-N-CA 118.996 -1.081 . . . . 0.0 113.776 176.528 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -63.16 -24.67 67.99 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 172.81 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.401 ' O ' ' HB2' ' A' ' 19' ' ' ASN . 6.8 mttp -101.53 -30.46 11.38 Favored 'General case' 0 C--O 1.201 -1.467 0 CA-C-O 114.038 -2.887 . . . . 0.0 111.023 174.998 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.421 ' HB3' ' NE2' ' A' ' 13' ' ' GLN . . . -54.42 -66.0 0.48 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 122.212 2.278 . . . . 0.0 112.204 176.477 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 26.4 pt-20 -61.27 -44.98 96.35 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-O 117.88 -1.057 . . . . 0.0 109.449 176.683 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 46.0 t -57.54 -47.86 80.88 Favored 'General case' 0 C--O 1.212 -0.909 0 CA-C-N 119.801 1.182 . . . . 0.0 109.003 -176.437 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.463 ' OD1' ' HA ' ' A' ' 85' ' ' THR . 5.0 t-20 -47.7 -37.1 12.36 Favored 'General case' 0 N--CA 1.442 -0.834 0 O-C-N 121.064 -1.023 . . . . 0.0 112.302 174.333 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.99 -29.46 39.49 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 172.736 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -53.19 -39.91 64.01 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 125.696 1.598 . . . . 0.0 110.539 176.403 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.447 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -82.16 -49.92 9.6 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-O 117.733 -1.127 . . . . 0.0 110.232 178.922 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.645 ' HB2' ' CZ ' ' A' ' 83' ' ' PHE . . . -42.15 136.63 2.23 Favored Pre-proline 0 N--CA 1.448 -0.57 0 O-C-N 125.504 1.753 . . . . 0.0 112.446 177.511 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.655 ' HG2' HG22 ' A' ' 30' ' ' THR . 19.1 Cg_endo -73.01 123.3 8.78 Favored 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 121.722 1.615 . . . . 0.0 109.228 -176.709 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.665 HD13 ' HE2' ' A' ' 115' ' ' LYS . 7.0 tp -59.62 103.07 0.17 Allowed 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.853 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.644 ' O ' HD22 ' A' ' 81' ' ' LEU . 0.3 OUTLIER -179.83 176.96 0.72 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.803 0.811 . . . . 0.0 110.5 -175.577 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.49 ' HB2' ' CE1' ' A' ' 79' ' ' TYR . 1.3 t0 -110.94 83.87 1.83 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.38 81.18 0.26 Allowed Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 173.547 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -149.47 40.3 0.84 Allowed 'General case' 0 CA--C 1.509 -0.62 0 O-C-N 121.852 -0.793 . . . . 0.0 111.972 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.655 HG22 ' HG2' ' A' ' 24' ' ' PRO . 17.7 p -128.2 152.22 48.32 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 -175.01 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -42.45 -49.25 5.76 Favored Glycine 0 C--N 1.334 0.47 0 CA-C-O 119.629 -0.539 . . . . 0.0 112.562 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.81 -78.31 0.06 Allowed 'General case' 0 N--CA 1.452 -0.357 0 O-C-N 123.792 0.348 . . . . 0.0 111.478 174.014 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 79.3 p -177.06 -65.77 0.01 OUTLIER 'General case' 0 C--O 1.22 -0.466 0 C-N-CA 125.121 1.368 . . . . 0.0 110.161 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.421 ' HA ' ' C ' ' A' ' 35' ' ' PRO . 90.7 m-85 -63.3 150.9 88.35 Favored Pre-proline 0 N--CA 1.43 -1.46 0 C-N-CA 125.498 1.519 . . . . 0.0 111.95 -176.771 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.989 ' HB2' HD13 ' A' ' 81' ' ' LEU . 17.2 Cg_endo -75.98 160.31 95.86 Favored 'Cis proline' 0 N--CA 1.449 -1.108 0 C-N-CA 122.621 -1.824 . . . . 0.0 110.957 2.244 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -135.75 166.12 24.0 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 118.197 -0.906 . . . . 0.0 109.181 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.933 ' CH2' HG22 ' A' ' 39' ' ' THR . 21.8 t90 -62.66 152.09 36.34 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 175.882 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.497 ' CZ ' HD13 ' A' ' 121' ' ' ILE . 18.5 t80 -128.78 78.27 1.84 Allowed 'General case' 0 N--CA 1.425 -1.7 0 N-CA-C 105.169 -2.16 . . . . 0.0 105.169 -173.204 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.933 HG22 ' CH2' ' A' ' 37' ' ' TRP . 73.1 p -39.24 -35.68 0.27 Allowed 'General case' 0 C--O 1.212 -0.899 0 C-N-CA 124.25 1.02 . . . . 0.0 110.179 173.3 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.425 ' HB2' ' CD2' ' A' ' 38' ' ' PHE . 44.6 t30 57.04 19.6 4.81 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 123.306 1.527 . . . . 0.0 110.023 176.929 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.655 ' C ' HD23 ' A' ' 48' ' ' LEU . . . 107.68 -40.8 2.39 Favored Glycine 0 N--CA 1.428 -1.846 0 CA-C-O 116.194 -2.448 . . . . 0.0 115.208 -169.457 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.496 ' CE2' ' HD3' ' A' ' 66' ' ' PRO . 77.0 m-85 -45.85 153.75 0.27 Allowed 'General case' 0 C--N 1.339 0.145 0 CA-C-N 119.385 1.592 . . . . 0.0 112.18 176.338 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.98 -36.38 27.95 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.764 0.792 . . . . 0.0 111.496 177.909 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.531 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -175.18 -63.6 0.05 OUTLIER Glycine 0 C--N 1.337 0.595 0 C-N-CA 124.513 1.054 . . . . 0.0 111.337 -178.584 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -117.88 -68.15 0.94 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.373 0.606 . . . . 0.0 111.277 -179.075 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.13 -173.86 0.25 Allowed Glycine 0 C--N 1.341 0.839 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 178.764 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.526 ' HD2' HD12 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -55.97 -174.04 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 124.874 2.273 . . . . 0.0 113.336 174.108 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.655 HD23 ' C ' ' A' ' 41' ' ' GLY . 0.0 OUTLIER -80.6 163.58 55.73 Favored Pre-proline 0 C--N 1.313 -1.016 0 O-C-N 119.837 -1.789 . . . . 0.0 110.723 -179.66 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -71.18 160.14 49.95 Favored 'Trans proline' 0 N--CA 1.446 -1.27 0 C-N-CA 122.06 1.84 . . . . 0.0 109.764 178.38 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.5 ttpt -50.95 99.04 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.987 0.915 . . . . 0.0 110.324 177.082 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.92 85.64 1.86 Allowed Glycine 0 C--O 1.227 -0.316 0 CA-C-N 116.387 -0.37 . . . . 0.0 112.652 -174.569 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.02 165.21 18.09 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 124.205 1.002 . . . . 0.0 111.361 174.82 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 93.5 m -138.46 96.05 9.93 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.023 -177.944 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.53 ' HB3' HD21 ' A' ' 48' ' ' LEU . 18.4 Cg_endo -72.49 145.6 42.72 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 122.355 2.036 . . . . 0.0 110.672 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.484 HD12 HG21 ' A' ' 121' ' ' ILE . 7.1 mt -73.94 119.74 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -179.258 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.6 tppt? -81.5 135.36 35.6 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 177.819 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.58 ' CD1' ' HB3' ' A' ' 118' ' ' CYS . 28.6 m-85 -113.55 -52.09 2.77 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.276 1.031 . . . . 0.0 110.587 179.119 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 121.16 -3.1 11.5 Favored Glycine 0 C--O 1.223 -0.554 0 C-N-CA 123.642 0.639 . . . . 0.0 112.85 -175.07 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 16.2 mttt -101.87 130.37 48.33 Favored 'General case' 0 CA--C 1.502 -0.903 0 CA-C-N 118.173 0.987 . . . . 0.0 109.26 177.169 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 28.1 t -63.55 -12.2 30.61 Favored 'General case' 0 C--O 1.223 -0.307 0 O-C-N 124.665 1.228 . . . . 0.0 111.581 175.292 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -86.99 -47.79 8.66 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.867 1.267 . . . . 0.0 110.615 178.697 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 71.6 m -74.68 -10.59 59.68 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 123.967 0.792 . . . . 0.0 112.731 173.984 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -93.24 -40.12 10.61 Favored 'General case' 0 CA--C 1.507 -0.674 0 C-N-CA 124.795 1.238 . . . . 0.0 110.151 176.513 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.48 158.77 0.58 Allowed Pre-proline 0 CA--C 1.539 0.53 0 CA-C-O 121.827 0.822 . . . . 0.0 111.825 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -70.76 132.94 22.69 Favored 'Trans proline' 0 N--CA 1.442 -1.534 0 C-N-CA 120.823 1.015 . . . . 0.0 113.336 174.802 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.496 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 17.8 Cg_endo -71.45 170.78 17.61 Favored 'Trans proline' 0 N--CA 1.446 -1.301 0 C-N-CA 123.404 2.736 . . . . 0.0 111.057 178.709 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.8 tptt -124.46 53.0 1.47 Allowed 'General case' 0 C--O 1.205 -1.243 0 O-C-N 121.417 -0.802 . . . . 0.0 108.954 178.061 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.475 ' CD2' ' CG ' ' A' ' 37' ' ' TRP . 52.3 t-80 -78.89 161.0 27.03 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 119.333 -2.104 . . . . 0.0 111.744 178.869 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -171.78 -163.93 0.29 Allowed 'General case' 0 CA--C 1.504 -0.812 0 O-C-N 117.813 -3.054 . . . . 0.0 109.396 175.292 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.31 53.66 0.14 Allowed 'General case' 0 C--O 1.215 -0.723 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 172.164 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 71' ' ' ASP . . . . . 0.402 ' O ' ' C ' ' A' ' 72' ' ' GLY . 3.5 m-20 -177.49 74.48 0.02 OUTLIER 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 -178.634 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.424 ' O ' ' CE2' ' A' ' 79' ' ' TYR . . . -11.68 -70.27 0.01 OUTLIER Glycine 0 C--O 1.219 -0.79 0 C-N-CA 125.175 1.369 . . . . 0.0 114.305 178.827 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 18.3 t30 -121.96 78.61 1.49 Allowed 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 124.924 1.29 . . . . 0.0 112.68 165.192 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.13 -98.8 0.04 OUTLIER Glycine 0 CA--C 1.521 0.436 0 CA-C-O 122.74 1.189 . . . . 0.0 111.546 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.0 mttt -72.12 -102.57 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.38 0 CA-C-O 122.827 1.299 . . . . 0.0 111.059 176.779 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.496 HG23 ' O ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -112.29 14.75 20.51 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 121.104 -0.997 . . . . 0.0 110.844 178.87 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -31.72 100.21 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.561 0 C-N-CA 124.514 1.126 . . . . 0.0 112.202 -178.04 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.433 ' CD2' ' H ' ' A' ' 78' ' ' HIS . 6.1 p80 -87.7 45.45 1.28 Allowed 'General case' 0 CA--C 1.516 -0.329 0 O-C-N 119.942 -1.724 . . . . 0.0 108.174 -172.388 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.49 ' CE1' ' HB2' ' A' ' 27' ' ' ASP . 40.7 p90 -71.07 135.52 47.78 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 124.42 1.088 . . . . 0.0 110.398 -178.922 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.464 ' HG ' HG22 ' A' ' 111' ' ' THR . 0.3 OUTLIER -71.5 138.2 48.75 Favored 'General case' 0 C--O 1.218 -0.57 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 176.327 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.989 HD13 ' HB2' ' A' ' 35' ' ' PRO . 0.4 OUTLIER -130.54 141.92 50.47 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 176.432 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -104.03 167.69 9.6 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-O 121.974 0.893 . . . . 0.0 112.628 174.563 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.645 ' CZ ' ' HB2' ' A' ' 23' ' ' ALA . 31.9 t80 -154.31 139.33 11.83 Favored Pre-proline 0 C--O 1.225 -0.209 0 O-C-N 120.974 -1.079 . . . . 0.0 113.368 178.636 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.519 ' HD2' ' CD1' ' A' ' 83' ' ' PHE . 19.3 Cg_endo -74.49 94.89 0.92 Allowed 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 124.346 3.364 . . . . 0.0 110.832 -175.321 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.463 ' HA ' ' OD1' ' A' ' 19' ' ' ASN . 6.3 t -98.86 105.24 17.37 Favored 'General case' 0 CA--C 1.508 -0.64 0 O-C-N 124.879 1.362 . . . . 0.0 112.577 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.526 ' CE1' ' CD1' ' A' ' 92' ' ' TYR . 56.4 m-85 -82.35 159.55 64.38 Favored Pre-proline 0 N--CA 1.446 -0.632 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.321 -179.414 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -76.55 -36.28 1.75 Allowed 'Trans proline' 0 CA--C 1.498 -1.309 0 C-N-CA 122.283 1.989 . . . . 0.0 112.973 178.438 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 88' ' ' ASP . . . . . 0.42 ' HB2' ' CD2' ' A' ' 90' ' ' HIS . 2.5 m-20 -45.87 -31.14 1.98 Allowed 'General case' 0 N--CA 1.468 0.439 0 O-C-N 125.016 1.448 . . . . 0.0 110.406 176.974 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.15 17.69 68.87 Favored Glycine 0 N--CA 1.438 -1.193 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 177.374 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.42 ' CD2' ' HB2' ' A' ' 88' ' ' ASP . 4.3 p80 -82.66 140.99 32.83 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 178.399 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -72.33 85.63 1.09 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 175.369 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.526 ' CD1' ' CE1' ' A' ' 86' ' ' PHE . 70.8 t80 -40.82 151.91 0.05 Allowed 'General case' 0 C--O 1.22 -0.472 0 CA-C-O 122.655 1.217 . . . . 0.0 111.57 -179.357 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.71 64.99 5.69 Favored 'General case' 0 C--N 1.314 -0.972 0 O-C-N 119.153 -2.217 . . . . 0.0 110.541 177.211 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.477 ' CD2' ' HZ ' ' A' ' 83' ' ' PHE . 33.2 p90 -82.2 -12.27 58.21 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 118.17 -0.919 . . . . 0.0 110.732 178.678 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -97.88 -30.91 12.48 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 123.782 1.753 . . . . 0.0 110.485 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 69.2 m -80.3 108.92 14.31 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 119.662 -1.899 . . . . 0.0 109.492 178.917 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.25 -48.56 80.04 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.611 0.72 . . . . 0.0 111.135 178.231 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -137.81 125.25 13.81 Favored Pre-proline 0 N--CA 1.438 -1.058 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.105 -175.729 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.432 ' HA ' ' HA ' ' A' ' 98' ' ' LYS . 25.3 Cg_endo -71.75 175.02 44.07 Favored 'Cis proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.819 -1.742 . . . . 0.0 110.84 -3.471 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.85 130.12 31.29 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 123.919 0.888 . . . . 0.0 109.49 178.409 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.465 ' HB3' ' CE1' ' A' ' 92' ' ' TYR . 0.4 OUTLIER -78.86 -177.99 5.79 Favored 'General case' 0 C--O 1.238 0.479 0 O-C-N 125.59 1.806 . . . . 0.0 112.863 177.061 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -76.74 152.36 82.91 Favored Pre-proline 0 N--CA 1.451 -0.425 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 172.18 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -69.92 -165.07 0.15 Allowed 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.372 2.048 . . . . 0.0 112.688 175.568 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -131.52 158.19 22.67 Favored Glycine 0 CA--C 1.526 0.772 0 O-C-N 121.43 -0.794 . . . . 0.0 112.799 176.565 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -76.02 -42.78 0.37 Allowed 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.394 2.063 . . . . 0.0 111.313 178.244 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.897 ' HB1' ' CG2' ' A' ' 120' ' ' ILE . . . -92.72 145.56 24.32 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 123.23 0.612 . . . . 0.0 110.709 177.069 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.491 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 4.4 mtm-85 -145.4 149.5 34.85 Favored 'General case' 0 CA--C 1.495 -1.136 0 CA-C-O 117.104 -1.427 . . . . 0.0 111.597 177.875 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.644 HG23 ' CD1' ' A' ' 117' ' ' PHE . 2.3 p -83.65 110.43 18.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 O-C-N 124.136 0.898 . . . . 0.0 110.434 178.641 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.411 HG12 ' CE2' ' A' ' 38' ' ' PHE . 1.7 mp -95.93 125.06 48.83 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.104 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 -174.735 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.615 ' CZ ' HD11 ' A' ' 81' ' ' LEU . 8.6 p90 -146.23 154.97 42.34 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.782 0.801 . . . . 0.0 109.061 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.464 HG22 ' HG ' ' A' ' 80' ' ' LEU . 1.8 p -91.79 164.8 13.57 Favored 'General case' 0 C--N 1.317 -0.817 0 O-C-N 121.931 -0.48 . . . . 0.0 109.734 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.511 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -110.88 155.77 41.84 Favored Pre-proline 0 CA--C 1.544 0.729 0 O-C-N 121.759 -0.588 . . . . 0.0 110.911 179.18 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.511 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 19.3 Cg_endo -73.18 -50.17 0.2 OUTLIER 'Cis proline' 0 CA--C 1.5 -1.188 0 C-N-CA 123.544 -1.44 . . . . 0.0 111.099 -8.249 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.541 ' HB3' HG23 ' A' ' 116' ' ' VAL . 1.4 m-20 -46.32 110.51 0.28 Allowed 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 115.999 -1.953 . . . . 0.0 108.846 178.295 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.665 ' HE2' HD13 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -67.71 68.36 0.1 Allowed 'General case' 0 CA--C 1.511 -0.549 0 O-C-N 125.904 2.003 . . . . 0.0 108.154 -178.49 . . . . . . . . 3 3 . 1 . 012 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.541 HG23 ' HB3' ' A' ' 114' ' ' ASN . 72.0 t -73.66 71.43 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 105.358 -2.089 . . . . 0.0 105.358 -177.763 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.644 ' CD1' HG23 ' A' ' 108' ' ' VAL . 29.9 t80 -39.44 116.44 0.61 Allowed 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 125.832 1.653 . . . . 0.0 109.352 179.597 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 118' ' ' CYS . . . . . 0.58 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 4.6 m -89.09 -46.55 8.75 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -178.978 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.598 ' HA2' ' CZ ' ' A' ' 117' ' ' PHE . . . 155.08 -171.62 33.34 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 -179.235 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.897 ' CG2' ' HB1' ' A' ' 106' ' ' ALA . 2.8 mp -109.65 129.69 64.06 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.269 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 -177.847 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.716 HG22 HD12 ' A' ' 133' ' ' LEU . 8.9 pt -102.55 155.42 5.09 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 CA-C-N 119.535 1.061 . . . . 0.0 108.318 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.665 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . . . . . . . . 0 C--N 1.324 -0.518 0 CA-C-O 122.879 1.324 . . . . 0.0 110.07 175.561 . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.507 -0.684 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 . . . . . . . . . 1 1 . 1 . 012 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.716 HD12 HG22 ' A' ' 121' ' ' ILE . 7.2 tp -83.8 147.46 27.57 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 176.612 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 134' ' ' CYS . . . . . 0.574 ' SG ' HG22 ' A' ' 120' ' ' ILE . 99.5 m -60.18 -177.67 0.07 Allowed 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 123.708 1.718 . . . . 0.0 109.985 176.219 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -162.96 109.43 1.18 Allowed 'General case' 0 C--N 1.319 -0.746 0 O-C-N 120.588 -1.32 . . . . 0.0 107.475 -177.916 . . . . . . . . 2 2 . 1 . 012 nuclear build core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.254 1.303 0 CA-C-O 115.335 -2.269 . . . . 0.0 111.438 174.227 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.1 p . . . . . 0 C--O 1.237 0.425 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 . . . . . . . . . 0 0 . 1 . 013 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.408 HG23 ' HA ' ' A' ' 12' ' ' ASN . 2.5 m -98.78 118.34 35.3 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 124.26 1.024 . . . . 0.0 108.944 -176.219 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 4' ' ' TRP . . . . . 0.413 ' CE2' ' ND1' ' A' ' 136' ' ' HIS . 28.6 m95 -82.35 137.07 34.87 Favored 'General case' 0 CA--C 1.506 -0.716 0 O-C-N 120.851 -1.156 . . . . 0.0 109.024 -172.833 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -127.14 132.12 50.62 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 122.115 0.959 . . . . 0.0 108.43 -176.265 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.482 ' SG ' ' HB3' ' A' ' 122' ' ' ALA . 0.0 OUTLIER -121.6 66.68 0.89 Allowed 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.707 176.919 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 42.44 56.2 4.21 Favored Glycine 0 N--CA 1.471 1.019 0 O-C-N 124.061 0.851 . . . . 0.0 113.28 -176.673 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -168.36 -88.69 0.07 OUTLIER Glycine 0 C--O 1.226 -0.387 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 -175.607 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 32.5 mt -132.14 165.16 24.7 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.304 1.441 . . . . 0.0 109.983 177.592 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -90.83 111.04 22.27 Favored 'General case' 0 C--O 1.223 -0.336 0 C-N-CA 124.48 1.112 . . . . 0.0 110.137 179.197 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -89.64 111.2 22.09 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 130.635 3.574 . . . . 0.0 109.067 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.408 ' HA ' HG23 ' A' ' 3' ' ' THR . 0.1 OUTLIER -54.6 122.16 10.0 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 176.374 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 31.5 tp60 -55.12 -48.33 73.78 Favored 'General case' 0 C--O 1.215 -0.739 0 C-N-CA 118.754 -1.178 . . . . 0.0 113.227 177.482 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -48.94 -37.21 19.33 Favored 'General case' 0 C--O 1.204 -1.301 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 173.903 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.5 mttp -71.61 -42.08 68.11 Favored 'General case' 0 C--O 1.21 -1.021 0 CA-C-O 116.369 -1.777 . . . . 0.0 113.132 167.057 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.528 ' HA ' HG21 ' A' ' 85' ' ' THR . . . -51.98 -48.27 64.45 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 122.828 2.558 . . . . 0.0 113.475 172.984 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -74.5 -47.79 31.06 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 119.0 0.818 . . . . 0.0 111.753 172.048 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 38.0 t -66.55 -55.73 14.09 Favored 'General case' 0 N--CA 1.481 1.098 0 O-C-N 119.738 -1.851 . . . . 0.0 112.301 -175.148 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -40.5 -46.15 2.4 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.711 1.205 . . . . 0.0 110.894 169.474 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.435 ' O ' ' HB3' ' A' ' 23' ' ' ALA . 0.1 OUTLIER -76.16 -28.87 57.54 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 126.976 2.11 . . . . 0.0 116.437 174.981 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -54.68 -35.6 63.74 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 127.802 2.441 . . . . 0.0 111.037 177.572 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -75.91 -42.6 48.51 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 126.569 1.948 . . . . 0.0 112.506 174.325 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.596 ' HB1' ' HG3' ' A' ' 35' ' ' PRO . . . -45.65 127.6 6.54 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 127.318 2.247 . . . . 0.0 111.844 175.037 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -66.28 146.66 81.7 Favored 'Trans proline' 0 N--CA 1.445 -1.346 0 C-N-CA 122.833 2.355 . . . . 0.0 111.272 -175.44 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.535 HD13 ' CE2' ' A' ' 112' ' ' TYR . 0.6 OUTLIER -79.72 94.57 5.76 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.613 -179.781 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.6 m 179.78 167.96 1.2 Allowed 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.711 1.604 . . . . 0.0 110.665 -174.926 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.453 ' HA ' ' HA ' ' A' ' 36' ' ' HIS . 0.3 OUTLIER -108.71 118.29 36.41 Favored 'General case' 0 CA--C 1.51 -0.594 0 C-N-CA 125.988 1.715 . . . . 0.0 109.169 175.12 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 55.27 62.39 6.34 Favored Glycine 0 CA--C 1.522 0.495 0 O-C-N 123.663 0.602 . . . . 0.0 112.713 171.233 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt -145.73 20.68 1.48 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.755 1.622 . . . . 0.0 115.243 -176.306 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 45.2 p -118.42 158.3 25.56 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 125.715 1.606 . . . . 0.0 108.513 179.335 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.45 ' HA3' ' O ' ' A' ' 95' ' ' ASP . . . -50.52 -55.01 18.46 Favored Glycine 0 CA--C 1.504 -0.596 0 N-CA-C 116.222 1.249 . . . . 0.0 116.222 -177.02 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.5 t -62.72 -62.06 1.99 Allowed 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 116.695 -1.621 . . . . 0.0 112.896 171.057 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 160.22 -42.15 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 131.427 3.891 . . . . 0.0 115.963 178.478 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.511 ' CD2' ' HD3' ' A' ' 84' ' ' PRO . 86.0 m-85 -78.47 147.32 71.67 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 125.182 1.393 . . . . 0.0 113.999 -177.954 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.596 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 35.1 Cg_endo -71.84 162.28 89.64 Favored 'Cis proline' 0 N--CA 1.441 -1.603 0 CA-C-N 120.626 1.259 . . . . 0.0 110.609 -2.725 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 27' ' ' ASP . 1.6 p80 -139.36 173.65 11.33 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 113.16 -1.836 . . . . 0.0 108.068 -177.14 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.82 ' CH2' HG22 ' A' ' 39' ' ' THR . 19.7 t90 -75.96 138.47 40.99 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 123.222 1.487 . . . . 0.0 110.78 173.298 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.48 ' CE2' HG21 ' A' ' 109' ' ' ILE . 28.4 t80 -106.89 91.83 3.83 Favored 'General case' 0 N--CA 1.419 -1.994 0 C-N-CA 130.297 3.439 . . . . 0.0 104.688 177.712 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.82 HG22 ' CH2' ' A' ' 37' ' ' TRP . 80.4 p -41.47 -37.98 1.18 Allowed 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 112.794 -2.003 . . . . 0.0 111.851 164.162 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.466 ' HA ' ' CZ ' ' A' ' 38' ' ' PHE . 65.8 t30 59.31 17.12 5.53 Favored 'General case' 0 C--O 1.213 -0.842 0 CA-C-N 118.901 0.773 . . . . 0.0 111.995 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.482 ' HA2' ' NE ' ' A' ' 52' ' ' ARG . . . 107.38 -43.3 1.72 Allowed Glycine 0 N--CA 1.44 -1.085 0 CA-C-O 115.132 -3.038 . . . . 0.0 114.62 -166.01 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -45.94 154.85 0.21 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 128.789 2.836 . . . . 0.0 111.667 178.032 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -82.04 -34.7 29.39 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 178.282 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.538 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -175.95 -68.38 0.06 OUTLIER Glycine 0 CA--C 1.528 0.848 0 C-N-CA 126.199 1.856 . . . . 0.0 113.036 -175.815 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 45' ' ' ASP . . . . . 0.414 ' OD2' ' HE2' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -118.78 -62.73 1.49 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 127.188 2.195 . . . . 0.0 113.955 -176.322 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.39 -168.54 1.59 Allowed Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 125.732 1.635 . . . . 0.0 111.021 178.12 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 43.8 pttt -59.06 -172.15 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 124.696 2.189 . . . . 0.0 113.631 173.342 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.601 ' H ' HD12 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -87.41 170.02 12.97 Favored Pre-proline 0 C--N 1.316 -0.852 0 CA-C-N 114.333 -1.303 . . . . 0.0 111.947 -177.755 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -62.59 164.68 17.59 Favored 'Trans proline' 0 N--CA 1.44 -1.662 0 CA-C-O 123.093 1.205 . . . . 0.0 109.955 177.26 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.13 102.06 0.12 Allowed 'General case' 0 C--O 1.218 -0.58 0 O-C-N 120.307 -1.495 . . . . 0.0 110.695 170.333 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.08 78.35 1.4 Allowed Glycine 0 N--CA 1.466 0.638 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -176.756 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.482 ' NE ' ' HA2' ' A' ' 41' ' ' GLY . 0.4 OUTLIER -148.93 154.48 39.48 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 124.303 1.041 . . . . 0.0 109.96 170.974 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.9 m -124.72 101.46 33.2 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 125.087 1.355 . . . . 0.0 108.882 175.829 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.533 ' HG3' HD21 ' A' ' 48' ' ' LEU . 32.5 Cg_endo -69.22 148.9 69.6 Favored 'Trans proline' 0 N--CA 1.444 -1.437 0 C-N-CA 123.316 2.677 . . . . 0.0 111.078 172.518 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.5 mt -61.19 118.38 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 175.378 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.0 tppt? -86.52 132.29 33.96 Favored 'General case' 0 C--N 1.332 -0.179 0 O-C-N 121.611 -0.681 . . . . 0.0 109.516 174.111 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.57 ' CD1' ' HB3' ' A' ' 118' ' ' CYS . 7.9 m-85 -114.84 -36.32 4.52 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.518 1.927 . . . . 0.0 112.495 178.409 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.47 0.42 55.59 Favored Glycine 0 N--CA 1.474 1.221 0 C-N-CA 125.494 1.521 . . . . 0.0 114.114 -172.847 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.45 134.78 42.88 Favored 'General case' 0 CA--C 1.506 -0.726 0 C-N-CA 123.939 0.896 . . . . 0.0 111.299 175.315 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 79.6 p -68.91 -8.78 47.43 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.092 0.957 . . . . 0.0 113.502 176.939 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.708 ' HB2' HG21 ' A' ' 111' ' ' THR . 0.0 OUTLIER -84.03 -52.3 6.42 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 126.926 2.09 . . . . 0.0 108.977 176.091 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.438 ' HB2' ' CD2' ' A' ' 57' ' ' PHE . 3.7 m -78.75 -15.49 58.38 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -179.28 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -86.05 -30.8 22.35 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 127.212 2.205 . . . . 0.0 111.977 167.888 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.43 153.86 13.3 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 119.463 1.029 . . . . 0.0 113.76 179.111 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -67.11 136.85 42.21 Favored 'Trans proline' 0 CA--C 1.553 1.43 0 C-N-CA 120.363 0.709 . . . . 0.0 111.789 173.628 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.449 ' HB3' ' HA ' ' A' ' 79' ' ' TYR . 19.6 Cg_endo -67.09 174.76 6.46 Favored 'Trans proline' 0 N--CA 1.459 -0.539 1 C-N-CA 125.428 4.085 . . . . 0.0 113.225 175.421 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.414 ' HE2' ' OD2' ' A' ' 45' ' ' ASP 0.355 4.2 mmtt -133.9 41.21 3.03 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 116.073 1.879 . . . . 0.0 116.073 178.35 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.536 ' HA ' ' OD2' ' A' ' 77' ' ' ASP 0.312 56.3 t-80 -58.32 152.3 17.8 Favored 'General case' 0 C--O 1.218 -0.564 0 CA-C-O 124.798 2.237 . . . . 0.0 114.284 -177.527 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -148.56 -172.13 4.02 Favored 'General case' 0 CA--C 1.512 -0.51 0 O-C-N 119.777 -1.827 . . . . 0.0 111.026 179.147 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.02 69.79 5.25 Favored 'General case' 0 C--O 1.213 -0.821 0 O-C-N 121.151 -0.968 . . . . 0.0 112.002 172.626 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -170.03 -45.43 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 124.158 0.983 . . . . 0.0 111.887 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 133.98 -66.75 0.56 Allowed Glycine 0 C--O 1.204 -1.738 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 -179.148 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -107.48 -3.24 19.65 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 130.311 3.444 . . . . 0.0 113.417 -176.411 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 34.4 -122.13 0.42 Allowed Glycine 0 C--O 1.221 -0.712 0 C-N-CA 128.282 2.849 . . . . 0.0 113.783 -176.63 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 24.4 mttt -69.72 -79.02 0.06 Allowed 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 115.209 1.559 . . . . 0.0 115.209 167.716 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -123.45 11.22 9.26 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-O 116.676 -1.63 . . . . 0.0 111.957 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.536 ' OD2' ' HA ' ' A' ' 68' ' ' HIS . 58.1 t0 -17.78 94.53 0.01 OUTLIER 'General case' 0 C--O 1.214 -0.792 0 C-N-CA 126.689 1.996 . . . . 0.0 114.293 -171.867 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.43 ' CD2' ' H ' ' A' ' 78' ' ' HIS . 19.2 p80 -84.32 11.47 8.32 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -172.87 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.843 ' CZ ' HD21 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -43.87 162.42 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 126.684 1.994 . . . . 0.0 113.223 169.372 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -83.02 150.45 26.34 Favored 'General case' 0 N--CA 1.427 -1.585 0 CA-C-N 113.236 -1.802 . . . . 0.0 110.441 169.641 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.843 HD21 ' CZ ' ' A' ' 79' ' ' TYR . 1.6 mt -132.42 130.47 40.65 Favored 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 123.743 0.817 . . . . 0.0 109.218 173.719 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.06 155.19 17.23 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 123.734 0.814 . . . . 0.0 112.088 176.955 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.463 ' HZ ' ' CE2' ' A' ' 94' ' ' PHE . 59.8 t80 -149.05 127.16 5.82 Favored Pre-proline 0 CA--C 1.551 1.004 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 179.146 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.511 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 23.4 Cg_endo -71.59 94.78 0.69 Allowed 'Trans proline' 0 N--CA 1.45 -1.065 1 C-N-CA 126.062 4.508 . . . . 0.0 110.119 -176.093 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.528 HG21 ' HA ' ' A' ' 16' ' ' ALA . 6.2 t -94.49 114.3 26.28 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 113.233 -1.803 . . . . 0.0 110.127 178.719 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -82.31 154.25 69.15 Favored Pre-proline 0 CA--C 1.54 0.581 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.136 178.268 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -73.31 -35.12 5.28 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.953 2.435 . . . . 0.0 115.204 177.943 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -50.79 -30.95 15.47 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 128.182 2.593 . . . . 0.0 110.983 175.082 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.27 11.53 82.08 Favored Glycine 0 CA--C 1.499 -0.955 0 CA-C-N 114.568 -1.197 . . . . 0.0 115.067 177.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . 0.255 5.2 p-80 -62.36 132.37 52.38 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 171.834 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -56.76 99.51 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 157.359 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -47.07 137.02 8.06 Favored 'General case' 0 N--CA 1.436 -1.153 0 O-C-N 118.823 -2.423 . . . . 0.0 108.484 169.021 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.36 59.01 1.02 Allowed 'General case' 0 C--N 1.324 -0.536 0 O-C-N 120.786 -1.196 . . . . 0.0 112.326 171.26 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.463 ' CE2' ' HZ ' ' A' ' 83' ' ' PHE . 32.6 p90 -71.72 -29.43 64.54 Favored 'General case' 0 C--O 1.219 -0.506 0 C-N-CA 124.794 1.237 . . . . 0.0 112.644 173.884 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.45 ' O ' ' HA3' ' A' ' 31' ' ' GLY . 1.1 t70 -75.65 -38.9 58.46 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.527 1.931 . . . . 0.0 111.402 175.764 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.3 t -77.75 107.76 10.49 Favored 'General case' 0 C--N 1.33 -0.248 0 O-C-N 121.33 -0.856 . . . . 0.0 109.046 -176.315 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.5 pttt -60.35 -41.17 93.09 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 122.593 1.187 . . . . 0.0 114.109 178.655 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -145.24 131.13 9.54 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 114.174 -1.376 . . . . 0.0 110.837 178.913 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.67 165.21 70.39 Favored 'Cis proline' 0 N--CA 1.455 -0.771 0 O-C-N 123.283 1.149 . . . . 0.0 110.349 -11.102 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.37 148.5 47.49 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 125.484 1.513 . . . . 0.0 107.712 177.681 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -96.14 171.0 8.88 Favored 'General case' 0 C--N 1.319 -0.761 0 O-C-N 124.014 0.821 . . . . 0.0 109.577 169.2 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -46.5 152.17 0.91 Allowed Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 127.424 2.29 . . . . 0.0 111.865 168.038 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -72.74 -84.77 0.0 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.336 0 C-N-CA 123.107 2.538 . . . . 0.0 112.284 176.972 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 138.48 146.07 4.93 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.069 -1.213 . . . . 0.0 110.069 -178.605 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -76.62 -67.5 0.02 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 124.062 3.175 . . . . 0.0 112.162 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.405 ' HA ' ' HB2' ' A' ' 122' ' ' ALA . . . -68.99 132.16 46.23 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 123.125 1.44 . . . . 0.0 111.658 176.172 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.68 152.12 48.95 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 113.615 -1.63 . . . . 0.0 110.194 -177.99 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.418 ' CG1' ' HB3' ' A' ' 83' ' ' PHE . 2.5 p -87.54 116.62 30.04 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.642 0 C-N-CA 125.247 1.419 . . . . 0.0 109.438 175.928 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.48 HG21 ' CE2' ' A' ' 38' ' ' PHE . 1.6 mp -104.22 115.64 46.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 104.877 -2.268 . . . . 0.0 104.877 -178.582 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -126.81 156.22 41.63 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 114.48 -1.236 . . . . 0.0 108.467 177.245 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.708 HG21 ' HB2' ' A' ' 61' ' ' ASP . 3.2 p -82.98 166.48 18.79 Favored 'General case' 0 CA--C 1.505 -0.783 0 C-N-CA 124.844 1.258 . . . . 0.0 111.277 177.225 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.535 ' CE2' HD13 ' A' ' 25' ' ' LEU 0.276 8.7 t80 -109.94 158.49 34.86 Favored Pre-proline 0 CA--C 1.544 0.748 0 O-C-N 120.962 -1.086 . . . . 0.0 112.33 176.333 . . . . . . . . 3 3 . 1 . 013 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.525 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 18.9 Cg_endo -69.01 -41.9 0.81 Allowed 'Cis proline' 0 C--N 1.348 0.516 0 N-CA-C 114.794 1.036 . . . . 0.0 114.794 -21.544 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.469 ' HB3' HG23 ' A' ' 116' ' ' VAL . 1.3 t-20 -50.37 106.48 0.12 Allowed 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 125.528 1.531 . . . . 0.0 108.92 170.431 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.503 ' HE2' HD21 ' A' ' 25' ' ' LEU . 2.3 mtmt -67.12 65.41 0.06 Allowed 'General case' 0 C--N 1.339 0.111 0 C-N-CA 127.959 2.503 . . . . 0.0 108.792 177.431 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.469 HG23 ' HB3' ' A' ' 114' ' ' ASN . 47.3 t -72.93 86.54 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.586 0 N-CA-C 103.254 -2.869 . . . . 0.0 103.254 175.951 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.451 ' CZ ' ' HA2' ' A' ' 119' ' ' GLY . 37.8 t80 -46.12 103.8 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 129.142 2.977 . . . . 0.0 109.427 176.933 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 118' ' ' CYS . . . . . 0.57 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 22.4 m -80.21 -41.7 24.68 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 122.884 1.326 . . . . 0.0 110.447 -176.056 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.451 ' HA2' ' CZ ' ' A' ' 117' ' ' PHE . . . 159.44 -154.22 25.28 Favored Glycine 0 N--CA 1.433 -1.552 0 CA-C-N 113.651 -1.613 . . . . 0.0 110.09 -178.555 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.424 HD11 ' CB ' ' A' ' 16' ' ' ALA . 1.3 mm -123.08 147.99 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 N-CA-C 105.208 -2.145 . . . . 0.0 105.208 -179.092 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.418 HG12 ' CD1' ' A' ' 109' ' ' ILE . 4.3 pt -136.99 151.65 27.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 O-C-N 119.851 -1.781 . . . . 0.0 109.175 179.397 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.482 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . . . . . . . . 0 C--N 1.324 -0.5 0 CA-C-O 121.742 0.782 . . . . 0.0 110.355 176.747 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.513 -0.448 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 . . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 14.7 tp -77.4 141.67 39.67 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.036 173.946 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 134' ' ' CYS . . . . . 0.419 ' SG ' HG22 ' A' ' 120' ' ' ILE . 34.9 m -70.56 176.78 3.86 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 126.448 1.899 . . . . 0.0 111.243 169.686 . . . . . . . . 2 2 . 1 . 013 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 92.5 p -142.37 100.45 3.7 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 105.284 -2.117 . . . . 0.0 105.284 -177.866 . . . . . . . . 1 1 . 1 . 013 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.413 ' ND1' ' CE2' ' A' ' 4' ' ' TRP . 0.5 OUTLIER . . . . . 0 C--O 1.246 0.921 0 CA-C-O 114.972 -2.442 . . . . 0.0 114.671 165.022 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.655 HG22 ' HB2' ' A' ' 136' ' ' HIS . 11.0 p . . . . . 0 N--CA 1.449 -0.485 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 . . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.55 HG21 HD23 ' A' ' 10' ' ' LEU . 1.1 m -84.46 112.38 20.33 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-O 121.546 0.688 . . . . 0.0 110.008 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 4' ' ' TRP . . . . . 0.497 ' CG ' HG13 ' A' ' 120' ' ' ILE . 27.5 m95 -78.44 138.08 38.3 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 123.877 0.871 . . . . 0.0 111.248 175.089 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 m -120.16 120.52 36.43 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -177.679 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.876 ' HB3' ' HB3' ' A' ' 122' ' ' ALA . 55.6 m -106.88 51.89 0.73 Allowed 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.581 178.916 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 45.46 48.06 11.79 Favored Glycine 0 C--O 1.218 -0.863 0 O-C-N 123.951 0.782 . . . . 0.0 111.974 -176.964 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -162.2 -80.97 0.04 OUTLIER Glycine 0 C--O 1.225 -0.407 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 -177.52 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.6 mt -127.39 163.91 23.01 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.148 0.499 . . . . 0.0 110.008 177.684 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.55 HD23 HG21 ' A' ' 3' ' ' THR . 9.2 mp -85.55 133.78 34.05 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.144 -179.353 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.504 ' CE2' ' CB ' ' A' ' 106' ' ' ALA . 64.5 m-85 -122.89 110.37 15.34 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 124.41 1.084 . . . . 0.0 110.17 -175.321 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -65.74 119.16 10.7 Favored 'General case' 0 N--CA 1.444 -0.751 0 O-C-N 120.335 -1.478 . . . . 0.0 108.517 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.441 ' HB2' ' CD1' ' A' ' 4' ' ' TRP . 33.0 tp60 -48.47 -42.46 32.77 Favored 'General case' 0 C--O 1.197 -1.687 0 CA-C-N 118.542 0.61 . . . . 0.0 111.518 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.4 ' O ' ' CB ' ' A' ' 18' ' ' SER . 21.2 t30 -48.8 -48.36 41.43 Favored 'General case' 0 C--O 1.189 -2.087 0 CA-C-N 117.785 0.266 . . . . 0.0 111.106 175.875 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -67.28 -34.94 78.45 Favored 'General case' 0 C--O 1.196 -1.742 0 O-C-N 120.641 -1.287 . . . . 0.0 112.502 171.277 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.37 -45.1 80.68 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 121.337 1.88 . . . . 0.0 113.106 172.904 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -85.94 -37.8 18.67 Favored 'General case' 0 C--O 1.206 -1.197 0 CA-C-O 118.575 -0.726 . . . . 0.0 109.14 178.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.4 ' CB ' ' O ' ' A' ' 14' ' ' ASN . 47.8 t -71.75 -61.29 1.83 Allowed 'General case' 0 CA--C 1.5 -0.947 0 C-N-CA 126.6 1.96 . . . . 0.0 108.819 -177.037 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.51 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 8.7 t-20 -40.97 -35.93 0.59 Allowed 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 119.285 0.948 . . . . 0.0 112.555 173.311 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.421 ' O ' ' HB3' ' A' ' 23' ' ' ALA . 0.2 OUTLIER -81.61 -37.96 26.77 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 174.228 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -44.09 -39.2 4.07 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 126.436 1.894 . . . . 0.0 109.518 178.652 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.51 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -73.41 -49.09 28.9 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-O 118.435 -0.793 . . . . 0.0 112.1 175.77 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.585 ' HB1' ' HG3' ' A' ' 35' ' ' PRO . . . -35.64 129.77 0.57 Allowed Pre-proline 0 N--CA 1.439 -1.006 0 O-C-N 124.634 1.209 . . . . 0.0 112.566 174.076 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.703 ' HG2' HG22 ' A' ' 30' ' ' THR . 19.4 Cg_endo -73.4 124.23 9.26 Favored 'Trans proline' 0 N--CA 1.442 -1.54 0 C-N-CA 121.898 1.732 . . . . 0.0 109.707 -176.86 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.753 HD13 ' HE2' ' A' ' 115' ' ' LYS . 5.4 tp -60.44 95.45 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.103 0.561 . . . . 0.0 110.925 179.48 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.477 ' O ' HD22 ' A' ' 81' ' ' LEU . 0.4 OUTLIER 179.13 173.07 0.8 Allowed 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 123.322 0.649 . . . . 0.0 110.445 -176.745 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -109.25 119.37 39.28 Favored 'General case' 0 CA--C 1.511 -0.53 0 C-N-CA 124.101 0.961 . . . . 0.0 109.934 179.095 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 45.98 64.06 2.62 Favored Glycine 0 C--O 1.225 -0.413 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.209 177.94 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 29' ' ' LYS . . . . . 0.421 ' CD ' ' HB2' ' A' ' 26' ' ' SER . 3.0 ptmt -127.5 8.51 6.47 Favored 'General case' 0 CA--C 1.511 -0.543 0 O-C-N 122.247 -0.56 . . . . 0.0 111.463 179.102 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.703 HG22 ' HG2' ' A' ' 24' ' ' PRO . 8.1 p -115.06 152.45 32.47 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -174.055 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -39.37 -59.16 1.92 Allowed Glycine 0 C--N 1.335 0.493 0 O-C-N 124.001 0.813 . . . . 0.0 112.544 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 29.7 t -62.46 -63.3 1.27 Allowed 'General case' 0 N--CA 1.441 -0.895 0 CA-C-O 116.273 -1.822 . . . . 0.0 111.166 176.042 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 159.63 -57.85 0.0 OUTLIER 'General case' 0 C--O 1.221 -0.418 0 O-C-N 126.085 2.115 . . . . 0.0 109.537 179.099 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.526 ' CD2' ' HD3' ' A' ' 84' ' ' PRO . 55.3 m-85 -55.8 145.09 53.8 Favored Pre-proline 0 N--CA 1.434 -1.229 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 179.234 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.585 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 22.5 Cg_endo -74.4 163.4 90.4 Favored 'Cis proline' 0 N--CA 1.447 -1.221 0 C-N-CA 122.822 -1.741 . . . . 0.0 111.428 -1.87 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.773 ' C ' HD23 ' A' ' 81' ' ' LEU . 1.5 p80 -137.22 175.1 9.91 Favored 'General case' 0 C--O 1.212 -0.914 0 O-C-N 120.981 -1.074 . . . . 0.0 110.339 -177.148 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.838 ' CZ3' HG22 ' A' ' 39' ' ' THR . 21.0 t90 -75.15 130.83 39.87 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.486 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.545 ' CE1' ' CD1' ' A' ' 121' ' ' ILE . 42.2 t80 -101.81 77.74 1.75 Allowed 'General case' 0 N--CA 1.427 -1.608 0 C-N-CA 126.009 1.724 . . . . 0.0 107.309 -178.975 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.838 HG22 ' CZ3' ' A' ' 37' ' ' TRP . 64.0 p -39.63 -31.78 0.11 Allowed 'General case' 0 C--O 1.215 -0.716 0 C-N-CA 124.297 1.039 . . . . 0.0 110.694 175.458 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.414 ' HB2' ' CD2' ' A' ' 38' ' ' PHE . 43.7 t30 60.47 14.08 4.57 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 122.861 1.315 . . . . 0.0 109.147 177.693 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.529 ' C ' HD23 ' A' ' 48' ' ' LEU . . . 116.3 -40.3 2.44 Favored Glycine 0 N--CA 1.423 -2.178 0 O-C-N 119.556 -1.965 . . . . 0.0 111.875 -174.312 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.734 ' N ' HD23 ' A' ' 48' ' ' LEU . 65.0 m-85 -49.54 156.12 0.69 Allowed 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.732 1.213 . . . . 0.0 110.392 -178.214 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.37 -39.4 20.74 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.576 178.08 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.416 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -162.41 -76.67 0.03 OUTLIER Glycine 0 C--N 1.339 0.741 0 C-N-CA 123.715 0.674 . . . . 0.0 111.623 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -114.0 -63.81 1.4 Allowed 'General case' 0 CA--C 1.509 -0.62 0 C-N-CA 122.514 0.326 . . . . 0.0 110.959 -179.598 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.12 -168.25 0.07 OUTLIER Glycine 0 C--N 1.353 1.513 0 O-C-N 124.274 0.983 . . . . 0.0 111.119 178.588 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.1 -164.43 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 124.62 2.152 . . . . 0.0 111.987 176.101 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.734 HD23 ' N ' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -105.9 178.04 1.21 Allowed Pre-proline 0 N--CA 1.433 -1.311 0 O-C-N 119.647 -1.908 . . . . 0.0 110.568 -179.478 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 49' ' ' PRO . . . . . 0.403 ' CD ' ' CB ' ' A' ' 48' ' ' LEU . 23.9 Cg_endo -73.01 177.61 7.54 Favored 'Trans proline' 0 N--CA 1.444 -1.416 0 C-N-CA 122.138 1.892 . . . . 0.0 111.685 178.396 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.8 tttm -83.83 102.0 12.03 Favored 'General case' 0 N--CA 1.444 -0.767 0 O-C-N 120.955 -1.091 . . . . 0.0 109.87 177.74 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 117.96 65.12 0.32 Allowed Glycine 0 C--O 1.223 -0.577 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.726 ' CD ' HD13 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -153.23 176.3 12.11 Favored 'General case' 0 CA--C 1.51 -0.574 0 C-N-CA 123.066 0.547 . . . . 0.0 110.625 178.72 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.9 m -154.24 107.0 2.43 Favored Pre-proline 0 C--O 1.215 -0.711 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.786 173.75 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -71.26 174.4 10.82 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 121.879 1.719 . . . . 0.0 111.783 178.809 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.506 HD12 HG21 ' A' ' 121' ' ' ILE . 4.1 mt -95.11 132.95 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.2 136.68 39.72 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.227 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.446 ' CD1' HD13 ' A' ' 133' ' ' LEU . 8.2 m-85 -121.94 -52.99 1.97 Allowed 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 123.098 0.559 . . . . 0.0 109.959 -179.273 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 126.45 -6.37 7.57 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 123.654 0.645 . . . . 0.0 112.285 -176.884 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.73 131.52 37.05 Favored 'General case' 0 CA--C 1.5 -0.975 0 CA-C-O 118.087 -0.958 . . . . 0.0 109.207 178.749 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 87.5 p -67.05 -7.53 23.48 Favored 'General case' 0 C--O 1.22 -0.496 0 O-C-N 125.056 1.473 . . . . 0.0 111.532 176.984 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.467 ' HB2' HG11 ' A' ' 116' ' ' VAL . 9.5 m-20 -89.64 -56.88 3.07 Favored 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 124.42 1.088 . . . . 0.0 109.629 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 68.6 m -69.64 -20.29 63.6 Favored 'General case' 0 N--CA 1.448 -0.569 0 O-C-N 123.859 0.724 . . . . 0.0 110.364 177.522 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -78.46 -41.77 31.79 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.321 0.648 . . . . 0.0 110.674 176.599 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.612 ' HD2' ' CD2' ' A' ' 78' ' ' HIS . 0.0 OUTLIER -50.7 159.8 0.87 Allowed Pre-proline 0 N--CA 1.443 -0.809 0 CA-C-O 121.503 0.668 . . . . 0.0 110.832 179.699 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.413 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 28.3 Cg_endo -72.01 136.88 28.14 Favored 'Trans proline' 0 N--CA 1.439 -1.695 0 C-N-CA 121.521 1.481 . . . . 0.0 114.264 173.704 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.535 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 19.0 Cg_endo -72.29 170.06 20.08 Favored 'Trans proline' 0 N--CA 1.445 -1.379 0 C-N-CA 122.786 2.324 . . . . 0.0 111.236 178.943 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -128.87 53.28 1.87 Allowed 'General case' 0 C--O 1.2 -1.514 0 CA-C-O 118.166 -0.921 . . . . 0.0 110.596 178.468 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 67.3 t60 -76.87 165.72 24.31 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 119.468 1.031 . . . . 0.0 111.061 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -157.55 -165.29 1.74 Allowed 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 121.17 -0.956 . . . . 0.0 110.962 177.194 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.85 75.01 10.4 Favored 'General case' 0 N--CA 1.445 -0.676 0 O-C-N 120.174 -1.579 . . . . 0.0 111.332 176.67 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -177.46 -45.25 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 123.291 0.636 . . . . 0.0 109.881 179.124 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.482 ' O ' ' CE2' ' A' ' 79' ' ' TYR . . . 122.92 -50.89 0.82 Allowed Glycine 0 N--CA 1.438 -1.203 0 CA-C-O 118.636 -1.091 . . . . 0.0 111.632 -176.888 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -151.54 82.97 1.3 Allowed 'General case' 0 N--CA 1.438 -1.075 0 CA-C-N 118.603 1.202 . . . . 0.0 107.962 178.116 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.03 -115.96 0.01 OUTLIER Glycine 0 C--O 1.222 -0.616 0 CA-C-O 123.083 1.38 . . . . 0.0 111.451 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.0 mttp -60.39 -98.37 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.46 0 O-C-N 119.681 -2.07 . . . . 0.0 110.648 178.052 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.57 HG23 ' O ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -109.37 16.1 22.59 Favored 'General case' 0 N--CA 1.447 -0.581 0 O-C-N 120.633 -1.292 . . . . 0.0 110.833 179.717 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.488 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 5.7 m-20 -29.31 103.44 0.02 OUTLIER 'General case' 0 C--O 1.203 -1.364 0 C-N-CA 124.807 1.243 . . . . 0.0 110.85 -177.958 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.612 ' CD2' ' HD2' ' A' ' 64' ' ' ARG . 5.9 p-80 -85.74 14.19 6.19 Favored 'General case' 0 CA--C 1.513 -0.447 0 O-C-N 121.39 -0.819 . . . . 0.0 110.209 -176.9 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.999 ' CZ ' HD11 ' A' ' 81' ' ' LEU . 0.3 OUTLIER -35.84 132.29 0.49 Allowed 'General case' 0 N--CA 1.426 -1.645 0 C-N-CA 124.911 1.285 . . . . 0.0 113.795 173.071 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.675 HD23 ' O ' ' A' ' 110' ' ' TYR . 0.4 OUTLIER -74.05 154.99 38.99 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 118.346 -0.835 . . . . 0.0 109.034 179.376 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.999 HD11 ' CZ ' ' A' ' 79' ' ' TYR . 1.2 mp -142.34 143.34 32.7 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 123.956 0.902 . . . . 0.0 109.647 178.322 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.495 ' CB ' ' CD1' ' A' ' 109' ' ' ILE . 0.2 OUTLIER -108.93 162.78 13.89 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-O 122.186 0.994 . . . . 0.0 111.233 179.464 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.552 ' CZ ' ' HB2' ' A' ' 23' ' ' ALA . 38.0 t80 -150.64 126.33 4.95 Favored Pre-proline 0 N--CA 1.443 -0.801 0 CA-C-N 115.626 -0.716 . . . . 0.0 112.312 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.526 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 21.5 Cg_endo -71.98 101.35 1.19 Allowed 'Trans proline' 0 N--CA 1.446 -1.292 0 C-N-CA 123.764 2.976 . . . . 0.0 111.01 -179.572 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -101.01 114.88 29.21 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 121.943 0.877 . . . . 0.0 110.661 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -81.4 160.96 63.69 Favored Pre-proline 0 N--CA 1.442 -0.868 0 O-C-N 121.423 -0.798 . . . . 0.0 112.483 178.478 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -76.67 -41.61 0.41 Allowed 'Trans proline' 0 CA--C 1.497 -1.358 0 C-N-CA 122.496 2.131 . . . . 0.0 112.962 179.071 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -45.09 -30.99 1.21 Allowed 'General case' 0 C--N 1.349 0.574 0 O-C-N 125.052 1.47 . . . . 0.0 110.021 177.895 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.66 -4.08 83.57 Favored Glycine 0 N--CA 1.427 -1.964 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 177.228 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -61.53 127.73 32.9 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.733 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -61.02 93.29 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 176.879 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.498 ' CD2' ' HB3' ' A' ' 94' ' ' PHE . 7.1 t80 -38.32 143.3 0.14 Allowed 'General case' 0 C--O 1.212 -0.92 0 CA-C-O 121.994 0.902 . . . . 0.0 110.813 179.572 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 12.2 ptpt -78.49 62.04 3.01 Favored 'General case' 0 C--N 1.318 -0.796 0 O-C-N 119.712 -1.867 . . . . 0.0 110.368 176.911 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.498 ' HB3' ' CD2' ' A' ' 92' ' ' TYR . 30.6 p90 -80.84 -8.34 59.68 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 123.372 0.669 . . . . 0.0 111.299 177.641 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -97.21 -32.63 11.83 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 122.095 0.95 . . . . 0.0 110.179 178.972 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.8 m -81.85 107.1 14.3 Favored 'General case' 0 N--CA 1.443 -0.8 0 O-C-N 121.181 -0.95 . . . . 0.0 108.731 -178.485 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.5 ptpt -59.31 -48.8 80.26 Favored 'General case' 0 C--O 1.224 -0.286 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.312 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.6 pttt -142.66 128.42 10.42 Favored Pre-proline 0 N--CA 1.431 -1.415 0 C-N-CA 124.208 1.003 . . . . 0.0 109.64 -176.371 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -71.25 176.92 34.72 Favored 'Cis proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.682 -1.799 . . . . 0.0 111.421 -3.827 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.4 146.52 38.46 Favored 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 122.953 0.501 . . . . 0.0 110.172 177.985 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -99.62 165.06 11.8 Favored 'General case' 0 C--N 1.319 -0.76 0 O-C-N 123.939 0.774 . . . . 0.0 110.776 178.725 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -57.45 153.42 28.4 Favored Pre-proline 0 N--CA 1.439 -1.013 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.528 177.595 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -74.12 -164.69 0.22 Allowed 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 122.453 2.102 . . . . 0.0 111.468 177.413 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -132.89 157.8 22.8 Favored Glycine 0 N--CA 1.444 -0.782 0 O-C-N 121.342 -0.848 . . . . 0.0 112.643 178.241 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -74.92 -64.36 0.03 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 122.474 2.116 . . . . 0.0 110.101 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.821 ' HA ' ' HB2' ' A' ' 122' ' ' ALA . . . -69.39 141.43 54.14 Favored 'General case' 0 N--CA 1.441 -0.883 0 O-C-N 123.502 0.501 . . . . 0.0 111.017 179.212 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 5.2 mtm-85 -142.86 143.86 32.26 Favored 'General case' 0 N--CA 1.442 -0.852 0 O-C-N 124.257 0.973 . . . . 0.0 111.204 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.441 ' CG1' ' HB3' ' A' ' 83' ' ' PHE . 4.8 p -83.39 124.67 39.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 O-C-N 124.016 0.823 . . . . 0.0 110.377 178.823 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.638 ' CG2' HD22 ' A' ' 80' ' ' LEU . 6.2 mm -103.91 140.44 22.05 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.914 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -179.336 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.675 ' O ' HD23 ' A' ' 80' ' ' LEU . 9.9 p90 -164.21 152.05 12.43 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-O 122.53 1.157 . . . . 0.0 111.287 -178.543 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.6 p -89.64 166.76 13.41 Favored 'General case' 0 C--N 1.319 -0.725 0 O-C-N 121.593 -0.692 . . . . 0.0 109.204 -178.255 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.578 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -110.95 153.8 43.65 Favored Pre-proline 0 N--CA 1.438 -1.029 0 C-N-CA 122.971 0.508 . . . . 0.0 111.168 179.263 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.578 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 19.5 Cg_endo -73.78 -55.28 0.14 OUTLIER 'Cis proline' 0 CA--C 1.501 -1.134 0 C-N-CA 123.001 -1.666 . . . . 0.0 109.759 -5.677 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.451 ' O ' HG23 ' A' ' 116' ' ' VAL . 2.3 t-20 -44.18 113.67 0.56 Allowed 'General case' 0 CA--C 1.5 -0.976 0 CA-C-O 115.653 -2.117 . . . . 0.0 109.823 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.753 ' HE2' HD13 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -63.24 78.61 0.02 OUTLIER 'General case' 0 CA--C 1.508 -0.663 0 O-C-N 125.529 1.768 . . . . 0.0 108.64 -178.3 . . . . . . . . 3 3 . 1 . 014 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.467 HG11 ' HB2' ' A' ' 61' ' ' ASP . 77.6 t -73.54 72.11 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 -176.011 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.411 ' HZ ' ' CZ2' ' A' ' 4' ' ' TRP . 42.0 t80 -37.46 104.96 0.03 OUTLIER 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 125.647 1.579 . . . . 0.0 110.15 -178.791 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 118' ' ' CYS . . . . . 0.528 ' SG ' HD21 ' A' ' 80' ' ' LEU . 5.7 m -82.72 -44.68 15.35 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 -178.184 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 158.03 -145.71 12.22 Favored Glycine 0 N--CA 1.44 -1.09 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.497 HG13 ' CG ' ' A' ' 4' ' ' TRP . 1.1 mm -127.43 145.7 34.43 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.212 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 -175.528 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.545 ' CD1' ' CE1' ' A' ' 38' ' ' PHE . 5.7 pt -137.39 151.93 27.01 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.937 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 -177.717 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.876 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . . . . . . . . 0 N--CA 1.447 -0.605 0 CA-C-O 122.088 0.947 . . . . 0.0 109.711 -178.719 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.2 pttt . . . . . 0 CA--C 1.501 -0.924 0 CA-C-O 118.263 -0.875 . . . . 0.0 108.779 . . . . . . . . . 0 0 . 1 . 014 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.468 ' HB2' ' CG2' ' A' ' 55' ' ' ILE . 9.0 tp -61.56 127.7 32.71 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 124.798 1.311 . . . . 0.0 109.1 179.613 . . . . . . . . 2 2 . 1 . 014 nuclear build core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 35.2 m -67.19 -174.36 0.36 Allowed 'General case' 0 N--CA 1.436 -1.156 0 CA-C-O 122.707 1.242 . . . . 0.0 109.39 177.612 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 66.3 m -151.1 101.33 2.86 Favored 'General case' 0 C--N 1.322 -0.613 0 O-C-N 121.468 -0.77 . . . . 0.0 109.354 -179.35 . . . . . . . . 1 1 . 1 . 014 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.655 ' HB2' HG22 ' A' ' 2' ' ' VAL . 0.4 OUTLIER . . . . . 0 C--O 1.247 0.969 0 CA-C-O 116.527 -1.702 . . . . 0.0 113.313 175.131 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.611 HG22 ' HB2' ' A' ' 136' ' ' HIS . 9.1 p . . . . . 0 C--O 1.237 0.441 0 CA-C-O 121.922 0.867 . . . . 0.0 109.564 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.9 m -90.09 115.38 27.31 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -176.537 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 4' ' ' TRP . . . . . 0.441 ' CD1' ' HB2' ' A' ' 13' ' ' GLN . 23.3 m95 -78.23 142.28 38.0 Favored 'General case' 0 C--O 1.215 -0.725 0 O-C-N 121.676 -0.64 . . . . 0.0 110.671 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -140.66 141.74 35.01 Favored 'General case' 0 CA--C 1.499 -1.008 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 -177.361 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.613 ' SG ' ' HB3' ' A' ' 122' ' ' ALA . 0.1 OUTLIER -119.67 -79.14 0.6 Allowed 'General case' 0 C--O 1.218 -0.598 0 O-C-N 124.467 1.104 . . . . 0.0 111.034 176.916 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -74.32 -87.45 0.23 Allowed Glycine 0 C--O 1.219 -0.804 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -179.125 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -143.67 12.61 2.2 Favored Glycine 0 C--O 1.221 -0.662 0 O-C-N 121.573 -0.957 . . . . 0.0 111.704 178.293 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 22.4 mt -113.9 155.49 25.68 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 117.824 0.812 . . . . 0.0 109.581 178.925 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.4 mp -106.78 133.37 51.54 Favored 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -175.668 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.606 ' CZ ' ' HB3' ' A' ' 106' ' ' ALA . 60.8 m-85 -124.58 91.4 3.44 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 125.749 1.62 . . . . 0.0 106.992 -170.349 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -53.48 121.07 6.95 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 117.708 -1.139 . . . . 0.0 108.745 179.095 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.441 ' HB2' ' CD1' ' A' ' 4' ' ' TRP . 2.4 tt0 -52.24 -50.78 61.35 Favored 'General case' 0 CA--C 1.498 -1.029 0 CA-C-O 117.243 -1.361 . . . . 0.0 111.173 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -50.42 -36.84 34.87 Favored 'General case' 0 C--O 1.194 -1.825 0 O-C-N 125.42 1.7 . . . . 0.0 110.615 178.75 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.4 mttp -71.59 -51.01 25.61 Favored 'General case' 0 C--O 1.212 -0.917 0 CA-C-O 116.526 -1.702 . . . . 0.0 115.428 166.893 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.86 -35.11 9.79 Favored 'General case' 0 C--O 1.211 -0.936 0 CA-C-N 121.653 2.024 . . . . 0.0 113.024 171.949 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -88.32 -40.81 13.31 Favored 'General case' 0 C--O 1.205 -1.285 0 C-N-CA 125.76 1.624 . . . . 0.0 110.471 172.139 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.434 ' O ' ' CE1' ' A' ' 22' ' ' HIS . 20.4 t -77.0 -59.12 2.91 Favored 'General case' 0 CA--C 1.501 -0.912 0 O-C-N 117.217 -3.427 . . . . 0.0 108.123 -172.488 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -45.38 -32.31 2.03 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 167.215 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.492 ' HB3' HG11 ' A' ' 108' ' ' VAL . 54.5 p -83.74 -24.56 31.1 Favored 'General case' 0 C--O 1.216 -0.691 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 173.049 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -55.98 -37.91 69.72 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 126.504 1.922 . . . . 0.0 108.701 178.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.434 ' CE1' ' O ' ' A' ' 18' ' ' SER . 0.1 OUTLIER -71.02 -44.45 65.85 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 117.15 -1.405 . . . . 0.0 110.178 178.899 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.598 ' HB1' ' HG3' ' A' ' 35' ' ' PRO . . . -39.99 126.04 1.62 Allowed Pre-proline 0 CA--C 1.549 0.934 0 O-C-N 126.058 2.099 . . . . 0.0 111.287 176.098 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.751 ' HG2' HG22 ' A' ' 30' ' ' THR . 13.5 Cg_endo -72.67 123.41 9.0 Favored 'Trans proline' 0 N--CA 1.445 -1.38 0 C-N-CA 122.433 2.089 . . . . 0.0 107.804 -175.972 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.65 HD13 ' HE2' ' A' ' 115' ' ' LYS . 3.4 tp -60.51 87.85 0.02 OUTLIER 'General case' 0 CA--C 1.507 -0.704 0 C-N-CA 124.514 1.126 . . . . 0.0 112.414 178.39 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.4 m -174.53 148.96 1.23 Allowed 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.993 1.317 . . . . 0.0 109.95 -171.581 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.407 ' HB3' ' HA3' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -86.81 113.71 22.86 Favored 'General case' 0 CA--C 1.508 -0.655 0 C-N-CA 124.136 0.974 . . . . 0.0 110.176 176.362 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 54.03 72.41 0.55 Allowed Glycine 0 CA--C 1.525 0.669 0 C-N-CA 119.402 -1.38 . . . . 0.0 111.996 177.189 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.04 21.41 2.27 Favored 'General case' 0 CA--C 1.504 -0.813 0 O-C-N 121.438 -1.036 . . . . 0.0 112.724 177.951 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.751 HG22 ' HG2' ' A' ' 24' ' ' PRO . 10.7 p -129.57 152.07 49.49 Favored 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 -171.693 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -38.43 -66.87 0.58 Allowed Glycine 0 N--CA 1.442 -0.919 0 O-C-N 124.502 1.126 . . . . 0.0 112.858 178.392 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.42 ' HA ' ' CE ' ' A' ' 100' ' ' LYS . 24.2 t -52.77 -65.46 0.55 Allowed 'General case' 0 CA--C 1.492 -1.28 0 CA-C-O 114.994 -2.431 . . . . 0.0 113.07 173.803 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 160.87 -53.18 0.0 OUTLIER 'General case' 0 C--O 1.219 -0.552 0 O-C-N 127.626 3.079 . . . . 0.0 109.507 178.611 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.533 ' CE2' ' CE1' ' A' ' 36' ' ' HIS . 50.9 m-85 -61.46 147.05 88.61 Favored Pre-proline 0 N--CA 1.439 -1.008 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.598 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 23.2 Cg_endo -74.55 150.53 95.66 Favored 'Cis proline' 0 N--CA 1.443 -1.477 0 C-N-CA 123.457 -1.476 . . . . 0.0 109.6 0.772 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.533 ' CE1' ' CE2' ' A' ' 34' ' ' TYR . 0.4 OUTLIER -126.72 160.64 30.21 Favored 'General case' 0 CA--C 1.499 -1.008 0 CA-C-O 117.062 -1.447 . . . . 0.0 109.003 179.242 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.918 ' CH2' HG22 ' A' ' 39' ' ' THR . 22.1 t90 -58.45 148.8 26.92 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 124.763 1.289 . . . . 0.0 109.184 177.527 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.501 ' CZ ' HD13 ' A' ' 121' ' ' ILE . 10.8 t80 -129.22 78.36 1.85 Allowed 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 103.711 -2.7 . . . . 0.0 103.711 -170.711 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.918 HG22 ' CH2' ' A' ' 37' ' ' TRP . 44.7 p -39.15 -34.96 0.2 Allowed 'General case' 0 C--O 1.204 -1.31 0 C-N-CA 124.81 1.244 . . . . 0.0 110.117 173.855 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 56.7 t30 66.86 11.98 8.62 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.683 1.593 . . . . 0.0 110.523 178.799 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 108.15 -6.83 34.76 Favored Glycine 0 CA--C 1.537 1.451 0 O-C-N 120.96 -1.088 . . . . 0.0 114.687 -170.066 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.695 ' CE1' HD11 ' A' ' 48' ' ' LEU . 6.1 m-85 -78.26 168.51 19.73 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 124.472 1.109 . . . . 0.0 109.782 -178.298 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.11 -37.36 17.46 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.748 175.973 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.58 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . 176.43 -60.31 0.1 Allowed Glycine 0 CA--C 1.506 -0.469 0 C-N-CA 124.179 0.895 . . . . 0.0 112.881 -177.784 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -115.85 -63.11 1.5 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 122.716 1.246 . . . . 0.0 110.819 179.125 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.24 165.89 8.95 Favored Glycine 0 C--N 1.339 0.728 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 177.872 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.56 ' HA ' ' CE2' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -59.2 -168.97 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 123.288 1.518 . . . . 0.0 111.325 178.082 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.695 HD11 ' CE1' ' A' ' 42' ' ' TYR . 4.7 mp -77.14 152.12 81.85 Favored Pre-proline 0 N--CA 1.43 -1.458 0 O-C-N 120.472 -1.392 . . . . 0.0 110.833 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -72.17 170.43 19.1 Favored 'Trans proline' 0 N--CA 1.445 -1.336 0 C-N-CA 122.539 2.159 . . . . 0.0 110.792 179.0 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.92 100.43 0.07 Allowed 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.619 -0.676 . . . . 0.0 109.378 176.338 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.75 56.48 0.37 Allowed Glycine 0 CA--C 1.51 -0.252 0 O-C-N 121.684 -0.635 . . . . 0.0 111.552 -177.844 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.429 ' CB ' ' HB3' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -150.36 165.52 32.82 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 118.573 -0.727 . . . . 0.0 112.454 174.214 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 54.1 m -145.02 97.29 4.86 Favored Pre-proline 0 C--O 1.233 0.21 0 O-C-N 125.338 1.649 . . . . 0.0 110.276 -176.807 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.507 ' HG3' HD13 ' A' ' 48' ' ' LEU . 20.4 Cg_endo -72.47 148.09 47.65 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.878 2.385 . . . . 0.0 110.88 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.438 HD12 HG21 ' A' ' 121' ' ' ILE . 6.7 mt -69.18 120.97 17.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -177.877 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.6 tppt? -83.03 135.24 34.92 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 120.897 -1.127 . . . . 0.0 108.652 177.805 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.61 ' CE1' HD13 ' A' ' 133' ' ' LEU . 7.9 m-85 -118.44 -51.61 2.4 Favored 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 123.786 0.834 . . . . 0.0 109.858 -178.982 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 122.32 -4.51 10.3 Favored Glycine 0 C--O 1.222 -0.613 0 CA-C-O 119.35 -0.695 . . . . 0.0 112.831 -175.282 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.435 ' HD3' ' CG1' ' A' ' 116' ' ' VAL . 1.6 mtpt -96.5 139.03 33.2 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-N 118.399 1.1 . . . . 0.0 110.553 175.832 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 23.2 t -74.77 -1.71 23.27 Favored 'General case' 0 C--O 1.222 -0.351 0 O-C-N 124.771 1.294 . . . . 0.0 111.961 175.027 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -87.95 -54.16 4.37 Favored 'General case' 0 CA--C 1.516 -0.364 0 O-C-N 120.793 -1.192 . . . . 0.0 108.709 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.585 ' HA ' HD11 ' A' ' 80' ' ' LEU . 2.7 m -75.47 -32.38 60.57 Favored 'General case' 0 N--CA 1.45 -0.438 0 O-C-N 124.028 0.83 . . . . 0.0 109.426 -178.845 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -62.88 -39.17 93.66 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 122.556 1.169 . . . . 0.0 110.811 173.056 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.602 ' HD3' ' CD2' ' A' ' 78' ' ' HIS . 0.0 OUTLIER -53.64 160.01 2.21 Favored Pre-proline 0 N--CA 1.444 -0.749 0 O-C-N 120.973 -1.079 . . . . 0.0 112.621 178.78 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -70.32 133.87 25.53 Favored 'Trans proline' 0 N--CA 1.438 -1.79 0 N-CA-C 114.697 0.999 . . . . 0.0 114.697 172.202 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.475 ' HD2' ' CD2' ' A' ' 42' ' ' TYR . 21.1 Cg_endo -70.46 168.92 21.07 Favored 'Trans proline' 0 N--CA 1.439 -1.685 0 C-N-CA 124.115 3.21 . . . . 0.0 111.238 176.665 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.9 tptt -128.05 51.75 1.94 Allowed 'General case' 0 C--O 1.199 -1.583 0 CA-C-N 115.02 -0.991 . . . . 0.0 108.826 177.808 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -75.66 168.82 19.3 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 119.921 -1.737 . . . . 0.0 110.972 178.395 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 24.0 p -161.67 -156.82 0.45 Allowed 'General case' 0 C--O 1.222 -0.375 0 O-C-N 120.994 -1.066 . . . . 0.0 111.846 174.317 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.11 70.88 9.13 Favored 'General case' 0 C--O 1.215 -0.719 0 O-C-N 120.67 -1.269 . . . . 0.0 112.739 172.315 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -176.08 -40.78 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.88 0.848 . . . . 0.0 109.701 177.483 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.407 ' HA3' ' HB3' ' A' ' 27' ' ' ASP . . . 108.67 -57.82 0.42 Allowed Glycine 0 C--O 1.212 -1.219 0 CA-C-O 118.389 -1.228 . . . . 0.0 111.761 -175.658 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -135.05 67.92 1.48 Allowed 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 105.529 -2.026 . . . . 0.0 105.529 -173.445 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.47 -119.24 0.01 OUTLIER Glycine 0 CA--C 1.529 0.93 0 CA-C-O 122.411 1.006 . . . . 0.0 113.001 177.801 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.7 mttt -63.79 -99.3 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.528 0 O-C-N 119.32 -2.282 . . . . 0.0 112.156 176.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.474 HG23 ' O ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -105.46 12.45 31.43 Favored 'General case' 0 C--N 1.317 -0.841 0 O-C-N 119.453 -2.03 . . . . 0.0 110.547 178.433 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.463 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 21.1 m-20 -29.66 105.83 0.03 OUTLIER 'General case' 0 C--O 1.201 -1.498 0 C-N-CA 126.234 1.813 . . . . 0.0 110.41 -176.479 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.602 ' CD2' ' HD3' ' A' ' 64' ' ' ARG . 2.7 p-80 -86.21 14.02 7.07 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 120.144 1.338 . . . . 0.0 110.082 -175.357 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.898 ' CZ ' HD11 ' A' ' 81' ' ' LEU . 0.4 OUTLIER -32.55 132.2 0.14 Allowed 'General case' 0 N--CA 1.439 -1.018 0 C-N-CA 126.015 1.726 . . . . 0.0 112.887 170.428 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.585 HD11 ' HA ' ' A' ' 62' ' ' CYS . 0.2 OUTLIER -75.61 155.53 35.8 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 121.015 -1.053 . . . . 0.0 109.067 178.238 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.898 HD11 ' CZ ' ' A' ' 79' ' ' TYR . 1.7 mp -141.81 134.36 28.28 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 118.874 0.761 . . . . 0.0 109.354 176.835 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.451 ' CB ' ' CD1' ' A' ' 109' ' ' ILE . 1.7 pm0 -103.13 154.56 19.17 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 122.842 1.306 . . . . 0.0 110.78 179.396 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.478 ' HZ ' ' CD2' ' A' ' 94' ' ' PHE . 37.8 t80 -141.79 138.82 17.5 Favored Pre-proline 0 C--O 1.218 -0.559 0 O-C-N 121.265 -0.897 . . . . 0.0 112.853 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.506 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 14.6 Cg_endo -72.15 88.35 0.84 Allowed 'Trans proline' 0 CA--C 1.485 -1.942 0 C-N-CA 124.658 3.572 . . . . 0.0 109.341 -173.29 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.7 t -80.11 116.62 20.32 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.674 0.789 . . . . 0.0 111.769 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.506 ' CD1' ' CE1' ' A' ' 92' ' ' TYR . 7.8 m-85 -84.65 159.09 58.88 Favored Pre-proline 0 C--N 1.318 -0.777 0 O-C-N 120.406 -1.434 . . . . 0.0 110.701 -179.556 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -76.42 -45.29 0.21 Allowed 'Trans proline' 0 N--CA 1.446 -1.291 0 C-N-CA 122.252 1.968 . . . . 0.0 111.544 178.766 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -53.62 -28.75 34.47 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 124.108 1.909 . . . . 0.0 110.229 177.275 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.73 -9.5 51.1 Favored Glycine 0 N--CA 1.436 -1.354 0 CA-C-O 116.458 -2.301 . . . . 0.0 112.133 -177.434 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 2.7 p80 -50.53 138.91 16.74 Favored 'General case' 0 C--O 1.209 -1.041 0 CA-C-O 116.805 -1.569 . . . . 0.0 107.887 178.609 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -62.1 143.51 56.57 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 120.88 1.673 . . . . 0.0 111.644 175.782 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.506 ' CE1' ' CD1' ' A' ' 86' ' ' PHE . 0.1 OUTLIER -98.01 155.08 17.28 Favored 'General case' 0 C--O 1.215 -0.756 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -174.159 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.73 55.11 2.59 Favored 'General case' 0 C--N 1.314 -0.935 0 O-C-N 118.515 -2.615 . . . . 0.0 111.053 172.18 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.478 ' CD2' ' HZ ' ' A' ' 83' ' ' PHE . 40.0 p90 -69.24 -26.74 64.94 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-O 117.828 -1.082 . . . . 0.0 110.877 175.412 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -90.09 -21.05 22.48 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 119.956 1.253 . . . . 0.0 111.442 179.234 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.7 m -108.77 101.05 10.21 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 -178.747 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.26 -29.57 67.5 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.896 0.855 . . . . 0.0 110.234 175.969 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.6 mttm -125.75 113.38 24.85 Favored Pre-proline 0 N--CA 1.444 -0.745 0 CA-C-O 117.654 -1.165 . . . . 0.0 109.276 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -70.29 173.36 46.84 Favored 'Cis proline' 0 C--N 1.356 0.926 0 O-C-N 124.44 1.758 . . . . 0.0 110.521 -3.556 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.42 ' CE ' ' HA ' ' A' ' 32' ' ' SER . 0.5 OUTLIER -130.39 145.99 51.89 Favored 'General case' 0 CA--C 1.507 -0.705 0 C-N-CA 125.293 1.437 . . . . 0.0 110.021 177.863 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.07 175.19 5.53 Favored 'General case' 0 C--O 1.243 0.733 0 O-C-N 125.751 1.907 . . . . 0.0 109.122 -177.869 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -76.49 139.83 67.9 Favored Pre-proline 0 N--CA 1.442 -0.849 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.916 176.626 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -72.74 -165.61 0.24 Allowed 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 122.523 2.149 . . . . 0.0 111.899 175.612 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -136.3 163.89 25.11 Favored Glycine 0 CA--C 1.525 0.679 0 O-C-N 120.853 -1.154 . . . . 0.0 112.891 176.236 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -76.62 -50.12 0.11 Allowed 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.464 2.109 . . . . 0.0 110.898 178.846 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.606 ' HB3' ' CZ ' ' A' ' 11' ' ' TYR . . . -75.29 142.51 43.27 Favored 'General case' 0 CA--C 1.51 -0.563 0 O-C-N 121.903 -0.498 . . . . 0.0 110.465 177.331 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.491 ' HG2' ' HA ' ' A' ' 84' ' ' PRO . 3.6 mtm-85 -143.81 145.69 32.53 Favored 'General case' 0 CA--C 1.5 -0.968 0 CA-C-O 117.721 -1.133 . . . . 0.0 112.415 178.32 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.492 HG11 ' HB3' ' A' ' 20' ' ' SER . 5.3 p -79.15 124.98 38.2 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.476 0 O-C-N 124.176 0.922 . . . . 0.0 110.62 177.769 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.524 HG12 HG23 ' A' ' 121' ' ' ILE . 4.4 mm -103.99 141.38 19.74 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 C-N-CA 123.914 0.886 . . . . 0.0 109.718 -179.086 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.502 ' O ' HD23 ' A' ' 80' ' ' LEU . 10.4 p90 -166.01 152.48 9.41 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 122.891 1.329 . . . . 0.0 110.034 -178.161 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.7 p -89.79 167.68 12.68 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.062 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.588 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.3 OUTLIER -108.46 153.83 41.86 Favored Pre-proline 0 CA--C 1.552 1.031 0 O-C-N 123.534 0.521 . . . . 0.0 111.341 177.182 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.588 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 14.1 Cg_endo -75.81 -55.27 0.14 OUTLIER 'Cis proline' 0 CA--C 1.49 -1.706 0 N-CA-C 107.998 -1.578 . . . . 0.0 107.998 -5.681 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -44.17 112.24 0.38 Allowed 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 116.279 -1.82 . . . . 0.0 109.713 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.65 ' HE2' HD13 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -66.44 76.17 0.1 Allowed 'General case' 0 CA--C 1.505 -0.755 0 C-N-CA 124.797 1.239 . . . . 0.0 107.985 -177.666 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.435 ' CG1' ' HD3' ' A' ' 59' ' ' LYS . 54.8 t -75.83 72.03 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 -176.255 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.56 ' CE1' ' HA2' ' A' ' 119' ' ' GLY . 7.6 t80 -39.08 111.17 0.17 Allowed 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 126.321 1.848 . . . . 0.0 106.84 -178.819 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 118' ' ' CYS . . . . . 0.548 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 0.1 OUTLIER -91.25 -22.78 20.41 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 121.126 -0.23 . . . . 0.0 110.405 175.974 . . . . . . . . 3 3 . 1 . 015 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.56 ' HA2' ' CE1' ' A' ' 117' ' ' PHE . . . 134.82 -170.31 22.86 Favored Glycine 0 CA--C 1.496 -1.148 0 C-N-CA 123.621 0.629 . . . . 0.0 112.1 -176.636 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.539 HG21 ' HB1' ' A' ' 106' ' ' ALA . 3.4 mp -107.67 151.53 9.66 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 -179.274 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.72 HG22 HD12 ' A' ' 133' ' ' LEU . 9.9 pt -120.94 154.72 24.5 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.621 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 177.327 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.613 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . . . . . . . . 0 C--N 1.325 -0.475 0 CA-C-O 123.644 1.688 . . . . 0.0 110.069 175.117 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.509 -0.631 0 CA-C-O 118.715 -0.66 . . . . 0.0 109.759 . . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.72 HD12 HG22 ' A' ' 121' ' ' ILE . 10.4 tp -84.41 141.44 30.83 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.656 1.223 . . . . 0.0 108.387 177.245 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 134' ' ' CYS . . . . . 0.537 ' SG ' HG22 ' A' ' 120' ' ' ILE . 79.4 m -60.64 -179.42 0.12 Allowed 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 123.264 1.507 . . . . 0.0 110.312 174.889 . . . . . . . . 2 2 . 1 . 015 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 13.2 m -159.06 87.79 0.87 Allowed 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 104.002 -2.592 . . . . 0.0 104.002 -176.993 . . . . . . . . 1 1 . 1 . 015 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.611 ' HB2' HG22 ' A' ' 2' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.257 1.48 0 CA-C-O 114.024 -2.893 . . . . 0.0 114.756 167.939 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.7 p . . . . . 0 C--O 1.234 0.285 0 CA-C-O 121.611 0.719 . . . . 0.0 109.974 . . . . . . . . . 0 0 . 1 . 016 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.9 m -88.04 114.49 24.71 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 123.665 0.786 . . . . 0.0 109.368 -178.927 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 19.5 m95 -79.01 144.32 34.81 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.052 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -138.61 134.35 33.65 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -178.426 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.617 ' SG ' ' HB3' ' A' ' 122' ' ' ALA . 0.1 OUTLIER -118.78 -84.19 0.65 Allowed 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.42 0.628 . . . . 0.0 110.374 176.911 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 7' ' ' GLY . . . . . 0.46 ' O ' HD12 ' A' ' 9' ' ' LEU . . . -92.85 75.1 1.26 Allowed Glycine 0 C--O 1.217 -0.927 0 CA-C-O 117.564 -1.687 . . . . 0.0 111.813 -177.447 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 45.9 27.5 2.4 Favored Glycine 0 N--CA 1.473 1.145 0 CA-C-N 118.96 1.38 . . . . 0.0 113.948 -175.885 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.46 HD12 ' O ' ' A' ' 7' ' ' GLY . 2.6 mt -129.98 149.17 51.82 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -174.912 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.584 HD22 ' H ' ' A' ' 10' ' ' LEU . 0.1 OUTLIER -100.42 155.15 17.98 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 124.487 1.117 . . . . 0.0 108.102 -173.826 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.775 ' CZ ' ' HB3' ' A' ' 106' ' ' ALA . 50.7 m-85 -158.72 86.03 0.84 Allowed 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 122.181 0.991 . . . . 0.0 108.872 -172.463 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -54.99 125.22 19.5 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-O 117.058 -1.449 . . . . 0.0 108.727 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -49.74 -35.07 20.88 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-N 119.106 0.866 . . . . 0.0 111.271 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.404 ' O ' ' CB ' ' A' ' 18' ' ' SER . 8.4 t-20 -61.07 -44.91 96.65 Favored 'General case' 0 C--O 1.204 -1.317 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.41 175.95 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.4 -42.88 64.67 Favored 'General case' 0 C--O 1.207 -1.15 0 CA-C-O 117.736 -1.126 . . . . 0.0 111.899 173.73 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -52.09 -39.8 60.3 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 119.893 1.224 . . . . 0.0 111.422 176.521 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -85.81 -47.91 9.27 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-O 117.907 -1.044 . . . . 0.0 110.387 176.099 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.404 ' CB ' ' O ' ' A' ' 14' ' ' ASN . 29.0 t -64.39 -59.42 4.38 Favored 'General case' 0 CA--C 1.499 -0.992 0 C-N-CA 125.982 1.713 . . . . 0.0 107.948 -173.368 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.471 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 13.4 t-20 -38.07 -40.51 0.49 Allowed 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 118.919 0.782 . . . . 0.0 112.362 172.019 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.6 -38.2 40.53 Favored 'General case' 0 C--O 1.218 -0.602 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 174.52 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -43.55 -36.04 1.93 Allowed 'General case' 0 C--N 1.34 0.191 0 C-N-CA 126.25 1.82 . . . . 0.0 109.87 178.037 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.471 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.1 OUTLIER -74.8 -52.0 12.59 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 124.318 1.047 . . . . 0.0 111.105 177.226 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.442 ' HB1' ' HG3' ' A' ' 35' ' ' PRO . . . -37.58 126.08 0.92 Allowed Pre-proline 0 CA--C 1.544 0.722 0 O-C-N 124.967 1.417 . . . . 0.0 111.629 174.826 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.637 ' HG2' HG22 ' A' ' 30' ' ' THR . 19.2 Cg_endo -73.09 132.18 17.77 Favored 'Trans proline' 0 N--CA 1.445 -1.343 0 C-N-CA 122.033 1.822 . . . . 0.0 110.125 -178.088 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.644 HD13 ' HE2' ' A' ' 115' ' ' LYS . 7.3 tp -59.79 112.42 1.83 Allowed 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.561 179.017 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 179.71 149.98 0.33 Allowed 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 122.617 0.367 . . . . 0.0 111.193 -178.715 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.549 ' HB2' ' CE2' ' A' ' 79' ' ' TYR . 4.2 t0 -86.86 78.99 8.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 122.024 0.916 . . . . 0.0 108.62 -179.378 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 28' ' ' GLY . . . . . 0.44 ' N ' ' HA ' ' A' ' 36' ' ' HIS . . . 68.38 76.93 0.4 Allowed Glycine 0 N--CA 1.451 -0.333 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 177.019 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -152.13 40.55 0.63 Allowed 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 122.342 1.068 . . . . 0.0 111.876 178.503 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.637 HG22 ' HG2' ' A' ' 24' ' ' PRO . 8.4 p -121.32 159.1 26.76 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 -176.665 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -37.66 -77.81 0.05 OUTLIER Glycine 0 C--N 1.333 0.407 0 C-N-CA 125.145 1.355 . . . . 0.0 111.846 -178.607 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.417 ' OG ' ' HE2' ' A' ' 100' ' ' LYS . 18.0 t -55.24 -57.11 13.15 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.137 177.493 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 161.1 -51.16 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.568 0 O-C-N 124.859 1.35 . . . . 0.0 111.44 178.191 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.426 ' CD1' ' HD3' ' A' ' 84' ' ' PRO . 90.2 m-85 -69.53 147.36 96.71 Favored Pre-proline 0 N--CA 1.444 -0.775 0 O-C-N 124.089 0.868 . . . . 0.0 112.915 178.591 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.597 ' CB ' HD21 ' A' ' 81' ' ' LEU . 28.4 Cg_endo -77.42 179.3 31.66 Favored 'Cis proline' 0 N--CA 1.446 -1.314 0 C-N-CA 122.359 -1.934 . . . . 0.0 112.426 2.572 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.44 ' HA ' ' N ' ' A' ' 28' ' ' GLY . 0.5 OUTLIER -154.29 167.58 29.47 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-O 118.322 -0.847 . . . . 0.0 110.972 -179.87 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.908 ' CH2' HG22 ' A' ' 39' ' ' THR . 17.9 t90 -61.74 152.23 31.76 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 122.183 0.992 . . . . 0.0 109.546 175.638 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.48 ' CE2' ' HB2' ' A' ' 40' ' ' ASN . 8.7 t80 -125.27 84.46 2.28 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 -175.411 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.908 HG22 ' CH2' ' A' ' 37' ' ' TRP . 62.3 p -38.67 -36.4 0.25 Allowed 'General case' 0 C--O 1.214 -0.784 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.234 173.372 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.48 ' HB2' ' CE2' ' A' ' 38' ' ' PHE . 51.3 t30 55.07 21.15 3.65 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-O 122.697 1.237 . . . . 0.0 110.849 177.816 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.594 ' HA3' HD23 ' A' ' 48' ' ' LEU . . . 106.9 -40.08 2.64 Favored Glycine 0 N--CA 1.423 -2.186 0 CA-C-O 118.504 -1.164 . . . . 0.0 114.431 -171.038 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.496 ' CE2' ' HD3' ' A' ' 66' ' ' PRO . 76.1 m-85 -48.72 155.42 0.57 Allowed 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 118.998 1.399 . . . . 0.0 111.761 177.492 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.44 -36.29 22.45 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.376 0.608 . . . . 0.0 110.796 178.428 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.512 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -172.21 -61.87 0.04 OUTLIER Glycine 0 C--N 1.335 0.498 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -178.864 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -123.33 -64.19 1.18 Allowed 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 122.542 0.337 . . . . 0.0 110.891 -178.515 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.64 -174.13 0.14 Allowed Glycine 0 C--N 1.345 1.043 0 C-N-CA 124.435 1.016 . . . . 0.0 110.676 178.703 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -59.99 -166.28 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 123.793 1.759 . . . . 0.0 110.687 178.581 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.736 ' H ' HD12 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -94.31 170.17 8.65 Favored Pre-proline 0 C--N 1.312 -1.034 0 O-C-N 120.995 -1.066 . . . . 0.0 110.217 -178.518 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -71.64 158.18 54.12 Favored 'Trans proline' 0 N--CA 1.441 -1.582 0 C-N-CA 121.913 1.742 . . . . 0.0 111.062 178.539 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.28 97.59 0.09 Allowed 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.983 177.459 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 119.85 39.31 0.66 Allowed Glycine 0 C--O 1.227 -0.283 0 CA-C-O 119.476 -0.624 . . . . 0.0 111.952 -176.914 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.47 ' HG2' ' CA ' ' A' ' 41' ' ' GLY . 0.0 OUTLIER -122.63 161.81 23.09 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 117.759 0.779 . . . . 0.0 111.283 177.103 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 26.0 m -139.74 98.32 7.91 Favored Pre-proline 0 C--N 1.328 -0.357 0 O-C-N 124.265 0.978 . . . . 0.0 110.054 -178.773 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -72.06 161.19 45.47 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 122.052 1.835 . . . . 0.0 111.674 178.747 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.448 HD12 HG21 ' A' ' 121' ' ' ILE . 6.9 mt -85.43 121.47 37.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 -178.81 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.66 135.07 35.13 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 177.542 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.582 ' CE1' HD13 ' A' ' 133' ' ' LEU . 15.1 m-85 -118.3 -51.87 2.4 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 123.354 0.661 . . . . 0.0 110.617 179.361 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 122.42 -2.09 10.4 Favored Glycine 0 C--O 1.226 -0.366 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.302 -176.938 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 33.9 mmtt -100.0 141.61 32.58 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-N 117.567 0.683 . . . . 0.0 110.195 177.241 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 44.9 t -76.22 -2.06 29.48 Favored 'General case' 0 C--O 1.221 -0.429 0 O-C-N 124.66 1.225 . . . . 0.0 111.226 176.522 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.618 ' OD2' HG11 ' A' ' 116' ' ' VAL . 0.7 OUTLIER -87.83 -55.56 3.72 Favored 'General case' 0 CA--C 1.512 -0.511 0 O-C-N 120.876 -1.14 . . . . 0.0 109.075 -179.196 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.738 ' HA ' HD11 ' A' ' 80' ' ' LEU . 2.0 m -74.38 -31.77 62.49 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 124.586 1.179 . . . . 0.0 109.383 -179.57 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -64.89 -38.24 90.3 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 122.279 1.037 . . . . 0.0 110.586 175.053 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.12 160.1 2.57 Favored Pre-proline 0 N--CA 1.445 -0.676 0 O-C-N 121.179 -0.95 . . . . 0.0 112.251 179.304 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.4 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 22.2 Cg_endo -71.2 140.62 37.73 Favored 'Trans proline' 0 N--CA 1.441 -1.586 0 C-N-CA 120.326 0.684 . . . . 0.0 113.422 175.629 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.496 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 22.9 Cg_endo -73.1 170.3 20.14 Favored 'Trans proline' 0 N--CA 1.446 -1.307 0 C-N-CA 123.542 2.828 . . . . 0.0 111.415 177.949 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.9 tptp -136.15 57.38 1.78 Allowed 'General case' 0 C--O 1.214 -0.789 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -178.913 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 43.8 t-80 -74.0 154.95 39.07 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 124.486 2.089 . . . . 0.0 113.09 175.285 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.07 -172.08 3.5 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 118.677 -2.514 . . . . 0.0 110.411 178.2 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -85.26 69.48 10.74 Favored 'General case' 0 N--CA 1.45 -0.44 0 O-C-N 121.947 -0.471 . . . . 0.0 111.042 176.717 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -177.76 -42.68 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 123.555 0.535 . . . . 0.0 110.112 179.365 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.507 ' CA ' ' HB3' ' A' ' 27' ' ' ASP . . . 124.98 -78.95 0.37 Allowed Glycine 0 N--CA 1.441 -0.967 0 CA-C-N 115.189 -0.914 . . . . 0.0 112.727 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -118.86 58.66 0.84 Allowed 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.236 1.015 . . . . 0.0 108.956 178.353 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -57.28 -105.58 0.01 OUTLIER Glycine 0 CA--C 1.525 0.701 0 CA-C-O 121.661 0.589 . . . . 0.0 112.695 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 22.1 mttt -60.97 -96.32 0.0 OUTLIER 'General case' 0 C--O 1.222 -0.384 0 O-C-N 121.197 -1.178 . . . . 0.0 111.259 177.393 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.583 HG23 ' O ' ' A' ' 76' ' ' THR . 0.6 OUTLIER -126.63 26.88 6.2 Favored 'General case' 0 CA--C 1.511 -0.527 0 O-C-N 121.645 -0.659 . . . . 0.0 111.086 178.902 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.476 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 1.9 m-20 -34.49 106.23 0.04 OUTLIER 'General case' 0 C--O 1.216 -0.689 0 C-N-CA 124.597 1.159 . . . . 0.0 109.91 -176.732 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.461 ' CD2' ' H ' ' A' ' 78' ' ' HIS . 0.4 OUTLIER -84.19 19.49 1.83 Allowed 'General case' 0 C--N 1.328 -0.354 0 O-C-N 121.142 -0.974 . . . . 0.0 110.63 -177.37 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.549 ' CE2' ' HB2' ' A' ' 27' ' ' ASP . 22.9 p90 -48.49 135.46 14.19 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 124.695 1.198 . . . . 0.0 110.818 177.933 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.738 HD11 ' HA ' ' A' ' 62' ' ' CYS . 0.2 OUTLIER -76.07 137.24 40.05 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.431 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.85 HD22 ' CZ ' ' A' ' 110' ' ' TYR . 0.3 OUTLIER -123.91 148.76 46.58 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.132 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -115.16 163.45 15.63 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.725 -0.671 . . . . 0.0 112.134 176.965 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.508 ' CD1' ' HD2' ' A' ' 84' ' ' PRO . 40.2 t80 -152.61 133.93 8.19 Favored Pre-proline 0 CA--C 1.534 0.352 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -178.981 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.508 ' HD2' ' CD1' ' A' ' 83' ' ' PHE . 17.8 Cg_endo -72.27 104.3 1.66 Allowed 'Trans proline' 0 N--CA 1.446 -1.299 0 C-N-CA 123.345 2.697 . . . . 0.0 110.626 -176.573 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.426 ' HA ' ' OD1' ' A' ' 19' ' ' ASN . 1.6 t -105.92 108.36 19.83 Favored 'General case' 0 CA--C 1.5 -0.947 0 O-C-N 124.356 1.035 . . . . 0.0 110.136 -178.773 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.438 ' CD2' ' NE2' ' A' ' 90' ' ' HIS . 1.4 m-85 -85.29 161.25 52.45 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-O 121.138 0.494 . . . . 0.0 111.372 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -76.33 -41.23 0.49 Allowed 'Trans proline' 0 CA--C 1.496 -1.395 0 C-N-CA 121.871 1.714 . . . . 0.0 112.711 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -39.54 -31.13 0.08 Allowed 'General case' 0 N--CA 1.469 0.497 0 O-C-N 124.989 1.431 . . . . 0.0 111.363 175.176 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 91.58 -9.96 75.85 Favored Glycine 0 N--CA 1.43 -1.76 0 C-N-CA 124.749 1.166 . . . . 0.0 111.892 179.234 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.438 ' NE2' ' CD2' ' A' ' 86' ' ' PHE . 0.5 OUTLIER -57.63 143.8 39.97 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 122.712 1.244 . . . . 0.0 109.089 177.447 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -88.6 122.54 32.16 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 174.827 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -48.11 170.02 0.02 OUTLIER 'General case' 0 C--O 1.214 -0.78 0 CA-C-O 123.213 1.482 . . . . 0.0 113.614 175.761 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.86 60.83 1.1 Allowed 'General case' 0 C--N 1.321 -0.634 0 O-C-N 119.371 -2.081 . . . . 0.0 107.33 -176.937 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.415 ' CD2' ' HZ ' ' A' ' 83' ' ' PHE . 7.3 p90 -81.12 14.91 2.09 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 121.742 -0.599 . . . . 0.0 112.1 177.417 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -108.46 -31.41 7.82 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.458 0.647 . . . . 0.0 109.982 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.8 m -113.87 116.09 28.75 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 123.175 0.59 . . . . 0.0 109.474 -179.589 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.8 pttm -58.33 -45.48 88.02 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.058 177.741 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.419 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 9.7 ttmt -142.07 131.9 12.47 Favored Pre-proline 0 N--CA 1.442 -0.87 0 CA-C-O 118.424 -0.798 . . . . 0.0 109.948 -179.138 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.419 ' C ' ' HA ' ' A' ' 98' ' ' LYS . 30.9 Cg_endo -70.25 175.37 38.41 Favored 'Cis proline' 0 N--CA 1.456 -0.724 0 O-C-N 124.769 1.931 . . . . 0.0 112.256 -4.437 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.417 ' HE2' ' OG ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -145.18 147.54 32.58 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 177.765 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -84.86 175.87 8.85 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.24 0.543 . . . . 0.0 111.276 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -73.13 140.67 80.36 Favored Pre-proline 0 CA--C 1.545 0.754 0 O-C-N 121.469 -0.769 . . . . 0.0 111.361 175.258 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -70.26 -161.85 0.09 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.47 2.114 . . . . 0.0 113.356 175.431 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -137.83 158.08 24.49 Favored Glycine 0 CA--C 1.523 0.592 0 O-C-N 120.948 -1.095 . . . . 0.0 111.625 176.485 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -74.4 -41.03 0.95 Allowed 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 122.242 1.962 . . . . 0.0 111.374 179.184 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.775 ' HB3' ' CZ ' ' A' ' 11' ' ' TYR . . . -90.28 138.23 31.7 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 121.082 0.467 . . . . 0.0 110.03 177.739 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.463 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 0.0 OUTLIER -139.32 151.82 46.71 Favored 'General case' 0 C--O 1.213 -0.845 0 CA-C-O 117.916 -1.04 . . . . 0.0 111.483 177.753 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.517 ' C ' HD12 ' A' ' 109' ' ' ILE . 3.3 p -82.62 120.71 34.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 123.958 0.903 . . . . 0.0 110.584 177.403 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.517 HD12 ' C ' ' A' ' 108' ' ' VAL . 1.7 mp -108.16 120.49 59.61 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.628 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 -176.756 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.85 ' CZ ' HD22 ' A' ' 81' ' ' LEU . 5.8 p90 -140.92 152.42 45.01 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 122.733 1.254 . . . . 0.0 110.149 -178.853 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.44 HG22 HD21 ' A' ' 80' ' ' LEU . 3.0 p -84.33 160.88 20.6 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.788 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.56 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.3 OUTLIER -113.01 152.83 45.26 Favored Pre-proline 0 CA--C 1.545 0.758 0 CA-C-O 120.464 0.173 . . . . 0.0 110.927 179.506 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.56 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 19.3 Cg_endo -74.25 -50.03 0.2 Allowed 'Cis proline' 0 CA--C 1.499 -1.261 0 C-N-CA 123.462 -1.474 . . . . 0.0 111.043 -5.021 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 32.6 t-20 -44.39 106.57 0.07 Allowed 'General case' 0 CA--C 1.512 -0.516 0 O-C-N 125.03 1.456 . . . . 0.0 108.801 178.582 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.644 ' HE2' HD13 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -67.88 68.56 0.11 Allowed 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 124.322 1.049 . . . . 0.0 108.811 -178.828 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.618 HG11 ' OD2' ' A' ' 61' ' ' ASP . 24.2 t -73.87 73.32 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 -177.787 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.561 ' CE1' ' HA2' ' A' ' 119' ' ' GLY . 4.6 t80 -37.26 117.1 0.51 Allowed 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 124.65 1.18 . . . . 0.0 108.139 179.132 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 118' ' ' CYS . . . . . 0.563 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -97.15 -34.08 11.26 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.744 177.328 . . . . . . . . 3 3 . 1 . 016 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.561 ' HA2' ' CE1' ' A' ' 117' ' ' PHE . . . 146.25 -175.09 25.9 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 123.484 0.564 . . . . 0.0 111.708 -178.375 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.711 HG21 ' HB1' ' A' ' 106' ' ' ALA . 3.3 mp -103.66 149.38 7.63 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.745 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -179.185 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.448 HG21 HD12 ' A' ' 55' ' ' ILE . 5.3 pt -122.16 151.85 26.03 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 178.873 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.617 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . . . . . . . . 0 C--N 1.326 -0.418 0 CA-C-O 122.558 1.171 . . . . 0.0 109.504 178.204 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.502 -0.885 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 . . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.582 HD13 ' CE1' ' A' ' 57' ' ' PHE . 9.9 tp -59.63 129.64 42.9 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 125.141 1.526 . . . . 0.0 107.42 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 134' ' ' CYS . . . . . 0.59 ' SG ' HG22 ' A' ' 120' ' ' ILE . 79.9 m -58.64 -177.22 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 125.031 1.457 . . . . 0.0 109.313 178.204 . . . . . . . . 2 2 . 1 . 016 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.2 m -152.22 81.6 1.25 Allowed 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 -176.8 . . . . . . . . 1 1 . 1 . 016 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.531 ' CD2' ' N ' ' A' ' 136' ' ' HIS . 0.1 OUTLIER . . . . . 0 C--O 1.242 0.692 0 CA-C-O 116.021 -1.942 . . . . 0.0 112.546 173.35 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 N--CA 1.465 0.294 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.827 HG21 HD23 ' A' ' 10' ' ' LEU . 9.3 m -101.9 105.14 15.91 Favored 'General case' 0 C--N 1.313 -1.013 0 O-C-N 121.584 -0.698 . . . . 0.0 109.373 -176.864 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 20.3 m95 -73.81 141.97 46.17 Favored 'General case' 0 C--O 1.217 -0.615 0 C-N-CA 124.202 1.001 . . . . 0.0 108.628 -178.258 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -135.23 144.33 46.84 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -179.339 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.607 ' SG ' ' HB3' ' A' ' 122' ' ' ALA . 0.8 OUTLIER -124.47 30.68 5.94 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 123.324 0.65 . . . . 0.0 112.571 175.404 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 153.08 -96.78 0.17 Allowed Glycine 0 C--O 1.223 -0.539 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -118.45 -4.48 13.58 Favored Glycine 0 N--CA 1.468 0.802 0 C-N-CA 123.649 0.642 . . . . 0.0 113.862 176.135 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.422 ' H ' HD12 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -104.53 133.38 49.49 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 -176.894 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.827 HD23 HG21 ' A' ' 3' ' ' THR . 4.8 mp -94.25 164.81 12.88 Favored 'General case' 0 C--O 1.221 -0.426 0 O-C-N 125.373 1.67 . . . . 0.0 110.4 -179.569 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.479 ' H ' HG22 ' A' ' 3' ' ' THR . 41.3 m-85 -157.62 84.19 0.9 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 125.086 1.354 . . . . 0.0 108.548 -170.956 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -54.33 122.85 11.25 Favored 'General case' 0 C--O 1.218 -0.57 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -179.129 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -52.08 -48.56 64.62 Favored 'General case' 0 C--O 1.212 -0.915 0 CA-C-N 119.753 1.16 . . . . 0.0 111.876 -179.163 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -48.0 -34.98 10.16 Favored 'General case' 0 C--O 1.207 -1.169 0 O-C-N 124.455 1.097 . . . . 0.0 111.548 176.331 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -76.38 -55.7 5.31 Favored 'General case' 0 C--O 1.202 -1.429 0 CA-C-O 114.991 -2.433 . . . . 0.0 114.262 168.187 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -43.38 -37.96 2.53 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 122.274 2.306 . . . . 0.0 113.89 173.264 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -82.16 -53.11 6.34 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 117.136 -1.411 . . . . 0.0 110.54 172.999 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 34.8 t -57.77 -22.3 46.25 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-N 119.923 1.238 . . . . 0.0 109.466 -177.787 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -75.39 -46.31 33.71 Favored 'General case' 0 N--CA 1.433 -1.304 0 O-C-N 120.277 -1.514 . . . . 0.0 110.596 176.351 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.38 -6.31 34.54 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.311 1.044 . . . . 0.0 112.405 173.854 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -73.55 -43.32 60.17 Favored 'General case' 0 C--O 1.222 -0.379 0 O-C-N 120.017 -1.677 . . . . 0.0 110.758 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -81.89 -35.17 29.51 Favored 'General case' 0 C--O 1.22 -0.5 0 C-N-CA 123.636 0.775 . . . . 0.0 111.304 178.862 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.733 ' HB1' ' HG3' ' A' ' 35' ' ' PRO . . . -42.92 125.65 3.2 Favored Pre-proline 0 N--CA 1.442 -0.833 0 O-C-N 125.11 1.506 . . . . 0.0 112.706 177.463 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.46 ' HG2' ' CG2' ' A' ' 30' ' ' THR . 19.3 Cg_endo -72.87 127.01 11.81 Favored 'Trans proline' 0 N--CA 1.446 -1.322 0 C-N-CA 122.327 2.018 . . . . 0.0 108.589 -175.419 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.562 HD23 ' CE2' ' A' ' 112' ' ' TYR . 0.9 OUTLIER -63.49 111.15 2.21 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.519 0.728 . . . . 0.0 109.244 178.877 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 26' ' ' SER . . . . . 0.707 ' O ' HD12 ' A' ' 81' ' ' LEU . 0.2 OUTLIER -176.46 175.29 1.79 Allowed 'General case' 0 C--O 1.209 -1.034 0 C-N-CA 123.815 0.846 . . . . 0.0 111.552 -179.421 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.458 ' HB3' ' CA ' ' A' ' 72' ' ' GLY . 3.5 t0 -115.54 85.55 2.3 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 176.799 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.68 71.42 1.13 Allowed Glycine 0 C--O 1.226 -0.381 0 N-CA-C 110.146 -1.181 . . . . 0.0 110.146 174.261 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.79 51.42 0.86 Allowed 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 122.942 1.353 . . . . 0.0 112.583 179.139 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.539 HG21 ' HD2' ' A' ' 35' ' ' PRO . 0.8 OUTLIER -137.5 149.02 46.48 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -173.356 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -41.07 -69.93 0.46 Allowed Glycine 0 CA--C 1.509 -0.33 0 O-C-N 124.829 1.331 . . . . 0.0 113.59 -175.826 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 47.2 t -56.65 -53.29 59.4 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 116.344 -1.788 . . . . 0.0 111.727 175.306 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 155.65 -34.91 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 127.653 2.381 . . . . 0.0 112.178 177.318 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.462 ' CE1' ' CZ ' ' A' ' 107' ' ' ARG . 92.7 m-85 -85.24 144.16 40.49 Favored Pre-proline 0 CA--C 1.544 0.713 0 N-CA-C 115.027 1.491 . . . . 0.0 115.027 178.203 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.733 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 40.8 Cg_endo -80.95 174.93 44.88 Favored 'Cis proline' 0 N--CA 1.435 -1.914 0 C-N-CA 122.628 -1.822 . . . . 0.0 112.199 5.149 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.404 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 0.3 OUTLIER -149.89 165.76 31.61 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 117.587 -1.197 . . . . 0.0 110.694 -175.585 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.65 ' CH2' HG22 ' A' ' 39' ' ' THR . 19.9 t90 -70.87 146.06 49.86 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 118.686 -1.205 . . . . 0.0 111.107 173.349 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -114.46 85.73 2.29 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 104.026 -2.583 . . . . 0.0 104.026 -176.845 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.65 HG22 ' CH2' ' A' ' 37' ' ' TRP . 60.5 p -36.63 -41.39 0.3 Allowed 'General case' 0 C--O 1.212 -0.892 0 CA-C-N 114.275 -1.33 . . . . 0.0 110.914 169.701 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 57.4 t30 58.31 20.19 7.02 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 122.972 1.368 . . . . 0.0 111.224 178.514 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 107.37 -39.81 2.75 Favored Glycine 0 N--CA 1.436 -1.345 0 CA-C-O 118.425 -1.208 . . . . 0.0 114.181 -168.988 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.421 ' CE2' ' HD3' ' A' ' 66' ' ' PRO . 86.9 m-85 -53.85 147.4 12.09 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 118.574 1.187 . . . . 0.0 110.392 -178.966 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -82.04 -36.77 27.39 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 122.216 1.008 . . . . 0.0 111.516 179.065 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 179.59 -56.89 0.08 OUTLIER Glycine 0 C--N 1.332 0.36 0 C-N-CA 124.995 1.284 . . . . 0.0 110.833 -178.722 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -78.84 -156.93 0.11 Allowed 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 123.434 1.587 . . . . 0.0 110.861 179.504 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 46' ' ' GLY . . . . . 0.481 ' CA ' ' HB2' ' A' ' 65' ' ' PRO . . . -88.59 44.26 3.15 Favored Glycine 0 N--CA 1.442 -0.934 0 CA-C-O 118.347 -1.252 . . . . 0.0 114.562 174.344 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.2 mtpt -146.21 160.62 41.73 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.12 1.368 . . . . 0.0 110.233 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.1 mp -125.99 155.8 72.68 Favored Pre-proline 0 C--O 1.241 0.621 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.931 -177.911 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -71.2 158.22 55.32 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.045 1.83 . . . . 0.0 110.011 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.81 105.79 0.14 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.536 0.734 . . . . 0.0 109.214 176.161 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.32 61.09 0.98 Allowed Glycine 0 N--CA 1.465 0.585 0 O-C-N 121.574 -0.704 . . . . 0.0 112.237 -176.643 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.8 tpm_? -134.79 151.61 51.09 Favored 'General case' 0 CA--C 1.51 -0.588 0 O-C-N 122.083 -0.657 . . . . 0.0 111.117 174.396 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.6 m -147.97 103.98 3.62 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.181 0.926 . . . . 0.0 109.285 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -71.16 154.82 61.91 Favored 'Trans proline' 0 N--CA 1.445 -1.33 0 C-N-CA 122.459 2.106 . . . . 0.0 110.867 176.262 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.548 HD12 HG21 ' A' ' 121' ' ' ILE . 12.0 mt -63.91 123.83 17.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 178.734 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.06 135.25 34.91 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.949 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.577 ' CD1' ' HB3' ' A' ' 118' ' ' CYS . 21.7 m-85 -116.27 -33.58 4.93 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 124.458 1.103 . . . . 0.0 110.754 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.06 -2.38 56.65 Favored Glycine 0 CA--C 1.525 0.707 0 O-C-N 121.558 -0.713 . . . . 0.0 113.406 -174.583 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.65 132.95 43.64 Favored 'General case' 0 CA--C 1.498 -1.056 0 CA-C-N 118.086 0.943 . . . . 0.0 109.875 176.923 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.82 -13.94 57.57 Favored 'General case' 0 C--O 1.217 -0.645 0 O-C-N 124.535 1.147 . . . . 0.0 112.222 177.191 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.433 ' HB2' HG11 ' A' ' 116' ' ' VAL . 0.1 OUTLIER -86.88 -49.67 7.23 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 125.295 1.438 . . . . 0.0 110.106 178.438 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.45 ' HB3' ' CD2' ' A' ' 57' ' ' PHE . 79.4 m -74.89 -9.9 58.98 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 124.015 0.822 . . . . 0.0 112.906 174.711 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -92.67 -41.39 10.2 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.308 1.443 . . . . 0.0 109.224 176.468 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.571 ' HD2' ' CD2' ' A' ' 78' ' ' HIS . 0.0 OUTLIER -51.14 157.26 1.55 Allowed Pre-proline 0 N--CA 1.45 -0.462 0 CA-C-O 122.189 0.995 . . . . 0.0 111.552 -177.738 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.481 ' HB2' ' CA ' ' A' ' 46' ' ' GLY . 26.7 Cg_endo -69.75 132.44 23.36 Favored 'Trans proline' 0 N--CA 1.43 -2.224 0 N-CA-C 114.193 0.805 . . . . 0.0 114.193 174.354 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.421 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 29.1 Cg_endo -69.39 168.11 22.01 Favored 'Trans proline' 0 N--CA 1.433 -2.066 0 C-N-CA 123.691 2.928 . . . . 0.0 111.129 175.814 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.4 tptt -127.99 123.31 34.46 Favored 'General case' 0 CA--C 1.507 -0.675 0 CA-C-O 115.472 -2.204 . . . . 0.0 105.101 176.148 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 14.1 t-80 -107.37 164.18 12.41 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 127.528 3.017 . . . . 0.0 110.888 171.92 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.06 175.53 13.31 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 122.406 1.098 . . . . 0.0 109.633 -178.982 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.21 48.7 1.52 Allowed 'General case' 0 C--O 1.218 -0.594 0 O-C-N 121.568 -0.707 . . . . 0.0 112.3 175.19 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -161.64 22.14 0.12 Allowed 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 122.614 1.197 . . . . 0.0 112.23 -178.691 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.458 ' CA ' ' HB3' ' A' ' 27' ' ' ASP . . . 73.92 -63.73 1.98 Allowed Glycine 0 CA--C 1.538 1.48 0 O-C-N 120.793 -1.192 . . . . 0.0 112.897 -169.911 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -108.08 -98.65 0.37 Allowed 'General case' 0 C--O 1.207 -1.145 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 175.001 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 123.52 -157.93 18.04 Favored Glycine 0 C--O 1.222 -0.65 0 O-C-N 119.795 -1.815 . . . . 0.0 110.644 -168.154 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.9 mttp -50.54 -84.29 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.919 0.888 . . . . 0.0 113.268 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.427 HG23 ' O ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -117.61 9.55 13.16 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 118.554 -0.736 . . . . 0.0 111.879 175.6 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.422 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 0.4 OUTLIER -26.2 97.95 0.01 OUTLIER 'General case' 0 C--O 1.211 -0.958 0 C-N-CA 126.671 1.988 . . . . 0.0 112.1 -179.325 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.571 ' CD2' ' HD2' ' A' ' 64' ' ' ARG . 12.9 p-80 -89.12 69.4 8.34 Favored 'General case' 0 CA--C 1.506 -0.721 0 O-C-N 119.446 -2.034 . . . . 0.0 107.326 -170.076 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.424 ' HB2' ' CD1' ' A' ' 37' ' ' TRP . 35.9 p90 -92.84 135.55 34.03 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 124.674 1.189 . . . . 0.0 109.575 -177.274 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.47 127.96 34.15 Favored 'General case' 0 C--O 1.213 -0.86 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 175.292 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.921 HD22 ' CZ ' ' A' ' 110' ' ' TYR . 0.1 OUTLIER -115.08 146.08 41.67 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 174.965 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -106.83 161.73 14.43 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 122.355 1.074 . . . . 0.0 112.214 173.995 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -153.95 140.23 12.68 Favored Pre-proline 0 C--N 1.328 -0.368 0 O-C-N 121.444 -0.785 . . . . 0.0 112.715 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.408 ' HA ' ' HG2' ' A' ' 107' ' ' ARG . 20.1 Cg_endo -70.99 95.72 0.67 Allowed 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 124.366 3.378 . . . . 0.0 112.844 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.8 t -101.54 104.49 15.39 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 122.436 1.112 . . . . 0.0 110.347 -177.169 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -80.61 160.87 66.07 Favored Pre-proline 0 C--N 1.32 -0.681 0 O-C-N 121.099 -1.001 . . . . 0.0 111.932 -179.569 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -76.39 -35.05 2.38 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.194 1.929 . . . . 0.0 113.664 177.098 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -43.02 -31.61 0.55 Allowed 'General case' 0 N--CA 1.475 0.781 0 O-C-N 125.213 1.57 . . . . 0.0 110.868 174.589 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.71 15.81 76.91 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.5 178.379 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -81.62 160.74 23.7 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 121.36 0.6 . . . . 0.0 109.824 177.42 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -97.11 92.28 5.97 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 174.223 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.506 ' CE2' ' HB3' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -47.57 162.52 0.07 Allowed 'General case' 0 C--O 1.223 -0.303 0 CA-C-O 123.105 1.431 . . . . 0.0 113.194 175.68 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.18 59.1 5.39 Favored 'General case' 0 C--N 1.319 -0.759 0 O-C-N 120.026 -1.671 . . . . 0.0 110.899 177.531 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -75.09 -16.47 60.56 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.755 175.303 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -92.66 -23.25 19.03 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 123.873 1.797 . . . . 0.0 111.478 179.355 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.51 109.82 19.88 Favored 'General case' 0 CA--C 1.513 -0.458 0 O-C-N 119.892 -1.755 . . . . 0.0 109.131 177.871 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.2 ptpt -59.45 -46.55 88.45 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 121.354 0.597 . . . . 0.0 112.109 176.932 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 99' ' ' PRO . 1.1 mtmt -141.52 127.22 11.0 Favored Pre-proline 0 N--CA 1.444 -0.75 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.107 -178.151 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 98' ' ' LYS . 28.5 Cg_endo -70.5 173.04 48.9 Favored 'Cis proline' 0 N--CA 1.456 -0.714 0 C-N-CA 123.288 -1.547 . . . . 0.0 110.951 -5.018 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.47 149.62 52.06 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 123.526 0.73 . . . . 0.0 109.243 177.443 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 101' ' ' GLU . . . . . 0.506 ' HB3' ' CE2' ' A' ' 92' ' ' TYR . 2.9 tt0 -100.91 176.72 5.18 Favored 'General case' 0 C--N 1.316 -0.889 0 O-C-N 123.938 0.774 . . . . 0.0 111.773 176.437 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -83.14 126.34 72.47 Favored Pre-proline 0 CA--C 1.541 0.631 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 179.059 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.419 ' HB3' ' CE2' ' A' ' 34' ' ' TYR . 31.7 Cg_endo -67.6 -166.32 0.13 Allowed 'Trans proline' 0 N--CA 1.452 -0.94 0 CA-C-O 123.371 1.321 . . . . 0.0 113.226 176.407 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -139.42 173.04 22.97 Favored Glycine 0 CA--C 1.523 0.558 0 O-C-N 121.02 -1.05 . . . . 0.0 112.679 176.277 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -75.05 -57.92 0.05 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 123.017 2.478 . . . . 0.0 111.101 178.786 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.459 ' CB ' ' CE2' ' A' ' 11' ' ' TYR . . . -60.87 133.38 56.04 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-O 120.979 0.419 . . . . 0.0 111.155 177.879 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.476 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 6.8 mtm-85 -147.35 149.48 32.88 Favored 'General case' 0 CA--C 1.497 -1.084 0 CA-C-O 117.194 -1.384 . . . . 0.0 110.522 179.5 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.469 ' C ' HD12 ' A' ' 109' ' ' ILE . 2.8 p -81.86 118.92 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 O-C-N 124.434 1.084 . . . . 0.0 110.493 175.414 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.469 HD12 ' C ' ' A' ' 108' ' ' VAL . 1.8 mp -108.07 117.51 53.81 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.662 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 -177.656 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.921 ' CZ ' HD22 ' A' ' 81' ' ' LEU . 8.0 p90 -134.1 153.21 51.96 Favored 'General case' 0 N--CA 1.447 -0.621 0 O-C-N 124.252 0.97 . . . . 0.0 109.56 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.8 p -84.28 162.72 20.01 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.231 178.195 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.562 ' CE2' HD23 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -110.06 154.87 42.52 Favored Pre-proline 0 CA--C 1.548 0.884 0 O-C-N 122.014 -0.429 . . . . 0.0 110.61 178.747 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.496 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 17.9 Cg_endo -74.15 -48.81 0.25 Allowed 'Cis proline' 0 CA--C 1.509 -0.749 0 C-N-CA 123.934 -1.278 . . . . 0.0 111.515 -8.987 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -45.8 107.77 0.11 Allowed 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 117.62 -1.181 . . . . 0.0 108.895 175.496 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.445 ' HE2' HD13 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -67.84 68.46 0.11 Allowed 'General case' 0 CA--C 1.512 -0.509 0 C-N-CA 125.711 1.604 . . . . 0.0 108.09 -179.4 . . . . . . . . 3 3 . 1 . 017 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.433 HG11 ' HB2' ' A' ' 61' ' ' ASP . 18.0 t -73.19 78.89 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 N-CA-C 102.992 -2.966 . . . . 0.0 102.992 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.519 ' CE1' ' HA2' ' A' ' 119' ' ' GLY . 5.2 t80 -37.82 118.9 0.71 Allowed 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 125.339 1.456 . . . . 0.0 108.93 176.548 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 118' ' ' CYS . . . . . 0.577 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 7.3 m -95.22 -45.31 7.23 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 121.763 0.792 . . . . 0.0 109.304 179.367 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.519 ' HA2' ' CE1' ' A' ' 117' ' ' PHE . . . 156.16 -166.55 33.13 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 -178.713 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.592 HG22 ' SG ' ' A' ' 134' ' ' CYS . 3.0 mp -117.03 132.67 66.12 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.343 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 -178.275 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.774 HG22 HD12 ' A' ' 133' ' ' LEU . 10.2 pt -108.44 154.62 9.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.607 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . . . . . . . . 0 C--N 1.323 -0.564 0 CA-C-O 121.733 0.778 . . . . 0.0 110.637 175.449 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.512 -0.482 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 . . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.774 HD12 HG22 ' A' ' 121' ' ' ILE . 6.0 tp -81.33 146.18 30.49 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 175.894 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 134' ' ' CYS . . . . . 0.592 ' SG ' HG22 ' A' ' 120' ' ' ILE . 87.2 m -61.4 175.01 0.63 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 123.488 1.613 . . . . 0.0 109.614 172.241 . . . . . . . . 2 2 . 1 . 017 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 72.0 m -161.4 90.99 0.83 Allowed 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 104.198 -2.519 . . . . 0.0 104.198 -175.188 . . . . . . . . 1 1 . 1 . 017 nuclear build core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.474 0.726 0 CA-C-O 115.656 -2.116 . . . . 0.0 115.305 169.631 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.6 p . . . . . 0 CA--C 1.518 -0.285 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 . . . . . . . . . 0 0 . 1 . 018 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.599 HG21 HD22 ' A' ' 10' ' ' LEU . 0.9 OUTLIER -85.59 112.25 20.8 Favored 'General case' 0 C--N 1.32 -0.698 0 O-C-N 121.907 -0.496 . . . . 0.0 110.469 178.504 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 4' ' ' TRP . . . . . 0.471 ' CG ' HG13 ' A' ' 120' ' ' ILE . 29.9 m95 -79.13 139.16 38.11 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 123.091 0.556 . . . . 0.0 110.951 176.54 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.447 ' OG1' HD23 ' A' ' 10' ' ' LEU . 0.9 OUTLIER -121.36 124.66 45.07 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -177.81 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.673 ' HB3' ' HB3' ' A' ' 122' ' ' ALA . 13.6 m -113.65 40.68 2.35 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.267 0.556 . . . . 0.0 110.912 177.598 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 138.05 -94.84 0.22 Allowed Glycine 0 C--O 1.223 -0.574 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 -179.138 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.545 ' C ' HD13 ' A' ' 9' ' ' LEU . . . -123.79 1.62 9.3 Favored Glycine 0 N--CA 1.463 0.434 0 C-N-CA 123.074 0.369 . . . . 0.0 112.803 177.393 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.623 ' N ' HD13 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -107.8 140.44 40.88 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 -173.428 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.599 HD22 HG21 ' A' ' 3' ' ' THR . 17.1 mt -106.07 121.01 43.27 Favored 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 124.258 0.974 . . . . 0.0 109.311 -177.48 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.526 ' CE2' ' CB ' ' A' ' 106' ' ' ALA . 61.2 m-85 -116.06 99.94 7.61 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 124.966 1.307 . . . . 0.0 108.968 -175.137 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -56.26 122.28 11.42 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-O 118.234 -0.889 . . . . 0.0 108.982 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.416 ' HB2' ' CD1' ' A' ' 4' ' ' TRP . 23.2 tp60 -50.09 -46.97 53.92 Favored 'General case' 0 C--O 1.21 -0.987 0 O-C-N 123.978 0.799 . . . . 0.0 112.105 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 14' ' ' ASN . . . . . 0.402 ' O ' ' CB ' ' A' ' 18' ' ' SER . 5.5 t-20 -50.07 -41.54 48.22 Favored 'General case' 0 C--O 1.201 -1.482 0 O-C-N 123.211 0.319 . . . . 0.0 110.975 176.541 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.12 -37.12 75.23 Favored 'General case' 0 C--O 1.204 -1.302 0 CA-C-O 116.916 -1.516 . . . . 0.0 113.076 170.429 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.04 -44.95 79.28 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 121.813 2.097 . . . . 0.0 113.151 172.847 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -82.52 -37.67 24.9 Favored 'General case' 0 C--O 1.211 -0.927 0 C-N-CA 123.203 0.601 . . . . 0.0 109.715 176.836 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.402 ' CB ' ' O ' ' A' ' 14' ' ' ASN . 28.8 t -73.98 -60.02 2.45 Favored 'General case' 0 CA--C 1.505 -0.777 0 O-C-N 119.751 -1.843 . . . . 0.0 109.521 -176.422 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.474 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 45.9 t30 -40.75 -37.4 0.75 Allowed 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 124.543 1.137 . . . . 0.0 112.359 172.127 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.565 ' HB3' HG11 ' A' ' 108' ' ' VAL . 1.0 OUTLIER -82.52 -36.45 26.36 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 174.561 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -45.76 -38.56 7.19 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 126.288 1.835 . . . . 0.0 110.133 178.563 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.474 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -72.05 -47.43 51.65 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 123.826 0.85 . . . . 0.0 112.145 175.793 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.725 ' HB1' ' HG3' ' A' ' 35' ' ' PRO . . . -37.88 130.25 0.94 Allowed Pre-proline 0 N--CA 1.443 -0.785 0 O-C-N 124.762 1.289 . . . . 0.0 112.079 174.165 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.724 ' HG2' HG22 ' A' ' 30' ' ' THR . 16.4 Cg_endo -73.31 124.48 9.49 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 121.836 1.691 . . . . 0.0 108.939 -176.381 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.626 HD13 ' HE2' ' A' ' 115' ' ' LYS . 3.9 tp -60.94 93.27 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 123.635 0.774 . . . . 0.0 111.227 179.367 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 178.55 155.0 0.4 Allowed 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 122.957 0.503 . . . . 0.0 110.092 -174.032 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.77 123.18 39.22 Favored 'General case' 0 CA--C 1.508 -0.642 0 C-N-CA 123.973 0.909 . . . . 0.0 109.006 178.825 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 48.04 70.25 0.78 Allowed Glycine 0 C--N 1.335 0.482 0 CA-C-O 122.104 0.835 . . . . 0.0 111.895 176.602 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -149.09 30.18 0.79 Allowed 'General case' 0 CA--C 1.51 -0.58 0 O-C-N 121.831 -0.805 . . . . 0.0 111.962 179.562 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.724 HG22 ' HG2' ' A' ' 24' ' ' PRO . 36.4 p -127.52 147.23 50.32 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -175.859 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -41.23 -55.35 3.62 Favored Glycine 0 N--CA 1.448 -0.556 0 O-C-N 123.981 0.8 . . . . 0.0 112.082 -178.928 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 29.2 t -67.37 -70.64 0.24 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 118.803 -0.618 . . . . 0.0 111.474 175.183 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.1 p 176.03 -57.66 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 124.306 1.042 . . . . 0.0 112.85 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -67.48 151.55 97.05 Favored Pre-proline 0 N--CA 1.427 -1.609 0 C-N-CA 124.131 0.972 . . . . 0.0 112.066 178.583 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.725 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 24.5 Cg_endo -74.62 164.06 89.0 Favored 'Cis proline' 0 N--CA 1.455 -0.74 0 C-N-CA 123.144 -1.607 . . . . 0.0 111.103 -1.536 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.421 ' CD2' ' HG2' ' A' ' 82' ' ' GLU . 0.3 OUTLIER -143.17 161.4 38.32 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 117.474 -1.251 . . . . 0.0 109.662 -179.034 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.959 ' CH2' HG22 ' A' ' 39' ' ' THR . 13.7 t90 -59.33 138.67 57.55 Favored 'General case' 0 N--CA 1.446 -0.629 0 O-C-N 124.937 1.398 . . . . 0.0 110.137 177.827 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.538 ' CZ ' HD13 ' A' ' 121' ' ' ILE . 9.8 t80 -109.13 85.83 2.17 Favored 'General case' 0 N--CA 1.423 -1.782 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 -176.018 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.959 HG22 ' CH2' ' A' ' 37' ' ' TRP . 20.1 p -38.69 -34.6 0.15 Allowed 'General case' 0 CA--C 1.495 -1.138 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.653 170.745 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.484 ' HB2' ' CE2' ' A' ' 38' ' ' PHE . 62.9 t30 53.8 22.58 3.29 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 120.854 1.661 . . . . 0.0 111.625 177.675 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.738 ' C ' HD23 ' A' ' 48' ' ' LEU . . . 104.27 -44.28 1.51 Allowed Glycine 0 N--CA 1.419 -2.488 0 CA-C-O 117.26 -1.855 . . . . 0.0 115.218 -168.578 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.506 ' CE2' ' HD3' ' A' ' 66' ' ' PRO . 84.8 m-85 -43.34 151.1 0.17 Allowed 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.691 1.597 . . . . 0.0 112.279 176.294 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.82 -36.39 25.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.326 0.584 . . . . 0.0 111.884 177.894 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.52 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -165.3 -77.63 0.03 OUTLIER Glycine 0 C--N 1.34 0.794 0 C-N-CA 124.459 1.028 . . . . 0.0 111.846 -179.078 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -109.41 -67.98 0.95 Allowed 'General case' 0 CA--C 1.513 -0.459 0 C-N-CA 123.521 0.728 . . . . 0.0 111.029 -179.245 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.23 -170.71 0.11 Allowed Glycine 0 C--N 1.348 1.233 0 C-N-CA 124.436 1.017 . . . . 0.0 110.967 178.679 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -58.77 -167.64 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 124.296 1.998 . . . . 0.0 111.703 177.356 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.738 HD23 ' C ' ' A' ' 41' ' ' GLY . 0.0 OUTLIER -86.78 163.47 40.96 Favored Pre-proline 0 N--CA 1.44 -0.968 0 O-C-N 120.139 -1.601 . . . . 0.0 110.566 -179.354 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -71.83 171.51 16.39 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 122.067 1.844 . . . . 0.0 111.077 178.056 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -58.79 96.44 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.196 177.131 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.33 88.4 1.97 Allowed Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 111.895 -0.482 . . . . 0.0 111.895 -177.533 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.507 ' HB3' HD22 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -166.55 163.75 17.02 Favored 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 123.795 0.838 . . . . 0.0 111.557 176.283 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 97.7 m -143.6 95.07 5.94 Favored Pre-proline 0 C--O 1.236 0.389 0 O-C-N 124.33 1.019 . . . . 0.0 109.604 -176.882 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -72.98 169.75 21.43 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.529 2.153 . . . . 0.0 110.901 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.405 ' CG2' ' HB2' ' A' ' 133' ' ' LEU . 6.4 mt -99.58 134.22 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -178.2 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -86.09 157.6 20.01 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 121.107 0.479 . . . . 0.0 110.182 176.7 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.432 ' CD1' ' HB3' ' A' ' 118' ' ' CYS . 26.2 m-85 -140.65 -46.85 0.41 Allowed 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 123.805 0.842 . . . . 0.0 111.036 178.233 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 112.57 -4.42 26.29 Favored Glycine 0 C--N 1.338 0.664 0 C-N-CA 123.523 0.582 . . . . 0.0 113.057 -175.104 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.91 134.84 38.42 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-O 117.859 -1.067 . . . . 0.0 110.388 176.982 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 20.1 t -69.23 -6.36 28.68 Favored 'General case' 0 C--O 1.225 -0.222 0 O-C-N 125.127 1.517 . . . . 0.0 111.538 176.617 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.69 -56.88 3.07 Favored 'General case' 0 N--CA 1.446 -0.674 0 O-C-N 120.289 -1.507 . . . . 0.0 109.614 -179.45 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 27.7 m -70.99 -18.06 62.62 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 123.789 0.68 . . . . 0.0 110.688 177.218 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -80.28 -41.0 25.79 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 123.678 0.791 . . . . 0.0 111.515 174.806 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.598 ' HD2' ' CD2' ' A' ' 78' ' ' HIS . 0.0 OUTLIER -52.04 158.97 1.57 Allowed Pre-proline 0 N--CA 1.444 -0.766 0 CA-C-O 122.282 1.039 . . . . 0.0 111.033 179.404 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -71.02 136.21 29.17 Favored 'Trans proline' 0 N--CA 1.444 -1.395 0 C-N-CA 121.003 1.135 . . . . 0.0 113.673 174.149 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.506 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 19.2 Cg_endo -72.54 171.34 17.35 Favored 'Trans proline' 0 N--CA 1.446 -1.287 0 C-N-CA 122.957 2.438 . . . . 0.0 111.015 178.581 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.4 tptt -128.41 49.93 2.14 Favored 'General case' 0 C--O 1.212 -0.9 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.936 178.545 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.442 ' CE1' ' CE3' ' A' ' 37' ' ' TRP . 56.2 t-80 -77.13 161.25 28.39 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 120.132 -1.605 . . . . 0.0 112.126 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -161.56 177.89 9.6 Favored 'General case' 0 CA--C 1.502 -0.896 0 O-C-N 118.787 -2.445 . . . . 0.0 108.178 176.878 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.2 pttp -64.68 74.22 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 124.858 1.263 . . . . 0.0 111.724 175.379 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 179.56 -47.58 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 125.524 1.53 . . . . 0.0 110.294 -176.322 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 113.31 -71.89 0.22 Allowed Glycine 0 CA--C 1.488 -1.621 0 CA-C-O 118.805 -0.997 . . . . 0.0 112.157 -177.541 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -128.81 64.33 1.45 Allowed 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 125.934 1.694 . . . . 0.0 107.803 -177.731 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.56 -110.63 0.01 OUTLIER Glycine 0 C--N 1.334 0.454 0 CA-C-O 122.391 0.995 . . . . 0.0 112.543 178.817 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.5 mttp -63.22 -98.4 0.0 OUTLIER 'General case' 0 C--O 1.222 -0.372 0 O-C-N 119.792 -2.005 . . . . 0.0 111.75 177.562 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.54 HG23 ' O ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -114.23 15.93 18.06 Favored 'General case' 0 CA--C 1.51 -0.593 0 O-C-N 120.608 -1.307 . . . . 0.0 111.082 178.239 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.475 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 29.0 m-20 -30.5 107.5 0.04 OUTLIER 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 124.787 1.235 . . . . 0.0 110.16 -177.236 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.598 ' CD2' ' HD2' ' A' ' 64' ' ' ARG . 4.4 p-80 -87.43 14.52 7.94 Favored 'General case' 0 CA--C 1.511 -0.524 0 O-C-N 121.654 -0.654 . . . . 0.0 110.561 -177.068 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.529 ' HB2' ' CD1' ' A' ' 37' ' ' TRP . 14.9 p90 -39.51 137.34 0.83 Allowed 'General case' 0 N--CA 1.429 -1.514 0 C-N-CA 125.592 1.557 . . . . 0.0 110.715 176.973 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.669 HD22 ' CG2' ' A' ' 109' ' ' ILE . 0.3 OUTLIER -71.88 157.87 37.07 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.622 177.244 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.514 HD21 ' CE2' ' A' ' 79' ' ' TYR . 5.5 mp -139.67 120.77 14.7 Favored 'General case' 0 CA--C 1.501 -0.925 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 -177.903 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.497 ' CB ' ' CD1' ' A' ' 109' ' ' ILE . 0.5 OUTLIER -92.36 152.68 19.63 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-O 122.259 1.028 . . . . 0.0 111.585 178.723 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.505 ' CZ ' ' HB2' ' A' ' 23' ' ' ALA . 12.6 t80 -145.23 134.05 11.04 Favored Pre-proline 0 N--CA 1.444 -0.762 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.583 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -74.62 112.92 3.67 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.959 2.44 . . . . 0.0 110.188 -177.672 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.6 t -104.73 110.45 22.78 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 124.323 1.014 . . . . 0.0 110.079 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.438 ' CE1' ' HB2' ' A' ' 92' ' ' TYR . 70.1 m-85 -82.02 157.92 68.05 Favored Pre-proline 0 N--CA 1.445 -0.69 0 O-C-N 121.424 -0.797 . . . . 0.0 112.25 178.85 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -76.63 -42.25 0.36 Allowed 'Trans proline' 0 CA--C 1.501 -1.15 0 C-N-CA 122.555 2.17 . . . . 0.0 112.332 179.561 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -44.69 -30.92 1.02 Allowed 'General case' 0 C--N 1.353 0.731 0 CA-C-O 122.159 0.98 . . . . 0.0 110.855 176.688 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 85.23 8.77 81.06 Favored Glycine 0 N--CA 1.434 -1.47 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 177.279 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 4.2 p-80 -73.84 128.38 35.36 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.58 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.36 93.15 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 123.601 0.76 . . . . 0.0 109.76 173.286 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.47 ' O ' ' CD2' ' A' ' 94' ' ' PHE . 12.9 t80 -39.7 144.58 0.17 Allowed 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 121.967 0.889 . . . . 0.0 111.19 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.38 57.31 1.49 Allowed 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 120.011 -1.68 . . . . 0.0 109.988 176.666 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.47 ' CD2' ' O ' ' A' ' 92' ' ' TYR . 34.3 p90 -71.19 -9.91 58.88 Favored 'General case' 0 N--CA 1.439 -1.018 0 C-N-CA 124.085 0.954 . . . . 0.0 112.168 175.711 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -89.7 -36.41 15.23 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 123.131 1.443 . . . . 0.0 110.451 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.9 m -84.46 111.29 19.34 Favored 'General case' 0 N--CA 1.441 -0.904 0 O-C-N 120.341 -1.474 . . . . 0.0 109.394 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.0 ptpt -58.75 -47.92 82.99 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-O 120.945 0.403 . . . . 0.0 111.235 178.3 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -143.18 130.51 10.84 Favored Pre-proline 0 N--CA 1.432 -1.346 0 C-N-CA 123.78 0.832 . . . . 0.0 109.378 -177.312 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.403 ' HA ' ' HA ' ' A' ' 98' ' ' LYS . 24.7 Cg_endo -70.1 175.44 37.65 Favored 'Cis proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.284 -1.965 . . . . 0.0 111.007 -6.484 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.43 147.03 42.86 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.902 178.313 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -87.94 173.41 8.93 Favored 'General case' 0 C--O 1.24 0.591 0 O-C-N 123.837 0.711 . . . . 0.0 112.133 177.211 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -72.5 143.03 84.73 Favored Pre-proline 0 N--CA 1.442 -0.853 0 CA-C-O 118.117 -0.944 . . . . 0.0 111.165 177.295 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -73.15 -164.8 0.21 Allowed 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.266 2.644 . . . . 0.0 111.739 176.327 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -140.97 164.5 26.44 Favored Glycine 0 N--CA 1.44 -1.046 0 O-C-N 121.581 -0.7 . . . . 0.0 112.478 177.359 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -75.39 -60.24 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.692 2.262 . . . . 0.0 110.481 179.127 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.779 ' HA ' ' HB2' ' A' ' 122' ' ' ALA . . . -63.31 139.83 58.81 Favored 'General case' 0 N--CA 1.438 -1.031 0 O-C-N 123.689 0.618 . . . . 0.0 111.62 178.206 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 1.5 mtm-85 -143.14 143.48 31.83 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.307 -179.503 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.565 HG11 ' HB3' ' A' ' 20' ' ' SER . 7.0 p -83.14 124.13 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 O-C-N 123.92 0.762 . . . . 0.0 110.479 178.789 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.669 ' CG2' HD22 ' A' ' 80' ' ' LEU . 6.3 mm -106.23 140.91 22.8 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.892 0 C-N-CA 122.823 0.449 . . . . 0.0 110.157 -179.231 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.621 ' C ' HD23 ' A' ' 80' ' ' LEU . 9.7 p90 -165.48 153.1 10.83 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-O 122.042 0.925 . . . . 0.0 110.483 -177.413 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.4 p -88.8 165.53 14.62 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.776 -178.907 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.547 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.2 OUTLIER -111.29 154.09 43.79 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 122.184 0.193 . . . . 0.0 111.368 178.761 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.547 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 19.0 Cg_endo -73.87 -52.85 0.16 OUTLIER 'Cis proline' 0 CA--C 1.499 -1.256 0 C-N-CA 123.525 -1.448 . . . . 0.0 109.708 -6.883 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -43.24 110.93 0.22 Allowed 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 117.628 -1.177 . . . . 0.0 109.914 178.761 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.626 ' HE2' HD13 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -66.96 72.45 0.1 Allowed 'General case' 0 CA--C 1.51 -0.585 0 C-N-CA 124.429 1.092 . . . . 0.0 108.519 -178.116 . . . . . . . . 3 3 . 1 . 018 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.433 ' O ' HG12 ' A' ' 116' ' ' VAL . 36.9 t -72.32 77.4 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 N-CA-C 105.596 -2.001 . . . . 0.0 105.596 -176.919 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.428 ' CZ ' ' HA2' ' A' ' 119' ' ' GLY . 41.5 t80 -39.57 107.1 0.06 Allowed 'General case' 0 N--CA 1.435 -1.219 0 C-N-CA 126.002 1.721 . . . . 0.0 110.034 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 118' ' ' CYS . . . . . 0.474 ' SG ' HD21 ' A' ' 80' ' ' LEU . 10.2 m -81.94 -46.13 14.47 Favored 'General case' 0 N--CA 1.436 -1.175 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 -178.113 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.428 ' HA2' ' CZ ' ' A' ' 117' ' ' PHE . . . 160.4 -147.73 15.03 Favored Glycine 0 N--CA 1.441 -0.998 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.471 HG13 ' CG ' ' A' ' 4' ' ' TRP . 1.2 mm -128.64 138.94 53.23 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.929 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 -175.682 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.538 HD13 ' CZ ' ' A' ' 38' ' ' PHE . 7.6 pt -130.0 154.94 41.13 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -177.922 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.779 ' HB2' ' HA ' ' A' ' 106' ' ' ALA . . . . . . . . 0 N--CA 1.445 -0.72 0 CA-C-O 121.794 0.807 . . . . 0.0 109.714 179.109 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 132' ' ' LYS . . . . . 0.421 ' HE3' ' O ' ' A' ' 133' ' ' LEU . 2.5 ptmt . . . . . 0 CA--C 1.509 -0.615 0 CA-C-O 119.094 -0.479 . . . . 0.0 109.712 . . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.537 HD12 HG22 ' A' ' 121' ' ' ILE . 11.6 tp -86.76 136.25 33.07 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-O 121.646 0.736 . . . . 0.0 109.448 177.678 . . . . . . . . 2 2 . 1 . 018 nuclear build core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 50.7 m -66.02 -179.61 0.76 Allowed 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 124.152 0.981 . . . . 0.0 109.389 175.627 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 68.4 m -159.44 92.08 1.04 Allowed 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 -178.17 . . . . . . . . 1 1 . 1 . 018 nuclear build core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.257 1.496 0 CA-C-O 113.965 -2.921 . . . . 0.0 113.682 170.493 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.5 p . . . . . 0 C--O 1.235 0.29 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 . . . . . . . . . 0 0 . 1 . 019 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.937 HG21 HD23 ' A' ' 10' ' ' LEU . 5.9 m -94.79 107.78 19.8 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 123.634 0.774 . . . . 0.0 110.62 178.984 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 20.4 m95 -78.57 141.42 38.11 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.005 0.922 . . . . 0.0 108.879 179.416 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -132.63 138.09 47.24 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.659 ' SG ' ' HB3' ' A' ' 122' ' ' ALA . 0.5 OUTLIER -121.63 64.53 0.9 Allowed 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 114.838 -1.073 . . . . 0.0 108.674 177.834 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 37.6 75.03 0.09 OUTLIER Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.851 1.215 . . . . 0.0 114.104 178.803 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 159.87 -75.03 0.2 Allowed Glycine 0 C--O 1.226 -0.404 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 -175.346 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 74.2 mt -126.69 159.91 32.3 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 122.12 0.962 . . . . 0.0 110.34 177.337 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.937 HD23 HG21 ' A' ' 3' ' ' THR . 9.9 mp -87.96 167.48 13.68 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.143 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.656 ' CZ ' ' HB3' ' A' ' 106' ' ' ALA . 65.4 m-85 -156.09 87.17 1.05 Allowed 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 125.276 1.43 . . . . 0.0 108.386 -173.175 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -53.47 120.11 5.69 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-O 117.832 -1.08 . . . . 0.0 108.457 177.814 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -49.27 -43.77 43.31 Favored 'General case' 0 C--O 1.212 -0.876 0 CA-C-N 119.865 1.211 . . . . 0.0 111.629 178.842 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -48.89 -42.37 36.57 Favored 'General case' 0 C--O 1.201 -1.462 0 CA-C-N 117.779 0.263 . . . . 0.0 111.187 176.087 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.47 -44.36 62.42 Favored 'General case' 0 C--O 1.21 -1.026 0 O-C-N 120.416 -1.427 . . . . 0.0 112.644 169.602 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.503 ' HB1' HD11 ' A' ' 120' ' ' ILE . . . -52.11 -38.49 57.58 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 121.4 1.909 . . . . 0.0 112.907 175.379 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -86.06 -48.89 8.23 Favored 'General case' 0 C--O 1.21 -1.022 0 CA-C-O 117.51 -1.234 . . . . 0.0 108.971 175.66 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.2 t -69.45 -57.88 4.69 Favored 'General case' 0 CA--C 1.504 -0.797 0 C-N-CA 126.599 1.96 . . . . 0.0 109.483 -173.173 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.445 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 9.4 t-20 -42.17 -36.6 1.23 Allowed 'General case' 0 C--O 1.217 -0.627 0 CA-C-N 119.536 1.062 . . . . 0.0 110.745 169.664 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.448 ' O ' ' HB3' ' A' ' 23' ' ' ALA . 1.4 p -83.53 -29.74 27.66 Favored 'General case' 0 C--O 1.218 -0.564 0 N-CA-C 114.911 1.449 . . . . 0.0 114.911 176.161 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -50.31 -35.67 28.47 Favored 'General case' 0 C--O 1.222 -0.351 0 C-N-CA 126.696 1.999 . . . . 0.0 109.826 178.532 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.445 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.1 OUTLIER -71.59 -49.54 39.37 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 125.43 1.492 . . . . 0.0 111.193 175.946 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.719 ' HB1' ' HG3' ' A' ' 35' ' ' PRO . . . -39.39 123.15 1.38 Allowed Pre-proline 0 C--O 1.239 0.529 0 O-C-N 124.867 1.355 . . . . 0.0 111.807 174.852 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.536 ' HG2' HG22 ' A' ' 30' ' ' THR . 18.1 Cg_endo -70.76 126.37 12.57 Favored 'Trans proline' 0 N--CA 1.445 -1.366 0 C-N-CA 122.083 1.855 . . . . 0.0 108.868 -177.044 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.863 HD21 ' O ' ' A' ' 113' ' ' PRO . 4.9 tp -62.91 94.54 0.07 Allowed 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.449 0.7 . . . . 0.0 112.219 178.959 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.1 m 179.98 153.64 0.52 Allowed 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 125.082 1.353 . . . . 0.0 110.163 -173.022 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.61 119.16 31.77 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.436 1.494 . . . . 0.0 109.367 176.235 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 49.86 69.69 0.99 Allowed Glycine 0 CA--C 1.525 0.708 0 CA-C-O 122.189 0.883 . . . . 0.0 112.476 174.347 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.5 mtpt -145.95 22.89 1.39 Allowed 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -178.549 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.536 HG22 ' HG2' ' A' ' 24' ' ' PRO . 33.6 p -123.45 150.97 43.18 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 124.398 1.079 . . . . 0.0 108.693 -177.169 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -38.65 -63.44 1.01 Allowed Glycine 0 CA--C 1.522 0.477 0 C-N-CA 124.705 1.145 . . . . 0.0 113.712 178.448 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.415 ' HB3' ' HA ' ' A' ' 94' ' ' PHE . 44.1 t -63.64 -59.4 4.65 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 118.312 -0.851 . . . . 0.0 112.071 174.497 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.0 m 158.9 -48.61 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.872 2.069 . . . . 0.0 112.17 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.535 ' CD2' ' HD3' ' A' ' 84' ' ' PRO . 63.3 m-85 -64.48 145.54 98.43 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-O 117.801 -1.095 . . . . 0.0 112.909 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.719 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 28.6 Cg_endo -73.35 158.53 98.38 Favored 'Cis proline' 0 N--CA 1.448 -1.198 0 C-N-CA 123.577 -1.426 . . . . 0.0 111.137 -4.132 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.808 ' C ' HD23 ' A' ' 81' ' ' LEU . 2.1 p80 -137.19 170.56 15.88 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-N 114.713 -1.131 . . . . 0.0 109.565 -176.337 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.906 ' CH2' HG22 ' A' ' 39' ' ' THR . 22.7 t90 -71.56 148.03 47.07 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.99 0.9 . . . . 0.0 109.243 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.517 ' CE2' ' HB2' ' A' ' 40' ' ' ASN . 27.5 t80 -124.31 78.24 1.64 Allowed 'General case' 0 N--CA 1.435 -1.182 0 C-N-CA 127.11 2.164 . . . . 0.0 106.003 -177.71 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.906 HG22 ' CH2' ' A' ' 37' ' ' TRP . 77.0 p -37.04 -39.91 0.26 Allowed 'General case' 0 C--O 1.218 -0.571 0 C-N-CA 124.421 1.088 . . . . 0.0 111.6 171.911 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.517 ' HB2' ' CE2' ' A' ' 38' ' ' PHE . 46.0 t30 59.69 16.06 5.19 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 122.428 1.109 . . . . 0.0 110.907 178.678 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.545 ' C ' HD23 ' A' ' 48' ' ' LEU . . . 115.11 -40.89 2.31 Favored Glycine 0 N--CA 1.44 -1.049 0 CA-C-O 117.435 -1.758 . . . . 0.0 111.619 -172.7 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.442 ' CD1' ' HD2' ' A' ' 66' ' ' PRO . 76.2 m-85 -49.34 159.53 0.31 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.202 1.501 . . . . 0.0 112.295 -179.627 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.25 -35.82 23.14 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 122.589 1.185 . . . . 0.0 111.317 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.465 ' HA2' ' CZ2' ' A' ' 37' ' ' TRP . . . 145.04 -31.44 1.73 Allowed Glycine 0 C--O 1.218 -0.863 0 C-N-CA 125.185 1.374 . . . . 0.0 111.586 -176.701 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.9 -54.28 5.72 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 119.049 1.425 . . . . 0.0 111.575 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 157.23 33.13 0.02 OUTLIER Glycine 0 C--N 1.336 0.541 0 O-C-N 124.309 1.006 . . . . 0.0 112.748 -177.642 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 29.2 mttt -142.07 159.8 41.51 Favored 'General case' 0 CA--C 1.507 -0.7 0 C-N-CA 124.36 1.064 . . . . 0.0 109.088 178.846 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.545 HD23 ' C ' ' A' ' 41' ' ' GLY . 3.8 mt -108.01 147.96 36.52 Favored Pre-proline 0 N--CA 1.446 -0.657 0 O-C-N 124.429 1.081 . . . . 0.0 110.613 -179.406 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -72.62 177.66 7.23 Favored 'Trans proline' 0 N--CA 1.446 -1.3 0 C-N-CA 124.251 3.301 . . . . 0.0 111.278 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.9 ttpt -76.94 102.69 6.5 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 120.575 -1.328 . . . . 0.0 109.938 175.05 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.3 83.69 1.75 Allowed Glycine 0 C--O 1.222 -0.653 0 O-C-N 124.216 0.948 . . . . 0.0 110.945 177.55 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.452 ' CG ' HD22 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -163.2 172.91 14.09 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 124.444 1.097 . . . . 0.0 110.056 178.803 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.9 m -152.79 107.93 2.7 Favored Pre-proline 0 C--N 1.327 -0.384 0 O-C-N 123.635 0.585 . . . . 0.0 110.77 174.0 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -70.79 145.89 52.36 Favored 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 122.288 1.992 . . . . 0.0 111.166 177.012 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.508 HD12 HG21 ' A' ' 121' ' ' ILE . 16.9 mt -70.42 119.96 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.147 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 3.8 tttt -84.01 132.67 34.72 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 176.574 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.574 ' CD1' ' HB3' ' A' ' 118' ' ' CYS . 10.9 m-85 -114.54 -53.51 2.65 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 124.818 1.247 . . . . 0.0 111.273 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 121.28 -6.31 10.84 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.587 1.089 . . . . 0.0 113.21 -176.444 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -91.92 131.07 37.51 Favored 'General case' 0 CA--C 1.509 -0.621 0 O-C-N 121.606 -0.938 . . . . 0.0 110.233 177.188 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 32.3 t -68.77 -2.43 9.38 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 124.891 1.369 . . . . 0.0 111.802 176.456 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.466 ' OD2' HG11 ' A' ' 116' ' ' VAL . 0.5 OUTLIER -88.21 -54.06 4.39 Favored 'General case' 0 CA--C 1.518 -0.284 0 O-C-N 120.252 -1.53 . . . . 0.0 108.967 178.587 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.629 ' HB3' HD21 ' A' ' 80' ' ' LEU . 1.9 m -77.11 -34.27 56.81 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 123.814 0.696 . . . . 0.0 110.422 -178.954 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -62.27 -37.66 86.34 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.322 0.649 . . . . 0.0 111.186 173.874 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.493 ' HD3' ' CD2' ' A' ' 78' ' ' HIS . 0.0 OUTLIER -51.35 159.6 1.11 Allowed Pre-proline 0 N--CA 1.448 -0.557 0 CA-C-O 121.485 0.659 . . . . 0.0 112.123 178.77 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -68.73 120.62 7.52 Favored 'Trans proline' 0 N--CA 1.444 -1.392 0 C-N-CA 120.742 0.961 . . . . 0.0 111.573 174.455 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.442 ' HD2' ' CD1' ' A' ' 42' ' ' TYR . 25.4 Cg_endo -69.19 168.53 20.55 Favored 'Trans proline' 0 N--CA 1.447 -1.262 0 C-N-CA 124.233 3.289 . . . . 0.0 111.261 175.116 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.7 tptp -131.12 136.46 48.39 Favored 'General case' 0 C--O 1.211 -0.967 0 CA-C-O 118.042 -0.98 . . . . 0.0 108.43 176.902 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -115.32 160.52 19.7 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 125.516 1.527 . . . . 0.0 108.593 177.744 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -150.59 170.63 18.7 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.735 179.359 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.93 60.61 6.32 Favored 'General case' 0 C--O 1.217 -0.613 0 C-N-CA 123.068 0.547 . . . . 0.0 111.406 177.639 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -175.16 -38.4 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.299 0.64 . . . . 0.0 110.967 -179.07 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 125.48 -67.18 0.53 Allowed Glycine 0 C--N 1.336 0.573 0 C-N-CA 125.071 1.319 . . . . 0.0 109.929 -178.106 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -128.48 62.14 1.46 Allowed 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 127.905 2.482 . . . . 0.0 107.925 -174.501 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -61.64 -104.35 0.01 OUTLIER Glycine 0 CA--C 1.529 0.926 0 CA-C-O 121.706 0.615 . . . . 0.0 112.299 176.99 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.2 mttt -65.42 -92.92 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 O-C-N 120.736 -1.449 . . . . 0.0 112.009 177.763 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.484 HG23 ' O ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -128.62 14.4 6.49 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 121.553 -0.717 . . . . 0.0 110.877 178.282 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.448 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 47.1 m-20 -27.95 102.83 0.02 OUTLIER 'General case' 0 C--O 1.208 -1.098 0 C-N-CA 125.491 1.516 . . . . 0.0 111.564 -178.255 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.493 ' CD2' ' HD3' ' A' ' 64' ' ' ARG . 12.2 p-80 -94.59 65.34 3.13 Favored 'General case' 0 CA--C 1.505 -0.766 0 O-C-N 120.214 -1.554 . . . . 0.0 108.432 -170.268 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.898 ' CE2' HD11 ' A' ' 81' ' ' LEU . 13.7 p90 -93.97 141.75 28.16 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 124.523 1.129 . . . . 0.0 110.574 -176.471 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.629 HD21 ' HB3' ' A' ' 62' ' ' CYS . 0.3 OUTLIER -69.29 141.38 54.34 Favored 'General case' 0 C--O 1.216 -0.673 0 C-N-CA 119.694 -0.802 . . . . 0.0 110.496 173.895 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.898 HD11 ' CE2' ' A' ' 79' ' ' TYR . 0.8 OUTLIER -128.75 143.51 50.94 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 124.69 1.196 . . . . 0.0 110.339 176.236 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -106.41 153.93 21.53 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 122.717 1.246 . . . . 0.0 111.426 177.874 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.703 ' CZ ' ' HB2' ' A' ' 23' ' ' ALA . 6.9 t80 -142.94 128.99 10.4 Favored Pre-proline 0 N--CA 1.45 -0.459 0 O-C-N 121.379 -0.826 . . . . 0.0 112.506 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.535 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 23.7 Cg_endo -72.45 93.94 0.76 Allowed 'Trans proline' 0 N--CA 1.446 -1.277 0 C-N-CA 124.091 3.194 . . . . 0.0 110.612 179.037 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.2 t -99.95 113.23 25.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 122.503 1.145 . . . . 0.0 109.939 179.242 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.433 ' CD2' ' NE2' ' A' ' 90' ' ' HIS . 43.6 m-85 -81.51 158.5 68.64 Favored Pre-proline 0 C--N 1.324 -0.517 0 O-C-N 121.466 -0.772 . . . . 0.0 111.996 179.177 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -76.16 -39.27 0.89 Allowed 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.257 1.971 . . . . 0.0 113.87 178.321 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -40.43 -38.18 0.79 Allowed 'General case' 0 N--CA 1.471 0.603 0 O-C-N 125.145 1.528 . . . . 0.0 110.287 174.88 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 102.01 -7.58 55.03 Favored Glycine 0 N--CA 1.44 -1.062 0 C-N-CA 124.762 1.172 . . . . 0.0 112.716 -178.483 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.433 ' NE2' ' CD2' ' A' ' 86' ' ' PHE . 9.2 p-80 -62.75 123.56 18.75 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 177.75 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -62.64 117.04 5.72 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 171.585 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -44.16 154.44 0.11 Allowed 'General case' 0 C--O 1.21 -0.994 0 CA-C-O 123.018 1.389 . . . . 0.0 112.689 172.489 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.51 66.53 6.34 Favored 'General case' 0 C--N 1.32 -0.693 0 O-C-N 119.149 -2.219 . . . . 0.0 109.926 177.896 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.433 ' CE1' ' HZ ' ' A' ' 83' ' ' PHE . 15.7 p90 -80.79 -6.46 58.56 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 174.705 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -91.0 -38.35 12.88 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 122.677 1.227 . . . . 0.0 110.696 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 52.4 m -88.41 106.88 18.54 Favored 'General case' 0 CA--C 1.519 -0.243 0 O-C-N 121.346 -0.846 . . . . 0.0 109.202 179.141 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 9.7 ptpt -58.23 -46.48 85.84 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.16 0.505 . . . . 0.0 111.309 177.487 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -142.21 132.08 12.42 Favored Pre-proline 0 N--CA 1.444 -0.726 0 C-N-CA 125.065 1.346 . . . . 0.0 109.787 -178.858 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.426 ' HA ' ' HA ' ' A' ' 98' ' ' LYS . 29.0 Cg_endo -68.27 173.39 39.03 Favored 'Cis proline' 0 N--CA 1.459 -0.519 0 C-N-CA 123.06 -1.642 . . . . 0.0 110.505 -9.093 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.3 ptmm? -137.85 154.76 49.46 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 123.56 0.744 . . . . 0.0 109.563 178.345 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -98.11 171.07 8.47 Favored 'General case' 0 C--O 1.244 0.778 0 CA-C-O 122.159 0.981 . . . . 0.0 110.177 178.681 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -53.66 143.56 38.09 Favored Pre-proline 0 N--CA 1.443 -0.777 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.106 172.897 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -73.88 -68.58 0.02 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.344 0 C-N-CA 122.311 2.007 . . . . 0.0 110.688 176.496 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 124.63 152.81 8.41 Favored Glycine 0 CA--C 1.524 0.611 0 O-C-N 120.388 -1.445 . . . . 0.0 111.251 -178.661 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -75.78 -56.52 0.06 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.85 2.367 . . . . 0.0 111.115 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.656 ' HB3' ' CZ ' ' A' ' 11' ' ' TYR . . . -72.09 138.47 47.81 Favored 'General case' 0 N--CA 1.438 -1.049 0 O-C-N 123.369 0.418 . . . . 0.0 110.4 177.337 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.455 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 10.0 mtm-85 -144.43 149.28 35.77 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-O 118.073 -0.965 . . . . 0.0 110.429 177.864 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.443 ' CG1' ' HB3' ' A' ' 83' ' ' PHE . 3.1 p -83.92 114.26 24.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 125.145 1.378 . . . . 0.0 111.017 175.925 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.436 HG21 ' CE2' ' A' ' 38' ' ' PHE . 1.8 mp -101.43 120.68 51.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 -176.973 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.424 ' CG ' ' HG2' ' A' ' 115' ' ' LYS . 17.6 p90 -138.19 162.47 34.18 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.459 -178.849 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.5 p -91.52 161.94 14.75 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 122.755 0.422 . . . . 0.0 110.886 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.484 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.2 OUTLIER -110.64 154.96 42.93 Favored Pre-proline 0 CA--C 1.546 0.818 0 CA-C-N 118.216 0.462 . . . . 0.0 111.275 177.946 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.863 ' O ' HD21 ' A' ' 25' ' ' LEU . 18.9 Cg_endo -72.37 -54.28 0.15 OUTLIER 'Cis proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.689 -1.379 . . . . 0.0 108.771 -9.95 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 41.3 t-20 -40.18 108.45 0.09 Allowed 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 116.511 -1.709 . . . . 0.0 110.507 178.658 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.677 ' CE ' HD13 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -67.5 63.84 0.07 Allowed 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 126.455 1.902 . . . . 0.0 108.119 -178.223 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.466 HG11 ' OD2' ' A' ' 61' ' ' ASP . 35.9 t -73.34 75.52 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 103.712 -2.699 . . . . 0.0 103.712 178.937 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.477 ' CZ ' ' HA2' ' A' ' 119' ' ' GLY . 2.2 t80 -40.87 124.21 2.08 Favored 'General case' 0 N--CA 1.437 -1.111 0 C-N-CA 125.182 1.393 . . . . 0.0 107.714 174.361 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 118' ' ' CYS . . . . . 0.574 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 0.1 OUTLIER -100.64 -40.84 7.19 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.227 175.768 . . . . . . . . 3 3 . 1 . 019 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.477 ' HA2' ' CZ ' ' A' ' 117' ' ' PHE . . . 160.31 -174.79 37.09 Favored Glycine 0 CA--C 1.505 -0.589 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 -178.692 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.542 ' CG2' ' HB1' ' A' ' 106' ' ' ALA . 3.2 mp -106.06 145.34 14.1 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.004 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 178.065 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.508 HG21 HD12 ' A' ' 55' ' ' ILE . 8.5 pt -119.78 152.71 22.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.659 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . . . . . . . . 0 C--N 1.326 -0.445 0 CA-C-O 122.964 1.364 . . . . 0.0 109.741 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.504 -0.796 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 . . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.477 HD13 ' CE1' ' A' ' 57' ' ' PHE . 9.7 tp -56.75 131.85 50.43 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 125.415 1.697 . . . . 0.0 107.842 179.002 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 134' ' ' CYS . . . . . 0.539 ' SG ' HG22 ' A' ' 120' ' ' ILE . 71.3 m -58.54 178.0 0.12 Allowed 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 124.38 1.072 . . . . 0.0 109.554 174.585 . . . . . . . . 2 2 . 1 . 019 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 38.3 m -154.23 112.09 3.5 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 -176.287 . . . . . . . . 1 1 . 1 . 019 nuclear build core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.255 1.343 0 CA-C-O 115.519 -2.182 . . . . 0.0 110.943 172.035 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.555 HG22 ' HB3' ' A' ' 136' ' ' HIS . 3.5 p . . . . . 0 C--O 1.236 0.376 0 CA-C-O 121.858 0.837 . . . . 0.0 109.487 . . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.2 m -90.56 120.0 31.28 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -176.908 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 4' ' ' TRP . . . . . 0.462 ' CG ' HG13 ' A' ' 120' ' ' ILE . 31.9 m95 -79.75 141.34 36.42 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 -179.263 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -134.01 129.6 36.36 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-O 122.366 1.079 . . . . 0.0 108.669 -176.856 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.78 ' SG ' ' HB3' ' A' ' 122' ' ' ALA . 0.0 OUTLIER -125.96 67.24 1.19 Allowed 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 177.064 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 130.38 -98.36 0.41 Allowed Glycine 0 C--O 1.22 -0.741 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 178.899 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -133.32 8.42 5.04 Favored Glycine 0 N--CA 1.464 0.512 0 C-N-CA 123.416 0.532 . . . . 0.0 112.4 178.101 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.497 HD13 ' OH ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -115.85 142.36 46.87 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -176.754 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.6 mp -110.21 125.92 53.58 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -175.07 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.52 ' CZ ' ' HB3' ' A' ' 106' ' ' ALA . 77.5 m-85 -117.04 103.5 10.31 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 126.327 1.851 . . . . 0.0 108.2 -173.094 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -55.18 121.47 8.9 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 118.113 -0.946 . . . . 0.0 108.991 178.809 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 23.2 tp60 -51.33 -45.28 62.23 Favored 'General case' 0 C--O 1.206 -1.211 0 O-C-N 124.023 0.827 . . . . 0.0 111.881 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -51.02 -40.83 59.13 Favored 'General case' 0 C--O 1.197 -1.697 0 CA-C-N 117.801 0.273 . . . . 0.0 111.309 176.102 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.86 -36.78 72.98 Favored 'General case' 0 C--O 1.199 -1.604 0 O-C-N 120.1 -1.625 . . . . 0.0 113.395 168.979 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.61 -40.96 72.78 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 123.04 2.654 . . . . 0.0 113.871 171.705 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -86.45 -38.75 17.0 Favored 'General case' 0 C--O 1.206 -1.186 0 C-N-CA 123.622 0.769 . . . . 0.0 108.999 176.655 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.7 t -73.42 -58.74 3.1 Favored 'General case' 0 CA--C 1.502 -0.879 0 O-C-N 119.889 -1.757 . . . . 0.0 108.771 -176.469 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.476 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 7.6 t-20 -42.62 -36.13 1.3 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 119.624 1.102 . . . . 0.0 112.977 171.823 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.428 ' HB3' HG11 ' A' ' 108' ' ' VAL . 1.0 OUTLIER -82.27 -31.95 29.86 Favored 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 174.149 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -50.8 -39.33 52.57 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 126.204 1.802 . . . . 0.0 109.162 178.475 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.476 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -75.38 -45.7 37.56 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-O 117.388 -1.291 . . . . 0.0 110.689 177.844 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.723 ' HB1' ' HG3' ' A' ' 35' ' ' PRO . . . -40.4 135.15 1.49 Allowed Pre-proline 0 CA--C 1.543 0.706 0 O-C-N 125.609 1.818 . . . . 0.0 111.966 176.574 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.691 ' HG2' HG22 ' A' ' 30' ' ' THR . 18.5 Cg_endo -72.65 122.02 7.88 Favored 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 122.067 1.845 . . . . 0.0 109.319 -176.953 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.676 HD13 ' HE2' ' A' ' 115' ' ' LYS . 5.2 tp -59.88 94.39 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.311 0.644 . . . . 0.0 111.17 178.717 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -171.58 178.71 3.07 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 123.312 0.645 . . . . 0.0 109.673 -176.444 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.407 ' HB2' ' CE2' ' A' ' 79' ' ' TYR . 2.7 t0 -116.45 89.25 3.07 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 124.211 1.004 . . . . 0.0 109.673 177.413 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 71.86 78.69 0.46 Allowed Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 176.397 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.1 mmtp -149.77 30.24 0.73 Allowed 'General case' 0 CA--C 1.513 -0.46 0 C-N-CA 123.355 0.662 . . . . 0.0 111.723 178.094 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.691 HG22 ' HG2' ' A' ' 24' ' ' PRO . 11.8 p -122.02 149.37 43.6 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -175.116 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.4 ' C ' ' HA ' ' A' ' 97' ' ' LYS . . . -42.11 -52.62 4.94 Favored Glycine 0 C--N 1.332 0.353 0 O-C-N 123.814 0.696 . . . . 0.0 111.905 -179.181 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.5 t -67.75 -64.53 0.84 Allowed 'General case' 0 CA--C 1.503 -0.847 0 CA-C-O 116.266 -1.826 . . . . 0.0 112.303 174.237 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 166.24 -59.39 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 126.334 1.854 . . . . 0.0 111.423 177.723 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.52 ' CD2' ' HD3' ' A' ' 84' ' ' PRO . 60.5 m-85 -62.99 147.52 94.17 Favored Pre-proline 0 N--CA 1.436 -1.162 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 179.119 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.723 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 21.0 Cg_endo -75.6 164.56 87.79 Favored 'Cis proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.232 -1.57 . . . . 0.0 111.6 0.483 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.466 ' CD2' ' CD2' ' A' ' 34' ' ' TYR . 1.3 p80 -140.08 173.64 11.31 Favored 'General case' 0 C--O 1.21 -1.012 0 CA-C-O 117.865 -1.064 . . . . 0.0 110.305 -177.491 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.948 ' CH2' HG22 ' A' ' 39' ' ' THR . 19.6 t90 -75.95 127.1 32.28 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 119.441 1.018 . . . . 0.0 109.226 175.964 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.573 ' CZ ' ' HA ' ' A' ' 40' ' ' ASN . 34.6 t80 -97.38 86.69 3.94 Favored 'General case' 0 N--CA 1.427 -1.62 0 C-N-CA 125.928 1.691 . . . . 0.0 107.303 177.766 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.948 HG22 ' CH2' ' A' ' 37' ' ' TRP . 61.8 p -39.87 -35.1 0.32 Allowed 'General case' 0 CA--C 1.508 -0.67 0 C-N-CA 124.774 1.23 . . . . 0.0 111.042 173.603 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.573 ' HA ' ' CZ ' ' A' ' 38' ' ' PHE . 65.1 t30 69.19 8.77 7.01 Favored 'General case' 0 C--O 1.222 -0.381 0 C-N-CA 124.614 1.165 . . . . 0.0 110.376 177.757 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.461 ' CA ' ' HD3' ' A' ' 52' ' ' ARG . . . 112.7 -13.78 24.8 Favored Glycine 0 N--CA 1.428 -1.843 0 C-N-CA 124.741 1.162 . . . . 0.0 114.206 -172.563 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.621 ' CE1' HD11 ' A' ' 48' ' ' LEU . 16.0 m-85 -70.61 166.55 20.44 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.095 0.958 . . . . 0.0 110.682 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.01 -40.44 16.87 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.992 176.671 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.575 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . 174.84 -49.63 0.13 Allowed Glycine 0 C--N 1.335 0.484 0 C-N-CA 124.354 0.978 . . . . 0.0 111.794 -178.013 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -125.01 -63.24 1.17 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 122.026 0.917 . . . . 0.0 109.505 -179.652 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.48 161.38 21.76 Favored Glycine 0 C--N 1.341 0.823 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.585 ' HA ' ' CE2' ' A' ' 42' ' ' TYR . 19.5 mtmt -54.74 175.15 0.06 Allowed 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 122.303 1.049 . . . . 0.0 112.339 176.188 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.635 ' H ' HD12 ' A' ' 48' ' ' LEU . 5.8 mp -56.76 153.72 21.01 Favored Pre-proline 0 N--CA 1.447 -0.618 0 O-C-N 121.658 -0.651 . . . . 0.0 111.381 178.296 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -71.72 158.99 52.07 Favored 'Trans proline' 0 N--CA 1.448 -1.19 0 C-N-CA 121.88 1.72 . . . . 0.0 110.092 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.9 tttt -55.52 98.35 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.145 0.578 . . . . 0.0 109.921 177.133 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.8 72.89 0.62 Allowed Glycine 0 C--O 1.228 -0.226 0 CA-C-O 119.503 -0.609 . . . . 0.0 112.686 -176.15 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.461 ' HD3' ' CA ' ' A' ' 41' ' ' GLY . 12.3 ttm180 -174.42 162.8 3.59 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 124.175 0.99 . . . . 0.0 110.448 175.786 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.3 m -136.52 110.34 9.6 Favored Pre-proline 0 C--O 1.208 -1.089 0 O-C-N 123.909 0.756 . . . . 0.0 110.87 178.625 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.527 ' HG3' HD13 ' A' ' 48' ' ' LEU . 24.9 Cg_endo -71.98 -178.72 3.33 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 121.698 1.599 . . . . 0.0 112.232 177.592 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.429 ' CG2' ' HB2' ' A' ' 133' ' ' LEU . 6.6 mt -95.42 114.17 31.45 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 -178.646 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.61 135.46 35.55 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 120.954 -1.091 . . . . 0.0 108.635 177.277 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.49 ' CD2' ' HB3' ' A' ' 118' ' ' CYS . 4.7 m-85 -117.67 -52.4 2.45 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 123.234 0.614 . . . . 0.0 109.795 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 134.15 -12.26 4.71 Favored Glycine 0 C--O 1.224 -0.513 0 C-N-CA 123.92 0.772 . . . . 0.0 112.418 -176.785 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.51 134.33 34.44 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 117.43 0.615 . . . . 0.0 109.481 177.816 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 87.8 p -75.93 2.72 11.79 Favored 'General case' 0 C--O 1.222 -0.372 0 O-C-N 124.362 1.039 . . . . 0.0 111.713 176.084 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -89.11 -56.14 3.4 Favored 'General case' 0 C--O 1.217 -0.619 0 C-N-CA 124.867 1.267 . . . . 0.0 109.047 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.746 ' HB3' HD11 ' A' ' 80' ' ' LEU . 2.1 m -71.57 -29.97 65.33 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 178.849 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -66.66 -38.16 86.27 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-O 121.091 0.472 . . . . 0.0 110.909 175.259 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.84 164.18 0.58 Allowed Pre-proline 0 N--CA 1.447 -0.598 0 CA-C-O 122.156 0.979 . . . . 0.0 111.692 178.493 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -69.85 126.54 13.37 Favored 'Trans proline' 0 N--CA 1.443 -1.48 0 C-N-CA 121.239 1.293 . . . . 0.0 114.499 172.594 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.463 ' CD ' ' CD2' ' A' ' 42' ' ' TYR . 21.5 Cg_endo -70.64 168.16 23.51 Favored 'Trans proline' 0 N--CA 1.444 -1.44 0 C-N-CA 124.099 3.2 . . . . 0.0 111.48 177.171 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.2 tptt -130.61 61.22 1.62 Allowed 'General case' 0 C--O 1.202 -1.397 0 CA-C-O 116.95 -1.5 . . . . 0.0 108.854 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 40.6 t-80 -75.58 164.97 25.78 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 120.291 1.405 . . . . 0.0 111.029 178.737 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.9 -179.71 7.21 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 120.869 -1.144 . . . . 0.0 110.841 178.093 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.34 69.23 10.46 Favored 'General case' 0 C--O 1.211 -0.928 0 O-C-N 120.29 -1.506 . . . . 0.0 111.34 177.453 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -176.76 -41.98 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 O-C-N 123.772 0.67 . . . . 0.0 109.707 179.385 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.449 ' O ' ' CE2' ' A' ' 79' ' ' TYR . . . 138.11 -72.5 0.44 Allowed Glycine 0 C--O 1.21 -1.361 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 -178.749 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.437 ' ND2' ' CE1' ' A' ' 112' ' ' TYR . 11.1 t-20 -140.72 72.85 1.4 Allowed 'General case' 0 N--CA 1.438 -1.064 0 O-C-N 121.872 -0.781 . . . . 0.0 109.865 179.24 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.47 -101.98 0.01 OUTLIER Glycine 0 C--O 1.221 -0.717 0 CA-C-O 119.736 -0.48 . . . . 0.0 112.47 178.353 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -52.42 -90.29 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.457 0 CA-C-O 122.152 0.977 . . . . 0.0 111.25 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.533 HG23 ' O ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -134.47 20.66 3.64 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-O 117.765 -1.112 . . . . 0.0 111.192 178.586 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -20.54 90.1 0.01 OUTLIER 'General case' 0 C--O 1.211 -0.938 0 C-N-CA 125.424 1.49 . . . . 0.0 114.089 -177.461 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 28.4 p80 -92.22 29.45 1.66 Allowed 'General case' 0 N--CA 1.467 0.383 0 O-C-N 119.097 -2.252 . . . . 0.0 108.196 -170.1 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.967 ' CZ ' HD21 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -57.37 176.29 0.13 Allowed 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 115.073 1.508 . . . . 0.0 115.073 174.161 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.819 HD22 HG22 ' A' ' 109' ' ' ILE . 3.6 mt -95.84 154.99 16.94 Favored 'General case' 0 C--O 1.215 -0.758 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.371 173.946 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.967 HD21 ' CZ ' ' A' ' 79' ' ' TYR . 2.1 mt -141.14 129.28 22.12 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -177.96 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.495 ' CB ' ' CD1' ' A' ' 109' ' ' ILE . 0.2 OUTLIER -98.92 155.72 17.26 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 122.832 1.301 . . . . 0.0 111.543 178.66 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.451 ' HZ ' ' CD2' ' A' ' 94' ' ' PHE . 47.7 t80 -146.27 129.8 8.34 Favored Pre-proline 0 N--CA 1.452 -0.332 0 O-C-N 121.221 -0.924 . . . . 0.0 112.2 179.422 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.52 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 21.5 Cg_endo -71.96 106.02 1.93 Allowed 'Trans proline' 0 N--CA 1.445 -1.324 0 C-N-CA 124.531 3.487 . . . . 0.0 110.801 -179.462 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.94 114.99 29.46 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.937 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.419 ' CE1' ' HB2' ' A' ' 92' ' ' TYR . 70.7 m-85 -82.17 158.02 67.52 Favored Pre-proline 0 N--CA 1.449 -0.515 0 O-C-N 121.775 -0.578 . . . . 0.0 111.818 178.916 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -76.8 -38.88 0.77 Allowed 'Trans proline' 0 CA--C 1.498 -1.288 0 C-N-CA 122.467 2.112 . . . . 0.0 112.713 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -44.92 -30.7 1.06 Allowed 'General case' 0 N--CA 1.469 0.497 0 O-C-N 125.342 1.651 . . . . 0.0 110.98 176.674 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 90.42 -8.48 79.73 Favored Glycine 0 N--CA 1.438 -1.216 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 176.349 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.6 p-80 -59.71 129.25 41.0 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 178.072 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -62.68 96.58 0.09 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 175.483 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.492 ' CD2' ' HB3' ' A' ' 94' ' ' PHE . 7.0 t80 -37.82 142.34 0.16 Allowed 'General case' 0 C--O 1.212 -0.904 0 CA-C-O 121.843 0.83 . . . . 0.0 110.92 178.865 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 93' ' ' LYS . . . . . 0.423 ' HE2' ' O ' ' A' ' 99' ' ' PRO . 0.1 OUTLIER -77.43 57.29 1.5 Allowed 'General case' 0 C--N 1.314 -0.947 0 O-C-N 119.584 -1.947 . . . . 0.0 110.779 175.972 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.492 ' HB3' ' CD2' ' A' ' 92' ' ' TYR . 33.2 p90 -71.25 -9.26 57.82 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 124.319 1.048 . . . . 0.0 112.23 175.892 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -92.19 -37.27 12.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 122.223 1.011 . . . . 0.0 109.709 -179.456 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.9 m -75.41 106.15 6.8 Favored 'General case' 0 CA--C 1.513 -0.464 0 O-C-N 121.266 -0.896 . . . . 0.0 108.968 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 97' ' ' LYS . . . . . 0.4 ' HA ' ' C ' ' A' ' 31' ' ' GLY . 4.1 pttp -58.59 -49.91 75.76 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 121.882 0.848 . . . . 0.0 110.362 178.163 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 99' ' ' PRO . 0.7 OUTLIER -145.54 126.06 7.27 Favored Pre-proline 0 N--CA 1.436 -1.146 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.244 -176.612 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.423 ' O ' ' HE2' ' A' ' 93' ' ' LYS . 29.7 Cg_endo -70.11 175.96 35.58 Favored 'Cis proline' 0 N--CA 1.461 -0.397 0 O-C-N 124.419 1.747 . . . . 0.0 111.797 -4.686 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 15.3 tttm -141.95 132.34 25.12 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 123.526 0.73 . . . . 0.0 109.069 178.252 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -72.14 170.81 13.18 Favored 'General case' 0 C--O 1.237 0.442 0 O-C-N 124.747 1.279 . . . . 0.0 111.881 177.141 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -65.13 152.1 92.25 Favored Pre-proline 0 N--CA 1.445 -0.699 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.442 177.863 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -73.3 -164.83 0.21 Allowed 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.734 2.289 . . . . 0.0 112.139 175.983 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -141.4 157.43 26.14 Favored Glycine 0 CA--C 1.522 0.494 0 O-C-N 121.353 -0.842 . . . . 0.0 112.438 177.403 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -75.76 -67.56 0.02 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.868 2.379 . . . . 0.0 110.43 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.761 ' HA ' ' HB2' ' A' ' 122' ' ' ALA . . . -60.73 138.78 58.06 Favored 'General case' 0 N--CA 1.446 -0.634 0 O-C-N 123.9 0.75 . . . . 0.0 110.452 179.038 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 6.0 mtm-85 -144.1 144.07 31.43 Favored 'General case' 0 CA--C 1.508 -0.656 0 O-C-N 124.529 1.143 . . . . 0.0 111.148 -179.051 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.428 HG11 ' HB3' ' A' ' 20' ' ' SER . 4.3 p -82.52 123.95 38.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 123.907 0.754 . . . . 0.0 110.595 179.032 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.819 HG22 HD22 ' A' ' 80' ' ' LEU . 7.0 mm -104.67 138.68 28.34 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.903 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -178.923 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.807 ' C ' HD23 ' A' ' 80' ' ' LEU . 12.6 p90 -165.52 155.19 12.62 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-O 121.801 0.81 . . . . 0.0 111.517 -178.188 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 16.9 p -91.2 160.86 15.33 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -175.918 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.524 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -107.79 155.79 39.23 Favored Pre-proline 0 C--N 1.318 -0.776 0 O-C-N 122.029 -0.419 . . . . 0.0 110.694 179.905 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.524 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 17.8 Cg_endo -73.32 -53.87 0.15 OUTLIER 'Cis proline' 0 CA--C 1.5 -1.176 0 C-N-CA 123.351 -1.521 . . . . 0.0 109.399 -7.429 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.571 ' O ' HG23 ' A' ' 116' ' ' VAL . 11.6 t30 -44.17 107.38 0.09 Allowed 'General case' 0 C--O 1.217 -0.642 0 CA-C-O 116.187 -1.864 . . . . 0.0 109.632 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.676 ' HE2' HD13 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -62.35 85.37 0.02 OUTLIER 'General case' 0 CA--C 1.509 -0.627 0 O-C-N 124.568 1.168 . . . . 0.0 108.737 -176.099 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 114' ' ' ASN . 81.0 t -84.31 67.67 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.756 0 N-CA-C 104.964 -2.235 . . . . 0.0 104.964 -173.692 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.576 ' CZ ' ' HA2' ' A' ' 119' ' ' GLY . 47.1 t80 -37.13 101.98 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.225 1.41 . . . . 0.0 109.759 178.549 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 118' ' ' CYS . . . . . 0.49 ' HB3' ' CD2' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -81.79 -24.62 35.86 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 178.997 . . . . . . . . 3 3 . 1 . 020 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.576 ' HA2' ' CZ ' ' A' ' 117' ' ' PHE . . . 144.99 -147.42 18.58 Favored Glycine 0 N--CA 1.434 -1.435 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 -178.724 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.462 HG13 ' CG ' ' A' ' 4' ' ' TRP . 1.1 mm -127.31 148.27 32.08 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.273 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 -175.428 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.525 ' CD1' ' CE1' ' A' ' 38' ' ' PHE . 8.2 pt -136.23 154.99 34.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 108.139 -1.059 . . . . 0.0 108.139 -178.253 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.78 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . . . . . . . . 0 C--N 1.323 -0.575 0 CA-C-O 122.145 0.974 . . . . 0.0 109.502 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 3.8 ptmt . . . . . 0 CA--C 1.498 -1.021 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 . . . . . . . . . 0 0 . 1 . 020 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.465 HD13 ' CD2' ' A' ' 57' ' ' PHE . 13.4 tp -54.32 129.71 36.39 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 125.11 1.507 . . . . 0.0 108.339 -179.569 . . . . . . . . 2 2 . 1 . 020 nuclear build core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 76.4 m -66.57 -173.78 0.25 Allowed 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 124.363 2.03 . . . . 0.0 108.237 177.291 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 39.3 m -157.94 125.52 5.19 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 102.819 -3.03 . . . . 0.0 102.819 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.555 ' HB3' HG22 ' A' ' 2' ' ' VAL . 2.4 m80 . . . . . 0 CA--C 1.575 1.923 0 N-CA-C 118.489 2.774 . . . . 0.0 118.489 175.091 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.3 p . . . . . 0 N--CA 1.48 1.066 0 CA-C-O 123.12 1.438 . . . . 0.0 112.774 . . . . . . . . . 0 0 . 1 . 021 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.442 HG21 HD12 ' A' ' 10' ' ' LEU . 6.4 m -93.37 111.25 22.85 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 -173.089 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 18.0 m95 -75.59 143.77 42.16 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 -178.557 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.537 ' OG1' HD13 ' A' ' 10' ' ' LEU . 1.9 m -145.88 153.25 40.65 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 -179.975 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.608 ' CB ' ' HB3' ' A' ' 122' ' ' ALA . 0.8 OUTLIER -125.65 -84.64 0.63 Allowed 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 172.448 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -102.0 58.38 0.61 Allowed Glycine 0 N--CA 1.473 1.101 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 -178.032 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 72.92 -3.31 29.02 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 117.681 1.832 . . . . 0.0 117.681 -171.331 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.351 5.1 mt -94.73 132.61 39.3 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.087 1.755 . . . . 0.0 108.405 -177.438 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.537 HD13 ' OG1' ' A' ' 5' ' ' THR . 4.4 mm? -99.29 151.86 20.57 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.316 1.446 . . . . 0.0 110.102 -170.861 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.856 ' CZ ' ' HB3' ' A' ' 106' ' ' ALA . 40.9 m-85 -157.85 74.65 0.74 Allowed 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 -168.017 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 12' ' ' ASN . . . . . 0.431 ' HA ' ' HA ' ' A' ' 3' ' ' THR . 0.2 OUTLIER -50.67 128.0 19.47 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 120.053 -1.655 . . . . 0.0 108.606 178.251 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -44.66 -54.7 5.91 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-O 117.682 -1.151 . . . . 0.0 111.841 178.179 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -48.27 -51.2 26.76 Favored 'General case' 0 C--O 1.202 -1.403 0 O-C-N 124.235 0.959 . . . . 0.0 112.449 176.193 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.41 -35.64 74.36 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 114.329 -2.748 . . . . 0.0 117.491 169.981 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.665 ' HB1' HD11 ' A' ' 120' ' ' ILE . . . -63.13 -68.33 0.35 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 127.518 2.327 . . . . 0.0 115.487 169.537 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -48.35 -42.0 30.17 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 117.714 -1.136 . . . . 0.0 110.739 167.836 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 41.5 t -64.84 -53.09 52.25 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 126.687 1.995 . . . . 0.0 110.418 -179.702 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -44.98 -49.12 11.37 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 119.189 0.904 . . . . 0.0 111.247 173.152 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.507 ' HB2' ' CE2' ' A' ' 110' ' ' TYR . 1.7 p -67.72 -32.65 73.42 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 118.133 2.642 . . . . 0.0 118.133 172.933 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 11.0 m170 -58.64 -40.24 82.84 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 127.535 2.334 . . . . 0.0 110.73 174.38 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -80.6 -44.76 18.41 Favored 'General case' 0 CA--C 1.511 -0.521 0 C-N-CA 125.28 1.432 . . . . 0.0 111.658 176.407 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.582 ' HB1' ' HG3' ' A' ' 35' ' ' PRO . . . -47.35 126.45 9.67 Favored Pre-proline 0 CA--C 1.552 1.041 0 O-C-N 125.527 1.767 . . . . 0.0 112.76 177.457 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -68.28 128.96 18.28 Favored 'Trans proline' 0 N--CA 1.439 -1.718 0 N-CA-C 107.596 -1.732 . . . . 0.0 107.596 -176.272 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.744 HD21 ' O ' ' A' ' 113' ' ' PRO . 4.6 tp -65.31 90.65 0.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 126.397 1.879 . . . . 0.0 112.505 178.138 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 174.21 161.95 0.19 Allowed 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 125.84 1.656 . . . . 0.0 108.786 -172.148 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.456 ' HA ' ' HA ' ' A' ' 36' ' ' HIS . 2.9 t70 -104.74 119.17 38.36 Favored 'General case' 0 CA--C 1.495 -1.171 0 C-N-CA 128.558 2.743 . . . . 0.0 108.425 -179.062 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 56.76 50.02 66.47 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 119.69 -1.243 . . . . 0.0 112.069 172.407 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.81 -3.57 14.89 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 125.382 1.473 . . . . 0.0 114.344 176.119 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.2 p -114.27 158.42 21.44 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 -170.895 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -45.89 -55.08 7.55 Favored Glycine 0 N--CA 1.467 0.736 0 C-N-CA 124.331 0.967 . . . . 0.0 115.039 -178.745 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 30.4 t -57.52 -71.8 0.1 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 114.266 1.209 . . . . 0.0 114.266 165.64 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.5 m 161.44 -51.03 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 131.338 3.855 . . . . 0.0 110.929 -176.507 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.483 ' CE1' ' HG3' ' A' ' 103' ' ' PRO . 90.8 m-85 -57.38 147.72 57.36 Favored Pre-proline 0 CA--C 1.569 1.694 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -174.038 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.582 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 19.6 Cg_endo -66.79 148.31 78.21 Favored 'Cis proline' 0 N--CA 1.428 -2.324 0 N-CA-C 106.784 -2.045 . . . . 0.0 106.784 -7.467 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 27' ' ' ASP 0.27 0.3 OUTLIER -117.3 167.08 11.55 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 113.736 -1.574 . . . . 0.0 107.393 174.927 . . . . . . . . 4 4 . 1 . 021 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.704 ' CH2' HG22 ' A' ' 39' ' ' THR . 11.1 t90 -64.03 133.17 52.6 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 123.274 1.511 . . . . 0.0 112.329 168.768 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.482 ' CD2' ' HB2' ' A' ' 40' ' ' ASN . 18.0 t80 -98.7 89.98 4.55 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 102.995 -2.965 . . . . 0.0 102.995 -179.742 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.704 HG22 ' CH2' ' A' ' 37' ' ' TRP . 82.8 p -38.86 -41.52 0.75 Allowed 'General case' 0 CA--C 1.502 -0.887 0 CA-C-N 111.329 -2.669 . . . . 0.0 110.421 160.923 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.482 ' HB2' ' CD2' ' A' ' 38' ' ' PHE . 63.2 t30 57.36 25.09 10.84 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 120.625 1.557 . . . . 0.0 112.09 178.316 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.753 ' C ' HD23 ' A' ' 48' ' ' LEU . . . 94.4 -39.35 2.92 Favored Glycine 0 CA--C 1.542 1.779 0 CA-C-O 113.723 -3.82 . . . . 0.0 117.846 -163.92 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -45.14 148.72 0.56 Allowed 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 130.203 3.401 . . . . 0.0 111.687 173.853 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.68 -32.56 25.52 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 115.34 1.607 . . . . 0.0 115.34 177.363 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.407 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -168.79 -81.95 0.05 OUTLIER Glycine 0 CA--C 1.527 0.841 0 C-N-CA 126.133 1.825 . . . . 0.0 111.82 -176.647 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -108.26 -63.95 1.27 Allowed 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 127.337 2.255 . . . . 0.0 114.226 -178.307 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.52 -171.37 0.66 Allowed Glycine 0 C--O 1.222 -0.599 0 CA-C-N 114.54 -1.209 . . . . 0.0 111.989 177.012 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.55 -175.29 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.838 0 CA-C-O 124.375 2.036 . . . . 0.0 115.151 170.441 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.753 HD23 ' C ' ' A' ' 41' ' ' GLY . 0.0 OUTLIER -74.7 160.04 81.84 Favored Pre-proline 0 C--N 1.312 -1.044 0 CA-C-N 114.338 -1.301 . . . . 0.0 110.56 -177.889 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -62.03 168.72 8.58 Favored 'Trans proline' 0 N--CA 1.435 -1.967 0 CA-C-O 123.88 1.534 . . . . 0.0 110.119 171.306 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 6.5 ttpt -55.1 101.35 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.624 1.57 . . . . 0.0 111.665 170.222 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.37 90.24 1.67 Allowed Glycine 0 N--CA 1.474 1.203 0 N-CA-C 111.553 -0.619 . . . . 0.0 111.553 -173.822 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.446 ' CD ' ' HA2' ' A' ' 41' ' ' GLY . 0.0 OUTLIER -167.01 163.89 15.96 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 126.463 1.905 . . . . 0.0 111.148 171.98 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 42.4 m -134.89 101.93 11.37 Favored Pre-proline 0 N--CA 1.478 0.972 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -178.325 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.497 ' HB3' HD21 ' A' ' 48' ' ' LEU . 29.8 Cg_endo -71.46 140.71 37.05 Favored 'Trans proline' 0 N--CA 1.43 -2.247 0 C-N-CA 122.155 1.903 . . . . 0.0 109.911 176.472 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.0 mt -61.8 119.52 5.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 172.294 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.65 143.88 28.16 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.284 169.821 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.535 ' CD1' ' HB3' ' A' ' 118' ' ' CYS . 7.0 m-85 -124.68 -53.24 1.68 Allowed 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 126.308 1.843 . . . . 0.0 111.044 179.514 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 122.43 -5.62 10.05 Favored Glycine 0 N--CA 1.476 1.345 0 C-N-CA 126.735 2.112 . . . . 0.0 114.929 -172.982 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.79 131.48 39.12 Favored 'General case' 0 CA--C 1.503 -0.865 0 C-N-CA 125.013 1.325 . . . . 0.0 110.765 172.622 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 92.0 p -67.89 2.78 1.8 Allowed 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 174.976 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 61' ' ' ASP . . . . . 0.486 ' OD2' HG11 ' A' ' 116' ' ' VAL . 0.4 OUTLIER -94.38 -55.19 3.25 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 128.608 2.763 . . . . 0.0 108.201 -173.839 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.757 ' HA ' HD11 ' A' ' 80' ' ' LEU . 1.8 m -77.31 -26.32 52.12 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.528 1.131 . . . . 0.0 113.077 175.148 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -72.32 -26.74 62.06 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 126.274 1.829 . . . . 0.0 114.043 166.881 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.07 155.06 74.99 Favored Pre-proline 0 CA--C 1.539 0.52 0 O-C-N 120.247 -1.533 . . . . 0.0 114.32 175.412 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -63.85 129.55 25.04 Favored 'Trans proline' 0 CA--C 1.568 2.207 0 O-C-N 119.336 -0.929 . . . . 0.0 112.063 174.582 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.528 ' HB3' ' HA ' ' A' ' 79' ' ' TYR . 19.4 Cg_endo -65.75 177.43 2.87 Favored 'Trans proline' 0 N--CA 1.447 -1.253 1 C-N-CA 125.448 4.099 . . . . 0.0 111.146 176.587 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.4 tptt -132.75 53.0 2.04 Favored 'General case' 0 C--O 1.214 -0.767 0 O-C-N 120.331 -1.481 . . . . 0.0 110.309 170.649 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 46.3 t-80 -76.04 160.94 29.31 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-O 123.315 1.531 . . . . 0.0 112.978 -178.819 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.74 -171.48 3.87 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 117.949 -2.969 . . . . 0.0 110.947 177.116 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.76 79.94 7.32 Favored 'General case' 0 C--O 1.213 -0.832 0 O-C-N 120.736 -1.227 . . . . 0.0 110.043 170.113 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -175.25 -44.21 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 126.022 1.729 . . . . 0.0 111.766 176.218 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 123.8 -63.61 0.55 Allowed Glycine 0 C--O 1.221 -0.691 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 -176.287 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -140.28 96.84 3.11 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 128.165 2.586 . . . . 0.0 106.251 177.097 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.46 -99.21 0.08 OUTLIER Glycine 0 CA--C 1.536 1.353 0 N-CA-C 116.365 1.306 . . . . 0.0 116.365 170.444 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 23.9 mttt -75.33 -97.94 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.164 -1.786 . . . . 0.0 114.313 172.913 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -109.52 12.8 24.28 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.838 -1.164 . . . . 0.0 111.025 178.518 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -23.16 95.06 0.01 OUTLIER 'General case' 0 C--O 1.215 -0.718 0 C-N-CA 129.449 3.099 . . . . 0.0 111.51 -171.783 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.406 ' CD2' ' H ' ' A' ' 78' ' ' HIS . 5.7 p80 -91.13 54.67 2.66 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 118.048 -2.907 . . . . 0.0 106.529 -163.172 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.528 ' HA ' ' HB3' ' A' ' 66' ' ' PRO . 39.8 p90 -85.53 148.33 26.0 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 -172.439 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.757 HD11 ' HA ' ' A' ' 62' ' ' CYS . 0.9 OUTLIER -73.79 162.29 29.29 Favored 'General case' 0 C--O 1.217 -0.634 0 C-N-CA 116.817 -1.953 . . . . 0.0 112.951 168.455 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.445 ' HB2' ' CE1' ' A' ' 110' ' ' TYR . 4.1 mp -141.65 111.23 6.52 Favored 'General case' 0 CA--C 1.498 -1.04 0 CA-C-N 119.921 1.237 . . . . 0.0 111.701 179.003 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -80.2 152.69 29.03 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 119.243 -0.983 . . . . 0.0 111.291 -178.145 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.556 ' CE2' ' HB2' ' A' ' 23' ' ' ALA . 3.0 t80 -142.02 133.86 13.44 Favored Pre-proline 0 CA--C 1.544 0.741 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 179.073 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.644 ' HG2' ' CD2' ' A' ' 92' ' ' TYR . 30.9 Cg_endo -71.9 87.37 0.85 Allowed 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 124.633 3.555 . . . . 0.0 112.009 -177.29 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 6.4 t -89.89 96.73 10.82 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-N 114.316 -1.311 . . . . 0.0 110.592 -179.837 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -80.58 157.5 72.28 Favored Pre-proline 0 CA--C 1.552 1.052 0 O-C-N 120.963 -1.085 . . . . 0.0 112.407 179.695 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . 0.267 9.3 Cg_endo -71.59 -30.96 14.17 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 122.171 1.914 . . . . 0.0 115.711 175.107 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -43.74 -35.81 2.0 Favored 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 128.353 2.661 . . . . 0.0 109.899 174.931 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.71 7.85 70.86 Favored Glycine 0 C--N 1.328 0.106 0 N-CA-C 116.432 1.333 . . . . 0.0 116.432 -178.404 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -71.59 128.52 36.08 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 174.442 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -64.54 110.4 2.3 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 104.965 -2.235 . . . . 0.0 104.965 163.033 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.644 ' CD2' ' HG2' ' A' ' 84' ' ' PRO . 9.3 t80 -39.3 142.15 0.28 Allowed 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 126.735 2.014 . . . . 0.0 109.756 171.052 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.76 61.94 3.15 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 118.098 -2.877 . . . . 0.0 111.664 169.906 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.484 ' CD1' ' HZ ' ' A' ' 83' ' ' PHE . 11.9 p90 -70.93 -27.58 63.87 Favored 'General case' 0 C--O 1.221 -0.442 0 C-N-CA 124.775 1.23 . . . . 0.0 113.447 170.134 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -76.53 -42.47 42.97 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 125.728 1.611 . . . . 0.0 111.633 -179.256 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.1 m -76.51 116.39 17.15 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 119.807 -1.808 . . . . 0.0 109.316 -179.935 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.1 pttt -56.81 -44.22 81.76 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 123.534 1.635 . . . . 0.0 113.945 176.634 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.3 tttt -151.26 133.96 8.61 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 126.0 1.72 . . . . 0.0 111.938 179.831 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -66.63 165.4 64.79 Favored 'Cis proline' 0 N--CA 1.45 -1.045 0 C-N-CA 124.013 -1.244 . . . . 0.0 110.022 -9.862 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.6 pttm -142.11 145.94 34.83 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 105.62 -1.992 . . . . 0.0 105.62 176.265 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -69.17 173.01 6.03 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.205 1.002 . . . . 0.0 111.797 172.797 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -113.28 127.08 27.24 Favored Pre-proline 0 CA--C 1.556 1.175 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -178.258 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 103' ' ' PRO . . . . . 0.483 ' HG3' ' CE1' ' A' ' 34' ' ' TYR . 70.1 Cg_endo -74.35 -160.87 0.11 Allowed 'Trans proline' 0 CA--C 1.554 1.522 0 C-N-CA 125.217 3.945 . . . . 0.0 109.787 167.953 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 112.49 -39.61 2.81 Favored Glycine 0 CA--C 1.545 1.96 0 CA-C-O 114.797 -3.224 . . . . 0.0 112.505 -162.344 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -70.93 -163.67 0.13 Allowed 'Trans proline' 0 C--N 1.366 1.488 1 CA-C-N 125.577 4.689 . . . . 0.0 112.469 177.736 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.944 ' HB2' ' HB2' ' A' ' 122' ' ' ALA . . . -63.95 160.77 17.07 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 124.757 2.218 . . . . 0.0 113.052 169.451 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.74 151.95 39.65 Favored 'General case' 0 C--O 1.214 -0.799 0 CA-C-N 111.832 -2.44 . . . . 0.0 110.8 179.613 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.7 p -87.8 120.84 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 C-N-CA 127.13 2.172 . . . . 0.0 112.003 173.292 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.412 ' CG2' HD22 ' A' ' 80' ' ' LEU . 1.7 mp -112.1 127.32 69.36 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.886 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 -171.644 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.507 ' CE2' ' HB2' ' A' ' 20' ' ' SER . 14.1 p90 -145.98 156.24 43.37 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 -177.029 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.7 p -81.79 164.91 21.35 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.196 0.999 . . . . 0.0 112.187 176.306 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.466 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.4 OUTLIER -109.8 158.89 33.63 Favored Pre-proline 0 CA--C 1.556 1.185 0 N-CA-C 112.667 0.618 . . . . 0.0 112.667 175.415 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.744 ' O ' HD21 ' A' ' 25' ' ' LEU . 19.8 Cg_endo -69.45 -52.73 0.16 OUTLIER 'Cis proline' 0 CA--C 1.501 -1.167 0 N-CA-C 108.915 -1.225 . . . . 0.0 108.915 -15.837 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.45 ' O ' HG23 ' A' ' 116' ' ' VAL . 28.6 t30 -43.69 108.88 0.12 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.931 0.892 . . . . 0.0 110.098 177.004 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.703 ' HE2' HD13 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -67.54 75.05 0.17 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 127.99 2.516 . . . . 0.0 107.615 -179.344 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.486 HG11 ' OD2' ' A' ' 61' ' ' ASP . 72.0 t -85.06 78.45 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 101.112 -3.662 . . . . 0.0 101.112 -175.983 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -41.29 113.51 0.41 Allowed 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 129.071 2.948 . . . . 0.0 104.944 176.5 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 118' ' ' CYS . . . . . 0.535 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 0.1 OUTLIER -93.89 -37.95 11.46 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 122.101 0.953 . . . . 0.0 112.963 174.967 . . . . . . . . 3 3 . 1 . 021 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.564 ' HA3' HD11 ' A' ' 133' ' ' LEU . . . 163.72 -168.92 38.51 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 125.32 1.438 . . . . 0.0 111.648 -179.601 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.665 HD11 ' HB1' ' A' ' 16' ' ' ALA . 1.3 mp -114.72 120.39 64.24 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.356 0 N-CA-C 103.119 -2.919 . . . . 0.0 103.119 176.411 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.475 ' HA ' ' HA ' ' A' ' 133' ' ' LEU . 8.4 pt -89.52 153.5 3.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-O 117.707 -1.139 . . . . 0.0 109.333 172.427 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.944 ' HB2' ' HB2' ' A' ' 106' ' ' ALA . . . . . . . . 0 N--CA 1.491 1.579 0 CA-C-N 121.484 1.947 . . . . 0.0 113.25 172.062 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.879 0 CA-C-O 118.469 -0.777 . . . . 0.0 110.531 . . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.564 HD11 ' HA3' ' A' ' 119' ' ' GLY . 14.3 tp -71.99 142.67 49.37 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 118.82 0.736 . . . . 0.0 110.325 175.668 . . . . . . . . 2 2 . 1 . 021 nuclear build core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 75.1 m -69.27 179.52 1.95 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 124.764 2.221 . . . . 0.0 113.05 165.875 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 96.9 p -146.01 89.15 1.86 Allowed 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 -179.103 . . . . . . . . 1 1 . 1 . 021 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.427 ' O ' ' CD2' ' A' ' 136' ' ' HIS . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 113.814 -2.993 . . . . 0.0 116.852 163.596 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.534 0.349 0 CA-C-O 124.337 2.017 . . . . 0.0 109.825 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.679 HG21 HD22 ' A' ' 10' ' ' LEU . 0.9 OUTLIER -92.65 113.05 25.21 Favored 'General case' 0 C--N 1.312 -1.031 0 O-C-N 119.046 -2.284 . . . . 0.0 110.27 179.323 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 25.6 m95 -77.93 141.04 39.27 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 177.345 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.401 ' OG1' HD23 ' A' ' 10' ' ' LEU . 0.9 OUTLIER -130.88 119.91 22.88 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -178.695 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.588 ' SG ' ' HB3' ' A' ' 122' ' ' ALA . 0.8 OUTLIER -98.33 52.31 1.03 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.593 176.49 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 42.88 49.73 6.13 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 123.395 0.521 . . . . 0.0 112.619 -175.478 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -167.39 -82.89 0.05 OUTLIER Glycine 0 C--O 1.226 -0.396 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 -176.804 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 85.3 mt -119.41 159.33 24.43 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.546 0.689 . . . . 0.0 110.205 177.617 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.679 HD22 HG21 ' A' ' 3' ' ' THR . 3.5 mt -82.99 165.47 19.64 Favored 'General case' 0 C--O 1.219 -0.544 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.613 179.499 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.488 ' CZ ' ' HB3' ' A' ' 106' ' ' ALA . 55.7 m-85 -157.78 85.72 0.9 Allowed 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 -174.337 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -54.51 114.46 1.68 Allowed 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 177.231 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.51 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 8.1 tp-100 -51.16 -34.17 30.21 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -179.797 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -43.26 -34.28 1.14 Allowed 'General case' 0 C--O 1.22 -0.472 0 O-C-N 124.969 1.418 . . . . 0.0 112.137 174.406 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 15' ' ' LYS . . . . . 0.426 ' CD ' ' HA2' ' A' ' 89' ' ' GLY . 0.0 OUTLIER -95.92 -51.32 4.51 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 116.182 -1.866 . . . . 0.0 113.341 171.843 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.691 ' HB1' HD11 ' A' ' 120' ' ' ILE . . . -42.42 -33.39 0.66 Allowed 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 123.041 2.655 . . . . 0.0 114.021 174.863 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -85.06 -49.25 8.44 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 124.49 1.116 . . . . 0.0 109.537 172.5 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 36.8 t -62.42 -43.62 98.39 Favored 'General case' 0 C--O 1.217 -0.656 0 O-C-N 119.796 -1.815 . . . . 0.0 110.482 -174.553 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -46.03 -38.66 8.11 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 125.901 1.68 . . . . 0.0 110.713 171.111 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.9 p -79.32 -28.97 42.14 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.697 0.799 . . . . 0.0 112.554 176.25 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -57.16 -44.11 83.14 Favored 'General case' 0 C--O 1.225 -0.222 0 C-N-CA 124.251 1.021 . . . . 0.0 110.886 176.866 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -78.77 -46.13 19.51 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 118.392 -0.814 . . . . 0.0 110.719 178.583 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.86 ' HB1' ' HG3' ' A' ' 35' ' ' PRO . . . -43.38 130.72 3.62 Favored Pre-proline 0 N--CA 1.447 -0.596 0 O-C-N 125.312 1.632 . . . . 0.0 111.434 178.611 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.438 ' HG2' ' CG2' ' A' ' 30' ' ' THR . 18.0 Cg_endo -71.08 122.87 9.16 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.242 1.961 . . . . 0.0 108.908 -177.362 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.697 HD21 ' O ' ' A' ' 113' ' ' PRO . 2.0 tp -61.15 88.94 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.425 1.09 . . . . 0.0 111.77 177.744 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -177.77 167.65 2.13 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.448 -175.172 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.415 ' HA ' ' HA ' ' A' ' 36' ' ' HIS . 1.3 t70 -114.89 126.88 55.31 Favored 'General case' 0 CA--C 1.512 -0.494 0 C-N-CA 124.295 1.038 . . . . 0.0 110.112 179.756 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 56.09 55.51 28.9 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-O 122.348 0.971 . . . . 0.0 111.145 176.189 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.2 tttt -141.01 28.56 1.9 Allowed 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 124.197 1.951 . . . . 0.0 112.068 -179.386 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.579 HG21 ' HD2' ' A' ' 35' ' ' PRO . 34.6 p -134.74 143.31 47.08 Favored 'General case' 0 C--N 1.309 -1.157 0 O-C-N 119.854 -1.779 . . . . 0.0 108.506 -174.836 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -40.03 -65.8 0.88 Allowed Glycine 0 C--N 1.332 0.349 0 C-N-CA 124.223 0.916 . . . . 0.0 113.543 -177.794 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 25.3 t -54.65 -61.56 2.23 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 117.567 -1.206 . . . . 0.0 111.281 172.914 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.0 p 159.45 -43.02 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 O-C-N 125.637 1.836 . . . . 0.0 113.091 -178.584 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.589 ' CE2' ' CE1' ' A' ' 36' ' ' HIS . 62.2 m-85 -79.34 149.67 72.7 Favored Pre-proline 0 N--CA 1.442 -0.86 0 C-N-CA 124.88 1.272 . . . . 0.0 113.258 178.286 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.86 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 23.1 Cg_endo -74.26 157.93 99.09 Favored 'Cis proline' 0 N--CA 1.45 -1.037 0 C-N-CA 123.476 -1.468 . . . . 0.0 110.351 -1.118 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.589 ' CE1' ' CE2' ' A' ' 34' ' ' TYR . 0.3 OUTLIER -134.6 155.85 49.73 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 113.649 -1.614 . . . . 0.0 109.01 179.125 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.885 ' CH2' HG22 ' A' ' 39' ' ' THR . 25.2 t90 -55.49 121.6 9.37 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-O 122.158 0.98 . . . . 0.0 110.724 174.134 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.538 ' CE2' HG21 ' A' ' 109' ' ' ILE . 41.7 t80 -92.77 85.86 5.34 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 126.997 2.119 . . . . 0.0 106.343 177.929 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.885 HG22 ' CH2' ' A' ' 37' ' ' TRP . 43.8 p -38.98 -36.45 0.28 Allowed 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.505 171.533 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.48 ' HA ' ' CZ ' ' A' ' 38' ' ' PHE . 63.9 t30 66.45 9.93 6.89 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 122.402 1.096 . . . . 0.0 111.687 -179.261 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 113.21 -18.93 20.71 Favored Glycine 0 N--CA 1.433 -1.519 0 C-N-CA 124.874 1.226 . . . . 0.0 113.226 -171.824 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.605 ' CE1' HD11 ' A' ' 48' ' ' LEU . 11.4 m-85 -63.98 161.53 15.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 118.647 1.223 . . . . 0.0 110.993 179.983 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.41 -41.88 19.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.373 0.606 . . . . 0.0 111.287 176.047 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.558 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -173.33 -67.4 0.05 OUTLIER Glycine 0 C--N 1.339 0.696 0 C-N-CA 124.094 0.854 . . . . 0.0 112.497 -177.755 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -115.77 -63.21 1.48 Allowed 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 124.003 0.921 . . . . 0.0 110.045 -179.782 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -58.12 162.49 9.74 Favored Glycine 0 C--N 1.341 0.827 0 N-CA-C 110.971 -0.851 . . . . 0.0 110.971 178.454 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.56 ' HA ' ' CE2' ' A' ' 42' ' ' TYR . 11.8 mtmt -56.6 173.36 0.19 Allowed 'General case' 0 C--N 1.334 -0.089 0 CA-C-O 121.59 0.709 . . . . 0.0 111.152 179.097 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.665 ' H ' HD12 ' A' ' 48' ' ' LEU . 5.7 mp -57.63 154.17 26.76 Favored Pre-proline 0 N--CA 1.446 -0.667 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.708 -179.421 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -70.74 159.15 53.63 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 121.692 1.595 . . . . 0.0 110.066 179.919 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.6 tttt -56.45 97.68 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.247 0.619 . . . . 0.0 110.081 176.137 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 117.83 60.26 0.29 Allowed Glycine 0 C--N 1.329 0.172 0 CA-C-N 116.443 -0.344 . . . . 0.0 112.629 -176.343 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.413 ' HG2' HD23 ' A' ' 48' ' ' LEU . 14.0 ttm180 -164.06 162.56 23.13 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 123.287 0.635 . . . . 0.0 110.606 175.194 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.9 m -139.08 109.33 7.62 Favored Pre-proline 0 C--N 1.326 -0.449 0 C-N-CA 123.196 0.598 . . . . 0.0 109.584 179.641 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.542 ' HG3' HD13 ' A' ' 48' ' ' LEU . 26.3 Cg_endo -72.86 177.16 8.01 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 123.126 2.551 . . . . 0.0 111.129 177.287 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.47 HD12 HG21 ' A' ' 121' ' ' ILE . 6.5 mt -94.89 124.57 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -179.383 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.09 136.42 35.93 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 175.123 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.552 ' CD1' ' HB3' ' A' ' 118' ' ' CYS . 10.8 m-85 -118.89 -28.54 5.53 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.717 0.807 . . . . 0.0 111.027 177.747 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.66 -3.66 56.23 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 123.883 0.754 . . . . 0.0 113.209 -175.046 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.3 mmpt? -97.88 127.82 44.07 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-N 117.695 0.748 . . . . 0.0 109.414 176.868 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -66.35 -11.69 52.54 Favored 'General case' 0 C--O 1.219 -0.51 0 O-C-N 124.893 1.371 . . . . 0.0 111.819 175.854 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.15 -46.87 10.69 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 125.637 1.575 . . . . 0.0 111.049 175.806 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.459 ' SG ' ' CE2' ' A' ' 57' ' ' PHE . 2.0 t -73.1 -16.63 61.46 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 123.956 0.785 . . . . 0.0 112.071 176.688 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -90.04 -34.66 15.87 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.387 1.075 . . . . 0.0 110.812 175.246 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.21 163.1 0.97 Allowed Pre-proline 0 N--CA 1.446 -0.629 0 CA-C-O 121.538 0.685 . . . . 0.0 112.157 179.838 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.463 ' HA ' ' CE2' ' A' ' 42' ' ' TYR . 24.6 Cg_endo -71.74 129.45 15.54 Favored 'Trans proline' 0 N--CA 1.44 -1.651 0 C-N-CA 121.144 1.229 . . . . 0.0 113.093 174.605 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.469 ' HD2' ' CD2' ' A' ' 42' ' ' TYR . 20.4 Cg_endo -68.46 167.59 22.05 Favored 'Trans proline' 0 N--CA 1.443 -1.498 0 C-N-CA 123.713 2.942 . . . . 0.0 111.206 176.701 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 10.3 tptt -126.75 66.16 1.26 Allowed 'General case' 0 C--O 1.223 -0.328 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.787 177.423 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.409 ' CE1' ' O ' ' A' ' 69' ' ' SER . 41.7 t-80 -77.92 168.07 20.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.498 0.666 . . . . 0.0 110.932 177.39 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.409 ' O ' ' CE1' ' A' ' 68' ' ' HIS . 1.5 p -141.47 173.79 11.17 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 121.232 -0.918 . . . . 0.0 111.429 176.782 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.5 mtpt -84.77 71.97 10.79 Favored 'General case' 0 C--O 1.219 -0.521 0 O-C-N 120.495 -1.378 . . . . 0.0 110.993 175.338 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -177.29 -43.07 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 O-C-N 124.54 1.15 . . . . 0.0 111.014 178.509 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 161.71 -85.08 0.11 Allowed Glycine 0 N--CA 1.442 -0.912 0 N-CA-C 108.626 -1.79 . . . . 0.0 108.626 -178.801 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -94.14 -98.27 0.15 Allowed 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 124.424 1.089 . . . . 0.0 108.465 -178.171 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 125.9 -162.92 20.02 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 125.781 1.658 . . . . 0.0 110.614 -175.503 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.3 mttt -43.65 -81.49 0.01 OUTLIER 'General case' 0 C--O 1.218 -0.554 0 C-N-CA 125.118 1.367 . . . . 0.0 112.942 -179.678 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.525 HG23 ' O ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -117.96 14.53 14.17 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 116.062 -1.923 . . . . 0.0 111.856 176.01 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.471 ' OD2' ' CE1' ' A' ' 79' ' ' TYR . 11.6 p-10 -11.77 83.08 0.0 OUTLIER 'General case' 0 C--O 1.214 -0.793 0 CA-C-O 124.469 2.08 . . . . 0.0 115.685 179.08 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 33.6 p80 -91.88 19.41 6.63 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 118.361 -2.712 . . . . 0.0 109.485 -170.531 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.942 ' CE1' HD11 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -52.91 179.12 0.02 OUTLIER 'General case' 0 N--CA 1.428 -1.542 0 C-N-CA 125.329 1.452 . . . . 0.0 113.987 175.229 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.496 HD21 HG22 ' A' ' 111' ' ' THR . 2.0 mt -100.63 154.34 18.67 Favored 'General case' 0 CA--C 1.504 -0.812 0 CA-C-O 118.444 -0.789 . . . . 0.0 110.869 173.871 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.942 HD11 ' CE1' ' A' ' 79' ' ' TYR . 2.6 mp -142.02 125.89 17.13 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 123.901 0.881 . . . . 0.0 109.803 179.175 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -92.34 154.24 18.69 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 121.386 0.613 . . . . 0.0 109.832 -179.125 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.53 ' CD1' ' HD2' ' A' ' 84' ' ' PRO . 6.4 t80 -143.68 135.13 12.73 Favored Pre-proline 0 N--CA 1.45 -0.449 0 O-C-N 121.538 -0.726 . . . . 0.0 112.65 179.078 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.53 ' HD2' ' CD1' ' A' ' 83' ' ' PHE . 18.2 Cg_endo -73.33 99.72 1.15 Allowed 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 123.988 3.125 . . . . 0.0 110.236 -177.374 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.4 t -95.93 108.12 20.46 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.743 -179.912 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.409 ' CE1' ' HB2' ' A' ' 92' ' ' TYR . 59.0 m-85 -83.36 150.82 61.31 Favored Pre-proline 0 C--O 1.241 0.638 0 CA-C-O 118.804 -0.617 . . . . 0.0 110.953 178.964 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -75.72 -36.55 2.09 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 123.311 2.674 . . . . 0.0 113.209 178.352 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -41.42 -34.4 0.53 Allowed 'General case' 0 C--N 1.351 0.669 0 O-C-N 125.53 1.769 . . . . 0.0 111.079 176.186 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 89' ' ' GLY . . . . . 0.426 ' HA2' ' CD ' ' A' ' 15' ' ' LYS . . . 98.03 -4.91 61.13 Favored Glycine 0 N--CA 1.439 -1.143 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 178.25 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -71.92 136.55 46.91 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 122.107 0.956 . . . . 0.0 108.813 177.501 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -75.45 104.2 5.91 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 173.432 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.417 ' O ' ' CD2' ' A' ' 94' ' ' PHE . 8.3 t80 -37.84 145.41 0.07 Allowed 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.991 0.9 . . . . 0.0 111.884 177.131 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.87 61.3 3.75 Favored 'General case' 0 C--N 1.322 -0.591 0 O-C-N 119.902 -1.749 . . . . 0.0 110.679 176.004 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.444 ' CD2' ' HZ ' ' A' ' 83' ' ' PHE . 43.6 p90 -75.56 1.88 13.16 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.325 1.05 . . . . 0.0 113.144 175.253 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -98.11 -41.16 8.06 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.407 1.083 . . . . 0.0 110.305 178.853 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 18.8 m -87.09 110.61 20.22 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -178.965 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 12.7 pttt -57.62 -49.13 77.46 Favored 'General case' 0 C--O 1.241 0.609 0 O-C-N 121.872 -0.518 . . . . 0.0 110.724 177.372 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 13.1 mtmt -141.56 128.54 11.54 Favored Pre-proline 0 N--CA 1.444 -0.758 0 C-N-CA 125.383 1.473 . . . . 0.0 110.765 -177.265 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -71.34 173.57 49.49 Favored 'Cis proline' 0 CA--C 1.54 0.821 0 C-N-CA 122.934 -1.694 . . . . 0.0 110.955 -4.891 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -141.99 142.4 32.94 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 123.895 0.878 . . . . 0.0 109.674 179.365 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -80.82 175.59 10.55 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.613 1.195 . . . . 0.0 111.557 179.061 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -73.61 140.39 78.51 Favored Pre-proline 0 N--CA 1.449 -0.522 0 CA-C-O 118.567 -0.73 . . . . 0.0 110.846 175.717 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -70.23 -163.14 0.11 Allowed 'Trans proline' 0 CA--C 1.548 1.188 0 C-N-CA 124.001 3.134 . . . . 0.0 112.687 175.375 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -145.37 163.44 28.15 Favored Glycine 0 N--CA 1.446 -0.693 0 O-C-N 120.487 -1.383 . . . . 0.0 111.707 174.747 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.43 -57.73 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.244 2.629 . . . . 0.0 110.829 178.689 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.734 ' HB1' ' CG2' ' A' ' 120' ' ' ILE . . . -63.64 135.72 56.97 Favored 'General case' 0 N--CA 1.438 -1.026 0 O-C-N 123.586 0.554 . . . . 0.0 110.589 178.045 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.479 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 3.1 mtm-85 -141.7 143.94 33.82 Favored 'General case' 0 C--O 1.211 -0.95 0 CA-C-O 117.225 -1.369 . . . . 0.0 110.807 178.578 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.669 HG23 ' CD1' ' A' ' 117' ' ' PHE . 2.8 p -81.98 119.2 31.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 C-N-CA 124.702 1.201 . . . . 0.0 110.104 176.904 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.538 HG21 ' CE2' ' A' ' 38' ' ' PHE . 1.8 mp -105.39 124.5 60.33 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.786 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 -177.113 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.453 ' CG ' ' HG2' ' A' ' 115' ' ' LYS . 15.3 p90 -141.33 162.73 34.79 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 123.192 0.597 . . . . 0.0 109.931 -179.42 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.496 HG22 HD21 ' A' ' 80' ' ' LEU . 1.2 p -95.34 165.11 12.54 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -177.83 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.585 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.6 OUTLIER -108.96 153.41 42.49 Favored Pre-proline 0 CA--C 1.54 0.593 0 O-C-N 122.121 -0.362 . . . . 0.0 111.442 177.454 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.697 ' O ' HD21 ' A' ' 25' ' ' LEU . 18.8 Cg_endo -74.44 -54.31 0.15 OUTLIER 'Cis proline' 0 N--CA 1.455 -0.769 0 C-N-CA 123.491 -1.462 . . . . 0.0 110.427 -7.803 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -42.6 112.57 0.36 Allowed 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 116.544 -1.693 . . . . 0.0 110.061 175.89 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.619 ' HE2' HD13 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -64.93 71.42 0.03 OUTLIER 'General case' 0 CA--C 1.514 -0.423 0 O-C-N 125.621 1.825 . . . . 0.0 108.357 179.529 . . . . . . . . 3 3 . 1 . 022 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.424 ' O ' HG12 ' A' ' 116' ' ' VAL . 18.0 t -74.55 75.67 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 -179.299 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.669 ' CD1' HG23 ' A' ' 108' ' ' VAL . 27.6 t80 -41.08 119.39 1.16 Allowed 'General case' 0 N--CA 1.437 -1.122 0 C-N-CA 125.217 1.407 . . . . 0.0 110.063 176.798 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 118' ' ' CYS . . . . . 0.552 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 5.5 m -95.15 -45.48 7.18 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.837 -178.937 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 119' ' ' GLY . . . . . 0.568 ' HA2' ' CZ ' ' A' ' 117' ' ' PHE . . . 157.64 177.95 31.23 Favored Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.48 -179.841 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.734 ' CG2' ' HB1' ' A' ' 106' ' ' ALA . 2.7 mp -101.23 124.37 54.89 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.289 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -178.586 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.686 HG22 HD12 ' A' ' 133' ' ' LEU . 7.5 pt -97.15 154.22 3.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 CA-C-N 120.232 1.378 . . . . 0.0 109.024 -179.598 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.588 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . . . . . . . . 0 C--N 1.326 -0.444 0 CA-C-O 122.468 1.128 . . . . 0.0 110.762 176.057 . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.513 -0.467 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 . . . . . . . . . 1 1 . 1 . 022 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.686 HD12 HG22 ' A' ' 121' ' ' ILE . 7.4 tp -82.29 149.82 27.59 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.47 1.106 . . . . 0.0 108.728 175.243 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 134' ' ' CYS . . . . . 0.479 ' SG ' HG22 ' A' ' 120' ' ' ILE . 8.3 m -63.11 -175.72 0.11 Allowed 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 124.01 1.862 . . . . 0.0 108.525 176.096 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -172.01 121.87 0.47 Allowed 'General case' 0 C--N 1.316 -0.868 0 O-C-N 120.482 -1.386 . . . . 0.0 107.601 -176.925 . . . . . . . . 2 2 . 1 . 022 nuclear build core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.258 1.5 0 CA-C-O 113.472 -3.156 . . . . 0.0 110.493 172.617 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.672 HG22 ' HB2' ' A' ' 136' ' ' HIS . 1.8 p . . . . . 0 N--CA 1.45 -0.47 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 . . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.449 HG21 ' HB3' ' A' ' 10' ' ' LEU . 2.9 m -86.83 119.75 27.39 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.467 -177.434 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 4' ' ' TRP . . . . . 0.474 ' CG ' HG13 ' A' ' 120' ' ' ILE . 28.8 m95 -79.98 139.63 36.93 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.956 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.862 ' OG1' HD13 ' A' ' 10' ' ' LEU . 0.9 OUTLIER -133.5 132.81 41.43 Favored 'General case' 0 CA--C 1.501 -0.905 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -178.36 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.71 ' SG ' ' HB3' ' A' ' 122' ' ' ALA . 0.1 OUTLIER -120.56 41.65 3.2 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.284 177.732 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 148.31 -96.26 0.17 Allowed Glycine 0 C--O 1.222 -0.637 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 -179.36 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 8' ' ' GLY . . . . . 0.599 ' C ' HD13 ' A' ' 9' ' ' LEU . . . -127.07 4.37 7.34 Favored Glycine 0 C--O 1.223 -0.593 0 N-CA-C 112.061 -0.416 . . . . 0.0 112.061 178.585 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.669 ' N ' HD13 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -111.13 141.29 44.82 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 -173.083 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.862 HD13 ' OG1' ' A' ' 5' ' ' THR . 1.2 mm? -113.42 120.23 40.33 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -171.808 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.575 ' CE2' ' CB ' ' A' ' 106' ' ' ALA . 63.4 m-85 -115.18 101.41 8.94 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 125.065 1.346 . . . . 0.0 109.595 -175.653 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -57.62 120.94 9.21 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.984 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.513 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 6.8 tp-100 -46.49 -43.58 16.9 Favored 'General case' 0 C--O 1.2 -1.547 0 O-C-N 124.246 0.967 . . . . 0.0 111.498 179.591 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -48.22 -49.22 33.89 Favored 'General case' 0 C--O 1.194 -1.821 0 CA-C-N 117.693 0.224 . . . . 0.0 110.768 176.474 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.46 -34.58 77.48 Favored 'General case' 0 C--O 1.195 -1.779 0 O-C-N 120.712 -1.242 . . . . 0.0 111.922 172.985 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.0 -50.59 72.9 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 121.1 1.773 . . . . 0.0 112.067 174.269 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -78.5 -36.94 44.36 Favored 'General case' 0 C--O 1.207 -1.145 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.754 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 43.2 t -71.37 -63.25 1.15 Allowed 'General case' 0 CA--C 1.503 -0.833 0 C-N-CA 125.463 1.505 . . . . 0.0 108.981 -177.863 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.503 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 10.4 t-20 -39.54 -37.92 0.54 Allowed 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 123.942 0.897 . . . . 0.0 111.768 174.771 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.428 ' O ' ' HB3' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -80.2 -40.35 27.36 Favored 'General case' 0 N--CA 1.443 -0.801 0 O-C-N 124.757 1.286 . . . . 0.0 113.342 175.229 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -42.44 -40.38 2.55 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.467 1.507 . . . . 0.0 109.611 178.442 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.503 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -71.16 -49.46 43.63 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-O 118.162 -0.923 . . . . 0.0 111.279 177.036 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.593 ' HB1' ' HG3' ' A' ' 35' ' ' PRO . . . -35.56 131.76 0.53 Allowed Pre-proline 0 N--CA 1.441 -0.902 0 O-C-N 125.067 1.479 . . . . 0.0 112.054 174.656 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.831 ' HG2' HG22 ' A' ' 30' ' ' THR . 18.9 Cg_endo -73.01 122.1 7.83 Favored 'Trans proline' 0 N--CA 1.446 -1.319 0 C-N-CA 122.24 1.96 . . . . 0.0 110.292 -178.115 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.634 HD13 ' HE2' ' A' ' 115' ' ' LYS . 3.3 tp -59.51 97.84 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.658 179.057 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -179.98 166.02 1.25 Allowed 'General case' 0 C--N 1.324 -0.516 0 O-C-N 123.548 0.53 . . . . 0.0 109.943 -177.699 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.462 ' OD2' ' CE1' ' A' ' 68' ' ' HIS . 1.7 t0 -103.46 98.46 8.36 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.531 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 66.83 79.19 0.22 Allowed Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 177.714 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -151.44 27.99 0.65 Allowed 'General case' 0 CA--C 1.513 -0.443 0 O-C-N 122.012 -0.699 . . . . 0.0 110.964 178.533 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.831 HG22 ' HG2' ' A' ' 24' ' ' PRO . 10.8 p -122.47 148.62 44.92 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -175.753 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -39.72 -56.14 2.6 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 111.752 -0.539 . . . . 0.0 111.752 -179.517 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 29.4 t -69.35 -60.14 2.54 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 116.909 -1.519 . . . . 0.0 111.354 176.958 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 163.04 -56.7 0.0 OUTLIER 'General case' 0 C--O 1.223 -0.329 0 O-C-N 125.603 1.814 . . . . 0.0 110.77 178.136 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.557 ' CD1' ' HD3' ' A' ' 84' ' ' PRO . 69.1 m-85 -60.25 144.7 87.22 Favored Pre-proline 0 N--CA 1.437 -1.08 0 CA-C-O 118.051 -0.976 . . . . 0.0 113.127 178.849 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.593 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 25.0 Cg_endo -74.92 165.05 86.91 Favored 'Cis proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.361 -1.933 . . . . 0.0 112.027 -0.53 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.445 ' CD2' ' CD1' ' A' ' 34' ' ' TYR . 1.0 OUTLIER -139.42 168.21 20.33 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 121.546 -0.721 . . . . 0.0 110.308 -178.343 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.895 ' CZ3' HG22 ' A' ' 39' ' ' THR . 22.7 t90 -70.31 113.72 7.74 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 179.094 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.436 ' CE1' ' HA ' ' A' ' 40' ' ' ASN . 8.5 t80 -84.71 79.44 9.6 Favored 'General case' 0 N--CA 1.427 -1.596 0 C-N-CA 124.888 1.275 . . . . 0.0 108.872 178.234 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.895 HG22 ' CZ3' ' A' ' 37' ' ' TRP . 60.6 p -36.51 -38.07 0.15 Allowed 'General case' 0 C--O 1.216 -0.677 0 C-N-CA 124.439 1.095 . . . . 0.0 110.596 176.9 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.436 ' HA ' ' CE1' ' A' ' 38' ' ' PHE . 65.2 t30 69.83 7.47 6.24 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 124.099 0.959 . . . . 0.0 108.599 176.992 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.459 ' C ' HD23 ' A' ' 48' ' ' LEU . . . 120.81 -35.37 3.72 Favored Glycine 0 N--CA 1.429 -1.811 0 CA-C-O 117.293 -1.837 . . . . 0.0 111.796 -175.705 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.665 ' N ' HD23 ' A' ' 48' ' ' LEU . 60.4 m-85 -51.42 173.13 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 118.066 0.933 . . . . 0.0 110.424 -178.354 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.66 -43.01 8.11 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -179.169 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.535 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -178.29 -52.2 0.07 OUTLIER Glycine 0 C--N 1.338 0.682 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 -179.657 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.5 -90.74 0.09 Allowed 'General case' 0 C--O 1.217 -0.647 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -179.86 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -148.93 28.75 1.27 Allowed Glycine 0 N--CA 1.443 -0.862 0 O-C-N 120.898 -1.126 . . . . 0.0 110.616 -176.362 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.3 mttp -126.06 144.28 50.79 Favored 'General case' 0 CA--C 1.501 -0.92 0 CA-C-O 117.703 -1.141 . . . . 0.0 109.115 -177.695 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.665 HD23 ' N ' ' A' ' 42' ' ' TYR . 1.5 mt -106.46 159.12 30.91 Favored Pre-proline 0 C--N 1.319 -0.738 0 O-C-N 124.151 0.907 . . . . 0.0 109.26 -179.232 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -73.54 -175.61 2.13 Favored 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 122.954 2.436 . . . . 0.0 111.564 179.05 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.7 tptp -68.35 98.38 0.83 Allowed 'General case' 0 N--CA 1.445 -0.691 0 O-C-N 121.35 -0.844 . . . . 0.0 109.259 177.185 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.23 88.3 1.07 Allowed Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 179.042 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.415 ' HD2' ' HA2' ' A' ' 41' ' ' GLY . 0.0 OUTLIER -151.32 137.93 18.75 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 119.286 -0.387 . . . . 0.0 111.294 177.347 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.9 m -128.95 103.36 18.76 Favored Pre-proline 0 C--N 1.327 -0.392 0 O-C-N 124.629 1.206 . . . . 0.0 110.225 -178.56 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -72.42 158.28 51.58 Favored 'Trans proline' 0 N--CA 1.448 -1.194 0 C-N-CA 122.226 1.95 . . . . 0.0 111.762 178.916 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.443 ' CG2' ' HB2' ' A' ' 133' ' ' LEU . 5.4 mt -77.41 123.41 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.023 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -91.12 135.69 33.6 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 179.01 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.501 ' CD1' ' HB3' ' A' ' 118' ' ' CYS . 15.3 m-85 -114.74 -52.48 2.7 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.225 179.91 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 126.9 -5.57 7.4 Favored Glycine 0 C--O 1.223 -0.585 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.853 -177.232 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.95 132.1 36.76 Favored 'General case' 0 CA--C 1.5 -0.978 0 CA-C-O 117.651 -1.166 . . . . 0.0 109.393 178.891 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 31.1 t -67.09 -9.78 43.07 Favored 'General case' 0 C--O 1.221 -0.439 0 O-C-N 125.034 1.459 . . . . 0.0 111.036 177.481 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -92.15 -49.77 6.02 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 124.032 0.933 . . . . 0.0 108.887 -179.193 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.838 ' SG ' HD21 ' A' ' 80' ' ' LEU . 3.9 t -75.89 -6.61 51.65 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 123.766 0.666 . . . . 0.0 111.214 175.988 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -99.94 -32.58 10.9 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.571 0.749 . . . . 0.0 110.165 177.987 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.531 ' HD3' ' CE1' ' A' ' 78' ' ' HIS . 0.0 OUTLIER -51.5 166.03 0.39 Allowed Pre-proline 0 N--CA 1.441 -0.89 0 CA-C-O 121.725 0.774 . . . . 0.0 111.018 179.913 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 65' ' ' PRO . . . . . 0.424 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 26.6 Cg_endo -72.11 135.24 24.7 Favored 'Trans proline' 0 N--CA 1.44 -1.645 0 C-N-CA 121.291 1.327 . . . . 0.0 113.865 174.959 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 65' ' ' PRO . 20.3 Cg_endo -71.72 171.31 16.69 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 122.529 2.153 . . . . 0.0 112.095 178.217 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.8 tptt -138.48 72.18 1.4 Allowed 'General case' 0 C--O 1.195 -1.813 0 CA-C-O 116.385 -1.769 . . . . 0.0 108.287 178.185 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.462 ' CE1' ' OD2' ' A' ' 27' ' ' ASP . 68.6 t60 -79.4 159.36 27.11 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 119.463 1.029 . . . . 0.0 110.603 178.207 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.31 -178.35 6.02 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.78 0.8 . . . . 0.0 110.011 -179.681 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -86.37 62.98 7.75 Favored 'General case' 0 C--O 1.209 -1.039 0 O-C-N 121.299 -0.875 . . . . 0.0 110.926 178.08 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -177.6 -39.27 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.831 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 129.82 -82.88 0.33 Allowed Glycine 0 C--O 1.207 -1.573 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 -179.301 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 73' ' ' ASN . . . . . 0.41 ' HA ' ' HB2' ' A' ' 77' ' ' ASP . 7.1 p-10 -115.88 53.17 0.86 Allowed 'General case' 0 C--N 1.313 -0.979 0 O-C-N 120.744 -1.445 . . . . 0.0 107.978 -177.762 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -55.8 -115.94 0.01 OUTLIER Glycine 0 C--O 1.217 -0.93 0 O-C-N 123.879 0.737 . . . . 0.0 111.9 178.172 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.9 mttm -42.73 -82.92 0.01 OUTLIER 'General case' 0 C--O 1.223 -0.311 0 O-C-N 121.443 -1.034 . . . . 0.0 110.894 179.946 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.633 HG23 ' O ' ' A' ' 76' ' ' THR . 0.6 OUTLIER -146.43 26.77 1.15 Allowed 'General case' 0 CA--C 1.507 -0.682 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.164 178.203 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.475 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 0.8 OUTLIER -26.54 96.52 0.01 OUTLIER 'General case' 0 C--O 1.213 -0.827 0 C-N-CA 124.231 1.012 . . . . 0.0 112.331 -178.688 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.531 ' CE1' ' HD3' ' A' ' 64' ' ' ARG . 16.5 p80 -94.71 23.77 5.17 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -173.756 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.656 ' CE1' HD11 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -57.51 -177.25 0.02 OUTLIER 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 174.889 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.838 HD21 ' SG ' ' A' ' 62' ' ' CYS . 0.4 OUTLIER -100.48 149.4 23.72 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.371 175.42 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.738 HD23 ' HA ' ' A' ' 37' ' ' TRP . 1.0 OUTLIER -138.42 118.92 13.83 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 124.021 0.825 . . . . 0.0 108.873 -179.027 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.511 ' CB ' ' CD1' ' A' ' 109' ' ' ILE . 0.2 OUTLIER -87.68 163.12 16.71 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-O 122.238 1.018 . . . . 0.0 111.581 178.702 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.539 ' CZ ' ' HB2' ' A' ' 23' ' ' ALA . 50.9 t80 -153.11 122.13 3.22 Favored Pre-proline 0 N--CA 1.446 -0.634 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.876 -179.424 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.557 ' HD3' ' CD1' ' A' ' 34' ' ' TYR . 18.2 Cg_endo -71.93 112.09 3.32 Favored 'Trans proline' 0 N--CA 1.447 -1.21 0 C-N-CA 123.506 2.804 . . . . 0.0 110.792 -177.946 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.78 121.22 43.39 Favored 'General case' 0 CA--C 1.51 -0.574 0 O-C-N 124.139 0.899 . . . . 0.0 110.268 -179.319 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.421 ' CE2' ' HB2' ' A' ' 92' ' ' TYR . 58.4 m-85 -82.11 157.7 68.13 Favored Pre-proline 0 N--CA 1.444 -0.76 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 178.725 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -75.52 -37.95 1.58 Allowed 'Trans proline' 0 CA--C 1.5 -1.176 0 C-N-CA 122.392 2.061 . . . . 0.0 112.84 179.542 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.35 -30.82 2.26 Favored 'General case' 0 C--O 1.224 -0.285 0 C-N-CA 124.902 1.281 . . . . 0.0 108.786 -179.648 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 95.91 -9.94 68.2 Favored Glycine 0 N--CA 1.431 -1.662 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 176.443 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.403 ' O ' ' CD2' ' A' ' 90' ' ' HIS . 4.1 p-80 -61.92 125.91 25.49 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.064 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.98 97.22 0.06 Allowed 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 123.12 0.568 . . . . 0.0 110.234 176.121 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.531 ' CD2' ' HB3' ' A' ' 94' ' ' PHE . 6.2 t80 -36.25 140.49 0.13 Allowed 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 121.919 0.866 . . . . 0.0 111.285 179.541 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.51 59.79 1.98 Allowed 'General case' 0 N--CA 1.444 -0.772 0 O-C-N 120.227 -1.546 . . . . 0.0 110.156 177.465 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.531 ' HB3' ' CD2' ' A' ' 92' ' ' TYR . 28.2 p90 -77.27 -8.12 57.08 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 123.443 0.697 . . . . 0.0 111.633 177.67 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.87 -33.33 13.56 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 122.166 0.984 . . . . 0.0 109.679 -179.624 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.87 104.08 11.99 Favored 'General case' 0 N--CA 1.443 -0.812 0 O-C-N 121.236 -0.915 . . . . 0.0 108.987 179.907 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.7 -49.38 77.96 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.724 178.818 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 99' ' ' PRO . 39.1 pttt -139.22 125.79 12.56 Favored Pre-proline 0 N--CA 1.435 -1.18 0 C-N-CA 123.633 0.773 . . . . 0.0 108.975 -176.833 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.454 ' HA ' ' HA ' ' A' ' 98' ' ' LYS . 24.0 Cg_endo -71.14 177.34 32.85 Favored 'Cis proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.376 -1.927 . . . . 0.0 111.469 -4.057 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -132.9 144.88 50.46 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 122.724 0.41 . . . . 0.0 109.988 177.48 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -95.9 152.64 18.32 Favored 'General case' 0 C--N 1.319 -0.747 0 O-C-N 124.338 1.024 . . . . 0.0 110.366 177.53 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -44.66 149.01 0.83 Allowed Pre-proline 0 N--CA 1.44 -0.948 0 O-C-N 123.926 0.766 . . . . 0.0 111.694 174.025 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -73.14 -164.88 0.21 Allowed 'Trans proline' 0 N--CA 1.446 -1.317 0 C-N-CA 122.394 2.063 . . . . 0.0 111.557 178.155 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -139.12 157.18 24.8 Favored Glycine 0 N--CA 1.443 -0.9 0 O-C-N 121.955 -0.465 . . . . 0.0 112.206 177.856 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -75.09 -75.91 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 122.806 2.338 . . . . 0.0 110.956 179.659 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.575 ' CB ' ' CE2' ' A' ' 11' ' ' TYR . . . -60.4 136.54 58.07 Favored 'General case' 0 N--CA 1.441 -0.922 0 O-C-N 123.434 0.459 . . . . 0.0 110.573 178.747 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.421 ' HG2' ' HA ' ' A' ' 84' ' ' PRO . 0.8 OUTLIER -141.71 146.98 36.71 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.853 -178.607 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.431 ' CG1' ' HB3' ' A' ' 83' ' ' PHE . 6.6 p -83.03 125.76 40.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 O-C-N 123.719 0.637 . . . . 0.0 110.119 178.589 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.663 ' CG2' HD22 ' A' ' 80' ' ' LEU . 9.4 mm -104.62 140.87 21.43 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.92 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.063 179.614 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.48 ' CG ' ' HG2' ' A' ' 115' ' ' LYS . 9.7 p90 -166.12 155.48 11.69 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 121.841 0.829 . . . . 0.0 110.38 -178.944 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.4 p -90.86 160.96 15.45 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.93 -179.977 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.547 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -109.48 153.95 42.56 Favored Pre-proline 0 N--CA 1.44 -0.969 0 C-N-CA 123.055 0.542 . . . . 0.0 111.367 179.149 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.547 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 19.1 Cg_endo -73.29 -54.05 0.15 OUTLIER 'Cis proline' 0 CA--C 1.504 -1.007 0 C-N-CA 122.538 -1.859 . . . . 0.0 110.18 -5.434 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -42.36 107.36 0.08 Allowed 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 116.961 -1.495 . . . . 0.0 110.237 179.803 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.634 ' HE2' HD13 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -64.44 76.6 0.04 OUTLIER 'General case' 0 CA--C 1.512 -0.493 0 O-C-N 125.061 1.476 . . . . 0.0 108.802 -177.621 . . . . . . . . 3 3 . 1 . 023 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.498 ' O ' HG12 ' A' ' 116' ' ' VAL . 38.1 t -75.95 74.23 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 -176.516 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.513 ' CZ ' ' NE2' ' A' ' 13' ' ' GLN . 39.1 t80 -36.35 105.97 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 124.629 1.171 . . . . 0.0 110.55 179.606 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 118' ' ' CYS . . . . . 0.501 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 8.7 m -83.52 -46.27 12.63 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -178.771 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 162.34 -144.96 10.15 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 179.727 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.474 HG13 ' CG ' ' A' ' 4' ' ' TRP . 1.2 mm -128.72 144.67 37.34 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.091 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -176.519 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.773 HG22 HD12 ' A' ' 133' ' ' LEU . 8.6 pt -133.64 155.46 40.21 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.722 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -178.561 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.71 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . . . . . . . . 0 C--N 1.324 -0.524 0 CA-C-O 121.69 0.757 . . . . 0.0 109.953 177.711 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 6.9 ptmm? . . . . . 0 CA--C 1.512 -0.484 0 CA-C-O 118.997 -0.525 . . . . 0.0 109.74 . . . . . . . . . 0 0 . 1 . 023 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.773 HD12 HG22 ' A' ' 121' ' ' ILE . 6.0 tp -88.39 141.77 28.27 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.237 0.96 . . . . 0.0 109.244 178.866 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 134' ' ' CYS . . . . . 0.466 ' SG ' HG22 ' A' ' 120' ' ' ILE . 57.5 m -67.57 -176.1 0.58 Allowed 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 121.862 0.839 . . . . 0.0 109.307 177.494 . . . . . . . . 2 2 . 1 . 023 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 2.1 m -156.27 84.92 0.99 Allowed 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -178.855 . . . . . . . . 1 1 . 1 . 023 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.672 ' HB2' HG22 ' A' ' 2' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--O 1.258 1.543 0 CA-C-O 115.151 -2.357 . . . . 0.0 112.528 173.957 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.65 HG13 ' CD2' ' A' ' 136' ' ' HIS . 7.6 p . . . . . 0 N--CA 1.455 -0.219 0 CA-C-O 120.758 0.314 . . . . 0.0 110.257 . . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.457 ' N ' HG22 ' A' ' 2' ' ' VAL . 2.4 m -85.94 109.13 18.54 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 125.936 1.695 . . . . 0.0 110.962 -179.493 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 4' ' ' TRP . . . . . 0.482 ' CD1' ' HB2' ' A' ' 13' ' ' GLN . 25.5 m95 -77.67 142.4 38.84 Favored 'General case' 0 N--CA 1.442 -0.863 0 O-C-N 121.709 -0.619 . . . . 0.0 110.164 179.546 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.419 ' OG1' HD13 ' A' ' 10' ' ' LEU . 0.9 OUTLIER -131.97 134.36 45.53 Favored 'General case' 0 CA--C 1.5 -0.943 0 C-N-CA 123.204 0.602 . . . . 0.0 110.117 -176.957 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.731 ' SG ' ' HB3' ' A' ' 122' ' ' ALA . 0.0 OUTLIER -134.07 -73.46 0.48 Allowed 'General case' 0 C--O 1.222 -0.393 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 177.367 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -80.44 42.5 2.61 Favored Glycine 0 C--O 1.211 -1.281 0 CA-C-O 117.844 -1.531 . . . . 0.0 111.373 179.905 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 64.04 12.78 50.69 Favored Glycine 0 C--O 1.22 -0.751 0 CA-C-N 119.361 1.581 . . . . 0.0 111.756 -175.067 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -114.33 149.45 36.01 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -176.119 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.419 HD13 ' OG1' ' A' ' 5' ' ' THR . 2.1 mm? -105.18 125.5 51.05 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 -172.169 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.658 ' CZ ' ' HB3' ' A' ' 106' ' ' ALA . 90.5 m-85 -120.27 106.96 12.41 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 124.509 1.124 . . . . 0.0 108.015 -174.076 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -54.19 116.28 2.52 Favored 'General case' 0 C--O 1.206 -1.187 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.724 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.482 ' HB2' ' CD1' ' A' ' 4' ' ' TRP . 36.2 tp60 -54.79 -45.46 74.32 Favored 'General case' 0 C--O 1.196 -1.757 0 CA-C-O 116.429 -1.748 . . . . 0.0 111.993 178.881 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -51.0 -36.28 38.49 Favored 'General case' 0 C--O 1.189 -2.126 0 O-C-N 124.117 0.886 . . . . 0.0 110.242 175.843 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -75.59 -40.85 55.9 Favored 'General case' 0 C--O 1.197 -1.696 0 CA-C-N 121.765 2.075 . . . . 0.0 112.177 170.039 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.465 ' O ' HG11 ' A' ' 108' ' ' VAL . . . -52.1 -35.9 49.26 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 117.463 -3.273 . . . . 0.0 113.406 171.018 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -94.5 -38.43 10.91 Favored 'General case' 0 C--O 1.2 -1.506 0 CA-C-O 122.657 1.218 . . . . 0.0 108.009 178.275 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.422 ' O ' ' CE1' ' A' ' 22' ' ' HIS . 26.1 t -73.22 -58.49 3.27 Favored 'General case' 0 C--O 1.201 -1.467 1 O-C-N 115.447 -4.533 . . . . 0.0 106.838 -177.306 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.439 ' CG ' ' CZ ' ' A' ' 92' ' ' TYR . 1.3 t-20 -50.46 -27.92 7.37 Favored 'General case' 0 C--N 1.311 -1.076 0 O-C-N 117.733 -3.104 . . . . 0.0 113.391 173.167 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.519 ' HB3' HG11 ' A' ' 108' ' ' VAL . 24.0 p -86.98 -16.95 34.26 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 123.629 0.581 . . . . 0.0 112.527 175.191 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -66.19 -39.5 89.73 Favored 'General case' 0 C--O 1.215 -0.719 0 C-N-CA 124.973 1.309 . . . . 0.0 107.881 179.773 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.422 ' CE1' ' O ' ' A' ' 18' ' ' SER . 0.1 OUTLIER -75.47 -41.78 54.75 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 116.647 -1.644 . . . . 0.0 109.269 -178.519 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.883 ' HB1' ' HG3' ' A' ' 35' ' ' PRO . . . -40.31 130.07 1.7 Allowed Pre-proline 0 N--CA 1.443 -0.778 0 O-C-N 126.649 2.468 . . . . 0.0 111.943 177.764 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.458 ' HG2' ' CG2' ' A' ' 30' ' ' THR . 14.5 Cg_endo -72.73 115.02 4.18 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 122.103 1.868 . . . . 0.0 109.83 -176.133 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.6 HD13 ' HE2' ' A' ' 115' ' ' LYS . 2.5 tp -56.14 100.28 0.04 OUTLIER 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 123.272 0.629 . . . . 0.0 111.225 178.711 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -167.72 166.27 13.86 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.788 0.804 . . . . 0.0 109.453 -177.195 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.492 ' HB2' ' CE1' ' A' ' 79' ' ' TYR . 5.8 t0 -100.42 73.3 1.65 Allowed 'General case' 0 CA--C 1.548 0.87 0 CA-C-O 124.048 1.88 . . . . 0.0 107.104 179.014 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.58 86.03 0.57 Allowed Glycine 0 N--CA 1.448 -0.503 0 O-C-N 118.816 -2.427 . . . . 0.0 109.36 176.504 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.14 33.52 0.58 Allowed 'General case' 0 CA--C 1.514 -0.425 0 O-C-N 121.205 -1.174 . . . . 0.0 111.23 177.204 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.474 HG21 ' HD2' ' A' ' 35' ' ' PRO . 55.3 p -129.73 143.85 51.01 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -175.927 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -38.08 -67.79 0.48 Allowed Glycine 0 C--N 1.338 0.642 0 O-C-N 124.117 0.885 . . . . 0.0 112.979 -178.552 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 32' ' ' SER . . . . . 0.461 ' HB3' ' HA ' ' A' ' 94' ' ' PHE . 32.2 t -51.86 -66.38 0.39 Allowed 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 115.744 -2.074 . . . . 0.0 110.554 174.328 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.2 p 167.44 -56.42 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.418 0 O-C-N 126.927 2.642 . . . . 0.0 111.256 179.895 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.528 ' CD1' ' HG3' ' A' ' 84' ' ' PRO . 32.3 m-85 -69.27 150.03 97.32 Favored Pre-proline 0 N--CA 1.429 -1.478 0 CA-C-O 116.494 -1.717 . . . . 0.0 112.708 178.995 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.883 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 37.5 Cg_endo -72.24 138.56 55.03 Favored 'Cis proline' 0 N--CA 1.442 -1.519 0 C-N-CA 121.281 -2.383 . . . . 0.0 112.264 -4.602 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -128.94 150.6 50.31 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-O 116.91 -1.519 . . . . 0.0 113.781 173.44 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.965 ' CH2' HG22 ' A' ' 39' ' ' THR . 19.1 t90 -44.42 151.85 0.23 Allowed 'General case' 0 C--O 1.237 0.428 0 CA-C-O 122.577 1.179 . . . . 0.0 110.872 176.305 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.522 ' CE1' ' HA ' ' A' ' 40' ' ' ASN . 3.0 t80 -127.87 79.64 1.91 Allowed 'General case' 0 N--CA 1.417 -2.089 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 -172.921 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.965 HG22 ' CH2' ' A' ' 37' ' ' TRP . 38.1 p -36.96 -39.51 0.23 Allowed 'General case' 0 C--O 1.205 -1.288 0 C-N-CA 125.388 1.475 . . . . 0.0 110.506 173.773 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.522 ' HA ' ' CE1' ' A' ' 38' ' ' PHE . 43.5 t30 59.14 17.42 5.58 Favored 'General case' 0 C--O 1.206 -1.211 0 CA-C-N 120.426 1.466 . . . . 0.0 107.39 173.154 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.492 ' C ' HD23 ' A' ' 48' ' ' LEU . . . 113.09 -45.84 1.26 Allowed Glycine 0 N--CA 1.428 -1.851 0 O-C-N 118.716 -2.49 . . . . 0.0 113.321 -170.639 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.57 ' N ' HD23 ' A' ' 48' ' ' LEU . 83.3 m-85 -45.21 153.61 0.2 Allowed 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.318 1.047 . . . . 0.0 111.942 178.097 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.09 -36.38 24.92 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.14 178.593 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 126.56 42.16 0.3 Allowed Glycine 0 C--N 1.341 0.819 0 C-N-CA 123.922 0.773 . . . . 0.0 111.299 -177.296 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -146.64 -69.64 0.25 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.294 179.707 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -146.43 -73.49 0.02 OUTLIER Glycine 0 C--O 1.195 -2.287 0 N-CA-C 107.591 -2.204 . . . . 0.0 107.591 -176.192 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.5 ptpt -100.96 -165.33 1.19 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 120.468 2.134 . . . . 0.0 110.35 178.638 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.713 ' H ' HD12 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -113.35 174.12 2.49 Favored Pre-proline 0 N--CA 1.438 -1.041 0 C-N-CA 123.623 0.769 . . . . 0.0 110.028 -178.93 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.27 156.91 46.22 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.362 2.041 . . . . 0.0 110.855 179.426 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.71 98.1 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.301 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.31 55.83 0.24 Allowed Glycine 0 CA--C 1.507 -0.442 0 CA-C-O 118.345 -1.253 . . . . 0.0 111.889 -178.318 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.418 ' HD2' ' HA2' ' A' ' 41' ' ' GLY . 1.3 mmt180 -149.79 143.07 25.15 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-N 117.671 0.735 . . . . 0.0 110.811 177.055 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.1 m -131.45 96.74 20.67 Favored Pre-proline 0 C--N 1.324 -0.531 0 O-C-N 124.318 1.011 . . . . 0.0 110.352 -178.628 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 54' ' ' PRO . . . . . 0.653 ' HG3' HD21 ' A' ' 48' ' ' LEU . 18.0 Cg_endo -72.36 173.23 13.44 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 122.022 1.814 . . . . 0.0 111.723 179.267 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.423 ' O ' ' CE1' ' A' ' 57' ' ' PHE . 8.4 mt -86.53 111.62 21.69 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.076 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 -176.348 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.23 137.49 36.66 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 120.617 -1.302 . . . . 0.0 108.703 178.922 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.491 ' CG ' ' SG ' ' A' ' 118' ' ' CYS . 3.0 m-85 -118.5 -52.79 2.35 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.628 -179.999 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 128.73 -9.95 6.39 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 123.48 0.562 . . . . 0.0 111.722 -176.74 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 59' ' ' LYS . . . . . 0.425 ' CB ' ' HB3' ' A' ' 62' ' ' CYS . 15.2 mmtt -69.08 170.57 9.71 Favored 'General case' 0 C--O 1.197 -1.692 0 CA-C-O 118.217 -0.897 . . . . 0.0 111.127 177.16 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.4 m -101.69 -47.54 4.59 Favored 'General case' 0 C--O 1.19 -2.027 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.596 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.29 -40.92 64.17 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-N 120.888 1.676 . . . . 0.0 108.974 178.698 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.488 ' SG ' ' CD1' ' A' ' 57' ' ' PHE . 11.0 t -71.84 -14.58 62.0 Favored 'General case' 0 C--N 1.348 0.533 0 O-C-N 123.468 0.48 . . . . 0.0 110.138 178.198 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -95.62 -32.75 12.65 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 174.693 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.94 168.36 0.43 Allowed Pre-proline 0 N--CA 1.429 -1.493 0 CA-C-O 122.349 1.071 . . . . 0.0 108.674 -177.635 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -72.71 124.7 9.94 Favored 'Trans proline' 0 N--CA 1.438 -1.768 0 C-N-CA 121.068 1.179 . . . . 0.0 115.13 172.123 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.419 ' HD2' ' CD1' ' A' ' 42' ' ' TYR . 18.6 Cg_endo -72.04 164.15 36.55 Favored 'Trans proline' 0 CA--C 1.502 -1.111 0 C-N-CA 123.595 2.863 . . . . 0.0 111.802 179.614 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 8.2 tptt -126.06 130.38 51.02 Favored 'General case' 0 C--O 1.205 -1.273 0 CA-C-O 117.329 -1.319 . . . . 0.0 108.382 178.951 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 41.4 t-80 -122.6 161.5 23.62 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 119.226 0.921 . . . . 0.0 110.214 174.612 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.6 179.08 8.92 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.2 179.223 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.8 mptt -84.82 69.18 10.69 Favored 'General case' 0 C--O 1.215 -0.757 0 O-C-N 121.828 -0.545 . . . . 0.0 111.422 177.146 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -176.94 -41.36 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.223 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.486 ' CA ' ' HB3' ' A' ' 27' ' ' ASP . . . 122.07 -63.9 0.51 Allowed Glycine 0 N--CA 1.442 -0.958 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -179.061 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -133.98 56.74 1.83 Allowed 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 -173.06 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.96 -109.73 0.01 OUTLIER Glycine 0 C--O 1.215 -1.035 0 CA-C-O 121.998 0.777 . . . . 0.0 111.583 179.412 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 19.8 mttt -60.98 -98.82 0.0 OUTLIER 'General case' 0 C--O 1.214 -0.794 0 O-C-N 120.017 -1.872 . . . . 0.0 109.941 179.374 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.593 HG23 ' O ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -120.94 15.66 11.67 Favored 'General case' 0 CA--C 1.493 -1.226 0 O-C-N 119.331 -2.105 . . . . 0.0 110.611 -179.241 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.433 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 1.3 m-20 -24.3 95.56 0.01 OUTLIER 'General case' 0 C--O 1.197 -1.689 0 C-N-CA 126.768 2.027 . . . . 0.0 112.948 -176.615 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 17.2 p-80 -88.98 60.45 5.46 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 -167.929 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.578 ' HB2' ' CD1' ' A' ' 37' ' ' TRP . 52.0 p90 -91.11 136.78 32.85 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 124.672 1.189 . . . . 0.0 111.602 -178.446 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.669 HD23 ' O ' ' A' ' 110' ' ' TYR . 2.5 mt -67.31 128.88 38.06 Favored 'General case' 0 C--O 1.205 -1.281 0 CA-C-O 117.481 -1.247 . . . . 0.0 109.271 178.811 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.844 HD11 ' HB2' ' A' ' 35' ' ' PRO . 0.2 OUTLIER -121.28 135.03 55.17 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 121.025 1.739 . . . . 0.0 107.329 178.608 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.562 ' N ' HD12 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -101.56 166.09 10.89 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-O 123.168 1.461 . . . . 0.0 114.503 171.218 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.502 ' CD1' ' HD2' ' A' ' 84' ' ' PRO . 52.2 t80 -146.3 131.82 9.26 Favored Pre-proline 0 CA--C 1.498 -1.024 0 O-C-N 117.823 -3.048 . . . . 0.0 113.115 179.462 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.544 ' HA ' ' HG2' ' A' ' 107' ' ' ARG . 19.3 Cg_endo -72.98 106.18 2.1 Favored 'Trans proline' 0 CA--C 1.473 -2.554 0 C-N-CA 124.645 3.563 . . . . 0.0 110.583 -175.698 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.55 ' HA ' ' CZ ' ' A' ' 92' ' ' TYR . 0.6 OUTLIER -100.73 121.01 40.94 Favored 'General case' 0 CA--C 1.49 -1.332 0 O-C-N 125.613 1.82 . . . . 0.0 112.36 -179.306 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.597 ' CD1' ' CD1' ' A' ' 92' ' ' TYR . 13.8 m-85 -85.19 162.66 48.3 Favored Pre-proline 0 N--CA 1.44 -0.963 0 CA-C-N 120.475 1.489 . . . . 0.0 111.179 -179.423 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -77.77 -44.34 0.18 Allowed 'Trans proline' 0 CA--C 1.516 -0.386 0 C-N-CA 122.161 1.907 . . . . 0.0 112.431 179.605 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -48.62 -26.4 2.23 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 125.279 1.612 . . . . 0.0 110.913 174.446 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.92 17.64 80.2 Favored Glycine 0 N--CA 1.431 -1.676 0 CA-C-O 117.39 -1.783 . . . . 0.0 109.706 179.592 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.419 ' O ' ' CE1' ' A' ' 92' ' ' TYR . 1.0 OUTLIER -82.74 147.52 28.39 Favored 'General case' 0 C--O 1.182 -2.454 0 CA-C-O 116.929 -1.51 . . . . 0.0 110.359 -179.593 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -62.09 134.39 56.54 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 123.54 2.882 . . . . 0.0 111.831 176.173 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.597 ' CD1' ' CD1' ' A' ' 86' ' ' PHE . 0.2 OUTLIER -93.6 136.48 33.83 Favored 'General case' 0 C--O 1.202 -1.399 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 -173.21 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.39 61.24 0.47 Allowed 'General case' 0 C--N 1.318 -0.778 0 O-C-N 119.769 -1.832 . . . . 0.0 111.029 175.075 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.49 ' CD2' ' HZ ' ' A' ' 83' ' ' PHE . 1.5 p90 -74.95 -23.96 58.39 Favored 'General case' 0 N--CA 1.426 -1.651 0 C-N-CA 126.401 1.88 . . . . 0.0 109.581 179.749 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.56 -31.49 21.19 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 -178.844 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.9 t -82.38 104.74 12.9 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 -177.61 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 32.6 pttt -58.27 -50.71 72.63 Favored 'General case' 0 C--O 1.227 -0.126 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 179.241 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 99' ' ' PRO . 4.4 mttp -137.41 124.88 14.04 Favored Pre-proline 0 N--CA 1.438 -1.027 0 C-N-CA 124.787 1.235 . . . . 0.0 109.095 -173.719 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.425 ' HA ' ' HA ' ' A' ' 98' ' ' LYS . 23.3 Cg_endo -73.26 175.01 47.31 Favored 'Cis proline' 0 CA--C 1.54 0.822 0 O-C-N 124.934 2.018 . . . . 0.0 111.564 -2.913 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 100' ' ' LYS . . . . . 0.413 ' HD2' ' HA ' ' A' ' 32' ' ' SER . 9.6 tttp -137.6 117.5 13.26 Favored 'General case' 0 C--O 1.22 -0.467 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.152 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -72.54 154.3 40.88 Favored 'General case' 0 C--O 1.253 1.243 0 O-C-N 124.62 1.2 . . . . 0.0 110.32 176.918 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -48.43 124.55 11.73 Favored Pre-proline 0 N--CA 1.438 -1.07 0 C-N-CA 125.113 1.365 . . . . 0.0 112.105 172.758 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -70.3 -164.95 0.15 Allowed 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 122.691 2.261 . . . . 0.0 112.125 177.681 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -134.73 158.66 23.59 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.561 177.288 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -76.07 -61.76 0.03 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.72 2.28 . . . . 0.0 110.109 179.9 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.658 ' HB3' ' CZ ' ' A' ' 11' ' ' TYR . . . -58.78 133.34 55.88 Favored 'General case' 0 N--CA 1.432 -1.328 0 O-C-N 124.653 1.22 . . . . 0.0 111.938 178.015 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.544 ' HG2' ' HA ' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -141.23 146.9 37.46 Favored 'General case' 0 CA--C 1.496 -1.11 0 O-C-N 124.632 1.208 . . . . 0.0 111.817 -178.489 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.519 HG11 ' HB3' ' A' ' 20' ' ' SER . 7.7 p -80.5 126.1 39.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.423 0.63 . . . . 0.0 110.407 178.839 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.558 ' CG2' HD22 ' A' ' 80' ' ' LEU . 24.5 mm -100.28 147.24 7.86 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.229 0 O-C-N 121.227 -0.921 . . . . 0.0 110.361 179.008 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.669 ' O ' HD23 ' A' ' 80' ' ' LEU . 11.4 p90 -176.76 148.14 0.66 Allowed 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 124.408 2.052 . . . . 0.0 110.131 -177.624 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 111' ' ' THR . . . . . 0.409 HG22 ' HA ' ' A' ' 62' ' ' CYS . 7.0 p -81.55 167.69 19.02 Favored 'General case' 0 C--N 1.311 -1.075 0 O-C-N 120.207 -1.558 . . . . 0.0 108.947 -177.612 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.464 ' CD1' ' C ' ' A' ' 112' ' ' TYR . 0.1 OUTLIER -116.2 152.56 47.99 Favored Pre-proline 0 N--CA 1.432 -1.34 0 C-N-CA 123.938 0.895 . . . . 0.0 109.892 179.875 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.467 ' O ' HD21 ' A' ' 25' ' ' LEU . 15.6 Cg_endo -72.7 -44.03 0.61 Allowed 'Cis proline' 0 CA--C 1.516 -0.413 0 C-N-CA 122.076 -2.052 . . . . 0.0 109.378 -9.213 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 43.4 m-20 -46.84 106.98 0.09 Allowed 'General case' 0 CA--C 1.49 -1.337 0 CA-C-O 113.631 -3.08 . . . . 0.0 109.816 -179.382 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.6 ' HE2' HD13 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -68.31 72.27 0.2 Allowed 'General case' 0 CA--C 1.501 -0.918 0 O-C-N 127.457 2.973 . . . . 0.0 107.03 -175.787 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.577 ' O ' HG12 ' A' ' 116' ' ' VAL . 14.6 t -74.08 70.16 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 -177.133 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.419 ' CD1' HG23 ' A' ' 108' ' ' VAL . 54.6 t80 -37.17 100.8 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 126.064 1.746 . . . . 0.0 110.732 178.831 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 118' ' ' CYS . . . . . 0.491 ' SG ' ' CG ' ' A' ' 57' ' ' PHE . 0.1 OUTLIER -81.43 -39.53 24.76 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 -178.235 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 159.82 -146.86 13.36 Favored Glycine 0 N--CA 1.441 -1.02 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 -179.734 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.441 HG13 ' CG ' ' A' ' 4' ' ' TRP . 1.0 OUTLIER -129.61 149.0 33.22 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.672 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 -172.923 . . . . . . . . 3 3 . 1 . 024 nuclear build core ' A' A ' 121' ' ' ILE . . . . . 0.518 ' CD1' ' CZ ' ' A' ' 38' ' ' PHE . 7.2 pt -138.23 154.69 28.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 120.304 1.411 . . . . 0.0 108.293 -178.177 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.731 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . . . . . . . . 0 C--N 1.32 -0.685 0 CA-C-O 122.338 1.066 . . . . 0.0 110.021 176.867 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 9.2 ptpt . . . . . 0 CA--C 1.511 -0.529 0 CA-C-O 117.448 -1.263 . . . . 0.0 110.608 . . . . . . . . . 0 0 . 1 . 024 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.481 HD12 HG22 ' A' ' 121' ' ' ILE . 12.2 tp -82.28 139.71 34.03 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.807 . . . . . . . . 2 2 . 1 . 024 nuclear build core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 73.3 m -67.28 -172.83 0.24 Allowed 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 124.072 0.949 . . . . 0.0 109.363 176.833 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 61.1 m -162.05 114.33 1.72 Allowed 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 117.056 -1.449 . . . . 0.0 107.835 -179.624 . . . . . . . . 1 1 . 1 . 024 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.65 ' CD2' HG13 ' A' ' 2' ' ' VAL . 2.4 m80 . . . . . 0 C--O 1.277 2.515 0 CA-C-O 113.525 -3.131 . . . . 0.0 113.22 176.206 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 2' ' ' VAL . . . . . 0.468 HG13 ' HB2' ' A' ' 136' ' ' HIS . 5.1 p . . . . . 0 C--O 1.24 0.565 0 CA-C-O 121.271 0.557 . . . . 0.0 110.188 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 3' ' ' THR . . . . . 0.478 HG21 ' HB3' ' A' ' 10' ' ' LEU . 3.2 m -94.51 121.34 35.95 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -174.581 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 4' ' ' TRP . . . . . 0.45 ' CG ' HG13 ' A' ' 120' ' ' ILE . 24.2 m95 -79.36 140.53 37.45 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.271 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 5' ' ' THR . . . . . 0.529 ' OG1' HD12 ' A' ' 10' ' ' LEU . 0.9 OUTLIER -128.56 134.48 48.64 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -178.079 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 6' ' ' CYS . . . . . 0.734 ' HB3' ' HB3' ' A' ' 122' ' ' ALA . 8.4 m -123.1 -71.46 0.72 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.689 178.868 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -86.27 32.26 3.9 Favored Glycine 0 C--O 1.221 -0.685 0 CA-C-O 119.773 -0.459 . . . . 0.0 111.996 176.906 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 82.53 -13.03 43.53 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-N 117.491 0.646 . . . . 0.0 112.854 -175.164 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 9' ' ' LEU . . . . . 0.424 HD13 ' OH ' ' A' ' 11' ' ' TYR . 0.2 OUTLIER -87.66 139.99 29.97 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -177.685 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 10' ' ' LEU . . . . . 0.529 HD12 ' OG1' ' A' ' 5' ' ' THR . 5.0 mp -86.22 135.09 33.7 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 124.032 0.832 . . . . 0.0 109.455 -178.589 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 11' ' ' TYR . . . . . 0.533 ' CE2' ' CB ' ' A' ' 106' ' ' ALA . 60.4 m-85 -124.06 105.84 9.88 Favored 'General case' 0 CA--C 1.506 -0.717 0 C-N-CA 125.539 1.536 . . . . 0.0 109.554 -175.14 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.79 112.97 1.46 Allowed 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -179.328 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 13' ' ' GLN . . . . . 0.444 ' HB2' ' CD1' ' A' ' 4' ' ' TRP . 35.3 tp60 -51.2 -48.68 61.94 Favored 'General case' 0 C--O 1.214 -0.792 0 C-N-CA 119.586 -0.846 . . . . 0.0 111.91 -179.024 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -49.2 -39.8 31.09 Favored 'General case' 0 C--O 1.197 -1.669 0 O-C-N 124.162 0.913 . . . . 0.0 111.263 176.862 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -71.59 -38.89 70.84 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-N 118.755 0.707 . . . . 0.0 112.904 171.217 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 16' ' ' ALA . . . . . 0.486 ' O ' HG11 ' A' ' 108' ' ' VAL . . . -53.67 -39.14 64.85 Favored 'General case' 0 C--O 1.215 -0.741 0 CA-C-N 119.87 1.213 . . . . 0.0 111.99 173.409 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -90.38 -38.78 13.09 Favored 'General case' 0 C--O 1.221 -0.431 0 C-N-CA 123.802 0.841 . . . . 0.0 110.809 176.228 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 18' ' ' SER . . . . . 0.413 ' O ' ' CE1' ' A' ' 22' ' ' HIS . 40.7 t -75.05 -60.12 2.43 Favored 'General case' 0 CA--C 1.506 -0.747 0 O-C-N 119.716 -1.865 . . . . 0.0 109.557 -176.508 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 19' ' ' ASN . . . . . 0.454 ' CG ' ' CZ ' ' A' ' 92' ' ' TYR . 0.1 OUTLIER -48.39 -29.45 4.02 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 171.062 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 20' ' ' SER . . . . . 0.558 ' HB3' HG11 ' A' ' 108' ' ' VAL . 31.7 p -85.19 -24.66 27.8 Favored 'General case' 0 C--O 1.221 -0.432 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 175.413 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -57.13 -35.97 70.12 Favored 'General case' 0 C--O 1.222 -0.351 0 C-N-CA 124.156 0.982 . . . . 0.0 109.217 178.061 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 22' ' ' HIS . . . . . 0.413 ' CE1' ' O ' ' A' ' 18' ' ' SER . 0.2 OUTLIER -71.69 -42.13 67.8 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 118.566 -0.731 . . . . 0.0 110.138 179.901 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 23' ' ' ALA . . . . . 0.796 ' HB1' ' HG3' ' A' ' 35' ' ' PRO . . . -39.99 133.77 1.43 Allowed Pre-proline 0 N--CA 1.443 -0.793 0 O-C-N 125.189 1.555 . . . . 0.0 111.124 176.505 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 24' ' ' PRO . . . . . 0.732 ' HG2' HG22 ' A' ' 30' ' ' THR . 19.5 Cg_endo -72.61 119.36 6.06 Favored 'Trans proline' 0 N--CA 1.443 -1.442 0 C-N-CA 122.1 1.867 . . . . 0.0 108.55 -177.8 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 25' ' ' LEU . . . . . 0.526 HD22 ' HE2' ' A' ' 115' ' ' LYS . 3.4 tp -60.58 84.19 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.284 1.033 . . . . 0.0 111.266 177.885 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.4 m -165.89 147.24 6.94 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.291 -174.682 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 27' ' ' ASP . . . . . 0.48 ' HB3' ' CA ' ' A' ' 72' ' ' GLY . 2.7 t0 -78.89 85.66 4.84 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 -178.843 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.68 86.31 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 177.812 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.2 mmtt -150.49 44.68 0.86 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.934 0.873 . . . . 0.0 111.615 178.749 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 30' ' ' THR . . . . . 0.732 HG22 ' HG2' ' A' ' 24' ' ' PRO . 12.2 p -130.64 -170.77 2.41 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.55 -174.695 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 31' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 95' ' ' ASP . . . -83.82 -55.23 2.86 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.706 177.446 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -76.05 9.56 2.4 Favored 'General case' 0 CA--C 1.514 -0.415 0 O-C-N 122.136 -0.626 . . . . 0.0 112.336 177.854 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.1 p 89.83 -58.45 0.02 OUTLIER 'General case' 0 CA--C 1.503 -0.855 0 C-N-CA 127.17 2.188 . . . . 0.0 109.258 -179.782 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 34' ' ' TYR . . . . . 0.491 ' CG ' ' HG3' ' A' ' 84' ' ' PRO . 85.9 m-85 -59.38 142.82 86.38 Favored Pre-proline 0 N--CA 1.437 -1.08 0 O-C-N 125.826 1.953 . . . . 0.0 112.768 -176.914 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 35' ' ' PRO . . . . . 0.796 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 36.0 Cg_endo -76.48 -172.69 11.47 Favored 'Cis proline' 0 N--CA 1.438 -1.764 0 C-N-CA 122.66 -1.808 . . . . 0.0 111.521 0.577 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 36' ' ' HIS . . . . . 0.429 ' CD2' ' N ' ' A' ' 36' ' ' HIS . 0.3 OUTLIER -159.62 159.75 33.5 Favored 'General case' 0 CA--C 1.502 -0.886 0 O-C-N 120.774 -1.204 . . . . 0.0 110.101 -178.68 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 37' ' ' TRP . . . . . 0.599 ' CD1' ' HB2' ' A' ' 79' ' ' TYR . 10.3 t90 -69.6 134.35 48.67 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-O 122.796 1.284 . . . . 0.0 110.044 175.458 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 38' ' ' PHE . . . . . 0.444 ' CZ ' ' HA ' ' A' ' 40' ' ' ASN . 14.0 t80 -97.63 97.59 9.16 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 178.939 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 39' ' ' THR . . . . . 0.438 ' HA ' ' CZ2' ' A' ' 37' ' ' TRP . 77.4 p -36.14 -35.18 0.07 Allowed 'General case' 0 C--O 1.208 -1.124 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.873 173.489 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 40' ' ' ASN . . . . . 0.444 ' HA ' ' CZ ' ' A' ' 38' ' ' PHE . 4.1 t-20 65.97 11.65 7.87 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 123.926 0.89 . . . . 0.0 110.631 179.717 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 41' ' ' GLY . . . . . 0.487 ' HA3' HD23 ' A' ' 48' ' ' LEU . . . 97.7 4.08 58.12 Favored Glycine 0 CA--C 1.536 1.384 0 N-CA-C 114.364 0.506 . . . . 0.0 114.364 -169.939 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 42' ' ' TYR . . . . . 0.708 ' CE1' HD11 ' A' ' 48' ' ' LEU . 2.6 m-85 -99.0 165.61 11.67 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 124.103 0.961 . . . . 0.0 109.339 -177.456 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.3 -34.88 25.62 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.625 176.911 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 44' ' ' GLY . . . . . 0.526 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . 173.24 -62.3 0.13 Allowed Glycine 0 C--N 1.335 0.489 0 C-N-CA 124.008 0.813 . . . . 0.0 112.06 -178.285 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -111.42 -61.81 1.64 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 122.607 1.194 . . . . 0.0 110.356 179.671 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.16 161.12 6.91 Favored Glycine 0 C--N 1.34 0.797 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.228 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 47' ' ' LYS . . . . . 0.568 ' HA ' ' CD2' ' A' ' 42' ' ' TYR . 8.5 ptpt -56.98 -163.14 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 122.998 1.38 . . . . 0.0 112.033 175.732 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 48' ' ' LEU . . . . . 0.708 HD11 ' CE1' ' A' ' 42' ' ' TYR . 4.0 mp -81.35 155.25 71.87 Favored Pre-proline 0 N--CA 1.44 -0.931 0 O-C-N 121.068 -1.02 . . . . 0.0 111.041 178.107 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -71.2 159.4 52.14 Favored 'Trans proline' 0 N--CA 1.444 -1.394 0 C-N-CA 121.947 1.765 . . . . 0.0 110.266 178.45 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -53.11 97.77 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.263 0.625 . . . . 0.0 110.083 177.274 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.26 79.19 0.95 Allowed Glycine 0 CA--C 1.517 0.191 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.184 -176.146 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 52' ' ' ARG . . . . . 0.472 ' HD3' ' CA ' ' A' ' 41' ' ' GLY . 0.0 OUTLIER -174.83 157.31 2.42 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 123.891 0.876 . . . . 0.0 110.733 175.547 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.2 m -141.47 108.76 6.15 Favored Pre-proline 0 C--N 1.328 -0.347 0 O-C-N 123.972 0.795 . . . . 0.0 109.829 -179.91 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -72.53 179.12 5.43 Favored 'Trans proline' 0 N--CA 1.447 -1.226 0 C-N-CA 122.479 2.119 . . . . 0.0 111.619 177.338 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 55' ' ' ILE . . . . . 0.409 ' CG2' ' HB2' ' A' ' 133' ' ' LEU . 5.2 mt -90.16 124.76 42.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.788 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.18 134.65 35.66 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.675 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 57' ' ' PHE . . . . . 0.521 ' CD1' ' HB3' ' A' ' 118' ' ' CYS . 40.1 m-85 -114.33 -47.83 2.91 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 123.494 0.718 . . . . 0.0 110.642 179.43 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 121.66 -1.81 11.12 Favored Glycine 0 C--O 1.223 -0.54 0 C-N-CA 123.767 0.698 . . . . 0.0 112.514 -176.36 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.5 mttm -103.24 145.53 29.8 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 117.74 0.77 . . . . 0.0 109.588 177.537 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 30.4 t -79.13 -9.16 59.48 Favored 'General case' 0 C--O 1.222 -0.374 0 O-C-N 124.794 1.309 . . . . 0.0 111.309 176.784 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -89.04 -48.99 7.03 Favored 'General case' 0 CA--C 1.515 -0.375 0 C-N-CA 123.788 0.835 . . . . 0.0 109.797 179.995 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 62' ' ' CYS . . . . . 0.7 ' SG ' HD21 ' A' ' 80' ' ' LEU . 1.4 t -72.91 -17.04 61.54 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 123.739 0.649 . . . . 0.0 111.814 175.871 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -86.43 -33.13 20.52 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-O 122.009 0.909 . . . . 0.0 111.295 174.422 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 64' ' ' ARG . . . . . 0.609 ' HD3' ' CD2' ' A' ' 78' ' ' HIS . 0.0 OUTLIER -57.27 158.99 9.09 Favored Pre-proline 0 N--CA 1.445 -0.691 0 O-C-N 121.369 -0.832 . . . . 0.0 111.343 179.492 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -71.14 140.09 36.86 Favored 'Trans proline' 0 N--CA 1.442 -1.5 0 C-N-CA 120.763 0.975 . . . . 0.0 113.74 174.365 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 66' ' ' PRO . . . . . 0.529 ' HD2' ' CD2' ' A' ' 42' ' ' TYR . 22.8 Cg_endo -70.77 169.88 19.13 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 123.482 2.788 . . . . 0.0 112.238 177.058 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 67' ' ' LYS . . . . . 0.536 ' HG3' ' CE1' ' A' ' 78' ' ' HIS . 0.8 OUTLIER -133.37 49.95 2.26 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 179.224 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 68' ' ' HIS . . . . . 0.483 ' HA ' ' OD2' ' A' ' 77' ' ' ASP . 25.1 t-80 -73.92 156.97 37.09 Favored 'General case' 0 C--O 1.22 -0.459 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.588 -177.536 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 69' ' ' SER . . . . . 0.443 ' O ' ' CE1' ' A' ' 68' ' ' HIS . 1.5 p -148.22 -160.05 1.12 Allowed 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 122.287 1.041 . . . . 0.0 111.3 177.169 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.59 75.64 9.49 Favored 'General case' 0 C--O 1.217 -0.625 0 O-C-N 120.259 -1.526 . . . . 0.0 111.722 172.148 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -177.22 -44.59 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.271 0.628 . . . . 0.0 109.958 177.6 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 72' ' ' GLY . . . . . 0.48 ' CA ' ' HB3' ' A' ' 27' ' ' ASP . . . 109.17 -54.46 0.55 Allowed Glycine 0 C--O 1.212 -1.239 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.912 -178.458 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -133.87 65.65 1.57 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 -179.574 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.44 -126.63 0.01 OUTLIER Glycine 0 CA--C 1.525 0.718 0 CA-C-O 121.94 0.745 . . . . 0.0 111.492 179.447 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.8 mttt -58.2 -92.66 0.0 OUTLIER 'General case' 0 C--O 1.221 -0.444 0 O-C-N 120.738 -1.448 . . . . 0.0 112.311 178.132 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 76' ' ' THR . . . . . 0.529 HG23 ' O ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -115.86 15.99 16.27 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-O 118.307 -0.854 . . . . 0.0 110.427 177.473 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 77' ' ' ASP . . . . . 0.505 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 20.1 t0 -29.11 102.06 0.02 OUTLIER 'General case' 0 C--O 1.212 -0.897 0 O-C-N 123.979 0.799 . . . . 0.0 110.99 -179.566 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 78' ' ' HIS . . . . . 0.609 ' CD2' ' HD3' ' A' ' 64' ' ' ARG . 11.2 p-80 -87.55 64.18 7.98 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -176.016 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 79' ' ' TYR . . . . . 0.599 ' HB2' ' CD1' ' A' ' 37' ' ' TRP . 34.4 p90 -90.29 136.56 32.98 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 124.242 1.017 . . . . 0.0 109.527 -178.128 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 80' ' ' LEU . . . . . 0.7 HD21 ' SG ' ' A' ' 62' ' ' CYS . 0.3 OUTLIER -74.44 142.51 44.92 Favored 'General case' 0 C--O 1.216 -0.697 0 C-N-CA 119.758 -0.777 . . . . 0.0 109.225 176.22 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 81' ' ' LEU . . . . . 0.668 HD21 ' HB2' ' A' ' 35' ' ' PRO . 1.1 tt -134.66 144.07 47.62 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 176.338 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 82' ' ' GLU . . . . . 0.508 ' HB2' HD11 ' A' ' 109' ' ' ILE . 6.1 pm0 -109.35 165.62 11.49 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 123.547 0.739 . . . . 0.0 111.429 -179.694 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 83' ' ' PHE . . . . . 0.605 ' HB3' HG12 ' A' ' 108' ' ' VAL . 36.7 t80 -148.93 135.23 10.12 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 117.795 -1.098 . . . . 0.0 112.444 -179.186 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 84' ' ' PRO . . . . . 0.565 ' HA ' ' HG2' ' A' ' 107' ' ' ARG . 19.1 Cg_endo -70.73 88.67 0.64 Allowed 'Trans proline' 0 CA--C 1.501 -1.152 0 C-N-CA 124.513 3.475 . . . . 0.0 110.679 -176.015 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 85' ' ' THR . . . . . 0.622 HG22 ' HA ' ' A' ' 107' ' ' ARG . 1.2 t -86.71 115.92 24.47 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 124.411 1.07 . . . . 0.0 111.958 179.741 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 86' ' ' PHE . . . . . 0.617 ' CD1' ' CD1' ' A' ' 92' ' ' TYR . 18.2 m-85 -83.67 160.42 58.78 Favored Pre-proline 0 N--CA 1.45 -0.473 0 C-N-CA 123.193 0.597 . . . . 0.0 111.525 -179.877 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.05 -44.54 0.33 Allowed 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 122.189 1.926 . . . . 0.0 111.748 179.041 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -52.21 -28.38 18.22 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 122.992 1.377 . . . . 0.0 110.031 177.89 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.1 -14.14 40.53 Favored Glycine 0 N--CA 1.438 -1.227 0 CA-C-O 118.23 -1.317 . . . . 0.0 111.809 -179.023 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 90' ' ' HIS . . . . . 0.425 ' O ' ' CE1' ' A' ' 92' ' ' TYR . 1.0 OUTLIER -48.69 143.22 5.36 Favored 'General case' 0 C--O 1.213 -0.838 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.425 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -63.64 137.66 58.18 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.793 0.806 . . . . 0.0 111.736 177.32 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 92' ' ' TYR . . . . . 0.617 ' CD1' ' CD1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -94.86 148.5 22.24 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 -174.876 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -84.4 68.62 10.31 Favored 'General case' 0 C--N 1.321 -0.649 0 O-C-N 121.272 -0.893 . . . . 0.0 109.564 176.079 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 94' ' ' PHE . . . . . 0.422 ' CD2' ' O ' ' A' ' 92' ' ' TYR . 30.7 p90 -83.4 -16.15 46.99 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.583 177.465 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 95' ' ' ASP . . . . . 0.403 ' O ' ' HA3' ' A' ' 31' ' ' GLY . 0.4 OUTLIER -89.8 -30.87 17.68 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 123.82 0.848 . . . . 0.0 110.448 178.55 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.0 t -90.91 110.29 21.52 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -177.014 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.52 -46.1 91.38 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-O 120.958 0.409 . . . . 0.0 110.347 179.723 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 98' ' ' LYS . . . . . 0.427 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 6.6 mttm -141.07 128.46 11.98 Favored Pre-proline 0 N--CA 1.438 -1.04 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.962 -178.251 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 99' ' ' PRO . . . . . 0.427 ' C ' ' HA ' ' A' ' 98' ' ' LYS . 20.0 Cg_endo -70.05 176.86 31.71 Favored 'Cis proline' 0 N--CA 1.458 -0.602 0 O-C-N 124.579 1.831 . . . . 0.0 111.472 -3.802 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.03 152.34 48.76 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 123.515 0.726 . . . . 0.0 109.891 177.731 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -104.13 146.37 28.84 Favored 'General case' 0 C--N 1.321 -0.656 0 O-C-N 124.327 1.017 . . . . 0.0 108.767 -179.875 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -56.23 120.26 33.64 Favored Pre-proline 0 N--CA 1.445 -0.706 0 CA-C-O 118.095 -0.955 . . . . 0.0 110.792 177.353 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -71.6 -163.22 0.13 Allowed 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 122.723 2.282 . . . . 0.0 111.753 178.303 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -142.5 172.29 24.38 Favored Glycine 0 CA--C 1.524 0.645 0 O-C-N 121.414 -0.804 . . . . 0.0 112.113 177.187 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 105' ' ' PRO . . . . . 0.569 ' HB2' ' HB1' ' A' ' 122' ' ' ALA . 18.7 Cg_endo -74.03 -50.88 0.15 Allowed 'Trans proline' 0 N--CA 1.447 -1.26 0 C-N-CA 122.112 1.875 . . . . 0.0 110.542 178.925 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 106' ' ' ALA . . . . . 0.604 ' HA ' ' HB2' ' A' ' 122' ' ' ALA . . . -61.24 135.74 57.83 Favored 'General case' 0 CA--C 1.507 -0.704 0 O-C-N 123.645 0.591 . . . . 0.0 109.892 -179.155 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 107' ' ' ARG . . . . . 0.622 ' HA ' HG22 ' A' ' 85' ' ' THR . 9.4 mtm-85 -151.39 148.1 27.71 Favored 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 124.224 0.952 . . . . 0.0 110.456 -179.085 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 108' ' ' VAL . . . . . 0.605 HG12 ' HB3' ' A' ' 83' ' ' PHE . 12.8 p -87.99 116.01 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 O-C-N 124.354 1.034 . . . . 0.0 111.525 178.584 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 109' ' ' ILE . . . . . 0.655 ' CG2' HD22 ' A' ' 80' ' ' LEU . 1.4 mp -107.39 122.05 61.08 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.885 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 -173.09 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 110' ' ' TYR . . . . . 0.465 ' CZ ' HD22 ' A' ' 81' ' ' LEU . 6.3 p90 -141.46 151.73 43.62 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 121.836 0.827 . . . . 0.0 109.711 -179.388 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.3 p -80.64 163.23 23.78 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.639 178.421 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 112' ' ' TYR . . . . . 0.524 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -111.9 154.73 44.04 Favored Pre-proline 0 CA--C 1.546 0.808 0 O-C-N 123.353 0.408 . . . . 0.0 110.893 178.86 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 113' ' ' PRO . . . . . 0.524 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 19.0 Cg_endo -74.16 -51.08 0.16 OUTLIER 'Cis proline' 0 CA--C 1.502 -1.094 0 C-N-CA 123.533 -1.444 . . . . 0.0 110.529 -5.956 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 114' ' ' ASN . . . . . 0.541 ' O ' HG23 ' A' ' 116' ' ' VAL . 43.8 t-20 -45.23 109.96 0.21 Allowed 'General case' 0 C--O 1.219 -0.549 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.971 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 115' ' ' LYS . . . . . 0.526 ' HE2' HD22 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -66.39 76.63 0.1 Allowed 'General case' 0 CA--C 1.512 -0.497 0 C-N-CA 123.675 0.79 . . . . 0.0 109.016 179.547 . . . . . . . . 3 3 . 1 . 025 nuclear build core ' A' A ' 116' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 114' ' ' ASN . 57.3 t -74.84 72.51 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 -176.188 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 117' ' ' PHE . . . . . 0.407 ' CE1' ' NE2' ' A' ' 13' ' ' GLN . 59.8 t80 -34.02 104.95 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 126.752 2.021 . . . . 0.0 109.22 -178.378 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 118' ' ' CYS . . . . . 0.521 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 14.6 m -84.84 -44.81 12.9 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -177.683 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 158.89 -151.03 21.94 Favored Glycine 0 N--CA 1.441 -1.02 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 179.657 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 120' ' ' ILE . . . . . 0.45 HG13 ' CG ' ' A' ' 4' ' ' TRP . 1.1 mm -127.44 133.14 68.51 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.806 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 -176.45 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 6.4 pt -119.72 155.14 22.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -177.327 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 122' ' ' ALA . . . . . 0.734 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . . . . . . . . 0 C--N 1.323 -0.545 0 CA-C-O 120.817 0.342 . . . . 0.0 110.249 178.635 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.514 -0.42 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 133' ' ' LEU . . . . . 0.409 ' HB2' ' CG2' ' A' ' 55' ' ' ILE . 14.9 tp -85.62 140.64 30.41 Favored 'General case' 0 C--O 1.244 0.765 0 O-C-N 123.886 0.741 . . . . 0.0 109.375 177.633 . . . . . . . . 2 2 . 1 . 025 nuclear build core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 60.8 m -68.71 -178.47 1.18 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.786 175.954 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 73.6 m -148.62 100.27 3.09 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 -178.787 . . . . . . . . 1 1 . 1 . 025 nuclear build core ' A' A ' 136' ' ' HIS . . . . . 0.468 ' HB2' HG13 ' A' ' 2' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--O 1.248 0.981 0 CA-C-O 117.892 -1.051 . . . . 0.0 113.268 173.312 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.346 0 CA-C-O 117.578 -1.201 . . . . 0.0 110.465 . . . . . . . . . 0 0 . 1 . 001 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -43.63 156.54 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.549 0 C-N-CA 125.347 1.459 . . . . 0.0 110.708 174.247 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 91.4 m -83.96 111.22 19.06 Favored 'General case' 0 C--N 1.31 -1.119 0 O-C-N 121.742 -0.599 . . . . 0.0 111.046 177.736 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.465 ' CD2' ' HB3' ' A' ' 136' ' ' HIS . 16.9 m95 -79.7 142.44 35.48 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 177.983 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -138.51 141.09 39.38 Favored 'General case' 0 CA--C 1.498 -1.046 0 O-C-N 121.068 -1.02 . . . . 0.0 108.429 -178.588 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.635 ' SG ' ' HB3' ' A' ' 122' ' ' ALA . 0.5 OUTLIER -122.81 61.08 1.01 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 118.612 -0.708 . . . . 0.0 110.502 177.54 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 39.0 78.69 0.05 OUTLIER Glycine 0 CA--C 1.532 1.114 0 O-C-N 124.207 0.942 . . . . 0.0 113.031 -177.828 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.01 -75.59 0.19 Allowed Glycine 0 C--O 1.224 -0.482 0 N-CA-C 111.189 -0.765 . . . . 0.0 111.189 -177.439 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.2 mt -128.33 163.2 25.32 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.593 0.711 . . . . 0.0 110.609 177.15 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.62 HD22 ' H ' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -88.58 170.34 10.94 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.978 -177.202 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.798 ' CZ ' ' HB3' ' A' ' 106' ' ' ALA . 70.6 m-85 -160.99 85.94 0.69 Allowed 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 122.278 1.037 . . . . 0.0 108.378 -171.254 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -54.11 122.98 11.34 Favored 'General case' 0 C--O 1.213 -0.864 0 CA-C-O 115.715 -2.088 . . . . 0.0 108.457 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.5 tt0 -46.49 -40.47 12.54 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 120.161 1.346 . . . . 0.0 112.543 175.716 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -57.75 -47.35 82.73 Favored 'General case' 0 C--O 1.199 -1.576 0 CA-C-O 118.573 -0.727 . . . . 0.0 111.093 176.195 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.423 ' CE ' ' HA3' ' A' ' 89' ' ' GLY . 6.3 mttt -70.52 -39.78 73.86 Favored 'General case' 0 C--O 1.203 -1.363 0 CA-C-N 120.912 1.687 . . . . 0.0 112.185 171.877 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.589 ' HA ' HG21 ' A' ' 85' ' ' THR . . . -52.58 -41.01 63.23 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 121.55 1.977 . . . . 0.0 110.855 175.937 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -87.06 -47.0 9.28 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-O 117.393 -1.289 . . . . 0.0 109.64 177.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 39.3 t -67.49 -54.18 22.31 Favored 'General case' 0 CA--C 1.496 -1.108 0 C-N-CA 127.311 2.244 . . . . 0.0 107.597 -171.499 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.519 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 5.9 t-20 -42.32 -36.46 1.26 Allowed 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 119.862 1.21 . . . . 0.0 113.514 169.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.422 ' O ' ' HB3' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -82.78 -33.97 27.19 Favored 'General case' 0 C--O 1.212 -0.906 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 172.813 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -44.96 -35.69 3.01 Favored 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 126.516 1.926 . . . . 0.0 110.33 177.476 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.519 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -74.3 -48.84 25.88 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-O 117.089 -1.434 . . . . 0.0 112.385 175.224 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.547 ' HB2' ' CE1' ' A' ' 83' ' ' PHE . . . -35.41 128.78 0.56 Allowed Pre-proline 0 CA--C 1.542 0.647 0 O-C-N 125.568 1.792 . . . . 0.0 112.51 172.569 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.759 ' HG2' HG22 ' A' ' 30' ' ' THR . 14.9 Cg_endo -73.98 123.04 8.1 Favored 'Trans proline' 0 N--CA 1.448 -1.189 0 C-N-CA 122.14 1.893 . . . . 0.0 108.661 -176.062 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.521 HD22 ' HE2' ' A' ' 115' ' ' LYS . 3.4 tp -59.47 102.86 0.16 Allowed 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.102 178.654 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 178.93 151.3 0.31 Allowed 'General case' 0 C--O 1.214 -0.795 0 CA-C-O 119.014 -0.517 . . . . 0.0 110.883 -176.674 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.48 ' HB3' ' CA ' ' A' ' 72' ' ' GLY . 0.9 OUTLIER -81.93 89.8 6.4 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 119.263 0.938 . . . . 0.0 109.571 -179.422 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 60.31 82.08 0.07 OUTLIER Glycine 0 C--O 1.226 -0.401 0 CA-C-O 121.617 0.565 . . . . 0.0 111.7 178.379 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.3 mttt -150.06 45.76 0.91 Allowed 'General case' 0 CA--C 1.511 -0.546 0 CA-C-O 122.521 1.153 . . . . 0.0 111.315 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.759 HG22 ' HG2' ' A' ' 24' ' ' PRO . 70.5 p -128.41 152.56 48.06 Favored 'General case' 0 CA--C 1.497 -1.076 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -175.251 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -42.77 -52.19 5.59 Favored Glycine 0 C--N 1.332 0.346 0 O-C-N 124.556 1.16 . . . . 0.0 112.139 -177.728 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.3 t -68.48 -77.98 0.07 Allowed 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 117.659 -1.162 . . . . 0.0 111.251 172.939 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 71.0 p -178.07 -61.73 0.01 OUTLIER 'General case' 0 C--O 1.218 -0.603 0 O-C-N 124.846 1.341 . . . . 0.0 110.888 -177.042 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -62.66 146.87 93.86 Favored Pre-proline 0 N--CA 1.428 -1.555 0 O-C-N 125.432 1.707 . . . . 0.0 112.714 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.599 ' HB2' HD21 ' A' ' 81' ' ' LEU . 29.3 Cg_endo -78.19 -179.39 26.88 Favored 'Cis proline' 0 N--CA 1.439 -1.731 0 C-N-CA 121.856 -2.143 . . . . 0.0 111.785 1.452 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.411 ' CD2' ' N ' ' A' ' 36' ' ' HIS . 0.2 OUTLIER -152.69 164.1 38.39 Favored 'General case' 0 C--O 1.209 -1.063 0 O-C-N 118.913 -2.367 . . . . 0.0 111.251 -177.27 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.986 ' CH2' HG22 ' A' ' 39' ' ' THR . 20.3 t90 -69.96 140.93 53.08 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 119.821 1.191 . . . . 0.0 108.422 176.826 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.463 ' CZ ' ' HA ' ' A' ' 40' ' ' ASN . 11.3 t80 -117.79 86.64 2.56 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 -177.766 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.986 HG22 ' CH2' ' A' ' 37' ' ' TRP . 70.4 p -38.91 -36.58 0.29 Allowed 'General case' 0 C--O 1.211 -0.965 0 C-N-CA 124.853 1.261 . . . . 0.0 111.185 175.007 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.463 ' HA ' ' CZ ' ' A' ' 38' ' ' PHE . 9.6 t-20 73.49 4.94 4.91 Favored 'General case' 0 C--O 1.219 -0.52 0 C-N-CA 126.329 1.852 . . . . 0.0 109.36 176.815 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.441 ' CA ' ' HD3' ' A' ' 52' ' ' ARG . . . 120.04 -9.74 11.18 Favored Glycine 0 N--CA 1.427 -1.918 0 C-N-CA 125.221 1.391 . . . . 0.0 114.059 -172.553 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.592 ' CE1' HD11 ' A' ' 48' ' ' LEU . 17.3 m-85 -77.36 172.04 13.93 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.012 0.925 . . . . 0.0 110.489 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.04 -39.12 12.38 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.87 176.382 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.583 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . 174.27 -42.46 0.14 Allowed Glycine 0 C--N 1.334 0.439 0 C-N-CA 124.449 1.023 . . . . 0.0 112.73 -177.996 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -133.27 -63.87 0.75 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.519 0.676 . . . . 0.0 109.736 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.7 154.54 17.19 Favored Glycine 0 C--N 1.341 0.825 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.589 ' HA ' ' CE2' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -53.16 174.8 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.839 0.828 . . . . 0.0 112.775 175.721 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.592 HD11 ' CE1' ' A' ' 42' ' ' TYR . 5.6 mp -57.27 149.97 44.86 Favored Pre-proline 0 N--CA 1.445 -0.686 0 O-C-N 121.697 -0.627 . . . . 0.0 111.431 177.888 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -72.47 159.07 50.0 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 122.03 1.82 . . . . 0.0 109.474 -179.011 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 6.7 ttpt -54.65 97.76 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.147 0.579 . . . . 0.0 110.246 177.36 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.42 74.44 0.69 Allowed Glycine 0 N--CA 1.452 -0.26 0 CA-C-O 119.02 -0.878 . . . . 0.0 112.831 -175.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.441 ' HD3' ' CA ' ' A' ' 41' ' ' GLY . 7.1 ttm180 -173.69 164.28 4.37 Favored 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 123.966 0.906 . . . . 0.0 110.493 175.327 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.3 m -142.59 110.16 5.72 Favored Pre-proline 0 N--CA 1.448 -0.553 0 O-C-N 123.472 0.482 . . . . 0.0 110.563 178.6 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.409 ' HG3' HD13 ' A' ' 48' ' ' LEU . 23.6 Cg_endo -73.15 178.7 6.23 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 122.286 1.991 . . . . 0.0 111.52 178.32 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.416 ' CG2' ' HB2' ' A' ' 133' ' ' LEU . 4.3 mt -88.63 119.07 35.27 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.552 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -179.131 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -82.65 134.96 35.16 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 120.85 -1.156 . . . . 0.0 109.076 176.884 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.598 ' CE1' HD13 ' A' ' 133' ' ' LEU . 6.9 m-85 -116.82 -44.33 2.83 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.575 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 122.5 -4.03 10.2 Favored Glycine 0 C--O 1.224 -0.508 0 CA-C-O 118.88 -0.956 . . . . 0.0 112.62 -176.203 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.7 mttt -101.49 139.15 37.54 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-N 118.307 1.054 . . . . 0.0 109.863 176.843 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.7 t -78.66 -1.0 32.25 Favored 'General case' 0 C--O 1.219 -0.507 0 O-C-N 125.097 1.498 . . . . 0.0 111.21 175.642 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -87.47 -51.22 6.04 Favored 'General case' 0 N--CA 1.451 -0.424 0 O-C-N 120.184 -1.572 . . . . 0.0 109.327 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.739 ' HB3' HD11 ' A' ' 80' ' ' LEU . 2.7 m -73.51 -35.55 65.62 Favored 'General case' 0 N--CA 1.451 -0.401 0 O-C-N 123.747 0.654 . . . . 0.0 109.624 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -63.05 -37.1 85.85 Favored 'General case' 0 C--O 1.225 -0.205 0 CA-C-O 121.531 0.681 . . . . 0.0 111.398 175.505 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.7 161.8 0.83 Allowed Pre-proline 0 N--CA 1.441 -0.908 0 CA-C-O 122.321 1.058 . . . . 0.0 112.642 177.781 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.424 ' HA ' ' CE2' ' A' ' 42' ' ' TYR . 27.5 Cg_endo -70.92 132.87 22.27 Favored 'Trans proline' 0 N--CA 1.438 -1.758 0 C-N-CA 120.72 0.947 . . . . 0.0 114.486 173.343 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.507 ' HD2' ' CD2' ' A' ' 42' ' ' TYR . 19.5 Cg_endo -72.04 168.01 25.15 Favored 'Trans proline' 0 N--CA 1.445 -1.37 0 C-N-CA 123.122 2.548 . . . . 0.0 110.905 177.736 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.6 tptt -126.92 52.98 1.73 Allowed 'General case' 0 C--O 1.203 -1.351 0 CA-C-N 115.136 -0.938 . . . . 0.0 108.51 178.892 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -75.52 164.88 25.9 Favored 'General case' 0 C--O 1.216 -0.692 0 O-C-N 120.411 -1.43 . . . . 0.0 111.347 178.404 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.4 p -157.87 -167.98 2.4 Favored 'General case' 0 C--N 1.322 -0.589 0 O-C-N 119.531 -1.98 . . . . 0.0 111.136 176.473 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.4 77.05 5.96 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 120.686 -1.259 . . . . 0.0 112.686 171.975 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -177.79 -44.86 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 O-C-N 123.694 0.621 . . . . 0.0 110.162 177.887 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.48 ' CA ' ' HB3' ' A' ' 27' ' ' ASP . . . 117.18 -69.24 0.3 Allowed Glycine 0 N--CA 1.439 -1.148 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.453 -178.986 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -128.84 60.95 1.52 Allowed 'General case' 0 CA--C 1.508 -0.67 0 C-N-CA 125.583 1.553 . . . . 0.0 107.367 -175.71 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.33 -106.45 0.01 OUTLIER Glycine 0 CA--C 1.535 1.292 0 CA-C-O 123.04 1.355 . . . . 0.0 112.862 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.8 mttm -73.11 -105.12 0.01 OUTLIER 'General case' 0 C--O 1.217 -0.608 0 O-C-N 119.699 -2.06 . . . . 0.0 110.621 177.121 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.519 HG23 ' O ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -106.47 16.8 24.21 Favored 'General case' 0 C--N 1.32 -0.711 0 O-C-N 121.486 -0.759 . . . . 0.0 111.116 179.329 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.425 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 10.0 m-20 -31.56 98.74 0.01 OUTLIER 'General case' 0 C--O 1.207 -1.132 0 C-N-CA 125.487 1.515 . . . . 0.0 111.856 -176.725 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 8.2 p-80 -85.11 44.41 1.08 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 119.752 -1.842 . . . . 0.0 107.745 -170.67 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.508 ' HB2' ' CD1' ' A' ' 37' ' ' TRP . 39.3 p90 -69.68 135.02 49.35 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 124.794 1.237 . . . . 0.0 111.011 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.817 HD22 HG23 ' A' ' 109' ' ' ILE . 2.1 mt -71.24 142.84 50.57 Favored 'General case' 0 C--O 1.216 -0.71 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 177.83 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.599 HD21 ' HB2' ' A' ' 35' ' ' PRO . 0.3 OUTLIER -137.12 137.12 38.92 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 119.128 0.876 . . . . 0.0 108.864 177.059 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.463 ' HB2' HD11 ' A' ' 109' ' ' ILE . 0.5 OUTLIER -99.78 168.66 9.76 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.649 176.432 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.547 ' CE1' ' HB2' ' A' ' 23' ' ' ALA . 78.6 t80 -157.04 130.02 4.42 Favored Pre-proline 0 C--N 1.327 -0.383 0 O-C-N 120.811 -1.181 . . . . 0.0 113.857 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.426 ' HA ' ' HG2' ' A' ' 107' ' ' ARG . 19.3 Cg_endo -72.6 98.76 0.98 Allowed 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 123.913 3.076 . . . . 0.0 109.713 -175.554 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.589 HG21 ' HA ' ' A' ' 16' ' ' ALA . 7.2 t -102.49 109.15 20.7 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.075 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -81.34 158.44 69.18 Favored Pre-proline 0 C--N 1.32 -0.696 0 O-C-N 121.607 -0.683 . . . . 0.0 112.112 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -78.12 -34.3 1.71 Allowed 'Trans proline' 0 CA--C 1.495 -1.473 0 C-N-CA 122.053 1.835 . . . . 0.0 112.802 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -43.83 -32.94 1.18 Allowed 'General case' 0 N--CA 1.474 0.77 0 O-C-N 125.537 1.773 . . . . 0.0 110.709 176.285 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.423 ' HA3' ' CE ' ' A' ' 15' ' ' LYS . . . 89.19 4.45 74.38 Favored Glycine 0 N--CA 1.431 -1.66 0 CA-C-O 118.586 -1.119 . . . . 0.0 111.268 177.191 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 4.5 p-80 -74.07 129.55 38.08 Favored 'General case' 0 N--CA 1.434 -1.253 0 O-C-N 125.669 1.452 . . . . 0.0 107.644 178.306 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -61.84 92.04 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 174.325 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.497 ' CD2' ' HB3' ' A' ' 94' ' ' PHE . 5.8 t80 -38.32 142.89 0.15 Allowed 'General case' 0 C--O 1.21 -0.99 0 CA-C-O 122.083 0.944 . . . . 0.0 110.382 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.46 58.73 1.03 Allowed 'General case' 0 C--N 1.312 -1.064 0 O-C-N 119.11 -2.244 . . . . 0.0 111.061 175.059 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.497 ' HB3' ' CD2' ' A' ' 92' ' ' TYR . 25.7 p90 -75.27 -18.3 60.1 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 123.925 0.89 . . . . 0.0 111.621 176.802 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -92.05 -22.39 19.97 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-O 122.21 1.005 . . . . 0.0 110.304 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.49 107.59 19.56 Favored 'General case' 0 CA--C 1.513 -0.459 0 O-C-N 120.369 -1.457 . . . . 0.0 109.001 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.23 -49.5 75.82 Favored 'General case' 0 C--N 1.33 -0.261 0 O-C-N 122.181 -0.325 . . . . 0.0 110.375 177.368 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -136.41 125.33 15.48 Favored Pre-proline 0 N--CA 1.44 -0.938 0 C-N-CA 124.338 1.055 . . . . 0.0 109.695 -175.2 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -71.94 176.12 39.81 Favored 'Cis proline' 0 C--N 1.349 0.601 0 O-C-N 124.94 2.021 . . . . 0.0 110.941 -2.661 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -138.07 124.0 20.1 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 124.059 0.943 . . . . 0.0 109.013 179.013 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.06 159.57 26.12 Favored 'General case' 0 C--N 1.322 -0.618 0 O-C-N 124.509 1.131 . . . . 0.0 111.399 177.483 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -60.06 138.97 91.11 Favored Pre-proline 0 N--CA 1.451 -0.403 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.32 177.707 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -72.25 -165.75 0.23 Allowed 'Trans proline' 0 N--CA 1.452 -0.971 0 C-N-CA 122.783 2.322 . . . . 0.0 111.725 176.907 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -131.58 155.7 21.51 Favored Glycine 0 CA--C 1.527 0.798 0 O-C-N 121.166 -0.959 . . . . 0.0 112.433 176.614 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -73.07 -17.46 24.81 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 122.389 2.059 . . . . 0.0 111.258 177.429 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.798 ' HB3' ' CZ ' ' A' ' 11' ' ' TYR . . . -110.76 134.92 52.08 Favored 'General case' 0 CA--C 1.507 -0.711 0 C-N-CA 124.177 0.991 . . . . 0.0 110.094 177.811 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.427 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 0.0 OUTLIER -138.37 151.04 47.15 Favored 'General case' 0 CA--C 1.5 -0.964 0 CA-C-O 116.489 -1.72 . . . . 0.0 111.41 176.964 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.513 ' C ' HD12 ' A' ' 109' ' ' ILE . 7.3 p -82.39 122.24 36.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 124.77 1.228 . . . . 0.0 112.109 175.942 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.817 HG23 HD22 ' A' ' 80' ' ' LEU . 1.7 mp -110.71 120.46 61.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 -174.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.498 ' O ' HD23 ' A' ' 80' ' ' LEU . 6.4 p90 -140.34 150.52 44.07 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 122.93 1.347 . . . . 0.0 109.958 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.6 p -82.32 160.58 22.85 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -178.647 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.52 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.0 OUTLIER -108.2 155.38 40.29 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 122.873 0.469 . . . . 0.0 110.568 179.203 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.52 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 14.7 Cg_endo -74.16 -51.21 0.16 OUTLIER 'Cis proline' 0 CA--C 1.501 -1.159 0 C-N-CA 123.343 -1.524 . . . . 0.0 109.596 -6.87 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -47.72 108.09 0.15 Allowed 'General case' 0 CA--C 1.505 -0.785 0 CA-C-O 116.101 -1.904 . . . . 0.0 108.919 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.521 ' HE2' HD22 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -62.91 79.75 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.547 0 O-C-N 125.233 1.583 . . . . 0.0 109.014 -177.775 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.481 ' O ' HG12 ' A' ' 116' ' ' VAL . 15.4 t -80.16 71.58 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 N-CA-C 103.965 -2.605 . . . . 0.0 103.965 -175.319 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.547 ' CE1' ' HA2' ' A' ' 119' ' ' GLY . 4.3 t80 -36.1 114.12 0.26 Allowed 'General case' 0 C--O 1.242 0.671 0 C-N-CA 124.049 0.94 . . . . 0.0 108.809 177.854 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 118' ' ' CYS . . . . . 0.546 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -97.03 -30.33 13.12 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.973 177.282 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.547 ' HA2' ' CE1' ' A' ' 117' ' ' PHE . . . 144.12 -170.32 25.98 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 123.864 0.745 . . . . 0.0 112.027 -177.274 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.679 HG21 ' HB1' ' A' ' 106' ' ' ALA . 3.2 mp -111.61 142.84 22.77 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.395 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 -177.077 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.72 HG22 HD12 ' A' ' 133' ' ' LEU . 8.4 pt -114.83 155.19 16.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 119.822 1.192 . . . . 0.0 108.087 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.635 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . . . -177.96 161.04 1.51 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 122.9 1.333 . . . . 0.0 110.117 178.522 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -90.61 93.23 9.18 Favored 'General case' 0 C--N 1.32 -0.707 0 O-C-N 121.26 -0.9 . . . . 0.0 109.04 -178.532 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.579 HG22 ' HD2' ' A' ' 132' ' ' LYS . 2.0 t -98.16 36.53 1.57 Allowed 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 124.689 2.185 . . . . 0.0 111.419 -179.336 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 25.9 tptt -100.43 -27.87 13.22 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 118.324 -2.735 . . . . 0.0 110.972 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -169.09 -63.14 0.02 OUTLIER 'General case' 0 C--O 1.219 -0.537 0 O-C-N 124.117 0.886 . . . . 0.0 110.298 178.36 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -155.5 -45.28 0.08 Allowed 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 122.567 1.175 . . . . 0.0 110.901 178.867 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.45 75.43 0.72 Allowed 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 122.052 0.93 . . . . 0.0 111.152 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -119.57 -104.55 2.09 Favored Glycine 0 N--CA 1.46 0.259 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -88.24 155.3 19.81 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 121.387 -1.067 . . . . 0.0 111.349 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.563 HD22 HD12 ' A' ' 121' ' ' ILE . 0.5 OUTLIER -99.8 138.2 37.21 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 121.663 -0.648 . . . . 0.0 110.133 178.57 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.579 ' HD2' HG22 ' A' ' 124' ' ' THR . 0.6 OUTLIER -150.16 167.09 27.89 Favored 'General case' 0 CA--C 1.502 -0.868 0 C-N-CA 123.984 0.914 . . . . 0.0 109.256 -177.827 . . . . . . . . 3 3 . 1 . 001 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.72 HD12 HG22 ' A' ' 121' ' ' ILE . 9.4 tp -83.97 148.07 27.11 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 177.783 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 134' ' ' CYS . . . . . 0.533 ' SG ' HG22 ' A' ' 120' ' ' ILE . 90.8 m -58.59 -174.32 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.186 1.394 . . . . 0.0 110.608 175.995 . . . . . . . . 2 2 . 1 . 001 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 61.3 m -131.22 93.28 3.34 Favored 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -177.58 . . . . . . . . 1 1 . 1 . 001 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.465 ' HB3' ' CD2' ' A' ' 4' ' ' TRP . 1.1 p80 . . . . . 0 C--O 1.25 1.111 0 CA-C-O 114.957 -2.449 . . . . 0.0 113.427 173.515 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.456 0 CA-C-O 118.316 -0.85 . . . . 0.0 108.78 . . . . . . . . . 0 0 . 1 . 002 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.545 HG22 ' HB3' ' A' ' 136' ' ' HIS . 14.4 p -72.79 146.68 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 O-C-N 123.98 0.8 . . . . 0.0 110.891 175.334 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.4 m -88.93 114.56 25.69 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 124.002 0.921 . . . . 0.0 109.47 -177.724 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.47 ' CD1' ' HB2' ' A' ' 13' ' ' GLN . 31.8 m95 -79.33 150.18 31.52 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-O 118.88 -0.581 . . . . 0.0 110.421 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.5 m -144.52 131.62 20.51 Favored 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 -176.035 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.736 ' SG ' ' HB3' ' A' ' 122' ' ' ALA . 0.0 OUTLIER -126.93 -80.4 0.6 Allowed 'General case' 0 C--O 1.217 -0.658 0 CA-C-O 117.708 -1.139 . . . . 0.0 110.742 176.911 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -56.89 -88.17 0.02 OUTLIER Glycine 0 C--N 1.344 1.018 0 O-C-N 124.395 1.059 . . . . 0.0 111.294 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -154.17 18.22 0.62 Allowed Glycine 0 C--O 1.223 -0.585 0 O-C-N 121.749 -0.853 . . . . 0.0 111.383 178.226 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 49.8 mt -129.98 158.79 38.6 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 123.511 0.724 . . . . 0.0 109.735 178.816 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.5 mp -96.6 134.42 39.86 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.228 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.471 ' CE2' ' CB ' ' A' ' 106' ' ' ALA . 76.2 m-85 -117.64 104.07 10.66 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 126.481 1.912 . . . . 0.0 108.267 -173.944 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 3.7 t-20 -55.69 119.6 5.97 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.986 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.47 ' HB2' ' CD1' ' A' ' 4' ' ' TRP . 22.1 tp60 -53.25 -41.42 65.44 Favored 'General case' 0 C--O 1.203 -1.344 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.91 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -49.78 -42.44 46.68 Favored 'General case' 0 C--O 1.197 -1.702 0 CA-C-O 119.544 -0.265 . . . . 0.0 111.377 175.781 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.3 mttp -70.86 -37.19 73.09 Favored 'General case' 0 C--O 1.202 -1.44 0 O-C-N 120.923 -1.111 . . . . 0.0 113.451 169.274 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.4 -38.44 66.22 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 122.353 2.342 . . . . 0.0 113.641 172.158 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -90.39 -39.63 12.55 Favored 'General case' 0 C--O 1.212 -0.877 0 CA-C-O 117.976 -1.012 . . . . 0.0 108.548 177.286 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 39.8 t -73.63 -59.79 2.55 Favored 'General case' 0 C--O 1.214 -0.806 0 C-N-CA 126.212 1.805 . . . . 0.0 109.911 -176.45 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.498 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 6.4 t-20 -41.0 -36.86 0.72 Allowed 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 119.72 1.145 . . . . 0.0 113.285 170.709 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.477 ' O ' ' HB3' ' A' ' 23' ' ' ALA . 0.5 OUTLIER -81.53 -36.79 28.75 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 115.035 1.495 . . . . 0.0 115.035 173.434 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -44.83 -38.68 4.72 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.382 1.873 . . . . 0.0 109.896 178.102 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.498 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -73.72 -47.01 42.52 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-O 117.88 -1.057 . . . . 0.0 112.732 175.064 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.831 ' HB1' ' HG3' ' A' ' 35' ' ' PRO . . . -35.74 127.59 0.61 Allowed Pre-proline 0 N--CA 1.439 -0.982 0 O-C-N 125.312 1.632 . . . . 0.0 112.885 173.011 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.719 ' HG2' HG22 ' A' ' 30' ' ' THR . 14.2 Cg_endo -73.63 125.87 10.39 Favored 'Trans proline' 0 N--CA 1.445 -1.369 0 C-N-CA 122.054 1.836 . . . . 0.0 108.576 -175.758 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.818 HD13 ' HE2' ' A' ' 115' ' ' LYS . 4.3 tp -60.6 93.92 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.472 0.709 . . . . 0.0 111.239 178.658 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 179.2 162.46 0.82 Allowed 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 123.102 0.561 . . . . 0.0 109.966 -176.079 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.2 118.44 34.85 Favored 'General case' 0 C--O 1.218 -0.595 0 C-N-CA 123.996 0.918 . . . . 0.0 110.344 177.648 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 46.71 64.72 2.51 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 120.048 -1.073 . . . . 0.0 112.7 177.469 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.9 ttpt -129.44 11.69 5.86 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 124.367 2.032 . . . . 0.0 111.079 178.024 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.719 HG22 ' HG2' ' A' ' 24' ' ' PRO . 25.9 p -112.71 150.53 31.4 Favored 'General case' 0 C--N 1.309 -1.165 0 O-C-N 119.27 -2.144 . . . . 0.0 107.233 -174.485 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -39.94 -51.13 3.4 Favored Glycine 0 C--N 1.335 0.474 0 O-C-N 124.404 1.065 . . . . 0.0 112.495 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.7 t -69.23 -78.09 0.07 Allowed 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 118.988 -0.53 . . . . 0.0 111.224 173.423 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.4 p -179.0 -63.75 0.01 OUTLIER 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 123.491 0.717 . . . . 0.0 110.202 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.588 ' CE2' ' CE1' ' A' ' 36' ' ' HIS . 65.6 m-85 -58.67 147.13 71.98 Favored Pre-proline 0 N--CA 1.426 -1.662 0 C-N-CA 124.708 1.203 . . . . 0.0 112.962 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.831 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 20.7 Cg_endo -74.77 151.37 96.86 Favored 'Cis proline' 0 N--CA 1.45 -1.081 0 C-N-CA 123.088 -1.63 . . . . 0.0 110.734 -0.738 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.614 ' C ' HD23 ' A' ' 81' ' ' LEU . 0.5 OUTLIER -129.39 166.38 19.66 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-O 117.474 -1.25 . . . . 0.0 110.347 -179.554 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.961 ' CH2' HG22 ' A' ' 39' ' ' THR . 16.7 t90 -64.02 144.41 57.11 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 124.329 1.018 . . . . 0.0 108.586 178.026 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.554 ' CE1' ' CD1' ' A' ' 121' ' ' ILE . 16.3 t80 -117.4 82.51 1.83 Allowed 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 -174.785 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.961 HG22 ' CH2' ' A' ' 37' ' ' TRP . 73.1 p -40.38 -33.08 0.22 Allowed 'General case' 0 C--O 1.211 -0.948 0 C-N-CA 124.537 1.135 . . . . 0.0 110.459 174.01 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.485 ' HB2' ' CE2' ' A' ' 38' ' ' PHE . 46.3 t30 60.18 16.33 5.97 Favored 'General case' 0 C--O 1.214 -0.784 0 CA-C-O 122.877 1.323 . . . . 0.0 109.374 177.704 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.434 ' O ' ' HD3' ' A' ' 52' ' ' ARG . . . 112.89 -38.39 3.25 Favored Glycine 0 N--CA 1.427 -1.905 0 O-C-N 119.469 -2.019 . . . . 0.0 113.367 -172.197 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.7 ' HA ' HD23 ' A' ' 48' ' ' LEU . 66.0 m-85 -50.64 170.53 0.03 OUTLIER 'General case' 0 C--O 1.231 0.081 0 CA-C-N 118.664 1.232 . . . . 0.0 111.695 178.849 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.44 -40.53 9.86 Favored 'General case' 0 C--N 1.32 -0.693 0 O-C-N 121.598 -0.689 . . . . 0.0 110.002 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.576 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -177.09 -53.31 0.06 OUTLIER Glycine 0 C--N 1.336 0.547 0 C-N-CA 123.855 0.74 . . . . 0.0 111.9 -178.439 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.76 -96.29 0.07 Allowed 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 -179.456 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.445 ' HA2' ' CD2' ' A' ' 42' ' ' TYR . . . -141.6 12.7 2.7 Favored Glycine 0 N--CA 1.438 -1.226 0 C-N-CA 125.306 1.432 . . . . 0.0 111.065 -176.328 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.2 pttt -112.06 146.41 38.0 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 117.991 -1.004 . . . . 0.0 108.804 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.7 HD23 ' HA ' ' A' ' 42' ' ' TYR . 0.4 OUTLIER -111.06 159.01 34.23 Favored Pre-proline 0 C--N 1.323 -0.555 0 O-C-N 124.624 1.203 . . . . 0.0 108.676 -178.473 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -74.48 157.37 44.99 Favored 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 121.857 1.704 . . . . 0.0 109.925 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.2 ttpt -54.89 101.12 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.99 0.516 . . . . 0.0 109.859 177.887 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.77 88.4 1.77 Allowed Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 116.495 -0.321 . . . . 0.0 112.535 -176.438 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.434 ' HD3' ' O ' ' A' ' 41' ' ' GLY . 0.9 OUTLIER -169.97 161.28 8.74 Favored 'General case' 0 CA--C 1.513 -0.475 0 C-N-CA 123.415 0.686 . . . . 0.0 110.506 175.683 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.0 m -147.69 113.57 4.01 Favored Pre-proline 0 N--CA 1.447 -0.616 0 O-C-N 124.485 1.115 . . . . 0.0 110.412 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -72.28 166.92 28.32 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 122.621 2.214 . . . . 0.0 111.344 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.401 ' O ' ' CE1' ' A' ' 57' ' ' PHE . 6.0 mt -81.6 129.87 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 -178.077 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.71 136.93 35.49 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 177.729 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.528 ' CE2' HD13 ' A' ' 133' ' ' LEU . 3.0 m-85 -125.93 -53.87 1.52 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 -177.436 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 120.37 -5.51 11.98 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 123.852 0.739 . . . . 0.0 112.602 -176.467 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.409 ' CB ' ' HB3' ' A' ' 62' ' ' CYS . 0.2 OUTLIER -65.75 177.5 1.25 Allowed 'General case' 0 C--O 1.207 -1.165 0 CA-C-N 118.251 1.026 . . . . 0.0 111.355 176.157 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.48 -45.13 4.73 Favored 'General case' 0 C--O 1.212 -0.885 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.404 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.55 -40.17 23.53 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.11 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.57 ' HA ' HD11 ' A' ' 80' ' ' LEU . 0.9 OUTLIER -71.43 -20.14 62.15 Favored 'General case' 0 C--N 1.342 0.253 0 O-C-N 123.871 0.732 . . . . 0.0 110.824 177.826 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -85.79 -42.24 14.36 Favored 'General case' 0 CA--C 1.509 -0.599 0 O-C-N 124.225 0.953 . . . . 0.0 112.196 174.714 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.419 ' HD2' ' CD2' ' A' ' 78' ' ' HIS . 0.0 OUTLIER -51.75 165.38 0.46 Allowed Pre-proline 0 N--CA 1.44 -0.951 0 CA-C-O 121.437 0.637 . . . . 0.0 111.542 -179.155 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -71.82 139.16 32.95 Favored 'Trans proline' 0 N--CA 1.437 -1.8 0 N-CA-C 114.807 1.041 . . . . 0.0 114.807 173.436 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.44 ' HD2' ' CE2' ' A' ' 42' ' ' TYR . 18.5 Cg_endo -70.51 174.28 10.39 Favored 'Trans proline' 0 N--CA 1.446 -1.286 0 C-N-CA 122.846 2.364 . . . . 0.0 111.09 178.424 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.417 ' HG3' ' CE1' ' A' ' 78' ' ' HIS . 1.4 mmtp -140.03 58.86 1.58 Allowed 'General case' 0 C--O 1.199 -1.569 0 CA-C-O 116.597 -1.668 . . . . 0.0 109.28 177.246 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.407 ' CE1' ' O ' ' A' ' 69' ' ' SER . 58.4 t-80 -75.4 164.02 26.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 119.534 1.061 . . . . 0.0 110.594 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.407 ' O ' ' CE1' ' A' ' 68' ' ' HIS . 0.3 OUTLIER -149.38 -168.66 3.17 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 123.574 0.75 . . . . 0.0 111.402 177.997 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.14 71.22 10.6 Favored 'General case' 0 C--O 1.216 -0.706 0 O-C-N 120.268 -1.52 . . . . 0.0 111.745 176.433 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -177.18 -42.4 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.103 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.418 ' O ' ' CE2' ' A' ' 79' ' ' TYR . . . 124.51 -46.69 1.07 Allowed Glycine 0 CA--C 1.487 -1.703 0 CA-C-O 117.757 -1.58 . . . . 0.0 112.469 -176.84 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -150.11 81.89 1.37 Allowed 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 177.829 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -61.42 -122.59 0.01 OUTLIER Glycine 0 C--O 1.219 -0.812 0 CA-C-O 121.197 0.332 . . . . 0.0 112.476 177.129 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.2 mttt -52.45 -89.34 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 O-C-N 120.411 -1.641 . . . . 0.0 112.086 178.298 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.561 HG23 ' O ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -119.62 17.01 12.85 Favored 'General case' 0 CA--C 1.508 -0.659 0 O-C-N 120.929 -1.107 . . . . 0.0 111.017 178.143 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.464 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 5.0 m-20 -27.05 105.08 0.02 OUTLIER 'General case' 0 C--O 1.203 -1.36 0 C-N-CA 125.44 1.496 . . . . 0.0 110.692 -177.075 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.419 ' CD2' ' HD2' ' A' ' 64' ' ' ARG . 3.5 p-80 -87.21 11.2 14.7 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 121.146 -0.971 . . . . 0.0 110.255 -176.072 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.996 ' CZ ' HD11 ' A' ' 81' ' ' LEU . 0.5 OUTLIER -33.96 132.95 0.22 Allowed 'General case' 0 N--CA 1.435 -1.206 0 C-N-CA 125.353 1.461 . . . . 0.0 113.205 172.37 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.662 HD22 ' CG2' ' A' ' 109' ' ' ILE . 0.2 OUTLIER -75.19 151.98 38.44 Favored 'General case' 0 C--O 1.218 -0.587 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.883 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.996 HD11 ' CZ ' ' A' ' 79' ' ' TYR . 1.4 mp -135.87 139.94 43.75 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-N 119.081 0.855 . . . . 0.0 109.155 176.744 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.452 ' HB2' HD11 ' A' ' 109' ' ' ILE . 1.8 pm0 -106.32 151.73 24.47 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-O 121.897 0.856 . . . . 0.0 110.793 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.424 ' CZ ' ' HB2' ' A' ' 23' ' ' ALA . 55.4 t80 -140.1 130.61 14.0 Favored Pre-proline 0 N--CA 1.449 -0.506 0 O-C-N 121.727 -0.608 . . . . 0.0 111.979 -179.11 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.455 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 18.6 Cg_endo -72.34 108.88 2.61 Favored 'Trans proline' 0 N--CA 1.446 -1.272 0 C-N-CA 123.674 2.916 . . . . 0.0 110.632 -178.935 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.93 109.27 21.16 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.74 0.816 . . . . 0.0 109.752 -179.259 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -81.1 160.7 65.13 Favored Pre-proline 0 N--CA 1.446 -0.662 0 O-C-N 121.598 -0.689 . . . . 0.0 112.433 178.195 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -77.21 -41.66 0.34 Allowed 'Trans proline' 0 CA--C 1.494 -1.507 0 C-N-CA 122.395 2.063 . . . . 0.0 112.256 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -45.57 -30.61 1.53 Allowed 'General case' 0 C--N 1.35 0.622 0 O-C-N 125.275 1.609 . . . . 0.0 110.282 177.473 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.34 -4.9 85.87 Favored Glycine 0 N--CA 1.432 -1.573 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 176.791 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 4.3 p-80 -60.55 129.64 42.6 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -64.19 89.72 0.06 Allowed 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 177.265 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.493 ' CD2' ' HB3' ' A' ' 94' ' ' PHE . 6.2 t80 -36.41 142.91 0.08 Allowed 'General case' 0 C--O 1.211 -0.959 0 C-N-CA 124.041 0.937 . . . . 0.0 110.507 -178.858 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.06 58.07 1.47 Allowed 'General case' 0 C--N 1.313 -0.996 0 O-C-N 119.766 -1.834 . . . . 0.0 110.738 175.969 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.493 ' HB3' ' CD2' ' A' ' 92' ' ' TYR . 28.8 p90 -74.03 -14.88 61.08 Favored 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 123.524 0.73 . . . . 0.0 111.954 176.679 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.86 -33.63 17.28 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 124.584 1.154 . . . . 0.0 110.794 178.732 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 32.2 m -85.96 109.89 19.08 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -178.558 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.5 ptpt -58.17 -49.68 76.16 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 178.623 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 99' ' ' PRO . 0.7 OUTLIER -140.7 126.81 11.6 Favored Pre-proline 0 N--CA 1.43 -1.459 0 C-N-CA 124.416 1.086 . . . . 0.0 110.329 -175.939 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' A' ' 98' ' ' LYS . 24.6 Cg_endo -71.95 175.98 40.44 Favored 'Cis proline' 0 C--N 1.35 0.606 0 O-C-N 124.909 2.005 . . . . 0.0 110.999 -2.925 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.2 tttp -141.09 130.23 23.42 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.773 0.829 . . . . 0.0 109.469 178.822 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -82.92 148.77 27.46 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.135 0.897 . . . . 0.0 110.372 176.687 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -43.86 137.94 3.31 Favored Pre-proline 0 N--CA 1.437 -1.116 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.021 173.489 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -73.18 -166.46 0.3 Allowed 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 122.449 2.1 . . . . 0.0 110.541 178.413 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -131.45 160.03 23.32 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-O 119.295 -0.725 . . . . 0.0 112.381 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -76.25 -65.84 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.778 2.319 . . . . 0.0 110.551 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.581 ' HA ' ' HB2' ' A' ' 122' ' ' ALA . . . -59.86 137.18 58.13 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 123.702 0.626 . . . . 0.0 110.996 177.991 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 5.1 mtm-85 -141.43 149.4 40.96 Favored 'General case' 0 CA--C 1.505 -0.767 0 O-C-N 124.211 0.944 . . . . 0.0 110.717 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.425 HG23 ' HD1' ' A' ' 117' ' ' PHE . 2.7 p -88.46 117.01 31.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.135 0.897 . . . . 0.0 111.862 178.772 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.714 HG12 HD13 ' A' ' 121' ' ' ILE . 1.2 mp -104.3 125.01 59.13 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.984 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 -171.847 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.621 ' C ' HD23 ' A' ' 80' ' ' LEU . 14.5 p90 -146.17 160.56 41.79 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.05 -178.939 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.0 p -93.86 166.0 12.4 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.867 -177.867 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.56 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -112.96 153.44 45.25 Favored Pre-proline 0 N--CA 1.44 -0.951 0 C-N-CA 122.478 0.311 . . . . 0.0 110.706 179.962 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.56 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 16.5 Cg_endo -74.46 -51.59 0.16 OUTLIER 'Cis proline' 0 CA--C 1.499 -1.253 0 C-N-CA 123.487 -1.464 . . . . 0.0 109.71 -5.864 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -45.44 111.99 0.4 Allowed 'General case' 0 CA--C 1.502 -0.901 0 CA-C-O 115.861 -2.019 . . . . 0.0 109.132 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.818 ' HE2' HD13 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -64.87 74.81 0.04 OUTLIER 'General case' 0 CA--C 1.51 -0.593 0 O-C-N 125.787 1.929 . . . . 0.0 108.476 -178.383 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.502 ' O ' HG12 ' A' ' 116' ' ' VAL . 9.5 t -73.45 72.16 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 105.696 -1.964 . . . . 0.0 105.696 -177.08 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.425 ' HD1' HG23 ' A' ' 108' ' ' VAL . 17.2 t80 -46.93 107.98 0.13 Allowed 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 124.67 1.188 . . . . 0.0 108.881 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 118' ' ' CYS . . . . . 0.419 ' SG ' ' CG ' ' A' ' 57' ' ' PHE . 0.1 OUTLIER -83.75 -56.41 3.72 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 -179.853 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.428 ' HA2' ' CH2' ' A' ' 4' ' ' TRP . . . -178.8 -145.09 5.97 Favored Glycine 0 N--CA 1.436 -1.357 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.451 HG13 ' CG ' ' A' ' 4' ' ' TRP . 1.2 mm -127.59 145.49 34.87 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.202 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 -175.088 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.714 HD13 HG12 ' A' ' 109' ' ' ILE . 3.1 pt -131.12 156.86 43.08 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.903 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.736 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . . . -176.14 162.61 2.52 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.781 0.8 . . . . 0.0 109.611 177.143 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 2.1 m80 -91.66 93.88 9.12 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 108.858 -0.794 . . . . 0.0 108.858 -178.187 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.542 ' O ' HG23 ' A' ' 124' ' ' THR . 2.4 t -97.63 38.55 1.27 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 123.176 1.465 . . . . 0.0 111.554 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 9.8 tttm -104.13 -27.83 11.84 Favored 'General case' 0 C--N 1.322 -0.601 0 O-C-N 120.493 -1.38 . . . . 0.0 111.014 178.339 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -171.03 -63.07 0.02 OUTLIER 'General case' 0 C--O 1.22 -0.453 0 O-C-N 123.546 0.529 . . . . 0.0 110.518 177.866 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -154.87 -46.02 0.08 Allowed 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.535 0.734 . . . . 0.0 110.664 178.64 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -157.08 75.01 0.81 Allowed 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 123.477 0.711 . . . . 0.0 110.988 -179.132 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -122.0 -102.1 1.71 Allowed Glycine 0 C--N 1.331 0.274 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.48 159.85 17.78 Favored 'General case' 0 CA--C 1.508 -0.645 0 O-C-N 121.816 -0.814 . . . . 0.0 110.303 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.437 HD22 HD12 ' A' ' 121' ' ' ILE . 0.8 OUTLIER -112.69 141.56 46.33 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.643 0.735 . . . . 0.0 109.864 177.811 . . . . . . . . 3 3 . 1 . 002 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.25 172.75 14.36 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 123.884 0.873 . . . . 0.0 109.725 -178.614 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.528 HD13 ' CE2' ' A' ' 57' ' ' PHE . 12.3 tp -82.94 136.0 34.71 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 83.7 m -63.43 -175.68 0.13 Allowed 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 124.082 0.953 . . . . 0.0 109.599 175.576 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 59.3 m -161.55 119.29 2.28 Favored 'General case' 0 CA--C 1.488 -1.427 0 N-CA-C 104.319 -2.474 . . . . 0.0 104.319 -177.479 . . . . . . . . 1 1 . 1 . 002 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.545 ' HB3' HG22 ' A' ' 2' ' ' VAL . 3.2 m80 . . . . . 0 CA--C 1.558 1.254 0 CA-C-O 114.733 -2.556 . . . . 0.0 115.822 177.184 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.71 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 . . . . . . . . . 0 0 . 1 . 003 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.1 p -104.19 148.47 8.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.583 HG22 ' H ' ' A' ' 11' ' ' TYR . 23.9 m -89.13 115.41 26.64 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 123.767 0.827 . . . . 0.0 109.625 -178.158 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.47 ' CG ' HG13 ' A' ' 120' ' ' ILE . 23.7 m95 -77.71 142.06 38.98 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -133.86 138.76 45.8 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -178.316 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.662 ' SG ' ' HB3' ' A' ' 122' ' ' ALA . 0.1 OUTLIER -129.59 49.98 2.21 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.868 0.842 . . . . 0.0 111.099 176.865 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 143.06 -99.45 0.23 Allowed Glycine 0 C--O 1.22 -0.778 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -129.32 5.38 6.32 Favored Glycine 0 N--CA 1.466 0.679 0 C-N-CA 123.676 0.655 . . . . 0.0 112.704 177.834 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.499 HD12 ' OH ' ' A' ' 11' ' ' TYR . 0.3 OUTLIER -112.72 138.79 49.02 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 -175.69 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.5 mp -95.62 160.83 14.31 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 123.981 0.801 . . . . 0.0 109.468 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.583 ' H ' HG22 ' A' ' 3' ' ' THR . 65.9 m-85 -152.37 94.87 1.97 Allowed 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 122.182 0.992 . . . . 0.0 109.564 -173.968 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.27 120.63 7.91 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-O 117.427 -1.273 . . . . 0.0 108.038 -178.315 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.402 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 6.7 tp-100 -50.05 -43.24 50.96 Favored 'General case' 0 C--O 1.205 -1.266 0 O-C-N 124.655 1.222 . . . . 0.0 112.032 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -47.98 -48.84 32.16 Favored 'General case' 0 C--O 1.193 -1.897 0 CA-C-O 118.97 -0.538 . . . . 0.0 112.257 174.59 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.31 -38.13 84.45 Favored 'General case' 0 C--O 1.206 -1.214 0 CA-C-N 119.99 1.268 . . . . 0.0 114.2 168.019 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.549 ' O ' HG11 ' A' ' 108' ' ' VAL . . . -49.96 -43.88 50.35 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 121.599 1.999 . . . . 0.0 114.455 170.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -88.59 -39.89 13.76 Favored 'General case' 0 C--O 1.206 -1.218 0 O-C-N 120.916 -1.115 . . . . 0.0 109.668 176.359 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 36.5 t -73.38 -60.2 2.36 Favored 'General case' 0 C--O 1.211 -0.942 0 C-N-CA 126.571 1.948 . . . . 0.0 109.896 -176.102 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.489 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 4.6 t-20 -40.26 -38.5 0.79 Allowed 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 120.268 1.394 . . . . 0.0 113.357 169.239 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.634 ' HB3' HG11 ' A' ' 108' ' ' VAL . 0.1 OUTLIER -81.81 -30.77 32.07 Favored 'General case' 0 C--O 1.217 -0.656 0 N-CA-C 116.11 1.892 . . . . 0.0 116.11 173.108 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -50.08 -35.35 25.03 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 125.733 1.613 . . . . 0.0 109.298 177.958 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.489 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.1 OUTLIER -73.9 -42.8 60.13 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 117.822 -1.085 . . . . 0.0 111.926 176.792 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.841 ' HB1' ' HG3' ' A' ' 35' ' ' PRO . . . -36.24 129.72 0.65 Allowed Pre-proline 0 N--CA 1.44 -0.974 0 O-C-N 125.233 1.583 . . . . 0.0 113.069 172.027 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.873 ' HG2' HG22 ' A' ' 30' ' ' THR . 17.4 Cg_endo -72.89 123.98 9.32 Favored 'Trans proline' 0 N--CA 1.444 -1.418 0 C-N-CA 122.053 1.835 . . . . 0.0 108.802 -176.439 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.489 ' HA ' HD12 ' A' ' 25' ' ' LEU . 2.1 tp -62.03 91.11 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.262 1.025 . . . . 0.0 110.668 178.769 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 179.78 157.8 0.67 Allowed 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 123.435 0.694 . . . . 0.0 109.427 -175.408 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.416 ' OD1' ' N ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -98.96 89.45 4.29 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 104.621 -2.362 . . . . 0.0 104.621 -164.281 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 63.2 75.48 0.34 Allowed Glycine 0 CA--C 1.529 0.943 0 C-N-CA 119.489 -1.338 . . . . 0.0 111.957 -176.266 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.8 ttpt -138.19 28.79 2.52 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 123.661 1.696 . . . . 0.0 111.825 176.224 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.873 HG22 ' HG2' ' A' ' 24' ' ' PRO . 7.7 p -118.39 146.76 44.17 Favored 'General case' 0 CA--C 1.492 -1.271 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 -172.643 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -42.43 -53.94 4.89 Favored Glycine 0 N--CA 1.452 -0.242 0 O-C-N 123.827 0.705 . . . . 0.0 111.561 -179.156 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.2 t -64.15 -62.43 1.62 Allowed 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 116.533 -1.698 . . . . 0.0 112.378 174.182 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 162.1 -59.11 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.475 0 C-N-CA 127.91 2.484 . . . . 0.0 111.396 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.577 ' CE1' ' CE1' ' A' ' 36' ' ' HIS . 70.8 m-85 -59.77 141.14 89.33 Favored Pre-proline 0 N--CA 1.446 -0.674 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 178.191 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.841 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 36.7 Cg_endo -77.4 167.23 79.88 Favored 'Cis proline' 0 N--CA 1.436 -1.902 0 C-N-CA 121.833 -2.153 . . . . 0.0 112.721 3.512 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.577 ' CE1' ' CE1' ' A' ' 34' ' ' TYR . 2.5 p-80 -137.61 174.4 10.63 Favored 'General case' 0 C--O 1.205 -1.241 0 O-C-N 120.629 -1.294 . . . . 0.0 111.86 178.192 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.93 ' CH2' HG22 ' A' ' 39' ' ' THR . 14.1 t90 -75.84 132.14 40.17 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 119.864 1.211 . . . . 0.0 110.726 173.515 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -97.52 89.56 4.72 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 105.148 -2.167 . . . . 0.0 105.148 -179.382 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.93 HG22 ' CH2' ' A' ' 37' ' ' TRP . 17.1 p -38.81 -36.01 0.24 Allowed 'General case' 0 C--O 1.203 -1.38 0 CA-C-O 117.733 -1.127 . . . . 0.0 110.286 169.989 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 50.4 t30 55.95 22.25 5.61 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 121.189 1.813 . . . . 0.0 109.973 176.499 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.559 ' HA3' HD23 ' A' ' 48' ' ' LEU . . . 101.37 -39.76 2.64 Favored Glycine 0 N--CA 1.425 -2.052 0 CA-C-O 116.726 -2.152 . . . . 0.0 116.587 -168.249 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.479 ' CE2' ' HD3' ' A' ' 66' ' ' PRO . 80.5 m-85 -46.58 152.65 0.44 Allowed 'General case' 0 C--O 1.233 0.202 0 C-N-CA 126.456 1.902 . . . . 0.0 110.695 177.348 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.82 -38.35 25.65 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.728 178.644 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.574 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -172.29 -59.07 0.04 OUTLIER Glycine 0 C--N 1.335 0.489 0 C-N-CA 124.689 1.138 . . . . 0.0 111.011 -178.173 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -125.16 -64.77 1.06 Allowed 'General case' 0 CA--C 1.507 -0.69 0 O-C-N 122.641 -0.329 . . . . 0.0 110.514 -176.802 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.99 -175.81 0.22 Allowed Glycine 0 C--N 1.342 0.872 0 C-N-CA 124.761 1.172 . . . . 0.0 110.988 178.835 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.54 -165.72 0.0 OUTLIER 'General case' 0 CA--C 1.551 0.987 0 CA-C-O 124.61 2.148 . . . . 0.0 112.623 175.697 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.723 ' H ' HD12 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -96.35 169.02 9.54 Favored Pre-proline 0 C--N 1.306 -1.286 0 O-C-N 119.829 -1.794 . . . . 0.0 110.889 -179.96 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -71.87 157.67 54.48 Favored 'Trans proline' 0 N--CA 1.441 -1.582 0 C-N-CA 121.888 1.725 . . . . 0.0 110.69 178.23 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.0 tttt -63.76 97.88 0.17 Allowed 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.713 -0.617 . . . . 0.0 110.205 176.685 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 123.62 40.0 0.48 Allowed Glycine 0 CA--C 1.52 0.351 0 N-CA-C 112.015 -0.434 . . . . 0.0 112.015 -176.528 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.443 ' HD3' ' HA2' ' A' ' 41' ' ' GLY . 0.0 OUTLIER -132.96 161.35 34.54 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-N 117.325 0.562 . . . . 0.0 111.495 176.85 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.9 m -140.48 102.85 6.55 Favored Pre-proline 0 C--N 1.324 -0.527 0 O-C-N 124.045 0.841 . . . . 0.0 109.61 -178.484 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -72.08 175.78 9.37 Favored 'Trans proline' 0 N--CA 1.448 -1.183 0 C-N-CA 122.504 2.136 . . . . 0.0 111.418 178.208 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.8 mt -98.35 130.52 47.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 -178.297 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.34 135.37 33.72 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 177.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.508 ' CD1' ' HB3' ' A' ' 118' ' ' CYS . 17.3 m-85 -118.83 -45.37 2.59 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 124.078 0.951 . . . . 0.0 110.142 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 121.03 -2.31 11.68 Favored Glycine 0 C--O 1.222 -0.642 0 C-N-CA 123.885 0.755 . . . . 0.0 112.59 -175.665 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 18.0 mttm -105.33 137.82 42.51 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 118.222 1.011 . . . . 0.0 109.373 177.507 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.2 t -73.26 -4.64 34.41 Favored 'General case' 0 C--O 1.217 -0.642 0 O-C-N 125.182 1.551 . . . . 0.0 111.504 176.157 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -89.0 -50.59 6.08 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 124.654 1.182 . . . . 0.0 109.745 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 10.1 m -71.52 -22.55 61.76 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.46 0.648 . . . . 0.0 111.564 175.41 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -79.75 -35.87 38.14 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-O 118.892 -0.575 . . . . 0.0 111.143 174.023 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -52.35 160.79 1.19 Allowed Pre-proline 0 CA--C 1.539 0.542 0 CA-C-O 122.084 0.945 . . . . 0.0 111.67 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -71.94 144.14 42.39 Favored 'Trans proline' 0 N--CA 1.443 -1.492 0 C-N-CA 120.461 0.774 . . . . 0.0 113.573 175.037 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.479 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 19.8 Cg_endo -72.74 169.12 22.75 Favored 'Trans proline' 0 N--CA 1.444 -1.433 0 C-N-CA 124.151 3.234 . . . . 0.0 111.056 178.513 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.4 tptp -128.47 51.92 1.96 Allowed 'General case' 0 C--O 1.197 -1.675 0 CA-C-O 114.987 -2.435 . . . . 0.0 107.216 -179.016 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.42 ' CD2' ' O ' ' A' ' 72' ' ' GLY . 57.1 t-80 -74.79 144.56 43.49 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 121.212 1.824 . . . . 0.0 113.897 175.011 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.06 -91.17 0.5 Allowed 'General case' 0 N--CA 1.469 0.496 0 O-C-N 119.207 -2.183 . . . . 0.0 109.607 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.95 -174.94 0.38 Allowed 'General case' 0 C--O 1.215 -0.733 0 C-N-CA 123.713 0.805 . . . . 0.0 111.123 178.974 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -50.31 -27.02 5.47 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 173.39 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.42 ' O ' ' CD2' ' A' ' 68' ' ' HIS . . . -104.22 -118.54 4.49 Favored Glycine 0 C--O 1.214 -1.139 0 N-CA-C 106.583 -2.607 . . . . 0.0 106.583 178.01 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -121.75 -100.0 0.43 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 100.413 -3.921 . . . . 0.0 100.413 -167.542 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 144.75 -131.99 4.55 Favored Glycine 0 N--CA 1.439 -1.134 0 CA-C-N 115.232 -0.894 . . . . 0.0 113.32 -167.678 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.2 mttm -63.01 -104.41 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 122.049 0.928 . . . . 0.0 112.673 175.986 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.534 HG23 ' O ' ' A' ' 76' ' ' THR . 0.6 OUTLIER -101.39 21.2 14.54 Favored 'General case' 0 CA--C 1.514 -0.423 0 O-C-N 120.785 -1.197 . . . . 0.0 111.588 -179.685 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.455 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 1.1 m-20 -33.25 105.06 0.03 OUTLIER 'General case' 0 CA--C 1.49 -1.343 0 C-N-CA 126.181 1.792 . . . . 0.0 109.924 -176.238 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -83.8 16.44 2.76 Favored 'General case' 0 C--N 1.319 -0.74 0 O-C-N 120.683 -1.261 . . . . 0.0 110.5 -176.759 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.487 ' CE2' ' HB2' ' A' ' 81' ' ' LEU . 10.8 p90 -41.27 136.28 1.7 Allowed 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 125.607 1.563 . . . . 0.0 110.963 177.495 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.446 HD21 HG22 ' A' ' 111' ' ' THR . 0.3 OUTLIER -77.02 136.27 38.69 Favored 'General case' 0 C--O 1.215 -0.728 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.08 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.578 HD21 ' HB2' ' A' ' 35' ' ' PRO . 0.5 OUTLIER -128.84 151.91 49.09 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.85 0.834 . . . . 0.0 109.1 175.442 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -121.81 163.33 19.34 Favored 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 124.242 1.017 . . . . 0.0 112.193 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.602 ' CE1' ' HB2' ' A' ' 23' ' ' ALA . 80.1 t80 -148.21 129.04 6.97 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -177.629 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.5 ' HD3' ' CD1' ' A' ' 34' ' ' TYR . 17.8 Cg_endo -72.0 109.61 2.73 Favored 'Trans proline' 0 N--CA 1.443 -1.477 0 C-N-CA 123.381 2.721 . . . . 0.0 110.887 -176.176 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.469 HG21 ' HA ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -107.25 107.31 18.18 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-N 114.662 -1.154 . . . . 0.0 109.65 -178.062 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -80.01 160.17 69.23 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 177.414 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -76.4 -38.66 0.98 Allowed 'Trans proline' 0 CA--C 1.493 -1.564 0 C-N-CA 122.092 1.861 . . . . 0.0 112.896 178.472 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -44.67 -30.43 0.93 Allowed 'General case' 0 N--CA 1.474 0.766 0 O-C-N 125.644 1.84 . . . . 0.0 110.92 176.874 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.74 6.61 86.94 Favored Glycine 0 N--CA 1.437 -1.281 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 176.799 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -72.74 136.08 45.44 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -68.18 85.31 0.25 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 175.304 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.494 ' CD2' ' HB3' ' A' ' 94' ' ' PHE . 6.7 t80 -37.29 144.25 0.08 Allowed 'General case' 0 C--O 1.214 -0.769 0 C-N-CA 123.95 0.9 . . . . 0.0 110.659 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.3 55.91 0.8 Allowed 'General case' 0 C--N 1.313 -0.986 0 O-C-N 119.781 -1.825 . . . . 0.0 110.936 174.687 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.494 ' HB3' ' CD2' ' A' ' 92' ' ' TYR . 34.1 p90 -71.35 -24.17 62.04 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 124.099 0.959 . . . . 0.0 111.025 175.884 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -86.11 -27.66 24.52 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 123.973 0.909 . . . . 0.0 110.401 178.103 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -88.9 111.57 22.25 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -178.872 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.3 pttt -58.04 -49.75 75.81 Favored 'General case' 0 CA--C 1.511 -0.522 0 O-C-N 121.648 -0.658 . . . . 0.0 111.003 177.471 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 99' ' ' PRO . 2.3 mtmm -138.07 126.08 14.03 Favored Pre-proline 0 N--CA 1.436 -1.155 0 CA-C-N 114.364 -1.289 . . . . 0.0 109.946 -175.826 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.409 ' HA ' ' HA ' ' A' ' 98' ' ' LYS . 22.9 Cg_endo -69.55 176.65 31.16 Favored 'Cis proline' 0 N--CA 1.459 -0.558 0 O-C-N 124.35 1.71 . . . . 0.0 110.949 -3.965 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.99 123.16 16.84 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 124.845 1.258 . . . . 0.0 109.484 177.345 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.49 -179.37 7.14 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 125.309 1.63 . . . . 0.0 110.378 178.677 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -46.64 153.14 0.81 Allowed Pre-proline 0 CA--C 1.541 0.622 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.937 176.462 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.49 -70.62 0.02 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.576 0 C-N-CA 121.998 1.799 . . . . 0.0 110.626 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 125.14 129.42 3.36 Favored Glycine 0 CA--C 1.533 1.178 0 CA-C-N 118.885 0.766 . . . . 0.0 111.214 -178.511 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.93 -69.56 0.02 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 122.924 2.416 . . . . 0.0 110.477 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.505 ' CB ' ' CE2' ' A' ' 11' ' ' TYR . . . -66.94 132.87 48.85 Favored 'General case' 0 CA--C 1.512 -0.491 0 O-C-N 123.18 0.3 . . . . 0.0 110.732 179.105 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.446 ' HG2' ' HA ' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -139.76 152.15 46.38 Favored 'General case' 0 CA--C 1.497 -1.082 0 CA-C-O 117.719 -1.134 . . . . 0.0 110.737 -178.237 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.634 HG11 ' HB3' ' A' ' 20' ' ' SER . 3.3 p -87.32 114.17 25.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 O-C-N 124.153 0.908 . . . . 0.0 111.673 178.246 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.641 HG12 HD13 ' A' ' 121' ' ' ILE . 1.4 mp -98.7 118.07 44.69 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.236 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 -173.312 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.485 ' CD1' ' CG ' ' A' ' 115' ' ' LYS . 4.6 p90 -139.03 148.0 42.82 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-O 123.918 1.818 . . . . 0.0 108.616 -178.897 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.446 HG22 HD21 ' A' ' 80' ' ' LEU . 4.8 p -83.27 164.87 19.82 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.142 178.444 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.543 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -107.46 154.81 40.47 Favored Pre-proline 0 CA--C 1.55 0.959 0 CA-C-O 121.014 0.435 . . . . 0.0 111.072 178.495 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.543 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 15.9 Cg_endo -74.96 -53.29 0.16 OUTLIER 'Cis proline' 0 CA--C 1.498 -1.297 0 C-N-CA 124.158 -1.184 . . . . 0.0 110.071 -6.622 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.539 ' O ' HG23 ' A' ' 116' ' ' VAL . 32.7 t30 -45.82 111.39 0.35 Allowed 'General case' 0 CA--C 1.509 -0.605 0 CA-C-O 117.174 -1.393 . . . . 0.0 108.783 177.29 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.485 ' CG ' ' CD1' ' A' ' 110' ' ' TYR . 0.1 OUTLIER -65.79 79.52 0.07 Allowed 'General case' 0 CA--C 1.507 -0.691 0 C-N-CA 125.008 1.323 . . . . 0.0 109.102 -179.905 . . . . . . . . 3 3 . 1 . 003 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 114' ' ' ASN . 80.9 t -76.54 75.72 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.763 0 N-CA-C 105.558 -2.015 . . . . 0.0 105.558 -173.248 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.402 ' CZ ' ' NE2' ' A' ' 13' ' ' GLN . 57.3 t80 -37.68 101.92 0.02 OUTLIER 'General case' 0 C--O 1.237 0.397 0 C-N-CA 127.723 2.409 . . . . 0.0 108.822 -175.898 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 118' ' ' CYS . . . . . 0.508 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 16.0 m -85.4 -43.16 13.88 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 -176.156 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 156.79 -146.94 14.65 Favored Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.194 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.47 HG13 ' CG ' ' A' ' 4' ' ' TRP . 1.4 mm -129.5 139.24 52.22 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.403 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 -174.792 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.641 HD13 HG12 ' A' ' 109' ' ' ILE . 4.3 pt -127.33 153.1 36.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 -177.321 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.662 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . . . -167.38 158.89 12.02 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 122.007 0.908 . . . . 0.0 109.711 175.665 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -91.51 93.04 8.79 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -177.482 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.517 HG22 ' HD3' ' A' ' 132' ' ' LYS . 1.7 t -97.63 37.63 1.36 Allowed 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 123.682 1.706 . . . . 0.0 111.871 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.0 tptm -102.98 -29.12 11.59 Favored 'General case' 0 C--O 1.218 -0.605 0 O-C-N 120.775 -1.203 . . . . 0.0 111.071 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -174.43 -65.01 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.373 0 O-C-N 124.22 0.95 . . . . 0.0 110.307 177.409 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -150.6 -46.52 0.12 Allowed 'General case' 0 N--CA 1.456 -0.137 0 CA-C-O 123.027 1.394 . . . . 0.0 110.709 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.07 76.45 0.85 Allowed 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 122.496 1.141 . . . . 0.0 111.072 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -127.03 -106.53 1.42 Allowed Glycine 0 N--CA 1.461 0.302 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.49 152.94 27.09 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 122.227 -0.573 . . . . 0.0 111.01 178.467 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -114.58 144.68 42.99 Favored 'General case' 0 C--O 1.221 -0.417 0 C-N-CA 123.666 0.786 . . . . 0.0 110.027 177.652 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.517 ' HD3' HG22 ' A' ' 124' ' ' THR . 5.8 ptmt -150.78 169.87 20.61 Favored 'General case' 0 CA--C 1.506 -0.72 0 C-N-CA 124.335 1.054 . . . . 0.0 109.261 -177.841 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 11.9 tp -81.99 138.85 34.84 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.557 1.161 . . . . 0.0 108.199 178.569 . . . . . . . . 1 1 . 1 . 003 nuclear build full ' A' A ' 134' ' ' CYS . . . . . 0.448 ' SG ' HG22 ' A' ' 120' ' ' ILE . 72.3 m -61.19 -176.57 0.07 Allowed 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 122.997 1.379 . . . . 0.0 111.133 174.716 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -158.69 112.88 2.46 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -178.469 . . . . . . . . 2 2 . 1 . 003 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.255 1.354 0 CA-C-O 113.429 -3.177 . . . . 0.0 110.944 173.777 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.652 ' O ' HG12 ' A' ' 2' ' ' VAL . . . . . . . . 0 CA--C 1.483 -1.598 0 CA-C-O 114.195 -2.812 . . . . 0.0 106.842 . . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.652 HG12 ' O ' ' A' ' 1' ' ' ALA . 6.9 p 49.79 176.71 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 O-C-N 127.062 2.726 . . . . 0.0 111.859 -176.658 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.706 HG21 HD23 ' A' ' 10' ' ' LEU . 29.9 m -106.84 115.56 30.4 Favored 'General case' 0 C--N 1.315 -0.925 0 O-C-N 121.277 -0.889 . . . . 0.0 109.923 179.422 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.543 ' CZ2' ' CE1' ' A' ' 136' ' ' HIS . 17.4 m95 -81.57 137.72 35.48 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -131.56 139.27 49.18 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -178.197 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.71 ' SG ' ' HB3' ' A' ' 122' ' ' ALA . 0.5 OUTLIER -125.48 65.86 1.16 Allowed 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 177.643 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 40.39 70.72 0.35 Allowed Glycine 0 CA--C 1.529 0.91 0 O-C-N 123.876 0.735 . . . . 0.0 112.335 -178.707 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 177.69 -79.84 0.07 OUTLIER Glycine 0 C--O 1.227 -0.293 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 -178.923 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 25.8 mt -135.81 164.34 28.13 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 178.364 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.706 HD23 HG21 ' A' ' 3' ' ' THR . 2.8 mp -83.41 139.87 32.72 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.194 179.133 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.446 ' CE2' ' CB ' ' A' ' 106' ' ' ALA . 78.5 m-85 -127.79 101.13 6.22 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 123.898 0.879 . . . . 0.0 109.643 -175.235 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -56.17 117.06 3.41 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-O 117.751 -1.119 . . . . 0.0 109.109 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.685 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 3.5 tp-100 -43.67 -43.41 5.85 Favored 'General case' 0 C--O 1.221 -0.425 0 O-C-N 124.399 1.062 . . . . 0.0 111.533 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -48.77 -56.2 9.31 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 118.39 -0.814 . . . . 0.0 110.083 176.455 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.433 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 0.2 OUTLIER -53.45 -32.02 48.08 Favored 'General case' 0 C--O 1.204 -1.34 0 CA-C-O 117.147 -1.406 . . . . 0.0 111.395 174.45 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.685 ' HB3' ' O ' ' A' ' 13' ' ' GLN . . . -55.4 -75.36 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 120.665 1.575 . . . . 0.0 111.784 174.013 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.5 pt-20 -61.98 -37.42 84.75 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-O 117.936 -1.03 . . . . 0.0 109.913 179.459 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 34.5 t -64.24 -65.26 0.7 Allowed 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 126.212 1.805 . . . . 0.0 109.798 -179.315 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.513 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 10.2 t-20 -43.28 -32.51 0.8 Allowed 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 123.459 0.704 . . . . 0.0 111.959 174.309 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.58 -41.43 27.18 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 175.237 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -41.93 -39.78 1.96 Allowed 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 125.594 1.557 . . . . 0.0 109.662 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.513 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -73.09 -51.21 18.9 Favored 'General case' 0 N--CA 1.439 -1.007 0 O-C-N 124.418 1.074 . . . . 0.0 111.561 176.513 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.698 ' HB1' ' HG3' ' A' ' 35' ' ' PRO . . . -37.03 130.76 0.74 Allowed Pre-proline 0 N--CA 1.442 -0.836 0 O-C-N 125.28 1.612 . . . . 0.0 111.873 175.628 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.679 ' HG2' HG22 ' A' ' 30' ' ' THR . 15.5 Cg_endo -74.11 124.33 8.99 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 121.662 1.574 . . . . 0.0 109.159 -177.031 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.712 HD13 ' HE2' ' A' ' 115' ' ' LYS . 5.9 tp -59.39 91.93 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.947 178.986 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 178.47 159.57 0.55 Allowed 'General case' 0 N--CA 1.448 -0.565 0 O-C-N 124.264 0.977 . . . . 0.0 110.236 -176.531 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -101.95 131.05 48.58 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-O 118.238 -0.887 . . . . 0.0 109.972 178.978 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 41.88 71.77 0.33 Allowed Glycine 0 CA--C 1.522 0.491 0 O-C-N 124.912 1.382 . . . . 0.0 111.504 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.16 25.43 0.72 Allowed 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.413 0.625 . . . . 0.0 110.685 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.679 HG22 ' HG2' ' A' ' 24' ' ' PRO . 69.2 p -123.86 150.84 44.12 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-O 118.663 -0.684 . . . . 0.0 109.513 -178.058 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.432 ' HA3' ' O ' ' A' ' 95' ' ' ASP . . . -39.0 -58.14 1.93 Allowed Glycine 0 N--CA 1.45 -0.42 0 O-C-N 124.853 1.345 . . . . 0.0 112.034 -178.792 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.6 t -70.28 -71.66 0.23 Allowed 'General case' 0 N--CA 1.443 -0.805 0 CA-C-O 118.621 -0.704 . . . . 0.0 110.648 176.509 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 58.6 p 178.91 -60.48 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.277 0 O-C-N 124.6 1.188 . . . . 0.0 111.531 -178.74 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.541 ' CD1' ' HD3' ' A' ' 84' ' ' PRO . 50.8 m-85 -62.48 149.1 89.04 Favored Pre-proline 0 N--CA 1.428 -1.542 0 C-N-CA 123.729 0.812 . . . . 0.0 111.85 178.776 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.698 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 18.5 Cg_endo -75.39 164.08 89.01 Favored 'Cis proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.48 -1.883 . . . . 0.0 110.868 -1.001 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.431 ' CD2' ' CD1' ' A' ' 34' ' ' TYR . 0.6 OUTLIER -142.24 162.09 36.36 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.211 -178.3 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.93 ' CZ3' HG22 ' A' ' 39' ' ' THR . 21.5 t90 -61.58 132.01 51.92 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -104.07 78.01 1.48 Allowed 'General case' 0 N--CA 1.428 -1.569 0 C-N-CA 124.903 1.281 . . . . 0.0 108.157 -178.388 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.93 HG22 ' CZ3' ' A' ' 37' ' ' TRP . 78.7 p -37.42 -38.67 0.25 Allowed 'General case' 0 CA--C 1.509 -0.62 0 O-C-N 124.167 0.917 . . . . 0.0 110.455 177.483 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 44.6 t30 62.8 12.63 5.84 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 122.747 1.26 . . . . 0.0 108.748 178.322 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 114.59 -35.49 4.4 Favored Glycine 0 N--CA 1.429 -1.797 0 O-C-N 119.666 -1.896 . . . . 0.0 112.309 -174.992 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.658 ' N ' HD23 ' A' ' 48' ' ' LEU . 59.8 m-85 -50.48 162.27 0.25 Allowed 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 121.185 0.517 . . . . 0.0 111.807 178.225 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.21 -38.24 22.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.464 178.654 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.445 ' CA ' ' HB3' ' A' ' 68' ' ' HIS . . . 125.98 41.37 0.34 Allowed Glycine 0 N--CA 1.437 -1.251 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.634 -176.923 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -146.01 -70.07 0.26 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.16 -74.61 0.01 OUTLIER Glycine 0 N--CA 1.435 -1.408 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -177.759 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.8 pttt -98.29 178.57 5.02 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 118.257 1.029 . . . . 0.0 110.648 178.311 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.697 ' H ' HD12 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -106.03 163.72 16.47 Favored Pre-proline 0 N--CA 1.444 -0.74 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.569 -179.548 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.63 163.11 36.61 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 121.762 1.641 . . . . 0.0 110.624 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.71 97.34 0.05 Allowed 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 125.06 54.59 0.17 Allowed Glycine 0 N--CA 1.447 -0.633 0 O-C-N 121.436 -0.79 . . . . 0.0 111.668 -179.032 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -150.95 145.9 25.9 Favored 'General case' 0 N--CA 1.452 -0.335 0 O-C-N 124.127 0.545 . . . . 0.0 110.963 177.864 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.3 m -139.01 98.99 8.31 Favored Pre-proline 0 N--CA 1.45 -0.457 0 O-C-N 124.407 1.067 . . . . 0.0 109.861 -178.702 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.509 ' HG3' HD21 ' A' ' 48' ' ' LEU . 19.1 Cg_endo -73.56 166.93 28.56 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 121.626 1.55 . . . . 0.0 111.207 179.112 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.562 HD11 ' HG ' ' A' ' 131' ' ' LEU . 5.6 mt -79.58 125.96 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -178.228 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.9 tppt? -81.69 155.71 25.42 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.125 0.488 . . . . 0.0 109.709 178.142 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.505 ' CD1' ' HB3' ' A' ' 118' ' ' CYS . 21.6 m-85 -139.01 -46.88 0.48 Allowed 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.233 178.314 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 119.44 -2.35 14.0 Favored Glycine 0 CA--C 1.522 0.491 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.178 -176.824 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.2 mmtt -96.07 141.86 28.96 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-O 117.625 -1.179 . . . . 0.0 109.774 178.847 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.43 -7.1 58.17 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 124.832 1.333 . . . . 0.0 110.721 177.926 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -90.9 -53.06 4.55 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 123.71 0.804 . . . . 0.0 109.135 -179.004 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.593 ' SG ' HD21 ' A' ' 80' ' ' LEU . 4.9 t -72.18 -16.02 61.96 Favored 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 124.103 0.877 . . . . 0.0 110.672 176.606 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -86.68 -37.79 17.63 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 123.57 0.544 . . . . 0.0 111.043 177.158 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.527 ' HD3' ' CD2' ' A' ' 78' ' ' HIS . 0.0 OUTLIER -49.17 165.15 0.28 Allowed Pre-proline 0 N--CA 1.441 -0.912 0 CA-C-O 121.991 0.9 . . . . 0.0 111.237 179.625 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -72.6 124.59 9.91 Favored 'Trans proline' 0 N--CA 1.441 -1.607 0 C-N-CA 120.927 1.084 . . . . 0.0 113.076 175.705 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.45 ' HD3' ' CZ ' ' A' ' 42' ' ' TYR . 19.0 Cg_endo -74.26 167.39 27.28 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 122.881 2.387 . . . . 0.0 110.253 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -127.54 104.03 7.66 Favored 'General case' 0 C--O 1.213 -0.82 0 CA-C-O 115.957 -1.973 . . . . 0.0 107.68 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.66 ' CE1' ' CE3' ' A' ' 37' ' ' TRP . 66.2 t60 -93.55 161.92 14.17 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.47 1.106 . . . . 0.0 110.341 176.587 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.405 ' HB2' ' OD2' ' A' ' 77' ' ' ASP . 0.3 OUTLIER -152.32 176.76 11.28 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.153 179.478 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.74 63.02 7.29 Favored 'General case' 0 C--O 1.224 -0.263 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.695 178.0 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -177.41 -39.0 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.885 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 122.59 -65.64 0.5 Allowed Glycine 0 N--CA 1.44 -1.056 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.515 -178.549 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 10.0 p-10 -120.51 62.03 0.86 Allowed 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -56.13 -105.61 0.01 OUTLIER Glycine 0 CA--C 1.532 1.149 0 CA-C-O 123.362 1.534 . . . . 0.0 112.236 -178.749 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 16.1 mttp -70.76 -104.59 0.0 OUTLIER 'General case' 0 C--O 1.218 -0.556 0 O-C-N 120.07 -1.841 . . . . 0.0 110.285 178.438 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.581 HG23 ' O ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -109.21 16.62 22.33 Favored 'General case' 0 N--CA 1.447 -0.607 0 O-C-N 121.553 -0.717 . . . . 0.0 110.65 179.45 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.47 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 5.4 m-20 -29.73 102.25 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 123.838 0.855 . . . . 0.0 111.651 -179.138 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.527 ' CD2' ' HD3' ' A' ' 64' ' ' ARG . 9.5 p-80 -87.88 28.13 1.07 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -175.908 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 1.062 ' CE1' HD11 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -54.46 168.16 0.28 Allowed 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 174.897 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.699 HD23 ' O ' ' A' ' 110' ' ' TYR . 0.6 OUTLIER -98.26 158.05 15.8 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 118.477 -0.773 . . . . 0.0 109.758 176.947 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 1.062 HD11 ' CE1' ' A' ' 79' ' ' TYR . 1.4 mp -141.82 130.69 23.01 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 123.298 0.639 . . . . 0.0 109.511 178.863 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.471 ' CB ' ' CD1' ' A' ' 109' ' ' ILE . 0.4 OUTLIER -99.95 151.08 21.74 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 121.565 0.698 . . . . 0.0 110.995 179.138 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.598 ' CZ ' ' HB2' ' A' ' 23' ' ' ALA . 28.7 t80 -142.0 121.01 7.85 Favored Pre-proline 0 N--CA 1.444 -0.774 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.273 -178.853 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.541 ' HD3' ' CD1' ' A' ' 34' ' ' TYR . 19.4 Cg_endo -72.9 111.73 3.34 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 122.886 2.391 . . . . 0.0 110.193 -177.191 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.55 125.54 51.94 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.125 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.485 ' CD2' ' NE2' ' A' ' 90' ' ' HIS . 63.5 m-85 -82.89 155.74 67.71 Favored Pre-proline 0 N--CA 1.443 -0.822 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.012 178.836 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -77.64 -42.12 0.29 Allowed 'Trans proline' 0 CA--C 1.505 -0.931 0 C-N-CA 122.104 1.869 . . . . 0.0 111.898 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -43.25 -30.88 0.54 Allowed 'General case' 0 C--N 1.346 0.426 0 O-C-N 125.078 1.486 . . . . 0.0 110.293 177.428 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 99.87 -12.48 60.86 Favored Glycine 0 N--CA 1.436 -1.364 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 177.151 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.485 ' NE2' ' CD2' ' A' ' 86' ' ' PHE . 4.8 p-80 -58.38 128.77 38.83 Favored 'General case' 0 N--CA 1.44 -0.925 0 O-C-N 124.325 0.662 . . . . 0.0 109.449 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -68.95 101.47 1.39 Allowed 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.086 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.488 ' O ' ' CD2' ' A' ' 94' ' ' PHE . 6.5 t80 -34.26 138.38 0.09 Allowed 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 122.028 0.918 . . . . 0.0 111.463 178.858 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.407 ' HE2' ' O ' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -78.96 60.08 2.81 Favored 'General case' 0 N--CA 1.442 -0.852 0 O-C-N 120.081 -1.637 . . . . 0.0 109.953 177.75 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.488 ' CD2' ' O ' ' A' ' 92' ' ' TYR . 30.4 p90 -75.55 1.7 13.61 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 123.269 0.628 . . . . 0.0 112.084 177.207 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.432 ' O ' ' HA3' ' A' ' 31' ' ' GLY . 36.7 t0 -95.79 -38.8 10.16 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 122.394 1.092 . . . . 0.0 109.115 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -80.75 110.03 15.86 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 120.862 -1.149 . . . . 0.0 109.36 -178.883 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.8 pttt -57.86 -50.28 73.85 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.04 178.51 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.46 127.51 7.26 Favored Pre-proline 0 N--CA 1.431 -1.401 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.802 -176.734 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.407 ' O ' ' HE2' ' A' ' 93' ' ' LYS . 21.7 Cg_endo -73.05 178.04 34.09 Favored 'Cis proline' 0 N--CA 1.458 -0.596 0 O-C-N 125.093 2.102 . . . . 0.0 111.232 -2.354 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.0 132.39 25.11 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.14 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -72.67 145.02 47.53 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 124.244 0.965 . . . . 0.0 109.312 178.922 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -42.09 156.83 0.22 Allowed Pre-proline 0 N--CA 1.45 -0.448 0 O-C-N 123.74 0.65 . . . . 0.0 111.411 177.709 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -72.49 -163.13 0.14 Allowed 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 121.235 1.29 . . . . 0.0 111.142 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -139.85 154.33 23.73 Favored Glycine 0 N--CA 1.441 -0.988 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.04 178.523 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -75.52 -66.55 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.143 1.895 . . . . 0.0 110.131 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.563 ' HA ' ' HB2' ' A' ' 122' ' ' ALA . . . -69.19 135.75 51.07 Favored 'General case' 0 N--CA 1.443 -0.78 0 O-C-N 124.298 0.999 . . . . 0.0 110.907 178.551 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.425 ' HG2' ' HA ' ' A' ' 84' ' ' PRO . 4.3 mtt85 -141.47 146.02 35.94 Favored 'General case' 0 N--CA 1.448 -0.541 0 O-C-N 123.913 0.758 . . . . 0.0 110.716 -178.848 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.452 ' O ' HD13 ' A' ' 109' ' ' ILE . 7.7 p -83.6 128.89 38.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 O-C-N 123.736 0.648 . . . . 0.0 109.869 178.865 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.656 ' CG2' HD22 ' A' ' 80' ' ' LEU . 9.1 mm -107.9 142.83 19.58 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.861 0 CA-C-O 118.571 -0.728 . . . . 0.0 109.938 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.699 ' O ' HD23 ' A' ' 80' ' ' LEU . 12.4 p90 -167.15 155.45 9.67 Favored 'General case' 0 N--CA 1.442 -0.839 0 O-C-N 124.121 0.888 . . . . 0.0 111.14 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.0 p -91.83 164.71 13.59 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.476 -177.91 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.568 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -111.93 154.35 44.19 Favored Pre-proline 0 N--CA 1.442 -0.866 0 C-N-CA 122.45 0.3 . . . . 0.0 110.898 179.536 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.568 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 18.6 Cg_endo -74.52 -54.03 0.15 OUTLIER 'Cis proline' 0 CA--C 1.509 -0.748 0 C-N-CA 122.523 -1.865 . . . . 0.0 109.468 -4.345 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -42.92 111.49 0.27 Allowed 'General case' 0 CA--C 1.507 -0.692 0 CA-C-O 116.45 -1.738 . . . . 0.0 109.722 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.712 ' HE2' HD13 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -63.09 76.35 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.375 0 O-C-N 125.77 1.919 . . . . 0.0 109.123 -178.44 . . . . . . . . 3 3 . 1 . 004 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.591 ' O ' HG12 ' A' ' 116' ' ' VAL . 8.8 t -77.01 71.25 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 -176.972 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.594 ' CZ ' ' HA2' ' A' ' 119' ' ' GLY . 27.9 t80 -35.63 110.6 0.11 Allowed 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 123.16 0.584 . . . . 0.0 111.132 178.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 118' ' ' CYS . . . . . 0.63 ' SG ' HD21 ' A' ' 80' ' ' LEU . 6.2 m -82.61 -45.5 14.49 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.594 ' HA2' ' CZ ' ' A' ' 117' ' ' PHE . . . 161.93 -145.05 10.32 Favored Glycine 0 N--CA 1.443 -0.87 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.511 HG13 ' CD2' ' A' ' 4' ' ' TRP . 1.1 mm -127.63 136.97 59.01 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.82 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 -176.45 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.729 HD12 HD21 ' A' ' 131' ' ' LEU . 9.2 pt -127.36 156.06 38.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -177.69 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.71 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . . . -173.9 145.9 1.17 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.515 0.674 . . . . 0.0 109.82 178.053 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.74 ' CE1' HD22 ' A' ' 131' ' ' LEU . 3.9 m-70 -90.37 93.59 9.39 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.038 -177.483 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.9 p -103.15 46.18 0.93 Allowed 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 -177.198 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -108.36 -23.68 11.79 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.833 177.493 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -174.25 -64.02 0.01 OUTLIER 'General case' 0 C--O 1.223 -0.314 0 O-C-N 123.72 0.638 . . . . 0.0 110.801 178.064 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -155.31 -46.03 0.08 Allowed 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 122.146 0.974 . . . . 0.0 110.028 179.076 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -159.57 76.89 0.68 Allowed 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.93 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -127.92 -104.3 1.23 Allowed Glycine 0 N--CA 1.452 -0.239 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.71 144.98 36.85 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 122.444 -0.445 . . . . 0.0 111.086 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.74 HD22 ' CE1' ' A' ' 123' ' ' HIS . 4.4 tp -109.77 136.79 48.54 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 122.475 0.31 . . . . 0.0 110.896 178.346 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.03 171.73 13.67 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -178.745 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.721 HD12 HG22 ' A' ' 121' ' ' ILE . 5.2 tp -88.12 143.23 27.18 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 124.562 1.164 . . . . 0.0 109.135 178.766 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 134' ' ' CYS . . . . . 0.47 ' SG ' HG22 ' A' ' 120' ' ' ILE . 76.0 m -62.04 -172.21 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 122.088 0.946 . . . . 0.0 109.707 177.302 . . . . . . . . 2 2 . 1 . 004 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 19.5 m -133.04 92.46 3.03 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.469 -179.006 . . . . . . . . 1 1 . 1 . 004 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.543 ' CE1' ' CZ2' ' A' ' 4' ' ' TRP . 0.2 OUTLIER . . . . . 0 C--O 1.25 1.097 0 CA-C-O 116.886 -1.531 . . . . 0.0 112.258 176.35 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.534 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 . . . . . . . . . 0 0 . 1 . 005 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.4 p -119.94 132.29 70.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -178.055 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.2 m -89.52 109.05 20.02 Favored 'General case' 0 C--N 1.317 -0.818 0 O-C-N 121.488 -0.758 . . . . 0.0 109.553 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.418 ' CG ' HG13 ' A' ' 120' ' ' ILE . 39.7 m95 -77.32 140.0 39.9 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 124.065 0.946 . . . . 0.0 110.54 178.549 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.6 m -124.57 120.24 31.37 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 122.093 0.949 . . . . 0.0 109.045 -176.118 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.555 ' HB3' ' HB3' ' A' ' 122' ' ' ALA . 74.9 m -103.87 64.56 0.79 Allowed 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 34.65 60.14 0.65 Allowed Glycine 0 C--N 1.341 0.806 0 C-N-CA 124.992 1.282 . . . . 0.0 113.007 178.95 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.599 ' C ' HD13 ' A' ' 9' ' ' LEU . . . 170.02 -80.97 0.09 OUTLIER Glycine 0 C--O 1.224 -0.491 0 N-CA-C 110.501 -1.039 . . . . 0.0 110.501 -175.21 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.707 HD23 ' OH ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -114.66 159.05 20.94 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.488 1.115 . . . . 0.0 108.787 -176.198 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.534 HD13 ' C ' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -110.74 125.33 53.4 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -172.019 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.707 ' OH ' HD23 ' A' ' 9' ' ' LEU . 89.5 m-85 -117.06 106.68 13.64 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 126.441 1.896 . . . . 0.0 108.537 -172.043 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -58.7 127.81 34.06 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.31 177.171 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.475 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 7.0 tp-100 -54.82 -44.49 73.9 Favored 'General case' 0 C--O 1.217 -0.626 0 O-C-N 121.373 -0.83 . . . . 0.0 112.773 178.311 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -51.71 -26.3 9.06 Favored 'General case' 0 C--O 1.213 -0.845 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 175.874 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.18 -41.66 15.43 Favored 'General case' 0 C--O 1.206 -1.217 0 CA-C-O 116.174 -1.87 . . . . 0.0 113.418 170.235 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.55 -62.91 1.35 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 121.705 2.048 . . . . 0.0 113.08 175.167 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -58.03 -43.61 86.87 Favored 'General case' 0 C--N 1.333 -0.137 0 O-C-N 121.543 -0.723 . . . . 0.0 110.73 174.214 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.5 t -61.93 -23.21 66.21 Favored 'General case' 0 C--O 1.222 -0.381 0 O-C-N 121.89 -0.506 . . . . 0.0 111.354 175.595 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -71.11 -63.89 1.02 Allowed 'General case' 0 N--CA 1.438 -1.059 0 O-C-N 120.603 -1.31 . . . . 0.0 108.439 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.39 -15.91 51.61 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 114.669 -1.151 . . . . 0.0 111.518 178.021 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -59.41 -51.86 68.08 Favored 'General case' 0 CA--C 1.517 -0.306 0 O-C-N 121.296 -0.878 . . . . 0.0 110.91 178.284 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -74.92 -41.02 60.51 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 123.811 0.694 . . . . 0.0 111.15 178.212 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.752 ' HB2' ' CZ ' ' A' ' 83' ' ' PHE . . . -43.14 131.4 3.33 Favored Pre-proline 0 N--CA 1.447 -0.577 0 O-C-N 124.651 1.219 . . . . 0.0 112.441 177.801 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.616 ' HG2' HG22 ' A' ' 30' ' ' THR . 19.2 Cg_endo -71.18 123.65 9.8 Favored 'Trans proline' 0 N--CA 1.444 -1.414 0 C-N-CA 122.053 1.835 . . . . 0.0 109.54 -177.195 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.75 HD13 ' HE2' ' A' ' 115' ' ' LYS . 5.7 tp -61.48 96.66 0.06 Allowed 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.625 0.77 . . . . 0.0 110.94 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 178.2 165.21 0.74 Allowed 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 124.041 0.936 . . . . 0.0 109.728 -175.118 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.73 121.28 42.13 Favored 'General case' 0 CA--C 1.511 -0.525 0 C-N-CA 124.749 1.22 . . . . 0.0 109.688 177.041 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 48.77 67.9 1.51 Allowed Glycine 0 CA--C 1.525 0.707 0 CA-C-O 121.772 0.651 . . . . 0.0 112.636 174.802 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.05 28.47 1.01 Allowed 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.599 0.76 . . . . 0.0 112.759 -178.233 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.616 HG22 ' HG2' ' A' ' 24' ' ' PRO . 71.9 p -127.56 151.03 49.42 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -175.442 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -40.17 -58.22 2.42 Favored Glycine 0 C--O 1.228 -0.242 0 C-N-CA 123.655 0.645 . . . . 0.0 113.714 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.444 ' HB3' ' HA ' ' A' ' 94' ' ' PHE . 29.2 t -67.18 -72.64 0.16 Allowed 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 123.772 0.336 . . . . 0.0 111.623 173.535 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 47.8 p 177.96 -56.05 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 124.194 0.998 . . . . 0.0 112.827 -178.474 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.509 ' CD2' ' HD3' ' A' ' 84' ' ' PRO . 69.9 m-85 -68.87 147.36 97.84 Favored Pre-proline 0 N--CA 1.442 -0.857 0 C-N-CA 124.931 1.292 . . . . 0.0 113.286 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.726 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 26.1 Cg_endo -75.49 165.53 85.46 Favored 'Cis proline' 0 N--CA 1.445 -1.353 0 C-N-CA 123.938 -1.276 . . . . 0.0 111.186 1.567 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.661 ' C ' HD23 ' A' ' 81' ' ' LEU . 1.1 p80 -141.47 171.8 13.56 Favored 'General case' 0 CA--C 1.504 -0.797 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.574 -177.987 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.885 ' CH2' HG22 ' A' ' 39' ' ' THR . 22.0 t90 -72.17 128.08 34.58 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 122.687 1.232 . . . . 0.0 109.726 175.564 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.497 ' CZ ' ' HA ' ' A' ' 40' ' ' ASN . 19.3 t80 -98.29 86.15 3.59 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 126.674 1.989 . . . . 0.0 107.041 176.612 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.885 HG22 ' CH2' ' A' ' 37' ' ' TRP . 69.0 p -40.36 -33.43 0.25 Allowed 'General case' 0 C--O 1.217 -0.645 0 CA-C-N 114.656 -1.156 . . . . 0.0 111.105 172.062 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.497 ' HA ' ' CZ ' ' A' ' 38' ' ' PHE . 11.7 t-20 68.56 5.92 5.13 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.519 1.128 . . . . 0.0 110.878 -178.516 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.4 ' CA ' ' HD2' ' A' ' 52' ' ' ARG . . . 115.96 -26.41 8.85 Favored Glycine 0 N--CA 1.432 -1.59 0 C-N-CA 125.066 1.317 . . . . 0.0 116.095 -171.427 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.517 ' N ' HD23 ' A' ' 48' ' ' LEU . 58.4 m-85 -54.57 -178.16 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 122.365 1.079 . . . . 0.0 110.299 176.755 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -103.87 -40.7 6.14 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 124.462 1.105 . . . . 0.0 110.763 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.493 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -174.05 -61.55 0.05 OUTLIER Glycine 0 C--N 1.336 0.549 0 C-N-CA 123.751 0.691 . . . . 0.0 112.641 -178.038 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -82.92 -98.62 0.05 OUTLIER 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.424 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.434 ' HA2' ' CD2' ' A' ' 42' ' ' TYR . . . -138.84 29.76 2.53 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 125.048 1.308 . . . . 0.0 111.674 -174.359 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.9 mttt -126.87 149.19 49.88 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 118.144 -0.931 . . . . 0.0 108.737 -178.718 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.517 HD23 ' N ' ' A' ' 42' ' ' TYR . 0.3 OUTLIER -115.38 160.51 34.11 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.406 1.066 . . . . 0.0 109.187 -178.11 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -69.02 157.54 61.43 Favored 'Trans proline' 0 N--CA 1.443 -1.459 0 C-N-CA 121.884 1.723 . . . . 0.0 110.161 177.671 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -49.27 104.41 0.06 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.094 0.958 . . . . 0.0 110.352 176.317 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.74 87.98 0.59 Allowed Glycine 0 CA--C 1.524 0.601 0 O-C-N 123.572 0.545 . . . . 0.0 111.851 -174.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.445 ' HD3' ' N ' ' A' ' 53' ' ' THR . 0.0 OUTLIER -150.83 155.53 39.4 Favored 'General case' 0 CA--C 1.516 -0.365 0 C-N-CA 123.164 0.586 . . . . 0.0 110.552 174.648 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 53' ' ' THR . . . . . 0.445 ' N ' ' HD3' ' A' ' 52' ' ' ARG . 4.0 m -138.92 101.59 7.78 Favored Pre-proline 0 C--N 1.329 -0.305 0 O-C-N 124.014 0.821 . . . . 0.0 111.439 178.925 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -66.4 153.74 76.87 Favored 'Trans proline' 0 N--CA 1.448 -1.148 0 C-N-CA 123.856 3.038 . . . . 0.0 112.073 177.518 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.479 HD11 ' HG ' ' A' ' 131' ' ' LEU . 4.8 mt -66.74 127.33 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -95.39 134.45 38.18 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 176.029 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.484 ' CE2' HD13 ' A' ' 133' ' ' LEU . 1.7 m-85 -119.62 -55.31 2.12 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 124.213 1.005 . . . . 0.0 110.623 -179.445 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 120.42 -2.9 12.49 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 124.88 1.228 . . . . 0.0 113.469 -176.058 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.413 ' HD2' ' CG1' ' A' ' 116' ' ' VAL . 1.8 mmtp -66.46 177.66 1.46 Allowed 'General case' 0 C--O 1.215 -0.735 0 O-C-N 122.065 -0.667 . . . . 0.0 111.364 173.481 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.0 p -104.23 -47.17 4.22 Favored 'General case' 0 C--O 1.216 -0.679 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.153 177.324 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.45 -41.03 41.21 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 123.097 0.559 . . . . 0.0 110.892 177.542 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.477 ' SG ' ' CD1' ' A' ' 57' ' ' PHE . 1.5 t -74.25 -17.37 60.88 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 122.786 0.434 . . . . 0.0 110.736 178.61 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -87.58 -38.31 16.08 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 123.115 0.566 . . . . 0.0 112.31 171.456 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.582 ' HD3' ' CD2' ' A' ' 78' ' ' HIS . 0.0 OUTLIER -55.78 163.8 1.92 Allowed Pre-proline 0 N--CA 1.448 -0.57 0 CA-C-O 121.785 0.803 . . . . 0.0 111.491 -178.247 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -70.54 138.75 36.01 Favored 'Trans proline' 0 N--CA 1.439 -1.69 0 C-N-CA 120.401 0.734 . . . . 0.0 112.232 175.735 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -68.21 175.29 6.89 Favored 'Trans proline' 0 N--CA 1.448 -1.2 0 C-N-CA 122.952 2.435 . . . . 0.0 111.965 175.817 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.8 tptt -136.98 56.27 1.8 Allowed 'General case' 0 C--O 1.209 -1.041 0 O-C-N 120.835 -1.165 . . . . 0.0 108.685 174.159 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -77.54 165.05 24.82 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 119.16 -1.016 . . . . 0.0 110.488 177.693 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.57 -165.62 2.03 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.908 0.883 . . . . 0.0 111.241 178.197 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.11 73.69 10.36 Favored 'General case' 0 C--O 1.219 -0.509 0 O-C-N 121.322 -0.862 . . . . 0.0 111.146 175.602 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -176.89 -43.35 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.507 0 O-C-N 124.419 1.074 . . . . 0.0 111.367 178.637 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.452 ' O ' ' CE2' ' A' ' 79' ' ' TYR . . . 122.53 -52.65 0.75 Allowed Glycine 0 C--O 1.217 -0.918 0 CA-C-N 114.693 -1.139 . . . . 0.0 111.208 -177.79 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -148.59 86.18 1.52 Allowed 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.25 -112.2 0.01 OUTLIER Glycine 0 CA--C 1.525 0.66 0 CA-C-O 122.331 0.962 . . . . 0.0 113.037 176.714 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -64.58 -96.73 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 O-C-N 120.427 -1.631 . . . . 0.0 112.436 176.582 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.486 HG23 ' O ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -110.55 16.27 21.6 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 121.379 -0.826 . . . . 0.0 110.272 178.46 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.459 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 8.6 m-20 -29.24 104.93 0.03 OUTLIER 'General case' 0 C--O 1.207 -1.141 0 C-N-CA 125.792 1.637 . . . . 0.0 109.94 -176.868 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.582 ' CD2' ' HD3' ' A' ' 64' ' ' ARG . 3.6 p-80 -87.17 16.31 5.28 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 118.968 0.803 . . . . 0.0 110.268 -175.421 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.926 ' CZ ' HD11 ' A' ' 81' ' ' LEU . 0.3 OUTLIER -36.19 134.27 0.43 Allowed 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 126.156 1.782 . . . . 0.0 111.311 172.148 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.622 HD23 ' O ' ' A' ' 110' ' ' TYR . 0.3 OUTLIER -76.68 153.65 34.95 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.797 176.648 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.926 HD11 ' CZ ' ' A' ' 79' ' ' TYR . 1.7 mp -140.27 139.06 35.44 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 123.191 0.596 . . . . 0.0 109.659 177.658 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.459 ' CB ' ' CD1' ' A' ' 109' ' ' ILE . 0.5 OUTLIER -105.81 154.2 20.85 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.593 0.711 . . . . 0.0 111.284 179.261 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.752 ' CZ ' ' HB2' ' A' ' 23' ' ' ALA . 5.7 t80 -141.79 126.35 10.32 Favored Pre-proline 0 CA--C 1.537 0.452 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.748 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.509 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 19.6 Cg_endo -73.87 104.44 1.83 Allowed 'Trans proline' 0 N--CA 1.448 -1.148 0 C-N-CA 124.789 3.659 . . . . 0.0 110.615 -177.56 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.8 t -104.38 119.66 39.46 Favored 'General case' 0 N--CA 1.446 -0.67 0 O-C-N 124.675 1.234 . . . . 0.0 109.963 -179.045 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.434 ' CD2' ' NE2' ' A' ' 90' ' ' HIS . 64.7 m-85 -81.17 158.8 69.2 Favored Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 176.505 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -74.78 -42.54 0.55 Allowed 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 122.504 2.136 . . . . 0.0 113.409 178.295 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -40.42 -37.03 0.62 Allowed 'General case' 0 N--CA 1.478 0.94 0 CA-C-O 123.529 1.633 . . . . 0.0 109.803 174.972 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 97.45 -1.88 60.54 Favored Glycine 0 N--CA 1.442 -0.931 0 O-C-N 121.053 -1.03 . . . . 0.0 112.248 -178.87 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.434 ' NE2' ' CD2' ' A' ' 86' ' ' PHE . 5.9 p-80 -65.39 126.74 29.18 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 176.589 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -59.62 106.07 0.43 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 171.049 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.44 ' O ' ' CD2' ' A' ' 94' ' ' PHE . 7.1 t80 -38.98 139.93 0.42 Allowed 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 121.684 0.754 . . . . 0.0 110.166 173.723 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 7.5 ptpt -75.68 58.44 1.08 Allowed 'General case' 0 C--N 1.326 -0.416 0 O-C-N 120.42 -1.425 . . . . 0.0 111.818 173.304 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.498 ' CD2' ' HZ ' ' A' ' 83' ' ' PHE . 34.2 p90 -73.08 -14.63 61.43 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 123.856 0.862 . . . . 0.0 112.327 176.143 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -88.8 -37.23 15.57 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 123.329 1.537 . . . . 0.0 111.298 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -79.9 106.9 12.26 Favored 'General case' 0 N--CA 1.455 -0.179 0 O-C-N 120.926 -1.109 . . . . 0.0 109.162 177.152 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt -57.99 -48.4 80.1 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.739 0.78 . . . . 0.0 111.713 176.652 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.7 tmtt? -137.49 130.66 17.04 Favored Pre-proline 0 N--CA 1.445 -0.701 0 C-N-CA 124.828 1.251 . . . . 0.0 110.199 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -68.57 174.53 35.9 Favored 'Cis proline' 0 N--CA 1.453 -0.873 0 C-N-CA 123.181 -1.591 . . . . 0.0 110.415 -9.179 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 22.0 tttm -139.03 116.95 11.6 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 29.4 tp10 -69.96 167.2 17.99 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 123.981 0.801 . . . . 0.0 110.639 174.401 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -42.68 153.28 0.32 Allowed Pre-proline 0 CA--C 1.536 0.41 0 C-N-CA 124.228 1.011 . . . . 0.0 112.064 173.377 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -72.85 -84.02 0.0 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 122.829 2.353 . . . . 0.0 112.547 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 146.58 142.4 3.73 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -74.75 -68.85 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 123.325 2.683 . . . . 0.0 110.71 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.679 ' HA ' ' HB2' ' A' ' 122' ' ' ALA . . . -68.3 139.67 55.94 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 121.735 0.779 . . . . 0.0 111.165 178.583 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.87 144.3 33.77 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.011 -178.651 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.436 ' CG1' ' HB3' ' A' ' 83' ' ' PHE . 4.3 p -81.58 124.81 39.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 O-C-N 124.341 1.025 . . . . 0.0 109.139 178.687 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.566 ' CG2' HD22 ' A' ' 80' ' ' LEU . 5.8 mm -105.54 141.16 21.51 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.701 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.061 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.622 ' O ' HD23 ' A' ' 80' ' ' LEU . 10.4 p90 -165.17 152.92 11.24 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-O 121.952 0.882 . . . . 0.0 111.294 -176.501 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.0 p -88.66 165.82 14.52 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.852 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.561 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.3 OUTLIER -108.21 156.84 37.73 Favored Pre-proline 0 CA--C 1.547 0.841 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 176.107 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.561 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 17.7 Cg_endo -72.07 -53.4 0.16 OUTLIER 'Cis proline' 0 CA--C 1.51 -0.683 0 C-N-CA 124.216 -1.16 . . . . 0.0 111.064 -10.27 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -45.61 111.43 0.34 Allowed 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 118.685 -0.674 . . . . 0.0 109.92 177.267 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.75 ' HE2' HD13 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -62.69 79.86 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.349 0 C-N-CA 124.911 1.285 . . . . 0.0 108.098 -178.262 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.461 ' O ' HG12 ' A' ' 116' ' ' VAL . 16.2 t -77.43 73.06 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 105.311 -2.107 . . . . 0.0 105.311 -178.263 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.475 ' CZ ' ' NE2' ' A' ' 13' ' ' GLN . 20.7 t80 -46.63 108.16 0.13 Allowed 'General case' 0 N--CA 1.44 -0.95 0 C-N-CA 124.918 1.287 . . . . 0.0 109.008 177.455 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 118' ' ' CYS . . . . . 0.424 ' SG ' ' CG ' ' A' ' 57' ' ' PHE . 0.1 OUTLIER -83.45 -53.0 6.03 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 121.952 0.882 . . . . 0.0 110.031 179.448 . . . . . . . . 3 3 . 1 . 005 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 177.18 -146.09 7.58 Favored Glycine 0 N--CA 1.437 -1.252 0 CA-C-N 114.464 -1.244 . . . . 0.0 110.43 179.242 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.418 HG13 ' CG ' ' A' ' 4' ' ' TRP . 1.2 mm -126.61 146.85 31.77 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 -177.136 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.589 HD12 HD21 ' A' ' 131' ' ' LEU . 8.0 pt -132.7 151.79 35.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -178.891 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.679 ' HB2' ' HA ' ' A' ' 106' ' ' ALA . . . -174.95 149.42 1.12 Allowed 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 122.807 0.443 . . . . 0.0 110.863 178.223 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.531 ' CD2' HD13 ' A' ' 131' ' ' LEU . 3.8 m-70 -89.91 96.57 10.74 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -177.005 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 4.3 p -101.59 46.18 0.94 Allowed 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 124.498 1.119 . . . . 0.0 109.816 -177.361 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.7 tttm -107.98 -24.59 11.55 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.543 175.896 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -174.12 -77.25 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 122.202 1.001 . . . . 0.0 109.808 177.954 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -140.63 -47.47 0.42 Allowed 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 125.83 1.652 . . . . 0.0 110.447 -177.025 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -160.0 82.41 0.72 Allowed 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 125.073 1.349 . . . . 0.0 108.995 -177.793 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -123.44 -108.95 1.9 Allowed Glycine 0 CA--C 1.518 0.236 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 175.146 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -87.72 141.2 28.79 Favored 'General case' 0 C--N 1.322 -0.622 0 O-C-N 121.555 -0.968 . . . . 0.0 111.187 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.589 HD21 HD12 ' A' ' 121' ' ' ILE . 4.9 tp -94.5 142.6 27.24 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 120.544 0.211 . . . . 0.0 110.819 177.733 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.44 167.55 23.35 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 124.442 1.097 . . . . 0.0 109.626 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.561 HD12 HG22 ' A' ' 121' ' ' ILE . 10.0 tp -84.51 137.61 33.24 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.127 0.892 . . . . 0.0 108.746 178.065 . . . . . . . . 2 2 . 1 . 005 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 35.0 m -70.71 -178.75 1.94 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 122.865 1.317 . . . . 0.0 109.821 174.252 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 13.7 p -160.24 100.01 1.35 Allowed 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 105.148 -2.167 . . . . 0.0 105.148 -178.15 . . . . . . . . 1 1 . 1 . 005 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.242 0.674 0 CA-C-O 115.921 -1.99 . . . . 0.0 112.441 168.141 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.513 -0.477 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 . . . . . . . . . 0 0 . 1 . 006 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.724 HG22 ' HB2' ' A' ' 136' ' ' HIS . 9.3 p -93.52 128.49 44.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 O-C-N 124.372 1.045 . . . . 0.0 109.654 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.924 HG21 HD23 ' A' ' 10' ' ' LEU . 48.9 m -85.78 119.67 26.36 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.148 -179.105 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 19.8 m95 -80.44 141.42 35.28 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.274 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -141.02 142.51 34.22 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.728 ' SG ' ' HB3' ' A' ' 122' ' ' ALA . 0.1 OUTLIER -120.42 50.38 1.32 Allowed 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.896 177.921 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 48.06 73.75 0.31 Allowed Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 -178.925 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 166.55 -74.95 0.15 Allowed Glycine 0 C--N 1.333 0.395 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 54.9 mt -123.82 158.18 32.42 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.924 HD23 HG21 ' A' ' 3' ' ' THR . 3.9 mp -83.02 165.64 19.46 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.049 179.266 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.763 ' CZ ' ' HB3' ' A' ' 106' ' ' ALA . 50.2 m-85 -159.12 85.56 0.81 Allowed 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 121.872 0.844 . . . . 0.0 109.981 -175.319 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -57.43 121.45 10.27 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 117.656 -1.164 . . . . 0.0 108.602 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.407 ' OE1' ' CZ ' ' A' ' 117' ' ' PHE . 1.2 tt0 -43.33 -57.93 2.79 Favored 'General case' 0 C--O 1.207 -1.167 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.386 -179.892 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.445 ' O ' ' CB ' ' A' ' 18' ' ' SER . 19.7 t-20 -44.98 -46.9 11.4 Favored 'General case' 0 C--O 1.198 -1.647 0 O-C-N 124.065 0.853 . . . . 0.0 109.766 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.442 ' CE ' ' HA3' ' A' ' 89' ' ' GLY . 0.0 OUTLIER -62.35 -48.23 80.74 Favored 'General case' 0 C--O 1.204 -1.307 0 CA-C-O 117.376 -1.297 . . . . 0.0 111.267 174.954 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -51.04 -68.19 0.19 Allowed 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 120.091 1.314 . . . . 0.0 111.685 175.501 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -55.99 -32.94 64.4 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.206 177.968 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.445 ' CB ' ' O ' ' A' ' 14' ' ' ASN . 12.6 t -68.05 -53.78 23.15 Favored 'General case' 0 C--O 1.216 -0.708 0 C-N-CA 123.949 0.9 . . . . 0.0 109.46 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.414 ' OD1' ' CD2' ' A' ' 83' ' ' PHE . 6.7 t-20 -49.37 -30.62 7.97 Favored 'General case' 0 N--CA 1.434 -1.266 0 O-C-N 120.443 -1.41 . . . . 0.0 109.291 178.415 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.99 -29.36 22.05 Favored 'General case' 0 N--CA 1.442 -0.873 0 O-C-N 123.521 0.513 . . . . 0.0 111.642 176.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -54.19 -42.93 70.27 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 124.029 0.931 . . . . 0.0 109.38 179.099 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.429 ' CD2' ' N ' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -79.59 -48.89 13.03 Favored 'General case' 0 N--CA 1.443 -0.78 0 O-C-N 123.769 0.668 . . . . 0.0 109.562 -179.892 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.571 ' HB2' ' CZ ' ' A' ' 83' ' ' PHE . . . -40.35 136.09 1.41 Allowed Pre-proline 0 N--CA 1.442 -0.871 0 O-C-N 125.187 1.554 . . . . 0.0 110.831 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.819 ' HG2' HG22 ' A' ' 30' ' ' THR . 18.6 Cg_endo -73.14 122.22 7.88 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 122.032 1.821 . . . . 0.0 110.631 -178.756 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.676 HD13 ' HE2' ' A' ' 115' ' ' LYS . 3.0 tp -60.23 95.5 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 123.597 0.56 . . . . 0.0 110.059 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 179.3 162.42 0.84 Allowed 'General case' 0 N--CA 1.448 -0.566 0 O-C-N 123.643 0.59 . . . . 0.0 109.883 -178.21 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -103.55 112.54 25.51 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 123.927 0.767 . . . . 0.0 109.083 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.01 64.69 4.12 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 177.845 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.418 ' O ' ' CG ' ' A' ' 29' ' ' LYS . 12.7 tttt -134.47 12.92 3.8 Favored 'General case' 0 C--N 1.334 -0.074 0 CA-C-O 123.003 1.382 . . . . 0.0 110.024 178.111 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.819 HG22 ' HG2' ' A' ' 24' ' ' PRO . 22.8 p -112.92 145.8 40.11 Favored 'General case' 0 C--N 1.315 -0.898 0 O-C-N 120.501 -1.374 . . . . 0.0 108.481 -176.604 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -38.42 -49.57 2.31 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.8 t -74.2 -60.69 2.15 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-O 117.177 -1.392 . . . . 0.0 110.165 177.594 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 162.2 -59.92 0.0 OUTLIER 'General case' 0 C--O 1.222 -0.344 0 O-C-N 125.256 1.597 . . . . 0.0 110.555 179.139 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.692 ' CE2' ' CE1' ' A' ' 36' ' ' HIS . 60.3 m-85 -58.83 145.78 77.7 Favored Pre-proline 0 N--CA 1.434 -1.256 0 CA-C-O 117.676 -1.154 . . . . 0.0 112.522 178.77 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.554 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 22.2 Cg_endo -74.23 153.41 99.14 Favored 'Cis proline' 0 N--CA 1.454 -0.82 0 C-N-CA 121.578 -2.259 . . . . 0.0 111.855 -1.523 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.692 ' CE1' ' CE2' ' A' ' 34' ' ' TYR . 0.5 OUTLIER -131.8 154.91 48.63 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-O 117.782 -1.104 . . . . 0.0 110.509 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 1.001 ' CH2' HG22 ' A' ' 39' ' ' THR . 13.4 t90 -48.98 144.78 4.42 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.227 0.954 . . . . 0.0 109.143 178.699 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.577 ' CZ ' HD13 ' A' ' 121' ' ' ILE . 24.6 t80 -114.93 80.96 1.49 Allowed 'General case' 0 N--CA 1.425 -1.717 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 -176.281 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 39' ' ' THR . . . . . 1.001 HG22 ' CH2' ' A' ' 37' ' ' TRP . 4.3 p -38.46 -32.86 0.08 Allowed 'General case' 0 C--O 1.21 -1.012 0 O-C-N 124.114 0.884 . . . . 0.0 109.933 176.404 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.498 ' HB2' ' CD2' ' A' ' 38' ' ' PHE . 51.0 t30 52.18 22.24 1.87 Allowed 'General case' 0 N--CA 1.447 -0.603 0 O-C-N 121.154 -0.966 . . . . 0.0 108.69 175.967 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.47 ' HA3' HD23 ' A' ' 48' ' ' LEU . . . 107.71 -41.42 2.21 Favored Glycine 0 N--CA 1.422 -2.263 0 CA-C-O 118.697 -1.057 . . . . 0.0 114.886 -173.605 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.529 ' CD2' ' HG3' ' A' ' 66' ' ' PRO . 62.4 m-85 -45.72 153.78 0.25 Allowed 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 123.721 0.808 . . . . 0.0 112.126 175.918 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.48 -40.32 16.51 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.708 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.512 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -164.97 -65.46 0.02 OUTLIER Glycine 0 C--N 1.339 0.717 0 N-CA-C 111.356 -0.698 . . . . 0.0 111.356 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.456 ' OD2' ' CE ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -121.08 -61.19 1.57 Allowed 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -179.708 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -50.47 179.24 0.03 OUTLIER Glycine 0 C--N 1.348 1.244 0 CA-C-O 123.598 1.666 . . . . 0.0 111.217 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.409 ' HA ' ' CE1' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -68.8 -171.06 0.26 Allowed 'General case' 0 C--N 1.326 -0.437 0 O-C-N 121.059 -1.259 . . . . 0.0 109.832 179.906 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.553 HD13 ' HG3' ' A' ' 54' ' ' PRO . 5.2 mp -69.96 154.52 94.59 Favored Pre-proline 0 N--CA 1.441 -0.914 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.213 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.09 156.53 47.13 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 122.114 1.876 . . . . 0.0 111.044 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.07 98.03 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.08 75.8 0.64 Allowed Glycine 0 N--CA 1.444 -0.775 0 CA-C-O 119.777 -0.457 . . . . 0.0 112.096 -178.348 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.46 ' HD3' ' CA ' ' A' ' 41' ' ' GLY . 6.9 ttt180 -177.22 163.85 2.12 Favored 'General case' 0 CA--C 1.517 -0.32 0 O-C-N 124.075 0.514 . . . . 0.0 110.419 177.914 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.2 m -137.05 111.81 9.41 Favored Pre-proline 0 N--CA 1.444 -0.774 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.972 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.553 ' HG3' HD13 ' A' ' 48' ' ' LEU . 23.0 Cg_endo -72.98 165.79 31.82 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 122.02 1.813 . . . . 0.0 112.01 178.733 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.486 HD11 ' HG ' ' A' ' 131' ' ' LEU . 4.3 mt -88.81 119.51 36.08 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.471 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -179.333 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 15.8 tptt -82.82 132.41 35.17 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.239 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.673 ' CE1' HD13 ' A' ' 133' ' ' LEU . 19.9 m-85 -117.56 -49.78 2.55 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.633 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 124.02 -1.63 9.13 Favored Glycine 0 CA--C 1.521 0.434 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.685 -178.381 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.4 mmtp -102.68 143.32 32.5 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 36.5 t -78.86 -1.26 34.16 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 124.315 1.01 . . . . 0.0 110.664 178.053 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.549 ' HB2' HG21 ' A' ' 111' ' ' THR . 0.9 OUTLIER -88.2 -57.48 2.91 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -178.995 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.9 m -72.44 -26.41 61.82 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 -179.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -71.37 -34.38 70.39 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 123.665 0.603 . . . . 0.0 110.154 177.763 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.99 160.81 14.37 Favored Pre-proline 0 N--CA 1.439 -0.995 0 CA-C-O 121.119 0.485 . . . . 0.0 110.354 179.286 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.438 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 26.5 Cg_endo -74.48 141.3 28.13 Favored 'Trans proline' 0 N--CA 1.445 -1.36 0 C-N-CA 121.713 1.608 . . . . 0.0 113.555 175.183 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.529 ' HG3' ' CD2' ' A' ' 42' ' ' TYR . 20.8 Cg_endo -73.66 167.93 26.04 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 122.43 2.087 . . . . 0.0 111.671 179.002 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.456 ' CE ' ' OD2' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -133.13 60.61 1.7 Allowed 'General case' 0 C--O 1.239 0.543 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.236 179.417 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.493 ' CE1' ' O ' ' A' ' 70' ' ' LYS . 57.0 t-80 -74.79 145.6 42.78 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-O 123.995 1.855 . . . . 0.0 112.01 178.144 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -133.12 -85.27 0.46 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 119.49 -2.006 . . . . 0.0 109.796 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.493 ' O ' ' CE1' ' A' ' 68' ' ' HIS . 0.2 OUTLIER -72.64 -171.07 0.76 Allowed 'General case' 0 C--O 1.203 -1.379 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.166 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -77.97 41.65 0.36 Allowed 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.664 0.745 . . . . 0.0 111.415 178.016 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -169.51 -105.58 0.18 Allowed Glycine 0 C--O 1.21 -1.368 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -178.36 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -113.44 -87.99 0.56 Allowed 'General case' 0 C--N 1.317 -0.847 0 O-C-N 120.968 -1.313 . . . . 0.0 107.567 -177.024 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 117.46 -141.73 16.74 Favored Glycine 0 N--CA 1.443 -0.896 0 CA-C-O 118.525 -1.153 . . . . 0.0 111.211 -178.515 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 36.8 mttt -49.01 -89.57 0.0 OUTLIER 'General case' 0 C--O 1.223 -0.308 0 O-C-N 125.21 1.182 . . . . 0.0 110.233 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.69 HG23 ' O ' ' A' ' 76' ' ' THR . 0.6 OUTLIER -127.23 28.51 5.72 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.868 179.331 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.549 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 41.0 t0 -30.01 97.78 0.01 OUTLIER 'General case' 0 C--O 1.214 -0.8 0 C-N-CA 122.93 0.492 . . . . 0.0 111.795 -178.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.404 ' CD2' ' H ' ' A' ' 78' ' ' HIS . 7.1 p80 -86.91 15.2 6.13 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -176.242 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 1.052 ' CE1' HD11 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -52.95 174.07 0.04 OUTLIER 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 174.484 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.769 HD22 ' CG2' ' A' ' 109' ' ' ILE . 0.6 OUTLIER -95.13 157.65 15.8 Favored 'General case' 0 C--O 1.218 -0.596 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.324 177.624 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 1.052 HD11 ' CE1' ' A' ' 79' ' ' TYR . 2.8 mp -143.03 108.55 5.07 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.533 0.682 . . . . 0.0 109.161 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.52 ' CB ' ' CD1' ' A' ' 109' ' ' ILE . 7.2 pm0 -80.9 150.58 28.98 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 122.148 0.975 . . . . 0.0 110.205 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.571 ' CZ ' ' HB2' ' A' ' 23' ' ' ALA . 15.8 t80 -141.16 137.03 16.39 Favored Pre-proline 0 N--CA 1.442 -0.87 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.161 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.484 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 19.4 Cg_endo -74.01 91.78 0.92 Allowed 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 123.293 2.662 . . . . 0.0 110.914 -178.572 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.0 t -95.48 109.1 21.35 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 122.194 0.997 . . . . 0.0 111.118 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -82.42 159.08 65.25 Favored Pre-proline 0 N--CA 1.443 -0.821 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.692 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -76.57 -40.78 0.51 Allowed 'Trans proline' 0 CA--C 1.501 -1.132 0 C-N-CA 122.324 2.016 . . . . 0.0 112.453 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -42.36 -32.2 0.49 Allowed 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 125.123 1.515 . . . . 0.0 109.854 178.312 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.442 ' HA3' ' CE ' ' A' ' 15' ' ' LYS . . . 87.14 10.0 72.36 Favored Glycine 0 N--CA 1.438 -1.169 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 177.252 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.419 ' O ' ' CD2' ' A' ' 90' ' ' HIS . 3.8 p-80 -80.82 130.33 35.0 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -62.21 88.45 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.779 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.533 ' CD2' ' HB3' ' A' ' 94' ' ' PHE . 7.7 t80 -36.42 146.72 0.03 OUTLIER 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 122.362 1.077 . . . . 0.0 110.809 -178.935 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -78.8 58.81 2.41 Favored 'General case' 0 C--N 1.317 -0.814 0 O-C-N 120.19 -1.569 . . . . 0.0 110.072 177.958 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.533 ' HB3' ' CD2' ' A' ' 92' ' ' TYR . 29.6 p90 -79.45 -8.9 59.44 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 122.837 0.455 . . . . 0.0 111.544 178.216 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -92.47 -33.16 14.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 49.3 m -79.82 110.54 15.28 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.234 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.41 ' CG ' ' N ' ' A' ' 98' ' ' LYS . 0.1 OUTLIER -58.86 -50.09 75.29 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.157 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -146.4 129.55 8.14 Favored Pre-proline 0 N--CA 1.432 -1.346 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -177.245 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.439 ' HA ' ' HA ' ' A' ' 98' ' ' LYS . 26.4 Cg_endo -72.15 177.66 33.85 Favored 'Cis proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.135 -2.027 . . . . 0.0 111.967 -2.87 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.17 135.82 21.99 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 123.789 0.68 . . . . 0.0 109.731 178.059 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.93 172.71 13.42 Favored 'General case' 0 C--O 1.245 0.856 0 O-C-N 124.27 0.981 . . . . 0.0 111.246 178.155 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -57.3 158.74 9.75 Favored Pre-proline 0 N--CA 1.438 -1.033 0 CA-C-O 121.604 0.716 . . . . 0.0 112.193 175.072 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -75.78 -89.87 0.0 OUTLIER 'Trans proline' 0 C--O 1.205 -1.14 0 C-N-CA 122.212 1.942 . . . . 0.0 111.115 179.014 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 151.77 148.68 4.89 Favored Glycine 0 N--CA 1.438 -1.214 0 O-C-N 120.983 -1.073 . . . . 0.0 111.358 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -74.45 -35.47 3.72 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.149 1.9 . . . . 0.0 111.779 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.763 ' HB3' ' CZ ' ' A' ' 11' ' ' TYR . . . -102.85 146.72 27.85 Favored 'General case' 0 N--CA 1.437 -1.078 0 O-C-N 124.232 0.958 . . . . 0.0 109.914 178.413 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.422 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 2.2 mtm-85 -146.44 148.82 32.67 Favored 'General case' 0 N--CA 1.445 -0.705 0 O-C-N 123.833 0.708 . . . . 0.0 111.417 179.173 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.474 ' CG1' ' HB3' ' A' ' 83' ' ' PHE . 3.8 p -82.63 117.71 29.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 123.19 0.596 . . . . 0.0 110.23 178.713 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.769 ' CG2' HD22 ' A' ' 80' ' ' LEU . 6.1 mm -96.01 140.71 16.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.631 ' C ' HD23 ' A' ' 80' ' ' LEU . 9.0 p90 -167.18 152.25 7.33 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.789 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.549 HG21 ' HB2' ' A' ' 61' ' ' ASP . 1.6 p -87.76 163.86 16.26 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.715 -178.863 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.572 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.2 OUTLIER -112.94 152.62 45.04 Favored Pre-proline 0 N--CA 1.434 -1.231 0 C-N-CA 123.209 0.604 . . . . 0.0 110.842 -179.783 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.608 ' O ' HD21 ' A' ' 25' ' ' LEU . 17.8 Cg_endo -73.56 -55.46 0.14 OUTLIER 'Cis proline' 0 CA--C 1.512 -0.601 0 C-N-CA 122.0 -2.083 . . . . 0.0 110.64 -4.14 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -41.65 111.18 0.21 Allowed 'General case' 0 N--CA 1.438 -1.057 0 CA-C-O 116.093 -1.908 . . . . 0.0 110.342 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.676 ' HE2' HD13 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -64.39 74.41 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.7 0 O-C-N 126.03 2.081 . . . . 0.0 108.755 -178.604 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.64 ' O ' HG12 ' A' ' 116' ' ' VAL . 13.3 t -71.47 69.81 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 -178.139 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.572 ' CE1' ' HA2' ' A' ' 119' ' ' GLY . 9.8 t80 -36.48 111.06 0.13 Allowed 'General case' 0 N--CA 1.437 -1.078 0 C-N-CA 124.074 0.949 . . . . 0.0 109.849 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 118' ' ' CYS . . . . . 0.577 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 0.1 OUTLIER -94.28 -26.69 16.5 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.258 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.572 ' HA2' ' CE1' ' A' ' 117' ' ' PHE . . . 137.39 -166.58 24.98 Favored Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 -178.749 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.665 HG22 ' SG ' ' A' ' 134' ' ' CYS . 3.5 mp -111.6 146.1 16.96 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.369 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 -177.612 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.681 ' CD1' HD21 ' A' ' 131' ' ' LEU . 6.2 pt -116.77 157.11 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 CA-C-N 119.237 0.926 . . . . 0.0 108.836 178.663 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.728 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . . . -176.73 147.15 0.6 Allowed 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.561 0.696 . . . . 0.0 110.126 177.965 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.579 ' CE1' HD13 ' A' ' 131' ' ' LEU . 0.8 OUTLIER -89.25 94.26 9.85 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 -177.873 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.612 ' O ' HG23 ' A' ' 124' ' ' THR . 3.9 t -99.53 44.65 1.01 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 123.315 1.531 . . . . 0.0 110.961 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 11.1 tttt -105.86 -26.73 11.61 Favored 'General case' 0 C--O 1.222 -0.391 0 O-C-N 120.664 -1.272 . . . . 0.0 110.395 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -171.17 -63.91 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 124.419 1.074 . . . . 0.0 110.957 178.417 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -155.16 -45.96 0.08 Allowed 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 121.998 0.904 . . . . 0.0 110.041 178.903 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -158.18 76.04 0.76 Allowed 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.59 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -120.47 -103.49 1.94 Allowed Glycine 0 C--N 1.331 0.289 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.09 143.61 26.52 Favored 'General case' 0 CA--C 1.513 -0.459 0 O-C-N 122.333 -0.51 . . . . 0.0 110.872 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.681 HD21 ' CD1' ' A' ' 121' ' ' ILE . 6.0 tp -96.62 138.27 34.44 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 121.057 0.456 . . . . 0.0 110.176 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.535 ' HD3' HG22 ' A' ' 124' ' ' THR . 0.1 OUTLIER -140.67 169.0 18.47 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.606 -178.954 . . . . . . . . 3 3 . 1 . 006 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.673 HD13 ' CE1' ' A' ' 57' ' ' PHE . 10.4 tp -89.6 136.47 33.02 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.396 1.06 . . . . 0.0 108.504 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 134' ' ' CYS . . . . . 0.665 ' SG ' HG22 ' A' ' 120' ' ' ILE . 70.7 m -56.97 -176.44 0.02 OUTLIER 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 124.793 1.237 . . . . 0.0 108.308 178.478 . . . . . . . . 2 2 . 1 . 006 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 6.8 m -161.16 83.99 0.65 Allowed 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.724 ' HB2' HG22 ' A' ' 2' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--O 1.258 1.527 0 CA-C-O 116.11 -1.9 . . . . 0.0 112.143 175.19 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.835 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 . . . . . . . . . 0 0 . 1 . 007 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.473 HG22 ' HB3' ' A' ' 136' ' ' HIS . 9.9 p -100.98 136.2 33.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.552 ' CG2' HD12 ' A' ' 10' ' ' LEU . 1.1 m -85.61 123.73 31.35 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 177.158 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.44 ' CG ' HG13 ' A' ' 120' ' ' ILE . 35.0 m95 -86.18 142.58 28.52 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 122.913 0.485 . . . . 0.0 110.059 177.13 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.574 ' OG1' HD13 ' A' ' 10' ' ' LEU . 0.8 OUTLIER -127.21 125.84 41.74 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 -176.751 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.548 ' HB3' ' HB3' ' A' ' 122' ' ' ALA . 7.2 m -120.7 53.75 1.1 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.691 178.541 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 132.68 -95.95 0.3 Allowed Glycine 0 C--O 1.223 -0.565 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -132.33 8.84 5.35 Favored Glycine 0 N--CA 1.469 0.897 0 C-N-CA 123.881 0.753 . . . . 0.0 113.624 177.995 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.454 HD13 ' OH ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -115.52 140.28 49.3 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 124.85 1.26 . . . . 0.0 108.858 -176.632 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.574 HD13 ' OG1' ' A' ' 5' ' ' THR . 2.7 mm? -105.24 116.5 32.05 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 124.509 1.131 . . . . 0.0 108.099 -170.451 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.454 ' OH ' HD13 ' A' ' 9' ' ' LEU . 73.8 m-85 -108.55 98.5 8.01 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 -172.119 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -55.14 117.87 3.86 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 177.557 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.431 ' HB2' ' CD1' ' A' ' 4' ' ' TRP . 28.3 tp60 -51.0 -44.42 60.96 Favored 'General case' 0 C--O 1.214 -0.796 0 C-N-CA 119.814 -0.754 . . . . 0.0 112.853 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -48.42 -42.91 33.54 Favored 'General case' 0 C--O 1.201 -1.479 0 O-C-N 123.771 0.67 . . . . 0.0 112.217 175.49 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.9 mttt -69.52 -40.8 76.73 Favored 'General case' 0 C--O 1.212 -0.879 0 CA-C-N 120.068 1.304 . . . . 0.0 113.454 168.623 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -52.5 -40.38 62.33 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 121.688 2.04 . . . . 0.0 113.82 173.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -85.66 -43.83 13.09 Favored 'General case' 0 C--O 1.217 -0.616 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.603 173.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 41.0 t -71.36 -62.88 1.24 Allowed 'General case' 0 C--O 1.217 -0.62 0 C-N-CA 126.914 2.086 . . . . 0.0 110.839 -176.315 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.421 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 8.3 t-20 -39.55 -38.16 0.57 Allowed 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 120.262 1.392 . . . . 0.0 111.673 168.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.576 ' HB3' HG11 ' A' ' 108' ' ' VAL . 1.1 p -83.51 -26.67 29.98 Favored 'General case' 0 C--O 1.218 -0.598 0 N-CA-C 116.464 2.024 . . . . 0.0 116.464 175.364 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -54.25 -32.99 57.44 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 125.186 1.394 . . . . 0.0 109.088 178.994 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.421 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.1 OUTLIER -75.48 -41.39 55.6 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 125.086 1.355 . . . . 0.0 111.208 177.111 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.861 ' HB1' ' HG3' ' A' ' 35' ' ' PRO . . . -39.04 125.47 1.25 Allowed Pre-proline 0 CA--C 1.539 0.526 0 C-N-CA 125.39 1.476 . . . . 0.0 111.503 174.44 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.403 ' HG2' ' CG2' ' A' ' 30' ' ' THR . 19.0 Cg_endo -71.02 123.2 9.47 Favored 'Trans proline' 0 N--CA 1.439 -1.68 0 C-N-CA 122.71 2.274 . . . . 0.0 109.101 -177.494 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.451 HD22 ' HE2' ' A' ' 115' ' ' LYS . 2.7 tp -60.41 97.17 0.05 OUTLIER 'General case' 0 C--O 1.222 -0.394 0 C-N-CA 124.18 0.992 . . . . 0.0 111.043 177.706 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -175.25 149.05 1.02 Allowed 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 123.729 0.812 . . . . 0.0 110.928 -176.324 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.508 ' HB3' ' CA ' ' A' ' 72' ' ' GLY . 3.6 t0 -82.02 82.74 7.51 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -178.521 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.415 ' N ' ' HA ' ' A' ' 36' ' ' HIS . . . 68.22 81.29 0.19 Allowed Glycine 0 C--O 1.227 -0.317 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 175.291 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.35 47.3 0.97 Allowed 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 122.748 1.261 . . . . 0.0 112.778 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.403 ' CG2' ' HG2' ' A' ' 24' ' ' PRO . 68.2 p -134.14 154.85 50.96 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.286 -175.111 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -41.6 -61.4 2.19 Favored Glycine 0 C--O 1.228 -0.243 0 C-N-CA 124.189 0.899 . . . . 0.0 112.704 -178.417 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.9 t -65.0 -72.35 0.15 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 118.103 -0.951 . . . . 0.0 112.186 173.434 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 60.7 p 179.74 -55.2 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.955 0.902 . . . . 0.0 112.278 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.475 ' CD1' ' HD3' ' A' ' 84' ' ' PRO . 80.9 m-85 -71.34 142.93 87.38 Favored Pre-proline 0 N--CA 1.437 -1.083 0 O-C-N 124.821 1.325 . . . . 0.0 112.04 -178.644 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.861 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 27.8 Cg_endo -79.04 158.81 91.22 Favored 'Cis proline' 0 N--CA 1.442 -1.552 0 C-N-CA 122.159 -2.017 . . . . 0.0 110.713 6.574 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.421 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 0.6 OUTLIER -140.91 157.72 44.97 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-O 118.582 -0.723 . . . . 0.0 111.944 178.275 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.939 ' CH2' HG22 ' A' ' 39' ' ' THR . 21.5 t90 -58.4 149.7 24.2 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 122.943 1.354 . . . . 0.0 110.879 172.948 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.496 ' CE2' HD13 ' A' ' 121' ' ' ILE . 8.1 t80 -123.69 83.87 2.2 Favored 'General case' 0 N--CA 1.434 -1.25 0 C-N-CA 127.515 2.326 . . . . 0.0 105.779 -174.993 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.939 HG22 ' CH2' ' A' ' 37' ' ' TRP . 71.1 p -36.46 -41.93 0.31 Allowed 'General case' 0 C--O 1.213 -0.849 0 CA-C-N 114.464 -1.244 . . . . 0.0 110.819 171.682 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 55.4 t30 57.05 20.08 5.2 Favored 'General case' 0 CA--C 1.55 0.965 0 CA-C-O 122.413 1.102 . . . . 0.0 111.028 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.84 -33.13 6.64 Favored Glycine 0 C--O 1.222 -0.626 0 CA-C-O 117.655 -1.636 . . . . 0.0 113.558 -171.896 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.604 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 84.3 m-85 -52.76 157.04 1.74 Allowed 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.328 1.451 . . . . 0.0 111.339 177.734 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.72 -31.2 46.29 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.635 0.731 . . . . 0.0 112.061 176.902 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.509 ' HA2' ' CZ2' ' A' ' 37' ' ' TRP . . . 114.83 34.47 1.52 Allowed Glycine 0 C--O 1.221 -0.699 0 CA-C-O 117.28 -1.845 . . . . 0.0 114.779 -174.56 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -147.54 -64.88 0.27 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.483 1.113 . . . . 0.0 112.219 -178.9 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -135.47 -100.81 0.64 Allowed Glycine 0 C--O 1.219 -0.804 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.88 -174.39 5.24 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.348 0.594 . . . . 0.0 109.79 178.232 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.72 HD13 ' NE ' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -101.47 168.87 8.47 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.507 -178.725 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -71.29 -179.13 3.34 Favored 'Trans proline' 0 N--CA 1.442 -1.53 0 C-N-CA 123.003 2.468 . . . . 0.0 112.166 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.15 104.0 11.33 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 119.98 -1.7 . . . . 0.0 110.014 174.304 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.43 71.21 0.52 Allowed Glycine 0 N--CA 1.469 0.863 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 177.662 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.72 ' NE ' HD13 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -161.66 169.29 21.83 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 124.013 0.925 . . . . 0.0 109.637 178.797 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.9 m -155.23 107.96 2.25 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 173.898 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.508 ' HG3' HD21 ' A' ' 48' ' ' LEU . 24.4 Cg_endo -71.76 172.87 13.6 Favored 'Trans proline' 0 N--CA 1.444 -1.4 0 C-N-CA 122.817 2.345 . . . . 0.0 111.246 177.03 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.8 mt -85.82 132.9 30.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.92 149.28 25.76 Favored 'General case' 0 C--N 1.33 -0.265 0 O-C-N 121.499 -0.75 . . . . 0.0 109.87 175.552 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.465 ' CE2' ' SG ' ' A' ' 62' ' ' CYS . 21.0 m-85 -132.67 -49.48 0.9 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.616 1.167 . . . . 0.0 110.856 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 111.33 -3.32 28.12 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 125.008 1.29 . . . . 0.0 113.249 -174.671 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.87 128.9 40.39 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-O 117.724 -1.131 . . . . 0.0 109.728 176.046 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 22.5 p -61.82 -10.62 9.55 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 125.617 1.823 . . . . 0.0 112.718 176.783 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.586 ' HB2' HG11 ' A' ' 116' ' ' VAL . 0.4 OUTLIER -88.14 -54.21 4.33 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 126.181 1.792 . . . . 0.0 110.505 179.329 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.465 ' SG ' ' CE2' ' A' ' 57' ' ' PHE . 2.6 t -73.34 -15.2 61.39 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 124.275 0.985 . . . . 0.0 113.092 174.91 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -84.68 -40.5 17.31 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.383 1.473 . . . . 0.0 110.259 173.471 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.63 155.41 3.9 Favored Pre-proline 0 CA--C 1.539 0.529 0 CA-C-O 122.636 1.208 . . . . 0.0 111.566 -178.683 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -69.02 138.02 39.1 Favored 'Trans proline' 0 N--CA 1.439 -1.689 0 C-N-CA 120.344 0.696 . . . . 0.0 112.411 175.093 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.454 ' HD2' ' CD1' ' A' ' 42' ' ' TYR . 27.9 Cg_endo -66.17 172.24 9.04 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 124.118 3.212 . . . . 0.0 110.713 173.93 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.7 mmtt -140.94 63.0 1.46 Allowed 'General case' 0 C--O 1.207 -1.133 0 CA-C-O 118.287 -0.863 . . . . 0.0 109.508 177.388 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 31.1 t-80 -74.29 163.86 27.3 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 123.433 0.458 . . . . 0.0 110.382 177.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 21.1 p -148.63 -173.37 4.32 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.483 1.113 . . . . 0.0 110.976 176.186 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.75 74.19 10.2 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 120.734 -1.229 . . . . 0.0 111.706 176.359 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -177.05 -46.46 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 124.281 1.033 . . . . 0.0 109.68 -179.255 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.508 ' CA ' ' HB3' ' A' ' 27' ' ' ASP . . . 120.66 -78.12 0.32 Allowed Glycine 0 N--CA 1.441 -1.017 0 O-C-N 124.441 1.088 . . . . 0.0 112.677 -174.766 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 3.6 p-10 -119.99 61.61 0.85 Allowed 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 128.874 2.869 . . . . 0.0 109.003 -178.079 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -70.56 -106.36 0.04 OUTLIER Glycine 0 CA--C 1.526 0.725 0 CA-C-O 123.088 1.382 . . . . 0.0 111.506 -175.239 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.0 mttt -61.35 -90.05 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.68 0 O-C-N 120.201 -1.764 . . . . 0.0 113.353 174.36 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.42 HG23 ' O ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -128.77 15.37 6.42 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.641 177.437 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -29.38 97.33 0.01 OUTLIER 'General case' 0 C--O 1.214 -0.806 0 C-N-CA 126.126 1.77 . . . . 0.0 112.349 -175.733 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.403 ' CD2' ' H ' ' A' ' 78' ' ' HIS . 6.1 p80 -88.53 58.0 4.48 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 119.866 -1.771 . . . . 0.0 107.527 -169.232 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.528 ' HB2' ' CD1' ' A' ' 37' ' ' TRP . 46.7 p90 -80.85 133.55 35.61 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 125.08 1.352 . . . . 0.0 108.885 -177.189 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.611 HD21 HG22 ' A' ' 111' ' ' THR . 5.3 mt -71.2 126.33 29.32 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 176.804 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.727 HD21 ' HB2' ' A' ' 35' ' ' PRO . 0.4 OUTLIER -120.23 141.79 49.62 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 177.962 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.407 ' HB2' HD11 ' A' ' 109' ' ' ILE . 0.6 OUTLIER -103.84 166.14 10.6 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 175.784 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.723 ' CE2' ' HB2' ' A' ' 23' ' ' ALA . 7.6 t80 -152.85 127.04 4.47 Favored Pre-proline 0 CA--C 1.538 0.511 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.475 ' HD3' ' CD1' ' A' ' 34' ' ' TYR . 17.8 Cg_endo -71.66 118.39 5.63 Favored 'Trans proline' 0 N--CA 1.444 -1.416 0 C-N-CA 124.755 3.637 . . . . 0.0 110.312 -176.871 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.99 111.29 17.72 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.742 -1.117 . . . . 0.0 108.61 -177.118 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -79.31 157.64 75.13 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 177.133 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -73.52 -36.1 4.19 Favored 'Trans proline' 0 N--CA 1.448 -1.18 0 C-N-CA 122.636 2.224 . . . . 0.0 113.321 178.694 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -46.74 -29.93 2.16 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 126.911 2.084 . . . . 0.0 110.044 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.93 6.08 76.37 Favored Glycine 0 N--CA 1.44 -1.099 0 C-N-CA 125.367 1.46 . . . . 0.0 112.344 178.599 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.1 p-80 -76.56 128.7 35.24 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 177.104 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -56.82 106.79 0.33 Allowed 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 171.485 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.46 ' CD2' ' HG2' ' A' ' 84' ' ' PRO . 3.0 t80 -37.08 131.96 0.74 Allowed 'General case' 0 C--O 1.215 -0.715 0 C-N-CA 123.833 0.853 . . . . 0.0 108.852 176.667 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.27 59.68 0.08 Allowed 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.385 -0.822 . . . . 0.0 112.162 173.361 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.482 ' CD2' ' HZ ' ' A' ' 83' ' ' PHE . 6.5 p90 -72.92 -5.09 36.17 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 127.347 2.259 . . . . 0.0 112.196 174.937 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.68 -40.6 10.16 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 123.652 1.691 . . . . 0.0 110.166 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 74.9 m -76.93 97.72 4.69 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 120.348 -1.47 . . . . 0.0 108.393 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.6 pttm -59.16 -46.71 87.67 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.955 0.883 . . . . 0.0 111.81 177.225 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.46 126.35 8.12 Favored Pre-proline 0 CA--C 1.54 0.576 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.909 -179.149 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -69.47 171.75 51.01 Favored 'Cis proline' 0 N--CA 1.454 -0.842 0 C-N-CA 123.183 -1.591 . . . . 0.0 111.184 -5.48 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -128.77 146.05 51.01 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 123.612 0.765 . . . . 0.0 109.107 177.004 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -95.19 165.96 12.14 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 173.935 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 6.1 t-20 -36.02 138.48 0.44 Allowed Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 125.034 1.334 . . . . 0.0 110.954 170.579 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -71.88 -68.43 0.02 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 123.174 2.583 . . . . 0.0 114.259 176.423 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 130.82 142.09 5.01 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -75.3 -66.62 0.02 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 123.468 2.778 . . . . 0.0 110.951 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.589 ' HA ' ' HB2' ' A' ' 122' ' ' ALA . . . -64.74 131.8 47.85 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.789 0.804 . . . . 0.0 111.356 178.652 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.406 ' HG2' ' HA ' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -139.75 150.61 44.99 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-N 114.63 -1.168 . . . . 0.0 110.057 -178.443 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.576 HG11 ' HB3' ' A' ' 20' ' ' SER . 3.6 p -88.36 119.19 35.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 O-C-N 124.58 1.175 . . . . 0.0 110.454 178.377 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.534 HG12 HD13 ' A' ' 121' ' ' ILE . 1.2 mp -107.25 117.8 53.74 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.011 0 N-CA-C 105.847 -1.908 . . . . 0.0 105.847 -173.975 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.649 ' CZ ' HD22 ' A' ' 81' ' ' LEU . 5.9 p90 -136.06 151.53 49.94 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-O 122.732 1.253 . . . . 0.0 108.213 -178.941 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.611 HG22 HD21 ' A' ' 80' ' ' LEU . 1.8 p -83.46 157.23 22.51 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.142 177.492 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.484 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -105.47 157.16 35.12 Favored Pre-proline 0 CA--C 1.552 1.022 0 O-C-N 121.966 -0.459 . . . . 0.0 111.317 178.188 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.484 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 19.1 Cg_endo -72.35 -49.77 0.21 Allowed 'Cis proline' 0 N--CA 1.454 -0.807 0 C-N-CA 124.412 -1.078 . . . . 0.0 111.375 -11.072 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -48.06 105.14 0.07 Allowed 'General case' 0 C--O 1.224 -0.268 0 C-N-CA 124.113 0.965 . . . . 0.0 109.24 176.55 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.451 ' HE2' HD22 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -61.85 79.87 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 126.113 1.765 . . . . 0.0 108.695 -178.152 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.586 HG11 ' HB2' ' A' ' 61' ' ' ASP . 39.4 t -81.41 72.8 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 104.271 -2.492 . . . . 0.0 104.271 -177.256 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 47.6 t80 -36.87 106.63 0.05 OUTLIER 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 125.864 1.665 . . . . 0.0 109.827 176.112 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 118' ' ' CYS . . . . . 0.421 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 7.8 m -84.79 -45.51 12.28 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 -177.912 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 163.7 -146.78 11.96 Favored Glycine 0 N--CA 1.439 -1.149 0 CA-C-N 114.75 -1.113 . . . . 0.0 110.682 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.44 HG13 ' CG ' ' A' ' 4' ' ' TRP . 1.3 mm -127.5 141.1 47.27 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.925 0 N-CA-C 104.93 -2.248 . . . . 0.0 104.93 -177.892 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.572 HD12 HD22 ' A' ' 131' ' ' LEU . 5.7 pt -130.51 150.44 34.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -178.74 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.589 ' HB2' ' HA ' ' A' ' 106' ' ' ALA . . . -169.19 162.22 10.59 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.439 0.638 . . . . 0.0 110.344 178.537 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.441 ' CD2' ' HG ' ' A' ' 131' ' ' LEU . 1.7 m80 -92.7 90.62 7.15 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-O 121.357 0.598 . . . . 0.0 109.515 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 8.4 p -101.79 43.21 1.08 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 122.056 0.932 . . . . 0.0 109.952 -177.274 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.65 -23.31 11.52 Favored 'General case' 0 C--O 1.217 -0.636 0 CA-C-N 114.77 -1.105 . . . . 0.0 111.855 175.455 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -171.45 -70.4 0.02 OUTLIER 'General case' 0 C--O 1.22 -0.485 0 O-C-N 123.971 0.794 . . . . 0.0 110.032 176.502 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -154.6 -45.47 0.09 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.316 1.447 . . . . 0.0 111.158 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -154.17 81.4 1.13 Allowed 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.838 1.255 . . . . 0.0 108.8 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -128.62 -108.2 1.38 Allowed Glycine 0 N--CA 1.464 0.5 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 175.119 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.53 159.84 19.16 Favored 'General case' 0 C--N 1.32 -0.679 0 O-C-N 122.237 -0.567 . . . . 0.0 111.328 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.572 HD22 HD12 ' A' ' 121' ' ' ILE . 0.6 OUTLIER -108.79 148.07 31.09 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 122.961 0.504 . . . . 0.0 109.956 177.577 . . . . . . . . 3 3 . 1 . 007 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.1 171.43 18.45 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 124.122 0.969 . . . . 0.0 109.104 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.401 HD12 HG22 ' A' ' 121' ' ' ILE . 12.4 tp -82.24 136.2 35.11 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.606 -0.886 . . . . 0.0 108.606 178.006 . . . . . . . . 2 2 . 1 . 007 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 64.1 m -67.08 -177.31 0.63 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 123.066 1.412 . . . . 0.0 109.979 173.126 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 2.1 m -158.72 124.6 4.48 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 104.836 -2.283 . . . . 0.0 104.836 -177.989 . . . . . . . . 1 1 . 1 . 007 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.473 ' HB3' HG22 ' A' ' 2' ' ' VAL . 3.0 m80 . . . . . 0 C--N 1.324 -0.503 0 CA-C-O 117.228 -1.367 . . . . 0.0 113.238 175.039 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.661 ' HB3' ' HB3' ' A' ' 13' ' ' GLN . . . . . . . . 0 N--CA 1.476 0.848 0 CA-C-O 117.892 -1.052 . . . . 0.0 109.172 . . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.41 HG13 ' CD2' ' A' ' 136' ' ' HIS . 7.7 p -51.6 153.45 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 O-C-N 124.153 0.908 . . . . 0.0 111.271 174.424 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.528 HG21 HD23 ' A' ' 10' ' ' LEU . 0.9 OUTLIER -83.58 114.59 21.63 Favored 'General case' 0 C--N 1.319 -0.723 0 O-C-N 122.092 -0.38 . . . . 0.0 110.538 178.354 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 23.0 m95 -81.17 139.57 35.48 Favored 'General case' 0 C--O 1.215 -0.721 0 O-C-N 121.994 -0.441 . . . . 0.0 110.345 177.609 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -130.69 138.5 50.06 Favored 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -178.809 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.645 ' SG ' ' HB3' ' A' ' 122' ' ' ALA . 0.1 OUTLIER -122.85 61.71 1.0 Allowed 'General case' 0 N--CA 1.442 -0.852 0 O-C-N 124.092 0.87 . . . . 0.0 108.755 175.553 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 43.7 52.22 6.58 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 123.133 0.396 . . . . 0.0 112.115 179.041 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -164.29 -85.3 0.06 OUTLIER Glycine 0 C--O 1.224 -0.476 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -177.967 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -127.19 164.0 22.64 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 121.749 0.785 . . . . 0.0 110.098 177.414 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.528 HD23 HG21 ' A' ' 3' ' ' THR . 10.9 mp -88.69 126.09 35.15 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -177.256 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.495 ' CZ ' ' HB3' ' A' ' 106' ' ' ALA . 70.2 m-85 -111.3 89.73 3.13 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 126.695 1.998 . . . . 0.0 108.586 -174.27 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 5.1 t-20 -54.71 125.39 19.73 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.265 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.661 ' HB3' ' HB3' ' A' ' 1' ' ' ALA . 7.5 tp-100 -60.59 -21.66 62.87 Favored 'General case' 0 C--O 1.213 -0.838 0 C-N-CA 119.028 -1.069 . . . . 0.0 113.249 176.793 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -64.64 -23.46 67.27 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 172.673 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.2 mtmt -103.73 -36.65 7.79 Favored 'General case' 0 C--O 1.202 -1.424 0 C-N-CA 126.492 1.917 . . . . 0.0 109.782 175.135 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.629 ' HA ' HG21 ' A' ' 85' ' ' THR . . . -54.27 -42.53 70.09 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 121.307 1.867 . . . . 0.0 111.736 177.112 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -84.13 -47.56 10.76 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-O 117.598 -1.191 . . . . 0.0 108.809 177.034 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.7 t -66.64 -53.01 38.62 Favored 'General case' 0 C--O 1.212 -0.884 0 CA-C-N 120.326 1.421 . . . . 0.0 109.514 -172.212 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.518 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 6.4 t-20 -42.78 -36.52 1.49 Allowed 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 123.946 0.898 . . . . 0.0 113.396 169.639 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.456 ' O ' ' HB3' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -82.01 -33.95 29.82 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 172.548 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -46.2 -37.01 6.57 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 126.469 1.908 . . . . 0.0 109.925 178.071 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.518 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -73.13 -48.8 32.48 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 117.635 -1.174 . . . . 0.0 112.698 175.182 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.769 ' HB1' ' HG3' ' A' ' 35' ' ' PRO . . . -36.59 128.38 0.71 Allowed Pre-proline 0 N--CA 1.442 -0.873 0 O-C-N 125.487 1.742 . . . . 0.0 112.226 173.153 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.552 ' HG2' HG22 ' A' ' 30' ' ' THR . 13.8 Cg_endo -73.69 125.96 10.42 Favored 'Trans proline' 0 N--CA 1.444 -1.417 0 C-N-CA 121.979 1.786 . . . . 0.0 107.573 -175.817 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.672 HD13 ' HE2' ' A' ' 115' ' ' LYS . 3.4 tp -61.77 84.98 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 124.552 1.141 . . . . 0.0 111.911 177.998 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.4 m -174.43 155.12 2.24 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.165 0.986 . . . . 0.0 110.047 -173.291 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -96.31 137.45 35.36 Favored 'General case' 0 CA--C 1.503 -0.849 0 CA-C-O 117.566 -1.207 . . . . 0.0 110.784 175.239 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 37.21 70.58 0.24 Allowed Glycine 0 C--N 1.338 0.673 0 O-C-N 125.008 1.442 . . . . 0.0 111.897 177.032 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -148.6 24.15 0.99 Allowed 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 121.997 0.903 . . . . 0.0 111.824 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.552 HG22 ' HG2' ' A' ' 24' ' ' PRO . 50.1 p -130.2 151.8 50.33 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -175.956 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -40.7 -64.98 1.1 Allowed Glycine 0 CA--C 1.505 -0.536 0 O-C-N 124.25 0.969 . . . . 0.0 112.764 -177.517 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 40.5 t -60.15 -60.99 2.94 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-O 115.809 -2.043 . . . . 0.0 112.641 174.691 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 161.16 -53.32 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.706 0 O-C-N 125.777 1.923 . . . . 0.0 111.863 176.705 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.485 ' CD2' ' HD3' ' A' ' 84' ' ' PRO . 62.2 m-85 -63.38 146.86 95.96 Favored Pre-proline 0 N--CA 1.438 -1.065 0 N-CA-C 114.757 1.392 . . . . 0.0 114.757 177.41 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.769 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 20.7 Cg_endo -75.41 166.32 83.44 Favored 'Cis proline' 0 N--CA 1.446 -1.308 0 C-N-CA 123.442 -1.483 . . . . 0.0 110.862 0.711 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.465 ' C ' HD23 ' A' ' 81' ' ' LEU . 0.8 OUTLIER -139.61 172.41 12.84 Favored 'General case' 0 CA--C 1.502 -0.884 0 O-C-N 120.867 -1.146 . . . . 0.0 109.89 -176.895 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.943 ' CH2' HG22 ' A' ' 39' ' ' THR . 21.3 t90 -71.4 141.4 50.32 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.889 0.852 . . . . 0.0 108.825 177.303 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.598 ' CZ ' HD13 ' A' ' 121' ' ' ILE . 55.4 t80 -121.05 83.0 2.0 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 -176.379 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.943 HG22 ' CH2' ' A' ' 37' ' ' TRP . 44.2 p -40.32 -31.23 0.13 Allowed 'General case' 0 C--O 1.212 -0.886 0 C-N-CA 124.512 1.125 . . . . 0.0 111.255 174.229 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.4 t30 71.32 7.67 6.14 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.039 1.735 . . . . 0.0 109.405 178.014 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.71 ' C ' HD23 ' A' ' 48' ' ' LEU . . . 117.58 -11.32 14.02 Favored Glycine 0 N--CA 1.434 -1.481 0 O-C-N 120.592 -1.318 . . . . 0.0 113.169 -170.9 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.579 ' CE2' ' HA ' ' A' ' 47' ' ' LYS . 4.9 m-85 -75.93 176.26 8.04 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 118.364 1.082 . . . . 0.0 109.852 -176.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.62 -39.11 9.26 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.563 174.993 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.485 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -172.49 -82.55 0.05 OUTLIER Glycine 0 C--N 1.333 0.406 0 C-N-CA 123.571 0.605 . . . . 0.0 111.983 -178.209 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.83 -63.1 1.15 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 122.021 0.915 . . . . 0.0 110.438 178.399 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.97 166.49 12.88 Favored Glycine 0 C--N 1.34 0.751 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.579 ' HA ' ' CE2' ' A' ' 42' ' ' TYR . 1.2 pttt -53.91 -176.25 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 123.13 1.443 . . . . 0.0 113.095 174.559 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.729 HD11 ' HG3' ' A' ' 54' ' ' PRO . 0.1 OUTLIER -65.07 156.77 79.63 Favored Pre-proline 0 C--N 1.313 -1.007 0 O-C-N 121.23 -0.919 . . . . 0.0 111.313 178.324 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -72.5 175.21 10.44 Favored 'Trans proline' 0 N--CA 1.447 -1.263 0 C-N-CA 122.225 1.95 . . . . 0.0 110.556 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.52 96.44 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.481 0 O-C-N 121.651 -0.656 . . . . 0.0 110.611 176.358 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.7 90.51 2.14 Favored Glycine 0 C--O 1.226 -0.4 0 CA-C-N 116.295 -0.412 . . . . 0.0 112.168 -176.559 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.461 ' HB3' HD22 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -173.18 162.63 4.51 Favored 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 123.808 0.843 . . . . 0.0 110.583 175.876 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 48.1 m -142.56 95.64 6.43 Favored Pre-proline 0 C--O 1.234 0.248 0 O-C-N 124.961 1.413 . . . . 0.0 110.132 -177.332 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.729 ' HG3' HD11 ' A' ' 48' ' ' LEU . 19.5 Cg_endo -73.31 146.84 40.9 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.531 2.154 . . . . 0.0 110.071 -179.234 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.413 HD12 HG21 ' A' ' 121' ' ' ILE . 5.3 mt -68.18 116.81 8.95 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.531 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -178.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.12 136.88 35.11 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 177.873 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.576 ' CD2' ' HB3' ' A' ' 118' ' ' CYS . 8.7 m-85 -114.96 -53.35 2.65 Favored 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 123.752 0.821 . . . . 0.0 110.128 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 128.99 -11.46 6.2 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 123.896 0.76 . . . . 0.0 112.845 -176.16 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.405 ' HA ' ' CE ' ' A' ' 59' ' ' LYS . 0.3 OUTLIER -90.0 132.21 35.48 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-N 117.27 0.535 . . . . 0.0 110.739 176.321 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -73.32 0.78 11.05 Favored 'General case' 0 C--O 1.223 -0.297 0 O-C-N 124.875 1.36 . . . . 0.0 111.946 175.835 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.428 ' OD2' HG11 ' A' ' 116' ' ' VAL . 0.6 OUTLIER -87.28 -54.37 4.34 Favored 'General case' 0 N--CA 1.446 -0.645 0 O-C-N 120.638 -1.289 . . . . 0.0 109.004 -179.948 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.442 ' HA ' HD11 ' A' ' 80' ' ' LEU . 1.8 m -75.66 -35.17 60.48 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 124.617 1.198 . . . . 0.0 109.013 -179.146 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -59.73 -39.97 86.5 Favored 'General case' 0 C--N 1.343 0.324 0 O-C-N 124.362 1.039 . . . . 0.0 111.286 175.496 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.0 159.02 0.5 Allowed Pre-proline 0 N--CA 1.446 -0.648 0 CA-C-O 122.94 1.352 . . . . 0.0 111.536 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -70.55 133.18 23.55 Favored 'Trans proline' 0 N--CA 1.437 -1.8 0 C-N-CA 120.212 0.608 . . . . 0.0 112.573 175.395 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.476 ' HD2' ' CD2' ' A' ' 42' ' ' TYR . 22.3 Cg_endo -72.51 170.36 19.56 Favored 'Trans proline' 0 N--CA 1.446 -1.32 0 C-N-CA 125.103 3.868 . . . . 0.0 111.239 176.904 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -136.85 53.0 1.92 Allowed 'General case' 0 CA--C 1.497 -1.075 0 CA-C-O 116.835 -1.555 . . . . 0.0 108.123 -177.54 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 21.5 t-80 -75.62 167.38 22.0 Favored 'General case' 0 C--O 1.216 -0.676 0 O-C-N 123.971 0.795 . . . . 0.0 110.933 178.529 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -154.18 -166.62 2.41 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 121.383 -0.823 . . . . 0.0 111.4 176.421 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.25 70.54 10.14 Favored 'General case' 0 C--O 1.212 -0.878 0 O-C-N 120.001 -1.687 . . . . 0.0 111.81 175.733 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -177.08 -41.27 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 123.33 0.652 . . . . 0.0 109.73 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.412 ' O ' ' CE2' ' A' ' 79' ' ' TYR . . . 120.81 -76.31 0.32 Allowed Glycine 0 N--CA 1.442 -0.914 0 N-CA-C 109.839 -1.305 . . . . 0.0 109.839 -177.836 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.414 ' HB3' ' OH ' ' A' ' 79' ' ' TYR . 2.9 p-10 -124.59 61.56 1.14 Allowed 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 -175.241 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -53.31 -102.94 0.01 OUTLIER Glycine 0 CA--C 1.535 1.33 0 CA-C-O 122.533 1.074 . . . . 0.0 113.855 178.286 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.7 mttm -72.3 -105.74 0.01 OUTLIER 'General case' 0 C--O 1.221 -0.442 0 O-C-N 120.51 -1.583 . . . . 0.0 110.916 175.836 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.538 HG23 ' O ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -105.36 19.04 21.26 Favored 'General case' 0 C--N 1.322 -0.597 0 O-C-N 121.05 -1.031 . . . . 0.0 110.782 179.623 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.43 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 1.2 m-20 -30.64 99.63 0.02 OUTLIER 'General case' 0 C--O 1.208 -1.117 0 C-N-CA 125.357 1.463 . . . . 0.0 110.665 -177.406 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.452 ' CD2' ' H ' ' A' ' 78' ' ' HIS . 0.5 OUTLIER -81.76 11.71 4.61 Favored 'General case' 0 C--O 1.221 -0.41 0 O-C-N 121.072 -1.017 . . . . 0.0 111.023 -176.703 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.872 ' CE1' HD11 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -38.6 141.46 0.26 Allowed 'General case' 0 N--CA 1.426 -1.653 0 CA-C-O 122.903 1.335 . . . . 0.0 114.559 170.625 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.586 HD22 ' CG2' ' A' ' 109' ' ' ILE . 0.2 OUTLIER -77.86 157.96 29.65 Favored 'General case' 0 CA--C 1.509 -0.611 0 O-C-N 120.448 -1.407 . . . . 0.0 109.412 177.409 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.872 HD11 ' CE1' ' A' ' 79' ' ' TYR . 1.1 mt -143.95 129.43 19.01 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 178.988 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.484 ' CB ' ' CD1' ' A' ' 109' ' ' ILE . 1.1 pm0 -97.17 151.54 19.71 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-O 122.917 1.342 . . . . 0.0 111.382 178.645 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.464 ' CE1' ' HB2' ' A' ' 23' ' ' ALA . 74.4 t80 -141.42 130.75 12.61 Favored Pre-proline 0 N--CA 1.448 -0.57 0 CA-C-N 114.801 -1.09 . . . . 0.0 111.504 -178.655 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.485 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 18.1 Cg_endo -75.74 97.02 1.07 Allowed 'Trans proline' 0 N--CA 1.443 -1.468 0 C-N-CA 123.995 3.13 . . . . 0.0 109.516 -177.728 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.629 HG21 ' HA ' ' A' ' 16' ' ' ALA . 10.5 t -101.18 116.28 32.46 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 122.233 1.016 . . . . 0.0 111.06 179.533 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.429 ' CD2' ' NE2' ' A' ' 90' ' ' HIS . 57.4 m-85 -82.31 159.77 63.95 Favored Pre-proline 0 N--CA 1.445 -0.676 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.101 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -77.24 -39.36 0.59 Allowed 'Trans proline' 0 N--CA 1.444 -1.398 0 C-N-CA 122.374 2.049 . . . . 0.0 112.613 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -43.58 -31.03 0.66 Allowed 'General case' 0 N--CA 1.476 0.857 0 O-C-N 125.11 1.506 . . . . 0.0 110.773 175.754 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.18 13.63 68.26 Favored Glycine 0 N--CA 1.436 -1.337 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 176.695 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.429 ' NE2' ' CD2' ' A' ' 86' ' ' PHE . 7.7 p-80 -77.93 130.06 36.1 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -59.12 90.91 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 123.801 0.84 . . . . 0.0 109.748 175.994 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.485 ' CD2' ' HB3' ' A' ' 94' ' ' PHE . 3.8 t80 -38.51 139.71 0.38 Allowed 'General case' 0 C--O 1.217 -0.644 0 C-N-CA 124.385 1.074 . . . . 0.0 109.295 -177.473 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 8.2 ptpt -77.41 64.25 2.74 Favored 'General case' 0 C--N 1.315 -0.927 0 O-C-N 119.582 -1.949 . . . . 0.0 110.359 175.119 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.485 ' HB3' ' CD2' ' A' ' 92' ' ' TYR . 23.1 p90 -80.09 -12.89 59.63 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 123.518 0.727 . . . . 0.0 112.544 176.135 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.1 -33.13 14.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 122.313 1.054 . . . . 0.0 109.888 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.1 m -82.12 110.32 17.23 Favored 'General case' 0 CA--C 1.514 -0.439 0 O-C-N 120.73 -1.231 . . . . 0.0 109.598 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.9 pttt -58.17 -49.51 76.79 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-O 121.587 0.708 . . . . 0.0 110.096 178.122 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 99' ' ' PRO . 6.3 tttm -140.87 126.68 11.36 Favored Pre-proline 0 N--CA 1.436 -1.149 0 C-N-CA 124.313 1.045 . . . . 0.0 110.0 -176.499 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.414 ' HA ' ' HA ' ' A' ' 98' ' ' LYS . 18.1 Cg_endo -71.68 176.42 37.91 Favored 'Cis proline' 0 C--N 1.352 0.711 0 O-C-N 124.545 1.813 . . . . 0.0 110.665 -3.34 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 20.8 tttm -141.93 135.82 29.79 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.431 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -85.02 147.76 26.52 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.153 0.908 . . . . 0.0 109.396 176.616 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -43.9 152.13 0.48 Allowed Pre-proline 0 C--O 1.219 -0.539 0 C-N-CA 123.325 0.65 . . . . 0.0 112.438 176.829 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.43 ' HB3' ' CE1' ' A' ' 34' ' ' TYR . 18.2 Cg_endo -71.83 -86.59 0.0 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.46 0 C-N-CA 121.214 1.276 . . . . 0.0 110.861 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 128.96 153.46 7.98 Favored Glycine 0 CA--C 1.529 0.925 0 O-C-N 120.84 -1.163 . . . . 0.0 111.835 -176.681 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -75.63 -61.15 0.04 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.404 0 C-N-CA 122.471 2.114 . . . . 0.0 110.102 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.495 ' HB3' ' CZ ' ' A' ' 11' ' ' TYR . . . -60.87 132.0 52.48 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 109.794 -0.446 . . . . 0.0 109.794 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.422 ' HG2' ' HA ' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -146.29 146.44 30.72 Favored 'General case' 0 CA--C 1.503 -0.843 0 O-C-N 124.109 0.881 . . . . 0.0 110.864 178.683 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.575 HG23 ' CD1' ' A' ' 117' ' ' PHE . 7.6 p -79.84 119.64 29.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.512 1.133 . . . . 0.0 110.243 177.274 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.586 ' CG2' HD22 ' A' ' 80' ' ' LEU . 7.0 mm -100.6 142.14 16.19 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.964 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.103 178.908 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.553 ' O ' HD23 ' A' ' 80' ' ' LEU . 10.8 p90 -164.91 153.66 12.42 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-O 122.537 1.16 . . . . 0.0 110.278 -178.664 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.6 p -87.18 168.6 13.09 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.47 -178.62 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.563 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.4 OUTLIER -114.49 152.04 45.77 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 122.124 0.17 . . . . 0.0 111.302 177.763 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.563 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 14.3 Cg_endo -75.21 -51.56 0.16 OUTLIER 'Cis proline' 0 CA--C 1.494 -1.493 0 N-CA-C 108.48 -1.392 . . . . 0.0 108.48 -4.977 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.482 ' HB3' HG23 ' A' ' 116' ' ' VAL . 3.0 m-20 -43.28 111.12 0.24 Allowed 'General case' 0 CA--C 1.5 -0.953 0 CA-C-O 116.59 -1.672 . . . . 0.0 109.912 179.013 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.672 ' HE2' HD13 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -68.66 67.96 0.14 Allowed 'General case' 0 CA--C 1.508 -0.646 0 O-C-N 125.944 2.027 . . . . 0.0 108.495 -177.989 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.483 ' O ' HG12 ' A' ' 116' ' ' VAL . 14.6 t -73.15 72.65 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 -178.343 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.594 ' CZ ' ' HA2' ' A' ' 119' ' ' GLY . 41.5 t80 -41.72 116.61 0.81 Allowed 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 124.701 1.2 . . . . 0.0 109.22 179.384 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 118' ' ' CYS . . . . . 0.576 ' HB3' ' CD2' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -90.91 -41.55 11.09 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-O 121.637 0.732 . . . . 0.0 109.79 178.582 . . . . . . . . 3 3 . 1 . 008 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.594 ' HA2' ' CZ ' ' A' ' 117' ' ' PHE . . . 157.65 -171.65 34.83 Favored Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 111.569 -0.612 . . . . 0.0 111.569 -178.431 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.649 HG22 ' SG ' ' A' ' 134' ' ' CYS . 3.2 mp -109.71 147.06 14.37 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.983 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 -178.803 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.598 HD13 ' CZ ' ' A' ' 38' ' ' PHE . 7.0 pt -119.76 155.47 22.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 177.891 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.645 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . . . -173.99 160.49 3.51 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.572 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -90.52 89.0 7.37 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.165 -177.913 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 2.9 p -103.85 43.4 1.09 Allowed 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 123.496 0.718 . . . . 0.0 109.66 -176.98 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -105.52 -24.79 12.53 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.146 176.041 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -169.42 -65.37 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.323 0 CA-C-O 121.061 0.458 . . . . 0.0 110.534 177.601 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -155.76 -44.59 0.08 Allowed 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.929 0.891 . . . . 0.0 110.612 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -156.12 81.03 0.99 Allowed 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 124.155 0.982 . . . . 0.0 109.24 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -131.77 -107.57 1.12 Allowed Glycine 0 N--CA 1.46 0.288 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 176.556 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -94.08 129.62 40.55 Favored 'General case' 0 C--N 1.322 -0.589 0 O-C-N 121.365 -1.079 . . . . 0.0 109.416 -178.893 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -89.53 149.23 22.98 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 121.728 0.775 . . . . 0.0 111.584 176.067 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.41 166.95 29.48 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 118.736 -0.649 . . . . 0.0 109.592 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.56 HD13 ' CE2' ' A' ' 57' ' ' PHE . 10.9 tp -66.34 133.11 49.85 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 134' ' ' CYS . . . . . 0.649 ' SG ' HG22 ' A' ' 120' ' ' ILE . 71.3 m -57.83 -178.34 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 124.94 1.4 . . . . 0.0 110.34 176.249 . . . . . . . . 2 2 . 1 . 008 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.2 m -161.34 112.63 1.76 Allowed 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 -178.239 . . . . . . . . 1 1 . 1 . 008 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.41 ' CD2' HG13 ' A' ' 2' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--O 1.241 0.636 0 CA-C-O 116.106 -1.902 . . . . 0.0 113.626 172.486 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.955 0 CA-C-O 115.284 -2.293 . . . . 0.0 109.346 . . . . . . . . . 0 0 . 1 . 009 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.4 p -41.91 132.53 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 O-C-N 126.332 2.27 . . . . 0.0 109.499 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.2 m -90.05 113.31 24.99 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -178.309 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.548 ' CH2' ' CE1' ' A' ' 136' ' ' HIS . 33.1 m95 -82.61 141.06 32.84 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.038 177.779 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -130.65 138.23 49.97 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -177.142 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.729 ' SG ' ' HB3' ' A' ' 122' ' ' ALA . 0.1 OUTLIER -133.33 -77.67 0.48 Allowed 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 176.433 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -75.54 34.96 1.16 Allowed Glycine 0 CA--C 1.533 1.209 0 CA-C-O 119.606 -0.552 . . . . 0.0 113.478 -179.284 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 72.3 5.05 61.83 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-N 118.453 1.126 . . . . 0.0 113.911 -170.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.573 HD13 ' OH ' ' A' ' 11' ' ' TYR . 0.4 OUTLIER -107.48 139.29 42.21 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 -174.996 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.6 mp -94.26 129.19 41.0 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 124.256 0.973 . . . . 0.0 108.655 -174.388 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.573 ' OH ' HD13 ' A' ' 9' ' ' LEU . 77.6 m-85 -125.2 98.01 5.47 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 -170.501 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -52.77 122.81 9.85 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.805 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 29.8 tp60 -54.7 -41.49 70.32 Favored 'General case' 0 C--O 1.21 -1.022 0 C-N-CA 119.089 -1.044 . . . . 0.0 111.781 -179.04 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -48.3 -44.19 33.69 Favored 'General case' 0 C--O 1.205 -1.287 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 173.211 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.448 ' CE ' ' HA3' ' A' ' 89' ' ' GLY . 6.6 mttt -69.93 -38.14 76.13 Favored 'General case' 0 C--O 1.211 -0.96 0 CA-C-O 117.03 -1.462 . . . . 0.0 114.295 167.208 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -52.9 -41.31 64.26 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 122.484 2.402 . . . . 0.0 114.081 170.913 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -85.98 -41.57 14.76 Favored 'General case' 0 C--O 1.214 -0.797 0 O-C-N 120.554 -1.341 . . . . 0.0 109.858 175.357 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 43.4 t -72.7 -59.13 2.87 Favored 'General case' 0 C--O 1.212 -0.882 0 C-N-CA 126.627 1.971 . . . . 0.0 109.665 -175.054 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.46 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 4.4 t-20 -39.39 -39.7 0.71 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 120.107 1.321 . . . . 0.0 113.773 168.687 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.501 ' O ' ' HB3' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -79.8 -33.72 40.24 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 172.965 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -48.22 -36.46 13.89 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 126.334 1.854 . . . . 0.0 110.152 178.23 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.46 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -73.49 -45.94 50.97 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 125.119 1.368 . . . . 0.0 111.702 176.076 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.801 ' HB1' ' HG3' ' A' ' 35' ' ' PRO . . . -39.13 130.03 1.24 Allowed Pre-proline 0 CA--C 1.539 0.552 0 O-C-N 125.411 1.694 . . . . 0.0 111.871 173.861 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.637 ' HG2' HG22 ' A' ' 30' ' ' THR . 17.0 Cg_endo -72.56 129.71 15.03 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 N-CA-C 107.296 -1.848 . . . . 0.0 107.296 -176.041 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.472 HD12 ' HA ' ' A' ' 25' ' ' LEU . 3.8 tp -63.3 83.86 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 125.265 1.426 . . . . 0.0 111.693 178.635 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 179.15 144.92 0.15 Allowed 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.044 0.938 . . . . 0.0 109.456 -172.887 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.448 ' CG ' ' H ' ' A' ' 37' ' ' TRP . 1.4 t0 -86.93 118.7 26.48 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.816 0.847 . . . . 0.0 110.134 179.045 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 54.16 63.65 4.98 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 175.595 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -127.83 11.48 6.65 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 123.412 1.577 . . . . 0.0 112.499 176.818 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.637 HG22 ' HG2' ' A' ' 24' ' ' PRO . 10.0 p -118.49 150.94 38.77 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 -171.173 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -44.04 -61.41 3.09 Favored Glycine 0 CA--C 1.506 -0.472 0 CA-C-O 119.142 -0.81 . . . . 0.0 111.959 -179.043 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.415 ' CA ' ' HE2' ' A' ' 100' ' ' LYS . 58.5 m -52.39 -66.96 0.29 Allowed 'General case' 0 CA--C 1.489 -1.396 0 CA-C-O 116.325 -1.798 . . . . 0.0 111.984 175.504 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.1 p 164.2 -64.4 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.655 0 O-C-N 126.712 2.507 . . . . 0.0 110.642 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.448 ' CD1' ' HD3' ' A' ' 84' ' ' PRO . 98.1 m-85 -59.6 149.1 72.49 Favored Pre-proline 0 N--CA 1.436 -1.172 0 CA-C-N 114.403 -1.272 . . . . 0.0 113.249 -177.877 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.801 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 28.7 Cg_endo -74.29 166.23 83.17 Favored 'Cis proline' 0 N--CA 1.435 -1.951 0 C-N-CA 122.405 -1.915 . . . . 0.0 111.775 -2.446 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 27' ' ' ASP . 0.5 OUTLIER -140.94 170.78 15.1 Favored 'General case' 0 C--O 1.214 -0.787 0 O-C-N 121.105 -0.997 . . . . 0.0 110.984 -177.891 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.856 ' CH2' HG22 ' A' ' 39' ' ' THR . 18.2 t90 -66.68 148.85 51.35 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 120.812 1.642 . . . . 0.0 109.539 173.894 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.477 ' CE2' ' HB2' ' A' ' 40' ' ' ASN . 11.7 t80 -120.74 86.92 2.66 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 104.079 -2.563 . . . . 0.0 104.079 -175.371 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.856 HG22 ' CH2' ' A' ' 37' ' ' TRP . 71.6 p -41.68 -35.77 0.84 Allowed 'General case' 0 C--O 1.214 -0.792 0 CA-C-N 114.308 -1.315 . . . . 0.0 110.252 171.52 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.477 ' HB2' ' CE2' ' A' ' 38' ' ' PHE . 56.3 t30 56.04 20.36 4.29 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 120.337 1.426 . . . . 0.0 111.916 178.36 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.72 ' C ' HD23 ' A' ' 48' ' ' LEU . . . 105.3 -41.17 2.23 Favored Glycine 0 N--CA 1.43 -1.728 0 CA-C-O 115.413 -2.882 . . . . 0.0 115.459 -167.955 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.425 ' CE2' ' HD3' ' A' ' 66' ' ' PRO . 83.6 m-85 -44.52 153.85 0.15 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 120.216 2.008 . . . . 0.0 112.558 174.734 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.59 -37.51 21.06 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 176.964 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.462 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -169.1 -72.58 0.04 OUTLIER Glycine 0 C--N 1.334 0.434 0 C-N-CA 124.529 1.061 . . . . 0.0 111.374 -178.523 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -113.59 -63.73 1.41 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.223 1.009 . . . . 0.0 110.669 -178.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.45 -173.32 0.62 Allowed Glycine 0 C--N 1.339 0.714 0 CA-C-O 122.299 0.944 . . . . 0.0 111.605 178.215 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.7 mttt -58.28 -171.46 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 124.555 2.121 . . . . 0.0 112.289 175.276 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.72 HD23 ' C ' ' A' ' 41' ' ' GLY . 0.0 OUTLIER -81.25 159.31 68.01 Favored Pre-proline 0 C--N 1.311 -1.086 0 O-C-N 120.102 -1.624 . . . . 0.0 110.232 -178.788 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -70.28 161.97 44.04 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 121.357 1.371 . . . . 0.0 109.481 177.733 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.47 100.26 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.993 0.917 . . . . 0.0 110.825 176.305 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.41 83.15 1.69 Allowed Glycine 0 N--CA 1.462 0.402 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.148 -174.224 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.7 mmt-85 -165.35 165.27 19.5 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 124.542 1.137 . . . . 0.0 110.993 173.502 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 87.6 m -140.69 96.8 7.46 Favored Pre-proline 0 N--CA 1.465 0.291 0 O-C-N 124.91 1.381 . . . . 0.0 109.538 -176.836 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.505 ' HB3' HD21 ' A' ' 48' ' ' LEU . 19.5 Cg_endo -72.72 145.37 41.12 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.572 2.181 . . . . 0.0 110.291 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.3 mt -69.98 120.52 17.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.4 tmtt? -81.9 136.33 35.34 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 176.519 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -119.75 -48.7 2.36 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 123.808 0.843 . . . . 0.0 110.39 178.408 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 120.78 -2.92 11.98 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 125.053 1.311 . . . . 0.0 113.246 -175.123 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.46 134.65 39.38 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-N 118.459 1.129 . . . . 0.0 109.854 175.815 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.7 t -73.49 -2.05 20.99 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 125.427 1.704 . . . . 0.0 112.141 175.574 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -89.47 -51.42 5.55 Favored 'General case' 0 CA--C 1.509 -0.604 0 C-N-CA 124.936 1.294 . . . . 0.0 109.305 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.882 ' HA ' HD11 ' A' ' 80' ' ' LEU . 1.8 m -74.99 -35.4 62.04 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 124.5 1.125 . . . . 0.0 111.667 177.871 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -64.22 -30.24 71.31 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 124.086 0.866 . . . . 0.0 112.114 172.996 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.54 159.21 25.65 Favored Pre-proline 0 N--CA 1.449 -0.486 0 CA-C-O 121.739 0.78 . . . . 0.0 111.751 176.334 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -70.38 139.41 38.04 Favored 'Trans proline' 0 CA--C 1.546 1.12 0 C-N-CA 120.45 0.767 . . . . 0.0 113.202 174.692 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.425 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 19.7 Cg_endo -71.85 173.37 12.84 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 124.968 3.779 . . . . 0.0 111.671 178.252 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -134.99 47.92 2.32 Favored 'General case' 0 C--O 1.241 0.625 0 O-C-N 120.214 -1.554 . . . . 0.0 110.981 -177.908 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.465 ' HA ' ' OD2' ' A' ' 77' ' ' ASP . 56.5 t-80 -65.04 130.0 41.78 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 176.474 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.6 t -111.74 -93.7 0.45 Allowed 'General case' 0 N--CA 1.486 1.361 0 O-C-N 119.224 -2.173 . . . . 0.0 110.384 177.636 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.9 mptt -68.92 -175.01 0.66 Allowed 'General case' 0 C--O 1.219 -0.539 0 C-N-CA 124.93 1.292 . . . . 0.0 110.629 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -68.81 38.93 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 173.13 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.54 -105.89 0.19 Allowed Glycine 0 C--O 1.217 -0.955 0 N-CA-C 107.701 -2.159 . . . . 0.0 107.701 -177.979 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -110.2 -89.92 0.48 Allowed 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 125.928 2.775 . . . . 0.0 106.19 -175.435 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 119.62 -135.27 11.09 Favored Glycine 0 N--CA 1.448 -0.565 0 O-C-N 119.294 -2.128 . . . . 0.0 110.296 -174.932 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 72.8 mttt -66.32 -78.69 0.05 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.2 1.0 . . . . 0.0 110.017 -176.843 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.514 HG23 ' O ' ' A' ' 76' ' ' THR . 0.7 OUTLIER -128.17 31.44 5.06 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 118.454 -0.784 . . . . 0.0 111.635 178.726 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.465 ' OD2' ' HA ' ' A' ' 68' ' ' HIS . 20.3 t0 -30.51 89.33 0.0 OUTLIER 'General case' 0 C--O 1.221 -0.438 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -177.084 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -85.52 11.92 9.59 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 119.681 -1.887 . . . . 0.0 109.322 -169.898 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.486 ' CD2' ' CD1' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -49.71 170.03 0.03 OUTLIER 'General case' 0 N--CA 1.438 -1.053 0 CA-C-O 123.463 1.601 . . . . 0.0 112.316 173.378 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.882 HD11 ' HA ' ' A' ' 62' ' ' CYS . 0.5 OUTLIER -95.14 141.5 28.68 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 113.634 -1.621 . . . . 0.0 109.996 172.203 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.755 HD22 ' CZ ' ' A' ' 110' ' ' TYR . 0.2 OUTLIER -123.96 129.8 51.54 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 174.492 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.425 ' HB2' HD11 ' A' ' 109' ' ' ILE . 2.2 pm0 -91.47 164.25 13.87 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 122.689 1.233 . . . . 0.0 113.26 172.418 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.453 ' CE1' ' HB2' ' A' ' 23' ' ' ALA . 84.1 t80 -152.04 132.42 7.36 Favored Pre-proline 0 CA--C 1.533 0.321 0 O-C-N 120.319 -1.488 . . . . 0.0 112.836 179.275 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.448 ' HD3' ' CD1' ' A' ' 34' ' ' TYR . 19.3 Cg_endo -73.96 108.53 2.68 Favored 'Trans proline' 0 CA--C 1.506 -0.88 1 C-N-CA 125.498 4.132 . . . . 0.0 109.632 -176.794 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -109.03 110.12 21.32 Favored 'General case' 0 CA--C 1.509 -0.627 0 O-C-N 125.435 1.709 . . . . 0.0 109.638 -178.632 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -81.58 158.02 69.08 Favored Pre-proline 0 C--O 1.238 0.494 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.114 178.565 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -75.58 -38.21 1.45 Allowed 'Trans proline' 0 CA--C 1.507 -0.829 0 C-N-CA 122.172 1.915 . . . . 0.0 112.224 179.29 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -45.73 -30.98 1.78 Allowed 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 123.977 1.846 . . . . 0.0 110.534 177.496 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.448 ' HA3' ' CE ' ' A' ' 15' ' ' LYS . . . 84.63 -0.44 89.21 Favored Glycine 0 N--CA 1.435 -1.368 0 CA-C-N 114.733 -1.121 . . . . 0.0 112.875 179.071 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -62.7 131.14 47.94 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 175.853 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -57.08 96.41 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 170.696 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.523 ' CD2' ' HB3' ' A' ' 94' ' ' PHE . 6.1 t80 -41.65 143.88 0.45 Allowed 'General case' 0 C--O 1.217 -0.633 0 C-N-CA 123.584 0.754 . . . . 0.0 109.532 178.736 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 12.5 ptpt -75.18 61.36 1.13 Allowed 'General case' 0 C--N 1.316 -0.88 0 O-C-N 119.696 -1.877 . . . . 0.0 109.096 173.528 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.523 ' HB3' ' CD2' ' A' ' 92' ' ' TYR . 36.3 p90 -75.8 -4.1 38.75 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 115.999 -1.953 . . . . 0.0 112.061 173.838 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -105.71 -26.1 11.95 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 120.417 1.462 . . . . 0.0 111.154 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 6.0 m -102.1 106.59 17.48 Favored 'General case' 0 CA--C 1.503 -0.839 0 O-C-N 120.574 -1.329 . . . . 0.0 108.8 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.8 ptpt -70.75 -32.74 70.0 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.424 0.631 . . . . 0.0 112.3 175.152 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 99' ' ' PRO . 29.7 tttt -129.5 113.82 18.09 Favored Pre-proline 0 CA--C 1.538 0.5 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -178.477 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.431 ' HA ' ' HA ' ' A' ' 98' ' ' LYS . 18.4 Cg_endo -71.4 174.09 47.4 Favored 'Cis proline' 0 C--O 1.221 -0.331 0 C-N-CA 123.82 -1.325 . . . . 0.0 111.066 -3.798 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.415 ' HE2' ' CA ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -133.63 128.38 34.98 Favored 'General case' 0 CA--C 1.502 -0.891 0 C-N-CA 124.6 1.16 . . . . 0.0 109.694 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -98.96 134.14 42.23 Favored 'General case' 0 C--O 1.244 0.769 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 -178.434 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -43.42 132.22 3.61 Favored Pre-proline 0 CA--C 1.534 0.354 0 O-C-N 124.264 0.977 . . . . 0.0 110.615 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -68.39 -163.94 0.1 OUTLIER 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 122.761 2.307 . . . . 0.0 111.623 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -123.48 161.18 17.89 Favored Glycine 0 CA--C 1.525 0.663 0 O-C-N 121.128 -0.982 . . . . 0.0 111.992 176.651 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -73.22 -43.28 0.74 Allowed 'Trans proline' 0 N--CA 1.449 -1.122 0 C-N-CA 121.711 1.608 . . . . 0.0 109.433 177.199 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.519 ' HA ' ' HB2' ' A' ' 122' ' ' ALA . . . -80.38 134.07 35.98 Favored 'General case' 0 N--CA 1.448 -0.555 0 O-C-N 124.329 1.018 . . . . 0.0 110.849 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 4.9 mtm-85 -140.35 150.22 43.68 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.569 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.441 ' C ' HD12 ' A' ' 109' ' ' ILE . 2.6 p -89.15 118.78 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 O-C-N 124.527 1.142 . . . . 0.0 111.469 177.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.59 HG12 HD13 ' A' ' 121' ' ' ILE . 1.4 mp -107.3 118.16 54.49 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.809 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 -172.399 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.755 ' CZ ' HD22 ' A' ' 81' ' ' LEU . 5.1 p90 -138.3 151.43 47.58 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-O 122.482 1.134 . . . . 0.0 108.032 -178.32 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.6 p -84.16 160.74 20.8 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.79 -1.095 . . . . 0.0 109.709 177.925 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.519 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -107.47 155.8 38.94 Favored Pre-proline 0 CA--C 1.555 1.14 0 CA-C-O 121.515 0.674 . . . . 0.0 110.639 178.956 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.519 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 14.9 Cg_endo -74.5 -48.94 0.25 Allowed 'Cis proline' 0 CA--C 1.506 -0.878 0 C-N-CA 124.475 -1.052 . . . . 0.0 110.574 -8.407 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -49.09 107.67 0.15 Allowed 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 117.171 -1.395 . . . . 0.0 108.96 177.578 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.416 ' CG ' ' CD1' ' A' ' 110' ' ' TYR . 0.1 OUTLIER -64.02 78.38 0.03 OUTLIER 'General case' 0 CA--C 1.508 -0.673 0 C-N-CA 125.724 1.61 . . . . 0.0 108.274 -177.965 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.436 ' O ' HG12 ' A' ' 116' ' ' VAL . 18.8 t -79.6 71.97 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 104.19 -2.522 . . . . 0.0 104.19 -176.869 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 46.0 t80 -40.42 105.14 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.561 1.544 . . . . 0.0 109.036 177.588 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -82.86 -40.46 20.26 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-O 122.417 1.103 . . . . 0.0 109.204 -179.471 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.438 ' HA2' ' CH2' ' A' ' 4' ' ' TRP . . . 162.56 -148.3 15.16 Favored Glycine 0 N--CA 1.435 -1.378 0 N-CA-C 109.811 -1.315 . . . . 0.0 109.811 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.498 HG13 ' CG ' ' A' ' 4' ' ' TRP . 1.3 mm -129.57 141.98 45.09 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.382 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 -175.023 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.717 HD12 HD22 ' A' ' 131' ' ' LEU . 4.7 pt -127.96 154.77 38.93 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 -175.445 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.729 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . . . -175.79 164.02 2.89 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.397 0.617 . . . . 0.0 109.342 178.764 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.489 ' CE1' ' HG ' ' A' ' 131' ' ' LEU . 2.6 m-70 -93.55 91.8 7.27 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -177.391 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.4 p -102.68 43.64 1.06 Allowed 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 123.909 0.884 . . . . 0.0 109.196 -176.56 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 7.1 tptm -107.41 -25.01 11.62 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.577 174.316 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -169.52 -65.46 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.15 0.5 . . . . 0.0 110.06 177.26 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -152.95 -46.91 0.1 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-O 122.581 1.182 . . . . 0.0 110.648 179.399 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.55 76.03 0.66 Allowed 'General case' 0 C--O 1.221 -0.446 0 C-N-CA 125.009 1.324 . . . . 0.0 111.103 -177.195 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -123.77 -107.16 1.78 Allowed Glycine 0 N--CA 1.465 0.63 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 178.834 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -80.31 158.29 26.15 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 121.532 -0.981 . . . . 0.0 111.642 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.717 HD22 HD12 ' A' ' 121' ' ' ILE . 0.9 OUTLIER -101.24 147.84 25.81 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 121.339 -0.85 . . . . 0.0 110.342 176.839 . . . . . . . . 3 3 . 1 . 009 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -158.14 167.41 29.9 Favored 'General case' 0 CA--C 1.506 -0.739 0 C-N-CA 124.438 1.095 . . . . 0.0 109.055 -177.284 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.426 HD12 HG22 ' A' ' 121' ' ' ILE . 12.0 tp -83.45 143.93 29.93 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 124.474 1.109 . . . . 0.0 108.577 178.558 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 134' ' ' CYS . . . . . 0.415 ' SG ' HG22 ' A' ' 120' ' ' ILE . 71.5 m -65.68 -175.13 0.25 Allowed 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 122.888 1.327 . . . . 0.0 111.165 173.189 . . . . . . . . 2 2 . 1 . 009 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 18.6 p -131.78 96.33 3.92 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -177.905 . . . . . . . . 1 1 . 1 . 009 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.548 ' CE1' ' CH2' ' A' ' 4' ' ' TRP . 27.9 p-80 . . . . . 0 C--O 1.246 0.913 0 CA-C-O 115.346 -2.264 . . . . 0.0 112.86 172.697 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.935 ' HB3' ' HB3' ' A' ' 13' ' ' GLN . . . . . . . . 0 CA--C 1.514 -0.423 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 . . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.5 p -67.15 152.21 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 O-C-N 124.204 0.94 . . . . 0.0 110.791 176.546 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.862 HG21 HD23 ' A' ' 10' ' ' LEU . 1.8 m -87.36 115.45 24.78 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 123.148 0.579 . . . . 0.0 111.071 178.935 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 14.5 m95 -83.1 140.58 32.56 Favored 'General case' 0 C--O 1.213 -0.858 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 m -124.55 133.84 53.17 Favored 'General case' 0 C--N 1.309 -1.155 0 O-C-N 120.478 -1.389 . . . . 0.0 108.787 -177.993 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.618 ' HB3' ' HB3' ' A' ' 122' ' ' ALA . 3.7 m -120.79 56.89 0.99 Allowed 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 118.215 -0.898 . . . . 0.0 109.273 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 39.64 60.62 1.73 Allowed Glycine 0 C--N 1.345 1.043 0 O-C-N 124.648 1.218 . . . . 0.0 112.088 -178.533 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 178.74 -81.57 0.06 OUTLIER Glycine 0 C--N 1.334 0.467 0 N-CA-C 110.881 -0.887 . . . . 0.0 110.881 -177.96 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.9 mt -123.97 160.11 28.32 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.45 0.643 . . . . 0.0 109.827 178.602 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.862 HD23 HG21 ' A' ' 3' ' ' THR . 9.0 mp -90.47 132.78 35.47 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 -177.78 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.669 ' CZ ' ' HB3' ' A' ' 106' ' ' ALA . 65.4 m-85 -116.43 91.08 3.48 Favored 'General case' 0 N--CA 1.433 -1.279 0 C-N-CA 127.826 2.45 . . . . 0.0 109.213 -175.838 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.5 t-20 -56.01 127.02 28.42 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-O 117.52 -1.229 . . . . 0.0 108.514 179.456 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.935 ' HB3' ' HB3' ' A' ' 1' ' ' ALA . 2.1 tp60 -50.38 -50.58 51.05 Favored 'General case' 0 C--O 1.209 -1.063 0 CA-C-O 116.752 -1.594 . . . . 0.0 110.682 -179.227 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.418 ' O ' ' CB ' ' A' ' 18' ' ' SER . 11.2 t-20 -47.45 -38.48 13.66 Favored 'General case' 0 C--O 1.191 -2.011 0 O-C-N 124.633 1.208 . . . . 0.0 110.232 177.771 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.25 -51.43 24.62 Favored 'General case' 0 C--O 1.2 -1.52 0 CA-C-O 116.687 -1.625 . . . . 0.0 113.376 170.25 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.597 ' HB1' HD11 ' A' ' 120' ' ' ILE . . . -48.59 -34.63 11.91 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 121.583 1.992 . . . . 0.0 112.687 173.677 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -89.91 -44.04 10.17 Favored 'General case' 0 N--CA 1.435 -1.183 0 C-N-CA 123.659 0.784 . . . . 0.0 109.68 177.737 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.418 ' CB ' ' O ' ' A' ' 14' ' ' ASN . 30.8 t -64.58 -25.65 68.06 Favored 'General case' 0 C--O 1.205 -1.242 0 C-N-CA 126.492 1.917 . . . . 0.0 106.787 -177.438 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -73.6 -53.37 10.64 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 119.153 -2.217 . . . . 0.0 108.711 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.26 -12.47 61.17 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 122.08 0.943 . . . . 0.0 111.626 177.803 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -62.28 -50.76 70.4 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 -176.412 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -74.03 -41.28 62.05 Favored 'General case' 0 N--CA 1.443 -0.8 0 O-C-N 124.418 1.074 . . . . 0.0 110.091 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.706 ' HB2' ' CZ ' ' A' ' 83' ' ' PHE . . . -41.64 129.54 2.38 Favored Pre-proline 0 N--CA 1.445 -0.699 0 O-C-N 125.644 1.84 . . . . 0.0 111.332 178.384 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.486 ' HG2' ' CG2' ' A' ' 30' ' ' THR . 18.2 Cg_endo -73.03 126.57 11.33 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 121.923 1.748 . . . . 0.0 109.573 -177.161 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.876 HD21 ' O ' ' A' ' 113' ' ' PRO . 4.1 tp -59.79 88.65 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.434 0 O-C-N 124.143 0.902 . . . . 0.0 111.19 178.861 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -175.88 167.12 3.08 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -176.163 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -115.19 132.34 56.64 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 117.704 -1.141 . . . . 0.0 109.579 177.612 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 50.71 62.0 5.59 Favored Glycine 0 C--N 1.34 0.796 0 N-CA-C 108.254 -1.938 . . . . 0.0 108.254 172.136 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -151.55 35.68 0.57 Allowed 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 122.304 1.05 . . . . 0.0 110.685 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.486 ' CG2' ' HG2' ' A' ' 24' ' ' PRO . 9.2 p -144.23 153.06 41.67 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -175.65 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.425 ' CA ' ' HB3' ' A' ' 97' ' ' LYS . . . -36.64 -78.33 0.04 OUTLIER Glycine 0 C--N 1.34 0.776 0 O-C-N 124.307 1.005 . . . . 0.0 111.314 -178.92 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.462 ' O ' ' HE3' ' A' ' 100' ' ' LYS . 30.8 t -52.41 -61.52 2.23 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-O 117.681 -1.152 . . . . 0.0 110.669 177.921 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 162.04 -51.86 0.0 OUTLIER 'General case' 0 C--O 1.218 -0.592 0 O-C-N 125.521 1.763 . . . . 0.0 110.421 179.124 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.518 ' CD2' ' HD3' ' A' ' 84' ' ' PRO . 61.6 m-85 -61.82 151.33 79.73 Favored Pre-proline 0 N--CA 1.43 -1.474 0 CA-C-O 117.13 -1.414 . . . . 0.0 111.511 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.489 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 22.7 Cg_endo -73.76 164.41 87.48 Favored 'Cis proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.032 -2.07 . . . . 0.0 111.931 -3.453 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -140.95 162.87 34.45 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-O 116.897 -1.525 . . . . 0.0 110.6 -178.345 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.728 ' CH2' HG22 ' A' ' 39' ' ' THR . 18.2 t90 -60.69 139.26 57.93 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 124.143 0.902 . . . . 0.0 108.772 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.665 ' CE2' HG21 ' A' ' 109' ' ' ILE . 25.7 t80 -110.98 79.02 1.16 Allowed 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 -176.123 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.728 HG22 ' CH2' ' A' ' 37' ' ' TRP . 23.6 p -37.79 -34.57 0.11 Allowed 'General case' 0 C--O 1.214 -0.782 0 C-N-CA 124.265 1.026 . . . . 0.0 110.778 175.171 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.55 ' HB2' ' CD2' ' A' ' 38' ' ' PHE . 43.4 t30 57.63 19.25 5.28 Favored 'General case' 0 C--O 1.209 -1.068 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 174.688 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.805 ' C ' HD23 ' A' ' 48' ' ' LEU . . . 112.49 -46.94 1.1 Allowed Glycine 0 N--CA 1.421 -2.364 0 O-C-N 118.682 -2.511 . . . . 0.0 112.353 -171.808 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.659 ' N ' HD23 ' A' ' 48' ' ' LEU . 58.2 m-85 -49.63 144.87 5.55 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 124.285 1.034 . . . . 0.0 110.372 -177.314 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.78 -35.79 26.21 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.214 178.362 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -164.13 -100.32 0.15 Allowed Glycine 0 N--CA 1.442 -0.906 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.89 175.98 8.33 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 118.111 -0.947 . . . . 0.0 109.778 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.422 ' O ' ' HD2' ' A' ' 66' ' ' PRO . . . 38.51 -156.93 0.01 OUTLIER Glycine 0 C--N 1.349 1.264 0 CA-C-O 123.14 1.411 . . . . 0.0 112.08 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.487 ' HA ' ' CE1' ' A' ' 42' ' ' TYR . 0.8 OUTLIER -65.11 -172.17 0.09 Allowed 'General case' 0 N--CA 1.444 -0.737 0 O-C-N 120.267 -1.726 . . . . 0.0 111.727 174.869 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.88 HD22 ' HB3' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -87.93 174.76 4.84 Favored Pre-proline 0 N--CA 1.441 -0.924 0 O-C-N 120.51 -1.369 . . . . 0.0 109.109 -178.774 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -73.92 -175.7 2.26 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 122.335 2.023 . . . . 0.0 111.734 178.305 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.4 tttt -67.47 94.89 0.43 Allowed 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 121.134 -0.979 . . . . 0.0 109.751 177.57 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.47 91.3 1.73 Allowed Glycine 0 CA--C 1.5 -0.866 0 CA-C-O 118.807 -0.996 . . . . 0.0 110.885 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.88 ' HB3' HD22 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -177.11 155.94 1.22 Allowed 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 123.767 0.827 . . . . 0.0 110.58 177.661 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.1 m -141.33 98.31 6.66 Favored Pre-proline 0 C--N 1.327 -0.39 0 O-C-N 124.374 1.046 . . . . 0.0 110.763 -178.536 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -71.23 177.46 6.57 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 122.24 1.96 . . . . 0.0 112.024 179.061 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.41 ' CG2' ' HB2' ' A' ' 133' ' ' LEU . 5.4 mt -97.96 136.64 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -179.228 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 56' ' ' LYS . . . . . 0.543 ' O ' HD22 ' A' ' 133' ' ' LEU . 0.1 OUTLIER -91.43 155.25 18.59 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 177.697 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.606 ' CE2' HD13 ' A' ' 133' ' ' LEU . 9.4 m-85 -140.26 -47.72 0.44 Allowed 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 123.765 0.826 . . . . 0.0 111.046 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 119.73 -3.72 13.27 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 116.284 -0.416 . . . . 0.0 112.148 -177.852 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -95.73 134.73 38.32 Favored 'General case' 0 CA--C 1.501 -0.925 0 CA-C-O 118.096 -0.954 . . . . 0.0 108.708 -179.138 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.7 t -72.15 -5.33 34.77 Favored 'General case' 0 C--O 1.221 -0.428 0 O-C-N 124.971 1.419 . . . . 0.0 111.581 177.21 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.683 ' HB2' HG21 ' A' ' 111' ' ' THR . 0.0 OUTLIER -91.92 -51.0 5.42 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 -177.398 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.812 ' HA ' HD11 ' A' ' 80' ' ' LEU . 1.9 m -75.15 -37.52 61.32 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -178.423 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -59.91 -41.63 92.13 Favored 'General case' 0 C--N 1.343 0.305 0 CA-C-O 121.927 0.87 . . . . 0.0 109.857 176.861 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -49.41 160.69 0.53 Allowed Pre-proline 0 N--CA 1.439 -1.024 0 CA-C-O 122.672 1.225 . . . . 0.0 110.177 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -75.21 144.84 30.04 Favored 'Trans proline' 0 N--CA 1.441 -1.592 0 C-N-CA 120.99 1.126 . . . . 0.0 113.231 175.115 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.514 ' HG3' ' CD2' ' A' ' 42' ' ' TYR . 21.0 Cg_endo -75.25 168.75 23.97 Favored 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 123.584 2.856 . . . . 0.0 111.443 178.786 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.1 tptt -132.22 52.18 2.09 Favored 'General case' 0 C--O 1.207 -1.17 0 CA-C-O 117.683 -1.151 . . . . 0.0 108.899 -178.419 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.454 ' CE1' ' O ' ' A' ' 70' ' ' LYS . 49.0 t-80 -83.84 158.56 21.63 Favored 'General case' 0 C--O 1.216 -0.672 0 CA-C-N 119.048 0.84 . . . . 0.0 110.011 179.074 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -175.71 -36.23 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.6 0.76 . . . . 0.0 109.658 173.455 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 70' ' ' LYS . . . . . 0.454 ' O ' ' CE1' ' A' ' 68' ' ' HIS . 0.0 OUTLIER -81.39 -171.51 3.32 Favored 'General case' 0 C--O 1.212 -0.909 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 178.389 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -82.69 36.34 0.49 Allowed 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 122.038 0.923 . . . . 0.0 111.827 177.067 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.427 ' O ' ' CE2' ' A' ' 79' ' ' TYR . . . 159.82 -83.67 0.13 Allowed Glycine 0 N--CA 1.44 -1.06 0 O-C-N 120.009 -1.682 . . . . 0.0 111.051 -177.045 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.54 ' ND2' ' CE1' ' A' ' 79' ' ' TYR . 17.2 t-20 -143.73 75.89 1.49 Allowed 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 117.436 -1.269 . . . . 0.0 108.548 179.366 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 74' ' ' GLY . . . . . 0.414 ' CA ' ' HB2' ' A' ' 70' ' ' LYS . . . -33.52 -94.89 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 119.517 1.053 . . . . 0.0 114.719 176.168 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.2 mttm -85.16 -108.88 0.05 OUTLIER 'General case' 0 C--O 1.216 -0.685 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.436 176.795 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.605 HG23 ' O ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -101.55 21.8 13.72 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 123.892 0.877 . . . . 0.0 111.046 -179.949 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.435 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 5.6 m-20 -30.25 104.56 0.03 OUTLIER 'General case' 0 C--O 1.19 -2.035 0 C-N-CA 124.292 1.037 . . . . 0.0 111.576 -177.529 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.456 ' CD2' ' H ' ' A' ' 78' ' ' HIS . 0.5 OUTLIER -80.76 10.69 4.59 Favored 'General case' 0 C--N 1.314 -0.951 0 O-C-N 118.081 -2.887 . . . . 0.0 110.824 -177.206 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.862 ' CZ ' HD21 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -38.37 141.01 0.27 Allowed 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 115.65 1.722 . . . . 0.0 115.65 172.948 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.812 HD11 ' HA ' ' A' ' 62' ' ' CYS . 0.2 OUTLIER -76.68 158.49 30.98 Favored 'General case' 0 C--N 1.317 -0.811 0 O-C-N 120.101 -1.624 . . . . 0.0 110.237 178.291 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.862 HD21 ' CZ ' ' A' ' 79' ' ' TYR . 1.3 mt -140.31 133.75 29.98 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.3 pm0 -101.65 151.69 21.71 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-O 122.489 1.138 . . . . 0.0 108.906 -178.549 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.706 ' CZ ' ' HB2' ' A' ' 23' ' ' ALA . 7.8 t80 -141.84 132.44 12.92 Favored Pre-proline 0 N--CA 1.44 -0.969 0 O-C-N 121.33 -0.856 . . . . 0.0 111.989 -179.11 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.518 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 18.6 Cg_endo -74.47 93.74 0.92 Allowed 'Trans proline' 0 N--CA 1.449 -1.145 0 C-N-CA 123.657 2.905 . . . . 0.0 110.264 -177.933 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.3 t -93.34 119.33 32.35 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 122.437 1.113 . . . . 0.0 111.028 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.645 ' CD2' ' CE1' ' A' ' 90' ' ' HIS . 25.1 m-85 -84.43 151.83 59.82 Favored Pre-proline 0 N--CA 1.438 -1.067 0 O-C-N 121.005 -1.059 . . . . 0.0 111.029 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -78.06 -42.46 0.24 Allowed 'Trans proline' 0 CA--C 1.503 -1.073 0 C-N-CA 122.291 1.994 . . . . 0.0 112.718 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -42.9 -33.33 0.76 Allowed 'General case' 0 C--N 1.348 0.533 0 O-C-N 126.032 2.082 . . . . 0.0 110.161 176.273 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 99.92 16.34 28.56 Favored Glycine 0 N--CA 1.432 -1.6 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 178.541 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.645 ' CE1' ' CD2' ' A' ' 86' ' ' PHE . 2.0 p-80 -87.93 131.16 34.7 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.82 100.67 1.96 Allowed 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 176.18 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.483 ' O ' ' CD2' ' A' ' 94' ' ' PHE . 19.9 t80 -35.77 140.74 0.1 Allowed 'General case' 0 C--O 1.205 -1.271 0 CA-C-O 122.051 0.929 . . . . 0.0 112.172 177.473 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.406 ' CE ' ' HB2' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -77.91 61.69 2.57 Favored 'General case' 0 C--N 1.315 -0.892 0 O-C-N 119.032 -2.293 . . . . 0.0 109.418 178.648 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.483 ' CD2' ' O ' ' A' ' 92' ' ' TYR . 30.4 p90 -76.07 4.13 9.08 Favored 'General case' 0 N--CA 1.439 -1.025 0 C-N-CA 124.077 0.951 . . . . 0.0 111.832 177.016 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -104.45 -33.3 8.64 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-O 122.578 1.18 . . . . 0.0 109.242 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 14.3 m -98.54 95.79 7.53 Favored 'General case' 0 CA--C 1.506 -0.725 0 O-C-N 120.554 -1.341 . . . . 0.0 107.915 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.425 ' HB3' ' CA ' ' A' ' 31' ' ' GLY . 0.1 OUTLIER -73.48 -35.39 65.67 Favored 'General case' 0 C--O 1.22 -0.448 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 177.27 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -119.56 105.77 43.21 Favored Pre-proline 0 N--CA 1.437 -1.121 0 O-C-N 120.006 -1.684 . . . . 0.0 109.451 -179.355 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.415 ' HA ' ' HA ' ' A' ' 98' ' ' LYS . 24.1 Cg_endo -73.88 172.14 63.0 Favored 'Cis proline' 0 C--O 1.213 -0.737 0 O-C-N 124.416 1.745 . . . . 0.0 112.039 -1.84 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.462 ' HE3' ' O ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -118.2 127.32 53.64 Favored 'General case' 0 CA--C 1.511 -0.54 0 C-N-CA 123.408 0.683 . . . . 0.0 109.544 -178.798 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.406 ' HB2' ' CE ' ' A' ' 93' ' ' LYS . 9.2 tp10 -82.34 149.76 27.57 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.857 1.348 . . . . 0.0 110.218 178.927 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -51.31 139.25 26.57 Favored Pre-proline 0 N--CA 1.43 -1.448 0 CA-C-O 122.364 1.078 . . . . 0.0 112.546 172.258 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -73.61 -164.22 0.19 Allowed 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 121.689 1.593 . . . . 0.0 111.885 177.741 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -140.14 158.94 26.02 Favored Glycine 0 N--CA 1.441 -0.986 0 O-C-N 121.338 -0.851 . . . . 0.0 112.368 177.038 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -74.88 -62.56 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.471 2.114 . . . . 0.0 110.867 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.669 ' HB3' ' CZ ' ' A' ' 11' ' ' TYR . . . -67.57 133.88 50.23 Favored 'General case' 0 N--CA 1.436 -1.174 0 O-C-N 123.868 0.73 . . . . 0.0 110.488 179.017 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.42 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 0.0 OUTLIER -140.33 147.03 39.25 Favored 'General case' 0 CA--C 1.498 -1.039 0 CA-C-O 117.206 -1.378 . . . . 0.0 111.51 178.766 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.525 ' C ' HD12 ' A' ' 109' ' ' ILE . 3.2 p -83.24 120.14 33.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 C-N-CA 124.221 1.008 . . . . 0.0 110.985 177.775 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.665 HG21 ' CE2' ' A' ' 38' ' ' PHE . 1.7 mp -105.84 124.35 60.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 -175.975 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.553 ' C ' HD23 ' A' ' 80' ' ' LEU . 19.3 p90 -142.27 164.2 30.78 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-O 121.661 0.743 . . . . 0.0 111.074 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.683 HG21 ' HB2' ' A' ' 61' ' ' ASP . 1.6 p -91.88 163.67 13.95 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -177.804 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.553 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.2 OUTLIER -117.04 152.22 48.52 Favored Pre-proline 0 N--CA 1.434 -1.226 0 C-N-CA 123.292 0.637 . . . . 0.0 110.646 -179.72 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.876 ' O ' HD21 ' A' ' 25' ' ' LEU . 19.1 Cg_endo -73.48 -51.68 0.16 OUTLIER 'Cis proline' 0 CA--C 1.51 -0.717 0 C-N-CA 122.252 -1.978 . . . . 0.0 109.484 -5.441 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -41.64 111.69 0.25 Allowed 'General case' 0 N--CA 1.438 -1.064 0 CA-C-O 113.612 -3.089 . . . . 0.0 110.012 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.733 ' CE ' HD13 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -65.76 68.89 0.05 OUTLIER 'General case' 0 CA--C 1.508 -0.669 0 O-C-N 127.12 2.763 . . . . 0.0 108.562 -178.707 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.578 ' O ' HG12 ' A' ' 116' ' ' VAL . 24.2 t -74.29 64.28 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 106.028 -1.842 . . . . 0.0 106.028 -177.623 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.551 ' CZ ' ' HA2' ' A' ' 119' ' ' GLY . 2.0 t80 -36.71 124.65 0.85 Allowed 'General case' 0 N--CA 1.432 -1.347 0 O-C-N 120.61 -1.306 . . . . 0.0 108.946 178.949 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 118' ' ' CYS . . . . . 0.568 ' HB3' ' CD2' ' A' ' 57' ' ' PHE . 0.1 OUTLIER -101.41 -38.23 8.1 Favored 'General case' 0 N--CA 1.439 -1.008 0 O-C-N 123.836 0.71 . . . . 0.0 109.383 177.29 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.551 ' HA2' ' CZ ' ' A' ' 117' ' ' PHE . . . 158.68 -159.9 30.61 Favored Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 -178.602 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.634 HG22 ' SG ' ' A' ' 134' ' ' CYS . 3.4 mp -117.91 145.4 23.86 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.349 0 CA-C-O 117.383 -1.294 . . . . 0.0 107.947 -178.12 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.537 HD13 ' CE1' ' A' ' 38' ' ' PHE . 6.6 pt -110.27 158.5 10.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-N 120.959 1.708 . . . . 0.0 109.101 178.008 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.618 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . . . 177.89 159.01 0.46 Allowed 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 124.063 0.945 . . . . 0.0 109.648 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.486 ' CE1' HD21 ' A' ' 131' ' ' LEU . 0.2 OUTLIER -91.11 96.04 10.39 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -178.407 . . . . . . . . 3 3 . 1 . 010 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.2 p -103.32 43.98 1.05 Allowed 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.706 0.765 . . . . 0.0 109.027 -177.008 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.6 tptt -105.78 -24.13 12.56 Favored 'General case' 0 C--O 1.221 -0.423 0 O-C-N 121.387 -0.821 . . . . 0.0 110.831 177.312 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -175.34 -70.95 0.01 OUTLIER 'General case' 0 C--O 1.223 -0.32 0 O-C-N 124.152 0.908 . . . . 0.0 110.831 178.404 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -136.38 -55.87 0.75 Allowed 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -177.426 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -163.67 77.85 0.4 Allowed 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 121.859 0.837 . . . . 0.0 110.796 -178.191 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -112.17 -102.66 2.63 Favored Glycine 0 C--N 1.332 0.324 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -91.99 147.76 22.72 Favored 'General case' 0 CA--C 1.511 -0.546 0 O-C-N 121.251 -1.146 . . . . 0.0 110.844 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.486 HD21 ' CE1' ' A' ' 123' ' ' HIS . 17.2 mt -83.43 145.77 28.79 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 121.989 0.899 . . . . 0.0 110.975 178.007 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 11.4 ptpt -157.09 169.57 24.49 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-O 118.521 -0.752 . . . . 0.0 109.975 -177.091 . . . . . . . . 1 1 . 1 . 010 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.606 HD13 ' CE2' ' A' ' 57' ' ' PHE . 9.7 tp -83.99 139.71 32.37 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.17 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 134' ' ' CYS . . . . . 0.634 ' SG ' HG22 ' A' ' 120' ' ' ILE . 72.1 m -58.98 -174.37 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.913 0 CA-C-O 124.124 1.916 . . . . 0.0 108.594 177.389 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.38 120.85 0.96 Allowed 'General case' 0 C--N 1.314 -0.949 0 O-C-N 120.057 -1.652 . . . . 0.0 108.575 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 1.8 m80 . . . . . 0 C--O 1.253 1.255 0 CA-C-O 115.143 -2.36 . . . . 0.0 111.847 177.212 . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.7 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 . . . . . . . . . 0 0 . 1 . 011 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.446 HG11 ' HD2' ' A' ' 136' ' ' HIS . 5.2 p -169.91 131.22 0.23 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 179.088 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.811 HG23 HD23 ' A' ' 10' ' ' LEU . 0.9 OUTLIER -85.65 117.54 24.6 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.693 177.468 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.601 ' CH2' ' CE1' ' A' ' 136' ' ' HIS . 26.9 m95 -85.02 140.76 30.78 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.036 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -136.05 132.87 36.78 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -176.908 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.676 ' SG ' ' HB3' ' A' ' 122' ' ' ALA . 0.5 OUTLIER -119.05 69.39 0.81 Allowed 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.651 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 34.79 86.65 0.01 OUTLIER Glycine 0 CA--C 1.53 0.983 0 C-N-CA 124.037 0.827 . . . . 0.0 113.648 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 147.78 -74.05 0.29 Allowed Glycine 0 N--CA 1.462 0.403 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 -176.855 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.441 HD13 ' HG3' ' A' ' 87' ' ' PRO . 5.7 mt -131.16 160.18 35.53 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.243 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.811 HD23 HG23 ' A' ' 3' ' ' THR . 0.0 OUTLIER -102.27 154.74 18.76 Favored 'General case' 0 C--O 1.218 -0.597 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.442 178.116 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.638 ' CZ ' ' HB3' ' A' ' 106' ' ' ALA . 30.6 m-85 -134.59 108.84 8.28 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -178.277 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -55.89 120.2 7.02 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 177.649 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.493 ' HB2' ' CD1' ' A' ' 4' ' ' TRP . 8.4 tp-100 -54.8 -42.01 71.28 Favored 'General case' 0 CA--C 1.503 -0.846 0 C-N-CA 119.959 -0.697 . . . . 0.0 112.387 178.822 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -50.35 -26.05 4.49 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 124.029 0.831 . . . . 0.0 112.306 177.379 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.2 mttp -96.36 -34.25 11.63 Favored 'General case' 0 C--O 1.219 -0.503 0 C-N-CA 124.569 1.148 . . . . 0.0 112.49 170.957 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.02 -39.52 69.2 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 120.406 1.457 . . . . 0.0 111.851 176.31 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -87.38 -44.56 11.27 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 122.962 0.505 . . . . 0.0 110.204 175.125 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.2 t -69.21 -57.67 5.06 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 118.959 0.799 . . . . 0.0 112.292 -177.982 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.529 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 0.2 OUTLIER -44.89 -30.97 1.1 Allowed 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 170.939 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.432 ' O ' ' HB3' ' A' ' 23' ' ' ALA . 1.5 p -83.64 -33.34 25.3 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 175.56 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -47.84 -36.79 12.53 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.037 0.935 . . . . 0.0 109.919 179.561 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.529 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.1 OUTLIER -70.17 -47.96 59.36 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 124.577 1.151 . . . . 0.0 110.573 177.87 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.507 ' HB1' ' HG3' ' A' ' 35' ' ' PRO . . . -39.61 127.21 1.46 Allowed Pre-proline 0 CA--C 1.537 0.447 0 O-C-N 124.602 1.189 . . . . 0.0 110.606 176.364 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.568 ' HG2' HG22 ' A' ' 30' ' ' THR . 18.7 Cg_endo -72.79 124.69 9.9 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 121.546 1.497 . . . . 0.0 109.096 -177.774 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.726 HD21 ' O ' ' A' ' 113' ' ' PRO . 3.8 tp -60.78 94.36 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 123.542 0.737 . . . . 0.0 111.291 178.416 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 179.89 160.35 0.84 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.35 -174.949 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -99.86 116.18 31.33 Favored 'General case' 0 CA--C 1.51 -0.567 0 C-N-CA 123.826 0.85 . . . . 0.0 108.898 177.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 50.51 72.47 0.49 Allowed Glycine 0 CA--C 1.528 0.873 0 O-C-N 124.394 1.059 . . . . 0.0 112.426 176.481 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.17 22.03 1.55 Allowed 'General case' 0 N--CA 1.473 0.708 0 O-C-N 122.429 -0.453 . . . . 0.0 112.033 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.568 HG22 ' HG2' ' A' ' 24' ' ' PRO . 33.5 p -121.91 156.8 32.58 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -176.471 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -43.68 -52.01 6.63 Favored Glycine 0 C--N 1.332 0.337 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.989 -178.792 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 12.2 t -68.03 -79.48 0.05 Allowed 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 119.306 -0.378 . . . . 0.0 111.235 173.726 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 89.1 p -178.42 -59.05 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 124.803 1.241 . . . . 0.0 109.83 -178.863 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.534 ' CE1' ' HB3' ' A' ' 103' ' ' PRO . 81.6 m-85 -63.57 148.95 93.22 Favored Pre-proline 0 CA--C 1.552 1.022 0 C-N-CA 123.303 0.641 . . . . 0.0 112.375 -176.54 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.507 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 25.2 Cg_endo -74.9 169.77 73.56 Favored 'Cis proline' 0 N--CA 1.455 -0.736 0 O-C-N 123.524 1.276 . . . . 0.0 112.116 1.347 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.753 ' C ' HD23 ' A' ' 81' ' ' LEU . 1.4 p80 -142.5 169.22 17.98 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 -177.29 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.899 ' CH2' HG22 ' A' ' 39' ' ' THR . 20.5 t90 -71.65 129.22 38.16 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.399 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.517 ' CZ ' HD13 ' A' ' 121' ' ' ILE . 33.9 t80 -99.48 82.74 2.7 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 105.869 -1.901 . . . . 0.0 105.869 179.331 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.899 HG22 ' CH2' ' A' ' 37' ' ' TRP . 41.6 p -39.51 -33.5 0.17 Allowed 'General case' 0 CA--C 1.503 -0.845 0 CA-C-N 114.337 -1.301 . . . . 0.0 110.815 170.905 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.499 ' HB2' ' CE2' ' A' ' 38' ' ' PHE . 59.0 t30 55.63 20.13 3.7 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 123.558 1.646 . . . . 0.0 112.125 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.464 ' C ' HD23 ' A' ' 48' ' ' LEU . . . 110.08 -44.52 1.48 Allowed Glycine 0 N--CA 1.436 -1.331 0 CA-C-O 116.039 -2.534 . . . . 0.0 113.661 -170.959 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.518 ' CE2' ' HD3' ' A' ' 66' ' ' PRO . 76.9 m-85 -45.94 150.99 0.5 Allowed 'General case' 0 C--N 1.343 0.296 0 C-N-CA 125.779 1.631 . . . . 0.0 110.666 -178.728 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.4 -37.73 27.67 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.049 178.052 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.436 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -164.29 -77.66 0.03 OUTLIER Glycine 0 C--N 1.335 0.503 0 N-CA-C 111.189 -0.765 . . . . 0.0 111.189 -178.38 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -113.22 -62.78 1.54 Allowed 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 123.289 0.636 . . . . 0.0 111.377 -178.303 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.6 -169.85 0.11 Allowed Glycine 0 C--N 1.342 0.892 0 C-N-CA 124.408 1.004 . . . . 0.0 111.135 177.809 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.9 mtpt -59.53 -169.49 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 123.279 1.514 . . . . 0.0 111.701 176.728 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.631 ' H ' HD12 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -93.18 176.58 2.44 Favored Pre-proline 0 C--N 1.318 -0.783 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.309 -178.091 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -70.83 158.85 54.43 Favored 'Trans proline' 0 N--CA 1.444 -1.386 0 O-C-N 123.807 1.425 . . . . 0.0 110.967 178.276 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.4 ttpp -64.71 97.23 0.21 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.263 176.39 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 119.19 40.12 0.65 Allowed Glycine 0 N--CA 1.464 0.509 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.853 -177.208 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.451 ' NE ' ' HA2' ' A' ' 41' ' ' GLY . 0.2 OUTLIER -122.07 159.79 26.34 Favored 'General case' 0 CA--C 1.513 -0.471 0 C-N-CA 122.837 0.455 . . . . 0.0 110.703 175.761 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 53.3 m -136.03 98.9 11.42 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.621 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -72.37 179.19 5.28 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.668 2.245 . . . . 0.0 111.275 177.191 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.8 mt -107.17 140.48 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -95.89 146.45 24.57 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 121.533 0.682 . . . . 0.0 109.621 176.669 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.568 ' CD1' ' HB3' ' A' ' 118' ' ' CYS . 24.0 m-85 -128.59 -50.14 1.27 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.263 1.025 . . . . 0.0 110.77 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 117.28 -3.18 18.57 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 123.742 0.687 . . . . 0.0 112.657 -175.135 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.98 133.33 42.6 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-N 117.759 0.779 . . . . 0.0 109.818 177.381 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 46.3 t -69.4 -6.09 27.79 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 124.749 1.281 . . . . 0.0 111.551 176.773 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.48 -57.16 2.98 Favored 'General case' 0 CA--C 1.517 -0.318 0 O-C-N 120.651 -1.28 . . . . 0.0 109.367 -178.58 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.502 ' SG ' HD21 ' A' ' 80' ' ' LEU . 2.1 t -68.9 -25.91 64.83 Favored 'General case' 0 N--CA 1.457 -0.107 0 O-C-N 124.492 1.12 . . . . 0.0 110.806 176.522 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -70.86 -38.45 73.14 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.367 0.603 . . . . 0.0 110.618 174.576 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.408 ' HD2' ' ND1' ' A' ' 78' ' ' HIS . 0.0 OUTLIER -55.44 158.16 6.05 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-O 122.163 0.982 . . . . 0.0 111.745 179.787 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -70.78 140.85 39.74 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 120.309 0.673 . . . . 0.0 113.029 175.751 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.518 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 19.3 Cg_endo -71.77 172.26 14.83 Favored 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 122.73 2.287 . . . . 0.0 111.514 177.896 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -134.18 54.67 1.93 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.899 178.721 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.441 ' CE1' ' O ' ' A' ' 69' ' ' SER . 49.9 t-80 -77.95 156.44 30.24 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 121.669 0.747 . . . . 0.0 110.249 -178.804 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.441 ' O ' ' CE1' ' A' ' 68' ' ' HIS . 0.2 OUTLIER -142.95 -166.02 2.2 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 121.251 -0.906 . . . . 0.0 110.568 179.047 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.6 72.51 10.3 Favored 'General case' 0 C--O 1.219 -0.535 0 O-C-N 121.894 -0.504 . . . . 0.0 110.647 176.619 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -178.58 -41.37 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.61 0.719 . . . . 0.0 110.563 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.409 ' O ' ' CE2' ' A' ' 79' ' ' TYR . . . 118.73 -48.18 0.96 Allowed Glycine 0 CA--C 1.499 -0.948 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.206 -177.149 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 6.9 t30 -147.56 85.17 1.57 Allowed 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 179.083 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -71.07 -119.35 0.05 OUTLIER Glycine 0 CA--C 1.529 0.909 0 CA-C-O 122.036 0.798 . . . . 0.0 111.807 177.119 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -52.79 -87.77 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.675 0 O-C-N 121.066 -1.255 . . . . 0.0 112.717 178.211 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.531 HG23 ' O ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -123.54 19.05 9.63 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.014 177.623 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.496 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 6.5 m-20 -32.18 105.18 0.03 OUTLIER 'General case' 0 CA--C 1.504 -0.815 0 C-N-CA 124.898 1.279 . . . . 0.0 109.15 -176.123 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.503 ' CD2' ' H ' ' A' ' 78' ' ' HIS . 3.2 p80 -88.42 18.43 4.51 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -175.987 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.964 ' CZ ' HD11 ' A' ' 81' ' ' LEU . 0.4 OUTLIER -40.15 135.25 1.42 Allowed 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 125.419 1.488 . . . . 0.0 110.948 173.804 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.687 HD23 ' C ' ' A' ' 110' ' ' TYR . 0.4 OUTLIER -75.45 155.37 36.34 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.851 176.113 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.964 HD11 ' CZ ' ' A' ' 79' ' ' TYR . 1.7 mp -140.69 150.49 43.54 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.883 0.373 . . . . 0.0 110.147 176.484 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.485 ' CB ' ' CD1' ' A' ' 109' ' ' ILE . 0.4 OUTLIER -115.76 157.53 24.2 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 122.009 0.909 . . . . 0.0 110.627 -179.699 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.493 ' HB3' HG12 ' A' ' 108' ' ' VAL . 30.3 t80 -139.99 133.76 15.46 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-O 118.698 -0.668 . . . . 0.0 112.204 -178.452 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.555 ' HA ' ' HG2' ' A' ' 107' ' ' ARG . 17.8 Cg_endo -70.03 87.71 0.58 Allowed 'Trans proline' 0 CA--C 1.505 -0.956 0 C-N-CA 123.937 3.091 . . . . 0.0 110.72 -174.706 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.64 HG22 ' HA ' ' A' ' 107' ' ' ARG . 2.7 t -83.5 129.02 34.96 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 124.237 0.961 . . . . 0.0 110.902 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.648 ' CD1' ' CD1' ' A' ' 92' ' ' TYR . 4.6 m-85 -96.54 152.34 38.55 Favored Pre-proline 0 C--O 1.237 0.395 0 C-N-CA 122.796 0.439 . . . . 0.0 110.203 -178.95 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 87' ' ' PRO . . . . . 0.441 ' HG3' HD13 ' A' ' 9' ' ' LEU . 18.8 Cg_endo -73.07 -47.74 0.31 Allowed 'Trans proline' 0 N--CA 1.447 -1.213 0 O-C-N 124.047 1.551 . . . . 0.0 112.266 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -42.74 -41.08 3.05 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 123.07 1.414 . . . . 0.0 110.278 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 94.85 18.0 36.17 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.146 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.437 ' O ' ' CE1' ' A' ' 92' ' ' TYR . 1.5 p80 -86.69 147.48 25.86 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-N 118.061 0.931 . . . . 0.0 109.601 176.526 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -63.92 139.82 58.81 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 118.642 0.655 . . . . 0.0 111.902 174.525 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.648 ' CD1' ' CD1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -96.18 146.97 24.23 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -174.608 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.21 69.05 9.85 Favored 'General case' 0 C--N 1.32 -0.696 0 O-C-N 121.371 -0.83 . . . . 0.0 110.08 175.478 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.441 ' CD2' ' HZ ' ' A' ' 83' ' ' PHE . 25.7 p90 -83.55 -23.58 31.96 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.113 177.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -91.17 -23.74 20.15 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 123.012 1.387 . . . . 0.0 110.924 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.15 108.9 18.53 Favored 'General case' 0 CA--C 1.517 -0.325 0 O-C-N 120.61 -1.306 . . . . 0.0 108.575 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.97 -48.2 82.69 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 121.609 0.719 . . . . 0.0 111.067 178.602 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 99' ' ' PRO . 0.3 OUTLIER -139.03 128.39 14.24 Favored Pre-proline 0 CA--C 1.543 0.7 0 CA-C-N 114.508 -1.223 . . . . 0.0 110.233 -178.995 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.438 ' HA ' ' HA ' ' A' ' 98' ' ' LYS . 25.9 Cg_endo -69.78 176.3 33.19 Favored 'Cis proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.789 -1.754 . . . . 0.0 111.527 -5.126 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -140.72 122.83 15.68 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 124.005 0.922 . . . . 0.0 109.092 178.803 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -87.6 162.32 17.22 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 125.47 1.731 . . . . 0.0 110.006 178.17 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -50.53 154.49 2.22 Favored Pre-proline 0 C--O 1.222 -0.382 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.116 177.646 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.534 ' HB3' ' CE1' ' A' ' 34' ' ' TYR . 20.5 Cg_endo -73.7 -87.39 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 121.096 1.197 . . . . 0.0 111.912 178.227 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 148.7 159.9 8.78 Favored Glycine 0 CA--C 1.524 0.654 0 O-C-N 121.146 -0.971 . . . . 0.0 110.905 -178.815 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -76.64 -73.17 0.01 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.725 2.284 . . . . 0.0 110.949 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.638 ' HB3' ' CZ ' ' A' ' 11' ' ' TYR . . . -62.26 151.42 36.39 Favored 'General case' 0 N--CA 1.442 -0.865 0 O-C-N 123.915 0.759 . . . . 0.0 110.105 178.969 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.64 ' HA ' HG22 ' A' ' 85' ' ' THR . 7.8 mtm-85 -152.7 142.74 22.27 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.983 -178.769 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.493 HG12 ' HB3' ' A' ' 83' ' ' PHE . 4.8 p -82.09 124.61 39.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 O-C-N 124.207 0.942 . . . . 0.0 109.477 178.725 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.616 ' CG2' HD22 ' A' ' 80' ' ' LEU . 6.1 mm -104.65 142.0 18.92 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.722 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.87 -179.444 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.687 ' C ' HD23 ' A' ' 80' ' ' LEU . 9.6 p90 -163.73 147.71 10.3 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 122.271 1.034 . . . . 0.0 111.711 -178.386 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 9.6 p -83.6 169.74 15.07 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.388 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.588 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.6 OUTLIER -111.37 154.61 43.65 Favored Pre-proline 0 CA--C 1.552 1.035 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.295 177.812 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.726 ' O ' HD21 ' A' ' 25' ' ' LEU . 18.8 Cg_endo -73.65 -56.92 0.14 OUTLIER 'Cis proline' 0 CA--C 1.504 -1.012 0 C-N-CA 123.724 -1.365 . . . . 0.0 110.466 -6.746 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.512 ' O ' HG23 ' A' ' 116' ' ' VAL . 1.1 m-20 -43.79 116.62 1.0 Allowed 'General case' 0 N--CA 1.448 -0.551 0 O-C-N 123.812 0.695 . . . . 0.0 109.352 178.233 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.561 ' HE2' HD22 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -65.39 79.67 0.06 Allowed 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -179.001 . . . . . . . . 3 3 . 1 . 011 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 114' ' ' ASN . 91.7 t -73.63 75.95 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 -177.039 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.436 ' CZ ' ' NE2' ' A' ' 13' ' ' GLN . 40.4 t80 -37.91 103.91 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 125.808 1.643 . . . . 0.0 109.432 -179.199 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 118' ' ' CYS . . . . . 0.568 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 10.9 m -83.25 -44.61 14.78 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -178.188 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 157.12 -147.71 16.36 Favored Glycine 0 N--CA 1.442 -0.906 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.49 HG13 ' CG ' ' A' ' 4' ' ' TRP . 1.2 mm -127.88 140.45 49.11 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.803 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -176.889 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.93 HG22 HD12 ' A' ' 133' ' ' LEU . 8.9 pt -129.05 155.24 40.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -177.952 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.676 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . . . -174.91 153.21 1.65 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 122.407 1.098 . . . . 0.0 109.255 178.242 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.649 ' CE1' HD13 ' A' ' 131' ' ' LEU . 2.1 m80 -90.57 92.46 8.86 Favored 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -177.743 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.597 HG22 ' HD2' ' A' ' 132' ' ' LYS . 2.0 t -97.55 43.32 1.07 Allowed 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 122.661 1.22 . . . . 0.0 110.829 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 7.5 ttpt -104.89 -27.42 11.73 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.534 178.413 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -172.09 -65.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 O-C-N 124.281 0.988 . . . . 0.0 110.683 179.37 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 24.1 t30 -153.95 -47.56 0.09 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-O 122.354 1.074 . . . . 0.0 109.864 178.991 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.4 76.23 0.82 Allowed 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.539 -177.974 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -125.39 -106.21 1.57 Allowed Glycine 0 CA--C 1.519 0.328 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 179.054 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -81.94 143.41 31.66 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 122.084 -0.656 . . . . 0.0 110.727 -179.301 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.649 HD13 ' CE1' ' A' ' 123' ' ' HIS . 5.2 tp -100.0 139.29 35.88 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 120.861 0.362 . . . . 0.0 110.503 177.999 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.597 ' HD2' HG22 ' A' ' 124' ' ' THR . 4.2 ptpt -148.04 169.75 19.27 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.93 HD12 HG22 ' A' ' 121' ' ' ILE . 4.0 tp -84.14 148.14 26.95 Favored 'General case' 0 C--O 1.235 0.296 0 O-C-N 124.31 1.007 . . . . 0.0 109.167 178.286 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 134' ' ' CYS . . . . . 0.459 ' SG ' HG22 ' A' ' 120' ' ' ILE . 72.2 m -67.26 -174.54 0.38 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 122.316 1.055 . . . . 0.0 109.95 175.131 . . . . . . . . 2 2 . 1 . 011 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 15.2 m -129.04 95.29 4.03 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -177.971 . . . . . . . . 1 1 . 1 . 011 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.601 ' CE1' ' CH2' ' A' ' 4' ' ' TRP . 24.5 p-80 . . . . . 0 C--N 1.328 -0.337 0 O-C-N 123.711 0.632 . . . . 0.0 110.928 176.814 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.799 0 CA-C-O 116.48 -1.724 . . . . 0.0 107.786 . . . . . . . . . 0 0 . 1 . 012 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.0 p -40.25 119.87 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 O-C-N 125.439 1.712 . . . . 0.0 110.791 178.637 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.45 ' CG2' ' HB3' ' A' ' 10' ' ' LEU . 3.7 m -86.71 111.56 20.81 Favored 'General case' 0 CA--C 1.505 -0.782 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -176.283 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 24.8 m95 -77.29 142.7 39.32 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 123.247 0.619 . . . . 0.0 110.011 178.114 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -140.01 135.82 33.08 Favored 'General case' 0 CA--C 1.496 -1.114 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -179.007 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.665 ' SG ' ' HB3' ' A' ' 122' ' ' ALA . 0.8 OUTLIER -116.24 60.76 0.72 Allowed 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.594 177.114 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 39.22 72.27 0.22 Allowed Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.018 0.824 . . . . 0.0 112.688 -178.346 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 168.38 -77.46 0.11 Allowed Glycine 0 C--O 1.224 -0.49 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 -177.206 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 16.9 mt -126.17 162.43 25.4 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 121.749 0.785 . . . . 0.0 109.908 178.177 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.617 HD22 ' H ' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -89.91 165.23 14.21 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.086 -177.242 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -156.1 82.95 1.0 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 -171.362 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -53.46 125.76 19.1 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.324 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.421 ' NE2' ' HB3' ' A' ' 16' ' ' ALA . 30.7 tp60 -59.43 -21.4 59.96 Favored 'General case' 0 C--O 1.217 -0.656 0 C-N-CA 118.996 -1.081 . . . . 0.0 113.776 176.528 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -63.16 -24.67 67.99 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 172.81 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.401 ' O ' ' HB2' ' A' ' 19' ' ' ASN . 6.8 mttp -101.53 -30.46 11.38 Favored 'General case' 0 C--O 1.201 -1.467 0 CA-C-O 114.038 -2.887 . . . . 0.0 111.023 174.998 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.421 ' HB3' ' NE2' ' A' ' 13' ' ' GLN . . . -54.42 -66.0 0.48 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 122.212 2.278 . . . . 0.0 112.204 176.477 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 26.4 pt-20 -61.27 -44.98 96.35 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-O 117.88 -1.057 . . . . 0.0 109.449 176.683 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 46.0 t -57.54 -47.86 80.88 Favored 'General case' 0 C--O 1.212 -0.909 0 CA-C-N 119.801 1.182 . . . . 0.0 109.003 -176.437 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.463 ' OD1' ' HA ' ' A' ' 85' ' ' THR . 5.0 t-20 -47.7 -37.1 12.36 Favored 'General case' 0 N--CA 1.442 -0.834 0 O-C-N 121.064 -1.023 . . . . 0.0 112.302 174.333 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.99 -29.46 39.49 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 172.736 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -53.19 -39.91 64.01 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 125.696 1.598 . . . . 0.0 110.539 176.403 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.447 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -82.16 -49.92 9.6 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-O 117.733 -1.127 . . . . 0.0 110.232 178.922 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.645 ' HB2' ' CZ ' ' A' ' 83' ' ' PHE . . . -42.15 136.63 2.23 Favored Pre-proline 0 N--CA 1.448 -0.57 0 O-C-N 125.504 1.753 . . . . 0.0 112.446 177.511 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.655 ' HG2' HG22 ' A' ' 30' ' ' THR . 19.1 Cg_endo -73.01 123.3 8.78 Favored 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 121.722 1.615 . . . . 0.0 109.228 -176.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.665 HD13 ' HE2' ' A' ' 115' ' ' LYS . 7.0 tp -59.62 103.07 0.17 Allowed 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.853 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.644 ' O ' HD22 ' A' ' 81' ' ' LEU . 0.3 OUTLIER -179.83 176.96 0.72 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.803 0.811 . . . . 0.0 110.5 -175.577 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.49 ' HB2' ' CE1' ' A' ' 79' ' ' TYR . 1.3 t0 -110.94 83.87 1.83 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.38 81.18 0.26 Allowed Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 173.547 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -149.47 40.3 0.84 Allowed 'General case' 0 CA--C 1.509 -0.62 0 O-C-N 121.852 -0.793 . . . . 0.0 111.972 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.655 HG22 ' HG2' ' A' ' 24' ' ' PRO . 17.7 p -128.2 152.22 48.32 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 -175.01 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -42.45 -49.25 5.76 Favored Glycine 0 C--N 1.334 0.47 0 CA-C-O 119.629 -0.539 . . . . 0.0 112.562 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.81 -78.31 0.06 Allowed 'General case' 0 N--CA 1.452 -0.357 0 O-C-N 123.792 0.348 . . . . 0.0 111.478 174.014 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 79.3 p -177.06 -65.77 0.01 OUTLIER 'General case' 0 C--O 1.22 -0.466 0 C-N-CA 125.121 1.368 . . . . 0.0 110.161 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.421 ' HA ' ' C ' ' A' ' 35' ' ' PRO . 90.7 m-85 -63.3 150.9 88.35 Favored Pre-proline 0 N--CA 1.43 -1.46 0 C-N-CA 125.498 1.519 . . . . 0.0 111.95 -176.771 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.989 ' HB2' HD13 ' A' ' 81' ' ' LEU . 17.2 Cg_endo -75.98 160.31 95.86 Favored 'Cis proline' 0 N--CA 1.449 -1.108 0 C-N-CA 122.621 -1.824 . . . . 0.0 110.957 2.244 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -135.75 166.12 24.0 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 118.197 -0.906 . . . . 0.0 109.181 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.933 ' CH2' HG22 ' A' ' 39' ' ' THR . 21.8 t90 -62.66 152.09 36.34 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 175.882 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.497 ' CZ ' HD13 ' A' ' 121' ' ' ILE . 18.5 t80 -128.78 78.27 1.84 Allowed 'General case' 0 N--CA 1.425 -1.7 0 N-CA-C 105.169 -2.16 . . . . 0.0 105.169 -173.204 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.933 HG22 ' CH2' ' A' ' 37' ' ' TRP . 73.1 p -39.24 -35.68 0.27 Allowed 'General case' 0 C--O 1.212 -0.899 0 C-N-CA 124.25 1.02 . . . . 0.0 110.179 173.3 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.425 ' HB2' ' CD2' ' A' ' 38' ' ' PHE . 44.6 t30 57.04 19.6 4.81 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 123.306 1.527 . . . . 0.0 110.023 176.929 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.655 ' C ' HD23 ' A' ' 48' ' ' LEU . . . 107.68 -40.8 2.39 Favored Glycine 0 N--CA 1.428 -1.846 0 CA-C-O 116.194 -2.448 . . . . 0.0 115.208 -169.457 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.496 ' CE2' ' HD3' ' A' ' 66' ' ' PRO . 77.0 m-85 -45.85 153.75 0.27 Allowed 'General case' 0 C--N 1.339 0.145 0 CA-C-N 119.385 1.592 . . . . 0.0 112.18 176.338 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.98 -36.38 27.95 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.764 0.792 . . . . 0.0 111.496 177.909 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.531 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -175.18 -63.6 0.05 OUTLIER Glycine 0 C--N 1.337 0.595 0 C-N-CA 124.513 1.054 . . . . 0.0 111.337 -178.584 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -117.88 -68.15 0.94 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.373 0.606 . . . . 0.0 111.277 -179.075 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.13 -173.86 0.25 Allowed Glycine 0 C--N 1.341 0.839 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 178.764 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.526 ' HD2' HD12 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -55.97 -174.04 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 124.874 2.273 . . . . 0.0 113.336 174.108 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.655 HD23 ' C ' ' A' ' 41' ' ' GLY . 0.0 OUTLIER -80.6 163.58 55.73 Favored Pre-proline 0 C--N 1.313 -1.016 0 O-C-N 119.837 -1.789 . . . . 0.0 110.723 -179.66 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -71.18 160.14 49.95 Favored 'Trans proline' 0 N--CA 1.446 -1.27 0 C-N-CA 122.06 1.84 . . . . 0.0 109.764 178.38 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.5 ttpt -50.95 99.04 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.987 0.915 . . . . 0.0 110.324 177.082 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.92 85.64 1.86 Allowed Glycine 0 C--O 1.227 -0.316 0 CA-C-N 116.387 -0.37 . . . . 0.0 112.652 -174.569 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.02 165.21 18.09 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 124.205 1.002 . . . . 0.0 111.361 174.82 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 93.5 m -138.46 96.05 9.93 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.023 -177.944 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.53 ' HB3' HD21 ' A' ' 48' ' ' LEU . 18.4 Cg_endo -72.49 145.6 42.72 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 122.355 2.036 . . . . 0.0 110.672 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.484 HD12 HG21 ' A' ' 121' ' ' ILE . 7.1 mt -73.94 119.74 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -179.258 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.6 tppt? -81.5 135.36 35.6 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 177.819 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.58 ' CD1' ' HB3' ' A' ' 118' ' ' CYS . 28.6 m-85 -113.55 -52.09 2.77 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.276 1.031 . . . . 0.0 110.587 179.119 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 121.16 -3.1 11.5 Favored Glycine 0 C--O 1.223 -0.554 0 C-N-CA 123.642 0.639 . . . . 0.0 112.85 -175.07 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 16.2 mttt -101.87 130.37 48.33 Favored 'General case' 0 CA--C 1.502 -0.903 0 CA-C-N 118.173 0.987 . . . . 0.0 109.26 177.169 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 28.1 t -63.55 -12.2 30.61 Favored 'General case' 0 C--O 1.223 -0.307 0 O-C-N 124.665 1.228 . . . . 0.0 111.581 175.292 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -86.99 -47.79 8.66 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.867 1.267 . . . . 0.0 110.615 178.697 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 71.6 m -74.68 -10.59 59.68 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 123.967 0.792 . . . . 0.0 112.731 173.984 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -93.24 -40.12 10.61 Favored 'General case' 0 CA--C 1.507 -0.674 0 C-N-CA 124.795 1.238 . . . . 0.0 110.151 176.513 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.48 158.77 0.58 Allowed Pre-proline 0 CA--C 1.539 0.53 0 CA-C-O 121.827 0.822 . . . . 0.0 111.825 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -70.76 132.94 22.69 Favored 'Trans proline' 0 N--CA 1.442 -1.534 0 C-N-CA 120.823 1.015 . . . . 0.0 113.336 174.802 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.496 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 17.8 Cg_endo -71.45 170.78 17.61 Favored 'Trans proline' 0 N--CA 1.446 -1.301 0 C-N-CA 123.404 2.736 . . . . 0.0 111.057 178.709 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.8 tptt -124.46 53.0 1.47 Allowed 'General case' 0 C--O 1.205 -1.243 0 O-C-N 121.417 -0.802 . . . . 0.0 108.954 178.061 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.475 ' CD2' ' CG ' ' A' ' 37' ' ' TRP . 52.3 t-80 -78.89 161.0 27.03 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 119.333 -2.104 . . . . 0.0 111.744 178.869 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -171.78 -163.93 0.29 Allowed 'General case' 0 CA--C 1.504 -0.812 0 O-C-N 117.813 -3.054 . . . . 0.0 109.396 175.292 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.31 53.66 0.14 Allowed 'General case' 0 C--O 1.215 -0.723 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 172.164 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 71' ' ' ASP . . . . . 0.402 ' O ' ' C ' ' A' ' 72' ' ' GLY . 3.5 m-20 -177.49 74.48 0.02 OUTLIER 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 -178.634 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.424 ' O ' ' CE2' ' A' ' 79' ' ' TYR . . . -11.68 -70.27 0.01 OUTLIER Glycine 0 C--O 1.219 -0.79 0 C-N-CA 125.175 1.369 . . . . 0.0 114.305 178.827 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 18.3 t30 -121.96 78.61 1.49 Allowed 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 124.924 1.29 . . . . 0.0 112.68 165.192 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.13 -98.8 0.04 OUTLIER Glycine 0 CA--C 1.521 0.436 0 CA-C-O 122.74 1.189 . . . . 0.0 111.546 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.0 mttt -72.12 -102.57 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.38 0 CA-C-O 122.827 1.299 . . . . 0.0 111.059 176.779 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.496 HG23 ' O ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -112.29 14.75 20.51 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 121.104 -0.997 . . . . 0.0 110.844 178.87 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -31.72 100.21 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.561 0 C-N-CA 124.514 1.126 . . . . 0.0 112.202 -178.04 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.433 ' CD2' ' H ' ' A' ' 78' ' ' HIS . 6.1 p80 -87.7 45.45 1.28 Allowed 'General case' 0 CA--C 1.516 -0.329 0 O-C-N 119.942 -1.724 . . . . 0.0 108.174 -172.388 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.49 ' CE1' ' HB2' ' A' ' 27' ' ' ASP . 40.7 p90 -71.07 135.52 47.78 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 124.42 1.088 . . . . 0.0 110.398 -178.922 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.464 ' HG ' HG22 ' A' ' 111' ' ' THR . 0.3 OUTLIER -71.5 138.2 48.75 Favored 'General case' 0 C--O 1.218 -0.57 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 176.327 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.989 HD13 ' HB2' ' A' ' 35' ' ' PRO . 0.4 OUTLIER -130.54 141.92 50.47 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 176.432 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -104.03 167.69 9.6 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-O 121.974 0.893 . . . . 0.0 112.628 174.563 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.645 ' CZ ' ' HB2' ' A' ' 23' ' ' ALA . 31.9 t80 -154.31 139.33 11.83 Favored Pre-proline 0 C--O 1.225 -0.209 0 O-C-N 120.974 -1.079 . . . . 0.0 113.368 178.636 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.519 ' HD2' ' CD1' ' A' ' 83' ' ' PHE . 19.3 Cg_endo -74.49 94.89 0.92 Allowed 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 124.346 3.364 . . . . 0.0 110.832 -175.321 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.463 ' HA ' ' OD1' ' A' ' 19' ' ' ASN . 6.3 t -98.86 105.24 17.37 Favored 'General case' 0 CA--C 1.508 -0.64 0 O-C-N 124.879 1.362 . . . . 0.0 112.577 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.526 ' CE1' ' CD1' ' A' ' 92' ' ' TYR . 56.4 m-85 -82.35 159.55 64.38 Favored Pre-proline 0 N--CA 1.446 -0.632 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.321 -179.414 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -76.55 -36.28 1.75 Allowed 'Trans proline' 0 CA--C 1.498 -1.309 0 C-N-CA 122.283 1.989 . . . . 0.0 112.973 178.438 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 88' ' ' ASP . . . . . 0.42 ' HB2' ' CD2' ' A' ' 90' ' ' HIS . 2.5 m-20 -45.87 -31.14 1.98 Allowed 'General case' 0 N--CA 1.468 0.439 0 O-C-N 125.016 1.448 . . . . 0.0 110.406 176.974 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.15 17.69 68.87 Favored Glycine 0 N--CA 1.438 -1.193 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 177.374 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.42 ' CD2' ' HB2' ' A' ' 88' ' ' ASP . 4.3 p80 -82.66 140.99 32.83 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 178.399 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -72.33 85.63 1.09 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 175.369 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.526 ' CD1' ' CE1' ' A' ' 86' ' ' PHE . 70.8 t80 -40.82 151.91 0.05 Allowed 'General case' 0 C--O 1.22 -0.472 0 CA-C-O 122.655 1.217 . . . . 0.0 111.57 -179.357 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.71 64.99 5.69 Favored 'General case' 0 C--N 1.314 -0.972 0 O-C-N 119.153 -2.217 . . . . 0.0 110.541 177.211 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.477 ' CD2' ' HZ ' ' A' ' 83' ' ' PHE . 33.2 p90 -82.2 -12.27 58.21 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 118.17 -0.919 . . . . 0.0 110.732 178.678 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -97.88 -30.91 12.48 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 123.782 1.753 . . . . 0.0 110.485 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 69.2 m -80.3 108.92 14.31 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 119.662 -1.899 . . . . 0.0 109.492 178.917 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.25 -48.56 80.04 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.611 0.72 . . . . 0.0 111.135 178.231 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -137.81 125.25 13.81 Favored Pre-proline 0 N--CA 1.438 -1.058 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.105 -175.729 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.432 ' HA ' ' HA ' ' A' ' 98' ' ' LYS . 25.3 Cg_endo -71.75 175.02 44.07 Favored 'Cis proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.819 -1.742 . . . . 0.0 110.84 -3.471 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.85 130.12 31.29 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 123.919 0.888 . . . . 0.0 109.49 178.409 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.465 ' HB3' ' CE1' ' A' ' 92' ' ' TYR . 0.4 OUTLIER -78.86 -177.99 5.79 Favored 'General case' 0 C--O 1.238 0.479 0 O-C-N 125.59 1.806 . . . . 0.0 112.863 177.061 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -76.74 152.36 82.91 Favored Pre-proline 0 N--CA 1.451 -0.425 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 172.18 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -69.92 -165.07 0.15 Allowed 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.372 2.048 . . . . 0.0 112.688 175.568 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -131.52 158.19 22.67 Favored Glycine 0 CA--C 1.526 0.772 0 O-C-N 121.43 -0.794 . . . . 0.0 112.799 176.565 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -76.02 -42.78 0.37 Allowed 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.394 2.063 . . . . 0.0 111.313 178.244 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.897 ' HB1' ' CG2' ' A' ' 120' ' ' ILE . . . -92.72 145.56 24.32 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 123.23 0.612 . . . . 0.0 110.709 177.069 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.491 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 4.4 mtm-85 -145.4 149.5 34.85 Favored 'General case' 0 CA--C 1.495 -1.136 0 CA-C-O 117.104 -1.427 . . . . 0.0 111.597 177.875 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.644 HG23 ' CD1' ' A' ' 117' ' ' PHE . 2.3 p -83.65 110.43 18.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 O-C-N 124.136 0.898 . . . . 0.0 110.434 178.641 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.411 HG12 ' CE2' ' A' ' 38' ' ' PHE . 1.7 mp -95.93 125.06 48.83 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.104 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 -174.735 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.615 ' CZ ' HD11 ' A' ' 81' ' ' LEU . 8.6 p90 -146.23 154.97 42.34 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.782 0.801 . . . . 0.0 109.061 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.464 HG22 ' HG ' ' A' ' 80' ' ' LEU . 1.8 p -91.79 164.8 13.57 Favored 'General case' 0 C--N 1.317 -0.817 0 O-C-N 121.931 -0.48 . . . . 0.0 109.734 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.511 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -110.88 155.77 41.84 Favored Pre-proline 0 CA--C 1.544 0.729 0 O-C-N 121.759 -0.588 . . . . 0.0 110.911 179.18 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.511 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 19.3 Cg_endo -73.18 -50.17 0.2 OUTLIER 'Cis proline' 0 CA--C 1.5 -1.188 0 C-N-CA 123.544 -1.44 . . . . 0.0 111.099 -8.249 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.541 ' HB3' HG23 ' A' ' 116' ' ' VAL . 1.4 m-20 -46.32 110.51 0.28 Allowed 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 115.999 -1.953 . . . . 0.0 108.846 178.295 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.665 ' HE2' HD13 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -67.71 68.36 0.1 Allowed 'General case' 0 CA--C 1.511 -0.549 0 O-C-N 125.904 2.003 . . . . 0.0 108.154 -178.49 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.541 HG23 ' HB3' ' A' ' 114' ' ' ASN . 72.0 t -73.66 71.43 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 105.358 -2.089 . . . . 0.0 105.358 -177.763 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.644 ' CD1' HG23 ' A' ' 108' ' ' VAL . 29.9 t80 -39.44 116.44 0.61 Allowed 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 125.832 1.653 . . . . 0.0 109.352 179.597 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 118' ' ' CYS . . . . . 0.58 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 4.6 m -89.09 -46.55 8.75 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -178.978 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.598 ' HA2' ' CZ ' ' A' ' 117' ' ' PHE . . . 155.08 -171.62 33.34 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 -179.235 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.897 ' CG2' ' HB1' ' A' ' 106' ' ' ALA . 2.8 mp -109.65 129.69 64.06 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.269 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 -177.847 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.716 HG22 HD12 ' A' ' 133' ' ' LEU . 8.9 pt -102.55 155.42 5.09 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 CA-C-N 119.535 1.061 . . . . 0.0 108.318 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.665 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . . . -175.51 157.98 2.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 122.879 1.324 . . . . 0.0 110.07 175.561 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 3.2 m80 -89.8 94.31 9.78 Favored 'General case' 0 N--CA 1.447 -0.579 0 O-C-N 121.31 -0.869 . . . . 0.0 108.69 -177.221 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.492 ' O ' HG23 ' A' ' 124' ' ' THR . 1.4 t -97.06 37.87 1.28 Allowed 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 123.643 1.687 . . . . 0.0 111.808 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.5 ttpp -102.86 -28.21 12.19 Favored 'General case' 0 C--O 1.219 -0.517 0 O-C-N 120.519 -1.363 . . . . 0.0 111.313 179.024 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -172.35 -68.1 0.02 OUTLIER 'General case' 0 C--O 1.219 -0.517 0 O-C-N 124.145 0.903 . . . . 0.0 109.954 178.084 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -155.3 -44.85 0.08 Allowed 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.056 0.942 . . . . 0.0 110.649 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -153.3 79.56 1.18 Allowed 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 124.671 1.189 . . . . 0.0 109.106 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -129.58 -104.8 1.13 Allowed Glycine 0 N--CA 1.459 0.212 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 176.496 . . . . . . . . 1 1 . 1 . 012 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -89.14 150.92 22.48 Favored 'General case' 0 CA--C 1.509 -0.61 0 O-C-N 121.845 -0.797 . . . . 0.0 111.055 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.563 HD23 ' H ' ' A' ' 132' ' ' LYS . 0.5 OUTLIER -103.23 145.91 29.23 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.226 0.536 . . . . 0.0 109.633 178.051 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.563 ' H ' HD23 ' A' ' 131' ' ' LEU . 0.1 OUTLIER -154.65 169.84 22.94 Favored 'General case' 0 CA--C 1.507 -0.684 0 C-N-CA 125.318 1.447 . . . . 0.0 109.931 179.464 . . . . . . . . 3 3 . 1 . 012 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.716 HD12 HG22 ' A' ' 121' ' ' ILE . 7.2 tp -83.8 147.46 27.57 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 176.612 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 134' ' ' CYS . . . . . 0.574 ' SG ' HG22 ' A' ' 120' ' ' ILE . 99.5 m -60.18 -177.67 0.07 Allowed 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 123.708 1.718 . . . . 0.0 109.985 176.219 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -162.96 109.43 1.18 Allowed 'General case' 0 C--N 1.319 -0.746 0 O-C-N 120.588 -1.32 . . . . 0.0 107.475 -177.916 . . . . . . . . 2 2 . 1 . 012 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.254 1.303 0 CA-C-O 115.335 -2.269 . . . . 0.0 111.438 174.227 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.473 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 . . . . . . . . . 0 0 . 1 . 013 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.1 p -67.26 139.94 20.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.102 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.408 HG23 ' HA ' ' A' ' 12' ' ' ASN . 2.5 m -98.78 118.34 35.3 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 124.26 1.024 . . . . 0.0 108.944 -176.219 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.413 ' CE2' ' ND1' ' A' ' 136' ' ' HIS . 28.6 m95 -82.35 137.07 34.87 Favored 'General case' 0 CA--C 1.506 -0.716 0 O-C-N 120.851 -1.156 . . . . 0.0 109.024 -172.833 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -127.14 132.12 50.62 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 122.115 0.959 . . . . 0.0 108.43 -176.265 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.482 ' SG ' ' HB3' ' A' ' 122' ' ' ALA . 0.0 OUTLIER -121.6 66.68 0.89 Allowed 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.707 176.919 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 42.44 56.2 4.21 Favored Glycine 0 N--CA 1.471 1.019 0 O-C-N 124.061 0.851 . . . . 0.0 113.28 -176.673 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -168.36 -88.69 0.07 OUTLIER Glycine 0 C--O 1.226 -0.387 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 -175.607 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 32.5 mt -132.14 165.16 24.7 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.304 1.441 . . . . 0.0 109.983 177.592 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -90.83 111.04 22.27 Favored 'General case' 0 C--O 1.223 -0.336 0 C-N-CA 124.48 1.112 . . . . 0.0 110.137 179.197 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -89.64 111.2 22.09 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 130.635 3.574 . . . . 0.0 109.067 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.408 ' HA ' HG23 ' A' ' 3' ' ' THR . 0.1 OUTLIER -54.6 122.16 10.0 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 176.374 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 31.5 tp60 -55.12 -48.33 73.78 Favored 'General case' 0 C--O 1.215 -0.739 0 C-N-CA 118.754 -1.178 . . . . 0.0 113.227 177.482 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -48.94 -37.21 19.33 Favored 'General case' 0 C--O 1.204 -1.301 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 173.903 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.5 mttp -71.61 -42.08 68.11 Favored 'General case' 0 C--O 1.21 -1.021 0 CA-C-O 116.369 -1.777 . . . . 0.0 113.132 167.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.528 ' HA ' HG21 ' A' ' 85' ' ' THR . . . -51.98 -48.27 64.45 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 122.828 2.558 . . . . 0.0 113.475 172.984 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -74.5 -47.79 31.06 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 119.0 0.818 . . . . 0.0 111.753 172.048 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 38.0 t -66.55 -55.73 14.09 Favored 'General case' 0 N--CA 1.481 1.098 0 O-C-N 119.738 -1.851 . . . . 0.0 112.301 -175.148 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -40.5 -46.15 2.4 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.711 1.205 . . . . 0.0 110.894 169.474 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.435 ' O ' ' HB3' ' A' ' 23' ' ' ALA . 0.1 OUTLIER -76.16 -28.87 57.54 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 126.976 2.11 . . . . 0.0 116.437 174.981 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -54.68 -35.6 63.74 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 127.802 2.441 . . . . 0.0 111.037 177.572 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -75.91 -42.6 48.51 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 126.569 1.948 . . . . 0.0 112.506 174.325 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.596 ' HB1' ' HG3' ' A' ' 35' ' ' PRO . . . -45.65 127.6 6.54 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 127.318 2.247 . . . . 0.0 111.844 175.037 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -66.28 146.66 81.7 Favored 'Trans proline' 0 N--CA 1.445 -1.346 0 C-N-CA 122.833 2.355 . . . . 0.0 111.272 -175.44 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.535 HD13 ' CE2' ' A' ' 112' ' ' TYR . 0.6 OUTLIER -79.72 94.57 5.76 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.613 -179.781 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.6 m 179.78 167.96 1.2 Allowed 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.711 1.604 . . . . 0.0 110.665 -174.926 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.453 ' HA ' ' HA ' ' A' ' 36' ' ' HIS . 0.3 OUTLIER -108.71 118.29 36.41 Favored 'General case' 0 CA--C 1.51 -0.594 0 C-N-CA 125.988 1.715 . . . . 0.0 109.169 175.12 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 55.27 62.39 6.34 Favored Glycine 0 CA--C 1.522 0.495 0 O-C-N 123.663 0.602 . . . . 0.0 112.713 171.233 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt -145.73 20.68 1.48 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.755 1.622 . . . . 0.0 115.243 -176.306 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 45.2 p -118.42 158.3 25.56 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 125.715 1.606 . . . . 0.0 108.513 179.335 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.45 ' HA3' ' O ' ' A' ' 95' ' ' ASP . . . -50.52 -55.01 18.46 Favored Glycine 0 CA--C 1.504 -0.596 0 N-CA-C 116.222 1.249 . . . . 0.0 116.222 -177.02 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.5 t -62.72 -62.06 1.99 Allowed 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 116.695 -1.621 . . . . 0.0 112.896 171.057 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 160.22 -42.15 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 131.427 3.891 . . . . 0.0 115.963 178.478 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.511 ' CD2' ' HD3' ' A' ' 84' ' ' PRO . 86.0 m-85 -78.47 147.32 71.67 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 125.182 1.393 . . . . 0.0 113.999 -177.954 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.596 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 35.1 Cg_endo -71.84 162.28 89.64 Favored 'Cis proline' 0 N--CA 1.441 -1.603 0 CA-C-N 120.626 1.259 . . . . 0.0 110.609 -2.725 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 27' ' ' ASP . 1.6 p80 -139.36 173.65 11.33 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 113.16 -1.836 . . . . 0.0 108.068 -177.14 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.82 ' CH2' HG22 ' A' ' 39' ' ' THR . 19.7 t90 -75.96 138.47 40.99 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 123.222 1.487 . . . . 0.0 110.78 173.298 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.48 ' CE2' HG21 ' A' ' 109' ' ' ILE . 28.4 t80 -106.89 91.83 3.83 Favored 'General case' 0 N--CA 1.419 -1.994 0 C-N-CA 130.297 3.439 . . . . 0.0 104.688 177.712 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.82 HG22 ' CH2' ' A' ' 37' ' ' TRP . 80.4 p -41.47 -37.98 1.18 Allowed 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 112.794 -2.003 . . . . 0.0 111.851 164.162 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.466 ' HA ' ' CZ ' ' A' ' 38' ' ' PHE . 65.8 t30 59.31 17.12 5.53 Favored 'General case' 0 C--O 1.213 -0.842 0 CA-C-N 118.901 0.773 . . . . 0.0 111.995 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.482 ' HA2' ' NE ' ' A' ' 52' ' ' ARG . . . 107.38 -43.3 1.72 Allowed Glycine 0 N--CA 1.44 -1.085 0 CA-C-O 115.132 -3.038 . . . . 0.0 114.62 -166.01 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -45.94 154.85 0.21 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 128.789 2.836 . . . . 0.0 111.667 178.032 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -82.04 -34.7 29.39 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 178.282 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.538 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -175.95 -68.38 0.06 OUTLIER Glycine 0 CA--C 1.528 0.848 0 C-N-CA 126.199 1.856 . . . . 0.0 113.036 -175.815 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 45' ' ' ASP . . . . . 0.414 ' OD2' ' HE2' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -118.78 -62.73 1.49 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 127.188 2.195 . . . . 0.0 113.955 -176.322 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.39 -168.54 1.59 Allowed Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 125.732 1.635 . . . . 0.0 111.021 178.12 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 43.8 pttt -59.06 -172.15 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 124.696 2.189 . . . . 0.0 113.631 173.342 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.601 ' H ' HD12 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -87.41 170.02 12.97 Favored Pre-proline 0 C--N 1.316 -0.852 0 CA-C-N 114.333 -1.303 . . . . 0.0 111.947 -177.755 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -62.59 164.68 17.59 Favored 'Trans proline' 0 N--CA 1.44 -1.662 0 CA-C-O 123.093 1.205 . . . . 0.0 109.955 177.26 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.13 102.06 0.12 Allowed 'General case' 0 C--O 1.218 -0.58 0 O-C-N 120.307 -1.495 . . . . 0.0 110.695 170.333 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.08 78.35 1.4 Allowed Glycine 0 N--CA 1.466 0.638 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -176.756 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.482 ' NE ' ' HA2' ' A' ' 41' ' ' GLY . 0.4 OUTLIER -148.93 154.48 39.48 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 124.303 1.041 . . . . 0.0 109.96 170.974 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.9 m -124.72 101.46 33.2 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 125.087 1.355 . . . . 0.0 108.882 175.829 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.533 ' HG3' HD21 ' A' ' 48' ' ' LEU . 32.5 Cg_endo -69.22 148.9 69.6 Favored 'Trans proline' 0 N--CA 1.444 -1.437 0 C-N-CA 123.316 2.677 . . . . 0.0 111.078 172.518 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.5 mt -61.19 118.38 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 175.378 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.0 tppt? -86.52 132.29 33.96 Favored 'General case' 0 C--N 1.332 -0.179 0 O-C-N 121.611 -0.681 . . . . 0.0 109.516 174.111 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.57 ' CD1' ' HB3' ' A' ' 118' ' ' CYS . 7.9 m-85 -114.84 -36.32 4.52 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.518 1.927 . . . . 0.0 112.495 178.409 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.47 0.42 55.59 Favored Glycine 0 N--CA 1.474 1.221 0 C-N-CA 125.494 1.521 . . . . 0.0 114.114 -172.847 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.45 134.78 42.88 Favored 'General case' 0 CA--C 1.506 -0.726 0 C-N-CA 123.939 0.896 . . . . 0.0 111.299 175.315 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 79.6 p -68.91 -8.78 47.43 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.092 0.957 . . . . 0.0 113.502 176.939 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.708 ' HB2' HG21 ' A' ' 111' ' ' THR . 0.0 OUTLIER -84.03 -52.3 6.42 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 126.926 2.09 . . . . 0.0 108.977 176.091 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.438 ' HB2' ' CD2' ' A' ' 57' ' ' PHE . 3.7 m -78.75 -15.49 58.38 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -179.28 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -86.05 -30.8 22.35 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 127.212 2.205 . . . . 0.0 111.977 167.888 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.43 153.86 13.3 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 119.463 1.029 . . . . 0.0 113.76 179.111 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -67.11 136.85 42.21 Favored 'Trans proline' 0 CA--C 1.553 1.43 0 C-N-CA 120.363 0.709 . . . . 0.0 111.789 173.628 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.449 ' HB3' ' HA ' ' A' ' 79' ' ' TYR . 19.6 Cg_endo -67.09 174.76 6.46 Favored 'Trans proline' 0 N--CA 1.459 -0.539 1 C-N-CA 125.428 4.085 . . . . 0.0 113.225 175.421 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.414 ' HE2' ' OD2' ' A' ' 45' ' ' ASP 0.355 4.2 mmtt -133.9 41.21 3.03 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 116.073 1.879 . . . . 0.0 116.073 178.35 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.536 ' HA ' ' OD2' ' A' ' 77' ' ' ASP 0.312 56.3 t-80 -58.32 152.3 17.8 Favored 'General case' 0 C--O 1.218 -0.564 0 CA-C-O 124.798 2.237 . . . . 0.0 114.284 -177.527 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -148.56 -172.13 4.02 Favored 'General case' 0 CA--C 1.512 -0.51 0 O-C-N 119.777 -1.827 . . . . 0.0 111.026 179.147 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.02 69.79 5.25 Favored 'General case' 0 C--O 1.213 -0.821 0 O-C-N 121.151 -0.968 . . . . 0.0 112.002 172.626 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -170.03 -45.43 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 124.158 0.983 . . . . 0.0 111.887 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 133.98 -66.75 0.56 Allowed Glycine 0 C--O 1.204 -1.738 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 -179.148 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 5.6 p-10 -107.48 -3.24 19.65 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 130.311 3.444 . . . . 0.0 113.417 -176.411 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 34.4 -122.13 0.42 Allowed Glycine 0 C--O 1.221 -0.712 0 C-N-CA 128.282 2.849 . . . . 0.0 113.783 -176.63 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 24.4 mttt -69.72 -79.02 0.06 Allowed 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 115.209 1.559 . . . . 0.0 115.209 167.716 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -123.45 11.22 9.26 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-O 116.676 -1.63 . . . . 0.0 111.957 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.536 ' OD2' ' HA ' ' A' ' 68' ' ' HIS . 58.1 t0 -17.78 94.53 0.01 OUTLIER 'General case' 0 C--O 1.214 -0.792 0 C-N-CA 126.689 1.996 . . . . 0.0 114.293 -171.867 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.43 ' CD2' ' H ' ' A' ' 78' ' ' HIS . 19.2 p80 -84.32 11.47 8.32 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -172.87 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.843 ' CZ ' HD21 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -43.87 162.42 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 126.684 1.994 . . . . 0.0 113.223 169.372 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -83.02 150.45 26.34 Favored 'General case' 0 N--CA 1.427 -1.585 0 CA-C-N 113.236 -1.802 . . . . 0.0 110.441 169.641 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.843 HD21 ' CZ ' ' A' ' 79' ' ' TYR . 1.6 mt -132.42 130.47 40.65 Favored 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 123.743 0.817 . . . . 0.0 109.218 173.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.06 155.19 17.23 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 123.734 0.814 . . . . 0.0 112.088 176.955 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.463 ' HZ ' ' CE2' ' A' ' 94' ' ' PHE . 59.8 t80 -149.05 127.16 5.82 Favored Pre-proline 0 CA--C 1.551 1.004 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 179.146 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.511 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 23.4 Cg_endo -71.59 94.78 0.69 Allowed 'Trans proline' 0 N--CA 1.45 -1.065 1 C-N-CA 126.062 4.508 . . . . 0.0 110.119 -176.093 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.528 HG21 ' HA ' ' A' ' 16' ' ' ALA . 6.2 t -94.49 114.3 26.28 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 113.233 -1.803 . . . . 0.0 110.127 178.719 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -82.31 154.25 69.15 Favored Pre-proline 0 CA--C 1.54 0.581 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.136 178.268 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -73.31 -35.12 5.28 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.953 2.435 . . . . 0.0 115.204 177.943 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -50.79 -30.95 15.47 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 128.182 2.593 . . . . 0.0 110.983 175.082 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.27 11.53 82.08 Favored Glycine 0 CA--C 1.499 -0.955 0 CA-C-N 114.568 -1.197 . . . . 0.0 115.067 177.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . 0.255 5.2 p-80 -62.36 132.37 52.38 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 171.834 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -56.76 99.51 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 157.359 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -47.07 137.02 8.06 Favored 'General case' 0 N--CA 1.436 -1.153 0 O-C-N 118.823 -2.423 . . . . 0.0 108.484 169.021 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.36 59.01 1.02 Allowed 'General case' 0 C--N 1.324 -0.536 0 O-C-N 120.786 -1.196 . . . . 0.0 112.326 171.26 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.463 ' CE2' ' HZ ' ' A' ' 83' ' ' PHE . 32.6 p90 -71.72 -29.43 64.54 Favored 'General case' 0 C--O 1.219 -0.506 0 C-N-CA 124.794 1.237 . . . . 0.0 112.644 173.884 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.45 ' O ' ' HA3' ' A' ' 31' ' ' GLY . 1.1 t70 -75.65 -38.9 58.46 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.527 1.931 . . . . 0.0 111.402 175.764 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.3 t -77.75 107.76 10.49 Favored 'General case' 0 C--N 1.33 -0.248 0 O-C-N 121.33 -0.856 . . . . 0.0 109.046 -176.315 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.5 pttt -60.35 -41.17 93.09 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 122.593 1.187 . . . . 0.0 114.109 178.655 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -145.24 131.13 9.54 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 114.174 -1.376 . . . . 0.0 110.837 178.913 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.67 165.21 70.39 Favored 'Cis proline' 0 N--CA 1.455 -0.771 0 O-C-N 123.283 1.149 . . . . 0.0 110.349 -11.102 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.37 148.5 47.49 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 125.484 1.513 . . . . 0.0 107.712 177.681 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -96.14 171.0 8.88 Favored 'General case' 0 C--N 1.319 -0.761 0 O-C-N 124.014 0.821 . . . . 0.0 109.577 169.2 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -46.5 152.17 0.91 Allowed Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 127.424 2.29 . . . . 0.0 111.865 168.038 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -72.74 -84.77 0.0 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.336 0 C-N-CA 123.107 2.538 . . . . 0.0 112.284 176.972 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 138.48 146.07 4.93 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.069 -1.213 . . . . 0.0 110.069 -178.605 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -76.62 -67.5 0.02 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 124.062 3.175 . . . . 0.0 112.162 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.405 ' HA ' ' HB2' ' A' ' 122' ' ' ALA . . . -68.99 132.16 46.23 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 123.125 1.44 . . . . 0.0 111.658 176.172 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.68 152.12 48.95 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 113.615 -1.63 . . . . 0.0 110.194 -177.99 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.418 ' CG1' ' HB3' ' A' ' 83' ' ' PHE . 2.5 p -87.54 116.62 30.04 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.642 0 C-N-CA 125.247 1.419 . . . . 0.0 109.438 175.928 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.48 HG21 ' CE2' ' A' ' 38' ' ' PHE . 1.6 mp -104.22 115.64 46.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 104.877 -2.268 . . . . 0.0 104.877 -178.582 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -126.81 156.22 41.63 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 114.48 -1.236 . . . . 0.0 108.467 177.245 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.708 HG21 ' HB2' ' A' ' 61' ' ' ASP . 3.2 p -82.98 166.48 18.79 Favored 'General case' 0 CA--C 1.505 -0.783 0 C-N-CA 124.844 1.258 . . . . 0.0 111.277 177.225 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.535 ' CE2' HD13 ' A' ' 25' ' ' LEU 0.276 8.7 t80 -109.94 158.49 34.86 Favored Pre-proline 0 CA--C 1.544 0.748 0 O-C-N 120.962 -1.086 . . . . 0.0 112.33 176.333 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.525 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 18.9 Cg_endo -69.01 -41.9 0.81 Allowed 'Cis proline' 0 C--N 1.348 0.516 0 N-CA-C 114.794 1.036 . . . . 0.0 114.794 -21.544 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.469 ' HB3' HG23 ' A' ' 116' ' ' VAL . 1.3 t-20 -50.37 106.48 0.12 Allowed 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 125.528 1.531 . . . . 0.0 108.92 170.431 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.503 ' HE2' HD21 ' A' ' 25' ' ' LEU . 2.3 mtmt -67.12 65.41 0.06 Allowed 'General case' 0 C--N 1.339 0.111 0 C-N-CA 127.959 2.503 . . . . 0.0 108.792 177.431 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.469 HG23 ' HB3' ' A' ' 114' ' ' ASN . 47.3 t -72.93 86.54 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.586 0 N-CA-C 103.254 -2.869 . . . . 0.0 103.254 175.951 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.451 ' CZ ' ' HA2' ' A' ' 119' ' ' GLY . 37.8 t80 -46.12 103.8 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 129.142 2.977 . . . . 0.0 109.427 176.933 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 118' ' ' CYS . . . . . 0.57 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 22.4 m -80.21 -41.7 24.68 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 122.884 1.326 . . . . 0.0 110.447 -176.056 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.451 ' HA2' ' CZ ' ' A' ' 117' ' ' PHE . . . 159.44 -154.22 25.28 Favored Glycine 0 N--CA 1.433 -1.552 0 CA-C-N 113.651 -1.613 . . . . 0.0 110.09 -178.555 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.424 HD11 ' CB ' ' A' ' 16' ' ' ALA . 1.3 mm -123.08 147.99 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 N-CA-C 105.208 -2.145 . . . . 0.0 105.208 -179.092 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.418 HG12 ' CD1' ' A' ' 109' ' ' ILE . 4.3 pt -136.99 151.65 27.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 O-C-N 119.851 -1.781 . . . . 0.0 109.175 179.397 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.482 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . . . -166.14 159.68 15.5 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.742 0.782 . . . . 0.0 110.355 176.747 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.428 ' CD2' HD13 ' A' ' 131' ' ' LEU . 32.9 m-70 -90.09 91.2 8.45 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.673 -178.46 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.453 HG22 ' HD3' ' A' ' 132' ' ' LYS . 2.0 t -92.29 33.33 1.1 Allowed 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 123.25 1.5 . . . . 0.0 112.944 -179.079 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.93 -33.95 12.58 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 120.905 -1.122 . . . . 0.0 112.019 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -170.73 -78.86 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.628 1.571 . . . . 0.0 109.566 -178.393 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -127.59 -58.65 1.24 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 129.28 3.032 . . . . 0.0 110.435 -176.9 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -160.95 74.73 0.51 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.671 1.988 . . . . 0.0 112.176 -176.226 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -122.4 -106.92 1.91 Allowed Glycine 0 N--CA 1.468 0.783 0 O-C-N 121.346 -0.846 . . . . 0.0 112.369 177.172 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.99 154.66 33.44 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 121.735 -0.862 . . . . 0.0 112.235 177.362 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.428 HD13 ' CD2' ' A' ' 123' ' ' HIS . 7.4 tp -125.59 135.06 51.79 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.925 1.29 . . . . 0.0 110.532 -178.271 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.453 ' HD3' HG22 ' A' ' 124' ' ' THR . 0.8 OUTLIER -147.35 166.42 27.18 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.48 -1.236 . . . . 0.0 109.057 -177.416 . . . . . . . . 3 3 . 1 . 013 nuclear build full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 14.7 tp -77.4 141.67 39.67 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.036 173.946 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 134' ' ' CYS . . . . . 0.419 ' SG ' HG22 ' A' ' 120' ' ' ILE . 34.9 m -70.56 176.78 3.86 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 126.448 1.899 . . . . 0.0 111.243 169.686 . . . . . . . . 2 2 . 1 . 013 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 92.5 p -142.37 100.45 3.7 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 105.284 -2.117 . . . . 0.0 105.284 -177.866 . . . . . . . . 1 1 . 1 . 013 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.413 ' ND1' ' CE2' ' A' ' 4' ' ' TRP . 0.5 OUTLIER . . . . . 0 C--O 1.246 0.921 0 CA-C-O 114.972 -2.442 . . . . 0.0 114.671 165.022 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.472 ' H2 ' ' H ' ' A' ' 14' ' ' ASN . . . . . . . . 0 CA--C 1.51 -0.561 0 CA-C-O 118.061 -0.971 . . . . 0.0 109.214 . . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.655 HG22 ' HB2' ' A' ' 136' ' ' HIS . 11.0 p -51.56 136.64 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 O-C-N 124.583 1.177 . . . . 0.0 109.145 -178.871 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.55 HG21 HD23 ' A' ' 10' ' ' LEU . 1.1 m -84.46 112.38 20.33 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-O 121.546 0.688 . . . . 0.0 110.008 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.497 ' CG ' HG13 ' A' ' 120' ' ' ILE . 27.5 m95 -78.44 138.08 38.3 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 123.877 0.871 . . . . 0.0 111.248 175.089 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 m -120.16 120.52 36.43 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -177.679 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.876 ' HB3' ' HB3' ' A' ' 122' ' ' ALA . 55.6 m -106.88 51.89 0.73 Allowed 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.581 178.916 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.743 ' HA3' HG21 ' A' ' 124' ' ' THR . . . 45.46 48.06 11.79 Favored Glycine 0 C--O 1.218 -0.863 0 O-C-N 123.951 0.782 . . . . 0.0 111.974 -176.964 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -162.2 -80.97 0.04 OUTLIER Glycine 0 C--O 1.225 -0.407 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 -177.52 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.6 mt -127.39 163.91 23.01 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.148 0.499 . . . . 0.0 110.008 177.684 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.55 HD23 HG21 ' A' ' 3' ' ' THR . 9.2 mp -85.55 133.78 34.05 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.144 -179.353 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.504 ' CE2' ' CB ' ' A' ' 106' ' ' ALA . 64.5 m-85 -122.89 110.37 15.34 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 124.41 1.084 . . . . 0.0 110.17 -175.321 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -65.74 119.16 10.7 Favored 'General case' 0 N--CA 1.444 -0.751 0 O-C-N 120.335 -1.478 . . . . 0.0 108.517 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.441 ' HB2' ' CD1' ' A' ' 4' ' ' TRP . 33.0 tp60 -48.47 -42.46 32.77 Favored 'General case' 0 C--O 1.197 -1.687 0 CA-C-N 118.542 0.61 . . . . 0.0 111.518 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.472 ' H ' ' H2 ' ' A' ' 1' ' ' ALA . 21.2 t30 -48.8 -48.36 41.43 Favored 'General case' 0 C--O 1.189 -2.087 0 CA-C-N 117.785 0.266 . . . . 0.0 111.106 175.875 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -67.28 -34.94 78.45 Favored 'General case' 0 C--O 1.196 -1.742 0 O-C-N 120.641 -1.287 . . . . 0.0 112.502 171.277 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.37 -45.1 80.68 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 121.337 1.88 . . . . 0.0 113.106 172.904 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -85.94 -37.8 18.67 Favored 'General case' 0 C--O 1.206 -1.197 0 CA-C-O 118.575 -0.726 . . . . 0.0 109.14 178.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.4 ' CB ' ' O ' ' A' ' 14' ' ' ASN . 47.8 t -71.75 -61.29 1.83 Allowed 'General case' 0 CA--C 1.5 -0.947 0 C-N-CA 126.6 1.96 . . . . 0.0 108.819 -177.037 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.51 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 8.7 t-20 -40.97 -35.93 0.59 Allowed 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 119.285 0.948 . . . . 0.0 112.555 173.311 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.421 ' O ' ' HB3' ' A' ' 23' ' ' ALA . 0.2 OUTLIER -81.61 -37.96 26.77 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 174.228 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -44.09 -39.2 4.07 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 126.436 1.894 . . . . 0.0 109.518 178.652 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.51 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -73.41 -49.09 28.9 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-O 118.435 -0.793 . . . . 0.0 112.1 175.77 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.585 ' HB1' ' HG3' ' A' ' 35' ' ' PRO . . . -35.64 129.77 0.57 Allowed Pre-proline 0 N--CA 1.439 -1.006 0 O-C-N 124.634 1.209 . . . . 0.0 112.566 174.076 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.703 ' HG2' HG22 ' A' ' 30' ' ' THR . 19.4 Cg_endo -73.4 124.23 9.26 Favored 'Trans proline' 0 N--CA 1.442 -1.54 0 C-N-CA 121.898 1.732 . . . . 0.0 109.707 -176.86 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.753 HD13 ' HE2' ' A' ' 115' ' ' LYS . 5.4 tp -60.44 95.45 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.103 0.561 . . . . 0.0 110.925 179.48 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.477 ' O ' HD22 ' A' ' 81' ' ' LEU . 0.4 OUTLIER 179.13 173.07 0.8 Allowed 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 123.322 0.649 . . . . 0.0 110.445 -176.745 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -109.25 119.37 39.28 Favored 'General case' 0 CA--C 1.511 -0.53 0 C-N-CA 124.101 0.961 . . . . 0.0 109.934 179.095 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 45.98 64.06 2.62 Favored Glycine 0 C--O 1.225 -0.413 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.209 177.94 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 29' ' ' LYS . . . . . 0.421 ' CD ' ' HB2' ' A' ' 26' ' ' SER . 3.0 ptmt -127.5 8.51 6.47 Favored 'General case' 0 CA--C 1.511 -0.543 0 O-C-N 122.247 -0.56 . . . . 0.0 111.463 179.102 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.703 HG22 ' HG2' ' A' ' 24' ' ' PRO . 8.1 p -115.06 152.45 32.47 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -174.055 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -39.37 -59.16 1.92 Allowed Glycine 0 C--N 1.335 0.493 0 O-C-N 124.001 0.813 . . . . 0.0 112.544 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 29.7 t -62.46 -63.3 1.27 Allowed 'General case' 0 N--CA 1.441 -0.895 0 CA-C-O 116.273 -1.822 . . . . 0.0 111.166 176.042 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 159.63 -57.85 0.0 OUTLIER 'General case' 0 C--O 1.221 -0.418 0 O-C-N 126.085 2.115 . . . . 0.0 109.537 179.099 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.526 ' CD2' ' HD3' ' A' ' 84' ' ' PRO . 55.3 m-85 -55.8 145.09 53.8 Favored Pre-proline 0 N--CA 1.434 -1.229 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 179.234 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.585 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 22.5 Cg_endo -74.4 163.4 90.4 Favored 'Cis proline' 0 N--CA 1.447 -1.221 0 C-N-CA 122.822 -1.741 . . . . 0.0 111.428 -1.87 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.773 ' C ' HD23 ' A' ' 81' ' ' LEU . 1.5 p80 -137.22 175.1 9.91 Favored 'General case' 0 C--O 1.212 -0.914 0 O-C-N 120.981 -1.074 . . . . 0.0 110.339 -177.148 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.838 ' CZ3' HG22 ' A' ' 39' ' ' THR . 21.0 t90 -75.15 130.83 39.87 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.486 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.545 ' CE1' ' CD1' ' A' ' 121' ' ' ILE . 42.2 t80 -101.81 77.74 1.75 Allowed 'General case' 0 N--CA 1.427 -1.608 0 C-N-CA 126.009 1.724 . . . . 0.0 107.309 -178.975 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.838 HG22 ' CZ3' ' A' ' 37' ' ' TRP . 64.0 p -39.63 -31.78 0.11 Allowed 'General case' 0 C--O 1.215 -0.716 0 C-N-CA 124.297 1.039 . . . . 0.0 110.694 175.458 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.414 ' HB2' ' CD2' ' A' ' 38' ' ' PHE . 43.7 t30 60.47 14.08 4.57 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 122.861 1.315 . . . . 0.0 109.147 177.693 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.529 ' C ' HD23 ' A' ' 48' ' ' LEU . . . 116.3 -40.3 2.44 Favored Glycine 0 N--CA 1.423 -2.178 0 O-C-N 119.556 -1.965 . . . . 0.0 111.875 -174.312 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.734 ' N ' HD23 ' A' ' 48' ' ' LEU . 65.0 m-85 -49.54 156.12 0.69 Allowed 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.732 1.213 . . . . 0.0 110.392 -178.214 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.37 -39.4 20.74 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.576 178.08 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.416 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -162.41 -76.67 0.03 OUTLIER Glycine 0 C--N 1.339 0.741 0 C-N-CA 123.715 0.674 . . . . 0.0 111.623 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -114.0 -63.81 1.4 Allowed 'General case' 0 CA--C 1.509 -0.62 0 C-N-CA 122.514 0.326 . . . . 0.0 110.959 -179.598 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.12 -168.25 0.07 OUTLIER Glycine 0 C--N 1.353 1.513 0 O-C-N 124.274 0.983 . . . . 0.0 111.119 178.588 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.1 -164.43 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 124.62 2.152 . . . . 0.0 111.987 176.101 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.734 HD23 ' N ' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -105.9 178.04 1.21 Allowed Pre-proline 0 N--CA 1.433 -1.311 0 O-C-N 119.647 -1.908 . . . . 0.0 110.568 -179.478 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 49' ' ' PRO . . . . . 0.403 ' CD ' ' CB ' ' A' ' 48' ' ' LEU . 23.9 Cg_endo -73.01 177.61 7.54 Favored 'Trans proline' 0 N--CA 1.444 -1.416 0 C-N-CA 122.138 1.892 . . . . 0.0 111.685 178.396 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.8 tttm -83.83 102.0 12.03 Favored 'General case' 0 N--CA 1.444 -0.767 0 O-C-N 120.955 -1.091 . . . . 0.0 109.87 177.74 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 117.96 65.12 0.32 Allowed Glycine 0 C--O 1.223 -0.577 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.726 ' CD ' HD13 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -153.23 176.3 12.11 Favored 'General case' 0 CA--C 1.51 -0.574 0 C-N-CA 123.066 0.547 . . . . 0.0 110.625 178.72 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.9 m -154.24 107.0 2.43 Favored Pre-proline 0 C--O 1.215 -0.711 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.786 173.75 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -71.26 174.4 10.82 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 121.879 1.719 . . . . 0.0 111.783 178.809 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.506 HD12 HG21 ' A' ' 121' ' ' ILE . 4.1 mt -95.11 132.95 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.2 136.68 39.72 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.227 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.446 ' CD1' HD13 ' A' ' 133' ' ' LEU . 8.2 m-85 -121.94 -52.99 1.97 Allowed 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 123.098 0.559 . . . . 0.0 109.959 -179.273 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 126.45 -6.37 7.57 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 123.654 0.645 . . . . 0.0 112.285 -176.884 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.73 131.52 37.05 Favored 'General case' 0 CA--C 1.5 -0.975 0 CA-C-O 118.087 -0.958 . . . . 0.0 109.207 178.749 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 87.5 p -67.05 -7.53 23.48 Favored 'General case' 0 C--O 1.22 -0.496 0 O-C-N 125.056 1.473 . . . . 0.0 111.532 176.984 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.467 ' HB2' HG11 ' A' ' 116' ' ' VAL . 9.5 m-20 -89.64 -56.88 3.07 Favored 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 124.42 1.088 . . . . 0.0 109.629 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 68.6 m -69.64 -20.29 63.6 Favored 'General case' 0 N--CA 1.448 -0.569 0 O-C-N 123.859 0.724 . . . . 0.0 110.364 177.522 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -78.46 -41.77 31.79 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.321 0.648 . . . . 0.0 110.674 176.599 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.612 ' HD2' ' CD2' ' A' ' 78' ' ' HIS . 0.0 OUTLIER -50.7 159.8 0.87 Allowed Pre-proline 0 N--CA 1.443 -0.809 0 CA-C-O 121.503 0.668 . . . . 0.0 110.832 179.699 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.413 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 28.3 Cg_endo -72.01 136.88 28.14 Favored 'Trans proline' 0 N--CA 1.439 -1.695 0 C-N-CA 121.521 1.481 . . . . 0.0 114.264 173.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.535 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 19.0 Cg_endo -72.29 170.06 20.08 Favored 'Trans proline' 0 N--CA 1.445 -1.379 0 C-N-CA 122.786 2.324 . . . . 0.0 111.236 178.943 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -128.87 53.28 1.87 Allowed 'General case' 0 C--O 1.2 -1.514 0 CA-C-O 118.166 -0.921 . . . . 0.0 110.596 178.468 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 67.3 t60 -76.87 165.72 24.31 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 119.468 1.031 . . . . 0.0 111.061 -179.91 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -157.55 -165.29 1.74 Allowed 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 121.17 -0.956 . . . . 0.0 110.962 177.194 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.85 75.01 10.4 Favored 'General case' 0 N--CA 1.445 -0.676 0 O-C-N 120.174 -1.579 . . . . 0.0 111.332 176.67 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -177.46 -45.25 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 123.291 0.636 . . . . 0.0 109.881 179.124 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.482 ' O ' ' CE2' ' A' ' 79' ' ' TYR . . . 122.92 -50.89 0.82 Allowed Glycine 0 N--CA 1.438 -1.203 0 CA-C-O 118.636 -1.091 . . . . 0.0 111.632 -176.888 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -151.54 82.97 1.3 Allowed 'General case' 0 N--CA 1.438 -1.075 0 CA-C-N 118.603 1.202 . . . . 0.0 107.962 178.116 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.03 -115.96 0.01 OUTLIER Glycine 0 C--O 1.222 -0.616 0 CA-C-O 123.083 1.38 . . . . 0.0 111.451 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.0 mttp -60.39 -98.37 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.46 0 O-C-N 119.681 -2.07 . . . . 0.0 110.648 178.052 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.57 HG23 ' O ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -109.37 16.1 22.59 Favored 'General case' 0 N--CA 1.447 -0.581 0 O-C-N 120.633 -1.292 . . . . 0.0 110.833 179.717 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.488 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 5.7 m-20 -29.31 103.44 0.02 OUTLIER 'General case' 0 C--O 1.203 -1.364 0 C-N-CA 124.807 1.243 . . . . 0.0 110.85 -177.958 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.612 ' CD2' ' HD2' ' A' ' 64' ' ' ARG . 5.9 p-80 -85.74 14.19 6.19 Favored 'General case' 0 CA--C 1.513 -0.447 0 O-C-N 121.39 -0.819 . . . . 0.0 110.209 -176.9 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.999 ' CZ ' HD11 ' A' ' 81' ' ' LEU . 0.3 OUTLIER -35.84 132.29 0.49 Allowed 'General case' 0 N--CA 1.426 -1.645 0 C-N-CA 124.911 1.285 . . . . 0.0 113.795 173.071 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.675 HD23 ' O ' ' A' ' 110' ' ' TYR . 0.4 OUTLIER -74.05 154.99 38.99 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 118.346 -0.835 . . . . 0.0 109.034 179.376 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.999 HD11 ' CZ ' ' A' ' 79' ' ' TYR . 1.2 mp -142.34 143.34 32.7 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 123.956 0.902 . . . . 0.0 109.647 178.322 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.495 ' CB ' ' CD1' ' A' ' 109' ' ' ILE . 0.2 OUTLIER -108.93 162.78 13.89 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-O 122.186 0.994 . . . . 0.0 111.233 179.464 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.552 ' CZ ' ' HB2' ' A' ' 23' ' ' ALA . 38.0 t80 -150.64 126.33 4.95 Favored Pre-proline 0 N--CA 1.443 -0.801 0 CA-C-N 115.626 -0.716 . . . . 0.0 112.312 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.526 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 21.5 Cg_endo -71.98 101.35 1.19 Allowed 'Trans proline' 0 N--CA 1.446 -1.292 0 C-N-CA 123.764 2.976 . . . . 0.0 111.01 -179.572 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -101.01 114.88 29.21 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 121.943 0.877 . . . . 0.0 110.661 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -81.4 160.96 63.69 Favored Pre-proline 0 N--CA 1.442 -0.868 0 O-C-N 121.423 -0.798 . . . . 0.0 112.483 178.478 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -76.67 -41.61 0.41 Allowed 'Trans proline' 0 CA--C 1.497 -1.358 0 C-N-CA 122.496 2.131 . . . . 0.0 112.962 179.071 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -45.09 -30.99 1.21 Allowed 'General case' 0 C--N 1.349 0.574 0 O-C-N 125.052 1.47 . . . . 0.0 110.021 177.895 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.66 -4.08 83.57 Favored Glycine 0 N--CA 1.427 -1.964 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 177.228 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -61.53 127.73 32.9 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.733 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -61.02 93.29 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 176.879 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.498 ' CD2' ' HB3' ' A' ' 94' ' ' PHE . 7.1 t80 -38.32 143.3 0.14 Allowed 'General case' 0 C--O 1.212 -0.92 0 CA-C-O 121.994 0.902 . . . . 0.0 110.813 179.572 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 12.2 ptpt -78.49 62.04 3.01 Favored 'General case' 0 C--N 1.318 -0.796 0 O-C-N 119.712 -1.867 . . . . 0.0 110.368 176.911 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.498 ' HB3' ' CD2' ' A' ' 92' ' ' TYR . 30.6 p90 -80.84 -8.34 59.68 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 123.372 0.669 . . . . 0.0 111.299 177.641 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -97.21 -32.63 11.83 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 122.095 0.95 . . . . 0.0 110.179 178.972 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.8 m -81.85 107.1 14.3 Favored 'General case' 0 N--CA 1.443 -0.8 0 O-C-N 121.181 -0.95 . . . . 0.0 108.731 -178.485 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.5 ptpt -59.31 -48.8 80.26 Favored 'General case' 0 C--O 1.224 -0.286 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.312 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.6 pttt -142.66 128.42 10.42 Favored Pre-proline 0 N--CA 1.431 -1.415 0 C-N-CA 124.208 1.003 . . . . 0.0 109.64 -176.371 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -71.25 176.92 34.72 Favored 'Cis proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.682 -1.799 . . . . 0.0 111.421 -3.827 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.4 146.52 38.46 Favored 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 122.953 0.501 . . . . 0.0 110.172 177.985 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -99.62 165.06 11.8 Favored 'General case' 0 C--N 1.319 -0.76 0 O-C-N 123.939 0.774 . . . . 0.0 110.776 178.725 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -57.45 153.42 28.4 Favored Pre-proline 0 N--CA 1.439 -1.013 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.528 177.595 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -74.12 -164.69 0.22 Allowed 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 122.453 2.102 . . . . 0.0 111.468 177.413 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -132.89 157.8 22.8 Favored Glycine 0 N--CA 1.444 -0.782 0 O-C-N 121.342 -0.848 . . . . 0.0 112.643 178.241 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -74.92 -64.36 0.03 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 122.474 2.116 . . . . 0.0 110.101 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.821 ' HA ' ' HB2' ' A' ' 122' ' ' ALA . . . -69.39 141.43 54.14 Favored 'General case' 0 N--CA 1.441 -0.883 0 O-C-N 123.502 0.501 . . . . 0.0 111.017 179.212 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 5.2 mtm-85 -142.86 143.86 32.26 Favored 'General case' 0 N--CA 1.442 -0.852 0 O-C-N 124.257 0.973 . . . . 0.0 111.204 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.441 ' CG1' ' HB3' ' A' ' 83' ' ' PHE . 4.8 p -83.39 124.67 39.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 O-C-N 124.016 0.823 . . . . 0.0 110.377 178.823 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.638 ' CG2' HD22 ' A' ' 80' ' ' LEU . 6.2 mm -103.91 140.44 22.05 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.914 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -179.336 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.675 ' O ' HD23 ' A' ' 80' ' ' LEU . 9.9 p90 -164.21 152.05 12.43 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-O 122.53 1.157 . . . . 0.0 111.287 -178.543 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.6 p -89.64 166.76 13.41 Favored 'General case' 0 C--N 1.319 -0.725 0 O-C-N 121.593 -0.692 . . . . 0.0 109.204 -178.255 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.578 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -110.95 153.8 43.65 Favored Pre-proline 0 N--CA 1.438 -1.029 0 C-N-CA 122.971 0.508 . . . . 0.0 111.168 179.263 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.578 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 19.5 Cg_endo -73.78 -55.28 0.14 OUTLIER 'Cis proline' 0 CA--C 1.501 -1.134 0 C-N-CA 123.001 -1.666 . . . . 0.0 109.759 -5.677 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.451 ' O ' HG23 ' A' ' 116' ' ' VAL . 2.3 t-20 -44.18 113.67 0.56 Allowed 'General case' 0 CA--C 1.5 -0.976 0 CA-C-O 115.653 -2.117 . . . . 0.0 109.823 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.753 ' HE2' HD13 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -63.24 78.61 0.02 OUTLIER 'General case' 0 CA--C 1.508 -0.663 0 O-C-N 125.529 1.768 . . . . 0.0 108.64 -178.3 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.467 HG11 ' HB2' ' A' ' 61' ' ' ASP . 77.6 t -73.54 72.11 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 -176.011 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.411 ' HZ ' ' CZ2' ' A' ' 4' ' ' TRP . 42.0 t80 -37.46 104.96 0.03 OUTLIER 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 125.647 1.579 . . . . 0.0 110.15 -178.791 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 118' ' ' CYS . . . . . 0.528 ' SG ' HD21 ' A' ' 80' ' ' LEU . 5.7 m -82.72 -44.68 15.35 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 -178.184 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 158.03 -145.71 12.22 Favored Glycine 0 N--CA 1.44 -1.09 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.497 HG13 ' CG ' ' A' ' 4' ' ' TRP . 1.1 mm -127.43 145.7 34.43 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.212 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 -175.528 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.656 HG13 HD23 ' A' ' 131' ' ' LEU . 5.7 pt -137.39 151.93 27.01 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.937 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 -177.717 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.876 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . . . 177.87 129.55 0.06 Allowed 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 122.088 0.947 . . . . 0.0 109.711 -178.719 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.534 ' CD2' HD12 ' A' ' 131' ' ' LEU . 0.0 OUTLIER -88.75 95.35 10.24 Favored 'General case' 0 N--CA 1.441 -0.881 0 O-C-N 121.431 -0.793 . . . . 0.0 110.583 179.594 . . . . . . . . 3 3 . 1 . 014 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.743 HG21 ' HA3' ' A' ' 7' ' ' GLY . 1.1 t -98.19 31.82 2.64 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 123.729 1.728 . . . . 0.0 112.221 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 70.1 tttt -84.32 -44.56 13.69 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 116.688 -1.625 . . . . 0.0 110.063 -178.642 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 169.86 -81.49 0.0 OUTLIER 'General case' 0 C--O 1.223 -0.313 0 O-C-N 126.013 2.071 . . . . 0.0 110.889 178.99 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -159.81 29.85 0.18 Allowed 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 124.387 1.075 . . . . 0.0 110.665 -178.344 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -171.8 89.72 0.11 Allowed 'General case' 0 N--CA 1.444 -0.744 0 CA-C-O 122.671 1.224 . . . . 0.0 110.267 -177.953 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 166.8 105.48 0.18 Allowed Glycine 0 CA--C 1.483 -1.933 0 CA-C-O 115.254 -2.97 . . . . 0.0 107.902 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -35.99 146.32 0.03 OUTLIER 'General case' 0 C--O 1.24 0.558 0 CA-C-N 119.494 1.647 . . . . 0.0 112.659 177.419 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.656 HD23 HG13 ' A' ' 121' ' ' ILE . 8.4 mp -57.45 148.25 24.0 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -175.704 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.2 pttt -123.56 149.96 44.63 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-O 118.263 -0.875 . . . . 0.0 108.779 -177.764 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.468 ' HB2' ' CG2' ' A' ' 55' ' ' ILE . 9.0 tp -61.56 127.7 32.71 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 124.798 1.311 . . . . 0.0 109.1 179.613 . . . . . . . . 2 2 . 1 . 014 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 35.2 m -67.19 -174.36 0.36 Allowed 'General case' 0 N--CA 1.436 -1.156 0 CA-C-O 122.707 1.242 . . . . 0.0 109.39 177.612 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 66.3 m -151.1 101.33 2.86 Favored 'General case' 0 C--N 1.322 -0.613 0 O-C-N 121.468 -0.77 . . . . 0.0 109.354 -179.35 . . . . . . . . 1 1 . 1 . 014 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.655 ' HB2' HG22 ' A' ' 2' ' ' VAL . 0.4 OUTLIER . . . . . 0 C--O 1.247 0.969 0 CA-C-O 116.527 -1.702 . . . . 0.0 113.313 175.131 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.945 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 . . . . . . . . . 0 0 . 1 . 015 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.611 HG22 ' HB2' ' A' ' 136' ' ' HIS . 9.1 p -119.66 135.52 59.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 C-N-CA 124.2 1.0 . . . . 0.0 109.564 177.037 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.9 m -90.09 115.38 27.31 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -176.537 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.441 ' CD1' ' HB2' ' A' ' 13' ' ' GLN . 23.3 m95 -78.23 142.28 38.0 Favored 'General case' 0 C--O 1.215 -0.725 0 O-C-N 121.676 -0.64 . . . . 0.0 110.671 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -140.66 141.74 35.01 Favored 'General case' 0 CA--C 1.499 -1.008 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 -177.361 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.613 ' SG ' ' HB3' ' A' ' 122' ' ' ALA . 0.1 OUTLIER -119.67 -79.14 0.6 Allowed 'General case' 0 C--O 1.218 -0.598 0 O-C-N 124.467 1.104 . . . . 0.0 111.034 176.916 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -74.32 -87.45 0.23 Allowed Glycine 0 C--O 1.219 -0.804 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -179.125 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -143.67 12.61 2.2 Favored Glycine 0 C--O 1.221 -0.662 0 O-C-N 121.573 -0.957 . . . . 0.0 111.704 178.293 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 22.4 mt -113.9 155.49 25.68 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 117.824 0.812 . . . . 0.0 109.581 178.925 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.4 mp -106.78 133.37 51.54 Favored 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -175.668 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.606 ' CZ ' ' HB3' ' A' ' 106' ' ' ALA . 60.8 m-85 -124.58 91.4 3.44 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 125.749 1.62 . . . . 0.0 106.992 -170.349 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -53.48 121.07 6.95 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 117.708 -1.139 . . . . 0.0 108.745 179.095 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.441 ' HB2' ' CD1' ' A' ' 4' ' ' TRP . 2.4 tt0 -52.24 -50.78 61.35 Favored 'General case' 0 CA--C 1.498 -1.029 0 CA-C-O 117.243 -1.361 . . . . 0.0 111.173 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -50.42 -36.84 34.87 Favored 'General case' 0 C--O 1.194 -1.825 0 O-C-N 125.42 1.7 . . . . 0.0 110.615 178.75 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.4 mttp -71.59 -51.01 25.61 Favored 'General case' 0 C--O 1.212 -0.917 0 CA-C-O 116.526 -1.702 . . . . 0.0 115.428 166.893 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.86 -35.11 9.79 Favored 'General case' 0 C--O 1.211 -0.936 0 CA-C-N 121.653 2.024 . . . . 0.0 113.024 171.949 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 16.0 pt-20 -88.32 -40.81 13.31 Favored 'General case' 0 C--O 1.205 -1.285 0 C-N-CA 125.76 1.624 . . . . 0.0 110.471 172.139 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.434 ' O ' ' CE1' ' A' ' 22' ' ' HIS . 20.4 t -77.0 -59.12 2.91 Favored 'General case' 0 CA--C 1.501 -0.912 0 O-C-N 117.217 -3.427 . . . . 0.0 108.123 -172.488 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -45.38 -32.31 2.03 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 167.215 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.492 ' HB3' HG11 ' A' ' 108' ' ' VAL . 54.5 p -83.74 -24.56 31.1 Favored 'General case' 0 C--O 1.216 -0.691 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 173.049 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -55.98 -37.91 69.72 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 126.504 1.922 . . . . 0.0 108.701 178.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.434 ' CE1' ' O ' ' A' ' 18' ' ' SER . 0.1 OUTLIER -71.02 -44.45 65.85 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 117.15 -1.405 . . . . 0.0 110.178 178.899 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.598 ' HB1' ' HG3' ' A' ' 35' ' ' PRO . . . -39.99 126.04 1.62 Allowed Pre-proline 0 CA--C 1.549 0.934 0 O-C-N 126.058 2.099 . . . . 0.0 111.287 176.098 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.751 ' HG2' HG22 ' A' ' 30' ' ' THR . 13.5 Cg_endo -72.67 123.41 9.0 Favored 'Trans proline' 0 N--CA 1.445 -1.38 0 C-N-CA 122.433 2.089 . . . . 0.0 107.804 -175.972 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.65 HD13 ' HE2' ' A' ' 115' ' ' LYS . 3.4 tp -60.51 87.85 0.02 OUTLIER 'General case' 0 CA--C 1.507 -0.704 0 C-N-CA 124.514 1.126 . . . . 0.0 112.414 178.39 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.4 m -174.53 148.96 1.23 Allowed 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.993 1.317 . . . . 0.0 109.95 -171.581 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.407 ' HB3' ' HA3' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -86.81 113.71 22.86 Favored 'General case' 0 CA--C 1.508 -0.655 0 C-N-CA 124.136 0.974 . . . . 0.0 110.176 176.362 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 54.03 72.41 0.55 Allowed Glycine 0 CA--C 1.525 0.669 0 C-N-CA 119.402 -1.38 . . . . 0.0 111.996 177.189 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.04 21.41 2.27 Favored 'General case' 0 CA--C 1.504 -0.813 0 O-C-N 121.438 -1.036 . . . . 0.0 112.724 177.951 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.751 HG22 ' HG2' ' A' ' 24' ' ' PRO . 10.7 p -129.57 152.07 49.49 Favored 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 -171.693 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -38.43 -66.87 0.58 Allowed Glycine 0 N--CA 1.442 -0.919 0 O-C-N 124.502 1.126 . . . . 0.0 112.858 178.392 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.42 ' HA ' ' CE ' ' A' ' 100' ' ' LYS . 24.2 t -52.77 -65.46 0.55 Allowed 'General case' 0 CA--C 1.492 -1.28 0 CA-C-O 114.994 -2.431 . . . . 0.0 113.07 173.803 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 160.87 -53.18 0.0 OUTLIER 'General case' 0 C--O 1.219 -0.552 0 O-C-N 127.626 3.079 . . . . 0.0 109.507 178.611 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.533 ' CE2' ' CE1' ' A' ' 36' ' ' HIS . 50.9 m-85 -61.46 147.05 88.61 Favored Pre-proline 0 N--CA 1.439 -1.008 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.598 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 23.2 Cg_endo -74.55 150.53 95.66 Favored 'Cis proline' 0 N--CA 1.443 -1.477 0 C-N-CA 123.457 -1.476 . . . . 0.0 109.6 0.772 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.533 ' CE1' ' CE2' ' A' ' 34' ' ' TYR . 0.4 OUTLIER -126.72 160.64 30.21 Favored 'General case' 0 CA--C 1.499 -1.008 0 CA-C-O 117.062 -1.447 . . . . 0.0 109.003 179.242 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.918 ' CH2' HG22 ' A' ' 39' ' ' THR . 22.1 t90 -58.45 148.8 26.92 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 124.763 1.289 . . . . 0.0 109.184 177.527 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.501 ' CZ ' HD13 ' A' ' 121' ' ' ILE . 10.8 t80 -129.22 78.36 1.85 Allowed 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 103.711 -2.7 . . . . 0.0 103.711 -170.711 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.918 HG22 ' CH2' ' A' ' 37' ' ' TRP . 44.7 p -39.15 -34.96 0.2 Allowed 'General case' 0 C--O 1.204 -1.31 0 C-N-CA 124.81 1.244 . . . . 0.0 110.117 173.855 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 56.7 t30 66.86 11.98 8.62 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.683 1.593 . . . . 0.0 110.523 178.799 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 108.15 -6.83 34.76 Favored Glycine 0 CA--C 1.537 1.451 0 O-C-N 120.96 -1.088 . . . . 0.0 114.687 -170.066 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.695 ' CE1' HD11 ' A' ' 48' ' ' LEU . 6.1 m-85 -78.26 168.51 19.73 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 124.472 1.109 . . . . 0.0 109.782 -178.298 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.11 -37.36 17.46 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.748 175.973 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.58 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . 176.43 -60.31 0.1 Allowed Glycine 0 CA--C 1.506 -0.469 0 C-N-CA 124.179 0.895 . . . . 0.0 112.881 -177.784 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -115.85 -63.11 1.5 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 122.716 1.246 . . . . 0.0 110.819 179.125 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.24 165.89 8.95 Favored Glycine 0 C--N 1.339 0.728 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 177.872 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.56 ' HA ' ' CE2' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -59.2 -168.97 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 123.288 1.518 . . . . 0.0 111.325 178.082 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.695 HD11 ' CE1' ' A' ' 42' ' ' TYR . 4.7 mp -77.14 152.12 81.85 Favored Pre-proline 0 N--CA 1.43 -1.458 0 O-C-N 120.472 -1.392 . . . . 0.0 110.833 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -72.17 170.43 19.1 Favored 'Trans proline' 0 N--CA 1.445 -1.336 0 C-N-CA 122.539 2.159 . . . . 0.0 110.792 179.0 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.92 100.43 0.07 Allowed 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.619 -0.676 . . . . 0.0 109.378 176.338 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.75 56.48 0.37 Allowed Glycine 0 CA--C 1.51 -0.252 0 O-C-N 121.684 -0.635 . . . . 0.0 111.552 -177.844 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.429 ' CB ' ' HB3' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -150.36 165.52 32.82 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 118.573 -0.727 . . . . 0.0 112.454 174.214 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 54.1 m -145.02 97.29 4.86 Favored Pre-proline 0 C--O 1.233 0.21 0 O-C-N 125.338 1.649 . . . . 0.0 110.276 -176.807 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.507 ' HG3' HD13 ' A' ' 48' ' ' LEU . 20.4 Cg_endo -72.47 148.09 47.65 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.878 2.385 . . . . 0.0 110.88 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.438 HD12 HG21 ' A' ' 121' ' ' ILE . 6.7 mt -69.18 120.97 17.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -177.877 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.6 tppt? -83.03 135.24 34.92 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 120.897 -1.127 . . . . 0.0 108.652 177.805 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.61 ' CE1' HD13 ' A' ' 133' ' ' LEU . 7.9 m-85 -118.44 -51.61 2.4 Favored 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 123.786 0.834 . . . . 0.0 109.858 -178.982 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 122.32 -4.51 10.3 Favored Glycine 0 C--O 1.222 -0.613 0 CA-C-O 119.35 -0.695 . . . . 0.0 112.831 -175.282 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.435 ' HD3' ' CG1' ' A' ' 116' ' ' VAL . 1.6 mtpt -96.5 139.03 33.2 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-N 118.399 1.1 . . . . 0.0 110.553 175.832 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 23.2 t -74.77 -1.71 23.27 Favored 'General case' 0 C--O 1.222 -0.351 0 O-C-N 124.771 1.294 . . . . 0.0 111.961 175.027 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -87.95 -54.16 4.37 Favored 'General case' 0 CA--C 1.516 -0.364 0 O-C-N 120.793 -1.192 . . . . 0.0 108.709 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.585 ' HA ' HD11 ' A' ' 80' ' ' LEU . 2.7 m -75.47 -32.38 60.57 Favored 'General case' 0 N--CA 1.45 -0.438 0 O-C-N 124.028 0.83 . . . . 0.0 109.426 -178.845 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -62.88 -39.17 93.66 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 122.556 1.169 . . . . 0.0 110.811 173.056 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.602 ' HD3' ' CD2' ' A' ' 78' ' ' HIS . 0.0 OUTLIER -53.64 160.01 2.21 Favored Pre-proline 0 N--CA 1.444 -0.749 0 O-C-N 120.973 -1.079 . . . . 0.0 112.621 178.78 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -70.32 133.87 25.53 Favored 'Trans proline' 0 N--CA 1.438 -1.79 0 N-CA-C 114.697 0.999 . . . . 0.0 114.697 172.202 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.475 ' HD2' ' CD2' ' A' ' 42' ' ' TYR . 21.1 Cg_endo -70.46 168.92 21.07 Favored 'Trans proline' 0 N--CA 1.439 -1.685 0 C-N-CA 124.115 3.21 . . . . 0.0 111.238 176.665 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.9 tptt -128.05 51.75 1.94 Allowed 'General case' 0 C--O 1.199 -1.583 0 CA-C-N 115.02 -0.991 . . . . 0.0 108.826 177.808 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -75.66 168.82 19.3 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 119.921 -1.737 . . . . 0.0 110.972 178.395 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 24.0 p -161.67 -156.82 0.45 Allowed 'General case' 0 C--O 1.222 -0.375 0 O-C-N 120.994 -1.066 . . . . 0.0 111.846 174.317 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.11 70.88 9.13 Favored 'General case' 0 C--O 1.215 -0.719 0 O-C-N 120.67 -1.269 . . . . 0.0 112.739 172.315 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -176.08 -40.78 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.88 0.848 . . . . 0.0 109.701 177.483 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.407 ' HA3' ' HB3' ' A' ' 27' ' ' ASP . . . 108.67 -57.82 0.42 Allowed Glycine 0 C--O 1.212 -1.219 0 CA-C-O 118.389 -1.228 . . . . 0.0 111.761 -175.658 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.6 p-10 -135.05 67.92 1.48 Allowed 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 105.529 -2.026 . . . . 0.0 105.529 -173.445 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.47 -119.24 0.01 OUTLIER Glycine 0 CA--C 1.529 0.93 0 CA-C-O 122.411 1.006 . . . . 0.0 113.001 177.801 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.7 mttt -63.79 -99.3 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.528 0 O-C-N 119.32 -2.282 . . . . 0.0 112.156 176.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.474 HG23 ' O ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -105.46 12.45 31.43 Favored 'General case' 0 C--N 1.317 -0.841 0 O-C-N 119.453 -2.03 . . . . 0.0 110.547 178.433 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.463 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 21.1 m-20 -29.66 105.83 0.03 OUTLIER 'General case' 0 C--O 1.201 -1.498 0 C-N-CA 126.234 1.813 . . . . 0.0 110.41 -176.479 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.602 ' CD2' ' HD3' ' A' ' 64' ' ' ARG . 2.7 p-80 -86.21 14.02 7.07 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 120.144 1.338 . . . . 0.0 110.082 -175.357 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.898 ' CZ ' HD11 ' A' ' 81' ' ' LEU . 0.4 OUTLIER -32.55 132.2 0.14 Allowed 'General case' 0 N--CA 1.439 -1.018 0 C-N-CA 126.015 1.726 . . . . 0.0 112.887 170.428 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.585 HD11 ' HA ' ' A' ' 62' ' ' CYS . 0.2 OUTLIER -75.61 155.53 35.8 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 121.015 -1.053 . . . . 0.0 109.067 178.238 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.898 HD11 ' CZ ' ' A' ' 79' ' ' TYR . 1.7 mp -141.81 134.36 28.28 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 118.874 0.761 . . . . 0.0 109.354 176.835 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.451 ' CB ' ' CD1' ' A' ' 109' ' ' ILE . 1.7 pm0 -103.13 154.56 19.17 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 122.842 1.306 . . . . 0.0 110.78 179.396 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.478 ' HZ ' ' CD2' ' A' ' 94' ' ' PHE . 37.8 t80 -141.79 138.82 17.5 Favored Pre-proline 0 C--O 1.218 -0.559 0 O-C-N 121.265 -0.897 . . . . 0.0 112.853 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.506 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 14.6 Cg_endo -72.15 88.35 0.84 Allowed 'Trans proline' 0 CA--C 1.485 -1.942 0 C-N-CA 124.658 3.572 . . . . 0.0 109.341 -173.29 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.7 t -80.11 116.62 20.32 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.674 0.789 . . . . 0.0 111.769 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.506 ' CD1' ' CE1' ' A' ' 92' ' ' TYR . 7.8 m-85 -84.65 159.09 58.88 Favored Pre-proline 0 C--N 1.318 -0.777 0 O-C-N 120.406 -1.434 . . . . 0.0 110.701 -179.556 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -76.42 -45.29 0.21 Allowed 'Trans proline' 0 N--CA 1.446 -1.291 0 C-N-CA 122.252 1.968 . . . . 0.0 111.544 178.766 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -53.62 -28.75 34.47 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 124.108 1.909 . . . . 0.0 110.229 177.275 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.73 -9.5 51.1 Favored Glycine 0 N--CA 1.436 -1.354 0 CA-C-O 116.458 -2.301 . . . . 0.0 112.133 -177.434 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 2.7 p80 -50.53 138.91 16.74 Favored 'General case' 0 C--O 1.209 -1.041 0 CA-C-O 116.805 -1.569 . . . . 0.0 107.887 178.609 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -62.1 143.51 56.57 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 120.88 1.673 . . . . 0.0 111.644 175.782 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.506 ' CE1' ' CD1' ' A' ' 86' ' ' PHE . 0.1 OUTLIER -98.01 155.08 17.28 Favored 'General case' 0 C--O 1.215 -0.756 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -174.159 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.73 55.11 2.59 Favored 'General case' 0 C--N 1.314 -0.935 0 O-C-N 118.515 -2.615 . . . . 0.0 111.053 172.18 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.478 ' CD2' ' HZ ' ' A' ' 83' ' ' PHE . 40.0 p90 -69.24 -26.74 64.94 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-O 117.828 -1.082 . . . . 0.0 110.877 175.412 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -90.09 -21.05 22.48 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 119.956 1.253 . . . . 0.0 111.442 179.234 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.7 m -108.77 101.05 10.21 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 -178.747 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.26 -29.57 67.5 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.896 0.855 . . . . 0.0 110.234 175.969 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.6 mttm -125.75 113.38 24.85 Favored Pre-proline 0 N--CA 1.444 -0.745 0 CA-C-O 117.654 -1.165 . . . . 0.0 109.276 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -70.29 173.36 46.84 Favored 'Cis proline' 0 C--N 1.356 0.926 0 O-C-N 124.44 1.758 . . . . 0.0 110.521 -3.556 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.42 ' CE ' ' HA ' ' A' ' 32' ' ' SER . 0.5 OUTLIER -130.39 145.99 51.89 Favored 'General case' 0 CA--C 1.507 -0.705 0 C-N-CA 125.293 1.437 . . . . 0.0 110.021 177.863 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.07 175.19 5.53 Favored 'General case' 0 C--O 1.243 0.733 0 O-C-N 125.751 1.907 . . . . 0.0 109.122 -177.869 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -76.49 139.83 67.9 Favored Pre-proline 0 N--CA 1.442 -0.849 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.916 176.626 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -72.74 -165.61 0.24 Allowed 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 122.523 2.149 . . . . 0.0 111.899 175.612 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -136.3 163.89 25.11 Favored Glycine 0 CA--C 1.525 0.679 0 O-C-N 120.853 -1.154 . . . . 0.0 112.891 176.236 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -76.62 -50.12 0.11 Allowed 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.464 2.109 . . . . 0.0 110.898 178.846 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.606 ' HB3' ' CZ ' ' A' ' 11' ' ' TYR . . . -75.29 142.51 43.27 Favored 'General case' 0 CA--C 1.51 -0.563 0 O-C-N 121.903 -0.498 . . . . 0.0 110.465 177.331 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.491 ' HG2' ' HA ' ' A' ' 84' ' ' PRO . 3.6 mtm-85 -143.81 145.69 32.53 Favored 'General case' 0 CA--C 1.5 -0.968 0 CA-C-O 117.721 -1.133 . . . . 0.0 112.415 178.32 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.492 HG11 ' HB3' ' A' ' 20' ' ' SER . 5.3 p -79.15 124.98 38.2 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.476 0 O-C-N 124.176 0.922 . . . . 0.0 110.62 177.769 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.524 HG12 HG23 ' A' ' 121' ' ' ILE . 4.4 mm -103.99 141.38 19.74 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 C-N-CA 123.914 0.886 . . . . 0.0 109.718 -179.086 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.502 ' O ' HD23 ' A' ' 80' ' ' LEU . 10.4 p90 -166.01 152.48 9.41 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 122.891 1.329 . . . . 0.0 110.034 -178.161 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.7 p -89.79 167.68 12.68 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.062 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.588 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.3 OUTLIER -108.46 153.83 41.86 Favored Pre-proline 0 CA--C 1.552 1.031 0 O-C-N 123.534 0.521 . . . . 0.0 111.341 177.182 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.588 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 14.1 Cg_endo -75.81 -55.27 0.14 OUTLIER 'Cis proline' 0 CA--C 1.49 -1.706 0 N-CA-C 107.998 -1.578 . . . . 0.0 107.998 -5.681 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -44.17 112.24 0.38 Allowed 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 116.279 -1.82 . . . . 0.0 109.713 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.65 ' HE2' HD13 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -66.44 76.17 0.1 Allowed 'General case' 0 CA--C 1.505 -0.755 0 C-N-CA 124.797 1.239 . . . . 0.0 107.985 -177.666 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.435 ' CG1' ' HD3' ' A' ' 59' ' ' LYS . 54.8 t -75.83 72.03 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 -176.255 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.56 ' CE1' ' HA2' ' A' ' 119' ' ' GLY . 7.6 t80 -39.08 111.17 0.17 Allowed 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 126.321 1.848 . . . . 0.0 106.84 -178.819 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 118' ' ' CYS . . . . . 0.548 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 0.1 OUTLIER -91.25 -22.78 20.41 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 121.126 -0.23 . . . . 0.0 110.405 175.974 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.56 ' HA2' ' CE1' ' A' ' 117' ' ' PHE . . . 134.82 -170.31 22.86 Favored Glycine 0 CA--C 1.496 -1.148 0 C-N-CA 123.621 0.629 . . . . 0.0 112.1 -176.636 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.539 HG21 ' HB1' ' A' ' 106' ' ' ALA . 3.4 mp -107.67 151.53 9.66 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 -179.274 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.72 HG22 HD12 ' A' ' 133' ' ' LEU . 9.9 pt -120.94 154.72 24.5 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.621 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 177.327 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.613 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . . . -174.34 157.97 2.83 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 123.644 1.688 . . . . 0.0 110.069 175.117 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.452 ' CE1' ' HG ' ' A' ' 131' ' ' LEU . 7.2 m-70 -90.57 95.78 10.33 Favored 'General case' 0 C--O 1.219 -0.547 0 O-C-N 120.717 -1.239 . . . . 0.0 108.457 -176.339 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.639 HG22 ' HD2' ' A' ' 132' ' ' LYS . 1.3 t -96.85 36.53 1.39 Allowed 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 124.391 2.043 . . . . 0.0 111.328 -179.492 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.5 tptt -101.53 -28.69 12.4 Favored 'General case' 0 C--O 1.217 -0.632 0 O-C-N 119.153 -2.217 . . . . 0.0 111.214 178.075 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -171.06 -66.18 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.57 0 O-C-N 123.62 0.575 . . . . 0.0 110.079 177.671 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -155.59 -44.77 0.08 Allowed 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 122.096 0.951 . . . . 0.0 110.194 179.348 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -153.55 79.1 1.15 Allowed 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 125.167 1.387 . . . . 0.0 109.269 -178.936 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -130.49 -103.54 1.0 Allowed Glycine 0 N--CA 1.463 0.486 0 O-C-N 120.399 -1.438 . . . . 0.0 109.723 176.814 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.25 150.57 21.9 Favored 'General case' 0 C--N 1.323 -0.577 0 O-C-N 120.99 -1.3 . . . . 0.0 110.701 -178.812 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.561 HD23 ' H ' ' A' ' 132' ' ' LYS . 0.6 OUTLIER -104.96 146.46 29.0 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 118.941 0.791 . . . . 0.0 109.246 179.445 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.639 ' HD2' HG22 ' A' ' 124' ' ' THR . 0.0 OUTLIER -151.96 168.35 25.49 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 125.412 1.485 . . . . 0.0 109.759 -179.9 . . . . . . . . 3 3 . 1 . 015 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.72 HD12 HG22 ' A' ' 121' ' ' ILE . 10.4 tp -84.41 141.44 30.83 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.656 1.223 . . . . 0.0 108.387 177.245 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 134' ' ' CYS . . . . . 0.537 ' SG ' HG22 ' A' ' 120' ' ' ILE . 79.4 m -60.64 -179.42 0.12 Allowed 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 123.264 1.507 . . . . 0.0 110.312 174.889 . . . . . . . . 2 2 . 1 . 015 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 13.2 m -159.06 87.79 0.87 Allowed 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 104.002 -2.592 . . . . 0.0 104.002 -176.993 . . . . . . . . 1 1 . 1 . 015 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.611 ' HB2' HG22 ' A' ' 2' ' ' VAL . 0.2 OUTLIER . . . . . 0 C--O 1.257 1.48 0 CA-C-O 114.024 -2.893 . . . . 0.0 114.756 167.939 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.514 -0.412 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 . . . . . . . . . 0 0 . 1 . 016 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.7 p -84.19 146.73 6.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.611 0.719 . . . . 0.0 109.974 177.733 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.9 m -88.04 114.49 24.71 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 123.665 0.786 . . . . 0.0 109.368 -178.927 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 19.5 m95 -79.01 144.32 34.81 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.052 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -138.61 134.35 33.65 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -178.426 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.617 ' SG ' ' HB3' ' A' ' 122' ' ' ALA . 0.1 OUTLIER -118.78 -84.19 0.65 Allowed 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.42 0.628 . . . . 0.0 110.374 176.911 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 7' ' ' GLY . . . . . 0.46 ' O ' HD12 ' A' ' 9' ' ' LEU . . . -92.85 75.1 1.26 Allowed Glycine 0 C--O 1.217 -0.927 0 CA-C-O 117.564 -1.687 . . . . 0.0 111.813 -177.447 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 45.9 27.5 2.4 Favored Glycine 0 N--CA 1.473 1.145 0 CA-C-N 118.96 1.38 . . . . 0.0 113.948 -175.885 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.46 HD12 ' O ' ' A' ' 7' ' ' GLY . 2.6 mt -129.98 149.17 51.82 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -174.912 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.584 HD22 ' H ' ' A' ' 10' ' ' LEU . 0.1 OUTLIER -100.42 155.15 17.98 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 124.487 1.117 . . . . 0.0 108.102 -173.826 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.775 ' CZ ' ' HB3' ' A' ' 106' ' ' ALA . 50.7 m-85 -158.72 86.03 0.84 Allowed 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 122.181 0.991 . . . . 0.0 108.872 -172.463 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -54.99 125.22 19.5 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-O 117.058 -1.449 . . . . 0.0 108.727 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 1.2 tt0 -49.74 -35.07 20.88 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-N 119.106 0.866 . . . . 0.0 111.271 178.585 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.404 ' O ' ' CB ' ' A' ' 18' ' ' SER . 8.4 t-20 -61.07 -44.91 96.65 Favored 'General case' 0 C--O 1.204 -1.317 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.41 175.95 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.4 -42.88 64.67 Favored 'General case' 0 C--O 1.207 -1.15 0 CA-C-O 117.736 -1.126 . . . . 0.0 111.899 173.73 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -52.09 -39.8 60.3 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 119.893 1.224 . . . . 0.0 111.422 176.521 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -85.81 -47.91 9.27 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-O 117.907 -1.044 . . . . 0.0 110.387 176.099 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.404 ' CB ' ' O ' ' A' ' 14' ' ' ASN . 29.0 t -64.39 -59.42 4.38 Favored 'General case' 0 CA--C 1.499 -0.992 0 C-N-CA 125.982 1.713 . . . . 0.0 107.948 -173.368 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.471 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 13.4 t-20 -38.07 -40.51 0.49 Allowed 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 118.919 0.782 . . . . 0.0 112.362 172.019 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.6 -38.2 40.53 Favored 'General case' 0 C--O 1.218 -0.602 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 174.52 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -43.55 -36.04 1.93 Allowed 'General case' 0 C--N 1.34 0.191 0 C-N-CA 126.25 1.82 . . . . 0.0 109.87 178.037 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.471 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.1 OUTLIER -74.8 -52.0 12.59 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 124.318 1.047 . . . . 0.0 111.105 177.226 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.442 ' HB1' ' HG3' ' A' ' 35' ' ' PRO . . . -37.58 126.08 0.92 Allowed Pre-proline 0 CA--C 1.544 0.722 0 O-C-N 124.967 1.417 . . . . 0.0 111.629 174.826 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.637 ' HG2' HG22 ' A' ' 30' ' ' THR . 19.2 Cg_endo -73.09 132.18 17.77 Favored 'Trans proline' 0 N--CA 1.445 -1.343 0 C-N-CA 122.033 1.822 . . . . 0.0 110.125 -178.088 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.644 HD13 ' HE2' ' A' ' 115' ' ' LYS . 7.3 tp -59.79 112.42 1.83 Allowed 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.561 179.017 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 179.71 149.98 0.33 Allowed 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 122.617 0.367 . . . . 0.0 111.193 -178.715 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.549 ' HB2' ' CE2' ' A' ' 79' ' ' TYR . 4.2 t0 -86.86 78.99 8.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 122.024 0.916 . . . . 0.0 108.62 -179.378 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 28' ' ' GLY . . . . . 0.44 ' N ' ' HA ' ' A' ' 36' ' ' HIS . . . 68.38 76.93 0.4 Allowed Glycine 0 N--CA 1.451 -0.333 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 177.019 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -152.13 40.55 0.63 Allowed 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 122.342 1.068 . . . . 0.0 111.876 178.503 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.637 HG22 ' HG2' ' A' ' 24' ' ' PRO . 8.4 p -121.32 159.1 26.76 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 -176.665 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -37.66 -77.81 0.05 OUTLIER Glycine 0 C--N 1.333 0.407 0 C-N-CA 125.145 1.355 . . . . 0.0 111.846 -178.607 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.417 ' OG ' ' HE2' ' A' ' 100' ' ' LYS . 18.0 t -55.24 -57.11 13.15 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.137 177.493 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 161.1 -51.16 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.568 0 O-C-N 124.859 1.35 . . . . 0.0 111.44 178.191 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.426 ' CD1' ' HD3' ' A' ' 84' ' ' PRO . 90.2 m-85 -69.53 147.36 96.71 Favored Pre-proline 0 N--CA 1.444 -0.775 0 O-C-N 124.089 0.868 . . . . 0.0 112.915 178.591 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.597 ' CB ' HD21 ' A' ' 81' ' ' LEU . 28.4 Cg_endo -77.42 179.3 31.66 Favored 'Cis proline' 0 N--CA 1.446 -1.314 0 C-N-CA 122.359 -1.934 . . . . 0.0 112.426 2.572 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.44 ' HA ' ' N ' ' A' ' 28' ' ' GLY . 0.5 OUTLIER -154.29 167.58 29.47 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-O 118.322 -0.847 . . . . 0.0 110.972 -179.87 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.908 ' CH2' HG22 ' A' ' 39' ' ' THR . 17.9 t90 -61.74 152.23 31.76 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 122.183 0.992 . . . . 0.0 109.546 175.638 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.48 ' CE2' ' HB2' ' A' ' 40' ' ' ASN . 8.7 t80 -125.27 84.46 2.28 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 -175.411 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.908 HG22 ' CH2' ' A' ' 37' ' ' TRP . 62.3 p -38.67 -36.4 0.25 Allowed 'General case' 0 C--O 1.214 -0.784 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.234 173.372 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.48 ' HB2' ' CE2' ' A' ' 38' ' ' PHE . 51.3 t30 55.07 21.15 3.65 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-O 122.697 1.237 . . . . 0.0 110.849 177.816 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.594 ' HA3' HD23 ' A' ' 48' ' ' LEU . . . 106.9 -40.08 2.64 Favored Glycine 0 N--CA 1.423 -2.186 0 CA-C-O 118.504 -1.164 . . . . 0.0 114.431 -171.038 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.496 ' CE2' ' HD3' ' A' ' 66' ' ' PRO . 76.1 m-85 -48.72 155.42 0.57 Allowed 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 118.998 1.399 . . . . 0.0 111.761 177.492 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.44 -36.29 22.45 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.376 0.608 . . . . 0.0 110.796 178.428 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.512 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -172.21 -61.87 0.04 OUTLIER Glycine 0 C--N 1.335 0.498 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -178.864 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -123.33 -64.19 1.18 Allowed 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 122.542 0.337 . . . . 0.0 110.891 -178.515 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.64 -174.13 0.14 Allowed Glycine 0 C--N 1.345 1.043 0 C-N-CA 124.435 1.016 . . . . 0.0 110.676 178.703 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -59.99 -166.28 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 123.793 1.759 . . . . 0.0 110.687 178.581 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.736 ' H ' HD12 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -94.31 170.17 8.65 Favored Pre-proline 0 C--N 1.312 -1.034 0 O-C-N 120.995 -1.066 . . . . 0.0 110.217 -178.518 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -71.64 158.18 54.12 Favored 'Trans proline' 0 N--CA 1.441 -1.582 0 C-N-CA 121.913 1.742 . . . . 0.0 111.062 178.539 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.28 97.59 0.09 Allowed 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.983 177.459 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 119.85 39.31 0.66 Allowed Glycine 0 C--O 1.227 -0.283 0 CA-C-O 119.476 -0.624 . . . . 0.0 111.952 -176.914 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.47 ' HG2' ' CA ' ' A' ' 41' ' ' GLY . 0.0 OUTLIER -122.63 161.81 23.09 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 117.759 0.779 . . . . 0.0 111.283 177.103 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 26.0 m -139.74 98.32 7.91 Favored Pre-proline 0 C--N 1.328 -0.357 0 O-C-N 124.265 0.978 . . . . 0.0 110.054 -178.773 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -72.06 161.19 45.47 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 122.052 1.835 . . . . 0.0 111.674 178.747 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.448 HD12 HG21 ' A' ' 121' ' ' ILE . 6.9 mt -85.43 121.47 37.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 -178.81 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.66 135.07 35.13 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 177.542 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.582 ' CE1' HD13 ' A' ' 133' ' ' LEU . 15.1 m-85 -118.3 -51.87 2.4 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 123.354 0.661 . . . . 0.0 110.617 179.361 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 122.42 -2.09 10.4 Favored Glycine 0 C--O 1.226 -0.366 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.302 -176.938 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 33.9 mmtt -100.0 141.61 32.58 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-N 117.567 0.683 . . . . 0.0 110.195 177.241 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 44.9 t -76.22 -2.06 29.48 Favored 'General case' 0 C--O 1.221 -0.429 0 O-C-N 124.66 1.225 . . . . 0.0 111.226 176.522 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.618 ' OD2' HG11 ' A' ' 116' ' ' VAL . 0.7 OUTLIER -87.83 -55.56 3.72 Favored 'General case' 0 CA--C 1.512 -0.511 0 O-C-N 120.876 -1.14 . . . . 0.0 109.075 -179.196 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.738 ' HA ' HD11 ' A' ' 80' ' ' LEU . 2.0 m -74.38 -31.77 62.49 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 124.586 1.179 . . . . 0.0 109.383 -179.57 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -64.89 -38.24 90.3 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 122.279 1.037 . . . . 0.0 110.586 175.053 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.12 160.1 2.57 Favored Pre-proline 0 N--CA 1.445 -0.676 0 O-C-N 121.179 -0.95 . . . . 0.0 112.251 179.304 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.4 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 22.2 Cg_endo -71.2 140.62 37.73 Favored 'Trans proline' 0 N--CA 1.441 -1.586 0 C-N-CA 120.326 0.684 . . . . 0.0 113.422 175.629 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.496 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 22.9 Cg_endo -73.1 170.3 20.14 Favored 'Trans proline' 0 N--CA 1.446 -1.307 0 C-N-CA 123.542 2.828 . . . . 0.0 111.415 177.949 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.9 tptp -136.15 57.38 1.78 Allowed 'General case' 0 C--O 1.214 -0.789 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -178.913 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 43.8 t-80 -74.0 154.95 39.07 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 124.486 2.089 . . . . 0.0 113.09 175.285 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.07 -172.08 3.5 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 118.677 -2.514 . . . . 0.0 110.411 178.2 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -85.26 69.48 10.74 Favored 'General case' 0 N--CA 1.45 -0.44 0 O-C-N 121.947 -0.471 . . . . 0.0 111.042 176.717 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -177.76 -42.68 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 123.555 0.535 . . . . 0.0 110.112 179.365 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.507 ' CA ' ' HB3' ' A' ' 27' ' ' ASP . . . 124.98 -78.95 0.37 Allowed Glycine 0 N--CA 1.441 -0.967 0 CA-C-N 115.189 -0.914 . . . . 0.0 112.727 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -118.86 58.66 0.84 Allowed 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.236 1.015 . . . . 0.0 108.956 178.353 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -57.28 -105.58 0.01 OUTLIER Glycine 0 CA--C 1.525 0.701 0 CA-C-O 121.661 0.589 . . . . 0.0 112.695 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 22.1 mttt -60.97 -96.32 0.0 OUTLIER 'General case' 0 C--O 1.222 -0.384 0 O-C-N 121.197 -1.178 . . . . 0.0 111.259 177.393 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.583 HG23 ' O ' ' A' ' 76' ' ' THR . 0.6 OUTLIER -126.63 26.88 6.2 Favored 'General case' 0 CA--C 1.511 -0.527 0 O-C-N 121.645 -0.659 . . . . 0.0 111.086 178.902 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.476 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 1.9 m-20 -34.49 106.23 0.04 OUTLIER 'General case' 0 C--O 1.216 -0.689 0 C-N-CA 124.597 1.159 . . . . 0.0 109.91 -176.732 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.461 ' CD2' ' H ' ' A' ' 78' ' ' HIS . 0.4 OUTLIER -84.19 19.49 1.83 Allowed 'General case' 0 C--N 1.328 -0.354 0 O-C-N 121.142 -0.974 . . . . 0.0 110.63 -177.37 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.549 ' CE2' ' HB2' ' A' ' 27' ' ' ASP . 22.9 p90 -48.49 135.46 14.19 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 124.695 1.198 . . . . 0.0 110.818 177.933 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.738 HD11 ' HA ' ' A' ' 62' ' ' CYS . 0.2 OUTLIER -76.07 137.24 40.05 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.431 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.85 HD22 ' CZ ' ' A' ' 110' ' ' TYR . 0.3 OUTLIER -123.91 148.76 46.58 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.132 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -115.16 163.45 15.63 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.725 -0.671 . . . . 0.0 112.134 176.965 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.508 ' CD1' ' HD2' ' A' ' 84' ' ' PRO . 40.2 t80 -152.61 133.93 8.19 Favored Pre-proline 0 CA--C 1.534 0.352 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -178.981 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.508 ' HD2' ' CD1' ' A' ' 83' ' ' PHE . 17.8 Cg_endo -72.27 104.3 1.66 Allowed 'Trans proline' 0 N--CA 1.446 -1.299 0 C-N-CA 123.345 2.697 . . . . 0.0 110.626 -176.573 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.426 ' HA ' ' OD1' ' A' ' 19' ' ' ASN . 1.6 t -105.92 108.36 19.83 Favored 'General case' 0 CA--C 1.5 -0.947 0 O-C-N 124.356 1.035 . . . . 0.0 110.136 -178.773 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.438 ' CD2' ' NE2' ' A' ' 90' ' ' HIS . 1.4 m-85 -85.29 161.25 52.45 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-O 121.138 0.494 . . . . 0.0 111.372 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -76.33 -41.23 0.49 Allowed 'Trans proline' 0 CA--C 1.496 -1.395 0 C-N-CA 121.871 1.714 . . . . 0.0 112.711 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -39.54 -31.13 0.08 Allowed 'General case' 0 N--CA 1.469 0.497 0 O-C-N 124.989 1.431 . . . . 0.0 111.363 175.176 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 91.58 -9.96 75.85 Favored Glycine 0 N--CA 1.43 -1.76 0 C-N-CA 124.749 1.166 . . . . 0.0 111.892 179.234 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.438 ' NE2' ' CD2' ' A' ' 86' ' ' PHE . 0.5 OUTLIER -57.63 143.8 39.97 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 122.712 1.244 . . . . 0.0 109.089 177.447 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -88.6 122.54 32.16 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 174.827 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -48.11 170.02 0.02 OUTLIER 'General case' 0 C--O 1.214 -0.78 0 CA-C-O 123.213 1.482 . . . . 0.0 113.614 175.761 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.86 60.83 1.1 Allowed 'General case' 0 C--N 1.321 -0.634 0 O-C-N 119.371 -2.081 . . . . 0.0 107.33 -176.937 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.415 ' CD2' ' HZ ' ' A' ' 83' ' ' PHE . 7.3 p90 -81.12 14.91 2.09 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 121.742 -0.599 . . . . 0.0 112.1 177.417 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -108.46 -31.41 7.82 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.458 0.647 . . . . 0.0 109.982 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.8 m -113.87 116.09 28.75 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 123.175 0.59 . . . . 0.0 109.474 -179.589 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.8 pttm -58.33 -45.48 88.02 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.058 177.741 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.419 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 9.7 ttmt -142.07 131.9 12.47 Favored Pre-proline 0 N--CA 1.442 -0.87 0 CA-C-O 118.424 -0.798 . . . . 0.0 109.948 -179.138 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.419 ' C ' ' HA ' ' A' ' 98' ' ' LYS . 30.9 Cg_endo -70.25 175.37 38.41 Favored 'Cis proline' 0 N--CA 1.456 -0.724 0 O-C-N 124.769 1.931 . . . . 0.0 112.256 -4.437 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.417 ' HE2' ' OG ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -145.18 147.54 32.58 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 177.765 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -84.86 175.87 8.85 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.24 0.543 . . . . 0.0 111.276 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -73.13 140.67 80.36 Favored Pre-proline 0 CA--C 1.545 0.754 0 O-C-N 121.469 -0.769 . . . . 0.0 111.361 175.258 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -70.26 -161.85 0.09 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.47 2.114 . . . . 0.0 113.356 175.431 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -137.83 158.08 24.49 Favored Glycine 0 CA--C 1.523 0.592 0 O-C-N 120.948 -1.095 . . . . 0.0 111.625 176.485 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -74.4 -41.03 0.95 Allowed 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 122.242 1.962 . . . . 0.0 111.374 179.184 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.775 ' HB3' ' CZ ' ' A' ' 11' ' ' TYR . . . -90.28 138.23 31.7 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 121.082 0.467 . . . . 0.0 110.03 177.739 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.463 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 0.0 OUTLIER -139.32 151.82 46.71 Favored 'General case' 0 C--O 1.213 -0.845 0 CA-C-O 117.916 -1.04 . . . . 0.0 111.483 177.753 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.517 ' C ' HD12 ' A' ' 109' ' ' ILE . 3.3 p -82.62 120.71 34.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 123.958 0.903 . . . . 0.0 110.584 177.403 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.517 HD12 ' C ' ' A' ' 108' ' ' VAL . 1.7 mp -108.16 120.49 59.61 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.628 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 -176.756 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.85 ' CZ ' HD22 ' A' ' 81' ' ' LEU . 5.8 p90 -140.92 152.42 45.01 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 122.733 1.254 . . . . 0.0 110.149 -178.853 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.44 HG22 HD21 ' A' ' 80' ' ' LEU . 3.0 p -84.33 160.88 20.6 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.788 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.56 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.3 OUTLIER -113.01 152.83 45.26 Favored Pre-proline 0 CA--C 1.545 0.758 0 CA-C-O 120.464 0.173 . . . . 0.0 110.927 179.506 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.56 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 19.3 Cg_endo -74.25 -50.03 0.2 Allowed 'Cis proline' 0 CA--C 1.499 -1.261 0 C-N-CA 123.462 -1.474 . . . . 0.0 111.043 -5.021 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 32.6 t-20 -44.39 106.57 0.07 Allowed 'General case' 0 CA--C 1.512 -0.516 0 O-C-N 125.03 1.456 . . . . 0.0 108.801 178.582 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.644 ' HE2' HD13 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -67.88 68.56 0.11 Allowed 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 124.322 1.049 . . . . 0.0 108.811 -178.828 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.618 HG11 ' OD2' ' A' ' 61' ' ' ASP . 24.2 t -73.87 73.32 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 -177.787 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.561 ' CE1' ' HA2' ' A' ' 119' ' ' GLY . 4.6 t80 -37.26 117.1 0.51 Allowed 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 124.65 1.18 . . . . 0.0 108.139 179.132 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 118' ' ' CYS . . . . . 0.563 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -97.15 -34.08 11.26 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.744 177.328 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.561 ' HA2' ' CE1' ' A' ' 117' ' ' PHE . . . 146.25 -175.09 25.9 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 123.484 0.564 . . . . 0.0 111.708 -178.375 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.711 HG21 ' HB1' ' A' ' 106' ' ' ALA . 3.3 mp -103.66 149.38 7.63 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.745 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -179.185 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.448 HG21 HD12 ' A' ' 55' ' ' ILE . 5.3 pt -122.16 151.85 26.03 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 178.873 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.617 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . . . -176.65 132.55 0.21 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 122.558 1.171 . . . . 0.0 109.504 178.204 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -88.17 94.83 9.94 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 121.079 -1.013 . . . . 0.0 110.687 179.188 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.504 ' O ' HG23 ' A' ' 124' ' ' THR . 1.1 t -98.48 33.19 2.3 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 123.154 1.454 . . . . 0.0 111.306 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.4 tttt -84.32 -46.42 11.8 Favored 'General case' 0 C--O 1.215 -0.728 0 CA-C-O 117.866 -1.064 . . . . 0.0 109.709 179.168 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 172.74 -82.39 0.0 OUTLIER 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 124.592 1.157 . . . . 0.0 110.371 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -157.99 25.64 0.26 Allowed 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.483 1.113 . . . . 0.0 110.704 -178.568 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -170.82 88.56 0.12 Allowed 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 122.069 0.938 . . . . 0.0 110.599 -177.631 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 167.94 104.15 0.17 Allowed Glycine 0 CA--C 1.491 -1.421 0 CA-C-O 116.04 -2.533 . . . . 0.0 107.134 179.266 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -33.02 139.23 0.05 Allowed 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.686 1.595 . . . . 0.0 112.35 177.878 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 122' ' ' ALA . 0.3 OUTLIER -56.94 156.01 7.32 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.185 -177.632 . . . . . . . . 3 3 . 1 . 016 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -132.87 153.37 51.39 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -176.905 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.582 HD13 ' CE1' ' A' ' 57' ' ' PHE . 9.9 tp -59.63 129.64 42.9 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 125.141 1.526 . . . . 0.0 107.42 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 134' ' ' CYS . . . . . 0.59 ' SG ' HG22 ' A' ' 120' ' ' ILE . 79.9 m -58.64 -177.22 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 125.031 1.457 . . . . 0.0 109.313 178.204 . . . . . . . . 2 2 . 1 . 016 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.2 m -152.22 81.6 1.25 Allowed 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 -176.8 . . . . . . . . 1 1 . 1 . 016 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.531 ' CD2' ' N ' ' A' ' 136' ' ' HIS . 0.1 OUTLIER . . . . . 0 C--O 1.242 0.692 0 CA-C-O 116.021 -1.942 . . . . 0.0 112.546 173.35 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 116.258 -1.829 . . . . 0.0 107.827 . . . . . . . . . 0 0 . 1 . 017 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER 77.87 148.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 C-N-CA 125.191 1.396 . . . . 0.0 109.155 -177.185 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.827 HG21 HD23 ' A' ' 10' ' ' LEU . 9.3 m -101.9 105.14 15.91 Favored 'General case' 0 C--N 1.313 -1.013 0 O-C-N 121.584 -0.698 . . . . 0.0 109.373 -176.864 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 20.3 m95 -73.81 141.97 46.17 Favored 'General case' 0 C--O 1.217 -0.615 0 C-N-CA 124.202 1.001 . . . . 0.0 108.628 -178.258 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -135.23 144.33 46.84 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -179.339 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.607 ' SG ' ' HB3' ' A' ' 122' ' ' ALA . 0.8 OUTLIER -124.47 30.68 5.94 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 123.324 0.65 . . . . 0.0 112.571 175.404 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 153.08 -96.78 0.17 Allowed Glycine 0 C--O 1.223 -0.539 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -118.45 -4.48 13.58 Favored Glycine 0 N--CA 1.468 0.802 0 C-N-CA 123.649 0.642 . . . . 0.0 113.862 176.135 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.422 ' H ' HD12 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -104.53 133.38 49.49 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 -176.894 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.827 HD23 HG21 ' A' ' 3' ' ' THR . 4.8 mp -94.25 164.81 12.88 Favored 'General case' 0 C--O 1.221 -0.426 0 O-C-N 125.373 1.67 . . . . 0.0 110.4 -179.569 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.479 ' H ' HG22 ' A' ' 3' ' ' THR . 41.3 m-85 -157.62 84.19 0.9 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 125.086 1.354 . . . . 0.0 108.548 -170.956 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -54.33 122.85 11.25 Favored 'General case' 0 C--O 1.218 -0.57 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -179.129 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 0.9 OUTLIER -52.08 -48.56 64.62 Favored 'General case' 0 C--O 1.212 -0.915 0 CA-C-N 119.753 1.16 . . . . 0.0 111.876 -179.163 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -48.0 -34.98 10.16 Favored 'General case' 0 C--O 1.207 -1.169 0 O-C-N 124.455 1.097 . . . . 0.0 111.548 176.331 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -76.38 -55.7 5.31 Favored 'General case' 0 C--O 1.202 -1.429 0 CA-C-O 114.991 -2.433 . . . . 0.0 114.262 168.187 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -43.38 -37.96 2.53 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 122.274 2.306 . . . . 0.0 113.89 173.264 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -82.16 -53.11 6.34 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 117.136 -1.411 . . . . 0.0 110.54 172.999 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 34.8 t -57.77 -22.3 46.25 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-N 119.923 1.238 . . . . 0.0 109.466 -177.787 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 4.1 t-20 -75.39 -46.31 33.71 Favored 'General case' 0 N--CA 1.433 -1.304 0 O-C-N 120.277 -1.514 . . . . 0.0 110.596 176.351 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.38 -6.31 34.54 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.311 1.044 . . . . 0.0 112.405 173.854 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -73.55 -43.32 60.17 Favored 'General case' 0 C--O 1.222 -0.379 0 O-C-N 120.017 -1.677 . . . . 0.0 110.758 -179.79 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -81.89 -35.17 29.51 Favored 'General case' 0 C--O 1.22 -0.5 0 C-N-CA 123.636 0.775 . . . . 0.0 111.304 178.862 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.733 ' HB1' ' HG3' ' A' ' 35' ' ' PRO . . . -42.92 125.65 3.2 Favored Pre-proline 0 N--CA 1.442 -0.833 0 O-C-N 125.11 1.506 . . . . 0.0 112.706 177.463 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.46 ' HG2' ' CG2' ' A' ' 30' ' ' THR . 19.3 Cg_endo -72.87 127.01 11.81 Favored 'Trans proline' 0 N--CA 1.446 -1.322 0 C-N-CA 122.327 2.018 . . . . 0.0 108.589 -175.419 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.562 HD23 ' CE2' ' A' ' 112' ' ' TYR . 0.9 OUTLIER -63.49 111.15 2.21 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.519 0.728 . . . . 0.0 109.244 178.877 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 26' ' ' SER . . . . . 0.707 ' O ' HD12 ' A' ' 81' ' ' LEU . 0.2 OUTLIER -176.46 175.29 1.79 Allowed 'General case' 0 C--O 1.209 -1.034 0 C-N-CA 123.815 0.846 . . . . 0.0 111.552 -179.421 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.458 ' HB3' ' CA ' ' A' ' 72' ' ' GLY . 3.5 t0 -115.54 85.55 2.3 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 176.799 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.68 71.42 1.13 Allowed Glycine 0 C--O 1.226 -0.381 0 N-CA-C 110.146 -1.181 . . . . 0.0 110.146 174.261 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.79 51.42 0.86 Allowed 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 122.942 1.353 . . . . 0.0 112.583 179.139 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.539 HG21 ' HD2' ' A' ' 35' ' ' PRO . 0.8 OUTLIER -137.5 149.02 46.48 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -173.356 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -41.07 -69.93 0.46 Allowed Glycine 0 CA--C 1.509 -0.33 0 O-C-N 124.829 1.331 . . . . 0.0 113.59 -175.826 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 47.2 t -56.65 -53.29 59.4 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 116.344 -1.788 . . . . 0.0 111.727 175.306 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 155.65 -34.91 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 127.653 2.381 . . . . 0.0 112.178 177.318 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.462 ' CE1' ' CZ ' ' A' ' 107' ' ' ARG . 92.7 m-85 -85.24 144.16 40.49 Favored Pre-proline 0 CA--C 1.544 0.713 0 N-CA-C 115.027 1.491 . . . . 0.0 115.027 178.203 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.733 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 40.8 Cg_endo -80.95 174.93 44.88 Favored 'Cis proline' 0 N--CA 1.435 -1.914 0 C-N-CA 122.628 -1.822 . . . . 0.0 112.199 5.149 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.404 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 0.3 OUTLIER -149.89 165.76 31.61 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 117.587 -1.197 . . . . 0.0 110.694 -175.585 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.65 ' CH2' HG22 ' A' ' 39' ' ' THR . 19.9 t90 -70.87 146.06 49.86 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 118.686 -1.205 . . . . 0.0 111.107 173.349 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -114.46 85.73 2.29 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 104.026 -2.583 . . . . 0.0 104.026 -176.845 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.65 HG22 ' CH2' ' A' ' 37' ' ' TRP . 60.5 p -36.63 -41.39 0.3 Allowed 'General case' 0 C--O 1.212 -0.892 0 CA-C-N 114.275 -1.33 . . . . 0.0 110.914 169.701 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 57.4 t30 58.31 20.19 7.02 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 122.972 1.368 . . . . 0.0 111.224 178.514 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 107.37 -39.81 2.75 Favored Glycine 0 N--CA 1.436 -1.345 0 CA-C-O 118.425 -1.208 . . . . 0.0 114.181 -168.988 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.421 ' CE2' ' HD3' ' A' ' 66' ' ' PRO . 86.9 m-85 -53.85 147.4 12.09 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 118.574 1.187 . . . . 0.0 110.392 -178.966 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -82.04 -36.77 27.39 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 122.216 1.008 . . . . 0.0 111.516 179.065 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 179.59 -56.89 0.08 OUTLIER Glycine 0 C--N 1.332 0.36 0 C-N-CA 124.995 1.284 . . . . 0.0 110.833 -178.722 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -78.84 -156.93 0.11 Allowed 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 123.434 1.587 . . . . 0.0 110.861 179.504 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 46' ' ' GLY . . . . . 0.481 ' CA ' ' HB2' ' A' ' 65' ' ' PRO . . . -88.59 44.26 3.15 Favored Glycine 0 N--CA 1.442 -0.934 0 CA-C-O 118.347 -1.252 . . . . 0.0 114.562 174.344 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.2 mtpt -146.21 160.62 41.73 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.12 1.368 . . . . 0.0 110.233 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.1 mp -125.99 155.8 72.68 Favored Pre-proline 0 C--O 1.241 0.621 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.931 -177.911 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -71.2 158.22 55.32 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.045 1.83 . . . . 0.0 110.011 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.81 105.79 0.14 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.536 0.734 . . . . 0.0 109.214 176.161 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.32 61.09 0.98 Allowed Glycine 0 N--CA 1.465 0.585 0 O-C-N 121.574 -0.704 . . . . 0.0 112.237 -176.643 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.8 tpm_? -134.79 151.61 51.09 Favored 'General case' 0 CA--C 1.51 -0.588 0 O-C-N 122.083 -0.657 . . . . 0.0 111.117 174.396 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.6 m -147.97 103.98 3.62 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.181 0.926 . . . . 0.0 109.285 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -71.16 154.82 61.91 Favored 'Trans proline' 0 N--CA 1.445 -1.33 0 C-N-CA 122.459 2.106 . . . . 0.0 110.867 176.262 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.548 HD12 HG21 ' A' ' 121' ' ' ILE . 12.0 mt -63.91 123.83 17.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 178.734 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.06 135.25 34.91 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.949 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.577 ' CD1' ' HB3' ' A' ' 118' ' ' CYS . 21.7 m-85 -116.27 -33.58 4.93 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 124.458 1.103 . . . . 0.0 110.754 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.06 -2.38 56.65 Favored Glycine 0 CA--C 1.525 0.707 0 O-C-N 121.558 -0.713 . . . . 0.0 113.406 -174.583 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.65 132.95 43.64 Favored 'General case' 0 CA--C 1.498 -1.056 0 CA-C-N 118.086 0.943 . . . . 0.0 109.875 176.923 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.82 -13.94 57.57 Favored 'General case' 0 C--O 1.217 -0.645 0 O-C-N 124.535 1.147 . . . . 0.0 112.222 177.191 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.433 ' HB2' HG11 ' A' ' 116' ' ' VAL . 0.1 OUTLIER -86.88 -49.67 7.23 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 125.295 1.438 . . . . 0.0 110.106 178.438 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.45 ' HB3' ' CD2' ' A' ' 57' ' ' PHE . 79.4 m -74.89 -9.9 58.98 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 124.015 0.822 . . . . 0.0 112.906 174.711 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -92.67 -41.39 10.2 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.308 1.443 . . . . 0.0 109.224 176.468 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.571 ' HD2' ' CD2' ' A' ' 78' ' ' HIS . 0.0 OUTLIER -51.14 157.26 1.55 Allowed Pre-proline 0 N--CA 1.45 -0.462 0 CA-C-O 122.189 0.995 . . . . 0.0 111.552 -177.738 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.481 ' HB2' ' CA ' ' A' ' 46' ' ' GLY . 26.7 Cg_endo -69.75 132.44 23.36 Favored 'Trans proline' 0 N--CA 1.43 -2.224 0 N-CA-C 114.193 0.805 . . . . 0.0 114.193 174.354 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.421 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 29.1 Cg_endo -69.39 168.11 22.01 Favored 'Trans proline' 0 N--CA 1.433 -2.066 0 C-N-CA 123.691 2.928 . . . . 0.0 111.129 175.814 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.4 tptt -127.99 123.31 34.46 Favored 'General case' 0 CA--C 1.507 -0.675 0 CA-C-O 115.472 -2.204 . . . . 0.0 105.101 176.148 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 14.1 t-80 -107.37 164.18 12.41 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 127.528 3.017 . . . . 0.0 110.888 171.92 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.06 175.53 13.31 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 122.406 1.098 . . . . 0.0 109.633 -178.982 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.21 48.7 1.52 Allowed 'General case' 0 C--O 1.218 -0.594 0 O-C-N 121.568 -0.707 . . . . 0.0 112.3 175.19 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -161.64 22.14 0.12 Allowed 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 122.614 1.197 . . . . 0.0 112.23 -178.691 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.458 ' CA ' ' HB3' ' A' ' 27' ' ' ASP . . . 73.92 -63.73 1.98 Allowed Glycine 0 CA--C 1.538 1.48 0 O-C-N 120.793 -1.192 . . . . 0.0 112.897 -169.911 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -108.08 -98.65 0.37 Allowed 'General case' 0 C--O 1.207 -1.145 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 175.001 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 123.52 -157.93 18.04 Favored Glycine 0 C--O 1.222 -0.65 0 O-C-N 119.795 -1.815 . . . . 0.0 110.644 -168.154 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.9 mttp -50.54 -84.29 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.919 0.888 . . . . 0.0 113.268 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.427 HG23 ' O ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -117.61 9.55 13.16 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 118.554 -0.736 . . . . 0.0 111.879 175.6 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.422 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 0.4 OUTLIER -26.2 97.95 0.01 OUTLIER 'General case' 0 C--O 1.211 -0.958 0 C-N-CA 126.671 1.988 . . . . 0.0 112.1 -179.325 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.571 ' CD2' ' HD2' ' A' ' 64' ' ' ARG . 12.9 p-80 -89.12 69.4 8.34 Favored 'General case' 0 CA--C 1.506 -0.721 0 O-C-N 119.446 -2.034 . . . . 0.0 107.326 -170.076 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.424 ' HB2' ' CD1' ' A' ' 37' ' ' TRP . 35.9 p90 -92.84 135.55 34.03 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 124.674 1.189 . . . . 0.0 109.575 -177.274 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.47 127.96 34.15 Favored 'General case' 0 C--O 1.213 -0.86 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 175.292 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.921 HD22 ' CZ ' ' A' ' 110' ' ' TYR . 0.1 OUTLIER -115.08 146.08 41.67 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 174.965 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -106.83 161.73 14.43 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 122.355 1.074 . . . . 0.0 112.214 173.995 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 83' ' ' PHE . . . . . . . . . . . . . 9.1 t80 -153.95 140.23 12.68 Favored Pre-proline 0 C--N 1.328 -0.368 0 O-C-N 121.444 -0.785 . . . . 0.0 112.715 179.703 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.408 ' HA ' ' HG2' ' A' ' 107' ' ' ARG . 20.1 Cg_endo -70.99 95.72 0.67 Allowed 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 124.366 3.378 . . . . 0.0 112.844 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.8 t -101.54 104.49 15.39 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 122.436 1.112 . . . . 0.0 110.347 -177.169 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -80.61 160.87 66.07 Favored Pre-proline 0 C--N 1.32 -0.681 0 O-C-N 121.099 -1.001 . . . . 0.0 111.932 -179.569 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -76.39 -35.05 2.38 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.194 1.929 . . . . 0.0 113.664 177.098 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -43.02 -31.61 0.55 Allowed 'General case' 0 N--CA 1.475 0.781 0 O-C-N 125.213 1.57 . . . . 0.0 110.868 174.589 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.71 15.81 76.91 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.5 178.379 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -81.62 160.74 23.7 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 121.36 0.6 . . . . 0.0 109.824 177.42 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -97.11 92.28 5.97 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 174.223 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.506 ' CE2' ' HB3' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -47.57 162.52 0.07 Allowed 'General case' 0 C--O 1.223 -0.303 0 CA-C-O 123.105 1.431 . . . . 0.0 113.194 175.68 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.18 59.1 5.39 Favored 'General case' 0 C--N 1.319 -0.759 0 O-C-N 120.026 -1.671 . . . . 0.0 110.899 177.531 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -75.09 -16.47 60.56 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.755 175.303 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -92.66 -23.25 19.03 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 123.873 1.797 . . . . 0.0 111.478 179.355 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.51 109.82 19.88 Favored 'General case' 0 CA--C 1.513 -0.458 0 O-C-N 119.892 -1.755 . . . . 0.0 109.131 177.871 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.2 ptpt -59.45 -46.55 88.45 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 121.354 0.597 . . . . 0.0 112.109 176.932 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 99' ' ' PRO . 1.1 mtmt -141.52 127.22 11.0 Favored Pre-proline 0 N--CA 1.444 -0.75 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.107 -178.151 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 98' ' ' LYS . 28.5 Cg_endo -70.5 173.04 48.9 Favored 'Cis proline' 0 N--CA 1.456 -0.714 0 C-N-CA 123.288 -1.547 . . . . 0.0 110.951 -5.018 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.47 149.62 52.06 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 123.526 0.73 . . . . 0.0 109.243 177.443 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 101' ' ' GLU . . . . . 0.506 ' HB3' ' CE2' ' A' ' 92' ' ' TYR . 2.9 tt0 -100.91 176.72 5.18 Favored 'General case' 0 C--N 1.316 -0.889 0 O-C-N 123.938 0.774 . . . . 0.0 111.773 176.437 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -83.14 126.34 72.47 Favored Pre-proline 0 CA--C 1.541 0.631 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 179.059 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.419 ' HB3' ' CE2' ' A' ' 34' ' ' TYR . 31.7 Cg_endo -67.6 -166.32 0.13 Allowed 'Trans proline' 0 N--CA 1.452 -0.94 0 CA-C-O 123.371 1.321 . . . . 0.0 113.226 176.407 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -139.42 173.04 22.97 Favored Glycine 0 CA--C 1.523 0.558 0 O-C-N 121.02 -1.05 . . . . 0.0 112.679 176.277 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -75.05 -57.92 0.05 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 123.017 2.478 . . . . 0.0 111.101 178.786 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.459 ' CB ' ' CE2' ' A' ' 11' ' ' TYR . . . -60.87 133.38 56.04 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-O 120.979 0.419 . . . . 0.0 111.155 177.879 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.476 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 6.8 mtm-85 -147.35 149.48 32.88 Favored 'General case' 0 CA--C 1.497 -1.084 0 CA-C-O 117.194 -1.384 . . . . 0.0 110.522 179.5 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.469 ' C ' HD12 ' A' ' 109' ' ' ILE . 2.8 p -81.86 118.92 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 O-C-N 124.434 1.084 . . . . 0.0 110.493 175.414 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.469 HD12 ' C ' ' A' ' 108' ' ' VAL . 1.8 mp -108.07 117.51 53.81 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.662 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 -177.656 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.921 ' CZ ' HD22 ' A' ' 81' ' ' LEU . 8.0 p90 -134.1 153.21 51.96 Favored 'General case' 0 N--CA 1.447 -0.621 0 O-C-N 124.252 0.97 . . . . 0.0 109.56 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.8 p -84.28 162.72 20.01 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.231 178.195 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.562 ' CE2' HD23 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -110.06 154.87 42.52 Favored Pre-proline 0 CA--C 1.548 0.884 0 O-C-N 122.014 -0.429 . . . . 0.0 110.61 178.747 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.496 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 17.9 Cg_endo -74.15 -48.81 0.25 Allowed 'Cis proline' 0 CA--C 1.509 -0.749 0 C-N-CA 123.934 -1.278 . . . . 0.0 111.515 -8.987 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -45.8 107.77 0.11 Allowed 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 117.62 -1.181 . . . . 0.0 108.895 175.496 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.445 ' HE2' HD13 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -67.84 68.46 0.11 Allowed 'General case' 0 CA--C 1.512 -0.509 0 C-N-CA 125.711 1.604 . . . . 0.0 108.09 -179.4 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.433 HG11 ' HB2' ' A' ' 61' ' ' ASP . 18.0 t -73.19 78.89 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 N-CA-C 102.992 -2.966 . . . . 0.0 102.992 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.519 ' CE1' ' HA2' ' A' ' 119' ' ' GLY . 5.2 t80 -37.82 118.9 0.71 Allowed 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 125.339 1.456 . . . . 0.0 108.93 176.548 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 118' ' ' CYS . . . . . 0.577 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 7.3 m -95.22 -45.31 7.23 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 121.763 0.792 . . . . 0.0 109.304 179.367 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.519 ' HA2' ' CE1' ' A' ' 117' ' ' PHE . . . 156.16 -166.55 33.13 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 -178.713 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.592 HG22 ' SG ' ' A' ' 134' ' ' CYS . 3.0 mp -117.03 132.67 66.12 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.343 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 -178.275 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.774 HG22 HD12 ' A' ' 133' ' ' LEU . 10.2 pt -108.44 154.62 9.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.607 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . . . -170.75 157.1 5.44 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.733 0.778 . . . . 0.0 110.637 175.449 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.439 ' CE1' ' HG ' ' A' ' 131' ' ' LEU . 8.3 m-70 -90.42 89.88 7.79 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -175.756 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.539 HG22 ' HD3' ' A' ' 132' ' ' LYS . 1.5 t -95.6 40.16 1.12 Allowed 'General case' 0 N--CA 1.483 1.22 0 CA-C-O 124.032 1.873 . . . . 0.0 111.02 -179.21 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 7.6 tptm -103.09 -28.47 11.94 Favored 'General case' 0 C--O 1.221 -0.432 0 O-C-N 120.193 -1.567 . . . . 0.0 111.358 177.998 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -171.45 -65.75 0.02 OUTLIER 'General case' 0 C--O 1.222 -0.369 0 O-C-N 124.076 0.86 . . . . 0.0 110.57 177.665 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -152.8 -46.01 0.1 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 122.985 1.374 . . . . 0.0 110.87 178.571 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -157.0 75.56 0.83 Allowed 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.986 0.898 . . . . 0.0 110.835 -178.431 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -129.73 -107.26 1.24 Allowed Glycine 0 N--CA 1.462 0.398 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 178.691 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.57 151.37 36.32 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 122.23 -0.571 . . . . 0.0 111.296 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.538 HD23 ' H ' ' A' ' 132' ' ' LYS . 0.6 OUTLIER -110.87 146.09 37.1 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 177.689 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.539 ' HD3' HG22 ' A' ' 124' ' ' THR . 0.0 OUTLIER -154.2 170.06 22.13 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 125.196 1.398 . . . . 0.0 110.093 177.743 . . . . . . . . 3 3 . 1 . 017 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.774 HD12 HG22 ' A' ' 121' ' ' ILE . 6.0 tp -81.33 146.18 30.49 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 175.894 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 134' ' ' CYS . . . . . 0.592 ' SG ' HG22 ' A' ' 120' ' ' ILE . 87.2 m -61.4 175.01 0.63 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 123.488 1.613 . . . . 0.0 109.614 172.241 . . . . . . . . 2 2 . 1 . 017 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 72.0 m -161.4 90.99 0.83 Allowed 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 104.198 -2.519 . . . . 0.0 104.198 -175.188 . . . . . . . . 1 1 . 1 . 017 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 N--CA 1.474 0.726 0 CA-C-O 115.656 -2.116 . . . . 0.0 115.305 169.631 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.657 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 . . . . . . . . . 0 0 . 1 . 018 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.6 p -106.8 141.94 20.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -179.256 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.599 HG21 HD22 ' A' ' 10' ' ' LEU . 0.9 OUTLIER -85.59 112.25 20.8 Favored 'General case' 0 C--N 1.32 -0.698 0 O-C-N 121.907 -0.496 . . . . 0.0 110.469 178.504 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.471 ' CG ' HG13 ' A' ' 120' ' ' ILE . 29.9 m95 -79.13 139.16 38.11 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 123.091 0.556 . . . . 0.0 110.951 176.54 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.447 ' OG1' HD23 ' A' ' 10' ' ' LEU . 0.9 OUTLIER -121.36 124.66 45.07 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -177.81 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.673 ' HB3' ' HB3' ' A' ' 122' ' ' ALA . 13.6 m -113.65 40.68 2.35 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.267 0.556 . . . . 0.0 110.912 177.598 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 138.05 -94.84 0.22 Allowed Glycine 0 C--O 1.223 -0.574 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 -179.138 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.545 ' C ' HD13 ' A' ' 9' ' ' LEU . . . -123.79 1.62 9.3 Favored Glycine 0 N--CA 1.463 0.434 0 C-N-CA 123.074 0.369 . . . . 0.0 112.803 177.393 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.623 ' N ' HD13 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -107.8 140.44 40.88 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 -173.428 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.599 HD22 HG21 ' A' ' 3' ' ' THR . 17.1 mt -106.07 121.01 43.27 Favored 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 124.258 0.974 . . . . 0.0 109.311 -177.48 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.526 ' CE2' ' CB ' ' A' ' 106' ' ' ALA . 61.2 m-85 -116.06 99.94 7.61 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 124.966 1.307 . . . . 0.0 108.968 -175.137 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -56.26 122.28 11.42 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-O 118.234 -0.889 . . . . 0.0 108.982 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.416 ' HB2' ' CD1' ' A' ' 4' ' ' TRP . 23.2 tp60 -50.09 -46.97 53.92 Favored 'General case' 0 C--O 1.21 -0.987 0 O-C-N 123.978 0.799 . . . . 0.0 112.105 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 14' ' ' ASN . . . . . 0.402 ' O ' ' CB ' ' A' ' 18' ' ' SER . 5.5 t-20 -50.07 -41.54 48.22 Favored 'General case' 0 C--O 1.201 -1.482 0 O-C-N 123.211 0.319 . . . . 0.0 110.975 176.541 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.12 -37.12 75.23 Favored 'General case' 0 C--O 1.204 -1.302 0 CA-C-O 116.916 -1.516 . . . . 0.0 113.076 170.429 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.04 -44.95 79.28 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 121.813 2.097 . . . . 0.0 113.151 172.847 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.1 pt-20 -82.52 -37.67 24.9 Favored 'General case' 0 C--O 1.211 -0.927 0 C-N-CA 123.203 0.601 . . . . 0.0 109.715 176.836 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.402 ' CB ' ' O ' ' A' ' 14' ' ' ASN . 28.8 t -73.98 -60.02 2.45 Favored 'General case' 0 CA--C 1.505 -0.777 0 O-C-N 119.751 -1.843 . . . . 0.0 109.521 -176.422 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.474 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 45.9 t30 -40.75 -37.4 0.75 Allowed 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 124.543 1.137 . . . . 0.0 112.359 172.127 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.565 ' HB3' HG11 ' A' ' 108' ' ' VAL . 1.0 OUTLIER -82.52 -36.45 26.36 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 174.561 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -45.76 -38.56 7.19 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 126.288 1.835 . . . . 0.0 110.133 178.563 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.474 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -72.05 -47.43 51.65 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 123.826 0.85 . . . . 0.0 112.145 175.793 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.725 ' HB1' ' HG3' ' A' ' 35' ' ' PRO . . . -37.88 130.25 0.94 Allowed Pre-proline 0 N--CA 1.443 -0.785 0 O-C-N 124.762 1.289 . . . . 0.0 112.079 174.165 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.724 ' HG2' HG22 ' A' ' 30' ' ' THR . 16.4 Cg_endo -73.31 124.48 9.49 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 121.836 1.691 . . . . 0.0 108.939 -176.381 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.626 HD13 ' HE2' ' A' ' 115' ' ' LYS . 3.9 tp -60.94 93.27 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 123.635 0.774 . . . . 0.0 111.227 179.367 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 178.55 155.0 0.4 Allowed 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 122.957 0.503 . . . . 0.0 110.092 -174.032 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.77 123.18 39.22 Favored 'General case' 0 CA--C 1.508 -0.642 0 C-N-CA 123.973 0.909 . . . . 0.0 109.006 178.825 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 48.04 70.25 0.78 Allowed Glycine 0 C--N 1.335 0.482 0 CA-C-O 122.104 0.835 . . . . 0.0 111.895 176.602 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -149.09 30.18 0.79 Allowed 'General case' 0 CA--C 1.51 -0.58 0 O-C-N 121.831 -0.805 . . . . 0.0 111.962 179.562 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.724 HG22 ' HG2' ' A' ' 24' ' ' PRO . 36.4 p -127.52 147.23 50.32 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -175.859 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -41.23 -55.35 3.62 Favored Glycine 0 N--CA 1.448 -0.556 0 O-C-N 123.981 0.8 . . . . 0.0 112.082 -178.928 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 29.2 t -67.37 -70.64 0.24 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 118.803 -0.618 . . . . 0.0 111.474 175.183 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.1 p 176.03 -57.66 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 124.306 1.042 . . . . 0.0 112.85 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -67.48 151.55 97.05 Favored Pre-proline 0 N--CA 1.427 -1.609 0 C-N-CA 124.131 0.972 . . . . 0.0 112.066 178.583 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.725 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 24.5 Cg_endo -74.62 164.06 89.0 Favored 'Cis proline' 0 N--CA 1.455 -0.74 0 C-N-CA 123.144 -1.607 . . . . 0.0 111.103 -1.536 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.421 ' CD2' ' HG2' ' A' ' 82' ' ' GLU . 0.3 OUTLIER -143.17 161.4 38.32 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 117.474 -1.251 . . . . 0.0 109.662 -179.034 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.959 ' CH2' HG22 ' A' ' 39' ' ' THR . 13.7 t90 -59.33 138.67 57.55 Favored 'General case' 0 N--CA 1.446 -0.629 0 O-C-N 124.937 1.398 . . . . 0.0 110.137 177.827 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.538 ' CZ ' HD13 ' A' ' 121' ' ' ILE . 9.8 t80 -109.13 85.83 2.17 Favored 'General case' 0 N--CA 1.423 -1.782 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 -176.018 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.959 HG22 ' CH2' ' A' ' 37' ' ' TRP . 20.1 p -38.69 -34.6 0.15 Allowed 'General case' 0 CA--C 1.495 -1.138 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.653 170.745 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.484 ' HB2' ' CE2' ' A' ' 38' ' ' PHE . 62.9 t30 53.8 22.58 3.29 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 120.854 1.661 . . . . 0.0 111.625 177.675 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.738 ' C ' HD23 ' A' ' 48' ' ' LEU . . . 104.27 -44.28 1.51 Allowed Glycine 0 N--CA 1.419 -2.488 0 CA-C-O 117.26 -1.855 . . . . 0.0 115.218 -168.578 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.506 ' CE2' ' HD3' ' A' ' 66' ' ' PRO . 84.8 m-85 -43.34 151.1 0.17 Allowed 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.691 1.597 . . . . 0.0 112.279 176.294 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.82 -36.39 25.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.326 0.584 . . . . 0.0 111.884 177.894 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.52 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -165.3 -77.63 0.03 OUTLIER Glycine 0 C--N 1.34 0.794 0 C-N-CA 124.459 1.028 . . . . 0.0 111.846 -179.078 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -109.41 -67.98 0.95 Allowed 'General case' 0 CA--C 1.513 -0.459 0 C-N-CA 123.521 0.728 . . . . 0.0 111.029 -179.245 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.23 -170.71 0.11 Allowed Glycine 0 C--N 1.348 1.233 0 C-N-CA 124.436 1.017 . . . . 0.0 110.967 178.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -58.77 -167.64 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 124.296 1.998 . . . . 0.0 111.703 177.356 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.738 HD23 ' C ' ' A' ' 41' ' ' GLY . 0.0 OUTLIER -86.78 163.47 40.96 Favored Pre-proline 0 N--CA 1.44 -0.968 0 O-C-N 120.139 -1.601 . . . . 0.0 110.566 -179.354 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -71.83 171.51 16.39 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 122.067 1.844 . . . . 0.0 111.077 178.056 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -58.79 96.44 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.196 177.131 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.33 88.4 1.97 Allowed Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 111.895 -0.482 . . . . 0.0 111.895 -177.533 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.507 ' HB3' HD22 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -166.55 163.75 17.02 Favored 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 123.795 0.838 . . . . 0.0 111.557 176.283 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 97.7 m -143.6 95.07 5.94 Favored Pre-proline 0 C--O 1.236 0.389 0 O-C-N 124.33 1.019 . . . . 0.0 109.604 -176.882 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -72.98 169.75 21.43 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.529 2.153 . . . . 0.0 110.901 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.405 ' CG2' ' HB2' ' A' ' 133' ' ' LEU . 6.4 mt -99.58 134.22 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -178.2 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -86.09 157.6 20.01 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 121.107 0.479 . . . . 0.0 110.182 176.7 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.432 ' CD1' ' HB3' ' A' ' 118' ' ' CYS . 26.2 m-85 -140.65 -46.85 0.41 Allowed 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 123.805 0.842 . . . . 0.0 111.036 178.233 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 112.57 -4.42 26.29 Favored Glycine 0 C--N 1.338 0.664 0 C-N-CA 123.523 0.582 . . . . 0.0 113.057 -175.104 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.91 134.84 38.42 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-O 117.859 -1.067 . . . . 0.0 110.388 176.982 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 20.1 t -69.23 -6.36 28.68 Favored 'General case' 0 C--O 1.225 -0.222 0 O-C-N 125.127 1.517 . . . . 0.0 111.538 176.617 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.69 -56.88 3.07 Favored 'General case' 0 N--CA 1.446 -0.674 0 O-C-N 120.289 -1.507 . . . . 0.0 109.614 -179.45 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 27.7 m -70.99 -18.06 62.62 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 123.789 0.68 . . . . 0.0 110.688 177.218 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -80.28 -41.0 25.79 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 123.678 0.791 . . . . 0.0 111.515 174.806 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.598 ' HD2' ' CD2' ' A' ' 78' ' ' HIS . 0.0 OUTLIER -52.04 158.97 1.57 Allowed Pre-proline 0 N--CA 1.444 -0.766 0 CA-C-O 122.282 1.039 . . . . 0.0 111.033 179.404 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -71.02 136.21 29.17 Favored 'Trans proline' 0 N--CA 1.444 -1.395 0 C-N-CA 121.003 1.135 . . . . 0.0 113.673 174.149 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.506 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 19.2 Cg_endo -72.54 171.34 17.35 Favored 'Trans proline' 0 N--CA 1.446 -1.287 0 C-N-CA 122.957 2.438 . . . . 0.0 111.015 178.581 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.4 tptt -128.41 49.93 2.14 Favored 'General case' 0 C--O 1.212 -0.9 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.936 178.545 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.442 ' CE1' ' CE3' ' A' ' 37' ' ' TRP . 56.2 t-80 -77.13 161.25 28.39 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 120.132 -1.605 . . . . 0.0 112.126 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -161.56 177.89 9.6 Favored 'General case' 0 CA--C 1.502 -0.896 0 O-C-N 118.787 -2.445 . . . . 0.0 108.178 176.878 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.2 pttp -64.68 74.22 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 124.858 1.263 . . . . 0.0 111.724 175.379 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 179.56 -47.58 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 125.524 1.53 . . . . 0.0 110.294 -176.322 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 113.31 -71.89 0.22 Allowed Glycine 0 CA--C 1.488 -1.621 0 CA-C-O 118.805 -0.997 . . . . 0.0 112.157 -177.541 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -128.81 64.33 1.45 Allowed 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 125.934 1.694 . . . . 0.0 107.803 -177.731 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.56 -110.63 0.01 OUTLIER Glycine 0 C--N 1.334 0.454 0 CA-C-O 122.391 0.995 . . . . 0.0 112.543 178.817 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.5 mttp -63.22 -98.4 0.0 OUTLIER 'General case' 0 C--O 1.222 -0.372 0 O-C-N 119.792 -2.005 . . . . 0.0 111.75 177.562 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.54 HG23 ' O ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -114.23 15.93 18.06 Favored 'General case' 0 CA--C 1.51 -0.593 0 O-C-N 120.608 -1.307 . . . . 0.0 111.082 178.239 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.475 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 29.0 m-20 -30.5 107.5 0.04 OUTLIER 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 124.787 1.235 . . . . 0.0 110.16 -177.236 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.598 ' CD2' ' HD2' ' A' ' 64' ' ' ARG . 4.4 p-80 -87.43 14.52 7.94 Favored 'General case' 0 CA--C 1.511 -0.524 0 O-C-N 121.654 -0.654 . . . . 0.0 110.561 -177.068 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.529 ' HB2' ' CD1' ' A' ' 37' ' ' TRP . 14.9 p90 -39.51 137.34 0.83 Allowed 'General case' 0 N--CA 1.429 -1.514 0 C-N-CA 125.592 1.557 . . . . 0.0 110.715 176.973 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.669 HD22 ' CG2' ' A' ' 109' ' ' ILE . 0.3 OUTLIER -71.88 157.87 37.07 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.622 177.244 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.514 HD21 ' CE2' ' A' ' 79' ' ' TYR . 5.5 mp -139.67 120.77 14.7 Favored 'General case' 0 CA--C 1.501 -0.925 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 -177.903 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.497 ' CB ' ' CD1' ' A' ' 109' ' ' ILE . 0.5 OUTLIER -92.36 152.68 19.63 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-O 122.259 1.028 . . . . 0.0 111.585 178.723 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.505 ' CZ ' ' HB2' ' A' ' 23' ' ' ALA . 12.6 t80 -145.23 134.05 11.04 Favored Pre-proline 0 N--CA 1.444 -0.762 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.583 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -74.62 112.92 3.67 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.959 2.44 . . . . 0.0 110.188 -177.672 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.6 t -104.73 110.45 22.78 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 124.323 1.014 . . . . 0.0 110.079 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.438 ' CE1' ' HB2' ' A' ' 92' ' ' TYR . 70.1 m-85 -82.02 157.92 68.05 Favored Pre-proline 0 N--CA 1.445 -0.69 0 O-C-N 121.424 -0.797 . . . . 0.0 112.25 178.85 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -76.63 -42.25 0.36 Allowed 'Trans proline' 0 CA--C 1.501 -1.15 0 C-N-CA 122.555 2.17 . . . . 0.0 112.332 179.561 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -44.69 -30.92 1.02 Allowed 'General case' 0 C--N 1.353 0.731 0 CA-C-O 122.159 0.98 . . . . 0.0 110.855 176.688 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 85.23 8.77 81.06 Favored Glycine 0 N--CA 1.434 -1.47 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 177.279 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 4.2 p-80 -73.84 128.38 35.36 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.58 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.36 93.15 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 123.601 0.76 . . . . 0.0 109.76 173.286 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.47 ' O ' ' CD2' ' A' ' 94' ' ' PHE . 12.9 t80 -39.7 144.58 0.17 Allowed 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 121.967 0.889 . . . . 0.0 111.19 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.38 57.31 1.49 Allowed 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 120.011 -1.68 . . . . 0.0 109.988 176.666 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.47 ' CD2' ' O ' ' A' ' 92' ' ' TYR . 34.3 p90 -71.19 -9.91 58.88 Favored 'General case' 0 N--CA 1.439 -1.018 0 C-N-CA 124.085 0.954 . . . . 0.0 112.168 175.711 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -89.7 -36.41 15.23 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 123.131 1.443 . . . . 0.0 110.451 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.9 m -84.46 111.29 19.34 Favored 'General case' 0 N--CA 1.441 -0.904 0 O-C-N 120.341 -1.474 . . . . 0.0 109.394 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.0 ptpt -58.75 -47.92 82.99 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-O 120.945 0.403 . . . . 0.0 111.235 178.3 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -143.18 130.51 10.84 Favored Pre-proline 0 N--CA 1.432 -1.346 0 C-N-CA 123.78 0.832 . . . . 0.0 109.378 -177.312 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.403 ' HA ' ' HA ' ' A' ' 98' ' ' LYS . 24.7 Cg_endo -70.1 175.44 37.65 Favored 'Cis proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.284 -1.965 . . . . 0.0 111.007 -6.484 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.43 147.03 42.86 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.902 178.313 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -87.94 173.41 8.93 Favored 'General case' 0 C--O 1.24 0.591 0 O-C-N 123.837 0.711 . . . . 0.0 112.133 177.211 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -72.5 143.03 84.73 Favored Pre-proline 0 N--CA 1.442 -0.853 0 CA-C-O 118.117 -0.944 . . . . 0.0 111.165 177.295 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -73.15 -164.8 0.21 Allowed 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.266 2.644 . . . . 0.0 111.739 176.327 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -140.97 164.5 26.44 Favored Glycine 0 N--CA 1.44 -1.046 0 O-C-N 121.581 -0.7 . . . . 0.0 112.478 177.359 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -75.39 -60.24 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.692 2.262 . . . . 0.0 110.481 179.127 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.779 ' HA ' ' HB2' ' A' ' 122' ' ' ALA . . . -63.31 139.83 58.81 Favored 'General case' 0 N--CA 1.438 -1.031 0 O-C-N 123.689 0.618 . . . . 0.0 111.62 178.206 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 1.5 mtm-85 -143.14 143.48 31.83 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.307 -179.503 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.565 HG11 ' HB3' ' A' ' 20' ' ' SER . 7.0 p -83.14 124.13 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 O-C-N 123.92 0.762 . . . . 0.0 110.479 178.789 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.669 ' CG2' HD22 ' A' ' 80' ' ' LEU . 6.3 mm -106.23 140.91 22.8 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.892 0 C-N-CA 122.823 0.449 . . . . 0.0 110.157 -179.231 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.621 ' C ' HD23 ' A' ' 80' ' ' LEU . 9.7 p90 -165.48 153.1 10.83 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-O 122.042 0.925 . . . . 0.0 110.483 -177.413 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.4 p -88.8 165.53 14.62 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.776 -178.907 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.547 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.2 OUTLIER -111.29 154.09 43.79 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 122.184 0.193 . . . . 0.0 111.368 178.761 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.547 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 19.0 Cg_endo -73.87 -52.85 0.16 OUTLIER 'Cis proline' 0 CA--C 1.499 -1.256 0 C-N-CA 123.525 -1.448 . . . . 0.0 109.708 -6.883 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -43.24 110.93 0.22 Allowed 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 117.628 -1.177 . . . . 0.0 109.914 178.761 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.626 ' HE2' HD13 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -66.96 72.45 0.1 Allowed 'General case' 0 CA--C 1.51 -0.585 0 C-N-CA 124.429 1.092 . . . . 0.0 108.519 -178.116 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.433 ' O ' HG12 ' A' ' 116' ' ' VAL . 36.9 t -72.32 77.4 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 N-CA-C 105.596 -2.001 . . . . 0.0 105.596 -176.919 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.428 ' CZ ' ' HA2' ' A' ' 119' ' ' GLY . 41.5 t80 -39.57 107.1 0.06 Allowed 'General case' 0 N--CA 1.435 -1.219 0 C-N-CA 126.002 1.721 . . . . 0.0 110.034 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 118' ' ' CYS . . . . . 0.474 ' SG ' HD21 ' A' ' 80' ' ' LEU . 10.2 m -81.94 -46.13 14.47 Favored 'General case' 0 N--CA 1.436 -1.175 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 -178.113 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.428 ' HA2' ' CZ ' ' A' ' 117' ' ' PHE . . . 160.4 -147.73 15.03 Favored Glycine 0 N--CA 1.441 -0.998 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.471 HG13 ' CG ' ' A' ' 4' ' ' TRP . 1.2 mm -128.64 138.94 53.23 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.929 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 -175.682 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.63 HD12 HD22 ' A' ' 131' ' ' LEU . 7.6 pt -130.0 154.94 41.13 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -177.922 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.779 ' HB2' ' HA ' ' A' ' 106' ' ' ALA . . . -178.89 159.68 1.05 Allowed 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 121.794 0.807 . . . . 0.0 109.714 179.109 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 1.0 OUTLIER -91.2 93.05 8.93 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -178.867 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.753 HG22 ' HD3' ' A' ' 132' ' ' LYS . 1.8 t -97.71 39.97 1.19 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 123.376 1.56 . . . . 0.0 111.395 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 8.0 tttm -103.75 -26.97 12.53 Favored 'General case' 0 C--O 1.221 -0.412 0 O-C-N 120.812 -1.18 . . . . 0.0 111.432 178.597 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -169.53 -64.06 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.292 0 O-C-N 124.296 0.998 . . . . 0.0 110.853 177.838 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -153.62 -46.84 0.09 Allowed 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 123.303 1.525 . . . . 0.0 110.586 178.454 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -157.58 75.59 0.79 Allowed 'General case' 0 N--CA 1.442 -0.853 0 CA-C-O 122.381 1.086 . . . . 0.0 110.913 -178.679 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -118.98 -105.89 2.21 Favored Glycine 0 C--N 1.334 0.425 0 O-C-N 121.186 -0.946 . . . . 0.0 110.982 178.84 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -85.59 156.78 20.58 Favored 'General case' 0 CA--C 1.516 -0.341 0 O-C-N 122.157 -0.613 . . . . 0.0 111.648 179.245 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.63 HD22 HD12 ' A' ' 121' ' ' ILE . 0.5 OUTLIER -105.95 141.99 36.42 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 178.208 . . . . . . . . 3 3 . 1 . 018 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.753 ' HD3' HG22 ' A' ' 124' ' ' THR . 2.5 ptmt -149.13 172.54 14.64 Favored 'General case' 0 CA--C 1.509 -0.615 0 C-N-CA 123.466 0.707 . . . . 0.0 109.712 179.173 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.537 HD12 HG22 ' A' ' 121' ' ' ILE . 11.6 tp -86.76 136.25 33.07 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-O 121.646 0.736 . . . . 0.0 109.448 177.678 . . . . . . . . 2 2 . 1 . 018 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 50.7 m -66.02 -179.61 0.76 Allowed 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 124.152 0.981 . . . . 0.0 109.389 175.627 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 68.4 m -159.44 92.08 1.04 Allowed 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 -178.17 . . . . . . . . 1 1 . 1 . 018 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.257 1.496 0 CA-C-O 113.965 -2.921 . . . . 0.0 113.682 170.493 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.622 ' HB1' ' HB3' ' A' ' 13' ' ' GLN . . . . . . . . 0 N--CA 1.474 0.761 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 . . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.5 p -89.69 159.06 2.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 O-C-N 123.85 0.719 . . . . 0.0 109.92 178.209 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.937 HG21 HD23 ' A' ' 10' ' ' LEU . 5.9 m -94.79 107.78 19.8 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 123.634 0.774 . . . . 0.0 110.62 178.984 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 20.4 m95 -78.57 141.42 38.11 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.005 0.922 . . . . 0.0 108.879 179.416 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -132.63 138.09 47.24 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.659 ' SG ' ' HB3' ' A' ' 122' ' ' ALA . 0.5 OUTLIER -121.63 64.53 0.9 Allowed 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 114.838 -1.073 . . . . 0.0 108.674 177.834 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 37.6 75.03 0.09 OUTLIER Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.851 1.215 . . . . 0.0 114.104 178.803 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 159.87 -75.03 0.2 Allowed Glycine 0 C--O 1.226 -0.404 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 -175.346 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 74.2 mt -126.69 159.91 32.3 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 122.12 0.962 . . . . 0.0 110.34 177.337 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.937 HD23 HG21 ' A' ' 3' ' ' THR . 9.9 mp -87.96 167.48 13.68 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.143 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.656 ' CZ ' ' HB3' ' A' ' 106' ' ' ALA . 65.4 m-85 -156.09 87.17 1.05 Allowed 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 125.276 1.43 . . . . 0.0 108.386 -173.175 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -53.47 120.11 5.69 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-O 117.832 -1.08 . . . . 0.0 108.457 177.814 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.622 ' HB3' ' HB1' ' A' ' 1' ' ' ALA . 1.5 tt0 -49.27 -43.77 43.31 Favored 'General case' 0 C--O 1.212 -0.876 0 CA-C-N 119.865 1.211 . . . . 0.0 111.629 178.842 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -48.89 -42.37 36.57 Favored 'General case' 0 C--O 1.201 -1.462 0 CA-C-N 117.779 0.263 . . . . 0.0 111.187 176.087 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.47 -44.36 62.42 Favored 'General case' 0 C--O 1.21 -1.026 0 O-C-N 120.416 -1.427 . . . . 0.0 112.644 169.602 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.503 ' HB1' HD11 ' A' ' 120' ' ' ILE . . . -52.11 -38.49 57.58 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 121.4 1.909 . . . . 0.0 112.907 175.379 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -86.06 -48.89 8.23 Favored 'General case' 0 C--O 1.21 -1.022 0 CA-C-O 117.51 -1.234 . . . . 0.0 108.971 175.66 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.2 t -69.45 -57.88 4.69 Favored 'General case' 0 CA--C 1.504 -0.797 0 C-N-CA 126.599 1.96 . . . . 0.0 109.483 -173.173 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.445 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 9.4 t-20 -42.17 -36.6 1.23 Allowed 'General case' 0 C--O 1.217 -0.627 0 CA-C-N 119.536 1.062 . . . . 0.0 110.745 169.664 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.448 ' O ' ' HB3' ' A' ' 23' ' ' ALA . 1.4 p -83.53 -29.74 27.66 Favored 'General case' 0 C--O 1.218 -0.564 0 N-CA-C 114.911 1.449 . . . . 0.0 114.911 176.161 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER -50.31 -35.67 28.47 Favored 'General case' 0 C--O 1.222 -0.351 0 C-N-CA 126.696 1.999 . . . . 0.0 109.826 178.532 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.445 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.1 OUTLIER -71.59 -49.54 39.37 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 125.43 1.492 . . . . 0.0 111.193 175.946 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.719 ' HB1' ' HG3' ' A' ' 35' ' ' PRO . . . -39.39 123.15 1.38 Allowed Pre-proline 0 C--O 1.239 0.529 0 O-C-N 124.867 1.355 . . . . 0.0 111.807 174.852 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.536 ' HG2' HG22 ' A' ' 30' ' ' THR . 18.1 Cg_endo -70.76 126.37 12.57 Favored 'Trans proline' 0 N--CA 1.445 -1.366 0 C-N-CA 122.083 1.855 . . . . 0.0 108.868 -177.044 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.863 HD21 ' O ' ' A' ' 113' ' ' PRO . 4.9 tp -62.91 94.54 0.07 Allowed 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.449 0.7 . . . . 0.0 112.219 178.959 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.1 m 179.98 153.64 0.52 Allowed 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 125.082 1.353 . . . . 0.0 110.163 -173.022 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.61 119.16 31.77 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.436 1.494 . . . . 0.0 109.367 176.235 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 49.86 69.69 0.99 Allowed Glycine 0 CA--C 1.525 0.708 0 CA-C-O 122.189 0.883 . . . . 0.0 112.476 174.347 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.5 mtpt -145.95 22.89 1.39 Allowed 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -178.549 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.536 HG22 ' HG2' ' A' ' 24' ' ' PRO . 33.6 p -123.45 150.97 43.18 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 124.398 1.079 . . . . 0.0 108.693 -177.169 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -38.65 -63.44 1.01 Allowed Glycine 0 CA--C 1.522 0.477 0 C-N-CA 124.705 1.145 . . . . 0.0 113.712 178.448 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.415 ' HB3' ' HA ' ' A' ' 94' ' ' PHE . 44.1 t -63.64 -59.4 4.65 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 118.312 -0.851 . . . . 0.0 112.071 174.497 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.0 m 158.9 -48.61 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.872 2.069 . . . . 0.0 112.17 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.535 ' CD2' ' HD3' ' A' ' 84' ' ' PRO . 63.3 m-85 -64.48 145.54 98.43 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-O 117.801 -1.095 . . . . 0.0 112.909 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.719 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 28.6 Cg_endo -73.35 158.53 98.38 Favored 'Cis proline' 0 N--CA 1.448 -1.198 0 C-N-CA 123.577 -1.426 . . . . 0.0 111.137 -4.132 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.808 ' C ' HD23 ' A' ' 81' ' ' LEU . 2.1 p80 -137.19 170.56 15.88 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-N 114.713 -1.131 . . . . 0.0 109.565 -176.337 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.906 ' CH2' HG22 ' A' ' 39' ' ' THR . 22.7 t90 -71.56 148.03 47.07 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.99 0.9 . . . . 0.0 109.243 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.517 ' CE2' ' HB2' ' A' ' 40' ' ' ASN . 27.5 t80 -124.31 78.24 1.64 Allowed 'General case' 0 N--CA 1.435 -1.182 0 C-N-CA 127.11 2.164 . . . . 0.0 106.003 -177.71 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.906 HG22 ' CH2' ' A' ' 37' ' ' TRP . 77.0 p -37.04 -39.91 0.26 Allowed 'General case' 0 C--O 1.218 -0.571 0 C-N-CA 124.421 1.088 . . . . 0.0 111.6 171.911 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.517 ' HB2' ' CE2' ' A' ' 38' ' ' PHE . 46.0 t30 59.69 16.06 5.19 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 122.428 1.109 . . . . 0.0 110.907 178.678 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.545 ' C ' HD23 ' A' ' 48' ' ' LEU . . . 115.11 -40.89 2.31 Favored Glycine 0 N--CA 1.44 -1.049 0 CA-C-O 117.435 -1.758 . . . . 0.0 111.619 -172.7 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.442 ' CD1' ' HD2' ' A' ' 66' ' ' PRO . 76.2 m-85 -49.34 159.53 0.31 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.202 1.501 . . . . 0.0 112.295 -179.627 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.25 -35.82 23.14 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 122.589 1.185 . . . . 0.0 111.317 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.465 ' HA2' ' CZ2' ' A' ' 37' ' ' TRP . . . 145.04 -31.44 1.73 Allowed Glycine 0 C--O 1.218 -0.863 0 C-N-CA 125.185 1.374 . . . . 0.0 111.586 -176.701 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.9 -54.28 5.72 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 119.049 1.425 . . . . 0.0 111.575 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 157.23 33.13 0.02 OUTLIER Glycine 0 C--N 1.336 0.541 0 O-C-N 124.309 1.006 . . . . 0.0 112.748 -177.642 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 29.2 mttt -142.07 159.8 41.51 Favored 'General case' 0 CA--C 1.507 -0.7 0 C-N-CA 124.36 1.064 . . . . 0.0 109.088 178.846 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.545 HD23 ' C ' ' A' ' 41' ' ' GLY . 3.8 mt -108.01 147.96 36.52 Favored Pre-proline 0 N--CA 1.446 -0.657 0 O-C-N 124.429 1.081 . . . . 0.0 110.613 -179.406 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -72.62 177.66 7.23 Favored 'Trans proline' 0 N--CA 1.446 -1.3 0 C-N-CA 124.251 3.301 . . . . 0.0 111.278 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.9 ttpt -76.94 102.69 6.5 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 120.575 -1.328 . . . . 0.0 109.938 175.05 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.3 83.69 1.75 Allowed Glycine 0 C--O 1.222 -0.653 0 O-C-N 124.216 0.948 . . . . 0.0 110.945 177.55 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.452 ' CG ' HD22 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -163.2 172.91 14.09 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 124.444 1.097 . . . . 0.0 110.056 178.803 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.9 m -152.79 107.93 2.7 Favored Pre-proline 0 C--N 1.327 -0.384 0 O-C-N 123.635 0.585 . . . . 0.0 110.77 174.0 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -70.79 145.89 52.36 Favored 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 122.288 1.992 . . . . 0.0 111.166 177.012 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.508 HD12 HG21 ' A' ' 121' ' ' ILE . 16.9 mt -70.42 119.96 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.147 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 3.8 tttt -84.01 132.67 34.72 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 176.574 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.574 ' CD1' ' HB3' ' A' ' 118' ' ' CYS . 10.9 m-85 -114.54 -53.51 2.65 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 124.818 1.247 . . . . 0.0 111.273 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 121.28 -6.31 10.84 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.587 1.089 . . . . 0.0 113.21 -176.444 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -91.92 131.07 37.51 Favored 'General case' 0 CA--C 1.509 -0.621 0 O-C-N 121.606 -0.938 . . . . 0.0 110.233 177.188 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 32.3 t -68.77 -2.43 9.38 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 124.891 1.369 . . . . 0.0 111.802 176.456 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.466 ' OD2' HG11 ' A' ' 116' ' ' VAL . 0.5 OUTLIER -88.21 -54.06 4.39 Favored 'General case' 0 CA--C 1.518 -0.284 0 O-C-N 120.252 -1.53 . . . . 0.0 108.967 178.587 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.629 ' HB3' HD21 ' A' ' 80' ' ' LEU . 1.9 m -77.11 -34.27 56.81 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 123.814 0.696 . . . . 0.0 110.422 -178.954 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -62.27 -37.66 86.34 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.322 0.649 . . . . 0.0 111.186 173.874 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.493 ' HD3' ' CD2' ' A' ' 78' ' ' HIS . 0.0 OUTLIER -51.35 159.6 1.11 Allowed Pre-proline 0 N--CA 1.448 -0.557 0 CA-C-O 121.485 0.659 . . . . 0.0 112.123 178.77 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -68.73 120.62 7.52 Favored 'Trans proline' 0 N--CA 1.444 -1.392 0 C-N-CA 120.742 0.961 . . . . 0.0 111.573 174.455 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.442 ' HD2' ' CD1' ' A' ' 42' ' ' TYR . 25.4 Cg_endo -69.19 168.53 20.55 Favored 'Trans proline' 0 N--CA 1.447 -1.262 0 C-N-CA 124.233 3.289 . . . . 0.0 111.261 175.116 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.7 tptp -131.12 136.46 48.39 Favored 'General case' 0 C--O 1.211 -0.967 0 CA-C-O 118.042 -0.98 . . . . 0.0 108.43 176.902 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -115.32 160.52 19.7 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 125.516 1.527 . . . . 0.0 108.593 177.744 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -150.59 170.63 18.7 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.735 179.359 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.93 60.61 6.32 Favored 'General case' 0 C--O 1.217 -0.613 0 C-N-CA 123.068 0.547 . . . . 0.0 111.406 177.639 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -175.16 -38.4 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.299 0.64 . . . . 0.0 110.967 -179.07 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 125.48 -67.18 0.53 Allowed Glycine 0 C--N 1.336 0.573 0 C-N-CA 125.071 1.319 . . . . 0.0 109.929 -178.106 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -128.48 62.14 1.46 Allowed 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 127.905 2.482 . . . . 0.0 107.925 -174.501 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -61.64 -104.35 0.01 OUTLIER Glycine 0 CA--C 1.529 0.926 0 CA-C-O 121.706 0.615 . . . . 0.0 112.299 176.99 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.2 mttt -65.42 -92.92 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 O-C-N 120.736 -1.449 . . . . 0.0 112.009 177.763 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.484 HG23 ' O ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -128.62 14.4 6.49 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 121.553 -0.717 . . . . 0.0 110.877 178.282 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.448 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 47.1 m-20 -27.95 102.83 0.02 OUTLIER 'General case' 0 C--O 1.208 -1.098 0 C-N-CA 125.491 1.516 . . . . 0.0 111.564 -178.255 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.493 ' CD2' ' HD3' ' A' ' 64' ' ' ARG . 12.2 p-80 -94.59 65.34 3.13 Favored 'General case' 0 CA--C 1.505 -0.766 0 O-C-N 120.214 -1.554 . . . . 0.0 108.432 -170.268 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.898 ' CE2' HD11 ' A' ' 81' ' ' LEU . 13.7 p90 -93.97 141.75 28.16 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 124.523 1.129 . . . . 0.0 110.574 -176.471 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.629 HD21 ' HB3' ' A' ' 62' ' ' CYS . 0.3 OUTLIER -69.29 141.38 54.34 Favored 'General case' 0 C--O 1.216 -0.673 0 C-N-CA 119.694 -0.802 . . . . 0.0 110.496 173.895 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.898 HD11 ' CE2' ' A' ' 79' ' ' TYR . 0.8 OUTLIER -128.75 143.51 50.94 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 124.69 1.196 . . . . 0.0 110.339 176.236 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -106.41 153.93 21.53 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 122.717 1.246 . . . . 0.0 111.426 177.874 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.703 ' CZ ' ' HB2' ' A' ' 23' ' ' ALA . 6.9 t80 -142.94 128.99 10.4 Favored Pre-proline 0 N--CA 1.45 -0.459 0 O-C-N 121.379 -0.826 . . . . 0.0 112.506 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.535 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 23.7 Cg_endo -72.45 93.94 0.76 Allowed 'Trans proline' 0 N--CA 1.446 -1.277 0 C-N-CA 124.091 3.194 . . . . 0.0 110.612 179.037 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.2 t -99.95 113.23 25.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 122.503 1.145 . . . . 0.0 109.939 179.242 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.433 ' CD2' ' NE2' ' A' ' 90' ' ' HIS . 43.6 m-85 -81.51 158.5 68.64 Favored Pre-proline 0 C--N 1.324 -0.517 0 O-C-N 121.466 -0.772 . . . . 0.0 111.996 179.177 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -76.16 -39.27 0.89 Allowed 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.257 1.971 . . . . 0.0 113.87 178.321 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -40.43 -38.18 0.79 Allowed 'General case' 0 N--CA 1.471 0.603 0 O-C-N 125.145 1.528 . . . . 0.0 110.287 174.88 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 102.01 -7.58 55.03 Favored Glycine 0 N--CA 1.44 -1.062 0 C-N-CA 124.762 1.172 . . . . 0.0 112.716 -178.483 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.433 ' NE2' ' CD2' ' A' ' 86' ' ' PHE . 9.2 p-80 -62.75 123.56 18.75 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 177.75 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -62.64 117.04 5.72 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 171.585 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -44.16 154.44 0.11 Allowed 'General case' 0 C--O 1.21 -0.994 0 CA-C-O 123.018 1.389 . . . . 0.0 112.689 172.489 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.51 66.53 6.34 Favored 'General case' 0 C--N 1.32 -0.693 0 O-C-N 119.149 -2.219 . . . . 0.0 109.926 177.896 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.433 ' CE1' ' HZ ' ' A' ' 83' ' ' PHE . 15.7 p90 -80.79 -6.46 58.56 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 174.705 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -91.0 -38.35 12.88 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 122.677 1.227 . . . . 0.0 110.696 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 52.4 m -88.41 106.88 18.54 Favored 'General case' 0 CA--C 1.519 -0.243 0 O-C-N 121.346 -0.846 . . . . 0.0 109.202 179.141 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 9.7 ptpt -58.23 -46.48 85.84 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.16 0.505 . . . . 0.0 111.309 177.487 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -142.21 132.08 12.42 Favored Pre-proline 0 N--CA 1.444 -0.726 0 C-N-CA 125.065 1.346 . . . . 0.0 109.787 -178.858 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.426 ' HA ' ' HA ' ' A' ' 98' ' ' LYS . 29.0 Cg_endo -68.27 173.39 39.03 Favored 'Cis proline' 0 N--CA 1.459 -0.519 0 C-N-CA 123.06 -1.642 . . . . 0.0 110.505 -9.093 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.3 ptmm? -137.85 154.76 49.46 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 123.56 0.744 . . . . 0.0 109.563 178.345 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -98.11 171.07 8.47 Favored 'General case' 0 C--O 1.244 0.778 0 CA-C-O 122.159 0.981 . . . . 0.0 110.177 178.681 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -53.66 143.56 38.09 Favored Pre-proline 0 N--CA 1.443 -0.777 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.106 172.897 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -73.88 -68.58 0.02 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.344 0 C-N-CA 122.311 2.007 . . . . 0.0 110.688 176.496 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 124.63 152.81 8.41 Favored Glycine 0 CA--C 1.524 0.611 0 O-C-N 120.388 -1.445 . . . . 0.0 111.251 -178.661 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -75.78 -56.52 0.06 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.85 2.367 . . . . 0.0 111.115 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.656 ' HB3' ' CZ ' ' A' ' 11' ' ' TYR . . . -72.09 138.47 47.81 Favored 'General case' 0 N--CA 1.438 -1.049 0 O-C-N 123.369 0.418 . . . . 0.0 110.4 177.337 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.455 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 10.0 mtm-85 -144.43 149.28 35.77 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-O 118.073 -0.965 . . . . 0.0 110.429 177.864 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.443 ' CG1' ' HB3' ' A' ' 83' ' ' PHE . 3.1 p -83.92 114.26 24.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 125.145 1.378 . . . . 0.0 111.017 175.925 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.436 HG21 ' CE2' ' A' ' 38' ' ' PHE . 1.8 mp -101.43 120.68 51.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 -176.973 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.424 ' CG ' ' HG2' ' A' ' 115' ' ' LYS . 17.6 p90 -138.19 162.47 34.18 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.459 -178.849 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.5 p -91.52 161.94 14.75 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 122.755 0.422 . . . . 0.0 110.886 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.484 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.2 OUTLIER -110.64 154.96 42.93 Favored Pre-proline 0 CA--C 1.546 0.818 0 CA-C-N 118.216 0.462 . . . . 0.0 111.275 177.946 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.863 ' O ' HD21 ' A' ' 25' ' ' LEU . 18.9 Cg_endo -72.37 -54.28 0.15 OUTLIER 'Cis proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.689 -1.379 . . . . 0.0 108.771 -9.95 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 41.3 t-20 -40.18 108.45 0.09 Allowed 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 116.511 -1.709 . . . . 0.0 110.507 178.658 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.677 ' CE ' HD13 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -67.5 63.84 0.07 Allowed 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 126.455 1.902 . . . . 0.0 108.119 -178.223 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.466 HG11 ' OD2' ' A' ' 61' ' ' ASP . 35.9 t -73.34 75.52 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 103.712 -2.699 . . . . 0.0 103.712 178.937 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.477 ' CZ ' ' HA2' ' A' ' 119' ' ' GLY . 2.2 t80 -40.87 124.21 2.08 Favored 'General case' 0 N--CA 1.437 -1.111 0 C-N-CA 125.182 1.393 . . . . 0.0 107.714 174.361 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 118' ' ' CYS . . . . . 0.574 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 0.1 OUTLIER -100.64 -40.84 7.19 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.227 175.768 . . . . . . . . 3 3 . 1 . 019 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.477 ' HA2' ' CZ ' ' A' ' 117' ' ' PHE . . . 160.31 -174.79 37.09 Favored Glycine 0 CA--C 1.505 -0.589 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 -178.692 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.542 ' CG2' ' HB1' ' A' ' 106' ' ' ALA . 3.2 mp -106.06 145.34 14.1 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.004 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 178.065 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.508 HG21 HD12 ' A' ' 55' ' ' ILE . 8.5 pt -119.78 152.71 22.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.659 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . . . -174.99 125.54 0.27 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 122.964 1.364 . . . . 0.0 109.741 179.508 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -88.09 89.89 8.17 Favored 'General case' 0 C--N 1.322 -0.591 0 O-C-N 120.86 -1.15 . . . . 0.0 111.734 178.193 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.401 HG21 ' O ' ' A' ' 6' ' ' CYS . 3.5 p -102.06 41.44 1.22 Allowed 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 123.86 0.864 . . . . 0.0 109.83 -177.908 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 9.2 ttpt -93.02 -41.11 10.17 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-O 116.638 -1.649 . . . . 0.0 111.559 177.277 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 170.64 -85.28 0.0 OUTLIER 'General case' 0 C--O 1.223 -0.307 0 C-N-CA 126.758 2.023 . . . . 0.0 109.168 178.886 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -158.48 26.12 0.24 Allowed 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 125.334 1.454 . . . . 0.0 111.768 -175.676 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -170.11 92.98 0.22 Allowed 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 123.095 1.426 . . . . 0.0 110.629 -175.104 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 163.54 109.73 0.23 Allowed Glycine 0 CA--C 1.494 -1.222 0 N-CA-C 106.442 -2.663 . . . . 0.0 106.442 178.659 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -37.49 143.89 0.09 Allowed 'General case' 0 C--O 1.24 0.581 0 CA-C-N 119.053 1.426 . . . . 0.0 112.465 175.078 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.497 ' H ' HD12 ' A' ' 131' ' ' LEU . 6.6 mp -54.41 144.54 20.54 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -179.322 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.15 148.42 45.76 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -178.979 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.477 HD13 ' CE1' ' A' ' 57' ' ' PHE . 9.7 tp -56.75 131.85 50.43 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 125.415 1.697 . . . . 0.0 107.842 179.002 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 134' ' ' CYS . . . . . 0.539 ' SG ' HG22 ' A' ' 120' ' ' ILE . 71.3 m -58.54 178.0 0.12 Allowed 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 124.38 1.072 . . . . 0.0 109.554 174.585 . . . . . . . . 2 2 . 1 . 019 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 38.3 m -154.23 112.09 3.5 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 -176.287 . . . . . . . . 1 1 . 1 . 019 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.255 1.343 0 CA-C-O 115.519 -2.182 . . . . 0.0 110.943 172.035 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.51 -0.581 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 . . . . . . . . . 0 0 . 1 . 020 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.555 HG22 ' HB3' ' A' ' 136' ' ' HIS . 3.5 p -74.24 134.79 28.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.858 0.837 . . . . 0.0 109.487 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.2 m -90.56 120.0 31.28 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -176.908 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.462 ' CG ' HG13 ' A' ' 120' ' ' ILE . 31.9 m95 -79.75 141.34 36.42 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 -179.263 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -134.01 129.6 36.36 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-O 122.366 1.079 . . . . 0.0 108.669 -176.856 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.78 ' SG ' ' HB3' ' A' ' 122' ' ' ALA . 0.0 OUTLIER -125.96 67.24 1.19 Allowed 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 177.064 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 130.38 -98.36 0.41 Allowed Glycine 0 C--O 1.22 -0.741 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 178.899 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -133.32 8.42 5.04 Favored Glycine 0 N--CA 1.464 0.512 0 C-N-CA 123.416 0.532 . . . . 0.0 112.4 178.101 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.497 HD13 ' OH ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -115.85 142.36 46.87 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -176.754 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.6 mp -110.21 125.92 53.58 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -175.07 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.52 ' CZ ' ' HB3' ' A' ' 106' ' ' ALA . 77.5 m-85 -117.04 103.5 10.31 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 126.327 1.851 . . . . 0.0 108.2 -173.094 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -55.18 121.47 8.9 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 118.113 -0.946 . . . . 0.0 108.991 178.809 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 13' ' ' GLN . . . . . . . . . . . . . 23.2 tp60 -51.33 -45.28 62.23 Favored 'General case' 0 C--O 1.206 -1.211 0 O-C-N 124.023 0.827 . . . . 0.0 111.881 179.672 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -51.02 -40.83 59.13 Favored 'General case' 0 C--O 1.197 -1.697 0 CA-C-N 117.801 0.273 . . . . 0.0 111.309 176.102 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.86 -36.78 72.98 Favored 'General case' 0 C--O 1.199 -1.604 0 O-C-N 120.1 -1.625 . . . . 0.0 113.395 168.979 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.61 -40.96 72.78 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 123.04 2.654 . . . . 0.0 113.871 171.705 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -86.45 -38.75 17.0 Favored 'General case' 0 C--O 1.206 -1.186 0 C-N-CA 123.622 0.769 . . . . 0.0 108.999 176.655 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.7 t -73.42 -58.74 3.1 Favored 'General case' 0 CA--C 1.502 -0.879 0 O-C-N 119.889 -1.757 . . . . 0.0 108.771 -176.469 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.476 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 7.6 t-20 -42.62 -36.13 1.3 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 119.624 1.102 . . . . 0.0 112.977 171.823 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.428 ' HB3' HG11 ' A' ' 108' ' ' VAL . 1.0 OUTLIER -82.27 -31.95 29.86 Favored 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 174.149 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -50.8 -39.33 52.57 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 126.204 1.802 . . . . 0.0 109.162 178.475 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.476 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -75.38 -45.7 37.56 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-O 117.388 -1.291 . . . . 0.0 110.689 177.844 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.723 ' HB1' ' HG3' ' A' ' 35' ' ' PRO . . . -40.4 135.15 1.49 Allowed Pre-proline 0 CA--C 1.543 0.706 0 O-C-N 125.609 1.818 . . . . 0.0 111.966 176.574 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.691 ' HG2' HG22 ' A' ' 30' ' ' THR . 18.5 Cg_endo -72.65 122.02 7.88 Favored 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 122.067 1.845 . . . . 0.0 109.319 -176.953 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.676 HD13 ' HE2' ' A' ' 115' ' ' LYS . 5.2 tp -59.88 94.39 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.311 0.644 . . . . 0.0 111.17 178.717 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -171.58 178.71 3.07 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 123.312 0.645 . . . . 0.0 109.673 -176.444 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.407 ' HB2' ' CE2' ' A' ' 79' ' ' TYR . 2.7 t0 -116.45 89.25 3.07 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 124.211 1.004 . . . . 0.0 109.673 177.413 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 71.86 78.69 0.46 Allowed Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 176.397 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.1 mmtp -149.77 30.24 0.73 Allowed 'General case' 0 CA--C 1.513 -0.46 0 C-N-CA 123.355 0.662 . . . . 0.0 111.723 178.094 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.691 HG22 ' HG2' ' A' ' 24' ' ' PRO . 11.8 p -122.02 149.37 43.6 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -175.116 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.4 ' C ' ' HA ' ' A' ' 97' ' ' LYS . . . -42.11 -52.62 4.94 Favored Glycine 0 C--N 1.332 0.353 0 O-C-N 123.814 0.696 . . . . 0.0 111.905 -179.181 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.5 t -67.75 -64.53 0.84 Allowed 'General case' 0 CA--C 1.503 -0.847 0 CA-C-O 116.266 -1.826 . . . . 0.0 112.303 174.237 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 166.24 -59.39 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 126.334 1.854 . . . . 0.0 111.423 177.723 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.52 ' CD2' ' HD3' ' A' ' 84' ' ' PRO . 60.5 m-85 -62.99 147.52 94.17 Favored Pre-proline 0 N--CA 1.436 -1.162 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 179.119 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.723 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 21.0 Cg_endo -75.6 164.56 87.79 Favored 'Cis proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.232 -1.57 . . . . 0.0 111.6 0.483 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.466 ' CD2' ' CD2' ' A' ' 34' ' ' TYR . 1.3 p80 -140.08 173.64 11.31 Favored 'General case' 0 C--O 1.21 -1.012 0 CA-C-O 117.865 -1.064 . . . . 0.0 110.305 -177.491 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.948 ' CH2' HG22 ' A' ' 39' ' ' THR . 19.6 t90 -75.95 127.1 32.28 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 119.441 1.018 . . . . 0.0 109.226 175.964 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.573 ' CZ ' ' HA ' ' A' ' 40' ' ' ASN . 34.6 t80 -97.38 86.69 3.94 Favored 'General case' 0 N--CA 1.427 -1.62 0 C-N-CA 125.928 1.691 . . . . 0.0 107.303 177.766 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.948 HG22 ' CH2' ' A' ' 37' ' ' TRP . 61.8 p -39.87 -35.1 0.32 Allowed 'General case' 0 CA--C 1.508 -0.67 0 C-N-CA 124.774 1.23 . . . . 0.0 111.042 173.603 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.573 ' HA ' ' CZ ' ' A' ' 38' ' ' PHE . 65.1 t30 69.19 8.77 7.01 Favored 'General case' 0 C--O 1.222 -0.381 0 C-N-CA 124.614 1.165 . . . . 0.0 110.376 177.757 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.461 ' CA ' ' HD3' ' A' ' 52' ' ' ARG . . . 112.7 -13.78 24.8 Favored Glycine 0 N--CA 1.428 -1.843 0 C-N-CA 124.741 1.162 . . . . 0.0 114.206 -172.563 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.621 ' CE1' HD11 ' A' ' 48' ' ' LEU . 16.0 m-85 -70.61 166.55 20.44 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.095 0.958 . . . . 0.0 110.682 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.01 -40.44 16.87 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.992 176.671 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.575 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . 174.84 -49.63 0.13 Allowed Glycine 0 C--N 1.335 0.484 0 C-N-CA 124.354 0.978 . . . . 0.0 111.794 -178.013 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -125.01 -63.24 1.17 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 122.026 0.917 . . . . 0.0 109.505 -179.652 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.48 161.38 21.76 Favored Glycine 0 C--N 1.341 0.823 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.585 ' HA ' ' CE2' ' A' ' 42' ' ' TYR . 19.5 mtmt -54.74 175.15 0.06 Allowed 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 122.303 1.049 . . . . 0.0 112.339 176.188 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.635 ' H ' HD12 ' A' ' 48' ' ' LEU . 5.8 mp -56.76 153.72 21.01 Favored Pre-proline 0 N--CA 1.447 -0.618 0 O-C-N 121.658 -0.651 . . . . 0.0 111.381 178.296 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -71.72 158.99 52.07 Favored 'Trans proline' 0 N--CA 1.448 -1.19 0 C-N-CA 121.88 1.72 . . . . 0.0 110.092 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.9 tttt -55.52 98.35 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.145 0.578 . . . . 0.0 109.921 177.133 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.8 72.89 0.62 Allowed Glycine 0 C--O 1.228 -0.226 0 CA-C-O 119.503 -0.609 . . . . 0.0 112.686 -176.15 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.461 ' HD3' ' CA ' ' A' ' 41' ' ' GLY . 12.3 ttm180 -174.42 162.8 3.59 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 124.175 0.99 . . . . 0.0 110.448 175.786 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.3 m -136.52 110.34 9.6 Favored Pre-proline 0 C--O 1.208 -1.089 0 O-C-N 123.909 0.756 . . . . 0.0 110.87 178.625 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.527 ' HG3' HD13 ' A' ' 48' ' ' LEU . 24.9 Cg_endo -71.98 -178.72 3.33 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 121.698 1.599 . . . . 0.0 112.232 177.592 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.456 HD11 ' O ' ' A' ' 131' ' ' LEU . 6.6 mt -95.42 114.17 31.45 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 -178.646 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.61 135.46 35.55 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 120.954 -1.091 . . . . 0.0 108.635 177.277 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.49 ' CD2' ' HB3' ' A' ' 118' ' ' CYS . 4.7 m-85 -117.67 -52.4 2.45 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 123.234 0.614 . . . . 0.0 109.795 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 134.15 -12.26 4.71 Favored Glycine 0 C--O 1.224 -0.513 0 C-N-CA 123.92 0.772 . . . . 0.0 112.418 -176.785 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.51 134.33 34.44 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 117.43 0.615 . . . . 0.0 109.481 177.816 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 87.8 p -75.93 2.72 11.79 Favored 'General case' 0 C--O 1.222 -0.372 0 O-C-N 124.362 1.039 . . . . 0.0 111.713 176.084 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -89.11 -56.14 3.4 Favored 'General case' 0 C--O 1.217 -0.619 0 C-N-CA 124.867 1.267 . . . . 0.0 109.047 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.746 ' HB3' HD11 ' A' ' 80' ' ' LEU . 2.1 m -71.57 -29.97 65.33 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 178.849 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -66.66 -38.16 86.27 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-O 121.091 0.472 . . . . 0.0 110.909 175.259 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.84 164.18 0.58 Allowed Pre-proline 0 N--CA 1.447 -0.598 0 CA-C-O 122.156 0.979 . . . . 0.0 111.692 178.493 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -69.85 126.54 13.37 Favored 'Trans proline' 0 N--CA 1.443 -1.48 0 C-N-CA 121.239 1.293 . . . . 0.0 114.499 172.594 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.463 ' CD ' ' CD2' ' A' ' 42' ' ' TYR . 21.5 Cg_endo -70.64 168.16 23.51 Favored 'Trans proline' 0 N--CA 1.444 -1.44 0 C-N-CA 124.099 3.2 . . . . 0.0 111.48 177.171 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.2 tptt -130.61 61.22 1.62 Allowed 'General case' 0 C--O 1.202 -1.397 0 CA-C-O 116.95 -1.5 . . . . 0.0 108.854 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 40.6 t-80 -75.58 164.97 25.78 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 120.291 1.405 . . . . 0.0 111.029 178.737 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.9 -179.71 7.21 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 120.869 -1.144 . . . . 0.0 110.841 178.093 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.34 69.23 10.46 Favored 'General case' 0 C--O 1.211 -0.928 0 O-C-N 120.29 -1.506 . . . . 0.0 111.34 177.453 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -176.76 -41.98 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 O-C-N 123.772 0.67 . . . . 0.0 109.707 179.385 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.449 ' O ' ' CE2' ' A' ' 79' ' ' TYR . . . 138.11 -72.5 0.44 Allowed Glycine 0 C--O 1.21 -1.361 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 -178.749 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.437 ' ND2' ' CE1' ' A' ' 112' ' ' TYR . 11.1 t-20 -140.72 72.85 1.4 Allowed 'General case' 0 N--CA 1.438 -1.064 0 O-C-N 121.872 -0.781 . . . . 0.0 109.865 179.24 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.47 -101.98 0.01 OUTLIER Glycine 0 C--O 1.221 -0.717 0 CA-C-O 119.736 -0.48 . . . . 0.0 112.47 178.353 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -52.42 -90.29 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.457 0 CA-C-O 122.152 0.977 . . . . 0.0 111.25 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.533 HG23 ' O ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -134.47 20.66 3.64 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-O 117.765 -1.112 . . . . 0.0 111.192 178.586 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -20.54 90.1 0.01 OUTLIER 'General case' 0 C--O 1.211 -0.938 0 C-N-CA 125.424 1.49 . . . . 0.0 114.089 -177.461 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 28.4 p80 -92.22 29.45 1.66 Allowed 'General case' 0 N--CA 1.467 0.383 0 O-C-N 119.097 -2.252 . . . . 0.0 108.196 -170.1 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.967 ' CZ ' HD21 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -57.37 176.29 0.13 Allowed 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 115.073 1.508 . . . . 0.0 115.073 174.161 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.819 HD22 HG22 ' A' ' 109' ' ' ILE . 3.6 mt -95.84 154.99 16.94 Favored 'General case' 0 C--O 1.215 -0.758 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.371 173.946 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.967 HD21 ' CZ ' ' A' ' 79' ' ' TYR . 2.1 mt -141.14 129.28 22.12 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -177.96 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.495 ' CB ' ' CD1' ' A' ' 109' ' ' ILE . 0.2 OUTLIER -98.92 155.72 17.26 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 122.832 1.301 . . . . 0.0 111.543 178.66 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.451 ' HZ ' ' CD2' ' A' ' 94' ' ' PHE . 47.7 t80 -146.27 129.8 8.34 Favored Pre-proline 0 N--CA 1.452 -0.332 0 O-C-N 121.221 -0.924 . . . . 0.0 112.2 179.422 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.52 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 21.5 Cg_endo -71.96 106.02 1.93 Allowed 'Trans proline' 0 N--CA 1.445 -1.324 0 C-N-CA 124.531 3.487 . . . . 0.0 110.801 -179.462 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.94 114.99 29.46 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.937 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.419 ' CE1' ' HB2' ' A' ' 92' ' ' TYR . 70.7 m-85 -82.17 158.02 67.52 Favored Pre-proline 0 N--CA 1.449 -0.515 0 O-C-N 121.775 -0.578 . . . . 0.0 111.818 178.916 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -76.8 -38.88 0.77 Allowed 'Trans proline' 0 CA--C 1.498 -1.288 0 C-N-CA 122.467 2.112 . . . . 0.0 112.713 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -44.92 -30.7 1.06 Allowed 'General case' 0 N--CA 1.469 0.497 0 O-C-N 125.342 1.651 . . . . 0.0 110.98 176.674 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 90.42 -8.48 79.73 Favored Glycine 0 N--CA 1.438 -1.216 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 176.349 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.6 p-80 -59.71 129.25 41.0 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 178.072 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -62.68 96.58 0.09 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 175.483 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.492 ' CD2' ' HB3' ' A' ' 94' ' ' PHE . 7.0 t80 -37.82 142.34 0.16 Allowed 'General case' 0 C--O 1.212 -0.904 0 CA-C-O 121.843 0.83 . . . . 0.0 110.92 178.865 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 93' ' ' LYS . . . . . 0.423 ' HE2' ' O ' ' A' ' 99' ' ' PRO . 0.1 OUTLIER -77.43 57.29 1.5 Allowed 'General case' 0 C--N 1.314 -0.947 0 O-C-N 119.584 -1.947 . . . . 0.0 110.779 175.972 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.492 ' HB3' ' CD2' ' A' ' 92' ' ' TYR . 33.2 p90 -71.25 -9.26 57.82 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 124.319 1.048 . . . . 0.0 112.23 175.892 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -92.19 -37.27 12.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 122.223 1.011 . . . . 0.0 109.709 -179.456 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.9 m -75.41 106.15 6.8 Favored 'General case' 0 CA--C 1.513 -0.464 0 O-C-N 121.266 -0.896 . . . . 0.0 108.968 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 97' ' ' LYS . . . . . 0.4 ' HA ' ' C ' ' A' ' 31' ' ' GLY . 4.1 pttp -58.59 -49.91 75.76 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 121.882 0.848 . . . . 0.0 110.362 178.163 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 99' ' ' PRO . 0.7 OUTLIER -145.54 126.06 7.27 Favored Pre-proline 0 N--CA 1.436 -1.146 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.244 -176.612 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.423 ' O ' ' HE2' ' A' ' 93' ' ' LYS . 29.7 Cg_endo -70.11 175.96 35.58 Favored 'Cis proline' 0 N--CA 1.461 -0.397 0 O-C-N 124.419 1.747 . . . . 0.0 111.797 -4.686 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 15.3 tttm -141.95 132.34 25.12 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 123.526 0.73 . . . . 0.0 109.069 178.252 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -72.14 170.81 13.18 Favored 'General case' 0 C--O 1.237 0.442 0 O-C-N 124.747 1.279 . . . . 0.0 111.881 177.141 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -65.13 152.1 92.25 Favored Pre-proline 0 N--CA 1.445 -0.699 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.442 177.863 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -73.3 -164.83 0.21 Allowed 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.734 2.289 . . . . 0.0 112.139 175.983 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -141.4 157.43 26.14 Favored Glycine 0 CA--C 1.522 0.494 0 O-C-N 121.353 -0.842 . . . . 0.0 112.438 177.403 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -75.76 -67.56 0.02 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.868 2.379 . . . . 0.0 110.43 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.761 ' HA ' ' HB2' ' A' ' 122' ' ' ALA . . . -60.73 138.78 58.06 Favored 'General case' 0 N--CA 1.446 -0.634 0 O-C-N 123.9 0.75 . . . . 0.0 110.452 179.038 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 6.0 mtm-85 -144.1 144.07 31.43 Favored 'General case' 0 CA--C 1.508 -0.656 0 O-C-N 124.529 1.143 . . . . 0.0 111.148 -179.051 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.428 HG11 ' HB3' ' A' ' 20' ' ' SER . 4.3 p -82.52 123.95 38.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 123.907 0.754 . . . . 0.0 110.595 179.032 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.819 HG22 HD22 ' A' ' 80' ' ' LEU . 7.0 mm -104.67 138.68 28.34 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.903 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -178.923 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.807 ' C ' HD23 ' A' ' 80' ' ' LEU . 12.6 p90 -165.52 155.19 12.62 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-O 121.801 0.81 . . . . 0.0 111.517 -178.188 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 16.9 p -91.2 160.86 15.33 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -175.918 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.524 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -107.79 155.79 39.23 Favored Pre-proline 0 C--N 1.318 -0.776 0 O-C-N 122.029 -0.419 . . . . 0.0 110.694 179.905 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.524 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 17.8 Cg_endo -73.32 -53.87 0.15 OUTLIER 'Cis proline' 0 CA--C 1.5 -1.176 0 C-N-CA 123.351 -1.521 . . . . 0.0 109.399 -7.429 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.571 ' O ' HG23 ' A' ' 116' ' ' VAL . 11.6 t30 -44.17 107.38 0.09 Allowed 'General case' 0 C--O 1.217 -0.642 0 CA-C-O 116.187 -1.864 . . . . 0.0 109.632 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.676 ' HE2' HD13 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -62.35 85.37 0.02 OUTLIER 'General case' 0 CA--C 1.509 -0.627 0 O-C-N 124.568 1.168 . . . . 0.0 108.737 -176.099 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 114' ' ' ASN . 81.0 t -84.31 67.67 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.756 0 N-CA-C 104.964 -2.235 . . . . 0.0 104.964 -173.692 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.576 ' CZ ' ' HA2' ' A' ' 119' ' ' GLY . 47.1 t80 -37.13 101.98 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.225 1.41 . . . . 0.0 109.759 178.549 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 118' ' ' CYS . . . . . 0.49 ' HB3' ' CD2' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -81.79 -24.62 35.86 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 178.997 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.576 ' HA2' ' CZ ' ' A' ' 117' ' ' PHE . . . 144.99 -147.42 18.58 Favored Glycine 0 N--CA 1.434 -1.435 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 -178.724 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.462 HG13 ' CG ' ' A' ' 4' ' ' TRP . 1.1 mm -127.31 148.27 32.08 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.273 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 -175.428 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.741 HD12 ' HB2' ' A' ' 131' ' ' LEU . 8.2 pt -136.23 154.99 34.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 108.139 -1.059 . . . . 0.0 108.139 -178.253 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.78 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . . . 179.25 131.43 0.08 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 122.145 0.974 . . . . 0.0 109.502 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.491 ' CD2' ' CD1' ' A' ' 131' ' ' LEU . 0.0 OUTLIER -88.05 94.61 9.85 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 122.372 1.082 . . . . 0.0 111.927 179.212 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.545 HG21 ' O ' ' A' ' 6' ' ' CYS . 1.3 p -103.84 42.21 1.21 Allowed 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.304 -0.872 . . . . 0.0 109.184 -176.7 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 15.0 tttt -95.72 -39.54 9.83 Favored 'General case' 0 C--O 1.211 -0.937 0 CA-C-O 115.328 -2.272 . . . . 0.0 111.117 178.009 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 169.89 -86.38 0.0 OUTLIER 'General case' 0 C--O 1.218 -0.568 0 O-C-N 126.136 2.148 . . . . 0.0 108.749 178.606 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -158.76 28.7 0.22 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.055 2.142 . . . . 0.0 110.384 -176.633 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -169.34 91.72 0.24 Allowed 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 122.829 1.3 . . . . 0.0 110.034 -177.646 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 163.31 109.62 0.23 Allowed Glycine 0 CA--C 1.483 -1.965 0 CA-C-O 115.245 -2.975 . . . . 0.0 106.146 179.077 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -35.44 151.73 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 119.877 1.839 . . . . 0.0 112.76 175.322 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.741 ' HB2' HD12 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -59.79 154.93 17.14 Favored 'General case' 0 C--N 1.32 -0.713 0 O-C-N 121.037 -1.039 . . . . 0.0 108.642 -176.504 . . . . . . . . 3 3 . 1 . 020 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 3.8 ptmt -132.64 151.39 51.97 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 -178.248 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.465 HD13 ' CD2' ' A' ' 57' ' ' PHE . 13.4 tp -54.32 129.71 36.39 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 125.11 1.507 . . . . 0.0 108.339 -179.569 . . . . . . . . 2 2 . 1 . 020 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 76.4 m -66.57 -173.78 0.25 Allowed 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 124.363 2.03 . . . . 0.0 108.237 177.291 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 39.3 m -157.94 125.52 5.19 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 102.819 -3.03 . . . . 0.0 102.819 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.555 ' HB3' HG22 ' A' ' 2' ' ' VAL . 2.4 m80 . . . . . 0 CA--C 1.575 1.923 0 N-CA-C 118.489 2.774 . . . . 0.0 118.489 175.091 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 1' ' ' ALA . . . . . 0.684 ' HB3' ' HB3' ' A' ' 13' ' ' GLN . . . . . . . . 0 N--CA 1.498 1.96 0 CA-C-O 116.669 -1.634 . . . . 0.0 107.644 . . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.3 p -41.51 142.82 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 CA-C-O 123.12 1.438 . . . . 0.0 112.774 169.752 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.442 HG21 HD12 ' A' ' 10' ' ' LEU . 6.4 m -93.37 111.25 22.85 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 -173.089 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 18.0 m95 -75.59 143.77 42.16 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 -178.557 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.537 ' OG1' HD13 ' A' ' 10' ' ' LEU . 1.9 m -145.88 153.25 40.65 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 -179.975 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.608 ' CB ' ' HB3' ' A' ' 122' ' ' ALA . 0.8 OUTLIER -125.65 -84.64 0.63 Allowed 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 172.448 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -102.0 58.38 0.61 Allowed Glycine 0 N--CA 1.473 1.101 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 -178.032 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 72.92 -3.31 29.02 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 117.681 1.832 . . . . 0.0 117.681 -171.331 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.351 5.1 mt -94.73 132.61 39.3 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.087 1.755 . . . . 0.0 108.405 -177.438 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.537 HD13 ' OG1' ' A' ' 5' ' ' THR . 4.4 mm? -99.29 151.86 20.57 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.316 1.446 . . . . 0.0 110.102 -170.861 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.856 ' CZ ' ' HB3' ' A' ' 106' ' ' ALA . 40.9 m-85 -157.85 74.65 0.74 Allowed 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 -168.017 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 12' ' ' ASN . . . . . 0.431 ' HA ' ' HA ' ' A' ' 3' ' ' THR . 0.2 OUTLIER -50.67 128.0 19.47 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 120.053 -1.655 . . . . 0.0 108.606 178.251 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.684 ' HB3' ' HB3' ' A' ' 1' ' ' ALA . 0.9 OUTLIER -44.66 -54.7 5.91 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-O 117.682 -1.151 . . . . 0.0 111.841 178.179 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -48.27 -51.2 26.76 Favored 'General case' 0 C--O 1.202 -1.403 0 O-C-N 124.235 0.959 . . . . 0.0 112.449 176.193 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.41 -35.64 74.36 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 114.329 -2.748 . . . . 0.0 117.491 169.981 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.665 ' HB1' HD11 ' A' ' 120' ' ' ILE . . . -63.13 -68.33 0.35 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 127.518 2.327 . . . . 0.0 115.487 169.537 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -48.35 -42.0 30.17 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 117.714 -1.136 . . . . 0.0 110.739 167.836 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 41.5 t -64.84 -53.09 52.25 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 126.687 1.995 . . . . 0.0 110.418 -179.702 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -44.98 -49.12 11.37 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 119.189 0.904 . . . . 0.0 111.247 173.152 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.507 ' HB2' ' CE2' ' A' ' 110' ' ' TYR . 1.7 p -67.72 -32.65 73.42 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 118.133 2.642 . . . . 0.0 118.133 172.933 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 11.0 m170 -58.64 -40.24 82.84 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 127.535 2.334 . . . . 0.0 110.73 174.38 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -80.6 -44.76 18.41 Favored 'General case' 0 CA--C 1.511 -0.521 0 C-N-CA 125.28 1.432 . . . . 0.0 111.658 176.407 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.582 ' HB1' ' HG3' ' A' ' 35' ' ' PRO . . . -47.35 126.45 9.67 Favored Pre-proline 0 CA--C 1.552 1.041 0 O-C-N 125.527 1.767 . . . . 0.0 112.76 177.457 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -68.28 128.96 18.28 Favored 'Trans proline' 0 N--CA 1.439 -1.718 0 N-CA-C 107.596 -1.732 . . . . 0.0 107.596 -176.272 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.744 HD21 ' O ' ' A' ' 113' ' ' PRO . 4.6 tp -65.31 90.65 0.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 126.397 1.879 . . . . 0.0 112.505 178.138 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 174.21 161.95 0.19 Allowed 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 125.84 1.656 . . . . 0.0 108.786 -172.148 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.456 ' HA ' ' HA ' ' A' ' 36' ' ' HIS . 2.9 t70 -104.74 119.17 38.36 Favored 'General case' 0 CA--C 1.495 -1.171 0 C-N-CA 128.558 2.743 . . . . 0.0 108.425 -179.062 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 56.76 50.02 66.47 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 119.69 -1.243 . . . . 0.0 112.069 172.407 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.81 -3.57 14.89 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 125.382 1.473 . . . . 0.0 114.344 176.119 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.2 p -114.27 158.42 21.44 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 -170.895 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -45.89 -55.08 7.55 Favored Glycine 0 N--CA 1.467 0.736 0 C-N-CA 124.331 0.967 . . . . 0.0 115.039 -178.745 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 30.4 t -57.52 -71.8 0.1 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 114.266 1.209 . . . . 0.0 114.266 165.64 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.5 m 161.44 -51.03 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 131.338 3.855 . . . . 0.0 110.929 -176.507 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.483 ' CE1' ' HG3' ' A' ' 103' ' ' PRO . 90.8 m-85 -57.38 147.72 57.36 Favored Pre-proline 0 CA--C 1.569 1.694 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -174.038 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.582 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 19.6 Cg_endo -66.79 148.31 78.21 Favored 'Cis proline' 0 N--CA 1.428 -2.324 0 N-CA-C 106.784 -2.045 . . . . 0.0 106.784 -7.467 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 27' ' ' ASP 0.27 0.3 OUTLIER -117.3 167.08 11.55 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 113.736 -1.574 . . . . 0.0 107.393 174.927 . . . . . . . . 4 4 . 1 . 021 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.704 ' CH2' HG22 ' A' ' 39' ' ' THR . 11.1 t90 -64.03 133.17 52.6 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 123.274 1.511 . . . . 0.0 112.329 168.768 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.482 ' CD2' ' HB2' ' A' ' 40' ' ' ASN . 18.0 t80 -98.7 89.98 4.55 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 102.995 -2.965 . . . . 0.0 102.995 -179.742 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.704 HG22 ' CH2' ' A' ' 37' ' ' TRP . 82.8 p -38.86 -41.52 0.75 Allowed 'General case' 0 CA--C 1.502 -0.887 0 CA-C-N 111.329 -2.669 . . . . 0.0 110.421 160.923 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.482 ' HB2' ' CD2' ' A' ' 38' ' ' PHE . 63.2 t30 57.36 25.09 10.84 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 120.625 1.557 . . . . 0.0 112.09 178.316 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.753 ' C ' HD23 ' A' ' 48' ' ' LEU . . . 94.4 -39.35 2.92 Favored Glycine 0 CA--C 1.542 1.779 0 CA-C-O 113.723 -3.82 . . . . 0.0 117.846 -163.92 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -45.14 148.72 0.56 Allowed 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 130.203 3.401 . . . . 0.0 111.687 173.853 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.68 -32.56 25.52 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 115.34 1.607 . . . . 0.0 115.34 177.363 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.407 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -168.79 -81.95 0.05 OUTLIER Glycine 0 CA--C 1.527 0.841 0 C-N-CA 126.133 1.825 . . . . 0.0 111.82 -176.647 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -108.26 -63.95 1.27 Allowed 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 127.337 2.255 . . . . 0.0 114.226 -178.307 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.52 -171.37 0.66 Allowed Glycine 0 C--O 1.222 -0.599 0 CA-C-N 114.54 -1.209 . . . . 0.0 111.989 177.012 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.55 -175.29 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.838 0 CA-C-O 124.375 2.036 . . . . 0.0 115.151 170.441 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.753 HD23 ' C ' ' A' ' 41' ' ' GLY . 0.0 OUTLIER -74.7 160.04 81.84 Favored Pre-proline 0 C--N 1.312 -1.044 0 CA-C-N 114.338 -1.301 . . . . 0.0 110.56 -177.889 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -62.03 168.72 8.58 Favored 'Trans proline' 0 N--CA 1.435 -1.967 0 CA-C-O 123.88 1.534 . . . . 0.0 110.119 171.306 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 6.5 ttpt -55.1 101.35 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.624 1.57 . . . . 0.0 111.665 170.222 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.37 90.24 1.67 Allowed Glycine 0 N--CA 1.474 1.203 0 N-CA-C 111.553 -0.619 . . . . 0.0 111.553 -173.822 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.446 ' CD ' ' HA2' ' A' ' 41' ' ' GLY . 0.0 OUTLIER -167.01 163.89 15.96 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 126.463 1.905 . . . . 0.0 111.148 171.98 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 42.4 m -134.89 101.93 11.37 Favored Pre-proline 0 N--CA 1.478 0.972 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -178.325 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.497 ' HB3' HD21 ' A' ' 48' ' ' LEU . 29.8 Cg_endo -71.46 140.71 37.05 Favored 'Trans proline' 0 N--CA 1.43 -2.247 0 C-N-CA 122.155 1.903 . . . . 0.0 109.911 176.472 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.0 mt -61.8 119.52 5.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 172.294 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.65 143.88 28.16 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.284 169.821 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.535 ' CD1' ' HB3' ' A' ' 118' ' ' CYS . 7.0 m-85 -124.68 -53.24 1.68 Allowed 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 126.308 1.843 . . . . 0.0 111.044 179.514 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 122.43 -5.62 10.05 Favored Glycine 0 N--CA 1.476 1.345 0 C-N-CA 126.735 2.112 . . . . 0.0 114.929 -172.982 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.79 131.48 39.12 Favored 'General case' 0 CA--C 1.503 -0.865 0 C-N-CA 125.013 1.325 . . . . 0.0 110.765 172.622 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 92.0 p -67.89 2.78 1.8 Allowed 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 174.976 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 61' ' ' ASP . . . . . 0.486 ' OD2' HG11 ' A' ' 116' ' ' VAL . 0.4 OUTLIER -94.38 -55.19 3.25 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 128.608 2.763 . . . . 0.0 108.201 -173.839 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.757 ' HA ' HD11 ' A' ' 80' ' ' LEU . 1.8 m -77.31 -26.32 52.12 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.528 1.131 . . . . 0.0 113.077 175.148 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -72.32 -26.74 62.06 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 126.274 1.829 . . . . 0.0 114.043 166.881 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.07 155.06 74.99 Favored Pre-proline 0 CA--C 1.539 0.52 0 O-C-N 120.247 -1.533 . . . . 0.0 114.32 175.412 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -63.85 129.55 25.04 Favored 'Trans proline' 0 CA--C 1.568 2.207 0 O-C-N 119.336 -0.929 . . . . 0.0 112.063 174.582 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.528 ' HB3' ' HA ' ' A' ' 79' ' ' TYR . 19.4 Cg_endo -65.75 177.43 2.87 Favored 'Trans proline' 0 N--CA 1.447 -1.253 1 C-N-CA 125.448 4.099 . . . . 0.0 111.146 176.587 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.4 tptt -132.75 53.0 2.04 Favored 'General case' 0 C--O 1.214 -0.767 0 O-C-N 120.331 -1.481 . . . . 0.0 110.309 170.649 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 46.3 t-80 -76.04 160.94 29.31 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-O 123.315 1.531 . . . . 0.0 112.978 -178.819 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.74 -171.48 3.87 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 117.949 -2.969 . . . . 0.0 110.947 177.116 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.76 79.94 7.32 Favored 'General case' 0 C--O 1.213 -0.832 0 O-C-N 120.736 -1.227 . . . . 0.0 110.043 170.113 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -175.25 -44.21 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 126.022 1.729 . . . . 0.0 111.766 176.218 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 123.8 -63.61 0.55 Allowed Glycine 0 C--O 1.221 -0.691 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 -176.287 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 17.1 t30 -140.28 96.84 3.11 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 128.165 2.586 . . . . 0.0 106.251 177.097 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.46 -99.21 0.08 OUTLIER Glycine 0 CA--C 1.536 1.353 0 N-CA-C 116.365 1.306 . . . . 0.0 116.365 170.444 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 23.9 mttt -75.33 -97.94 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.164 -1.786 . . . . 0.0 114.313 172.913 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -109.52 12.8 24.28 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.838 -1.164 . . . . 0.0 111.025 178.518 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -23.16 95.06 0.01 OUTLIER 'General case' 0 C--O 1.215 -0.718 0 C-N-CA 129.449 3.099 . . . . 0.0 111.51 -171.783 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.406 ' CD2' ' H ' ' A' ' 78' ' ' HIS . 5.7 p80 -91.13 54.67 2.66 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 118.048 -2.907 . . . . 0.0 106.529 -163.172 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.528 ' HA ' ' HB3' ' A' ' 66' ' ' PRO . 39.8 p90 -85.53 148.33 26.0 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 -172.439 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.757 HD11 ' HA ' ' A' ' 62' ' ' CYS . 0.9 OUTLIER -73.79 162.29 29.29 Favored 'General case' 0 C--O 1.217 -0.634 0 C-N-CA 116.817 -1.953 . . . . 0.0 112.951 168.455 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.445 ' HB2' ' CE1' ' A' ' 110' ' ' TYR . 4.1 mp -141.65 111.23 6.52 Favored 'General case' 0 CA--C 1.498 -1.04 0 CA-C-N 119.921 1.237 . . . . 0.0 111.701 179.003 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -80.2 152.69 29.03 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 119.243 -0.983 . . . . 0.0 111.291 -178.145 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.556 ' CE2' ' HB2' ' A' ' 23' ' ' ALA . 3.0 t80 -142.02 133.86 13.44 Favored Pre-proline 0 CA--C 1.544 0.741 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 179.073 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.644 ' HG2' ' CD2' ' A' ' 92' ' ' TYR . 30.9 Cg_endo -71.9 87.37 0.85 Allowed 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 124.633 3.555 . . . . 0.0 112.009 -177.29 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 6.4 t -89.89 96.73 10.82 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-N 114.316 -1.311 . . . . 0.0 110.592 -179.837 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -80.58 157.5 72.28 Favored Pre-proline 0 CA--C 1.552 1.052 0 O-C-N 120.963 -1.085 . . . . 0.0 112.407 179.695 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . 0.267 9.3 Cg_endo -71.59 -30.96 14.17 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 122.171 1.914 . . . . 0.0 115.711 175.107 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -43.74 -35.81 2.0 Favored 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 128.353 2.661 . . . . 0.0 109.899 174.931 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.71 7.85 70.86 Favored Glycine 0 C--N 1.328 0.106 0 N-CA-C 116.432 1.333 . . . . 0.0 116.432 -178.404 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -71.59 128.52 36.08 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 174.442 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -64.54 110.4 2.3 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 104.965 -2.235 . . . . 0.0 104.965 163.033 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.644 ' CD2' ' HG2' ' A' ' 84' ' ' PRO . 9.3 t80 -39.3 142.15 0.28 Allowed 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 126.735 2.014 . . . . 0.0 109.756 171.052 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.76 61.94 3.15 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 118.098 -2.877 . . . . 0.0 111.664 169.906 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.484 ' CD1' ' HZ ' ' A' ' 83' ' ' PHE . 11.9 p90 -70.93 -27.58 63.87 Favored 'General case' 0 C--O 1.221 -0.442 0 C-N-CA 124.775 1.23 . . . . 0.0 113.447 170.134 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -76.53 -42.47 42.97 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 125.728 1.611 . . . . 0.0 111.633 -179.256 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.1 m -76.51 116.39 17.15 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 119.807 -1.808 . . . . 0.0 109.316 -179.935 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.1 pttt -56.81 -44.22 81.76 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 123.534 1.635 . . . . 0.0 113.945 176.634 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.3 tttt -151.26 133.96 8.61 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 126.0 1.72 . . . . 0.0 111.938 179.831 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -66.63 165.4 64.79 Favored 'Cis proline' 0 N--CA 1.45 -1.045 0 C-N-CA 124.013 -1.244 . . . . 0.0 110.022 -9.862 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.6 pttm -142.11 145.94 34.83 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 105.62 -1.992 . . . . 0.0 105.62 176.265 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -69.17 173.01 6.03 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.205 1.002 . . . . 0.0 111.797 172.797 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -113.28 127.08 27.24 Favored Pre-proline 0 CA--C 1.556 1.175 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -178.258 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 103' ' ' PRO . . . . . 0.483 ' HG3' ' CE1' ' A' ' 34' ' ' TYR . 70.1 Cg_endo -74.35 -160.87 0.11 Allowed 'Trans proline' 0 CA--C 1.554 1.522 0 C-N-CA 125.217 3.945 . . . . 0.0 109.787 167.953 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 112.49 -39.61 2.81 Favored Glycine 0 CA--C 1.545 1.96 0 CA-C-O 114.797 -3.224 . . . . 0.0 112.505 -162.344 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -70.93 -163.67 0.13 Allowed 'Trans proline' 0 C--N 1.366 1.488 1 CA-C-N 125.577 4.689 . . . . 0.0 112.469 177.736 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.944 ' HB2' ' HB2' ' A' ' 122' ' ' ALA . . . -63.95 160.77 17.07 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 124.757 2.218 . . . . 0.0 113.052 169.451 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.74 151.95 39.65 Favored 'General case' 0 C--O 1.214 -0.799 0 CA-C-N 111.832 -2.44 . . . . 0.0 110.8 179.613 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.7 p -87.8 120.84 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 C-N-CA 127.13 2.172 . . . . 0.0 112.003 173.292 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.412 ' CG2' HD22 ' A' ' 80' ' ' LEU . 1.7 mp -112.1 127.32 69.36 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.886 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 -171.644 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.507 ' CE2' ' HB2' ' A' ' 20' ' ' SER . 14.1 p90 -145.98 156.24 43.37 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 -177.029 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.7 p -81.79 164.91 21.35 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.196 0.999 . . . . 0.0 112.187 176.306 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.466 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.4 OUTLIER -109.8 158.89 33.63 Favored Pre-proline 0 CA--C 1.556 1.185 0 N-CA-C 112.667 0.618 . . . . 0.0 112.667 175.415 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.744 ' O ' HD21 ' A' ' 25' ' ' LEU . 19.8 Cg_endo -69.45 -52.73 0.16 OUTLIER 'Cis proline' 0 CA--C 1.501 -1.167 0 N-CA-C 108.915 -1.225 . . . . 0.0 108.915 -15.837 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.45 ' O ' HG23 ' A' ' 116' ' ' VAL . 28.6 t30 -43.69 108.88 0.12 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.931 0.892 . . . . 0.0 110.098 177.004 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.703 ' HE2' HD13 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -67.54 75.05 0.17 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 127.99 2.516 . . . . 0.0 107.615 -179.344 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.486 HG11 ' OD2' ' A' ' 61' ' ' ASP . 72.0 t -85.06 78.45 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 101.112 -3.662 . . . . 0.0 101.112 -175.983 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 117' ' ' PHE . . . . . . . . . . . . . 5.9 t80 -41.29 113.51 0.41 Allowed 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 129.071 2.948 . . . . 0.0 104.944 176.5 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 118' ' ' CYS . . . . . 0.535 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 0.1 OUTLIER -93.89 -37.95 11.46 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 122.101 0.953 . . . . 0.0 112.963 174.967 . . . . . . . . 3 3 . 1 . 021 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.564 ' HA3' HD11 ' A' ' 133' ' ' LEU . . . 163.72 -168.92 38.51 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 125.32 1.438 . . . . 0.0 111.648 -179.601 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.665 HD11 ' HB1' ' A' ' 16' ' ' ALA . 1.3 mp -114.72 120.39 64.24 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.356 0 N-CA-C 103.119 -2.919 . . . . 0.0 103.119 176.411 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.582 HD12 ' HG ' ' A' ' 131' ' ' LEU . 8.4 pt -89.52 153.5 3.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-O 117.707 -1.139 . . . . 0.0 109.333 172.427 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.944 ' HB2' ' HB2' ' A' ' 106' ' ' ALA . . . -161.64 164.07 29.49 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 121.484 1.947 . . . . 0.0 113.25 172.062 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.546 ' CD2' HD13 ' A' ' 131' ' ' LEU . 39.2 m-70 -89.33 91.68 8.85 Favored 'General case' 0 C--O 1.217 -0.656 0 C-N-CA 119.168 -1.013 . . . . 0.0 109.404 -176.001 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.1 t -94.1 32.35 1.51 Allowed 'General case' 0 N--CA 1.502 2.148 0 CA-C-O 124.413 2.054 . . . . 0.0 112.661 -179.828 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.0 tptm -97.77 -33.53 11.24 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-O 117.154 -1.403 . . . . 0.0 112.225 178.465 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.25 -68.45 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.655 1.582 . . . . 0.0 110.629 178.991 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -150.91 -49.3 0.12 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 127.354 2.262 . . . . 0.0 111.908 -179.121 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -149.22 82.23 1.42 Allowed 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 127.984 2.514 . . . . 0.0 108.314 -177.763 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -130.95 -114.43 1.64 Allowed Glycine 0 N--CA 1.473 1.155 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 171.019 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -79.27 145.2 33.67 Favored 'General case' 0 C--N 1.308 -1.224 0 O-C-N 121.078 -1.248 . . . . 0.0 111.105 178.495 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.582 ' HG ' HD12 ' A' ' 121' ' ' ILE . 3.7 tp -104.89 126.34 51.86 Favored 'General case' 0 C--O 1.217 -0.605 0 C-N-CA 123.468 0.707 . . . . 0.0 110.999 175.479 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.65 168.54 19.3 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.052 1.741 . . . . 0.0 110.531 -179.488 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.564 HD11 ' HA3' ' A' ' 119' ' ' GLY . 14.3 tp -71.99 142.67 49.37 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 118.82 0.736 . . . . 0.0 110.325 175.668 . . . . . . . . 2 2 . 1 . 021 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 75.1 m -69.27 179.52 1.95 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 124.764 2.221 . . . . 0.0 113.05 165.875 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 96.9 p -146.01 89.15 1.86 Allowed 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 -179.103 . . . . . . . . 1 1 . 1 . 021 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.427 ' O ' ' CD2' ' A' ' 136' ' ' HIS . 0.3 OUTLIER . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 113.814 -2.993 . . . . 0.0 116.852 163.596 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 114.717 -2.563 . . . . 0.0 108.642 . . . . . . . . . 0 0 . 1 . 022 nuclear build full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER 61.71 110.27 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-O 124.337 2.017 . . . . 0.0 109.825 177.985 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.679 HG21 HD22 ' A' ' 10' ' ' LEU . 0.9 OUTLIER -92.65 113.05 25.21 Favored 'General case' 0 C--N 1.312 -1.031 0 O-C-N 119.046 -2.284 . . . . 0.0 110.27 179.323 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 25.6 m95 -77.93 141.04 39.27 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 177.345 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.401 ' OG1' HD23 ' A' ' 10' ' ' LEU . 0.9 OUTLIER -130.88 119.91 22.88 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -178.695 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.588 ' SG ' ' HB3' ' A' ' 122' ' ' ALA . 0.8 OUTLIER -98.33 52.31 1.03 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.593 176.49 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 42.88 49.73 6.13 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 123.395 0.521 . . . . 0.0 112.619 -175.478 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -167.39 -82.89 0.05 OUTLIER Glycine 0 C--O 1.226 -0.396 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 -176.804 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 85.3 mt -119.41 159.33 24.43 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.546 0.689 . . . . 0.0 110.205 177.617 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.679 HD22 HG21 ' A' ' 3' ' ' THR . 3.5 mt -82.99 165.47 19.64 Favored 'General case' 0 C--O 1.219 -0.544 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.613 179.499 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.488 ' CZ ' ' HB3' ' A' ' 106' ' ' ALA . 55.7 m-85 -157.78 85.72 0.9 Allowed 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 -174.337 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -54.51 114.46 1.68 Allowed 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 177.231 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.51 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 8.1 tp-100 -51.16 -34.17 30.21 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -179.797 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -43.26 -34.28 1.14 Allowed 'General case' 0 C--O 1.22 -0.472 0 O-C-N 124.969 1.418 . . . . 0.0 112.137 174.406 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 15' ' ' LYS . . . . . 0.426 ' CD ' ' HA2' ' A' ' 89' ' ' GLY . 0.0 OUTLIER -95.92 -51.32 4.51 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 116.182 -1.866 . . . . 0.0 113.341 171.843 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.691 ' HB1' HD11 ' A' ' 120' ' ' ILE . . . -42.42 -33.39 0.66 Allowed 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 123.041 2.655 . . . . 0.0 114.021 174.863 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -85.06 -49.25 8.44 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 124.49 1.116 . . . . 0.0 109.537 172.5 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 36.8 t -62.42 -43.62 98.39 Favored 'General case' 0 C--O 1.217 -0.656 0 O-C-N 119.796 -1.815 . . . . 0.0 110.482 -174.553 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -46.03 -38.66 8.11 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 125.901 1.68 . . . . 0.0 110.713 171.111 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.9 p -79.32 -28.97 42.14 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.697 0.799 . . . . 0.0 112.554 176.25 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER -57.16 -44.11 83.14 Favored 'General case' 0 C--O 1.225 -0.222 0 C-N-CA 124.251 1.021 . . . . 0.0 110.886 176.866 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -78.77 -46.13 19.51 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 118.392 -0.814 . . . . 0.0 110.719 178.583 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.86 ' HB1' ' HG3' ' A' ' 35' ' ' PRO . . . -43.38 130.72 3.62 Favored Pre-proline 0 N--CA 1.447 -0.596 0 O-C-N 125.312 1.632 . . . . 0.0 111.434 178.611 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.438 ' HG2' ' CG2' ' A' ' 30' ' ' THR . 18.0 Cg_endo -71.08 122.87 9.16 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.242 1.961 . . . . 0.0 108.908 -177.362 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.697 HD21 ' O ' ' A' ' 113' ' ' PRO . 2.0 tp -61.15 88.94 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.425 1.09 . . . . 0.0 111.77 177.744 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -177.77 167.65 2.13 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.448 -175.172 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.415 ' HA ' ' HA ' ' A' ' 36' ' ' HIS . 1.3 t70 -114.89 126.88 55.31 Favored 'General case' 0 CA--C 1.512 -0.494 0 C-N-CA 124.295 1.038 . . . . 0.0 110.112 179.756 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 56.09 55.51 28.9 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-O 122.348 0.971 . . . . 0.0 111.145 176.189 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.2 tttt -141.01 28.56 1.9 Allowed 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 124.197 1.951 . . . . 0.0 112.068 -179.386 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.579 HG21 ' HD2' ' A' ' 35' ' ' PRO . 34.6 p -134.74 143.31 47.08 Favored 'General case' 0 C--N 1.309 -1.157 0 O-C-N 119.854 -1.779 . . . . 0.0 108.506 -174.836 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -40.03 -65.8 0.88 Allowed Glycine 0 C--N 1.332 0.349 0 C-N-CA 124.223 0.916 . . . . 0.0 113.543 -177.794 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 25.3 t -54.65 -61.56 2.23 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 117.567 -1.206 . . . . 0.0 111.281 172.914 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.0 p 159.45 -43.02 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 O-C-N 125.637 1.836 . . . . 0.0 113.091 -178.584 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.589 ' CE2' ' CE1' ' A' ' 36' ' ' HIS . 62.2 m-85 -79.34 149.67 72.7 Favored Pre-proline 0 N--CA 1.442 -0.86 0 C-N-CA 124.88 1.272 . . . . 0.0 113.258 178.286 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.86 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 23.1 Cg_endo -74.26 157.93 99.09 Favored 'Cis proline' 0 N--CA 1.45 -1.037 0 C-N-CA 123.476 -1.468 . . . . 0.0 110.351 -1.118 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.589 ' CE1' ' CE2' ' A' ' 34' ' ' TYR . 0.3 OUTLIER -134.6 155.85 49.73 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 113.649 -1.614 . . . . 0.0 109.01 179.125 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.885 ' CH2' HG22 ' A' ' 39' ' ' THR . 25.2 t90 -55.49 121.6 9.37 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-O 122.158 0.98 . . . . 0.0 110.724 174.134 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.538 ' CE2' HG21 ' A' ' 109' ' ' ILE . 41.7 t80 -92.77 85.86 5.34 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 126.997 2.119 . . . . 0.0 106.343 177.929 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.885 HG22 ' CH2' ' A' ' 37' ' ' TRP . 43.8 p -38.98 -36.45 0.28 Allowed 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.505 171.533 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.48 ' HA ' ' CZ ' ' A' ' 38' ' ' PHE . 63.9 t30 66.45 9.93 6.89 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 122.402 1.096 . . . . 0.0 111.687 -179.261 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 113.21 -18.93 20.71 Favored Glycine 0 N--CA 1.433 -1.519 0 C-N-CA 124.874 1.226 . . . . 0.0 113.226 -171.824 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.605 ' CE1' HD11 ' A' ' 48' ' ' LEU . 11.4 m-85 -63.98 161.53 15.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 118.647 1.223 . . . . 0.0 110.993 179.983 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.41 -41.88 19.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.373 0.606 . . . . 0.0 111.287 176.047 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.558 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -173.33 -67.4 0.05 OUTLIER Glycine 0 C--N 1.339 0.696 0 C-N-CA 124.094 0.854 . . . . 0.0 112.497 -177.755 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -115.77 -63.21 1.48 Allowed 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 124.003 0.921 . . . . 0.0 110.045 -179.782 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -58.12 162.49 9.74 Favored Glycine 0 C--N 1.341 0.827 0 N-CA-C 110.971 -0.851 . . . . 0.0 110.971 178.454 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.56 ' HA ' ' CE2' ' A' ' 42' ' ' TYR . 11.8 mtmt -56.6 173.36 0.19 Allowed 'General case' 0 C--N 1.334 -0.089 0 CA-C-O 121.59 0.709 . . . . 0.0 111.152 179.097 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.665 ' H ' HD12 ' A' ' 48' ' ' LEU . 5.7 mp -57.63 154.17 26.76 Favored Pre-proline 0 N--CA 1.446 -0.667 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.708 -179.421 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -70.74 159.15 53.63 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 121.692 1.595 . . . . 0.0 110.066 179.919 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.6 tttt -56.45 97.68 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.247 0.619 . . . . 0.0 110.081 176.137 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 117.83 60.26 0.29 Allowed Glycine 0 C--N 1.329 0.172 0 CA-C-N 116.443 -0.344 . . . . 0.0 112.629 -176.343 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.413 ' HG2' HD23 ' A' ' 48' ' ' LEU . 14.0 ttm180 -164.06 162.56 23.13 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 123.287 0.635 . . . . 0.0 110.606 175.194 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.9 m -139.08 109.33 7.62 Favored Pre-proline 0 C--N 1.326 -0.449 0 C-N-CA 123.196 0.598 . . . . 0.0 109.584 179.641 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.542 ' HG3' HD13 ' A' ' 48' ' ' LEU . 26.3 Cg_endo -72.86 177.16 8.01 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 123.126 2.551 . . . . 0.0 111.129 177.287 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.47 HD12 HG21 ' A' ' 121' ' ' ILE . 6.5 mt -94.89 124.57 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -179.383 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.09 136.42 35.93 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 175.123 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.552 ' CD1' ' HB3' ' A' ' 118' ' ' CYS . 10.8 m-85 -118.89 -28.54 5.53 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.717 0.807 . . . . 0.0 111.027 177.747 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.66 -3.66 56.23 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 123.883 0.754 . . . . 0.0 113.209 -175.046 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.3 mmpt? -97.88 127.82 44.07 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-N 117.695 0.748 . . . . 0.0 109.414 176.868 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -66.35 -11.69 52.54 Favored 'General case' 0 C--O 1.219 -0.51 0 O-C-N 124.893 1.371 . . . . 0.0 111.819 175.854 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.15 -46.87 10.69 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 125.637 1.575 . . . . 0.0 111.049 175.806 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.459 ' SG ' ' CE2' ' A' ' 57' ' ' PHE . 2.0 t -73.1 -16.63 61.46 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 123.956 0.785 . . . . 0.0 112.071 176.688 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -90.04 -34.66 15.87 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.387 1.075 . . . . 0.0 110.812 175.246 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.21 163.1 0.97 Allowed Pre-proline 0 N--CA 1.446 -0.629 0 CA-C-O 121.538 0.685 . . . . 0.0 112.157 179.838 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.463 ' HA ' ' CE2' ' A' ' 42' ' ' TYR . 24.6 Cg_endo -71.74 129.45 15.54 Favored 'Trans proline' 0 N--CA 1.44 -1.651 0 C-N-CA 121.144 1.229 . . . . 0.0 113.093 174.605 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.469 ' HD2' ' CD2' ' A' ' 42' ' ' TYR . 20.4 Cg_endo -68.46 167.59 22.05 Favored 'Trans proline' 0 N--CA 1.443 -1.498 0 C-N-CA 123.713 2.942 . . . . 0.0 111.206 176.701 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 10.3 tptt -126.75 66.16 1.26 Allowed 'General case' 0 C--O 1.223 -0.328 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.787 177.423 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.409 ' CE1' ' O ' ' A' ' 69' ' ' SER . 41.7 t-80 -77.92 168.07 20.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.498 0.666 . . . . 0.0 110.932 177.39 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.409 ' O ' ' CE1' ' A' ' 68' ' ' HIS . 1.5 p -141.47 173.79 11.17 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 121.232 -0.918 . . . . 0.0 111.429 176.782 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.5 mtpt -84.77 71.97 10.79 Favored 'General case' 0 C--O 1.219 -0.521 0 O-C-N 120.495 -1.378 . . . . 0.0 110.993 175.338 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -177.29 -43.07 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 O-C-N 124.54 1.15 . . . . 0.0 111.014 178.509 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 161.71 -85.08 0.11 Allowed Glycine 0 N--CA 1.442 -0.912 0 N-CA-C 108.626 -1.79 . . . . 0.0 108.626 -178.801 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -94.14 -98.27 0.15 Allowed 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 124.424 1.089 . . . . 0.0 108.465 -178.171 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 125.9 -162.92 20.02 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 125.781 1.658 . . . . 0.0 110.614 -175.503 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.3 mttt -43.65 -81.49 0.01 OUTLIER 'General case' 0 C--O 1.218 -0.554 0 C-N-CA 125.118 1.367 . . . . 0.0 112.942 -179.678 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.525 HG23 ' O ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -117.96 14.53 14.17 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 116.062 -1.923 . . . . 0.0 111.856 176.01 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.471 ' OD2' ' CE1' ' A' ' 79' ' ' TYR . 11.6 p-10 -11.77 83.08 0.0 OUTLIER 'General case' 0 C--O 1.214 -0.793 0 CA-C-O 124.469 2.08 . . . . 0.0 115.685 179.08 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 33.6 p80 -91.88 19.41 6.63 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 118.361 -2.712 . . . . 0.0 109.485 -170.531 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.942 ' CE1' HD11 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -52.91 179.12 0.02 OUTLIER 'General case' 0 N--CA 1.428 -1.542 0 C-N-CA 125.329 1.452 . . . . 0.0 113.987 175.229 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.496 HD21 HG22 ' A' ' 111' ' ' THR . 2.0 mt -100.63 154.34 18.67 Favored 'General case' 0 CA--C 1.504 -0.812 0 CA-C-O 118.444 -0.789 . . . . 0.0 110.869 173.871 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.942 HD11 ' CE1' ' A' ' 79' ' ' TYR . 2.6 mp -142.02 125.89 17.13 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 123.901 0.881 . . . . 0.0 109.803 179.175 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -92.34 154.24 18.69 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 121.386 0.613 . . . . 0.0 109.832 -179.125 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.53 ' CD1' ' HD2' ' A' ' 84' ' ' PRO . 6.4 t80 -143.68 135.13 12.73 Favored Pre-proline 0 N--CA 1.45 -0.449 0 O-C-N 121.538 -0.726 . . . . 0.0 112.65 179.078 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.53 ' HD2' ' CD1' ' A' ' 83' ' ' PHE . 18.2 Cg_endo -73.33 99.72 1.15 Allowed 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 123.988 3.125 . . . . 0.0 110.236 -177.374 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.4 t -95.93 108.12 20.46 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.743 -179.912 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.409 ' CE1' ' HB2' ' A' ' 92' ' ' TYR . 59.0 m-85 -83.36 150.82 61.31 Favored Pre-proline 0 C--O 1.241 0.638 0 CA-C-O 118.804 -0.617 . . . . 0.0 110.953 178.964 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -75.72 -36.55 2.09 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 123.311 2.674 . . . . 0.0 113.209 178.352 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -41.42 -34.4 0.53 Allowed 'General case' 0 C--N 1.351 0.669 0 O-C-N 125.53 1.769 . . . . 0.0 111.079 176.186 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 89' ' ' GLY . . . . . 0.426 ' HA2' ' CD ' ' A' ' 15' ' ' LYS . . . 98.03 -4.91 61.13 Favored Glycine 0 N--CA 1.439 -1.143 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 178.25 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 2.2 p80 -71.92 136.55 46.91 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 122.107 0.956 . . . . 0.0 108.813 177.501 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -75.45 104.2 5.91 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 173.432 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.417 ' O ' ' CD2' ' A' ' 94' ' ' PHE . 8.3 t80 -37.84 145.41 0.07 Allowed 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.991 0.9 . . . . 0.0 111.884 177.131 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.87 61.3 3.75 Favored 'General case' 0 C--N 1.322 -0.591 0 O-C-N 119.902 -1.749 . . . . 0.0 110.679 176.004 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.444 ' CD2' ' HZ ' ' A' ' 83' ' ' PHE . 43.6 p90 -75.56 1.88 13.16 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.325 1.05 . . . . 0.0 113.144 175.253 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -98.11 -41.16 8.06 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.407 1.083 . . . . 0.0 110.305 178.853 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 18.8 m -87.09 110.61 20.22 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -178.965 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 12.7 pttt -57.62 -49.13 77.46 Favored 'General case' 0 C--O 1.241 0.609 0 O-C-N 121.872 -0.518 . . . . 0.0 110.724 177.372 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 13.1 mtmt -141.56 128.54 11.54 Favored Pre-proline 0 N--CA 1.444 -0.758 0 C-N-CA 125.383 1.473 . . . . 0.0 110.765 -177.265 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -71.34 173.57 49.49 Favored 'Cis proline' 0 CA--C 1.54 0.821 0 C-N-CA 122.934 -1.694 . . . . 0.0 110.955 -4.891 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -141.99 142.4 32.94 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 123.895 0.878 . . . . 0.0 109.674 179.365 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -80.82 175.59 10.55 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.613 1.195 . . . . 0.0 111.557 179.061 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -73.61 140.39 78.51 Favored Pre-proline 0 N--CA 1.449 -0.522 0 CA-C-O 118.567 -0.73 . . . . 0.0 110.846 175.717 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -70.23 -163.14 0.11 Allowed 'Trans proline' 0 CA--C 1.548 1.188 0 C-N-CA 124.001 3.134 . . . . 0.0 112.687 175.375 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -145.37 163.44 28.15 Favored Glycine 0 N--CA 1.446 -0.693 0 O-C-N 120.487 -1.383 . . . . 0.0 111.707 174.747 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.43 -57.73 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.244 2.629 . . . . 0.0 110.829 178.689 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.734 ' HB1' ' CG2' ' A' ' 120' ' ' ILE . . . -63.64 135.72 56.97 Favored 'General case' 0 N--CA 1.438 -1.026 0 O-C-N 123.586 0.554 . . . . 0.0 110.589 178.045 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.479 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 3.1 mtm-85 -141.7 143.94 33.82 Favored 'General case' 0 C--O 1.211 -0.95 0 CA-C-O 117.225 -1.369 . . . . 0.0 110.807 178.578 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.669 HG23 ' CD1' ' A' ' 117' ' ' PHE . 2.8 p -81.98 119.2 31.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 C-N-CA 124.702 1.201 . . . . 0.0 110.104 176.904 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.538 HG21 ' CE2' ' A' ' 38' ' ' PHE . 1.8 mp -105.39 124.5 60.33 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.786 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 -177.113 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.453 ' CG ' ' HG2' ' A' ' 115' ' ' LYS . 15.3 p90 -141.33 162.73 34.79 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 123.192 0.597 . . . . 0.0 109.931 -179.42 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.496 HG22 HD21 ' A' ' 80' ' ' LEU . 1.2 p -95.34 165.11 12.54 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -177.83 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.585 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.6 OUTLIER -108.96 153.41 42.49 Favored Pre-proline 0 CA--C 1.54 0.593 0 O-C-N 122.121 -0.362 . . . . 0.0 111.442 177.454 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.697 ' O ' HD21 ' A' ' 25' ' ' LEU . 18.8 Cg_endo -74.44 -54.31 0.15 OUTLIER 'Cis proline' 0 N--CA 1.455 -0.769 0 C-N-CA 123.491 -1.462 . . . . 0.0 110.427 -7.803 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -42.6 112.57 0.36 Allowed 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 116.544 -1.693 . . . . 0.0 110.061 175.89 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.619 ' HE2' HD13 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -64.93 71.42 0.03 OUTLIER 'General case' 0 CA--C 1.514 -0.423 0 O-C-N 125.621 1.825 . . . . 0.0 108.357 179.529 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.424 ' O ' HG12 ' A' ' 116' ' ' VAL . 18.0 t -74.55 75.67 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 -179.299 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.669 ' CD1' HG23 ' A' ' 108' ' ' VAL . 27.6 t80 -41.08 119.39 1.16 Allowed 'General case' 0 N--CA 1.437 -1.122 0 C-N-CA 125.217 1.407 . . . . 0.0 110.063 176.798 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 118' ' ' CYS . . . . . 0.552 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 5.5 m -95.15 -45.48 7.18 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.837 -178.937 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 119' ' ' GLY . . . . . 0.568 ' HA2' ' CZ ' ' A' ' 117' ' ' PHE . . . 157.64 177.95 31.23 Favored Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.48 -179.841 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.734 ' CG2' ' HB1' ' A' ' 106' ' ' ALA . 2.7 mp -101.23 124.37 54.89 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.289 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -178.586 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.686 HG22 HD12 ' A' ' 133' ' ' LEU . 7.5 pt -97.15 154.22 3.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 CA-C-N 120.232 1.378 . . . . 0.0 109.024 -179.598 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.588 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . . . -173.8 156.25 2.8 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 122.468 1.128 . . . . 0.0 110.762 176.057 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.455 ' CE1' ' HG ' ' A' ' 131' ' ' LEU . 6.1 m-70 -90.03 93.0 9.22 Favored 'General case' 0 C--O 1.221 -0.445 0 O-C-N 121.338 -0.851 . . . . 0.0 109.095 -177.24 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.65 HG22 ' HD2' ' A' ' 132' ' ' LYS . 1.8 t -96.89 38.18 1.25 Allowed 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 124.014 1.864 . . . . 0.0 110.995 -178.804 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.8 tptt -101.72 -30.32 11.39 Favored 'General case' 0 C--O 1.221 -0.414 0 O-C-N 119.739 -1.85 . . . . 0.0 110.919 178.5 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -170.8 -68.61 0.02 OUTLIER 'General case' 0 C--O 1.222 -0.384 0 O-C-N 124.593 1.183 . . . . 0.0 110.419 -179.907 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -154.9 -44.53 0.08 Allowed 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 122.855 1.312 . . . . 0.0 111.001 179.304 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -154.77 79.66 1.08 Allowed 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 124.526 1.13 . . . . 0.0 109.01 -179.219 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -131.31 -106.55 1.09 Allowed Glycine 0 N--CA 1.459 0.176 0 N-CA-C 110.459 -1.057 . . . . 0.0 110.459 175.865 . . . . . . . . 1 1 . 1 . 022 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.37 150.43 24.74 Favored 'General case' 0 C--N 1.322 -0.627 0 O-C-N 121.435 -1.038 . . . . 0.0 111.18 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.576 HD23 ' H ' ' A' ' 132' ' ' LYS . 0.6 OUTLIER -105.27 145.65 30.39 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.657 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.65 ' HD2' HG22 ' A' ' 124' ' ' THR . 0.0 OUTLIER -152.14 168.54 24.98 Favored 'General case' 0 CA--C 1.513 -0.467 0 C-N-CA 125.535 1.534 . . . . 0.0 109.82 179.922 . . . . . . . . 3 3 . 1 . 022 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.686 HD12 HG22 ' A' ' 121' ' ' ILE . 7.4 tp -82.29 149.82 27.59 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.47 1.106 . . . . 0.0 108.728 175.243 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 134' ' ' CYS . . . . . 0.479 ' SG ' HG22 ' A' ' 120' ' ' ILE . 8.3 m -63.11 -175.72 0.11 Allowed 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 124.01 1.862 . . . . 0.0 108.525 176.096 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -172.01 121.87 0.47 Allowed 'General case' 0 C--N 1.316 -0.868 0 O-C-N 120.482 -1.386 . . . . 0.0 107.601 -176.925 . . . . . . . . 2 2 . 1 . 022 nuclear build full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.258 1.5 0 CA-C-O 113.472 -3.156 . . . . 0.0 110.493 172.617 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.538 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 . . . . . . . . . 0 0 . 1 . 023 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.672 HG22 ' HB2' ' A' ' 136' ' ' HIS . 1.8 p -123.85 122.73 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.093 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.449 HG21 ' HB3' ' A' ' 10' ' ' LEU . 2.9 m -86.83 119.75 27.39 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.467 -177.434 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.474 ' CG ' HG13 ' A' ' 120' ' ' ILE . 28.8 m95 -79.98 139.63 36.93 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.956 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.862 ' OG1' HD13 ' A' ' 10' ' ' LEU . 0.9 OUTLIER -133.5 132.81 41.43 Favored 'General case' 0 CA--C 1.501 -0.905 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -178.36 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.71 ' SG ' ' HB3' ' A' ' 122' ' ' ALA . 0.1 OUTLIER -120.56 41.65 3.2 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.284 177.732 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 148.31 -96.26 0.17 Allowed Glycine 0 C--O 1.222 -0.637 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 -179.36 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 8' ' ' GLY . . . . . 0.599 ' C ' HD13 ' A' ' 9' ' ' LEU . . . -127.07 4.37 7.34 Favored Glycine 0 C--O 1.223 -0.593 0 N-CA-C 112.061 -0.416 . . . . 0.0 112.061 178.585 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.669 ' N ' HD13 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -111.13 141.29 44.82 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 -173.083 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.862 HD13 ' OG1' ' A' ' 5' ' ' THR . 1.2 mm? -113.42 120.23 40.33 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -171.808 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.575 ' CE2' ' CB ' ' A' ' 106' ' ' ALA . 63.4 m-85 -115.18 101.41 8.94 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 125.065 1.346 . . . . 0.0 109.595 -175.653 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -57.62 120.94 9.21 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.984 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.513 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 6.8 tp-100 -46.49 -43.58 16.9 Favored 'General case' 0 C--O 1.2 -1.547 0 O-C-N 124.246 0.967 . . . . 0.0 111.498 179.591 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -48.22 -49.22 33.89 Favored 'General case' 0 C--O 1.194 -1.821 0 CA-C-N 117.693 0.224 . . . . 0.0 110.768 176.474 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.46 -34.58 77.48 Favored 'General case' 0 C--O 1.195 -1.779 0 O-C-N 120.712 -1.242 . . . . 0.0 111.922 172.985 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.0 -50.59 72.9 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 121.1 1.773 . . . . 0.0 112.067 174.269 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.6 pt-20 -78.5 -36.94 44.36 Favored 'General case' 0 C--O 1.207 -1.145 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.754 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 43.2 t -71.37 -63.25 1.15 Allowed 'General case' 0 CA--C 1.503 -0.833 0 C-N-CA 125.463 1.505 . . . . 0.0 108.981 -177.863 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.503 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 10.4 t-20 -39.54 -37.92 0.54 Allowed 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 123.942 0.897 . . . . 0.0 111.768 174.771 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.428 ' O ' ' HB3' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -80.2 -40.35 27.36 Favored 'General case' 0 N--CA 1.443 -0.801 0 O-C-N 124.757 1.286 . . . . 0.0 113.342 175.229 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.1 OUTLIER -42.44 -40.38 2.55 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.467 1.507 . . . . 0.0 109.611 178.442 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.503 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -71.16 -49.46 43.63 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-O 118.162 -0.923 . . . . 0.0 111.279 177.036 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.593 ' HB1' ' HG3' ' A' ' 35' ' ' PRO . . . -35.56 131.76 0.53 Allowed Pre-proline 0 N--CA 1.441 -0.902 0 O-C-N 125.067 1.479 . . . . 0.0 112.054 174.656 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.831 ' HG2' HG22 ' A' ' 30' ' ' THR . 18.9 Cg_endo -73.01 122.1 7.83 Favored 'Trans proline' 0 N--CA 1.446 -1.319 0 C-N-CA 122.24 1.96 . . . . 0.0 110.292 -178.115 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.634 HD13 ' HE2' ' A' ' 115' ' ' LYS . 3.3 tp -59.51 97.84 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.658 179.057 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -179.98 166.02 1.25 Allowed 'General case' 0 C--N 1.324 -0.516 0 O-C-N 123.548 0.53 . . . . 0.0 109.943 -177.699 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.462 ' OD2' ' CE1' ' A' ' 68' ' ' HIS . 1.7 t0 -103.46 98.46 8.36 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.531 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 66.83 79.19 0.22 Allowed Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 177.714 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -151.44 27.99 0.65 Allowed 'General case' 0 CA--C 1.513 -0.443 0 O-C-N 122.012 -0.699 . . . . 0.0 110.964 178.533 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.831 HG22 ' HG2' ' A' ' 24' ' ' PRO . 10.8 p -122.47 148.62 44.92 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -175.753 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -39.72 -56.14 2.6 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 111.752 -0.539 . . . . 0.0 111.752 -179.517 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 29.4 t -69.35 -60.14 2.54 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 116.909 -1.519 . . . . 0.0 111.354 176.958 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 163.04 -56.7 0.0 OUTLIER 'General case' 0 C--O 1.223 -0.329 0 O-C-N 125.603 1.814 . . . . 0.0 110.77 178.136 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.557 ' CD1' ' HD3' ' A' ' 84' ' ' PRO . 69.1 m-85 -60.25 144.7 87.22 Favored Pre-proline 0 N--CA 1.437 -1.08 0 CA-C-O 118.051 -0.976 . . . . 0.0 113.127 178.849 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.593 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 25.0 Cg_endo -74.92 165.05 86.91 Favored 'Cis proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.361 -1.933 . . . . 0.0 112.027 -0.53 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.445 ' CD2' ' CD1' ' A' ' 34' ' ' TYR . 1.0 OUTLIER -139.42 168.21 20.33 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 121.546 -0.721 . . . . 0.0 110.308 -178.343 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.895 ' CZ3' HG22 ' A' ' 39' ' ' THR . 22.7 t90 -70.31 113.72 7.74 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 179.094 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.436 ' CE1' ' HA ' ' A' ' 40' ' ' ASN . 8.5 t80 -84.71 79.44 9.6 Favored 'General case' 0 N--CA 1.427 -1.596 0 C-N-CA 124.888 1.275 . . . . 0.0 108.872 178.234 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.895 HG22 ' CZ3' ' A' ' 37' ' ' TRP . 60.6 p -36.51 -38.07 0.15 Allowed 'General case' 0 C--O 1.216 -0.677 0 C-N-CA 124.439 1.095 . . . . 0.0 110.596 176.9 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.436 ' HA ' ' CE1' ' A' ' 38' ' ' PHE . 65.2 t30 69.83 7.47 6.24 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 124.099 0.959 . . . . 0.0 108.599 176.992 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.459 ' C ' HD23 ' A' ' 48' ' ' LEU . . . 120.81 -35.37 3.72 Favored Glycine 0 N--CA 1.429 -1.811 0 CA-C-O 117.293 -1.837 . . . . 0.0 111.796 -175.705 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.665 ' N ' HD23 ' A' ' 48' ' ' LEU . 60.4 m-85 -51.42 173.13 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 118.066 0.933 . . . . 0.0 110.424 -178.354 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.66 -43.01 8.11 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -179.169 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.535 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -178.29 -52.2 0.07 OUTLIER Glycine 0 C--N 1.338 0.682 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 -179.657 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.5 -90.74 0.09 Allowed 'General case' 0 C--O 1.217 -0.647 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -179.86 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -148.93 28.75 1.27 Allowed Glycine 0 N--CA 1.443 -0.862 0 O-C-N 120.898 -1.126 . . . . 0.0 110.616 -176.362 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.3 mttp -126.06 144.28 50.79 Favored 'General case' 0 CA--C 1.501 -0.92 0 CA-C-O 117.703 -1.141 . . . . 0.0 109.115 -177.695 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.665 HD23 ' N ' ' A' ' 42' ' ' TYR . 1.5 mt -106.46 159.12 30.91 Favored Pre-proline 0 C--N 1.319 -0.738 0 O-C-N 124.151 0.907 . . . . 0.0 109.26 -179.232 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -73.54 -175.61 2.13 Favored 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 122.954 2.436 . . . . 0.0 111.564 179.05 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.7 tptp -68.35 98.38 0.83 Allowed 'General case' 0 N--CA 1.445 -0.691 0 O-C-N 121.35 -0.844 . . . . 0.0 109.259 177.185 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.23 88.3 1.07 Allowed Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 179.042 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.415 ' HD2' ' HA2' ' A' ' 41' ' ' GLY . 0.0 OUTLIER -151.32 137.93 18.75 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 119.286 -0.387 . . . . 0.0 111.294 177.347 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.9 m -128.95 103.36 18.76 Favored Pre-proline 0 C--N 1.327 -0.392 0 O-C-N 124.629 1.206 . . . . 0.0 110.225 -178.56 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -72.42 158.28 51.58 Favored 'Trans proline' 0 N--CA 1.448 -1.194 0 C-N-CA 122.226 1.95 . . . . 0.0 111.762 178.916 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.517 HD11 ' HG ' ' A' ' 131' ' ' LEU . 5.4 mt -77.41 123.41 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.023 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -91.12 135.69 33.6 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 179.01 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.501 ' CD1' ' HB3' ' A' ' 118' ' ' CYS . 15.3 m-85 -114.74 -52.48 2.7 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.225 179.91 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 126.9 -5.57 7.4 Favored Glycine 0 C--O 1.223 -0.585 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.853 -177.232 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.95 132.1 36.76 Favored 'General case' 0 CA--C 1.5 -0.978 0 CA-C-O 117.651 -1.166 . . . . 0.0 109.393 178.891 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 31.1 t -67.09 -9.78 43.07 Favored 'General case' 0 C--O 1.221 -0.439 0 O-C-N 125.034 1.459 . . . . 0.0 111.036 177.481 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -92.15 -49.77 6.02 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 124.032 0.933 . . . . 0.0 108.887 -179.193 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.838 ' SG ' HD21 ' A' ' 80' ' ' LEU . 3.9 t -75.89 -6.61 51.65 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 123.766 0.666 . . . . 0.0 111.214 175.988 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -99.94 -32.58 10.9 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.571 0.749 . . . . 0.0 110.165 177.987 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.531 ' HD3' ' CE1' ' A' ' 78' ' ' HIS . 0.0 OUTLIER -51.5 166.03 0.39 Allowed Pre-proline 0 N--CA 1.441 -0.89 0 CA-C-O 121.725 0.774 . . . . 0.0 111.018 179.913 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 65' ' ' PRO . . . . . 0.424 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 26.6 Cg_endo -72.11 135.24 24.7 Favored 'Trans proline' 0 N--CA 1.44 -1.645 0 C-N-CA 121.291 1.327 . . . . 0.0 113.865 174.959 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 65' ' ' PRO . 20.3 Cg_endo -71.72 171.31 16.69 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 122.529 2.153 . . . . 0.0 112.095 178.217 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.8 tptt -138.48 72.18 1.4 Allowed 'General case' 0 C--O 1.195 -1.813 0 CA-C-O 116.385 -1.769 . . . . 0.0 108.287 178.185 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.462 ' CE1' ' OD2' ' A' ' 27' ' ' ASP . 68.6 t60 -79.4 159.36 27.11 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 119.463 1.029 . . . . 0.0 110.603 178.207 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.31 -178.35 6.02 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.78 0.8 . . . . 0.0 110.011 -179.681 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -86.37 62.98 7.75 Favored 'General case' 0 C--O 1.209 -1.039 0 O-C-N 121.299 -0.875 . . . . 0.0 110.926 178.08 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -177.6 -39.27 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.831 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 129.82 -82.88 0.33 Allowed Glycine 0 C--O 1.207 -1.573 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 -179.301 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 73' ' ' ASN . . . . . 0.41 ' HA ' ' HB2' ' A' ' 77' ' ' ASP . 7.1 p-10 -115.88 53.17 0.86 Allowed 'General case' 0 C--N 1.313 -0.979 0 O-C-N 120.744 -1.445 . . . . 0.0 107.978 -177.762 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -55.8 -115.94 0.01 OUTLIER Glycine 0 C--O 1.217 -0.93 0 O-C-N 123.879 0.737 . . . . 0.0 111.9 178.172 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.9 mttm -42.73 -82.92 0.01 OUTLIER 'General case' 0 C--O 1.223 -0.311 0 O-C-N 121.443 -1.034 . . . . 0.0 110.894 179.946 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.633 HG23 ' O ' ' A' ' 76' ' ' THR . 0.6 OUTLIER -146.43 26.77 1.15 Allowed 'General case' 0 CA--C 1.507 -0.682 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.164 178.203 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.475 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 0.8 OUTLIER -26.54 96.52 0.01 OUTLIER 'General case' 0 C--O 1.213 -0.827 0 C-N-CA 124.231 1.012 . . . . 0.0 112.331 -178.688 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.531 ' CE1' ' HD3' ' A' ' 64' ' ' ARG . 16.5 p80 -94.71 23.77 5.17 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -173.756 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.656 ' CE1' HD11 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -57.51 -177.25 0.02 OUTLIER 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 174.889 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.838 HD21 ' SG ' ' A' ' 62' ' ' CYS . 0.4 OUTLIER -100.48 149.4 23.72 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.371 175.42 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.738 HD23 ' HA ' ' A' ' 37' ' ' TRP . 1.0 OUTLIER -138.42 118.92 13.83 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 124.021 0.825 . . . . 0.0 108.873 -179.027 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.511 ' CB ' ' CD1' ' A' ' 109' ' ' ILE . 0.2 OUTLIER -87.68 163.12 16.71 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-O 122.238 1.018 . . . . 0.0 111.581 178.702 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.539 ' CZ ' ' HB2' ' A' ' 23' ' ' ALA . 50.9 t80 -153.11 122.13 3.22 Favored Pre-proline 0 N--CA 1.446 -0.634 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.876 -179.424 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.557 ' HD3' ' CD1' ' A' ' 34' ' ' TYR . 18.2 Cg_endo -71.93 112.09 3.32 Favored 'Trans proline' 0 N--CA 1.447 -1.21 0 C-N-CA 123.506 2.804 . . . . 0.0 110.792 -177.946 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.78 121.22 43.39 Favored 'General case' 0 CA--C 1.51 -0.574 0 O-C-N 124.139 0.899 . . . . 0.0 110.268 -179.319 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.421 ' CE2' ' HB2' ' A' ' 92' ' ' TYR . 58.4 m-85 -82.11 157.7 68.13 Favored Pre-proline 0 N--CA 1.444 -0.76 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 178.725 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -75.52 -37.95 1.58 Allowed 'Trans proline' 0 CA--C 1.5 -1.176 0 C-N-CA 122.392 2.061 . . . . 0.0 112.84 179.542 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.35 -30.82 2.26 Favored 'General case' 0 C--O 1.224 -0.285 0 C-N-CA 124.902 1.281 . . . . 0.0 108.786 -179.648 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 95.91 -9.94 68.2 Favored Glycine 0 N--CA 1.431 -1.662 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 176.443 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.403 ' O ' ' CD2' ' A' ' 90' ' ' HIS . 4.1 p-80 -61.92 125.91 25.49 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.064 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.98 97.22 0.06 Allowed 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 123.12 0.568 . . . . 0.0 110.234 176.121 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.531 ' CD2' ' HB3' ' A' ' 94' ' ' PHE . 6.2 t80 -36.25 140.49 0.13 Allowed 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 121.919 0.866 . . . . 0.0 111.285 179.541 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.51 59.79 1.98 Allowed 'General case' 0 N--CA 1.444 -0.772 0 O-C-N 120.227 -1.546 . . . . 0.0 110.156 177.465 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.531 ' HB3' ' CD2' ' A' ' 92' ' ' TYR . 28.2 p90 -77.27 -8.12 57.08 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 123.443 0.697 . . . . 0.0 111.633 177.67 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.87 -33.33 13.56 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 122.166 0.984 . . . . 0.0 109.679 -179.624 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.87 104.08 11.99 Favored 'General case' 0 N--CA 1.443 -0.812 0 O-C-N 121.236 -0.915 . . . . 0.0 108.987 179.907 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.7 -49.38 77.96 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.724 178.818 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 99' ' ' PRO . 39.1 pttt -139.22 125.79 12.56 Favored Pre-proline 0 N--CA 1.435 -1.18 0 C-N-CA 123.633 0.773 . . . . 0.0 108.975 -176.833 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.454 ' HA ' ' HA ' ' A' ' 98' ' ' LYS . 24.0 Cg_endo -71.14 177.34 32.85 Favored 'Cis proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.376 -1.927 . . . . 0.0 111.469 -4.057 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -132.9 144.88 50.46 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 122.724 0.41 . . . . 0.0 109.988 177.48 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -95.9 152.64 18.32 Favored 'General case' 0 C--N 1.319 -0.747 0 O-C-N 124.338 1.024 . . . . 0.0 110.366 177.53 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -44.66 149.01 0.83 Allowed Pre-proline 0 N--CA 1.44 -0.948 0 O-C-N 123.926 0.766 . . . . 0.0 111.694 174.025 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -73.14 -164.88 0.21 Allowed 'Trans proline' 0 N--CA 1.446 -1.317 0 C-N-CA 122.394 2.063 . . . . 0.0 111.557 178.155 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -139.12 157.18 24.8 Favored Glycine 0 N--CA 1.443 -0.9 0 O-C-N 121.955 -0.465 . . . . 0.0 112.206 177.856 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -75.09 -75.91 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 122.806 2.338 . . . . 0.0 110.956 179.659 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.575 ' CB ' ' CE2' ' A' ' 11' ' ' TYR . . . -60.4 136.54 58.07 Favored 'General case' 0 N--CA 1.441 -0.922 0 O-C-N 123.434 0.459 . . . . 0.0 110.573 178.747 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.421 ' HG2' ' HA ' ' A' ' 84' ' ' PRO . 0.8 OUTLIER -141.71 146.98 36.71 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.853 -178.607 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.431 ' CG1' ' HB3' ' A' ' 83' ' ' PHE . 6.6 p -83.03 125.76 40.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 O-C-N 123.719 0.637 . . . . 0.0 110.119 178.589 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.663 ' CG2' HD22 ' A' ' 80' ' ' LEU . 9.4 mm -104.62 140.87 21.43 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.92 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.063 179.614 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.48 ' CG ' ' HG2' ' A' ' 115' ' ' LYS . 9.7 p90 -166.12 155.48 11.69 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 121.841 0.829 . . . . 0.0 110.38 -178.944 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.4 p -90.86 160.96 15.45 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.93 -179.977 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.547 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -109.48 153.95 42.56 Favored Pre-proline 0 N--CA 1.44 -0.969 0 C-N-CA 123.055 0.542 . . . . 0.0 111.367 179.149 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.547 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 19.1 Cg_endo -73.29 -54.05 0.15 OUTLIER 'Cis proline' 0 CA--C 1.504 -1.007 0 C-N-CA 122.538 -1.859 . . . . 0.0 110.18 -5.434 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -42.36 107.36 0.08 Allowed 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 116.961 -1.495 . . . . 0.0 110.237 179.803 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.634 ' HE2' HD13 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -64.44 76.6 0.04 OUTLIER 'General case' 0 CA--C 1.512 -0.493 0 O-C-N 125.061 1.476 . . . . 0.0 108.802 -177.621 . . . . . . . . 3 3 . 1 . 023 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.498 ' O ' HG12 ' A' ' 116' ' ' VAL . 38.1 t -75.95 74.23 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 -176.516 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.513 ' CZ ' ' NE2' ' A' ' 13' ' ' GLN . 39.1 t80 -36.35 105.97 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 124.629 1.171 . . . . 0.0 110.55 179.606 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 118' ' ' CYS . . . . . 0.501 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 8.7 m -83.52 -46.27 12.63 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -178.771 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 162.34 -144.96 10.15 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 179.727 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.474 HG13 ' CG ' ' A' ' 4' ' ' TRP . 1.2 mm -128.72 144.67 37.34 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.091 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -176.519 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.773 HG22 HD12 ' A' ' 133' ' ' LEU . 8.6 pt -133.64 155.46 40.21 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.722 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -178.561 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.71 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . . . -171.93 148.83 2.35 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.69 0.757 . . . . 0.0 109.953 177.711 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.616 ' CE1' HD22 ' A' ' 131' ' ' LEU . 3.2 m80 -89.81 95.95 10.47 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 -176.922 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.7 HG22 ' HD3' ' A' ' 132' ' ' LYS . 3.0 t -98.16 41.13 1.14 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 122.349 1.071 . . . . 0.0 111.466 179.904 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.4 tptt -106.09 -27.55 11.04 Favored 'General case' 0 C--O 1.221 -0.42 0 O-C-N 121.563 -0.71 . . . . 0.0 110.477 178.921 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -173.07 -67.82 0.02 OUTLIER 'General case' 0 C--O 1.221 -0.408 0 CA-C-O 121.625 0.726 . . . . 0.0 110.617 178.39 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -155.54 -43.61 0.08 Allowed 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 122.64 1.21 . . . . 0.0 110.271 178.812 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -154.41 78.59 1.09 Allowed 'General case' 0 N--CA 1.443 -0.805 0 CA-C-O 122.582 1.182 . . . . 0.0 109.45 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -130.65 -104.19 1.02 Allowed Glycine 0 N--CA 1.452 -0.243 0 O-C-N 120.954 -1.091 . . . . 0.0 110.503 178.106 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -84.0 146.16 28.13 Favored 'General case' 0 CA--C 1.513 -0.473 0 O-C-N 122.197 -0.59 . . . . 0.0 110.871 -179.843 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.659 ' CD2' HD12 ' A' ' 121' ' ' ILE . 5.0 tp -111.33 137.32 49.23 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 122.826 0.451 . . . . 0.0 110.585 178.178 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.7 ' HD3' HG22 ' A' ' 124' ' ' THR . 6.9 ptmm? -140.34 171.94 13.44 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.74 -179.527 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.773 HD12 HG22 ' A' ' 121' ' ' ILE . 6.0 tp -88.39 141.77 28.27 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.237 0.96 . . . . 0.0 109.244 178.866 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 134' ' ' CYS . . . . . 0.466 ' SG ' HG22 ' A' ' 120' ' ' ILE . 57.5 m -67.57 -176.1 0.58 Allowed 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 121.862 0.839 . . . . 0.0 109.307 177.494 . . . . . . . . 2 2 . 1 . 023 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 2.1 m -156.27 84.92 0.99 Allowed 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -178.855 . . . . . . . . 1 1 . 1 . 023 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.672 ' HB2' HG22 ' A' ' 2' ' ' VAL . 0.1 OUTLIER . . . . . 0 C--O 1.258 1.543 0 CA-C-O 115.151 -2.357 . . . . 0.0 112.528 173.957 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.771 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 . . . . . . . . . 0 0 . 1 . 024 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.65 HG13 ' CD2' ' A' ' 136' ' ' HIS . 7.6 p -104.44 167.99 2.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 O-C-N 123.973 0.796 . . . . 0.0 110.257 177.995 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.457 ' N ' HG22 ' A' ' 2' ' ' VAL . 2.4 m -85.94 109.13 18.54 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 125.936 1.695 . . . . 0.0 110.962 -179.493 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.482 ' CD1' ' HB2' ' A' ' 13' ' ' GLN . 25.5 m95 -77.67 142.4 38.84 Favored 'General case' 0 N--CA 1.442 -0.863 0 O-C-N 121.709 -0.619 . . . . 0.0 110.164 179.546 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.419 ' OG1' HD13 ' A' ' 10' ' ' LEU . 0.9 OUTLIER -131.97 134.36 45.53 Favored 'General case' 0 CA--C 1.5 -0.943 0 C-N-CA 123.204 0.602 . . . . 0.0 110.117 -176.957 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.731 ' SG ' ' HB3' ' A' ' 122' ' ' ALA . 0.0 OUTLIER -134.07 -73.46 0.48 Allowed 'General case' 0 C--O 1.222 -0.393 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 177.367 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -80.44 42.5 2.61 Favored Glycine 0 C--O 1.211 -1.281 0 CA-C-O 117.844 -1.531 . . . . 0.0 111.373 179.905 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 64.04 12.78 50.69 Favored Glycine 0 C--O 1.22 -0.751 0 CA-C-N 119.361 1.581 . . . . 0.0 111.756 -175.067 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -114.33 149.45 36.01 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -176.119 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.419 HD13 ' OG1' ' A' ' 5' ' ' THR . 2.1 mm? -105.18 125.5 51.05 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 -172.169 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.658 ' CZ ' ' HB3' ' A' ' 106' ' ' ALA . 90.5 m-85 -120.27 106.96 12.41 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 124.509 1.124 . . . . 0.0 108.015 -174.076 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -54.19 116.28 2.52 Favored 'General case' 0 C--O 1.206 -1.187 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.724 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.482 ' HB2' ' CD1' ' A' ' 4' ' ' TRP . 36.2 tp60 -54.79 -45.46 74.32 Favored 'General case' 0 C--O 1.196 -1.757 0 CA-C-O 116.429 -1.748 . . . . 0.0 111.993 178.881 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -51.0 -36.28 38.49 Favored 'General case' 0 C--O 1.189 -2.126 0 O-C-N 124.117 0.886 . . . . 0.0 110.242 175.843 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -75.59 -40.85 55.9 Favored 'General case' 0 C--O 1.197 -1.696 0 CA-C-N 121.765 2.075 . . . . 0.0 112.177 170.039 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.465 ' O ' HG11 ' A' ' 108' ' ' VAL . . . -52.1 -35.9 49.26 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 117.463 -3.273 . . . . 0.0 113.406 171.018 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -94.5 -38.43 10.91 Favored 'General case' 0 C--O 1.2 -1.506 0 CA-C-O 122.657 1.218 . . . . 0.0 108.009 178.275 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.422 ' O ' ' CE1' ' A' ' 22' ' ' HIS . 26.1 t -73.22 -58.49 3.27 Favored 'General case' 0 C--O 1.201 -1.467 1 O-C-N 115.447 -4.533 . . . . 0.0 106.838 -177.306 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.439 ' CG ' ' CZ ' ' A' ' 92' ' ' TYR . 1.3 t-20 -50.46 -27.92 7.37 Favored 'General case' 0 C--N 1.311 -1.076 0 O-C-N 117.733 -3.104 . . . . 0.0 113.391 173.167 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.519 ' HB3' HG11 ' A' ' 108' ' ' VAL . 24.0 p -86.98 -16.95 34.26 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 123.629 0.581 . . . . 0.0 112.527 175.191 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -66.19 -39.5 89.73 Favored 'General case' 0 C--O 1.215 -0.719 0 C-N-CA 124.973 1.309 . . . . 0.0 107.881 179.773 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.422 ' CE1' ' O ' ' A' ' 18' ' ' SER . 0.1 OUTLIER -75.47 -41.78 54.75 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 116.647 -1.644 . . . . 0.0 109.269 -178.519 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.883 ' HB1' ' HG3' ' A' ' 35' ' ' PRO . . . -40.31 130.07 1.7 Allowed Pre-proline 0 N--CA 1.443 -0.778 0 O-C-N 126.649 2.468 . . . . 0.0 111.943 177.764 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.458 ' HG2' ' CG2' ' A' ' 30' ' ' THR . 14.5 Cg_endo -72.73 115.02 4.18 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 122.103 1.868 . . . . 0.0 109.83 -176.133 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.6 HD13 ' HE2' ' A' ' 115' ' ' LYS . 2.5 tp -56.14 100.28 0.04 OUTLIER 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 123.272 0.629 . . . . 0.0 111.225 178.711 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -167.72 166.27 13.86 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.788 0.804 . . . . 0.0 109.453 -177.195 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.492 ' HB2' ' CE1' ' A' ' 79' ' ' TYR . 5.8 t0 -100.42 73.3 1.65 Allowed 'General case' 0 CA--C 1.548 0.87 0 CA-C-O 124.048 1.88 . . . . 0.0 107.104 179.014 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.58 86.03 0.57 Allowed Glycine 0 N--CA 1.448 -0.503 0 O-C-N 118.816 -2.427 . . . . 0.0 109.36 176.504 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.14 33.52 0.58 Allowed 'General case' 0 CA--C 1.514 -0.425 0 O-C-N 121.205 -1.174 . . . . 0.0 111.23 177.204 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.474 HG21 ' HD2' ' A' ' 35' ' ' PRO . 55.3 p -129.73 143.85 51.01 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -175.927 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -38.08 -67.79 0.48 Allowed Glycine 0 C--N 1.338 0.642 0 O-C-N 124.117 0.885 . . . . 0.0 112.979 -178.552 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 32' ' ' SER . . . . . 0.461 ' HB3' ' HA ' ' A' ' 94' ' ' PHE . 32.2 t -51.86 -66.38 0.39 Allowed 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 115.744 -2.074 . . . . 0.0 110.554 174.328 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.2 p 167.44 -56.42 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.418 0 O-C-N 126.927 2.642 . . . . 0.0 111.256 179.895 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.528 ' CD1' ' HG3' ' A' ' 84' ' ' PRO . 32.3 m-85 -69.27 150.03 97.32 Favored Pre-proline 0 N--CA 1.429 -1.478 0 CA-C-O 116.494 -1.717 . . . . 0.0 112.708 178.995 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.883 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 37.5 Cg_endo -72.24 138.56 55.03 Favored 'Cis proline' 0 N--CA 1.442 -1.519 0 C-N-CA 121.281 -2.383 . . . . 0.0 112.264 -4.602 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -128.94 150.6 50.31 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-O 116.91 -1.519 . . . . 0.0 113.781 173.44 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.965 ' CH2' HG22 ' A' ' 39' ' ' THR . 19.1 t90 -44.42 151.85 0.23 Allowed 'General case' 0 C--O 1.237 0.428 0 CA-C-O 122.577 1.179 . . . . 0.0 110.872 176.305 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.522 ' CE1' ' HA ' ' A' ' 40' ' ' ASN . 3.0 t80 -127.87 79.64 1.91 Allowed 'General case' 0 N--CA 1.417 -2.089 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 -172.921 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.965 HG22 ' CH2' ' A' ' 37' ' ' TRP . 38.1 p -36.96 -39.51 0.23 Allowed 'General case' 0 C--O 1.205 -1.288 0 C-N-CA 125.388 1.475 . . . . 0.0 110.506 173.773 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.522 ' HA ' ' CE1' ' A' ' 38' ' ' PHE . 43.5 t30 59.14 17.42 5.58 Favored 'General case' 0 C--O 1.206 -1.211 0 CA-C-N 120.426 1.466 . . . . 0.0 107.39 173.154 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.492 ' C ' HD23 ' A' ' 48' ' ' LEU . . . 113.09 -45.84 1.26 Allowed Glycine 0 N--CA 1.428 -1.851 0 O-C-N 118.716 -2.49 . . . . 0.0 113.321 -170.639 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.57 ' N ' HD23 ' A' ' 48' ' ' LEU . 83.3 m-85 -45.21 153.61 0.2 Allowed 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.318 1.047 . . . . 0.0 111.942 178.097 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.09 -36.38 24.92 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.14 178.593 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 126.56 42.16 0.3 Allowed Glycine 0 C--N 1.341 0.819 0 C-N-CA 123.922 0.773 . . . . 0.0 111.299 -177.296 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -146.64 -69.64 0.25 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.294 179.707 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -146.43 -73.49 0.02 OUTLIER Glycine 0 C--O 1.195 -2.287 0 N-CA-C 107.591 -2.204 . . . . 0.0 107.591 -176.192 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.5 ptpt -100.96 -165.33 1.19 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 120.468 2.134 . . . . 0.0 110.35 178.638 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.713 ' H ' HD12 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -113.35 174.12 2.49 Favored Pre-proline 0 N--CA 1.438 -1.041 0 C-N-CA 123.623 0.769 . . . . 0.0 110.028 -178.93 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.27 156.91 46.22 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.362 2.041 . . . . 0.0 110.855 179.426 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.71 98.1 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.301 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.31 55.83 0.24 Allowed Glycine 0 CA--C 1.507 -0.442 0 CA-C-O 118.345 -1.253 . . . . 0.0 111.889 -178.318 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.418 ' HD2' ' HA2' ' A' ' 41' ' ' GLY . 1.3 mmt180 -149.79 143.07 25.15 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-N 117.671 0.735 . . . . 0.0 110.811 177.055 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.1 m -131.45 96.74 20.67 Favored Pre-proline 0 C--N 1.324 -0.531 0 O-C-N 124.318 1.011 . . . . 0.0 110.352 -178.628 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 54' ' ' PRO . . . . . 0.653 ' HG3' HD21 ' A' ' 48' ' ' LEU . 18.0 Cg_endo -72.36 173.23 13.44 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 122.022 1.814 . . . . 0.0 111.723 179.267 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.524 HD11 ' HG ' ' A' ' 131' ' ' LEU . 8.4 mt -86.53 111.62 21.69 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.076 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 -176.348 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.23 137.49 36.66 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 120.617 -1.302 . . . . 0.0 108.703 178.922 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.491 ' CG ' ' SG ' ' A' ' 118' ' ' CYS . 3.0 m-85 -118.5 -52.79 2.35 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.628 -179.999 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 128.73 -9.95 6.39 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 123.48 0.562 . . . . 0.0 111.722 -176.74 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 59' ' ' LYS . . . . . 0.425 ' CB ' ' HB3' ' A' ' 62' ' ' CYS . 15.2 mmtt -69.08 170.57 9.71 Favored 'General case' 0 C--O 1.197 -1.692 0 CA-C-O 118.217 -0.897 . . . . 0.0 111.127 177.16 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.4 m -101.69 -47.54 4.59 Favored 'General case' 0 C--O 1.19 -2.027 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.596 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.29 -40.92 64.17 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-N 120.888 1.676 . . . . 0.0 108.974 178.698 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.488 ' SG ' ' CD1' ' A' ' 57' ' ' PHE . 11.0 t -71.84 -14.58 62.0 Favored 'General case' 0 C--N 1.348 0.533 0 O-C-N 123.468 0.48 . . . . 0.0 110.138 178.198 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -95.62 -32.75 12.65 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 174.693 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.94 168.36 0.43 Allowed Pre-proline 0 N--CA 1.429 -1.493 0 CA-C-O 122.349 1.071 . . . . 0.0 108.674 -177.635 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -72.71 124.7 9.94 Favored 'Trans proline' 0 N--CA 1.438 -1.768 0 C-N-CA 121.068 1.179 . . . . 0.0 115.13 172.123 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.419 ' HD2' ' CD1' ' A' ' 42' ' ' TYR . 18.6 Cg_endo -72.04 164.15 36.55 Favored 'Trans proline' 0 CA--C 1.502 -1.111 0 C-N-CA 123.595 2.863 . . . . 0.0 111.802 179.614 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 8.2 tptt -126.06 130.38 51.02 Favored 'General case' 0 C--O 1.205 -1.273 0 CA-C-O 117.329 -1.319 . . . . 0.0 108.382 178.951 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 41.4 t-80 -122.6 161.5 23.62 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 119.226 0.921 . . . . 0.0 110.214 174.612 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.6 179.08 8.92 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.2 179.223 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.8 mptt -84.82 69.18 10.69 Favored 'General case' 0 C--O 1.215 -0.757 0 O-C-N 121.828 -0.545 . . . . 0.0 111.422 177.146 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -176.94 -41.36 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.223 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.486 ' CA ' ' HB3' ' A' ' 27' ' ' ASP . . . 122.07 -63.9 0.51 Allowed Glycine 0 N--CA 1.442 -0.958 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -179.061 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -133.98 56.74 1.83 Allowed 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 -173.06 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.96 -109.73 0.01 OUTLIER Glycine 0 C--O 1.215 -1.035 0 CA-C-O 121.998 0.777 . . . . 0.0 111.583 179.412 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 19.8 mttt -60.98 -98.82 0.0 OUTLIER 'General case' 0 C--O 1.214 -0.794 0 O-C-N 120.017 -1.872 . . . . 0.0 109.941 179.374 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.593 HG23 ' O ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -120.94 15.66 11.67 Favored 'General case' 0 CA--C 1.493 -1.226 0 O-C-N 119.331 -2.105 . . . . 0.0 110.611 -179.241 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.433 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 1.3 m-20 -24.3 95.56 0.01 OUTLIER 'General case' 0 C--O 1.197 -1.689 0 C-N-CA 126.768 2.027 . . . . 0.0 112.948 -176.615 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 17.2 p-80 -88.98 60.45 5.46 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 -167.929 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.578 ' HB2' ' CD1' ' A' ' 37' ' ' TRP . 52.0 p90 -91.11 136.78 32.85 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 124.672 1.189 . . . . 0.0 111.602 -178.446 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.669 HD23 ' O ' ' A' ' 110' ' ' TYR . 2.5 mt -67.31 128.88 38.06 Favored 'General case' 0 C--O 1.205 -1.281 0 CA-C-O 117.481 -1.247 . . . . 0.0 109.271 178.811 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.844 HD11 ' HB2' ' A' ' 35' ' ' PRO . 0.2 OUTLIER -121.28 135.03 55.17 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 121.025 1.739 . . . . 0.0 107.329 178.608 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.562 ' N ' HD12 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -101.56 166.09 10.89 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-O 123.168 1.461 . . . . 0.0 114.503 171.218 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.502 ' CD1' ' HD2' ' A' ' 84' ' ' PRO . 52.2 t80 -146.3 131.82 9.26 Favored Pre-proline 0 CA--C 1.498 -1.024 0 O-C-N 117.823 -3.048 . . . . 0.0 113.115 179.462 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.544 ' HA ' ' HG2' ' A' ' 107' ' ' ARG . 19.3 Cg_endo -72.98 106.18 2.1 Favored 'Trans proline' 0 CA--C 1.473 -2.554 0 C-N-CA 124.645 3.563 . . . . 0.0 110.583 -175.698 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.55 ' HA ' ' CZ ' ' A' ' 92' ' ' TYR . 0.6 OUTLIER -100.73 121.01 40.94 Favored 'General case' 0 CA--C 1.49 -1.332 0 O-C-N 125.613 1.82 . . . . 0.0 112.36 -179.306 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.597 ' CD1' ' CD1' ' A' ' 92' ' ' TYR . 13.8 m-85 -85.19 162.66 48.3 Favored Pre-proline 0 N--CA 1.44 -0.963 0 CA-C-N 120.475 1.489 . . . . 0.0 111.179 -179.423 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -77.77 -44.34 0.18 Allowed 'Trans proline' 0 CA--C 1.516 -0.386 0 C-N-CA 122.161 1.907 . . . . 0.0 112.431 179.605 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -48.62 -26.4 2.23 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 125.279 1.612 . . . . 0.0 110.913 174.446 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.92 17.64 80.2 Favored Glycine 0 N--CA 1.431 -1.676 0 CA-C-O 117.39 -1.783 . . . . 0.0 109.706 179.592 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.419 ' O ' ' CE1' ' A' ' 92' ' ' TYR . 1.0 OUTLIER -82.74 147.52 28.39 Favored 'General case' 0 C--O 1.182 -2.454 0 CA-C-O 116.929 -1.51 . . . . 0.0 110.359 -179.593 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -62.09 134.39 56.54 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 123.54 2.882 . . . . 0.0 111.831 176.173 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.597 ' CD1' ' CD1' ' A' ' 86' ' ' PHE . 0.2 OUTLIER -93.6 136.48 33.83 Favored 'General case' 0 C--O 1.202 -1.399 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 -173.21 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.39 61.24 0.47 Allowed 'General case' 0 C--N 1.318 -0.778 0 O-C-N 119.769 -1.832 . . . . 0.0 111.029 175.075 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.49 ' CD2' ' HZ ' ' A' ' 83' ' ' PHE . 1.5 p90 -74.95 -23.96 58.39 Favored 'General case' 0 N--CA 1.426 -1.651 0 C-N-CA 126.401 1.88 . . . . 0.0 109.581 179.749 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.56 -31.49 21.19 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 -178.844 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.9 t -82.38 104.74 12.9 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 -177.61 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 32.6 pttt -58.27 -50.71 72.63 Favored 'General case' 0 C--O 1.227 -0.126 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 179.241 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 99' ' ' PRO . 4.4 mttp -137.41 124.88 14.04 Favored Pre-proline 0 N--CA 1.438 -1.027 0 C-N-CA 124.787 1.235 . . . . 0.0 109.095 -173.719 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.425 ' HA ' ' HA ' ' A' ' 98' ' ' LYS . 23.3 Cg_endo -73.26 175.01 47.31 Favored 'Cis proline' 0 CA--C 1.54 0.822 0 O-C-N 124.934 2.018 . . . . 0.0 111.564 -2.913 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 100' ' ' LYS . . . . . 0.413 ' HD2' ' HA ' ' A' ' 32' ' ' SER . 9.6 tttp -137.6 117.5 13.26 Favored 'General case' 0 C--O 1.22 -0.467 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.152 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -72.54 154.3 40.88 Favored 'General case' 0 C--O 1.253 1.243 0 O-C-N 124.62 1.2 . . . . 0.0 110.32 176.918 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -48.43 124.55 11.73 Favored Pre-proline 0 N--CA 1.438 -1.07 0 C-N-CA 125.113 1.365 . . . . 0.0 112.105 172.758 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -70.3 -164.95 0.15 Allowed 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 122.691 2.261 . . . . 0.0 112.125 177.681 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -134.73 158.66 23.59 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.561 177.288 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -76.07 -61.76 0.03 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.72 2.28 . . . . 0.0 110.109 179.9 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.658 ' HB3' ' CZ ' ' A' ' 11' ' ' TYR . . . -58.78 133.34 55.88 Favored 'General case' 0 N--CA 1.432 -1.328 0 O-C-N 124.653 1.22 . . . . 0.0 111.938 178.015 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.544 ' HG2' ' HA ' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -141.23 146.9 37.46 Favored 'General case' 0 CA--C 1.496 -1.11 0 O-C-N 124.632 1.208 . . . . 0.0 111.817 -178.489 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.519 HG11 ' HB3' ' A' ' 20' ' ' SER . 7.7 p -80.5 126.1 39.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.423 0.63 . . . . 0.0 110.407 178.839 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.558 ' CG2' HD22 ' A' ' 80' ' ' LEU . 24.5 mm -100.28 147.24 7.86 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.229 0 O-C-N 121.227 -0.921 . . . . 0.0 110.361 179.008 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.669 ' O ' HD23 ' A' ' 80' ' ' LEU . 11.4 p90 -176.76 148.14 0.66 Allowed 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 124.408 2.052 . . . . 0.0 110.131 -177.624 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 111' ' ' THR . . . . . 0.409 HG22 ' HA ' ' A' ' 62' ' ' CYS . 7.0 p -81.55 167.69 19.02 Favored 'General case' 0 C--N 1.311 -1.075 0 O-C-N 120.207 -1.558 . . . . 0.0 108.947 -177.612 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.464 ' CD1' ' C ' ' A' ' 112' ' ' TYR . 0.1 OUTLIER -116.2 152.56 47.99 Favored Pre-proline 0 N--CA 1.432 -1.34 0 C-N-CA 123.938 0.895 . . . . 0.0 109.892 179.875 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.467 ' O ' HD21 ' A' ' 25' ' ' LEU . 15.6 Cg_endo -72.7 -44.03 0.61 Allowed 'Cis proline' 0 CA--C 1.516 -0.413 0 C-N-CA 122.076 -2.052 . . . . 0.0 109.378 -9.213 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 43.4 m-20 -46.84 106.98 0.09 Allowed 'General case' 0 CA--C 1.49 -1.337 0 CA-C-O 113.631 -3.08 . . . . 0.0 109.816 -179.382 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.6 ' HE2' HD13 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -68.31 72.27 0.2 Allowed 'General case' 0 CA--C 1.501 -0.918 0 O-C-N 127.457 2.973 . . . . 0.0 107.03 -175.787 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.577 ' O ' HG12 ' A' ' 116' ' ' VAL . 14.6 t -74.08 70.16 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 -177.133 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.419 ' CD1' HG23 ' A' ' 108' ' ' VAL . 54.6 t80 -37.17 100.8 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 126.064 1.746 . . . . 0.0 110.732 178.831 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 118' ' ' CYS . . . . . 0.491 ' SG ' ' CG ' ' A' ' 57' ' ' PHE . 0.1 OUTLIER -81.43 -39.53 24.76 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 -178.235 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 159.82 -146.86 13.36 Favored Glycine 0 N--CA 1.441 -1.02 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 -179.734 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.441 HG13 ' CG ' ' A' ' 4' ' ' TRP . 1.0 OUTLIER -129.61 149.0 33.22 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.672 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 -172.923 . . . . . . . . 3 3 . 1 . 024 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.565 ' CD1' HD21 ' A' ' 131' ' ' LEU . 7.2 pt -138.23 154.69 28.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 120.304 1.411 . . . . 0.0 108.293 -178.177 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.731 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . . . -172.31 151.77 2.61 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 122.338 1.066 . . . . 0.0 110.021 176.867 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.636 ' CE1' HD13 ' A' ' 131' ' ' LEU . 1.2 m80 -89.46 94.96 10.07 Favored 'General case' 0 N--CA 1.445 -0.681 0 O-C-N 120.996 -1.065 . . . . 0.0 108.278 -176.89 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.553 ' O ' HG23 ' A' ' 124' ' ' THR . 3.4 t -98.17 41.27 1.14 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 123.798 1.761 . . . . 0.0 110.611 -179.544 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.6 tttt -103.04 -26.44 13.06 Favored 'General case' 0 C--N 1.321 -0.662 0 O-C-N 119.072 -2.267 . . . . 0.0 111.183 177.866 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -170.28 -61.38 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.593 0 O-C-N 123.633 0.583 . . . . 0.0 110.524 177.493 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -156.03 -45.29 0.08 Allowed 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 122.499 1.142 . . . . 0.0 110.108 178.995 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -159.46 75.54 0.65 Allowed 'General case' 0 C--O 1.218 -0.575 0 CA-C-O 122.173 0.987 . . . . 0.0 110.523 -179.017 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -119.1 -101.89 2.01 Favored Glycine 0 N--CA 1.459 0.214 0 CA-C-O 122.578 1.099 . . . . 0.0 110.863 179.816 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.84 140.45 29.49 Favored 'General case' 0 CA--C 1.506 -0.719 0 O-C-N 120.934 -1.333 . . . . 0.0 111.035 -179.317 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.636 HD13 ' CE1' ' A' ' 123' ' ' HIS . 6.0 tp -92.49 145.32 24.55 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 121.519 -0.738 . . . . 0.0 111.484 177.847 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.434 ' HD2' HG22 ' A' ' 124' ' ' THR . 9.2 ptpt -150.02 173.92 13.3 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 117.448 -1.263 . . . . 0.0 110.608 179.111 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.481 HD12 HG22 ' A' ' 121' ' ' ILE . 12.2 tp -82.28 139.71 34.03 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.807 . . . . . . . . 2 2 . 1 . 024 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 73.3 m -67.28 -172.83 0.24 Allowed 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 124.072 0.949 . . . . 0.0 109.363 176.833 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 61.1 m -162.05 114.33 1.72 Allowed 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 117.056 -1.449 . . . . 0.0 107.835 -179.624 . . . . . . . . 1 1 . 1 . 024 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.65 ' CD2' HG13 ' A' ' 2' ' ' VAL . 2.4 m80 . . . . . 0 C--O 1.277 2.515 0 CA-C-O 113.525 -3.131 . . . . 0.0 113.22 176.206 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.701 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 025 nuclear build full ' A' A ' 2' ' ' VAL . . . . . 0.468 HG13 ' HB2' ' A' ' 136' ' ' HIS . 5.1 p -50.46 149.57 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-O 121.271 0.557 . . . . 0.0 110.188 179.542 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 3' ' ' THR . . . . . 0.478 HG21 ' HB3' ' A' ' 10' ' ' LEU . 3.2 m -94.51 121.34 35.95 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -174.581 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 4' ' ' TRP . . . . . 0.45 ' CG ' HG13 ' A' ' 120' ' ' ILE . 24.2 m95 -79.36 140.53 37.45 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.271 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 5' ' ' THR . . . . . 0.529 ' OG1' HD12 ' A' ' 10' ' ' LEU . 0.9 OUTLIER -128.56 134.48 48.64 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -178.079 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 6' ' ' CYS . . . . . 0.734 ' HB3' ' HB3' ' A' ' 122' ' ' ALA . 8.4 m -123.1 -71.46 0.72 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.689 178.868 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -86.27 32.26 3.9 Favored Glycine 0 C--O 1.221 -0.685 0 CA-C-O 119.773 -0.459 . . . . 0.0 111.996 176.906 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 82.53 -13.03 43.53 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-N 117.491 0.646 . . . . 0.0 112.854 -175.164 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 9' ' ' LEU . . . . . 0.424 HD13 ' OH ' ' A' ' 11' ' ' TYR . 0.2 OUTLIER -87.66 139.99 29.97 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -177.685 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 10' ' ' LEU . . . . . 0.529 HD12 ' OG1' ' A' ' 5' ' ' THR . 5.0 mp -86.22 135.09 33.7 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 124.032 0.832 . . . . 0.0 109.455 -178.589 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 11' ' ' TYR . . . . . 0.533 ' CE2' ' CB ' ' A' ' 106' ' ' ALA . 60.4 m-85 -124.06 105.84 9.88 Favored 'General case' 0 CA--C 1.506 -0.717 0 C-N-CA 125.539 1.536 . . . . 0.0 109.554 -175.14 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.79 112.97 1.46 Allowed 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -179.328 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 13' ' ' GLN . . . . . 0.444 ' HB2' ' CD1' ' A' ' 4' ' ' TRP . 35.3 tp60 -51.2 -48.68 61.94 Favored 'General case' 0 C--O 1.214 -0.792 0 C-N-CA 119.586 -0.846 . . . . 0.0 111.91 -179.024 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -49.2 -39.8 31.09 Favored 'General case' 0 C--O 1.197 -1.669 0 O-C-N 124.162 0.913 . . . . 0.0 111.263 176.862 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -71.59 -38.89 70.84 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-N 118.755 0.707 . . . . 0.0 112.904 171.217 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 16' ' ' ALA . . . . . 0.486 ' O ' HG11 ' A' ' 108' ' ' VAL . . . -53.67 -39.14 64.85 Favored 'General case' 0 C--O 1.215 -0.741 0 CA-C-N 119.87 1.213 . . . . 0.0 111.99 173.409 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.0 pt-20 -90.38 -38.78 13.09 Favored 'General case' 0 C--O 1.221 -0.431 0 C-N-CA 123.802 0.841 . . . . 0.0 110.809 176.228 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 18' ' ' SER . . . . . 0.413 ' O ' ' CE1' ' A' ' 22' ' ' HIS . 40.7 t -75.05 -60.12 2.43 Favored 'General case' 0 CA--C 1.506 -0.747 0 O-C-N 119.716 -1.865 . . . . 0.0 109.557 -176.508 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 19' ' ' ASN . . . . . 0.454 ' CG ' ' CZ ' ' A' ' 92' ' ' TYR . 0.1 OUTLIER -48.39 -29.45 4.02 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 171.062 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 20' ' ' SER . . . . . 0.558 ' HB3' HG11 ' A' ' 108' ' ' VAL . 31.7 p -85.19 -24.66 27.8 Favored 'General case' 0 C--O 1.221 -0.432 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 175.413 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER -57.13 -35.97 70.12 Favored 'General case' 0 C--O 1.222 -0.351 0 C-N-CA 124.156 0.982 . . . . 0.0 109.217 178.061 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 22' ' ' HIS . . . . . 0.413 ' CE1' ' O ' ' A' ' 18' ' ' SER . 0.2 OUTLIER -71.69 -42.13 67.8 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 118.566 -0.731 . . . . 0.0 110.138 179.901 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 23' ' ' ALA . . . . . 0.796 ' HB1' ' HG3' ' A' ' 35' ' ' PRO . . . -39.99 133.77 1.43 Allowed Pre-proline 0 N--CA 1.443 -0.793 0 O-C-N 125.189 1.555 . . . . 0.0 111.124 176.505 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 24' ' ' PRO . . . . . 0.732 ' HG2' HG22 ' A' ' 30' ' ' THR . 19.5 Cg_endo -72.61 119.36 6.06 Favored 'Trans proline' 0 N--CA 1.443 -1.442 0 C-N-CA 122.1 1.867 . . . . 0.0 108.55 -177.8 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 25' ' ' LEU . . . . . 0.526 HD22 ' HE2' ' A' ' 115' ' ' LYS . 3.4 tp -60.58 84.19 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.284 1.033 . . . . 0.0 111.266 177.885 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.4 m -165.89 147.24 6.94 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.291 -174.682 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 27' ' ' ASP . . . . . 0.48 ' HB3' ' CA ' ' A' ' 72' ' ' GLY . 2.7 t0 -78.89 85.66 4.84 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 -178.843 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.68 86.31 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 177.812 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.2 mmtt -150.49 44.68 0.86 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.934 0.873 . . . . 0.0 111.615 178.749 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 30' ' ' THR . . . . . 0.732 HG22 ' HG2' ' A' ' 24' ' ' PRO . 12.2 p -130.64 -170.77 2.41 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.55 -174.695 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 31' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 95' ' ' ASP . . . -83.82 -55.23 2.86 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.706 177.446 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -76.05 9.56 2.4 Favored 'General case' 0 CA--C 1.514 -0.415 0 O-C-N 122.136 -0.626 . . . . 0.0 112.336 177.854 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.1 p 89.83 -58.45 0.02 OUTLIER 'General case' 0 CA--C 1.503 -0.855 0 C-N-CA 127.17 2.188 . . . . 0.0 109.258 -179.782 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 34' ' ' TYR . . . . . 0.491 ' CG ' ' HG3' ' A' ' 84' ' ' PRO . 85.9 m-85 -59.38 142.82 86.38 Favored Pre-proline 0 N--CA 1.437 -1.08 0 O-C-N 125.826 1.953 . . . . 0.0 112.768 -176.914 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 35' ' ' PRO . . . . . 0.796 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 36.0 Cg_endo -76.48 -172.69 11.47 Favored 'Cis proline' 0 N--CA 1.438 -1.764 0 C-N-CA 122.66 -1.808 . . . . 0.0 111.521 0.577 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 36' ' ' HIS . . . . . 0.429 ' CD2' ' N ' ' A' ' 36' ' ' HIS . 0.3 OUTLIER -159.62 159.75 33.5 Favored 'General case' 0 CA--C 1.502 -0.886 0 O-C-N 120.774 -1.204 . . . . 0.0 110.101 -178.68 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 37' ' ' TRP . . . . . 0.599 ' CD1' ' HB2' ' A' ' 79' ' ' TYR . 10.3 t90 -69.6 134.35 48.67 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-O 122.796 1.284 . . . . 0.0 110.044 175.458 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 38' ' ' PHE . . . . . 0.444 ' CZ ' ' HA ' ' A' ' 40' ' ' ASN . 14.0 t80 -97.63 97.59 9.16 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 178.939 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 39' ' ' THR . . . . . 0.438 ' HA ' ' CZ2' ' A' ' 37' ' ' TRP . 77.4 p -36.14 -35.18 0.07 Allowed 'General case' 0 C--O 1.208 -1.124 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.873 173.489 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 40' ' ' ASN . . . . . 0.444 ' HA ' ' CZ ' ' A' ' 38' ' ' PHE . 4.1 t-20 65.97 11.65 7.87 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 123.926 0.89 . . . . 0.0 110.631 179.717 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 41' ' ' GLY . . . . . 0.487 ' HA3' HD23 ' A' ' 48' ' ' LEU . . . 97.7 4.08 58.12 Favored Glycine 0 CA--C 1.536 1.384 0 N-CA-C 114.364 0.506 . . . . 0.0 114.364 -169.939 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 42' ' ' TYR . . . . . 0.708 ' CE1' HD11 ' A' ' 48' ' ' LEU . 2.6 m-85 -99.0 165.61 11.67 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 124.103 0.961 . . . . 0.0 109.339 -177.456 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.3 -34.88 25.62 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.625 176.911 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 44' ' ' GLY . . . . . 0.526 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . 173.24 -62.3 0.13 Allowed Glycine 0 C--N 1.335 0.489 0 C-N-CA 124.008 0.813 . . . . 0.0 112.06 -178.285 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -111.42 -61.81 1.64 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 122.607 1.194 . . . . 0.0 110.356 179.671 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.16 161.12 6.91 Favored Glycine 0 C--N 1.34 0.797 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.228 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 47' ' ' LYS . . . . . 0.568 ' HA ' ' CD2' ' A' ' 42' ' ' TYR . 8.5 ptpt -56.98 -163.14 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 122.998 1.38 . . . . 0.0 112.033 175.732 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 48' ' ' LEU . . . . . 0.708 HD11 ' CE1' ' A' ' 42' ' ' TYR . 4.0 mp -81.35 155.25 71.87 Favored Pre-proline 0 N--CA 1.44 -0.931 0 O-C-N 121.068 -1.02 . . . . 0.0 111.041 178.107 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -71.2 159.4 52.14 Favored 'Trans proline' 0 N--CA 1.444 -1.394 0 C-N-CA 121.947 1.765 . . . . 0.0 110.266 178.45 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -53.11 97.77 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.263 0.625 . . . . 0.0 110.083 177.274 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.26 79.19 0.95 Allowed Glycine 0 CA--C 1.517 0.191 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.184 -176.146 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 52' ' ' ARG . . . . . 0.472 ' HD3' ' CA ' ' A' ' 41' ' ' GLY . 0.0 OUTLIER -174.83 157.31 2.42 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 123.891 0.876 . . . . 0.0 110.733 175.547 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.2 m -141.47 108.76 6.15 Favored Pre-proline 0 C--N 1.328 -0.347 0 O-C-N 123.972 0.795 . . . . 0.0 109.829 -179.91 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -72.53 179.12 5.43 Favored 'Trans proline' 0 N--CA 1.447 -1.226 0 C-N-CA 122.479 2.119 . . . . 0.0 111.619 177.338 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 55' ' ' ILE . . . . . 0.409 ' CG2' ' HB2' ' A' ' 133' ' ' LEU . 5.2 mt -90.16 124.76 42.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.788 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.18 134.65 35.66 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.675 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 57' ' ' PHE . . . . . 0.521 ' CD1' ' HB3' ' A' ' 118' ' ' CYS . 40.1 m-85 -114.33 -47.83 2.91 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 123.494 0.718 . . . . 0.0 110.642 179.43 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 121.66 -1.81 11.12 Favored Glycine 0 C--O 1.223 -0.54 0 C-N-CA 123.767 0.698 . . . . 0.0 112.514 -176.36 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.5 mttm -103.24 145.53 29.8 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 117.74 0.77 . . . . 0.0 109.588 177.537 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 30.4 t -79.13 -9.16 59.48 Favored 'General case' 0 C--O 1.222 -0.374 0 O-C-N 124.794 1.309 . . . . 0.0 111.309 176.784 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -89.04 -48.99 7.03 Favored 'General case' 0 CA--C 1.515 -0.375 0 C-N-CA 123.788 0.835 . . . . 0.0 109.797 179.995 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 62' ' ' CYS . . . . . 0.7 ' SG ' HD21 ' A' ' 80' ' ' LEU . 1.4 t -72.91 -17.04 61.54 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 123.739 0.649 . . . . 0.0 111.814 175.871 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -86.43 -33.13 20.52 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-O 122.009 0.909 . . . . 0.0 111.295 174.422 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 64' ' ' ARG . . . . . 0.609 ' HD3' ' CD2' ' A' ' 78' ' ' HIS . 0.0 OUTLIER -57.27 158.99 9.09 Favored Pre-proline 0 N--CA 1.445 -0.691 0 O-C-N 121.369 -0.832 . . . . 0.0 111.343 179.492 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -71.14 140.09 36.86 Favored 'Trans proline' 0 N--CA 1.442 -1.5 0 C-N-CA 120.763 0.975 . . . . 0.0 113.74 174.365 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 66' ' ' PRO . . . . . 0.529 ' HD2' ' CD2' ' A' ' 42' ' ' TYR . 22.8 Cg_endo -70.77 169.88 19.13 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 123.482 2.788 . . . . 0.0 112.238 177.058 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 67' ' ' LYS . . . . . 0.536 ' HG3' ' CE1' ' A' ' 78' ' ' HIS . 0.8 OUTLIER -133.37 49.95 2.26 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 179.224 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 68' ' ' HIS . . . . . 0.483 ' HA ' ' OD2' ' A' ' 77' ' ' ASP . 25.1 t-80 -73.92 156.97 37.09 Favored 'General case' 0 C--O 1.22 -0.459 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.588 -177.536 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 69' ' ' SER . . . . . 0.443 ' O ' ' CE1' ' A' ' 68' ' ' HIS . 1.5 p -148.22 -160.05 1.12 Allowed 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 122.287 1.041 . . . . 0.0 111.3 177.169 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.59 75.64 9.49 Favored 'General case' 0 C--O 1.217 -0.625 0 O-C-N 120.259 -1.526 . . . . 0.0 111.722 172.148 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -177.22 -44.59 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.271 0.628 . . . . 0.0 109.958 177.6 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 72' ' ' GLY . . . . . 0.48 ' CA ' ' HB3' ' A' ' 27' ' ' ASP . . . 109.17 -54.46 0.55 Allowed Glycine 0 C--O 1.212 -1.239 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.912 -178.458 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -133.87 65.65 1.57 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 -179.574 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.44 -126.63 0.01 OUTLIER Glycine 0 CA--C 1.525 0.718 0 CA-C-O 121.94 0.745 . . . . 0.0 111.492 179.447 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.8 mttt -58.2 -92.66 0.0 OUTLIER 'General case' 0 C--O 1.221 -0.444 0 O-C-N 120.738 -1.448 . . . . 0.0 112.311 178.132 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 76' ' ' THR . . . . . 0.529 HG23 ' O ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -115.86 15.99 16.27 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-O 118.307 -0.854 . . . . 0.0 110.427 177.473 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 77' ' ' ASP . . . . . 0.505 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 20.1 t0 -29.11 102.06 0.02 OUTLIER 'General case' 0 C--O 1.212 -0.897 0 O-C-N 123.979 0.799 . . . . 0.0 110.99 -179.566 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 78' ' ' HIS . . . . . 0.609 ' CD2' ' HD3' ' A' ' 64' ' ' ARG . 11.2 p-80 -87.55 64.18 7.98 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -176.016 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 79' ' ' TYR . . . . . 0.599 ' HB2' ' CD1' ' A' ' 37' ' ' TRP . 34.4 p90 -90.29 136.56 32.98 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 124.242 1.017 . . . . 0.0 109.527 -178.128 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 80' ' ' LEU . . . . . 0.7 HD21 ' SG ' ' A' ' 62' ' ' CYS . 0.3 OUTLIER -74.44 142.51 44.92 Favored 'General case' 0 C--O 1.216 -0.697 0 C-N-CA 119.758 -0.777 . . . . 0.0 109.225 176.22 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 81' ' ' LEU . . . . . 0.668 HD21 ' HB2' ' A' ' 35' ' ' PRO . 1.1 tt -134.66 144.07 47.62 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 176.338 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 82' ' ' GLU . . . . . 0.508 ' HB2' HD11 ' A' ' 109' ' ' ILE . 6.1 pm0 -109.35 165.62 11.49 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 123.547 0.739 . . . . 0.0 111.429 -179.694 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 83' ' ' PHE . . . . . 0.605 ' HB3' HG12 ' A' ' 108' ' ' VAL . 36.7 t80 -148.93 135.23 10.12 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 117.795 -1.098 . . . . 0.0 112.444 -179.186 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 84' ' ' PRO . . . . . 0.565 ' HA ' ' HG2' ' A' ' 107' ' ' ARG . 19.1 Cg_endo -70.73 88.67 0.64 Allowed 'Trans proline' 0 CA--C 1.501 -1.152 0 C-N-CA 124.513 3.475 . . . . 0.0 110.679 -176.015 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 85' ' ' THR . . . . . 0.622 HG22 ' HA ' ' A' ' 107' ' ' ARG . 1.2 t -86.71 115.92 24.47 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 124.411 1.07 . . . . 0.0 111.958 179.741 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 86' ' ' PHE . . . . . 0.617 ' CD1' ' CD1' ' A' ' 92' ' ' TYR . 18.2 m-85 -83.67 160.42 58.78 Favored Pre-proline 0 N--CA 1.45 -0.473 0 C-N-CA 123.193 0.597 . . . . 0.0 111.525 -179.877 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.05 -44.54 0.33 Allowed 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 122.189 1.926 . . . . 0.0 111.748 179.041 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -52.21 -28.38 18.22 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 122.992 1.377 . . . . 0.0 110.031 177.89 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.1 -14.14 40.53 Favored Glycine 0 N--CA 1.438 -1.227 0 CA-C-O 118.23 -1.317 . . . . 0.0 111.809 -179.023 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 90' ' ' HIS . . . . . 0.425 ' O ' ' CE1' ' A' ' 92' ' ' TYR . 1.0 OUTLIER -48.69 143.22 5.36 Favored 'General case' 0 C--O 1.213 -0.838 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.425 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -63.64 137.66 58.18 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.793 0.806 . . . . 0.0 111.736 177.32 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 92' ' ' TYR . . . . . 0.617 ' CD1' ' CD1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -94.86 148.5 22.24 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 -174.876 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -84.4 68.62 10.31 Favored 'General case' 0 C--N 1.321 -0.649 0 O-C-N 121.272 -0.893 . . . . 0.0 109.564 176.079 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 94' ' ' PHE . . . . . 0.422 ' CD2' ' O ' ' A' ' 92' ' ' TYR . 30.7 p90 -83.4 -16.15 46.99 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.583 177.465 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 95' ' ' ASP . . . . . 0.403 ' O ' ' HA3' ' A' ' 31' ' ' GLY . 0.4 OUTLIER -89.8 -30.87 17.68 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 123.82 0.848 . . . . 0.0 110.448 178.55 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.0 t -90.91 110.29 21.52 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -177.014 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.52 -46.1 91.38 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-O 120.958 0.409 . . . . 0.0 110.347 179.723 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 98' ' ' LYS . . . . . 0.427 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 6.6 mttm -141.07 128.46 11.98 Favored Pre-proline 0 N--CA 1.438 -1.04 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.962 -178.251 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 99' ' ' PRO . . . . . 0.427 ' C ' ' HA ' ' A' ' 98' ' ' LYS . 20.0 Cg_endo -70.05 176.86 31.71 Favored 'Cis proline' 0 N--CA 1.458 -0.602 0 O-C-N 124.579 1.831 . . . . 0.0 111.472 -3.802 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.03 152.34 48.76 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 123.515 0.726 . . . . 0.0 109.891 177.731 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -104.13 146.37 28.84 Favored 'General case' 0 C--N 1.321 -0.656 0 O-C-N 124.327 1.017 . . . . 0.0 108.767 -179.875 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -56.23 120.26 33.64 Favored Pre-proline 0 N--CA 1.445 -0.706 0 CA-C-O 118.095 -0.955 . . . . 0.0 110.792 177.353 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -71.6 -163.22 0.13 Allowed 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 122.723 2.282 . . . . 0.0 111.753 178.303 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -142.5 172.29 24.38 Favored Glycine 0 CA--C 1.524 0.645 0 O-C-N 121.414 -0.804 . . . . 0.0 112.113 177.187 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 105' ' ' PRO . . . . . 0.569 ' HB2' ' HB1' ' A' ' 122' ' ' ALA . 18.7 Cg_endo -74.03 -50.88 0.15 Allowed 'Trans proline' 0 N--CA 1.447 -1.26 0 C-N-CA 122.112 1.875 . . . . 0.0 110.542 178.925 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 106' ' ' ALA . . . . . 0.604 ' HA ' ' HB2' ' A' ' 122' ' ' ALA . . . -61.24 135.74 57.83 Favored 'General case' 0 CA--C 1.507 -0.704 0 O-C-N 123.645 0.591 . . . . 0.0 109.892 -179.155 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 107' ' ' ARG . . . . . 0.622 ' HA ' HG22 ' A' ' 85' ' ' THR . 9.4 mtm-85 -151.39 148.1 27.71 Favored 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 124.224 0.952 . . . . 0.0 110.456 -179.085 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 108' ' ' VAL . . . . . 0.605 HG12 ' HB3' ' A' ' 83' ' ' PHE . 12.8 p -87.99 116.01 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 O-C-N 124.354 1.034 . . . . 0.0 111.525 178.584 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 109' ' ' ILE . . . . . 0.655 ' CG2' HD22 ' A' ' 80' ' ' LEU . 1.4 mp -107.39 122.05 61.08 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.885 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 -173.09 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 110' ' ' TYR . . . . . 0.465 ' CZ ' HD22 ' A' ' 81' ' ' LEU . 6.3 p90 -141.46 151.73 43.62 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 121.836 0.827 . . . . 0.0 109.711 -179.388 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.3 p -80.64 163.23 23.78 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.639 178.421 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 112' ' ' TYR . . . . . 0.524 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -111.9 154.73 44.04 Favored Pre-proline 0 CA--C 1.546 0.808 0 O-C-N 123.353 0.408 . . . . 0.0 110.893 178.86 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 113' ' ' PRO . . . . . 0.524 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 19.0 Cg_endo -74.16 -51.08 0.16 OUTLIER 'Cis proline' 0 CA--C 1.502 -1.094 0 C-N-CA 123.533 -1.444 . . . . 0.0 110.529 -5.956 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 114' ' ' ASN . . . . . 0.541 ' O ' HG23 ' A' ' 116' ' ' VAL . 43.8 t-20 -45.23 109.96 0.21 Allowed 'General case' 0 C--O 1.219 -0.549 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.971 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 115' ' ' LYS . . . . . 0.526 ' HE2' HD22 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -66.39 76.63 0.1 Allowed 'General case' 0 CA--C 1.512 -0.497 0 C-N-CA 123.675 0.79 . . . . 0.0 109.016 179.547 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 116' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 114' ' ' ASN . 57.3 t -74.84 72.51 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 -176.188 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 117' ' ' PHE . . . . . 0.407 ' CE1' ' NE2' ' A' ' 13' ' ' GLN . 59.8 t80 -34.02 104.95 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 126.752 2.021 . . . . 0.0 109.22 -178.378 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 118' ' ' CYS . . . . . 0.521 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 14.6 m -84.84 -44.81 12.9 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -177.683 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 158.89 -151.03 21.94 Favored Glycine 0 N--CA 1.441 -1.02 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 179.657 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 120' ' ' ILE . . . . . 0.45 HG13 ' CG ' ' A' ' 4' ' ' TRP . 1.1 mm -127.44 133.14 68.51 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.806 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 -176.45 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 121' ' ' ILE . . . . . 0.661 HD12 HD21 ' A' ' 131' ' ' LEU . 6.4 pt -119.72 155.14 22.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -177.327 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 122' ' ' ALA . . . . . 0.734 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . . . -176.11 153.75 1.32 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.817 0.342 . . . . 0.0 110.249 178.635 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 123' ' ' HIS . . . . . 0.654 ' CE1' HD13 ' A' ' 131' ' ' LEU . 3.2 m80 -90.23 97.56 11.26 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -176.922 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 124' ' ' THR . . . . . 0.668 HG22 ' HD3' ' A' ' 132' ' ' LYS . 1.7 t -97.27 40.84 1.13 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 123.169 1.462 . . . . 0.0 111.47 179.595 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 12.7 tttm -105.02 -27.05 11.89 Favored 'General case' 0 C--O 1.219 -0.515 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.118 178.229 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -172.82 -66.59 0.02 OUTLIER 'General case' 0 C--O 1.22 -0.469 0 O-C-N 123.934 0.771 . . . . 0.0 110.234 178.265 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -155.34 -44.22 0.08 Allowed 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 122.241 1.02 . . . . 0.0 110.782 179.514 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -155.39 79.64 1.03 Allowed 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 124.159 0.984 . . . . 0.0 109.414 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -130.06 -105.67 1.14 Allowed Glycine 0 C--N 1.329 0.193 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 176.821 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -83.66 143.07 30.32 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 122.439 -0.447 . . . . 0.0 111.352 179.774 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 131' ' ' LEU . . . . . 0.661 HD21 HD12 ' A' ' 121' ' ' ILE . 5.7 tp -99.12 145.75 26.84 Favored 'General case' 0 C--O 1.22 -0.448 0 CA-C-O 120.769 0.319 . . . . 0.0 111.066 177.506 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 132' ' ' LYS . . . . . 0.668 ' HD3' HG22 ' A' ' 124' ' ' THR . 0.0 OUTLIER -152.79 172.26 16.99 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -179.743 . . . . . . . . 3 3 . 1 . 025 nuclear build full ' A' A ' 133' ' ' LEU . . . . . 0.409 ' HB2' ' CG2' ' A' ' 55' ' ' ILE . 14.9 tp -85.62 140.64 30.41 Favored 'General case' 0 C--O 1.244 0.765 0 O-C-N 123.886 0.741 . . . . 0.0 109.375 177.633 . . . . . . . . 2 2 . 1 . 025 nuclear build full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 60.8 m -68.71 -178.47 1.18 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.786 175.954 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 73.6 m -148.62 100.27 3.09 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 -178.787 . . . . . . . . 1 1 . 1 . 025 nuclear build full ' A' A ' 136' ' ' HIS . . . . . 0.468 ' HB2' HG13 ' A' ' 2' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--O 1.248 0.981 0 CA-C-O 117.892 -1.051 . . . . 0.0 113.268 173.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER . . . . . 0 CA--C 1.529 0.158 0 CA-C-O 122.004 0.907 . . . . 0.0 110.708 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 91.4 m -83.96 111.22 19.06 Favored 'General case' 0 C--N 1.31 -1.119 0 O-C-N 121.742 -0.599 . . . . 0.0 111.046 177.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . 0.62 ' CZ2' ' CD2' ' A' ' 136' ' ' HIS . 16.9 m95 -79.7 142.44 35.48 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 177.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -138.51 141.09 39.38 Favored 'General case' 0 CA--C 1.498 -1.046 0 O-C-N 121.068 -1.02 . . . . 0.0 108.429 -178.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.635 ' SG ' ' HB3' ' A' ' 122' ' ' ALA . 0.5 OUTLIER -122.81 61.08 1.01 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 118.612 -0.708 . . . . 0.0 110.502 177.54 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 39.0 78.69 0.05 OUTLIER Glycine 0 CA--C 1.532 1.114 0 O-C-N 124.207 0.942 . . . . 0.0 113.031 -177.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.01 -75.59 0.19 Allowed Glycine 0 C--O 1.224 -0.482 0 N-CA-C 111.189 -0.765 . . . . 0.0 111.189 -177.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.2 mt -128.33 163.2 25.32 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.593 0.711 . . . . 0.0 110.609 177.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.62 HD22 ' H ' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -88.58 170.34 10.94 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.978 -177.202 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.798 ' CZ ' ' HB3' ' A' ' 106' ' ' ALA . 70.6 m-85 -160.99 85.94 0.69 Allowed 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 122.278 1.037 . . . . 0.0 108.378 -171.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -54.11 122.98 11.34 Favored 'General case' 0 C--O 1.213 -0.864 0 CA-C-O 115.715 -2.088 . . . . 0.0 108.457 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.486 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 0.7 OUTLIER -46.49 -40.47 12.54 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 120.161 1.346 . . . . 0.0 112.543 175.716 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -57.75 -47.35 82.73 Favored 'General case' 0 C--O 1.199 -1.576 0 CA-C-O 118.573 -0.727 . . . . 0.0 111.093 176.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.423 ' CE ' ' HA3' ' A' ' 89' ' ' GLY . 6.3 mttt -70.52 -39.78 73.86 Favored 'General case' 0 C--O 1.203 -1.363 0 CA-C-N 120.912 1.687 . . . . 0.0 112.185 171.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.589 ' HA ' HG21 ' A' ' 85' ' ' THR . . . -52.58 -41.01 63.23 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 121.55 1.977 . . . . 0.0 110.855 175.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -87.06 -47.0 9.28 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-O 117.393 -1.289 . . . . 0.0 109.64 177.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 39.3 t -67.49 -54.18 22.31 Favored 'General case' 0 CA--C 1.496 -1.108 0 C-N-CA 127.311 2.244 . . . . 0.0 107.597 -171.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.519 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 5.9 t-20 -42.32 -36.46 1.26 Allowed 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 119.862 1.21 . . . . 0.0 113.514 169.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.422 ' O ' ' HB3' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -82.78 -33.97 27.19 Favored 'General case' 0 C--O 1.212 -0.906 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 172.813 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 14.9 m170 -44.96 -35.69 3.01 Favored 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 126.516 1.926 . . . . 0.0 110.33 177.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.519 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -74.3 -48.84 25.88 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-O 117.089 -1.434 . . . . 0.0 112.385 175.224 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.547 ' HB2' ' CE1' ' A' ' 83' ' ' PHE . . . -35.41 128.78 0.56 Allowed Pre-proline 0 CA--C 1.542 0.647 0 O-C-N 125.568 1.792 . . . . 0.0 112.51 172.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.759 ' HG2' HG22 ' A' ' 30' ' ' THR . 14.9 Cg_endo -73.98 123.04 8.1 Favored 'Trans proline' 0 N--CA 1.448 -1.189 0 C-N-CA 122.14 1.893 . . . . 0.0 108.661 -176.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.521 HD22 ' HE2' ' A' ' 115' ' ' LYS . 3.4 tp -59.47 102.86 0.16 Allowed 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.102 178.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 178.93 151.3 0.31 Allowed 'General case' 0 C--O 1.214 -0.795 0 CA-C-O 119.014 -0.517 . . . . 0.0 110.883 -176.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.48 ' HB3' ' CA ' ' A' ' 72' ' ' GLY . 0.9 OUTLIER -81.93 89.8 6.4 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 119.263 0.938 . . . . 0.0 109.571 -179.422 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 60.31 82.08 0.07 OUTLIER Glycine 0 C--O 1.226 -0.401 0 CA-C-O 121.617 0.565 . . . . 0.0 111.7 178.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.3 mttt -150.06 45.76 0.91 Allowed 'General case' 0 CA--C 1.511 -0.546 0 CA-C-O 122.521 1.153 . . . . 0.0 111.315 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.759 HG22 ' HG2' ' A' ' 24' ' ' PRO . 70.5 p -128.41 152.56 48.06 Favored 'General case' 0 CA--C 1.497 -1.076 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -175.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -42.77 -52.19 5.59 Favored Glycine 0 C--N 1.332 0.346 0 O-C-N 124.556 1.16 . . . . 0.0 112.139 -177.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.3 t -68.48 -77.98 0.07 Allowed 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 117.659 -1.162 . . . . 0.0 111.251 172.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 71.0 p -178.07 -61.73 0.01 OUTLIER 'General case' 0 C--O 1.218 -0.603 0 O-C-N 124.846 1.341 . . . . 0.0 110.888 -177.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -62.66 146.87 93.86 Favored Pre-proline 0 N--CA 1.428 -1.555 0 O-C-N 125.432 1.707 . . . . 0.0 112.714 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.599 ' HB2' HD21 ' A' ' 81' ' ' LEU . 29.3 Cg_endo -78.19 -179.39 26.88 Favored 'Cis proline' 0 N--CA 1.439 -1.731 0 C-N-CA 121.856 -2.143 . . . . 0.0 111.785 1.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.411 ' CD2' ' N ' ' A' ' 36' ' ' HIS . 0.2 OUTLIER -152.69 164.1 38.39 Favored 'General case' 0 C--O 1.209 -1.063 0 O-C-N 118.913 -2.367 . . . . 0.0 111.251 -177.27 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.986 ' CH2' HG22 ' A' ' 39' ' ' THR . 20.3 t90 -69.96 140.93 53.08 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 119.821 1.191 . . . . 0.0 108.422 176.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.463 ' CZ ' ' HA ' ' A' ' 40' ' ' ASN . 11.3 t80 -117.79 86.64 2.56 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 -177.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.986 HG22 ' CH2' ' A' ' 37' ' ' TRP . 70.4 p -38.91 -36.58 0.29 Allowed 'General case' 0 C--O 1.211 -0.965 0 C-N-CA 124.853 1.261 . . . . 0.0 111.185 175.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.463 ' HA ' ' CZ ' ' A' ' 38' ' ' PHE . 61.7 t30 73.49 4.94 4.91 Favored 'General case' 0 C--O 1.219 -0.52 0 C-N-CA 126.329 1.852 . . . . 0.0 109.36 176.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.441 ' CA ' ' HD3' ' A' ' 52' ' ' ARG . . . 120.04 -9.74 11.18 Favored Glycine 0 N--CA 1.427 -1.918 0 C-N-CA 125.221 1.391 . . . . 0.0 114.059 -172.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.592 ' CE1' HD11 ' A' ' 48' ' ' LEU . 17.3 m-85 -77.36 172.04 13.93 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.012 0.925 . . . . 0.0 110.489 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.04 -39.12 12.38 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.87 176.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.583 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . 174.27 -42.46 0.14 Allowed Glycine 0 C--N 1.334 0.439 0 C-N-CA 124.449 1.023 . . . . 0.0 112.73 -177.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -133.27 -63.87 0.75 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.519 0.676 . . . . 0.0 109.736 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.7 154.54 17.19 Favored Glycine 0 C--N 1.341 0.825 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.589 ' HA ' ' CE2' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -53.16 174.8 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.839 0.828 . . . . 0.0 112.775 175.721 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.592 HD11 ' CE1' ' A' ' 42' ' ' TYR . 5.6 mp -57.27 149.97 44.86 Favored Pre-proline 0 N--CA 1.445 -0.686 0 O-C-N 121.697 -0.627 . . . . 0.0 111.431 177.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -72.47 159.07 50.0 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 122.03 1.82 . . . . 0.0 109.474 -179.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 6.7 ttpt -54.65 97.76 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.147 0.579 . . . . 0.0 110.246 177.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.42 74.44 0.69 Allowed Glycine 0 N--CA 1.452 -0.26 0 CA-C-O 119.02 -0.878 . . . . 0.0 112.831 -175.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.441 ' HD3' ' CA ' ' A' ' 41' ' ' GLY . 7.1 ttm180 -173.69 164.28 4.37 Favored 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 123.966 0.906 . . . . 0.0 110.493 175.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.3 m -142.59 110.16 5.72 Favored Pre-proline 0 N--CA 1.448 -0.553 0 O-C-N 123.472 0.482 . . . . 0.0 110.563 178.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.409 ' HG3' HD13 ' A' ' 48' ' ' LEU . 23.6 Cg_endo -73.15 178.7 6.23 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 122.286 1.991 . . . . 0.0 111.52 178.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.416 ' CG2' ' HB2' ' A' ' 133' ' ' LEU . 4.3 mt -88.63 119.07 35.27 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.552 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -179.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -82.65 134.96 35.16 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 120.85 -1.156 . . . . 0.0 109.076 176.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.598 ' CE1' HD13 ' A' ' 133' ' ' LEU . 6.9 m-85 -116.82 -44.33 2.83 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.575 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 122.5 -4.03 10.2 Favored Glycine 0 C--O 1.224 -0.508 0 CA-C-O 118.88 -0.956 . . . . 0.0 112.62 -176.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.7 mttt -101.49 139.15 37.54 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-N 118.307 1.054 . . . . 0.0 109.863 176.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.7 t -78.66 -1.0 32.25 Favored 'General case' 0 C--O 1.219 -0.507 0 O-C-N 125.097 1.498 . . . . 0.0 111.21 175.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -87.47 -51.22 6.04 Favored 'General case' 0 N--CA 1.451 -0.424 0 O-C-N 120.184 -1.572 . . . . 0.0 109.327 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.739 ' HB3' HD11 ' A' ' 80' ' ' LEU . 2.7 m -73.51 -35.55 65.62 Favored 'General case' 0 N--CA 1.451 -0.401 0 O-C-N 123.747 0.654 . . . . 0.0 109.624 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -63.05 -37.1 85.85 Favored 'General case' 0 C--O 1.225 -0.205 0 CA-C-O 121.531 0.681 . . . . 0.0 111.398 175.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.7 161.8 0.83 Allowed Pre-proline 0 N--CA 1.441 -0.908 0 CA-C-O 122.321 1.058 . . . . 0.0 112.642 177.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.424 ' HA ' ' CE2' ' A' ' 42' ' ' TYR . 27.5 Cg_endo -70.92 132.87 22.27 Favored 'Trans proline' 0 N--CA 1.438 -1.758 0 C-N-CA 120.72 0.947 . . . . 0.0 114.486 173.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.507 ' HD2' ' CD2' ' A' ' 42' ' ' TYR . 19.5 Cg_endo -72.04 168.01 25.15 Favored 'Trans proline' 0 N--CA 1.445 -1.37 0 C-N-CA 123.122 2.548 . . . . 0.0 110.905 177.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.6 tptt -126.92 52.98 1.73 Allowed 'General case' 0 C--O 1.203 -1.351 0 CA-C-N 115.136 -0.938 . . . . 0.0 108.51 178.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -75.52 164.88 25.9 Favored 'General case' 0 C--O 1.216 -0.692 0 O-C-N 120.411 -1.43 . . . . 0.0 111.347 178.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.4 p -157.87 -167.98 2.4 Favored 'General case' 0 C--N 1.322 -0.589 0 O-C-N 119.531 -1.98 . . . . 0.0 111.136 176.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.4 77.05 5.96 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 120.686 -1.259 . . . . 0.0 112.686 171.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -177.79 -44.86 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 O-C-N 123.694 0.621 . . . . 0.0 110.162 177.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.48 ' CA ' ' HB3' ' A' ' 27' ' ' ASP . . . 117.18 -69.24 0.3 Allowed Glycine 0 N--CA 1.439 -1.148 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.453 -178.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -128.84 60.95 1.52 Allowed 'General case' 0 CA--C 1.508 -0.67 0 C-N-CA 125.583 1.553 . . . . 0.0 107.367 -175.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.33 -106.45 0.01 OUTLIER Glycine 0 CA--C 1.535 1.292 0 CA-C-O 123.04 1.355 . . . . 0.0 112.862 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.8 mttm -73.11 -105.12 0.01 OUTLIER 'General case' 0 C--O 1.217 -0.608 0 O-C-N 119.699 -2.06 . . . . 0.0 110.621 177.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.519 HG23 ' O ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -106.47 16.8 24.21 Favored 'General case' 0 C--N 1.32 -0.711 0 O-C-N 121.486 -0.759 . . . . 0.0 111.116 179.329 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.425 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 10.0 m-20 -31.56 98.74 0.01 OUTLIER 'General case' 0 C--O 1.207 -1.132 0 C-N-CA 125.487 1.515 . . . . 0.0 111.856 -176.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.511 ' CD2' ' H ' ' A' ' 78' ' ' HIS . 4.4 p80 -85.11 44.41 1.08 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 119.752 -1.842 . . . . 0.0 107.745 -170.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.508 ' HB2' ' CD1' ' A' ' 37' ' ' TRP . 39.3 p90 -69.68 135.02 49.35 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 124.794 1.237 . . . . 0.0 111.011 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.817 HD22 HG23 ' A' ' 109' ' ' ILE . 2.1 mt -71.24 142.84 50.57 Favored 'General case' 0 C--O 1.216 -0.71 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 177.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.599 HD21 ' HB2' ' A' ' 35' ' ' PRO . 0.3 OUTLIER -137.12 137.12 38.92 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 119.128 0.876 . . . . 0.0 108.864 177.059 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.463 ' HB2' HD11 ' A' ' 109' ' ' ILE . 0.5 OUTLIER -99.78 168.66 9.76 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.649 176.432 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.547 ' CE1' ' HB2' ' A' ' 23' ' ' ALA . 78.6 t80 -157.04 130.02 4.42 Favored Pre-proline 0 C--N 1.327 -0.383 0 O-C-N 120.811 -1.181 . . . . 0.0 113.857 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.426 ' HA ' ' HG2' ' A' ' 107' ' ' ARG . 19.3 Cg_endo -72.6 98.76 0.98 Allowed 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 123.913 3.076 . . . . 0.0 109.713 -175.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.589 HG21 ' HA ' ' A' ' 16' ' ' ALA . 7.2 t -102.49 109.15 20.7 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.075 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -81.34 158.44 69.18 Favored Pre-proline 0 C--N 1.32 -0.696 0 O-C-N 121.607 -0.683 . . . . 0.0 112.112 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -78.12 -34.3 1.71 Allowed 'Trans proline' 0 CA--C 1.495 -1.473 0 C-N-CA 122.053 1.835 . . . . 0.0 112.802 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -43.83 -32.94 1.18 Allowed 'General case' 0 N--CA 1.474 0.77 0 O-C-N 125.537 1.773 . . . . 0.0 110.709 176.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.423 ' HA3' ' CE ' ' A' ' 15' ' ' LYS . . . 89.19 4.45 74.38 Favored Glycine 0 N--CA 1.431 -1.66 0 CA-C-O 118.586 -1.119 . . . . 0.0 111.268 177.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 4.5 p-80 -74.07 129.55 38.08 Favored 'General case' 0 N--CA 1.434 -1.253 0 O-C-N 125.669 1.452 . . . . 0.0 107.644 178.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -61.84 92.04 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 174.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.497 ' CD2' ' HB3' ' A' ' 94' ' ' PHE . 5.8 t80 -38.32 142.89 0.15 Allowed 'General case' 0 C--O 1.21 -0.99 0 CA-C-O 122.083 0.944 . . . . 0.0 110.382 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.46 58.73 1.03 Allowed 'General case' 0 C--N 1.312 -1.064 0 O-C-N 119.11 -2.244 . . . . 0.0 111.061 175.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.497 ' HB3' ' CD2' ' A' ' 92' ' ' TYR . 25.7 p90 -75.27 -18.3 60.1 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 123.925 0.89 . . . . 0.0 111.621 176.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -92.05 -22.39 19.97 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-O 122.21 1.005 . . . . 0.0 110.304 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.49 107.59 19.56 Favored 'General case' 0 CA--C 1.513 -0.459 0 O-C-N 120.369 -1.457 . . . . 0.0 109.001 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.23 -49.5 75.82 Favored 'General case' 0 C--N 1.33 -0.261 0 O-C-N 122.181 -0.325 . . . . 0.0 110.375 177.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -136.41 125.33 15.48 Favored Pre-proline 0 N--CA 1.44 -0.938 0 C-N-CA 124.338 1.055 . . . . 0.0 109.695 -175.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -71.94 176.12 39.81 Favored 'Cis proline' 0 C--N 1.349 0.601 0 O-C-N 124.94 2.021 . . . . 0.0 110.941 -2.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -138.07 124.0 20.1 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 124.059 0.943 . . . . 0.0 109.013 179.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.06 159.57 26.12 Favored 'General case' 0 C--N 1.322 -0.618 0 O-C-N 124.509 1.131 . . . . 0.0 111.399 177.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -60.06 138.97 91.11 Favored Pre-proline 0 N--CA 1.451 -0.403 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.32 177.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -72.25 -165.75 0.23 Allowed 'Trans proline' 0 N--CA 1.452 -0.971 0 C-N-CA 122.783 2.322 . . . . 0.0 111.725 176.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -131.58 155.7 21.51 Favored Glycine 0 CA--C 1.527 0.798 0 O-C-N 121.166 -0.959 . . . . 0.0 112.433 176.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -73.07 -17.46 24.81 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 122.389 2.059 . . . . 0.0 111.258 177.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.798 ' HB3' ' CZ ' ' A' ' 11' ' ' TYR . . . -110.76 134.92 52.08 Favored 'General case' 0 CA--C 1.507 -0.711 0 C-N-CA 124.177 0.991 . . . . 0.0 110.094 177.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.427 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 0.0 OUTLIER -138.37 151.04 47.15 Favored 'General case' 0 CA--C 1.5 -0.964 0 CA-C-O 116.489 -1.72 . . . . 0.0 111.41 176.964 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.513 ' C ' HD12 ' A' ' 109' ' ' ILE . 7.3 p -82.39 122.24 36.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 124.77 1.228 . . . . 0.0 112.109 175.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.817 HG23 HD22 ' A' ' 80' ' ' LEU . 1.7 mp -110.71 120.46 61.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 -174.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.498 ' O ' HD23 ' A' ' 80' ' ' LEU . 6.4 p90 -140.34 150.52 44.07 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 122.93 1.347 . . . . 0.0 109.958 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.6 p -82.32 160.58 22.85 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -178.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.52 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.0 OUTLIER -108.2 155.38 40.29 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 122.873 0.469 . . . . 0.0 110.568 179.203 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.52 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 14.7 Cg_endo -74.16 -51.21 0.16 OUTLIER 'Cis proline' 0 CA--C 1.501 -1.159 0 C-N-CA 123.343 -1.524 . . . . 0.0 109.596 -6.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -47.72 108.09 0.15 Allowed 'General case' 0 CA--C 1.505 -0.785 0 CA-C-O 116.101 -1.904 . . . . 0.0 108.919 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.521 ' HE2' HD22 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -62.91 79.75 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.547 0 O-C-N 125.233 1.583 . . . . 0.0 109.014 -177.775 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.481 ' O ' HG12 ' A' ' 116' ' ' VAL . 15.4 t -80.16 71.58 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 N-CA-C 103.965 -2.605 . . . . 0.0 103.965 -175.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.547 ' CE1' ' HA2' ' A' ' 119' ' ' GLY . 4.3 t80 -36.1 114.12 0.26 Allowed 'General case' 0 C--O 1.242 0.671 0 C-N-CA 124.049 0.94 . . . . 0.0 108.809 177.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . 0.546 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -97.03 -30.33 13.12 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.973 177.282 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.547 ' HA2' ' CE1' ' A' ' 117' ' ' PHE . . . 144.12 -170.32 25.98 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 123.864 0.745 . . . . 0.0 112.027 -177.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.679 HG21 ' HB1' ' A' ' 106' ' ' ALA . 3.2 mp -111.61 142.84 22.77 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.395 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 -177.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.72 HG22 HD12 ' A' ' 133' ' ' LEU . 8.4 pt -114.83 155.19 16.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 119.822 1.192 . . . . 0.0 108.087 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.635 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . . . . . . . . 0 C--N 1.323 -0.567 0 CA-C-O 122.9 1.333 . . . . 0.0 110.117 178.522 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER . . . . . 0 CA--C 1.502 -0.868 0 CA-C-O 118.313 -0.851 . . . . 0.0 109.256 . . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.72 HD12 HG22 ' A' ' 121' ' ' ILE . 9.4 tp -83.97 148.07 27.11 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 177.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . 0.533 ' SG ' HG22 ' A' ' 120' ' ' ILE . 90.8 m -58.59 -174.32 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.186 1.394 . . . . 0.0 110.608 175.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 61.3 m -131.22 93.28 3.34 Favored 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -177.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.62 ' CD2' ' CZ2' ' A' ' 4' ' ' TRP . 5.8 p-80 . . . . . 0 C--O 1.25 1.111 0 CA-C-O 114.957 -2.449 . . . . 0.0 113.427 173.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.545 HG22 ' HB3' ' A' ' 136' ' ' HIS . 14.4 p . . . . . 0 N--CA 1.449 -0.505 0 CA-C-O 121.666 0.745 . . . . 0.0 110.891 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.4 m -88.93 114.56 25.69 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 124.002 0.921 . . . . 0.0 109.47 -177.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . 0.47 ' CD1' ' HB2' ' A' ' 13' ' ' GLN . 31.8 m95 -79.33 150.18 31.52 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-O 118.88 -0.581 . . . . 0.0 110.421 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.5 m -144.52 131.62 20.51 Favored 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 -176.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.736 ' SG ' ' HB3' ' A' ' 122' ' ' ALA . 0.0 OUTLIER -126.93 -80.4 0.6 Allowed 'General case' 0 C--O 1.217 -0.658 0 CA-C-O 117.708 -1.139 . . . . 0.0 110.742 176.911 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -56.89 -88.17 0.02 OUTLIER Glycine 0 C--N 1.344 1.018 0 O-C-N 124.395 1.059 . . . . 0.0 111.294 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -154.17 18.22 0.62 Allowed Glycine 0 C--O 1.223 -0.585 0 O-C-N 121.749 -0.853 . . . . 0.0 111.383 178.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 49.8 mt -129.98 158.79 38.6 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 123.511 0.724 . . . . 0.0 109.735 178.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.5 mp -96.6 134.42 39.86 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.228 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.471 ' CE2' ' CB ' ' A' ' 106' ' ' ALA . 76.2 m-85 -117.64 104.07 10.66 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 126.481 1.912 . . . . 0.0 108.267 -173.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -55.69 119.6 5.97 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.473 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 5.5 tp-100 -53.25 -41.42 65.44 Favored 'General case' 0 C--O 1.203 -1.344 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.91 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -49.78 -42.44 46.68 Favored 'General case' 0 C--O 1.197 -1.702 0 CA-C-O 119.544 -0.265 . . . . 0.0 111.377 175.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.3 mttp -70.86 -37.19 73.09 Favored 'General case' 0 C--O 1.202 -1.44 0 O-C-N 120.923 -1.111 . . . . 0.0 113.451 169.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.4 -38.44 66.22 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 122.353 2.342 . . . . 0.0 113.641 172.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -90.39 -39.63 12.55 Favored 'General case' 0 C--O 1.212 -0.877 0 CA-C-O 117.976 -1.012 . . . . 0.0 108.548 177.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 39.8 t -73.63 -59.79 2.55 Favored 'General case' 0 C--O 1.214 -0.806 0 C-N-CA 126.212 1.805 . . . . 0.0 109.911 -176.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.498 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 6.4 t-20 -41.0 -36.86 0.72 Allowed 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 119.72 1.145 . . . . 0.0 113.285 170.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.477 ' O ' ' HB3' ' A' ' 23' ' ' ALA . 0.5 OUTLIER -81.53 -36.79 28.75 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 115.035 1.495 . . . . 0.0 115.035 173.434 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 5.2 m170 -44.83 -38.68 4.72 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.382 1.873 . . . . 0.0 109.896 178.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.498 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -73.72 -47.01 42.52 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-O 117.88 -1.057 . . . . 0.0 112.732 175.064 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.831 ' HB1' ' HG3' ' A' ' 35' ' ' PRO . . . -35.74 127.59 0.61 Allowed Pre-proline 0 N--CA 1.439 -0.982 0 O-C-N 125.312 1.632 . . . . 0.0 112.885 173.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.719 ' HG2' HG22 ' A' ' 30' ' ' THR . 14.2 Cg_endo -73.63 125.87 10.39 Favored 'Trans proline' 0 N--CA 1.445 -1.369 0 C-N-CA 122.054 1.836 . . . . 0.0 108.576 -175.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.818 HD13 ' HE2' ' A' ' 115' ' ' LYS . 4.3 tp -60.6 93.92 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.472 0.709 . . . . 0.0 111.239 178.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 179.2 162.46 0.82 Allowed 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 123.102 0.561 . . . . 0.0 109.966 -176.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.2 118.44 34.85 Favored 'General case' 0 C--O 1.218 -0.595 0 C-N-CA 123.996 0.918 . . . . 0.0 110.344 177.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 46.71 64.72 2.51 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 120.048 -1.073 . . . . 0.0 112.7 177.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.9 ttpt -129.44 11.69 5.86 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 124.367 2.032 . . . . 0.0 111.079 178.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.719 HG22 ' HG2' ' A' ' 24' ' ' PRO . 25.9 p -112.71 150.53 31.4 Favored 'General case' 0 C--N 1.309 -1.165 0 O-C-N 119.27 -2.144 . . . . 0.0 107.233 -174.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -39.94 -51.13 3.4 Favored Glycine 0 C--N 1.335 0.474 0 O-C-N 124.404 1.065 . . . . 0.0 112.495 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.7 t -69.23 -78.09 0.07 Allowed 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 118.988 -0.53 . . . . 0.0 111.224 173.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.4 p -179.0 -63.75 0.01 OUTLIER 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 123.491 0.717 . . . . 0.0 110.202 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.588 ' CE2' ' CE1' ' A' ' 36' ' ' HIS . 65.6 m-85 -58.67 147.13 71.98 Favored Pre-proline 0 N--CA 1.426 -1.662 0 C-N-CA 124.708 1.203 . . . . 0.0 112.962 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.831 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 20.7 Cg_endo -74.77 151.37 96.86 Favored 'Cis proline' 0 N--CA 1.45 -1.081 0 C-N-CA 123.088 -1.63 . . . . 0.0 110.734 -0.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.614 ' C ' HD23 ' A' ' 81' ' ' LEU . 0.5 OUTLIER -129.39 166.38 19.66 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-O 117.474 -1.25 . . . . 0.0 110.347 -179.554 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.961 ' CH2' HG22 ' A' ' 39' ' ' THR . 16.7 t90 -64.02 144.41 57.11 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 124.329 1.018 . . . . 0.0 108.586 178.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.554 ' CE1' ' CD1' ' A' ' 121' ' ' ILE . 16.3 t80 -117.4 82.51 1.83 Allowed 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 -174.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.961 HG22 ' CH2' ' A' ' 37' ' ' TRP . 73.1 p -40.38 -33.08 0.22 Allowed 'General case' 0 C--O 1.211 -0.948 0 C-N-CA 124.537 1.135 . . . . 0.0 110.459 174.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.485 ' HB2' ' CE2' ' A' ' 38' ' ' PHE . 46.3 t30 60.18 16.33 5.97 Favored 'General case' 0 C--O 1.214 -0.784 0 CA-C-O 122.877 1.323 . . . . 0.0 109.374 177.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.434 ' O ' ' HD3' ' A' ' 52' ' ' ARG . . . 112.89 -38.39 3.25 Favored Glycine 0 N--CA 1.427 -1.905 0 O-C-N 119.469 -2.019 . . . . 0.0 113.367 -172.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.7 ' HA ' HD23 ' A' ' 48' ' ' LEU . 66.0 m-85 -50.64 170.53 0.03 OUTLIER 'General case' 0 C--O 1.231 0.081 0 CA-C-N 118.664 1.232 . . . . 0.0 111.695 178.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.44 -40.53 9.86 Favored 'General case' 0 C--N 1.32 -0.693 0 O-C-N 121.598 -0.689 . . . . 0.0 110.002 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.576 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -177.09 -53.31 0.06 OUTLIER Glycine 0 C--N 1.336 0.547 0 C-N-CA 123.855 0.74 . . . . 0.0 111.9 -178.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.76 -96.29 0.07 Allowed 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 -179.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.445 ' HA2' ' CD2' ' A' ' 42' ' ' TYR . . . -141.6 12.7 2.7 Favored Glycine 0 N--CA 1.438 -1.226 0 C-N-CA 125.306 1.432 . . . . 0.0 111.065 -176.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.2 pttt -112.06 146.41 38.0 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 117.991 -1.004 . . . . 0.0 108.804 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.7 HD23 ' HA ' ' A' ' 42' ' ' TYR . 0.4 OUTLIER -111.06 159.01 34.23 Favored Pre-proline 0 C--N 1.323 -0.555 0 O-C-N 124.624 1.203 . . . . 0.0 108.676 -178.473 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -74.48 157.37 44.99 Favored 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 121.857 1.704 . . . . 0.0 109.925 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.2 ttpt -54.89 101.12 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.99 0.516 . . . . 0.0 109.859 177.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.77 88.4 1.77 Allowed Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 116.495 -0.321 . . . . 0.0 112.535 -176.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.434 ' HD3' ' O ' ' A' ' 41' ' ' GLY . 0.9 OUTLIER -169.97 161.28 8.74 Favored 'General case' 0 CA--C 1.513 -0.475 0 C-N-CA 123.415 0.686 . . . . 0.0 110.506 175.683 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.0 m -147.69 113.57 4.01 Favored Pre-proline 0 N--CA 1.447 -0.616 0 O-C-N 124.485 1.115 . . . . 0.0 110.412 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -72.28 166.92 28.32 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 122.621 2.214 . . . . 0.0 111.344 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.401 ' O ' ' CE1' ' A' ' 57' ' ' PHE . 6.0 mt -81.6 129.87 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 -178.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.71 136.93 35.49 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 177.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.528 ' CE2' HD13 ' A' ' 133' ' ' LEU . 3.0 m-85 -125.93 -53.87 1.52 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 -177.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 120.37 -5.51 11.98 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 123.852 0.739 . . . . 0.0 112.602 -176.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.409 ' CB ' ' HB3' ' A' ' 62' ' ' CYS . 0.2 OUTLIER -65.75 177.5 1.25 Allowed 'General case' 0 C--O 1.207 -1.165 0 CA-C-N 118.251 1.026 . . . . 0.0 111.355 176.157 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.48 -45.13 4.73 Favored 'General case' 0 C--O 1.212 -0.885 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.55 -40.17 23.53 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.57 ' HA ' HD11 ' A' ' 80' ' ' LEU . 0.9 OUTLIER -71.43 -20.14 62.15 Favored 'General case' 0 C--N 1.342 0.253 0 O-C-N 123.871 0.732 . . . . 0.0 110.824 177.826 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -85.79 -42.24 14.36 Favored 'General case' 0 CA--C 1.509 -0.599 0 O-C-N 124.225 0.953 . . . . 0.0 112.196 174.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.75 165.38 0.46 Allowed Pre-proline 0 N--CA 1.44 -0.951 0 CA-C-O 121.437 0.637 . . . . 0.0 111.542 -179.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -71.82 139.16 32.95 Favored 'Trans proline' 0 N--CA 1.437 -1.8 0 N-CA-C 114.807 1.041 . . . . 0.0 114.807 173.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.44 ' HD2' ' CE2' ' A' ' 42' ' ' TYR . 18.5 Cg_endo -70.51 174.28 10.39 Favored 'Trans proline' 0 N--CA 1.446 -1.286 0 C-N-CA 122.846 2.364 . . . . 0.0 111.09 178.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.4 mmtp -140.03 58.86 1.58 Allowed 'General case' 0 C--O 1.199 -1.569 0 CA-C-O 116.597 -1.668 . . . . 0.0 109.28 177.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.407 ' CE1' ' O ' ' A' ' 69' ' ' SER . 58.4 t-80 -75.4 164.02 26.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 119.534 1.061 . . . . 0.0 110.594 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.407 ' O ' ' CE1' ' A' ' 68' ' ' HIS . 0.3 OUTLIER -149.38 -168.66 3.17 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 123.574 0.75 . . . . 0.0 111.402 177.997 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.14 71.22 10.6 Favored 'General case' 0 C--O 1.216 -0.706 0 O-C-N 120.268 -1.52 . . . . 0.0 111.745 176.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -177.18 -42.4 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.418 ' O ' ' CE2' ' A' ' 79' ' ' TYR . . . 124.51 -46.69 1.07 Allowed Glycine 0 CA--C 1.487 -1.703 0 CA-C-O 117.757 -1.58 . . . . 0.0 112.469 -176.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -150.11 81.89 1.37 Allowed 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 177.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -61.42 -122.59 0.01 OUTLIER Glycine 0 C--O 1.219 -0.812 0 CA-C-O 121.197 0.332 . . . . 0.0 112.476 177.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.2 mttt -52.45 -89.34 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 O-C-N 120.411 -1.641 . . . . 0.0 112.086 178.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.561 HG23 ' O ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -119.62 17.01 12.85 Favored 'General case' 0 CA--C 1.508 -0.659 0 O-C-N 120.929 -1.107 . . . . 0.0 111.017 178.143 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.464 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 5.0 m-20 -27.05 105.08 0.02 OUTLIER 'General case' 0 C--O 1.203 -1.36 0 C-N-CA 125.44 1.496 . . . . 0.0 110.692 -177.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.585 ' CD2' ' H ' ' A' ' 78' ' ' HIS . 2.5 p80 -87.21 11.2 14.7 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 121.146 -0.971 . . . . 0.0 110.255 -176.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.996 ' CZ ' HD11 ' A' ' 81' ' ' LEU . 0.5 OUTLIER -33.96 132.95 0.22 Allowed 'General case' 0 N--CA 1.435 -1.206 0 C-N-CA 125.353 1.461 . . . . 0.0 113.205 172.37 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.662 HD22 ' CG2' ' A' ' 109' ' ' ILE . 0.2 OUTLIER -75.19 151.98 38.44 Favored 'General case' 0 C--O 1.218 -0.587 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.883 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.996 HD11 ' CZ ' ' A' ' 79' ' ' TYR . 1.4 mp -135.87 139.94 43.75 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-N 119.081 0.855 . . . . 0.0 109.155 176.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.452 ' HB2' HD11 ' A' ' 109' ' ' ILE . 1.8 pm0 -106.32 151.73 24.47 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-O 121.897 0.856 . . . . 0.0 110.793 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.424 ' CZ ' ' HB2' ' A' ' 23' ' ' ALA . 55.4 t80 -140.1 130.61 14.0 Favored Pre-proline 0 N--CA 1.449 -0.506 0 O-C-N 121.727 -0.608 . . . . 0.0 111.979 -179.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.455 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 18.6 Cg_endo -72.34 108.88 2.61 Favored 'Trans proline' 0 N--CA 1.446 -1.272 0 C-N-CA 123.674 2.916 . . . . 0.0 110.632 -178.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.93 109.27 21.16 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.74 0.816 . . . . 0.0 109.752 -179.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -81.1 160.7 65.13 Favored Pre-proline 0 N--CA 1.446 -0.662 0 O-C-N 121.598 -0.689 . . . . 0.0 112.433 178.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -77.21 -41.66 0.34 Allowed 'Trans proline' 0 CA--C 1.494 -1.507 0 C-N-CA 122.395 2.063 . . . . 0.0 112.256 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -45.57 -30.61 1.53 Allowed 'General case' 0 C--N 1.35 0.622 0 O-C-N 125.275 1.609 . . . . 0.0 110.282 177.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.34 -4.9 85.87 Favored Glycine 0 N--CA 1.432 -1.573 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 176.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 4.3 p-80 -60.55 129.64 42.6 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -64.19 89.72 0.06 Allowed 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 177.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.493 ' CD2' ' HB3' ' A' ' 94' ' ' PHE . 6.2 t80 -36.41 142.91 0.08 Allowed 'General case' 0 C--O 1.211 -0.959 0 C-N-CA 124.041 0.937 . . . . 0.0 110.507 -178.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.06 58.07 1.47 Allowed 'General case' 0 C--N 1.313 -0.996 0 O-C-N 119.766 -1.834 . . . . 0.0 110.738 175.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.493 ' HB3' ' CD2' ' A' ' 92' ' ' TYR . 28.8 p90 -74.03 -14.88 61.08 Favored 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 123.524 0.73 . . . . 0.0 111.954 176.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.86 -33.63 17.28 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 124.584 1.154 . . . . 0.0 110.794 178.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 32.2 m -85.96 109.89 19.08 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -178.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.5 ptpt -58.17 -49.68 76.16 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 178.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 99' ' ' PRO . 0.7 OUTLIER -140.7 126.81 11.6 Favored Pre-proline 0 N--CA 1.43 -1.459 0 C-N-CA 124.416 1.086 . . . . 0.0 110.329 -175.939 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' A' ' 98' ' ' LYS . 24.6 Cg_endo -71.95 175.98 40.44 Favored 'Cis proline' 0 C--N 1.35 0.606 0 O-C-N 124.909 2.005 . . . . 0.0 110.999 -2.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.2 tttp -141.09 130.23 23.42 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.773 0.829 . . . . 0.0 109.469 178.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -82.92 148.77 27.46 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.135 0.897 . . . . 0.0 110.372 176.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -43.86 137.94 3.31 Favored Pre-proline 0 N--CA 1.437 -1.116 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.021 173.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -73.18 -166.46 0.3 Allowed 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 122.449 2.1 . . . . 0.0 110.541 178.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -131.45 160.03 23.32 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-O 119.295 -0.725 . . . . 0.0 112.381 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -76.25 -65.84 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.778 2.319 . . . . 0.0 110.551 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.581 ' HA ' ' HB2' ' A' ' 122' ' ' ALA . . . -59.86 137.18 58.13 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 123.702 0.626 . . . . 0.0 110.996 177.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 5.1 mtm-85 -141.43 149.4 40.96 Favored 'General case' 0 CA--C 1.505 -0.767 0 O-C-N 124.211 0.944 . . . . 0.0 110.717 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.425 HG23 ' HD1' ' A' ' 117' ' ' PHE . 2.7 p -88.46 117.01 31.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.135 0.897 . . . . 0.0 111.862 178.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.714 HG12 HD13 ' A' ' 121' ' ' ILE . 1.2 mp -104.3 125.01 59.13 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.984 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 -171.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.621 ' C ' HD23 ' A' ' 80' ' ' LEU . 14.5 p90 -146.17 160.56 41.79 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.05 -178.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.0 p -93.86 166.0 12.4 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.867 -177.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.56 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -112.96 153.44 45.25 Favored Pre-proline 0 N--CA 1.44 -0.951 0 C-N-CA 122.478 0.311 . . . . 0.0 110.706 179.962 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.56 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 16.5 Cg_endo -74.46 -51.59 0.16 OUTLIER 'Cis proline' 0 CA--C 1.499 -1.253 0 C-N-CA 123.487 -1.464 . . . . 0.0 109.71 -5.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -45.44 111.99 0.4 Allowed 'General case' 0 CA--C 1.502 -0.901 0 CA-C-O 115.861 -2.019 . . . . 0.0 109.132 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.818 ' HE2' HD13 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -64.87 74.81 0.04 OUTLIER 'General case' 0 CA--C 1.51 -0.593 0 O-C-N 125.787 1.929 . . . . 0.0 108.476 -178.383 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.502 ' O ' HG12 ' A' ' 116' ' ' VAL . 9.5 t -73.45 72.16 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 105.696 -1.964 . . . . 0.0 105.696 -177.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.473 ' CZ ' ' NE2' ' A' ' 13' ' ' GLN . 17.2 t80 -46.93 107.98 0.13 Allowed 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 124.67 1.188 . . . . 0.0 108.881 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . 0.419 ' SG ' ' CG ' ' A' ' 57' ' ' PHE . 0.1 OUTLIER -83.75 -56.41 3.72 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 -179.853 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.428 ' HA2' ' CH2' ' A' ' 4' ' ' TRP . . . -178.8 -145.09 5.97 Favored Glycine 0 N--CA 1.436 -1.357 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.451 HG13 ' CG ' ' A' ' 4' ' ' TRP . 1.2 mm -127.59 145.49 34.87 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.202 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 -175.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.714 HD13 HG12 ' A' ' 109' ' ' ILE . 3.1 pt -131.12 156.86 43.08 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.903 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.736 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . . . . . . . . 0 C--N 1.325 -0.473 0 CA-C-O 121.781 0.8 . . . . 0.0 109.611 177.143 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.514 -0.44 0 N-CA-C 109.725 -0.472 . . . . 0.0 109.725 . . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.528 HD13 ' CE2' ' A' ' 57' ' ' PHE . 12.3 tp -82.94 136.0 34.71 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 83.7 m -63.43 -175.68 0.13 Allowed 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 124.082 0.953 . . . . 0.0 109.599 175.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 59.3 m -161.55 119.29 2.28 Favored 'General case' 0 CA--C 1.488 -1.427 0 N-CA-C 104.319 -2.474 . . . . 0.0 104.319 -177.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.545 ' HB3' HG22 ' A' ' 2' ' ' VAL . 3.2 m80 . . . . . 0 CA--C 1.558 1.254 0 CA-C-O 114.733 -2.556 . . . . 0.0 115.822 177.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.1 p . . . . . 0 N--CA 1.465 0.278 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.583 HG22 ' H ' ' A' ' 11' ' ' TYR . 23.9 m -89.13 115.41 26.64 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 123.767 0.827 . . . . 0.0 109.625 -178.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . 0.47 ' CG ' HG13 ' A' ' 120' ' ' ILE . 23.7 m95 -77.71 142.06 38.98 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -133.86 138.76 45.8 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -178.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.662 ' SG ' ' HB3' ' A' ' 122' ' ' ALA . 0.1 OUTLIER -129.59 49.98 2.21 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.868 0.842 . . . . 0.0 111.099 176.865 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 143.06 -99.45 0.23 Allowed Glycine 0 C--O 1.22 -0.778 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -129.32 5.38 6.32 Favored Glycine 0 N--CA 1.466 0.679 0 C-N-CA 123.676 0.655 . . . . 0.0 112.704 177.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.499 HD12 ' OH ' ' A' ' 11' ' ' TYR . 0.3 OUTLIER -112.72 138.79 49.02 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 -175.69 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.5 mp -95.62 160.83 14.31 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 123.981 0.801 . . . . 0.0 109.468 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.583 ' H ' HG22 ' A' ' 3' ' ' THR . 65.9 m-85 -152.37 94.87 1.97 Allowed 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 122.182 0.992 . . . . 0.0 109.564 -173.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.27 120.63 7.91 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-O 117.427 -1.273 . . . . 0.0 108.038 -178.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.402 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 6.7 tp-100 -50.05 -43.24 50.96 Favored 'General case' 0 C--O 1.205 -1.266 0 O-C-N 124.655 1.222 . . . . 0.0 112.032 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -47.98 -48.84 32.16 Favored 'General case' 0 C--O 1.193 -1.897 0 CA-C-O 118.97 -0.538 . . . . 0.0 112.257 174.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.31 -38.13 84.45 Favored 'General case' 0 C--O 1.206 -1.214 0 CA-C-N 119.99 1.268 . . . . 0.0 114.2 168.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.549 ' O ' HG11 ' A' ' 108' ' ' VAL . . . -49.96 -43.88 50.35 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 121.599 1.999 . . . . 0.0 114.455 170.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -88.59 -39.89 13.76 Favored 'General case' 0 C--O 1.206 -1.218 0 O-C-N 120.916 -1.115 . . . . 0.0 109.668 176.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 36.5 t -73.38 -60.2 2.36 Favored 'General case' 0 C--O 1.211 -0.942 0 C-N-CA 126.571 1.948 . . . . 0.0 109.896 -176.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.489 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 4.6 t-20 -40.26 -38.5 0.79 Allowed 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 120.268 1.394 . . . . 0.0 113.357 169.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.634 ' HB3' HG11 ' A' ' 108' ' ' VAL . 0.1 OUTLIER -81.81 -30.77 32.07 Favored 'General case' 0 C--O 1.217 -0.656 0 N-CA-C 116.11 1.892 . . . . 0.0 116.11 173.108 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 3.6 m170 -50.08 -35.35 25.03 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 125.733 1.613 . . . . 0.0 109.298 177.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.489 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.1 OUTLIER -73.9 -42.8 60.13 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 117.822 -1.085 . . . . 0.0 111.926 176.792 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.841 ' HB1' ' HG3' ' A' ' 35' ' ' PRO . . . -36.24 129.72 0.65 Allowed Pre-proline 0 N--CA 1.44 -0.974 0 O-C-N 125.233 1.583 . . . . 0.0 113.069 172.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.873 ' HG2' HG22 ' A' ' 30' ' ' THR . 17.4 Cg_endo -72.89 123.98 9.32 Favored 'Trans proline' 0 N--CA 1.444 -1.418 0 C-N-CA 122.053 1.835 . . . . 0.0 108.802 -176.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.489 ' HA ' HD12 ' A' ' 25' ' ' LEU . 2.1 tp -62.03 91.11 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.262 1.025 . . . . 0.0 110.668 178.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 179.78 157.8 0.67 Allowed 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 123.435 0.694 . . . . 0.0 109.427 -175.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.416 ' OD1' ' N ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -98.96 89.45 4.29 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 104.621 -2.362 . . . . 0.0 104.621 -164.281 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 63.2 75.48 0.34 Allowed Glycine 0 CA--C 1.529 0.943 0 C-N-CA 119.489 -1.338 . . . . 0.0 111.957 -176.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.8 ttpt -138.19 28.79 2.52 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 123.661 1.696 . . . . 0.0 111.825 176.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.873 HG22 ' HG2' ' A' ' 24' ' ' PRO . 7.7 p -118.39 146.76 44.17 Favored 'General case' 0 CA--C 1.492 -1.271 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 -172.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -42.43 -53.94 4.89 Favored Glycine 0 N--CA 1.452 -0.242 0 O-C-N 123.827 0.705 . . . . 0.0 111.561 -179.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.2 t -64.15 -62.43 1.62 Allowed 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 116.533 -1.698 . . . . 0.0 112.378 174.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 162.1 -59.11 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.475 0 C-N-CA 127.91 2.484 . . . . 0.0 111.396 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.577 ' CE1' ' CE1' ' A' ' 36' ' ' HIS . 70.8 m-85 -59.77 141.14 89.33 Favored Pre-proline 0 N--CA 1.446 -0.674 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 178.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.841 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 36.7 Cg_endo -77.4 167.23 79.88 Favored 'Cis proline' 0 N--CA 1.436 -1.902 0 C-N-CA 121.833 -2.153 . . . . 0.0 112.721 3.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.577 ' CE1' ' CE1' ' A' ' 34' ' ' TYR . 2.5 p-80 -137.61 174.4 10.63 Favored 'General case' 0 C--O 1.205 -1.241 0 O-C-N 120.629 -1.294 . . . . 0.0 111.86 178.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.93 ' CH2' HG22 ' A' ' 39' ' ' THR . 14.1 t90 -75.84 132.14 40.17 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 119.864 1.211 . . . . 0.0 110.726 173.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -97.52 89.56 4.72 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 105.148 -2.167 . . . . 0.0 105.148 -179.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.93 HG22 ' CH2' ' A' ' 37' ' ' TRP . 17.1 p -38.81 -36.01 0.24 Allowed 'General case' 0 C--O 1.203 -1.38 0 CA-C-O 117.733 -1.127 . . . . 0.0 110.286 169.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 50.4 t30 55.95 22.25 5.61 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 121.189 1.813 . . . . 0.0 109.973 176.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.559 ' HA3' HD23 ' A' ' 48' ' ' LEU . . . 101.37 -39.76 2.64 Favored Glycine 0 N--CA 1.425 -2.052 0 CA-C-O 116.726 -2.152 . . . . 0.0 116.587 -168.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.479 ' CE2' ' HD3' ' A' ' 66' ' ' PRO . 80.5 m-85 -46.58 152.65 0.44 Allowed 'General case' 0 C--O 1.233 0.202 0 C-N-CA 126.456 1.902 . . . . 0.0 110.695 177.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.82 -38.35 25.65 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.728 178.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.574 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -172.29 -59.07 0.04 OUTLIER Glycine 0 C--N 1.335 0.489 0 C-N-CA 124.689 1.138 . . . . 0.0 111.011 -178.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -125.16 -64.77 1.06 Allowed 'General case' 0 CA--C 1.507 -0.69 0 O-C-N 122.641 -0.329 . . . . 0.0 110.514 -176.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.99 -175.81 0.22 Allowed Glycine 0 C--N 1.342 0.872 0 C-N-CA 124.761 1.172 . . . . 0.0 110.988 178.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.54 -165.72 0.0 OUTLIER 'General case' 0 CA--C 1.551 0.987 0 CA-C-O 124.61 2.148 . . . . 0.0 112.623 175.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.723 ' H ' HD12 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -96.35 169.02 9.54 Favored Pre-proline 0 C--N 1.306 -1.286 0 O-C-N 119.829 -1.794 . . . . 0.0 110.889 -179.96 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -71.87 157.67 54.48 Favored 'Trans proline' 0 N--CA 1.441 -1.582 0 C-N-CA 121.888 1.725 . . . . 0.0 110.69 178.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.0 tttt -63.76 97.88 0.17 Allowed 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.713 -0.617 . . . . 0.0 110.205 176.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 123.62 40.0 0.48 Allowed Glycine 0 CA--C 1.52 0.351 0 N-CA-C 112.015 -0.434 . . . . 0.0 112.015 -176.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.443 ' HD3' ' HA2' ' A' ' 41' ' ' GLY . 0.0 OUTLIER -132.96 161.35 34.54 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-N 117.325 0.562 . . . . 0.0 111.495 176.85 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.9 m -140.48 102.85 6.55 Favored Pre-proline 0 C--N 1.324 -0.527 0 O-C-N 124.045 0.841 . . . . 0.0 109.61 -178.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -72.08 175.78 9.37 Favored 'Trans proline' 0 N--CA 1.448 -1.183 0 C-N-CA 122.504 2.136 . . . . 0.0 111.418 178.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.8 mt -98.35 130.52 47.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 -178.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.34 135.37 33.72 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 177.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.508 ' CD1' ' HB3' ' A' ' 118' ' ' CYS . 17.3 m-85 -118.83 -45.37 2.59 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 124.078 0.951 . . . . 0.0 110.142 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 121.03 -2.31 11.68 Favored Glycine 0 C--O 1.222 -0.642 0 C-N-CA 123.885 0.755 . . . . 0.0 112.59 -175.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 18.0 mttm -105.33 137.82 42.51 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 118.222 1.011 . . . . 0.0 109.373 177.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.2 t -73.26 -4.64 34.41 Favored 'General case' 0 C--O 1.217 -0.642 0 O-C-N 125.182 1.551 . . . . 0.0 111.504 176.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -89.0 -50.59 6.08 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 124.654 1.182 . . . . 0.0 109.745 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 10.1 m -71.52 -22.55 61.76 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.46 0.648 . . . . 0.0 111.564 175.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -79.75 -35.87 38.14 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-O 118.892 -0.575 . . . . 0.0 111.143 174.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -52.35 160.79 1.19 Allowed Pre-proline 0 CA--C 1.539 0.542 0 CA-C-O 122.084 0.945 . . . . 0.0 111.67 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -71.94 144.14 42.39 Favored 'Trans proline' 0 N--CA 1.443 -1.492 0 C-N-CA 120.461 0.774 . . . . 0.0 113.573 175.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.479 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 19.8 Cg_endo -72.74 169.12 22.75 Favored 'Trans proline' 0 N--CA 1.444 -1.433 0 C-N-CA 124.151 3.234 . . . . 0.0 111.056 178.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.4 tptp -128.47 51.92 1.96 Allowed 'General case' 0 C--O 1.197 -1.675 0 CA-C-O 114.987 -2.435 . . . . 0.0 107.216 -179.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.42 ' CD2' ' O ' ' A' ' 72' ' ' GLY . 57.1 t-80 -74.79 144.56 43.49 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 121.212 1.824 . . . . 0.0 113.897 175.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.06 -91.17 0.5 Allowed 'General case' 0 N--CA 1.469 0.496 0 O-C-N 119.207 -2.183 . . . . 0.0 109.607 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.95 -174.94 0.38 Allowed 'General case' 0 C--O 1.215 -0.733 0 C-N-CA 123.713 0.805 . . . . 0.0 111.123 178.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -50.31 -27.02 5.47 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 173.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.42 ' O ' ' CD2' ' A' ' 68' ' ' HIS . . . -104.22 -118.54 4.49 Favored Glycine 0 C--O 1.214 -1.139 0 N-CA-C 106.583 -2.607 . . . . 0.0 106.583 178.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -121.75 -100.0 0.43 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 100.413 -3.921 . . . . 0.0 100.413 -167.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 144.75 -131.99 4.55 Favored Glycine 0 N--CA 1.439 -1.134 0 CA-C-N 115.232 -0.894 . . . . 0.0 113.32 -167.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.2 mttm -63.01 -104.41 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 122.049 0.928 . . . . 0.0 112.673 175.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.534 HG23 ' O ' ' A' ' 76' ' ' THR . 0.6 OUTLIER -101.39 21.2 14.54 Favored 'General case' 0 CA--C 1.514 -0.423 0 O-C-N 120.785 -1.197 . . . . 0.0 111.588 -179.685 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.455 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 1.1 m-20 -33.25 105.06 0.03 OUTLIER 'General case' 0 CA--C 1.49 -1.343 0 C-N-CA 126.181 1.792 . . . . 0.0 109.924 -176.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -83.8 16.44 2.76 Favored 'General case' 0 C--N 1.319 -0.74 0 O-C-N 120.683 -1.261 . . . . 0.0 110.5 -176.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.487 ' CE2' ' HB2' ' A' ' 81' ' ' LEU . 10.8 p90 -41.27 136.28 1.7 Allowed 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 125.607 1.563 . . . . 0.0 110.963 177.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.446 HD21 HG22 ' A' ' 111' ' ' THR . 0.3 OUTLIER -77.02 136.27 38.69 Favored 'General case' 0 C--O 1.215 -0.728 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.08 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.578 HD21 ' HB2' ' A' ' 35' ' ' PRO . 0.5 OUTLIER -128.84 151.91 49.09 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.85 0.834 . . . . 0.0 109.1 175.442 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -121.81 163.33 19.34 Favored 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 124.242 1.017 . . . . 0.0 112.193 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.602 ' CE1' ' HB2' ' A' ' 23' ' ' ALA . 80.1 t80 -148.21 129.04 6.97 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -177.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.5 ' HD3' ' CD1' ' A' ' 34' ' ' TYR . 17.8 Cg_endo -72.0 109.61 2.73 Favored 'Trans proline' 0 N--CA 1.443 -1.477 0 C-N-CA 123.381 2.721 . . . . 0.0 110.887 -176.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.469 HG21 ' HA ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -107.25 107.31 18.18 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-N 114.662 -1.154 . . . . 0.0 109.65 -178.062 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -80.01 160.17 69.23 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 177.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -76.4 -38.66 0.98 Allowed 'Trans proline' 0 CA--C 1.493 -1.564 0 C-N-CA 122.092 1.861 . . . . 0.0 112.896 178.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -44.67 -30.43 0.93 Allowed 'General case' 0 N--CA 1.474 0.766 0 O-C-N 125.644 1.84 . . . . 0.0 110.92 176.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.74 6.61 86.94 Favored Glycine 0 N--CA 1.437 -1.281 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 176.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -72.74 136.08 45.44 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -68.18 85.31 0.25 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 175.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.494 ' CD2' ' HB3' ' A' ' 94' ' ' PHE . 6.7 t80 -37.29 144.25 0.08 Allowed 'General case' 0 C--O 1.214 -0.769 0 C-N-CA 123.95 0.9 . . . . 0.0 110.659 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.3 55.91 0.8 Allowed 'General case' 0 C--N 1.313 -0.986 0 O-C-N 119.781 -1.825 . . . . 0.0 110.936 174.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.494 ' HB3' ' CD2' ' A' ' 92' ' ' TYR . 34.1 p90 -71.35 -24.17 62.04 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 124.099 0.959 . . . . 0.0 111.025 175.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -86.11 -27.66 24.52 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 123.973 0.909 . . . . 0.0 110.401 178.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -88.9 111.57 22.25 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -178.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.3 pttt -58.04 -49.75 75.81 Favored 'General case' 0 CA--C 1.511 -0.522 0 O-C-N 121.648 -0.658 . . . . 0.0 111.003 177.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 99' ' ' PRO . 2.3 mtmm -138.07 126.08 14.03 Favored Pre-proline 0 N--CA 1.436 -1.155 0 CA-C-N 114.364 -1.289 . . . . 0.0 109.946 -175.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.409 ' HA ' ' HA ' ' A' ' 98' ' ' LYS . 22.9 Cg_endo -69.55 176.65 31.16 Favored 'Cis proline' 0 N--CA 1.459 -0.558 0 O-C-N 124.35 1.71 . . . . 0.0 110.949 -3.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.99 123.16 16.84 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 124.845 1.258 . . . . 0.0 109.484 177.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.49 -179.37 7.14 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 125.309 1.63 . . . . 0.0 110.378 178.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -46.64 153.14 0.81 Allowed Pre-proline 0 CA--C 1.541 0.622 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.937 176.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.49 -70.62 0.02 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.576 0 C-N-CA 121.998 1.799 . . . . 0.0 110.626 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 125.14 129.42 3.36 Favored Glycine 0 CA--C 1.533 1.178 0 CA-C-N 118.885 0.766 . . . . 0.0 111.214 -178.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.93 -69.56 0.02 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 122.924 2.416 . . . . 0.0 110.477 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.505 ' CB ' ' CE2' ' A' ' 11' ' ' TYR . . . -66.94 132.87 48.85 Favored 'General case' 0 CA--C 1.512 -0.491 0 O-C-N 123.18 0.3 . . . . 0.0 110.732 179.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.446 ' HG2' ' HA ' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -139.76 152.15 46.38 Favored 'General case' 0 CA--C 1.497 -1.082 0 CA-C-O 117.719 -1.134 . . . . 0.0 110.737 -178.237 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.634 HG11 ' HB3' ' A' ' 20' ' ' SER . 3.3 p -87.32 114.17 25.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 O-C-N 124.153 0.908 . . . . 0.0 111.673 178.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.641 HG12 HD13 ' A' ' 121' ' ' ILE . 1.4 mp -98.7 118.07 44.69 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.236 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 -173.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.485 ' CD1' ' CG ' ' A' ' 115' ' ' LYS . 4.6 p90 -139.03 148.0 42.82 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-O 123.918 1.818 . . . . 0.0 108.616 -178.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.446 HG22 HD21 ' A' ' 80' ' ' LEU . 4.8 p -83.27 164.87 19.82 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.142 178.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.543 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -107.46 154.81 40.47 Favored Pre-proline 0 CA--C 1.55 0.959 0 CA-C-O 121.014 0.435 . . . . 0.0 111.072 178.495 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.543 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 15.9 Cg_endo -74.96 -53.29 0.16 OUTLIER 'Cis proline' 0 CA--C 1.498 -1.297 0 C-N-CA 124.158 -1.184 . . . . 0.0 110.071 -6.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.539 ' O ' HG23 ' A' ' 116' ' ' VAL . 32.7 t30 -45.82 111.39 0.35 Allowed 'General case' 0 CA--C 1.509 -0.605 0 CA-C-O 117.174 -1.393 . . . . 0.0 108.783 177.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.485 ' CG ' ' CD1' ' A' ' 110' ' ' TYR . 0.1 OUTLIER -65.79 79.52 0.07 Allowed 'General case' 0 CA--C 1.507 -0.691 0 C-N-CA 125.008 1.323 . . . . 0.0 109.102 -179.905 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 114' ' ' ASN . 80.9 t -76.54 75.72 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.763 0 N-CA-C 105.558 -2.015 . . . . 0.0 105.558 -173.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.402 ' CZ ' ' NE2' ' A' ' 13' ' ' GLN . 57.3 t80 -37.68 101.92 0.02 OUTLIER 'General case' 0 C--O 1.237 0.397 0 C-N-CA 127.723 2.409 . . . . 0.0 108.822 -175.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . 0.508 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 16.0 m -85.4 -43.16 13.88 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 -176.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 156.79 -146.94 14.65 Favored Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.47 HG13 ' CG ' ' A' ' 4' ' ' TRP . 1.4 mm -129.5 139.24 52.22 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.403 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 -174.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.641 HD13 HG12 ' A' ' 109' ' ' ILE . 4.3 pt -127.33 153.1 36.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 -177.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.662 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . . . . . . . . 0 C--N 1.323 -0.569 0 CA-C-O 122.007 0.908 . . . . 0.0 109.711 175.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 5.8 ptmt . . . . . 0 CA--C 1.506 -0.72 0 N-CA-C 109.261 -0.644 . . . . 0.0 109.261 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 11.9 tp -81.99 138.85 34.84 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.557 1.161 . . . . 0.0 108.199 178.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . 0.448 ' SG ' HG22 ' A' ' 120' ' ' ILE . 72.3 m -61.19 -176.57 0.07 Allowed 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 122.997 1.379 . . . . 0.0 111.133 174.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -158.69 112.88 2.46 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -178.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.255 1.354 0 CA-C-O 113.429 -3.177 . . . . 0.0 110.944 173.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.61 HG22 ' H ' ' A' ' 3' ' ' THR . 6.9 p . . . . . 0 CA--C 1.539 0.527 0 CA-C-O 122.556 1.169 . . . . 0.0 111.859 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.706 HG21 HD23 ' A' ' 10' ' ' LEU . 29.9 m -106.84 115.56 30.4 Favored 'General case' 0 C--N 1.315 -0.925 0 O-C-N 121.277 -0.889 . . . . 0.0 109.923 179.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . 0.681 ' CZ2' ' CD2' ' A' ' 136' ' ' HIS . 17.4 m95 -81.57 137.72 35.48 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -131.56 139.27 49.18 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -178.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.71 ' SG ' ' HB3' ' A' ' 122' ' ' ALA . 0.5 OUTLIER -125.48 65.86 1.16 Allowed 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 177.643 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 40.39 70.72 0.35 Allowed Glycine 0 CA--C 1.529 0.91 0 O-C-N 123.876 0.735 . . . . 0.0 112.335 -178.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 177.69 -79.84 0.07 OUTLIER Glycine 0 C--O 1.227 -0.293 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 -178.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 25.8 mt -135.81 164.34 28.13 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 178.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.706 HD23 HG21 ' A' ' 3' ' ' THR . 2.8 mp -83.41 139.87 32.72 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.194 179.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.446 ' CE2' ' CB ' ' A' ' 106' ' ' ALA . 78.5 m-85 -127.79 101.13 6.22 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 123.898 0.879 . . . . 0.0 109.643 -175.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -56.17 117.06 3.41 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-O 117.751 -1.119 . . . . 0.0 109.109 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.685 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 1.7 tp60 -43.67 -43.41 5.85 Favored 'General case' 0 C--O 1.221 -0.425 0 O-C-N 124.399 1.062 . . . . 0.0 111.533 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -48.77 -56.2 9.31 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 118.39 -0.814 . . . . 0.0 110.083 176.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.433 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 0.2 OUTLIER -53.45 -32.02 48.08 Favored 'General case' 0 C--O 1.204 -1.34 0 CA-C-O 117.147 -1.406 . . . . 0.0 111.395 174.45 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.685 ' HB3' ' O ' ' A' ' 13' ' ' GLN . . . -55.4 -75.36 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 120.665 1.575 . . . . 0.0 111.784 174.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.405 ' O ' ' CD2' ' A' ' 21' ' ' HIS . 2.5 pt-20 -61.98 -37.42 84.75 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-O 117.936 -1.03 . . . . 0.0 109.913 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 34.5 t -64.24 -65.26 0.7 Allowed 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 126.212 1.805 . . . . 0.0 109.798 -179.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.513 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 10.2 t-20 -43.28 -32.51 0.8 Allowed 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 123.459 0.704 . . . . 0.0 111.959 174.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.58 -41.43 27.18 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 175.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.405 ' CD2' ' O ' ' A' ' 17' ' ' GLU . 10.1 m170 -41.93 -39.78 1.96 Allowed 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 125.594 1.557 . . . . 0.0 109.662 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.513 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -73.09 -51.21 18.9 Favored 'General case' 0 N--CA 1.439 -1.007 0 O-C-N 124.418 1.074 . . . . 0.0 111.561 176.513 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.698 ' HB1' ' HG3' ' A' ' 35' ' ' PRO . . . -37.03 130.76 0.74 Allowed Pre-proline 0 N--CA 1.442 -0.836 0 O-C-N 125.28 1.612 . . . . 0.0 111.873 175.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.679 ' HG2' HG22 ' A' ' 30' ' ' THR . 15.5 Cg_endo -74.11 124.33 8.99 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 121.662 1.574 . . . . 0.0 109.159 -177.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.712 HD13 ' HE2' ' A' ' 115' ' ' LYS . 5.9 tp -59.39 91.93 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.947 178.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 178.47 159.57 0.55 Allowed 'General case' 0 N--CA 1.448 -0.565 0 O-C-N 124.264 0.977 . . . . 0.0 110.236 -176.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -101.95 131.05 48.58 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-O 118.238 -0.887 . . . . 0.0 109.972 178.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 41.88 71.77 0.33 Allowed Glycine 0 CA--C 1.522 0.491 0 O-C-N 124.912 1.382 . . . . 0.0 111.504 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.16 25.43 0.72 Allowed 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.413 0.625 . . . . 0.0 110.685 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.679 HG22 ' HG2' ' A' ' 24' ' ' PRO . 69.2 p -123.86 150.84 44.12 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-O 118.663 -0.684 . . . . 0.0 109.513 -178.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.432 ' HA3' ' O ' ' A' ' 95' ' ' ASP . . . -39.0 -58.14 1.93 Allowed Glycine 0 N--CA 1.45 -0.42 0 O-C-N 124.853 1.345 . . . . 0.0 112.034 -178.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.6 t -70.28 -71.66 0.23 Allowed 'General case' 0 N--CA 1.443 -0.805 0 CA-C-O 118.621 -0.704 . . . . 0.0 110.648 176.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 58.6 p 178.91 -60.48 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.277 0 O-C-N 124.6 1.188 . . . . 0.0 111.531 -178.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.541 ' CD1' ' HD3' ' A' ' 84' ' ' PRO . 50.8 m-85 -62.48 149.1 89.04 Favored Pre-proline 0 N--CA 1.428 -1.542 0 C-N-CA 123.729 0.812 . . . . 0.0 111.85 178.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.698 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 18.5 Cg_endo -75.39 164.08 89.01 Favored 'Cis proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.48 -1.883 . . . . 0.0 110.868 -1.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.431 ' CD2' ' CD1' ' A' ' 34' ' ' TYR . 0.6 OUTLIER -142.24 162.09 36.36 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.211 -178.3 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.93 ' CZ3' HG22 ' A' ' 39' ' ' THR . 21.5 t90 -61.58 132.01 51.92 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -104.07 78.01 1.48 Allowed 'General case' 0 N--CA 1.428 -1.569 0 C-N-CA 124.903 1.281 . . . . 0.0 108.157 -178.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.93 HG22 ' CZ3' ' A' ' 37' ' ' TRP . 78.7 p -37.42 -38.67 0.25 Allowed 'General case' 0 CA--C 1.509 -0.62 0 O-C-N 124.167 0.917 . . . . 0.0 110.455 177.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 44.6 t30 62.8 12.63 5.84 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 122.747 1.26 . . . . 0.0 108.748 178.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 114.59 -35.49 4.4 Favored Glycine 0 N--CA 1.429 -1.797 0 O-C-N 119.666 -1.896 . . . . 0.0 112.309 -174.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.658 ' N ' HD23 ' A' ' 48' ' ' LEU . 59.8 m-85 -50.48 162.27 0.25 Allowed 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 121.185 0.517 . . . . 0.0 111.807 178.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.21 -38.24 22.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.464 178.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.445 ' CA ' ' HB3' ' A' ' 68' ' ' HIS . . . 125.98 41.37 0.34 Allowed Glycine 0 N--CA 1.437 -1.251 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.634 -176.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -146.01 -70.07 0.26 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.16 -74.61 0.01 OUTLIER Glycine 0 N--CA 1.435 -1.408 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -177.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.8 pttt -98.29 178.57 5.02 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 118.257 1.029 . . . . 0.0 110.648 178.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.697 ' H ' HD12 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -106.03 163.72 16.47 Favored Pre-proline 0 N--CA 1.444 -0.74 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.569 -179.548 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.63 163.11 36.61 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 121.762 1.641 . . . . 0.0 110.624 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.71 97.34 0.05 Allowed 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 125.06 54.59 0.17 Allowed Glycine 0 N--CA 1.447 -0.633 0 O-C-N 121.436 -0.79 . . . . 0.0 111.668 -179.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -150.95 145.9 25.9 Favored 'General case' 0 N--CA 1.452 -0.335 0 O-C-N 124.127 0.545 . . . . 0.0 110.963 177.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.3 m -139.01 98.99 8.31 Favored Pre-proline 0 N--CA 1.45 -0.457 0 O-C-N 124.407 1.067 . . . . 0.0 109.861 -178.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.509 ' HG3' HD21 ' A' ' 48' ' ' LEU . 19.1 Cg_endo -73.56 166.93 28.56 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 121.626 1.55 . . . . 0.0 111.207 179.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.461 ' O ' ' CE2' ' A' ' 57' ' ' PHE . 5.6 mt -79.58 125.96 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -178.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.9 tppt? -81.69 155.71 25.42 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.125 0.488 . . . . 0.0 109.709 178.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.505 ' CD1' ' HB3' ' A' ' 118' ' ' CYS . 21.6 m-85 -139.01 -46.88 0.48 Allowed 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.233 178.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 119.44 -2.35 14.0 Favored Glycine 0 CA--C 1.522 0.491 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.178 -176.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.2 mmtt -96.07 141.86 28.96 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-O 117.625 -1.179 . . . . 0.0 109.774 178.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.43 -7.1 58.17 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 124.832 1.333 . . . . 0.0 110.721 177.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -90.9 -53.06 4.55 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 123.71 0.804 . . . . 0.0 109.135 -179.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.593 ' SG ' HD21 ' A' ' 80' ' ' LEU . 4.9 t -72.18 -16.02 61.96 Favored 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 124.103 0.877 . . . . 0.0 110.672 176.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -86.68 -37.79 17.63 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 123.57 0.544 . . . . 0.0 111.043 177.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.17 165.15 0.28 Allowed Pre-proline 0 N--CA 1.441 -0.912 0 CA-C-O 121.991 0.9 . . . . 0.0 111.237 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -72.6 124.59 9.91 Favored 'Trans proline' 0 N--CA 1.441 -1.607 0 C-N-CA 120.927 1.084 . . . . 0.0 113.076 175.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.45 ' HD3' ' CZ ' ' A' ' 42' ' ' TYR . 19.0 Cg_endo -74.26 167.39 27.28 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 122.881 2.387 . . . . 0.0 110.253 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -127.54 104.03 7.66 Favored 'General case' 0 C--O 1.213 -0.82 0 CA-C-O 115.957 -1.973 . . . . 0.0 107.68 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.621 ' CD2' ' CD2' ' A' ' 37' ' ' TRP . 19.2 t-80 -93.55 161.92 14.17 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.47 1.106 . . . . 0.0 110.341 176.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.405 ' HB2' ' OD2' ' A' ' 77' ' ' ASP . 0.3 OUTLIER -152.32 176.76 11.28 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.153 179.478 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.74 63.02 7.29 Favored 'General case' 0 C--O 1.224 -0.263 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.695 178.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -177.41 -39.0 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.885 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 122.59 -65.64 0.5 Allowed Glycine 0 N--CA 1.44 -1.056 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.515 -178.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -120.51 62.03 0.86 Allowed 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -56.13 -105.61 0.01 OUTLIER Glycine 0 CA--C 1.532 1.149 0 CA-C-O 123.362 1.534 . . . . 0.0 112.236 -178.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 16.1 mttp -70.76 -104.59 0.0 OUTLIER 'General case' 0 C--O 1.218 -0.556 0 O-C-N 120.07 -1.841 . . . . 0.0 110.285 178.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.581 HG23 ' O ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -109.21 16.62 22.33 Favored 'General case' 0 N--CA 1.447 -0.607 0 O-C-N 121.553 -0.717 . . . . 0.0 110.65 179.45 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.47 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 5.4 m-20 -29.73 102.25 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 123.838 0.855 . . . . 0.0 111.651 -179.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.57 ' CD2' ' H ' ' A' ' 78' ' ' HIS . 4.9 p80 -87.88 28.13 1.07 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -175.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 1.062 ' CE1' HD11 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -54.46 168.16 0.28 Allowed 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 174.897 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.699 HD23 ' O ' ' A' ' 110' ' ' TYR . 0.6 OUTLIER -98.26 158.05 15.8 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 118.477 -0.773 . . . . 0.0 109.758 176.947 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 1.062 HD11 ' CE1' ' A' ' 79' ' ' TYR . 1.4 mp -141.82 130.69 23.01 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 123.298 0.639 . . . . 0.0 109.511 178.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.471 ' CB ' ' CD1' ' A' ' 109' ' ' ILE . 0.4 OUTLIER -99.95 151.08 21.74 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 121.565 0.698 . . . . 0.0 110.995 179.138 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.598 ' CZ ' ' HB2' ' A' ' 23' ' ' ALA . 28.7 t80 -142.0 121.01 7.85 Favored Pre-proline 0 N--CA 1.444 -0.774 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.273 -178.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.541 ' HD3' ' CD1' ' A' ' 34' ' ' TYR . 19.4 Cg_endo -72.9 111.73 3.34 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 122.886 2.391 . . . . 0.0 110.193 -177.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.55 125.54 51.94 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.125 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.485 ' CD2' ' NE2' ' A' ' 90' ' ' HIS . 63.5 m-85 -82.89 155.74 67.71 Favored Pre-proline 0 N--CA 1.443 -0.822 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.012 178.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -77.64 -42.12 0.29 Allowed 'Trans proline' 0 CA--C 1.505 -0.931 0 C-N-CA 122.104 1.869 . . . . 0.0 111.898 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -43.25 -30.88 0.54 Allowed 'General case' 0 C--N 1.346 0.426 0 O-C-N 125.078 1.486 . . . . 0.0 110.293 177.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 99.87 -12.48 60.86 Favored Glycine 0 N--CA 1.436 -1.364 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 177.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.485 ' NE2' ' CD2' ' A' ' 86' ' ' PHE . 4.8 p-80 -58.38 128.77 38.83 Favored 'General case' 0 N--CA 1.44 -0.925 0 O-C-N 124.325 0.662 . . . . 0.0 109.449 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -68.95 101.47 1.39 Allowed 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.488 ' O ' ' CD2' ' A' ' 94' ' ' PHE . 6.5 t80 -34.26 138.38 0.09 Allowed 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 122.028 0.918 . . . . 0.0 111.463 178.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.407 ' HE2' ' O ' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -78.96 60.08 2.81 Favored 'General case' 0 N--CA 1.442 -0.852 0 O-C-N 120.081 -1.637 . . . . 0.0 109.953 177.75 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.488 ' CD2' ' O ' ' A' ' 92' ' ' TYR . 30.4 p90 -75.55 1.7 13.61 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 123.269 0.628 . . . . 0.0 112.084 177.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.432 ' O ' ' HA3' ' A' ' 31' ' ' GLY . 36.7 t0 -95.79 -38.8 10.16 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 122.394 1.092 . . . . 0.0 109.115 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -80.75 110.03 15.86 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 120.862 -1.149 . . . . 0.0 109.36 -178.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.8 pttt -57.86 -50.28 73.85 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.04 178.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.46 127.51 7.26 Favored Pre-proline 0 N--CA 1.431 -1.401 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.802 -176.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.407 ' O ' ' HE2' ' A' ' 93' ' ' LYS . 21.7 Cg_endo -73.05 178.04 34.09 Favored 'Cis proline' 0 N--CA 1.458 -0.596 0 O-C-N 125.093 2.102 . . . . 0.0 111.232 -2.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.0 132.39 25.11 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -72.67 145.02 47.53 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 124.244 0.965 . . . . 0.0 109.312 178.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -42.09 156.83 0.22 Allowed Pre-proline 0 N--CA 1.45 -0.448 0 O-C-N 123.74 0.65 . . . . 0.0 111.411 177.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -72.49 -163.13 0.14 Allowed 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 121.235 1.29 . . . . 0.0 111.142 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -139.85 154.33 23.73 Favored Glycine 0 N--CA 1.441 -0.988 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.04 178.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -75.52 -66.55 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.143 1.895 . . . . 0.0 110.131 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.563 ' HA ' ' HB2' ' A' ' 122' ' ' ALA . . . -69.19 135.75 51.07 Favored 'General case' 0 N--CA 1.443 -0.78 0 O-C-N 124.298 0.999 . . . . 0.0 110.907 178.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.425 ' HG2' ' HA ' ' A' ' 84' ' ' PRO . 4.3 mtt85 -141.47 146.02 35.94 Favored 'General case' 0 N--CA 1.448 -0.541 0 O-C-N 123.913 0.758 . . . . 0.0 110.716 -178.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.452 ' O ' HD13 ' A' ' 109' ' ' ILE . 7.7 p -83.6 128.89 38.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 O-C-N 123.736 0.648 . . . . 0.0 109.869 178.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.656 ' CG2' HD22 ' A' ' 80' ' ' LEU . 9.1 mm -107.9 142.83 19.58 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.861 0 CA-C-O 118.571 -0.728 . . . . 0.0 109.938 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.699 ' O ' HD23 ' A' ' 80' ' ' LEU . 12.4 p90 -167.15 155.45 9.67 Favored 'General case' 0 N--CA 1.442 -0.839 0 O-C-N 124.121 0.888 . . . . 0.0 111.14 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.0 p -91.83 164.71 13.59 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.476 -177.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.568 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -111.93 154.35 44.19 Favored Pre-proline 0 N--CA 1.442 -0.866 0 C-N-CA 122.45 0.3 . . . . 0.0 110.898 179.536 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.568 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 18.6 Cg_endo -74.52 -54.03 0.15 OUTLIER 'Cis proline' 0 CA--C 1.509 -0.748 0 C-N-CA 122.523 -1.865 . . . . 0.0 109.468 -4.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -42.92 111.49 0.27 Allowed 'General case' 0 CA--C 1.507 -0.692 0 CA-C-O 116.45 -1.738 . . . . 0.0 109.722 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.712 ' HE2' HD13 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -63.09 76.35 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.375 0 O-C-N 125.77 1.919 . . . . 0.0 109.123 -178.44 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.591 ' O ' HG12 ' A' ' 116' ' ' VAL . 8.8 t -77.01 71.25 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 -176.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.594 ' CZ ' ' HA2' ' A' ' 119' ' ' GLY . 27.9 t80 -35.63 110.6 0.11 Allowed 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 123.16 0.584 . . . . 0.0 111.132 178.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . 0.63 ' SG ' HD21 ' A' ' 80' ' ' LEU . 6.2 m -82.61 -45.5 14.49 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.594 ' HA2' ' CZ ' ' A' ' 117' ' ' PHE . . . 161.93 -145.05 10.32 Favored Glycine 0 N--CA 1.443 -0.87 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.511 HG13 ' CD2' ' A' ' 4' ' ' TRP . 1.1 mm -127.63 136.97 59.01 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.82 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 -176.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.721 HG22 HD12 ' A' ' 133' ' ' LEU . 9.2 pt -127.36 156.06 38.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -177.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.71 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . . . . . . . . 0 C--N 1.323 -0.558 0 CA-C-O 121.515 0.674 . . . . 0.0 109.82 178.053 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.51 -0.577 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.721 HD12 HG22 ' A' ' 121' ' ' ILE . 5.2 tp -88.12 143.23 27.18 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 124.562 1.164 . . . . 0.0 109.135 178.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . 0.47 ' SG ' HG22 ' A' ' 120' ' ' ILE . 76.0 m -62.04 -172.21 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 122.088 0.946 . . . . 0.0 109.707 177.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 19.5 m -133.04 92.46 3.03 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.469 -179.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.681 ' CD2' ' CZ2' ' A' ' 4' ' ' TRP . 2.1 p-80 . . . . . 0 C--O 1.25 1.097 0 CA-C-O 116.886 -1.531 . . . . 0.0 112.258 176.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.4 p . . . . . 0 N--CA 1.451 -0.39 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.2 m -89.52 109.05 20.02 Favored 'General case' 0 C--N 1.317 -0.818 0 O-C-N 121.488 -0.758 . . . . 0.0 109.553 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . 0.418 ' CG ' HG13 ' A' ' 120' ' ' ILE . 39.7 m95 -77.32 140.0 39.9 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 124.065 0.946 . . . . 0.0 110.54 178.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.6 m -124.57 120.24 31.37 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 122.093 0.949 . . . . 0.0 109.045 -176.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.555 ' HB3' ' HB3' ' A' ' 122' ' ' ALA . 74.9 m -103.87 64.56 0.79 Allowed 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 34.65 60.14 0.65 Allowed Glycine 0 C--N 1.341 0.806 0 C-N-CA 124.992 1.282 . . . . 0.0 113.007 178.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.599 ' C ' HD13 ' A' ' 9' ' ' LEU . . . 170.02 -80.97 0.09 OUTLIER Glycine 0 C--O 1.224 -0.491 0 N-CA-C 110.501 -1.039 . . . . 0.0 110.501 -175.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.707 HD23 ' OH ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -114.66 159.05 20.94 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.488 1.115 . . . . 0.0 108.787 -176.198 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.534 HD13 ' C ' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -110.74 125.33 53.4 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -172.019 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.707 ' OH ' HD23 ' A' ' 9' ' ' LEU . 89.5 m-85 -117.06 106.68 13.64 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 126.441 1.896 . . . . 0.0 108.537 -172.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -58.7 127.81 34.06 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.31 177.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.475 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 7.0 tp-100 -54.82 -44.49 73.9 Favored 'General case' 0 C--O 1.217 -0.626 0 O-C-N 121.373 -0.83 . . . . 0.0 112.773 178.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -51.71 -26.3 9.06 Favored 'General case' 0 C--O 1.213 -0.845 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 175.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.18 -41.66 15.43 Favored 'General case' 0 C--O 1.206 -1.217 0 CA-C-O 116.174 -1.87 . . . . 0.0 113.418 170.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.55 -62.91 1.35 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 121.705 2.048 . . . . 0.0 113.08 175.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -58.03 -43.61 86.87 Favored 'General case' 0 C--N 1.333 -0.137 0 O-C-N 121.543 -0.723 . . . . 0.0 110.73 174.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.5 t -61.93 -23.21 66.21 Favored 'General case' 0 C--O 1.222 -0.381 0 O-C-N 121.89 -0.506 . . . . 0.0 111.354 175.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -71.11 -63.89 1.02 Allowed 'General case' 0 N--CA 1.438 -1.059 0 O-C-N 120.603 -1.31 . . . . 0.0 108.439 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.39 -15.91 51.61 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 114.669 -1.151 . . . . 0.0 111.518 178.021 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 1.4 m170 -59.41 -51.86 68.08 Favored 'General case' 0 CA--C 1.517 -0.306 0 O-C-N 121.296 -0.878 . . . . 0.0 110.91 178.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -74.92 -41.02 60.51 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 123.811 0.694 . . . . 0.0 111.15 178.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.752 ' HB2' ' CZ ' ' A' ' 83' ' ' PHE . . . -43.14 131.4 3.33 Favored Pre-proline 0 N--CA 1.447 -0.577 0 O-C-N 124.651 1.219 . . . . 0.0 112.441 177.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.616 ' HG2' HG22 ' A' ' 30' ' ' THR . 19.2 Cg_endo -71.18 123.65 9.8 Favored 'Trans proline' 0 N--CA 1.444 -1.414 0 C-N-CA 122.053 1.835 . . . . 0.0 109.54 -177.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.75 HD13 ' HE2' ' A' ' 115' ' ' LYS . 5.7 tp -61.48 96.66 0.06 Allowed 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.625 0.77 . . . . 0.0 110.94 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 178.2 165.21 0.74 Allowed 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 124.041 0.936 . . . . 0.0 109.728 -175.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.73 121.28 42.13 Favored 'General case' 0 CA--C 1.511 -0.525 0 C-N-CA 124.749 1.22 . . . . 0.0 109.688 177.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 48.77 67.9 1.51 Allowed Glycine 0 CA--C 1.525 0.707 0 CA-C-O 121.772 0.651 . . . . 0.0 112.636 174.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.05 28.47 1.01 Allowed 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.599 0.76 . . . . 0.0 112.759 -178.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.616 HG22 ' HG2' ' A' ' 24' ' ' PRO . 71.9 p -127.56 151.03 49.42 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -175.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -40.17 -58.22 2.42 Favored Glycine 0 C--O 1.228 -0.242 0 C-N-CA 123.655 0.645 . . . . 0.0 113.714 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.444 ' HB3' ' HA ' ' A' ' 94' ' ' PHE . 29.2 t -67.18 -72.64 0.16 Allowed 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 123.772 0.336 . . . . 0.0 111.623 173.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 47.8 p 177.96 -56.05 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 124.194 0.998 . . . . 0.0 112.827 -178.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.509 ' CD2' ' HD3' ' A' ' 84' ' ' PRO . 69.9 m-85 -68.87 147.36 97.84 Favored Pre-proline 0 N--CA 1.442 -0.857 0 C-N-CA 124.931 1.292 . . . . 0.0 113.286 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.726 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 26.1 Cg_endo -75.49 165.53 85.46 Favored 'Cis proline' 0 N--CA 1.445 -1.353 0 C-N-CA 123.938 -1.276 . . . . 0.0 111.186 1.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.661 ' C ' HD23 ' A' ' 81' ' ' LEU . 1.1 p80 -141.47 171.8 13.56 Favored 'General case' 0 CA--C 1.504 -0.797 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.574 -177.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.885 ' CH2' HG22 ' A' ' 39' ' ' THR . 22.0 t90 -72.17 128.08 34.58 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 122.687 1.232 . . . . 0.0 109.726 175.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.497 ' CZ ' ' HA ' ' A' ' 40' ' ' ASN . 19.3 t80 -98.29 86.15 3.59 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 126.674 1.989 . . . . 0.0 107.041 176.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.885 HG22 ' CH2' ' A' ' 37' ' ' TRP . 69.0 p -40.36 -33.43 0.25 Allowed 'General case' 0 C--O 1.217 -0.645 0 CA-C-N 114.656 -1.156 . . . . 0.0 111.105 172.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.497 ' HA ' ' CZ ' ' A' ' 38' ' ' PHE . 57.1 t30 68.56 5.92 5.13 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.519 1.128 . . . . 0.0 110.878 -178.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.4 ' CA ' ' HD2' ' A' ' 52' ' ' ARG . . . 115.96 -26.41 8.85 Favored Glycine 0 N--CA 1.432 -1.59 0 C-N-CA 125.066 1.317 . . . . 0.0 116.095 -171.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.517 ' N ' HD23 ' A' ' 48' ' ' LEU . 58.4 m-85 -54.57 -178.16 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 122.365 1.079 . . . . 0.0 110.299 176.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -103.87 -40.7 6.14 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 124.462 1.105 . . . . 0.0 110.763 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.493 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -174.05 -61.55 0.05 OUTLIER Glycine 0 C--N 1.336 0.549 0 C-N-CA 123.751 0.691 . . . . 0.0 112.641 -178.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -82.92 -98.62 0.05 OUTLIER 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.434 ' HA2' ' CD2' ' A' ' 42' ' ' TYR . . . -138.84 29.76 2.53 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 125.048 1.308 . . . . 0.0 111.674 -174.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.9 mttt -126.87 149.19 49.88 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 118.144 -0.931 . . . . 0.0 108.737 -178.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.517 HD23 ' N ' ' A' ' 42' ' ' TYR . 0.3 OUTLIER -115.38 160.51 34.11 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.406 1.066 . . . . 0.0 109.187 -178.11 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -69.02 157.54 61.43 Favored 'Trans proline' 0 N--CA 1.443 -1.459 0 C-N-CA 121.884 1.723 . . . . 0.0 110.161 177.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -49.27 104.41 0.06 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.094 0.958 . . . . 0.0 110.352 176.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.74 87.98 0.59 Allowed Glycine 0 CA--C 1.524 0.601 0 O-C-N 123.572 0.545 . . . . 0.0 111.851 -174.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.445 ' HD3' ' N ' ' A' ' 53' ' ' THR . 0.0 OUTLIER -150.83 155.53 39.4 Favored 'General case' 0 CA--C 1.516 -0.365 0 C-N-CA 123.164 0.586 . . . . 0.0 110.552 174.648 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . 0.445 ' N ' ' HD3' ' A' ' 52' ' ' ARG . 4.0 m -138.92 101.59 7.78 Favored Pre-proline 0 C--N 1.329 -0.305 0 O-C-N 124.014 0.821 . . . . 0.0 111.439 178.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -66.4 153.74 76.87 Favored 'Trans proline' 0 N--CA 1.448 -1.148 0 C-N-CA 123.856 3.038 . . . . 0.0 112.073 177.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.8 mt -66.74 127.33 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 179.372 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -95.39 134.45 38.18 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 176.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.484 ' CE2' HD13 ' A' ' 133' ' ' LEU . 1.7 m-85 -119.62 -55.31 2.12 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 124.213 1.005 . . . . 0.0 110.623 -179.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 120.42 -2.9 12.49 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 124.88 1.228 . . . . 0.0 113.469 -176.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.413 ' HD2' ' CG1' ' A' ' 116' ' ' VAL . 1.8 mmtp -66.46 177.66 1.46 Allowed 'General case' 0 C--O 1.215 -0.735 0 O-C-N 122.065 -0.667 . . . . 0.0 111.364 173.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.0 p -104.23 -47.17 4.22 Favored 'General case' 0 C--O 1.216 -0.679 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.153 177.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.45 -41.03 41.21 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 123.097 0.559 . . . . 0.0 110.892 177.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.477 ' SG ' ' CD1' ' A' ' 57' ' ' PHE . 1.5 t -74.25 -17.37 60.88 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 122.786 0.434 . . . . 0.0 110.736 178.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -87.58 -38.31 16.08 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 123.115 0.566 . . . . 0.0 112.31 171.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.78 163.8 1.92 Allowed Pre-proline 0 N--CA 1.448 -0.57 0 CA-C-O 121.785 0.803 . . . . 0.0 111.491 -178.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -70.54 138.75 36.01 Favored 'Trans proline' 0 N--CA 1.439 -1.69 0 C-N-CA 120.401 0.734 . . . . 0.0 112.232 175.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -68.21 175.29 6.89 Favored 'Trans proline' 0 N--CA 1.448 -1.2 0 C-N-CA 122.952 2.435 . . . . 0.0 111.965 175.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.8 tptt -136.98 56.27 1.8 Allowed 'General case' 0 C--O 1.209 -1.041 0 O-C-N 120.835 -1.165 . . . . 0.0 108.685 174.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -77.54 165.05 24.82 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 119.16 -1.016 . . . . 0.0 110.488 177.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.57 -165.62 2.03 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.908 0.883 . . . . 0.0 111.241 178.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.11 73.69 10.36 Favored 'General case' 0 C--O 1.219 -0.509 0 O-C-N 121.322 -0.862 . . . . 0.0 111.146 175.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -176.89 -43.35 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.507 0 O-C-N 124.419 1.074 . . . . 0.0 111.367 178.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.452 ' O ' ' CE2' ' A' ' 79' ' ' TYR . . . 122.53 -52.65 0.75 Allowed Glycine 0 C--O 1.217 -0.918 0 CA-C-N 114.693 -1.139 . . . . 0.0 111.208 -177.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -148.59 86.18 1.52 Allowed 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.25 -112.2 0.01 OUTLIER Glycine 0 CA--C 1.525 0.66 0 CA-C-O 122.331 0.962 . . . . 0.0 113.037 176.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -64.58 -96.73 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 O-C-N 120.427 -1.631 . . . . 0.0 112.436 176.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.486 HG23 ' O ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -110.55 16.27 21.6 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 121.379 -0.826 . . . . 0.0 110.272 178.46 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.459 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 8.6 m-20 -29.24 104.93 0.03 OUTLIER 'General case' 0 C--O 1.207 -1.141 0 C-N-CA 125.792 1.637 . . . . 0.0 109.94 -176.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.588 ' CD2' ' H ' ' A' ' 78' ' ' HIS . 2.5 p80 -87.17 16.31 5.28 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 118.968 0.803 . . . . 0.0 110.268 -175.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.926 ' CZ ' HD11 ' A' ' 81' ' ' LEU . 0.3 OUTLIER -36.19 134.27 0.43 Allowed 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 126.156 1.782 . . . . 0.0 111.311 172.148 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.622 HD23 ' O ' ' A' ' 110' ' ' TYR . 0.3 OUTLIER -76.68 153.65 34.95 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.797 176.648 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.926 HD11 ' CZ ' ' A' ' 79' ' ' TYR . 1.7 mp -140.27 139.06 35.44 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 123.191 0.596 . . . . 0.0 109.659 177.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.459 ' CB ' ' CD1' ' A' ' 109' ' ' ILE . 0.5 OUTLIER -105.81 154.2 20.85 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.593 0.711 . . . . 0.0 111.284 179.261 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.752 ' CZ ' ' HB2' ' A' ' 23' ' ' ALA . 5.7 t80 -141.79 126.35 10.32 Favored Pre-proline 0 CA--C 1.537 0.452 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.748 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.509 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 19.6 Cg_endo -73.87 104.44 1.83 Allowed 'Trans proline' 0 N--CA 1.448 -1.148 0 C-N-CA 124.789 3.659 . . . . 0.0 110.615 -177.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.8 t -104.38 119.66 39.46 Favored 'General case' 0 N--CA 1.446 -0.67 0 O-C-N 124.675 1.234 . . . . 0.0 109.963 -179.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.434 ' CD2' ' NE2' ' A' ' 90' ' ' HIS . 64.7 m-85 -81.17 158.8 69.2 Favored Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 176.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -74.78 -42.54 0.55 Allowed 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 122.504 2.136 . . . . 0.0 113.409 178.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -40.42 -37.03 0.62 Allowed 'General case' 0 N--CA 1.478 0.94 0 CA-C-O 123.529 1.633 . . . . 0.0 109.803 174.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 97.45 -1.88 60.54 Favored Glycine 0 N--CA 1.442 -0.931 0 O-C-N 121.053 -1.03 . . . . 0.0 112.248 -178.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.434 ' NE2' ' CD2' ' A' ' 86' ' ' PHE . 5.9 p-80 -65.39 126.74 29.18 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 176.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -59.62 106.07 0.43 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 171.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.44 ' O ' ' CD2' ' A' ' 94' ' ' PHE . 7.1 t80 -38.98 139.93 0.42 Allowed 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 121.684 0.754 . . . . 0.0 110.166 173.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 7.5 ptpt -75.68 58.44 1.08 Allowed 'General case' 0 C--N 1.326 -0.416 0 O-C-N 120.42 -1.425 . . . . 0.0 111.818 173.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.498 ' CD2' ' HZ ' ' A' ' 83' ' ' PHE . 34.2 p90 -73.08 -14.63 61.43 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 123.856 0.862 . . . . 0.0 112.327 176.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -88.8 -37.23 15.57 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 123.329 1.537 . . . . 0.0 111.298 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -79.9 106.9 12.26 Favored 'General case' 0 N--CA 1.455 -0.179 0 O-C-N 120.926 -1.109 . . . . 0.0 109.162 177.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt -57.99 -48.4 80.1 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.739 0.78 . . . . 0.0 111.713 176.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.7 tmtt? -137.49 130.66 17.04 Favored Pre-proline 0 N--CA 1.445 -0.701 0 C-N-CA 124.828 1.251 . . . . 0.0 110.199 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -68.57 174.53 35.9 Favored 'Cis proline' 0 N--CA 1.453 -0.873 0 C-N-CA 123.181 -1.591 . . . . 0.0 110.415 -9.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 22.0 tttm -139.03 116.95 11.6 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 29.4 tp10 -69.96 167.2 17.99 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 123.981 0.801 . . . . 0.0 110.639 174.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -42.68 153.28 0.32 Allowed Pre-proline 0 CA--C 1.536 0.41 0 C-N-CA 124.228 1.011 . . . . 0.0 112.064 173.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -72.85 -84.02 0.0 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 122.829 2.353 . . . . 0.0 112.547 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 146.58 142.4 3.73 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -74.75 -68.85 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 123.325 2.683 . . . . 0.0 110.71 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.679 ' HA ' ' HB2' ' A' ' 122' ' ' ALA . . . -68.3 139.67 55.94 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 121.735 0.779 . . . . 0.0 111.165 178.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.87 144.3 33.77 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.011 -178.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.436 ' CG1' ' HB3' ' A' ' 83' ' ' PHE . 4.3 p -81.58 124.81 39.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 O-C-N 124.341 1.025 . . . . 0.0 109.139 178.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.566 ' CG2' HD22 ' A' ' 80' ' ' LEU . 5.8 mm -105.54 141.16 21.51 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.701 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.061 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.622 ' O ' HD23 ' A' ' 80' ' ' LEU . 10.4 p90 -165.17 152.92 11.24 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-O 121.952 0.882 . . . . 0.0 111.294 -176.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.0 p -88.66 165.82 14.52 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.852 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.561 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.3 OUTLIER -108.21 156.84 37.73 Favored Pre-proline 0 CA--C 1.547 0.841 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 176.107 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.561 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 17.7 Cg_endo -72.07 -53.4 0.16 OUTLIER 'Cis proline' 0 CA--C 1.51 -0.683 0 C-N-CA 124.216 -1.16 . . . . 0.0 111.064 -10.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -45.61 111.43 0.34 Allowed 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 118.685 -0.674 . . . . 0.0 109.92 177.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.75 ' HE2' HD13 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -62.69 79.86 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.349 0 C-N-CA 124.911 1.285 . . . . 0.0 108.098 -178.262 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.461 ' O ' HG12 ' A' ' 116' ' ' VAL . 16.2 t -77.43 73.06 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 105.311 -2.107 . . . . 0.0 105.311 -178.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.475 ' CZ ' ' NE2' ' A' ' 13' ' ' GLN . 20.7 t80 -46.63 108.16 0.13 Allowed 'General case' 0 N--CA 1.44 -0.95 0 C-N-CA 124.918 1.287 . . . . 0.0 109.008 177.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . 0.424 ' SG ' ' CG ' ' A' ' 57' ' ' PHE . 0.1 OUTLIER -83.45 -53.0 6.03 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 121.952 0.882 . . . . 0.0 110.031 179.448 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 177.18 -146.09 7.58 Favored Glycine 0 N--CA 1.437 -1.252 0 CA-C-N 114.464 -1.244 . . . . 0.0 110.43 179.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.418 HG13 ' CG ' ' A' ' 4' ' ' TRP . 1.2 mm -126.61 146.85 31.77 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 -177.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.561 HG22 HD12 ' A' ' 133' ' ' LEU . 8.0 pt -132.7 151.79 35.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -178.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.679 ' HB2' ' HA ' ' A' ' 106' ' ' ALA . . . . . . . . 0 C--N 1.325 -0.495 0 C-N-CA 122.807 0.443 . . . . 0.0 110.863 178.223 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.514 -0.415 0 N-CA-C 109.626 -0.509 . . . . 0.0 109.626 . . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.561 HD12 HG22 ' A' ' 121' ' ' ILE . 10.0 tp -84.51 137.61 33.24 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.127 0.892 . . . . 0.0 108.746 178.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 35.0 m -70.71 -178.75 1.94 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 122.865 1.317 . . . . 0.0 109.821 174.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 13.7 p -160.24 100.01 1.35 Allowed 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 105.148 -2.167 . . . . 0.0 105.148 -178.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.242 0.674 0 CA-C-O 115.921 -1.99 . . . . 0.0 112.441 168.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.724 HG22 ' HB2' ' A' ' 136' ' ' HIS . 9.3 p . . . . . 0 C--O 1.238 0.494 0 CA-C-O 121.43 0.633 . . . . 0.0 109.654 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.924 HG21 HD23 ' A' ' 10' ' ' LEU . 48.9 m -85.78 119.67 26.36 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.148 -179.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . 0.528 ' CE2' ' CD2' ' A' ' 136' ' ' HIS . 19.8 m95 -80.44 141.42 35.28 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -141.02 142.51 34.22 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.728 ' SG ' ' HB3' ' A' ' 122' ' ' ALA . 0.1 OUTLIER -120.42 50.38 1.32 Allowed 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.896 177.921 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 48.06 73.75 0.31 Allowed Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 -178.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 166.55 -74.95 0.15 Allowed Glycine 0 C--N 1.333 0.395 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 54.9 mt -123.82 158.18 32.42 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.924 HD23 HG21 ' A' ' 3' ' ' THR . 3.9 mp -83.02 165.64 19.46 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.049 179.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.763 ' CZ ' ' HB3' ' A' ' 106' ' ' ALA . 50.2 m-85 -159.12 85.56 0.81 Allowed 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 121.872 0.844 . . . . 0.0 109.981 -175.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -57.43 121.45 10.27 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 117.656 -1.164 . . . . 0.0 108.602 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.563 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 0.6 OUTLIER -43.33 -57.93 2.79 Favored 'General case' 0 C--O 1.207 -1.167 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.386 -179.892 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.445 ' O ' ' CB ' ' A' ' 18' ' ' SER . 19.7 t-20 -44.98 -46.9 11.4 Favored 'General case' 0 C--O 1.198 -1.647 0 O-C-N 124.065 0.853 . . . . 0.0 109.766 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.442 ' CE ' ' HA3' ' A' ' 89' ' ' GLY . 0.0 OUTLIER -62.35 -48.23 80.74 Favored 'General case' 0 C--O 1.204 -1.307 0 CA-C-O 117.376 -1.297 . . . . 0.0 111.267 174.954 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -51.04 -68.19 0.19 Allowed 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 120.091 1.314 . . . . 0.0 111.685 175.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.431 ' O ' ' CD2' ' A' ' 21' ' ' HIS . 1.5 pt-20 -55.99 -32.94 64.4 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.206 177.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.445 ' CB ' ' O ' ' A' ' 14' ' ' ASN . 12.6 t -68.05 -53.78 23.15 Favored 'General case' 0 C--O 1.216 -0.708 0 C-N-CA 123.949 0.9 . . . . 0.0 109.46 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.414 ' OD1' ' CD2' ' A' ' 83' ' ' PHE . 6.7 t-20 -49.37 -30.62 7.97 Favored 'General case' 0 N--CA 1.434 -1.266 0 O-C-N 120.443 -1.41 . . . . 0.0 109.291 178.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.99 -29.36 22.05 Favored 'General case' 0 N--CA 1.442 -0.873 0 O-C-N 123.521 0.513 . . . . 0.0 111.642 176.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.431 ' CD2' ' O ' ' A' ' 17' ' ' GLU . 7.7 m170 -54.19 -42.93 70.27 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 124.029 0.931 . . . . 0.0 109.38 179.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.429 ' CD2' ' N ' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -79.59 -48.89 13.03 Favored 'General case' 0 N--CA 1.443 -0.78 0 O-C-N 123.769 0.668 . . . . 0.0 109.562 -179.892 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.571 ' HB2' ' CZ ' ' A' ' 83' ' ' PHE . . . -40.35 136.09 1.41 Allowed Pre-proline 0 N--CA 1.442 -0.871 0 O-C-N 125.187 1.554 . . . . 0.0 110.831 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.819 ' HG2' HG22 ' A' ' 30' ' ' THR . 18.6 Cg_endo -73.14 122.22 7.88 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 122.032 1.821 . . . . 0.0 110.631 -178.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.676 HD13 ' HE2' ' A' ' 115' ' ' LYS . 3.0 tp -60.23 95.5 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 123.597 0.56 . . . . 0.0 110.059 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 179.3 162.42 0.84 Allowed 'General case' 0 N--CA 1.448 -0.566 0 O-C-N 123.643 0.59 . . . . 0.0 109.883 -178.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -103.55 112.54 25.51 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 123.927 0.767 . . . . 0.0 109.083 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.01 64.69 4.12 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 177.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.418 ' O ' ' CG ' ' A' ' 29' ' ' LYS . 12.7 tttt -134.47 12.92 3.8 Favored 'General case' 0 C--N 1.334 -0.074 0 CA-C-O 123.003 1.382 . . . . 0.0 110.024 178.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.819 HG22 ' HG2' ' A' ' 24' ' ' PRO . 22.8 p -112.92 145.8 40.11 Favored 'General case' 0 C--N 1.315 -0.898 0 O-C-N 120.501 -1.374 . . . . 0.0 108.481 -176.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -38.42 -49.57 2.31 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.8 t -74.2 -60.69 2.15 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-O 117.177 -1.392 . . . . 0.0 110.165 177.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 162.2 -59.92 0.0 OUTLIER 'General case' 0 C--O 1.222 -0.344 0 O-C-N 125.256 1.597 . . . . 0.0 110.555 179.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.692 ' CE2' ' CE1' ' A' ' 36' ' ' HIS . 60.3 m-85 -58.83 145.78 77.7 Favored Pre-proline 0 N--CA 1.434 -1.256 0 CA-C-O 117.676 -1.154 . . . . 0.0 112.522 178.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.554 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 22.2 Cg_endo -74.23 153.41 99.14 Favored 'Cis proline' 0 N--CA 1.454 -0.82 0 C-N-CA 121.578 -2.259 . . . . 0.0 111.855 -1.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.692 ' CE1' ' CE2' ' A' ' 34' ' ' TYR . 0.5 OUTLIER -131.8 154.91 48.63 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-O 117.782 -1.104 . . . . 0.0 110.509 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 1.001 ' CH2' HG22 ' A' ' 39' ' ' THR . 13.4 t90 -48.98 144.78 4.42 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.227 0.954 . . . . 0.0 109.143 178.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.577 ' CZ ' HD13 ' A' ' 121' ' ' ILE . 24.6 t80 -114.93 80.96 1.49 Allowed 'General case' 0 N--CA 1.425 -1.717 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 -176.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 1.001 HG22 ' CH2' ' A' ' 37' ' ' TRP . 4.3 p -38.46 -32.86 0.08 Allowed 'General case' 0 C--O 1.21 -1.012 0 O-C-N 124.114 0.884 . . . . 0.0 109.933 176.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.498 ' HB2' ' CD2' ' A' ' 38' ' ' PHE . 51.0 t30 52.18 22.24 1.87 Allowed 'General case' 0 N--CA 1.447 -0.603 0 O-C-N 121.154 -0.966 . . . . 0.0 108.69 175.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.47 ' HA3' HD23 ' A' ' 48' ' ' LEU . . . 107.71 -41.42 2.21 Favored Glycine 0 N--CA 1.422 -2.263 0 CA-C-O 118.697 -1.057 . . . . 0.0 114.886 -173.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.529 ' CD2' ' HG3' ' A' ' 66' ' ' PRO . 62.4 m-85 -45.72 153.78 0.25 Allowed 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 123.721 0.808 . . . . 0.0 112.126 175.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.48 -40.32 16.51 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.708 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.512 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -164.97 -65.46 0.02 OUTLIER Glycine 0 C--N 1.339 0.717 0 N-CA-C 111.356 -0.698 . . . . 0.0 111.356 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.456 ' OD2' ' CE ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -121.08 -61.19 1.57 Allowed 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -179.708 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -50.47 179.24 0.03 OUTLIER Glycine 0 C--N 1.348 1.244 0 CA-C-O 123.598 1.666 . . . . 0.0 111.217 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.409 ' HA ' ' CE1' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -68.8 -171.06 0.26 Allowed 'General case' 0 C--N 1.326 -0.437 0 O-C-N 121.059 -1.259 . . . . 0.0 109.832 179.906 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.553 HD13 ' HG3' ' A' ' 54' ' ' PRO . 5.2 mp -69.96 154.52 94.59 Favored Pre-proline 0 N--CA 1.441 -0.914 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.213 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.09 156.53 47.13 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 122.114 1.876 . . . . 0.0 111.044 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.07 98.03 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.08 75.8 0.64 Allowed Glycine 0 N--CA 1.444 -0.775 0 CA-C-O 119.777 -0.457 . . . . 0.0 112.096 -178.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.46 ' HD3' ' CA ' ' A' ' 41' ' ' GLY . 6.9 ttt180 -177.22 163.85 2.12 Favored 'General case' 0 CA--C 1.517 -0.32 0 O-C-N 124.075 0.514 . . . . 0.0 110.419 177.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.2 m -137.05 111.81 9.41 Favored Pre-proline 0 N--CA 1.444 -0.774 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.972 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.553 ' HG3' HD13 ' A' ' 48' ' ' LEU . 23.0 Cg_endo -72.98 165.79 31.82 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 122.02 1.813 . . . . 0.0 112.01 178.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.483 ' O ' ' CE2' ' A' ' 57' ' ' PHE . 4.3 mt -88.81 119.51 36.08 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.471 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -179.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 15.8 tptt -82.82 132.41 35.17 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.673 ' CE1' HD13 ' A' ' 133' ' ' LEU . 19.9 m-85 -117.56 -49.78 2.55 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.633 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 124.02 -1.63 9.13 Favored Glycine 0 CA--C 1.521 0.434 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.685 -178.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.4 mmtp -102.68 143.32 32.5 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 36.5 t -78.86 -1.26 34.16 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 124.315 1.01 . . . . 0.0 110.664 178.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.549 ' HB2' HG21 ' A' ' 111' ' ' THR . 0.9 OUTLIER -88.2 -57.48 2.91 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -178.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.9 m -72.44 -26.41 61.82 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 -179.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -71.37 -34.38 70.39 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 123.665 0.603 . . . . 0.0 110.154 177.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.99 160.81 14.37 Favored Pre-proline 0 N--CA 1.439 -0.995 0 CA-C-O 121.119 0.485 . . . . 0.0 110.354 179.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.438 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 26.5 Cg_endo -74.48 141.3 28.13 Favored 'Trans proline' 0 N--CA 1.445 -1.36 0 C-N-CA 121.713 1.608 . . . . 0.0 113.555 175.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.529 ' HG3' ' CD2' ' A' ' 42' ' ' TYR . 20.8 Cg_endo -73.66 167.93 26.04 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 122.43 2.087 . . . . 0.0 111.671 179.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.456 ' CE ' ' OD2' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -133.13 60.61 1.7 Allowed 'General case' 0 C--O 1.239 0.543 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.236 179.417 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.493 ' CE1' ' O ' ' A' ' 70' ' ' LYS . 57.0 t-80 -74.79 145.6 42.78 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-O 123.995 1.855 . . . . 0.0 112.01 178.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -133.12 -85.27 0.46 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 119.49 -2.006 . . . . 0.0 109.796 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.493 ' O ' ' CE1' ' A' ' 68' ' ' HIS . 0.2 OUTLIER -72.64 -171.07 0.76 Allowed 'General case' 0 C--O 1.203 -1.379 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.166 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -77.97 41.65 0.36 Allowed 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.664 0.745 . . . . 0.0 111.415 178.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -169.51 -105.58 0.18 Allowed Glycine 0 C--O 1.21 -1.368 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -178.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -113.44 -87.99 0.56 Allowed 'General case' 0 C--N 1.317 -0.847 0 O-C-N 120.968 -1.313 . . . . 0.0 107.567 -177.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 117.46 -141.73 16.74 Favored Glycine 0 N--CA 1.443 -0.896 0 CA-C-O 118.525 -1.153 . . . . 0.0 111.211 -178.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 36.8 mttt -49.01 -89.57 0.0 OUTLIER 'General case' 0 C--O 1.223 -0.308 0 O-C-N 125.21 1.182 . . . . 0.0 110.233 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.69 HG23 ' O ' ' A' ' 76' ' ' THR . 0.6 OUTLIER -127.23 28.51 5.72 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.868 179.331 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.549 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 41.0 t0 -30.01 97.78 0.01 OUTLIER 'General case' 0 C--O 1.214 -0.8 0 C-N-CA 122.93 0.492 . . . . 0.0 111.795 -178.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.404 ' CD2' ' H ' ' A' ' 78' ' ' HIS . 7.1 p80 -86.91 15.2 6.13 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -176.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 1.052 ' CE1' HD11 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -52.95 174.07 0.04 OUTLIER 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 174.484 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.769 HD22 ' CG2' ' A' ' 109' ' ' ILE . 0.6 OUTLIER -95.13 157.65 15.8 Favored 'General case' 0 C--O 1.218 -0.596 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.324 177.624 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 1.052 HD11 ' CE1' ' A' ' 79' ' ' TYR . 2.8 mp -143.03 108.55 5.07 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.533 0.682 . . . . 0.0 109.161 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.52 ' CB ' ' CD1' ' A' ' 109' ' ' ILE . 7.2 pm0 -80.9 150.58 28.98 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 122.148 0.975 . . . . 0.0 110.205 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.571 ' CZ ' ' HB2' ' A' ' 23' ' ' ALA . 15.8 t80 -141.16 137.03 16.39 Favored Pre-proline 0 N--CA 1.442 -0.87 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.161 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.484 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 19.4 Cg_endo -74.01 91.78 0.92 Allowed 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 123.293 2.662 . . . . 0.0 110.914 -178.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.0 t -95.48 109.1 21.35 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 122.194 0.997 . . . . 0.0 111.118 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -82.42 159.08 65.25 Favored Pre-proline 0 N--CA 1.443 -0.821 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.692 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -76.57 -40.78 0.51 Allowed 'Trans proline' 0 CA--C 1.501 -1.132 0 C-N-CA 122.324 2.016 . . . . 0.0 112.453 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -42.36 -32.2 0.49 Allowed 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 125.123 1.515 . . . . 0.0 109.854 178.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.442 ' HA3' ' CE ' ' A' ' 15' ' ' LYS . . . 87.14 10.0 72.36 Favored Glycine 0 N--CA 1.438 -1.169 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 177.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.419 ' O ' ' CD2' ' A' ' 90' ' ' HIS . 3.8 p-80 -80.82 130.33 35.0 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -62.21 88.45 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.533 ' CD2' ' HB3' ' A' ' 94' ' ' PHE . 7.7 t80 -36.42 146.72 0.03 OUTLIER 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 122.362 1.077 . . . . 0.0 110.809 -178.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -78.8 58.81 2.41 Favored 'General case' 0 C--N 1.317 -0.814 0 O-C-N 120.19 -1.569 . . . . 0.0 110.072 177.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.533 ' HB3' ' CD2' ' A' ' 92' ' ' TYR . 29.6 p90 -79.45 -8.9 59.44 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 122.837 0.455 . . . . 0.0 111.544 178.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -92.47 -33.16 14.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 49.3 m -79.82 110.54 15.28 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.41 ' CG ' ' N ' ' A' ' 98' ' ' LYS . 0.1 OUTLIER -58.86 -50.09 75.29 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.157 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -146.4 129.55 8.14 Favored Pre-proline 0 N--CA 1.432 -1.346 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -177.245 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.439 ' HA ' ' HA ' ' A' ' 98' ' ' LYS . 26.4 Cg_endo -72.15 177.66 33.85 Favored 'Cis proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.135 -2.027 . . . . 0.0 111.967 -2.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.17 135.82 21.99 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 123.789 0.68 . . . . 0.0 109.731 178.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.93 172.71 13.42 Favored 'General case' 0 C--O 1.245 0.856 0 O-C-N 124.27 0.981 . . . . 0.0 111.246 178.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -57.3 158.74 9.75 Favored Pre-proline 0 N--CA 1.438 -1.033 0 CA-C-O 121.604 0.716 . . . . 0.0 112.193 175.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -75.78 -89.87 0.0 OUTLIER 'Trans proline' 0 C--O 1.205 -1.14 0 C-N-CA 122.212 1.942 . . . . 0.0 111.115 179.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 151.77 148.68 4.89 Favored Glycine 0 N--CA 1.438 -1.214 0 O-C-N 120.983 -1.073 . . . . 0.0 111.358 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -74.45 -35.47 3.72 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.149 1.9 . . . . 0.0 111.779 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.763 ' HB3' ' CZ ' ' A' ' 11' ' ' TYR . . . -102.85 146.72 27.85 Favored 'General case' 0 N--CA 1.437 -1.078 0 O-C-N 124.232 0.958 . . . . 0.0 109.914 178.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.422 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 2.2 mtm-85 -146.44 148.82 32.67 Favored 'General case' 0 N--CA 1.445 -0.705 0 O-C-N 123.833 0.708 . . . . 0.0 111.417 179.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.474 ' CG1' ' HB3' ' A' ' 83' ' ' PHE . 3.8 p -82.63 117.71 29.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 123.19 0.596 . . . . 0.0 110.23 178.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.769 ' CG2' HD22 ' A' ' 80' ' ' LEU . 6.1 mm -96.01 140.71 16.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.631 ' C ' HD23 ' A' ' 80' ' ' LEU . 9.0 p90 -167.18 152.25 7.33 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.789 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.549 HG21 ' HB2' ' A' ' 61' ' ' ASP . 1.6 p -87.76 163.86 16.26 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.715 -178.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.572 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.2 OUTLIER -112.94 152.62 45.04 Favored Pre-proline 0 N--CA 1.434 -1.231 0 C-N-CA 123.209 0.604 . . . . 0.0 110.842 -179.783 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.608 ' O ' HD21 ' A' ' 25' ' ' LEU . 17.8 Cg_endo -73.56 -55.46 0.14 OUTLIER 'Cis proline' 0 CA--C 1.512 -0.601 0 C-N-CA 122.0 -2.083 . . . . 0.0 110.64 -4.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -41.65 111.18 0.21 Allowed 'General case' 0 N--CA 1.438 -1.057 0 CA-C-O 116.093 -1.908 . . . . 0.0 110.342 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.676 ' HE2' HD13 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -64.39 74.41 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.7 0 O-C-N 126.03 2.081 . . . . 0.0 108.755 -178.604 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.64 ' O ' HG12 ' A' ' 116' ' ' VAL . 13.3 t -71.47 69.81 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 -178.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.572 ' CE1' ' HA2' ' A' ' 119' ' ' GLY . 9.8 t80 -36.48 111.06 0.13 Allowed 'General case' 0 N--CA 1.437 -1.078 0 C-N-CA 124.074 0.949 . . . . 0.0 109.849 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . 0.577 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 0.1 OUTLIER -94.28 -26.69 16.5 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.258 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.572 ' HA2' ' CE1' ' A' ' 117' ' ' PHE . . . 137.39 -166.58 24.98 Favored Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 -178.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.665 HG22 ' SG ' ' A' ' 134' ' ' CYS . 3.5 mp -111.6 146.1 16.96 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.369 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 -177.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.654 HG22 HD12 ' A' ' 133' ' ' LEU . 6.2 pt -116.77 157.11 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 CA-C-N 119.237 0.926 . . . . 0.0 108.836 178.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.728 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . . . . . . . . 0 N--CA 1.449 -0.511 0 CA-C-O 121.561 0.696 . . . . 0.0 110.126 177.965 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.513 -0.477 0 CA-C-O 118.941 -0.552 . . . . 0.0 109.606 . . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.673 HD13 ' CE1' ' A' ' 57' ' ' PHE . 10.4 tp -89.6 136.47 33.02 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.396 1.06 . . . . 0.0 108.504 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . 0.665 ' SG ' HG22 ' A' ' 120' ' ' ILE . 70.7 m -56.97 -176.44 0.02 OUTLIER 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 124.793 1.237 . . . . 0.0 108.308 178.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 6.8 m -161.16 83.99 0.65 Allowed 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.724 ' HB2' HG22 ' A' ' 2' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.258 1.527 0 CA-C-O 116.11 -1.9 . . . . 0.0 112.143 175.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.473 HG22 ' HB3' ' A' ' 136' ' ' HIS . 9.9 p . . . . . 0 C--O 1.233 0.206 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.552 ' CG2' HD12 ' A' ' 10' ' ' LEU . 1.1 m -85.61 123.73 31.35 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 177.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . 0.44 ' CG ' HG13 ' A' ' 120' ' ' ILE . 35.0 m95 -86.18 142.58 28.52 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 122.913 0.485 . . . . 0.0 110.059 177.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.574 ' OG1' HD13 ' A' ' 10' ' ' LEU . 0.8 OUTLIER -127.21 125.84 41.74 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 -176.751 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.548 ' HB3' ' HB3' ' A' ' 122' ' ' ALA . 7.2 m -120.7 53.75 1.1 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.691 178.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 132.68 -95.95 0.3 Allowed Glycine 0 C--O 1.223 -0.565 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -132.33 8.84 5.35 Favored Glycine 0 N--CA 1.469 0.897 0 C-N-CA 123.881 0.753 . . . . 0.0 113.624 177.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.454 HD13 ' OH ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -115.52 140.28 49.3 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 124.85 1.26 . . . . 0.0 108.858 -176.632 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.574 HD13 ' OG1' ' A' ' 5' ' ' THR . 2.7 mm? -105.24 116.5 32.05 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 124.509 1.131 . . . . 0.0 108.099 -170.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.454 ' OH ' HD13 ' A' ' 9' ' ' LEU . 73.8 m-85 -108.55 98.5 8.01 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 -172.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -55.14 117.87 3.86 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 177.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.457 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 6.4 tp-100 -51.0 -44.42 60.96 Favored 'General case' 0 C--O 1.214 -0.796 0 C-N-CA 119.814 -0.754 . . . . 0.0 112.853 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -48.42 -42.91 33.54 Favored 'General case' 0 C--O 1.201 -1.479 0 O-C-N 123.771 0.67 . . . . 0.0 112.217 175.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.9 mttt -69.52 -40.8 76.73 Favored 'General case' 0 C--O 1.212 -0.879 0 CA-C-N 120.068 1.304 . . . . 0.0 113.454 168.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -52.5 -40.38 62.33 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 121.688 2.04 . . . . 0.0 113.82 173.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -85.66 -43.83 13.09 Favored 'General case' 0 C--O 1.217 -0.616 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.603 173.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 41.0 t -71.36 -62.88 1.24 Allowed 'General case' 0 C--O 1.217 -0.62 0 C-N-CA 126.914 2.086 . . . . 0.0 110.839 -176.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.421 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 0.6 OUTLIER -39.55 -38.16 0.57 Allowed 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 120.262 1.392 . . . . 0.0 111.673 168.942 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.576 ' HB3' HG11 ' A' ' 108' ' ' VAL . 1.1 p -83.51 -26.67 29.98 Favored 'General case' 0 C--O 1.218 -0.598 0 N-CA-C 116.464 2.024 . . . . 0.0 116.464 175.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 2.9 m170 -54.25 -32.99 57.44 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 125.186 1.394 . . . . 0.0 109.088 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.421 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.1 OUTLIER -75.48 -41.39 55.6 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 125.086 1.355 . . . . 0.0 111.208 177.111 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.861 ' HB1' ' HG3' ' A' ' 35' ' ' PRO . . . -39.04 125.47 1.25 Allowed Pre-proline 0 CA--C 1.539 0.526 0 C-N-CA 125.39 1.476 . . . . 0.0 111.503 174.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.403 ' HG2' ' CG2' ' A' ' 30' ' ' THR . 19.0 Cg_endo -71.02 123.2 9.47 Favored 'Trans proline' 0 N--CA 1.439 -1.68 0 C-N-CA 122.71 2.274 . . . . 0.0 109.101 -177.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.451 HD22 ' HE2' ' A' ' 115' ' ' LYS . 2.7 tp -60.41 97.17 0.05 OUTLIER 'General case' 0 C--O 1.222 -0.394 0 C-N-CA 124.18 0.992 . . . . 0.0 111.043 177.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -175.25 149.05 1.02 Allowed 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 123.729 0.812 . . . . 0.0 110.928 -176.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.508 ' HB3' ' CA ' ' A' ' 72' ' ' GLY . 3.6 t0 -82.02 82.74 7.51 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -178.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.415 ' N ' ' HA ' ' A' ' 36' ' ' HIS . . . 68.22 81.29 0.19 Allowed Glycine 0 C--O 1.227 -0.317 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 175.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.35 47.3 0.97 Allowed 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 122.748 1.261 . . . . 0.0 112.778 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.403 ' CG2' ' HG2' ' A' ' 24' ' ' PRO . 68.2 p -134.14 154.85 50.96 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.286 -175.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -41.6 -61.4 2.19 Favored Glycine 0 C--O 1.228 -0.243 0 C-N-CA 124.189 0.899 . . . . 0.0 112.704 -178.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.9 t -65.0 -72.35 0.15 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 118.103 -0.951 . . . . 0.0 112.186 173.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 60.7 p 179.74 -55.2 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.955 0.902 . . . . 0.0 112.278 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.475 ' CD1' ' HD3' ' A' ' 84' ' ' PRO . 80.9 m-85 -71.34 142.93 87.38 Favored Pre-proline 0 N--CA 1.437 -1.083 0 O-C-N 124.821 1.325 . . . . 0.0 112.04 -178.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.861 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 27.8 Cg_endo -79.04 158.81 91.22 Favored 'Cis proline' 0 N--CA 1.442 -1.552 0 C-N-CA 122.159 -2.017 . . . . 0.0 110.713 6.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.421 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 0.6 OUTLIER -140.91 157.72 44.97 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-O 118.582 -0.723 . . . . 0.0 111.944 178.275 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.939 ' CH2' HG22 ' A' ' 39' ' ' THR . 21.5 t90 -58.4 149.7 24.2 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 122.943 1.354 . . . . 0.0 110.879 172.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.496 ' CE2' HD13 ' A' ' 121' ' ' ILE . 8.1 t80 -123.69 83.87 2.2 Favored 'General case' 0 N--CA 1.434 -1.25 0 C-N-CA 127.515 2.326 . . . . 0.0 105.779 -174.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.939 HG22 ' CH2' ' A' ' 37' ' ' TRP . 71.1 p -36.46 -41.93 0.31 Allowed 'General case' 0 C--O 1.213 -0.849 0 CA-C-N 114.464 -1.244 . . . . 0.0 110.819 171.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 55.4 t30 57.05 20.08 5.2 Favored 'General case' 0 CA--C 1.55 0.965 0 CA-C-O 122.413 1.102 . . . . 0.0 111.028 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.84 -33.13 6.64 Favored Glycine 0 C--O 1.222 -0.626 0 CA-C-O 117.655 -1.636 . . . . 0.0 113.558 -171.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.604 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 84.3 m-85 -52.76 157.04 1.74 Allowed 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.328 1.451 . . . . 0.0 111.339 177.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.72 -31.2 46.29 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.635 0.731 . . . . 0.0 112.061 176.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.509 ' HA2' ' CZ2' ' A' ' 37' ' ' TRP . . . 114.83 34.47 1.52 Allowed Glycine 0 C--O 1.221 -0.699 0 CA-C-O 117.28 -1.845 . . . . 0.0 114.779 -174.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -147.54 -64.88 0.27 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.483 1.113 . . . . 0.0 112.219 -178.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -135.47 -100.81 0.64 Allowed Glycine 0 C--O 1.219 -0.804 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.88 -174.39 5.24 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.348 0.594 . . . . 0.0 109.79 178.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.72 HD13 ' NE ' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -101.47 168.87 8.47 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.507 -178.725 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -71.29 -179.13 3.34 Favored 'Trans proline' 0 N--CA 1.442 -1.53 0 C-N-CA 123.003 2.468 . . . . 0.0 112.166 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.15 104.0 11.33 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 119.98 -1.7 . . . . 0.0 110.014 174.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.43 71.21 0.52 Allowed Glycine 0 N--CA 1.469 0.863 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 177.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.72 ' NE ' HD13 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -161.66 169.29 21.83 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 124.013 0.925 . . . . 0.0 109.637 178.797 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.9 m -155.23 107.96 2.25 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 173.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.508 ' HG3' HD21 ' A' ' 48' ' ' LEU . 24.4 Cg_endo -71.76 172.87 13.6 Favored 'Trans proline' 0 N--CA 1.444 -1.4 0 C-N-CA 122.817 2.345 . . . . 0.0 111.246 177.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.8 mt -85.82 132.9 30.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.92 149.28 25.76 Favored 'General case' 0 C--N 1.33 -0.265 0 O-C-N 121.499 -0.75 . . . . 0.0 109.87 175.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.465 ' CE2' ' SG ' ' A' ' 62' ' ' CYS . 21.0 m-85 -132.67 -49.48 0.9 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.616 1.167 . . . . 0.0 110.856 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 111.33 -3.32 28.12 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 125.008 1.29 . . . . 0.0 113.249 -174.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.87 128.9 40.39 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-O 117.724 -1.131 . . . . 0.0 109.728 176.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 22.5 p -61.82 -10.62 9.55 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 125.617 1.823 . . . . 0.0 112.718 176.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.586 ' HB2' HG11 ' A' ' 116' ' ' VAL . 0.4 OUTLIER -88.14 -54.21 4.33 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 126.181 1.792 . . . . 0.0 110.505 179.329 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.465 ' SG ' ' CE2' ' A' ' 57' ' ' PHE . 2.6 t -73.34 -15.2 61.39 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 124.275 0.985 . . . . 0.0 113.092 174.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -84.68 -40.5 17.31 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.383 1.473 . . . . 0.0 110.259 173.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.63 155.41 3.9 Favored Pre-proline 0 CA--C 1.539 0.529 0 CA-C-O 122.636 1.208 . . . . 0.0 111.566 -178.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -69.02 138.02 39.1 Favored 'Trans proline' 0 N--CA 1.439 -1.689 0 C-N-CA 120.344 0.696 . . . . 0.0 112.411 175.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.454 ' HD2' ' CD1' ' A' ' 42' ' ' TYR . 27.9 Cg_endo -66.17 172.24 9.04 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 124.118 3.212 . . . . 0.0 110.713 173.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.7 mmtt -140.94 63.0 1.46 Allowed 'General case' 0 C--O 1.207 -1.133 0 CA-C-O 118.287 -0.863 . . . . 0.0 109.508 177.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 31.1 t-80 -74.29 163.86 27.3 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 123.433 0.458 . . . . 0.0 110.382 177.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 21.1 p -148.63 -173.37 4.32 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.483 1.113 . . . . 0.0 110.976 176.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.75 74.19 10.2 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 120.734 -1.229 . . . . 0.0 111.706 176.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -177.05 -46.46 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 124.281 1.033 . . . . 0.0 109.68 -179.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.508 ' CA ' ' HB3' ' A' ' 27' ' ' ASP . . . 120.66 -78.12 0.32 Allowed Glycine 0 N--CA 1.441 -1.017 0 O-C-N 124.441 1.088 . . . . 0.0 112.677 -174.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -119.99 61.61 0.85 Allowed 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 128.874 2.869 . . . . 0.0 109.003 -178.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -70.56 -106.36 0.04 OUTLIER Glycine 0 CA--C 1.526 0.725 0 CA-C-O 123.088 1.382 . . . . 0.0 111.506 -175.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.0 mttt -61.35 -90.05 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.68 0 O-C-N 120.201 -1.764 . . . . 0.0 113.353 174.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.42 HG23 ' O ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -128.77 15.37 6.42 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.641 177.437 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -29.38 97.33 0.01 OUTLIER 'General case' 0 C--O 1.214 -0.806 0 C-N-CA 126.126 1.77 . . . . 0.0 112.349 -175.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.403 ' CD2' ' H ' ' A' ' 78' ' ' HIS . 6.1 p80 -88.53 58.0 4.48 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 119.866 -1.771 . . . . 0.0 107.527 -169.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.528 ' HB2' ' CD1' ' A' ' 37' ' ' TRP . 46.7 p90 -80.85 133.55 35.61 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 125.08 1.352 . . . . 0.0 108.885 -177.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.611 HD21 HG22 ' A' ' 111' ' ' THR . 5.3 mt -71.2 126.33 29.32 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 176.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.727 HD21 ' HB2' ' A' ' 35' ' ' PRO . 0.4 OUTLIER -120.23 141.79 49.62 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 177.962 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.407 ' HB2' HD11 ' A' ' 109' ' ' ILE . 0.6 OUTLIER -103.84 166.14 10.6 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 175.784 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.723 ' CE2' ' HB2' ' A' ' 23' ' ' ALA . 7.6 t80 -152.85 127.04 4.47 Favored Pre-proline 0 CA--C 1.538 0.511 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.475 ' HD3' ' CD1' ' A' ' 34' ' ' TYR . 17.8 Cg_endo -71.66 118.39 5.63 Favored 'Trans proline' 0 N--CA 1.444 -1.416 0 C-N-CA 124.755 3.637 . . . . 0.0 110.312 -176.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.99 111.29 17.72 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.742 -1.117 . . . . 0.0 108.61 -177.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -79.31 157.64 75.13 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 177.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -73.52 -36.1 4.19 Favored 'Trans proline' 0 N--CA 1.448 -1.18 0 C-N-CA 122.636 2.224 . . . . 0.0 113.321 178.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -46.74 -29.93 2.16 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 126.911 2.084 . . . . 0.0 110.044 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.93 6.08 76.37 Favored Glycine 0 N--CA 1.44 -1.099 0 C-N-CA 125.367 1.46 . . . . 0.0 112.344 178.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.1 p-80 -76.56 128.7 35.24 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 177.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -56.82 106.79 0.33 Allowed 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 171.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.46 ' CD2' ' HG2' ' A' ' 84' ' ' PRO . 3.0 t80 -37.08 131.96 0.74 Allowed 'General case' 0 C--O 1.215 -0.715 0 C-N-CA 123.833 0.853 . . . . 0.0 108.852 176.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.27 59.68 0.08 Allowed 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.385 -0.822 . . . . 0.0 112.162 173.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.482 ' CD2' ' HZ ' ' A' ' 83' ' ' PHE . 6.5 p90 -72.92 -5.09 36.17 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 127.347 2.259 . . . . 0.0 112.196 174.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.68 -40.6 10.16 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 123.652 1.691 . . . . 0.0 110.166 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 74.9 m -76.93 97.72 4.69 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 120.348 -1.47 . . . . 0.0 108.393 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.6 pttm -59.16 -46.71 87.67 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.955 0.883 . . . . 0.0 111.81 177.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.46 126.35 8.12 Favored Pre-proline 0 CA--C 1.54 0.576 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.909 -179.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -69.47 171.75 51.01 Favored 'Cis proline' 0 N--CA 1.454 -0.842 0 C-N-CA 123.183 -1.591 . . . . 0.0 111.184 -5.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -128.77 146.05 51.01 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 123.612 0.765 . . . . 0.0 109.107 177.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -95.19 165.96 12.14 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 173.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -36.02 138.48 0.44 Allowed Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 125.034 1.334 . . . . 0.0 110.954 170.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -71.88 -68.43 0.02 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 123.174 2.583 . . . . 0.0 114.259 176.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 130.82 142.09 5.01 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -75.3 -66.62 0.02 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 123.468 2.778 . . . . 0.0 110.951 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.589 ' HA ' ' HB2' ' A' ' 122' ' ' ALA . . . -64.74 131.8 47.85 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.789 0.804 . . . . 0.0 111.356 178.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.406 ' HG2' ' HA ' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -139.75 150.61 44.99 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-N 114.63 -1.168 . . . . 0.0 110.057 -178.443 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.576 HG11 ' HB3' ' A' ' 20' ' ' SER . 3.6 p -88.36 119.19 35.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 O-C-N 124.58 1.175 . . . . 0.0 110.454 178.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.534 HG12 HD13 ' A' ' 121' ' ' ILE . 1.2 mp -107.25 117.8 53.74 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.011 0 N-CA-C 105.847 -1.908 . . . . 0.0 105.847 -173.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.649 ' CZ ' HD22 ' A' ' 81' ' ' LEU . 5.9 p90 -136.06 151.53 49.94 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-O 122.732 1.253 . . . . 0.0 108.213 -178.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.611 HG22 HD21 ' A' ' 80' ' ' LEU . 1.8 p -83.46 157.23 22.51 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.142 177.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.484 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -105.47 157.16 35.12 Favored Pre-proline 0 CA--C 1.552 1.022 0 O-C-N 121.966 -0.459 . . . . 0.0 111.317 178.188 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.484 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 19.1 Cg_endo -72.35 -49.77 0.21 Allowed 'Cis proline' 0 N--CA 1.454 -0.807 0 C-N-CA 124.412 -1.078 . . . . 0.0 111.375 -11.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -48.06 105.14 0.07 Allowed 'General case' 0 C--O 1.224 -0.268 0 C-N-CA 124.113 0.965 . . . . 0.0 109.24 176.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.451 ' HE2' HD22 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -61.85 79.87 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 126.113 1.765 . . . . 0.0 108.695 -178.152 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.586 HG11 ' HB2' ' A' ' 61' ' ' ASP . 39.4 t -81.41 72.8 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 104.271 -2.492 . . . . 0.0 104.271 -177.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.457 ' CZ ' ' NE2' ' A' ' 13' ' ' GLN . 47.6 t80 -36.87 106.63 0.05 OUTLIER 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 125.864 1.665 . . . . 0.0 109.827 176.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . 0.421 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 7.8 m -84.79 -45.51 12.28 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 -177.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 163.7 -146.78 11.96 Favored Glycine 0 N--CA 1.439 -1.149 0 CA-C-N 114.75 -1.113 . . . . 0.0 110.682 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.44 HG13 ' CG ' ' A' ' 4' ' ' TRP . 1.3 mm -127.5 141.1 47.27 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.925 0 N-CA-C 104.93 -2.248 . . . . 0.0 104.93 -177.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.534 HD13 HG12 ' A' ' 109' ' ' ILE . 5.7 pt -130.51 150.44 34.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -178.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.589 ' HB2' ' HA ' ' A' ' 106' ' ' ALA . . . . . . . . 0 C--N 1.321 -0.633 0 CA-C-O 121.439 0.638 . . . . 0.0 110.344 178.537 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.513 -0.446 0 N-CA-C 109.104 -0.702 . . . . 0.0 109.104 . . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.401 HD12 HG22 ' A' ' 121' ' ' ILE . 12.4 tp -82.24 136.2 35.11 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.606 -0.886 . . . . 0.0 108.606 178.006 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 64.1 m -67.08 -177.31 0.63 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 123.066 1.412 . . . . 0.0 109.979 173.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 2.1 m -158.72 124.6 4.48 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 104.836 -2.283 . . . . 0.0 104.836 -177.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.473 ' HB3' HG22 ' A' ' 2' ' ' VAL . 3.0 m80 . . . . . 0 C--N 1.324 -0.503 0 CA-C-O 117.228 -1.367 . . . . 0.0 113.238 175.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.41 HG13 ' CD2' ' A' ' 136' ' ' HIS . 7.7 p . . . . . 0 CA--C 1.531 0.228 0 CA-C-O 121.297 0.57 . . . . 0.0 111.271 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.528 HG21 HD23 ' A' ' 10' ' ' LEU . 0.9 OUTLIER -83.58 114.59 21.63 Favored 'General case' 0 C--N 1.319 -0.723 0 O-C-N 122.092 -0.38 . . . . 0.0 110.538 178.354 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 23.0 m95 -81.17 139.57 35.48 Favored 'General case' 0 C--O 1.215 -0.721 0 O-C-N 121.994 -0.441 . . . . 0.0 110.345 177.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -130.69 138.5 50.06 Favored 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -178.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.645 ' SG ' ' HB3' ' A' ' 122' ' ' ALA . 0.1 OUTLIER -122.85 61.71 1.0 Allowed 'General case' 0 N--CA 1.442 -0.852 0 O-C-N 124.092 0.87 . . . . 0.0 108.755 175.553 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 43.7 52.22 6.58 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 123.133 0.396 . . . . 0.0 112.115 179.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -164.29 -85.3 0.06 OUTLIER Glycine 0 C--O 1.224 -0.476 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -177.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -127.19 164.0 22.64 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 121.749 0.785 . . . . 0.0 110.098 177.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.528 HD23 HG21 ' A' ' 3' ' ' THR . 10.9 mp -88.69 126.09 35.15 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -177.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.495 ' CZ ' ' HB3' ' A' ' 106' ' ' ALA . 70.2 m-85 -111.3 89.73 3.13 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 126.695 1.998 . . . . 0.0 108.586 -174.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.405 HD22 ' N ' ' A' ' 13' ' ' GLN . 0.2 OUTLIER -54.71 125.39 19.73 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.265 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.544 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 7.5 tp-100 -60.59 -21.66 62.87 Favored 'General case' 0 C--O 1.213 -0.838 0 C-N-CA 119.028 -1.069 . . . . 0.0 113.249 176.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -64.64 -23.46 67.27 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 172.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.2 mtmt -103.73 -36.65 7.79 Favored 'General case' 0 C--O 1.202 -1.424 0 C-N-CA 126.492 1.917 . . . . 0.0 109.782 175.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.629 ' HA ' HG21 ' A' ' 85' ' ' THR . . . -54.27 -42.53 70.09 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 121.307 1.867 . . . . 0.0 111.736 177.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -84.13 -47.56 10.76 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-O 117.598 -1.191 . . . . 0.0 108.809 177.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.7 t -66.64 -53.01 38.62 Favored 'General case' 0 C--O 1.212 -0.884 0 CA-C-N 120.326 1.421 . . . . 0.0 109.514 -172.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.518 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 6.4 t-20 -42.78 -36.52 1.49 Allowed 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 123.946 0.898 . . . . 0.0 113.396 169.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.456 ' O ' ' HB3' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -82.01 -33.95 29.82 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 172.548 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -46.2 -37.01 6.57 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 126.469 1.908 . . . . 0.0 109.925 178.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.518 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -73.13 -48.8 32.48 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 117.635 -1.174 . . . . 0.0 112.698 175.182 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.769 ' HB1' ' HG3' ' A' ' 35' ' ' PRO . . . -36.59 128.38 0.71 Allowed Pre-proline 0 N--CA 1.442 -0.873 0 O-C-N 125.487 1.742 . . . . 0.0 112.226 173.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.552 ' HG2' HG22 ' A' ' 30' ' ' THR . 13.8 Cg_endo -73.69 125.96 10.42 Favored 'Trans proline' 0 N--CA 1.444 -1.417 0 C-N-CA 121.979 1.786 . . . . 0.0 107.573 -175.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.672 HD13 ' HE2' ' A' ' 115' ' ' LYS . 3.4 tp -61.77 84.98 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 124.552 1.141 . . . . 0.0 111.911 177.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.4 m -174.43 155.12 2.24 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.165 0.986 . . . . 0.0 110.047 -173.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -96.31 137.45 35.36 Favored 'General case' 0 CA--C 1.503 -0.849 0 CA-C-O 117.566 -1.207 . . . . 0.0 110.784 175.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 37.21 70.58 0.24 Allowed Glycine 0 C--N 1.338 0.673 0 O-C-N 125.008 1.442 . . . . 0.0 111.897 177.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -148.6 24.15 0.99 Allowed 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 121.997 0.903 . . . . 0.0 111.824 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.552 HG22 ' HG2' ' A' ' 24' ' ' PRO . 50.1 p -130.2 151.8 50.33 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -175.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -40.7 -64.98 1.1 Allowed Glycine 0 CA--C 1.505 -0.536 0 O-C-N 124.25 0.969 . . . . 0.0 112.764 -177.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 40.5 t -60.15 -60.99 2.94 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-O 115.809 -2.043 . . . . 0.0 112.641 174.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 161.16 -53.32 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.706 0 O-C-N 125.777 1.923 . . . . 0.0 111.863 176.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.485 ' CD2' ' HD3' ' A' ' 84' ' ' PRO . 62.2 m-85 -63.38 146.86 95.96 Favored Pre-proline 0 N--CA 1.438 -1.065 0 N-CA-C 114.757 1.392 . . . . 0.0 114.757 177.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.769 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 20.7 Cg_endo -75.41 166.32 83.44 Favored 'Cis proline' 0 N--CA 1.446 -1.308 0 C-N-CA 123.442 -1.483 . . . . 0.0 110.862 0.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.465 ' C ' HD23 ' A' ' 81' ' ' LEU . 0.8 OUTLIER -139.61 172.41 12.84 Favored 'General case' 0 CA--C 1.502 -0.884 0 O-C-N 120.867 -1.146 . . . . 0.0 109.89 -176.895 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.943 ' CH2' HG22 ' A' ' 39' ' ' THR . 21.3 t90 -71.4 141.4 50.32 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.889 0.852 . . . . 0.0 108.825 177.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.598 ' CZ ' HD13 ' A' ' 121' ' ' ILE . 55.4 t80 -121.05 83.0 2.0 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 -176.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.943 HG22 ' CH2' ' A' ' 37' ' ' TRP . 44.2 p -40.32 -31.23 0.13 Allowed 'General case' 0 C--O 1.212 -0.886 0 C-N-CA 124.512 1.125 . . . . 0.0 111.255 174.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.4 t30 71.32 7.67 6.14 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.039 1.735 . . . . 0.0 109.405 178.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.71 ' C ' HD23 ' A' ' 48' ' ' LEU . . . 117.58 -11.32 14.02 Favored Glycine 0 N--CA 1.434 -1.481 0 O-C-N 120.592 -1.318 . . . . 0.0 113.169 -170.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.579 ' CE2' ' HA ' ' A' ' 47' ' ' LYS . 4.9 m-85 -75.93 176.26 8.04 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 118.364 1.082 . . . . 0.0 109.852 -176.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.62 -39.11 9.26 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.563 174.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.485 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -172.49 -82.55 0.05 OUTLIER Glycine 0 C--N 1.333 0.406 0 C-N-CA 123.571 0.605 . . . . 0.0 111.983 -178.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.83 -63.1 1.15 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 122.021 0.915 . . . . 0.0 110.438 178.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.97 166.49 12.88 Favored Glycine 0 C--N 1.34 0.751 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.579 ' HA ' ' CE2' ' A' ' 42' ' ' TYR . 1.2 pttt -53.91 -176.25 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 123.13 1.443 . . . . 0.0 113.095 174.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.729 HD11 ' HG3' ' A' ' 54' ' ' PRO . 0.1 OUTLIER -65.07 156.77 79.63 Favored Pre-proline 0 C--N 1.313 -1.007 0 O-C-N 121.23 -0.919 . . . . 0.0 111.313 178.324 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -72.5 175.21 10.44 Favored 'Trans proline' 0 N--CA 1.447 -1.263 0 C-N-CA 122.225 1.95 . . . . 0.0 110.556 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.52 96.44 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.481 0 O-C-N 121.651 -0.656 . . . . 0.0 110.611 176.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.7 90.51 2.14 Favored Glycine 0 C--O 1.226 -0.4 0 CA-C-N 116.295 -0.412 . . . . 0.0 112.168 -176.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.461 ' HB3' HD22 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -173.18 162.63 4.51 Favored 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 123.808 0.843 . . . . 0.0 110.583 175.876 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 48.1 m -142.56 95.64 6.43 Favored Pre-proline 0 C--O 1.234 0.248 0 O-C-N 124.961 1.413 . . . . 0.0 110.132 -177.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.729 ' HG3' HD11 ' A' ' 48' ' ' LEU . 19.5 Cg_endo -73.31 146.84 40.9 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.531 2.154 . . . . 0.0 110.071 -179.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.413 HD12 HG21 ' A' ' 121' ' ' ILE . 5.3 mt -68.18 116.81 8.95 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.531 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -178.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.12 136.88 35.11 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 177.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.576 ' CD2' ' HB3' ' A' ' 118' ' ' CYS . 8.7 m-85 -114.96 -53.35 2.65 Favored 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 123.752 0.821 . . . . 0.0 110.128 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 128.99 -11.46 6.2 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 123.896 0.76 . . . . 0.0 112.845 -176.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.405 ' HA ' ' CE ' ' A' ' 59' ' ' LYS . 0.3 OUTLIER -90.0 132.21 35.48 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-N 117.27 0.535 . . . . 0.0 110.739 176.321 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -73.32 0.78 11.05 Favored 'General case' 0 C--O 1.223 -0.297 0 O-C-N 124.875 1.36 . . . . 0.0 111.946 175.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.428 ' OD2' HG11 ' A' ' 116' ' ' VAL . 0.6 OUTLIER -87.28 -54.37 4.34 Favored 'General case' 0 N--CA 1.446 -0.645 0 O-C-N 120.638 -1.289 . . . . 0.0 109.004 -179.948 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.442 ' HA ' HD11 ' A' ' 80' ' ' LEU . 1.8 m -75.66 -35.17 60.48 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 124.617 1.198 . . . . 0.0 109.013 -179.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -59.73 -39.97 86.5 Favored 'General case' 0 C--N 1.343 0.324 0 O-C-N 124.362 1.039 . . . . 0.0 111.286 175.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.0 159.02 0.5 Allowed Pre-proline 0 N--CA 1.446 -0.648 0 CA-C-O 122.94 1.352 . . . . 0.0 111.536 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -70.55 133.18 23.55 Favored 'Trans proline' 0 N--CA 1.437 -1.8 0 C-N-CA 120.212 0.608 . . . . 0.0 112.573 175.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.476 ' HD2' ' CD2' ' A' ' 42' ' ' TYR . 22.3 Cg_endo -72.51 170.36 19.56 Favored 'Trans proline' 0 N--CA 1.446 -1.32 0 C-N-CA 125.103 3.868 . . . . 0.0 111.239 176.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -136.85 53.0 1.92 Allowed 'General case' 0 CA--C 1.497 -1.075 0 CA-C-O 116.835 -1.555 . . . . 0.0 108.123 -177.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 21.5 t-80 -75.62 167.38 22.0 Favored 'General case' 0 C--O 1.216 -0.676 0 O-C-N 123.971 0.795 . . . . 0.0 110.933 178.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -154.18 -166.62 2.41 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 121.383 -0.823 . . . . 0.0 111.4 176.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.25 70.54 10.14 Favored 'General case' 0 C--O 1.212 -0.878 0 O-C-N 120.001 -1.687 . . . . 0.0 111.81 175.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -177.08 -41.27 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 123.33 0.652 . . . . 0.0 109.73 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.412 ' O ' ' CE2' ' A' ' 79' ' ' TYR . . . 120.81 -76.31 0.32 Allowed Glycine 0 N--CA 1.442 -0.914 0 N-CA-C 109.839 -1.305 . . . . 0.0 109.839 -177.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.414 ' HB3' ' OH ' ' A' ' 79' ' ' TYR . 2.9 p-10 -124.59 61.56 1.14 Allowed 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 -175.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -53.31 -102.94 0.01 OUTLIER Glycine 0 CA--C 1.535 1.33 0 CA-C-O 122.533 1.074 . . . . 0.0 113.855 178.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.7 mttm -72.3 -105.74 0.01 OUTLIER 'General case' 0 C--O 1.221 -0.442 0 O-C-N 120.51 -1.583 . . . . 0.0 110.916 175.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.538 HG23 ' O ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -105.36 19.04 21.26 Favored 'General case' 0 C--N 1.322 -0.597 0 O-C-N 121.05 -1.031 . . . . 0.0 110.782 179.623 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.43 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 1.2 m-20 -30.64 99.63 0.02 OUTLIER 'General case' 0 C--O 1.208 -1.117 0 C-N-CA 125.357 1.463 . . . . 0.0 110.665 -177.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.452 ' CD2' ' H ' ' A' ' 78' ' ' HIS . 0.5 OUTLIER -81.76 11.71 4.61 Favored 'General case' 0 C--O 1.221 -0.41 0 O-C-N 121.072 -1.017 . . . . 0.0 111.023 -176.703 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.872 ' CE1' HD11 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -38.6 141.46 0.26 Allowed 'General case' 0 N--CA 1.426 -1.653 0 CA-C-O 122.903 1.335 . . . . 0.0 114.559 170.625 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.586 HD22 ' CG2' ' A' ' 109' ' ' ILE . 0.2 OUTLIER -77.86 157.96 29.65 Favored 'General case' 0 CA--C 1.509 -0.611 0 O-C-N 120.448 -1.407 . . . . 0.0 109.412 177.409 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.872 HD11 ' CE1' ' A' ' 79' ' ' TYR . 1.1 mt -143.95 129.43 19.01 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 178.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.484 ' CB ' ' CD1' ' A' ' 109' ' ' ILE . 1.1 pm0 -97.17 151.54 19.71 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-O 122.917 1.342 . . . . 0.0 111.382 178.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.464 ' CE1' ' HB2' ' A' ' 23' ' ' ALA . 74.4 t80 -141.42 130.75 12.61 Favored Pre-proline 0 N--CA 1.448 -0.57 0 CA-C-N 114.801 -1.09 . . . . 0.0 111.504 -178.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.485 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 18.1 Cg_endo -75.74 97.02 1.07 Allowed 'Trans proline' 0 N--CA 1.443 -1.468 0 C-N-CA 123.995 3.13 . . . . 0.0 109.516 -177.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.629 HG21 ' HA ' ' A' ' 16' ' ' ALA . 10.5 t -101.18 116.28 32.46 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 122.233 1.016 . . . . 0.0 111.06 179.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.429 ' CD2' ' NE2' ' A' ' 90' ' ' HIS . 57.4 m-85 -82.31 159.77 63.95 Favored Pre-proline 0 N--CA 1.445 -0.676 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.101 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -77.24 -39.36 0.59 Allowed 'Trans proline' 0 N--CA 1.444 -1.398 0 C-N-CA 122.374 2.049 . . . . 0.0 112.613 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -43.58 -31.03 0.66 Allowed 'General case' 0 N--CA 1.476 0.857 0 O-C-N 125.11 1.506 . . . . 0.0 110.773 175.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.18 13.63 68.26 Favored Glycine 0 N--CA 1.436 -1.337 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 176.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.429 ' NE2' ' CD2' ' A' ' 86' ' ' PHE . 7.7 p-80 -77.93 130.06 36.1 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -59.12 90.91 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 123.801 0.84 . . . . 0.0 109.748 175.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.485 ' CD2' ' HB3' ' A' ' 94' ' ' PHE . 3.8 t80 -38.51 139.71 0.38 Allowed 'General case' 0 C--O 1.217 -0.644 0 C-N-CA 124.385 1.074 . . . . 0.0 109.295 -177.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 8.2 ptpt -77.41 64.25 2.74 Favored 'General case' 0 C--N 1.315 -0.927 0 O-C-N 119.582 -1.949 . . . . 0.0 110.359 175.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.485 ' HB3' ' CD2' ' A' ' 92' ' ' TYR . 23.1 p90 -80.09 -12.89 59.63 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 123.518 0.727 . . . . 0.0 112.544 176.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.1 -33.13 14.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 122.313 1.054 . . . . 0.0 109.888 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.1 m -82.12 110.32 17.23 Favored 'General case' 0 CA--C 1.514 -0.439 0 O-C-N 120.73 -1.231 . . . . 0.0 109.598 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.9 pttt -58.17 -49.51 76.79 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-O 121.587 0.708 . . . . 0.0 110.096 178.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 99' ' ' PRO . 6.3 tttm -140.87 126.68 11.36 Favored Pre-proline 0 N--CA 1.436 -1.149 0 C-N-CA 124.313 1.045 . . . . 0.0 110.0 -176.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.414 ' HA ' ' HA ' ' A' ' 98' ' ' LYS . 18.1 Cg_endo -71.68 176.42 37.91 Favored 'Cis proline' 0 C--N 1.352 0.711 0 O-C-N 124.545 1.813 . . . . 0.0 110.665 -3.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 20.8 tttm -141.93 135.82 29.79 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -85.02 147.76 26.52 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.153 0.908 . . . . 0.0 109.396 176.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -43.9 152.13 0.48 Allowed Pre-proline 0 C--O 1.219 -0.539 0 C-N-CA 123.325 0.65 . . . . 0.0 112.438 176.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.43 ' HB3' ' CE1' ' A' ' 34' ' ' TYR . 18.2 Cg_endo -71.83 -86.59 0.0 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.46 0 C-N-CA 121.214 1.276 . . . . 0.0 110.861 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 128.96 153.46 7.98 Favored Glycine 0 CA--C 1.529 0.925 0 O-C-N 120.84 -1.163 . . . . 0.0 111.835 -176.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -75.63 -61.15 0.04 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.404 0 C-N-CA 122.471 2.114 . . . . 0.0 110.102 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.495 ' HB3' ' CZ ' ' A' ' 11' ' ' TYR . . . -60.87 132.0 52.48 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 109.794 -0.446 . . . . 0.0 109.794 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.422 ' HG2' ' HA ' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -146.29 146.44 30.72 Favored 'General case' 0 CA--C 1.503 -0.843 0 O-C-N 124.109 0.881 . . . . 0.0 110.864 178.683 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.575 HG23 ' CD1' ' A' ' 117' ' ' PHE . 7.6 p -79.84 119.64 29.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.512 1.133 . . . . 0.0 110.243 177.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.586 ' CG2' HD22 ' A' ' 80' ' ' LEU . 7.0 mm -100.6 142.14 16.19 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.964 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.103 178.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.553 ' O ' HD23 ' A' ' 80' ' ' LEU . 10.8 p90 -164.91 153.66 12.42 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-O 122.537 1.16 . . . . 0.0 110.278 -178.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.6 p -87.18 168.6 13.09 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.47 -178.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.563 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.4 OUTLIER -114.49 152.04 45.77 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 122.124 0.17 . . . . 0.0 111.302 177.763 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.563 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 14.3 Cg_endo -75.21 -51.56 0.16 OUTLIER 'Cis proline' 0 CA--C 1.494 -1.493 0 N-CA-C 108.48 -1.392 . . . . 0.0 108.48 -4.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.482 ' HB3' HG23 ' A' ' 116' ' ' VAL . 3.0 m-20 -43.28 111.12 0.24 Allowed 'General case' 0 CA--C 1.5 -0.953 0 CA-C-O 116.59 -1.672 . . . . 0.0 109.912 179.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.672 ' HE2' HD13 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -68.66 67.96 0.14 Allowed 'General case' 0 CA--C 1.508 -0.646 0 O-C-N 125.944 2.027 . . . . 0.0 108.495 -177.989 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.483 ' O ' HG12 ' A' ' 116' ' ' VAL . 14.6 t -73.15 72.65 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 -178.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.594 ' CZ ' ' HA2' ' A' ' 119' ' ' GLY . 41.5 t80 -41.72 116.61 0.81 Allowed 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 124.701 1.2 . . . . 0.0 109.22 179.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . 0.576 ' HB3' ' CD2' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -90.91 -41.55 11.09 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-O 121.637 0.732 . . . . 0.0 109.79 178.582 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.594 ' HA2' ' CZ ' ' A' ' 117' ' ' PHE . . . 157.65 -171.65 34.83 Favored Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 111.569 -0.612 . . . . 0.0 111.569 -178.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.649 HG22 ' SG ' ' A' ' 134' ' ' CYS . 3.2 mp -109.71 147.06 14.37 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.983 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 -178.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.598 HD13 ' CZ ' ' A' ' 38' ' ' PHE . 7.0 pt -119.76 155.47 22.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 177.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.645 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . . . . . . . . 0 C--N 1.322 -0.598 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.572 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.509 -0.613 0 CA-C-O 118.736 -0.649 . . . . 0.0 109.592 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.56 HD13 ' CE2' ' A' ' 57' ' ' PHE . 10.9 tp -66.34 133.11 49.85 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . 0.649 ' SG ' HG22 ' A' ' 120' ' ' ILE . 71.3 m -57.83 -178.34 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 124.94 1.4 . . . . 0.0 110.34 176.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.2 m -161.34 112.63 1.76 Allowed 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 -178.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.41 ' CD2' HG13 ' A' ' 2' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--O 1.241 0.636 0 CA-C-O 116.106 -1.902 . . . . 0.0 113.626 172.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.4 p . . . . . 0 N--CA 1.465 0.309 0 N-CA-C 109.499 -0.556 . . . . 0.0 109.499 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.2 m -90.05 113.31 24.99 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -178.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . 0.548 ' CH2' ' CE1' ' A' ' 136' ' ' HIS . 33.1 m95 -82.61 141.06 32.84 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.038 177.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -130.65 138.23 49.97 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -177.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.729 ' SG ' ' HB3' ' A' ' 122' ' ' ALA . 0.1 OUTLIER -133.33 -77.67 0.48 Allowed 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 176.433 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -75.54 34.96 1.16 Allowed Glycine 0 CA--C 1.533 1.209 0 CA-C-O 119.606 -0.552 . . . . 0.0 113.478 -179.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 72.3 5.05 61.83 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-N 118.453 1.126 . . . . 0.0 113.911 -170.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.573 HD13 ' OH ' ' A' ' 11' ' ' TYR . 0.4 OUTLIER -107.48 139.29 42.21 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 -174.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.6 mp -94.26 129.19 41.0 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 124.256 0.973 . . . . 0.0 108.655 -174.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.573 ' OH ' HD13 ' A' ' 9' ' ' LEU . 77.6 m-85 -125.2 98.01 5.47 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 -170.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -52.77 122.81 9.85 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.485 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 6.6 tp-100 -54.7 -41.49 70.32 Favored 'General case' 0 C--O 1.21 -1.022 0 C-N-CA 119.089 -1.044 . . . . 0.0 111.781 -179.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -48.3 -44.19 33.69 Favored 'General case' 0 C--O 1.205 -1.287 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 173.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.448 ' CE ' ' HA3' ' A' ' 89' ' ' GLY . 6.6 mttt -69.93 -38.14 76.13 Favored 'General case' 0 C--O 1.211 -0.96 0 CA-C-O 117.03 -1.462 . . . . 0.0 114.295 167.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -52.9 -41.31 64.26 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 122.484 2.402 . . . . 0.0 114.081 170.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -85.98 -41.57 14.76 Favored 'General case' 0 C--O 1.214 -0.797 0 O-C-N 120.554 -1.341 . . . . 0.0 109.858 175.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 43.4 t -72.7 -59.13 2.87 Favored 'General case' 0 C--O 1.212 -0.882 0 C-N-CA 126.627 1.971 . . . . 0.0 109.665 -175.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.46 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 4.4 t-20 -39.39 -39.7 0.71 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 120.107 1.321 . . . . 0.0 113.773 168.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.501 ' O ' ' HB3' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -79.8 -33.72 40.24 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 172.965 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 6.6 m170 -48.22 -36.46 13.89 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 126.334 1.854 . . . . 0.0 110.152 178.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.46 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -73.49 -45.94 50.97 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 125.119 1.368 . . . . 0.0 111.702 176.076 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.801 ' HB1' ' HG3' ' A' ' 35' ' ' PRO . . . -39.13 130.03 1.24 Allowed Pre-proline 0 CA--C 1.539 0.552 0 O-C-N 125.411 1.694 . . . . 0.0 111.871 173.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.637 ' HG2' HG22 ' A' ' 30' ' ' THR . 17.0 Cg_endo -72.56 129.71 15.03 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 N-CA-C 107.296 -1.848 . . . . 0.0 107.296 -176.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.472 HD12 ' HA ' ' A' ' 25' ' ' LEU . 3.8 tp -63.3 83.86 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 125.265 1.426 . . . . 0.0 111.693 178.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 179.15 144.92 0.15 Allowed 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.044 0.938 . . . . 0.0 109.456 -172.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.448 ' CG ' ' H ' ' A' ' 37' ' ' TRP . 1.4 t0 -86.93 118.7 26.48 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.816 0.847 . . . . 0.0 110.134 179.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 54.16 63.65 4.98 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 175.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -127.83 11.48 6.65 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 123.412 1.577 . . . . 0.0 112.499 176.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.637 HG22 ' HG2' ' A' ' 24' ' ' PRO . 10.0 p -118.49 150.94 38.77 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 -171.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -44.04 -61.41 3.09 Favored Glycine 0 CA--C 1.506 -0.472 0 CA-C-O 119.142 -0.81 . . . . 0.0 111.959 -179.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.415 ' CA ' ' HE2' ' A' ' 100' ' ' LYS . 58.5 m -52.39 -66.96 0.29 Allowed 'General case' 0 CA--C 1.489 -1.396 0 CA-C-O 116.325 -1.798 . . . . 0.0 111.984 175.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.1 p 164.2 -64.4 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.655 0 O-C-N 126.712 2.507 . . . . 0.0 110.642 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.448 ' CD1' ' HD3' ' A' ' 84' ' ' PRO . 98.1 m-85 -59.6 149.1 72.49 Favored Pre-proline 0 N--CA 1.436 -1.172 0 CA-C-N 114.403 -1.272 . . . . 0.0 113.249 -177.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.801 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 28.7 Cg_endo -74.29 166.23 83.17 Favored 'Cis proline' 0 N--CA 1.435 -1.951 0 C-N-CA 122.405 -1.915 . . . . 0.0 111.775 -2.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 27' ' ' ASP . 0.5 OUTLIER -140.94 170.78 15.1 Favored 'General case' 0 C--O 1.214 -0.787 0 O-C-N 121.105 -0.997 . . . . 0.0 110.984 -177.891 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.856 ' CH2' HG22 ' A' ' 39' ' ' THR . 18.2 t90 -66.68 148.85 51.35 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 120.812 1.642 . . . . 0.0 109.539 173.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.477 ' CE2' ' HB2' ' A' ' 40' ' ' ASN . 11.7 t80 -120.74 86.92 2.66 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 104.079 -2.563 . . . . 0.0 104.079 -175.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.856 HG22 ' CH2' ' A' ' 37' ' ' TRP . 71.6 p -41.68 -35.77 0.84 Allowed 'General case' 0 C--O 1.214 -0.792 0 CA-C-N 114.308 -1.315 . . . . 0.0 110.252 171.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.477 ' HB2' ' CE2' ' A' ' 38' ' ' PHE . 56.3 t30 56.04 20.36 4.29 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 120.337 1.426 . . . . 0.0 111.916 178.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.72 ' C ' HD23 ' A' ' 48' ' ' LEU . . . 105.3 -41.17 2.23 Favored Glycine 0 N--CA 1.43 -1.728 0 CA-C-O 115.413 -2.882 . . . . 0.0 115.459 -167.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.425 ' CE2' ' HD3' ' A' ' 66' ' ' PRO . 83.6 m-85 -44.52 153.85 0.15 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 120.216 2.008 . . . . 0.0 112.558 174.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.59 -37.51 21.06 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 176.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.462 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -169.1 -72.58 0.04 OUTLIER Glycine 0 C--N 1.334 0.434 0 C-N-CA 124.529 1.061 . . . . 0.0 111.374 -178.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -113.59 -63.73 1.41 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.223 1.009 . . . . 0.0 110.669 -178.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.45 -173.32 0.62 Allowed Glycine 0 C--N 1.339 0.714 0 CA-C-O 122.299 0.944 . . . . 0.0 111.605 178.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.7 mttt -58.28 -171.46 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 124.555 2.121 . . . . 0.0 112.289 175.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.72 HD23 ' C ' ' A' ' 41' ' ' GLY . 0.0 OUTLIER -81.25 159.31 68.01 Favored Pre-proline 0 C--N 1.311 -1.086 0 O-C-N 120.102 -1.624 . . . . 0.0 110.232 -178.788 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -70.28 161.97 44.04 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 121.357 1.371 . . . . 0.0 109.481 177.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.47 100.26 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.993 0.917 . . . . 0.0 110.825 176.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.41 83.15 1.69 Allowed Glycine 0 N--CA 1.462 0.402 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.148 -174.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.7 mmt-85 -165.35 165.27 19.5 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 124.542 1.137 . . . . 0.0 110.993 173.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 87.6 m -140.69 96.8 7.46 Favored Pre-proline 0 N--CA 1.465 0.291 0 O-C-N 124.91 1.381 . . . . 0.0 109.538 -176.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.505 ' HB3' HD21 ' A' ' 48' ' ' LEU . 19.5 Cg_endo -72.72 145.37 41.12 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.572 2.181 . . . . 0.0 110.291 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.3 mt -69.98 120.52 17.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.4 tmtt? -81.9 136.33 35.34 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 176.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -119.75 -48.7 2.36 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 123.808 0.843 . . . . 0.0 110.39 178.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 120.78 -2.92 11.98 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 125.053 1.311 . . . . 0.0 113.246 -175.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.46 134.65 39.38 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-N 118.459 1.129 . . . . 0.0 109.854 175.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.7 t -73.49 -2.05 20.99 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 125.427 1.704 . . . . 0.0 112.141 175.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -89.47 -51.42 5.55 Favored 'General case' 0 CA--C 1.509 -0.604 0 C-N-CA 124.936 1.294 . . . . 0.0 109.305 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.882 ' HA ' HD11 ' A' ' 80' ' ' LEU . 1.8 m -74.99 -35.4 62.04 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 124.5 1.125 . . . . 0.0 111.667 177.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -64.22 -30.24 71.31 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 124.086 0.866 . . . . 0.0 112.114 172.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.54 159.21 25.65 Favored Pre-proline 0 N--CA 1.449 -0.486 0 CA-C-O 121.739 0.78 . . . . 0.0 111.751 176.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -70.38 139.41 38.04 Favored 'Trans proline' 0 CA--C 1.546 1.12 0 C-N-CA 120.45 0.767 . . . . 0.0 113.202 174.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.425 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 19.7 Cg_endo -71.85 173.37 12.84 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 124.968 3.779 . . . . 0.0 111.671 178.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -134.99 47.92 2.32 Favored 'General case' 0 C--O 1.241 0.625 0 O-C-N 120.214 -1.554 . . . . 0.0 110.981 -177.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.465 ' HA ' ' OD2' ' A' ' 77' ' ' ASP . 56.5 t-80 -65.04 130.0 41.78 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 176.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.6 t -111.74 -93.7 0.45 Allowed 'General case' 0 N--CA 1.486 1.361 0 O-C-N 119.224 -2.173 . . . . 0.0 110.384 177.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.9 mptt -68.92 -175.01 0.66 Allowed 'General case' 0 C--O 1.219 -0.539 0 C-N-CA 124.93 1.292 . . . . 0.0 110.629 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -68.81 38.93 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 173.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.54 -105.89 0.19 Allowed Glycine 0 C--O 1.217 -0.955 0 N-CA-C 107.701 -2.159 . . . . 0.0 107.701 -177.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -110.2 -89.92 0.48 Allowed 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 125.928 2.775 . . . . 0.0 106.19 -175.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 119.62 -135.27 11.09 Favored Glycine 0 N--CA 1.448 -0.565 0 O-C-N 119.294 -2.128 . . . . 0.0 110.296 -174.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 72.8 mttt -66.32 -78.69 0.05 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.2 1.0 . . . . 0.0 110.017 -176.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.514 HG23 ' O ' ' A' ' 76' ' ' THR . 0.7 OUTLIER -128.17 31.44 5.06 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 118.454 -0.784 . . . . 0.0 111.635 178.726 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.465 ' OD2' ' HA ' ' A' ' 68' ' ' HIS . 20.3 t0 -30.51 89.33 0.0 OUTLIER 'General case' 0 C--O 1.221 -0.438 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -177.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -85.52 11.92 9.59 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 119.681 -1.887 . . . . 0.0 109.322 -169.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.486 ' CD2' ' CD1' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -49.71 170.03 0.03 OUTLIER 'General case' 0 N--CA 1.438 -1.053 0 CA-C-O 123.463 1.601 . . . . 0.0 112.316 173.378 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.882 HD11 ' HA ' ' A' ' 62' ' ' CYS . 0.5 OUTLIER -95.14 141.5 28.68 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 113.634 -1.621 . . . . 0.0 109.996 172.203 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.755 HD22 ' CZ ' ' A' ' 110' ' ' TYR . 0.2 OUTLIER -123.96 129.8 51.54 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 174.492 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.425 ' HB2' HD11 ' A' ' 109' ' ' ILE . 2.2 pm0 -91.47 164.25 13.87 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 122.689 1.233 . . . . 0.0 113.26 172.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.453 ' CE1' ' HB2' ' A' ' 23' ' ' ALA . 84.1 t80 -152.04 132.42 7.36 Favored Pre-proline 0 CA--C 1.533 0.321 0 O-C-N 120.319 -1.488 . . . . 0.0 112.836 179.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.448 ' HD3' ' CD1' ' A' ' 34' ' ' TYR . 19.3 Cg_endo -73.96 108.53 2.68 Favored 'Trans proline' 0 CA--C 1.506 -0.88 1 C-N-CA 125.498 4.132 . . . . 0.0 109.632 -176.794 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -109.03 110.12 21.32 Favored 'General case' 0 CA--C 1.509 -0.627 0 O-C-N 125.435 1.709 . . . . 0.0 109.638 -178.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -81.58 158.02 69.08 Favored Pre-proline 0 C--O 1.238 0.494 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.114 178.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -75.58 -38.21 1.45 Allowed 'Trans proline' 0 CA--C 1.507 -0.829 0 C-N-CA 122.172 1.915 . . . . 0.0 112.224 179.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -45.73 -30.98 1.78 Allowed 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 123.977 1.846 . . . . 0.0 110.534 177.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.448 ' HA3' ' CE ' ' A' ' 15' ' ' LYS . . . 84.63 -0.44 89.21 Favored Glycine 0 N--CA 1.435 -1.368 0 CA-C-N 114.733 -1.121 . . . . 0.0 112.875 179.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -62.7 131.14 47.94 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 175.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -57.08 96.41 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 170.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.523 ' CD2' ' HB3' ' A' ' 94' ' ' PHE . 6.1 t80 -41.65 143.88 0.45 Allowed 'General case' 0 C--O 1.217 -0.633 0 C-N-CA 123.584 0.754 . . . . 0.0 109.532 178.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 12.5 ptpt -75.18 61.36 1.13 Allowed 'General case' 0 C--N 1.316 -0.88 0 O-C-N 119.696 -1.877 . . . . 0.0 109.096 173.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.523 ' HB3' ' CD2' ' A' ' 92' ' ' TYR . 36.3 p90 -75.8 -4.1 38.75 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 115.999 -1.953 . . . . 0.0 112.061 173.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -105.71 -26.1 11.95 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 120.417 1.462 . . . . 0.0 111.154 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 6.0 m -102.1 106.59 17.48 Favored 'General case' 0 CA--C 1.503 -0.839 0 O-C-N 120.574 -1.329 . . . . 0.0 108.8 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.8 ptpt -70.75 -32.74 70.0 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.424 0.631 . . . . 0.0 112.3 175.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 99' ' ' PRO . 29.7 tttt -129.5 113.82 18.09 Favored Pre-proline 0 CA--C 1.538 0.5 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -178.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.431 ' HA ' ' HA ' ' A' ' 98' ' ' LYS . 18.4 Cg_endo -71.4 174.09 47.4 Favored 'Cis proline' 0 C--O 1.221 -0.331 0 C-N-CA 123.82 -1.325 . . . . 0.0 111.066 -3.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.415 ' HE2' ' CA ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -133.63 128.38 34.98 Favored 'General case' 0 CA--C 1.502 -0.891 0 C-N-CA 124.6 1.16 . . . . 0.0 109.694 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -98.96 134.14 42.23 Favored 'General case' 0 C--O 1.244 0.769 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 -178.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -43.42 132.22 3.61 Favored Pre-proline 0 CA--C 1.534 0.354 0 O-C-N 124.264 0.977 . . . . 0.0 110.615 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -68.39 -163.94 0.1 OUTLIER 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 122.761 2.307 . . . . 0.0 111.623 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -123.48 161.18 17.89 Favored Glycine 0 CA--C 1.525 0.663 0 O-C-N 121.128 -0.982 . . . . 0.0 111.992 176.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -73.22 -43.28 0.74 Allowed 'Trans proline' 0 N--CA 1.449 -1.122 0 C-N-CA 121.711 1.608 . . . . 0.0 109.433 177.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.519 ' HA ' ' HB2' ' A' ' 122' ' ' ALA . . . -80.38 134.07 35.98 Favored 'General case' 0 N--CA 1.448 -0.555 0 O-C-N 124.329 1.018 . . . . 0.0 110.849 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 4.9 mtm-85 -140.35 150.22 43.68 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.569 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.441 ' C ' HD12 ' A' ' 109' ' ' ILE . 2.6 p -89.15 118.78 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 O-C-N 124.527 1.142 . . . . 0.0 111.469 177.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.59 HG12 HD13 ' A' ' 121' ' ' ILE . 1.4 mp -107.3 118.16 54.49 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.809 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 -172.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.755 ' CZ ' HD22 ' A' ' 81' ' ' LEU . 5.1 p90 -138.3 151.43 47.58 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-O 122.482 1.134 . . . . 0.0 108.032 -178.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.6 p -84.16 160.74 20.8 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.79 -1.095 . . . . 0.0 109.709 177.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.519 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -107.47 155.8 38.94 Favored Pre-proline 0 CA--C 1.555 1.14 0 CA-C-O 121.515 0.674 . . . . 0.0 110.639 178.956 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.519 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 14.9 Cg_endo -74.5 -48.94 0.25 Allowed 'Cis proline' 0 CA--C 1.506 -0.878 0 C-N-CA 124.475 -1.052 . . . . 0.0 110.574 -8.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -49.09 107.67 0.15 Allowed 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 117.171 -1.395 . . . . 0.0 108.96 177.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.416 ' CG ' ' CD1' ' A' ' 110' ' ' TYR . 0.1 OUTLIER -64.02 78.38 0.03 OUTLIER 'General case' 0 CA--C 1.508 -0.673 0 C-N-CA 125.724 1.61 . . . . 0.0 108.274 -177.965 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.436 ' O ' HG12 ' A' ' 116' ' ' VAL . 18.8 t -79.6 71.97 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 104.19 -2.522 . . . . 0.0 104.19 -176.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.485 ' CZ ' ' NE2' ' A' ' 13' ' ' GLN . 46.0 t80 -40.42 105.14 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.561 1.544 . . . . 0.0 109.036 177.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -82.86 -40.46 20.26 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-O 122.417 1.103 . . . . 0.0 109.204 -179.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.438 ' HA2' ' CH2' ' A' ' 4' ' ' TRP . . . 162.56 -148.3 15.16 Favored Glycine 0 N--CA 1.435 -1.378 0 N-CA-C 109.811 -1.315 . . . . 0.0 109.811 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.498 HG13 ' CG ' ' A' ' 4' ' ' TRP . 1.3 mm -129.57 141.98 45.09 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.382 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 -175.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.59 HD13 HG12 ' A' ' 109' ' ' ILE . 4.7 pt -127.96 154.77 38.93 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 -175.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.729 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . . . . . . . . 0 C--N 1.325 -0.491 0 CA-C-O 121.397 0.617 . . . . 0.0 109.342 178.764 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 CA--C 1.506 -0.739 0 N-CA-C 109.055 -0.72 . . . . 0.0 109.055 . . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.426 HD12 HG22 ' A' ' 121' ' ' ILE . 12.0 tp -83.45 143.93 29.93 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 124.474 1.109 . . . . 0.0 108.577 178.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . 0.415 ' SG ' HG22 ' A' ' 120' ' ' ILE . 71.5 m -65.68 -175.13 0.25 Allowed 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 122.888 1.327 . . . . 0.0 111.165 173.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 18.6 p -131.78 96.33 3.92 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -177.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.548 ' CE1' ' CH2' ' A' ' 4' ' ' TRP . 27.9 p-80 . . . . . 0 C--O 1.246 0.913 0 CA-C-O 115.346 -2.264 . . . . 0.0 112.86 172.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.5 p . . . . . 0 N--CA 1.447 -0.619 0 CA-C-O 120.687 0.28 . . . . 0.0 110.791 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.862 HG21 HD23 ' A' ' 10' ' ' LEU . 1.8 m -87.36 115.45 24.78 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 123.148 0.579 . . . . 0.0 111.071 178.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 14.5 m95 -83.1 140.58 32.56 Favored 'General case' 0 C--O 1.213 -0.858 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 m -124.55 133.84 53.17 Favored 'General case' 0 C--N 1.309 -1.155 0 O-C-N 120.478 -1.389 . . . . 0.0 108.787 -177.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.618 ' HB3' ' HB3' ' A' ' 122' ' ' ALA . 3.7 m -120.79 56.89 0.99 Allowed 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 118.215 -0.898 . . . . 0.0 109.273 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 39.64 60.62 1.73 Allowed Glycine 0 C--N 1.345 1.043 0 O-C-N 124.648 1.218 . . . . 0.0 112.088 -178.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 178.74 -81.57 0.06 OUTLIER Glycine 0 C--N 1.334 0.467 0 N-CA-C 110.881 -0.887 . . . . 0.0 110.881 -177.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.9 mt -123.97 160.11 28.32 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.45 0.643 . . . . 0.0 109.827 178.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.862 HD23 HG21 ' A' ' 3' ' ' THR . 9.0 mp -90.47 132.78 35.47 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 -177.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.669 ' CZ ' ' HB3' ' A' ' 106' ' ' ALA . 65.4 m-85 -116.43 91.08 3.48 Favored 'General case' 0 N--CA 1.433 -1.279 0 C-N-CA 127.826 2.45 . . . . 0.0 109.213 -175.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.01 127.02 28.42 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-O 117.52 -1.229 . . . . 0.0 108.514 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.605 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 0.0 OUTLIER -50.38 -50.58 51.05 Favored 'General case' 0 C--O 1.209 -1.063 0 CA-C-O 116.752 -1.594 . . . . 0.0 110.682 -179.227 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.418 ' O ' ' CB ' ' A' ' 18' ' ' SER . 11.2 t-20 -47.45 -38.48 13.66 Favored 'General case' 0 C--O 1.191 -2.011 0 O-C-N 124.633 1.208 . . . . 0.0 110.232 177.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.25 -51.43 24.62 Favored 'General case' 0 C--O 1.2 -1.52 0 CA-C-O 116.687 -1.625 . . . . 0.0 113.376 170.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.597 ' HB1' HD11 ' A' ' 120' ' ' ILE . . . -48.59 -34.63 11.91 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 121.583 1.992 . . . . 0.0 112.687 173.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -89.91 -44.04 10.17 Favored 'General case' 0 N--CA 1.435 -1.183 0 C-N-CA 123.659 0.784 . . . . 0.0 109.68 177.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.418 ' CB ' ' O ' ' A' ' 14' ' ' ASN . 30.8 t -64.58 -25.65 68.06 Favored 'General case' 0 C--O 1.205 -1.242 0 C-N-CA 126.492 1.917 . . . . 0.0 106.787 -177.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -73.6 -53.37 10.64 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 119.153 -2.217 . . . . 0.0 108.711 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.26 -12.47 61.17 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 122.08 0.943 . . . . 0.0 111.626 177.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 1.4 m170 -62.28 -50.76 70.4 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 -176.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -74.03 -41.28 62.05 Favored 'General case' 0 N--CA 1.443 -0.8 0 O-C-N 124.418 1.074 . . . . 0.0 110.091 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.706 ' HB2' ' CZ ' ' A' ' 83' ' ' PHE . . . -41.64 129.54 2.38 Favored Pre-proline 0 N--CA 1.445 -0.699 0 O-C-N 125.644 1.84 . . . . 0.0 111.332 178.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.486 ' HG2' ' CG2' ' A' ' 30' ' ' THR . 18.2 Cg_endo -73.03 126.57 11.33 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 121.923 1.748 . . . . 0.0 109.573 -177.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.876 HD21 ' O ' ' A' ' 113' ' ' PRO . 4.1 tp -59.79 88.65 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.434 0 O-C-N 124.143 0.902 . . . . 0.0 111.19 178.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -175.88 167.12 3.08 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -176.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -115.19 132.34 56.64 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 117.704 -1.141 . . . . 0.0 109.579 177.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 50.71 62.0 5.59 Favored Glycine 0 C--N 1.34 0.796 0 N-CA-C 108.254 -1.938 . . . . 0.0 108.254 172.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -151.55 35.68 0.57 Allowed 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 122.304 1.05 . . . . 0.0 110.685 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.486 ' CG2' ' HG2' ' A' ' 24' ' ' PRO . 9.2 p -144.23 153.06 41.67 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -175.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.425 ' CA ' ' HB3' ' A' ' 97' ' ' LYS . . . -36.64 -78.33 0.04 OUTLIER Glycine 0 C--N 1.34 0.776 0 O-C-N 124.307 1.005 . . . . 0.0 111.314 -178.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.462 ' O ' ' HE3' ' A' ' 100' ' ' LYS . 30.8 t -52.41 -61.52 2.23 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-O 117.681 -1.152 . . . . 0.0 110.669 177.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 162.04 -51.86 0.0 OUTLIER 'General case' 0 C--O 1.218 -0.592 0 O-C-N 125.521 1.763 . . . . 0.0 110.421 179.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.518 ' CD2' ' HD3' ' A' ' 84' ' ' PRO . 61.6 m-85 -61.82 151.33 79.73 Favored Pre-proline 0 N--CA 1.43 -1.474 0 CA-C-O 117.13 -1.414 . . . . 0.0 111.511 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.489 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 22.7 Cg_endo -73.76 164.41 87.48 Favored 'Cis proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.032 -2.07 . . . . 0.0 111.931 -3.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -140.95 162.87 34.45 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-O 116.897 -1.525 . . . . 0.0 110.6 -178.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.728 ' CH2' HG22 ' A' ' 39' ' ' THR . 18.2 t90 -60.69 139.26 57.93 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 124.143 0.902 . . . . 0.0 108.772 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.665 ' CE2' HG21 ' A' ' 109' ' ' ILE . 25.7 t80 -110.98 79.02 1.16 Allowed 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 -176.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.728 HG22 ' CH2' ' A' ' 37' ' ' TRP . 23.6 p -37.79 -34.57 0.11 Allowed 'General case' 0 C--O 1.214 -0.782 0 C-N-CA 124.265 1.026 . . . . 0.0 110.778 175.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.55 ' HB2' ' CD2' ' A' ' 38' ' ' PHE . 43.4 t30 57.63 19.25 5.28 Favored 'General case' 0 C--O 1.209 -1.068 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 174.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.805 ' C ' HD23 ' A' ' 48' ' ' LEU . . . 112.49 -46.94 1.1 Allowed Glycine 0 N--CA 1.421 -2.364 0 O-C-N 118.682 -2.511 . . . . 0.0 112.353 -171.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.659 ' N ' HD23 ' A' ' 48' ' ' LEU . 58.2 m-85 -49.63 144.87 5.55 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 124.285 1.034 . . . . 0.0 110.372 -177.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.78 -35.79 26.21 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.214 178.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -164.13 -100.32 0.15 Allowed Glycine 0 N--CA 1.442 -0.906 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.89 175.98 8.33 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 118.111 -0.947 . . . . 0.0 109.778 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.422 ' O ' ' HD2' ' A' ' 66' ' ' PRO . . . 38.51 -156.93 0.01 OUTLIER Glycine 0 C--N 1.349 1.264 0 CA-C-O 123.14 1.411 . . . . 0.0 112.08 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.487 ' HA ' ' CE1' ' A' ' 42' ' ' TYR . 0.8 OUTLIER -65.11 -172.17 0.09 Allowed 'General case' 0 N--CA 1.444 -0.737 0 O-C-N 120.267 -1.726 . . . . 0.0 111.727 174.869 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.88 HD22 ' HB3' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -87.93 174.76 4.84 Favored Pre-proline 0 N--CA 1.441 -0.924 0 O-C-N 120.51 -1.369 . . . . 0.0 109.109 -178.774 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -73.92 -175.7 2.26 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 122.335 2.023 . . . . 0.0 111.734 178.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.4 tttt -67.47 94.89 0.43 Allowed 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 121.134 -0.979 . . . . 0.0 109.751 177.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.47 91.3 1.73 Allowed Glycine 0 CA--C 1.5 -0.866 0 CA-C-O 118.807 -0.996 . . . . 0.0 110.885 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.88 ' HB3' HD22 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -177.11 155.94 1.22 Allowed 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 123.767 0.827 . . . . 0.0 110.58 177.661 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.1 m -141.33 98.31 6.66 Favored Pre-proline 0 C--N 1.327 -0.39 0 O-C-N 124.374 1.046 . . . . 0.0 110.763 -178.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -71.23 177.46 6.57 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 122.24 1.96 . . . . 0.0 112.024 179.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.41 ' CG2' ' HB2' ' A' ' 133' ' ' LEU . 5.4 mt -97.96 136.64 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -179.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . 0.543 ' O ' HD22 ' A' ' 133' ' ' LEU . 0.1 OUTLIER -91.43 155.25 18.59 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 177.697 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.606 ' CE2' HD13 ' A' ' 133' ' ' LEU . 9.4 m-85 -140.26 -47.72 0.44 Allowed 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 123.765 0.826 . . . . 0.0 111.046 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 119.73 -3.72 13.27 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 116.284 -0.416 . . . . 0.0 112.148 -177.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -95.73 134.73 38.32 Favored 'General case' 0 CA--C 1.501 -0.925 0 CA-C-O 118.096 -0.954 . . . . 0.0 108.708 -179.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.7 t -72.15 -5.33 34.77 Favored 'General case' 0 C--O 1.221 -0.428 0 O-C-N 124.971 1.419 . . . . 0.0 111.581 177.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.683 ' HB2' HG21 ' A' ' 111' ' ' THR . 0.0 OUTLIER -91.92 -51.0 5.42 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 -177.398 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.812 ' HA ' HD11 ' A' ' 80' ' ' LEU . 1.9 m -75.15 -37.52 61.32 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -178.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -59.91 -41.63 92.13 Favored 'General case' 0 C--N 1.343 0.305 0 CA-C-O 121.927 0.87 . . . . 0.0 109.857 176.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -49.41 160.69 0.53 Allowed Pre-proline 0 N--CA 1.439 -1.024 0 CA-C-O 122.672 1.225 . . . . 0.0 110.177 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -75.21 144.84 30.04 Favored 'Trans proline' 0 N--CA 1.441 -1.592 0 C-N-CA 120.99 1.126 . . . . 0.0 113.231 175.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.514 ' HG3' ' CD2' ' A' ' 42' ' ' TYR . 21.0 Cg_endo -75.25 168.75 23.97 Favored 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 123.584 2.856 . . . . 0.0 111.443 178.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.1 tptt -132.22 52.18 2.09 Favored 'General case' 0 C--O 1.207 -1.17 0 CA-C-O 117.683 -1.151 . . . . 0.0 108.899 -178.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.454 ' CE1' ' O ' ' A' ' 70' ' ' LYS . 49.0 t-80 -83.84 158.56 21.63 Favored 'General case' 0 C--O 1.216 -0.672 0 CA-C-N 119.048 0.84 . . . . 0.0 110.011 179.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -175.71 -36.23 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.6 0.76 . . . . 0.0 109.658 173.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . 0.454 ' O ' ' CE1' ' A' ' 68' ' ' HIS . 0.0 OUTLIER -81.39 -171.51 3.32 Favored 'General case' 0 C--O 1.212 -0.909 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 178.389 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -82.69 36.34 0.49 Allowed 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 122.038 0.923 . . . . 0.0 111.827 177.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.427 ' O ' ' CE2' ' A' ' 79' ' ' TYR . . . 159.82 -83.67 0.13 Allowed Glycine 0 N--CA 1.44 -1.06 0 O-C-N 120.009 -1.682 . . . . 0.0 111.051 -177.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.442 ' OD1' ' CE1' ' A' ' 79' ' ' TYR . 0.5 OUTLIER -143.73 75.89 1.49 Allowed 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 117.436 -1.269 . . . . 0.0 108.548 179.366 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . 0.414 ' CA ' ' HB2' ' A' ' 70' ' ' LYS . . . -33.52 -94.89 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 119.517 1.053 . . . . 0.0 114.719 176.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.2 mttm -85.16 -108.88 0.05 OUTLIER 'General case' 0 C--O 1.216 -0.685 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.436 176.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.605 HG23 ' O ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -101.55 21.8 13.72 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 123.892 0.877 . . . . 0.0 111.046 -179.949 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.435 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 5.6 m-20 -30.25 104.56 0.03 OUTLIER 'General case' 0 C--O 1.19 -2.035 0 C-N-CA 124.292 1.037 . . . . 0.0 111.576 -177.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.456 ' CD2' ' H ' ' A' ' 78' ' ' HIS . 0.5 OUTLIER -80.76 10.69 4.59 Favored 'General case' 0 C--N 1.314 -0.951 0 O-C-N 118.081 -2.887 . . . . 0.0 110.824 -177.206 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.862 ' CZ ' HD21 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -38.37 141.01 0.27 Allowed 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 115.65 1.722 . . . . 0.0 115.65 172.948 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.812 HD11 ' HA ' ' A' ' 62' ' ' CYS . 0.2 OUTLIER -76.68 158.49 30.98 Favored 'General case' 0 C--N 1.317 -0.811 0 O-C-N 120.101 -1.624 . . . . 0.0 110.237 178.291 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.862 HD21 ' CZ ' ' A' ' 79' ' ' TYR . 1.3 mt -140.31 133.75 29.98 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.3 pm0 -101.65 151.69 21.71 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-O 122.489 1.138 . . . . 0.0 108.906 -178.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.706 ' CZ ' ' HB2' ' A' ' 23' ' ' ALA . 7.8 t80 -141.84 132.44 12.92 Favored Pre-proline 0 N--CA 1.44 -0.969 0 O-C-N 121.33 -0.856 . . . . 0.0 111.989 -179.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.518 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 18.6 Cg_endo -74.47 93.74 0.92 Allowed 'Trans proline' 0 N--CA 1.449 -1.145 0 C-N-CA 123.657 2.905 . . . . 0.0 110.264 -177.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.3 t -93.34 119.33 32.35 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 122.437 1.113 . . . . 0.0 111.028 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.645 ' CD2' ' CE1' ' A' ' 90' ' ' HIS . 25.1 m-85 -84.43 151.83 59.82 Favored Pre-proline 0 N--CA 1.438 -1.067 0 O-C-N 121.005 -1.059 . . . . 0.0 111.029 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -78.06 -42.46 0.24 Allowed 'Trans proline' 0 CA--C 1.503 -1.073 0 C-N-CA 122.291 1.994 . . . . 0.0 112.718 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -42.9 -33.33 0.76 Allowed 'General case' 0 C--N 1.348 0.533 0 O-C-N 126.032 2.082 . . . . 0.0 110.161 176.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 99.92 16.34 28.56 Favored Glycine 0 N--CA 1.432 -1.6 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 178.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.645 ' CE1' ' CD2' ' A' ' 86' ' ' PHE . 2.0 p-80 -87.93 131.16 34.7 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.82 100.67 1.96 Allowed 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 176.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.483 ' O ' ' CD2' ' A' ' 94' ' ' PHE . 19.9 t80 -35.77 140.74 0.1 Allowed 'General case' 0 C--O 1.205 -1.271 0 CA-C-O 122.051 0.929 . . . . 0.0 112.172 177.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.406 ' CE ' ' HB2' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -77.91 61.69 2.57 Favored 'General case' 0 C--N 1.315 -0.892 0 O-C-N 119.032 -2.293 . . . . 0.0 109.418 178.648 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.483 ' CD2' ' O ' ' A' ' 92' ' ' TYR . 30.4 p90 -76.07 4.13 9.08 Favored 'General case' 0 N--CA 1.439 -1.025 0 C-N-CA 124.077 0.951 . . . . 0.0 111.832 177.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -104.45 -33.3 8.64 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-O 122.578 1.18 . . . . 0.0 109.242 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 14.3 m -98.54 95.79 7.53 Favored 'General case' 0 CA--C 1.506 -0.725 0 O-C-N 120.554 -1.341 . . . . 0.0 107.915 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.425 ' HB3' ' CA ' ' A' ' 31' ' ' GLY . 0.1 OUTLIER -73.48 -35.39 65.67 Favored 'General case' 0 C--O 1.22 -0.448 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 177.27 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -119.56 105.77 43.21 Favored Pre-proline 0 N--CA 1.437 -1.121 0 O-C-N 120.006 -1.684 . . . . 0.0 109.451 -179.355 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.415 ' HA ' ' HA ' ' A' ' 98' ' ' LYS . 24.1 Cg_endo -73.88 172.14 63.0 Favored 'Cis proline' 0 C--O 1.213 -0.737 0 O-C-N 124.416 1.745 . . . . 0.0 112.039 -1.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.462 ' HE3' ' O ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -118.2 127.32 53.64 Favored 'General case' 0 CA--C 1.511 -0.54 0 C-N-CA 123.408 0.683 . . . . 0.0 109.544 -178.798 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.406 ' HB2' ' CE ' ' A' ' 93' ' ' LYS . 9.2 tp10 -82.34 149.76 27.57 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.857 1.348 . . . . 0.0 110.218 178.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -51.31 139.25 26.57 Favored Pre-proline 0 N--CA 1.43 -1.448 0 CA-C-O 122.364 1.078 . . . . 0.0 112.546 172.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -73.61 -164.22 0.19 Allowed 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 121.689 1.593 . . . . 0.0 111.885 177.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -140.14 158.94 26.02 Favored Glycine 0 N--CA 1.441 -0.986 0 O-C-N 121.338 -0.851 . . . . 0.0 112.368 177.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -74.88 -62.56 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.471 2.114 . . . . 0.0 110.867 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.669 ' HB3' ' CZ ' ' A' ' 11' ' ' TYR . . . -67.57 133.88 50.23 Favored 'General case' 0 N--CA 1.436 -1.174 0 O-C-N 123.868 0.73 . . . . 0.0 110.488 179.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.42 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 0.0 OUTLIER -140.33 147.03 39.25 Favored 'General case' 0 CA--C 1.498 -1.039 0 CA-C-O 117.206 -1.378 . . . . 0.0 111.51 178.766 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.525 ' C ' HD12 ' A' ' 109' ' ' ILE . 3.2 p -83.24 120.14 33.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 C-N-CA 124.221 1.008 . . . . 0.0 110.985 177.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.665 HG21 ' CE2' ' A' ' 38' ' ' PHE . 1.7 mp -105.84 124.35 60.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 -175.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.553 ' C ' HD23 ' A' ' 80' ' ' LEU . 19.3 p90 -142.27 164.2 30.78 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-O 121.661 0.743 . . . . 0.0 111.074 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.683 HG21 ' HB2' ' A' ' 61' ' ' ASP . 1.6 p -91.88 163.67 13.95 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -177.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.553 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.2 OUTLIER -117.04 152.22 48.52 Favored Pre-proline 0 N--CA 1.434 -1.226 0 C-N-CA 123.292 0.637 . . . . 0.0 110.646 -179.72 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.876 ' O ' HD21 ' A' ' 25' ' ' LEU . 19.1 Cg_endo -73.48 -51.68 0.16 OUTLIER 'Cis proline' 0 CA--C 1.51 -0.717 0 C-N-CA 122.252 -1.978 . . . . 0.0 109.484 -5.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -41.64 111.69 0.25 Allowed 'General case' 0 N--CA 1.438 -1.064 0 CA-C-O 113.612 -3.089 . . . . 0.0 110.012 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.733 ' CE ' HD13 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -65.76 68.89 0.05 OUTLIER 'General case' 0 CA--C 1.508 -0.669 0 O-C-N 127.12 2.763 . . . . 0.0 108.562 -178.707 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.578 ' O ' HG12 ' A' ' 116' ' ' VAL . 24.2 t -74.29 64.28 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 106.028 -1.842 . . . . 0.0 106.028 -177.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.605 ' CZ ' ' NE2' ' A' ' 13' ' ' GLN . 2.0 t80 -36.71 124.65 0.85 Allowed 'General case' 0 N--CA 1.432 -1.347 0 O-C-N 120.61 -1.306 . . . . 0.0 108.946 178.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . 0.568 ' HB3' ' CD2' ' A' ' 57' ' ' PHE . 0.1 OUTLIER -101.41 -38.23 8.1 Favored 'General case' 0 N--CA 1.439 -1.008 0 O-C-N 123.836 0.71 . . . . 0.0 109.383 177.29 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.551 ' HA2' ' CZ ' ' A' ' 117' ' ' PHE . . . 158.68 -159.9 30.61 Favored Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 -178.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.634 HG22 ' SG ' ' A' ' 134' ' ' CYS . 3.4 mp -117.91 145.4 23.86 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.349 0 CA-C-O 117.383 -1.294 . . . . 0.0 107.947 -178.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.537 HD13 ' CE1' ' A' ' 38' ' ' PHE . 6.6 pt -110.27 158.5 10.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-N 120.959 1.708 . . . . 0.0 109.101 178.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.618 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . . . . . . . . 0 N--CA 1.44 -0.946 0 C-N-CA 124.063 0.945 . . . . 0.0 109.648 -179.95 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 11.4 ptpt . . . . . 0 CA--C 1.505 -0.786 0 CA-C-O 118.521 -0.752 . . . . 0.0 109.975 . . . . . . . . . 0 0 . 1 . 010 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.606 HD13 ' CE2' ' A' ' 57' ' ' PHE . 9.7 tp -83.99 139.71 32.37 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . 0.634 ' SG ' HG22 ' A' ' 120' ' ' ILE . 72.1 m -58.98 -174.37 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.913 0 CA-C-O 124.124 1.916 . . . . 0.0 108.594 177.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.38 120.85 0.96 Allowed 'General case' 0 C--N 1.314 -0.949 0 O-C-N 120.057 -1.652 . . . . 0.0 108.575 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 1.8 m80 . . . . . 0 C--O 1.253 1.255 0 CA-C-O 115.143 -2.36 . . . . 0.0 111.847 177.212 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.446 HG11 ' HD2' ' A' ' 136' ' ' HIS . 5.2 p . . . . . 0 C--O 1.234 0.237 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 . . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.811 HG23 HD23 ' A' ' 10' ' ' LEU . 0.9 OUTLIER -85.65 117.54 24.6 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.693 177.468 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . 0.601 ' CH2' ' CE1' ' A' ' 136' ' ' HIS . 26.9 m95 -85.02 140.76 30.78 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -136.05 132.87 36.78 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -176.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.676 ' SG ' ' HB3' ' A' ' 122' ' ' ALA . 0.5 OUTLIER -119.05 69.39 0.81 Allowed 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.651 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 34.79 86.65 0.01 OUTLIER Glycine 0 CA--C 1.53 0.983 0 C-N-CA 124.037 0.827 . . . . 0.0 113.648 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 147.78 -74.05 0.29 Allowed Glycine 0 N--CA 1.462 0.403 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 -176.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.441 HD13 ' HG3' ' A' ' 87' ' ' PRO . 5.7 mt -131.16 160.18 35.53 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.811 HD23 HG23 ' A' ' 3' ' ' THR . 0.0 OUTLIER -102.27 154.74 18.76 Favored 'General case' 0 C--O 1.218 -0.597 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.442 178.116 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.638 ' CZ ' ' HB3' ' A' ' 106' ' ' ALA . 30.6 m-85 -134.59 108.84 8.28 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -178.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -55.89 120.2 7.02 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 177.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.493 ' HB2' ' CD1' ' A' ' 4' ' ' TRP . 8.4 tp-100 -54.8 -42.01 71.28 Favored 'General case' 0 CA--C 1.503 -0.846 0 C-N-CA 119.959 -0.697 . . . . 0.0 112.387 178.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -50.35 -26.05 4.49 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 124.029 0.831 . . . . 0.0 112.306 177.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.2 mttp -96.36 -34.25 11.63 Favored 'General case' 0 C--O 1.219 -0.503 0 C-N-CA 124.569 1.148 . . . . 0.0 112.49 170.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.02 -39.52 69.2 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 120.406 1.457 . . . . 0.0 111.851 176.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -87.38 -44.56 11.27 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 122.962 0.505 . . . . 0.0 110.204 175.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.2 t -69.21 -57.67 5.06 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 118.959 0.799 . . . . 0.0 112.292 -177.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.529 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 3.9 t-20 -44.89 -30.97 1.1 Allowed 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 170.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.432 ' O ' ' HB3' ' A' ' 23' ' ' ALA . 1.5 p -83.64 -33.34 25.3 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 175.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -47.84 -36.79 12.53 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.037 0.935 . . . . 0.0 109.919 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.529 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.1 OUTLIER -70.17 -47.96 59.36 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 124.577 1.151 . . . . 0.0 110.573 177.87 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.507 ' HB1' ' HG3' ' A' ' 35' ' ' PRO . . . -39.61 127.21 1.46 Allowed Pre-proline 0 CA--C 1.537 0.447 0 O-C-N 124.602 1.189 . . . . 0.0 110.606 176.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.568 ' HG2' HG22 ' A' ' 30' ' ' THR . 18.7 Cg_endo -72.79 124.69 9.9 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 121.546 1.497 . . . . 0.0 109.096 -177.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.726 HD21 ' O ' ' A' ' 113' ' ' PRO . 3.8 tp -60.78 94.36 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 123.542 0.737 . . . . 0.0 111.291 178.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 179.89 160.35 0.84 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.35 -174.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -99.86 116.18 31.33 Favored 'General case' 0 CA--C 1.51 -0.567 0 C-N-CA 123.826 0.85 . . . . 0.0 108.898 177.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 50.51 72.47 0.49 Allowed Glycine 0 CA--C 1.528 0.873 0 O-C-N 124.394 1.059 . . . . 0.0 112.426 176.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.17 22.03 1.55 Allowed 'General case' 0 N--CA 1.473 0.708 0 O-C-N 122.429 -0.453 . . . . 0.0 112.033 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.568 HG22 ' HG2' ' A' ' 24' ' ' PRO . 33.5 p -121.91 156.8 32.58 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -176.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -43.68 -52.01 6.63 Favored Glycine 0 C--N 1.332 0.337 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.989 -178.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 12.2 t -68.03 -79.48 0.05 Allowed 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 119.306 -0.378 . . . . 0.0 111.235 173.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 89.1 p -178.42 -59.05 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 124.803 1.241 . . . . 0.0 109.83 -178.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.534 ' CE1' ' HB3' ' A' ' 103' ' ' PRO . 81.6 m-85 -63.57 148.95 93.22 Favored Pre-proline 0 CA--C 1.552 1.022 0 C-N-CA 123.303 0.641 . . . . 0.0 112.375 -176.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.507 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 25.2 Cg_endo -74.9 169.77 73.56 Favored 'Cis proline' 0 N--CA 1.455 -0.736 0 O-C-N 123.524 1.276 . . . . 0.0 112.116 1.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.753 ' C ' HD23 ' A' ' 81' ' ' LEU . 1.4 p80 -142.5 169.22 17.98 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 -177.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.899 ' CH2' HG22 ' A' ' 39' ' ' THR . 20.5 t90 -71.65 129.22 38.16 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.517 ' CZ ' HD13 ' A' ' 121' ' ' ILE . 33.9 t80 -99.48 82.74 2.7 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 105.869 -1.901 . . . . 0.0 105.869 179.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.899 HG22 ' CH2' ' A' ' 37' ' ' TRP . 41.6 p -39.51 -33.5 0.17 Allowed 'General case' 0 CA--C 1.503 -0.845 0 CA-C-N 114.337 -1.301 . . . . 0.0 110.815 170.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.499 ' HB2' ' CE2' ' A' ' 38' ' ' PHE . 59.0 t30 55.63 20.13 3.7 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 123.558 1.646 . . . . 0.0 112.125 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.464 ' C ' HD23 ' A' ' 48' ' ' LEU . . . 110.08 -44.52 1.48 Allowed Glycine 0 N--CA 1.436 -1.331 0 CA-C-O 116.039 -2.534 . . . . 0.0 113.661 -170.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.518 ' CE2' ' HD3' ' A' ' 66' ' ' PRO . 76.9 m-85 -45.94 150.99 0.5 Allowed 'General case' 0 C--N 1.343 0.296 0 C-N-CA 125.779 1.631 . . . . 0.0 110.666 -178.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.4 -37.73 27.67 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.049 178.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.436 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -164.29 -77.66 0.03 OUTLIER Glycine 0 C--N 1.335 0.503 0 N-CA-C 111.189 -0.765 . . . . 0.0 111.189 -178.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -113.22 -62.78 1.54 Allowed 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 123.289 0.636 . . . . 0.0 111.377 -178.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.6 -169.85 0.11 Allowed Glycine 0 C--N 1.342 0.892 0 C-N-CA 124.408 1.004 . . . . 0.0 111.135 177.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.9 mtpt -59.53 -169.49 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 123.279 1.514 . . . . 0.0 111.701 176.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.631 ' H ' HD12 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -93.18 176.58 2.44 Favored Pre-proline 0 C--N 1.318 -0.783 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.309 -178.091 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -70.83 158.85 54.43 Favored 'Trans proline' 0 N--CA 1.444 -1.386 0 O-C-N 123.807 1.425 . . . . 0.0 110.967 178.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.4 ttpp -64.71 97.23 0.21 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.263 176.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 119.19 40.12 0.65 Allowed Glycine 0 N--CA 1.464 0.509 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.853 -177.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.451 ' NE ' ' HA2' ' A' ' 41' ' ' GLY . 0.2 OUTLIER -122.07 159.79 26.34 Favored 'General case' 0 CA--C 1.513 -0.471 0 C-N-CA 122.837 0.455 . . . . 0.0 110.703 175.761 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 53.3 m -136.03 98.9 11.42 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.621 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -72.37 179.19 5.28 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.668 2.245 . . . . 0.0 111.275 177.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.8 mt -107.17 140.48 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -95.89 146.45 24.57 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 121.533 0.682 . . . . 0.0 109.621 176.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.568 ' CD1' ' HB3' ' A' ' 118' ' ' CYS . 24.0 m-85 -128.59 -50.14 1.27 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.263 1.025 . . . . 0.0 110.77 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 117.28 -3.18 18.57 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 123.742 0.687 . . . . 0.0 112.657 -175.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.98 133.33 42.6 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-N 117.759 0.779 . . . . 0.0 109.818 177.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 46.3 t -69.4 -6.09 27.79 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 124.749 1.281 . . . . 0.0 111.551 176.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.48 -57.16 2.98 Favored 'General case' 0 CA--C 1.517 -0.318 0 O-C-N 120.651 -1.28 . . . . 0.0 109.367 -178.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.502 ' SG ' HD21 ' A' ' 80' ' ' LEU . 2.1 t -68.9 -25.91 64.83 Favored 'General case' 0 N--CA 1.457 -0.107 0 O-C-N 124.492 1.12 . . . . 0.0 110.806 176.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -70.86 -38.45 73.14 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.367 0.603 . . . . 0.0 110.618 174.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.408 ' HD2' ' ND1' ' A' ' 78' ' ' HIS . 0.0 OUTLIER -55.44 158.16 6.05 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-O 122.163 0.982 . . . . 0.0 111.745 179.787 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -70.78 140.85 39.74 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 120.309 0.673 . . . . 0.0 113.029 175.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.518 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 19.3 Cg_endo -71.77 172.26 14.83 Favored 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 122.73 2.287 . . . . 0.0 111.514 177.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -134.18 54.67 1.93 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.899 178.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.441 ' CE1' ' O ' ' A' ' 69' ' ' SER . 49.9 t-80 -77.95 156.44 30.24 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 121.669 0.747 . . . . 0.0 110.249 -178.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.441 ' O ' ' CE1' ' A' ' 68' ' ' HIS . 0.2 OUTLIER -142.95 -166.02 2.2 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 121.251 -0.906 . . . . 0.0 110.568 179.047 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.6 72.51 10.3 Favored 'General case' 0 C--O 1.219 -0.535 0 O-C-N 121.894 -0.504 . . . . 0.0 110.647 176.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -178.58 -41.37 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.61 0.719 . . . . 0.0 110.563 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.409 ' O ' ' CE2' ' A' ' 79' ' ' TYR . . . 118.73 -48.18 0.96 Allowed Glycine 0 CA--C 1.499 -0.948 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.206 -177.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.426 ' ND2' ' CZ ' ' A' ' 112' ' ' TYR . 2.0 t-20 -147.56 85.17 1.57 Allowed 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 179.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -71.07 -119.35 0.05 OUTLIER Glycine 0 CA--C 1.529 0.909 0 CA-C-O 122.036 0.798 . . . . 0.0 111.807 177.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -52.79 -87.77 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.675 0 O-C-N 121.066 -1.255 . . . . 0.0 112.717 178.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.531 HG23 ' O ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -123.54 19.05 9.63 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.014 177.623 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.496 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 6.5 m-20 -32.18 105.18 0.03 OUTLIER 'General case' 0 CA--C 1.504 -0.815 0 C-N-CA 124.898 1.279 . . . . 0.0 109.15 -176.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.503 ' CD2' ' H ' ' A' ' 78' ' ' HIS . 3.2 p80 -88.42 18.43 4.51 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -175.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.964 ' CZ ' HD11 ' A' ' 81' ' ' LEU . 0.4 OUTLIER -40.15 135.25 1.42 Allowed 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 125.419 1.488 . . . . 0.0 110.948 173.804 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.687 HD23 ' C ' ' A' ' 110' ' ' TYR . 0.4 OUTLIER -75.45 155.37 36.34 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.851 176.113 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.964 HD11 ' CZ ' ' A' ' 79' ' ' TYR . 1.7 mp -140.69 150.49 43.54 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.883 0.373 . . . . 0.0 110.147 176.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.485 ' CB ' ' CD1' ' A' ' 109' ' ' ILE . 0.4 OUTLIER -115.76 157.53 24.2 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 122.009 0.909 . . . . 0.0 110.627 -179.699 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.493 ' HB3' HG12 ' A' ' 108' ' ' VAL . 30.3 t80 -139.99 133.76 15.46 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-O 118.698 -0.668 . . . . 0.0 112.204 -178.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.555 ' HA ' ' HG2' ' A' ' 107' ' ' ARG . 17.8 Cg_endo -70.03 87.71 0.58 Allowed 'Trans proline' 0 CA--C 1.505 -0.956 0 C-N-CA 123.937 3.091 . . . . 0.0 110.72 -174.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.64 HG22 ' HA ' ' A' ' 107' ' ' ARG . 2.7 t -83.5 129.02 34.96 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 124.237 0.961 . . . . 0.0 110.902 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.648 ' CD1' ' CD1' ' A' ' 92' ' ' TYR . 4.6 m-85 -96.54 152.34 38.55 Favored Pre-proline 0 C--O 1.237 0.395 0 C-N-CA 122.796 0.439 . . . . 0.0 110.203 -178.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . 0.441 ' HG3' HD13 ' A' ' 9' ' ' LEU . 18.8 Cg_endo -73.07 -47.74 0.31 Allowed 'Trans proline' 0 N--CA 1.447 -1.213 0 O-C-N 124.047 1.551 . . . . 0.0 112.266 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -42.74 -41.08 3.05 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 123.07 1.414 . . . . 0.0 110.278 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 94.85 18.0 36.17 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.146 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.437 ' O ' ' CE1' ' A' ' 92' ' ' TYR . 1.8 p-80 -86.69 147.48 25.86 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-N 118.061 0.931 . . . . 0.0 109.601 176.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -63.92 139.82 58.81 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 118.642 0.655 . . . . 0.0 111.902 174.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.648 ' CD1' ' CD1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -96.18 146.97 24.23 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -174.608 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.21 69.05 9.85 Favored 'General case' 0 C--N 1.32 -0.696 0 O-C-N 121.371 -0.83 . . . . 0.0 110.08 175.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.441 ' CD2' ' HZ ' ' A' ' 83' ' ' PHE . 25.7 p90 -83.55 -23.58 31.96 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.113 177.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -91.17 -23.74 20.15 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 123.012 1.387 . . . . 0.0 110.924 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.15 108.9 18.53 Favored 'General case' 0 CA--C 1.517 -0.325 0 O-C-N 120.61 -1.306 . . . . 0.0 108.575 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.97 -48.2 82.69 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 121.609 0.719 . . . . 0.0 111.067 178.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 99' ' ' PRO . 0.3 OUTLIER -139.03 128.39 14.24 Favored Pre-proline 0 CA--C 1.543 0.7 0 CA-C-N 114.508 -1.223 . . . . 0.0 110.233 -178.995 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.438 ' HA ' ' HA ' ' A' ' 98' ' ' LYS . 25.9 Cg_endo -69.78 176.3 33.19 Favored 'Cis proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.789 -1.754 . . . . 0.0 111.527 -5.126 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -140.72 122.83 15.68 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 124.005 0.922 . . . . 0.0 109.092 178.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -87.6 162.32 17.22 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 125.47 1.731 . . . . 0.0 110.006 178.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -50.53 154.49 2.22 Favored Pre-proline 0 C--O 1.222 -0.382 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.116 177.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.534 ' HB3' ' CE1' ' A' ' 34' ' ' TYR . 20.5 Cg_endo -73.7 -87.39 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 121.096 1.197 . . . . 0.0 111.912 178.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 148.7 159.9 8.78 Favored Glycine 0 CA--C 1.524 0.654 0 O-C-N 121.146 -0.971 . . . . 0.0 110.905 -178.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -76.64 -73.17 0.01 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.725 2.284 . . . . 0.0 110.949 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.638 ' HB3' ' CZ ' ' A' ' 11' ' ' TYR . . . -62.26 151.42 36.39 Favored 'General case' 0 N--CA 1.442 -0.865 0 O-C-N 123.915 0.759 . . . . 0.0 110.105 178.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.64 ' HA ' HG22 ' A' ' 85' ' ' THR . 7.8 mtm-85 -152.7 142.74 22.27 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.983 -178.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.493 HG12 ' HB3' ' A' ' 83' ' ' PHE . 4.8 p -82.09 124.61 39.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 O-C-N 124.207 0.942 . . . . 0.0 109.477 178.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.616 ' CG2' HD22 ' A' ' 80' ' ' LEU . 6.1 mm -104.65 142.0 18.92 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.722 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.87 -179.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.687 ' C ' HD23 ' A' ' 80' ' ' LEU . 9.6 p90 -163.73 147.71 10.3 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 122.271 1.034 . . . . 0.0 111.711 -178.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 9.6 p -83.6 169.74 15.07 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.388 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.588 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.6 OUTLIER -111.37 154.61 43.65 Favored Pre-proline 0 CA--C 1.552 1.035 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.295 177.812 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.726 ' O ' HD21 ' A' ' 25' ' ' LEU . 18.8 Cg_endo -73.65 -56.92 0.14 OUTLIER 'Cis proline' 0 CA--C 1.504 -1.012 0 C-N-CA 123.724 -1.365 . . . . 0.0 110.466 -6.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.512 ' O ' HG23 ' A' ' 116' ' ' VAL . 1.1 m-20 -43.79 116.62 1.0 Allowed 'General case' 0 N--CA 1.448 -0.551 0 O-C-N 123.812 0.695 . . . . 0.0 109.352 178.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.561 ' HE2' HD22 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -65.39 79.67 0.06 Allowed 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -179.001 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 114' ' ' ASN . 91.7 t -73.63 75.95 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 -177.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.436 ' CZ ' ' NE2' ' A' ' 13' ' ' GLN . 40.4 t80 -37.91 103.91 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 125.808 1.643 . . . . 0.0 109.432 -179.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . 0.568 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 10.9 m -83.25 -44.61 14.78 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -178.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 157.12 -147.71 16.36 Favored Glycine 0 N--CA 1.442 -0.906 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.49 HG13 ' CG ' ' A' ' 4' ' ' TRP . 1.2 mm -127.88 140.45 49.11 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.803 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -176.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.93 HG22 HD12 ' A' ' 133' ' ' LEU . 8.9 pt -129.05 155.24 40.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -177.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.676 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . . . . . . . . 0 C--N 1.329 -0.306 0 CA-C-O 122.407 1.098 . . . . 0.0 109.255 178.242 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 4.2 ptpt . . . . . 0 CA--C 1.514 -0.419 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.93 HD12 HG22 ' A' ' 121' ' ' ILE . 4.0 tp -84.14 148.14 26.95 Favored 'General case' 0 C--O 1.235 0.296 0 O-C-N 124.31 1.007 . . . . 0.0 109.167 178.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . 0.459 ' SG ' HG22 ' A' ' 120' ' ' ILE . 72.2 m -67.26 -174.54 0.38 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 122.316 1.055 . . . . 0.0 109.95 175.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 15.2 m -129.04 95.29 4.03 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -177.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.601 ' CE1' ' CH2' ' A' ' 4' ' ' TRP . 24.5 p-80 . . . . . 0 C--N 1.328 -0.337 0 O-C-N 123.711 0.632 . . . . 0.0 110.928 176.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.0 p . . . . . 0 CA--C 1.533 0.302 0 CA-C-O 121.864 0.84 . . . . 0.0 110.791 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.45 ' CG2' ' HB3' ' A' ' 10' ' ' LEU . 3.7 m -86.71 111.56 20.81 Favored 'General case' 0 CA--C 1.505 -0.782 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -176.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 24.8 m95 -77.29 142.7 39.32 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 123.247 0.619 . . . . 0.0 110.011 178.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -140.01 135.82 33.08 Favored 'General case' 0 CA--C 1.496 -1.114 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -179.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.665 ' SG ' ' HB3' ' A' ' 122' ' ' ALA . 0.8 OUTLIER -116.24 60.76 0.72 Allowed 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.594 177.114 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 39.22 72.27 0.22 Allowed Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.018 0.824 . . . . 0.0 112.688 -178.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 168.38 -77.46 0.11 Allowed Glycine 0 C--O 1.224 -0.49 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 -177.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 16.9 mt -126.17 162.43 25.4 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 121.749 0.785 . . . . 0.0 109.908 178.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.617 HD22 ' H ' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -89.91 165.23 14.21 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.086 -177.242 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -156.1 82.95 1.0 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 -171.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -53.46 125.76 19.1 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.546 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 7.2 tp-100 -59.43 -21.4 59.96 Favored 'General case' 0 C--O 1.217 -0.656 0 C-N-CA 118.996 -1.081 . . . . 0.0 113.776 176.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -63.16 -24.67 67.99 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 172.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.401 ' O ' ' HB2' ' A' ' 19' ' ' ASN . 6.8 mttp -101.53 -30.46 11.38 Favored 'General case' 0 C--O 1.201 -1.467 0 CA-C-O 114.038 -2.887 . . . . 0.0 111.023 174.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.42 -66.0 0.48 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 122.212 2.278 . . . . 0.0 112.204 176.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 26.4 pt-20 -61.27 -44.98 96.35 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-O 117.88 -1.057 . . . . 0.0 109.449 176.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 46.0 t -57.54 -47.86 80.88 Favored 'General case' 0 C--O 1.212 -0.909 0 CA-C-N 119.801 1.182 . . . . 0.0 109.003 -176.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.463 ' OD1' ' HA ' ' A' ' 85' ' ' THR . 5.0 t-20 -47.7 -37.1 12.36 Favored 'General case' 0 N--CA 1.442 -0.834 0 O-C-N 121.064 -1.023 . . . . 0.0 112.302 174.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.99 -29.46 39.49 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 172.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 17.9 m170 -53.19 -39.91 64.01 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 125.696 1.598 . . . . 0.0 110.539 176.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.447 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -82.16 -49.92 9.6 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-O 117.733 -1.127 . . . . 0.0 110.232 178.922 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.645 ' HB2' ' CZ ' ' A' ' 83' ' ' PHE . . . -42.15 136.63 2.23 Favored Pre-proline 0 N--CA 1.448 -0.57 0 O-C-N 125.504 1.753 . . . . 0.0 112.446 177.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.655 ' HG2' HG22 ' A' ' 30' ' ' THR . 19.1 Cg_endo -73.01 123.3 8.78 Favored 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 121.722 1.615 . . . . 0.0 109.228 -176.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.665 HD13 ' HE2' ' A' ' 115' ' ' LYS . 7.0 tp -59.62 103.07 0.17 Allowed 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.853 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.644 ' O ' HD22 ' A' ' 81' ' ' LEU . 0.3 OUTLIER -179.83 176.96 0.72 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.803 0.811 . . . . 0.0 110.5 -175.577 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.49 ' HB2' ' CE1' ' A' ' 79' ' ' TYR . 1.3 t0 -110.94 83.87 1.83 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.38 81.18 0.26 Allowed Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 173.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -149.47 40.3 0.84 Allowed 'General case' 0 CA--C 1.509 -0.62 0 O-C-N 121.852 -0.793 . . . . 0.0 111.972 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.655 HG22 ' HG2' ' A' ' 24' ' ' PRO . 17.7 p -128.2 152.22 48.32 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 -175.01 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -42.45 -49.25 5.76 Favored Glycine 0 C--N 1.334 0.47 0 CA-C-O 119.629 -0.539 . . . . 0.0 112.562 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.81 -78.31 0.06 Allowed 'General case' 0 N--CA 1.452 -0.357 0 O-C-N 123.792 0.348 . . . . 0.0 111.478 174.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 79.3 p -177.06 -65.77 0.01 OUTLIER 'General case' 0 C--O 1.22 -0.466 0 C-N-CA 125.121 1.368 . . . . 0.0 110.161 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.421 ' HA ' ' C ' ' A' ' 35' ' ' PRO . 90.7 m-85 -63.3 150.9 88.35 Favored Pre-proline 0 N--CA 1.43 -1.46 0 C-N-CA 125.498 1.519 . . . . 0.0 111.95 -176.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.989 ' HB2' HD13 ' A' ' 81' ' ' LEU . 17.2 Cg_endo -75.98 160.31 95.86 Favored 'Cis proline' 0 N--CA 1.449 -1.108 0 C-N-CA 122.621 -1.824 . . . . 0.0 110.957 2.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -135.75 166.12 24.0 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 118.197 -0.906 . . . . 0.0 109.181 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.933 ' CH2' HG22 ' A' ' 39' ' ' THR . 21.8 t90 -62.66 152.09 36.34 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 175.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.497 ' CZ ' HD13 ' A' ' 121' ' ' ILE . 18.5 t80 -128.78 78.27 1.84 Allowed 'General case' 0 N--CA 1.425 -1.7 0 N-CA-C 105.169 -2.16 . . . . 0.0 105.169 -173.204 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.933 HG22 ' CH2' ' A' ' 37' ' ' TRP . 73.1 p -39.24 -35.68 0.27 Allowed 'General case' 0 C--O 1.212 -0.899 0 C-N-CA 124.25 1.02 . . . . 0.0 110.179 173.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.425 ' HB2' ' CD2' ' A' ' 38' ' ' PHE . 44.6 t30 57.04 19.6 4.81 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 123.306 1.527 . . . . 0.0 110.023 176.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.655 ' C ' HD23 ' A' ' 48' ' ' LEU . . . 107.68 -40.8 2.39 Favored Glycine 0 N--CA 1.428 -1.846 0 CA-C-O 116.194 -2.448 . . . . 0.0 115.208 -169.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.496 ' CE2' ' HD3' ' A' ' 66' ' ' PRO . 77.0 m-85 -45.85 153.75 0.27 Allowed 'General case' 0 C--N 1.339 0.145 0 CA-C-N 119.385 1.592 . . . . 0.0 112.18 176.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.98 -36.38 27.95 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.764 0.792 . . . . 0.0 111.496 177.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.531 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -175.18 -63.6 0.05 OUTLIER Glycine 0 C--N 1.337 0.595 0 C-N-CA 124.513 1.054 . . . . 0.0 111.337 -178.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -117.88 -68.15 0.94 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.373 0.606 . . . . 0.0 111.277 -179.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.13 -173.86 0.25 Allowed Glycine 0 C--N 1.341 0.839 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 178.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.526 ' HD2' HD12 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -55.97 -174.04 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 124.874 2.273 . . . . 0.0 113.336 174.108 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.655 HD23 ' C ' ' A' ' 41' ' ' GLY . 0.0 OUTLIER -80.6 163.58 55.73 Favored Pre-proline 0 C--N 1.313 -1.016 0 O-C-N 119.837 -1.789 . . . . 0.0 110.723 -179.66 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -71.18 160.14 49.95 Favored 'Trans proline' 0 N--CA 1.446 -1.27 0 C-N-CA 122.06 1.84 . . . . 0.0 109.764 178.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.5 ttpt -50.95 99.04 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.987 0.915 . . . . 0.0 110.324 177.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.92 85.64 1.86 Allowed Glycine 0 C--O 1.227 -0.316 0 CA-C-N 116.387 -0.37 . . . . 0.0 112.652 -174.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.02 165.21 18.09 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 124.205 1.002 . . . . 0.0 111.361 174.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 93.5 m -138.46 96.05 9.93 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.023 -177.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.53 ' HB3' HD21 ' A' ' 48' ' ' LEU . 18.4 Cg_endo -72.49 145.6 42.72 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 122.355 2.036 . . . . 0.0 110.672 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.484 HD12 HG21 ' A' ' 121' ' ' ILE . 7.1 mt -73.94 119.74 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -179.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.6 tppt? -81.5 135.36 35.6 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 177.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.58 ' CD1' ' HB3' ' A' ' 118' ' ' CYS . 28.6 m-85 -113.55 -52.09 2.77 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.276 1.031 . . . . 0.0 110.587 179.119 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 121.16 -3.1 11.5 Favored Glycine 0 C--O 1.223 -0.554 0 C-N-CA 123.642 0.639 . . . . 0.0 112.85 -175.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 16.2 mttt -101.87 130.37 48.33 Favored 'General case' 0 CA--C 1.502 -0.903 0 CA-C-N 118.173 0.987 . . . . 0.0 109.26 177.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 28.1 t -63.55 -12.2 30.61 Favored 'General case' 0 C--O 1.223 -0.307 0 O-C-N 124.665 1.228 . . . . 0.0 111.581 175.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -86.99 -47.79 8.66 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.867 1.267 . . . . 0.0 110.615 178.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 71.6 m -74.68 -10.59 59.68 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 123.967 0.792 . . . . 0.0 112.731 173.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -93.24 -40.12 10.61 Favored 'General case' 0 CA--C 1.507 -0.674 0 C-N-CA 124.795 1.238 . . . . 0.0 110.151 176.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.48 158.77 0.58 Allowed Pre-proline 0 CA--C 1.539 0.53 0 CA-C-O 121.827 0.822 . . . . 0.0 111.825 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -70.76 132.94 22.69 Favored 'Trans proline' 0 N--CA 1.442 -1.534 0 C-N-CA 120.823 1.015 . . . . 0.0 113.336 174.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.496 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 17.8 Cg_endo -71.45 170.78 17.61 Favored 'Trans proline' 0 N--CA 1.446 -1.301 0 C-N-CA 123.404 2.736 . . . . 0.0 111.057 178.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.8 tptt -124.46 53.0 1.47 Allowed 'General case' 0 C--O 1.205 -1.243 0 O-C-N 121.417 -0.802 . . . . 0.0 108.954 178.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.475 ' CD2' ' CG ' ' A' ' 37' ' ' TRP . 52.3 t-80 -78.89 161.0 27.03 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 119.333 -2.104 . . . . 0.0 111.744 178.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -171.78 -163.93 0.29 Allowed 'General case' 0 CA--C 1.504 -0.812 0 O-C-N 117.813 -3.054 . . . . 0.0 109.396 175.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.31 53.66 0.14 Allowed 'General case' 0 C--O 1.215 -0.723 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 172.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . 0.402 ' O ' ' C ' ' A' ' 72' ' ' GLY . 3.5 m-20 -177.49 74.48 0.02 OUTLIER 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 -178.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.424 ' O ' ' CE2' ' A' ' 79' ' ' TYR . . . -11.68 -70.27 0.01 OUTLIER Glycine 0 C--O 1.219 -0.79 0 C-N-CA 125.175 1.369 . . . . 0.0 114.305 178.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 18.3 t30 -121.96 78.61 1.49 Allowed 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 124.924 1.29 . . . . 0.0 112.68 165.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.13 -98.8 0.04 OUTLIER Glycine 0 CA--C 1.521 0.436 0 CA-C-O 122.74 1.189 . . . . 0.0 111.546 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.0 mttt -72.12 -102.57 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.38 0 CA-C-O 122.827 1.299 . . . . 0.0 111.059 176.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.496 HG23 ' O ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -112.29 14.75 20.51 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 121.104 -0.997 . . . . 0.0 110.844 178.87 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -31.72 100.21 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.561 0 C-N-CA 124.514 1.126 . . . . 0.0 112.202 -178.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.433 ' CD2' ' H ' ' A' ' 78' ' ' HIS . 6.1 p80 -87.7 45.45 1.28 Allowed 'General case' 0 CA--C 1.516 -0.329 0 O-C-N 119.942 -1.724 . . . . 0.0 108.174 -172.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.49 ' CE1' ' HB2' ' A' ' 27' ' ' ASP . 40.7 p90 -71.07 135.52 47.78 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 124.42 1.088 . . . . 0.0 110.398 -178.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.464 ' HG ' HG22 ' A' ' 111' ' ' THR . 0.3 OUTLIER -71.5 138.2 48.75 Favored 'General case' 0 C--O 1.218 -0.57 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 176.327 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.989 HD13 ' HB2' ' A' ' 35' ' ' PRO . 0.4 OUTLIER -130.54 141.92 50.47 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 176.432 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -104.03 167.69 9.6 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-O 121.974 0.893 . . . . 0.0 112.628 174.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.645 ' CZ ' ' HB2' ' A' ' 23' ' ' ALA . 31.9 t80 -154.31 139.33 11.83 Favored Pre-proline 0 C--O 1.225 -0.209 0 O-C-N 120.974 -1.079 . . . . 0.0 113.368 178.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.519 ' HD2' ' CD1' ' A' ' 83' ' ' PHE . 19.3 Cg_endo -74.49 94.89 0.92 Allowed 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 124.346 3.364 . . . . 0.0 110.832 -175.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.463 ' HA ' ' OD1' ' A' ' 19' ' ' ASN . 6.3 t -98.86 105.24 17.37 Favored 'General case' 0 CA--C 1.508 -0.64 0 O-C-N 124.879 1.362 . . . . 0.0 112.577 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.526 ' CE1' ' CD1' ' A' ' 92' ' ' TYR . 56.4 m-85 -82.35 159.55 64.38 Favored Pre-proline 0 N--CA 1.446 -0.632 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.321 -179.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -76.55 -36.28 1.75 Allowed 'Trans proline' 0 CA--C 1.498 -1.309 0 C-N-CA 122.283 1.989 . . . . 0.0 112.973 178.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -45.87 -31.14 1.98 Allowed 'General case' 0 N--CA 1.468 0.439 0 O-C-N 125.016 1.448 . . . . 0.0 110.406 176.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.15 17.69 68.87 Favored Glycine 0 N--CA 1.438 -1.193 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 177.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -82.66 140.99 32.83 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 178.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -72.33 85.63 1.09 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 175.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.526 ' CD1' ' CE1' ' A' ' 86' ' ' PHE . 70.8 t80 -40.82 151.91 0.05 Allowed 'General case' 0 C--O 1.22 -0.472 0 CA-C-O 122.655 1.217 . . . . 0.0 111.57 -179.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.71 64.99 5.69 Favored 'General case' 0 C--N 1.314 -0.972 0 O-C-N 119.153 -2.217 . . . . 0.0 110.541 177.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.477 ' CD2' ' HZ ' ' A' ' 83' ' ' PHE . 33.2 p90 -82.2 -12.27 58.21 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 118.17 -0.919 . . . . 0.0 110.732 178.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -97.88 -30.91 12.48 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 123.782 1.753 . . . . 0.0 110.485 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 69.2 m -80.3 108.92 14.31 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 119.662 -1.899 . . . . 0.0 109.492 178.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.25 -48.56 80.04 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.611 0.72 . . . . 0.0 111.135 178.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -137.81 125.25 13.81 Favored Pre-proline 0 N--CA 1.438 -1.058 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.105 -175.729 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.432 ' HA ' ' HA ' ' A' ' 98' ' ' LYS . 25.3 Cg_endo -71.75 175.02 44.07 Favored 'Cis proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.819 -1.742 . . . . 0.0 110.84 -3.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.85 130.12 31.29 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 123.919 0.888 . . . . 0.0 109.49 178.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.465 ' HB3' ' CE1' ' A' ' 92' ' ' TYR . 0.4 OUTLIER -78.86 -177.99 5.79 Favored 'General case' 0 C--O 1.238 0.479 0 O-C-N 125.59 1.806 . . . . 0.0 112.863 177.061 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -76.74 152.36 82.91 Favored Pre-proline 0 N--CA 1.451 -0.425 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 172.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -69.92 -165.07 0.15 Allowed 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.372 2.048 . . . . 0.0 112.688 175.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -131.52 158.19 22.67 Favored Glycine 0 CA--C 1.526 0.772 0 O-C-N 121.43 -0.794 . . . . 0.0 112.799 176.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -76.02 -42.78 0.37 Allowed 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.394 2.063 . . . . 0.0 111.313 178.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.897 ' HB1' ' CG2' ' A' ' 120' ' ' ILE . . . -92.72 145.56 24.32 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 123.23 0.612 . . . . 0.0 110.709 177.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.491 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 4.4 mtm-85 -145.4 149.5 34.85 Favored 'General case' 0 CA--C 1.495 -1.136 0 CA-C-O 117.104 -1.427 . . . . 0.0 111.597 177.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.644 HG23 ' CD1' ' A' ' 117' ' ' PHE . 2.3 p -83.65 110.43 18.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 O-C-N 124.136 0.898 . . . . 0.0 110.434 178.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.411 HG12 ' CE2' ' A' ' 38' ' ' PHE . 1.7 mp -95.93 125.06 48.83 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.104 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 -174.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.615 ' CZ ' HD11 ' A' ' 81' ' ' LEU . 8.6 p90 -146.23 154.97 42.34 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.782 0.801 . . . . 0.0 109.061 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.464 HG22 ' HG ' ' A' ' 80' ' ' LEU . 1.8 p -91.79 164.8 13.57 Favored 'General case' 0 C--N 1.317 -0.817 0 O-C-N 121.931 -0.48 . . . . 0.0 109.734 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.511 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -110.88 155.77 41.84 Favored Pre-proline 0 CA--C 1.544 0.729 0 O-C-N 121.759 -0.588 . . . . 0.0 110.911 179.18 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.511 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 19.3 Cg_endo -73.18 -50.17 0.2 OUTLIER 'Cis proline' 0 CA--C 1.5 -1.188 0 C-N-CA 123.544 -1.44 . . . . 0.0 111.099 -8.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.541 ' HB3' HG23 ' A' ' 116' ' ' VAL . 1.4 m-20 -46.32 110.51 0.28 Allowed 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 115.999 -1.953 . . . . 0.0 108.846 178.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.665 ' HE2' HD13 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -67.71 68.36 0.1 Allowed 'General case' 0 CA--C 1.511 -0.549 0 O-C-N 125.904 2.003 . . . . 0.0 108.154 -178.49 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.541 HG23 ' HB3' ' A' ' 114' ' ' ASN . 72.0 t -73.66 71.43 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 105.358 -2.089 . . . . 0.0 105.358 -177.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.644 ' CD1' HG23 ' A' ' 108' ' ' VAL . 29.9 t80 -39.44 116.44 0.61 Allowed 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 125.832 1.653 . . . . 0.0 109.352 179.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . 0.58 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 4.6 m -89.09 -46.55 8.75 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -178.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.598 ' HA2' ' CZ ' ' A' ' 117' ' ' PHE . . . 155.08 -171.62 33.34 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 -179.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.897 ' CG2' ' HB1' ' A' ' 106' ' ' ALA . 2.8 mp -109.65 129.69 64.06 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.269 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 -177.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.716 HG22 HD12 ' A' ' 133' ' ' LEU . 8.9 pt -102.55 155.42 5.09 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 CA-C-N 119.535 1.061 . . . . 0.0 108.318 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.665 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . . . . . . . . 0 C--N 1.324 -0.518 0 CA-C-O 122.879 1.324 . . . . 0.0 110.07 175.561 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER . . . . . 0 CA--C 1.507 -0.684 0 N-CA-C 109.931 -0.396 . . . . 0.0 109.931 . . . . . . . . . 1 1 . 1 . 012 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.716 HD12 HG22 ' A' ' 121' ' ' ILE . 7.2 tp -83.8 147.46 27.57 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 176.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . 0.574 ' SG ' HG22 ' A' ' 120' ' ' ILE . 99.5 m -60.18 -177.67 0.07 Allowed 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 123.708 1.718 . . . . 0.0 109.985 176.219 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -162.96 109.43 1.18 Allowed 'General case' 0 C--N 1.319 -0.746 0 O-C-N 120.588 -1.32 . . . . 0.0 107.475 -177.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.254 1.303 0 CA-C-O 115.335 -2.269 . . . . 0.0 111.438 174.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.1 p . . . . . 0 C--O 1.237 0.425 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.408 HG23 ' HA ' ' A' ' 12' ' ' ASN . 2.5 m -98.78 118.34 35.3 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 124.26 1.024 . . . . 0.0 108.944 -176.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . 0.413 ' CE2' ' ND1' ' A' ' 136' ' ' HIS . 28.6 m95 -82.35 137.07 34.87 Favored 'General case' 0 CA--C 1.506 -0.716 0 O-C-N 120.851 -1.156 . . . . 0.0 109.024 -172.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -127.14 132.12 50.62 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 122.115 0.959 . . . . 0.0 108.43 -176.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.482 ' SG ' ' HB3' ' A' ' 122' ' ' ALA . 0.0 OUTLIER -121.6 66.68 0.89 Allowed 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.707 176.919 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 42.44 56.2 4.21 Favored Glycine 0 N--CA 1.471 1.019 0 O-C-N 124.061 0.851 . . . . 0.0 113.28 -176.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -168.36 -88.69 0.07 OUTLIER Glycine 0 C--O 1.226 -0.387 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 -175.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 32.5 mt -132.14 165.16 24.7 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.304 1.441 . . . . 0.0 109.983 177.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -90.83 111.04 22.27 Favored 'General case' 0 C--O 1.223 -0.336 0 C-N-CA 124.48 1.112 . . . . 0.0 110.137 179.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -89.64 111.2 22.09 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 130.635 3.574 . . . . 0.0 109.067 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.408 ' HA ' HG23 ' A' ' 3' ' ' THR . 0.1 OUTLIER -54.6 122.16 10.0 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 176.374 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.447 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 6.9 tp-100 -55.12 -48.33 73.78 Favored 'General case' 0 C--O 1.215 -0.739 0 C-N-CA 118.754 -1.178 . . . . 0.0 113.227 177.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -48.94 -37.21 19.33 Favored 'General case' 0 C--O 1.204 -1.301 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 173.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.5 mttp -71.61 -42.08 68.11 Favored 'General case' 0 C--O 1.21 -1.021 0 CA-C-O 116.369 -1.777 . . . . 0.0 113.132 167.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.528 ' HA ' HG21 ' A' ' 85' ' ' THR . . . -51.98 -48.27 64.45 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 122.828 2.558 . . . . 0.0 113.475 172.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -74.5 -47.79 31.06 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 119.0 0.818 . . . . 0.0 111.753 172.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 38.0 t -66.55 -55.73 14.09 Favored 'General case' 0 N--CA 1.481 1.098 0 O-C-N 119.738 -1.851 . . . . 0.0 112.301 -175.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -40.5 -46.15 2.4 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.711 1.205 . . . . 0.0 110.894 169.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.435 ' O ' ' HB3' ' A' ' 23' ' ' ALA . 0.1 OUTLIER -76.16 -28.87 57.54 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 126.976 2.11 . . . . 0.0 116.437 174.981 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -54.68 -35.6 63.74 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 127.802 2.441 . . . . 0.0 111.037 177.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -75.91 -42.6 48.51 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 126.569 1.948 . . . . 0.0 112.506 174.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.596 ' HB1' ' HG3' ' A' ' 35' ' ' PRO . . . -45.65 127.6 6.54 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 127.318 2.247 . . . . 0.0 111.844 175.037 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -66.28 146.66 81.7 Favored 'Trans proline' 0 N--CA 1.445 -1.346 0 C-N-CA 122.833 2.355 . . . . 0.0 111.272 -175.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.535 HD13 ' CE2' ' A' ' 112' ' ' TYR . 0.6 OUTLIER -79.72 94.57 5.76 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.613 -179.781 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.6 m 179.78 167.96 1.2 Allowed 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.711 1.604 . . . . 0.0 110.665 -174.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.453 ' HA ' ' HA ' ' A' ' 36' ' ' HIS . 0.3 OUTLIER -108.71 118.29 36.41 Favored 'General case' 0 CA--C 1.51 -0.594 0 C-N-CA 125.988 1.715 . . . . 0.0 109.169 175.12 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 55.27 62.39 6.34 Favored Glycine 0 CA--C 1.522 0.495 0 O-C-N 123.663 0.602 . . . . 0.0 112.713 171.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt -145.73 20.68 1.48 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.755 1.622 . . . . 0.0 115.243 -176.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 45.2 p -118.42 158.3 25.56 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 125.715 1.606 . . . . 0.0 108.513 179.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.45 ' HA3' ' O ' ' A' ' 95' ' ' ASP . . . -50.52 -55.01 18.46 Favored Glycine 0 CA--C 1.504 -0.596 0 N-CA-C 116.222 1.249 . . . . 0.0 116.222 -177.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.5 t -62.72 -62.06 1.99 Allowed 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 116.695 -1.621 . . . . 0.0 112.896 171.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 160.22 -42.15 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 131.427 3.891 . . . . 0.0 115.963 178.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.511 ' CD2' ' HD3' ' A' ' 84' ' ' PRO . 86.0 m-85 -78.47 147.32 71.67 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 125.182 1.393 . . . . 0.0 113.999 -177.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.596 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 35.1 Cg_endo -71.84 162.28 89.64 Favored 'Cis proline' 0 N--CA 1.441 -1.603 0 CA-C-N 120.626 1.259 . . . . 0.0 110.609 -2.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 27' ' ' ASP . 1.6 p80 -139.36 173.65 11.33 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 113.16 -1.836 . . . . 0.0 108.068 -177.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.82 ' CH2' HG22 ' A' ' 39' ' ' THR . 19.7 t90 -75.96 138.47 40.99 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 123.222 1.487 . . . . 0.0 110.78 173.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.48 ' CE2' HG21 ' A' ' 109' ' ' ILE . 28.4 t80 -106.89 91.83 3.83 Favored 'General case' 0 N--CA 1.419 -1.994 0 C-N-CA 130.297 3.439 . . . . 0.0 104.688 177.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.82 HG22 ' CH2' ' A' ' 37' ' ' TRP . 80.4 p -41.47 -37.98 1.18 Allowed 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 112.794 -2.003 . . . . 0.0 111.851 164.162 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.466 ' HA ' ' CZ ' ' A' ' 38' ' ' PHE . 65.8 t30 59.31 17.12 5.53 Favored 'General case' 0 C--O 1.213 -0.842 0 CA-C-N 118.901 0.773 . . . . 0.0 111.995 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.482 ' HA2' ' NE ' ' A' ' 52' ' ' ARG . . . 107.38 -43.3 1.72 Allowed Glycine 0 N--CA 1.44 -1.085 0 CA-C-O 115.132 -3.038 . . . . 0.0 114.62 -166.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -45.94 154.85 0.21 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 128.789 2.836 . . . . 0.0 111.667 178.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -82.04 -34.7 29.39 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 178.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.538 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -175.95 -68.38 0.06 OUTLIER Glycine 0 CA--C 1.528 0.848 0 C-N-CA 126.199 1.856 . . . . 0.0 113.036 -175.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . 0.414 ' OD2' ' HE2' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -118.78 -62.73 1.49 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 127.188 2.195 . . . . 0.0 113.955 -176.322 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.39 -168.54 1.59 Allowed Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 125.732 1.635 . . . . 0.0 111.021 178.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 43.8 pttt -59.06 -172.15 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 124.696 2.189 . . . . 0.0 113.631 173.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.601 ' H ' HD12 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -87.41 170.02 12.97 Favored Pre-proline 0 C--N 1.316 -0.852 0 CA-C-N 114.333 -1.303 . . . . 0.0 111.947 -177.755 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -62.59 164.68 17.59 Favored 'Trans proline' 0 N--CA 1.44 -1.662 0 CA-C-O 123.093 1.205 . . . . 0.0 109.955 177.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.13 102.06 0.12 Allowed 'General case' 0 C--O 1.218 -0.58 0 O-C-N 120.307 -1.495 . . . . 0.0 110.695 170.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.08 78.35 1.4 Allowed Glycine 0 N--CA 1.466 0.638 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -176.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.482 ' NE ' ' HA2' ' A' ' 41' ' ' GLY . 0.4 OUTLIER -148.93 154.48 39.48 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 124.303 1.041 . . . . 0.0 109.96 170.974 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.9 m -124.72 101.46 33.2 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 125.087 1.355 . . . . 0.0 108.882 175.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.533 ' HG3' HD21 ' A' ' 48' ' ' LEU . 32.5 Cg_endo -69.22 148.9 69.6 Favored 'Trans proline' 0 N--CA 1.444 -1.437 0 C-N-CA 123.316 2.677 . . . . 0.0 111.078 172.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.5 mt -61.19 118.38 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 175.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.0 tppt? -86.52 132.29 33.96 Favored 'General case' 0 C--N 1.332 -0.179 0 O-C-N 121.611 -0.681 . . . . 0.0 109.516 174.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.57 ' CD1' ' HB3' ' A' ' 118' ' ' CYS . 7.9 m-85 -114.84 -36.32 4.52 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.518 1.927 . . . . 0.0 112.495 178.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.47 0.42 55.59 Favored Glycine 0 N--CA 1.474 1.221 0 C-N-CA 125.494 1.521 . . . . 0.0 114.114 -172.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.45 134.78 42.88 Favored 'General case' 0 CA--C 1.506 -0.726 0 C-N-CA 123.939 0.896 . . . . 0.0 111.299 175.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 79.6 p -68.91 -8.78 47.43 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.092 0.957 . . . . 0.0 113.502 176.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.708 ' HB2' HG21 ' A' ' 111' ' ' THR . 0.0 OUTLIER -84.03 -52.3 6.42 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 126.926 2.09 . . . . 0.0 108.977 176.091 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.438 ' HB2' ' CD2' ' A' ' 57' ' ' PHE . 3.7 m -78.75 -15.49 58.38 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -179.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -86.05 -30.8 22.35 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 127.212 2.205 . . . . 0.0 111.977 167.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.43 153.86 13.3 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 119.463 1.029 . . . . 0.0 113.76 179.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -67.11 136.85 42.21 Favored 'Trans proline' 0 CA--C 1.553 1.43 0 C-N-CA 120.363 0.709 . . . . 0.0 111.789 173.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.449 ' HB3' ' HA ' ' A' ' 79' ' ' TYR . 19.6 Cg_endo -67.09 174.76 6.46 Favored 'Trans proline' 0 N--CA 1.459 -0.539 1 C-N-CA 125.428 4.085 . . . . 0.0 113.225 175.421 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . 0.414 ' HE2' ' OD2' ' A' ' 45' ' ' ASP 0.355 4.2 mmtt -133.9 41.21 3.03 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 116.073 1.879 . . . . 0.0 116.073 178.35 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.536 ' HA ' ' OD2' ' A' ' 77' ' ' ASP 0.312 56.3 t-80 -58.32 152.3 17.8 Favored 'General case' 0 C--O 1.218 -0.564 0 CA-C-O 124.798 2.237 . . . . 0.0 114.284 -177.527 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -148.56 -172.13 4.02 Favored 'General case' 0 CA--C 1.512 -0.51 0 O-C-N 119.777 -1.827 . . . . 0.0 111.026 179.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.02 69.79 5.25 Favored 'General case' 0 C--O 1.213 -0.821 0 O-C-N 121.151 -0.968 . . . . 0.0 112.002 172.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -170.03 -45.43 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 124.158 0.983 . . . . 0.0 111.887 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 133.98 -66.75 0.56 Allowed Glycine 0 C--O 1.204 -1.738 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 -179.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.501 ' H ' ' ND2' ' A' ' 73' ' ' ASN . 0.1 OUTLIER -107.48 -3.24 19.65 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 130.311 3.444 . . . . 0.0 113.417 -176.411 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 34.4 -122.13 0.42 Allowed Glycine 0 C--O 1.221 -0.712 0 C-N-CA 128.282 2.849 . . . . 0.0 113.783 -176.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 24.4 mttt -69.72 -79.02 0.06 Allowed 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 115.209 1.559 . . . . 0.0 115.209 167.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -123.45 11.22 9.26 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-O 116.676 -1.63 . . . . 0.0 111.957 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.536 ' OD2' ' HA ' ' A' ' 68' ' ' HIS . 58.1 t0 -17.78 94.53 0.01 OUTLIER 'General case' 0 C--O 1.214 -0.792 0 C-N-CA 126.689 1.996 . . . . 0.0 114.293 -171.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.43 ' CD2' ' H ' ' A' ' 78' ' ' HIS . 19.2 p80 -84.32 11.47 8.32 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -172.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.843 ' CZ ' HD21 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -43.87 162.42 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 126.684 1.994 . . . . 0.0 113.223 169.372 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -83.02 150.45 26.34 Favored 'General case' 0 N--CA 1.427 -1.585 0 CA-C-N 113.236 -1.802 . . . . 0.0 110.441 169.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.843 HD21 ' CZ ' ' A' ' 79' ' ' TYR . 1.6 mt -132.42 130.47 40.65 Favored 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 123.743 0.817 . . . . 0.0 109.218 173.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.06 155.19 17.23 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 123.734 0.814 . . . . 0.0 112.088 176.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.463 ' HZ ' ' CE2' ' A' ' 94' ' ' PHE . 59.8 t80 -149.05 127.16 5.82 Favored Pre-proline 0 CA--C 1.551 1.004 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 179.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.511 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 23.4 Cg_endo -71.59 94.78 0.69 Allowed 'Trans proline' 0 N--CA 1.45 -1.065 1 C-N-CA 126.062 4.508 . . . . 0.0 110.119 -176.093 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.528 HG21 ' HA ' ' A' ' 16' ' ' ALA . 6.2 t -94.49 114.3 26.28 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 113.233 -1.803 . . . . 0.0 110.127 178.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -82.31 154.25 69.15 Favored Pre-proline 0 CA--C 1.54 0.581 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.136 178.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -73.31 -35.12 5.28 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.953 2.435 . . . . 0.0 115.204 177.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -50.79 -30.95 15.47 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 128.182 2.593 . . . . 0.0 110.983 175.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.27 11.53 82.08 Favored Glycine 0 CA--C 1.499 -0.955 0 CA-C-N 114.568 -1.197 . . . . 0.0 115.067 177.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . 0.255 5.2 p-80 -62.36 132.37 52.38 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 171.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -56.76 99.51 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 157.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -47.07 137.02 8.06 Favored 'General case' 0 N--CA 1.436 -1.153 0 O-C-N 118.823 -2.423 . . . . 0.0 108.484 169.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.36 59.01 1.02 Allowed 'General case' 0 C--N 1.324 -0.536 0 O-C-N 120.786 -1.196 . . . . 0.0 112.326 171.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.463 ' CE2' ' HZ ' ' A' ' 83' ' ' PHE . 32.6 p90 -71.72 -29.43 64.54 Favored 'General case' 0 C--O 1.219 -0.506 0 C-N-CA 124.794 1.237 . . . . 0.0 112.644 173.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.45 ' O ' ' HA3' ' A' ' 31' ' ' GLY . 1.1 t70 -75.65 -38.9 58.46 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.527 1.931 . . . . 0.0 111.402 175.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.3 t -77.75 107.76 10.49 Favored 'General case' 0 C--N 1.33 -0.248 0 O-C-N 121.33 -0.856 . . . . 0.0 109.046 -176.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.5 pttt -60.35 -41.17 93.09 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 122.593 1.187 . . . . 0.0 114.109 178.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -145.24 131.13 9.54 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 114.174 -1.376 . . . . 0.0 110.837 178.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.67 165.21 70.39 Favored 'Cis proline' 0 N--CA 1.455 -0.771 0 O-C-N 123.283 1.149 . . . . 0.0 110.349 -11.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.37 148.5 47.49 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 125.484 1.513 . . . . 0.0 107.712 177.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -96.14 171.0 8.88 Favored 'General case' 0 C--N 1.319 -0.761 0 O-C-N 124.014 0.821 . . . . 0.0 109.577 169.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -46.5 152.17 0.91 Allowed Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 127.424 2.29 . . . . 0.0 111.865 168.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -72.74 -84.77 0.0 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.336 0 C-N-CA 123.107 2.538 . . . . 0.0 112.284 176.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 138.48 146.07 4.93 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.069 -1.213 . . . . 0.0 110.069 -178.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -76.62 -67.5 0.02 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 124.062 3.175 . . . . 0.0 112.162 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.405 ' HA ' ' HB2' ' A' ' 122' ' ' ALA . . . -68.99 132.16 46.23 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 123.125 1.44 . . . . 0.0 111.658 176.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.68 152.12 48.95 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 113.615 -1.63 . . . . 0.0 110.194 -177.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.418 ' CG1' ' HB3' ' A' ' 83' ' ' PHE . 2.5 p -87.54 116.62 30.04 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.642 0 C-N-CA 125.247 1.419 . . . . 0.0 109.438 175.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.48 HG21 ' CE2' ' A' ' 38' ' ' PHE . 1.6 mp -104.22 115.64 46.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 104.877 -2.268 . . . . 0.0 104.877 -178.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -126.81 156.22 41.63 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 114.48 -1.236 . . . . 0.0 108.467 177.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.708 HG21 ' HB2' ' A' ' 61' ' ' ASP . 3.2 p -82.98 166.48 18.79 Favored 'General case' 0 CA--C 1.505 -0.783 0 C-N-CA 124.844 1.258 . . . . 0.0 111.277 177.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.535 ' CE2' HD13 ' A' ' 25' ' ' LEU 0.276 8.7 t80 -109.94 158.49 34.86 Favored Pre-proline 0 CA--C 1.544 0.748 0 O-C-N 120.962 -1.086 . . . . 0.0 112.33 176.333 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.525 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 18.9 Cg_endo -69.01 -41.9 0.81 Allowed 'Cis proline' 0 C--N 1.348 0.516 0 N-CA-C 114.794 1.036 . . . . 0.0 114.794 -21.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.469 ' HB3' HG23 ' A' ' 116' ' ' VAL . 1.3 t-20 -50.37 106.48 0.12 Allowed 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 125.528 1.531 . . . . 0.0 108.92 170.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.503 ' HE2' HD21 ' A' ' 25' ' ' LEU . 2.3 mtmt -67.12 65.41 0.06 Allowed 'General case' 0 C--N 1.339 0.111 0 C-N-CA 127.959 2.503 . . . . 0.0 108.792 177.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.469 HG23 ' HB3' ' A' ' 114' ' ' ASN . 47.3 t -72.93 86.54 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.586 0 N-CA-C 103.254 -2.869 . . . . 0.0 103.254 175.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.451 ' CZ ' ' HA2' ' A' ' 119' ' ' GLY . 37.8 t80 -46.12 103.8 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 129.142 2.977 . . . . 0.0 109.427 176.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . 0.57 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 22.4 m -80.21 -41.7 24.68 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 122.884 1.326 . . . . 0.0 110.447 -176.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.451 ' HA2' ' CZ ' ' A' ' 117' ' ' PHE . . . 159.44 -154.22 25.28 Favored Glycine 0 N--CA 1.433 -1.552 0 CA-C-N 113.651 -1.613 . . . . 0.0 110.09 -178.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.424 HD11 ' CB ' ' A' ' 16' ' ' ALA . 1.3 mm -123.08 147.99 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 N-CA-C 105.208 -2.145 . . . . 0.0 105.208 -179.092 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.418 HG12 ' CD1' ' A' ' 109' ' ' ILE . 4.3 pt -136.99 151.65 27.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 O-C-N 119.851 -1.781 . . . . 0.0 109.175 179.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.482 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . . . . . . . . 0 C--N 1.324 -0.5 0 CA-C-O 121.742 0.782 . . . . 0.0 110.355 176.747 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER . . . . . 0 CA--C 1.513 -0.448 0 N-CA-C 109.057 -0.72 . . . . 0.0 109.057 . . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 14.7 tp -77.4 141.67 39.67 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.036 173.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . 0.419 ' SG ' HG22 ' A' ' 120' ' ' ILE . 34.9 m -70.56 176.78 3.86 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 126.448 1.899 . . . . 0.0 111.243 169.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 92.5 p -142.37 100.45 3.7 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 105.284 -2.117 . . . . 0.0 105.284 -177.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.413 ' ND1' ' CE2' ' A' ' 4' ' ' TRP . 0.5 OUTLIER . . . . . 0 C--O 1.246 0.921 0 CA-C-O 114.972 -2.442 . . . . 0.0 114.671 165.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.655 HG22 ' HB2' ' A' ' 136' ' ' HIS . 11.0 p . . . . . 0 N--CA 1.449 -0.485 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.55 HG21 HD23 ' A' ' 10' ' ' LEU . 1.1 m -84.46 112.38 20.33 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-O 121.546 0.688 . . . . 0.0 110.008 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . 0.497 ' CG ' HG13 ' A' ' 120' ' ' ILE . 27.5 m95 -78.44 138.08 38.3 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 123.877 0.871 . . . . 0.0 111.248 175.089 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 m -120.16 120.52 36.43 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -177.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.876 ' HB3' ' HB3' ' A' ' 122' ' ' ALA . 55.6 m -106.88 51.89 0.73 Allowed 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.581 178.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 45.46 48.06 11.79 Favored Glycine 0 C--O 1.218 -0.863 0 O-C-N 123.951 0.782 . . . . 0.0 111.974 -176.964 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -162.2 -80.97 0.04 OUTLIER Glycine 0 C--O 1.225 -0.407 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 -177.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.6 mt -127.39 163.91 23.01 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.148 0.499 . . . . 0.0 110.008 177.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.55 HD23 HG21 ' A' ' 3' ' ' THR . 9.2 mp -85.55 133.78 34.05 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.144 -179.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.504 ' CE2' ' CB ' ' A' ' 106' ' ' ALA . 64.5 m-85 -122.89 110.37 15.34 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 124.41 1.084 . . . . 0.0 110.17 -175.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -65.74 119.16 10.7 Favored 'General case' 0 N--CA 1.444 -0.751 0 O-C-N 120.335 -1.478 . . . . 0.0 108.517 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.462 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 7.0 tp-100 -48.47 -42.46 32.77 Favored 'General case' 0 C--O 1.197 -1.687 0 CA-C-N 118.542 0.61 . . . . 0.0 111.518 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.4 ' O ' ' CB ' ' A' ' 18' ' ' SER . 21.2 t30 -48.8 -48.36 41.43 Favored 'General case' 0 C--O 1.189 -2.087 0 CA-C-N 117.785 0.266 . . . . 0.0 111.106 175.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -67.28 -34.94 78.45 Favored 'General case' 0 C--O 1.196 -1.742 0 O-C-N 120.641 -1.287 . . . . 0.0 112.502 171.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.37 -45.1 80.68 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 121.337 1.88 . . . . 0.0 113.106 172.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.401 ' O ' ' CD2' ' A' ' 21' ' ' HIS . 4.2 pt-20 -85.94 -37.8 18.67 Favored 'General case' 0 C--O 1.206 -1.197 0 CA-C-O 118.575 -0.726 . . . . 0.0 109.14 178.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.4 ' CB ' ' O ' ' A' ' 14' ' ' ASN . 47.8 t -71.75 -61.29 1.83 Allowed 'General case' 0 CA--C 1.5 -0.947 0 C-N-CA 126.6 1.96 . . . . 0.0 108.819 -177.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.51 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 8.7 t-20 -40.97 -35.93 0.59 Allowed 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 119.285 0.948 . . . . 0.0 112.555 173.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.421 ' O ' ' HB3' ' A' ' 23' ' ' ALA . 0.2 OUTLIER -81.61 -37.96 26.77 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 174.228 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.401 ' CD2' ' O ' ' A' ' 17' ' ' GLU . 5.5 m170 -44.09 -39.2 4.07 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 126.436 1.894 . . . . 0.0 109.518 178.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.51 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -73.41 -49.09 28.9 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-O 118.435 -0.793 . . . . 0.0 112.1 175.77 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.585 ' HB1' ' HG3' ' A' ' 35' ' ' PRO . . . -35.64 129.77 0.57 Allowed Pre-proline 0 N--CA 1.439 -1.006 0 O-C-N 124.634 1.209 . . . . 0.0 112.566 174.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.703 ' HG2' HG22 ' A' ' 30' ' ' THR . 19.4 Cg_endo -73.4 124.23 9.26 Favored 'Trans proline' 0 N--CA 1.442 -1.54 0 C-N-CA 121.898 1.732 . . . . 0.0 109.707 -176.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.753 HD13 ' HE2' ' A' ' 115' ' ' LYS . 5.4 tp -60.44 95.45 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.103 0.561 . . . . 0.0 110.925 179.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.477 ' O ' HD22 ' A' ' 81' ' ' LEU . 0.4 OUTLIER 179.13 173.07 0.8 Allowed 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 123.322 0.649 . . . . 0.0 110.445 -176.745 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -109.25 119.37 39.28 Favored 'General case' 0 CA--C 1.511 -0.53 0 C-N-CA 124.101 0.961 . . . . 0.0 109.934 179.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 45.98 64.06 2.62 Favored Glycine 0 C--O 1.225 -0.413 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.209 177.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . 0.421 ' CD ' ' HB2' ' A' ' 26' ' ' SER . 3.0 ptmt -127.5 8.51 6.47 Favored 'General case' 0 CA--C 1.511 -0.543 0 O-C-N 122.247 -0.56 . . . . 0.0 111.463 179.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.703 HG22 ' HG2' ' A' ' 24' ' ' PRO . 8.1 p -115.06 152.45 32.47 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -174.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -39.37 -59.16 1.92 Allowed Glycine 0 C--N 1.335 0.493 0 O-C-N 124.001 0.813 . . . . 0.0 112.544 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 29.7 t -62.46 -63.3 1.27 Allowed 'General case' 0 N--CA 1.441 -0.895 0 CA-C-O 116.273 -1.822 . . . . 0.0 111.166 176.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 159.63 -57.85 0.0 OUTLIER 'General case' 0 C--O 1.221 -0.418 0 O-C-N 126.085 2.115 . . . . 0.0 109.537 179.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.526 ' CD2' ' HD3' ' A' ' 84' ' ' PRO . 55.3 m-85 -55.8 145.09 53.8 Favored Pre-proline 0 N--CA 1.434 -1.229 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 179.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.585 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 22.5 Cg_endo -74.4 163.4 90.4 Favored 'Cis proline' 0 N--CA 1.447 -1.221 0 C-N-CA 122.822 -1.741 . . . . 0.0 111.428 -1.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.773 ' C ' HD23 ' A' ' 81' ' ' LEU . 1.5 p80 -137.22 175.1 9.91 Favored 'General case' 0 C--O 1.212 -0.914 0 O-C-N 120.981 -1.074 . . . . 0.0 110.339 -177.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.838 ' CZ3' HG22 ' A' ' 39' ' ' THR . 21.0 t90 -75.15 130.83 39.87 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.545 ' CE1' ' CD1' ' A' ' 121' ' ' ILE . 42.2 t80 -101.81 77.74 1.75 Allowed 'General case' 0 N--CA 1.427 -1.608 0 C-N-CA 126.009 1.724 . . . . 0.0 107.309 -178.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.838 HG22 ' CZ3' ' A' ' 37' ' ' TRP . 64.0 p -39.63 -31.78 0.11 Allowed 'General case' 0 C--O 1.215 -0.716 0 C-N-CA 124.297 1.039 . . . . 0.0 110.694 175.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.414 ' HB2' ' CD2' ' A' ' 38' ' ' PHE . 43.7 t30 60.47 14.08 4.57 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 122.861 1.315 . . . . 0.0 109.147 177.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.529 ' C ' HD23 ' A' ' 48' ' ' LEU . . . 116.3 -40.3 2.44 Favored Glycine 0 N--CA 1.423 -2.178 0 O-C-N 119.556 -1.965 . . . . 0.0 111.875 -174.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.734 ' N ' HD23 ' A' ' 48' ' ' LEU . 65.0 m-85 -49.54 156.12 0.69 Allowed 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.732 1.213 . . . . 0.0 110.392 -178.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.37 -39.4 20.74 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.576 178.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.416 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -162.41 -76.67 0.03 OUTLIER Glycine 0 C--N 1.339 0.741 0 C-N-CA 123.715 0.674 . . . . 0.0 111.623 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -114.0 -63.81 1.4 Allowed 'General case' 0 CA--C 1.509 -0.62 0 C-N-CA 122.514 0.326 . . . . 0.0 110.959 -179.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.12 -168.25 0.07 OUTLIER Glycine 0 C--N 1.353 1.513 0 O-C-N 124.274 0.983 . . . . 0.0 111.119 178.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.1 -164.43 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 124.62 2.152 . . . . 0.0 111.987 176.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.734 HD23 ' N ' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -105.9 178.04 1.21 Allowed Pre-proline 0 N--CA 1.433 -1.311 0 O-C-N 119.647 -1.908 . . . . 0.0 110.568 -179.478 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . 0.403 ' CD ' ' CB ' ' A' ' 48' ' ' LEU . 23.9 Cg_endo -73.01 177.61 7.54 Favored 'Trans proline' 0 N--CA 1.444 -1.416 0 C-N-CA 122.138 1.892 . . . . 0.0 111.685 178.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.8 tttm -83.83 102.0 12.03 Favored 'General case' 0 N--CA 1.444 -0.767 0 O-C-N 120.955 -1.091 . . . . 0.0 109.87 177.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 117.96 65.12 0.32 Allowed Glycine 0 C--O 1.223 -0.577 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.726 ' CD ' HD13 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -153.23 176.3 12.11 Favored 'General case' 0 CA--C 1.51 -0.574 0 C-N-CA 123.066 0.547 . . . . 0.0 110.625 178.72 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.9 m -154.24 107.0 2.43 Favored Pre-proline 0 C--O 1.215 -0.711 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.786 173.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -71.26 174.4 10.82 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 121.879 1.719 . . . . 0.0 111.783 178.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.506 HD12 HG21 ' A' ' 121' ' ' ILE . 4.1 mt -95.11 132.95 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.2 136.68 39.72 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.446 ' CD1' HD13 ' A' ' 133' ' ' LEU . 8.2 m-85 -121.94 -52.99 1.97 Allowed 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 123.098 0.559 . . . . 0.0 109.959 -179.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 126.45 -6.37 7.57 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 123.654 0.645 . . . . 0.0 112.285 -176.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.73 131.52 37.05 Favored 'General case' 0 CA--C 1.5 -0.975 0 CA-C-O 118.087 -0.958 . . . . 0.0 109.207 178.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 87.5 p -67.05 -7.53 23.48 Favored 'General case' 0 C--O 1.22 -0.496 0 O-C-N 125.056 1.473 . . . . 0.0 111.532 176.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.467 ' HB2' HG11 ' A' ' 116' ' ' VAL . 9.5 m-20 -89.64 -56.88 3.07 Favored 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 124.42 1.088 . . . . 0.0 109.629 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 68.6 m -69.64 -20.29 63.6 Favored 'General case' 0 N--CA 1.448 -0.569 0 O-C-N 123.859 0.724 . . . . 0.0 110.364 177.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -78.46 -41.77 31.79 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.321 0.648 . . . . 0.0 110.674 176.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.418 ' HD2' ' ND1' ' A' ' 78' ' ' HIS . 0.0 OUTLIER -50.7 159.8 0.87 Allowed Pre-proline 0 N--CA 1.443 -0.809 0 CA-C-O 121.503 0.668 . . . . 0.0 110.832 179.699 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.413 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 28.3 Cg_endo -72.01 136.88 28.14 Favored 'Trans proline' 0 N--CA 1.439 -1.695 0 C-N-CA 121.521 1.481 . . . . 0.0 114.264 173.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.535 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 19.0 Cg_endo -72.29 170.06 20.08 Favored 'Trans proline' 0 N--CA 1.445 -1.379 0 C-N-CA 122.786 2.324 . . . . 0.0 111.236 178.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -128.87 53.28 1.87 Allowed 'General case' 0 C--O 1.2 -1.514 0 CA-C-O 118.166 -0.921 . . . . 0.0 110.596 178.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.432 ' CE1' ' O ' ' A' ' 69' ' ' SER . 46.7 t-80 -76.87 165.72 24.31 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 119.468 1.031 . . . . 0.0 111.061 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.432 ' O ' ' CE1' ' A' ' 68' ' ' HIS . 0.2 OUTLIER -157.55 -165.29 1.74 Allowed 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 121.17 -0.956 . . . . 0.0 110.962 177.194 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.85 75.01 10.4 Favored 'General case' 0 N--CA 1.445 -0.676 0 O-C-N 120.174 -1.579 . . . . 0.0 111.332 176.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -177.46 -45.25 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 123.291 0.636 . . . . 0.0 109.881 179.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.482 ' O ' ' CE2' ' A' ' 79' ' ' TYR . . . 122.92 -50.89 0.82 Allowed Glycine 0 N--CA 1.438 -1.203 0 CA-C-O 118.636 -1.091 . . . . 0.0 111.632 -176.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -151.54 82.97 1.3 Allowed 'General case' 0 N--CA 1.438 -1.075 0 CA-C-N 118.603 1.202 . . . . 0.0 107.962 178.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.03 -115.96 0.01 OUTLIER Glycine 0 C--O 1.222 -0.616 0 CA-C-O 123.083 1.38 . . . . 0.0 111.451 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.0 mttp -60.39 -98.37 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.46 0 O-C-N 119.681 -2.07 . . . . 0.0 110.648 178.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.57 HG23 ' O ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -109.37 16.1 22.59 Favored 'General case' 0 N--CA 1.447 -0.581 0 O-C-N 120.633 -1.292 . . . . 0.0 110.833 179.717 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.488 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 5.7 m-20 -29.31 103.44 0.02 OUTLIER 'General case' 0 C--O 1.203 -1.364 0 C-N-CA 124.807 1.243 . . . . 0.0 110.85 -177.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.574 ' CD2' ' H ' ' A' ' 78' ' ' HIS . 3.5 p80 -85.74 14.19 6.19 Favored 'General case' 0 CA--C 1.513 -0.447 0 O-C-N 121.39 -0.819 . . . . 0.0 110.209 -176.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.999 ' CZ ' HD11 ' A' ' 81' ' ' LEU . 0.3 OUTLIER -35.84 132.29 0.49 Allowed 'General case' 0 N--CA 1.426 -1.645 0 C-N-CA 124.911 1.285 . . . . 0.0 113.795 173.071 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.675 HD23 ' O ' ' A' ' 110' ' ' TYR . 0.4 OUTLIER -74.05 154.99 38.99 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 118.346 -0.835 . . . . 0.0 109.034 179.376 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.999 HD11 ' CZ ' ' A' ' 79' ' ' TYR . 1.2 mp -142.34 143.34 32.7 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 123.956 0.902 . . . . 0.0 109.647 178.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.495 ' CB ' ' CD1' ' A' ' 109' ' ' ILE . 0.2 OUTLIER -108.93 162.78 13.89 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-O 122.186 0.994 . . . . 0.0 111.233 179.464 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.552 ' CZ ' ' HB2' ' A' ' 23' ' ' ALA . 38.0 t80 -150.64 126.33 4.95 Favored Pre-proline 0 N--CA 1.443 -0.801 0 CA-C-N 115.626 -0.716 . . . . 0.0 112.312 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.526 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 21.5 Cg_endo -71.98 101.35 1.19 Allowed 'Trans proline' 0 N--CA 1.446 -1.292 0 C-N-CA 123.764 2.976 . . . . 0.0 111.01 -179.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -101.01 114.88 29.21 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 121.943 0.877 . . . . 0.0 110.661 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -81.4 160.96 63.69 Favored Pre-proline 0 N--CA 1.442 -0.868 0 O-C-N 121.423 -0.798 . . . . 0.0 112.483 178.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -76.67 -41.61 0.41 Allowed 'Trans proline' 0 CA--C 1.497 -1.358 0 C-N-CA 122.496 2.131 . . . . 0.0 112.962 179.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -45.09 -30.99 1.21 Allowed 'General case' 0 C--N 1.349 0.574 0 O-C-N 125.052 1.47 . . . . 0.0 110.021 177.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.66 -4.08 83.57 Favored Glycine 0 N--CA 1.427 -1.964 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 177.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -61.53 127.73 32.9 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -61.02 93.29 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 176.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.498 ' CD2' ' HB3' ' A' ' 94' ' ' PHE . 7.1 t80 -38.32 143.3 0.14 Allowed 'General case' 0 C--O 1.212 -0.92 0 CA-C-O 121.994 0.902 . . . . 0.0 110.813 179.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 12.2 ptpt -78.49 62.04 3.01 Favored 'General case' 0 C--N 1.318 -0.796 0 O-C-N 119.712 -1.867 . . . . 0.0 110.368 176.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.498 ' HB3' ' CD2' ' A' ' 92' ' ' TYR . 30.6 p90 -80.84 -8.34 59.68 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 123.372 0.669 . . . . 0.0 111.299 177.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -97.21 -32.63 11.83 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 122.095 0.95 . . . . 0.0 110.179 178.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.8 m -81.85 107.1 14.3 Favored 'General case' 0 N--CA 1.443 -0.8 0 O-C-N 121.181 -0.95 . . . . 0.0 108.731 -178.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.5 ptpt -59.31 -48.8 80.26 Favored 'General case' 0 C--O 1.224 -0.286 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.6 pttt -142.66 128.42 10.42 Favored Pre-proline 0 N--CA 1.431 -1.415 0 C-N-CA 124.208 1.003 . . . . 0.0 109.64 -176.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -71.25 176.92 34.72 Favored 'Cis proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.682 -1.799 . . . . 0.0 111.421 -3.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.4 146.52 38.46 Favored 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 122.953 0.501 . . . . 0.0 110.172 177.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -99.62 165.06 11.8 Favored 'General case' 0 C--N 1.319 -0.76 0 O-C-N 123.939 0.774 . . . . 0.0 110.776 178.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -57.45 153.42 28.4 Favored Pre-proline 0 N--CA 1.439 -1.013 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.528 177.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -74.12 -164.69 0.22 Allowed 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 122.453 2.102 . . . . 0.0 111.468 177.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -132.89 157.8 22.8 Favored Glycine 0 N--CA 1.444 -0.782 0 O-C-N 121.342 -0.848 . . . . 0.0 112.643 178.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -74.92 -64.36 0.03 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 122.474 2.116 . . . . 0.0 110.101 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.821 ' HA ' ' HB2' ' A' ' 122' ' ' ALA . . . -69.39 141.43 54.14 Favored 'General case' 0 N--CA 1.441 -0.883 0 O-C-N 123.502 0.501 . . . . 0.0 111.017 179.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 5.2 mtm-85 -142.86 143.86 32.26 Favored 'General case' 0 N--CA 1.442 -0.852 0 O-C-N 124.257 0.973 . . . . 0.0 111.204 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.441 ' CG1' ' HB3' ' A' ' 83' ' ' PHE . 4.8 p -83.39 124.67 39.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 O-C-N 124.016 0.823 . . . . 0.0 110.377 178.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.638 ' CG2' HD22 ' A' ' 80' ' ' LEU . 6.2 mm -103.91 140.44 22.05 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.914 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -179.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.675 ' O ' HD23 ' A' ' 80' ' ' LEU . 9.9 p90 -164.21 152.05 12.43 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-O 122.53 1.157 . . . . 0.0 111.287 -178.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.6 p -89.64 166.76 13.41 Favored 'General case' 0 C--N 1.319 -0.725 0 O-C-N 121.593 -0.692 . . . . 0.0 109.204 -178.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.578 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -110.95 153.8 43.65 Favored Pre-proline 0 N--CA 1.438 -1.029 0 C-N-CA 122.971 0.508 . . . . 0.0 111.168 179.263 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.578 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 19.5 Cg_endo -73.78 -55.28 0.14 OUTLIER 'Cis proline' 0 CA--C 1.501 -1.134 0 C-N-CA 123.001 -1.666 . . . . 0.0 109.759 -5.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.451 ' O ' HG23 ' A' ' 116' ' ' VAL . 2.3 t-20 -44.18 113.67 0.56 Allowed 'General case' 0 CA--C 1.5 -0.976 0 CA-C-O 115.653 -2.117 . . . . 0.0 109.823 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.753 ' HE2' HD13 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -63.24 78.61 0.02 OUTLIER 'General case' 0 CA--C 1.508 -0.663 0 O-C-N 125.529 1.768 . . . . 0.0 108.64 -178.3 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.467 HG11 ' HB2' ' A' ' 61' ' ' ASP . 77.6 t -73.54 72.11 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 -176.011 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.462 ' CZ ' ' NE2' ' A' ' 13' ' ' GLN . 42.0 t80 -37.46 104.96 0.03 OUTLIER 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 125.647 1.579 . . . . 0.0 110.15 -178.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . 0.528 ' SG ' HD21 ' A' ' 80' ' ' LEU . 5.7 m -82.72 -44.68 15.35 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 -178.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 158.03 -145.71 12.22 Favored Glycine 0 N--CA 1.44 -1.09 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.497 HG13 ' CG ' ' A' ' 4' ' ' TRP . 1.1 mm -127.43 145.7 34.43 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.212 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 -175.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.545 ' CD1' ' CE1' ' A' ' 38' ' ' PHE . 5.7 pt -137.39 151.93 27.01 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.937 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 -177.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.876 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . . . . . . . . 0 N--CA 1.447 -0.605 0 CA-C-O 122.088 0.947 . . . . 0.0 109.711 -178.719 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.2 pttt . . . . . 0 CA--C 1.501 -0.924 0 CA-C-O 118.263 -0.875 . . . . 0.0 108.779 . . . . . . . . . 0 0 . 1 . 014 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.468 ' HB2' ' CG2' ' A' ' 55' ' ' ILE . 9.0 tp -61.56 127.7 32.71 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 124.798 1.311 . . . . 0.0 109.1 179.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 35.2 m -67.19 -174.36 0.36 Allowed 'General case' 0 N--CA 1.436 -1.156 0 CA-C-O 122.707 1.242 . . . . 0.0 109.39 177.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 66.3 m -151.1 101.33 2.86 Favored 'General case' 0 C--N 1.322 -0.613 0 O-C-N 121.468 -0.77 . . . . 0.0 109.354 -179.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.655 ' HB2' HG22 ' A' ' 2' ' ' VAL . 0.4 OUTLIER . . . . . 0 C--O 1.247 0.969 0 CA-C-O 116.527 -1.702 . . . . 0.0 113.313 175.131 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.611 HG22 ' HB2' ' A' ' 136' ' ' HIS . 9.1 p . . . . . 0 C--O 1.237 0.441 0 CA-C-O 121.922 0.867 . . . . 0.0 109.564 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.9 m -90.09 115.38 27.31 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -176.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . 0.509 ' CE2' ' CD2' ' A' ' 136' ' ' HIS . 23.3 m95 -78.23 142.28 38.0 Favored 'General case' 0 C--O 1.215 -0.725 0 O-C-N 121.676 -0.64 . . . . 0.0 110.671 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -140.66 141.74 35.01 Favored 'General case' 0 CA--C 1.499 -1.008 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 -177.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.613 ' SG ' ' HB3' ' A' ' 122' ' ' ALA . 0.1 OUTLIER -119.67 -79.14 0.6 Allowed 'General case' 0 C--O 1.218 -0.598 0 O-C-N 124.467 1.104 . . . . 0.0 111.034 176.916 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -74.32 -87.45 0.23 Allowed Glycine 0 C--O 1.219 -0.804 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -179.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -143.67 12.61 2.2 Favored Glycine 0 C--O 1.221 -0.662 0 O-C-N 121.573 -0.957 . . . . 0.0 111.704 178.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 22.4 mt -113.9 155.49 25.68 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 117.824 0.812 . . . . 0.0 109.581 178.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.4 mp -106.78 133.37 51.54 Favored 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -175.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.606 ' CZ ' ' HB3' ' A' ' 106' ' ' ALA . 60.8 m-85 -124.58 91.4 3.44 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 125.749 1.62 . . . . 0.0 106.992 -170.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -53.48 121.07 6.95 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 117.708 -1.139 . . . . 0.0 108.745 179.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.498 ' NE2' ' CE1' ' A' ' 117' ' ' PHE . 1.2 tt0 -52.24 -50.78 61.35 Favored 'General case' 0 CA--C 1.498 -1.029 0 CA-C-O 117.243 -1.361 . . . . 0.0 111.173 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -50.42 -36.84 34.87 Favored 'General case' 0 C--O 1.194 -1.825 0 O-C-N 125.42 1.7 . . . . 0.0 110.615 178.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.4 mttp -71.59 -51.01 25.61 Favored 'General case' 0 C--O 1.212 -0.917 0 CA-C-O 116.526 -1.702 . . . . 0.0 115.428 166.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.86 -35.11 9.79 Favored 'General case' 0 C--O 1.211 -0.936 0 CA-C-N 121.653 2.024 . . . . 0.0 113.024 171.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.443 ' O ' ' CD2' ' A' ' 21' ' ' HIS . 16.0 pt-20 -88.32 -40.81 13.31 Favored 'General case' 0 C--O 1.205 -1.285 0 C-N-CA 125.76 1.624 . . . . 0.0 110.471 172.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.4 t -77.0 -59.12 2.91 Favored 'General case' 0 CA--C 1.501 -0.912 0 O-C-N 117.217 -3.427 . . . . 0.0 108.123 -172.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.534 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -45.38 -32.31 2.03 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 167.215 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.492 ' HB3' HG11 ' A' ' 108' ' ' VAL . 54.5 p -83.74 -24.56 31.1 Favored 'General case' 0 C--O 1.216 -0.691 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 173.049 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.443 ' CD2' ' O ' ' A' ' 17' ' ' GLU . 10.0 m170 -55.98 -37.91 69.72 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 126.504 1.922 . . . . 0.0 108.701 178.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.534 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.1 OUTLIER -71.02 -44.45 65.85 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 117.15 -1.405 . . . . 0.0 110.178 178.899 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.598 ' HB1' ' HG3' ' A' ' 35' ' ' PRO . . . -39.99 126.04 1.62 Allowed Pre-proline 0 CA--C 1.549 0.934 0 O-C-N 126.058 2.099 . . . . 0.0 111.287 176.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.751 ' HG2' HG22 ' A' ' 30' ' ' THR . 13.5 Cg_endo -72.67 123.41 9.0 Favored 'Trans proline' 0 N--CA 1.445 -1.38 0 C-N-CA 122.433 2.089 . . . . 0.0 107.804 -175.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.65 HD13 ' HE2' ' A' ' 115' ' ' LYS . 3.4 tp -60.51 87.85 0.02 OUTLIER 'General case' 0 CA--C 1.507 -0.704 0 C-N-CA 124.514 1.126 . . . . 0.0 112.414 178.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.4 m -174.53 148.96 1.23 Allowed 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.993 1.317 . . . . 0.0 109.95 -171.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.407 ' HB3' ' HA3' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -86.81 113.71 22.86 Favored 'General case' 0 CA--C 1.508 -0.655 0 C-N-CA 124.136 0.974 . . . . 0.0 110.176 176.362 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 54.03 72.41 0.55 Allowed Glycine 0 CA--C 1.525 0.669 0 C-N-CA 119.402 -1.38 . . . . 0.0 111.996 177.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.04 21.41 2.27 Favored 'General case' 0 CA--C 1.504 -0.813 0 O-C-N 121.438 -1.036 . . . . 0.0 112.724 177.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.751 HG22 ' HG2' ' A' ' 24' ' ' PRO . 10.7 p -129.57 152.07 49.49 Favored 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 -171.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -38.43 -66.87 0.58 Allowed Glycine 0 N--CA 1.442 -0.919 0 O-C-N 124.502 1.126 . . . . 0.0 112.858 178.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.42 ' HA ' ' CE ' ' A' ' 100' ' ' LYS . 24.2 t -52.77 -65.46 0.55 Allowed 'General case' 0 CA--C 1.492 -1.28 0 CA-C-O 114.994 -2.431 . . . . 0.0 113.07 173.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 160.87 -53.18 0.0 OUTLIER 'General case' 0 C--O 1.219 -0.552 0 O-C-N 127.626 3.079 . . . . 0.0 109.507 178.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.533 ' CE2' ' CE1' ' A' ' 36' ' ' HIS . 50.9 m-85 -61.46 147.05 88.61 Favored Pre-proline 0 N--CA 1.439 -1.008 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.598 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 23.2 Cg_endo -74.55 150.53 95.66 Favored 'Cis proline' 0 N--CA 1.443 -1.477 0 C-N-CA 123.457 -1.476 . . . . 0.0 109.6 0.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.533 ' CE1' ' CE2' ' A' ' 34' ' ' TYR . 0.4 OUTLIER -126.72 160.64 30.21 Favored 'General case' 0 CA--C 1.499 -1.008 0 CA-C-O 117.062 -1.447 . . . . 0.0 109.003 179.242 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.918 ' CH2' HG22 ' A' ' 39' ' ' THR . 22.1 t90 -58.45 148.8 26.92 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 124.763 1.289 . . . . 0.0 109.184 177.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.501 ' CZ ' HD13 ' A' ' 121' ' ' ILE . 10.8 t80 -129.22 78.36 1.85 Allowed 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 103.711 -2.7 . . . . 0.0 103.711 -170.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.918 HG22 ' CH2' ' A' ' 37' ' ' TRP . 44.7 p -39.15 -34.96 0.2 Allowed 'General case' 0 C--O 1.204 -1.31 0 C-N-CA 124.81 1.244 . . . . 0.0 110.117 173.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 56.7 t30 66.86 11.98 8.62 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.683 1.593 . . . . 0.0 110.523 178.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 108.15 -6.83 34.76 Favored Glycine 0 CA--C 1.537 1.451 0 O-C-N 120.96 -1.088 . . . . 0.0 114.687 -170.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.695 ' CE1' HD11 ' A' ' 48' ' ' LEU . 6.1 m-85 -78.26 168.51 19.73 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 124.472 1.109 . . . . 0.0 109.782 -178.298 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.11 -37.36 17.46 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.748 175.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.58 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . 176.43 -60.31 0.1 Allowed Glycine 0 CA--C 1.506 -0.469 0 C-N-CA 124.179 0.895 . . . . 0.0 112.881 -177.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -115.85 -63.11 1.5 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 122.716 1.246 . . . . 0.0 110.819 179.125 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.24 165.89 8.95 Favored Glycine 0 C--N 1.339 0.728 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 177.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.56 ' HA ' ' CE2' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -59.2 -168.97 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 123.288 1.518 . . . . 0.0 111.325 178.082 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.695 HD11 ' CE1' ' A' ' 42' ' ' TYR . 4.7 mp -77.14 152.12 81.85 Favored Pre-proline 0 N--CA 1.43 -1.458 0 O-C-N 120.472 -1.392 . . . . 0.0 110.833 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -72.17 170.43 19.1 Favored 'Trans proline' 0 N--CA 1.445 -1.336 0 C-N-CA 122.539 2.159 . . . . 0.0 110.792 179.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.92 100.43 0.07 Allowed 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.619 -0.676 . . . . 0.0 109.378 176.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.75 56.48 0.37 Allowed Glycine 0 CA--C 1.51 -0.252 0 O-C-N 121.684 -0.635 . . . . 0.0 111.552 -177.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.429 ' CB ' ' HB3' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -150.36 165.52 32.82 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 118.573 -0.727 . . . . 0.0 112.454 174.214 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 54.1 m -145.02 97.29 4.86 Favored Pre-proline 0 C--O 1.233 0.21 0 O-C-N 125.338 1.649 . . . . 0.0 110.276 -176.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.507 ' HG3' HD13 ' A' ' 48' ' ' LEU . 20.4 Cg_endo -72.47 148.09 47.65 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.878 2.385 . . . . 0.0 110.88 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.438 HD12 HG21 ' A' ' 121' ' ' ILE . 6.7 mt -69.18 120.97 17.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -177.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.6 tppt? -83.03 135.24 34.92 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 120.897 -1.127 . . . . 0.0 108.652 177.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.61 ' CE1' HD13 ' A' ' 133' ' ' LEU . 7.9 m-85 -118.44 -51.61 2.4 Favored 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 123.786 0.834 . . . . 0.0 109.858 -178.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 122.32 -4.51 10.3 Favored Glycine 0 C--O 1.222 -0.613 0 CA-C-O 119.35 -0.695 . . . . 0.0 112.831 -175.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.435 ' HD3' ' CG1' ' A' ' 116' ' ' VAL . 1.6 mtpt -96.5 139.03 33.2 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-N 118.399 1.1 . . . . 0.0 110.553 175.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 23.2 t -74.77 -1.71 23.27 Favored 'General case' 0 C--O 1.222 -0.351 0 O-C-N 124.771 1.294 . . . . 0.0 111.961 175.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -87.95 -54.16 4.37 Favored 'General case' 0 CA--C 1.516 -0.364 0 O-C-N 120.793 -1.192 . . . . 0.0 108.709 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.585 ' HA ' HD11 ' A' ' 80' ' ' LEU . 2.7 m -75.47 -32.38 60.57 Favored 'General case' 0 N--CA 1.45 -0.438 0 O-C-N 124.028 0.83 . . . . 0.0 109.426 -178.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -62.88 -39.17 93.66 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 122.556 1.169 . . . . 0.0 110.811 173.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.467 ' HD3' ' CE1' ' A' ' 78' ' ' HIS . 0.0 OUTLIER -53.64 160.01 2.21 Favored Pre-proline 0 N--CA 1.444 -0.749 0 O-C-N 120.973 -1.079 . . . . 0.0 112.621 178.78 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -70.32 133.87 25.53 Favored 'Trans proline' 0 N--CA 1.438 -1.79 0 N-CA-C 114.697 0.999 . . . . 0.0 114.697 172.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.475 ' HD2' ' CD2' ' A' ' 42' ' ' TYR . 21.1 Cg_endo -70.46 168.92 21.07 Favored 'Trans proline' 0 N--CA 1.439 -1.685 0 C-N-CA 124.115 3.21 . . . . 0.0 111.238 176.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.9 tptt -128.05 51.75 1.94 Allowed 'General case' 0 C--O 1.199 -1.583 0 CA-C-N 115.02 -0.991 . . . . 0.0 108.826 177.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -75.66 168.82 19.3 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 119.921 -1.737 . . . . 0.0 110.972 178.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 24.0 p -161.67 -156.82 0.45 Allowed 'General case' 0 C--O 1.222 -0.375 0 O-C-N 120.994 -1.066 . . . . 0.0 111.846 174.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.11 70.88 9.13 Favored 'General case' 0 C--O 1.215 -0.719 0 O-C-N 120.67 -1.269 . . . . 0.0 112.739 172.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -176.08 -40.78 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.88 0.848 . . . . 0.0 109.701 177.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.407 ' HA3' ' HB3' ' A' ' 27' ' ' ASP . . . 108.67 -57.82 0.42 Allowed Glycine 0 C--O 1.212 -1.219 0 CA-C-O 118.389 -1.228 . . . . 0.0 111.761 -175.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -135.05 67.92 1.48 Allowed 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 105.529 -2.026 . . . . 0.0 105.529 -173.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.47 -119.24 0.01 OUTLIER Glycine 0 CA--C 1.529 0.93 0 CA-C-O 122.411 1.006 . . . . 0.0 113.001 177.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.7 mttt -63.79 -99.3 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.528 0 O-C-N 119.32 -2.282 . . . . 0.0 112.156 176.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.474 HG23 ' O ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -105.46 12.45 31.43 Favored 'General case' 0 C--N 1.317 -0.841 0 O-C-N 119.453 -2.03 . . . . 0.0 110.547 178.433 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.463 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 21.1 m-20 -29.66 105.83 0.03 OUTLIER 'General case' 0 C--O 1.201 -1.498 0 C-N-CA 126.234 1.813 . . . . 0.0 110.41 -176.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.626 ' CD2' ' H ' ' A' ' 78' ' ' HIS . 2.3 p80 -86.21 14.02 7.07 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 120.144 1.338 . . . . 0.0 110.082 -175.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.898 ' CZ ' HD11 ' A' ' 81' ' ' LEU . 0.4 OUTLIER -32.55 132.2 0.14 Allowed 'General case' 0 N--CA 1.439 -1.018 0 C-N-CA 126.015 1.726 . . . . 0.0 112.887 170.428 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.585 HD11 ' HA ' ' A' ' 62' ' ' CYS . 0.2 OUTLIER -75.61 155.53 35.8 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 121.015 -1.053 . . . . 0.0 109.067 178.238 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.898 HD11 ' CZ ' ' A' ' 79' ' ' TYR . 1.7 mp -141.81 134.36 28.28 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 118.874 0.761 . . . . 0.0 109.354 176.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.451 ' CB ' ' CD1' ' A' ' 109' ' ' ILE . 1.7 pm0 -103.13 154.56 19.17 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 122.842 1.306 . . . . 0.0 110.78 179.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.478 ' HZ ' ' CD2' ' A' ' 94' ' ' PHE . 37.8 t80 -141.79 138.82 17.5 Favored Pre-proline 0 C--O 1.218 -0.559 0 O-C-N 121.265 -0.897 . . . . 0.0 112.853 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.506 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 14.6 Cg_endo -72.15 88.35 0.84 Allowed 'Trans proline' 0 CA--C 1.485 -1.942 0 C-N-CA 124.658 3.572 . . . . 0.0 109.341 -173.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.7 t -80.11 116.62 20.32 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.674 0.789 . . . . 0.0 111.769 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.506 ' CD1' ' CE1' ' A' ' 92' ' ' TYR . 7.8 m-85 -84.65 159.09 58.88 Favored Pre-proline 0 C--N 1.318 -0.777 0 O-C-N 120.406 -1.434 . . . . 0.0 110.701 -179.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -76.42 -45.29 0.21 Allowed 'Trans proline' 0 N--CA 1.446 -1.291 0 C-N-CA 122.252 1.968 . . . . 0.0 111.544 178.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -53.62 -28.75 34.47 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 124.108 1.909 . . . . 0.0 110.229 177.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.73 -9.5 51.1 Favored Glycine 0 N--CA 1.436 -1.354 0 CA-C-O 116.458 -2.301 . . . . 0.0 112.133 -177.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -50.53 138.91 16.74 Favored 'General case' 0 C--O 1.209 -1.041 0 CA-C-O 116.805 -1.569 . . . . 0.0 107.887 178.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -62.1 143.51 56.57 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 120.88 1.673 . . . . 0.0 111.644 175.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.506 ' CE1' ' CD1' ' A' ' 86' ' ' PHE . 0.1 OUTLIER -98.01 155.08 17.28 Favored 'General case' 0 C--O 1.215 -0.756 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -174.159 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.73 55.11 2.59 Favored 'General case' 0 C--N 1.314 -0.935 0 O-C-N 118.515 -2.615 . . . . 0.0 111.053 172.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.478 ' CD2' ' HZ ' ' A' ' 83' ' ' PHE . 40.0 p90 -69.24 -26.74 64.94 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-O 117.828 -1.082 . . . . 0.0 110.877 175.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -90.09 -21.05 22.48 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 119.956 1.253 . . . . 0.0 111.442 179.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.7 m -108.77 101.05 10.21 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 -178.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.26 -29.57 67.5 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.896 0.855 . . . . 0.0 110.234 175.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.6 mttm -125.75 113.38 24.85 Favored Pre-proline 0 N--CA 1.444 -0.745 0 CA-C-O 117.654 -1.165 . . . . 0.0 109.276 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -70.29 173.36 46.84 Favored 'Cis proline' 0 C--N 1.356 0.926 0 O-C-N 124.44 1.758 . . . . 0.0 110.521 -3.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.42 ' CE ' ' HA ' ' A' ' 32' ' ' SER . 0.5 OUTLIER -130.39 145.99 51.89 Favored 'General case' 0 CA--C 1.507 -0.705 0 C-N-CA 125.293 1.437 . . . . 0.0 110.021 177.863 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.07 175.19 5.53 Favored 'General case' 0 C--O 1.243 0.733 0 O-C-N 125.751 1.907 . . . . 0.0 109.122 -177.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -76.49 139.83 67.9 Favored Pre-proline 0 N--CA 1.442 -0.849 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.916 176.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -72.74 -165.61 0.24 Allowed 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 122.523 2.149 . . . . 0.0 111.899 175.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -136.3 163.89 25.11 Favored Glycine 0 CA--C 1.525 0.679 0 O-C-N 120.853 -1.154 . . . . 0.0 112.891 176.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -76.62 -50.12 0.11 Allowed 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.464 2.109 . . . . 0.0 110.898 178.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.606 ' HB3' ' CZ ' ' A' ' 11' ' ' TYR . . . -75.29 142.51 43.27 Favored 'General case' 0 CA--C 1.51 -0.563 0 O-C-N 121.903 -0.498 . . . . 0.0 110.465 177.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.491 ' HG2' ' HA ' ' A' ' 84' ' ' PRO . 3.6 mtm-85 -143.81 145.69 32.53 Favored 'General case' 0 CA--C 1.5 -0.968 0 CA-C-O 117.721 -1.133 . . . . 0.0 112.415 178.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.492 HG11 ' HB3' ' A' ' 20' ' ' SER . 5.3 p -79.15 124.98 38.2 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.476 0 O-C-N 124.176 0.922 . . . . 0.0 110.62 177.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.524 HG12 HG23 ' A' ' 121' ' ' ILE . 4.4 mm -103.99 141.38 19.74 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 C-N-CA 123.914 0.886 . . . . 0.0 109.718 -179.086 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.502 ' O ' HD23 ' A' ' 80' ' ' LEU . 10.4 p90 -166.01 152.48 9.41 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 122.891 1.329 . . . . 0.0 110.034 -178.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.7 p -89.79 167.68 12.68 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.062 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.588 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.3 OUTLIER -108.46 153.83 41.86 Favored Pre-proline 0 CA--C 1.552 1.031 0 O-C-N 123.534 0.521 . . . . 0.0 111.341 177.182 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.588 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 14.1 Cg_endo -75.81 -55.27 0.14 OUTLIER 'Cis proline' 0 CA--C 1.49 -1.706 0 N-CA-C 107.998 -1.578 . . . . 0.0 107.998 -5.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -44.17 112.24 0.38 Allowed 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 116.279 -1.82 . . . . 0.0 109.713 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.65 ' HE2' HD13 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -66.44 76.17 0.1 Allowed 'General case' 0 CA--C 1.505 -0.755 0 C-N-CA 124.797 1.239 . . . . 0.0 107.985 -177.666 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.435 ' CG1' ' HD3' ' A' ' 59' ' ' LYS . 54.8 t -75.83 72.03 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 -176.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.56 ' CE1' ' HA2' ' A' ' 119' ' ' GLY . 7.6 t80 -39.08 111.17 0.17 Allowed 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 126.321 1.848 . . . . 0.0 106.84 -178.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . 0.548 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 0.1 OUTLIER -91.25 -22.78 20.41 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 121.126 -0.23 . . . . 0.0 110.405 175.974 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.56 ' HA2' ' CE1' ' A' ' 117' ' ' PHE . . . 134.82 -170.31 22.86 Favored Glycine 0 CA--C 1.496 -1.148 0 C-N-CA 123.621 0.629 . . . . 0.0 112.1 -176.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.539 HG21 ' HB1' ' A' ' 106' ' ' ALA . 3.4 mp -107.67 151.53 9.66 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 -179.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.72 HG22 HD12 ' A' ' 133' ' ' LEU . 9.9 pt -120.94 154.72 24.5 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.621 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 177.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.613 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . . . . . . . . 0 C--N 1.325 -0.475 0 CA-C-O 123.644 1.688 . . . . 0.0 110.069 175.117 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.509 -0.631 0 CA-C-O 118.715 -0.66 . . . . 0.0 109.759 . . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.72 HD12 HG22 ' A' ' 121' ' ' ILE . 10.4 tp -84.41 141.44 30.83 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.656 1.223 . . . . 0.0 108.387 177.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . 0.537 ' SG ' HG22 ' A' ' 120' ' ' ILE . 79.4 m -60.64 -179.42 0.12 Allowed 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 123.264 1.507 . . . . 0.0 110.312 174.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 13.2 m -159.06 87.79 0.87 Allowed 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 104.002 -2.592 . . . . 0.0 104.002 -176.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.611 ' HB2' HG22 ' A' ' 2' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.257 1.48 0 CA-C-O 114.024 -2.893 . . . . 0.0 114.756 167.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.7 p . . . . . 0 C--O 1.234 0.285 0 CA-C-O 121.611 0.719 . . . . 0.0 109.974 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.9 m -88.04 114.49 24.71 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 123.665 0.786 . . . . 0.0 109.368 -178.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . 0.515 ' CE2' ' CD2' ' A' ' 136' ' ' HIS . 19.5 m95 -79.01 144.32 34.81 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.052 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -138.61 134.35 33.65 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -178.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.617 ' SG ' ' HB3' ' A' ' 122' ' ' ALA . 0.1 OUTLIER -118.78 -84.19 0.65 Allowed 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.42 0.628 . . . . 0.0 110.374 176.911 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . 0.46 ' O ' HD12 ' A' ' 9' ' ' LEU . . . -92.85 75.1 1.26 Allowed Glycine 0 C--O 1.217 -0.927 0 CA-C-O 117.564 -1.687 . . . . 0.0 111.813 -177.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 45.9 27.5 2.4 Favored Glycine 0 N--CA 1.473 1.145 0 CA-C-N 118.96 1.38 . . . . 0.0 113.948 -175.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.46 HD12 ' O ' ' A' ' 7' ' ' GLY . 2.6 mt -129.98 149.17 51.82 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -174.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.584 HD22 ' H ' ' A' ' 10' ' ' LEU . 0.1 OUTLIER -100.42 155.15 17.98 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 124.487 1.117 . . . . 0.0 108.102 -173.826 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.775 ' CZ ' ' HB3' ' A' ' 106' ' ' ALA . 50.7 m-85 -158.72 86.03 0.84 Allowed 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 122.181 0.991 . . . . 0.0 108.872 -172.463 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -54.99 125.22 19.5 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-O 117.058 -1.449 . . . . 0.0 108.727 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.54 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 0.8 OUTLIER -49.74 -35.07 20.88 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-N 119.106 0.866 . . . . 0.0 111.271 178.585 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.404 ' O ' ' CB ' ' A' ' 18' ' ' SER . 8.4 t-20 -61.07 -44.91 96.65 Favored 'General case' 0 C--O 1.204 -1.317 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.41 175.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.4 -42.88 64.67 Favored 'General case' 0 C--O 1.207 -1.15 0 CA-C-O 117.736 -1.126 . . . . 0.0 111.899 173.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -52.09 -39.8 60.3 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 119.893 1.224 . . . . 0.0 111.422 176.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -85.81 -47.91 9.27 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-O 117.907 -1.044 . . . . 0.0 110.387 176.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.404 ' CB ' ' O ' ' A' ' 14' ' ' ASN . 29.0 t -64.39 -59.42 4.38 Favored 'General case' 0 CA--C 1.499 -0.992 0 C-N-CA 125.982 1.713 . . . . 0.0 107.948 -173.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.471 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 13.4 t-20 -38.07 -40.51 0.49 Allowed 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 118.919 0.782 . . . . 0.0 112.362 172.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.6 -38.2 40.53 Favored 'General case' 0 C--O 1.218 -0.602 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 174.52 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 10.3 m170 -43.55 -36.04 1.93 Allowed 'General case' 0 C--N 1.34 0.191 0 C-N-CA 126.25 1.82 . . . . 0.0 109.87 178.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.471 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.1 OUTLIER -74.8 -52.0 12.59 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 124.318 1.047 . . . . 0.0 111.105 177.226 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.442 ' HB1' ' HG3' ' A' ' 35' ' ' PRO . . . -37.58 126.08 0.92 Allowed Pre-proline 0 CA--C 1.544 0.722 0 O-C-N 124.967 1.417 . . . . 0.0 111.629 174.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.637 ' HG2' HG22 ' A' ' 30' ' ' THR . 19.2 Cg_endo -73.09 132.18 17.77 Favored 'Trans proline' 0 N--CA 1.445 -1.343 0 C-N-CA 122.033 1.822 . . . . 0.0 110.125 -178.088 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.644 HD13 ' HE2' ' A' ' 115' ' ' LYS . 7.3 tp -59.79 112.42 1.83 Allowed 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.561 179.017 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 179.71 149.98 0.33 Allowed 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 122.617 0.367 . . . . 0.0 111.193 -178.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.549 ' HB2' ' CE2' ' A' ' 79' ' ' TYR . 4.2 t0 -86.86 78.99 8.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 122.024 0.916 . . . . 0.0 108.62 -179.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . 0.44 ' N ' ' HA ' ' A' ' 36' ' ' HIS . . . 68.38 76.93 0.4 Allowed Glycine 0 N--CA 1.451 -0.333 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 177.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -152.13 40.55 0.63 Allowed 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 122.342 1.068 . . . . 0.0 111.876 178.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.637 HG22 ' HG2' ' A' ' 24' ' ' PRO . 8.4 p -121.32 159.1 26.76 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 -176.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -37.66 -77.81 0.05 OUTLIER Glycine 0 C--N 1.333 0.407 0 C-N-CA 125.145 1.355 . . . . 0.0 111.846 -178.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.417 ' OG ' ' HE2' ' A' ' 100' ' ' LYS . 18.0 t -55.24 -57.11 13.15 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.137 177.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 161.1 -51.16 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.568 0 O-C-N 124.859 1.35 . . . . 0.0 111.44 178.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.426 ' CD1' ' HD3' ' A' ' 84' ' ' PRO . 90.2 m-85 -69.53 147.36 96.71 Favored Pre-proline 0 N--CA 1.444 -0.775 0 O-C-N 124.089 0.868 . . . . 0.0 112.915 178.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.597 ' CB ' HD21 ' A' ' 81' ' ' LEU . 28.4 Cg_endo -77.42 179.3 31.66 Favored 'Cis proline' 0 N--CA 1.446 -1.314 0 C-N-CA 122.359 -1.934 . . . . 0.0 112.426 2.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.44 ' HA ' ' N ' ' A' ' 28' ' ' GLY . 0.5 OUTLIER -154.29 167.58 29.47 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-O 118.322 -0.847 . . . . 0.0 110.972 -179.87 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.908 ' CH2' HG22 ' A' ' 39' ' ' THR . 17.9 t90 -61.74 152.23 31.76 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 122.183 0.992 . . . . 0.0 109.546 175.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.48 ' CE2' ' HB2' ' A' ' 40' ' ' ASN . 8.7 t80 -125.27 84.46 2.28 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 -175.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.908 HG22 ' CH2' ' A' ' 37' ' ' TRP . 62.3 p -38.67 -36.4 0.25 Allowed 'General case' 0 C--O 1.214 -0.784 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.234 173.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.48 ' HB2' ' CE2' ' A' ' 38' ' ' PHE . 51.3 t30 55.07 21.15 3.65 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-O 122.697 1.237 . . . . 0.0 110.849 177.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.594 ' HA3' HD23 ' A' ' 48' ' ' LEU . . . 106.9 -40.08 2.64 Favored Glycine 0 N--CA 1.423 -2.186 0 CA-C-O 118.504 -1.164 . . . . 0.0 114.431 -171.038 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.496 ' CE2' ' HD3' ' A' ' 66' ' ' PRO . 76.1 m-85 -48.72 155.42 0.57 Allowed 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 118.998 1.399 . . . . 0.0 111.761 177.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.44 -36.29 22.45 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.376 0.608 . . . . 0.0 110.796 178.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.512 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -172.21 -61.87 0.04 OUTLIER Glycine 0 C--N 1.335 0.498 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -178.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -123.33 -64.19 1.18 Allowed 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 122.542 0.337 . . . . 0.0 110.891 -178.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.64 -174.13 0.14 Allowed Glycine 0 C--N 1.345 1.043 0 C-N-CA 124.435 1.016 . . . . 0.0 110.676 178.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -59.99 -166.28 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 123.793 1.759 . . . . 0.0 110.687 178.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.736 ' H ' HD12 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -94.31 170.17 8.65 Favored Pre-proline 0 C--N 1.312 -1.034 0 O-C-N 120.995 -1.066 . . . . 0.0 110.217 -178.518 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -71.64 158.18 54.12 Favored 'Trans proline' 0 N--CA 1.441 -1.582 0 C-N-CA 121.913 1.742 . . . . 0.0 111.062 178.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.28 97.59 0.09 Allowed 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.983 177.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 119.85 39.31 0.66 Allowed Glycine 0 C--O 1.227 -0.283 0 CA-C-O 119.476 -0.624 . . . . 0.0 111.952 -176.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.47 ' HG2' ' CA ' ' A' ' 41' ' ' GLY . 0.0 OUTLIER -122.63 161.81 23.09 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 117.759 0.779 . . . . 0.0 111.283 177.103 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 26.0 m -139.74 98.32 7.91 Favored Pre-proline 0 C--N 1.328 -0.357 0 O-C-N 124.265 0.978 . . . . 0.0 110.054 -178.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -72.06 161.19 45.47 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 122.052 1.835 . . . . 0.0 111.674 178.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.448 HD12 HG21 ' A' ' 121' ' ' ILE . 6.9 mt -85.43 121.47 37.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 -178.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.66 135.07 35.13 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 177.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.582 ' CE1' HD13 ' A' ' 133' ' ' LEU . 15.1 m-85 -118.3 -51.87 2.4 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 123.354 0.661 . . . . 0.0 110.617 179.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 122.42 -2.09 10.4 Favored Glycine 0 C--O 1.226 -0.366 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.302 -176.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 33.9 mmtt -100.0 141.61 32.58 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-N 117.567 0.683 . . . . 0.0 110.195 177.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 44.9 t -76.22 -2.06 29.48 Favored 'General case' 0 C--O 1.221 -0.429 0 O-C-N 124.66 1.225 . . . . 0.0 111.226 176.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.618 ' OD2' HG11 ' A' ' 116' ' ' VAL . 0.7 OUTLIER -87.83 -55.56 3.72 Favored 'General case' 0 CA--C 1.512 -0.511 0 O-C-N 120.876 -1.14 . . . . 0.0 109.075 -179.196 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.738 ' HA ' HD11 ' A' ' 80' ' ' LEU . 2.0 m -74.38 -31.77 62.49 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 124.586 1.179 . . . . 0.0 109.383 -179.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -64.89 -38.24 90.3 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 122.279 1.037 . . . . 0.0 110.586 175.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.12 160.1 2.57 Favored Pre-proline 0 N--CA 1.445 -0.676 0 O-C-N 121.179 -0.95 . . . . 0.0 112.251 179.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.4 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 22.2 Cg_endo -71.2 140.62 37.73 Favored 'Trans proline' 0 N--CA 1.441 -1.586 0 C-N-CA 120.326 0.684 . . . . 0.0 113.422 175.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.496 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 22.9 Cg_endo -73.1 170.3 20.14 Favored 'Trans proline' 0 N--CA 1.446 -1.307 0 C-N-CA 123.542 2.828 . . . . 0.0 111.415 177.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.9 tptp -136.15 57.38 1.78 Allowed 'General case' 0 C--O 1.214 -0.789 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -178.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 43.8 t-80 -74.0 154.95 39.07 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 124.486 2.089 . . . . 0.0 113.09 175.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.07 -172.08 3.5 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 118.677 -2.514 . . . . 0.0 110.411 178.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -85.26 69.48 10.74 Favored 'General case' 0 N--CA 1.45 -0.44 0 O-C-N 121.947 -0.471 . . . . 0.0 111.042 176.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -177.76 -42.68 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 123.555 0.535 . . . . 0.0 110.112 179.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.507 ' CA ' ' HB3' ' A' ' 27' ' ' ASP . . . 124.98 -78.95 0.37 Allowed Glycine 0 N--CA 1.441 -0.967 0 CA-C-N 115.189 -0.914 . . . . 0.0 112.727 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -118.86 58.66 0.84 Allowed 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.236 1.015 . . . . 0.0 108.956 178.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -57.28 -105.58 0.01 OUTLIER Glycine 0 CA--C 1.525 0.701 0 CA-C-O 121.661 0.589 . . . . 0.0 112.695 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 22.1 mttt -60.97 -96.32 0.0 OUTLIER 'General case' 0 C--O 1.222 -0.384 0 O-C-N 121.197 -1.178 . . . . 0.0 111.259 177.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.583 HG23 ' O ' ' A' ' 76' ' ' THR . 0.6 OUTLIER -126.63 26.88 6.2 Favored 'General case' 0 CA--C 1.511 -0.527 0 O-C-N 121.645 -0.659 . . . . 0.0 111.086 178.902 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.476 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 1.9 m-20 -34.49 106.23 0.04 OUTLIER 'General case' 0 C--O 1.216 -0.689 0 C-N-CA 124.597 1.159 . . . . 0.0 109.91 -176.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.461 ' CD2' ' H ' ' A' ' 78' ' ' HIS . 0.4 OUTLIER -84.19 19.49 1.83 Allowed 'General case' 0 C--N 1.328 -0.354 0 O-C-N 121.142 -0.974 . . . . 0.0 110.63 -177.37 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.549 ' CE2' ' HB2' ' A' ' 27' ' ' ASP . 22.9 p90 -48.49 135.46 14.19 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 124.695 1.198 . . . . 0.0 110.818 177.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.738 HD11 ' HA ' ' A' ' 62' ' ' CYS . 0.2 OUTLIER -76.07 137.24 40.05 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.431 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.85 HD22 ' CZ ' ' A' ' 110' ' ' TYR . 0.3 OUTLIER -123.91 148.76 46.58 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.132 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -115.16 163.45 15.63 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.725 -0.671 . . . . 0.0 112.134 176.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.508 ' CD1' ' HD2' ' A' ' 84' ' ' PRO . 40.2 t80 -152.61 133.93 8.19 Favored Pre-proline 0 CA--C 1.534 0.352 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -178.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.508 ' HD2' ' CD1' ' A' ' 83' ' ' PHE . 17.8 Cg_endo -72.27 104.3 1.66 Allowed 'Trans proline' 0 N--CA 1.446 -1.299 0 C-N-CA 123.345 2.697 . . . . 0.0 110.626 -176.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.426 ' HA ' ' OD1' ' A' ' 19' ' ' ASN . 1.6 t -105.92 108.36 19.83 Favored 'General case' 0 CA--C 1.5 -0.947 0 O-C-N 124.356 1.035 . . . . 0.0 110.136 -178.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.438 ' CD2' ' NE2' ' A' ' 90' ' ' HIS . 1.4 m-85 -85.29 161.25 52.45 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-O 121.138 0.494 . . . . 0.0 111.372 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -76.33 -41.23 0.49 Allowed 'Trans proline' 0 CA--C 1.496 -1.395 0 C-N-CA 121.871 1.714 . . . . 0.0 112.711 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -39.54 -31.13 0.08 Allowed 'General case' 0 N--CA 1.469 0.497 0 O-C-N 124.989 1.431 . . . . 0.0 111.363 175.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 91.58 -9.96 75.85 Favored Glycine 0 N--CA 1.43 -1.76 0 C-N-CA 124.749 1.166 . . . . 0.0 111.892 179.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.438 ' NE2' ' CD2' ' A' ' 86' ' ' PHE . 0.5 OUTLIER -57.63 143.8 39.97 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 122.712 1.244 . . . . 0.0 109.089 177.447 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -88.6 122.54 32.16 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 174.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -48.11 170.02 0.02 OUTLIER 'General case' 0 C--O 1.214 -0.78 0 CA-C-O 123.213 1.482 . . . . 0.0 113.614 175.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.86 60.83 1.1 Allowed 'General case' 0 C--N 1.321 -0.634 0 O-C-N 119.371 -2.081 . . . . 0.0 107.33 -176.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.415 ' CD2' ' HZ ' ' A' ' 83' ' ' PHE . 7.3 p90 -81.12 14.91 2.09 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 121.742 -0.599 . . . . 0.0 112.1 177.417 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -108.46 -31.41 7.82 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.458 0.647 . . . . 0.0 109.982 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.8 m -113.87 116.09 28.75 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 123.175 0.59 . . . . 0.0 109.474 -179.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.8 pttm -58.33 -45.48 88.02 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.058 177.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.419 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 9.7 ttmt -142.07 131.9 12.47 Favored Pre-proline 0 N--CA 1.442 -0.87 0 CA-C-O 118.424 -0.798 . . . . 0.0 109.948 -179.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.419 ' C ' ' HA ' ' A' ' 98' ' ' LYS . 30.9 Cg_endo -70.25 175.37 38.41 Favored 'Cis proline' 0 N--CA 1.456 -0.724 0 O-C-N 124.769 1.931 . . . . 0.0 112.256 -4.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.417 ' HE2' ' OG ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -145.18 147.54 32.58 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 177.765 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -84.86 175.87 8.85 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.24 0.543 . . . . 0.0 111.276 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -73.13 140.67 80.36 Favored Pre-proline 0 CA--C 1.545 0.754 0 O-C-N 121.469 -0.769 . . . . 0.0 111.361 175.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -70.26 -161.85 0.09 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.47 2.114 . . . . 0.0 113.356 175.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -137.83 158.08 24.49 Favored Glycine 0 CA--C 1.523 0.592 0 O-C-N 120.948 -1.095 . . . . 0.0 111.625 176.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -74.4 -41.03 0.95 Allowed 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 122.242 1.962 . . . . 0.0 111.374 179.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.775 ' HB3' ' CZ ' ' A' ' 11' ' ' TYR . . . -90.28 138.23 31.7 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 121.082 0.467 . . . . 0.0 110.03 177.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.463 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 0.0 OUTLIER -139.32 151.82 46.71 Favored 'General case' 0 C--O 1.213 -0.845 0 CA-C-O 117.916 -1.04 . . . . 0.0 111.483 177.753 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.517 ' C ' HD12 ' A' ' 109' ' ' ILE . 3.3 p -82.62 120.71 34.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 123.958 0.903 . . . . 0.0 110.584 177.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.517 HD12 ' C ' ' A' ' 108' ' ' VAL . 1.7 mp -108.16 120.49 59.61 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.628 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 -176.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.85 ' CZ ' HD22 ' A' ' 81' ' ' LEU . 5.8 p90 -140.92 152.42 45.01 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 122.733 1.254 . . . . 0.0 110.149 -178.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.44 HG22 HD21 ' A' ' 80' ' ' LEU . 3.0 p -84.33 160.88 20.6 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.788 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.56 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.3 OUTLIER -113.01 152.83 45.26 Favored Pre-proline 0 CA--C 1.545 0.758 0 CA-C-O 120.464 0.173 . . . . 0.0 110.927 179.506 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.56 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 19.3 Cg_endo -74.25 -50.03 0.2 Allowed 'Cis proline' 0 CA--C 1.499 -1.261 0 C-N-CA 123.462 -1.474 . . . . 0.0 111.043 -5.021 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 32.6 t-20 -44.39 106.57 0.07 Allowed 'General case' 0 CA--C 1.512 -0.516 0 O-C-N 125.03 1.456 . . . . 0.0 108.801 178.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.644 ' HE2' HD13 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -67.88 68.56 0.11 Allowed 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 124.322 1.049 . . . . 0.0 108.811 -178.828 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.618 HG11 ' OD2' ' A' ' 61' ' ' ASP . 24.2 t -73.87 73.32 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 -177.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.561 ' CE1' ' HA2' ' A' ' 119' ' ' GLY . 4.6 t80 -37.26 117.1 0.51 Allowed 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 124.65 1.18 . . . . 0.0 108.139 179.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . 0.563 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -97.15 -34.08 11.26 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.744 177.328 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.561 ' HA2' ' CE1' ' A' ' 117' ' ' PHE . . . 146.25 -175.09 25.9 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 123.484 0.564 . . . . 0.0 111.708 -178.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.711 HG21 ' HB1' ' A' ' 106' ' ' ALA . 3.3 mp -103.66 149.38 7.63 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.745 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -179.185 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.448 HG21 HD12 ' A' ' 55' ' ' ILE . 5.3 pt -122.16 151.85 26.03 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 178.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.617 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . . . . . . . . 0 C--N 1.326 -0.418 0 CA-C-O 122.558 1.171 . . . . 0.0 109.504 178.204 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.502 -0.885 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 . . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.582 HD13 ' CE1' ' A' ' 57' ' ' PHE . 9.9 tp -59.63 129.64 42.9 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 125.141 1.526 . . . . 0.0 107.42 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . 0.59 ' SG ' HG22 ' A' ' 120' ' ' ILE . 79.9 m -58.64 -177.22 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 125.031 1.457 . . . . 0.0 109.313 178.204 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.2 m -152.22 81.6 1.25 Allowed 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 -176.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.515 ' CD2' ' CE2' ' A' ' 4' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--O 1.242 0.692 0 CA-C-O 116.021 -1.942 . . . . 0.0 112.546 173.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.484 HG11 ' CD2' ' A' ' 136' ' ' HIS . 0.4 OUTLIER . . . . . 0 N--CA 1.465 0.294 0 N-CA-C 109.155 -0.683 . . . . 0.0 109.155 . . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.827 HG21 HD23 ' A' ' 10' ' ' LEU . 9.3 m -101.9 105.14 15.91 Favored 'General case' 0 C--N 1.313 -1.013 0 O-C-N 121.584 -0.698 . . . . 0.0 109.373 -176.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 20.3 m95 -73.81 141.97 46.17 Favored 'General case' 0 C--O 1.217 -0.615 0 C-N-CA 124.202 1.001 . . . . 0.0 108.628 -178.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -135.23 144.33 46.84 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -179.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.607 ' SG ' ' HB3' ' A' ' 122' ' ' ALA . 0.8 OUTLIER -124.47 30.68 5.94 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 123.324 0.65 . . . . 0.0 112.571 175.404 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 153.08 -96.78 0.17 Allowed Glycine 0 C--O 1.223 -0.539 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -118.45 -4.48 13.58 Favored Glycine 0 N--CA 1.468 0.802 0 C-N-CA 123.649 0.642 . . . . 0.0 113.862 176.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.422 ' H ' HD12 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -104.53 133.38 49.49 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 -176.894 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.827 HD23 HG21 ' A' ' 3' ' ' THR . 4.8 mp -94.25 164.81 12.88 Favored 'General case' 0 C--O 1.221 -0.426 0 O-C-N 125.373 1.67 . . . . 0.0 110.4 -179.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.479 ' H ' HG22 ' A' ' 3' ' ' THR . 41.3 m-85 -157.62 84.19 0.9 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 125.086 1.354 . . . . 0.0 108.548 -170.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -54.33 122.85 11.25 Favored 'General case' 0 C--O 1.218 -0.57 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -179.129 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.544 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 0.7 OUTLIER -52.08 -48.56 64.62 Favored 'General case' 0 C--O 1.212 -0.915 0 CA-C-N 119.753 1.16 . . . . 0.0 111.876 -179.163 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -48.0 -34.98 10.16 Favored 'General case' 0 C--O 1.207 -1.169 0 O-C-N 124.455 1.097 . . . . 0.0 111.548 176.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -76.38 -55.7 5.31 Favored 'General case' 0 C--O 1.202 -1.429 0 CA-C-O 114.991 -2.433 . . . . 0.0 114.262 168.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -43.38 -37.96 2.53 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 122.274 2.306 . . . . 0.0 113.89 173.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -82.16 -53.11 6.34 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 117.136 -1.411 . . . . 0.0 110.54 172.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 34.8 t -57.77 -22.3 46.25 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-N 119.923 1.238 . . . . 0.0 109.466 -177.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.451 ' ND2' ' CE1' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -75.39 -46.31 33.71 Favored 'General case' 0 N--CA 1.433 -1.304 0 O-C-N 120.277 -1.514 . . . . 0.0 110.596 176.351 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.38 -6.31 34.54 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.311 1.044 . . . . 0.0 112.405 173.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 20.0 m170 -73.55 -43.32 60.17 Favored 'General case' 0 C--O 1.222 -0.379 0 O-C-N 120.017 -1.677 . . . . 0.0 110.758 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -81.89 -35.17 29.51 Favored 'General case' 0 C--O 1.22 -0.5 0 C-N-CA 123.636 0.775 . . . . 0.0 111.304 178.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.733 ' HB1' ' HG3' ' A' ' 35' ' ' PRO . . . -42.92 125.65 3.2 Favored Pre-proline 0 N--CA 1.442 -0.833 0 O-C-N 125.11 1.506 . . . . 0.0 112.706 177.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.46 ' HG2' ' CG2' ' A' ' 30' ' ' THR . 19.3 Cg_endo -72.87 127.01 11.81 Favored 'Trans proline' 0 N--CA 1.446 -1.322 0 C-N-CA 122.327 2.018 . . . . 0.0 108.589 -175.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.562 HD23 ' CE2' ' A' ' 112' ' ' TYR . 0.9 OUTLIER -63.49 111.15 2.21 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.519 0.728 . . . . 0.0 109.244 178.877 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . 0.707 ' O ' HD12 ' A' ' 81' ' ' LEU . 0.2 OUTLIER -176.46 175.29 1.79 Allowed 'General case' 0 C--O 1.209 -1.034 0 C-N-CA 123.815 0.846 . . . . 0.0 111.552 -179.421 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.458 ' HB3' ' CA ' ' A' ' 72' ' ' GLY . 3.5 t0 -115.54 85.55 2.3 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 176.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.68 71.42 1.13 Allowed Glycine 0 C--O 1.226 -0.381 0 N-CA-C 110.146 -1.181 . . . . 0.0 110.146 174.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.79 51.42 0.86 Allowed 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 122.942 1.353 . . . . 0.0 112.583 179.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.539 HG21 ' HD2' ' A' ' 35' ' ' PRO . 0.8 OUTLIER -137.5 149.02 46.48 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -173.356 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -41.07 -69.93 0.46 Allowed Glycine 0 CA--C 1.509 -0.33 0 O-C-N 124.829 1.331 . . . . 0.0 113.59 -175.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 47.2 t -56.65 -53.29 59.4 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 116.344 -1.788 . . . . 0.0 111.727 175.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 155.65 -34.91 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 127.653 2.381 . . . . 0.0 112.178 177.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.462 ' CE1' ' CZ ' ' A' ' 107' ' ' ARG . 92.7 m-85 -85.24 144.16 40.49 Favored Pre-proline 0 CA--C 1.544 0.713 0 N-CA-C 115.027 1.491 . . . . 0.0 115.027 178.203 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.733 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 40.8 Cg_endo -80.95 174.93 44.88 Favored 'Cis proline' 0 N--CA 1.435 -1.914 0 C-N-CA 122.628 -1.822 . . . . 0.0 112.199 5.149 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.404 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 0.3 OUTLIER -149.89 165.76 31.61 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 117.587 -1.197 . . . . 0.0 110.694 -175.585 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.65 ' CH2' HG22 ' A' ' 39' ' ' THR . 19.9 t90 -70.87 146.06 49.86 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 118.686 -1.205 . . . . 0.0 111.107 173.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -114.46 85.73 2.29 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 104.026 -2.583 . . . . 0.0 104.026 -176.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.65 HG22 ' CH2' ' A' ' 37' ' ' TRP . 60.5 p -36.63 -41.39 0.3 Allowed 'General case' 0 C--O 1.212 -0.892 0 CA-C-N 114.275 -1.33 . . . . 0.0 110.914 169.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 57.4 t30 58.31 20.19 7.02 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 122.972 1.368 . . . . 0.0 111.224 178.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 107.37 -39.81 2.75 Favored Glycine 0 N--CA 1.436 -1.345 0 CA-C-O 118.425 -1.208 . . . . 0.0 114.181 -168.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.421 ' CE2' ' HD3' ' A' ' 66' ' ' PRO . 86.9 m-85 -53.85 147.4 12.09 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 118.574 1.187 . . . . 0.0 110.392 -178.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -82.04 -36.77 27.39 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 122.216 1.008 . . . . 0.0 111.516 179.065 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 179.59 -56.89 0.08 OUTLIER Glycine 0 C--N 1.332 0.36 0 C-N-CA 124.995 1.284 . . . . 0.0 110.833 -178.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -78.84 -156.93 0.11 Allowed 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 123.434 1.587 . . . . 0.0 110.861 179.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . 0.481 ' CA ' ' HB2' ' A' ' 65' ' ' PRO . . . -88.59 44.26 3.15 Favored Glycine 0 N--CA 1.442 -0.934 0 CA-C-O 118.347 -1.252 . . . . 0.0 114.562 174.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.2 mtpt -146.21 160.62 41.73 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.12 1.368 . . . . 0.0 110.233 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.1 mp -125.99 155.8 72.68 Favored Pre-proline 0 C--O 1.241 0.621 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.931 -177.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -71.2 158.22 55.32 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.045 1.83 . . . . 0.0 110.011 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.81 105.79 0.14 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.536 0.734 . . . . 0.0 109.214 176.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.32 61.09 0.98 Allowed Glycine 0 N--CA 1.465 0.585 0 O-C-N 121.574 -0.704 . . . . 0.0 112.237 -176.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.8 tpm_? -134.79 151.61 51.09 Favored 'General case' 0 CA--C 1.51 -0.588 0 O-C-N 122.083 -0.657 . . . . 0.0 111.117 174.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.6 m -147.97 103.98 3.62 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.181 0.926 . . . . 0.0 109.285 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -71.16 154.82 61.91 Favored 'Trans proline' 0 N--CA 1.445 -1.33 0 C-N-CA 122.459 2.106 . . . . 0.0 110.867 176.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.548 HD12 HG21 ' A' ' 121' ' ' ILE . 12.0 mt -63.91 123.83 17.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 178.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.06 135.25 34.91 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.577 ' CD1' ' HB3' ' A' ' 118' ' ' CYS . 21.7 m-85 -116.27 -33.58 4.93 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 124.458 1.103 . . . . 0.0 110.754 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.06 -2.38 56.65 Favored Glycine 0 CA--C 1.525 0.707 0 O-C-N 121.558 -0.713 . . . . 0.0 113.406 -174.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.65 132.95 43.64 Favored 'General case' 0 CA--C 1.498 -1.056 0 CA-C-N 118.086 0.943 . . . . 0.0 109.875 176.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.82 -13.94 57.57 Favored 'General case' 0 C--O 1.217 -0.645 0 O-C-N 124.535 1.147 . . . . 0.0 112.222 177.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.433 ' HB2' HG11 ' A' ' 116' ' ' VAL . 0.1 OUTLIER -86.88 -49.67 7.23 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 125.295 1.438 . . . . 0.0 110.106 178.438 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.45 ' HB3' ' CD2' ' A' ' 57' ' ' PHE . 79.4 m -74.89 -9.9 58.98 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 124.015 0.822 . . . . 0.0 112.906 174.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -92.67 -41.39 10.2 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.308 1.443 . . . . 0.0 109.224 176.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.14 157.26 1.55 Allowed Pre-proline 0 N--CA 1.45 -0.462 0 CA-C-O 122.189 0.995 . . . . 0.0 111.552 -177.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.481 ' HB2' ' CA ' ' A' ' 46' ' ' GLY . 26.7 Cg_endo -69.75 132.44 23.36 Favored 'Trans proline' 0 N--CA 1.43 -2.224 0 N-CA-C 114.193 0.805 . . . . 0.0 114.193 174.354 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.421 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 29.1 Cg_endo -69.39 168.11 22.01 Favored 'Trans proline' 0 N--CA 1.433 -2.066 0 C-N-CA 123.691 2.928 . . . . 0.0 111.129 175.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.4 tptt -127.99 123.31 34.46 Favored 'General case' 0 CA--C 1.507 -0.675 0 CA-C-O 115.472 -2.204 . . . . 0.0 105.101 176.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 14.1 t-80 -107.37 164.18 12.41 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 127.528 3.017 . . . . 0.0 110.888 171.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.06 175.53 13.31 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 122.406 1.098 . . . . 0.0 109.633 -178.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.21 48.7 1.52 Allowed 'General case' 0 C--O 1.218 -0.594 0 O-C-N 121.568 -0.707 . . . . 0.0 112.3 175.19 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -161.64 22.14 0.12 Allowed 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 122.614 1.197 . . . . 0.0 112.23 -178.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.458 ' CA ' ' HB3' ' A' ' 27' ' ' ASP . . . 73.92 -63.73 1.98 Allowed Glycine 0 CA--C 1.538 1.48 0 O-C-N 120.793 -1.192 . . . . 0.0 112.897 -169.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -108.08 -98.65 0.37 Allowed 'General case' 0 C--O 1.207 -1.145 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 175.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 123.52 -157.93 18.04 Favored Glycine 0 C--O 1.222 -0.65 0 O-C-N 119.795 -1.815 . . . . 0.0 110.644 -168.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.9 mttp -50.54 -84.29 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.919 0.888 . . . . 0.0 113.268 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.427 HG23 ' O ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -117.61 9.55 13.16 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 118.554 -0.736 . . . . 0.0 111.879 175.6 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.422 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 0.4 OUTLIER -26.2 97.95 0.01 OUTLIER 'General case' 0 C--O 1.211 -0.958 0 C-N-CA 126.671 1.988 . . . . 0.0 112.1 -179.325 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.467 ' CD2' ' H ' ' A' ' 78' ' ' HIS . 6.0 p80 -89.12 69.4 8.34 Favored 'General case' 0 CA--C 1.506 -0.721 0 O-C-N 119.446 -2.034 . . . . 0.0 107.326 -170.076 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.424 ' HB2' ' CD1' ' A' ' 37' ' ' TRP . 35.9 p90 -92.84 135.55 34.03 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 124.674 1.189 . . . . 0.0 109.575 -177.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.47 127.96 34.15 Favored 'General case' 0 C--O 1.213 -0.86 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 175.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.921 HD22 ' CZ ' ' A' ' 110' ' ' TYR . 0.1 OUTLIER -115.08 146.08 41.67 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 174.965 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -106.83 161.73 14.43 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 122.355 1.074 . . . . 0.0 112.214 173.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.451 ' CE1' ' ND2' ' A' ' 19' ' ' ASN . 9.1 t80 -153.95 140.23 12.68 Favored Pre-proline 0 C--N 1.328 -0.368 0 O-C-N 121.444 -0.785 . . . . 0.0 112.715 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.408 ' HA ' ' HG2' ' A' ' 107' ' ' ARG . 20.1 Cg_endo -70.99 95.72 0.67 Allowed 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 124.366 3.378 . . . . 0.0 112.844 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.8 t -101.54 104.49 15.39 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 122.436 1.112 . . . . 0.0 110.347 -177.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -80.61 160.87 66.07 Favored Pre-proline 0 C--N 1.32 -0.681 0 O-C-N 121.099 -1.001 . . . . 0.0 111.932 -179.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -76.39 -35.05 2.38 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.194 1.929 . . . . 0.0 113.664 177.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -43.02 -31.61 0.55 Allowed 'General case' 0 N--CA 1.475 0.781 0 O-C-N 125.213 1.57 . . . . 0.0 110.868 174.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.71 15.81 76.91 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.5 178.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -81.62 160.74 23.7 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 121.36 0.6 . . . . 0.0 109.824 177.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -97.11 92.28 5.97 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 174.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.506 ' CE2' ' HB3' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -47.57 162.52 0.07 Allowed 'General case' 0 C--O 1.223 -0.303 0 CA-C-O 123.105 1.431 . . . . 0.0 113.194 175.68 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.18 59.1 5.39 Favored 'General case' 0 C--N 1.319 -0.759 0 O-C-N 120.026 -1.671 . . . . 0.0 110.899 177.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -75.09 -16.47 60.56 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.755 175.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -92.66 -23.25 19.03 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 123.873 1.797 . . . . 0.0 111.478 179.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.51 109.82 19.88 Favored 'General case' 0 CA--C 1.513 -0.458 0 O-C-N 119.892 -1.755 . . . . 0.0 109.131 177.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.2 ptpt -59.45 -46.55 88.45 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 121.354 0.597 . . . . 0.0 112.109 176.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 99' ' ' PRO . 1.1 mtmt -141.52 127.22 11.0 Favored Pre-proline 0 N--CA 1.444 -0.75 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.107 -178.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 98' ' ' LYS . 28.5 Cg_endo -70.5 173.04 48.9 Favored 'Cis proline' 0 N--CA 1.456 -0.714 0 C-N-CA 123.288 -1.547 . . . . 0.0 110.951 -5.018 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.47 149.62 52.06 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 123.526 0.73 . . . . 0.0 109.243 177.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . 0.506 ' HB3' ' CE2' ' A' ' 92' ' ' TYR . 2.9 tt0 -100.91 176.72 5.18 Favored 'General case' 0 C--N 1.316 -0.889 0 O-C-N 123.938 0.774 . . . . 0.0 111.773 176.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -83.14 126.34 72.47 Favored Pre-proline 0 CA--C 1.541 0.631 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 179.059 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.419 ' HB3' ' CE2' ' A' ' 34' ' ' TYR . 31.7 Cg_endo -67.6 -166.32 0.13 Allowed 'Trans proline' 0 N--CA 1.452 -0.94 0 CA-C-O 123.371 1.321 . . . . 0.0 113.226 176.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -139.42 173.04 22.97 Favored Glycine 0 CA--C 1.523 0.558 0 O-C-N 121.02 -1.05 . . . . 0.0 112.679 176.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -75.05 -57.92 0.05 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 123.017 2.478 . . . . 0.0 111.101 178.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.459 ' CB ' ' CE2' ' A' ' 11' ' ' TYR . . . -60.87 133.38 56.04 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-O 120.979 0.419 . . . . 0.0 111.155 177.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.476 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 6.8 mtm-85 -147.35 149.48 32.88 Favored 'General case' 0 CA--C 1.497 -1.084 0 CA-C-O 117.194 -1.384 . . . . 0.0 110.522 179.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.469 ' C ' HD12 ' A' ' 109' ' ' ILE . 2.8 p -81.86 118.92 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 O-C-N 124.434 1.084 . . . . 0.0 110.493 175.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.469 HD12 ' C ' ' A' ' 108' ' ' VAL . 1.8 mp -108.07 117.51 53.81 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.662 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 -177.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.921 ' CZ ' HD22 ' A' ' 81' ' ' LEU . 8.0 p90 -134.1 153.21 51.96 Favored 'General case' 0 N--CA 1.447 -0.621 0 O-C-N 124.252 0.97 . . . . 0.0 109.56 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.8 p -84.28 162.72 20.01 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.231 178.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.562 ' CE2' HD23 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -110.06 154.87 42.52 Favored Pre-proline 0 CA--C 1.548 0.884 0 O-C-N 122.014 -0.429 . . . . 0.0 110.61 178.747 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.496 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 17.9 Cg_endo -74.15 -48.81 0.25 Allowed 'Cis proline' 0 CA--C 1.509 -0.749 0 C-N-CA 123.934 -1.278 . . . . 0.0 111.515 -8.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -45.8 107.77 0.11 Allowed 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 117.62 -1.181 . . . . 0.0 108.895 175.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.445 ' HE2' HD13 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -67.84 68.46 0.11 Allowed 'General case' 0 CA--C 1.512 -0.509 0 C-N-CA 125.711 1.604 . . . . 0.0 108.09 -179.4 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.433 HG11 ' HB2' ' A' ' 61' ' ' ASP . 18.0 t -73.19 78.89 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 N-CA-C 102.992 -2.966 . . . . 0.0 102.992 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.544 ' CZ ' ' NE2' ' A' ' 13' ' ' GLN . 5.2 t80 -37.82 118.9 0.71 Allowed 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 125.339 1.456 . . . . 0.0 108.93 176.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . 0.577 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 7.3 m -95.22 -45.31 7.23 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 121.763 0.792 . . . . 0.0 109.304 179.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.519 ' HA2' ' CE1' ' A' ' 117' ' ' PHE . . . 156.16 -166.55 33.13 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 -178.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.592 HG22 ' SG ' ' A' ' 134' ' ' CYS . 3.0 mp -117.03 132.67 66.12 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.343 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 -178.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.774 HG22 HD12 ' A' ' 133' ' ' LEU . 10.2 pt -108.44 154.62 9.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.607 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . . . . . . . . 0 C--N 1.323 -0.564 0 CA-C-O 121.733 0.778 . . . . 0.0 110.637 175.449 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.512 -0.482 0 N-CA-C 110.093 -0.336 . . . . 0.0 110.093 . . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.774 HD12 HG22 ' A' ' 121' ' ' ILE . 6.0 tp -81.33 146.18 30.49 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 175.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . 0.592 ' SG ' HG22 ' A' ' 120' ' ' ILE . 87.2 m -61.4 175.01 0.63 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 123.488 1.613 . . . . 0.0 109.614 172.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 72.0 m -161.4 90.99 0.83 Allowed 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 104.198 -2.519 . . . . 0.0 104.198 -175.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.484 ' CD2' HG11 ' A' ' 2' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.474 0.726 0 CA-C-O 115.656 -2.116 . . . . 0.0 115.305 169.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.6 p . . . . . 0 CA--C 1.518 -0.285 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.599 HG21 HD22 ' A' ' 10' ' ' LEU . 0.9 OUTLIER -85.59 112.25 20.8 Favored 'General case' 0 C--N 1.32 -0.698 0 O-C-N 121.907 -0.496 . . . . 0.0 110.469 178.504 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . 0.471 ' CG ' HG13 ' A' ' 120' ' ' ILE . 29.9 m95 -79.13 139.16 38.11 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 123.091 0.556 . . . . 0.0 110.951 176.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.447 ' OG1' HD23 ' A' ' 10' ' ' LEU . 0.9 OUTLIER -121.36 124.66 45.07 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -177.81 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.673 ' HB3' ' HB3' ' A' ' 122' ' ' ALA . 13.6 m -113.65 40.68 2.35 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.267 0.556 . . . . 0.0 110.912 177.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 138.05 -94.84 0.22 Allowed Glycine 0 C--O 1.223 -0.574 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 -179.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.545 ' C ' HD13 ' A' ' 9' ' ' LEU . . . -123.79 1.62 9.3 Favored Glycine 0 N--CA 1.463 0.434 0 C-N-CA 123.074 0.369 . . . . 0.0 112.803 177.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.623 ' N ' HD13 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -107.8 140.44 40.88 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 -173.428 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.599 HD22 HG21 ' A' ' 3' ' ' THR . 17.1 mt -106.07 121.01 43.27 Favored 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 124.258 0.974 . . . . 0.0 109.311 -177.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.526 ' CE2' ' CB ' ' A' ' 106' ' ' ALA . 61.2 m-85 -116.06 99.94 7.61 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 124.966 1.307 . . . . 0.0 108.968 -175.137 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -56.26 122.28 11.42 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-O 118.234 -0.889 . . . . 0.0 108.982 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.495 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 6.1 tp-100 -50.09 -46.97 53.92 Favored 'General case' 0 C--O 1.21 -0.987 0 O-C-N 123.978 0.799 . . . . 0.0 112.105 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . 0.402 ' O ' ' CB ' ' A' ' 18' ' ' SER . 5.5 t-20 -50.07 -41.54 48.22 Favored 'General case' 0 C--O 1.201 -1.482 0 O-C-N 123.211 0.319 . . . . 0.0 110.975 176.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.12 -37.12 75.23 Favored 'General case' 0 C--O 1.204 -1.302 0 CA-C-O 116.916 -1.516 . . . . 0.0 113.076 170.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.04 -44.95 79.28 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 121.813 2.097 . . . . 0.0 113.151 172.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.434 ' O ' ' CD2' ' A' ' 21' ' ' HIS . 5.1 pt-20 -82.52 -37.67 24.9 Favored 'General case' 0 C--O 1.211 -0.927 0 C-N-CA 123.203 0.601 . . . . 0.0 109.715 176.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . 0.402 ' CB ' ' O ' ' A' ' 14' ' ' ASN . 28.8 t -73.98 -60.02 2.45 Favored 'General case' 0 CA--C 1.505 -0.777 0 O-C-N 119.751 -1.843 . . . . 0.0 109.521 -176.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.474 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 12.1 t-20 -40.75 -37.4 0.75 Allowed 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 124.543 1.137 . . . . 0.0 112.359 172.127 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.565 ' HB3' HG11 ' A' ' 108' ' ' VAL . 1.0 OUTLIER -82.52 -36.45 26.36 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 174.561 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.434 ' CD2' ' O ' ' A' ' 17' ' ' GLU . 4.4 m170 -45.76 -38.56 7.19 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 126.288 1.835 . . . . 0.0 110.133 178.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.474 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -72.05 -47.43 51.65 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 123.826 0.85 . . . . 0.0 112.145 175.793 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.725 ' HB1' ' HG3' ' A' ' 35' ' ' PRO . . . -37.88 130.25 0.94 Allowed Pre-proline 0 N--CA 1.443 -0.785 0 O-C-N 124.762 1.289 . . . . 0.0 112.079 174.165 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.724 ' HG2' HG22 ' A' ' 30' ' ' THR . 16.4 Cg_endo -73.31 124.48 9.49 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 121.836 1.691 . . . . 0.0 108.939 -176.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.626 HD13 ' HE2' ' A' ' 115' ' ' LYS . 3.9 tp -60.94 93.27 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 123.635 0.774 . . . . 0.0 111.227 179.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 178.55 155.0 0.4 Allowed 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 122.957 0.503 . . . . 0.0 110.092 -174.032 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.77 123.18 39.22 Favored 'General case' 0 CA--C 1.508 -0.642 0 C-N-CA 123.973 0.909 . . . . 0.0 109.006 178.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 48.04 70.25 0.78 Allowed Glycine 0 C--N 1.335 0.482 0 CA-C-O 122.104 0.835 . . . . 0.0 111.895 176.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -149.09 30.18 0.79 Allowed 'General case' 0 CA--C 1.51 -0.58 0 O-C-N 121.831 -0.805 . . . . 0.0 111.962 179.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.724 HG22 ' HG2' ' A' ' 24' ' ' PRO . 36.4 p -127.52 147.23 50.32 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -175.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -41.23 -55.35 3.62 Favored Glycine 0 N--CA 1.448 -0.556 0 O-C-N 123.981 0.8 . . . . 0.0 112.082 -178.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 29.2 t -67.37 -70.64 0.24 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 118.803 -0.618 . . . . 0.0 111.474 175.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.1 p 176.03 -57.66 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 124.306 1.042 . . . . 0.0 112.85 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -67.48 151.55 97.05 Favored Pre-proline 0 N--CA 1.427 -1.609 0 C-N-CA 124.131 0.972 . . . . 0.0 112.066 178.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.725 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 24.5 Cg_endo -74.62 164.06 89.0 Favored 'Cis proline' 0 N--CA 1.455 -0.74 0 C-N-CA 123.144 -1.607 . . . . 0.0 111.103 -1.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.421 ' CD2' ' HG2' ' A' ' 82' ' ' GLU . 0.3 OUTLIER -143.17 161.4 38.32 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 117.474 -1.251 . . . . 0.0 109.662 -179.034 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.959 ' CH2' HG22 ' A' ' 39' ' ' THR . 13.7 t90 -59.33 138.67 57.55 Favored 'General case' 0 N--CA 1.446 -0.629 0 O-C-N 124.937 1.398 . . . . 0.0 110.137 177.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.538 ' CZ ' HD13 ' A' ' 121' ' ' ILE . 9.8 t80 -109.13 85.83 2.17 Favored 'General case' 0 N--CA 1.423 -1.782 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 -176.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.959 HG22 ' CH2' ' A' ' 37' ' ' TRP . 20.1 p -38.69 -34.6 0.15 Allowed 'General case' 0 CA--C 1.495 -1.138 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.653 170.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.484 ' HB2' ' CE2' ' A' ' 38' ' ' PHE . 62.9 t30 53.8 22.58 3.29 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 120.854 1.661 . . . . 0.0 111.625 177.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.738 ' C ' HD23 ' A' ' 48' ' ' LEU . . . 104.27 -44.28 1.51 Allowed Glycine 0 N--CA 1.419 -2.488 0 CA-C-O 117.26 -1.855 . . . . 0.0 115.218 -168.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.506 ' CE2' ' HD3' ' A' ' 66' ' ' PRO . 84.8 m-85 -43.34 151.1 0.17 Allowed 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.691 1.597 . . . . 0.0 112.279 176.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.82 -36.39 25.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.326 0.584 . . . . 0.0 111.884 177.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.52 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -165.3 -77.63 0.03 OUTLIER Glycine 0 C--N 1.34 0.794 0 C-N-CA 124.459 1.028 . . . . 0.0 111.846 -179.078 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -109.41 -67.98 0.95 Allowed 'General case' 0 CA--C 1.513 -0.459 0 C-N-CA 123.521 0.728 . . . . 0.0 111.029 -179.245 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.23 -170.71 0.11 Allowed Glycine 0 C--N 1.348 1.233 0 C-N-CA 124.436 1.017 . . . . 0.0 110.967 178.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -58.77 -167.64 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 124.296 1.998 . . . . 0.0 111.703 177.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.738 HD23 ' C ' ' A' ' 41' ' ' GLY . 0.0 OUTLIER -86.78 163.47 40.96 Favored Pre-proline 0 N--CA 1.44 -0.968 0 O-C-N 120.139 -1.601 . . . . 0.0 110.566 -179.354 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -71.83 171.51 16.39 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 122.067 1.844 . . . . 0.0 111.077 178.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -58.79 96.44 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.196 177.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.33 88.4 1.97 Allowed Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 111.895 -0.482 . . . . 0.0 111.895 -177.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.507 ' HB3' HD22 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -166.55 163.75 17.02 Favored 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 123.795 0.838 . . . . 0.0 111.557 176.283 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 97.7 m -143.6 95.07 5.94 Favored Pre-proline 0 C--O 1.236 0.389 0 O-C-N 124.33 1.019 . . . . 0.0 109.604 -176.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -72.98 169.75 21.43 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.529 2.153 . . . . 0.0 110.901 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.405 ' CG2' ' HB2' ' A' ' 133' ' ' LEU . 6.4 mt -99.58 134.22 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -178.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -86.09 157.6 20.01 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 121.107 0.479 . . . . 0.0 110.182 176.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.432 ' CD1' ' HB3' ' A' ' 118' ' ' CYS . 26.2 m-85 -140.65 -46.85 0.41 Allowed 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 123.805 0.842 . . . . 0.0 111.036 178.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 112.57 -4.42 26.29 Favored Glycine 0 C--N 1.338 0.664 0 C-N-CA 123.523 0.582 . . . . 0.0 113.057 -175.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.91 134.84 38.42 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-O 117.859 -1.067 . . . . 0.0 110.388 176.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 20.1 t -69.23 -6.36 28.68 Favored 'General case' 0 C--O 1.225 -0.222 0 O-C-N 125.127 1.517 . . . . 0.0 111.538 176.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.69 -56.88 3.07 Favored 'General case' 0 N--CA 1.446 -0.674 0 O-C-N 120.289 -1.507 . . . . 0.0 109.614 -179.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 27.7 m -70.99 -18.06 62.62 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 123.789 0.68 . . . . 0.0 110.688 177.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -80.28 -41.0 25.79 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 123.678 0.791 . . . . 0.0 111.515 174.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.04 158.97 1.57 Allowed Pre-proline 0 N--CA 1.444 -0.766 0 CA-C-O 122.282 1.039 . . . . 0.0 111.033 179.404 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -71.02 136.21 29.17 Favored 'Trans proline' 0 N--CA 1.444 -1.395 0 C-N-CA 121.003 1.135 . . . . 0.0 113.673 174.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.506 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 19.2 Cg_endo -72.54 171.34 17.35 Favored 'Trans proline' 0 N--CA 1.446 -1.287 0 C-N-CA 122.957 2.438 . . . . 0.0 111.015 178.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.4 tptt -128.41 49.93 2.14 Favored 'General case' 0 C--O 1.212 -0.9 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.936 178.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.442 ' CE1' ' CE3' ' A' ' 37' ' ' TRP . 56.2 t-80 -77.13 161.25 28.39 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 120.132 -1.605 . . . . 0.0 112.126 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -161.56 177.89 9.6 Favored 'General case' 0 CA--C 1.502 -0.896 0 O-C-N 118.787 -2.445 . . . . 0.0 108.178 176.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.2 pttp -64.68 74.22 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 124.858 1.263 . . . . 0.0 111.724 175.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 179.56 -47.58 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 125.524 1.53 . . . . 0.0 110.294 -176.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 113.31 -71.89 0.22 Allowed Glycine 0 CA--C 1.488 -1.621 0 CA-C-O 118.805 -0.997 . . . . 0.0 112.157 -177.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -128.81 64.33 1.45 Allowed 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 125.934 1.694 . . . . 0.0 107.803 -177.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.56 -110.63 0.01 OUTLIER Glycine 0 C--N 1.334 0.454 0 CA-C-O 122.391 0.995 . . . . 0.0 112.543 178.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.5 mttp -63.22 -98.4 0.0 OUTLIER 'General case' 0 C--O 1.222 -0.372 0 O-C-N 119.792 -2.005 . . . . 0.0 111.75 177.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.54 HG23 ' O ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -114.23 15.93 18.06 Favored 'General case' 0 CA--C 1.51 -0.593 0 O-C-N 120.608 -1.307 . . . . 0.0 111.082 178.239 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.475 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 29.0 m-20 -30.5 107.5 0.04 OUTLIER 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 124.787 1.235 . . . . 0.0 110.16 -177.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.557 ' CD2' ' H ' ' A' ' 78' ' ' HIS . 2.8 p80 -87.43 14.52 7.94 Favored 'General case' 0 CA--C 1.511 -0.524 0 O-C-N 121.654 -0.654 . . . . 0.0 110.561 -177.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.529 ' HB2' ' CD1' ' A' ' 37' ' ' TRP . 14.9 p90 -39.51 137.34 0.83 Allowed 'General case' 0 N--CA 1.429 -1.514 0 C-N-CA 125.592 1.557 . . . . 0.0 110.715 176.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.669 HD22 ' CG2' ' A' ' 109' ' ' ILE . 0.3 OUTLIER -71.88 157.87 37.07 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.622 177.244 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.514 HD21 ' CE2' ' A' ' 79' ' ' TYR . 5.5 mp -139.67 120.77 14.7 Favored 'General case' 0 CA--C 1.501 -0.925 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 -177.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.497 ' CB ' ' CD1' ' A' ' 109' ' ' ILE . 0.5 OUTLIER -92.36 152.68 19.63 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-O 122.259 1.028 . . . . 0.0 111.585 178.723 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.505 ' CZ ' ' HB2' ' A' ' 23' ' ' ALA . 12.6 t80 -145.23 134.05 11.04 Favored Pre-proline 0 N--CA 1.444 -0.762 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.583 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -74.62 112.92 3.67 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.959 2.44 . . . . 0.0 110.188 -177.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.6 t -104.73 110.45 22.78 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 124.323 1.014 . . . . 0.0 110.079 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.438 ' CE1' ' HB2' ' A' ' 92' ' ' TYR . 70.1 m-85 -82.02 157.92 68.05 Favored Pre-proline 0 N--CA 1.445 -0.69 0 O-C-N 121.424 -0.797 . . . . 0.0 112.25 178.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -76.63 -42.25 0.36 Allowed 'Trans proline' 0 CA--C 1.501 -1.15 0 C-N-CA 122.555 2.17 . . . . 0.0 112.332 179.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -44.69 -30.92 1.02 Allowed 'General case' 0 C--N 1.353 0.731 0 CA-C-O 122.159 0.98 . . . . 0.0 110.855 176.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 85.23 8.77 81.06 Favored Glycine 0 N--CA 1.434 -1.47 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 177.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 4.2 p-80 -73.84 128.38 35.36 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.36 93.15 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 123.601 0.76 . . . . 0.0 109.76 173.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.47 ' O ' ' CD2' ' A' ' 94' ' ' PHE . 12.9 t80 -39.7 144.58 0.17 Allowed 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 121.967 0.889 . . . . 0.0 111.19 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.38 57.31 1.49 Allowed 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 120.011 -1.68 . . . . 0.0 109.988 176.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.47 ' CD2' ' O ' ' A' ' 92' ' ' TYR . 34.3 p90 -71.19 -9.91 58.88 Favored 'General case' 0 N--CA 1.439 -1.018 0 C-N-CA 124.085 0.954 . . . . 0.0 112.168 175.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -89.7 -36.41 15.23 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 123.131 1.443 . . . . 0.0 110.451 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.9 m -84.46 111.29 19.34 Favored 'General case' 0 N--CA 1.441 -0.904 0 O-C-N 120.341 -1.474 . . . . 0.0 109.394 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.0 ptpt -58.75 -47.92 82.99 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-O 120.945 0.403 . . . . 0.0 111.235 178.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -143.18 130.51 10.84 Favored Pre-proline 0 N--CA 1.432 -1.346 0 C-N-CA 123.78 0.832 . . . . 0.0 109.378 -177.312 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.403 ' HA ' ' HA ' ' A' ' 98' ' ' LYS . 24.7 Cg_endo -70.1 175.44 37.65 Favored 'Cis proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.284 -1.965 . . . . 0.0 111.007 -6.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.43 147.03 42.86 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.902 178.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -87.94 173.41 8.93 Favored 'General case' 0 C--O 1.24 0.591 0 O-C-N 123.837 0.711 . . . . 0.0 112.133 177.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -72.5 143.03 84.73 Favored Pre-proline 0 N--CA 1.442 -0.853 0 CA-C-O 118.117 -0.944 . . . . 0.0 111.165 177.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -73.15 -164.8 0.21 Allowed 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.266 2.644 . . . . 0.0 111.739 176.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -140.97 164.5 26.44 Favored Glycine 0 N--CA 1.44 -1.046 0 O-C-N 121.581 -0.7 . . . . 0.0 112.478 177.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -75.39 -60.24 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.692 2.262 . . . . 0.0 110.481 179.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.779 ' HA ' ' HB2' ' A' ' 122' ' ' ALA . . . -63.31 139.83 58.81 Favored 'General case' 0 N--CA 1.438 -1.031 0 O-C-N 123.689 0.618 . . . . 0.0 111.62 178.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 1.5 mtm-85 -143.14 143.48 31.83 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.307 -179.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.565 HG11 ' HB3' ' A' ' 20' ' ' SER . 7.0 p -83.14 124.13 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 O-C-N 123.92 0.762 . . . . 0.0 110.479 178.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.669 ' CG2' HD22 ' A' ' 80' ' ' LEU . 6.3 mm -106.23 140.91 22.8 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.892 0 C-N-CA 122.823 0.449 . . . . 0.0 110.157 -179.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.621 ' C ' HD23 ' A' ' 80' ' ' LEU . 9.7 p90 -165.48 153.1 10.83 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-O 122.042 0.925 . . . . 0.0 110.483 -177.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.4 p -88.8 165.53 14.62 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.776 -178.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.547 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.2 OUTLIER -111.29 154.09 43.79 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 122.184 0.193 . . . . 0.0 111.368 178.761 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.547 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 19.0 Cg_endo -73.87 -52.85 0.16 OUTLIER 'Cis proline' 0 CA--C 1.499 -1.256 0 C-N-CA 123.525 -1.448 . . . . 0.0 109.708 -6.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -43.24 110.93 0.22 Allowed 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 117.628 -1.177 . . . . 0.0 109.914 178.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.626 ' HE2' HD13 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -66.96 72.45 0.1 Allowed 'General case' 0 CA--C 1.51 -0.585 0 C-N-CA 124.429 1.092 . . . . 0.0 108.519 -178.116 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.433 ' O ' HG12 ' A' ' 116' ' ' VAL . 36.9 t -72.32 77.4 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 N-CA-C 105.596 -2.001 . . . . 0.0 105.596 -176.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.495 ' CZ ' ' NE2' ' A' ' 13' ' ' GLN . 41.5 t80 -39.57 107.1 0.06 Allowed 'General case' 0 N--CA 1.435 -1.219 0 C-N-CA 126.002 1.721 . . . . 0.0 110.034 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . 0.474 ' SG ' HD21 ' A' ' 80' ' ' LEU . 10.2 m -81.94 -46.13 14.47 Favored 'General case' 0 N--CA 1.436 -1.175 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 -178.113 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.428 ' HA2' ' CZ ' ' A' ' 117' ' ' PHE . . . 160.4 -147.73 15.03 Favored Glycine 0 N--CA 1.441 -0.998 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.471 HG13 ' CG ' ' A' ' 4' ' ' TRP . 1.2 mm -128.64 138.94 53.23 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.929 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 -175.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.538 HD13 ' CZ ' ' A' ' 38' ' ' PHE . 7.6 pt -130.0 154.94 41.13 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -177.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.779 ' HB2' ' HA ' ' A' ' 106' ' ' ALA . . . . . . . . 0 N--CA 1.445 -0.72 0 CA-C-O 121.794 0.807 . . . . 0.0 109.714 179.109 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . 0.421 ' HE3' ' O ' ' A' ' 133' ' ' LEU . 2.5 ptmt . . . . . 0 CA--C 1.509 -0.615 0 CA-C-O 119.094 -0.479 . . . . 0.0 109.712 . . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.537 HD12 HG22 ' A' ' 121' ' ' ILE . 11.6 tp -86.76 136.25 33.07 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-O 121.646 0.736 . . . . 0.0 109.448 177.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 50.7 m -66.02 -179.61 0.76 Allowed 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 124.152 0.981 . . . . 0.0 109.389 175.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 68.4 m -159.44 92.08 1.04 Allowed 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 -178.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.257 1.496 0 CA-C-O 113.965 -2.921 . . . . 0.0 113.682 170.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.5 p . . . . . 0 C--O 1.235 0.29 0 N-CA-C 109.92 -0.4 . . . . 0.0 109.92 . . . . . . . . . 0 0 . 1 . 019 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.937 HG21 HD23 ' A' ' 10' ' ' LEU . 5.9 m -94.79 107.78 19.8 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 123.634 0.774 . . . . 0.0 110.62 178.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 20.4 m95 -78.57 141.42 38.11 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.005 0.922 . . . . 0.0 108.879 179.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -132.63 138.09 47.24 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.659 ' SG ' ' HB3' ' A' ' 122' ' ' ALA . 0.5 OUTLIER -121.63 64.53 0.9 Allowed 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 114.838 -1.073 . . . . 0.0 108.674 177.834 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 37.6 75.03 0.09 OUTLIER Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.851 1.215 . . . . 0.0 114.104 178.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 159.87 -75.03 0.2 Allowed Glycine 0 C--O 1.226 -0.404 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 -175.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 74.2 mt -126.69 159.91 32.3 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 122.12 0.962 . . . . 0.0 110.34 177.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.937 HD23 HG21 ' A' ' 3' ' ' THR . 9.9 mp -87.96 167.48 13.68 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.143 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.656 ' CZ ' ' HB3' ' A' ' 106' ' ' ALA . 65.4 m-85 -156.09 87.17 1.05 Allowed 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 125.276 1.43 . . . . 0.0 108.386 -173.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -53.47 120.11 5.69 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-O 117.832 -1.08 . . . . 0.0 108.457 177.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.533 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 0.9 OUTLIER -49.27 -43.77 43.31 Favored 'General case' 0 C--O 1.212 -0.876 0 CA-C-N 119.865 1.211 . . . . 0.0 111.629 178.842 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -48.89 -42.37 36.57 Favored 'General case' 0 C--O 1.201 -1.462 0 CA-C-N 117.779 0.263 . . . . 0.0 111.187 176.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.47 -44.36 62.42 Favored 'General case' 0 C--O 1.21 -1.026 0 O-C-N 120.416 -1.427 . . . . 0.0 112.644 169.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.503 ' HB1' HD11 ' A' ' 120' ' ' ILE . . . -52.11 -38.49 57.58 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 121.4 1.909 . . . . 0.0 112.907 175.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -86.06 -48.89 8.23 Favored 'General case' 0 C--O 1.21 -1.022 0 CA-C-O 117.51 -1.234 . . . . 0.0 108.971 175.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.2 t -69.45 -57.88 4.69 Favored 'General case' 0 CA--C 1.504 -0.797 0 C-N-CA 126.599 1.96 . . . . 0.0 109.483 -173.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.445 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 0.5 OUTLIER -42.17 -36.6 1.23 Allowed 'General case' 0 C--O 1.217 -0.627 0 CA-C-N 119.536 1.062 . . . . 0.0 110.745 169.664 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.448 ' O ' ' HB3' ' A' ' 23' ' ' ALA . 1.4 p -83.53 -29.74 27.66 Favored 'General case' 0 C--O 1.218 -0.564 0 N-CA-C 114.911 1.449 . . . . 0.0 114.911 176.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -50.31 -35.67 28.47 Favored 'General case' 0 C--O 1.222 -0.351 0 C-N-CA 126.696 1.999 . . . . 0.0 109.826 178.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.445 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.1 OUTLIER -71.59 -49.54 39.37 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 125.43 1.492 . . . . 0.0 111.193 175.946 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.719 ' HB1' ' HG3' ' A' ' 35' ' ' PRO . . . -39.39 123.15 1.38 Allowed Pre-proline 0 C--O 1.239 0.529 0 O-C-N 124.867 1.355 . . . . 0.0 111.807 174.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.536 ' HG2' HG22 ' A' ' 30' ' ' THR . 18.1 Cg_endo -70.76 126.37 12.57 Favored 'Trans proline' 0 N--CA 1.445 -1.366 0 C-N-CA 122.083 1.855 . . . . 0.0 108.868 -177.044 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.863 HD21 ' O ' ' A' ' 113' ' ' PRO . 4.9 tp -62.91 94.54 0.07 Allowed 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.449 0.7 . . . . 0.0 112.219 178.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.1 m 179.98 153.64 0.52 Allowed 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 125.082 1.353 . . . . 0.0 110.163 -173.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.61 119.16 31.77 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.436 1.494 . . . . 0.0 109.367 176.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 49.86 69.69 0.99 Allowed Glycine 0 CA--C 1.525 0.708 0 CA-C-O 122.189 0.883 . . . . 0.0 112.476 174.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.5 mtpt -145.95 22.89 1.39 Allowed 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -178.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.536 HG22 ' HG2' ' A' ' 24' ' ' PRO . 33.6 p -123.45 150.97 43.18 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 124.398 1.079 . . . . 0.0 108.693 -177.169 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -38.65 -63.44 1.01 Allowed Glycine 0 CA--C 1.522 0.477 0 C-N-CA 124.705 1.145 . . . . 0.0 113.712 178.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.415 ' HB3' ' HA ' ' A' ' 94' ' ' PHE . 44.1 t -63.64 -59.4 4.65 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 118.312 -0.851 . . . . 0.0 112.071 174.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.0 m 158.9 -48.61 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.872 2.069 . . . . 0.0 112.17 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.535 ' CD2' ' HD3' ' A' ' 84' ' ' PRO . 63.3 m-85 -64.48 145.54 98.43 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-O 117.801 -1.095 . . . . 0.0 112.909 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.719 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 28.6 Cg_endo -73.35 158.53 98.38 Favored 'Cis proline' 0 N--CA 1.448 -1.198 0 C-N-CA 123.577 -1.426 . . . . 0.0 111.137 -4.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.808 ' C ' HD23 ' A' ' 81' ' ' LEU . 2.1 p80 -137.19 170.56 15.88 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-N 114.713 -1.131 . . . . 0.0 109.565 -176.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.906 ' CH2' HG22 ' A' ' 39' ' ' THR . 22.7 t90 -71.56 148.03 47.07 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.99 0.9 . . . . 0.0 109.243 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.517 ' CE2' ' HB2' ' A' ' 40' ' ' ASN . 27.5 t80 -124.31 78.24 1.64 Allowed 'General case' 0 N--CA 1.435 -1.182 0 C-N-CA 127.11 2.164 . . . . 0.0 106.003 -177.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.906 HG22 ' CH2' ' A' ' 37' ' ' TRP . 77.0 p -37.04 -39.91 0.26 Allowed 'General case' 0 C--O 1.218 -0.571 0 C-N-CA 124.421 1.088 . . . . 0.0 111.6 171.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.517 ' HB2' ' CE2' ' A' ' 38' ' ' PHE . 46.0 t30 59.69 16.06 5.19 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 122.428 1.109 . . . . 0.0 110.907 178.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.545 ' C ' HD23 ' A' ' 48' ' ' LEU . . . 115.11 -40.89 2.31 Favored Glycine 0 N--CA 1.44 -1.049 0 CA-C-O 117.435 -1.758 . . . . 0.0 111.619 -172.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.442 ' CD1' ' HD2' ' A' ' 66' ' ' PRO . 76.2 m-85 -49.34 159.53 0.31 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.202 1.501 . . . . 0.0 112.295 -179.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.25 -35.82 23.14 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 122.589 1.185 . . . . 0.0 111.317 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.465 ' HA2' ' CZ2' ' A' ' 37' ' ' TRP . . . 145.04 -31.44 1.73 Allowed Glycine 0 C--O 1.218 -0.863 0 C-N-CA 125.185 1.374 . . . . 0.0 111.586 -176.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.9 -54.28 5.72 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 119.049 1.425 . . . . 0.0 111.575 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 157.23 33.13 0.02 OUTLIER Glycine 0 C--N 1.336 0.541 0 O-C-N 124.309 1.006 . . . . 0.0 112.748 -177.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 29.2 mttt -142.07 159.8 41.51 Favored 'General case' 0 CA--C 1.507 -0.7 0 C-N-CA 124.36 1.064 . . . . 0.0 109.088 178.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.545 HD23 ' C ' ' A' ' 41' ' ' GLY . 3.8 mt -108.01 147.96 36.52 Favored Pre-proline 0 N--CA 1.446 -0.657 0 O-C-N 124.429 1.081 . . . . 0.0 110.613 -179.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -72.62 177.66 7.23 Favored 'Trans proline' 0 N--CA 1.446 -1.3 0 C-N-CA 124.251 3.301 . . . . 0.0 111.278 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.9 ttpt -76.94 102.69 6.5 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 120.575 -1.328 . . . . 0.0 109.938 175.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.3 83.69 1.75 Allowed Glycine 0 C--O 1.222 -0.653 0 O-C-N 124.216 0.948 . . . . 0.0 110.945 177.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.452 ' CG ' HD22 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -163.2 172.91 14.09 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 124.444 1.097 . . . . 0.0 110.056 178.803 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.9 m -152.79 107.93 2.7 Favored Pre-proline 0 C--N 1.327 -0.384 0 O-C-N 123.635 0.585 . . . . 0.0 110.77 174.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -70.79 145.89 52.36 Favored 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 122.288 1.992 . . . . 0.0 111.166 177.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.508 HD12 HG21 ' A' ' 121' ' ' ILE . 16.9 mt -70.42 119.96 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 3.8 tttt -84.01 132.67 34.72 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 176.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.574 ' CD1' ' HB3' ' A' ' 118' ' ' CYS . 10.9 m-85 -114.54 -53.51 2.65 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 124.818 1.247 . . . . 0.0 111.273 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 121.28 -6.31 10.84 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.587 1.089 . . . . 0.0 113.21 -176.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -91.92 131.07 37.51 Favored 'General case' 0 CA--C 1.509 -0.621 0 O-C-N 121.606 -0.938 . . . . 0.0 110.233 177.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 32.3 t -68.77 -2.43 9.38 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 124.891 1.369 . . . . 0.0 111.802 176.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.466 ' OD2' HG11 ' A' ' 116' ' ' VAL . 0.5 OUTLIER -88.21 -54.06 4.39 Favored 'General case' 0 CA--C 1.518 -0.284 0 O-C-N 120.252 -1.53 . . . . 0.0 108.967 178.587 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.629 ' HB3' HD21 ' A' ' 80' ' ' LEU . 1.9 m -77.11 -34.27 56.81 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 123.814 0.696 . . . . 0.0 110.422 -178.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -62.27 -37.66 86.34 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.322 0.649 . . . . 0.0 111.186 173.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.35 159.6 1.11 Allowed Pre-proline 0 N--CA 1.448 -0.557 0 CA-C-O 121.485 0.659 . . . . 0.0 112.123 178.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -68.73 120.62 7.52 Favored 'Trans proline' 0 N--CA 1.444 -1.392 0 C-N-CA 120.742 0.961 . . . . 0.0 111.573 174.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.442 ' HD2' ' CD1' ' A' ' 42' ' ' TYR . 25.4 Cg_endo -69.19 168.53 20.55 Favored 'Trans proline' 0 N--CA 1.447 -1.262 0 C-N-CA 124.233 3.289 . . . . 0.0 111.261 175.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.7 tptp -131.12 136.46 48.39 Favored 'General case' 0 C--O 1.211 -0.967 0 CA-C-O 118.042 -0.98 . . . . 0.0 108.43 176.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -115.32 160.52 19.7 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 125.516 1.527 . . . . 0.0 108.593 177.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -150.59 170.63 18.7 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.735 179.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.93 60.61 6.32 Favored 'General case' 0 C--O 1.217 -0.613 0 C-N-CA 123.068 0.547 . . . . 0.0 111.406 177.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -175.16 -38.4 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.299 0.64 . . . . 0.0 110.967 -179.07 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 125.48 -67.18 0.53 Allowed Glycine 0 C--N 1.336 0.573 0 C-N-CA 125.071 1.319 . . . . 0.0 109.929 -178.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -128.48 62.14 1.46 Allowed 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 127.905 2.482 . . . . 0.0 107.925 -174.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -61.64 -104.35 0.01 OUTLIER Glycine 0 CA--C 1.529 0.926 0 CA-C-O 121.706 0.615 . . . . 0.0 112.299 176.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.2 mttt -65.42 -92.92 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 O-C-N 120.736 -1.449 . . . . 0.0 112.009 177.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.484 HG23 ' O ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -128.62 14.4 6.49 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 121.553 -0.717 . . . . 0.0 110.877 178.282 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.448 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 47.1 m-20 -27.95 102.83 0.02 OUTLIER 'General case' 0 C--O 1.208 -1.098 0 C-N-CA 125.491 1.516 . . . . 0.0 111.564 -178.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.491 ' CD2' ' H ' ' A' ' 78' ' ' HIS . 5.6 p80 -94.59 65.34 3.13 Favored 'General case' 0 CA--C 1.505 -0.766 0 O-C-N 120.214 -1.554 . . . . 0.0 108.432 -170.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.898 ' CE2' HD11 ' A' ' 81' ' ' LEU . 13.7 p90 -93.97 141.75 28.16 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 124.523 1.129 . . . . 0.0 110.574 -176.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.629 HD21 ' HB3' ' A' ' 62' ' ' CYS . 0.3 OUTLIER -69.29 141.38 54.34 Favored 'General case' 0 C--O 1.216 -0.673 0 C-N-CA 119.694 -0.802 . . . . 0.0 110.496 173.895 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.898 HD11 ' CE2' ' A' ' 79' ' ' TYR . 0.8 OUTLIER -128.75 143.51 50.94 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 124.69 1.196 . . . . 0.0 110.339 176.236 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -106.41 153.93 21.53 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 122.717 1.246 . . . . 0.0 111.426 177.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.703 ' CZ ' ' HB2' ' A' ' 23' ' ' ALA . 6.9 t80 -142.94 128.99 10.4 Favored Pre-proline 0 N--CA 1.45 -0.459 0 O-C-N 121.379 -0.826 . . . . 0.0 112.506 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.535 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 23.7 Cg_endo -72.45 93.94 0.76 Allowed 'Trans proline' 0 N--CA 1.446 -1.277 0 C-N-CA 124.091 3.194 . . . . 0.0 110.612 179.037 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.2 t -99.95 113.23 25.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 122.503 1.145 . . . . 0.0 109.939 179.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.433 ' CD2' ' NE2' ' A' ' 90' ' ' HIS . 43.6 m-85 -81.51 158.5 68.64 Favored Pre-proline 0 C--N 1.324 -0.517 0 O-C-N 121.466 -0.772 . . . . 0.0 111.996 179.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -76.16 -39.27 0.89 Allowed 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.257 1.971 . . . . 0.0 113.87 178.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -40.43 -38.18 0.79 Allowed 'General case' 0 N--CA 1.471 0.603 0 O-C-N 125.145 1.528 . . . . 0.0 110.287 174.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 102.01 -7.58 55.03 Favored Glycine 0 N--CA 1.44 -1.062 0 C-N-CA 124.762 1.172 . . . . 0.0 112.716 -178.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.433 ' NE2' ' CD2' ' A' ' 86' ' ' PHE . 9.2 p-80 -62.75 123.56 18.75 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 177.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -62.64 117.04 5.72 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 171.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -44.16 154.44 0.11 Allowed 'General case' 0 C--O 1.21 -0.994 0 CA-C-O 123.018 1.389 . . . . 0.0 112.689 172.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.51 66.53 6.34 Favored 'General case' 0 C--N 1.32 -0.693 0 O-C-N 119.149 -2.219 . . . . 0.0 109.926 177.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.433 ' CE1' ' HZ ' ' A' ' 83' ' ' PHE . 15.7 p90 -80.79 -6.46 58.56 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 174.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -91.0 -38.35 12.88 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 122.677 1.227 . . . . 0.0 110.696 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 52.4 m -88.41 106.88 18.54 Favored 'General case' 0 CA--C 1.519 -0.243 0 O-C-N 121.346 -0.846 . . . . 0.0 109.202 179.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 9.7 ptpt -58.23 -46.48 85.84 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.16 0.505 . . . . 0.0 111.309 177.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -142.21 132.08 12.42 Favored Pre-proline 0 N--CA 1.444 -0.726 0 C-N-CA 125.065 1.346 . . . . 0.0 109.787 -178.858 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.426 ' HA ' ' HA ' ' A' ' 98' ' ' LYS . 29.0 Cg_endo -68.27 173.39 39.03 Favored 'Cis proline' 0 N--CA 1.459 -0.519 0 C-N-CA 123.06 -1.642 . . . . 0.0 110.505 -9.093 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.3 ptmm? -137.85 154.76 49.46 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 123.56 0.744 . . . . 0.0 109.563 178.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -98.11 171.07 8.47 Favored 'General case' 0 C--O 1.244 0.778 0 CA-C-O 122.159 0.981 . . . . 0.0 110.177 178.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -53.66 143.56 38.09 Favored Pre-proline 0 N--CA 1.443 -0.777 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.106 172.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -73.88 -68.58 0.02 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.344 0 C-N-CA 122.311 2.007 . . . . 0.0 110.688 176.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 124.63 152.81 8.41 Favored Glycine 0 CA--C 1.524 0.611 0 O-C-N 120.388 -1.445 . . . . 0.0 111.251 -178.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -75.78 -56.52 0.06 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.85 2.367 . . . . 0.0 111.115 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.656 ' HB3' ' CZ ' ' A' ' 11' ' ' TYR . . . -72.09 138.47 47.81 Favored 'General case' 0 N--CA 1.438 -1.049 0 O-C-N 123.369 0.418 . . . . 0.0 110.4 177.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.455 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 10.0 mtm-85 -144.43 149.28 35.77 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-O 118.073 -0.965 . . . . 0.0 110.429 177.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.443 ' CG1' ' HB3' ' A' ' 83' ' ' PHE . 3.1 p -83.92 114.26 24.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 125.145 1.378 . . . . 0.0 111.017 175.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.436 HG21 ' CE2' ' A' ' 38' ' ' PHE . 1.8 mp -101.43 120.68 51.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 -176.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.424 ' CG ' ' HG2' ' A' ' 115' ' ' LYS . 17.6 p90 -138.19 162.47 34.18 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.459 -178.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.5 p -91.52 161.94 14.75 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 122.755 0.422 . . . . 0.0 110.886 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.484 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.2 OUTLIER -110.64 154.96 42.93 Favored Pre-proline 0 CA--C 1.546 0.818 0 CA-C-N 118.216 0.462 . . . . 0.0 111.275 177.946 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.863 ' O ' HD21 ' A' ' 25' ' ' LEU . 18.9 Cg_endo -72.37 -54.28 0.15 OUTLIER 'Cis proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.689 -1.379 . . . . 0.0 108.771 -9.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 41.3 t-20 -40.18 108.45 0.09 Allowed 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 116.511 -1.709 . . . . 0.0 110.507 178.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.677 ' CE ' HD13 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -67.5 63.84 0.07 Allowed 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 126.455 1.902 . . . . 0.0 108.119 -178.223 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.466 HG11 ' OD2' ' A' ' 61' ' ' ASP . 35.9 t -73.34 75.52 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 103.712 -2.699 . . . . 0.0 103.712 178.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.533 ' CZ ' ' NE2' ' A' ' 13' ' ' GLN . 2.2 t80 -40.87 124.21 2.08 Favored 'General case' 0 N--CA 1.437 -1.111 0 C-N-CA 125.182 1.393 . . . . 0.0 107.714 174.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . 0.574 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 0.1 OUTLIER -100.64 -40.84 7.19 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.227 175.768 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.477 ' HA2' ' CZ ' ' A' ' 117' ' ' PHE . . . 160.31 -174.79 37.09 Favored Glycine 0 CA--C 1.505 -0.589 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 -178.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.542 ' CG2' ' HB1' ' A' ' 106' ' ' ALA . 3.2 mp -106.06 145.34 14.1 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.004 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 178.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.508 HG21 HD12 ' A' ' 55' ' ' ILE . 8.5 pt -119.78 152.71 22.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.659 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . . . . . . . . 0 C--N 1.326 -0.445 0 CA-C-O 122.964 1.364 . . . . 0.0 109.741 179.508 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.504 -0.796 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.477 HD13 ' CE1' ' A' ' 57' ' ' PHE . 9.7 tp -56.75 131.85 50.43 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 125.415 1.697 . . . . 0.0 107.842 179.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . 0.539 ' SG ' HG22 ' A' ' 120' ' ' ILE . 71.3 m -58.54 178.0 0.12 Allowed 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 124.38 1.072 . . . . 0.0 109.554 174.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 38.3 m -154.23 112.09 3.5 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 -176.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.255 1.343 0 CA-C-O 115.519 -2.182 . . . . 0.0 110.943 172.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.555 HG22 ' HB3' ' A' ' 136' ' ' HIS . 3.5 p . . . . . 0 C--O 1.236 0.376 0 CA-C-O 121.858 0.837 . . . . 0.0 109.487 . . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.2 m -90.56 120.0 31.28 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -176.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . 0.462 ' CG ' HG13 ' A' ' 120' ' ' ILE . 31.9 m95 -79.75 141.34 36.42 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 -179.263 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -134.01 129.6 36.36 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-O 122.366 1.079 . . . . 0.0 108.669 -176.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.78 ' SG ' ' HB3' ' A' ' 122' ' ' ALA . 0.0 OUTLIER -125.96 67.24 1.19 Allowed 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 177.064 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 130.38 -98.36 0.41 Allowed Glycine 0 C--O 1.22 -0.741 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 178.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -133.32 8.42 5.04 Favored Glycine 0 N--CA 1.464 0.512 0 C-N-CA 123.416 0.532 . . . . 0.0 112.4 178.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.497 HD13 ' OH ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -115.85 142.36 46.87 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -176.754 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.6 mp -110.21 125.92 53.58 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -175.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.52 ' CZ ' ' HB3' ' A' ' 106' ' ' ALA . 77.5 m-85 -117.04 103.5 10.31 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 126.327 1.851 . . . . 0.0 108.2 -173.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -55.18 121.47 8.9 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 118.113 -0.946 . . . . 0.0 108.991 178.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.533 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 5.9 tp-100 -51.33 -45.28 62.23 Favored 'General case' 0 C--O 1.206 -1.211 0 O-C-N 124.023 0.827 . . . . 0.0 111.881 179.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -51.02 -40.83 59.13 Favored 'General case' 0 C--O 1.197 -1.697 0 CA-C-N 117.801 0.273 . . . . 0.0 111.309 176.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.86 -36.78 72.98 Favored 'General case' 0 C--O 1.199 -1.604 0 O-C-N 120.1 -1.625 . . . . 0.0 113.395 168.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.61 -40.96 72.78 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 123.04 2.654 . . . . 0.0 113.871 171.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -86.45 -38.75 17.0 Favored 'General case' 0 C--O 1.206 -1.186 0 C-N-CA 123.622 0.769 . . . . 0.0 108.999 176.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.7 t -73.42 -58.74 3.1 Favored 'General case' 0 CA--C 1.502 -0.879 0 O-C-N 119.889 -1.757 . . . . 0.0 108.771 -176.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.476 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 7.6 t-20 -42.62 -36.13 1.3 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 119.624 1.102 . . . . 0.0 112.977 171.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.428 ' HB3' HG11 ' A' ' 108' ' ' VAL . 1.0 OUTLIER -82.27 -31.95 29.86 Favored 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 174.149 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 5.0 m170 -50.8 -39.33 52.57 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 126.204 1.802 . . . . 0.0 109.162 178.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.476 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -75.38 -45.7 37.56 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-O 117.388 -1.291 . . . . 0.0 110.689 177.844 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.723 ' HB1' ' HG3' ' A' ' 35' ' ' PRO . . . -40.4 135.15 1.49 Allowed Pre-proline 0 CA--C 1.543 0.706 0 O-C-N 125.609 1.818 . . . . 0.0 111.966 176.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.691 ' HG2' HG22 ' A' ' 30' ' ' THR . 18.5 Cg_endo -72.65 122.02 7.88 Favored 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 122.067 1.845 . . . . 0.0 109.319 -176.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.676 HD13 ' HE2' ' A' ' 115' ' ' LYS . 5.2 tp -59.88 94.39 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.311 0.644 . . . . 0.0 111.17 178.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -171.58 178.71 3.07 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 123.312 0.645 . . . . 0.0 109.673 -176.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.407 ' HB2' ' CE2' ' A' ' 79' ' ' TYR . 2.7 t0 -116.45 89.25 3.07 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 124.211 1.004 . . . . 0.0 109.673 177.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 71.86 78.69 0.46 Allowed Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 176.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.1 mmtp -149.77 30.24 0.73 Allowed 'General case' 0 CA--C 1.513 -0.46 0 C-N-CA 123.355 0.662 . . . . 0.0 111.723 178.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.691 HG22 ' HG2' ' A' ' 24' ' ' PRO . 11.8 p -122.02 149.37 43.6 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -175.116 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.4 ' C ' ' HA ' ' A' ' 97' ' ' LYS . . . -42.11 -52.62 4.94 Favored Glycine 0 C--N 1.332 0.353 0 O-C-N 123.814 0.696 . . . . 0.0 111.905 -179.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.5 t -67.75 -64.53 0.84 Allowed 'General case' 0 CA--C 1.503 -0.847 0 CA-C-O 116.266 -1.826 . . . . 0.0 112.303 174.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 166.24 -59.39 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 126.334 1.854 . . . . 0.0 111.423 177.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.52 ' CD2' ' HD3' ' A' ' 84' ' ' PRO . 60.5 m-85 -62.99 147.52 94.17 Favored Pre-proline 0 N--CA 1.436 -1.162 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 179.119 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.723 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 21.0 Cg_endo -75.6 164.56 87.79 Favored 'Cis proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.232 -1.57 . . . . 0.0 111.6 0.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.466 ' CD2' ' CD2' ' A' ' 34' ' ' TYR . 1.3 p80 -140.08 173.64 11.31 Favored 'General case' 0 C--O 1.21 -1.012 0 CA-C-O 117.865 -1.064 . . . . 0.0 110.305 -177.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.948 ' CH2' HG22 ' A' ' 39' ' ' THR . 19.6 t90 -75.95 127.1 32.28 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 119.441 1.018 . . . . 0.0 109.226 175.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.573 ' CZ ' ' HA ' ' A' ' 40' ' ' ASN . 34.6 t80 -97.38 86.69 3.94 Favored 'General case' 0 N--CA 1.427 -1.62 0 C-N-CA 125.928 1.691 . . . . 0.0 107.303 177.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.948 HG22 ' CH2' ' A' ' 37' ' ' TRP . 61.8 p -39.87 -35.1 0.32 Allowed 'General case' 0 CA--C 1.508 -0.67 0 C-N-CA 124.774 1.23 . . . . 0.0 111.042 173.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.573 ' HA ' ' CZ ' ' A' ' 38' ' ' PHE . 65.1 t30 69.19 8.77 7.01 Favored 'General case' 0 C--O 1.222 -0.381 0 C-N-CA 124.614 1.165 . . . . 0.0 110.376 177.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.461 ' CA ' ' HD3' ' A' ' 52' ' ' ARG . . . 112.7 -13.78 24.8 Favored Glycine 0 N--CA 1.428 -1.843 0 C-N-CA 124.741 1.162 . . . . 0.0 114.206 -172.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.621 ' CE1' HD11 ' A' ' 48' ' ' LEU . 16.0 m-85 -70.61 166.55 20.44 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.095 0.958 . . . . 0.0 110.682 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.01 -40.44 16.87 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.992 176.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.575 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . 174.84 -49.63 0.13 Allowed Glycine 0 C--N 1.335 0.484 0 C-N-CA 124.354 0.978 . . . . 0.0 111.794 -178.013 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -125.01 -63.24 1.17 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 122.026 0.917 . . . . 0.0 109.505 -179.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.48 161.38 21.76 Favored Glycine 0 C--N 1.341 0.823 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.585 ' HA ' ' CE2' ' A' ' 42' ' ' TYR . 19.5 mtmt -54.74 175.15 0.06 Allowed 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 122.303 1.049 . . . . 0.0 112.339 176.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.635 ' H ' HD12 ' A' ' 48' ' ' LEU . 5.8 mp -56.76 153.72 21.01 Favored Pre-proline 0 N--CA 1.447 -0.618 0 O-C-N 121.658 -0.651 . . . . 0.0 111.381 178.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -71.72 158.99 52.07 Favored 'Trans proline' 0 N--CA 1.448 -1.19 0 C-N-CA 121.88 1.72 . . . . 0.0 110.092 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.9 tttt -55.52 98.35 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.145 0.578 . . . . 0.0 109.921 177.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.8 72.89 0.62 Allowed Glycine 0 C--O 1.228 -0.226 0 CA-C-O 119.503 -0.609 . . . . 0.0 112.686 -176.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.461 ' HD3' ' CA ' ' A' ' 41' ' ' GLY . 12.3 ttm180 -174.42 162.8 3.59 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 124.175 0.99 . . . . 0.0 110.448 175.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.3 m -136.52 110.34 9.6 Favored Pre-proline 0 C--O 1.208 -1.089 0 O-C-N 123.909 0.756 . . . . 0.0 110.87 178.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.527 ' HG3' HD13 ' A' ' 48' ' ' LEU . 24.9 Cg_endo -71.98 -178.72 3.33 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 121.698 1.599 . . . . 0.0 112.232 177.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.429 ' CG2' ' HB2' ' A' ' 133' ' ' LEU . 6.6 mt -95.42 114.17 31.45 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 -178.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.61 135.46 35.55 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 120.954 -1.091 . . . . 0.0 108.635 177.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.49 ' CD2' ' HB3' ' A' ' 118' ' ' CYS . 4.7 m-85 -117.67 -52.4 2.45 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 123.234 0.614 . . . . 0.0 109.795 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 134.15 -12.26 4.71 Favored Glycine 0 C--O 1.224 -0.513 0 C-N-CA 123.92 0.772 . . . . 0.0 112.418 -176.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.51 134.33 34.44 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 117.43 0.615 . . . . 0.0 109.481 177.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 87.8 p -75.93 2.72 11.79 Favored 'General case' 0 C--O 1.222 -0.372 0 O-C-N 124.362 1.039 . . . . 0.0 111.713 176.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -89.11 -56.14 3.4 Favored 'General case' 0 C--O 1.217 -0.619 0 C-N-CA 124.867 1.267 . . . . 0.0 109.047 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.746 ' HB3' HD11 ' A' ' 80' ' ' LEU . 2.1 m -71.57 -29.97 65.33 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 178.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -66.66 -38.16 86.27 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-O 121.091 0.472 . . . . 0.0 110.909 175.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.84 164.18 0.58 Allowed Pre-proline 0 N--CA 1.447 -0.598 0 CA-C-O 122.156 0.979 . . . . 0.0 111.692 178.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -69.85 126.54 13.37 Favored 'Trans proline' 0 N--CA 1.443 -1.48 0 C-N-CA 121.239 1.293 . . . . 0.0 114.499 172.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.463 ' CD ' ' CD2' ' A' ' 42' ' ' TYR . 21.5 Cg_endo -70.64 168.16 23.51 Favored 'Trans proline' 0 N--CA 1.444 -1.44 0 C-N-CA 124.099 3.2 . . . . 0.0 111.48 177.171 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.2 tptt -130.61 61.22 1.62 Allowed 'General case' 0 C--O 1.202 -1.397 0 CA-C-O 116.95 -1.5 . . . . 0.0 108.854 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 40.6 t-80 -75.58 164.97 25.78 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 120.291 1.405 . . . . 0.0 111.029 178.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.9 -179.71 7.21 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 120.869 -1.144 . . . . 0.0 110.841 178.093 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.34 69.23 10.46 Favored 'General case' 0 C--O 1.211 -0.928 0 O-C-N 120.29 -1.506 . . . . 0.0 111.34 177.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -176.76 -41.98 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 O-C-N 123.772 0.67 . . . . 0.0 109.707 179.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.449 ' O ' ' CE2' ' A' ' 79' ' ' TYR . . . 138.11 -72.5 0.44 Allowed Glycine 0 C--O 1.21 -1.361 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 -178.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -140.72 72.85 1.4 Allowed 'General case' 0 N--CA 1.438 -1.064 0 O-C-N 121.872 -0.781 . . . . 0.0 109.865 179.24 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.47 -101.98 0.01 OUTLIER Glycine 0 C--O 1.221 -0.717 0 CA-C-O 119.736 -0.48 . . . . 0.0 112.47 178.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -52.42 -90.29 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.457 0 CA-C-O 122.152 0.977 . . . . 0.0 111.25 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.533 HG23 ' O ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -134.47 20.66 3.64 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-O 117.765 -1.112 . . . . 0.0 111.192 178.586 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -20.54 90.1 0.01 OUTLIER 'General case' 0 C--O 1.211 -0.938 0 C-N-CA 125.424 1.49 . . . . 0.0 114.089 -177.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 28.4 p80 -92.22 29.45 1.66 Allowed 'General case' 0 N--CA 1.467 0.383 0 O-C-N 119.097 -2.252 . . . . 0.0 108.196 -170.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.967 ' CZ ' HD21 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -57.37 176.29 0.13 Allowed 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 115.073 1.508 . . . . 0.0 115.073 174.161 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.819 HD22 HG22 ' A' ' 109' ' ' ILE . 3.6 mt -95.84 154.99 16.94 Favored 'General case' 0 C--O 1.215 -0.758 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.371 173.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.967 HD21 ' CZ ' ' A' ' 79' ' ' TYR . 2.1 mt -141.14 129.28 22.12 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -177.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.495 ' CB ' ' CD1' ' A' ' 109' ' ' ILE . 0.2 OUTLIER -98.92 155.72 17.26 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 122.832 1.301 . . . . 0.0 111.543 178.66 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.451 ' HZ ' ' CD2' ' A' ' 94' ' ' PHE . 47.7 t80 -146.27 129.8 8.34 Favored Pre-proline 0 N--CA 1.452 -0.332 0 O-C-N 121.221 -0.924 . . . . 0.0 112.2 179.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.52 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 21.5 Cg_endo -71.96 106.02 1.93 Allowed 'Trans proline' 0 N--CA 1.445 -1.324 0 C-N-CA 124.531 3.487 . . . . 0.0 110.801 -179.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.94 114.99 29.46 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.937 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.419 ' CE1' ' HB2' ' A' ' 92' ' ' TYR . 70.7 m-85 -82.17 158.02 67.52 Favored Pre-proline 0 N--CA 1.449 -0.515 0 O-C-N 121.775 -0.578 . . . . 0.0 111.818 178.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -76.8 -38.88 0.77 Allowed 'Trans proline' 0 CA--C 1.498 -1.288 0 C-N-CA 122.467 2.112 . . . . 0.0 112.713 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -44.92 -30.7 1.06 Allowed 'General case' 0 N--CA 1.469 0.497 0 O-C-N 125.342 1.651 . . . . 0.0 110.98 176.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 90.42 -8.48 79.73 Favored Glycine 0 N--CA 1.438 -1.216 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 176.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.6 p-80 -59.71 129.25 41.0 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 178.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -62.68 96.58 0.09 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 175.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.492 ' CD2' ' HB3' ' A' ' 94' ' ' PHE . 7.0 t80 -37.82 142.34 0.16 Allowed 'General case' 0 C--O 1.212 -0.904 0 CA-C-O 121.843 0.83 . . . . 0.0 110.92 178.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . 0.423 ' HE2' ' O ' ' A' ' 99' ' ' PRO . 0.1 OUTLIER -77.43 57.29 1.5 Allowed 'General case' 0 C--N 1.314 -0.947 0 O-C-N 119.584 -1.947 . . . . 0.0 110.779 175.972 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.492 ' HB3' ' CD2' ' A' ' 92' ' ' TYR . 33.2 p90 -71.25 -9.26 57.82 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 124.319 1.048 . . . . 0.0 112.23 175.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -92.19 -37.27 12.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 122.223 1.011 . . . . 0.0 109.709 -179.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.9 m -75.41 106.15 6.8 Favored 'General case' 0 CA--C 1.513 -0.464 0 O-C-N 121.266 -0.896 . . . . 0.0 108.968 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . 0.4 ' HA ' ' C ' ' A' ' 31' ' ' GLY . 4.1 pttp -58.59 -49.91 75.76 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 121.882 0.848 . . . . 0.0 110.362 178.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 99' ' ' PRO . 0.7 OUTLIER -145.54 126.06 7.27 Favored Pre-proline 0 N--CA 1.436 -1.146 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.244 -176.612 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.423 ' O ' ' HE2' ' A' ' 93' ' ' LYS . 29.7 Cg_endo -70.11 175.96 35.58 Favored 'Cis proline' 0 N--CA 1.461 -0.397 0 O-C-N 124.419 1.747 . . . . 0.0 111.797 -4.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 15.3 tttm -141.95 132.34 25.12 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 123.526 0.73 . . . . 0.0 109.069 178.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -72.14 170.81 13.18 Favored 'General case' 0 C--O 1.237 0.442 0 O-C-N 124.747 1.279 . . . . 0.0 111.881 177.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -65.13 152.1 92.25 Favored Pre-proline 0 N--CA 1.445 -0.699 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.442 177.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -73.3 -164.83 0.21 Allowed 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.734 2.289 . . . . 0.0 112.139 175.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -141.4 157.43 26.14 Favored Glycine 0 CA--C 1.522 0.494 0 O-C-N 121.353 -0.842 . . . . 0.0 112.438 177.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -75.76 -67.56 0.02 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.868 2.379 . . . . 0.0 110.43 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.761 ' HA ' ' HB2' ' A' ' 122' ' ' ALA . . . -60.73 138.78 58.06 Favored 'General case' 0 N--CA 1.446 -0.634 0 O-C-N 123.9 0.75 . . . . 0.0 110.452 179.038 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 6.0 mtm-85 -144.1 144.07 31.43 Favored 'General case' 0 CA--C 1.508 -0.656 0 O-C-N 124.529 1.143 . . . . 0.0 111.148 -179.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.428 HG11 ' HB3' ' A' ' 20' ' ' SER . 4.3 p -82.52 123.95 38.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 123.907 0.754 . . . . 0.0 110.595 179.032 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.819 HG22 HD22 ' A' ' 80' ' ' LEU . 7.0 mm -104.67 138.68 28.34 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.903 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -178.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.807 ' C ' HD23 ' A' ' 80' ' ' LEU . 12.6 p90 -165.52 155.19 12.62 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-O 121.801 0.81 . . . . 0.0 111.517 -178.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 16.9 p -91.2 160.86 15.33 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -175.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.524 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -107.79 155.79 39.23 Favored Pre-proline 0 C--N 1.318 -0.776 0 O-C-N 122.029 -0.419 . . . . 0.0 110.694 179.905 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.524 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 17.8 Cg_endo -73.32 -53.87 0.15 OUTLIER 'Cis proline' 0 CA--C 1.5 -1.176 0 C-N-CA 123.351 -1.521 . . . . 0.0 109.399 -7.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.571 ' O ' HG23 ' A' ' 116' ' ' VAL . 11.6 t30 -44.17 107.38 0.09 Allowed 'General case' 0 C--O 1.217 -0.642 0 CA-C-O 116.187 -1.864 . . . . 0.0 109.632 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.676 ' HE2' HD13 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -62.35 85.37 0.02 OUTLIER 'General case' 0 CA--C 1.509 -0.627 0 O-C-N 124.568 1.168 . . . . 0.0 108.737 -176.099 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 114' ' ' ASN . 81.0 t -84.31 67.67 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.756 0 N-CA-C 104.964 -2.235 . . . . 0.0 104.964 -173.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.576 ' CZ ' ' HA2' ' A' ' 119' ' ' GLY . 47.1 t80 -37.13 101.98 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.225 1.41 . . . . 0.0 109.759 178.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . 0.49 ' HB3' ' CD2' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -81.79 -24.62 35.86 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 178.997 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.576 ' HA2' ' CZ ' ' A' ' 117' ' ' PHE . . . 144.99 -147.42 18.58 Favored Glycine 0 N--CA 1.434 -1.435 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 -178.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.462 HG13 ' CG ' ' A' ' 4' ' ' TRP . 1.1 mm -127.31 148.27 32.08 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.273 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 -175.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.525 ' CD1' ' CE1' ' A' ' 38' ' ' PHE . 8.2 pt -136.23 154.99 34.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 108.139 -1.059 . . . . 0.0 108.139 -178.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.78 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . . . . . . . . 0 C--N 1.323 -0.575 0 CA-C-O 122.145 0.974 . . . . 0.0 109.502 -179.976 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 3.8 ptmt . . . . . 0 CA--C 1.498 -1.021 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.465 HD13 ' CD2' ' A' ' 57' ' ' PHE . 13.4 tp -54.32 129.71 36.39 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 125.11 1.507 . . . . 0.0 108.339 -179.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 76.4 m -66.57 -173.78 0.25 Allowed 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 124.363 2.03 . . . . 0.0 108.237 177.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 39.3 m -157.94 125.52 5.19 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 102.819 -3.03 . . . . 0.0 102.819 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.555 ' HB3' HG22 ' A' ' 2' ' ' VAL . 2.4 m80 . . . . . 0 CA--C 1.575 1.923 0 N-CA-C 118.489 2.774 . . . . 0.0 118.489 175.091 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.3 p . . . . . 0 N--CA 1.48 1.066 0 CA-C-O 123.12 1.438 . . . . 0.0 112.774 . . . . . . . . . 0 0 . 1 . 021 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.442 HG21 HD12 ' A' ' 10' ' ' LEU . 6.4 m -93.37 111.25 22.85 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 -173.089 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . 0.414 ' CZ2' ' CD2' ' A' ' 136' ' ' HIS . 18.0 m95 -75.59 143.77 42.16 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 -178.557 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.537 ' OG1' HD13 ' A' ' 10' ' ' LEU . 1.9 m -145.88 153.25 40.65 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 -179.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.608 ' CB ' ' HB3' ' A' ' 122' ' ' ALA . 0.8 OUTLIER -125.65 -84.64 0.63 Allowed 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 172.448 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -102.0 58.38 0.61 Allowed Glycine 0 N--CA 1.473 1.101 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 -178.032 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 72.92 -3.31 29.02 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 117.681 1.832 . . . . 0.0 117.681 -171.331 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.351 5.1 mt -94.73 132.61 39.3 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.087 1.755 . . . . 0.0 108.405 -177.438 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.537 HD13 ' OG1' ' A' ' 5' ' ' THR . 4.4 mm? -99.29 151.86 20.57 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.316 1.446 . . . . 0.0 110.102 -170.861 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.856 ' CZ ' ' HB3' ' A' ' 106' ' ' ALA . 40.9 m-85 -157.85 74.65 0.74 Allowed 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 -168.017 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . 0.431 ' HA ' ' HA ' ' A' ' 3' ' ' THR . 0.2 OUTLIER -50.67 128.0 19.47 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 120.053 -1.655 . . . . 0.0 108.606 178.251 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.486 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 0.2 OUTLIER -44.66 -54.7 5.91 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-O 117.682 -1.151 . . . . 0.0 111.841 178.179 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -48.27 -51.2 26.76 Favored 'General case' 0 C--O 1.202 -1.403 0 O-C-N 124.235 0.959 . . . . 0.0 112.449 176.193 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.41 -35.64 74.36 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 114.329 -2.748 . . . . 0.0 117.491 169.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.665 ' HB1' HD11 ' A' ' 120' ' ' ILE . . . -63.13 -68.33 0.35 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 127.518 2.327 . . . . 0.0 115.487 169.537 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -48.35 -42.0 30.17 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 117.714 -1.136 . . . . 0.0 110.739 167.836 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 41.5 t -64.84 -53.09 52.25 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 126.687 1.995 . . . . 0.0 110.418 -179.702 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -44.98 -49.12 11.37 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 119.189 0.904 . . . . 0.0 111.247 173.152 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.507 ' HB2' ' CE2' ' A' ' 110' ' ' TYR . 1.7 p -67.72 -32.65 73.42 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 118.133 2.642 . . . . 0.0 118.133 172.933 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 11.0 m170 -58.64 -40.24 82.84 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 127.535 2.334 . . . . 0.0 110.73 174.38 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -80.6 -44.76 18.41 Favored 'General case' 0 CA--C 1.511 -0.521 0 C-N-CA 125.28 1.432 . . . . 0.0 111.658 176.407 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.582 ' HB1' ' HG3' ' A' ' 35' ' ' PRO . . . -47.35 126.45 9.67 Favored Pre-proline 0 CA--C 1.552 1.041 0 O-C-N 125.527 1.767 . . . . 0.0 112.76 177.457 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -68.28 128.96 18.28 Favored 'Trans proline' 0 N--CA 1.439 -1.718 0 N-CA-C 107.596 -1.732 . . . . 0.0 107.596 -176.272 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.744 HD21 ' O ' ' A' ' 113' ' ' PRO . 4.6 tp -65.31 90.65 0.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 126.397 1.879 . . . . 0.0 112.505 178.138 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 174.21 161.95 0.19 Allowed 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 125.84 1.656 . . . . 0.0 108.786 -172.148 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.456 ' HA ' ' HA ' ' A' ' 36' ' ' HIS . 2.9 t70 -104.74 119.17 38.36 Favored 'General case' 0 CA--C 1.495 -1.171 0 C-N-CA 128.558 2.743 . . . . 0.0 108.425 -179.062 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 56.76 50.02 66.47 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 119.69 -1.243 . . . . 0.0 112.069 172.407 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.81 -3.57 14.89 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 125.382 1.473 . . . . 0.0 114.344 176.119 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.2 p -114.27 158.42 21.44 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 -170.895 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -45.89 -55.08 7.55 Favored Glycine 0 N--CA 1.467 0.736 0 C-N-CA 124.331 0.967 . . . . 0.0 115.039 -178.745 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 30.4 t -57.52 -71.8 0.1 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 114.266 1.209 . . . . 0.0 114.266 165.64 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.5 m 161.44 -51.03 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 131.338 3.855 . . . . 0.0 110.929 -176.507 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.483 ' CE1' ' HG3' ' A' ' 103' ' ' PRO . 90.8 m-85 -57.38 147.72 57.36 Favored Pre-proline 0 CA--C 1.569 1.694 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -174.038 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.582 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 19.6 Cg_endo -66.79 148.31 78.21 Favored 'Cis proline' 0 N--CA 1.428 -2.324 0 N-CA-C 106.784 -2.045 . . . . 0.0 106.784 -7.467 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 27' ' ' ASP 0.27 0.3 OUTLIER -117.3 167.08 11.55 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 113.736 -1.574 . . . . 0.0 107.393 174.927 . . . . . . . . 4 4 . 1 . 021 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.704 ' CH2' HG22 ' A' ' 39' ' ' THR . 11.1 t90 -64.03 133.17 52.6 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 123.274 1.511 . . . . 0.0 112.329 168.768 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.482 ' CD2' ' HB2' ' A' ' 40' ' ' ASN . 18.0 t80 -98.7 89.98 4.55 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 102.995 -2.965 . . . . 0.0 102.995 -179.742 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.704 HG22 ' CH2' ' A' ' 37' ' ' TRP . 82.8 p -38.86 -41.52 0.75 Allowed 'General case' 0 CA--C 1.502 -0.887 0 CA-C-N 111.329 -2.669 . . . . 0.0 110.421 160.923 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.482 ' HB2' ' CD2' ' A' ' 38' ' ' PHE . 63.2 t30 57.36 25.09 10.84 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 120.625 1.557 . . . . 0.0 112.09 178.316 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.753 ' C ' HD23 ' A' ' 48' ' ' LEU . . . 94.4 -39.35 2.92 Favored Glycine 0 CA--C 1.542 1.779 0 CA-C-O 113.723 -3.82 . . . . 0.0 117.846 -163.92 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -45.14 148.72 0.56 Allowed 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 130.203 3.401 . . . . 0.0 111.687 173.853 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.68 -32.56 25.52 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 115.34 1.607 . . . . 0.0 115.34 177.363 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.407 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -168.79 -81.95 0.05 OUTLIER Glycine 0 CA--C 1.527 0.841 0 C-N-CA 126.133 1.825 . . . . 0.0 111.82 -176.647 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -108.26 -63.95 1.27 Allowed 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 127.337 2.255 . . . . 0.0 114.226 -178.307 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.52 -171.37 0.66 Allowed Glycine 0 C--O 1.222 -0.599 0 CA-C-N 114.54 -1.209 . . . . 0.0 111.989 177.012 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.55 -175.29 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.838 0 CA-C-O 124.375 2.036 . . . . 0.0 115.151 170.441 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.753 HD23 ' C ' ' A' ' 41' ' ' GLY . 0.0 OUTLIER -74.7 160.04 81.84 Favored Pre-proline 0 C--N 1.312 -1.044 0 CA-C-N 114.338 -1.301 . . . . 0.0 110.56 -177.889 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -62.03 168.72 8.58 Favored 'Trans proline' 0 N--CA 1.435 -1.967 0 CA-C-O 123.88 1.534 . . . . 0.0 110.119 171.306 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 6.5 ttpt -55.1 101.35 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.624 1.57 . . . . 0.0 111.665 170.222 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.37 90.24 1.67 Allowed Glycine 0 N--CA 1.474 1.203 0 N-CA-C 111.553 -0.619 . . . . 0.0 111.553 -173.822 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.446 ' CD ' ' HA2' ' A' ' 41' ' ' GLY . 0.0 OUTLIER -167.01 163.89 15.96 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 126.463 1.905 . . . . 0.0 111.148 171.98 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 42.4 m -134.89 101.93 11.37 Favored Pre-proline 0 N--CA 1.478 0.972 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -178.325 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.497 ' HB3' HD21 ' A' ' 48' ' ' LEU . 29.8 Cg_endo -71.46 140.71 37.05 Favored 'Trans proline' 0 N--CA 1.43 -2.247 0 C-N-CA 122.155 1.903 . . . . 0.0 109.911 176.472 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.0 mt -61.8 119.52 5.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 172.294 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.65 143.88 28.16 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.284 169.821 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.535 ' CD1' ' HB3' ' A' ' 118' ' ' CYS . 7.0 m-85 -124.68 -53.24 1.68 Allowed 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 126.308 1.843 . . . . 0.0 111.044 179.514 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 122.43 -5.62 10.05 Favored Glycine 0 N--CA 1.476 1.345 0 C-N-CA 126.735 2.112 . . . . 0.0 114.929 -172.982 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.79 131.48 39.12 Favored 'General case' 0 CA--C 1.503 -0.865 0 C-N-CA 125.013 1.325 . . . . 0.0 110.765 172.622 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 92.0 p -67.89 2.78 1.8 Allowed 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 174.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . 0.486 ' OD2' HG11 ' A' ' 116' ' ' VAL . 0.4 OUTLIER -94.38 -55.19 3.25 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 128.608 2.763 . . . . 0.0 108.201 -173.839 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.757 ' HA ' HD11 ' A' ' 80' ' ' LEU . 1.8 m -77.31 -26.32 52.12 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.528 1.131 . . . . 0.0 113.077 175.148 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -72.32 -26.74 62.06 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 126.274 1.829 . . . . 0.0 114.043 166.881 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.07 155.06 74.99 Favored Pre-proline 0 CA--C 1.539 0.52 0 O-C-N 120.247 -1.533 . . . . 0.0 114.32 175.412 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -63.85 129.55 25.04 Favored 'Trans proline' 0 CA--C 1.568 2.207 0 O-C-N 119.336 -0.929 . . . . 0.0 112.063 174.582 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.528 ' HB3' ' HA ' ' A' ' 79' ' ' TYR . 19.4 Cg_endo -65.75 177.43 2.87 Favored 'Trans proline' 0 N--CA 1.447 -1.253 1 C-N-CA 125.448 4.099 . . . . 0.0 111.146 176.587 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.4 tptt -132.75 53.0 2.04 Favored 'General case' 0 C--O 1.214 -0.767 0 O-C-N 120.331 -1.481 . . . . 0.0 110.309 170.649 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 46.3 t-80 -76.04 160.94 29.31 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-O 123.315 1.531 . . . . 0.0 112.978 -178.819 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.74 -171.48 3.87 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 117.949 -2.969 . . . . 0.0 110.947 177.116 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.76 79.94 7.32 Favored 'General case' 0 C--O 1.213 -0.832 0 O-C-N 120.736 -1.227 . . . . 0.0 110.043 170.113 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -175.25 -44.21 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 126.022 1.729 . . . . 0.0 111.766 176.218 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 123.8 -63.61 0.55 Allowed Glycine 0 C--O 1.221 -0.691 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 -176.287 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -140.28 96.84 3.11 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 128.165 2.586 . . . . 0.0 106.251 177.097 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.46 -99.21 0.08 OUTLIER Glycine 0 CA--C 1.536 1.353 0 N-CA-C 116.365 1.306 . . . . 0.0 116.365 170.444 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 23.9 mttt -75.33 -97.94 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.164 -1.786 . . . . 0.0 114.313 172.913 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -109.52 12.8 24.28 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.838 -1.164 . . . . 0.0 111.025 178.518 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -23.16 95.06 0.01 OUTLIER 'General case' 0 C--O 1.215 -0.718 0 C-N-CA 129.449 3.099 . . . . 0.0 111.51 -171.783 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.406 ' CD2' ' H ' ' A' ' 78' ' ' HIS . 5.7 p80 -91.13 54.67 2.66 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 118.048 -2.907 . . . . 0.0 106.529 -163.172 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.528 ' HA ' ' HB3' ' A' ' 66' ' ' PRO . 39.8 p90 -85.53 148.33 26.0 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 -172.439 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.757 HD11 ' HA ' ' A' ' 62' ' ' CYS . 0.9 OUTLIER -73.79 162.29 29.29 Favored 'General case' 0 C--O 1.217 -0.634 0 C-N-CA 116.817 -1.953 . . . . 0.0 112.951 168.455 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.445 ' HB2' ' CE1' ' A' ' 110' ' ' TYR . 4.1 mp -141.65 111.23 6.52 Favored 'General case' 0 CA--C 1.498 -1.04 0 CA-C-N 119.921 1.237 . . . . 0.0 111.701 179.003 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -80.2 152.69 29.03 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 119.243 -0.983 . . . . 0.0 111.291 -178.145 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.556 ' CE2' ' HB2' ' A' ' 23' ' ' ALA . 3.0 t80 -142.02 133.86 13.44 Favored Pre-proline 0 CA--C 1.544 0.741 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 179.073 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.644 ' HG2' ' CD2' ' A' ' 92' ' ' TYR . 30.9 Cg_endo -71.9 87.37 0.85 Allowed 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 124.633 3.555 . . . . 0.0 112.009 -177.29 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 6.4 t -89.89 96.73 10.82 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-N 114.316 -1.311 . . . . 0.0 110.592 -179.837 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -80.58 157.5 72.28 Favored Pre-proline 0 CA--C 1.552 1.052 0 O-C-N 120.963 -1.085 . . . . 0.0 112.407 179.695 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . 0.267 9.3 Cg_endo -71.59 -30.96 14.17 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 122.171 1.914 . . . . 0.0 115.711 175.107 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -43.74 -35.81 2.0 Favored 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 128.353 2.661 . . . . 0.0 109.899 174.931 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.71 7.85 70.86 Favored Glycine 0 C--N 1.328 0.106 0 N-CA-C 116.432 1.333 . . . . 0.0 116.432 -178.404 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -71.59 128.52 36.08 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 174.442 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -64.54 110.4 2.3 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 104.965 -2.235 . . . . 0.0 104.965 163.033 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.644 ' CD2' ' HG2' ' A' ' 84' ' ' PRO . 9.3 t80 -39.3 142.15 0.28 Allowed 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 126.735 2.014 . . . . 0.0 109.756 171.052 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.76 61.94 3.15 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 118.098 -2.877 . . . . 0.0 111.664 169.906 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.484 ' CD1' ' HZ ' ' A' ' 83' ' ' PHE . 11.9 p90 -70.93 -27.58 63.87 Favored 'General case' 0 C--O 1.221 -0.442 0 C-N-CA 124.775 1.23 . . . . 0.0 113.447 170.134 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -76.53 -42.47 42.97 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 125.728 1.611 . . . . 0.0 111.633 -179.256 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.1 m -76.51 116.39 17.15 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 119.807 -1.808 . . . . 0.0 109.316 -179.935 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.1 pttt -56.81 -44.22 81.76 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 123.534 1.635 . . . . 0.0 113.945 176.634 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.3 tttt -151.26 133.96 8.61 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 126.0 1.72 . . . . 0.0 111.938 179.831 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -66.63 165.4 64.79 Favored 'Cis proline' 0 N--CA 1.45 -1.045 0 C-N-CA 124.013 -1.244 . . . . 0.0 110.022 -9.862 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.6 pttm -142.11 145.94 34.83 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 105.62 -1.992 . . . . 0.0 105.62 176.265 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -69.17 173.01 6.03 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.205 1.002 . . . . 0.0 111.797 172.797 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -113.28 127.08 27.24 Favored Pre-proline 0 CA--C 1.556 1.175 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -178.258 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . 0.483 ' HG3' ' CE1' ' A' ' 34' ' ' TYR . 70.1 Cg_endo -74.35 -160.87 0.11 Allowed 'Trans proline' 0 CA--C 1.554 1.522 0 C-N-CA 125.217 3.945 . . . . 0.0 109.787 167.953 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 112.49 -39.61 2.81 Favored Glycine 0 CA--C 1.545 1.96 0 CA-C-O 114.797 -3.224 . . . . 0.0 112.505 -162.344 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -70.93 -163.67 0.13 Allowed 'Trans proline' 0 C--N 1.366 1.488 1 CA-C-N 125.577 4.689 . . . . 0.0 112.469 177.736 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.944 ' HB2' ' HB2' ' A' ' 122' ' ' ALA . . . -63.95 160.77 17.07 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 124.757 2.218 . . . . 0.0 113.052 169.451 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.74 151.95 39.65 Favored 'General case' 0 C--O 1.214 -0.799 0 CA-C-N 111.832 -2.44 . . . . 0.0 110.8 179.613 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.7 p -87.8 120.84 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 C-N-CA 127.13 2.172 . . . . 0.0 112.003 173.292 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.412 ' CG2' HD22 ' A' ' 80' ' ' LEU . 1.7 mp -112.1 127.32 69.36 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.886 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 -171.644 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.507 ' CE2' ' HB2' ' A' ' 20' ' ' SER . 14.1 p90 -145.98 156.24 43.37 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 -177.029 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.7 p -81.79 164.91 21.35 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.196 0.999 . . . . 0.0 112.187 176.306 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.466 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.4 OUTLIER -109.8 158.89 33.63 Favored Pre-proline 0 CA--C 1.556 1.185 0 N-CA-C 112.667 0.618 . . . . 0.0 112.667 175.415 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.744 ' O ' HD21 ' A' ' 25' ' ' LEU . 19.8 Cg_endo -69.45 -52.73 0.16 OUTLIER 'Cis proline' 0 CA--C 1.501 -1.167 0 N-CA-C 108.915 -1.225 . . . . 0.0 108.915 -15.837 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.45 ' O ' HG23 ' A' ' 116' ' ' VAL . 28.6 t30 -43.69 108.88 0.12 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.931 0.892 . . . . 0.0 110.098 177.004 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.703 ' HE2' HD13 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -67.54 75.05 0.17 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 127.99 2.516 . . . . 0.0 107.615 -179.344 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.486 HG11 ' OD2' ' A' ' 61' ' ' ASP . 72.0 t -85.06 78.45 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 101.112 -3.662 . . . . 0.0 101.112 -175.983 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.486 ' CZ ' ' NE2' ' A' ' 13' ' ' GLN . 5.9 t80 -41.29 113.51 0.41 Allowed 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 129.071 2.948 . . . . 0.0 104.944 176.5 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . 0.535 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 0.1 OUTLIER -93.89 -37.95 11.46 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 122.101 0.953 . . . . 0.0 112.963 174.967 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.564 ' HA3' HD11 ' A' ' 133' ' ' LEU . . . 163.72 -168.92 38.51 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 125.32 1.438 . . . . 0.0 111.648 -179.601 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.665 HD11 ' HB1' ' A' ' 16' ' ' ALA . 1.3 mp -114.72 120.39 64.24 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.356 0 N-CA-C 103.119 -2.919 . . . . 0.0 103.119 176.411 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.475 ' HA ' ' HA ' ' A' ' 133' ' ' LEU . 8.4 pt -89.52 153.5 3.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-O 117.707 -1.139 . . . . 0.0 109.333 172.427 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.944 ' HB2' ' HB2' ' A' ' 106' ' ' ALA . . . . . . . . 0 N--CA 1.491 1.579 0 CA-C-N 121.484 1.947 . . . . 0.0 113.25 172.062 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 N--CA 1.477 0.879 0 CA-C-O 118.469 -0.777 . . . . 0.0 110.531 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.564 HD11 ' HA3' ' A' ' 119' ' ' GLY . 14.3 tp -71.99 142.67 49.37 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 118.82 0.736 . . . . 0.0 110.325 175.668 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 75.1 m -69.27 179.52 1.95 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 124.764 2.221 . . . . 0.0 113.05 165.875 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 96.9 p -146.01 89.15 1.86 Allowed 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 -179.103 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.414 ' CD2' ' CZ2' ' A' ' 4' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 113.814 -2.993 . . . . 0.0 116.852 163.596 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 CA--C 1.534 0.349 0 CA-C-O 124.337 2.017 . . . . 0.0 109.825 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.679 HG21 HD22 ' A' ' 10' ' ' LEU . 0.9 OUTLIER -92.65 113.05 25.21 Favored 'General case' 0 C--N 1.312 -1.031 0 O-C-N 119.046 -2.284 . . . . 0.0 110.27 179.323 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 25.6 m95 -77.93 141.04 39.27 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 177.345 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.401 ' OG1' HD23 ' A' ' 10' ' ' LEU . 0.9 OUTLIER -130.88 119.91 22.88 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -178.695 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.588 ' SG ' ' HB3' ' A' ' 122' ' ' ALA . 0.8 OUTLIER -98.33 52.31 1.03 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.593 176.49 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 42.88 49.73 6.13 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 123.395 0.521 . . . . 0.0 112.619 -175.478 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -167.39 -82.89 0.05 OUTLIER Glycine 0 C--O 1.226 -0.396 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 -176.804 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 85.3 mt -119.41 159.33 24.43 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.546 0.689 . . . . 0.0 110.205 177.617 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.679 HD22 HG21 ' A' ' 3' ' ' THR . 3.5 mt -82.99 165.47 19.64 Favored 'General case' 0 C--O 1.219 -0.544 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.613 179.499 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.488 ' CZ ' ' HB3' ' A' ' 106' ' ' ALA . 55.7 m-85 -157.78 85.72 0.9 Allowed 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 -174.337 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -54.51 114.46 1.68 Allowed 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 177.231 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.51 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 8.1 tp-100 -51.16 -34.17 30.21 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -179.797 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -43.26 -34.28 1.14 Allowed 'General case' 0 C--O 1.22 -0.472 0 O-C-N 124.969 1.418 . . . . 0.0 112.137 174.406 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . 0.426 ' CD ' ' HA2' ' A' ' 89' ' ' GLY . 0.0 OUTLIER -95.92 -51.32 4.51 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 116.182 -1.866 . . . . 0.0 113.341 171.843 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.691 ' HB1' HD11 ' A' ' 120' ' ' ILE . . . -42.42 -33.39 0.66 Allowed 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 123.041 2.655 . . . . 0.0 114.021 174.863 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -85.06 -49.25 8.44 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 124.49 1.116 . . . . 0.0 109.537 172.5 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 36.8 t -62.42 -43.62 98.39 Favored 'General case' 0 C--O 1.217 -0.656 0 O-C-N 119.796 -1.815 . . . . 0.0 110.482 -174.553 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -46.03 -38.66 8.11 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 125.901 1.68 . . . . 0.0 110.713 171.111 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.9 p -79.32 -28.97 42.14 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.697 0.799 . . . . 0.0 112.554 176.25 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.6 m170 -57.16 -44.11 83.14 Favored 'General case' 0 C--O 1.225 -0.222 0 C-N-CA 124.251 1.021 . . . . 0.0 110.886 176.866 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -78.77 -46.13 19.51 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 118.392 -0.814 . . . . 0.0 110.719 178.583 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.86 ' HB1' ' HG3' ' A' ' 35' ' ' PRO . . . -43.38 130.72 3.62 Favored Pre-proline 0 N--CA 1.447 -0.596 0 O-C-N 125.312 1.632 . . . . 0.0 111.434 178.611 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.438 ' HG2' ' CG2' ' A' ' 30' ' ' THR . 18.0 Cg_endo -71.08 122.87 9.16 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.242 1.961 . . . . 0.0 108.908 -177.362 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.697 HD21 ' O ' ' A' ' 113' ' ' PRO . 2.0 tp -61.15 88.94 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.425 1.09 . . . . 0.0 111.77 177.744 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -177.77 167.65 2.13 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.448 -175.172 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.415 ' HA ' ' HA ' ' A' ' 36' ' ' HIS . 1.3 t70 -114.89 126.88 55.31 Favored 'General case' 0 CA--C 1.512 -0.494 0 C-N-CA 124.295 1.038 . . . . 0.0 110.112 179.756 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 56.09 55.51 28.9 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-O 122.348 0.971 . . . . 0.0 111.145 176.189 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.2 tttt -141.01 28.56 1.9 Allowed 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 124.197 1.951 . . . . 0.0 112.068 -179.386 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.579 HG21 ' HD2' ' A' ' 35' ' ' PRO . 34.6 p -134.74 143.31 47.08 Favored 'General case' 0 C--N 1.309 -1.157 0 O-C-N 119.854 -1.779 . . . . 0.0 108.506 -174.836 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -40.03 -65.8 0.88 Allowed Glycine 0 C--N 1.332 0.349 0 C-N-CA 124.223 0.916 . . . . 0.0 113.543 -177.794 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 25.3 t -54.65 -61.56 2.23 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 117.567 -1.206 . . . . 0.0 111.281 172.914 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.0 p 159.45 -43.02 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 O-C-N 125.637 1.836 . . . . 0.0 113.091 -178.584 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.589 ' CE2' ' CE1' ' A' ' 36' ' ' HIS . 62.2 m-85 -79.34 149.67 72.7 Favored Pre-proline 0 N--CA 1.442 -0.86 0 C-N-CA 124.88 1.272 . . . . 0.0 113.258 178.286 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.86 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 23.1 Cg_endo -74.26 157.93 99.09 Favored 'Cis proline' 0 N--CA 1.45 -1.037 0 C-N-CA 123.476 -1.468 . . . . 0.0 110.351 -1.118 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.589 ' CE1' ' CE2' ' A' ' 34' ' ' TYR . 0.3 OUTLIER -134.6 155.85 49.73 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 113.649 -1.614 . . . . 0.0 109.01 179.125 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.885 ' CH2' HG22 ' A' ' 39' ' ' THR . 25.2 t90 -55.49 121.6 9.37 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-O 122.158 0.98 . . . . 0.0 110.724 174.134 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.538 ' CE2' HG21 ' A' ' 109' ' ' ILE . 41.7 t80 -92.77 85.86 5.34 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 126.997 2.119 . . . . 0.0 106.343 177.929 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.885 HG22 ' CH2' ' A' ' 37' ' ' TRP . 43.8 p -38.98 -36.45 0.28 Allowed 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.505 171.533 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.48 ' HA ' ' CZ ' ' A' ' 38' ' ' PHE . 63.9 t30 66.45 9.93 6.89 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 122.402 1.096 . . . . 0.0 111.687 -179.261 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 113.21 -18.93 20.71 Favored Glycine 0 N--CA 1.433 -1.519 0 C-N-CA 124.874 1.226 . . . . 0.0 113.226 -171.824 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.605 ' CE1' HD11 ' A' ' 48' ' ' LEU . 11.4 m-85 -63.98 161.53 15.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 118.647 1.223 . . . . 0.0 110.993 179.983 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.41 -41.88 19.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.373 0.606 . . . . 0.0 111.287 176.047 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.558 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -173.33 -67.4 0.05 OUTLIER Glycine 0 C--N 1.339 0.696 0 C-N-CA 124.094 0.854 . . . . 0.0 112.497 -177.755 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -115.77 -63.21 1.48 Allowed 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 124.003 0.921 . . . . 0.0 110.045 -179.782 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -58.12 162.49 9.74 Favored Glycine 0 C--N 1.341 0.827 0 N-CA-C 110.971 -0.851 . . . . 0.0 110.971 178.454 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.56 ' HA ' ' CE2' ' A' ' 42' ' ' TYR . 11.8 mtmt -56.6 173.36 0.19 Allowed 'General case' 0 C--N 1.334 -0.089 0 CA-C-O 121.59 0.709 . . . . 0.0 111.152 179.097 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.665 ' H ' HD12 ' A' ' 48' ' ' LEU . 5.7 mp -57.63 154.17 26.76 Favored Pre-proline 0 N--CA 1.446 -0.667 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.708 -179.421 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -70.74 159.15 53.63 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 121.692 1.595 . . . . 0.0 110.066 179.919 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.6 tttt -56.45 97.68 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.247 0.619 . . . . 0.0 110.081 176.137 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 117.83 60.26 0.29 Allowed Glycine 0 C--N 1.329 0.172 0 CA-C-N 116.443 -0.344 . . . . 0.0 112.629 -176.343 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.413 ' HG2' HD23 ' A' ' 48' ' ' LEU . 14.0 ttm180 -164.06 162.56 23.13 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 123.287 0.635 . . . . 0.0 110.606 175.194 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.9 m -139.08 109.33 7.62 Favored Pre-proline 0 C--N 1.326 -0.449 0 C-N-CA 123.196 0.598 . . . . 0.0 109.584 179.641 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.542 ' HG3' HD13 ' A' ' 48' ' ' LEU . 26.3 Cg_endo -72.86 177.16 8.01 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 123.126 2.551 . . . . 0.0 111.129 177.287 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.47 HD12 HG21 ' A' ' 121' ' ' ILE . 6.5 mt -94.89 124.57 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -179.383 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.09 136.42 35.93 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 175.123 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.552 ' CD1' ' HB3' ' A' ' 118' ' ' CYS . 10.8 m-85 -118.89 -28.54 5.53 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.717 0.807 . . . . 0.0 111.027 177.747 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.66 -3.66 56.23 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 123.883 0.754 . . . . 0.0 113.209 -175.046 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.3 mmpt? -97.88 127.82 44.07 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-N 117.695 0.748 . . . . 0.0 109.414 176.868 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -66.35 -11.69 52.54 Favored 'General case' 0 C--O 1.219 -0.51 0 O-C-N 124.893 1.371 . . . . 0.0 111.819 175.854 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.15 -46.87 10.69 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 125.637 1.575 . . . . 0.0 111.049 175.806 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.459 ' SG ' ' CE2' ' A' ' 57' ' ' PHE . 2.0 t -73.1 -16.63 61.46 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 123.956 0.785 . . . . 0.0 112.071 176.688 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -90.04 -34.66 15.87 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.387 1.075 . . . . 0.0 110.812 175.246 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.21 163.1 0.97 Allowed Pre-proline 0 N--CA 1.446 -0.629 0 CA-C-O 121.538 0.685 . . . . 0.0 112.157 179.838 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.463 ' HA ' ' CE2' ' A' ' 42' ' ' TYR . 24.6 Cg_endo -71.74 129.45 15.54 Favored 'Trans proline' 0 N--CA 1.44 -1.651 0 C-N-CA 121.144 1.229 . . . . 0.0 113.093 174.605 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.469 ' HD2' ' CD2' ' A' ' 42' ' ' TYR . 20.4 Cg_endo -68.46 167.59 22.05 Favored 'Trans proline' 0 N--CA 1.443 -1.498 0 C-N-CA 123.713 2.942 . . . . 0.0 111.206 176.701 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 10.3 tptt -126.75 66.16 1.26 Allowed 'General case' 0 C--O 1.223 -0.328 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.787 177.423 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.409 ' CE1' ' O ' ' A' ' 69' ' ' SER . 41.7 t-80 -77.92 168.07 20.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.498 0.666 . . . . 0.0 110.932 177.39 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.409 ' O ' ' CE1' ' A' ' 68' ' ' HIS . 1.5 p -141.47 173.79 11.17 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 121.232 -0.918 . . . . 0.0 111.429 176.782 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.5 mtpt -84.77 71.97 10.79 Favored 'General case' 0 C--O 1.219 -0.521 0 O-C-N 120.495 -1.378 . . . . 0.0 110.993 175.338 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -177.29 -43.07 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 O-C-N 124.54 1.15 . . . . 0.0 111.014 178.509 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 161.71 -85.08 0.11 Allowed Glycine 0 N--CA 1.442 -0.912 0 N-CA-C 108.626 -1.79 . . . . 0.0 108.626 -178.801 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -94.14 -98.27 0.15 Allowed 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 124.424 1.089 . . . . 0.0 108.465 -178.171 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 125.9 -162.92 20.02 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 125.781 1.658 . . . . 0.0 110.614 -175.503 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.3 mttt -43.65 -81.49 0.01 OUTLIER 'General case' 0 C--O 1.218 -0.554 0 C-N-CA 125.118 1.367 . . . . 0.0 112.942 -179.678 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.525 HG23 ' O ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -117.96 14.53 14.17 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 116.062 -1.923 . . . . 0.0 111.856 176.01 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.471 ' OD2' ' CE1' ' A' ' 79' ' ' TYR . 11.6 p-10 -11.77 83.08 0.0 OUTLIER 'General case' 0 C--O 1.214 -0.793 0 CA-C-O 124.469 2.08 . . . . 0.0 115.685 179.08 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 33.6 p80 -91.88 19.41 6.63 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 118.361 -2.712 . . . . 0.0 109.485 -170.531 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.942 ' CE1' HD11 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -52.91 179.12 0.02 OUTLIER 'General case' 0 N--CA 1.428 -1.542 0 C-N-CA 125.329 1.452 . . . . 0.0 113.987 175.229 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.496 HD21 HG22 ' A' ' 111' ' ' THR . 2.0 mt -100.63 154.34 18.67 Favored 'General case' 0 CA--C 1.504 -0.812 0 CA-C-O 118.444 -0.789 . . . . 0.0 110.869 173.871 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.942 HD11 ' CE1' ' A' ' 79' ' ' TYR . 2.6 mp -142.02 125.89 17.13 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 123.901 0.881 . . . . 0.0 109.803 179.175 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -92.34 154.24 18.69 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 121.386 0.613 . . . . 0.0 109.832 -179.125 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.53 ' CD1' ' HD2' ' A' ' 84' ' ' PRO . 6.4 t80 -143.68 135.13 12.73 Favored Pre-proline 0 N--CA 1.45 -0.449 0 O-C-N 121.538 -0.726 . . . . 0.0 112.65 179.078 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.53 ' HD2' ' CD1' ' A' ' 83' ' ' PHE . 18.2 Cg_endo -73.33 99.72 1.15 Allowed 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 123.988 3.125 . . . . 0.0 110.236 -177.374 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.4 t -95.93 108.12 20.46 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.743 -179.912 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.409 ' CE1' ' HB2' ' A' ' 92' ' ' TYR . 59.0 m-85 -83.36 150.82 61.31 Favored Pre-proline 0 C--O 1.241 0.638 0 CA-C-O 118.804 -0.617 . . . . 0.0 110.953 178.964 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -75.72 -36.55 2.09 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 123.311 2.674 . . . . 0.0 113.209 178.352 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -41.42 -34.4 0.53 Allowed 'General case' 0 C--N 1.351 0.669 0 O-C-N 125.53 1.769 . . . . 0.0 111.079 176.186 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . 0.426 ' HA2' ' CD ' ' A' ' 15' ' ' LYS . . . 98.03 -4.91 61.13 Favored Glycine 0 N--CA 1.439 -1.143 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 178.25 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -71.92 136.55 46.91 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 122.107 0.956 . . . . 0.0 108.813 177.501 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -75.45 104.2 5.91 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 173.432 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.417 ' O ' ' CD2' ' A' ' 94' ' ' PHE . 8.3 t80 -37.84 145.41 0.07 Allowed 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.991 0.9 . . . . 0.0 111.884 177.131 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.87 61.3 3.75 Favored 'General case' 0 C--N 1.322 -0.591 0 O-C-N 119.902 -1.749 . . . . 0.0 110.679 176.004 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.444 ' CD2' ' HZ ' ' A' ' 83' ' ' PHE . 43.6 p90 -75.56 1.88 13.16 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.325 1.05 . . . . 0.0 113.144 175.253 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -98.11 -41.16 8.06 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.407 1.083 . . . . 0.0 110.305 178.853 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 18.8 m -87.09 110.61 20.22 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -178.965 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 12.7 pttt -57.62 -49.13 77.46 Favored 'General case' 0 C--O 1.241 0.609 0 O-C-N 121.872 -0.518 . . . . 0.0 110.724 177.372 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 13.1 mtmt -141.56 128.54 11.54 Favored Pre-proline 0 N--CA 1.444 -0.758 0 C-N-CA 125.383 1.473 . . . . 0.0 110.765 -177.265 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -71.34 173.57 49.49 Favored 'Cis proline' 0 CA--C 1.54 0.821 0 C-N-CA 122.934 -1.694 . . . . 0.0 110.955 -4.891 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -141.99 142.4 32.94 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 123.895 0.878 . . . . 0.0 109.674 179.365 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -80.82 175.59 10.55 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.613 1.195 . . . . 0.0 111.557 179.061 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -73.61 140.39 78.51 Favored Pre-proline 0 N--CA 1.449 -0.522 0 CA-C-O 118.567 -0.73 . . . . 0.0 110.846 175.717 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -70.23 -163.14 0.11 Allowed 'Trans proline' 0 CA--C 1.548 1.188 0 C-N-CA 124.001 3.134 . . . . 0.0 112.687 175.375 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -145.37 163.44 28.15 Favored Glycine 0 N--CA 1.446 -0.693 0 O-C-N 120.487 -1.383 . . . . 0.0 111.707 174.747 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.43 -57.73 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.244 2.629 . . . . 0.0 110.829 178.689 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.734 ' HB1' ' CG2' ' A' ' 120' ' ' ILE . . . -63.64 135.72 56.97 Favored 'General case' 0 N--CA 1.438 -1.026 0 O-C-N 123.586 0.554 . . . . 0.0 110.589 178.045 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.479 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 3.1 mtm-85 -141.7 143.94 33.82 Favored 'General case' 0 C--O 1.211 -0.95 0 CA-C-O 117.225 -1.369 . . . . 0.0 110.807 178.578 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.669 HG23 ' CD1' ' A' ' 117' ' ' PHE . 2.8 p -81.98 119.2 31.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 C-N-CA 124.702 1.201 . . . . 0.0 110.104 176.904 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.538 HG21 ' CE2' ' A' ' 38' ' ' PHE . 1.8 mp -105.39 124.5 60.33 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.786 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 -177.113 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.453 ' CG ' ' HG2' ' A' ' 115' ' ' LYS . 15.3 p90 -141.33 162.73 34.79 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 123.192 0.597 . . . . 0.0 109.931 -179.42 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.496 HG22 HD21 ' A' ' 80' ' ' LEU . 1.2 p -95.34 165.11 12.54 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -177.83 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.585 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.6 OUTLIER -108.96 153.41 42.49 Favored Pre-proline 0 CA--C 1.54 0.593 0 O-C-N 122.121 -0.362 . . . . 0.0 111.442 177.454 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.697 ' O ' HD21 ' A' ' 25' ' ' LEU . 18.8 Cg_endo -74.44 -54.31 0.15 OUTLIER 'Cis proline' 0 N--CA 1.455 -0.769 0 C-N-CA 123.491 -1.462 . . . . 0.0 110.427 -7.803 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -42.6 112.57 0.36 Allowed 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 116.544 -1.693 . . . . 0.0 110.061 175.89 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.619 ' HE2' HD13 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -64.93 71.42 0.03 OUTLIER 'General case' 0 CA--C 1.514 -0.423 0 O-C-N 125.621 1.825 . . . . 0.0 108.357 179.529 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.424 ' O ' HG12 ' A' ' 116' ' ' VAL . 18.0 t -74.55 75.67 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 -179.299 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.669 ' CD1' HG23 ' A' ' 108' ' ' VAL . 27.6 t80 -41.08 119.39 1.16 Allowed 'General case' 0 N--CA 1.437 -1.122 0 C-N-CA 125.217 1.407 . . . . 0.0 110.063 176.798 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . 0.552 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 5.5 m -95.15 -45.48 7.18 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.837 -178.937 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . 0.568 ' HA2' ' CZ ' ' A' ' 117' ' ' PHE . . . 157.64 177.95 31.23 Favored Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.48 -179.841 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.734 ' CG2' ' HB1' ' A' ' 106' ' ' ALA . 2.7 mp -101.23 124.37 54.89 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.289 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -178.586 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.686 HG22 HD12 ' A' ' 133' ' ' LEU . 7.5 pt -97.15 154.22 3.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 CA-C-N 120.232 1.378 . . . . 0.0 109.024 -179.598 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.588 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . . . . . . . . 0 C--N 1.326 -0.444 0 CA-C-O 122.468 1.128 . . . . 0.0 110.762 176.057 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.513 -0.467 0 N-CA-C 109.82 -0.437 . . . . 0.0 109.82 . . . . . . . . . 1 1 . 1 . 022 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.686 HD12 HG22 ' A' ' 121' ' ' ILE . 7.4 tp -82.29 149.82 27.59 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.47 1.106 . . . . 0.0 108.728 175.243 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . 0.479 ' SG ' HG22 ' A' ' 120' ' ' ILE . 8.3 m -63.11 -175.72 0.11 Allowed 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 124.01 1.862 . . . . 0.0 108.525 176.096 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -172.01 121.87 0.47 Allowed 'General case' 0 C--N 1.316 -0.868 0 O-C-N 120.482 -1.386 . . . . 0.0 107.601 -176.925 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.258 1.5 0 CA-C-O 113.472 -3.156 . . . . 0.0 110.493 172.617 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.672 HG22 ' HB2' ' A' ' 136' ' ' HIS . 1.8 p . . . . . 0 N--CA 1.45 -0.47 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 . . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.449 HG21 ' HB3' ' A' ' 10' ' ' LEU . 2.9 m -86.83 119.75 27.39 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.467 -177.434 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . 0.474 ' CG ' HG13 ' A' ' 120' ' ' ILE . 28.8 m95 -79.98 139.63 36.93 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.956 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.862 ' OG1' HD13 ' A' ' 10' ' ' LEU . 0.9 OUTLIER -133.5 132.81 41.43 Favored 'General case' 0 CA--C 1.501 -0.905 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -178.36 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.71 ' SG ' ' HB3' ' A' ' 122' ' ' ALA . 0.1 OUTLIER -120.56 41.65 3.2 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.284 177.732 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 148.31 -96.26 0.17 Allowed Glycine 0 C--O 1.222 -0.637 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 -179.36 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . 0.599 ' C ' HD13 ' A' ' 9' ' ' LEU . . . -127.07 4.37 7.34 Favored Glycine 0 C--O 1.223 -0.593 0 N-CA-C 112.061 -0.416 . . . . 0.0 112.061 178.585 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.669 ' N ' HD13 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -111.13 141.29 44.82 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 -173.083 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.862 HD13 ' OG1' ' A' ' 5' ' ' THR . 1.2 mm? -113.42 120.23 40.33 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -171.808 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.575 ' CE2' ' CB ' ' A' ' 106' ' ' ALA . 63.4 m-85 -115.18 101.41 8.94 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 125.065 1.346 . . . . 0.0 109.595 -175.653 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -57.62 120.94 9.21 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.984 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.513 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 6.8 tp-100 -46.49 -43.58 16.9 Favored 'General case' 0 C--O 1.2 -1.547 0 O-C-N 124.246 0.967 . . . . 0.0 111.498 179.591 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -48.22 -49.22 33.89 Favored 'General case' 0 C--O 1.194 -1.821 0 CA-C-N 117.693 0.224 . . . . 0.0 110.768 176.474 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.46 -34.58 77.48 Favored 'General case' 0 C--O 1.195 -1.779 0 O-C-N 120.712 -1.242 . . . . 0.0 111.922 172.985 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.0 -50.59 72.9 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 121.1 1.773 . . . . 0.0 112.067 174.269 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.434 ' O ' ' CD2' ' A' ' 21' ' ' HIS . 3.6 pt-20 -78.5 -36.94 44.36 Favored 'General case' 0 C--O 1.207 -1.145 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.754 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 43.2 t -71.37 -63.25 1.15 Allowed 'General case' 0 CA--C 1.503 -0.833 0 C-N-CA 125.463 1.505 . . . . 0.0 108.981 -177.863 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.503 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 10.4 t-20 -39.54 -37.92 0.54 Allowed 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 123.942 0.897 . . . . 0.0 111.768 174.771 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.428 ' O ' ' HB3' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -80.2 -40.35 27.36 Favored 'General case' 0 N--CA 1.443 -0.801 0 O-C-N 124.757 1.286 . . . . 0.0 113.342 175.229 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.434 ' CD2' ' O ' ' A' ' 17' ' ' GLU . 4.6 m170 -42.44 -40.38 2.55 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.467 1.507 . . . . 0.0 109.611 178.442 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.503 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -71.16 -49.46 43.63 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-O 118.162 -0.923 . . . . 0.0 111.279 177.036 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.593 ' HB1' ' HG3' ' A' ' 35' ' ' PRO . . . -35.56 131.76 0.53 Allowed Pre-proline 0 N--CA 1.441 -0.902 0 O-C-N 125.067 1.479 . . . . 0.0 112.054 174.656 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.831 ' HG2' HG22 ' A' ' 30' ' ' THR . 18.9 Cg_endo -73.01 122.1 7.83 Favored 'Trans proline' 0 N--CA 1.446 -1.319 0 C-N-CA 122.24 1.96 . . . . 0.0 110.292 -178.115 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.634 HD13 ' HE2' ' A' ' 115' ' ' LYS . 3.3 tp -59.51 97.84 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.658 179.057 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -179.98 166.02 1.25 Allowed 'General case' 0 C--N 1.324 -0.516 0 O-C-N 123.548 0.53 . . . . 0.0 109.943 -177.699 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -103.46 98.46 8.36 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.531 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 66.83 79.19 0.22 Allowed Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 177.714 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -151.44 27.99 0.65 Allowed 'General case' 0 CA--C 1.513 -0.443 0 O-C-N 122.012 -0.699 . . . . 0.0 110.964 178.533 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.831 HG22 ' HG2' ' A' ' 24' ' ' PRO . 10.8 p -122.47 148.62 44.92 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -175.753 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -39.72 -56.14 2.6 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 111.752 -0.539 . . . . 0.0 111.752 -179.517 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 29.4 t -69.35 -60.14 2.54 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 116.909 -1.519 . . . . 0.0 111.354 176.958 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 163.04 -56.7 0.0 OUTLIER 'General case' 0 C--O 1.223 -0.329 0 O-C-N 125.603 1.814 . . . . 0.0 110.77 178.136 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.557 ' CD1' ' HD3' ' A' ' 84' ' ' PRO . 69.1 m-85 -60.25 144.7 87.22 Favored Pre-proline 0 N--CA 1.437 -1.08 0 CA-C-O 118.051 -0.976 . . . . 0.0 113.127 178.849 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.593 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 25.0 Cg_endo -74.92 165.05 86.91 Favored 'Cis proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.361 -1.933 . . . . 0.0 112.027 -0.53 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.445 ' CD2' ' CD1' ' A' ' 34' ' ' TYR . 1.0 OUTLIER -139.42 168.21 20.33 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 121.546 -0.721 . . . . 0.0 110.308 -178.343 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.895 ' CZ3' HG22 ' A' ' 39' ' ' THR . 22.7 t90 -70.31 113.72 7.74 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 179.094 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.436 ' CE1' ' HA ' ' A' ' 40' ' ' ASN . 8.5 t80 -84.71 79.44 9.6 Favored 'General case' 0 N--CA 1.427 -1.596 0 C-N-CA 124.888 1.275 . . . . 0.0 108.872 178.234 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.895 HG22 ' CZ3' ' A' ' 37' ' ' TRP . 60.6 p -36.51 -38.07 0.15 Allowed 'General case' 0 C--O 1.216 -0.677 0 C-N-CA 124.439 1.095 . . . . 0.0 110.596 176.9 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.436 ' HA ' ' CE1' ' A' ' 38' ' ' PHE . 65.2 t30 69.83 7.47 6.24 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 124.099 0.959 . . . . 0.0 108.599 176.992 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.459 ' C ' HD23 ' A' ' 48' ' ' LEU . . . 120.81 -35.37 3.72 Favored Glycine 0 N--CA 1.429 -1.811 0 CA-C-O 117.293 -1.837 . . . . 0.0 111.796 -175.705 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.665 ' N ' HD23 ' A' ' 48' ' ' LEU . 60.4 m-85 -51.42 173.13 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 118.066 0.933 . . . . 0.0 110.424 -178.354 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.66 -43.01 8.11 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -179.169 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.535 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -178.29 -52.2 0.07 OUTLIER Glycine 0 C--N 1.338 0.682 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 -179.657 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.5 -90.74 0.09 Allowed 'General case' 0 C--O 1.217 -0.647 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -179.86 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -148.93 28.75 1.27 Allowed Glycine 0 N--CA 1.443 -0.862 0 O-C-N 120.898 -1.126 . . . . 0.0 110.616 -176.362 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.3 mttp -126.06 144.28 50.79 Favored 'General case' 0 CA--C 1.501 -0.92 0 CA-C-O 117.703 -1.141 . . . . 0.0 109.115 -177.695 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.665 HD23 ' N ' ' A' ' 42' ' ' TYR . 1.5 mt -106.46 159.12 30.91 Favored Pre-proline 0 C--N 1.319 -0.738 0 O-C-N 124.151 0.907 . . . . 0.0 109.26 -179.232 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -73.54 -175.61 2.13 Favored 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 122.954 2.436 . . . . 0.0 111.564 179.05 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.7 tptp -68.35 98.38 0.83 Allowed 'General case' 0 N--CA 1.445 -0.691 0 O-C-N 121.35 -0.844 . . . . 0.0 109.259 177.185 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.23 88.3 1.07 Allowed Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 179.042 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.415 ' HD2' ' HA2' ' A' ' 41' ' ' GLY . 0.0 OUTLIER -151.32 137.93 18.75 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 119.286 -0.387 . . . . 0.0 111.294 177.347 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.9 m -128.95 103.36 18.76 Favored Pre-proline 0 C--N 1.327 -0.392 0 O-C-N 124.629 1.206 . . . . 0.0 110.225 -178.56 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -72.42 158.28 51.58 Favored 'Trans proline' 0 N--CA 1.448 -1.194 0 C-N-CA 122.226 1.95 . . . . 0.0 111.762 178.916 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.443 ' CG2' ' HB2' ' A' ' 133' ' ' LEU . 5.4 mt -77.41 123.41 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.023 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -91.12 135.69 33.6 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 179.01 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.501 ' CD1' ' HB3' ' A' ' 118' ' ' CYS . 15.3 m-85 -114.74 -52.48 2.7 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.225 179.91 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 126.9 -5.57 7.4 Favored Glycine 0 C--O 1.223 -0.585 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.853 -177.232 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.95 132.1 36.76 Favored 'General case' 0 CA--C 1.5 -0.978 0 CA-C-O 117.651 -1.166 . . . . 0.0 109.393 178.891 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 31.1 t -67.09 -9.78 43.07 Favored 'General case' 0 C--O 1.221 -0.439 0 O-C-N 125.034 1.459 . . . . 0.0 111.036 177.481 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -92.15 -49.77 6.02 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 124.032 0.933 . . . . 0.0 108.887 -179.193 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.838 ' SG ' HD21 ' A' ' 80' ' ' LEU . 3.9 t -75.89 -6.61 51.65 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 123.766 0.666 . . . . 0.0 111.214 175.988 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -99.94 -32.58 10.9 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.571 0.749 . . . . 0.0 110.165 177.987 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.531 ' HD3' ' CE1' ' A' ' 78' ' ' HIS . 0.0 OUTLIER -51.5 166.03 0.39 Allowed Pre-proline 0 N--CA 1.441 -0.89 0 CA-C-O 121.725 0.774 . . . . 0.0 111.018 179.913 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . 0.424 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 26.6 Cg_endo -72.11 135.24 24.7 Favored 'Trans proline' 0 N--CA 1.44 -1.645 0 C-N-CA 121.291 1.327 . . . . 0.0 113.865 174.959 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 65' ' ' PRO . 20.3 Cg_endo -71.72 171.31 16.69 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 122.529 2.153 . . . . 0.0 112.095 178.217 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.8 tptt -138.48 72.18 1.4 Allowed 'General case' 0 C--O 1.195 -1.813 0 CA-C-O 116.385 -1.769 . . . . 0.0 108.287 178.185 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.458 ' CD2' ' CD2' ' A' ' 37' ' ' TRP . 53.2 t-80 -79.4 159.36 27.11 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 119.463 1.029 . . . . 0.0 110.603 178.207 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.31 -178.35 6.02 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.78 0.8 . . . . 0.0 110.011 -179.681 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -86.37 62.98 7.75 Favored 'General case' 0 C--O 1.209 -1.039 0 O-C-N 121.299 -0.875 . . . . 0.0 110.926 178.08 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -177.6 -39.27 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.831 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 129.82 -82.88 0.33 Allowed Glycine 0 C--O 1.207 -1.573 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 -179.301 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.41 ' HA ' ' HB2' ' A' ' 77' ' ' ASP . 7.1 p-10 -115.88 53.17 0.86 Allowed 'General case' 0 C--N 1.313 -0.979 0 O-C-N 120.744 -1.445 . . . . 0.0 107.978 -177.762 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -55.8 -115.94 0.01 OUTLIER Glycine 0 C--O 1.217 -0.93 0 O-C-N 123.879 0.737 . . . . 0.0 111.9 178.172 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.9 mttm -42.73 -82.92 0.01 OUTLIER 'General case' 0 C--O 1.223 -0.311 0 O-C-N 121.443 -1.034 . . . . 0.0 110.894 179.946 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.633 HG23 ' O ' ' A' ' 76' ' ' THR . 0.6 OUTLIER -146.43 26.77 1.15 Allowed 'General case' 0 CA--C 1.507 -0.682 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.164 178.203 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.475 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 0.8 OUTLIER -26.54 96.52 0.01 OUTLIER 'General case' 0 C--O 1.213 -0.827 0 C-N-CA 124.231 1.012 . . . . 0.0 112.331 -178.688 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.531 ' CE1' ' HD3' ' A' ' 64' ' ' ARG . 16.5 p80 -94.71 23.77 5.17 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -173.756 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.656 ' CE1' HD11 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -57.51 -177.25 0.02 OUTLIER 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 174.889 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.838 HD21 ' SG ' ' A' ' 62' ' ' CYS . 0.4 OUTLIER -100.48 149.4 23.72 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.371 175.42 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.738 HD23 ' HA ' ' A' ' 37' ' ' TRP . 1.0 OUTLIER -138.42 118.92 13.83 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 124.021 0.825 . . . . 0.0 108.873 -179.027 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.511 ' CB ' ' CD1' ' A' ' 109' ' ' ILE . 0.2 OUTLIER -87.68 163.12 16.71 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-O 122.238 1.018 . . . . 0.0 111.581 178.702 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.539 ' CZ ' ' HB2' ' A' ' 23' ' ' ALA . 50.9 t80 -153.11 122.13 3.22 Favored Pre-proline 0 N--CA 1.446 -0.634 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.876 -179.424 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.557 ' HD3' ' CD1' ' A' ' 34' ' ' TYR . 18.2 Cg_endo -71.93 112.09 3.32 Favored 'Trans proline' 0 N--CA 1.447 -1.21 0 C-N-CA 123.506 2.804 . . . . 0.0 110.792 -177.946 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.78 121.22 43.39 Favored 'General case' 0 CA--C 1.51 -0.574 0 O-C-N 124.139 0.899 . . . . 0.0 110.268 -179.319 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.421 ' CE2' ' HB2' ' A' ' 92' ' ' TYR . 58.4 m-85 -82.11 157.7 68.13 Favored Pre-proline 0 N--CA 1.444 -0.76 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 178.725 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -75.52 -37.95 1.58 Allowed 'Trans proline' 0 CA--C 1.5 -1.176 0 C-N-CA 122.392 2.061 . . . . 0.0 112.84 179.542 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.35 -30.82 2.26 Favored 'General case' 0 C--O 1.224 -0.285 0 C-N-CA 124.902 1.281 . . . . 0.0 108.786 -179.648 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 95.91 -9.94 68.2 Favored Glycine 0 N--CA 1.431 -1.662 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 176.443 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.403 ' O ' ' CD2' ' A' ' 90' ' ' HIS . 4.1 p-80 -61.92 125.91 25.49 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.064 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.98 97.22 0.06 Allowed 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 123.12 0.568 . . . . 0.0 110.234 176.121 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.531 ' CD2' ' HB3' ' A' ' 94' ' ' PHE . 6.2 t80 -36.25 140.49 0.13 Allowed 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 121.919 0.866 . . . . 0.0 111.285 179.541 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.51 59.79 1.98 Allowed 'General case' 0 N--CA 1.444 -0.772 0 O-C-N 120.227 -1.546 . . . . 0.0 110.156 177.465 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.531 ' HB3' ' CD2' ' A' ' 92' ' ' TYR . 28.2 p90 -77.27 -8.12 57.08 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 123.443 0.697 . . . . 0.0 111.633 177.67 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.87 -33.33 13.56 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 122.166 0.984 . . . . 0.0 109.679 -179.624 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.87 104.08 11.99 Favored 'General case' 0 N--CA 1.443 -0.812 0 O-C-N 121.236 -0.915 . . . . 0.0 108.987 179.907 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.7 -49.38 77.96 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.724 178.818 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 99' ' ' PRO . 39.1 pttt -139.22 125.79 12.56 Favored Pre-proline 0 N--CA 1.435 -1.18 0 C-N-CA 123.633 0.773 . . . . 0.0 108.975 -176.833 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.454 ' HA ' ' HA ' ' A' ' 98' ' ' LYS . 24.0 Cg_endo -71.14 177.34 32.85 Favored 'Cis proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.376 -1.927 . . . . 0.0 111.469 -4.057 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -132.9 144.88 50.46 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 122.724 0.41 . . . . 0.0 109.988 177.48 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -95.9 152.64 18.32 Favored 'General case' 0 C--N 1.319 -0.747 0 O-C-N 124.338 1.024 . . . . 0.0 110.366 177.53 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -44.66 149.01 0.83 Allowed Pre-proline 0 N--CA 1.44 -0.948 0 O-C-N 123.926 0.766 . . . . 0.0 111.694 174.025 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -73.14 -164.88 0.21 Allowed 'Trans proline' 0 N--CA 1.446 -1.317 0 C-N-CA 122.394 2.063 . . . . 0.0 111.557 178.155 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -139.12 157.18 24.8 Favored Glycine 0 N--CA 1.443 -0.9 0 O-C-N 121.955 -0.465 . . . . 0.0 112.206 177.856 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -75.09 -75.91 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 122.806 2.338 . . . . 0.0 110.956 179.659 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.575 ' CB ' ' CE2' ' A' ' 11' ' ' TYR . . . -60.4 136.54 58.07 Favored 'General case' 0 N--CA 1.441 -0.922 0 O-C-N 123.434 0.459 . . . . 0.0 110.573 178.747 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.421 ' HG2' ' HA ' ' A' ' 84' ' ' PRO . 0.8 OUTLIER -141.71 146.98 36.71 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.853 -178.607 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.431 ' CG1' ' HB3' ' A' ' 83' ' ' PHE . 6.6 p -83.03 125.76 40.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 O-C-N 123.719 0.637 . . . . 0.0 110.119 178.589 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.663 ' CG2' HD22 ' A' ' 80' ' ' LEU . 9.4 mm -104.62 140.87 21.43 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.92 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.063 179.614 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.48 ' CG ' ' HG2' ' A' ' 115' ' ' LYS . 9.7 p90 -166.12 155.48 11.69 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 121.841 0.829 . . . . 0.0 110.38 -178.944 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.4 p -90.86 160.96 15.45 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.93 -179.977 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.547 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -109.48 153.95 42.56 Favored Pre-proline 0 N--CA 1.44 -0.969 0 C-N-CA 123.055 0.542 . . . . 0.0 111.367 179.149 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.547 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 19.1 Cg_endo -73.29 -54.05 0.15 OUTLIER 'Cis proline' 0 CA--C 1.504 -1.007 0 C-N-CA 122.538 -1.859 . . . . 0.0 110.18 -5.434 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -42.36 107.36 0.08 Allowed 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 116.961 -1.495 . . . . 0.0 110.237 179.803 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.634 ' HE2' HD13 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -64.44 76.6 0.04 OUTLIER 'General case' 0 CA--C 1.512 -0.493 0 O-C-N 125.061 1.476 . . . . 0.0 108.802 -177.621 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.498 ' O ' HG12 ' A' ' 116' ' ' VAL . 38.1 t -75.95 74.23 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 -176.516 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.513 ' CZ ' ' NE2' ' A' ' 13' ' ' GLN . 39.1 t80 -36.35 105.97 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 124.629 1.171 . . . . 0.0 110.55 179.606 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . 0.501 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 8.7 m -83.52 -46.27 12.63 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -178.771 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 162.34 -144.96 10.15 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 179.727 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.474 HG13 ' CG ' ' A' ' 4' ' ' TRP . 1.2 mm -128.72 144.67 37.34 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.091 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -176.519 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.773 HG22 HD12 ' A' ' 133' ' ' LEU . 8.6 pt -133.64 155.46 40.21 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.722 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -178.561 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.71 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . . . . . . . . 0 C--N 1.324 -0.524 0 CA-C-O 121.69 0.757 . . . . 0.0 109.953 177.711 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 6.9 ptmm? . . . . . 0 CA--C 1.512 -0.484 0 CA-C-O 118.997 -0.525 . . . . 0.0 109.74 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.773 HD12 HG22 ' A' ' 121' ' ' ILE . 6.0 tp -88.39 141.77 28.27 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.237 0.96 . . . . 0.0 109.244 178.866 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . 0.466 ' SG ' HG22 ' A' ' 120' ' ' ILE . 57.5 m -67.57 -176.1 0.58 Allowed 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 121.862 0.839 . . . . 0.0 109.307 177.494 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 2.1 m -156.27 84.92 0.99 Allowed 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -178.855 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.672 ' HB2' HG22 ' A' ' 2' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.258 1.543 0 CA-C-O 115.151 -2.357 . . . . 0.0 112.528 173.957 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.65 HG13 ' CD2' ' A' ' 136' ' ' HIS . 7.6 p . . . . . 0 N--CA 1.455 -0.219 0 CA-C-O 120.758 0.314 . . . . 0.0 110.257 . . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.457 ' N ' HG22 ' A' ' 2' ' ' VAL . 2.4 m -85.94 109.13 18.54 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 125.936 1.695 . . . . 0.0 110.962 -179.493 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . 0.482 ' CD1' ' HB2' ' A' ' 13' ' ' GLN . 25.5 m95 -77.67 142.4 38.84 Favored 'General case' 0 N--CA 1.442 -0.863 0 O-C-N 121.709 -0.619 . . . . 0.0 110.164 179.546 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.419 ' OG1' HD13 ' A' ' 10' ' ' LEU . 0.9 OUTLIER -131.97 134.36 45.53 Favored 'General case' 0 CA--C 1.5 -0.943 0 C-N-CA 123.204 0.602 . . . . 0.0 110.117 -176.957 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.731 ' SG ' ' HB3' ' A' ' 122' ' ' ALA . 0.0 OUTLIER -134.07 -73.46 0.48 Allowed 'General case' 0 C--O 1.222 -0.393 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 177.367 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -80.44 42.5 2.61 Favored Glycine 0 C--O 1.211 -1.281 0 CA-C-O 117.844 -1.531 . . . . 0.0 111.373 179.905 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 64.04 12.78 50.69 Favored Glycine 0 C--O 1.22 -0.751 0 CA-C-N 119.361 1.581 . . . . 0.0 111.756 -175.067 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -114.33 149.45 36.01 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -176.119 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.419 HD13 ' OG1' ' A' ' 5' ' ' THR . 2.1 mm? -105.18 125.5 51.05 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 -172.169 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.658 ' CZ ' ' HB3' ' A' ' 106' ' ' ALA . 90.5 m-85 -120.27 106.96 12.41 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 124.509 1.124 . . . . 0.0 108.015 -174.076 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -54.19 116.28 2.52 Favored 'General case' 0 C--O 1.206 -1.187 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.724 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.482 ' HB2' ' CD1' ' A' ' 4' ' ' TRP . 6.3 tp-100 -54.79 -45.46 74.32 Favored 'General case' 0 C--O 1.196 -1.757 0 CA-C-O 116.429 -1.748 . . . . 0.0 111.993 178.881 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -51.0 -36.28 38.49 Favored 'General case' 0 C--O 1.189 -2.126 0 O-C-N 124.117 0.886 . . . . 0.0 110.242 175.843 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -75.59 -40.85 55.9 Favored 'General case' 0 C--O 1.197 -1.696 0 CA-C-N 121.765 2.075 . . . . 0.0 112.177 170.039 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.465 ' O ' HG11 ' A' ' 108' ' ' VAL . . . -52.1 -35.9 49.26 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 117.463 -3.273 . . . . 0.0 113.406 171.018 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.428 ' O ' ' CD2' ' A' ' 21' ' ' HIS . 0.9 OUTLIER -94.5 -38.43 10.91 Favored 'General case' 0 C--O 1.2 -1.506 0 CA-C-O 122.657 1.218 . . . . 0.0 108.009 178.275 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 26.1 t -73.22 -58.49 3.27 Favored 'General case' 0 C--O 1.201 -1.467 1 O-C-N 115.447 -4.533 . . . . 0.0 106.838 -177.306 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.525 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 1.3 t-20 -50.46 -27.92 7.37 Favored 'General case' 0 C--N 1.311 -1.076 0 O-C-N 117.733 -3.104 . . . . 0.0 113.391 173.167 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.519 ' HB3' HG11 ' A' ' 108' ' ' VAL . 24.0 p -86.98 -16.95 34.26 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 123.629 0.581 . . . . 0.0 112.527 175.191 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.428 ' CD2' ' O ' ' A' ' 17' ' ' GLU . 7.5 m170 -66.19 -39.5 89.73 Favored 'General case' 0 C--O 1.215 -0.719 0 C-N-CA 124.973 1.309 . . . . 0.0 107.881 179.773 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.525 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -75.47 -41.78 54.75 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 116.647 -1.644 . . . . 0.0 109.269 -178.519 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.883 ' HB1' ' HG3' ' A' ' 35' ' ' PRO . . . -40.31 130.07 1.7 Allowed Pre-proline 0 N--CA 1.443 -0.778 0 O-C-N 126.649 2.468 . . . . 0.0 111.943 177.764 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.458 ' HG2' ' CG2' ' A' ' 30' ' ' THR . 14.5 Cg_endo -72.73 115.02 4.18 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 122.103 1.868 . . . . 0.0 109.83 -176.133 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.6 HD13 ' HE2' ' A' ' 115' ' ' LYS . 2.5 tp -56.14 100.28 0.04 OUTLIER 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 123.272 0.629 . . . . 0.0 111.225 178.711 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -167.72 166.27 13.86 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.788 0.804 . . . . 0.0 109.453 -177.195 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.492 ' HB2' ' CE1' ' A' ' 79' ' ' TYR . 5.8 t0 -100.42 73.3 1.65 Allowed 'General case' 0 CA--C 1.548 0.87 0 CA-C-O 124.048 1.88 . . . . 0.0 107.104 179.014 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.58 86.03 0.57 Allowed Glycine 0 N--CA 1.448 -0.503 0 O-C-N 118.816 -2.427 . . . . 0.0 109.36 176.504 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.14 33.52 0.58 Allowed 'General case' 0 CA--C 1.514 -0.425 0 O-C-N 121.205 -1.174 . . . . 0.0 111.23 177.204 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.474 HG21 ' HD2' ' A' ' 35' ' ' PRO . 55.3 p -129.73 143.85 51.01 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -175.927 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -38.08 -67.79 0.48 Allowed Glycine 0 C--N 1.338 0.642 0 O-C-N 124.117 0.885 . . . . 0.0 112.979 -178.552 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . 0.461 ' HB3' ' HA ' ' A' ' 94' ' ' PHE . 32.2 t -51.86 -66.38 0.39 Allowed 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 115.744 -2.074 . . . . 0.0 110.554 174.328 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.2 p 167.44 -56.42 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.418 0 O-C-N 126.927 2.642 . . . . 0.0 111.256 179.895 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.528 ' CD1' ' HG3' ' A' ' 84' ' ' PRO . 32.3 m-85 -69.27 150.03 97.32 Favored Pre-proline 0 N--CA 1.429 -1.478 0 CA-C-O 116.494 -1.717 . . . . 0.0 112.708 178.995 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.883 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 37.5 Cg_endo -72.24 138.56 55.03 Favored 'Cis proline' 0 N--CA 1.442 -1.519 0 C-N-CA 121.281 -2.383 . . . . 0.0 112.264 -4.602 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -128.94 150.6 50.31 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-O 116.91 -1.519 . . . . 0.0 113.781 173.44 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.965 ' CH2' HG22 ' A' ' 39' ' ' THR . 19.1 t90 -44.42 151.85 0.23 Allowed 'General case' 0 C--O 1.237 0.428 0 CA-C-O 122.577 1.179 . . . . 0.0 110.872 176.305 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.522 ' CE1' ' HA ' ' A' ' 40' ' ' ASN . 3.0 t80 -127.87 79.64 1.91 Allowed 'General case' 0 N--CA 1.417 -2.089 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 -172.921 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.965 HG22 ' CH2' ' A' ' 37' ' ' TRP . 38.1 p -36.96 -39.51 0.23 Allowed 'General case' 0 C--O 1.205 -1.288 0 C-N-CA 125.388 1.475 . . . . 0.0 110.506 173.773 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.522 ' HA ' ' CE1' ' A' ' 38' ' ' PHE . 43.5 t30 59.14 17.42 5.58 Favored 'General case' 0 C--O 1.206 -1.211 0 CA-C-N 120.426 1.466 . . . . 0.0 107.39 173.154 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.492 ' C ' HD23 ' A' ' 48' ' ' LEU . . . 113.09 -45.84 1.26 Allowed Glycine 0 N--CA 1.428 -1.851 0 O-C-N 118.716 -2.49 . . . . 0.0 113.321 -170.639 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.57 ' N ' HD23 ' A' ' 48' ' ' LEU . 83.3 m-85 -45.21 153.61 0.2 Allowed 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.318 1.047 . . . . 0.0 111.942 178.097 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.09 -36.38 24.92 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.14 178.593 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 126.56 42.16 0.3 Allowed Glycine 0 C--N 1.341 0.819 0 C-N-CA 123.922 0.773 . . . . 0.0 111.299 -177.296 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -146.64 -69.64 0.25 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.294 179.707 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -146.43 -73.49 0.02 OUTLIER Glycine 0 C--O 1.195 -2.287 0 N-CA-C 107.591 -2.204 . . . . 0.0 107.591 -176.192 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.5 ptpt -100.96 -165.33 1.19 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 120.468 2.134 . . . . 0.0 110.35 178.638 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.713 ' H ' HD12 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -113.35 174.12 2.49 Favored Pre-proline 0 N--CA 1.438 -1.041 0 C-N-CA 123.623 0.769 . . . . 0.0 110.028 -178.93 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.27 156.91 46.22 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.362 2.041 . . . . 0.0 110.855 179.426 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.71 98.1 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.301 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.31 55.83 0.24 Allowed Glycine 0 CA--C 1.507 -0.442 0 CA-C-O 118.345 -1.253 . . . . 0.0 111.889 -178.318 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.418 ' HD2' ' HA2' ' A' ' 41' ' ' GLY . 1.3 mmt180 -149.79 143.07 25.15 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-N 117.671 0.735 . . . . 0.0 110.811 177.055 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.1 m -131.45 96.74 20.67 Favored Pre-proline 0 C--N 1.324 -0.531 0 O-C-N 124.318 1.011 . . . . 0.0 110.352 -178.628 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . 0.653 ' HG3' HD21 ' A' ' 48' ' ' LEU . 18.0 Cg_endo -72.36 173.23 13.44 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 122.022 1.814 . . . . 0.0 111.723 179.267 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.423 ' O ' ' CE1' ' A' ' 57' ' ' PHE . 8.4 mt -86.53 111.62 21.69 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.076 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 -176.348 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.23 137.49 36.66 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 120.617 -1.302 . . . . 0.0 108.703 178.922 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.491 ' CG ' ' SG ' ' A' ' 118' ' ' CYS . 3.0 m-85 -118.5 -52.79 2.35 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.628 -179.999 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 128.73 -9.95 6.39 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 123.48 0.562 . . . . 0.0 111.722 -176.74 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . 0.425 ' CB ' ' HB3' ' A' ' 62' ' ' CYS . 15.2 mmtt -69.08 170.57 9.71 Favored 'General case' 0 C--O 1.197 -1.692 0 CA-C-O 118.217 -0.897 . . . . 0.0 111.127 177.16 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.4 m -101.69 -47.54 4.59 Favored 'General case' 0 C--O 1.19 -2.027 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.596 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.29 -40.92 64.17 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-N 120.888 1.676 . . . . 0.0 108.974 178.698 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.488 ' SG ' ' CD1' ' A' ' 57' ' ' PHE . 11.0 t -71.84 -14.58 62.0 Favored 'General case' 0 C--N 1.348 0.533 0 O-C-N 123.468 0.48 . . . . 0.0 110.138 178.198 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -95.62 -32.75 12.65 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 174.693 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.94 168.36 0.43 Allowed Pre-proline 0 N--CA 1.429 -1.493 0 CA-C-O 122.349 1.071 . . . . 0.0 108.674 -177.635 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -72.71 124.7 9.94 Favored 'Trans proline' 0 N--CA 1.438 -1.768 0 C-N-CA 121.068 1.179 . . . . 0.0 115.13 172.123 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.419 ' HD2' ' CD1' ' A' ' 42' ' ' TYR . 18.6 Cg_endo -72.04 164.15 36.55 Favored 'Trans proline' 0 CA--C 1.502 -1.111 0 C-N-CA 123.595 2.863 . . . . 0.0 111.802 179.614 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 8.2 tptt -126.06 130.38 51.02 Favored 'General case' 0 C--O 1.205 -1.273 0 CA-C-O 117.329 -1.319 . . . . 0.0 108.382 178.951 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 41.4 t-80 -122.6 161.5 23.62 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 119.226 0.921 . . . . 0.0 110.214 174.612 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.6 179.08 8.92 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.2 179.223 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.8 mptt -84.82 69.18 10.69 Favored 'General case' 0 C--O 1.215 -0.757 0 O-C-N 121.828 -0.545 . . . . 0.0 111.422 177.146 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -176.94 -41.36 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.223 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.486 ' CA ' ' HB3' ' A' ' 27' ' ' ASP . . . 122.07 -63.9 0.51 Allowed Glycine 0 N--CA 1.442 -0.958 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -179.061 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . 0.408 ' ND2' ' N ' ' A' ' 73' ' ' ASN . 0.1 OUTLIER -133.98 56.74 1.83 Allowed 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 -173.06 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.96 -109.73 0.01 OUTLIER Glycine 0 C--O 1.215 -1.035 0 CA-C-O 121.998 0.777 . . . . 0.0 111.583 179.412 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 19.8 mttt -60.98 -98.82 0.0 OUTLIER 'General case' 0 C--O 1.214 -0.794 0 O-C-N 120.017 -1.872 . . . . 0.0 109.941 179.374 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.593 HG23 ' O ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -120.94 15.66 11.67 Favored 'General case' 0 CA--C 1.493 -1.226 0 O-C-N 119.331 -2.105 . . . . 0.0 110.611 -179.241 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.433 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 1.3 m-20 -24.3 95.56 0.01 OUTLIER 'General case' 0 C--O 1.197 -1.689 0 C-N-CA 126.768 2.027 . . . . 0.0 112.948 -176.615 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.5 ' CD2' ' H ' ' A' ' 78' ' ' HIS . 6.4 p80 -88.98 60.45 5.46 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 -167.929 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.578 ' HB2' ' CD1' ' A' ' 37' ' ' TRP . 52.0 p90 -91.11 136.78 32.85 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 124.672 1.189 . . . . 0.0 111.602 -178.446 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.669 HD23 ' O ' ' A' ' 110' ' ' TYR . 2.5 mt -67.31 128.88 38.06 Favored 'General case' 0 C--O 1.205 -1.281 0 CA-C-O 117.481 -1.247 . . . . 0.0 109.271 178.811 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.844 HD11 ' HB2' ' A' ' 35' ' ' PRO . 0.2 OUTLIER -121.28 135.03 55.17 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 121.025 1.739 . . . . 0.0 107.329 178.608 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.562 ' N ' HD12 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -101.56 166.09 10.89 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-O 123.168 1.461 . . . . 0.0 114.503 171.218 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.502 ' CD1' ' HD2' ' A' ' 84' ' ' PRO . 52.2 t80 -146.3 131.82 9.26 Favored Pre-proline 0 CA--C 1.498 -1.024 0 O-C-N 117.823 -3.048 . . . . 0.0 113.115 179.462 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.544 ' HA ' ' HG2' ' A' ' 107' ' ' ARG . 19.3 Cg_endo -72.98 106.18 2.1 Favored 'Trans proline' 0 CA--C 1.473 -2.554 0 C-N-CA 124.645 3.563 . . . . 0.0 110.583 -175.698 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.55 ' HA ' ' CZ ' ' A' ' 92' ' ' TYR . 0.6 OUTLIER -100.73 121.01 40.94 Favored 'General case' 0 CA--C 1.49 -1.332 0 O-C-N 125.613 1.82 . . . . 0.0 112.36 -179.306 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.597 ' CD1' ' CD1' ' A' ' 92' ' ' TYR . 13.8 m-85 -85.19 162.66 48.3 Favored Pre-proline 0 N--CA 1.44 -0.963 0 CA-C-N 120.475 1.489 . . . . 0.0 111.179 -179.423 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -77.77 -44.34 0.18 Allowed 'Trans proline' 0 CA--C 1.516 -0.386 0 C-N-CA 122.161 1.907 . . . . 0.0 112.431 179.605 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -48.62 -26.4 2.23 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 125.279 1.612 . . . . 0.0 110.913 174.446 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.92 17.64 80.2 Favored Glycine 0 N--CA 1.431 -1.676 0 CA-C-O 117.39 -1.783 . . . . 0.0 109.706 179.592 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.419 ' O ' ' CE1' ' A' ' 92' ' ' TYR . 1.0 OUTLIER -82.74 147.52 28.39 Favored 'General case' 0 C--O 1.182 -2.454 0 CA-C-O 116.929 -1.51 . . . . 0.0 110.359 -179.593 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -62.09 134.39 56.54 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 123.54 2.882 . . . . 0.0 111.831 176.173 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.597 ' CD1' ' CD1' ' A' ' 86' ' ' PHE . 0.2 OUTLIER -93.6 136.48 33.83 Favored 'General case' 0 C--O 1.202 -1.399 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 -173.21 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.39 61.24 0.47 Allowed 'General case' 0 C--N 1.318 -0.778 0 O-C-N 119.769 -1.832 . . . . 0.0 111.029 175.075 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.49 ' CD2' ' HZ ' ' A' ' 83' ' ' PHE . 1.5 p90 -74.95 -23.96 58.39 Favored 'General case' 0 N--CA 1.426 -1.651 0 C-N-CA 126.401 1.88 . . . . 0.0 109.581 179.749 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.56 -31.49 21.19 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 -178.844 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.9 t -82.38 104.74 12.9 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 -177.61 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 32.6 pttt -58.27 -50.71 72.63 Favored 'General case' 0 C--O 1.227 -0.126 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 179.241 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 99' ' ' PRO . 4.4 mttp -137.41 124.88 14.04 Favored Pre-proline 0 N--CA 1.438 -1.027 0 C-N-CA 124.787 1.235 . . . . 0.0 109.095 -173.719 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.425 ' HA ' ' HA ' ' A' ' 98' ' ' LYS . 23.3 Cg_endo -73.26 175.01 47.31 Favored 'Cis proline' 0 CA--C 1.54 0.822 0 O-C-N 124.934 2.018 . . . . 0.0 111.564 -2.913 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . 0.413 ' HD2' ' HA ' ' A' ' 32' ' ' SER . 9.6 tttp -137.6 117.5 13.26 Favored 'General case' 0 C--O 1.22 -0.467 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.152 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -72.54 154.3 40.88 Favored 'General case' 0 C--O 1.253 1.243 0 O-C-N 124.62 1.2 . . . . 0.0 110.32 176.918 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -48.43 124.55 11.73 Favored Pre-proline 0 N--CA 1.438 -1.07 0 C-N-CA 125.113 1.365 . . . . 0.0 112.105 172.758 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -70.3 -164.95 0.15 Allowed 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 122.691 2.261 . . . . 0.0 112.125 177.681 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -134.73 158.66 23.59 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.561 177.288 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -76.07 -61.76 0.03 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.72 2.28 . . . . 0.0 110.109 179.9 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.658 ' HB3' ' CZ ' ' A' ' 11' ' ' TYR . . . -58.78 133.34 55.88 Favored 'General case' 0 N--CA 1.432 -1.328 0 O-C-N 124.653 1.22 . . . . 0.0 111.938 178.015 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.544 ' HG2' ' HA ' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -141.23 146.9 37.46 Favored 'General case' 0 CA--C 1.496 -1.11 0 O-C-N 124.632 1.208 . . . . 0.0 111.817 -178.489 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.519 HG11 ' HB3' ' A' ' 20' ' ' SER . 7.7 p -80.5 126.1 39.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.423 0.63 . . . . 0.0 110.407 178.839 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.558 ' CG2' HD22 ' A' ' 80' ' ' LEU . 24.5 mm -100.28 147.24 7.86 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.229 0 O-C-N 121.227 -0.921 . . . . 0.0 110.361 179.008 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.669 ' O ' HD23 ' A' ' 80' ' ' LEU . 11.4 p90 -176.76 148.14 0.66 Allowed 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 124.408 2.052 . . . . 0.0 110.131 -177.624 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . 0.409 HG22 ' HA ' ' A' ' 62' ' ' CYS . 7.0 p -81.55 167.69 19.02 Favored 'General case' 0 C--N 1.311 -1.075 0 O-C-N 120.207 -1.558 . . . . 0.0 108.947 -177.612 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.464 ' CD1' ' C ' ' A' ' 112' ' ' TYR . 0.1 OUTLIER -116.2 152.56 47.99 Favored Pre-proline 0 N--CA 1.432 -1.34 0 C-N-CA 123.938 0.895 . . . . 0.0 109.892 179.875 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.467 ' O ' HD21 ' A' ' 25' ' ' LEU . 15.6 Cg_endo -72.7 -44.03 0.61 Allowed 'Cis proline' 0 CA--C 1.516 -0.413 0 C-N-CA 122.076 -2.052 . . . . 0.0 109.378 -9.213 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 43.4 m-20 -46.84 106.98 0.09 Allowed 'General case' 0 CA--C 1.49 -1.337 0 CA-C-O 113.631 -3.08 . . . . 0.0 109.816 -179.382 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.6 ' HE2' HD13 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -68.31 72.27 0.2 Allowed 'General case' 0 CA--C 1.501 -0.918 0 O-C-N 127.457 2.973 . . . . 0.0 107.03 -175.787 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.577 ' O ' HG12 ' A' ' 116' ' ' VAL . 14.6 t -74.08 70.16 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 -177.133 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.449 ' CZ ' ' NE2' ' A' ' 13' ' ' GLN . 54.6 t80 -37.17 100.8 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 126.064 1.746 . . . . 0.0 110.732 178.831 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . 0.491 ' SG ' ' CG ' ' A' ' 57' ' ' PHE . 0.1 OUTLIER -81.43 -39.53 24.76 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 -178.235 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 159.82 -146.86 13.36 Favored Glycine 0 N--CA 1.441 -1.02 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 -179.734 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.441 HG13 ' CG ' ' A' ' 4' ' ' TRP . 1.0 OUTLIER -129.61 149.0 33.22 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.672 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 -172.923 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . 0.518 ' CD1' ' CZ ' ' A' ' 38' ' ' PHE . 7.2 pt -138.23 154.69 28.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 120.304 1.411 . . . . 0.0 108.293 -178.177 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.731 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . . . . . . . . 0 C--N 1.32 -0.685 0 CA-C-O 122.338 1.066 . . . . 0.0 110.021 176.867 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 9.2 ptpt . . . . . 0 CA--C 1.511 -0.529 0 CA-C-O 117.448 -1.263 . . . . 0.0 110.608 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.481 HD12 HG22 ' A' ' 121' ' ' ILE . 12.2 tp -82.28 139.71 34.03 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.807 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 73.3 m -67.28 -172.83 0.24 Allowed 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 124.072 0.949 . . . . 0.0 109.363 176.833 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 61.1 m -162.05 114.33 1.72 Allowed 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 117.056 -1.449 . . . . 0.0 107.835 -179.624 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.65 ' CD2' HG13 ' A' ' 2' ' ' VAL . 2.4 m80 . . . . . 0 C--O 1.277 2.515 0 CA-C-O 113.525 -3.131 . . . . 0.0 113.22 176.206 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 2' ' ' VAL . . . . . 0.468 HG13 ' HB2' ' A' ' 136' ' ' HIS . 5.1 p . . . . . 0 C--O 1.24 0.565 0 CA-C-O 121.271 0.557 . . . . 0.0 110.188 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 3' ' ' THR . . . . . 0.478 HG21 ' HB3' ' A' ' 10' ' ' LEU . 3.2 m -94.51 121.34 35.95 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -174.581 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 4' ' ' TRP . . . . . 0.45 ' CG ' HG13 ' A' ' 120' ' ' ILE . 24.2 m95 -79.36 140.53 37.45 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.271 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 5' ' ' THR . . . . . 0.529 ' OG1' HD12 ' A' ' 10' ' ' LEU . 0.9 OUTLIER -128.56 134.48 48.64 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -178.079 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 6' ' ' CYS . . . . . 0.734 ' HB3' ' HB3' ' A' ' 122' ' ' ALA . 8.4 m -123.1 -71.46 0.72 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.689 178.868 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -86.27 32.26 3.9 Favored Glycine 0 C--O 1.221 -0.685 0 CA-C-O 119.773 -0.459 . . . . 0.0 111.996 176.906 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 82.53 -13.03 43.53 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-N 117.491 0.646 . . . . 0.0 112.854 -175.164 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 9' ' ' LEU . . . . . 0.424 HD13 ' OH ' ' A' ' 11' ' ' TYR . 0.2 OUTLIER -87.66 139.99 29.97 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -177.685 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 10' ' ' LEU . . . . . 0.529 HD12 ' OG1' ' A' ' 5' ' ' THR . 5.0 mp -86.22 135.09 33.7 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 124.032 0.832 . . . . 0.0 109.455 -178.589 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 11' ' ' TYR . . . . . 0.533 ' CE2' ' CB ' ' A' ' 106' ' ' ALA . 60.4 m-85 -124.06 105.84 9.88 Favored 'General case' 0 CA--C 1.506 -0.717 0 C-N-CA 125.539 1.536 . . . . 0.0 109.554 -175.14 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.79 112.97 1.46 Allowed 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -179.328 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 13' ' ' GLN . . . . . 0.455 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 6.1 tp-100 -51.2 -48.68 61.94 Favored 'General case' 0 C--O 1.214 -0.792 0 C-N-CA 119.586 -0.846 . . . . 0.0 111.91 -179.024 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -49.2 -39.8 31.09 Favored 'General case' 0 C--O 1.197 -1.669 0 O-C-N 124.162 0.913 . . . . 0.0 111.263 176.862 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -71.59 -38.89 70.84 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-N 118.755 0.707 . . . . 0.0 112.904 171.217 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 16' ' ' ALA . . . . . 0.486 ' O ' HG11 ' A' ' 108' ' ' VAL . . . -53.67 -39.14 64.85 Favored 'General case' 0 C--O 1.215 -0.741 0 CA-C-N 119.87 1.213 . . . . 0.0 111.99 173.409 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 17' ' ' GLU . . . . . 0.456 ' O ' ' CD2' ' A' ' 21' ' ' HIS . 6.0 pt-20 -90.38 -38.78 13.09 Favored 'General case' 0 C--O 1.221 -0.431 0 C-N-CA 123.802 0.841 . . . . 0.0 110.809 176.228 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.7 t -75.05 -60.12 2.43 Favored 'General case' 0 CA--C 1.506 -0.747 0 O-C-N 119.716 -1.865 . . . . 0.0 109.557 -176.508 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 19' ' ' ASN . . . . . 0.535 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -48.39 -29.45 4.02 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 171.062 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 20' ' ' SER . . . . . 0.558 ' HB3' HG11 ' A' ' 108' ' ' VAL . 31.7 p -85.19 -24.66 27.8 Favored 'General case' 0 C--O 1.221 -0.432 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 175.413 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 21' ' ' HIS . . . . . 0.456 ' CD2' ' O ' ' A' ' 17' ' ' GLU . 10.2 m170 -57.13 -35.97 70.12 Favored 'General case' 0 C--O 1.222 -0.351 0 C-N-CA 124.156 0.982 . . . . 0.0 109.217 178.061 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 22' ' ' HIS . . . . . 0.535 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.1 OUTLIER -71.69 -42.13 67.8 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 118.566 -0.731 . . . . 0.0 110.138 179.901 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 23' ' ' ALA . . . . . 0.796 ' HB1' ' HG3' ' A' ' 35' ' ' PRO . . . -39.99 133.77 1.43 Allowed Pre-proline 0 N--CA 1.443 -0.793 0 O-C-N 125.189 1.555 . . . . 0.0 111.124 176.505 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 24' ' ' PRO . . . . . 0.732 ' HG2' HG22 ' A' ' 30' ' ' THR . 19.5 Cg_endo -72.61 119.36 6.06 Favored 'Trans proline' 0 N--CA 1.443 -1.442 0 C-N-CA 122.1 1.867 . . . . 0.0 108.55 -177.8 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 25' ' ' LEU . . . . . 0.526 HD22 ' HE2' ' A' ' 115' ' ' LYS . 3.4 tp -60.58 84.19 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.284 1.033 . . . . 0.0 111.266 177.885 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.4 m -165.89 147.24 6.94 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.291 -174.682 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 27' ' ' ASP . . . . . 0.48 ' HB3' ' CA ' ' A' ' 72' ' ' GLY . 2.7 t0 -78.89 85.66 4.84 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 -178.843 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.68 86.31 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 177.812 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.2 mmtt -150.49 44.68 0.86 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.934 0.873 . . . . 0.0 111.615 178.749 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 30' ' ' THR . . . . . 0.732 HG22 ' HG2' ' A' ' 24' ' ' PRO . 12.2 p -130.64 -170.77 2.41 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.55 -174.695 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 31' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 95' ' ' ASP . . . -83.82 -55.23 2.86 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.706 177.446 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -76.05 9.56 2.4 Favored 'General case' 0 CA--C 1.514 -0.415 0 O-C-N 122.136 -0.626 . . . . 0.0 112.336 177.854 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.1 p 89.83 -58.45 0.02 OUTLIER 'General case' 0 CA--C 1.503 -0.855 0 C-N-CA 127.17 2.188 . . . . 0.0 109.258 -179.782 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 34' ' ' TYR . . . . . 0.491 ' CG ' ' HG3' ' A' ' 84' ' ' PRO . 85.9 m-85 -59.38 142.82 86.38 Favored Pre-proline 0 N--CA 1.437 -1.08 0 O-C-N 125.826 1.953 . . . . 0.0 112.768 -176.914 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 35' ' ' PRO . . . . . 0.796 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 36.0 Cg_endo -76.48 -172.69 11.47 Favored 'Cis proline' 0 N--CA 1.438 -1.764 0 C-N-CA 122.66 -1.808 . . . . 0.0 111.521 0.577 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 36' ' ' HIS . . . . . 0.429 ' CD2' ' N ' ' A' ' 36' ' ' HIS . 0.3 OUTLIER -159.62 159.75 33.5 Favored 'General case' 0 CA--C 1.502 -0.886 0 O-C-N 120.774 -1.204 . . . . 0.0 110.101 -178.68 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 37' ' ' TRP . . . . . 0.599 ' CD1' ' HB2' ' A' ' 79' ' ' TYR . 10.3 t90 -69.6 134.35 48.67 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-O 122.796 1.284 . . . . 0.0 110.044 175.458 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 38' ' ' PHE . . . . . 0.444 ' CZ ' ' HA ' ' A' ' 40' ' ' ASN . 14.0 t80 -97.63 97.59 9.16 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 178.939 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 39' ' ' THR . . . . . 0.438 ' HA ' ' CZ2' ' A' ' 37' ' ' TRP . 77.4 p -36.14 -35.18 0.07 Allowed 'General case' 0 C--O 1.208 -1.124 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.873 173.489 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 40' ' ' ASN . . . . . 0.444 ' HA ' ' CZ ' ' A' ' 38' ' ' PHE . 4.1 t-20 65.97 11.65 7.87 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 123.926 0.89 . . . . 0.0 110.631 179.717 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 41' ' ' GLY . . . . . 0.487 ' HA3' HD23 ' A' ' 48' ' ' LEU . . . 97.7 4.08 58.12 Favored Glycine 0 CA--C 1.536 1.384 0 N-CA-C 114.364 0.506 . . . . 0.0 114.364 -169.939 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 42' ' ' TYR . . . . . 0.708 ' CE1' HD11 ' A' ' 48' ' ' LEU . 2.6 m-85 -99.0 165.61 11.67 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 124.103 0.961 . . . . 0.0 109.339 -177.456 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.3 -34.88 25.62 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.625 176.911 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 44' ' ' GLY . . . . . 0.526 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . 173.24 -62.3 0.13 Allowed Glycine 0 C--N 1.335 0.489 0 C-N-CA 124.008 0.813 . . . . 0.0 112.06 -178.285 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -111.42 -61.81 1.64 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 122.607 1.194 . . . . 0.0 110.356 179.671 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.16 161.12 6.91 Favored Glycine 0 C--N 1.34 0.797 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.228 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 47' ' ' LYS . . . . . 0.568 ' HA ' ' CD2' ' A' ' 42' ' ' TYR . 8.5 ptpt -56.98 -163.14 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 122.998 1.38 . . . . 0.0 112.033 175.732 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 48' ' ' LEU . . . . . 0.708 HD11 ' CE1' ' A' ' 42' ' ' TYR . 4.0 mp -81.35 155.25 71.87 Favored Pre-proline 0 N--CA 1.44 -0.931 0 O-C-N 121.068 -1.02 . . . . 0.0 111.041 178.107 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -71.2 159.4 52.14 Favored 'Trans proline' 0 N--CA 1.444 -1.394 0 C-N-CA 121.947 1.765 . . . . 0.0 110.266 178.45 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -53.11 97.77 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.263 0.625 . . . . 0.0 110.083 177.274 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.26 79.19 0.95 Allowed Glycine 0 CA--C 1.517 0.191 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.184 -176.146 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 52' ' ' ARG . . . . . 0.472 ' HD3' ' CA ' ' A' ' 41' ' ' GLY . 0.0 OUTLIER -174.83 157.31 2.42 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 123.891 0.876 . . . . 0.0 110.733 175.547 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.2 m -141.47 108.76 6.15 Favored Pre-proline 0 C--N 1.328 -0.347 0 O-C-N 123.972 0.795 . . . . 0.0 109.829 -179.91 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -72.53 179.12 5.43 Favored 'Trans proline' 0 N--CA 1.447 -1.226 0 C-N-CA 122.479 2.119 . . . . 0.0 111.619 177.338 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 55' ' ' ILE . . . . . 0.409 ' CG2' ' HB2' ' A' ' 133' ' ' LEU . 5.2 mt -90.16 124.76 42.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.788 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.18 134.65 35.66 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.675 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 57' ' ' PHE . . . . . 0.521 ' CD1' ' HB3' ' A' ' 118' ' ' CYS . 40.1 m-85 -114.33 -47.83 2.91 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 123.494 0.718 . . . . 0.0 110.642 179.43 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 121.66 -1.81 11.12 Favored Glycine 0 C--O 1.223 -0.54 0 C-N-CA 123.767 0.698 . . . . 0.0 112.514 -176.36 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.5 mttm -103.24 145.53 29.8 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 117.74 0.77 . . . . 0.0 109.588 177.537 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 30.4 t -79.13 -9.16 59.48 Favored 'General case' 0 C--O 1.222 -0.374 0 O-C-N 124.794 1.309 . . . . 0.0 111.309 176.784 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -89.04 -48.99 7.03 Favored 'General case' 0 CA--C 1.515 -0.375 0 C-N-CA 123.788 0.835 . . . . 0.0 109.797 179.995 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 62' ' ' CYS . . . . . 0.7 ' SG ' HD21 ' A' ' 80' ' ' LEU . 1.4 t -72.91 -17.04 61.54 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 123.739 0.649 . . . . 0.0 111.814 175.871 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -86.43 -33.13 20.52 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-O 122.009 0.909 . . . . 0.0 111.295 174.422 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 64' ' ' ARG . . . . . 0.511 ' HD3' ' CE1' ' A' ' 78' ' ' HIS . 0.0 OUTLIER -57.27 158.99 9.09 Favored Pre-proline 0 N--CA 1.445 -0.691 0 O-C-N 121.369 -0.832 . . . . 0.0 111.343 179.492 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -71.14 140.09 36.86 Favored 'Trans proline' 0 N--CA 1.442 -1.5 0 C-N-CA 120.763 0.975 . . . . 0.0 113.74 174.365 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 66' ' ' PRO . . . . . 0.529 ' HD2' ' CD2' ' A' ' 42' ' ' TYR . 22.8 Cg_endo -70.77 169.88 19.13 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 123.482 2.788 . . . . 0.0 112.238 177.058 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -133.37 49.95 2.26 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 179.224 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 68' ' ' HIS . . . . . 0.483 ' HA ' ' OD2' ' A' ' 77' ' ' ASP . 25.1 t-80 -73.92 156.97 37.09 Favored 'General case' 0 C--O 1.22 -0.459 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.588 -177.536 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 69' ' ' SER . . . . . 0.443 ' O ' ' CE1' ' A' ' 68' ' ' HIS . 1.5 p -148.22 -160.05 1.12 Allowed 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 122.287 1.041 . . . . 0.0 111.3 177.169 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.59 75.64 9.49 Favored 'General case' 0 C--O 1.217 -0.625 0 O-C-N 120.259 -1.526 . . . . 0.0 111.722 172.148 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -177.22 -44.59 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.271 0.628 . . . . 0.0 109.958 177.6 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 72' ' ' GLY . . . . . 0.48 ' CA ' ' HB3' ' A' ' 27' ' ' ASP . . . 109.17 -54.46 0.55 Allowed Glycine 0 C--O 1.212 -1.239 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.912 -178.458 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -133.87 65.65 1.57 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 -179.574 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.44 -126.63 0.01 OUTLIER Glycine 0 CA--C 1.525 0.718 0 CA-C-O 121.94 0.745 . . . . 0.0 111.492 179.447 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.8 mttt -58.2 -92.66 0.0 OUTLIER 'General case' 0 C--O 1.221 -0.444 0 O-C-N 120.738 -1.448 . . . . 0.0 112.311 178.132 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 76' ' ' THR . . . . . 0.529 HG23 ' O ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -115.86 15.99 16.27 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-O 118.307 -0.854 . . . . 0.0 110.427 177.473 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 77' ' ' ASP . . . . . 0.505 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 20.1 t0 -29.11 102.06 0.02 OUTLIER 'General case' 0 C--O 1.212 -0.897 0 O-C-N 123.979 0.799 . . . . 0.0 110.99 -179.566 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 78' ' ' HIS . . . . . 0.511 ' CE1' ' HD3' ' A' ' 64' ' ' ARG . 5.7 p80 -87.55 64.18 7.98 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -176.016 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 79' ' ' TYR . . . . . 0.599 ' HB2' ' CD1' ' A' ' 37' ' ' TRP . 34.4 p90 -90.29 136.56 32.98 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 124.242 1.017 . . . . 0.0 109.527 -178.128 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 80' ' ' LEU . . . . . 0.7 HD21 ' SG ' ' A' ' 62' ' ' CYS . 0.3 OUTLIER -74.44 142.51 44.92 Favored 'General case' 0 C--O 1.216 -0.697 0 C-N-CA 119.758 -0.777 . . . . 0.0 109.225 176.22 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 81' ' ' LEU . . . . . 0.668 HD21 ' HB2' ' A' ' 35' ' ' PRO . 1.1 tt -134.66 144.07 47.62 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 176.338 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 82' ' ' GLU . . . . . 0.508 ' HB2' HD11 ' A' ' 109' ' ' ILE . 6.1 pm0 -109.35 165.62 11.49 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 123.547 0.739 . . . . 0.0 111.429 -179.694 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 83' ' ' PHE . . . . . 0.605 ' HB3' HG12 ' A' ' 108' ' ' VAL . 36.7 t80 -148.93 135.23 10.12 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 117.795 -1.098 . . . . 0.0 112.444 -179.186 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 84' ' ' PRO . . . . . 0.565 ' HA ' ' HG2' ' A' ' 107' ' ' ARG . 19.1 Cg_endo -70.73 88.67 0.64 Allowed 'Trans proline' 0 CA--C 1.501 -1.152 0 C-N-CA 124.513 3.475 . . . . 0.0 110.679 -176.015 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 85' ' ' THR . . . . . 0.622 HG22 ' HA ' ' A' ' 107' ' ' ARG . 1.2 t -86.71 115.92 24.47 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 124.411 1.07 . . . . 0.0 111.958 179.741 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 86' ' ' PHE . . . . . 0.617 ' CD1' ' CD1' ' A' ' 92' ' ' TYR . 18.2 m-85 -83.67 160.42 58.78 Favored Pre-proline 0 N--CA 1.45 -0.473 0 C-N-CA 123.193 0.597 . . . . 0.0 111.525 -179.877 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.05 -44.54 0.33 Allowed 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 122.189 1.926 . . . . 0.0 111.748 179.041 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -52.21 -28.38 18.22 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 122.992 1.377 . . . . 0.0 110.031 177.89 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.1 -14.14 40.53 Favored Glycine 0 N--CA 1.438 -1.227 0 CA-C-O 118.23 -1.317 . . . . 0.0 111.809 -179.023 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 90' ' ' HIS . . . . . 0.425 ' O ' ' CE1' ' A' ' 92' ' ' TYR . 1.6 p-80 -48.69 143.22 5.36 Favored 'General case' 0 C--O 1.213 -0.838 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.425 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -63.64 137.66 58.18 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.793 0.806 . . . . 0.0 111.736 177.32 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 92' ' ' TYR . . . . . 0.617 ' CD1' ' CD1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -94.86 148.5 22.24 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 -174.876 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -84.4 68.62 10.31 Favored 'General case' 0 C--N 1.321 -0.649 0 O-C-N 121.272 -0.893 . . . . 0.0 109.564 176.079 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 94' ' ' PHE . . . . . 0.422 ' CD2' ' O ' ' A' ' 92' ' ' TYR . 30.7 p90 -83.4 -16.15 46.99 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.583 177.465 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 95' ' ' ASP . . . . . 0.403 ' O ' ' HA3' ' A' ' 31' ' ' GLY . 0.4 OUTLIER -89.8 -30.87 17.68 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 123.82 0.848 . . . . 0.0 110.448 178.55 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.0 t -90.91 110.29 21.52 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -177.014 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.52 -46.1 91.38 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-O 120.958 0.409 . . . . 0.0 110.347 179.723 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 98' ' ' LYS . . . . . 0.427 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 6.6 mttm -141.07 128.46 11.98 Favored Pre-proline 0 N--CA 1.438 -1.04 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.962 -178.251 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 99' ' ' PRO . . . . . 0.427 ' C ' ' HA ' ' A' ' 98' ' ' LYS . 20.0 Cg_endo -70.05 176.86 31.71 Favored 'Cis proline' 0 N--CA 1.458 -0.602 0 O-C-N 124.579 1.831 . . . . 0.0 111.472 -3.802 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.03 152.34 48.76 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 123.515 0.726 . . . . 0.0 109.891 177.731 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -104.13 146.37 28.84 Favored 'General case' 0 C--N 1.321 -0.656 0 O-C-N 124.327 1.017 . . . . 0.0 108.767 -179.875 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -56.23 120.26 33.64 Favored Pre-proline 0 N--CA 1.445 -0.706 0 CA-C-O 118.095 -0.955 . . . . 0.0 110.792 177.353 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -71.6 -163.22 0.13 Allowed 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 122.723 2.282 . . . . 0.0 111.753 178.303 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -142.5 172.29 24.38 Favored Glycine 0 CA--C 1.524 0.645 0 O-C-N 121.414 -0.804 . . . . 0.0 112.113 177.187 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 105' ' ' PRO . . . . . 0.569 ' HB2' ' HB1' ' A' ' 122' ' ' ALA . 18.7 Cg_endo -74.03 -50.88 0.15 Allowed 'Trans proline' 0 N--CA 1.447 -1.26 0 C-N-CA 122.112 1.875 . . . . 0.0 110.542 178.925 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 106' ' ' ALA . . . . . 0.604 ' HA ' ' HB2' ' A' ' 122' ' ' ALA . . . -61.24 135.74 57.83 Favored 'General case' 0 CA--C 1.507 -0.704 0 O-C-N 123.645 0.591 . . . . 0.0 109.892 -179.155 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 107' ' ' ARG . . . . . 0.622 ' HA ' HG22 ' A' ' 85' ' ' THR . 9.4 mtm-85 -151.39 148.1 27.71 Favored 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 124.224 0.952 . . . . 0.0 110.456 -179.085 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 108' ' ' VAL . . . . . 0.605 HG12 ' HB3' ' A' ' 83' ' ' PHE . 12.8 p -87.99 116.01 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 O-C-N 124.354 1.034 . . . . 0.0 111.525 178.584 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 109' ' ' ILE . . . . . 0.655 ' CG2' HD22 ' A' ' 80' ' ' LEU . 1.4 mp -107.39 122.05 61.08 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.885 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 -173.09 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 110' ' ' TYR . . . . . 0.465 ' CZ ' HD22 ' A' ' 81' ' ' LEU . 6.3 p90 -141.46 151.73 43.62 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 121.836 0.827 . . . . 0.0 109.711 -179.388 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.3 p -80.64 163.23 23.78 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.639 178.421 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 112' ' ' TYR . . . . . 0.524 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -111.9 154.73 44.04 Favored Pre-proline 0 CA--C 1.546 0.808 0 O-C-N 123.353 0.408 . . . . 0.0 110.893 178.86 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 113' ' ' PRO . . . . . 0.524 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 19.0 Cg_endo -74.16 -51.08 0.16 OUTLIER 'Cis proline' 0 CA--C 1.502 -1.094 0 C-N-CA 123.533 -1.444 . . . . 0.0 110.529 -5.956 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 114' ' ' ASN . . . . . 0.541 ' O ' HG23 ' A' ' 116' ' ' VAL . 43.8 t-20 -45.23 109.96 0.21 Allowed 'General case' 0 C--O 1.219 -0.549 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.971 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 115' ' ' LYS . . . . . 0.526 ' HE2' HD22 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -66.39 76.63 0.1 Allowed 'General case' 0 CA--C 1.512 -0.497 0 C-N-CA 123.675 0.79 . . . . 0.0 109.016 179.547 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild core ' A' A ' 116' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 114' ' ' ASN . 57.3 t -74.84 72.51 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 -176.188 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 117' ' ' PHE . . . . . 0.455 ' CZ ' ' NE2' ' A' ' 13' ' ' GLN . 59.8 t80 -34.02 104.95 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 126.752 2.021 . . . . 0.0 109.22 -178.378 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 118' ' ' CYS . . . . . 0.521 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 14.6 m -84.84 -44.81 12.9 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -177.683 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 158.89 -151.03 21.94 Favored Glycine 0 N--CA 1.441 -1.02 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 179.657 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 120' ' ' ILE . . . . . 0.45 HG13 ' CG ' ' A' ' 4' ' ' TRP . 1.1 mm -127.44 133.14 68.51 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.806 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 -176.45 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 121' ' ' ILE . . . . . . . . . . . . . 6.4 pt -119.72 155.14 22.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -177.327 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 122' ' ' ALA . . . . . 0.734 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . . . . . . . . 0 C--N 1.323 -0.545 0 CA-C-O 120.817 0.342 . . . . 0.0 110.249 178.635 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 CA--C 1.514 -0.42 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 . . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 133' ' ' LEU . . . . . 0.409 ' HB2' ' CG2' ' A' ' 55' ' ' ILE . 14.9 tp -85.62 140.64 30.41 Favored 'General case' 0 C--O 1.244 0.765 0 O-C-N 123.886 0.741 . . . . 0.0 109.375 177.633 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild core ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 60.8 m -68.71 -178.47 1.18 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.786 175.954 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 73.6 m -148.62 100.27 3.09 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 -178.787 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild core ' A' A ' 136' ' ' HIS . . . . . 0.468 ' HB2' HG13 ' A' ' 2' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--O 1.248 0.981 0 CA-C-O 117.892 -1.051 . . . . 0.0 113.268 173.312 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.466 0.346 0 CA-C-O 117.578 -1.201 . . . . 0.0 110.465 . . . . . . . . . 0 0 . 1 . 001 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.9 OUTLIER -43.63 156.54 0.06 OUTLIER 'Isoleucine or valine' 0 C--N 1.349 0.549 0 C-N-CA 125.347 1.459 . . . . 0.0 110.708 174.247 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 91.4 m -83.96 111.22 19.06 Favored 'General case' 0 C--N 1.31 -1.119 0 O-C-N 121.742 -0.599 . . . . 0.0 111.046 177.736 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.62 ' CZ2' ' CD2' ' A' ' 136' ' ' HIS . 16.9 m95 -79.7 142.44 35.48 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 109.292 -0.633 . . . . 0.0 109.292 177.983 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -138.51 141.09 39.38 Favored 'General case' 0 CA--C 1.498 -1.046 0 O-C-N 121.068 -1.02 . . . . 0.0 108.429 -178.588 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.635 ' SG ' ' HB3' ' A' ' 122' ' ' ALA . 0.5 OUTLIER -122.81 61.08 1.01 Allowed 'General case' 0 C--N 1.324 -0.541 0 CA-C-O 118.612 -0.708 . . . . 0.0 110.502 177.54 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 39.0 78.69 0.05 OUTLIER Glycine 0 CA--C 1.532 1.114 0 O-C-N 124.207 0.942 . . . . 0.0 113.031 -177.828 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 161.01 -75.59 0.19 Allowed Glycine 0 C--O 1.224 -0.482 0 N-CA-C 111.189 -0.765 . . . . 0.0 111.189 -177.439 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 3.2 mt -128.33 163.2 25.32 Favored 'General case' 0 C--O 1.236 0.36 0 CA-C-O 121.593 0.711 . . . . 0.0 110.609 177.15 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.62 HD22 ' H ' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -88.58 170.34 10.94 Favored 'General case' 0 N--CA 1.45 -0.452 0 CA-C-N 114.927 -1.033 . . . . 0.0 108.978 -177.202 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.798 ' CZ ' ' HB3' ' A' ' 106' ' ' ALA . 70.6 m-85 -160.99 85.94 0.69 Allowed 'General case' 0 N--CA 1.445 -0.687 0 CA-C-O 122.278 1.037 . . . . 0.0 108.378 -171.254 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 2.1 t-20 -54.11 122.98 11.34 Favored 'General case' 0 C--O 1.213 -0.864 0 CA-C-O 115.715 -2.088 . . . . 0.0 108.457 179.682 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.486 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 0.7 OUTLIER -46.49 -40.47 12.54 Favored 'General case' 0 C--O 1.222 -0.39 0 CA-C-N 120.161 1.346 . . . . 0.0 112.543 175.716 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -57.75 -47.35 82.73 Favored 'General case' 0 C--O 1.199 -1.576 0 CA-C-O 118.573 -0.727 . . . . 0.0 111.093 176.195 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.423 ' CE ' ' HA3' ' A' ' 89' ' ' GLY . 6.3 mttt -70.52 -39.78 73.86 Favored 'General case' 0 C--O 1.203 -1.363 0 CA-C-N 120.912 1.687 . . . . 0.0 112.185 171.877 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.589 ' HA ' HG21 ' A' ' 85' ' ' THR . . . -52.58 -41.01 63.23 Favored 'General case' 0 C--N 1.316 -0.882 0 CA-C-N 121.55 1.977 . . . . 0.0 110.855 175.937 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -87.06 -47.0 9.28 Favored 'General case' 0 N--CA 1.44 -0.931 0 CA-C-O 117.393 -1.289 . . . . 0.0 109.64 177.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 39.3 t -67.49 -54.18 22.31 Favored 'General case' 0 CA--C 1.496 -1.108 0 C-N-CA 127.311 2.244 . . . . 0.0 107.597 -171.499 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.519 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 5.9 t-20 -42.32 -36.46 1.26 Allowed 'General case' 0 N--CA 1.448 -0.548 0 CA-C-N 119.862 1.21 . . . . 0.0 113.514 169.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.422 ' O ' ' HB3' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -82.78 -33.97 27.19 Favored 'General case' 0 C--O 1.212 -0.906 0 N-CA-C 115.031 1.493 . . . . 0.0 115.031 172.813 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 14.9 m170 -44.96 -35.69 3.01 Favored 'General case' 0 C--O 1.223 -0.297 0 C-N-CA 126.516 1.926 . . . . 0.0 110.33 177.476 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.519 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -74.3 -48.84 25.88 Favored 'General case' 0 N--CA 1.435 -1.184 0 CA-C-O 117.089 -1.434 . . . . 0.0 112.385 175.224 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.547 ' HB2' ' CE1' ' A' ' 83' ' ' PHE . . . -35.41 128.78 0.56 Allowed Pre-proline 0 CA--C 1.542 0.647 0 O-C-N 125.568 1.792 . . . . 0.0 112.51 172.569 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.759 ' HG2' HG22 ' A' ' 30' ' ' THR . 14.9 Cg_endo -73.98 123.04 8.1 Favored 'Trans proline' 0 N--CA 1.448 -1.189 0 C-N-CA 122.14 1.893 . . . . 0.0 108.661 -176.062 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.521 HD22 ' HE2' ' A' ' 115' ' ' LYS . 3.4 tp -59.47 102.86 0.16 Allowed 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.102 178.654 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 178.93 151.3 0.31 Allowed 'General case' 0 C--O 1.214 -0.795 0 CA-C-O 119.014 -0.517 . . . . 0.0 110.883 -176.674 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.48 ' HB3' ' CA ' ' A' ' 72' ' ' GLY . 0.9 OUTLIER -81.93 89.8 6.4 Favored 'General case' 0 C--N 1.322 -0.599 0 CA-C-N 119.263 0.938 . . . . 0.0 109.571 -179.422 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 60.31 82.08 0.07 OUTLIER Glycine 0 C--O 1.226 -0.401 0 CA-C-O 121.617 0.565 . . . . 0.0 111.7 178.379 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.3 mttt -150.06 45.76 0.91 Allowed 'General case' 0 CA--C 1.511 -0.546 0 CA-C-O 122.521 1.153 . . . . 0.0 111.315 179.364 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.759 HG22 ' HG2' ' A' ' 24' ' ' PRO . 70.5 p -128.41 152.56 48.06 Favored 'General case' 0 CA--C 1.497 -1.076 0 N-CA-C 108.26 -1.015 . . . . 0.0 108.26 -175.251 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -42.77 -52.19 5.59 Favored Glycine 0 C--N 1.332 0.346 0 O-C-N 124.556 1.16 . . . . 0.0 112.139 -177.728 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.3 t -68.48 -77.98 0.07 Allowed 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 117.659 -1.162 . . . . 0.0 111.251 172.939 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 71.0 p -178.07 -61.73 0.01 OUTLIER 'General case' 0 C--O 1.218 -0.603 0 O-C-N 124.846 1.341 . . . . 0.0 110.888 -177.042 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 98.6 m-85 -62.66 146.87 93.86 Favored Pre-proline 0 N--CA 1.428 -1.555 0 O-C-N 125.432 1.707 . . . . 0.0 112.714 -179.638 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.599 ' HB2' HD21 ' A' ' 81' ' ' LEU . 29.3 Cg_endo -78.19 -179.39 26.88 Favored 'Cis proline' 0 N--CA 1.439 -1.731 0 C-N-CA 121.856 -2.143 . . . . 0.0 111.785 1.452 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.411 ' CD2' ' N ' ' A' ' 36' ' ' HIS . 0.2 OUTLIER -152.69 164.1 38.39 Favored 'General case' 0 C--O 1.209 -1.063 0 O-C-N 118.913 -2.367 . . . . 0.0 111.251 -177.27 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.986 ' CH2' HG22 ' A' ' 39' ' ' THR . 20.3 t90 -69.96 140.93 53.08 Favored 'General case' 0 C--N 1.314 -0.955 0 CA-C-N 119.821 1.191 . . . . 0.0 108.422 176.826 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.463 ' CZ ' ' HA ' ' A' ' 40' ' ' ASN . 11.3 t80 -117.79 86.64 2.56 Favored 'General case' 0 N--CA 1.428 -1.568 0 N-CA-C 105.467 -2.049 . . . . 0.0 105.467 -177.766 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.986 HG22 ' CH2' ' A' ' 37' ' ' TRP . 70.4 p -38.91 -36.58 0.29 Allowed 'General case' 0 C--O 1.211 -0.965 0 C-N-CA 124.853 1.261 . . . . 0.0 111.185 175.007 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.463 ' HA ' ' CZ ' ' A' ' 38' ' ' PHE . 61.7 t30 73.49 4.94 4.91 Favored 'General case' 0 C--O 1.219 -0.52 0 C-N-CA 126.329 1.852 . . . . 0.0 109.36 176.815 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.441 ' CA ' ' HD3' ' A' ' 52' ' ' ARG . . . 120.04 -9.74 11.18 Favored Glycine 0 N--CA 1.427 -1.918 0 C-N-CA 125.221 1.391 . . . . 0.0 114.059 -172.553 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.592 ' CE1' HD11 ' A' ' 48' ' ' LEU . 17.3 m-85 -77.36 172.04 13.93 Favored 'General case' 0 N--CA 1.448 -0.528 0 C-N-CA 124.012 0.925 . . . . 0.0 110.489 -179.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -91.04 -39.12 12.38 Favored 'General case' 0 C--N 1.324 -0.54 0 CA-C-N 115.977 -0.556 . . . . 0.0 110.87 176.382 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.583 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . 174.27 -42.46 0.14 Allowed Glycine 0 C--N 1.334 0.439 0 C-N-CA 124.449 1.023 . . . . 0.0 112.73 -177.996 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -133.27 -63.87 0.75 Allowed 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.519 0.676 . . . . 0.0 109.736 179.703 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.7 154.54 17.19 Favored Glycine 0 C--N 1.341 0.825 0 N-CA-C 109.779 -1.328 . . . . 0.0 109.779 179.958 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.589 ' HA ' ' CE2' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -53.16 174.8 0.04 OUTLIER 'General case' 0 CA--C 1.532 0.275 0 CA-C-O 121.839 0.828 . . . . 0.0 112.775 175.721 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.592 HD11 ' CE1' ' A' ' 42' ' ' TYR . 5.6 mp -57.27 149.97 44.86 Favored Pre-proline 0 N--CA 1.445 -0.686 0 O-C-N 121.697 -0.627 . . . . 0.0 111.431 177.888 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -72.47 159.07 50.0 Favored 'Trans proline' 0 N--CA 1.45 -1.074 0 C-N-CA 122.03 1.82 . . . . 0.0 109.474 -179.011 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 6.7 ttpt -54.65 97.76 0.02 OUTLIER 'General case' 0 CA--C 1.538 0.509 0 C-N-CA 123.147 0.579 . . . . 0.0 110.246 177.36 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.42 74.44 0.69 Allowed Glycine 0 N--CA 1.452 -0.26 0 CA-C-O 119.02 -0.878 . . . . 0.0 112.831 -175.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.441 ' HD3' ' CA ' ' A' ' 41' ' ' GLY . 7.1 ttm180 -173.69 164.28 4.37 Favored 'General case' 0 CA--C 1.52 -0.209 0 C-N-CA 123.966 0.906 . . . . 0.0 110.493 175.327 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.3 m -142.59 110.16 5.72 Favored Pre-proline 0 N--CA 1.448 -0.553 0 O-C-N 123.472 0.482 . . . . 0.0 110.563 178.6 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.409 ' HG3' HD13 ' A' ' 48' ' ' LEU . 23.6 Cg_endo -73.15 178.7 6.23 Favored 'Trans proline' 0 N--CA 1.45 -1.037 0 C-N-CA 122.286 1.991 . . . . 0.0 111.52 178.32 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.416 ' CG2' ' HB2' ' A' ' 133' ' ' LEU . 4.3 mt -88.63 119.07 35.27 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.552 0 N-CA-C 108.202 -1.036 . . . . 0.0 108.202 -179.131 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.4 tppp? -82.65 134.96 35.16 Favored 'General case' 0 C--N 1.325 -0.483 0 O-C-N 120.85 -1.156 . . . . 0.0 109.076 176.884 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.598 ' CE1' HD13 ' A' ' 133' ' ' LEU . 6.9 m-85 -116.82 -44.33 2.83 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-N 115.557 -0.747 . . . . 0.0 110.575 179.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 122.5 -4.03 10.2 Favored Glycine 0 C--O 1.224 -0.508 0 CA-C-O 118.88 -0.956 . . . . 0.0 112.62 -176.203 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 10.7 mttt -101.49 139.15 37.54 Favored 'General case' 0 CA--C 1.508 -0.64 0 CA-C-N 118.307 1.054 . . . . 0.0 109.863 176.843 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 38.7 t -78.66 -1.0 32.25 Favored 'General case' 0 C--O 1.219 -0.507 0 O-C-N 125.097 1.498 . . . . 0.0 111.21 175.642 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 52.8 m-20 -87.47 -51.22 6.04 Favored 'General case' 0 N--CA 1.451 -0.424 0 O-C-N 120.184 -1.572 . . . . 0.0 109.327 179.401 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.739 ' HB3' HD11 ' A' ' 80' ' ' LEU . 2.7 m -73.51 -35.55 65.62 Favored 'General case' 0 N--CA 1.451 -0.401 0 O-C-N 123.747 0.654 . . . . 0.0 109.624 179.342 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 20.3 t70 -63.05 -37.1 85.85 Favored 'General case' 0 C--O 1.225 -0.205 0 CA-C-O 121.531 0.681 . . . . 0.0 111.398 175.505 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.7 161.8 0.83 Allowed Pre-proline 0 N--CA 1.441 -0.908 0 CA-C-O 122.321 1.058 . . . . 0.0 112.642 177.781 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.424 ' HA ' ' CE2' ' A' ' 42' ' ' TYR . 27.5 Cg_endo -70.92 132.87 22.27 Favored 'Trans proline' 0 N--CA 1.438 -1.758 0 C-N-CA 120.72 0.947 . . . . 0.0 114.486 173.343 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.507 ' HD2' ' CD2' ' A' ' 42' ' ' TYR . 19.5 Cg_endo -72.04 168.01 25.15 Favored 'Trans proline' 0 N--CA 1.445 -1.37 0 C-N-CA 123.122 2.548 . . . . 0.0 110.905 177.736 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.6 tptt -126.92 52.98 1.73 Allowed 'General case' 0 C--O 1.203 -1.351 0 CA-C-N 115.136 -0.938 . . . . 0.0 108.51 178.892 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 58.2 t-80 -75.52 164.88 25.9 Favored 'General case' 0 C--O 1.216 -0.692 0 O-C-N 120.411 -1.43 . . . . 0.0 111.347 178.404 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 1.4 p -157.87 -167.98 2.4 Favored 'General case' 0 C--N 1.322 -0.589 0 O-C-N 119.531 -1.98 . . . . 0.0 111.136 176.473 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.4 77.05 5.96 Favored 'General case' 0 C--N 1.322 -0.614 0 O-C-N 120.686 -1.259 . . . . 0.0 112.686 171.975 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -177.79 -44.86 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 O-C-N 123.694 0.621 . . . . 0.0 110.162 177.887 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.48 ' CA ' ' HB3' ' A' ' 27' ' ' ASP . . . 117.18 -69.24 0.3 Allowed Glycine 0 N--CA 1.439 -1.148 0 CA-C-N 114.88 -1.055 . . . . 0.0 111.453 -178.986 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -128.84 60.95 1.52 Allowed 'General case' 0 CA--C 1.508 -0.67 0 C-N-CA 125.583 1.553 . . . . 0.0 107.367 -175.71 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.33 -106.45 0.01 OUTLIER Glycine 0 CA--C 1.535 1.292 0 CA-C-O 123.04 1.355 . . . . 0.0 112.862 179.81 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.8 mttm -73.11 -105.12 0.01 OUTLIER 'General case' 0 C--O 1.217 -0.608 0 O-C-N 119.699 -2.06 . . . . 0.0 110.621 177.121 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.519 HG23 ' O ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -106.47 16.8 24.21 Favored 'General case' 0 C--N 1.32 -0.711 0 O-C-N 121.486 -0.759 . . . . 0.0 111.116 179.329 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.425 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 10.0 m-20 -31.56 98.74 0.01 OUTLIER 'General case' 0 C--O 1.207 -1.132 0 C-N-CA 125.487 1.515 . . . . 0.0 111.856 -176.725 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.511 ' CD2' ' H ' ' A' ' 78' ' ' HIS . 4.4 p80 -85.11 44.41 1.08 Allowed 'General case' 0 C--N 1.326 -0.449 0 O-C-N 119.752 -1.842 . . . . 0.0 107.745 -170.67 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.508 ' HB2' ' CD1' ' A' ' 37' ' ' TRP . 39.3 p90 -69.68 135.02 49.35 Favored 'General case' 0 N--CA 1.433 -1.298 0 C-N-CA 124.794 1.237 . . . . 0.0 111.011 -179.4 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.817 HD22 HG23 ' A' ' 109' ' ' ILE . 2.1 mt -71.24 142.84 50.57 Favored 'General case' 0 C--O 1.216 -0.71 0 N-CA-C 108.709 -0.848 . . . . 0.0 108.709 177.83 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.599 HD21 ' HB2' ' A' ' 35' ' ' PRO . 0.3 OUTLIER -137.12 137.12 38.92 Favored 'General case' 0 C--N 1.318 -0.766 0 CA-C-N 119.128 0.876 . . . . 0.0 108.864 177.059 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.463 ' HB2' HD11 ' A' ' 109' ' ' ILE . 0.5 OUTLIER -99.78 168.66 9.76 Favored 'General case' 0 C--N 1.324 -0.519 0 CA-C-N 115.771 -0.65 . . . . 0.0 112.649 176.432 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.547 ' CE1' ' HB2' ' A' ' 23' ' ' ALA . 78.6 t80 -157.04 130.02 4.42 Favored Pre-proline 0 C--N 1.327 -0.383 0 O-C-N 120.811 -1.181 . . . . 0.0 113.857 -179.932 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.426 ' HA ' ' HG2' ' A' ' 107' ' ' ARG . 19.3 Cg_endo -72.6 98.76 0.98 Allowed 'Trans proline' 0 N--CA 1.45 -1.079 0 C-N-CA 123.913 3.076 . . . . 0.0 109.713 -175.554 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.589 HG21 ' HA ' ' A' ' 16' ' ' ALA . 7.2 t -102.49 109.15 20.7 Favored 'General case' 0 CA--C 1.507 -0.687 0 CA-C-N 115.339 -0.846 . . . . 0.0 111.075 -179.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 64.8 m-85 -81.34 158.44 69.18 Favored Pre-proline 0 C--N 1.32 -0.696 0 O-C-N 121.607 -0.683 . . . . 0.0 112.112 179.696 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 12.3 Cg_endo -78.12 -34.3 1.71 Allowed 'Trans proline' 0 CA--C 1.495 -1.473 0 C-N-CA 122.053 1.835 . . . . 0.0 112.802 178.949 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 3.2 m-20 -43.83 -32.94 1.18 Allowed 'General case' 0 N--CA 1.474 0.77 0 O-C-N 125.537 1.773 . . . . 0.0 110.709 176.285 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.423 ' HA3' ' CE ' ' A' ' 15' ' ' LYS . . . 89.19 4.45 74.38 Favored Glycine 0 N--CA 1.431 -1.66 0 CA-C-O 118.586 -1.119 . . . . 0.0 111.268 177.191 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 4.5 p-80 -74.07 129.55 38.08 Favored 'General case' 0 N--CA 1.434 -1.253 0 O-C-N 125.669 1.452 . . . . 0.0 107.644 178.306 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 13.7 t70 -61.84 92.04 0.04 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 N-CA-C 108.342 -0.984 . . . . 0.0 108.342 174.325 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.497 ' CD2' ' HB3' ' A' ' 94' ' ' PHE . 5.8 t80 -38.32 142.89 0.15 Allowed 'General case' 0 C--O 1.21 -0.99 0 CA-C-O 122.083 0.944 . . . . 0.0 110.382 179.682 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -75.46 58.73 1.03 Allowed 'General case' 0 C--N 1.312 -1.064 0 O-C-N 119.11 -2.244 . . . . 0.0 111.061 175.059 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.497 ' HB3' ' CD2' ' A' ' 92' ' ' TYR . 25.7 p90 -75.27 -18.3 60.1 Favored 'General case' 0 N--CA 1.443 -0.796 0 C-N-CA 123.925 0.89 . . . . 0.0 111.621 176.802 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 15.1 t0 -92.05 -22.39 19.97 Favored 'General case' 0 C--O 1.222 -0.392 0 CA-C-O 122.21 1.005 . . . . 0.0 110.304 179.079 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -94.49 107.59 19.56 Favored 'General case' 0 CA--C 1.513 -0.459 0 O-C-N 120.369 -1.457 . . . . 0.0 109.001 179.507 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -57.23 -49.5 75.82 Favored 'General case' 0 C--N 1.33 -0.261 0 O-C-N 122.181 -0.325 . . . . 0.0 110.375 177.368 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -136.41 125.33 15.48 Favored Pre-proline 0 N--CA 1.44 -0.938 0 C-N-CA 124.338 1.055 . . . . 0.0 109.695 -175.2 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 24.0 Cg_endo -71.94 176.12 39.81 Favored 'Cis proline' 0 C--N 1.349 0.601 0 O-C-N 124.94 2.021 . . . . 0.0 110.941 -2.661 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 7.9 ttmt -138.07 124.0 20.1 Favored 'General case' 0 C--N 1.327 -0.404 0 C-N-CA 124.059 0.943 . . . . 0.0 109.013 179.013 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.06 159.57 26.12 Favored 'General case' 0 C--N 1.322 -0.618 0 O-C-N 124.509 1.131 . . . . 0.0 111.399 177.483 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -60.06 138.97 91.11 Favored Pre-proline 0 N--CA 1.451 -0.403 0 CA-C-N 115.701 -0.682 . . . . 0.0 111.32 177.707 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 24.4 Cg_endo -72.25 -165.75 0.23 Allowed 'Trans proline' 0 N--CA 1.452 -0.971 0 C-N-CA 122.783 2.322 . . . . 0.0 111.725 176.907 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -131.58 155.7 21.51 Favored Glycine 0 CA--C 1.527 0.798 0 O-C-N 121.166 -0.959 . . . . 0.0 112.433 176.614 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -73.07 -17.46 24.81 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 122.389 2.059 . . . . 0.0 111.258 177.429 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.798 ' HB3' ' CZ ' ' A' ' 11' ' ' TYR . . . -110.76 134.92 52.08 Favored 'General case' 0 CA--C 1.507 -0.711 0 C-N-CA 124.177 0.991 . . . . 0.0 110.094 177.811 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.427 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 0.0 OUTLIER -138.37 151.04 47.15 Favored 'General case' 0 CA--C 1.5 -0.964 0 CA-C-O 116.489 -1.72 . . . . 0.0 111.41 176.964 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.513 ' C ' HD12 ' A' ' 109' ' ' ILE . 7.3 p -82.39 122.24 36.75 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 C-N-CA 124.77 1.228 . . . . 0.0 112.109 175.942 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.817 HG23 HD22 ' A' ' 80' ' ' LEU . 1.7 mp -110.71 120.46 61.55 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.684 0 N-CA-C 105.753 -1.943 . . . . 0.0 105.753 -174.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.498 ' O ' HD23 ' A' ' 80' ' ' LEU . 6.4 p90 -140.34 150.52 44.07 Favored 'General case' 0 N--CA 1.444 -0.774 0 CA-C-O 122.93 1.347 . . . . 0.0 109.958 -179.582 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.6 p -82.32 160.58 22.85 Favored 'General case' 0 C--N 1.32 -0.681 0 N-CA-C 108.2 -1.037 . . . . 0.0 108.2 -178.647 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.52 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.0 OUTLIER -108.2 155.38 40.29 Favored Pre-proline 0 CA--C 1.543 0.707 0 C-N-CA 122.873 0.469 . . . . 0.0 110.568 179.203 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.52 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 14.7 Cg_endo -74.16 -51.21 0.16 OUTLIER 'Cis proline' 0 CA--C 1.501 -1.159 0 C-N-CA 123.343 -1.524 . . . . 0.0 109.596 -6.87 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.8 t30 -47.72 108.09 0.15 Allowed 'General case' 0 CA--C 1.505 -0.785 0 CA-C-O 116.101 -1.904 . . . . 0.0 108.919 179.207 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.521 ' HE2' HD22 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -62.91 79.75 0.02 OUTLIER 'General case' 0 CA--C 1.511 -0.547 0 O-C-N 125.233 1.583 . . . . 0.0 109.014 -177.775 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.481 ' O ' HG12 ' A' ' 116' ' ' VAL . 15.4 t -80.16 71.58 0.6 Allowed 'Isoleucine or valine' 0 CA--C 1.512 -0.517 0 N-CA-C 103.965 -2.605 . . . . 0.0 103.965 -175.319 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.547 ' CE1' ' HA2' ' A' ' 119' ' ' GLY . 4.3 t80 -36.1 114.12 0.26 Allowed 'General case' 0 C--O 1.242 0.671 0 C-N-CA 124.049 0.94 . . . . 0.0 108.809 177.854 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . 0.546 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -97.03 -30.33 13.12 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-N 116.106 -0.497 . . . . 0.0 109.973 177.282 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.547 ' HA2' ' CE1' ' A' ' 117' ' ' PHE . . . 144.12 -170.32 25.98 Favored Glycine 0 N--CA 1.444 -0.824 0 C-N-CA 123.864 0.745 . . . . 0.0 112.027 -177.274 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.679 HG21 ' HB1' ' A' ' 106' ' ' ALA . 3.2 mp -111.61 142.84 22.77 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.395 0 N-CA-C 107.502 -1.296 . . . . 0.0 107.502 -177.077 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.72 HG22 HD12 ' A' ' 133' ' ' LEU . 8.4 pt -114.83 155.19 16.07 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.97 0 CA-C-N 119.822 1.192 . . . . 0.0 108.087 -179.879 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.635 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . . . -177.96 161.04 1.51 Allowed 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 122.9 1.333 . . . . 0.0 110.117 178.522 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.508 ' CE1' ' HG ' ' A' ' 131' ' ' LEU . 1.5 m-70 -90.61 93.23 9.18 Favored 'General case' 0 C--N 1.32 -0.707 0 O-C-N 121.26 -0.9 . . . . 0.0 109.04 -178.532 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.579 HG22 ' HD2' ' A' ' 132' ' ' LYS . 2.0 t -98.16 36.53 1.57 Allowed 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 124.689 2.185 . . . . 0.0 111.419 -179.336 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 25.9 tptt -100.43 -27.87 13.22 Favored 'General case' 0 C--N 1.324 -0.535 0 O-C-N 118.324 -2.735 . . . . 0.0 110.972 179.173 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -169.09 -63.14 0.02 OUTLIER 'General case' 0 C--O 1.219 -0.537 0 O-C-N 124.117 0.886 . . . . 0.0 110.298 178.36 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -155.5 -45.28 0.08 Allowed 'General case' 0 N--CA 1.453 -0.285 0 CA-C-O 122.567 1.175 . . . . 0.0 110.901 178.867 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -158.45 75.43 0.72 Allowed 'General case' 0 N--CA 1.447 -0.609 0 CA-C-O 122.052 0.93 . . . . 0.0 111.152 -179.652 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -119.57 -104.55 2.09 Favored Glycine 0 N--CA 1.46 0.259 0 N-CA-C 110.446 -1.062 . . . . 0.0 110.446 179.633 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -88.24 155.3 19.81 Favored 'General case' 0 C--N 1.324 -0.509 0 O-C-N 121.387 -1.067 . . . . 0.0 111.349 -179.787 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.563 HD22 HD12 ' A' ' 121' ' ' ILE . 0.5 OUTLIER -99.8 138.2 37.21 Favored 'General case' 0 C--N 1.322 -0.593 0 O-C-N 121.663 -0.648 . . . . 0.0 110.133 178.57 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.579 ' HD2' HG22 ' A' ' 124' ' ' THR . 0.6 OUTLIER -150.16 167.09 27.89 Favored 'General case' 0 CA--C 1.502 -0.868 0 C-N-CA 123.984 0.914 . . . . 0.0 109.256 -177.827 . . . . . . . . 3 3 . 1 . 001 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.72 HD12 HG22 ' A' ' 121' ' ' ILE . 9.4 tp -83.97 148.07 27.11 Favored 'General case' 0 C--N 1.321 -0.659 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 177.783 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . 0.533 ' SG ' HG22 ' A' ' 120' ' ' ILE . 90.8 m -58.59 -174.32 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.405 0 C-N-CA 125.186 1.394 . . . . 0.0 110.608 175.995 . . . . . . . . 2 2 . 1 . 001 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 61.3 m -131.22 93.28 3.34 Favored 'General case' 0 CA--C 1.504 -0.795 0 N-CA-C 107.698 -1.223 . . . . 0.0 107.698 -177.58 . . . . . . . . 1 1 . 1 . 001 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.62 ' CD2' ' CZ2' ' A' ' 4' ' ' TRP . 5.8 p-80 . . . . . 0 C--O 1.25 1.111 0 CA-C-O 114.957 -2.449 . . . . 0.0 113.427 173.515 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.468 0.456 0 CA-C-O 118.316 -0.85 . . . . 0.0 108.78 . . . . . . . . . 0 0 . 1 . 002 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.545 HG22 ' HB3' ' A' ' 136' ' ' HIS . 14.4 p -72.79 146.68 10.65 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.505 0 O-C-N 123.98 0.8 . . . . 0.0 110.891 175.334 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 2.4 m -88.93 114.56 25.69 Favored 'General case' 0 C--N 1.316 -0.848 0 C-N-CA 124.002 0.921 . . . . 0.0 109.47 -177.724 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.47 ' CD1' ' HB2' ' A' ' 13' ' ' GLN . 31.8 m95 -79.33 150.18 31.52 Favored 'General case' 0 N--CA 1.444 -0.762 0 CA-C-O 118.88 -0.581 . . . . 0.0 110.421 -179.692 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 17.5 m -144.52 131.62 20.51 Favored 'General case' 0 CA--C 1.498 -1.041 0 N-CA-C 108.334 -0.987 . . . . 0.0 108.334 -176.035 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.736 ' SG ' ' HB3' ' A' ' 122' ' ' ALA . 0.0 OUTLIER -126.93 -80.4 0.6 Allowed 'General case' 0 C--O 1.217 -0.658 0 CA-C-O 117.708 -1.139 . . . . 0.0 110.742 176.911 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -56.89 -88.17 0.02 OUTLIER Glycine 0 C--N 1.344 1.018 0 O-C-N 124.395 1.059 . . . . 0.0 111.294 -179.571 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -154.17 18.22 0.62 Allowed Glycine 0 C--O 1.223 -0.585 0 O-C-N 121.749 -0.853 . . . . 0.0 111.383 178.226 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 49.8 mt -129.98 158.79 38.6 Favored 'General case' 0 N--CA 1.447 -0.608 0 C-N-CA 123.511 0.724 . . . . 0.0 109.735 178.816 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.5 mp -96.6 134.42 39.86 Favored 'General case' 0 N--CA 1.449 -0.522 0 CA-C-N 115.215 -0.902 . . . . 0.0 109.228 -179.175 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.471 ' CE2' ' CB ' ' A' ' 106' ' ' ALA . 76.2 m-85 -117.64 104.07 10.66 Favored 'General case' 0 N--CA 1.444 -0.746 0 C-N-CA 126.481 1.912 . . . . 0.0 108.267 -173.944 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -55.69 119.6 5.97 Favored 'General case' 0 N--CA 1.434 -1.259 0 N-CA-C 108.487 -0.931 . . . . 0.0 108.487 178.986 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.473 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 5.5 tp-100 -53.25 -41.42 65.44 Favored 'General case' 0 C--O 1.203 -1.344 0 C-N-CA 120.515 -0.474 . . . . 0.0 111.91 179.53 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 2.6 t-20 -49.78 -42.44 46.68 Favored 'General case' 0 C--O 1.197 -1.702 0 CA-C-O 119.544 -0.265 . . . . 0.0 111.377 175.781 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.3 mttp -70.86 -37.19 73.09 Favored 'General case' 0 C--O 1.202 -1.44 0 O-C-N 120.923 -1.111 . . . . 0.0 113.451 169.274 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.4 -38.44 66.22 Favored 'General case' 0 C--N 1.305 -1.359 0 CA-C-N 122.353 2.342 . . . . 0.0 113.641 172.158 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 4.2 pt-20 -90.39 -39.63 12.55 Favored 'General case' 0 C--O 1.212 -0.877 0 CA-C-O 117.976 -1.012 . . . . 0.0 108.548 177.286 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 39.8 t -73.63 -59.79 2.55 Favored 'General case' 0 C--O 1.214 -0.806 0 C-N-CA 126.212 1.805 . . . . 0.0 109.911 -176.45 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.498 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 6.4 t-20 -41.0 -36.86 0.72 Allowed 'General case' 0 N--CA 1.449 -0.501 0 CA-C-N 119.72 1.145 . . . . 0.0 113.285 170.709 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.477 ' O ' ' HB3' ' A' ' 23' ' ' ALA . 0.5 OUTLIER -81.53 -36.79 28.75 Favored 'General case' 0 N--CA 1.444 -0.728 0 N-CA-C 115.035 1.495 . . . . 0.0 115.035 173.434 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 5.2 m170 -44.83 -38.68 4.72 Favored 'General case' 0 N--CA 1.449 -0.509 0 C-N-CA 126.382 1.873 . . . . 0.0 109.896 178.102 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.498 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -73.72 -47.01 42.52 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-O 117.88 -1.057 . . . . 0.0 112.732 175.064 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.831 ' HB1' ' HG3' ' A' ' 35' ' ' PRO . . . -35.74 127.59 0.61 Allowed Pre-proline 0 N--CA 1.439 -0.982 0 O-C-N 125.312 1.632 . . . . 0.0 112.885 173.011 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.719 ' HG2' HG22 ' A' ' 30' ' ' THR . 14.2 Cg_endo -73.63 125.87 10.39 Favored 'Trans proline' 0 N--CA 1.445 -1.369 0 C-N-CA 122.054 1.836 . . . . 0.0 108.576 -175.758 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.818 HD13 ' HE2' ' A' ' 115' ' ' LYS . 4.3 tp -60.6 93.92 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.376 0 C-N-CA 123.472 0.709 . . . . 0.0 111.239 178.658 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 179.2 162.46 0.82 Allowed 'General case' 0 C--N 1.322 -0.628 0 C-N-CA 123.102 0.561 . . . . 0.0 109.966 -176.079 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -98.2 118.44 34.85 Favored 'General case' 0 C--O 1.218 -0.595 0 C-N-CA 123.996 0.918 . . . . 0.0 110.344 177.648 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 46.71 64.72 2.51 Favored Glycine 0 CA--C 1.529 0.908 0 C-N-CA 120.048 -1.073 . . . . 0.0 112.7 177.469 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 9.9 ttpt -129.44 11.69 5.86 Favored 'General case' 0 N--CA 1.465 0.323 0 CA-C-O 124.367 2.032 . . . . 0.0 111.079 178.024 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.719 HG22 ' HG2' ' A' ' 24' ' ' PRO . 25.9 p -112.71 150.53 31.4 Favored 'General case' 0 C--N 1.309 -1.165 0 O-C-N 119.27 -2.144 . . . . 0.0 107.233 -174.485 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -39.94 -51.13 3.4 Favored Glycine 0 C--N 1.335 0.474 0 O-C-N 124.404 1.065 . . . . 0.0 112.495 179.524 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 4.7 t -69.23 -78.09 0.07 Allowed 'General case' 0 N--CA 1.452 -0.328 0 CA-C-O 118.988 -0.53 . . . . 0.0 111.224 173.423 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 35.4 p -179.0 -63.75 0.01 OUTLIER 'General case' 0 C--O 1.224 -0.272 0 C-N-CA 123.491 0.717 . . . . 0.0 110.202 -179.548 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.588 ' CE2' ' CE1' ' A' ' 36' ' ' HIS . 65.6 m-85 -58.67 147.13 71.98 Favored Pre-proline 0 N--CA 1.426 -1.662 0 C-N-CA 124.708 1.203 . . . . 0.0 112.962 179.967 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.831 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 20.7 Cg_endo -74.77 151.37 96.86 Favored 'Cis proline' 0 N--CA 1.45 -1.081 0 C-N-CA 123.088 -1.63 . . . . 0.0 110.734 -0.738 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.614 ' C ' HD23 ' A' ' 81' ' ' LEU . 0.5 OUTLIER -129.39 166.38 19.66 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-O 117.474 -1.25 . . . . 0.0 110.347 -179.554 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.961 ' CH2' HG22 ' A' ' 39' ' ' THR . 16.7 t90 -64.02 144.41 57.11 Favored 'General case' 0 N--CA 1.452 -0.328 0 O-C-N 124.329 1.018 . . . . 0.0 108.586 178.026 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.554 ' CE1' ' CD1' ' A' ' 121' ' ' ILE . 16.3 t80 -117.4 82.51 1.83 Allowed 'General case' 0 N--CA 1.431 -1.419 0 N-CA-C 105.103 -2.184 . . . . 0.0 105.103 -174.785 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.961 HG22 ' CH2' ' A' ' 37' ' ' TRP . 73.1 p -40.38 -33.08 0.22 Allowed 'General case' 0 C--O 1.211 -0.948 0 C-N-CA 124.537 1.135 . . . . 0.0 110.459 174.01 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.485 ' HB2' ' CE2' ' A' ' 38' ' ' PHE . 46.3 t30 60.18 16.33 5.97 Favored 'General case' 0 C--O 1.214 -0.784 0 CA-C-O 122.877 1.323 . . . . 0.0 109.374 177.704 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.434 ' O ' ' HD3' ' A' ' 52' ' ' ARG . . . 112.89 -38.39 3.25 Favored Glycine 0 N--CA 1.427 -1.905 0 O-C-N 119.469 -2.019 . . . . 0.0 113.367 -172.197 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.7 ' HA ' HD23 ' A' ' 48' ' ' LEU . 66.0 m-85 -50.64 170.53 0.03 OUTLIER 'General case' 0 C--O 1.231 0.081 0 CA-C-N 118.664 1.232 . . . . 0.0 111.695 178.849 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -94.44 -40.53 9.86 Favored 'General case' 0 C--N 1.32 -0.693 0 O-C-N 121.598 -0.689 . . . . 0.0 110.002 179.372 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.576 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -177.09 -53.31 0.06 OUTLIER Glycine 0 C--N 1.336 0.547 0 C-N-CA 123.855 0.74 . . . . 0.0 111.9 -178.439 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -85.76 -96.29 0.07 Allowed 'General case' 0 N--CA 1.45 -0.433 0 N-CA-C 107.4 -1.333 . . . . 0.0 107.4 -179.456 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.445 ' HA2' ' CD2' ' A' ' 42' ' ' TYR . . . -141.6 12.7 2.7 Favored Glycine 0 N--CA 1.438 -1.226 0 C-N-CA 125.306 1.432 . . . . 0.0 111.065 -176.328 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 13.2 pttt -112.06 146.41 38.0 Favored 'General case' 0 CA--C 1.503 -0.834 0 CA-C-O 117.991 -1.004 . . . . 0.0 108.804 -179.223 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.7 HD23 ' HA ' ' A' ' 42' ' ' TYR . 0.4 OUTLIER -111.06 159.01 34.23 Favored Pre-proline 0 C--N 1.323 -0.555 0 O-C-N 124.624 1.203 . . . . 0.0 108.676 -178.473 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -74.48 157.37 44.99 Favored 'Trans proline' 0 N--CA 1.448 -1.149 0 C-N-CA 121.857 1.704 . . . . 0.0 109.925 -179.866 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.2 ttpt -54.89 101.12 0.04 OUTLIER 'General case' 0 CA--C 1.534 0.33 0 C-N-CA 122.99 0.516 . . . . 0.0 109.859 177.887 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 95.77 88.4 1.77 Allowed Glycine 0 N--CA 1.451 -0.364 0 CA-C-N 116.495 -0.321 . . . . 0.0 112.535 -176.438 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.434 ' HD3' ' O ' ' A' ' 41' ' ' GLY . 0.9 OUTLIER -169.97 161.28 8.74 Favored 'General case' 0 CA--C 1.513 -0.475 0 C-N-CA 123.415 0.686 . . . . 0.0 110.506 175.683 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.0 m -147.69 113.57 4.01 Favored Pre-proline 0 N--CA 1.447 -0.616 0 O-C-N 124.485 1.115 . . . . 0.0 110.412 179.347 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 18.9 Cg_endo -72.28 166.92 28.32 Favored 'Trans proline' 0 N--CA 1.449 -1.142 0 C-N-CA 122.621 2.214 . . . . 0.0 111.344 179.062 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.401 ' O ' ' CE1' ' A' ' 57' ' ' PHE . 6.0 mt -81.6 129.87 36.78 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.429 0 N-CA-C 107.39 -1.337 . . . . 0.0 107.39 -178.077 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -95.71 136.93 35.49 Favored 'General case' 0 C--N 1.327 -0.4 0 N-CA-C 108.957 -0.757 . . . . 0.0 108.957 177.729 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.528 ' CE2' HD13 ' A' ' 133' ' ' LEU . 3.0 m-85 -125.93 -53.87 1.52 Allowed 'General case' 0 C--N 1.325 -0.468 0 N-CA-C 108.936 -0.765 . . . . 0.0 108.936 -177.436 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 120.37 -5.51 11.98 Favored Glycine 0 CA--C 1.524 0.612 0 C-N-CA 123.852 0.739 . . . . 0.0 112.602 -176.467 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.409 ' CB ' ' HB3' ' A' ' 62' ' ' CYS . 0.2 OUTLIER -65.75 177.5 1.25 Allowed 'General case' 0 C--O 1.207 -1.165 0 CA-C-N 118.251 1.026 . . . . 0.0 111.355 176.157 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -104.48 -45.13 4.73 Favored 'General case' 0 C--O 1.212 -0.885 0 N-CA-C 109.515 -0.55 . . . . 0.0 109.515 178.404 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -81.55 -40.17 23.53 Favored 'General case' 0 CA--C 1.514 -0.432 0 N-CA-C 109.349 -0.612 . . . . 0.0 109.349 179.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.57 ' HA ' HD11 ' A' ' 80' ' ' LEU . 0.9 OUTLIER -71.43 -20.14 62.15 Favored 'General case' 0 C--N 1.342 0.253 0 O-C-N 123.871 0.732 . . . . 0.0 110.824 177.826 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.5 t70 -85.79 -42.24 14.36 Favored 'General case' 0 CA--C 1.509 -0.599 0 O-C-N 124.225 0.953 . . . . 0.0 112.196 174.714 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.75 165.38 0.46 Allowed Pre-proline 0 N--CA 1.44 -0.951 0 CA-C-O 121.437 0.637 . . . . 0.0 111.542 -179.155 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 27.5 Cg_endo -71.82 139.16 32.95 Favored 'Trans proline' 0 N--CA 1.437 -1.8 0 N-CA-C 114.807 1.041 . . . . 0.0 114.807 173.436 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.44 ' HD2' ' CE2' ' A' ' 42' ' ' TYR . 18.5 Cg_endo -70.51 174.28 10.39 Favored 'Trans proline' 0 N--CA 1.446 -1.286 0 C-N-CA 122.846 2.364 . . . . 0.0 111.09 178.424 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.4 mmtp -140.03 58.86 1.58 Allowed 'General case' 0 C--O 1.199 -1.569 0 CA-C-O 116.597 -1.668 . . . . 0.0 109.28 177.246 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.407 ' CE1' ' O ' ' A' ' 69' ' ' SER . 58.4 t-80 -75.4 164.02 26.82 Favored 'General case' 0 C--N 1.328 -0.329 0 CA-C-N 119.534 1.061 . . . . 0.0 110.594 179.535 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.407 ' O ' ' CE1' ' A' ' 68' ' ' HIS . 0.3 OUTLIER -149.38 -168.66 3.17 Favored 'General case' 0 C--N 1.325 -0.464 0 C-N-CA 123.574 0.75 . . . . 0.0 111.402 177.997 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -84.14 71.22 10.6 Favored 'General case' 0 C--O 1.216 -0.706 0 O-C-N 120.268 -1.52 . . . . 0.0 111.745 176.433 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -177.18 -42.4 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.534 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.103 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.418 ' O ' ' CE2' ' A' ' 79' ' ' TYR . . . 124.51 -46.69 1.07 Allowed Glycine 0 CA--C 1.487 -1.703 0 CA-C-O 117.757 -1.58 . . . . 0.0 112.469 -176.84 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 5.4 t30 -150.11 81.89 1.37 Allowed 'General case' 0 N--CA 1.438 -1.03 0 N-CA-C 106.89 -1.522 . . . . 0.0 106.89 177.829 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -61.42 -122.59 0.01 OUTLIER Glycine 0 C--O 1.219 -0.812 0 CA-C-O 121.197 0.332 . . . . 0.0 112.476 177.129 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.2 mttt -52.45 -89.34 0.0 OUTLIER 'General case' 0 CA--C 1.536 0.411 0 O-C-N 120.411 -1.641 . . . . 0.0 112.086 178.298 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.561 HG23 ' O ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -119.62 17.01 12.85 Favored 'General case' 0 CA--C 1.508 -0.659 0 O-C-N 120.929 -1.107 . . . . 0.0 111.017 178.143 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.464 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 5.0 m-20 -27.05 105.08 0.02 OUTLIER 'General case' 0 C--O 1.203 -1.36 0 C-N-CA 125.44 1.496 . . . . 0.0 110.692 -177.075 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.585 ' CD2' ' H ' ' A' ' 78' ' ' HIS . 2.5 p80 -87.21 11.2 14.7 Favored 'General case' 0 C--N 1.326 -0.429 0 O-C-N 121.146 -0.971 . . . . 0.0 110.255 -176.072 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.996 ' CZ ' HD11 ' A' ' 81' ' ' LEU . 0.5 OUTLIER -33.96 132.95 0.22 Allowed 'General case' 0 N--CA 1.435 -1.206 0 C-N-CA 125.353 1.461 . . . . 0.0 113.205 172.37 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.662 HD22 ' CG2' ' A' ' 109' ' ' ILE . 0.2 OUTLIER -75.19 151.98 38.44 Favored 'General case' 0 C--O 1.218 -0.587 0 N-CA-C 108.92 -0.77 . . . . 0.0 108.92 178.883 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.996 HD11 ' CZ ' ' A' ' 79' ' ' TYR . 1.4 mp -135.87 139.94 43.75 Favored 'General case' 0 CA--C 1.508 -0.641 0 CA-C-N 119.081 0.855 . . . . 0.0 109.155 176.744 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.452 ' HB2' HD11 ' A' ' 109' ' ' ILE . 1.8 pm0 -106.32 151.73 24.47 Favored 'General case' 0 N--CA 1.436 -1.132 0 CA-C-O 121.897 0.856 . . . . 0.0 110.793 179.757 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.424 ' CZ ' ' HB2' ' A' ' 23' ' ' ALA . 55.4 t80 -140.1 130.61 14.0 Favored Pre-proline 0 N--CA 1.449 -0.506 0 O-C-N 121.727 -0.608 . . . . 0.0 111.979 -179.11 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.455 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 18.6 Cg_endo -72.34 108.88 2.61 Favored 'Trans proline' 0 N--CA 1.446 -1.272 0 C-N-CA 123.674 2.916 . . . . 0.0 110.632 -178.935 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.93 109.27 21.16 Favored 'General case' 0 CA--C 1.51 -0.588 0 C-N-CA 123.74 0.816 . . . . 0.0 109.752 -179.259 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 67.3 m-85 -81.1 160.7 65.13 Favored Pre-proline 0 N--CA 1.446 -0.662 0 O-C-N 121.598 -0.689 . . . . 0.0 112.433 178.195 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 14.4 Cg_endo -77.21 -41.66 0.34 Allowed 'Trans proline' 0 CA--C 1.494 -1.507 0 C-N-CA 122.395 2.063 . . . . 0.0 112.256 179.453 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -45.57 -30.61 1.53 Allowed 'General case' 0 C--N 1.35 0.622 0 O-C-N 125.275 1.609 . . . . 0.0 110.282 177.473 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.34 -4.9 85.87 Favored Glycine 0 N--CA 1.432 -1.573 0 N-CA-C 110.153 -1.179 . . . . 0.0 110.153 176.791 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 4.3 p-80 -60.55 129.64 42.6 Favored 'General case' 0 N--CA 1.436 -1.168 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 178.807 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 33.6 t70 -64.19 89.72 0.06 Allowed 'General case' 0 N--CA 1.448 -0.541 0 N-CA-C 108.762 -0.829 . . . . 0.0 108.762 177.265 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.493 ' CD2' ' HB3' ' A' ' 94' ' ' PHE . 6.2 t80 -36.41 142.91 0.08 Allowed 'General case' 0 C--O 1.211 -0.959 0 C-N-CA 124.041 0.937 . . . . 0.0 110.507 -178.858 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.06 58.07 1.47 Allowed 'General case' 0 C--N 1.313 -0.996 0 O-C-N 119.766 -1.834 . . . . 0.0 110.738 175.969 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.493 ' HB3' ' CD2' ' A' ' 92' ' ' TYR . 28.8 p90 -74.03 -14.88 61.08 Favored 'General case' 0 N--CA 1.437 -1.082 0 C-N-CA 123.524 0.73 . . . . 0.0 111.954 176.679 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -88.86 -33.63 17.28 Favored 'General case' 0 N--CA 1.447 -0.593 0 C-N-CA 124.584 1.154 . . . . 0.0 110.794 178.732 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 32.2 m -85.96 109.89 19.08 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -178.558 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 4.5 ptpt -58.17 -49.68 76.16 Favored 'General case' 0 CA--C 1.518 -0.256 0 N-CA-C 109.982 -0.377 . . . . 0.0 109.982 178.623 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.405 ' HA ' ' HA ' ' A' ' 99' ' ' PRO . 0.7 OUTLIER -140.7 126.81 11.6 Favored Pre-proline 0 N--CA 1.43 -1.459 0 C-N-CA 124.416 1.086 . . . . 0.0 110.329 -175.939 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.405 ' HA ' ' HA ' ' A' ' 98' ' ' LYS . 24.6 Cg_endo -71.95 175.98 40.44 Favored 'Cis proline' 0 C--N 1.35 0.606 0 O-C-N 124.909 2.005 . . . . 0.0 110.999 -2.925 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 2.2 tttp -141.09 130.23 23.42 Favored 'General case' 0 N--CA 1.451 -0.378 0 C-N-CA 123.773 0.829 . . . . 0.0 109.469 178.822 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 7.6 tt0 -82.92 148.77 27.46 Favored 'General case' 0 C--N 1.326 -0.433 0 O-C-N 124.135 0.897 . . . . 0.0 110.372 176.687 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.4 t30 -43.86 137.94 3.31 Favored Pre-proline 0 N--CA 1.437 -1.116 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.021 173.489 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 22.8 Cg_endo -73.18 -166.46 0.3 Allowed 'Trans proline' 0 N--CA 1.45 -1.072 0 C-N-CA 122.449 2.1 . . . . 0.0 110.541 178.413 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -131.45 160.03 23.32 Favored Glycine 0 N--CA 1.448 -0.537 0 CA-C-O 119.295 -0.725 . . . . 0.0 112.381 179.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -76.25 -65.84 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.83 0 C-N-CA 122.778 2.319 . . . . 0.0 110.551 -179.748 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.581 ' HA ' ' HB2' ' A' ' 122' ' ' ALA . . . -59.86 137.18 58.13 Favored 'General case' 0 N--CA 1.444 -0.761 0 O-C-N 123.702 0.626 . . . . 0.0 110.996 177.991 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 5.1 mtm-85 -141.43 149.4 40.96 Favored 'General case' 0 CA--C 1.505 -0.767 0 O-C-N 124.211 0.944 . . . . 0.0 110.717 -179.415 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.425 HG23 ' HD1' ' A' ' 117' ' ' PHE . 2.7 p -88.46 117.01 31.21 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.514 0 O-C-N 124.135 0.897 . . . . 0.0 111.862 178.772 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.714 HG12 HD13 ' A' ' 121' ' ' ILE . 1.2 mp -104.3 125.01 59.13 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.984 0 N-CA-C 105.196 -2.15 . . . . 0.0 105.196 -171.847 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.621 ' C ' HD23 ' A' ' 80' ' ' LEU . 14.5 p90 -146.17 160.56 41.79 Favored 'General case' 0 N--CA 1.442 -0.844 0 CA-C-N 115.02 -0.991 . . . . 0.0 111.05 -178.939 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.0 p -93.86 166.0 12.4 Favored 'General case' 0 CA--C 1.5 -0.961 0 CA-C-N 115.907 -0.588 . . . . 0.0 109.867 -177.867 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.56 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -112.96 153.44 45.25 Favored Pre-proline 0 N--CA 1.44 -0.951 0 C-N-CA 122.478 0.311 . . . . 0.0 110.706 179.962 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.56 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 16.5 Cg_endo -74.46 -51.59 0.16 OUTLIER 'Cis proline' 0 CA--C 1.499 -1.253 0 C-N-CA 123.487 -1.464 . . . . 0.0 109.71 -5.864 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 7.6 t-20 -45.44 111.99 0.4 Allowed 'General case' 0 CA--C 1.502 -0.901 0 CA-C-O 115.861 -2.019 . . . . 0.0 109.132 179.358 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.818 ' HE2' HD13 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -64.87 74.81 0.04 OUTLIER 'General case' 0 CA--C 1.51 -0.593 0 O-C-N 125.787 1.929 . . . . 0.0 108.476 -178.383 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.502 ' O ' HG12 ' A' ' 116' ' ' VAL . 9.5 t -73.45 72.16 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.455 -0.222 0 N-CA-C 105.696 -1.964 . . . . 0.0 105.696 -177.08 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.473 ' CZ ' ' NE2' ' A' ' 13' ' ' GLN . 17.2 t80 -46.93 107.98 0.13 Allowed 'General case' 0 N--CA 1.439 -0.981 0 C-N-CA 124.67 1.188 . . . . 0.0 108.881 -179.542 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . 0.419 ' SG ' ' CG ' ' A' ' 57' ' ' PHE . 0.1 OUTLIER -83.75 -56.41 3.72 Favored 'General case' 0 N--CA 1.438 -1.049 0 N-CA-C 108.361 -0.978 . . . . 0.0 108.361 -179.853 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.428 ' HA2' ' CH2' ' A' ' 4' ' ' TRP . . . -178.8 -145.09 5.97 Favored Glycine 0 N--CA 1.436 -1.357 0 N-CA-C 110.622 -0.991 . . . . 0.0 110.622 179.67 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.451 HG13 ' CG ' ' A' ' 4' ' ' TRP . 1.2 mm -127.59 145.49 34.87 Favored 'Isoleucine or valine' 0 CA--C 1.494 -1.202 0 N-CA-C 106.097 -1.816 . . . . 0.0 106.097 -175.088 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.714 HD13 HG12 ' A' ' 109' ' ' ILE . 3.1 pt -131.12 156.86 43.08 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.903 0 N-CA-C 107.866 -1.161 . . . . 0.0 107.866 -179.394 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.736 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . . . -176.14 162.61 2.52 Favored 'General case' 0 C--N 1.325 -0.473 0 CA-C-O 121.781 0.8 . . . . 0.0 109.611 177.143 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.495 ' CE1' ' HG ' ' A' ' 131' ' ' LEU . 2.7 m-70 -91.66 93.88 9.12 Favored 'General case' 0 N--CA 1.444 -0.747 0 N-CA-C 108.858 -0.794 . . . . 0.0 108.858 -178.187 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.542 ' O ' HG23 ' A' ' 124' ' ' THR . 2.4 t -97.63 38.55 1.27 Allowed 'General case' 0 C--N 1.326 -0.424 0 CA-C-O 123.176 1.465 . . . . 0.0 111.554 179.608 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 9.8 tttm -104.13 -27.83 11.84 Favored 'General case' 0 C--N 1.322 -0.601 0 O-C-N 120.493 -1.38 . . . . 0.0 111.014 178.339 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -171.03 -63.07 0.02 OUTLIER 'General case' 0 C--O 1.22 -0.453 0 O-C-N 123.546 0.529 . . . . 0.0 110.518 177.866 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.2 m-20 -154.87 -46.02 0.08 Allowed 'General case' 0 N--CA 1.449 -0.508 0 C-N-CA 123.535 0.734 . . . . 0.0 110.664 178.64 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -157.08 75.01 0.81 Allowed 'General case' 0 N--CA 1.445 -0.69 0 C-N-CA 123.477 0.711 . . . . 0.0 110.988 -179.132 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -122.0 -102.1 1.71 Allowed Glycine 0 C--N 1.331 0.274 0 N-CA-C 110.784 -0.926 . . . . 0.0 110.784 179.869 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -88.48 159.85 17.78 Favored 'General case' 0 CA--C 1.508 -0.645 0 O-C-N 121.816 -0.814 . . . . 0.0 110.303 -179.332 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.495 ' HG ' ' CE1' ' A' ' 123' ' ' HIS . 0.8 OUTLIER -112.69 141.56 46.33 Favored 'General case' 0 C--N 1.324 -0.521 0 CA-C-O 121.643 0.735 . . . . 0.0 109.864 177.811 . . . . . . . . 3 3 . 1 . 002 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -149.25 172.75 14.36 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 123.884 0.873 . . . . 0.0 109.725 -178.614 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.528 HD13 ' CE2' ' A' ' 57' ' ' PHE . 12.3 tp -82.94 136.0 34.71 Favored 'General case' 0 C--N 1.326 -0.424 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 179.319 . . . . . . . . 2 2 . 1 . 002 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 83.7 m -63.43 -175.68 0.13 Allowed 'General case' 0 N--CA 1.446 -0.64 0 C-N-CA 124.082 0.953 . . . . 0.0 109.599 175.576 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 59.3 m -161.55 119.29 2.28 Favored 'General case' 0 CA--C 1.488 -1.427 0 N-CA-C 104.319 -2.474 . . . . 0.0 104.319 -177.479 . . . . . . . . 1 1 . 1 . 002 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.545 ' HB3' HG22 ' A' ' 2' ' ' VAL . 3.2 m80 . . . . . 0 CA--C 1.558 1.254 0 CA-C-O 114.733 -2.556 . . . . 0.0 115.822 177.184 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.71 0 N-CA-C 108.28 -1.007 . . . . 0.0 108.28 . . . . . . . . . 0 0 . 1 . 003 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.1 p -104.19 148.47 8.92 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.365 0 N-CA-C 108.917 -0.772 . . . . 0.0 108.917 179.887 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.583 HG22 ' H ' ' A' ' 11' ' ' TYR . 23.9 m -89.13 115.41 26.64 Favored 'General case' 0 C--N 1.318 -0.789 0 C-N-CA 123.767 0.827 . . . . 0.0 109.625 -178.158 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.47 ' CG ' HG13 ' A' ' 120' ' ' ILE . 23.7 m95 -77.71 142.06 38.98 Favored 'General case' 0 N--CA 1.445 -0.683 0 N-CA-C 109.122 -0.695 . . . . 0.0 109.122 -179.672 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -133.86 138.76 45.8 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 108.75 -0.833 . . . . 0.0 108.75 -178.316 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.662 ' SG ' ' HB3' ' A' ' 122' ' ' ALA . 0.1 OUTLIER -129.59 49.98 2.21 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.868 0.842 . . . . 0.0 111.099 176.865 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 143.06 -99.45 0.23 Allowed Glycine 0 C--O 1.22 -0.778 0 N-CA-C 111.079 -0.808 . . . . 0.0 111.079 -179.204 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -129.32 5.38 6.32 Favored Glycine 0 N--CA 1.466 0.679 0 C-N-CA 123.676 0.655 . . . . 0.0 112.704 177.834 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.499 HD12 ' OH ' ' A' ' 11' ' ' TYR . 0.3 OUTLIER -112.72 138.79 49.02 Favored 'General case' 0 C--O 1.237 0.42 0 N-CA-C 106.796 -1.557 . . . . 0.0 106.796 -175.69 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 6.5 mp -95.62 160.83 14.31 Favored 'General case' 0 C--N 1.324 -0.501 0 O-C-N 123.981 0.801 . . . . 0.0 109.468 -179.883 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.583 ' H ' HG22 ' A' ' 3' ' ' THR . 65.9 m-85 -152.37 94.87 1.97 Allowed 'General case' 0 CA--C 1.513 -0.45 0 CA-C-O 122.182 0.992 . . . . 0.0 109.564 -173.968 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.27 120.63 7.91 Favored 'General case' 0 CA--C 1.506 -0.733 0 CA-C-O 117.427 -1.273 . . . . 0.0 108.038 -178.315 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.402 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 6.7 tp-100 -50.05 -43.24 50.96 Favored 'General case' 0 C--O 1.205 -1.266 0 O-C-N 124.655 1.222 . . . . 0.0 112.032 -179.58 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.1 t-20 -47.98 -48.84 32.16 Favored 'General case' 0 C--O 1.193 -1.897 0 CA-C-O 118.97 -0.538 . . . . 0.0 112.257 174.59 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -67.31 -38.13 84.45 Favored 'General case' 0 C--O 1.206 -1.214 0 CA-C-N 119.99 1.268 . . . . 0.0 114.2 168.019 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.549 ' O ' HG11 ' A' ' 108' ' ' VAL . . . -49.96 -43.88 50.35 Favored 'General case' 0 C--N 1.313 -0.99 0 CA-C-N 121.599 1.999 . . . . 0.0 114.455 170.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -88.59 -39.89 13.76 Favored 'General case' 0 C--O 1.206 -1.218 0 O-C-N 120.916 -1.115 . . . . 0.0 109.668 176.359 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 36.5 t -73.38 -60.2 2.36 Favored 'General case' 0 C--O 1.211 -0.942 0 C-N-CA 126.571 1.948 . . . . 0.0 109.896 -176.102 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.489 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 4.6 t-20 -40.26 -38.5 0.79 Allowed 'General case' 0 C--O 1.223 -0.336 0 CA-C-N 120.268 1.394 . . . . 0.0 113.357 169.239 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.634 ' HB3' HG11 ' A' ' 108' ' ' VAL . 0.1 OUTLIER -81.81 -30.77 32.07 Favored 'General case' 0 C--O 1.217 -0.656 0 N-CA-C 116.11 1.892 . . . . 0.0 116.11 173.108 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 3.6 m170 -50.08 -35.35 25.03 Favored 'General case' 0 C--O 1.223 -0.332 0 C-N-CA 125.733 1.613 . . . . 0.0 109.298 177.958 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.489 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.1 OUTLIER -73.9 -42.8 60.13 Favored 'General case' 0 N--CA 1.442 -0.867 0 CA-C-O 117.822 -1.085 . . . . 0.0 111.926 176.792 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.841 ' HB1' ' HG3' ' A' ' 35' ' ' PRO . . . -36.24 129.72 0.65 Allowed Pre-proline 0 N--CA 1.44 -0.974 0 O-C-N 125.233 1.583 . . . . 0.0 113.069 172.027 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.873 ' HG2' HG22 ' A' ' 30' ' ' THR . 17.4 Cg_endo -72.89 123.98 9.32 Favored 'Trans proline' 0 N--CA 1.444 -1.418 0 C-N-CA 122.053 1.835 . . . . 0.0 108.802 -176.439 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.489 ' HA ' HD12 ' A' ' 25' ' ' LEU . 2.1 tp -62.03 91.11 0.03 OUTLIER 'General case' 0 N--CA 1.454 -0.254 0 C-N-CA 124.262 1.025 . . . . 0.0 110.668 178.769 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 179.78 157.8 0.67 Allowed 'General case' 0 C--N 1.322 -0.589 0 C-N-CA 123.435 0.694 . . . . 0.0 109.427 -175.408 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.416 ' OD1' ' N ' ' A' ' 27' ' ' ASP . 0.0 OUTLIER -98.96 89.45 4.29 Favored 'General case' 0 C--N 1.314 -0.972 0 N-CA-C 104.621 -2.362 . . . . 0.0 104.621 -164.281 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 63.2 75.48 0.34 Allowed Glycine 0 CA--C 1.529 0.943 0 C-N-CA 119.489 -1.338 . . . . 0.0 111.957 -176.266 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.8 ttpt -138.19 28.79 2.52 Favored 'General case' 0 N--CA 1.473 0.687 0 CA-C-O 123.661 1.696 . . . . 0.0 111.825 176.224 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.873 HG22 ' HG2' ' A' ' 24' ' ' PRO . 7.7 p -118.39 146.76 44.17 Favored 'General case' 0 CA--C 1.492 -1.271 0 N-CA-C 105.692 -1.966 . . . . 0.0 105.692 -172.643 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -42.43 -53.94 4.89 Favored Glycine 0 N--CA 1.452 -0.242 0 O-C-N 123.827 0.705 . . . . 0.0 111.561 -179.156 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.2 t -64.15 -62.43 1.62 Allowed 'General case' 0 CA--C 1.507 -0.681 0 CA-C-O 116.533 -1.698 . . . . 0.0 112.378 174.182 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 162.1 -59.11 0.0 OUTLIER 'General case' 0 CA--C 1.513 -0.475 0 C-N-CA 127.91 2.484 . . . . 0.0 111.396 179.676 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.577 ' CE1' ' CE1' ' A' ' 36' ' ' HIS . 70.8 m-85 -59.77 141.14 89.33 Favored Pre-proline 0 N--CA 1.446 -0.674 0 N-CA-C 114.966 1.469 . . . . 0.0 114.966 178.191 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.841 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 36.7 Cg_endo -77.4 167.23 79.88 Favored 'Cis proline' 0 N--CA 1.436 -1.902 0 C-N-CA 121.833 -2.153 . . . . 0.0 112.721 3.512 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.577 ' CE1' ' CE1' ' A' ' 34' ' ' TYR . 2.5 p-80 -137.61 174.4 10.63 Favored 'General case' 0 C--O 1.205 -1.241 0 O-C-N 120.629 -1.294 . . . . 0.0 111.86 178.192 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.93 ' CH2' HG22 ' A' ' 39' ' ' THR . 14.1 t90 -75.84 132.14 40.17 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 119.864 1.211 . . . . 0.0 110.726 173.515 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 4.5 t80 -97.52 89.56 4.72 Favored 'General case' 0 N--CA 1.429 -1.491 0 N-CA-C 105.148 -2.167 . . . . 0.0 105.148 -179.382 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.93 HG22 ' CH2' ' A' ' 37' ' ' TRP . 17.1 p -38.81 -36.01 0.24 Allowed 'General case' 0 C--O 1.203 -1.38 0 CA-C-O 117.733 -1.127 . . . . 0.0 110.286 169.989 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 50.4 t30 55.95 22.25 5.61 Favored 'General case' 0 N--CA 1.471 0.619 0 CA-C-N 121.189 1.813 . . . . 0.0 109.973 176.499 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.559 ' HA3' HD23 ' A' ' 48' ' ' LEU . . . 101.37 -39.76 2.64 Favored Glycine 0 N--CA 1.425 -2.052 0 CA-C-O 116.726 -2.152 . . . . 0.0 116.587 -168.249 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.479 ' CE2' ' HD3' ' A' ' 66' ' ' PRO . 80.5 m-85 -46.58 152.65 0.44 Allowed 'General case' 0 C--O 1.233 0.202 0 C-N-CA 126.456 1.902 . . . . 0.0 110.695 177.348 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.82 -38.35 25.65 Favored 'General case' 0 C--N 1.325 -0.458 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.728 178.644 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.574 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -172.29 -59.07 0.04 OUTLIER Glycine 0 C--N 1.335 0.489 0 C-N-CA 124.689 1.138 . . . . 0.0 111.011 -178.173 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -125.16 -64.77 1.06 Allowed 'General case' 0 CA--C 1.507 -0.69 0 O-C-N 122.641 -0.329 . . . . 0.0 110.514 -176.802 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.99 -175.81 0.22 Allowed Glycine 0 C--N 1.342 0.872 0 C-N-CA 124.761 1.172 . . . . 0.0 110.988 178.835 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.54 -165.72 0.0 OUTLIER 'General case' 0 CA--C 1.551 0.987 0 CA-C-O 124.61 2.148 . . . . 0.0 112.623 175.697 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.723 ' H ' HD12 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -96.35 169.02 9.54 Favored Pre-proline 0 C--N 1.306 -1.286 0 O-C-N 119.829 -1.794 . . . . 0.0 110.889 -179.96 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -71.87 157.67 54.48 Favored 'Trans proline' 0 N--CA 1.441 -1.582 0 C-N-CA 121.888 1.725 . . . . 0.0 110.69 178.23 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.0 tttt -63.76 97.88 0.17 Allowed 'General case' 0 CA--C 1.532 0.254 0 O-C-N 121.713 -0.617 . . . . 0.0 110.205 176.685 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 123.62 40.0 0.48 Allowed Glycine 0 CA--C 1.52 0.351 0 N-CA-C 112.015 -0.434 . . . . 0.0 112.015 -176.528 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.443 ' HD3' ' HA2' ' A' ' 41' ' ' GLY . 0.0 OUTLIER -132.96 161.35 34.54 Favored 'General case' 0 CA--C 1.506 -0.743 0 CA-C-N 117.325 0.562 . . . . 0.0 111.495 176.85 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.9 m -140.48 102.85 6.55 Favored Pre-proline 0 C--N 1.324 -0.527 0 O-C-N 124.045 0.841 . . . . 0.0 109.61 -178.484 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -72.08 175.78 9.37 Favored 'Trans proline' 0 N--CA 1.448 -1.183 0 C-N-CA 122.504 2.136 . . . . 0.0 111.418 178.208 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 5.8 mt -98.35 130.52 47.03 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.658 0 N-CA-C 107.715 -1.217 . . . . 0.0 107.715 -178.297 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -90.34 135.37 33.72 Favored 'General case' 0 CA--C 1.514 -0.423 0 N-CA-C 109.272 -0.64 . . . . 0.0 109.272 177.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.508 ' CD1' ' HB3' ' A' ' 118' ' ' CYS . 17.3 m-85 -118.83 -45.37 2.59 Favored 'General case' 0 C--N 1.325 -0.472 0 C-N-CA 124.078 0.951 . . . . 0.0 110.142 179.993 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 121.03 -2.31 11.68 Favored Glycine 0 C--O 1.222 -0.642 0 C-N-CA 123.885 0.755 . . . . 0.0 112.59 -175.665 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 18.0 mttm -105.33 137.82 42.51 Favored 'General case' 0 CA--C 1.505 -0.76 0 CA-C-N 118.222 1.011 . . . . 0.0 109.373 177.507 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 8.2 t -73.26 -4.64 34.41 Favored 'General case' 0 C--O 1.217 -0.642 0 O-C-N 125.182 1.551 . . . . 0.0 111.504 176.157 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.3 m-20 -89.0 -50.59 6.08 Favored 'General case' 0 CA--C 1.515 -0.399 0 C-N-CA 124.654 1.182 . . . . 0.0 109.745 179.686 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 10.1 m -71.52 -22.55 61.76 Favored 'General case' 0 CA--C 1.535 0.381 0 CA-C-O 121.46 0.648 . . . . 0.0 111.564 175.41 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.5 t70 -79.75 -35.87 38.14 Favored 'General case' 0 C--O 1.217 -0.625 0 CA-C-O 118.892 -0.575 . . . . 0.0 111.143 174.023 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 1.2 ptm180 -52.35 160.79 1.19 Allowed Pre-proline 0 CA--C 1.539 0.542 0 CA-C-O 122.084 0.945 . . . . 0.0 111.67 179.242 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -71.94 144.14 42.39 Favored 'Trans proline' 0 N--CA 1.443 -1.492 0 C-N-CA 120.461 0.774 . . . . 0.0 113.573 175.037 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.479 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 19.8 Cg_endo -72.74 169.12 22.75 Favored 'Trans proline' 0 N--CA 1.444 -1.433 0 C-N-CA 124.151 3.234 . . . . 0.0 111.056 178.513 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.4 tptp -128.47 51.92 1.96 Allowed 'General case' 0 C--O 1.197 -1.675 0 CA-C-O 114.987 -2.435 . . . . 0.0 107.216 -179.016 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.42 ' CD2' ' O ' ' A' ' 72' ' ' GLY . 57.1 t-80 -74.79 144.56 43.49 Favored 'General case' 0 CA--C 1.546 0.8 0 CA-C-N 121.212 1.824 . . . . 0.0 113.897 175.011 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -128.06 -91.17 0.5 Allowed 'General case' 0 N--CA 1.469 0.496 0 O-C-N 119.207 -2.183 . . . . 0.0 109.607 179.758 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -66.95 -174.94 0.38 Allowed 'General case' 0 C--O 1.215 -0.733 0 C-N-CA 123.713 0.805 . . . . 0.0 111.123 178.974 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 2.0 p30 -50.31 -27.02 5.47 Favored 'General case' 0 N--CA 1.47 0.575 0 N-CA-C 114.386 1.254 . . . . 0.0 114.386 173.39 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.42 ' O ' ' CD2' ' A' ' 68' ' ' HIS . . . -104.22 -118.54 4.49 Favored Glycine 0 C--O 1.214 -1.139 0 N-CA-C 106.583 -2.607 . . . . 0.0 106.583 178.01 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -121.75 -100.0 0.43 Allowed 'General case' 0 C--N 1.324 -0.505 0 N-CA-C 100.413 -3.921 . . . . 0.0 100.413 -167.542 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 144.75 -131.99 4.55 Favored Glycine 0 N--CA 1.439 -1.134 0 CA-C-N 115.232 -0.894 . . . . 0.0 113.32 -167.678 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 11.2 mttm -63.01 -104.41 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.432 0 CA-C-O 122.049 0.928 . . . . 0.0 112.673 175.986 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.534 HG23 ' O ' ' A' ' 76' ' ' THR . 0.6 OUTLIER -101.39 21.2 14.54 Favored 'General case' 0 CA--C 1.514 -0.423 0 O-C-N 120.785 -1.197 . . . . 0.0 111.588 -179.685 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.455 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 1.1 m-20 -33.25 105.06 0.03 OUTLIER 'General case' 0 CA--C 1.49 -1.343 0 C-N-CA 126.181 1.792 . . . . 0.0 109.924 -176.238 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -83.8 16.44 2.76 Favored 'General case' 0 C--N 1.319 -0.74 0 O-C-N 120.683 -1.261 . . . . 0.0 110.5 -176.759 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.487 ' CE2' ' HB2' ' A' ' 81' ' ' LEU . 10.8 p90 -41.27 136.28 1.7 Allowed 'General case' 0 N--CA 1.44 -0.952 0 C-N-CA 125.607 1.563 . . . . 0.0 110.963 177.495 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.446 HD21 HG22 ' A' ' 111' ' ' THR . 0.3 OUTLIER -77.02 136.27 38.69 Favored 'General case' 0 C--O 1.215 -0.728 0 N-CA-C 108.185 -1.043 . . . . 0.0 108.185 178.08 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.578 HD21 ' HB2' ' A' ' 35' ' ' PRO . 0.5 OUTLIER -128.84 151.91 49.09 Favored 'General case' 0 C--N 1.317 -0.832 0 CA-C-O 121.85 0.834 . . . . 0.0 109.1 175.442 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.2 pm0 -121.81 163.33 19.34 Favored 'General case' 0 N--CA 1.439 -0.985 0 C-N-CA 124.242 1.017 . . . . 0.0 112.193 178.412 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.602 ' CE1' ' HB2' ' A' ' 23' ' ' ALA . 80.1 t80 -148.21 129.04 6.97 Favored Pre-proline 0 C--N 1.329 -0.315 0 N-CA-C 113.586 0.958 . . . . 0.0 113.586 -177.629 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.5 ' HD3' ' CD1' ' A' ' 34' ' ' TYR . 17.8 Cg_endo -72.0 109.61 2.73 Favored 'Trans proline' 0 N--CA 1.443 -1.477 0 C-N-CA 123.381 2.721 . . . . 0.0 110.887 -176.176 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.469 HG21 ' HA ' ' A' ' 16' ' ' ALA . 0.0 OUTLIER -107.25 107.31 18.18 Favored 'General case' 0 CA--C 1.504 -0.789 0 CA-C-N 114.662 -1.154 . . . . 0.0 109.65 -178.062 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 68.3 m-85 -80.01 160.17 69.23 Favored Pre-proline 0 C--N 1.323 -0.548 0 N-CA-C 112.9 0.704 . . . . 0.0 112.9 177.414 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 12.8 Cg_endo -76.4 -38.66 0.98 Allowed 'Trans proline' 0 CA--C 1.493 -1.564 0 C-N-CA 122.092 1.861 . . . . 0.0 112.896 178.472 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -44.67 -30.43 0.93 Allowed 'General case' 0 N--CA 1.474 0.766 0 O-C-N 125.644 1.84 . . . . 0.0 110.92 176.874 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.74 6.61 86.94 Favored Glycine 0 N--CA 1.437 -1.281 0 N-CA-C 110.271 -1.132 . . . . 0.0 110.271 176.799 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -72.74 136.08 45.44 Favored 'General case' 0 N--CA 1.438 -1.032 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 178.858 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 37.2 t70 -68.18 85.31 0.25 Allowed 'General case' 0 C--N 1.323 -0.554 0 N-CA-C 108.149 -1.056 . . . . 0.0 108.149 175.304 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.494 ' CD2' ' HB3' ' A' ' 94' ' ' PHE . 6.7 t80 -37.29 144.25 0.08 Allowed 'General case' 0 C--O 1.214 -0.769 0 C-N-CA 123.95 0.9 . . . . 0.0 110.659 -179.554 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -75.3 55.91 0.8 Allowed 'General case' 0 C--N 1.313 -0.986 0 O-C-N 119.781 -1.825 . . . . 0.0 110.936 174.687 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.494 ' HB3' ' CD2' ' A' ' 92' ' ' TYR . 34.1 p90 -71.35 -24.17 62.04 Favored 'General case' 0 N--CA 1.441 -0.907 0 C-N-CA 124.099 0.959 . . . . 0.0 111.025 175.884 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.1 t70 -86.11 -27.66 24.52 Favored 'General case' 0 C--O 1.222 -0.383 0 C-N-CA 123.973 0.909 . . . . 0.0 110.401 178.103 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -88.9 111.57 22.25 Favored 'General case' 0 N--CA 1.451 -0.421 0 N-CA-C 108.501 -0.925 . . . . 0.0 108.501 -178.872 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.3 pttt -58.04 -49.75 75.81 Favored 'General case' 0 CA--C 1.511 -0.522 0 O-C-N 121.648 -0.658 . . . . 0.0 111.003 177.471 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.409 ' HA ' ' HA ' ' A' ' 99' ' ' PRO . 2.3 mtmm -138.07 126.08 14.03 Favored Pre-proline 0 N--CA 1.436 -1.155 0 CA-C-N 114.364 -1.289 . . . . 0.0 109.946 -175.826 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.409 ' HA ' ' HA ' ' A' ' 98' ' ' LYS . 22.9 Cg_endo -69.55 176.65 31.16 Favored 'Cis proline' 0 N--CA 1.459 -0.558 0 O-C-N 124.35 1.71 . . . . 0.0 110.949 -3.965 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -139.99 123.16 16.84 Favored 'General case' 0 C--N 1.323 -0.559 0 C-N-CA 124.845 1.258 . . . . 0.0 109.484 177.345 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -80.49 -179.37 7.14 Favored 'General case' 0 C--N 1.325 -0.462 0 O-C-N 125.309 1.63 . . . . 0.0 110.378 178.677 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -46.64 153.14 0.81 Allowed Pre-proline 0 CA--C 1.541 0.622 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.937 176.462 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -75.49 -70.62 0.02 OUTLIER 'Trans proline' 0 N--CA 1.441 -1.576 0 C-N-CA 121.998 1.799 . . . . 0.0 110.626 179.014 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 125.14 129.42 3.36 Favored Glycine 0 CA--C 1.533 1.178 0 CA-C-N 118.885 0.766 . . . . 0.0 111.214 -178.511 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.93 -69.56 0.02 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 122.924 2.416 . . . . 0.0 110.477 -179.73 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.505 ' CB ' ' CE2' ' A' ' 11' ' ' TYR . . . -66.94 132.87 48.85 Favored 'General case' 0 CA--C 1.512 -0.491 0 O-C-N 123.18 0.3 . . . . 0.0 110.732 179.105 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.446 ' HG2' ' HA ' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -139.76 152.15 46.38 Favored 'General case' 0 CA--C 1.497 -1.082 0 CA-C-O 117.719 -1.134 . . . . 0.0 110.737 -178.237 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.634 HG11 ' HB3' ' A' ' 20' ' ' SER . 3.3 p -87.32 114.17 25.91 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.665 0 O-C-N 124.153 0.908 . . . . 0.0 111.673 178.246 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.641 HG12 HD13 ' A' ' 121' ' ' ILE . 1.4 mp -98.7 118.07 44.69 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.236 0 N-CA-C 105.907 -1.886 . . . . 0.0 105.907 -173.312 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.485 ' CD1' ' CG ' ' A' ' 115' ' ' LYS . 4.6 p90 -139.03 148.0 42.82 Favored 'General case' 0 N--CA 1.438 -1.064 0 CA-C-O 123.918 1.818 . . . . 0.0 108.616 -178.897 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.446 HG22 HD21 ' A' ' 80' ' ' LEU . 4.8 p -83.27 164.87 19.82 Favored 'General case' 0 C--N 1.314 -0.942 0 CA-C-N 114.827 -1.079 . . . . 0.0 109.142 178.444 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.543 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -107.46 154.81 40.47 Favored Pre-proline 0 CA--C 1.55 0.959 0 CA-C-O 121.014 0.435 . . . . 0.0 111.072 178.495 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.543 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 15.9 Cg_endo -74.96 -53.29 0.16 OUTLIER 'Cis proline' 0 CA--C 1.498 -1.297 0 C-N-CA 124.158 -1.184 . . . . 0.0 110.071 -6.622 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.539 ' O ' HG23 ' A' ' 116' ' ' VAL . 32.7 t30 -45.82 111.39 0.35 Allowed 'General case' 0 CA--C 1.509 -0.605 0 CA-C-O 117.174 -1.393 . . . . 0.0 108.783 177.29 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.485 ' CG ' ' CD1' ' A' ' 110' ' ' TYR . 0.1 OUTLIER -65.79 79.52 0.07 Allowed 'General case' 0 CA--C 1.507 -0.691 0 C-N-CA 125.008 1.323 . . . . 0.0 109.102 -179.905 . . . . . . . . 3 3 . 1 . 003 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.539 HG23 ' O ' ' A' ' 114' ' ' ASN . 80.9 t -76.54 75.72 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.763 0 N-CA-C 105.558 -2.015 . . . . 0.0 105.558 -173.248 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.402 ' CZ ' ' NE2' ' A' ' 13' ' ' GLN . 57.3 t80 -37.68 101.92 0.02 OUTLIER 'General case' 0 C--O 1.237 0.397 0 C-N-CA 127.723 2.409 . . . . 0.0 108.822 -175.898 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . 0.508 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 16.0 m -85.4 -43.16 13.88 Favored 'General case' 0 N--CA 1.442 -0.829 0 N-CA-C 107.248 -1.39 . . . . 0.0 107.248 -176.156 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 156.79 -146.94 14.65 Favored Glycine 0 N--CA 1.443 -0.877 0 N-CA-C 109.809 -1.316 . . . . 0.0 109.809 179.194 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.47 HG13 ' CG ' ' A' ' 4' ' ' TRP . 1.4 mm -129.5 139.24 52.22 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.403 0 N-CA-C 107.717 -1.216 . . . . 0.0 107.717 -174.792 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.641 HD13 HG12 ' A' ' 109' ' ' ILE . 4.3 pt -127.33 153.1 36.14 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.912 0 N-CA-C 108.002 -1.111 . . . . 0.0 108.002 -177.321 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.662 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . . . -167.38 158.89 12.02 Favored 'General case' 0 C--N 1.323 -0.569 0 CA-C-O 122.007 0.908 . . . . 0.0 109.711 175.665 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . . . . . . . . . 5.8 m-70 -91.51 93.04 8.79 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 -177.482 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.517 HG22 ' HD3' ' A' ' 132' ' ' LYS . 1.7 t -97.63 37.63 1.36 Allowed 'General case' 0 N--CA 1.474 0.768 0 CA-C-O 123.682 1.706 . . . . 0.0 111.871 -179.5 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.0 tptm -102.98 -29.12 11.59 Favored 'General case' 0 C--O 1.218 -0.605 0 O-C-N 120.775 -1.203 . . . . 0.0 111.071 179.351 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -174.43 -65.01 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.373 0 O-C-N 124.22 0.95 . . . . 0.0 110.307 177.409 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 10.7 t30 -150.6 -46.52 0.12 Allowed 'General case' 0 N--CA 1.456 -0.137 0 CA-C-O 123.027 1.394 . . . . 0.0 110.709 179.326 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.07 76.45 0.85 Allowed 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 122.496 1.141 . . . . 0.0 111.072 -179.254 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -127.03 -106.53 1.42 Allowed Glycine 0 N--CA 1.461 0.302 0 N-CA-C 109.83 -1.308 . . . . 0.0 109.83 179.932 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -81.49 152.94 27.09 Favored 'General case' 0 C--N 1.326 -0.43 0 O-C-N 122.227 -0.573 . . . . 0.0 111.01 178.467 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . . . . . . . . . 0.6 OUTLIER -114.58 144.68 42.99 Favored 'General case' 0 C--O 1.221 -0.417 0 C-N-CA 123.666 0.786 . . . . 0.0 110.027 177.652 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.517 ' HD3' HG22 ' A' ' 124' ' ' THR . 5.8 ptmt -150.78 169.87 20.61 Favored 'General case' 0 CA--C 1.506 -0.72 0 C-N-CA 124.335 1.054 . . . . 0.0 109.261 -177.841 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 11.9 tp -81.99 138.85 34.84 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 124.557 1.161 . . . . 0.0 108.199 178.569 . . . . . . . . 1 1 . 1 . 003 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . 0.448 ' SG ' HG22 ' A' ' 120' ' ' ILE . 72.3 m -61.19 -176.57 0.07 Allowed 'General case' 0 N--CA 1.449 -0.484 0 CA-C-O 122.997 1.379 . . . . 0.0 111.133 174.716 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -158.69 112.88 2.46 Favored 'General case' 0 C--N 1.32 -0.703 0 N-CA-C 107.441 -1.318 . . . . 0.0 107.441 -178.469 . . . . . . . . 2 2 . 1 . 003 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.255 1.354 0 CA-C-O 113.429 -3.177 . . . . 0.0 110.944 173.777 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.652 ' O ' HG12 ' A' ' 2' ' ' VAL . . . . . . . . 0 CA--C 1.483 -1.598 0 CA-C-O 114.195 -2.812 . . . . 0.0 106.842 . . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.652 HG12 ' O ' ' A' ' 1' ' ' ALA . 6.9 p 49.79 176.71 0.0 OUTLIER 'Isoleucine or valine' 0 CA--C 1.539 0.527 0 O-C-N 127.062 2.726 . . . . 0.0 111.859 -176.658 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.706 HG21 HD23 ' A' ' 10' ' ' LEU . 29.9 m -106.84 115.56 30.4 Favored 'General case' 0 C--N 1.315 -0.925 0 O-C-N 121.277 -0.889 . . . . 0.0 109.923 179.422 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.681 ' CZ2' ' CD2' ' A' ' 136' ' ' HIS . 17.4 m95 -81.57 137.72 35.48 Favored 'General case' 0 N--CA 1.438 -1.027 0 N-CA-C 109.473 -0.566 . . . . 0.0 109.473 179.732 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.8 OUTLIER -131.56 139.27 49.18 Favored 'General case' 0 C--N 1.317 -0.846 0 N-CA-C 108.943 -0.762 . . . . 0.0 108.943 -178.197 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.71 ' SG ' ' HB3' ' A' ' 122' ' ' ALA . 0.5 OUTLIER -125.48 65.86 1.16 Allowed 'General case' 0 N--CA 1.445 -0.695 0 N-CA-C 109.483 -0.562 . . . . 0.0 109.483 177.643 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 40.39 70.72 0.35 Allowed Glycine 0 CA--C 1.529 0.91 0 O-C-N 123.876 0.735 . . . . 0.0 112.335 -178.707 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 177.69 -79.84 0.07 OUTLIER Glycine 0 C--O 1.227 -0.293 0 N-CA-C 111.033 -0.827 . . . . 0.0 111.033 -178.923 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 25.8 mt -135.81 164.34 28.13 Favored 'General case' 0 N--CA 1.453 -0.318 0 N-CA-C 109.888 -0.412 . . . . 0.0 109.888 178.364 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.706 HD23 HG21 ' A' ' 3' ' ' THR . 2.8 mp -83.41 139.87 32.72 Favored 'General case' 0 N--CA 1.446 -0.633 0 CA-C-N 115.604 -0.725 . . . . 0.0 110.194 179.133 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.446 ' CE2' ' CB ' ' A' ' 106' ' ' ALA . 78.5 m-85 -127.79 101.13 6.22 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 123.898 0.879 . . . . 0.0 109.643 -175.235 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -56.17 117.06 3.41 Favored 'General case' 0 N--CA 1.438 -1.067 0 CA-C-O 117.751 -1.119 . . . . 0.0 109.109 -179.822 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.685 ' O ' ' HB3' ' A' ' 16' ' ' ALA . 1.7 tp60 -43.67 -43.41 5.85 Favored 'General case' 0 C--O 1.221 -0.425 0 O-C-N 124.399 1.062 . . . . 0.0 111.533 -179.9 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.3 t-20 -48.77 -56.2 9.31 Favored 'General case' 0 N--CA 1.441 -0.912 0 CA-C-O 118.39 -0.814 . . . . 0.0 110.083 176.455 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.433 ' O ' ' CB ' ' A' ' 19' ' ' ASN . 0.2 OUTLIER -53.45 -32.02 48.08 Favored 'General case' 0 C--O 1.204 -1.34 0 CA-C-O 117.147 -1.406 . . . . 0.0 111.395 174.45 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.685 ' HB3' ' O ' ' A' ' 13' ' ' GLN . . . -55.4 -75.36 0.04 OUTLIER 'General case' 0 C--N 1.315 -0.897 0 CA-C-N 120.665 1.575 . . . . 0.0 111.784 174.013 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.405 ' O ' ' CD2' ' A' ' 21' ' ' HIS . 2.5 pt-20 -61.98 -37.42 84.75 Favored 'General case' 0 N--CA 1.438 -1.028 0 CA-C-O 117.936 -1.03 . . . . 0.0 109.913 179.459 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 34.5 t -64.24 -65.26 0.7 Allowed 'General case' 0 N--CA 1.447 -0.603 0 C-N-CA 126.212 1.805 . . . . 0.0 109.798 -179.315 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.513 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 10.2 t-20 -43.28 -32.51 0.8 Allowed 'General case' 0 N--CA 1.446 -0.667 0 C-N-CA 123.459 0.704 . . . . 0.0 111.959 174.309 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -79.58 -41.43 27.18 Favored 'General case' 0 N--CA 1.44 -0.966 0 N-CA-C 113.044 0.757 . . . . 0.0 113.044 175.237 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.405 ' CD2' ' O ' ' A' ' 17' ' ' GLU . 10.1 m170 -41.93 -39.78 1.96 Allowed 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 125.594 1.557 . . . . 0.0 109.662 179.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.513 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -73.09 -51.21 18.9 Favored 'General case' 0 N--CA 1.439 -1.007 0 O-C-N 124.418 1.074 . . . . 0.0 111.561 176.513 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.698 ' HB1' ' HG3' ' A' ' 35' ' ' PRO . . . -37.03 130.76 0.74 Allowed Pre-proline 0 N--CA 1.442 -0.836 0 O-C-N 125.28 1.612 . . . . 0.0 111.873 175.628 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.679 ' HG2' HG22 ' A' ' 30' ' ' THR . 15.5 Cg_endo -74.11 124.33 8.99 Favored 'Trans proline' 0 N--CA 1.452 -0.924 0 C-N-CA 121.662 1.574 . . . . 0.0 109.159 -177.031 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.712 HD13 ' HE2' ' A' ' 115' ' ' LYS . 5.9 tp -59.39 91.93 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.675 0 CA-C-N 115.932 -0.577 . . . . 0.0 110.947 178.986 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 178.47 159.57 0.55 Allowed 'General case' 0 N--CA 1.448 -0.565 0 O-C-N 124.264 0.977 . . . . 0.0 110.236 -176.531 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -101.95 131.05 48.58 Favored 'General case' 0 CA--C 1.507 -0.68 0 CA-C-O 118.238 -0.887 . . . . 0.0 109.972 178.978 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 41.88 71.77 0.33 Allowed Glycine 0 CA--C 1.522 0.491 0 O-C-N 124.912 1.382 . . . . 0.0 111.504 178.948 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.16 25.43 0.72 Allowed 'General case' 0 CA--C 1.514 -0.405 0 CA-C-O 121.413 0.625 . . . . 0.0 110.685 -179.925 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.679 HG22 ' HG2' ' A' ' 24' ' ' PRO . 69.2 p -123.86 150.84 44.12 Favored 'General case' 0 CA--C 1.5 -0.956 0 CA-C-O 118.663 -0.684 . . . . 0.0 109.513 -178.058 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.432 ' HA3' ' O ' ' A' ' 95' ' ' ASP . . . -39.0 -58.14 1.93 Allowed Glycine 0 N--CA 1.45 -0.42 0 O-C-N 124.853 1.345 . . . . 0.0 112.034 -178.792 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 9.6 t -70.28 -71.66 0.23 Allowed 'General case' 0 N--CA 1.443 -0.805 0 CA-C-O 118.621 -0.704 . . . . 0.0 110.648 176.509 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 58.6 p 178.91 -60.48 0.01 OUTLIER 'General case' 0 CA--C 1.518 -0.277 0 O-C-N 124.6 1.188 . . . . 0.0 111.531 -178.74 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.541 ' CD1' ' HD3' ' A' ' 84' ' ' PRO . 50.8 m-85 -62.48 149.1 89.04 Favored Pre-proline 0 N--CA 1.428 -1.542 0 C-N-CA 123.729 0.812 . . . . 0.0 111.85 178.776 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.698 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 18.5 Cg_endo -75.39 164.08 89.01 Favored 'Cis proline' 0 N--CA 1.451 -0.981 0 C-N-CA 122.48 -1.883 . . . . 0.0 110.868 -1.001 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.431 ' CD2' ' CD1' ' A' ' 34' ' ' TYR . 0.6 OUTLIER -142.24 162.09 36.36 Favored 'General case' 0 CA--C 1.511 -0.521 0 CA-C-N 115.297 -0.865 . . . . 0.0 110.211 -178.3 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.93 ' CZ3' HG22 ' A' ' 39' ' ' THR . 21.5 t90 -61.58 132.01 51.92 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 108.298 -1.001 . . . . 0.0 108.298 179.308 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 8.2 t80 -104.07 78.01 1.48 Allowed 'General case' 0 N--CA 1.428 -1.569 0 C-N-CA 124.903 1.281 . . . . 0.0 108.157 -178.388 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.93 HG22 ' CZ3' ' A' ' 37' ' ' TRP . 78.7 p -37.42 -38.67 0.25 Allowed 'General case' 0 CA--C 1.509 -0.62 0 O-C-N 124.167 0.917 . . . . 0.0 110.455 177.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 44.6 t30 62.8 12.63 5.84 Favored 'General case' 0 N--CA 1.447 -0.588 0 CA-C-O 122.747 1.26 . . . . 0.0 108.748 178.322 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 114.59 -35.49 4.4 Favored Glycine 0 N--CA 1.429 -1.797 0 O-C-N 119.666 -1.896 . . . . 0.0 112.309 -174.992 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.658 ' N ' HD23 ' A' ' 48' ' ' LEU . 59.8 m-85 -50.48 162.27 0.25 Allowed 'General case' 0 N--CA 1.448 -0.547 0 CA-C-O 121.185 0.517 . . . . 0.0 111.807 178.225 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.21 -38.24 22.52 Favored 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.248 -0.887 . . . . 0.0 110.464 178.654 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.445 ' CA ' ' HB3' ' A' ' 68' ' ' HIS . . . 125.98 41.37 0.34 Allowed Glycine 0 N--CA 1.437 -1.251 0 CA-C-N 115.71 -0.677 . . . . 0.0 112.634 -176.923 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -146.01 -70.07 0.26 Allowed 'General case' 0 C--N 1.327 -0.404 0 N-CA-C 109.758 -0.46 . . . . 0.0 109.758 -179.496 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -150.16 -74.61 0.01 OUTLIER Glycine 0 N--CA 1.435 -1.408 0 N-CA-C 109.352 -1.499 . . . . 0.0 109.352 -177.759 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.8 pttt -98.29 178.57 5.02 Favored 'General case' 0 C--N 1.326 -0.415 0 CA-C-N 118.257 1.029 . . . . 0.0 110.648 178.311 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.697 ' H ' HD12 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -106.03 163.72 16.47 Favored Pre-proline 0 N--CA 1.444 -0.74 0 CA-C-N 115.984 -0.553 . . . . 0.0 109.569 -179.548 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -74.63 163.11 36.61 Favored 'Trans proline' 0 N--CA 1.453 -0.866 0 C-N-CA 121.762 1.641 . . . . 0.0 110.624 179.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.71 97.34 0.05 Allowed 'General case' 0 N--CA 1.45 -0.456 0 N-CA-C 108.897 -0.779 . . . . 0.0 108.897 178.715 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 125.06 54.59 0.17 Allowed Glycine 0 N--CA 1.447 -0.633 0 O-C-N 121.436 -0.79 . . . . 0.0 111.668 -179.032 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.8 OUTLIER -150.95 145.9 25.9 Favored 'General case' 0 N--CA 1.452 -0.335 0 O-C-N 124.127 0.545 . . . . 0.0 110.963 177.864 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 6.3 m -139.01 98.99 8.31 Favored Pre-proline 0 N--CA 1.45 -0.457 0 O-C-N 124.407 1.067 . . . . 0.0 109.861 -178.702 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.509 ' HG3' HD21 ' A' ' 48' ' ' LEU . 19.1 Cg_endo -73.56 166.93 28.56 Favored 'Trans proline' 0 N--CA 1.45 -1.03 0 C-N-CA 121.626 1.55 . . . . 0.0 111.207 179.112 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.562 HD11 ' HG ' ' A' ' 131' ' ' LEU . 5.6 mt -79.58 125.96 38.95 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.687 0 N-CA-C 108.102 -1.073 . . . . 0.0 108.102 -178.228 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.9 tppt? -81.69 155.71 25.42 Favored 'General case' 0 N--CA 1.448 -0.542 0 CA-C-O 121.125 0.488 . . . . 0.0 109.709 178.142 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.505 ' CD1' ' HB3' ' A' ' 118' ' ' CYS . 21.6 m-85 -139.01 -46.88 0.48 Allowed 'General case' 0 N--CA 1.448 -0.533 0 CA-C-N 115.619 -0.719 . . . . 0.0 111.233 178.314 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 119.44 -2.35 14.0 Favored Glycine 0 CA--C 1.522 0.491 0 CA-C-N 116.005 -0.543 . . . . 0.0 112.178 -176.824 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.2 mmtt -96.07 141.86 28.96 Favored 'General case' 0 CA--C 1.507 -0.709 0 CA-C-O 117.625 -1.179 . . . . 0.0 109.774 178.847 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -79.43 -7.1 58.17 Favored 'General case' 0 C--N 1.327 -0.388 0 O-C-N 124.832 1.333 . . . . 0.0 110.721 177.926 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 2.7 m-20 -90.9 -53.06 4.55 Favored 'General case' 0 N--CA 1.446 -0.65 0 C-N-CA 123.71 0.804 . . . . 0.0 109.135 -179.004 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.593 ' SG ' HD21 ' A' ' 80' ' ' LEU . 4.9 t -72.18 -16.02 61.96 Favored 'General case' 0 N--CA 1.45 -0.473 0 O-C-N 124.103 0.877 . . . . 0.0 110.672 176.606 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.5 t70 -86.68 -37.79 17.63 Favored 'General case' 0 N--CA 1.449 -0.483 0 O-C-N 123.57 0.544 . . . . 0.0 111.043 177.158 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -49.17 165.15 0.28 Allowed Pre-proline 0 N--CA 1.441 -0.912 0 CA-C-O 121.991 0.9 . . . . 0.0 111.237 179.625 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 22.4 Cg_endo -72.6 124.59 9.91 Favored 'Trans proline' 0 N--CA 1.441 -1.607 0 C-N-CA 120.927 1.084 . . . . 0.0 113.076 175.705 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.45 ' HD3' ' CZ ' ' A' ' 42' ' ' TYR . 19.0 Cg_endo -74.26 167.39 27.28 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 122.881 2.387 . . . . 0.0 110.253 -179.748 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.2 tptt -127.54 104.03 7.66 Favored 'General case' 0 C--O 1.213 -0.82 0 CA-C-O 115.957 -1.973 . . . . 0.0 107.68 -179.84 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.621 ' CD2' ' CD2' ' A' ' 37' ' ' TRP . 19.2 t-80 -93.55 161.92 14.17 Favored 'General case' 0 C--N 1.325 -0.473 0 O-C-N 124.47 1.106 . . . . 0.0 110.341 176.587 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.405 ' HB2' ' OD2' ' A' ' 77' ' ' ASP . 0.3 OUTLIER -152.32 176.76 11.28 Favored 'General case' 0 N--CA 1.449 -0.489 0 CA-C-N 115.423 -0.808 . . . . 0.0 110.153 179.478 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -87.74 63.02 7.29 Favored 'General case' 0 C--O 1.224 -0.263 0 CA-C-N 116.234 -0.439 . . . . 0.0 110.695 178.0 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -177.41 -39.0 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.547 0 CA-C-N 115.757 -0.656 . . . . 0.0 109.885 179.533 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 122.59 -65.64 0.5 Allowed Glycine 0 N--CA 1.44 -1.056 0 CA-C-N 115.638 -0.71 . . . . 0.0 111.515 -178.549 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.6 p30 -120.51 62.03 0.86 Allowed 'General case' 0 N--CA 1.444 -0.754 0 N-CA-C 109.327 -0.62 . . . . 0.0 109.327 179.041 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -56.13 -105.61 0.01 OUTLIER Glycine 0 CA--C 1.532 1.149 0 CA-C-O 123.362 1.534 . . . . 0.0 112.236 -178.749 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 16.1 mttp -70.76 -104.59 0.0 OUTLIER 'General case' 0 C--O 1.218 -0.556 0 O-C-N 120.07 -1.841 . . . . 0.0 110.285 178.438 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.581 HG23 ' O ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -109.21 16.62 22.33 Favored 'General case' 0 N--CA 1.447 -0.607 0 O-C-N 121.553 -0.717 . . . . 0.0 110.65 179.45 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.47 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 5.4 m-20 -29.73 102.25 0.02 OUTLIER 'General case' 0 N--CA 1.446 -0.672 0 C-N-CA 123.838 0.855 . . . . 0.0 111.651 -179.138 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.57 ' CD2' ' H ' ' A' ' 78' ' ' HIS . 4.9 p80 -87.88 28.13 1.07 Allowed 'General case' 0 C--N 1.33 -0.255 0 N-CA-C 109.316 -0.624 . . . . 0.0 109.316 -175.908 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 1.062 ' CE1' HD11 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -54.46 168.16 0.28 Allowed 'General case' 0 N--CA 1.43 -1.454 0 N-CA-C 114.832 1.419 . . . . 0.0 114.832 174.897 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.699 HD23 ' O ' ' A' ' 110' ' ' TYR . 0.6 OUTLIER -98.26 158.05 15.8 Favored 'General case' 0 CA--C 1.512 -0.488 0 CA-C-O 118.477 -0.773 . . . . 0.0 109.758 176.947 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 1.062 HD11 ' CE1' ' A' ' 79' ' ' TYR . 1.4 mp -141.82 130.69 23.01 Favored 'General case' 0 CA--C 1.514 -0.433 0 C-N-CA 123.298 0.639 . . . . 0.0 109.511 178.863 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.471 ' CB ' ' CD1' ' A' ' 109' ' ' ILE . 0.4 OUTLIER -99.95 151.08 21.74 Favored 'General case' 0 N--CA 1.446 -0.652 0 CA-C-O 121.565 0.698 . . . . 0.0 110.995 179.138 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.598 ' CZ ' ' HB2' ' A' ' 23' ' ' ALA . 28.7 t80 -142.0 121.01 7.85 Favored Pre-proline 0 N--CA 1.444 -0.774 0 CA-C-N 115.68 -0.691 . . . . 0.0 112.273 -178.853 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.541 ' HD3' ' CD1' ' A' ' 34' ' ' TYR . 19.4 Cg_endo -72.9 111.73 3.34 Favored 'Trans proline' 0 N--CA 1.451 -0.976 0 C-N-CA 122.886 2.391 . . . . 0.0 110.193 -177.191 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -108.55 125.54 51.94 Favored 'General case' 0 N--CA 1.449 -0.52 0 CA-C-N 115.341 -0.845 . . . . 0.0 110.125 -179.855 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.485 ' CD2' ' NE2' ' A' ' 90' ' ' HIS . 63.5 m-85 -82.89 155.74 67.71 Favored Pre-proline 0 N--CA 1.443 -0.822 0 CA-C-N 115.577 -0.738 . . . . 0.0 112.012 178.836 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 17.5 Cg_endo -77.64 -42.12 0.29 Allowed 'Trans proline' 0 CA--C 1.505 -0.931 0 C-N-CA 122.104 1.869 . . . . 0.0 111.898 -179.861 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -43.25 -30.88 0.54 Allowed 'General case' 0 C--N 1.346 0.426 0 O-C-N 125.078 1.486 . . . . 0.0 110.293 177.428 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 99.87 -12.48 60.86 Favored Glycine 0 N--CA 1.436 -1.364 0 N-CA-C 109.908 -1.277 . . . . 0.0 109.908 177.151 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.485 ' NE2' ' CD2' ' A' ' 86' ' ' PHE . 4.8 p-80 -58.38 128.77 38.83 Favored 'General case' 0 N--CA 1.44 -0.925 0 O-C-N 124.325 0.662 . . . . 0.0 109.449 179.005 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 36.7 t70 -68.95 101.47 1.39 Allowed 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 108.893 -0.78 . . . . 0.0 108.893 179.086 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.488 ' O ' ' CD2' ' A' ' 94' ' ' PHE . 6.5 t80 -34.26 138.38 0.09 Allowed 'General case' 0 N--CA 1.448 -0.574 0 CA-C-O 122.028 0.918 . . . . 0.0 111.463 178.858 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.407 ' HE2' ' O ' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -78.96 60.08 2.81 Favored 'General case' 0 N--CA 1.442 -0.852 0 O-C-N 120.081 -1.637 . . . . 0.0 109.953 177.75 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.488 ' CD2' ' O ' ' A' ' 92' ' ' TYR . 30.4 p90 -75.55 1.7 13.61 Favored 'General case' 0 N--CA 1.441 -0.905 0 C-N-CA 123.269 0.628 . . . . 0.0 112.084 177.207 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.432 ' O ' ' HA3' ' A' ' 31' ' ' GLY . 36.7 t0 -95.79 -38.8 10.16 Favored 'General case' 0 N--CA 1.452 -0.375 0 CA-C-O 122.394 1.092 . . . . 0.0 109.115 179.397 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -80.75 110.03 15.86 Favored 'General case' 0 N--CA 1.447 -0.612 0 O-C-N 120.862 -1.149 . . . . 0.0 109.36 -178.883 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 6.8 pttt -57.86 -50.28 73.85 Favored 'General case' 0 N--CA 1.451 -0.404 0 CA-C-N 116.192 -0.458 . . . . 0.0 110.04 178.51 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -146.46 127.51 7.26 Favored Pre-proline 0 N--CA 1.431 -1.401 0 CA-C-N 115.504 -0.771 . . . . 0.0 109.802 -176.734 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.407 ' O ' ' HE2' ' A' ' 93' ' ' LYS . 21.7 Cg_endo -73.05 178.04 34.09 Favored 'Cis proline' 0 N--CA 1.458 -0.596 0 O-C-N 125.093 2.102 . . . . 0.0 111.232 -2.354 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -142.0 132.39 25.11 Favored 'General case' 0 N--CA 1.452 -0.364 0 N-CA-C 109.563 -0.532 . . . . 0.0 109.563 179.14 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 3.6 tt0 -72.67 145.02 47.53 Favored 'General case' 0 C--N 1.322 -0.616 0 O-C-N 124.244 0.965 . . . . 0.0 109.312 178.922 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -42.09 156.83 0.22 Allowed Pre-proline 0 N--CA 1.45 -0.448 0 O-C-N 123.74 0.65 . . . . 0.0 111.411 177.709 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -72.49 -163.13 0.14 Allowed 'Trans proline' 0 N--CA 1.454 -0.816 0 C-N-CA 121.235 1.29 . . . . 0.0 111.142 179.704 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -139.85 154.33 23.73 Favored Glycine 0 N--CA 1.441 -0.988 0 CA-C-N 115.961 -0.563 . . . . 0.0 112.04 178.523 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -75.52 -66.55 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.841 0 C-N-CA 122.143 1.895 . . . . 0.0 110.131 -179.871 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.563 ' HA ' ' HB2' ' A' ' 122' ' ' ALA . . . -69.19 135.75 51.07 Favored 'General case' 0 N--CA 1.443 -0.78 0 O-C-N 124.298 0.999 . . . . 0.0 110.907 178.551 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.425 ' HG2' ' HA ' ' A' ' 84' ' ' PRO . 4.3 mtt85 -141.47 146.02 35.94 Favored 'General case' 0 N--CA 1.448 -0.541 0 O-C-N 123.913 0.758 . . . . 0.0 110.716 -178.848 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.452 ' O ' HD13 ' A' ' 109' ' ' ILE . 7.7 p -83.6 128.89 38.37 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.52 0 O-C-N 123.736 0.648 . . . . 0.0 109.869 178.865 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.656 ' CG2' HD22 ' A' ' 80' ' ' LEU . 9.1 mm -107.9 142.83 19.58 Favored 'Isoleucine or valine' 0 CA--C 1.503 -0.861 0 CA-C-O 118.571 -0.728 . . . . 0.0 109.938 179.509 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.699 ' O ' HD23 ' A' ' 80' ' ' LEU . 12.4 p90 -167.15 155.45 9.67 Favored 'General case' 0 N--CA 1.442 -0.839 0 O-C-N 124.121 0.888 . . . . 0.0 111.14 -179.767 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.0 p -91.83 164.71 13.59 Favored 'General case' 0 C--N 1.32 -0.687 0 CA-C-N 115.778 -0.646 . . . . 0.0 109.476 -177.91 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.568 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -111.93 154.35 44.19 Favored Pre-proline 0 N--CA 1.442 -0.866 0 C-N-CA 122.45 0.3 . . . . 0.0 110.898 179.536 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.568 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 18.6 Cg_endo -74.52 -54.03 0.15 OUTLIER 'Cis proline' 0 CA--C 1.509 -0.748 0 C-N-CA 122.523 -1.865 . . . . 0.0 109.468 -4.345 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 2.2 t-20 -42.92 111.49 0.27 Allowed 'General case' 0 CA--C 1.507 -0.692 0 CA-C-O 116.45 -1.738 . . . . 0.0 109.722 -179.985 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.712 ' HE2' HD13 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -63.09 76.35 0.02 OUTLIER 'General case' 0 CA--C 1.515 -0.375 0 O-C-N 125.77 1.919 . . . . 0.0 109.123 -178.44 . . . . . . . . 3 3 . 1 . 004 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.591 ' O ' HG12 ' A' ' 116' ' ' VAL . 8.8 t -77.01 71.25 0.44 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.595 0 N-CA-C 106.278 -1.749 . . . . 0.0 106.278 -176.972 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.594 ' CZ ' ' HA2' ' A' ' 119' ' ' GLY . 27.9 t80 -35.63 110.6 0.11 Allowed 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 123.16 0.584 . . . . 0.0 111.132 178.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . 0.63 ' SG ' HD21 ' A' ' 80' ' ' LEU . 6.2 m -82.61 -45.5 14.49 Favored 'General case' 0 N--CA 1.437 -1.122 0 N-CA-C 108.312 -0.996 . . . . 0.0 108.312 -179.984 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.594 ' HA2' ' CZ ' ' A' ' 117' ' ' PHE . . . 161.93 -145.05 10.32 Favored Glycine 0 N--CA 1.443 -0.87 0 N-CA-C 110.867 -0.893 . . . . 0.0 110.867 -179.239 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.511 HG13 ' CD2' ' A' ' 4' ' ' TRP . 1.1 mm -127.63 136.97 59.01 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.82 0 N-CA-C 107.629 -1.248 . . . . 0.0 107.629 -176.45 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.729 HD12 HD21 ' A' ' 131' ' ' LEU . 9.2 pt -127.36 156.06 38.8 Favored 'Isoleucine or valine' 0 C--N 1.315 -0.918 0 N-CA-C 108.179 -1.045 . . . . 0.0 108.179 -177.69 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.71 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . . . -173.9 145.9 1.17 Allowed 'General case' 0 C--N 1.323 -0.558 0 CA-C-O 121.515 0.674 . . . . 0.0 109.82 178.053 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.74 ' CE1' HD22 ' A' ' 131' ' ' LEU . 3.9 m-70 -90.37 93.59 9.39 Favored 'General case' 0 N--CA 1.444 -0.759 0 CA-C-N 115.557 -0.747 . . . . 0.0 109.038 -177.483 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.9 p -103.15 46.18 0.93 Allowed 'General case' 0 C--N 1.315 -0.893 0 N-CA-C 109.233 -0.655 . . . . 0.0 109.233 -177.198 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -108.36 -23.68 11.79 Favored 'General case' 0 N--CA 1.453 -0.319 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.833 177.493 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.4 OUTLIER -174.25 -64.02 0.01 OUTLIER 'General case' 0 C--O 1.223 -0.314 0 O-C-N 123.72 0.638 . . . . 0.0 110.801 178.064 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 4.0 t30 -155.31 -46.03 0.08 Allowed 'General case' 0 N--CA 1.448 -0.532 0 CA-C-O 122.146 0.974 . . . . 0.0 110.028 179.076 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.2 OUTLIER -159.57 76.89 0.68 Allowed 'General case' 0 N--CA 1.444 -0.77 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.93 -179.53 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -127.92 -104.3 1.23 Allowed Glycine 0 N--CA 1.452 -0.239 0 N-CA-C 110.892 -0.883 . . . . 0.0 110.892 179.875 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -77.71 144.98 36.85 Favored 'General case' 0 C--N 1.328 -0.343 0 O-C-N 122.444 -0.445 . . . . 0.0 111.086 179.946 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.74 HD22 ' CE1' ' A' ' 123' ' ' HIS . 4.4 tp -109.77 136.79 48.54 Favored 'General case' 0 N--CA 1.447 -0.589 0 C-N-CA 122.475 0.31 . . . . 0.0 110.896 178.346 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -143.03 171.73 13.67 Favored 'General case' 0 CA--C 1.51 -0.577 0 N-CA-C 109.309 -0.626 . . . . 0.0 109.309 -178.745 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.721 HD12 HG22 ' A' ' 121' ' ' ILE . 5.2 tp -88.12 143.23 27.18 Favored 'General case' 0 C--N 1.328 -0.365 0 O-C-N 124.562 1.164 . . . . 0.0 109.135 178.766 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . 0.47 ' SG ' HG22 ' A' ' 120' ' ' ILE . 76.0 m -62.04 -172.21 0.03 OUTLIER 'General case' 0 N--CA 1.442 -0.862 0 CA-C-O 122.088 0.946 . . . . 0.0 109.707 177.302 . . . . . . . . 2 2 . 1 . 004 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 19.5 m -133.04 92.46 3.03 Favored 'General case' 0 C--N 1.321 -0.647 0 CA-C-N 115.625 -0.716 . . . . 0.0 109.469 -179.006 . . . . . . . . 1 1 . 1 . 004 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.681 ' CD2' ' CZ2' ' A' ' 4' ' ' TRP . 2.1 p-80 . . . . . 0 C--O 1.25 1.097 0 CA-C-O 116.886 -1.531 . . . . 0.0 112.258 176.35 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.534 0 N-CA-C 107.472 -1.307 . . . . 0.0 107.472 . . . . . . . . . 0 0 . 1 . 005 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 12.4 p -119.94 132.29 70.03 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.4 0 N-CA-C 108.12 -1.067 . . . . 0.0 108.12 -178.055 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 17.2 m -89.52 109.05 20.02 Favored 'General case' 0 C--N 1.317 -0.818 0 O-C-N 121.488 -0.758 . . . . 0.0 109.553 -179.261 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.418 ' CG ' HG13 ' A' ' 120' ' ' ILE . 39.7 m95 -77.32 140.0 39.9 Favored 'General case' 0 N--CA 1.444 -0.77 0 C-N-CA 124.065 0.946 . . . . 0.0 110.54 178.549 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 4.6 m -124.57 120.24 31.37 Favored 'General case' 0 C--N 1.317 -0.847 0 CA-C-O 122.093 0.949 . . . . 0.0 109.045 -176.118 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.555 ' HB3' ' HB3' ' A' ' 122' ' ' ALA . 74.9 m -103.87 64.56 0.79 Allowed 'General case' 0 N--CA 1.445 -0.714 0 N-CA-C 107.461 -1.311 . . . . 0.0 107.461 -179.943 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 34.65 60.14 0.65 Allowed Glycine 0 C--N 1.341 0.806 0 C-N-CA 124.992 1.282 . . . . 0.0 113.007 178.95 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.599 ' C ' HD13 ' A' ' 9' ' ' LEU . . . 170.02 -80.97 0.09 OUTLIER Glycine 0 C--O 1.224 -0.491 0 N-CA-C 110.501 -1.039 . . . . 0.0 110.501 -175.21 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.707 HD23 ' OH ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -114.66 159.05 20.94 Favored 'General case' 0 C--O 1.24 0.567 0 C-N-CA 124.488 1.115 . . . . 0.0 108.787 -176.198 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.534 HD13 ' C ' ' A' ' 9' ' ' LEU . 0.0 OUTLIER -110.74 125.33 53.4 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 108.101 -1.074 . . . . 0.0 108.101 -172.019 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.707 ' OH ' HD23 ' A' ' 9' ' ' LEU . 89.5 m-85 -117.06 106.68 13.64 Favored 'General case' 0 C--N 1.316 -0.876 0 C-N-CA 126.441 1.896 . . . . 0.0 108.537 -172.043 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 12.6 t-20 -58.7 127.81 34.06 Favored 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 119.631 -0.828 . . . . 0.0 110.31 177.171 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.475 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 7.0 tp-100 -54.82 -44.49 73.9 Favored 'General case' 0 C--O 1.217 -0.626 0 O-C-N 121.373 -0.83 . . . . 0.0 112.773 178.311 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -51.71 -26.3 9.06 Favored 'General case' 0 C--O 1.213 -0.845 0 N-CA-C 112.435 0.532 . . . . 0.0 112.435 175.874 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -85.18 -41.66 15.43 Favored 'General case' 0 C--O 1.206 -1.217 0 CA-C-O 116.174 -1.87 . . . . 0.0 113.418 170.235 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.55 -62.91 1.35 Allowed 'General case' 0 CA--C 1.537 0.469 0 CA-C-N 121.705 2.048 . . . . 0.0 113.08 175.167 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 2.3 pt-20 -58.03 -43.61 86.87 Favored 'General case' 0 C--N 1.333 -0.137 0 O-C-N 121.543 -0.723 . . . . 0.0 110.73 174.214 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 45.5 t -61.93 -23.21 66.21 Favored 'General case' 0 C--O 1.222 -0.381 0 O-C-N 121.89 -0.506 . . . . 0.0 111.354 175.595 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -71.11 -63.89 1.02 Allowed 'General case' 0 N--CA 1.438 -1.059 0 O-C-N 120.603 -1.31 . . . . 0.0 108.439 -179.531 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.7 OUTLIER -62.39 -15.91 51.61 Favored 'General case' 0 C--N 1.332 -0.163 0 CA-C-N 114.669 -1.151 . . . . 0.0 111.518 178.021 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 1.4 m170 -59.41 -51.86 68.08 Favored 'General case' 0 CA--C 1.517 -0.306 0 O-C-N 121.296 -0.878 . . . . 0.0 110.91 178.284 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -74.92 -41.02 60.51 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 123.811 0.694 . . . . 0.0 111.15 178.212 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.752 ' HB2' ' CZ ' ' A' ' 83' ' ' PHE . . . -43.14 131.4 3.33 Favored Pre-proline 0 N--CA 1.447 -0.577 0 O-C-N 124.651 1.219 . . . . 0.0 112.441 177.801 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.616 ' HG2' HG22 ' A' ' 30' ' ' THR . 19.2 Cg_endo -71.18 123.65 9.8 Favored 'Trans proline' 0 N--CA 1.444 -1.414 0 C-N-CA 122.053 1.835 . . . . 0.0 109.54 -177.195 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.75 HD13 ' HE2' ' A' ' 115' ' ' LYS . 5.7 tp -61.48 96.66 0.06 Allowed 'General case' 0 N--CA 1.452 -0.333 0 C-N-CA 123.625 0.77 . . . . 0.0 110.94 179.028 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 178.2 165.21 0.74 Allowed 'General case' 0 C--N 1.323 -0.558 0 C-N-CA 124.041 0.936 . . . . 0.0 109.728 -175.118 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -102.73 121.28 42.13 Favored 'General case' 0 CA--C 1.511 -0.525 0 C-N-CA 124.749 1.22 . . . . 0.0 109.688 177.041 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 48.77 67.9 1.51 Allowed Glycine 0 CA--C 1.525 0.707 0 CA-C-O 121.772 0.651 . . . . 0.0 112.636 174.802 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.05 28.47 1.01 Allowed 'General case' 0 N--CA 1.469 0.514 0 C-N-CA 123.599 0.76 . . . . 0.0 112.759 -178.233 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.616 HG22 ' HG2' ' A' ' 24' ' ' PRO . 71.9 p -127.56 151.03 49.42 Favored 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.042 -1.096 . . . . 0.0 108.042 -175.442 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -40.17 -58.22 2.42 Favored Glycine 0 C--O 1.228 -0.242 0 C-N-CA 123.655 0.645 . . . . 0.0 113.714 -179.398 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.444 ' HB3' ' HA ' ' A' ' 94' ' ' PHE . 29.2 t -67.18 -72.64 0.16 Allowed 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 123.772 0.336 . . . . 0.0 111.623 173.535 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 47.8 p 177.96 -56.05 0.01 OUTLIER 'General case' 0 N--CA 1.465 0.287 0 C-N-CA 124.194 0.998 . . . . 0.0 112.827 -178.474 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.509 ' CD2' ' HD3' ' A' ' 84' ' ' PRO . 69.9 m-85 -68.87 147.36 97.84 Favored Pre-proline 0 N--CA 1.442 -0.857 0 C-N-CA 124.931 1.292 . . . . 0.0 113.286 179.8 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.726 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 26.1 Cg_endo -75.49 165.53 85.46 Favored 'Cis proline' 0 N--CA 1.445 -1.353 0 C-N-CA 123.938 -1.276 . . . . 0.0 111.186 1.567 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.661 ' C ' HD23 ' A' ' 81' ' ' LEU . 1.1 p80 -141.47 171.8 13.56 Favored 'General case' 0 CA--C 1.504 -0.797 0 CA-C-N 114.87 -1.059 . . . . 0.0 109.574 -177.987 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.885 ' CH2' HG22 ' A' ' 39' ' ' THR . 22.0 t90 -72.17 128.08 34.58 Favored 'General case' 0 N--CA 1.447 -0.613 0 CA-C-O 122.687 1.232 . . . . 0.0 109.726 175.564 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.497 ' CZ ' ' HA ' ' A' ' 40' ' ' ASN . 19.3 t80 -98.29 86.15 3.59 Favored 'General case' 0 N--CA 1.431 -1.403 0 C-N-CA 126.674 1.989 . . . . 0.0 107.041 176.612 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.885 HG22 ' CH2' ' A' ' 37' ' ' TRP . 69.0 p -40.36 -33.43 0.25 Allowed 'General case' 0 C--O 1.217 -0.645 0 CA-C-N 114.656 -1.156 . . . . 0.0 111.105 172.062 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.497 ' HA ' ' CZ ' ' A' ' 38' ' ' PHE . 57.1 t30 68.56 5.92 5.13 Favored 'General case' 0 N--CA 1.453 -0.319 0 C-N-CA 124.519 1.128 . . . . 0.0 110.878 -178.516 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.4 ' CA ' ' HD2' ' A' ' 52' ' ' ARG . . . 115.96 -26.41 8.85 Favored Glycine 0 N--CA 1.432 -1.59 0 C-N-CA 125.066 1.317 . . . . 0.0 116.095 -171.427 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.517 ' N ' HD23 ' A' ' 48' ' ' LEU . 58.4 m-85 -54.57 -178.16 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.534 0 CA-C-O 122.365 1.079 . . . . 0.0 110.299 176.755 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -103.87 -40.7 6.14 Favored 'General case' 0 C--N 1.321 -0.638 0 C-N-CA 124.462 1.105 . . . . 0.0 110.763 179.574 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.493 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -174.05 -61.55 0.05 OUTLIER Glycine 0 C--N 1.336 0.549 0 C-N-CA 123.751 0.691 . . . . 0.0 112.641 -178.038 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 6.7 m-20 -82.92 -98.62 0.05 OUTLIER 'General case' 0 N--CA 1.448 -0.537 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 178.424 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.434 ' HA2' ' CD2' ' A' ' 42' ' ' TYR . . . -138.84 29.76 2.53 Favored Glycine 0 N--CA 1.444 -0.833 0 C-N-CA 125.048 1.308 . . . . 0.0 111.674 -174.359 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 1.9 mttt -126.87 149.19 49.88 Favored 'General case' 0 CA--C 1.509 -0.604 0 CA-C-O 118.144 -0.931 . . . . 0.0 108.737 -178.718 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.517 HD23 ' N ' ' A' ' 42' ' ' TYR . 0.3 OUTLIER -115.38 160.51 34.11 Favored Pre-proline 0 C--N 1.325 -0.485 0 O-C-N 124.406 1.066 . . . . 0.0 109.187 -178.11 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -69.02 157.54 61.43 Favored 'Trans proline' 0 N--CA 1.443 -1.459 0 C-N-CA 121.884 1.723 . . . . 0.0 110.161 177.671 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.9 ttpm? -49.27 104.41 0.06 Allowed 'General case' 0 CA--C 1.532 0.259 0 C-N-CA 124.094 0.958 . . . . 0.0 110.352 176.317 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 80.74 87.98 0.59 Allowed Glycine 0 CA--C 1.524 0.601 0 O-C-N 123.572 0.545 . . . . 0.0 111.851 -174.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.445 ' HD3' ' N ' ' A' ' 53' ' ' THR . 0.0 OUTLIER -150.83 155.53 39.4 Favored 'General case' 0 CA--C 1.516 -0.365 0 C-N-CA 123.164 0.586 . . . . 0.0 110.552 174.648 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . 0.445 ' N ' ' HD3' ' A' ' 52' ' ' ARG . 4.0 m -138.92 101.59 7.78 Favored Pre-proline 0 C--N 1.329 -0.305 0 O-C-N 124.014 0.821 . . . . 0.0 111.439 178.925 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -66.4 153.74 76.87 Favored 'Trans proline' 0 N--CA 1.448 -1.148 0 C-N-CA 123.856 3.038 . . . . 0.0 112.073 177.518 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.479 HD11 ' HG ' ' A' ' 131' ' ' LEU . 4.8 mt -66.74 127.33 28.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.499 0 N-CA-C 106.897 -1.52 . . . . 0.0 106.897 179.372 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -95.39 134.45 38.18 Favored 'General case' 0 CA--C 1.518 -0.28 0 N-CA-C 108.945 -0.761 . . . . 0.0 108.945 176.029 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.484 ' CE2' HD13 ' A' ' 133' ' ' LEU . 1.7 m-85 -119.62 -55.31 2.12 Favored 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 124.213 1.005 . . . . 0.0 110.623 -179.445 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 120.42 -2.9 12.49 Favored Glycine 0 CA--C 1.524 0.611 0 C-N-CA 124.88 1.228 . . . . 0.0 113.469 -176.058 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.413 ' HD2' ' CG1' ' A' ' 116' ' ' VAL . 1.8 mmtp -66.46 177.66 1.46 Allowed 'General case' 0 C--O 1.215 -0.735 0 O-C-N 122.065 -0.667 . . . . 0.0 111.364 173.481 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.0 p -104.23 -47.17 4.22 Favored 'General case' 0 C--O 1.216 -0.679 0 CA-C-N 115.817 -0.629 . . . . 0.0 111.153 177.324 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -77.45 -41.03 41.21 Favored 'General case' 0 CA--C 1.518 -0.275 0 C-N-CA 123.097 0.559 . . . . 0.0 110.892 177.542 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.477 ' SG ' ' CD1' ' A' ' 57' ' ' PHE . 1.5 t -74.25 -17.37 60.88 Favored 'General case' 0 N--CA 1.465 0.309 0 C-N-CA 122.786 0.434 . . . . 0.0 110.736 178.61 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.1 t70 -87.58 -38.31 16.08 Favored 'General case' 0 C--N 1.332 -0.181 0 C-N-CA 123.115 0.566 . . . . 0.0 112.31 171.456 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.78 163.8 1.92 Allowed Pre-proline 0 N--CA 1.448 -0.57 0 CA-C-O 121.785 0.803 . . . . 0.0 111.491 -178.247 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -70.54 138.75 36.01 Favored 'Trans proline' 0 N--CA 1.439 -1.69 0 C-N-CA 120.401 0.734 . . . . 0.0 112.232 175.735 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -68.21 175.29 6.89 Favored 'Trans proline' 0 N--CA 1.448 -1.2 0 C-N-CA 122.952 2.435 . . . . 0.0 111.965 175.817 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 4.8 tptt -136.98 56.27 1.8 Allowed 'General case' 0 C--O 1.209 -1.041 0 O-C-N 120.835 -1.165 . . . . 0.0 108.685 174.159 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 51.5 t-80 -77.54 165.05 24.82 Favored 'General case' 0 C--N 1.329 -0.285 0 C-N-CA 119.16 -1.016 . . . . 0.0 110.488 177.693 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -155.57 -165.62 2.03 Favored 'General case' 0 C--N 1.328 -0.349 0 C-N-CA 123.908 0.883 . . . . 0.0 111.241 178.197 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.11 73.69 10.36 Favored 'General case' 0 C--O 1.219 -0.509 0 O-C-N 121.322 -0.862 . . . . 0.0 111.146 175.602 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -176.89 -43.35 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.507 0 O-C-N 124.419 1.074 . . . . 0.0 111.367 178.637 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.452 ' O ' ' CE2' ' A' ' 79' ' ' TYR . . . 122.53 -52.65 0.75 Allowed Glycine 0 C--O 1.217 -0.918 0 CA-C-N 114.693 -1.139 . . . . 0.0 111.208 -177.79 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 8.0 t30 -148.59 86.18 1.52 Allowed 'General case' 0 N--CA 1.437 -1.092 0 N-CA-C 106.873 -1.528 . . . . 0.0 106.873 179.405 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.25 -112.2 0.01 OUTLIER Glycine 0 CA--C 1.525 0.66 0 CA-C-O 122.331 0.962 . . . . 0.0 113.037 176.714 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 22.3 mttt -64.58 -96.73 0.0 OUTLIER 'General case' 0 N--CA 1.468 0.435 0 O-C-N 120.427 -1.631 . . . . 0.0 112.436 176.582 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.486 HG23 ' O ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -110.55 16.27 21.6 Favored 'General case' 0 C--N 1.328 -0.356 0 O-C-N 121.379 -0.826 . . . . 0.0 110.272 178.46 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.459 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 8.6 m-20 -29.24 104.93 0.03 OUTLIER 'General case' 0 C--O 1.207 -1.141 0 C-N-CA 125.792 1.637 . . . . 0.0 109.94 -176.868 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.588 ' CD2' ' H ' ' A' ' 78' ' ' HIS . 2.5 p80 -87.17 16.31 5.28 Favored 'General case' 0 N--CA 1.47 0.534 0 CA-C-N 118.968 0.803 . . . . 0.0 110.268 -175.421 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.926 ' CZ ' HD11 ' A' ' 81' ' ' LEU . 0.3 OUTLIER -36.19 134.27 0.43 Allowed 'General case' 0 N--CA 1.436 -1.135 0 C-N-CA 126.156 1.782 . . . . 0.0 111.311 172.148 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.622 HD23 ' O ' ' A' ' 110' ' ' TYR . 0.3 OUTLIER -76.68 153.65 34.95 Favored 'General case' 0 C--N 1.324 -0.541 0 CA-C-N 115.545 -0.752 . . . . 0.0 109.797 176.648 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.926 HD11 ' CZ ' ' A' ' 79' ' ' TYR . 1.7 mp -140.27 139.06 35.44 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 123.191 0.596 . . . . 0.0 109.659 177.658 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.459 ' CB ' ' CD1' ' A' ' 109' ' ' ILE . 0.5 OUTLIER -105.81 154.2 20.85 Favored 'General case' 0 N--CA 1.447 -0.603 0 CA-C-O 121.593 0.711 . . . . 0.0 111.284 179.261 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.752 ' CZ ' ' HB2' ' A' ' 23' ' ' ALA . 5.7 t80 -141.79 126.35 10.32 Favored Pre-proline 0 CA--C 1.537 0.452 0 CA-C-N 115.64 -0.709 . . . . 0.0 112.748 -179.812 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.509 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 19.6 Cg_endo -73.87 104.44 1.83 Allowed 'Trans proline' 0 N--CA 1.448 -1.148 0 C-N-CA 124.789 3.659 . . . . 0.0 110.615 -177.56 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.8 t -104.38 119.66 39.46 Favored 'General case' 0 N--CA 1.446 -0.67 0 O-C-N 124.675 1.234 . . . . 0.0 109.963 -179.045 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.434 ' CD2' ' NE2' ' A' ' 90' ' ' HIS . 64.7 m-85 -81.17 158.8 69.2 Favored Pre-proline 0 C--N 1.327 -0.372 0 N-CA-C 113.185 0.809 . . . . 0.0 113.185 176.505 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -74.78 -42.54 0.55 Allowed 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 122.504 2.136 . . . . 0.0 113.409 178.295 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 18.8 t0 -40.42 -37.03 0.62 Allowed 'General case' 0 N--CA 1.478 0.94 0 CA-C-O 123.529 1.633 . . . . 0.0 109.803 174.972 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 97.45 -1.88 60.54 Favored Glycine 0 N--CA 1.442 -0.931 0 O-C-N 121.053 -1.03 . . . . 0.0 112.248 -178.87 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.434 ' NE2' ' CD2' ' A' ' 86' ' ' PHE . 5.9 p-80 -65.39 126.74 29.18 Favored 'General case' 0 N--CA 1.442 -0.853 0 N-CA-C 108.028 -1.101 . . . . 0.0 108.028 176.589 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 4.0 t70 -59.62 106.07 0.43 Allowed 'General case' 0 C--N 1.323 -0.585 0 N-CA-C 107.061 -1.459 . . . . 0.0 107.061 171.049 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.44 ' O ' ' CD2' ' A' ' 94' ' ' PHE . 7.1 t80 -38.98 139.93 0.42 Allowed 'General case' 0 N--CA 1.444 -0.743 0 CA-C-O 121.684 0.754 . . . . 0.0 110.166 173.723 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 7.5 ptpt -75.68 58.44 1.08 Allowed 'General case' 0 C--N 1.326 -0.416 0 O-C-N 120.42 -1.425 . . . . 0.0 111.818 173.304 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.498 ' CD2' ' HZ ' ' A' ' 83' ' ' PHE . 34.2 p90 -73.08 -14.63 61.43 Favored 'General case' 0 N--CA 1.448 -0.564 0 C-N-CA 123.856 0.862 . . . . 0.0 112.327 176.143 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.6 t0 -88.8 -37.23 15.57 Favored 'General case' 0 CA--C 1.531 0.223 0 CA-C-O 123.329 1.537 . . . . 0.0 111.298 -179.587 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -79.9 106.9 12.26 Favored 'General case' 0 N--CA 1.455 -0.179 0 O-C-N 120.926 -1.109 . . . . 0.0 109.162 177.152 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.3 ptpt -57.99 -48.4 80.1 Favored 'General case' 0 N--CA 1.469 0.509 0 CA-C-O 121.739 0.78 . . . . 0.0 111.713 176.652 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 4.7 tmtt? -137.49 130.66 17.04 Favored Pre-proline 0 N--CA 1.445 -0.701 0 C-N-CA 124.828 1.251 . . . . 0.0 110.199 -178.889 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 26.7 Cg_endo -68.57 174.53 35.9 Favored 'Cis proline' 0 N--CA 1.453 -0.873 0 C-N-CA 123.181 -1.591 . . . . 0.0 110.415 -9.179 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 22.0 tttm -139.03 116.95 11.6 Favored 'General case' 0 CA--C 1.511 -0.531 0 N-CA-C 107.695 -1.224 . . . . 0.0 107.695 179.449 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 29.4 tp10 -69.96 167.2 17.99 Favored 'General case' 0 C--N 1.323 -0.559 0 O-C-N 123.981 0.801 . . . . 0.0 110.639 174.401 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.1 t30 -42.68 153.28 0.32 Allowed Pre-proline 0 CA--C 1.536 0.41 0 C-N-CA 124.228 1.011 . . . . 0.0 112.064 173.377 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 28.0 Cg_endo -72.85 -84.02 0.0 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 122.829 2.353 . . . . 0.0 112.547 -179.489 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 146.58 142.4 3.73 Favored Glycine 0 N--CA 1.444 -0.793 0 N-CA-C 110.615 -0.994 . . . . 0.0 110.615 -179.88 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -74.75 -68.85 0.02 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.805 0 C-N-CA 123.325 2.683 . . . . 0.0 110.71 -179.726 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.679 ' HA ' ' HB2' ' A' ' 122' ' ' ALA . . . -68.3 139.67 55.94 Favored 'General case' 0 N--CA 1.444 -0.757 0 CA-C-O 121.735 0.779 . . . . 0.0 111.165 178.583 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -141.87 144.3 33.77 Favored 'General case' 0 CA--C 1.509 -0.629 0 CA-C-N 114.588 -1.187 . . . . 0.0 111.011 -178.651 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.436 ' CG1' ' HB3' ' A' ' 83' ' ' PHE . 4.3 p -81.58 124.81 39.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.622 0 O-C-N 124.341 1.025 . . . . 0.0 109.139 178.687 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.566 ' CG2' HD22 ' A' ' 80' ' ' LEU . 5.8 mm -105.54 141.16 21.51 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.701 0 CA-C-N 116.211 -0.45 . . . . 0.0 111.061 179.725 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.622 ' O ' HD23 ' A' ' 80' ' ' LEU . 10.4 p90 -165.17 152.92 11.24 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-O 121.952 0.882 . . . . 0.0 111.294 -176.501 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 2.0 p -88.66 165.82 14.52 Favored 'General case' 0 C--N 1.321 -0.632 0 CA-C-N 115.656 -0.702 . . . . 0.0 109.852 -179.798 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.561 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.3 OUTLIER -108.21 156.84 37.73 Favored Pre-proline 0 CA--C 1.547 0.841 0 N-CA-C 112.195 0.443 . . . . 0.0 112.195 176.107 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.561 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 17.7 Cg_endo -72.07 -53.4 0.16 OUTLIER 'Cis proline' 0 CA--C 1.51 -0.683 0 C-N-CA 124.216 -1.16 . . . . 0.0 111.064 -10.27 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 6.0 t30 -45.61 111.43 0.34 Allowed 'General case' 0 N--CA 1.448 -0.549 0 CA-C-O 118.685 -0.674 . . . . 0.0 109.92 177.267 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.75 ' HE2' HD13 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -62.69 79.86 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.349 0 C-N-CA 124.911 1.285 . . . . 0.0 108.098 -178.262 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.461 ' O ' HG12 ' A' ' 116' ' ' VAL . 16.2 t -77.43 73.06 0.51 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.591 0 N-CA-C 105.311 -2.107 . . . . 0.0 105.311 -178.263 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.475 ' CZ ' ' NE2' ' A' ' 13' ' ' GLN . 20.7 t80 -46.63 108.16 0.13 Allowed 'General case' 0 N--CA 1.44 -0.95 0 C-N-CA 124.918 1.287 . . . . 0.0 109.008 177.455 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . 0.424 ' SG ' ' CG ' ' A' ' 57' ' ' PHE . 0.1 OUTLIER -83.45 -53.0 6.03 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 121.952 0.882 . . . . 0.0 110.031 179.448 . . . . . . . . 3 3 . 1 . 005 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 177.18 -146.09 7.58 Favored Glycine 0 N--CA 1.437 -1.252 0 CA-C-N 114.464 -1.244 . . . . 0.0 110.43 179.242 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.418 HG13 ' CG ' ' A' ' 4' ' ' TRP . 1.2 mm -126.61 146.85 31.77 Favored 'Isoleucine or valine' 0 CA--C 1.507 -0.693 0 N-CA-C 106.87 -1.53 . . . . 0.0 106.87 -177.136 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.589 HD12 HD21 ' A' ' 131' ' ' LEU . 8.0 pt -132.7 151.79 35.11 Favored 'Isoleucine or valine' 0 C--N 1.316 -0.887 0 N-CA-C 108.568 -0.901 . . . . 0.0 108.568 -178.891 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.679 ' HB2' ' HA ' ' A' ' 106' ' ' ALA . . . -174.95 149.42 1.12 Allowed 'General case' 0 C--N 1.325 -0.495 0 C-N-CA 122.807 0.443 . . . . 0.0 110.863 178.223 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.531 ' CD2' HD13 ' A' ' 131' ' ' LEU . 3.8 m-70 -89.91 96.57 10.74 Favored 'General case' 0 C--O 1.221 -0.397 0 N-CA-C 108.876 -0.787 . . . . 0.0 108.876 -177.005 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 4.3 p -101.59 46.18 0.94 Allowed 'General case' 0 C--N 1.319 -0.75 0 C-N-CA 124.498 1.119 . . . . 0.0 109.816 -177.361 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.7 tttm -107.98 -24.59 11.55 Favored 'General case' 0 C--O 1.218 -0.581 0 CA-C-N 114.776 -1.102 . . . . 0.0 111.543 175.896 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -174.12 -77.25 0.01 OUTLIER 'General case' 0 CA--C 1.537 0.472 0 CA-C-O 122.202 1.001 . . . . 0.0 109.808 177.954 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -140.63 -47.47 0.42 Allowed 'General case' 0 C--N 1.331 -0.234 0 C-N-CA 125.83 1.652 . . . . 0.0 110.447 -177.025 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 5.3 tt0 -160.0 82.41 0.72 Allowed 'General case' 0 N--CA 1.445 -0.716 0 C-N-CA 125.073 1.349 . . . . 0.0 108.995 -177.793 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -123.44 -108.95 1.9 Allowed Glycine 0 CA--C 1.518 0.236 0 N-CA-C 110.422 -1.071 . . . . 0.0 110.422 175.146 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.9 mt-10 -87.72 141.2 28.79 Favored 'General case' 0 C--N 1.322 -0.622 0 O-C-N 121.555 -0.968 . . . . 0.0 111.187 -179.882 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.589 HD21 HD12 ' A' ' 121' ' ' ILE . 4.9 tp -94.5 142.6 27.24 Favored 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 120.544 0.211 . . . . 0.0 110.819 177.733 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -146.44 167.55 23.35 Favored 'General case' 0 C--N 1.325 -0.491 0 C-N-CA 124.442 1.097 . . . . 0.0 109.626 -179.609 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.561 HD12 HG22 ' A' ' 121' ' ' ILE . 10.0 tp -84.51 137.61 33.24 Favored 'General case' 0 C--N 1.324 -0.519 0 O-C-N 124.127 0.892 . . . . 0.0 108.746 178.065 . . . . . . . . 2 2 . 1 . 005 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 35.0 m -70.71 -178.75 1.94 Allowed 'General case' 0 C--N 1.321 -0.669 0 CA-C-O 122.865 1.317 . . . . 0.0 109.821 174.252 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 13.7 p -160.24 100.01 1.35 Allowed 'General case' 0 C--N 1.32 -0.688 0 N-CA-C 105.148 -2.167 . . . . 0.0 105.148 -178.15 . . . . . . . . 1 1 . 1 . 005 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.242 0.674 0 CA-C-O 115.921 -1.99 . . . . 0.0 112.441 168.141 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.513 -0.477 0 N-CA-C 108.859 -0.793 . . . . 0.0 108.859 . . . . . . . . . 0 0 . 1 . 006 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.724 HG22 ' HB2' ' A' ' 136' ' ' HIS . 9.3 p -93.52 128.49 44.9 Favored 'Isoleucine or valine' 0 C--O 1.238 0.494 0 O-C-N 124.372 1.045 . . . . 0.0 109.654 179.788 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.924 HG21 HD23 ' A' ' 10' ' ' LEU . 48.9 m -85.78 119.67 26.36 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-N 115.941 -0.572 . . . . 0.0 110.148 -179.105 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.528 ' CE2' ' CD2' ' A' ' 136' ' ' HIS . 19.8 m95 -80.44 141.42 35.28 Favored 'General case' 0 N--CA 1.445 -0.703 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 179.274 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -141.02 142.51 34.22 Favored 'General case' 0 C--N 1.317 -0.818 0 N-CA-C 109.329 -0.619 . . . . 0.0 109.329 -179.214 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.728 ' SG ' ' HB3' ' A' ' 122' ' ' ALA . 0.1 OUTLIER -120.42 50.38 1.32 Allowed 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 116.216 -0.447 . . . . 0.0 109.896 177.921 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 48.06 73.75 0.31 Allowed Glycine 0 CA--C 1.526 0.773 0 N-CA-C 111.339 -0.704 . . . . 0.0 111.339 -178.925 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 166.55 -74.95 0.15 Allowed Glycine 0 C--N 1.333 0.395 0 N-CA-C 111.038 -0.825 . . . . 0.0 111.038 -179.866 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 54.9 mt -123.82 158.18 32.42 Favored 'General case' 0 C--O 1.236 0.365 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 179.121 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.924 HD23 HG21 ' A' ' 3' ' ' THR . 3.9 mp -83.02 165.64 19.46 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-N 115.413 -0.812 . . . . 0.0 110.049 179.266 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.763 ' CZ ' ' HB3' ' A' ' 106' ' ' ALA . 50.2 m-85 -159.12 85.56 0.81 Allowed 'General case' 0 N--CA 1.442 -0.854 0 CA-C-O 121.872 0.844 . . . . 0.0 109.981 -175.319 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -57.43 121.45 10.27 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-O 117.656 -1.164 . . . . 0.0 108.602 -179.585 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.563 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 0.6 OUTLIER -43.33 -57.93 2.79 Favored 'General case' 0 C--O 1.207 -1.167 0 CA-C-O 117.953 -1.022 . . . . 0.0 110.386 -179.892 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.445 ' O ' ' CB ' ' A' ' 18' ' ' SER . 19.7 t-20 -44.98 -46.9 11.4 Favored 'General case' 0 C--O 1.198 -1.647 0 O-C-N 124.065 0.853 . . . . 0.0 109.766 179.917 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.442 ' CE ' ' HA3' ' A' ' 89' ' ' GLY . 0.0 OUTLIER -62.35 -48.23 80.74 Favored 'General case' 0 C--O 1.204 -1.307 0 CA-C-O 117.376 -1.297 . . . . 0.0 111.267 174.954 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -51.04 -68.19 0.19 Allowed 'General case' 0 N--CA 1.44 -0.935 0 CA-C-N 120.091 1.314 . . . . 0.0 111.685 175.501 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.431 ' O ' ' CD2' ' A' ' 21' ' ' HIS . 1.5 pt-20 -55.99 -32.94 64.4 Favored 'General case' 0 N--CA 1.445 -0.707 0 CA-C-N 116.108 -0.496 . . . . 0.0 110.206 177.968 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.445 ' CB ' ' O ' ' A' ' 14' ' ' ASN . 12.6 t -68.05 -53.78 23.15 Favored 'General case' 0 C--O 1.216 -0.708 0 C-N-CA 123.949 0.9 . . . . 0.0 109.46 179.753 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.414 ' OD1' ' CD2' ' A' ' 83' ' ' PHE . 6.7 t-20 -49.37 -30.62 7.97 Favored 'General case' 0 N--CA 1.434 -1.266 0 O-C-N 120.443 -1.41 . . . . 0.0 109.291 178.415 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -86.99 -29.36 22.05 Favored 'General case' 0 N--CA 1.442 -0.873 0 O-C-N 123.521 0.513 . . . . 0.0 111.642 176.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.431 ' CD2' ' O ' ' A' ' 17' ' ' GLU . 7.7 m170 -54.19 -42.93 70.27 Favored 'General case' 0 N--CA 1.441 -0.897 0 C-N-CA 124.029 0.931 . . . . 0.0 109.38 179.099 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.429 ' CD2' ' N ' ' A' ' 22' ' ' HIS . 0.0 OUTLIER -79.59 -48.89 13.03 Favored 'General case' 0 N--CA 1.443 -0.78 0 O-C-N 123.769 0.668 . . . . 0.0 109.562 -179.892 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.571 ' HB2' ' CZ ' ' A' ' 83' ' ' PHE . . . -40.35 136.09 1.41 Allowed Pre-proline 0 N--CA 1.442 -0.871 0 O-C-N 125.187 1.554 . . . . 0.0 110.831 179.226 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.819 ' HG2' HG22 ' A' ' 30' ' ' THR . 18.6 Cg_endo -73.14 122.22 7.88 Favored 'Trans proline' 0 N--CA 1.449 -1.138 0 C-N-CA 122.032 1.821 . . . . 0.0 110.631 -178.756 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.676 HD13 ' HE2' ' A' ' 115' ' ' LYS . 3.0 tp -60.23 95.5 0.03 OUTLIER 'General case' 0 N--CA 1.449 -0.502 0 O-C-N 123.597 0.56 . . . . 0.0 110.059 179.643 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 179.3 162.42 0.84 Allowed 'General case' 0 N--CA 1.448 -0.566 0 O-C-N 123.643 0.59 . . . . 0.0 109.883 -178.21 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -103.55 112.54 25.51 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 123.927 0.767 . . . . 0.0 109.083 -179.934 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 58.01 64.69 4.12 Favored Glycine 0 N--CA 1.447 -0.58 0 N-CA-C 110.059 -1.216 . . . . 0.0 110.059 177.845 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.418 ' O ' ' CG ' ' A' ' 29' ' ' LYS . 12.7 tttt -134.47 12.92 3.8 Favored 'General case' 0 C--N 1.334 -0.074 0 CA-C-O 123.003 1.382 . . . . 0.0 110.024 178.111 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.819 HG22 ' HG2' ' A' ' 24' ' ' PRO . 22.8 p -112.92 145.8 40.11 Favored 'General case' 0 C--N 1.315 -0.898 0 O-C-N 120.501 -1.374 . . . . 0.0 108.481 -176.604 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -38.42 -49.57 2.31 Favored Glycine 0 CA--C 1.523 0.563 0 N-CA-C 111.275 -0.73 . . . . 0.0 111.275 179.972 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.8 t -74.2 -60.69 2.15 Favored 'General case' 0 N--CA 1.441 -0.905 0 CA-C-O 117.177 -1.392 . . . . 0.0 110.165 177.594 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 162.2 -59.92 0.0 OUTLIER 'General case' 0 C--O 1.222 -0.344 0 O-C-N 125.256 1.597 . . . . 0.0 110.555 179.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.692 ' CE2' ' CE1' ' A' ' 36' ' ' HIS . 60.3 m-85 -58.83 145.78 77.7 Favored Pre-proline 0 N--CA 1.434 -1.256 0 CA-C-O 117.676 -1.154 . . . . 0.0 112.522 178.77 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.554 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 22.2 Cg_endo -74.23 153.41 99.14 Favored 'Cis proline' 0 N--CA 1.454 -0.82 0 C-N-CA 121.578 -2.259 . . . . 0.0 111.855 -1.523 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.692 ' CE1' ' CE2' ' A' ' 34' ' ' TYR . 0.5 OUTLIER -131.8 154.91 48.63 Favored 'General case' 0 CA--C 1.507 -0.705 0 CA-C-O 117.782 -1.104 . . . . 0.0 110.509 179.953 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 1.001 ' CH2' HG22 ' A' ' 39' ' ' THR . 13.4 t90 -48.98 144.78 4.42 Favored 'General case' 0 C--N 1.324 -0.503 0 O-C-N 124.227 0.954 . . . . 0.0 109.143 178.699 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.577 ' CZ ' HD13 ' A' ' 121' ' ' ILE . 24.6 t80 -114.93 80.96 1.49 Allowed 'General case' 0 N--CA 1.425 -1.717 0 N-CA-C 107.271 -1.381 . . . . 0.0 107.271 -176.281 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 1.001 HG22 ' CH2' ' A' ' 37' ' ' TRP . 4.3 p -38.46 -32.86 0.08 Allowed 'General case' 0 C--O 1.21 -1.012 0 O-C-N 124.114 0.884 . . . . 0.0 109.933 176.404 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.498 ' HB2' ' CD2' ' A' ' 38' ' ' PHE . 51.0 t30 52.18 22.24 1.87 Allowed 'General case' 0 N--CA 1.447 -0.603 0 O-C-N 121.154 -0.966 . . . . 0.0 108.69 175.967 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.47 ' HA3' HD23 ' A' ' 48' ' ' LEU . . . 107.71 -41.42 2.21 Favored Glycine 0 N--CA 1.422 -2.263 0 CA-C-O 118.697 -1.057 . . . . 0.0 114.886 -173.605 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.529 ' CD2' ' HG3' ' A' ' 66' ' ' PRO . 62.4 m-85 -45.72 153.78 0.25 Allowed 'General case' 0 N--CA 1.443 -0.808 0 C-N-CA 123.721 0.808 . . . . 0.0 112.126 175.918 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -85.48 -40.32 16.51 Favored 'General case' 0 C--N 1.326 -0.441 0 CA-C-N 115.426 -0.806 . . . . 0.0 109.708 179.503 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.512 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -164.97 -65.46 0.02 OUTLIER Glycine 0 C--N 1.339 0.717 0 N-CA-C 111.356 -0.698 . . . . 0.0 111.356 -179.681 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.456 ' OD2' ' CE ' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -121.08 -61.19 1.57 Allowed 'General case' 0 CA--C 1.514 -0.436 0 N-CA-C 109.751 -0.463 . . . . 0.0 109.751 -179.708 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -50.47 179.24 0.03 OUTLIER Glycine 0 C--N 1.348 1.244 0 CA-C-O 123.598 1.666 . . . . 0.0 111.217 178.985 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.409 ' HA ' ' CE1' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -68.8 -171.06 0.26 Allowed 'General case' 0 C--N 1.326 -0.437 0 O-C-N 121.059 -1.259 . . . . 0.0 109.832 179.906 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.553 HD13 ' HG3' ' A' ' 54' ' ' PRO . 5.2 mp -69.96 154.52 94.59 Favored Pre-proline 0 N--CA 1.441 -0.914 0 CA-C-N 115.903 -0.59 . . . . 0.0 110.213 179.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.09 156.53 47.13 Favored 'Trans proline' 0 N--CA 1.451 -0.987 0 C-N-CA 122.114 1.876 . . . . 0.0 111.044 179.877 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -54.07 98.03 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.385 0 N-CA-C 108.7 -0.852 . . . . 0.0 108.7 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.08 75.8 0.64 Allowed Glycine 0 N--CA 1.444 -0.775 0 CA-C-O 119.777 -0.457 . . . . 0.0 112.096 -178.348 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.46 ' HD3' ' CA ' ' A' ' 41' ' ' GLY . 6.9 ttt180 -177.22 163.85 2.12 Favored 'General case' 0 CA--C 1.517 -0.32 0 O-C-N 124.075 0.514 . . . . 0.0 110.419 177.914 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.2 m -137.05 111.81 9.41 Favored Pre-proline 0 N--CA 1.444 -0.774 0 CA-C-N 115.922 -0.581 . . . . 0.0 110.972 179.614 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.553 ' HG3' HD13 ' A' ' 48' ' ' LEU . 23.0 Cg_endo -72.98 165.79 31.82 Favored 'Trans proline' 0 N--CA 1.45 -1.078 0 C-N-CA 122.02 1.813 . . . . 0.0 112.01 178.733 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.486 HD11 ' HG ' ' A' ' 131' ' ' LEU . 4.3 mt -88.81 119.51 36.08 Favored 'Isoleucine or valine' 0 C--O 1.22 -0.471 0 N-CA-C 108.923 -0.769 . . . . 0.0 108.923 -179.333 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 15.8 tptt -82.82 132.41 35.17 Favored 'General case' 0 N--CA 1.449 -0.523 0 N-CA-C 108.781 -0.822 . . . . 0.0 108.781 179.239 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.673 ' CE1' HD13 ' A' ' 133' ' ' LEU . 19.9 m-85 -117.56 -49.78 2.55 Favored 'General case' 0 N--CA 1.447 -0.597 0 CA-C-N 115.44 -0.8 . . . . 0.0 110.633 179.944 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 124.02 -1.63 9.13 Favored Glycine 0 CA--C 1.521 0.434 0 CA-C-N 115.936 -0.574 . . . . 0.0 111.685 -178.381 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.4 mmtp -102.68 143.32 32.5 Favored 'General case' 0 CA--C 1.509 -0.634 0 N-CA-C 109.809 -0.441 . . . . 0.0 109.809 178.937 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 36.5 t -78.86 -1.26 34.16 Favored 'General case' 0 C--N 1.328 -0.332 0 O-C-N 124.315 1.01 . . . . 0.0 110.664 178.053 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.549 ' HB2' HG21 ' A' ' 111' ' ' THR . 0.9 OUTLIER -88.2 -57.48 2.91 Favored 'General case' 0 N--CA 1.441 -0.92 0 N-CA-C 108.749 -0.834 . . . . 0.0 108.749 -178.995 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 1.9 m -72.44 -26.41 61.82 Favored 'General case' 0 N--CA 1.446 -0.652 0 N-CA-C 108.207 -1.034 . . . . 0.0 108.207 -179.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.7 t70 -71.37 -34.38 70.39 Favored 'General case' 0 N--CA 1.449 -0.489 0 O-C-N 123.665 0.603 . . . . 0.0 110.154 177.763 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -59.99 160.81 14.37 Favored Pre-proline 0 N--CA 1.439 -0.995 0 CA-C-O 121.119 0.485 . . . . 0.0 110.354 179.286 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.438 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 26.5 Cg_endo -74.48 141.3 28.13 Favored 'Trans proline' 0 N--CA 1.445 -1.36 0 C-N-CA 121.713 1.608 . . . . 0.0 113.555 175.183 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.529 ' HG3' ' CD2' ' A' ' 42' ' ' TYR . 20.8 Cg_endo -73.66 167.93 26.04 Favored 'Trans proline' 0 N--CA 1.45 -1.075 0 C-N-CA 122.43 2.087 . . . . 0.0 111.671 179.002 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.456 ' CE ' ' OD2' ' A' ' 45' ' ' ASP . 0.0 OUTLIER -133.13 60.61 1.7 Allowed 'General case' 0 C--O 1.239 0.543 0 CA-C-N 115.669 -0.696 . . . . 0.0 111.236 179.417 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.493 ' CE1' ' O ' ' A' ' 70' ' ' LYS . 57.0 t-80 -74.79 145.6 42.78 Favored 'General case' 0 N--CA 1.443 -0.825 0 CA-C-O 123.995 1.855 . . . . 0.0 112.01 178.144 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -133.12 -85.27 0.46 Allowed 'General case' 0 C--N 1.325 -0.489 0 O-C-N 119.49 -2.006 . . . . 0.0 109.796 178.905 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.493 ' O ' ' CE1' ' A' ' 68' ' ' HIS . 0.2 OUTLIER -72.64 -171.07 0.76 Allowed 'General case' 0 C--O 1.203 -1.379 0 CA-C-N 116.126 -0.488 . . . . 0.0 110.166 179.947 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 4.0 t0 -77.97 41.65 0.36 Allowed 'General case' 0 C--N 1.316 -0.87 0 CA-C-O 121.664 0.745 . . . . 0.0 111.415 178.016 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -169.51 -105.58 0.18 Allowed Glycine 0 C--O 1.21 -1.368 0 N-CA-C 110.645 -0.982 . . . . 0.0 110.645 -178.36 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -113.44 -87.99 0.56 Allowed 'General case' 0 C--N 1.317 -0.847 0 O-C-N 120.968 -1.313 . . . . 0.0 107.567 -177.024 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 117.46 -141.73 16.74 Favored Glycine 0 N--CA 1.443 -0.896 0 CA-C-O 118.525 -1.153 . . . . 0.0 111.211 -178.515 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 36.8 mttt -49.01 -89.57 0.0 OUTLIER 'General case' 0 C--O 1.223 -0.308 0 O-C-N 125.21 1.182 . . . . 0.0 110.233 -179.652 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.69 HG23 ' O ' ' A' ' 76' ' ' THR . 0.6 OUTLIER -127.23 28.51 5.72 Favored 'General case' 0 CA--C 1.511 -0.552 0 CA-C-N 115.898 -0.592 . . . . 0.0 110.868 179.331 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.549 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 41.0 t0 -30.01 97.78 0.01 OUTLIER 'General case' 0 C--O 1.214 -0.8 0 C-N-CA 122.93 0.492 . . . . 0.0 111.795 -178.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.404 ' CD2' ' H ' ' A' ' 78' ' ' HIS . 7.1 p80 -86.91 15.2 6.13 Favored 'General case' 0 N--CA 1.448 -0.551 0 N-CA-C 109.0 -0.741 . . . . 0.0 109.0 -176.242 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 1.052 ' CE1' HD11 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -52.95 174.07 0.04 OUTLIER 'General case' 0 N--CA 1.44 -0.94 0 N-CA-C 114.551 1.315 . . . . 0.0 114.551 174.484 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.769 HD22 ' CG2' ' A' ' 109' ' ' ILE . 0.6 OUTLIER -95.13 157.65 15.8 Favored 'General case' 0 C--O 1.218 -0.596 0 CA-C-N 115.648 -0.705 . . . . 0.0 110.324 177.624 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 1.052 HD11 ' CE1' ' A' ' 79' ' ' TYR . 2.8 mp -143.03 108.55 5.07 Favored 'General case' 0 N--CA 1.448 -0.556 0 CA-C-O 121.533 0.682 . . . . 0.0 109.161 179.805 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.52 ' CB ' ' CD1' ' A' ' 109' ' ' ILE . 7.2 pm0 -80.9 150.58 28.98 Favored 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 122.148 0.975 . . . . 0.0 110.205 179.305 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.571 ' CZ ' ' HB2' ' A' ' 23' ' ' ALA . 15.8 t80 -141.16 137.03 16.39 Favored Pre-proline 0 N--CA 1.442 -0.87 0 CA-C-N 115.551 -0.75 . . . . 0.0 112.161 -179.838 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.484 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 19.4 Cg_endo -74.01 91.78 0.92 Allowed 'Trans proline' 0 N--CA 1.449 -1.115 0 C-N-CA 123.293 2.662 . . . . 0.0 110.914 -178.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 5.0 t -95.48 109.1 21.35 Favored 'General case' 0 N--CA 1.446 -0.661 0 CA-C-O 122.194 0.997 . . . . 0.0 111.118 -179.816 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 67.9 m-85 -82.42 159.08 65.25 Favored Pre-proline 0 N--CA 1.443 -0.821 0 CA-C-N 115.9 -0.591 . . . . 0.0 111.692 -179.989 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -76.57 -40.78 0.51 Allowed 'Trans proline' 0 CA--C 1.501 -1.132 0 C-N-CA 122.324 2.016 . . . . 0.0 112.453 179.203 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.3 m-20 -42.36 -32.2 0.49 Allowed 'General case' 0 N--CA 1.45 -0.427 0 O-C-N 125.123 1.515 . . . . 0.0 109.854 178.312 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.442 ' HA3' ' CE ' ' A' ' 15' ' ' LYS . . . 87.14 10.0 72.36 Favored Glycine 0 N--CA 1.438 -1.169 0 N-CA-C 109.51 -1.436 . . . . 0.0 109.51 177.252 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.419 ' O ' ' CD2' ' A' ' 90' ' ' HIS . 3.8 p-80 -80.82 130.33 35.0 Favored 'General case' 0 N--CA 1.438 -1.036 0 N-CA-C 109.1 -0.704 . . . . 0.0 109.1 179.572 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 16.7 t0 -62.21 88.45 0.03 OUTLIER 'General case' 0 C--N 1.324 -0.507 0 N-CA-C 109.45 -0.574 . . . . 0.0 109.45 178.779 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.533 ' CD2' ' HB3' ' A' ' 94' ' ' PHE . 7.7 t80 -36.42 146.72 0.03 OUTLIER 'General case' 0 N--CA 1.44 -0.956 0 CA-C-O 122.362 1.077 . . . . 0.0 110.809 -178.935 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 14.0 ptpt -78.8 58.81 2.41 Favored 'General case' 0 C--N 1.317 -0.814 0 O-C-N 120.19 -1.569 . . . . 0.0 110.072 177.958 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.533 ' HB3' ' CD2' ' A' ' 92' ' ' TYR . 29.6 p90 -79.45 -8.9 59.44 Favored 'General case' 0 N--CA 1.442 -0.828 0 C-N-CA 122.837 0.455 . . . . 0.0 111.544 178.216 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -92.47 -33.16 14.62 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 109.491 -0.559 . . . . 0.0 109.491 179.608 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 49.3 m -79.82 110.54 15.28 Favored 'General case' 0 N--CA 1.443 -0.778 0 N-CA-C 108.856 -0.794 . . . . 0.0 108.856 -179.234 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.41 ' CG ' ' N ' ' A' ' 98' ' ' LYS . 0.1 OUTLIER -58.86 -50.09 75.29 Favored 'General case' 0 N--CA 1.452 -0.35 0 N-CA-C 109.33 -0.619 . . . . 0.0 109.33 179.157 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.439 ' HA ' ' HA ' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -146.4 129.55 8.14 Favored Pre-proline 0 N--CA 1.432 -1.346 0 N-CA-C 109.021 -0.733 . . . . 0.0 109.021 -177.245 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.439 ' HA ' ' HA ' ' A' ' 98' ' ' LYS . 26.4 Cg_endo -72.15 177.66 33.85 Favored 'Cis proline' 0 N--CA 1.46 -0.442 0 C-N-CA 122.135 -2.027 . . . . 0.0 111.967 -2.87 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -147.17 135.82 21.99 Favored 'General case' 0 N--CA 1.449 -0.506 0 O-C-N 123.789 0.68 . . . . 0.0 109.731 178.059 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -79.93 172.71 13.42 Favored 'General case' 0 C--O 1.245 0.856 0 O-C-N 124.27 0.981 . . . . 0.0 111.246 178.155 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.1 m120 -57.3 158.74 9.75 Favored Pre-proline 0 N--CA 1.438 -1.033 0 CA-C-O 121.604 0.716 . . . . 0.0 112.193 175.072 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -75.78 -89.87 0.0 OUTLIER 'Trans proline' 0 C--O 1.205 -1.14 0 C-N-CA 122.212 1.942 . . . . 0.0 111.115 179.014 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 151.77 148.68 4.89 Favored Glycine 0 N--CA 1.438 -1.214 0 O-C-N 120.983 -1.073 . . . . 0.0 111.358 -179.293 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -74.45 -35.47 3.72 Favored 'Trans proline' 0 N--CA 1.455 -0.763 0 C-N-CA 122.149 1.9 . . . . 0.0 111.779 179.292 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.763 ' HB3' ' CZ ' ' A' ' 11' ' ' TYR . . . -102.85 146.72 27.85 Favored 'General case' 0 N--CA 1.437 -1.078 0 O-C-N 124.232 0.958 . . . . 0.0 109.914 178.413 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.422 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 2.2 mtm-85 -146.44 148.82 32.67 Favored 'General case' 0 N--CA 1.445 -0.705 0 O-C-N 123.833 0.708 . . . . 0.0 111.417 179.173 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.474 ' CG1' ' HB3' ' A' ' 83' ' ' PHE . 3.8 p -82.63 117.71 29.05 Favored 'Isoleucine or valine' 0 C--N 1.321 -0.632 0 C-N-CA 123.19 0.596 . . . . 0.0 110.23 178.713 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.769 ' CG2' HD22 ' A' ' 80' ' ' LEU . 6.1 mm -96.01 140.71 16.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.72 0 N-CA-C 109.679 -0.489 . . . . 0.0 109.679 179.95 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.631 ' C ' HD23 ' A' ' 80' ' ' LEU . 9.0 p90 -167.18 152.25 7.33 Favored 'General case' 0 N--CA 1.443 -0.797 0 CA-C-N 115.727 -0.669 . . . . 0.0 110.789 -179.439 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.549 HG21 ' HB2' ' A' ' 61' ' ' ASP . 1.6 p -87.76 163.86 16.26 Favored 'General case' 0 C--N 1.321 -0.665 0 CA-C-N 115.664 -0.698 . . . . 0.0 109.715 -178.863 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.572 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.2 OUTLIER -112.94 152.62 45.04 Favored Pre-proline 0 N--CA 1.434 -1.231 0 C-N-CA 123.209 0.604 . . . . 0.0 110.842 -179.783 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.608 ' O ' HD21 ' A' ' 25' ' ' LEU . 17.8 Cg_endo -73.56 -55.46 0.14 OUTLIER 'Cis proline' 0 CA--C 1.512 -0.601 0 C-N-CA 122.0 -2.083 . . . . 0.0 110.64 -4.14 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 25.9 t-20 -41.65 111.18 0.21 Allowed 'General case' 0 N--CA 1.438 -1.057 0 CA-C-O 116.093 -1.908 . . . . 0.0 110.342 179.698 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.676 ' HE2' HD13 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -64.39 74.41 0.04 OUTLIER 'General case' 0 N--CA 1.445 -0.7 0 O-C-N 126.03 2.081 . . . . 0.0 108.755 -178.604 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.64 ' O ' HG12 ' A' ' 116' ' ' VAL . 13.3 t -71.47 69.81 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.748 0 N-CA-C 106.953 -1.499 . . . . 0.0 106.953 -178.139 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.572 ' CE1' ' HA2' ' A' ' 119' ' ' GLY . 9.8 t80 -36.48 111.06 0.13 Allowed 'General case' 0 N--CA 1.437 -1.078 0 C-N-CA 124.074 0.949 . . . . 0.0 109.849 -179.777 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . 0.577 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 0.1 OUTLIER -94.28 -26.69 16.5 Favored 'General case' 0 N--CA 1.441 -0.889 0 N-CA-C 108.552 -0.907 . . . . 0.0 108.552 179.258 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.572 ' HA2' ' CE1' ' A' ' 117' ' ' PHE . . . 137.39 -166.58 24.98 Favored Glycine 0 N--CA 1.443 -0.898 0 N-CA-C 111.5 -0.64 . . . . 0.0 111.5 -178.749 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.665 HG22 ' SG ' ' A' ' 134' ' ' CYS . 3.5 mp -111.6 146.1 16.96 Favored 'Isoleucine or valine' 0 C--O 1.203 -1.369 0 N-CA-C 108.115 -1.069 . . . . 0.0 108.115 -177.612 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.681 ' CD1' HD21 ' A' ' 131' ' ' LEU . 6.2 pt -116.77 157.11 17.84 Favored 'Isoleucine or valine' 0 N--CA 1.444 -0.774 0 CA-C-N 119.237 0.926 . . . . 0.0 108.836 178.663 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.728 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . . . -176.73 147.15 0.6 Allowed 'General case' 0 N--CA 1.449 -0.511 0 CA-C-O 121.561 0.696 . . . . 0.0 110.126 177.965 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.481 ' CD2' HD13 ' A' ' 131' ' ' LEU . 1.4 m-70 -89.25 94.26 9.85 Favored 'General case' 0 N--CA 1.444 -0.746 0 N-CA-C 108.787 -0.819 . . . . 0.0 108.787 -177.873 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.612 ' O ' HG23 ' A' ' 124' ' ' THR . 3.9 t -99.53 44.65 1.01 Allowed 'General case' 0 C--N 1.326 -0.429 0 CA-C-O 123.315 1.531 . . . . 0.0 110.961 -179.706 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 11.1 tttt -105.86 -26.73 11.61 Favored 'General case' 0 C--O 1.222 -0.391 0 O-C-N 120.664 -1.272 . . . . 0.0 110.395 179.212 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -171.17 -63.91 0.02 OUTLIER 'General case' 0 N--CA 1.447 -0.58 0 O-C-N 124.419 1.074 . . . . 0.0 110.957 178.417 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.2 m-20 -155.16 -45.96 0.08 Allowed 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 121.998 0.904 . . . . 0.0 110.041 178.903 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -158.18 76.04 0.76 Allowed 'General case' 0 N--CA 1.444 -0.769 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.59 -179.741 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -120.47 -103.49 1.94 Allowed Glycine 0 C--N 1.331 0.289 0 N-CA-C 110.995 -0.842 . . . . 0.0 110.995 179.893 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -91.09 143.61 26.52 Favored 'General case' 0 CA--C 1.513 -0.459 0 O-C-N 122.333 -0.51 . . . . 0.0 110.872 -179.888 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.681 HD21 ' CD1' ' A' ' 121' ' ' ILE . 6.0 tp -96.62 138.27 34.44 Favored 'General case' 0 N--CA 1.448 -0.553 0 CA-C-O 121.057 0.456 . . . . 0.0 110.176 179.149 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.535 ' HD3' HG22 ' A' ' 124' ' ' THR . 0.1 OUTLIER -140.67 169.0 18.47 Favored 'General case' 0 C--N 1.323 -0.555 0 CA-C-N 115.885 -0.598 . . . . 0.0 109.606 -178.954 . . . . . . . . 3 3 . 1 . 006 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.673 HD13 ' CE1' ' A' ' 57' ' ' PHE . 10.4 tp -89.6 136.47 33.02 Favored 'General case' 0 C--N 1.324 -0.513 0 O-C-N 124.396 1.06 . . . . 0.0 108.504 179.737 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . 0.665 ' SG ' HG22 ' A' ' 120' ' ' ILE . 70.7 m -56.97 -176.44 0.02 OUTLIER 'General case' 0 N--CA 1.435 -1.18 0 C-N-CA 124.793 1.237 . . . . 0.0 108.308 178.478 . . . . . . . . 2 2 . 1 . 006 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 6.8 m -161.16 83.99 0.65 Allowed 'General case' 0 C--N 1.323 -0.587 0 N-CA-C 108.396 -0.965 . . . . 0.0 108.396 -179.154 . . . . . . . . 1 1 . 1 . 006 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.724 ' HB2' HG22 ' A' ' 2' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.258 1.527 0 CA-C-O 116.11 -1.9 . . . . 0.0 112.143 175.19 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.476 0.835 0 N-CA-C 107.807 -1.182 . . . . 0.0 107.807 . . . . . . . . . 0 0 . 1 . 007 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.473 HG22 ' HB3' ' A' ' 136' ' ' HIS . 9.9 p -100.98 136.2 33.69 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.407 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 179.543 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.552 ' CG2' HD12 ' A' ' 10' ' ' LEU . 1.1 m -85.61 123.73 31.35 Favored 'General case' 0 C--N 1.317 -0.824 0 N-CA-C 108.642 -0.873 . . . . 0.0 108.642 177.158 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.44 ' CG ' HG13 ' A' ' 120' ' ' ILE . 35.0 m95 -86.18 142.58 28.52 Favored 'General case' 0 N--CA 1.448 -0.574 0 C-N-CA 122.913 0.485 . . . . 0.0 110.059 177.13 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.574 ' OG1' HD13 ' A' ' 10' ' ' LEU . 0.8 OUTLIER -127.21 125.84 41.74 Favored 'General case' 0 CA--C 1.509 -0.627 0 N-CA-C 108.369 -0.975 . . . . 0.0 108.369 -176.751 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.548 ' HB3' ' HB3' ' A' ' 122' ' ' ALA . 7.2 m -120.7 53.75 1.1 Allowed 'General case' 0 C--N 1.325 -0.493 0 CA-C-N 115.776 -0.647 . . . . 0.0 109.691 178.541 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 132.68 -95.95 0.3 Allowed Glycine 0 C--O 1.223 -0.565 0 N-CA-C 111.121 -0.792 . . . . 0.0 111.121 -179.297 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -132.33 8.84 5.35 Favored Glycine 0 N--CA 1.469 0.897 0 C-N-CA 123.881 0.753 . . . . 0.0 113.624 177.995 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.454 HD13 ' OH ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -115.52 140.28 49.3 Favored 'General case' 0 CA--C 1.519 -0.22 0 C-N-CA 124.85 1.26 . . . . 0.0 108.858 -176.632 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.574 HD13 ' OG1' ' A' ' 5' ' ' THR . 2.7 mm? -105.24 116.5 32.05 Favored 'General case' 0 C--N 1.328 -0.331 0 O-C-N 124.509 1.131 . . . . 0.0 108.099 -170.451 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.454 ' OH ' HD13 ' A' ' 9' ' ' LEU . 73.8 m-85 -108.55 98.5 8.01 Favored 'General case' 0 C--N 1.32 -0.689 0 N-CA-C 106.93 -1.507 . . . . 0.0 106.93 -172.119 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.2 t-20 -55.14 117.87 3.86 Favored 'General case' 0 N--CA 1.449 -0.489 0 N-CA-C 108.869 -0.789 . . . . 0.0 108.869 177.557 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.457 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 6.4 tp-100 -51.0 -44.42 60.96 Favored 'General case' 0 C--O 1.214 -0.796 0 C-N-CA 119.814 -0.754 . . . . 0.0 112.853 179.696 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 6.2 t-20 -48.42 -42.91 33.54 Favored 'General case' 0 C--O 1.201 -1.479 0 O-C-N 123.771 0.67 . . . . 0.0 112.217 175.49 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.9 mttt -69.52 -40.8 76.73 Favored 'General case' 0 C--O 1.212 -0.879 0 CA-C-N 120.068 1.304 . . . . 0.0 113.454 168.623 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -52.5 -40.38 62.33 Favored 'General case' 0 C--N 1.319 -0.754 0 CA-C-N 121.688 2.04 . . . . 0.0 113.82 173.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 6.3 pt-20 -85.66 -43.83 13.09 Favored 'General case' 0 C--O 1.217 -0.616 0 CA-C-O 118.1 -0.952 . . . . 0.0 110.603 173.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 41.0 t -71.36 -62.88 1.24 Allowed 'General case' 0 C--O 1.217 -0.62 0 C-N-CA 126.914 2.086 . . . . 0.0 110.839 -176.315 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.421 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 0.6 OUTLIER -39.55 -38.16 0.57 Allowed 'General case' 0 CA--C 1.538 0.509 0 CA-C-N 120.262 1.392 . . . . 0.0 111.673 168.942 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.576 ' HB3' HG11 ' A' ' 108' ' ' VAL . 1.1 p -83.51 -26.67 29.98 Favored 'General case' 0 C--O 1.218 -0.598 0 N-CA-C 116.464 2.024 . . . . 0.0 116.464 175.364 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 2.9 m170 -54.25 -32.99 57.44 Favored 'General case' 0 C--N 1.331 -0.237 0 C-N-CA 125.186 1.394 . . . . 0.0 109.088 178.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.421 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.1 OUTLIER -75.48 -41.39 55.6 Favored 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 125.086 1.355 . . . . 0.0 111.208 177.111 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.861 ' HB1' ' HG3' ' A' ' 35' ' ' PRO . . . -39.04 125.47 1.25 Allowed Pre-proline 0 CA--C 1.539 0.526 0 C-N-CA 125.39 1.476 . . . . 0.0 111.503 174.44 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.403 ' HG2' ' CG2' ' A' ' 30' ' ' THR . 19.0 Cg_endo -71.02 123.2 9.47 Favored 'Trans proline' 0 N--CA 1.439 -1.68 0 C-N-CA 122.71 2.274 . . . . 0.0 109.101 -177.494 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.451 HD22 ' HE2' ' A' ' 115' ' ' LYS . 2.7 tp -60.41 97.17 0.05 OUTLIER 'General case' 0 C--O 1.222 -0.394 0 C-N-CA 124.18 0.992 . . . . 0.0 111.043 177.706 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -175.25 149.05 1.02 Allowed 'General case' 0 C--N 1.328 -0.36 0 C-N-CA 123.729 0.812 . . . . 0.0 110.928 -176.324 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.508 ' HB3' ' CA ' ' A' ' 72' ' ' GLY . 3.6 t0 -82.02 82.74 7.51 Favored 'General case' 0 CA--C 1.532 0.262 0 N-CA-C 108.049 -1.093 . . . . 0.0 108.049 -178.521 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.415 ' N ' ' HA ' ' A' ' 36' ' ' HIS . . . 68.22 81.29 0.19 Allowed Glycine 0 C--O 1.227 -0.317 0 N-CA-C 110.811 -0.916 . . . . 0.0 110.811 175.291 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -149.35 47.3 0.97 Allowed 'General case' 0 N--CA 1.476 0.864 0 CA-C-O 122.748 1.261 . . . . 0.0 112.778 -179.839 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.403 ' CG2' ' HG2' ' A' ' 24' ' ' PRO . 68.2 p -134.14 154.85 50.96 Favored 'General case' 0 C--N 1.314 -0.935 0 CA-C-N 114.895 -1.048 . . . . 0.0 108.286 -175.111 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -41.6 -61.4 2.19 Favored Glycine 0 C--O 1.228 -0.243 0 C-N-CA 124.189 0.899 . . . . 0.0 112.704 -178.417 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 22.9 t -65.0 -72.35 0.15 Allowed 'General case' 0 C--N 1.33 -0.264 0 CA-C-O 118.103 -0.951 . . . . 0.0 112.186 173.434 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 60.7 p 179.74 -55.2 0.01 OUTLIER 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 123.955 0.902 . . . . 0.0 112.278 -179.761 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.475 ' CD1' ' HD3' ' A' ' 84' ' ' PRO . 80.9 m-85 -71.34 142.93 87.38 Favored Pre-proline 0 N--CA 1.437 -1.083 0 O-C-N 124.821 1.325 . . . . 0.0 112.04 -178.644 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.861 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 27.8 Cg_endo -79.04 158.81 91.22 Favored 'Cis proline' 0 N--CA 1.442 -1.552 0 C-N-CA 122.159 -2.017 . . . . 0.0 110.713 6.574 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.421 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 0.6 OUTLIER -140.91 157.72 44.97 Favored 'General case' 0 CA--C 1.511 -0.544 0 CA-C-O 118.582 -0.723 . . . . 0.0 111.944 178.275 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.939 ' CH2' HG22 ' A' ' 39' ' ' THR . 21.5 t90 -58.4 149.7 24.2 Favored 'General case' 0 C--N 1.325 -0.484 0 CA-C-O 122.943 1.354 . . . . 0.0 110.879 172.948 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.496 ' CE2' HD13 ' A' ' 121' ' ' ILE . 8.1 t80 -123.69 83.87 2.2 Favored 'General case' 0 N--CA 1.434 -1.25 0 C-N-CA 127.515 2.326 . . . . 0.0 105.779 -174.993 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.939 HG22 ' CH2' ' A' ' 37' ' ' TRP . 71.1 p -36.46 -41.93 0.31 Allowed 'General case' 0 C--O 1.213 -0.849 0 CA-C-N 114.464 -1.244 . . . . 0.0 110.819 171.682 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 55.4 t30 57.05 20.08 5.2 Favored 'General case' 0 CA--C 1.55 0.965 0 CA-C-O 122.413 1.102 . . . . 0.0 111.028 -179.943 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 106.84 -33.13 6.64 Favored Glycine 0 C--O 1.222 -0.626 0 CA-C-O 117.655 -1.636 . . . . 0.0 113.558 -171.896 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.604 ' CD1' ' HG ' ' A' ' 48' ' ' LEU . 84.3 m-85 -52.76 157.04 1.74 Allowed 'General case' 0 N--CA 1.469 0.512 0 C-N-CA 125.328 1.451 . . . . 0.0 111.339 177.734 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -78.72 -31.2 46.29 Favored 'General case' 0 N--CA 1.471 0.613 0 CA-C-O 121.635 0.731 . . . . 0.0 112.061 176.902 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.509 ' HA2' ' CZ2' ' A' ' 37' ' ' TRP . . . 114.83 34.47 1.52 Allowed Glycine 0 C--O 1.221 -0.699 0 CA-C-O 117.28 -1.845 . . . . 0.0 114.779 -174.56 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -147.54 -64.88 0.27 Allowed 'General case' 0 N--CA 1.467 0.399 0 C-N-CA 124.483 1.113 . . . . 0.0 112.219 -178.9 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -135.47 -100.81 0.64 Allowed Glycine 0 C--O 1.219 -0.804 0 N-CA-C 110.421 -1.072 . . . . 0.0 110.421 -179.558 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -84.88 -174.39 5.24 Favored 'General case' 0 N--CA 1.465 0.308 0 CA-C-O 121.348 0.594 . . . . 0.0 109.79 178.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.72 HD13 ' NE ' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -101.47 168.87 8.47 Favored Pre-proline 0 C--N 1.317 -0.809 0 CA-C-N 115.518 -0.765 . . . . 0.0 110.507 -178.725 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 24.7 Cg_endo -71.29 -179.13 3.34 Favored 'Trans proline' 0 N--CA 1.442 -1.53 0 C-N-CA 123.003 2.468 . . . . 0.0 112.166 179.424 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.15 104.0 11.33 Favored 'General case' 0 C--N 1.327 -0.411 0 O-C-N 119.98 -1.7 . . . . 0.0 110.014 174.304 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.43 71.21 0.52 Allowed Glycine 0 N--CA 1.469 0.863 0 N-CA-C 111.401 -0.68 . . . . 0.0 111.401 177.662 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.72 ' NE ' HD13 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -161.66 169.29 21.83 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 124.013 0.925 . . . . 0.0 109.637 178.797 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.9 m -155.23 107.96 2.25 Favored Pre-proline 0 C--N 1.321 -0.639 0 N-CA-C 109.292 -0.632 . . . . 0.0 109.292 173.898 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.508 ' HG3' HD21 ' A' ' 48' ' ' LEU . 24.4 Cg_endo -71.76 172.87 13.6 Favored 'Trans proline' 0 N--CA 1.444 -1.4 0 C-N-CA 122.817 2.345 . . . . 0.0 111.246 177.03 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.8 mt -85.82 132.9 30.87 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.551 0 N-CA-C 107.462 -1.31 . . . . 0.0 107.462 -179.712 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.92 149.28 25.76 Favored 'General case' 0 C--N 1.33 -0.265 0 O-C-N 121.499 -0.75 . . . . 0.0 109.87 175.552 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.465 ' CE2' ' SG ' ' A' ' 62' ' ' CYS . 21.0 m-85 -132.67 -49.48 0.9 Allowed 'General case' 0 N--CA 1.468 0.444 0 C-N-CA 124.616 1.167 . . . . 0.0 110.856 -179.705 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 111.33 -3.32 28.12 Favored Glycine 0 CA--C 1.527 0.785 0 C-N-CA 125.008 1.29 . . . . 0.0 113.249 -174.671 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.87 128.9 40.39 Favored 'General case' 0 CA--C 1.499 -1.015 0 CA-C-O 117.724 -1.131 . . . . 0.0 109.728 176.046 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 22.5 p -61.82 -10.62 9.55 Favored 'General case' 0 CA--C 1.539 0.524 0 O-C-N 125.617 1.823 . . . . 0.0 112.718 176.783 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.586 ' HB2' HG11 ' A' ' 116' ' ' VAL . 0.4 OUTLIER -88.14 -54.21 4.33 Favored 'General case' 0 CA--C 1.515 -0.384 0 C-N-CA 126.181 1.792 . . . . 0.0 110.505 179.329 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.465 ' SG ' ' CE2' ' A' ' 57' ' ' PHE . 2.6 t -73.34 -15.2 61.39 Favored 'General case' 0 CA--C 1.538 0.488 0 O-C-N 124.275 0.985 . . . . 0.0 113.092 174.91 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 14.8 t0 -84.68 -40.5 17.31 Favored 'General case' 0 N--CA 1.469 0.478 0 C-N-CA 125.383 1.473 . . . . 0.0 110.259 173.471 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.63 155.41 3.9 Favored Pre-proline 0 CA--C 1.539 0.529 0 CA-C-O 122.636 1.208 . . . . 0.0 111.566 -178.683 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -69.02 138.02 39.1 Favored 'Trans proline' 0 N--CA 1.439 -1.689 0 C-N-CA 120.344 0.696 . . . . 0.0 112.411 175.093 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.454 ' HD2' ' CD1' ' A' ' 42' ' ' TYR . 27.9 Cg_endo -66.17 172.24 9.04 Favored 'Trans proline' 0 N--CA 1.442 -1.529 0 C-N-CA 124.118 3.212 . . . . 0.0 110.713 173.93 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.7 mmtt -140.94 63.0 1.46 Allowed 'General case' 0 C--O 1.207 -1.133 0 CA-C-O 118.287 -0.863 . . . . 0.0 109.508 177.388 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 31.1 t-80 -74.29 163.86 27.3 Favored 'General case' 0 CA--C 1.543 0.693 0 O-C-N 123.433 0.458 . . . . 0.0 110.382 177.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 21.1 p -148.63 -173.37 4.32 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 124.483 1.113 . . . . 0.0 110.976 176.186 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.75 74.19 10.2 Favored 'General case' 0 C--N 1.327 -0.389 0 O-C-N 120.734 -1.229 . . . . 0.0 111.706 176.359 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -177.05 -46.46 0.01 OUTLIER 'General case' 0 C--N 1.324 -0.54 0 C-N-CA 124.281 1.033 . . . . 0.0 109.68 -179.255 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.508 ' CA ' ' HB3' ' A' ' 27' ' ' ASP . . . 120.66 -78.12 0.32 Allowed Glycine 0 N--CA 1.441 -1.017 0 O-C-N 124.441 1.088 . . . . 0.0 112.677 -174.766 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -119.99 61.61 0.85 Allowed 'General case' 0 C--N 1.329 -0.29 0 C-N-CA 128.874 2.869 . . . . 0.0 109.003 -178.079 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -70.56 -106.36 0.04 OUTLIER Glycine 0 CA--C 1.526 0.725 0 CA-C-O 123.088 1.382 . . . . 0.0 111.506 -175.239 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.0 mttt -61.35 -90.05 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.68 0 O-C-N 120.201 -1.764 . . . . 0.0 113.353 174.36 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.42 HG23 ' O ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -128.77 15.37 6.42 Favored 'General case' 0 CA--C 1.512 -0.492 0 CA-C-N 115.367 -0.833 . . . . 0.0 111.641 177.437 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 13.6 m-20 -29.38 97.33 0.01 OUTLIER 'General case' 0 C--O 1.214 -0.806 0 C-N-CA 126.126 1.77 . . . . 0.0 112.349 -175.733 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.403 ' CD2' ' H ' ' A' ' 78' ' ' HIS . 6.1 p80 -88.53 58.0 4.48 Favored 'General case' 0 N--CA 1.474 0.732 0 O-C-N 119.866 -1.771 . . . . 0.0 107.527 -169.232 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.528 ' HB2' ' CD1' ' A' ' 37' ' ' TRP . 46.7 p90 -80.85 133.55 35.61 Favored 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 125.08 1.352 . . . . 0.0 108.885 -177.189 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.611 HD21 HG22 ' A' ' 111' ' ' THR . 5.3 mt -71.2 126.33 29.32 Favored 'General case' 0 CA--C 1.51 -0.588 0 N-CA-C 107.97 -1.122 . . . . 0.0 107.97 176.804 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.727 HD21 ' HB2' ' A' ' 35' ' ' PRO . 0.4 OUTLIER -120.23 141.79 49.62 Favored 'General case' 0 C--N 1.321 -0.65 0 N-CA-C 109.145 -0.687 . . . . 0.0 109.145 177.962 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.407 ' HB2' HD11 ' A' ' 109' ' ' ILE . 0.6 OUTLIER -103.84 166.14 10.6 Favored 'General case' 0 C--O 1.237 0.412 0 N-CA-C 113.837 1.051 . . . . 0.0 113.837 175.784 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.723 ' CE2' ' HB2' ' A' ' 23' ' ' ALA . 7.6 t80 -152.85 127.04 4.47 Favored Pre-proline 0 CA--C 1.538 0.511 0 N-CA-C 113.99 1.107 . . . . 0.0 113.99 179.535 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.475 ' HD3' ' CD1' ' A' ' 34' ' ' TYR . 17.8 Cg_endo -71.66 118.39 5.63 Favored 'Trans proline' 0 N--CA 1.444 -1.416 0 C-N-CA 124.755 3.637 . . . . 0.0 110.312 -176.871 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.0 OUTLIER -119.99 111.29 17.72 Favored 'General case' 0 C--N 1.323 -0.548 0 CA-C-N 114.742 -1.117 . . . . 0.0 108.61 -177.118 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 52.7 m-85 -79.31 157.64 75.13 Favored Pre-proline 0 C--N 1.326 -0.417 0 N-CA-C 112.811 0.671 . . . . 0.0 112.811 177.133 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -73.52 -36.1 4.19 Favored 'Trans proline' 0 N--CA 1.448 -1.18 0 C-N-CA 122.636 2.224 . . . . 0.0 113.321 178.694 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -46.74 -29.93 2.16 Favored 'General case' 0 N--CA 1.469 0.479 0 C-N-CA 126.911 2.084 . . . . 0.0 110.044 179.167 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 87.93 6.08 76.37 Favored Glycine 0 N--CA 1.44 -1.099 0 C-N-CA 125.367 1.46 . . . . 0.0 112.344 178.599 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.1 p-80 -76.56 128.7 35.24 Favored 'General case' 0 N--CA 1.443 -0.812 0 N-CA-C 107.181 -1.415 . . . . 0.0 107.181 177.104 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 14.8 t70 -56.82 106.79 0.33 Allowed 'General case' 0 N--CA 1.444 -0.737 0 N-CA-C 107.296 -1.372 . . . . 0.0 107.296 171.485 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.46 ' CD2' ' HG2' ' A' ' 84' ' ' PRO . 3.0 t80 -37.08 131.96 0.74 Allowed 'General case' 0 C--O 1.215 -0.715 0 C-N-CA 123.833 0.853 . . . . 0.0 108.852 176.667 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -68.27 59.68 0.08 Allowed 'General case' 0 CA--C 1.541 0.628 0 O-C-N 121.385 -0.822 . . . . 0.0 112.162 173.361 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.482 ' CD2' ' HZ ' ' A' ' 83' ' ' PHE . 6.5 p90 -72.92 -5.09 36.17 Favored 'General case' 0 C--N 1.324 -0.513 0 C-N-CA 127.347 2.259 . . . . 0.0 112.196 174.937 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -93.68 -40.6 10.16 Favored 'General case' 0 CA--C 1.541 0.633 0 CA-C-O 123.652 1.691 . . . . 0.0 110.166 -179.869 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 74.9 m -76.93 97.72 4.69 Favored 'General case' 0 N--CA 1.455 -0.215 0 O-C-N 120.348 -1.47 . . . . 0.0 108.393 179.594 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.6 pttm -59.16 -46.71 87.67 Favored 'General case' 0 N--CA 1.471 0.609 0 CA-C-O 121.955 0.883 . . . . 0.0 111.81 177.225 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -144.46 126.35 8.12 Favored Pre-proline 0 CA--C 1.54 0.576 0 CA-C-N 114.797 -1.092 . . . . 0.0 110.909 -179.149 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 30.5 Cg_endo -69.47 171.75 51.01 Favored 'Cis proline' 0 N--CA 1.454 -0.842 0 C-N-CA 123.183 -1.591 . . . . 0.0 111.184 -5.48 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -128.77 146.05 51.01 Favored 'General case' 0 C--N 1.328 -0.367 0 C-N-CA 123.612 0.765 . . . . 0.0 109.107 177.004 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 30.6 tt0 -95.19 165.96 12.14 Favored 'General case' 0 C--N 1.318 -0.783 0 N-CA-C 109.287 -0.635 . . . . 0.0 109.287 173.935 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.0 t30 -36.02 138.48 0.44 Allowed Pre-proline 0 CA--C 1.539 0.549 0 C-N-CA 125.034 1.334 . . . . 0.0 110.954 170.579 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 28.5 Cg_endo -71.88 -68.43 0.02 OUTLIER 'Trans proline' 0 N--CA 1.449 -1.101 0 C-N-CA 123.174 2.583 . . . . 0.0 114.259 176.423 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 130.82 142.09 5.01 Favored Glycine 0 CA--C 1.527 0.807 0 N-CA-C 110.842 -0.903 . . . . 0.0 110.842 178.892 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -75.3 -66.62 0.02 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.035 0 C-N-CA 123.468 2.778 . . . . 0.0 110.951 -179.723 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.589 ' HA ' ' HB2' ' A' ' 122' ' ' ALA . . . -64.74 131.8 47.85 Favored 'General case' 0 N--CA 1.45 -0.449 0 CA-C-O 121.789 0.804 . . . . 0.0 111.356 178.652 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.406 ' HG2' ' HA ' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -139.75 150.61 44.99 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-N 114.63 -1.168 . . . . 0.0 110.057 -178.443 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.576 HG11 ' HB3' ' A' ' 20' ' ' SER . 3.6 p -88.36 119.19 35.29 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.577 0 O-C-N 124.58 1.175 . . . . 0.0 110.454 178.377 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.534 HG12 HD13 ' A' ' 121' ' ' ILE . 1.2 mp -107.25 117.8 53.74 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.011 0 N-CA-C 105.847 -1.908 . . . . 0.0 105.847 -173.975 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.649 ' CZ ' HD22 ' A' ' 81' ' ' LEU . 5.9 p90 -136.06 151.53 49.94 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-O 122.732 1.253 . . . . 0.0 108.213 -178.941 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.611 HG22 HD21 ' A' ' 80' ' ' LEU . 1.8 p -83.46 157.23 22.51 Favored 'General case' 0 C--N 1.321 -0.655 0 CA-C-N 114.663 -1.153 . . . . 0.0 109.142 177.492 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.484 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -105.47 157.16 35.12 Favored Pre-proline 0 CA--C 1.552 1.022 0 O-C-N 121.966 -0.459 . . . . 0.0 111.317 178.188 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.484 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 19.1 Cg_endo -72.35 -49.77 0.21 Allowed 'Cis proline' 0 N--CA 1.454 -0.807 0 C-N-CA 124.412 -1.078 . . . . 0.0 111.375 -11.072 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 54.4 t30 -48.06 105.14 0.07 Allowed 'General case' 0 C--O 1.224 -0.268 0 C-N-CA 124.113 0.965 . . . . 0.0 109.24 176.55 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.451 ' HE2' HD22 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -61.85 79.87 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.356 0 C-N-CA 126.113 1.765 . . . . 0.0 108.695 -178.152 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.586 HG11 ' HB2' ' A' ' 61' ' ' ASP . 39.4 t -81.41 72.8 0.72 Allowed 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 N-CA-C 104.271 -2.492 . . . . 0.0 104.271 -177.256 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.457 ' CZ ' ' NE2' ' A' ' 13' ' ' GLN . 47.6 t80 -36.87 106.63 0.05 OUTLIER 'General case' 0 N--CA 1.45 -0.43 0 C-N-CA 125.864 1.665 . . . . 0.0 109.827 176.112 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . 0.421 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 7.8 m -84.79 -45.51 12.28 Favored 'General case' 0 N--CA 1.445 -0.679 0 N-CA-C 109.13 -0.692 . . . . 0.0 109.13 -177.912 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 163.7 -146.78 11.96 Favored Glycine 0 N--CA 1.439 -1.149 0 CA-C-N 114.75 -1.113 . . . . 0.0 110.682 179.994 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.44 HG13 ' CG ' ' A' ' 4' ' ' TRP . 1.3 mm -127.5 141.1 47.27 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.925 0 N-CA-C 104.93 -2.248 . . . . 0.0 104.93 -177.892 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.572 HD12 HD22 ' A' ' 131' ' ' LEU . 5.7 pt -130.51 150.44 34.61 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.755 0 N-CA-C 108.189 -1.041 . . . . 0.0 108.189 -178.74 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.589 ' HB2' ' HA ' ' A' ' 106' ' ' ALA . . . -169.19 162.22 10.59 Favored 'General case' 0 C--N 1.321 -0.633 0 CA-C-O 121.439 0.638 . . . . 0.0 110.344 178.537 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.482 ' CE1' ' HG ' ' A' ' 131' ' ' LEU . 2.1 m-70 -92.7 90.62 7.15 Favored 'General case' 0 C--O 1.221 -0.398 0 CA-C-O 121.357 0.598 . . . . 0.0 109.515 -179.326 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 8.4 p -101.79 43.21 1.08 Allowed 'General case' 0 C--N 1.318 -0.803 0 CA-C-O 122.056 0.932 . . . . 0.0 109.952 -177.274 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -109.65 -23.31 11.52 Favored 'General case' 0 C--O 1.217 -0.636 0 CA-C-N 114.77 -1.105 . . . . 0.0 111.855 175.455 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -171.45 -70.4 0.02 OUTLIER 'General case' 0 C--O 1.22 -0.485 0 O-C-N 123.971 0.794 . . . . 0.0 110.032 176.502 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.9 m-20 -154.6 -45.47 0.09 Allowed 'General case' 0 CA--C 1.533 0.317 0 C-N-CA 125.316 1.447 . . . . 0.0 111.158 179.86 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -154.17 81.4 1.13 Allowed 'General case' 0 N--CA 1.447 -0.576 0 C-N-CA 124.838 1.255 . . . . 0.0 108.8 179.968 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -128.62 -108.2 1.38 Allowed Glycine 0 N--CA 1.464 0.5 0 N-CA-C 109.647 -1.381 . . . . 0.0 109.647 175.119 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -86.53 159.84 19.16 Favored 'General case' 0 C--N 1.32 -0.679 0 O-C-N 122.237 -0.567 . . . . 0.0 111.328 -179.818 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.572 HD22 HD12 ' A' ' 121' ' ' ILE . 0.6 OUTLIER -108.79 148.07 31.09 Favored 'General case' 0 C--N 1.325 -0.457 0 C-N-CA 122.961 0.504 . . . . 0.0 109.956 177.577 . . . . . . . . 3 3 . 1 . 007 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -153.1 171.43 18.45 Favored 'General case' 0 C--N 1.324 -0.505 0 C-N-CA 124.122 0.969 . . . . 0.0 109.104 -179.942 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.401 HD12 HG22 ' A' ' 121' ' ' ILE . 12.4 tp -82.24 136.2 35.11 Favored 'General case' 0 C--N 1.326 -0.437 0 N-CA-C 108.606 -0.886 . . . . 0.0 108.606 178.006 . . . . . . . . 2 2 . 1 . 007 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 64.1 m -67.08 -177.31 0.63 Allowed 'General case' 0 C--N 1.329 -0.317 0 CA-C-O 123.066 1.412 . . . . 0.0 109.979 173.126 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 2.1 m -158.72 124.6 4.48 Favored 'General case' 0 C--N 1.316 -0.866 0 N-CA-C 104.836 -2.283 . . . . 0.0 104.836 -177.989 . . . . . . . . 1 1 . 1 . 007 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.473 ' HB3' HG22 ' A' ' 2' ' ' VAL . 3.0 m80 . . . . . 0 C--N 1.324 -0.503 0 CA-C-O 117.228 -1.367 . . . . 0.0 113.238 175.039 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.661 ' HB3' ' HB3' ' A' ' 13' ' ' GLN . . . . . . . . 0 N--CA 1.476 0.848 0 CA-C-O 117.892 -1.052 . . . . 0.0 109.172 . . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.41 HG13 ' CD2' ' A' ' 136' ' ' HIS . 7.7 p -51.6 153.45 0.65 Allowed 'Isoleucine or valine' 0 CA--C 1.531 0.228 0 O-C-N 124.153 0.908 . . . . 0.0 111.271 174.424 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.528 HG21 HD23 ' A' ' 10' ' ' LEU . 0.9 OUTLIER -83.58 114.59 21.63 Favored 'General case' 0 C--N 1.319 -0.723 0 O-C-N 122.092 -0.38 . . . . 0.0 110.538 178.354 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 23.0 m95 -81.17 139.57 35.48 Favored 'General case' 0 C--O 1.215 -0.721 0 O-C-N 121.994 -0.441 . . . . 0.0 110.345 177.609 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -130.69 138.5 50.06 Favored 'General case' 0 CA--C 1.495 -1.155 0 N-CA-C 108.193 -1.04 . . . . 0.0 108.193 -178.809 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.645 ' SG ' ' HB3' ' A' ' 122' ' ' ALA . 0.1 OUTLIER -122.85 61.71 1.0 Allowed 'General case' 0 N--CA 1.442 -0.852 0 O-C-N 124.092 0.87 . . . . 0.0 108.755 175.553 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 43.7 52.22 6.58 Favored Glycine 0 CA--C 1.531 1.046 0 C-N-CA 123.133 0.396 . . . . 0.0 112.115 179.041 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -164.29 -85.3 0.06 OUTLIER Glycine 0 C--O 1.224 -0.476 0 N-CA-C 110.938 -0.865 . . . . 0.0 110.938 -177.967 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.9 OUTLIER -127.19 164.0 22.64 Favored 'General case' 0 N--CA 1.455 -0.217 0 CA-C-O 121.749 0.785 . . . . 0.0 110.098 177.414 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.528 HD23 HG21 ' A' ' 3' ' ' THR . 10.9 mp -88.69 126.09 35.15 Favored 'General case' 0 N--CA 1.448 -0.56 0 N-CA-C 108.244 -1.021 . . . . 0.0 108.244 -177.256 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.495 ' CZ ' ' HB3' ' A' ' 106' ' ' ALA . 70.2 m-85 -111.3 89.73 3.13 Favored 'General case' 0 C--N 1.322 -0.618 0 C-N-CA 126.695 1.998 . . . . 0.0 108.586 -174.27 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.405 HD22 ' N ' ' A' ' 13' ' ' GLN . 0.2 OUTLIER -54.71 125.39 19.73 Favored 'General case' 0 N--CA 1.436 -1.151 0 N-CA-C 108.229 -1.026 . . . . 0.0 108.229 179.265 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.661 ' HB3' ' HB3' ' A' ' 1' ' ' ALA . 7.5 tp-100 -60.59 -21.66 62.87 Favored 'General case' 0 C--O 1.213 -0.838 0 C-N-CA 119.028 -1.069 . . . . 0.0 113.249 176.793 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.6 t30 -64.64 -23.46 67.27 Favored 'General case' 0 N--CA 1.439 -1.007 0 N-CA-C 114.464 1.283 . . . . 0.0 114.464 172.673 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 2.2 mtmt -103.73 -36.65 7.79 Favored 'General case' 0 C--O 1.202 -1.424 0 C-N-CA 126.492 1.917 . . . . 0.0 109.782 175.135 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.629 ' HA ' HG21 ' A' ' 85' ' ' THR . . . -54.27 -42.53 70.09 Favored 'General case' 0 C--N 1.322 -0.626 0 CA-C-N 121.307 1.867 . . . . 0.0 111.736 177.112 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.4 pt-20 -84.13 -47.56 10.76 Favored 'General case' 0 N--CA 1.438 -1.055 0 CA-C-O 117.598 -1.191 . . . . 0.0 108.809 177.034 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 30.7 t -66.64 -53.01 38.62 Favored 'General case' 0 C--O 1.212 -0.884 0 CA-C-N 120.326 1.421 . . . . 0.0 109.514 -172.212 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.518 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 6.4 t-20 -42.78 -36.52 1.49 Allowed 'General case' 0 N--CA 1.447 -0.606 0 C-N-CA 123.946 0.898 . . . . 0.0 113.396 169.639 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.456 ' O ' ' HB3' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -82.01 -33.95 29.82 Favored 'General case' 0 N--CA 1.447 -0.578 0 N-CA-C 115.531 1.678 . . . . 0.0 115.531 172.548 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 12.6 m170 -46.2 -37.01 6.57 Favored 'General case' 0 N--CA 1.453 -0.28 0 C-N-CA 126.469 1.908 . . . . 0.0 109.925 178.071 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.518 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -73.13 -48.8 32.48 Favored 'General case' 0 N--CA 1.437 -1.083 0 CA-C-O 117.635 -1.174 . . . . 0.0 112.698 175.182 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.769 ' HB1' ' HG3' ' A' ' 35' ' ' PRO . . . -36.59 128.38 0.71 Allowed Pre-proline 0 N--CA 1.442 -0.873 0 O-C-N 125.487 1.742 . . . . 0.0 112.226 173.153 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.552 ' HG2' HG22 ' A' ' 30' ' ' THR . 13.8 Cg_endo -73.69 125.96 10.42 Favored 'Trans proline' 0 N--CA 1.444 -1.417 0 C-N-CA 121.979 1.786 . . . . 0.0 107.573 -175.817 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.672 HD13 ' HE2' ' A' ' 115' ' ' LYS . 3.4 tp -61.77 84.98 0.02 OUTLIER 'General case' 0 CA--C 1.516 -0.343 0 C-N-CA 124.552 1.141 . . . . 0.0 111.911 177.998 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.4 m -174.43 155.12 2.24 Favored 'General case' 0 N--CA 1.447 -0.617 0 C-N-CA 124.165 0.986 . . . . 0.0 110.047 -173.291 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -96.31 137.45 35.36 Favored 'General case' 0 CA--C 1.503 -0.849 0 CA-C-O 117.566 -1.207 . . . . 0.0 110.784 175.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 37.21 70.58 0.24 Allowed Glycine 0 C--N 1.338 0.673 0 O-C-N 125.008 1.442 . . . . 0.0 111.897 177.032 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.5 mttt -148.6 24.15 0.99 Allowed 'General case' 0 CA--C 1.51 -0.587 0 CA-C-O 121.997 0.903 . . . . 0.0 111.824 -178.525 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.552 HG22 ' HG2' ' A' ' 24' ' ' PRO . 50.1 p -130.2 151.8 50.33 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.354 -0.98 . . . . 0.0 108.354 -175.956 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -40.7 -64.98 1.1 Allowed Glycine 0 CA--C 1.505 -0.536 0 O-C-N 124.25 0.969 . . . . 0.0 112.764 -177.517 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 40.5 t -60.15 -60.99 2.94 Favored 'General case' 0 N--CA 1.431 -1.382 0 CA-C-O 115.809 -2.043 . . . . 0.0 112.641 174.691 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 161.16 -53.32 0.0 OUTLIER 'General case' 0 N--CA 1.473 0.706 0 O-C-N 125.777 1.923 . . . . 0.0 111.863 176.705 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.485 ' CD2' ' HD3' ' A' ' 84' ' ' PRO . 62.2 m-85 -63.38 146.86 95.96 Favored Pre-proline 0 N--CA 1.438 -1.065 0 N-CA-C 114.757 1.392 . . . . 0.0 114.757 177.41 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.769 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 20.7 Cg_endo -75.41 166.32 83.44 Favored 'Cis proline' 0 N--CA 1.446 -1.308 0 C-N-CA 123.442 -1.483 . . . . 0.0 110.862 0.711 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.465 ' C ' HD23 ' A' ' 81' ' ' LEU . 0.8 OUTLIER -139.61 172.41 12.84 Favored 'General case' 0 CA--C 1.502 -0.884 0 O-C-N 120.867 -1.146 . . . . 0.0 109.89 -176.895 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.943 ' CH2' HG22 ' A' ' 39' ' ' THR . 21.3 t90 -71.4 141.4 50.32 Favored 'General case' 0 C--N 1.322 -0.61 0 CA-C-O 121.889 0.852 . . . . 0.0 108.825 177.303 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.598 ' CZ ' HD13 ' A' ' 121' ' ' ILE . 55.4 t80 -121.05 83.0 2.0 Favored 'General case' 0 N--CA 1.435 -1.199 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 -176.379 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.943 HG22 ' CH2' ' A' ' 37' ' ' TRP . 44.2 p -40.32 -31.23 0.13 Allowed 'General case' 0 C--O 1.212 -0.886 0 C-N-CA 124.512 1.125 . . . . 0.0 111.255 174.229 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 8.4 t30 71.32 7.67 6.14 Favored 'General case' 0 CA--C 1.54 0.575 0 C-N-CA 126.039 1.735 . . . . 0.0 109.405 178.014 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.71 ' C ' HD23 ' A' ' 48' ' ' LEU . . . 117.58 -11.32 14.02 Favored Glycine 0 N--CA 1.434 -1.481 0 O-C-N 120.592 -1.318 . . . . 0.0 113.169 -170.9 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.579 ' CE2' ' HA ' ' A' ' 47' ' ' LYS . 4.9 m-85 -75.93 176.26 8.04 Favored 'General case' 0 N--CA 1.448 -0.537 0 CA-C-N 118.364 1.082 . . . . 0.0 109.852 -176.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -97.62 -39.11 9.26 Favored 'General case' 0 C--N 1.326 -0.438 0 CA-C-N 115.747 -0.66 . . . . 0.0 111.563 174.993 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.485 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -172.49 -82.55 0.05 OUTLIER Glycine 0 C--N 1.333 0.406 0 C-N-CA 123.571 0.605 . . . . 0.0 111.983 -178.209 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -98.83 -63.1 1.15 Allowed 'General case' 0 C--N 1.33 -0.262 0 CA-C-O 122.021 0.915 . . . . 0.0 110.438 178.399 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.97 166.49 12.88 Favored Glycine 0 C--N 1.34 0.751 0 N-CA-C 110.325 -1.11 . . . . 0.0 110.325 179.177 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.579 ' HA ' ' CE2' ' A' ' 42' ' ' TYR . 1.2 pttt -53.91 -176.25 0.01 OUTLIER 'General case' 0 CA--C 1.532 0.264 0 CA-C-O 123.13 1.443 . . . . 0.0 113.095 174.559 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.729 HD11 ' HG3' ' A' ' 54' ' ' PRO . 0.1 OUTLIER -65.07 156.77 79.63 Favored Pre-proline 0 C--N 1.313 -1.007 0 O-C-N 121.23 -0.919 . . . . 0.0 111.313 178.324 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -72.5 175.21 10.44 Favored 'Trans proline' 0 N--CA 1.447 -1.263 0 C-N-CA 122.225 1.95 . . . . 0.0 110.556 179.418 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.52 96.44 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.481 0 O-C-N 121.651 -0.656 . . . . 0.0 110.611 176.358 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 107.7 90.51 2.14 Favored Glycine 0 C--O 1.226 -0.4 0 CA-C-N 116.295 -0.412 . . . . 0.0 112.168 -176.559 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.461 ' HB3' HD22 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -173.18 162.63 4.51 Favored 'General case' 0 CA--C 1.512 -0.483 0 C-N-CA 123.808 0.843 . . . . 0.0 110.583 175.876 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 48.1 m -142.56 95.64 6.43 Favored Pre-proline 0 C--O 1.234 0.248 0 O-C-N 124.961 1.413 . . . . 0.0 110.132 -177.332 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.729 ' HG3' HD11 ' A' ' 48' ' ' LEU . 19.5 Cg_endo -73.31 146.84 40.9 Favored 'Trans proline' 0 N--CA 1.451 -0.974 0 C-N-CA 122.531 2.154 . . . . 0.0 110.071 -179.234 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.413 HD12 HG21 ' A' ' 121' ' ' ILE . 5.3 mt -68.18 116.81 8.95 Favored 'Isoleucine or valine' 0 C--O 1.219 -0.531 0 N-CA-C 107.7 -1.222 . . . . 0.0 107.7 -178.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.12 136.88 35.11 Favored 'General case' 0 C--N 1.326 -0.414 0 N-CA-C 108.122 -1.066 . . . . 0.0 108.122 177.873 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.576 ' CD2' ' HB3' ' A' ' 118' ' ' CYS . 8.7 m-85 -114.96 -53.35 2.65 Favored 'General case' 0 CA--C 1.513 -0.466 0 C-N-CA 123.752 0.821 . . . . 0.0 110.128 179.504 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 128.99 -11.46 6.2 Favored Glycine 0 N--CA 1.45 -0.413 0 C-N-CA 123.896 0.76 . . . . 0.0 112.845 -176.16 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.405 ' HA ' ' CE ' ' A' ' 59' ' ' LYS . 0.3 OUTLIER -90.0 132.21 35.48 Favored 'General case' 0 CA--C 1.507 -0.674 0 CA-C-N 117.27 0.535 . . . . 0.0 110.739 176.321 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -73.32 0.78 11.05 Favored 'General case' 0 C--O 1.223 -0.297 0 O-C-N 124.875 1.36 . . . . 0.0 111.946 175.835 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.428 ' OD2' HG11 ' A' ' 116' ' ' VAL . 0.6 OUTLIER -87.28 -54.37 4.34 Favored 'General case' 0 N--CA 1.446 -0.645 0 O-C-N 120.638 -1.289 . . . . 0.0 109.004 -179.948 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.442 ' HA ' HD11 ' A' ' 80' ' ' LEU . 1.8 m -75.66 -35.17 60.48 Favored 'General case' 0 N--CA 1.453 -0.292 0 O-C-N 124.617 1.198 . . . . 0.0 109.013 -179.146 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 5.8 t70 -59.73 -39.97 86.5 Favored 'General case' 0 C--N 1.343 0.324 0 O-C-N 124.362 1.039 . . . . 0.0 111.286 175.496 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.0 159.02 0.5 Allowed Pre-proline 0 N--CA 1.446 -0.648 0 CA-C-O 122.94 1.352 . . . . 0.0 111.536 179.179 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -70.55 133.18 23.55 Favored 'Trans proline' 0 N--CA 1.437 -1.8 0 C-N-CA 120.212 0.608 . . . . 0.0 112.573 175.395 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.476 ' HD2' ' CD2' ' A' ' 42' ' ' TYR . 22.3 Cg_endo -72.51 170.36 19.56 Favored 'Trans proline' 0 N--CA 1.446 -1.32 0 C-N-CA 125.103 3.868 . . . . 0.0 111.239 176.904 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -136.85 53.0 1.92 Allowed 'General case' 0 CA--C 1.497 -1.075 0 CA-C-O 116.835 -1.555 . . . . 0.0 108.123 -177.54 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 21.5 t-80 -75.62 167.38 22.0 Favored 'General case' 0 C--O 1.216 -0.676 0 O-C-N 123.971 0.795 . . . . 0.0 110.933 178.529 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -154.18 -166.62 2.41 Favored 'General case' 0 C--N 1.324 -0.526 0 O-C-N 121.383 -0.823 . . . . 0.0 111.4 176.421 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.25 70.54 10.14 Favored 'General case' 0 C--O 1.212 -0.878 0 O-C-N 120.001 -1.687 . . . . 0.0 111.81 175.733 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -177.08 -41.27 0.01 OUTLIER 'General case' 0 C--N 1.326 -0.426 0 C-N-CA 123.33 0.652 . . . . 0.0 109.73 179.302 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.412 ' O ' ' CE2' ' A' ' 79' ' ' TYR . . . 120.81 -76.31 0.32 Allowed Glycine 0 N--CA 1.442 -0.914 0 N-CA-C 109.839 -1.305 . . . . 0.0 109.839 -177.836 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.414 ' HB3' ' OH ' ' A' ' 79' ' ' TYR . 2.9 p-10 -124.59 61.56 1.14 Allowed 'General case' 0 C--N 1.32 -0.695 0 N-CA-C 106.867 -1.531 . . . . 0.0 106.867 -175.241 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -53.31 -102.94 0.01 OUTLIER Glycine 0 CA--C 1.535 1.33 0 CA-C-O 122.533 1.074 . . . . 0.0 113.855 178.286 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.7 mttm -72.3 -105.74 0.01 OUTLIER 'General case' 0 C--O 1.221 -0.442 0 O-C-N 120.51 -1.583 . . . . 0.0 110.916 175.836 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.538 HG23 ' O ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -105.36 19.04 21.26 Favored 'General case' 0 C--N 1.322 -0.597 0 O-C-N 121.05 -1.031 . . . . 0.0 110.782 179.623 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.43 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 1.2 m-20 -30.64 99.63 0.02 OUTLIER 'General case' 0 C--O 1.208 -1.117 0 C-N-CA 125.357 1.463 . . . . 0.0 110.665 -177.406 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.452 ' CD2' ' H ' ' A' ' 78' ' ' HIS . 0.5 OUTLIER -81.76 11.71 4.61 Favored 'General case' 0 C--O 1.221 -0.41 0 O-C-N 121.072 -1.017 . . . . 0.0 111.023 -176.703 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.872 ' CE1' HD11 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -38.6 141.46 0.26 Allowed 'General case' 0 N--CA 1.426 -1.653 0 CA-C-O 122.903 1.335 . . . . 0.0 114.559 170.625 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.586 HD22 ' CG2' ' A' ' 109' ' ' ILE . 0.2 OUTLIER -77.86 157.96 29.65 Favored 'General case' 0 CA--C 1.509 -0.611 0 O-C-N 120.448 -1.407 . . . . 0.0 109.412 177.409 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.872 HD11 ' CE1' ' A' ' 79' ' ' TYR . 1.1 mt -143.95 129.43 19.01 Favored 'General case' 0 CA--C 1.517 -0.308 0 N-CA-C 108.623 -0.881 . . . . 0.0 108.623 178.988 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.484 ' CB ' ' CD1' ' A' ' 109' ' ' ILE . 1.1 pm0 -97.17 151.54 19.71 Favored 'General case' 0 N--CA 1.443 -0.814 0 CA-C-O 122.917 1.342 . . . . 0.0 111.382 178.645 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.464 ' CE1' ' HB2' ' A' ' 23' ' ' ALA . 74.4 t80 -141.42 130.75 12.61 Favored Pre-proline 0 N--CA 1.448 -0.57 0 CA-C-N 114.801 -1.09 . . . . 0.0 111.504 -178.655 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.485 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 18.1 Cg_endo -75.74 97.02 1.07 Allowed 'Trans proline' 0 N--CA 1.443 -1.468 0 C-N-CA 123.995 3.13 . . . . 0.0 109.516 -177.728 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.629 HG21 ' HA ' ' A' ' 16' ' ' ALA . 10.5 t -101.18 116.28 32.46 Favored 'General case' 0 N--CA 1.447 -0.602 0 CA-C-O 122.233 1.016 . . . . 0.0 111.06 179.533 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.429 ' CD2' ' NE2' ' A' ' 90' ' ' HIS . 57.4 m-85 -82.31 159.77 63.95 Favored Pre-proline 0 N--CA 1.445 -0.676 0 CA-C-N 115.93 -0.577 . . . . 0.0 112.101 179.239 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 15.0 Cg_endo -77.24 -39.36 0.59 Allowed 'Trans proline' 0 N--CA 1.444 -1.398 0 C-N-CA 122.374 2.049 . . . . 0.0 112.613 179.579 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -43.58 -31.03 0.66 Allowed 'General case' 0 N--CA 1.476 0.857 0 O-C-N 125.11 1.506 . . . . 0.0 110.773 175.754 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 86.18 13.63 68.26 Favored Glycine 0 N--CA 1.436 -1.337 0 N-CA-C 110.039 -1.224 . . . . 0.0 110.039 176.695 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.429 ' NE2' ' CD2' ' A' ' 86' ' ' PHE . 7.7 p-80 -77.93 130.06 36.1 Favored 'General case' 0 N--CA 1.439 -0.975 0 N-CA-C 107.69 -1.226 . . . . 0.0 107.69 179.391 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 27.6 t70 -59.12 90.91 0.01 OUTLIER 'General case' 0 C--N 1.327 -0.378 0 C-N-CA 123.801 0.84 . . . . 0.0 109.748 175.994 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.485 ' CD2' ' HB3' ' A' ' 94' ' ' PHE . 3.8 t80 -38.51 139.71 0.38 Allowed 'General case' 0 C--O 1.217 -0.644 0 C-N-CA 124.385 1.074 . . . . 0.0 109.295 -177.473 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 8.2 ptpt -77.41 64.25 2.74 Favored 'General case' 0 C--N 1.315 -0.927 0 O-C-N 119.582 -1.949 . . . . 0.0 110.359 175.119 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.485 ' HB3' ' CD2' ' A' ' 92' ' ' TYR . 23.1 p90 -80.09 -12.89 59.63 Favored 'General case' 0 N--CA 1.443 -0.813 0 C-N-CA 123.518 0.727 . . . . 0.0 112.544 176.135 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -93.1 -33.13 14.19 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-O 122.313 1.054 . . . . 0.0 109.888 -179.71 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.1 m -82.12 110.32 17.23 Favored 'General case' 0 CA--C 1.514 -0.439 0 O-C-N 120.73 -1.231 . . . . 0.0 109.598 178.635 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 10.9 pttt -58.17 -49.51 76.79 Favored 'General case' 0 N--CA 1.461 0.121 0 CA-C-O 121.587 0.708 . . . . 0.0 110.096 178.122 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.414 ' HA ' ' HA ' ' A' ' 99' ' ' PRO . 6.3 tttm -140.87 126.68 11.36 Favored Pre-proline 0 N--CA 1.436 -1.149 0 C-N-CA 124.313 1.045 . . . . 0.0 110.0 -176.499 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.414 ' HA ' ' HA ' ' A' ' 98' ' ' LYS . 18.1 Cg_endo -71.68 176.42 37.91 Favored 'Cis proline' 0 C--N 1.352 0.711 0 O-C-N 124.545 1.813 . . . . 0.0 110.665 -3.34 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 20.8 tttm -141.93 135.82 29.79 Favored 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 108.682 -0.859 . . . . 0.0 108.682 178.431 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.2 tt0 -85.02 147.76 26.52 Favored 'General case' 0 C--N 1.324 -0.505 0 O-C-N 124.153 0.908 . . . . 0.0 109.396 176.616 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.3 OUTLIER -43.9 152.13 0.48 Allowed Pre-proline 0 C--O 1.219 -0.539 0 C-N-CA 123.325 0.65 . . . . 0.0 112.438 176.829 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.43 ' HB3' ' CE1' ' A' ' 34' ' ' TYR . 18.2 Cg_endo -71.83 -86.59 0.0 OUTLIER 'Trans proline' 0 N--CA 1.443 -1.46 0 C-N-CA 121.214 1.276 . . . . 0.0 110.861 -179.744 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 128.96 153.46 7.98 Favored Glycine 0 CA--C 1.529 0.925 0 O-C-N 120.84 -1.163 . . . . 0.0 111.835 -176.681 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -75.63 -61.15 0.04 OUTLIER 'Trans proline' 0 N--CA 1.444 -1.404 0 C-N-CA 122.471 2.114 . . . . 0.0 110.102 -179.685 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.495 ' HB3' ' CZ ' ' A' ' 11' ' ' TYR . . . -60.87 132.0 52.48 Favored 'General case' 0 CA--C 1.511 -0.533 0 N-CA-C 109.794 -0.446 . . . . 0.0 109.794 179.623 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.422 ' HG2' ' HA ' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -146.29 146.44 30.72 Favored 'General case' 0 CA--C 1.503 -0.843 0 O-C-N 124.109 0.881 . . . . 0.0 110.864 178.683 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.575 HG23 ' CD1' ' A' ' 117' ' ' PHE . 7.6 p -79.84 119.64 29.65 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.464 0 O-C-N 124.512 1.133 . . . . 0.0 110.243 177.274 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.586 ' CG2' HD22 ' A' ' 80' ' ' LEU . 7.0 mm -100.6 142.14 16.19 Favored 'Isoleucine or valine' 0 CA--C 1.5 -0.964 0 CA-C-N 115.846 -0.615 . . . . 0.0 110.103 178.908 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.553 ' O ' HD23 ' A' ' 80' ' ' LEU . 10.8 p90 -164.91 153.66 12.42 Favored 'General case' 0 N--CA 1.443 -0.794 0 CA-C-O 122.537 1.16 . . . . 0.0 110.278 -178.664 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.6 p -87.18 168.6 13.09 Favored 'General case' 0 C--N 1.32 -0.704 0 CA-C-N 115.093 -0.958 . . . . 0.0 109.47 -178.62 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.563 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.4 OUTLIER -114.49 152.04 45.77 Favored Pre-proline 0 CA--C 1.546 0.796 0 C-N-CA 122.124 0.17 . . . . 0.0 111.302 177.763 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.563 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 14.3 Cg_endo -75.21 -51.56 0.16 OUTLIER 'Cis proline' 0 CA--C 1.494 -1.493 0 N-CA-C 108.48 -1.392 . . . . 0.0 108.48 -4.977 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.482 ' HB3' HG23 ' A' ' 116' ' ' VAL . 3.0 m-20 -43.28 111.12 0.24 Allowed 'General case' 0 CA--C 1.5 -0.953 0 CA-C-O 116.59 -1.672 . . . . 0.0 109.912 179.013 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.672 ' HE2' HD13 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -68.66 67.96 0.14 Allowed 'General case' 0 CA--C 1.508 -0.646 0 O-C-N 125.944 2.027 . . . . 0.0 108.495 -177.989 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.483 ' O ' HG12 ' A' ' 116' ' ' VAL . 14.6 t -73.15 72.65 0.24 Allowed 'Isoleucine or valine' 0 C--N 1.326 -0.427 0 N-CA-C 105.679 -1.971 . . . . 0.0 105.679 -178.343 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.594 ' CZ ' ' HA2' ' A' ' 119' ' ' GLY . 41.5 t80 -41.72 116.61 0.81 Allowed 'General case' 0 N--CA 1.439 -1.008 0 C-N-CA 124.701 1.2 . . . . 0.0 109.22 179.384 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . 0.576 ' HB3' ' CD2' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -90.91 -41.55 11.09 Favored 'General case' 0 N--CA 1.438 -1.062 0 CA-C-O 121.637 0.732 . . . . 0.0 109.79 178.582 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.594 ' HA2' ' CZ ' ' A' ' 117' ' ' PHE . . . 157.65 -171.65 34.83 Favored Glycine 0 N--CA 1.443 -0.862 0 N-CA-C 111.569 -0.612 . . . . 0.0 111.569 -178.431 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.649 HG22 ' SG ' ' A' ' 134' ' ' CYS . 3.2 mp -109.71 147.06 14.37 Favored 'Isoleucine or valine' 0 CA--C 1.499 -0.983 0 N-CA-C 107.098 -1.445 . . . . 0.0 107.098 -178.803 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.598 HD13 ' CZ ' ' A' ' 38' ' ' PHE . 7.0 pt -119.76 155.47 22.51 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.687 0 N-CA-C 109.098 -0.705 . . . . 0.0 109.098 177.891 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.645 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . . . -173.99 160.49 3.51 Favored 'General case' 0 C--N 1.322 -0.598 0 N-CA-C 109.17 -0.678 . . . . 0.0 109.17 178.572 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.536 ' CE1' HD23 ' A' ' 131' ' ' LEU . 1.6 m-70 -90.52 89.0 7.37 Favored 'General case' 0 CA--C 1.511 -0.527 0 CA-C-N 115.798 -0.637 . . . . 0.0 110.165 -177.913 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 2.9 p -103.85 43.4 1.09 Allowed 'General case' 0 C--N 1.317 -0.847 0 C-N-CA 123.496 0.718 . . . . 0.0 109.66 -176.98 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -105.52 -24.79 12.53 Favored 'General case' 0 C--O 1.221 -0.401 0 CA-C-N 115.559 -0.746 . . . . 0.0 111.146 176.041 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -169.42 -65.37 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.323 0 CA-C-O 121.061 0.458 . . . . 0.0 110.534 177.601 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -155.76 -44.59 0.08 Allowed 'General case' 0 N--CA 1.453 -0.302 0 C-N-CA 123.929 0.891 . . . . 0.0 110.612 179.458 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 5.7 tt0 -156.12 81.03 0.99 Allowed 'General case' 0 N--CA 1.443 -0.797 0 C-N-CA 124.155 0.982 . . . . 0.0 109.24 -179.934 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -131.77 -107.57 1.12 Allowed Glycine 0 N--CA 1.46 0.288 0 N-CA-C 110.122 -1.191 . . . . 0.0 110.122 176.556 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.9 OUTLIER -94.08 129.62 40.55 Favored 'General case' 0 C--N 1.322 -0.589 0 O-C-N 121.365 -1.079 . . . . 0.0 109.416 -178.893 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.536 HD23 ' CE1' ' A' ' 123' ' ' HIS . 0.4 OUTLIER -89.53 149.23 22.98 Favored 'General case' 0 N--CA 1.448 -0.543 0 CA-C-O 121.728 0.775 . . . . 0.0 111.584 176.067 . . . . . . . . 3 3 . 1 . 008 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -151.41 166.95 29.48 Favored 'General case' 0 C--N 1.322 -0.622 0 CA-C-O 118.736 -0.649 . . . . 0.0 109.592 179.824 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.56 HD13 ' CE2' ' A' ' 57' ' ' PHE . 10.9 tp -66.34 133.11 49.85 Favored 'General case' 0 C--N 1.327 -0.408 0 N-CA-C 107.515 -1.291 . . . . 0.0 107.515 179.46 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . 0.649 ' SG ' HG22 ' A' ' 120' ' ' ILE . 71.3 m -57.83 -178.34 0.04 OUTLIER 'General case' 0 N--CA 1.452 -0.338 0 O-C-N 124.94 1.4 . . . . 0.0 110.34 176.249 . . . . . . . . 2 2 . 1 . 008 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.2 m -161.34 112.63 1.76 Allowed 'General case' 0 CA--C 1.503 -0.861 0 N-CA-C 107.237 -1.394 . . . . 0.0 107.237 -178.239 . . . . . . . . 1 1 . 1 . 008 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.41 ' CD2' HG13 ' A' ' 2' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--O 1.241 0.636 0 CA-C-O 116.106 -1.902 . . . . 0.0 113.626 172.486 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.5 -0.955 0 CA-C-O 115.284 -2.293 . . . . 0.0 109.346 . . . . . . . . . 0 0 . 1 . 009 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 3.4 p -41.91 132.53 0.81 Allowed 'Isoleucine or valine' 0 N--CA 1.465 0.309 0 O-C-N 126.332 2.27 . . . . 0.0 109.499 -179.86 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 1.2 m -90.05 113.31 24.99 Favored 'General case' 0 C--N 1.313 -1.013 0 N-CA-C 108.375 -0.972 . . . . 0.0 108.375 -178.309 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.548 ' CH2' ' CE1' ' A' ' 136' ' ' HIS . 33.1 m95 -82.61 141.06 32.84 Favored 'General case' 0 N--CA 1.437 -1.081 0 CA-C-N 116.163 -0.471 . . . . 0.0 110.038 177.779 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -130.65 138.23 49.97 Favored 'General case' 0 CA--C 1.502 -0.887 0 N-CA-C 108.728 -0.841 . . . . 0.0 108.728 -177.142 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.729 ' SG ' ' HB3' ' A' ' 122' ' ' ALA . 0.1 OUTLIER -133.33 -77.67 0.48 Allowed 'General case' 0 N--CA 1.447 -0.577 0 N-CA-C 108.913 -0.773 . . . . 0.0 108.913 176.433 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -75.54 34.96 1.16 Allowed Glycine 0 CA--C 1.533 1.209 0 CA-C-O 119.606 -0.552 . . . . 0.0 113.478 -179.284 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 72.3 5.05 61.83 Favored Glycine 0 CA--C 1.529 0.91 0 CA-C-N 118.453 1.126 . . . . 0.0 113.911 -170.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.573 HD13 ' OH ' ' A' ' 11' ' ' TYR . 0.4 OUTLIER -107.48 139.29 42.21 Favored 'General case' 0 CA--C 1.507 -0.693 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 -174.996 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 10.6 mp -94.26 129.19 41.0 Favored 'General case' 0 C--N 1.323 -0.55 0 O-C-N 124.256 0.973 . . . . 0.0 108.655 -174.388 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.573 ' OH ' HD13 ' A' ' 9' ' ' LEU . 77.6 m-85 -125.2 98.01 5.47 Favored 'General case' 0 CA--C 1.508 -0.652 0 N-CA-C 107.077 -1.453 . . . . 0.0 107.077 -170.501 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -52.77 122.81 9.85 Favored 'General case' 0 CA--C 1.516 -0.354 0 N-CA-C 108.535 -0.913 . . . . 0.0 108.535 178.805 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.485 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 6.6 tp-100 -54.7 -41.49 70.32 Favored 'General case' 0 C--O 1.21 -1.022 0 C-N-CA 119.089 -1.044 . . . . 0.0 111.781 -179.04 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 42.1 t30 -48.3 -44.19 33.69 Favored 'General case' 0 C--O 1.205 -1.287 0 N-CA-C 112.909 0.707 . . . . 0.0 112.909 173.211 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.448 ' CE ' ' HA3' ' A' ' 89' ' ' GLY . 6.6 mttt -69.93 -38.14 76.13 Favored 'General case' 0 C--O 1.211 -0.96 0 CA-C-O 117.03 -1.462 . . . . 0.0 114.295 167.208 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -52.9 -41.31 64.26 Favored 'General case' 0 C--N 1.314 -0.962 0 CA-C-N 122.484 2.402 . . . . 0.0 114.081 170.913 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 5.6 pt-20 -85.98 -41.57 14.76 Favored 'General case' 0 C--O 1.214 -0.797 0 O-C-N 120.554 -1.341 . . . . 0.0 109.858 175.357 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 43.4 t -72.7 -59.13 2.87 Favored 'General case' 0 C--O 1.212 -0.882 0 C-N-CA 126.627 1.971 . . . . 0.0 109.665 -175.054 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.46 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 4.4 t-20 -39.39 -39.7 0.71 Allowed 'General case' 0 N--CA 1.468 0.456 0 CA-C-N 120.107 1.321 . . . . 0.0 113.773 168.687 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.501 ' O ' ' HB3' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -79.8 -33.72 40.24 Favored 'General case' 0 N--CA 1.47 0.538 0 N-CA-C 115.93 1.826 . . . . 0.0 115.93 172.965 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 6.6 m170 -48.22 -36.46 13.89 Favored 'General case' 0 N--CA 1.47 0.533 0 C-N-CA 126.334 1.854 . . . . 0.0 110.152 178.23 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.46 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -73.49 -45.94 50.97 Favored 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 125.119 1.368 . . . . 0.0 111.702 176.076 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.801 ' HB1' ' HG3' ' A' ' 35' ' ' PRO . . . -39.13 130.03 1.24 Allowed Pre-proline 0 CA--C 1.539 0.552 0 O-C-N 125.411 1.694 . . . . 0.0 111.871 173.861 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.637 ' HG2' HG22 ' A' ' 30' ' ' THR . 17.0 Cg_endo -72.56 129.71 15.03 Favored 'Trans proline' 0 N--CA 1.449 -1.134 0 N-CA-C 107.296 -1.848 . . . . 0.0 107.296 -176.041 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.472 HD12 ' HA ' ' A' ' 25' ' ' LEU . 3.8 tp -63.3 83.86 0.02 OUTLIER 'General case' 0 CA--C 1.521 -0.166 0 C-N-CA 125.265 1.426 . . . . 0.0 111.693 178.635 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 179.15 144.92 0.15 Allowed 'General case' 0 N--CA 1.466 0.343 0 C-N-CA 124.044 0.938 . . . . 0.0 109.456 -172.887 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.448 ' CG ' ' H ' ' A' ' 37' ' ' TRP . 1.4 t0 -86.93 118.7 26.48 Favored 'General case' 0 N--CA 1.468 0.43 0 C-N-CA 123.816 0.847 . . . . 0.0 110.134 179.045 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 54.16 63.65 4.98 Favored Glycine 0 CA--C 1.526 0.725 0 N-CA-C 110.353 -1.099 . . . . 0.0 110.353 175.595 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 3.4 tttt -127.83 11.48 6.65 Favored 'General case' 0 N--CA 1.477 0.92 0 CA-C-O 123.412 1.577 . . . . 0.0 112.499 176.818 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.637 HG22 ' HG2' ' A' ' 24' ' ' PRO . 10.0 p -118.49 150.94 38.77 Favored 'General case' 0 C--N 1.309 -1.174 0 N-CA-C 106.108 -1.812 . . . . 0.0 106.108 -171.173 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -44.04 -61.41 3.09 Favored Glycine 0 CA--C 1.506 -0.472 0 CA-C-O 119.142 -0.81 . . . . 0.0 111.959 -179.043 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.415 ' CA ' ' HE2' ' A' ' 100' ' ' LYS . 58.5 m -52.39 -66.96 0.29 Allowed 'General case' 0 CA--C 1.489 -1.396 0 CA-C-O 116.325 -1.798 . . . . 0.0 111.984 175.504 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 4.1 p 164.2 -64.4 0.0 OUTLIER 'General case' 0 CA--C 1.508 -0.655 0 O-C-N 126.712 2.507 . . . . 0.0 110.642 179.885 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.448 ' CD1' ' HD3' ' A' ' 84' ' ' PRO . 98.1 m-85 -59.6 149.1 72.49 Favored Pre-proline 0 N--CA 1.436 -1.172 0 CA-C-N 114.403 -1.272 . . . . 0.0 113.249 -177.877 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.801 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 28.7 Cg_endo -74.29 166.23 83.17 Favored 'Cis proline' 0 N--CA 1.435 -1.951 0 C-N-CA 122.405 -1.915 . . . . 0.0 111.775 -2.446 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.418 ' HA ' ' HA ' ' A' ' 27' ' ' ASP . 0.5 OUTLIER -140.94 170.78 15.1 Favored 'General case' 0 C--O 1.214 -0.787 0 O-C-N 121.105 -0.997 . . . . 0.0 110.984 -177.891 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.856 ' CH2' HG22 ' A' ' 39' ' ' THR . 18.2 t90 -66.68 148.85 51.35 Favored 'General case' 0 C--N 1.312 -1.023 0 CA-C-N 120.812 1.642 . . . . 0.0 109.539 173.894 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.477 ' CE2' ' HB2' ' A' ' 40' ' ' ASN . 11.7 t80 -120.74 86.92 2.66 Favored 'General case' 0 N--CA 1.434 -1.238 0 N-CA-C 104.079 -2.563 . . . . 0.0 104.079 -175.371 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.856 HG22 ' CH2' ' A' ' 37' ' ' TRP . 71.6 p -41.68 -35.77 0.84 Allowed 'General case' 0 C--O 1.214 -0.792 0 CA-C-N 114.308 -1.315 . . . . 0.0 110.252 171.52 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.477 ' HB2' ' CE2' ' A' ' 38' ' ' PHE . 56.3 t30 56.04 20.36 4.29 Favored 'General case' 0 N--CA 1.476 0.87 0 CA-C-N 120.337 1.426 . . . . 0.0 111.916 178.36 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.72 ' C ' HD23 ' A' ' 48' ' ' LEU . . . 105.3 -41.17 2.23 Favored Glycine 0 N--CA 1.43 -1.728 0 CA-C-O 115.413 -2.882 . . . . 0.0 115.459 -167.955 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.425 ' CE2' ' HD3' ' A' ' 66' ' ' PRO . 83.6 m-85 -44.52 153.85 0.15 Allowed 'General case' 0 N--CA 1.469 0.485 0 CA-C-N 120.216 2.008 . . . . 0.0 112.558 174.734 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -84.59 -37.51 21.06 Favored 'General case' 0 N--CA 1.47 0.525 0 N-CA-C 112.728 0.64 . . . . 0.0 112.728 176.964 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.462 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -169.1 -72.58 0.04 OUTLIER Glycine 0 C--N 1.334 0.434 0 C-N-CA 124.529 1.061 . . . . 0.0 111.374 -178.523 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -113.59 -63.73 1.41 Allowed 'General case' 0 N--CA 1.476 0.869 0 C-N-CA 124.223 1.009 . . . . 0.0 110.669 -178.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.45 -173.32 0.62 Allowed Glycine 0 C--N 1.339 0.714 0 CA-C-O 122.299 0.944 . . . . 0.0 111.605 178.215 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 26.7 mttt -58.28 -171.46 0.01 OUTLIER 'General case' 0 CA--C 1.543 0.692 0 CA-C-O 124.555 2.121 . . . . 0.0 112.289 175.276 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.72 HD23 ' C ' ' A' ' 41' ' ' GLY . 0.0 OUTLIER -81.25 159.31 68.01 Favored Pre-proline 0 C--N 1.311 -1.086 0 O-C-N 120.102 -1.624 . . . . 0.0 110.232 -178.788 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -70.28 161.97 44.04 Favored 'Trans proline' 0 N--CA 1.45 -1.032 0 C-N-CA 121.357 1.371 . . . . 0.0 109.481 177.733 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -50.47 100.26 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.444 0 C-N-CA 123.993 0.917 . . . . 0.0 110.825 176.305 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 103.41 83.15 1.69 Allowed Glycine 0 N--CA 1.462 0.402 0 CA-C-N 116.048 -0.524 . . . . 0.0 112.148 -174.224 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.7 mmt-85 -165.35 165.27 19.5 Favored 'General case' 0 CA--C 1.517 -0.323 0 C-N-CA 124.542 1.137 . . . . 0.0 110.993 173.502 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 87.6 m -140.69 96.8 7.46 Favored Pre-proline 0 N--CA 1.465 0.291 0 O-C-N 124.91 1.381 . . . . 0.0 109.538 -176.836 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.505 ' HB3' HD21 ' A' ' 48' ' ' LEU . 19.5 Cg_endo -72.72 145.37 41.12 Favored 'Trans proline' 0 N--CA 1.453 -0.868 0 C-N-CA 122.572 2.181 . . . . 0.0 110.291 179.923 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.3 mt -69.98 120.52 17.85 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.532 0 N-CA-C 107.283 -1.377 . . . . 0.0 107.283 -179.535 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.4 tmtt? -81.9 136.33 35.34 Favored 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 176.519 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . . . . . . . . . 8.7 m-85 -119.75 -48.7 2.36 Favored 'General case' 0 C--N 1.324 -0.536 0 C-N-CA 123.808 0.843 . . . . 0.0 110.39 178.408 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 120.78 -2.92 11.98 Favored Glycine 0 CA--C 1.524 0.638 0 C-N-CA 125.053 1.311 . . . . 0.0 113.246 -175.123 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -96.46 134.65 39.38 Favored 'General case' 0 CA--C 1.503 -0.845 0 CA-C-N 118.459 1.129 . . . . 0.0 109.854 175.815 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.7 t -73.49 -2.05 20.99 Favored 'General case' 0 N--CA 1.466 0.359 0 O-C-N 125.427 1.704 . . . . 0.0 112.141 175.574 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 38.5 m-20 -89.47 -51.42 5.55 Favored 'General case' 0 CA--C 1.509 -0.604 0 C-N-CA 124.936 1.294 . . . . 0.0 109.305 -179.8 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.882 ' HA ' HD11 ' A' ' 80' ' ' LEU . 1.8 m -74.99 -35.4 62.04 Favored 'General case' 0 N--CA 1.451 -0.411 0 O-C-N 124.5 1.125 . . . . 0.0 111.667 177.871 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -64.22 -30.24 71.31 Favored 'General case' 0 N--CA 1.469 0.507 0 O-C-N 124.086 0.866 . . . . 0.0 112.114 172.996 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.3 OUTLIER -60.54 159.21 25.65 Favored Pre-proline 0 N--CA 1.449 -0.486 0 CA-C-O 121.739 0.78 . . . . 0.0 111.751 176.334 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -70.38 139.41 38.04 Favored 'Trans proline' 0 CA--C 1.546 1.12 0 C-N-CA 120.45 0.767 . . . . 0.0 113.202 174.692 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.425 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 19.7 Cg_endo -71.85 173.37 12.84 Favored 'Trans proline' 0 N--CA 1.454 -0.835 0 C-N-CA 124.968 3.779 . . . . 0.0 111.671 178.252 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -134.99 47.92 2.32 Favored 'General case' 0 C--O 1.241 0.625 0 O-C-N 120.214 -1.554 . . . . 0.0 110.981 -177.908 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.465 ' HA ' ' OD2' ' A' ' 77' ' ' ASP . 56.5 t-80 -65.04 130.0 41.78 Favored 'General case' 0 CA--C 1.533 0.321 0 N-CA-C 115.338 1.607 . . . . 0.0 115.338 176.474 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 3.6 t -111.74 -93.7 0.45 Allowed 'General case' 0 N--CA 1.486 1.361 0 O-C-N 119.224 -2.173 . . . . 0.0 110.384 177.636 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.9 mptt -68.92 -175.01 0.66 Allowed 'General case' 0 C--O 1.219 -0.539 0 C-N-CA 124.93 1.292 . . . . 0.0 110.629 -179.176 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 8.9 p-10 -68.81 38.93 0.03 OUTLIER 'General case' 0 CA--C 1.552 1.049 0 N-CA-C 114.235 1.198 . . . . 0.0 114.235 173.13 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . -167.54 -105.89 0.19 Allowed Glycine 0 C--O 1.217 -0.955 0 N-CA-C 107.701 -2.159 . . . . 0.0 107.701 -177.979 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -110.2 -89.92 0.48 Allowed 'General case' 0 CA--C 1.544 0.745 0 CA-C-O 125.928 2.775 . . . . 0.0 106.19 -175.435 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 119.62 -135.27 11.09 Favored Glycine 0 N--CA 1.448 -0.565 0 O-C-N 119.294 -2.128 . . . . 0.0 110.296 -174.932 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 72.8 mttt -66.32 -78.69 0.05 Allowed 'General case' 0 N--CA 1.474 0.727 0 C-N-CA 124.2 1.0 . . . . 0.0 110.017 -176.843 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.514 HG23 ' O ' ' A' ' 76' ' ' THR . 0.7 OUTLIER -128.17 31.44 5.06 Favored 'General case' 0 CA--C 1.511 -0.536 0 CA-C-O 118.454 -0.784 . . . . 0.0 111.635 178.726 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.465 ' OD2' ' HA ' ' A' ' 68' ' ' HIS . 20.3 t0 -30.51 89.33 0.0 OUTLIER 'General case' 0 C--O 1.221 -0.438 0 N-CA-C 114.816 1.413 . . . . 0.0 114.816 -177.084 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -85.52 11.92 9.59 Favored 'General case' 0 N--CA 1.473 0.683 0 O-C-N 119.681 -1.887 . . . . 0.0 109.322 -169.898 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.486 ' CD2' ' CD1' ' A' ' 37' ' ' TRP . 0.0 OUTLIER -49.71 170.03 0.03 OUTLIER 'General case' 0 N--CA 1.438 -1.053 0 CA-C-O 123.463 1.601 . . . . 0.0 112.316 173.378 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.882 HD11 ' HA ' ' A' ' 62' ' ' CYS . 0.5 OUTLIER -95.14 141.5 28.68 Favored 'General case' 0 C--N 1.315 -0.916 0 CA-C-N 113.634 -1.621 . . . . 0.0 109.996 172.203 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.755 HD22 ' CZ ' ' A' ' 110' ' ' TYR . 0.2 OUTLIER -123.96 129.8 51.54 Favored 'General case' 0 C--N 1.32 -0.683 0 N-CA-C 106.442 -1.688 . . . . 0.0 106.442 174.492 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.425 ' HB2' HD11 ' A' ' 109' ' ' ILE . 2.2 pm0 -91.47 164.25 13.87 Favored 'General case' 0 N--CA 1.446 -0.627 0 CA-C-O 122.689 1.233 . . . . 0.0 113.26 172.418 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.453 ' CE1' ' HB2' ' A' ' 23' ' ' ALA . 84.1 t80 -152.04 132.42 7.36 Favored Pre-proline 0 CA--C 1.533 0.321 0 O-C-N 120.319 -1.488 . . . . 0.0 112.836 179.275 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.448 ' HD3' ' CD1' ' A' ' 34' ' ' TYR . 19.3 Cg_endo -73.96 108.53 2.68 Favored 'Trans proline' 0 CA--C 1.506 -0.88 1 C-N-CA 125.498 4.132 . . . . 0.0 109.632 -176.794 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -109.03 110.12 21.32 Favored 'General case' 0 CA--C 1.509 -0.627 0 O-C-N 125.435 1.709 . . . . 0.0 109.638 -178.632 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 60.9 m-85 -81.58 158.02 69.08 Favored Pre-proline 0 C--O 1.238 0.494 0 CA-C-N 115.795 -0.639 . . . . 0.0 112.114 178.565 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -75.58 -38.21 1.45 Allowed 'Trans proline' 0 CA--C 1.507 -0.829 0 C-N-CA 122.172 1.915 . . . . 0.0 112.224 179.29 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -45.73 -30.98 1.78 Allowed 'General case' 0 N--CA 1.477 0.878 0 CA-C-O 123.977 1.846 . . . . 0.0 110.534 177.496 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.448 ' HA3' ' CE ' ' A' ' 15' ' ' LYS . . . 84.63 -0.44 89.21 Favored Glycine 0 N--CA 1.435 -1.368 0 CA-C-N 114.733 -1.121 . . . . 0.0 112.875 179.071 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -62.7 131.14 47.94 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 106.055 -1.831 . . . . 0.0 106.055 175.853 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -57.08 96.41 0.02 OUTLIER 'General case' 0 N--CA 1.467 0.408 0 N-CA-C 106.928 -1.508 . . . . 0.0 106.928 170.696 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.523 ' CD2' ' HB3' ' A' ' 94' ' ' PHE . 6.1 t80 -41.65 143.88 0.45 Allowed 'General case' 0 C--O 1.217 -0.633 0 C-N-CA 123.584 0.754 . . . . 0.0 109.532 178.736 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 12.5 ptpt -75.18 61.36 1.13 Allowed 'General case' 0 C--N 1.316 -0.88 0 O-C-N 119.696 -1.877 . . . . 0.0 109.096 173.528 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.523 ' HB3' ' CD2' ' A' ' 92' ' ' TYR . 36.3 p90 -75.8 -4.1 38.75 Favored 'General case' 0 N--CA 1.44 -0.935 0 CA-C-O 115.999 -1.953 . . . . 0.0 112.061 173.838 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.2 t0 -105.71 -26.1 11.95 Favored 'General case' 0 N--CA 1.471 0.615 0 CA-C-N 120.417 1.462 . . . . 0.0 111.154 -179.765 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 6.0 m -102.1 106.59 17.48 Favored 'General case' 0 CA--C 1.503 -0.839 0 O-C-N 120.574 -1.329 . . . . 0.0 108.8 -179.766 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 1.8 ptpt -70.75 -32.74 70.0 Favored 'General case' 0 N--CA 1.469 0.505 0 CA-C-O 121.424 0.631 . . . . 0.0 112.3 175.152 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.431 ' HA ' ' HA ' ' A' ' 99' ' ' PRO . 29.7 tttt -129.5 113.82 18.09 Favored Pre-proline 0 CA--C 1.538 0.5 0 N-CA-C 108.418 -0.956 . . . . 0.0 108.418 -178.477 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.431 ' HA ' ' HA ' ' A' ' 98' ' ' LYS . 18.4 Cg_endo -71.4 174.09 47.4 Favored 'Cis proline' 0 C--O 1.221 -0.331 0 C-N-CA 123.82 -1.325 . . . . 0.0 111.066 -3.798 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.415 ' HE2' ' CA ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -133.63 128.38 34.98 Favored 'General case' 0 CA--C 1.502 -0.891 0 C-N-CA 124.6 1.16 . . . . 0.0 109.694 179.914 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 28.0 tt0 -98.96 134.14 42.23 Favored 'General case' 0 C--O 1.244 0.769 0 N-CA-C 106.729 -1.582 . . . . 0.0 106.729 -178.434 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 11.4 t30 -43.42 132.22 3.61 Favored Pre-proline 0 CA--C 1.534 0.354 0 O-C-N 124.264 0.977 . . . . 0.0 110.615 177.244 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 23.1 Cg_endo -68.39 -163.94 0.1 OUTLIER 'Trans proline' 0 CA--C 1.544 1.006 0 C-N-CA 122.761 2.307 . . . . 0.0 111.623 179.114 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -123.48 161.18 17.89 Favored Glycine 0 CA--C 1.525 0.663 0 O-C-N 121.128 -0.982 . . . . 0.0 111.992 176.651 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 19.6 Cg_endo -73.22 -43.28 0.74 Allowed 'Trans proline' 0 N--CA 1.449 -1.122 0 C-N-CA 121.711 1.608 . . . . 0.0 109.433 177.199 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.519 ' HA ' ' HB2' ' A' ' 122' ' ' ALA . . . -80.38 134.07 35.98 Favored 'General case' 0 N--CA 1.448 -0.555 0 O-C-N 124.329 1.018 . . . . 0.0 110.849 179.931 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 4.9 mtm-85 -140.35 150.22 43.68 Favored 'General case' 0 CA--C 1.502 -0.901 0 CA-C-N 115.054 -0.975 . . . . 0.0 110.569 179.657 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.441 ' C ' HD12 ' A' ' 109' ' ' ILE . 2.6 p -89.15 118.78 35.12 Favored 'Isoleucine or valine' 0 N--CA 1.47 0.562 0 O-C-N 124.527 1.142 . . . . 0.0 111.469 177.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.59 HG12 HD13 ' A' ' 121' ' ' ILE . 1.4 mp -107.3 118.16 54.49 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.809 0 N-CA-C 106.027 -1.842 . . . . 0.0 106.027 -172.399 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.755 ' CZ ' HD22 ' A' ' 81' ' ' LEU . 5.1 p90 -138.3 151.43 47.58 Favored 'General case' 0 N--CA 1.437 -1.1 0 CA-C-O 122.482 1.134 . . . . 0.0 108.032 -178.32 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 6.6 p -84.16 160.74 20.8 Favored 'General case' 0 C--N 1.323 -0.58 0 CA-C-N 114.79 -1.095 . . . . 0.0 109.709 177.925 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.519 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -107.47 155.8 38.94 Favored Pre-proline 0 CA--C 1.555 1.14 0 CA-C-O 121.515 0.674 . . . . 0.0 110.639 178.956 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.519 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 14.9 Cg_endo -74.5 -48.94 0.25 Allowed 'Cis proline' 0 CA--C 1.506 -0.878 0 C-N-CA 124.475 -1.052 . . . . 0.0 110.574 -8.407 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 12.6 t30 -49.09 107.67 0.15 Allowed 'General case' 0 N--CA 1.449 -0.487 0 CA-C-O 117.171 -1.395 . . . . 0.0 108.96 177.578 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.416 ' CG ' ' CD1' ' A' ' 110' ' ' TYR . 0.1 OUTLIER -64.02 78.38 0.03 OUTLIER 'General case' 0 CA--C 1.508 -0.673 0 C-N-CA 125.724 1.61 . . . . 0.0 108.274 -177.965 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.436 ' O ' HG12 ' A' ' 116' ' ' VAL . 18.8 t -79.6 71.97 0.59 Allowed 'Isoleucine or valine' 0 N--CA 1.466 0.357 0 N-CA-C 104.19 -2.522 . . . . 0.0 104.19 -176.869 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.485 ' CZ ' ' NE2' ' A' ' 13' ' ' GLN . 46.0 t80 -40.42 105.14 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.545 0 C-N-CA 125.561 1.544 . . . . 0.0 109.036 177.588 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . . . . . . . . . 0.0 OUTLIER -82.86 -40.46 20.26 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-O 122.417 1.103 . . . . 0.0 109.204 -179.471 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.438 ' HA2' ' CH2' ' A' ' 4' ' ' TRP . . . 162.56 -148.3 15.16 Favored Glycine 0 N--CA 1.435 -1.378 0 N-CA-C 109.811 -1.315 . . . . 0.0 109.811 179.9 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.498 HG13 ' CG ' ' A' ' 4' ' ' TRP . 1.3 mm -129.57 141.98 45.09 Favored 'Isoleucine or valine' 0 CA--C 1.489 -1.382 0 N-CA-C 106.378 -1.712 . . . . 0.0 106.378 -175.023 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.717 HD12 HD22 ' A' ' 131' ' ' LEU . 4.7 pt -127.96 154.77 38.93 Favored 'Isoleucine or valine' 0 C--N 1.312 -1.024 0 N-CA-C 107.628 -1.249 . . . . 0.0 107.628 -175.445 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.729 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . . . -175.79 164.02 2.89 Favored 'General case' 0 C--N 1.325 -0.491 0 CA-C-O 121.397 0.617 . . . . 0.0 109.342 178.764 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.489 ' CE1' ' HG ' ' A' ' 131' ' ' LEU . 2.6 m-70 -93.55 91.8 7.27 Favored 'General case' 0 CA--C 1.513 -0.457 0 N-CA-C 109.253 -0.647 . . . . 0.0 109.253 -177.391 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.4 p -102.68 43.64 1.06 Allowed 'General case' 0 C--N 1.318 -0.765 0 C-N-CA 123.909 0.884 . . . . 0.0 109.196 -176.56 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 7.1 tptm -107.41 -25.01 11.62 Favored 'General case' 0 C--O 1.219 -0.528 0 CA-C-N 115.194 -0.912 . . . . 0.0 111.577 174.316 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -169.52 -65.46 0.02 OUTLIER 'General case' 0 N--CA 1.469 0.482 0 CA-C-O 121.15 0.5 . . . . 0.0 110.06 177.26 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -152.95 -46.91 0.1 Allowed 'General case' 0 C--O 1.232 0.15 0 CA-C-O 122.581 1.182 . . . . 0.0 110.648 179.399 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -159.55 76.03 0.66 Allowed 'General case' 0 C--O 1.221 -0.446 0 C-N-CA 125.009 1.324 . . . . 0.0 111.103 -177.195 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -123.77 -107.16 1.78 Allowed Glycine 0 N--CA 1.465 0.63 0 N-CA-C 109.683 -1.367 . . . . 0.0 109.683 178.834 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER -80.31 158.29 26.15 Favored 'General case' 0 C--N 1.327 -0.387 0 O-C-N 121.532 -0.981 . . . . 0.0 111.642 179.893 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.717 HD22 HD12 ' A' ' 121' ' ' ILE . 0.9 OUTLIER -101.24 147.84 25.81 Favored 'General case' 0 C--N 1.325 -0.467 0 O-C-N 121.339 -0.85 . . . . 0.0 110.342 176.839 . . . . . . . . 3 3 . 1 . 009 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -158.14 167.41 29.9 Favored 'General case' 0 CA--C 1.506 -0.739 0 C-N-CA 124.438 1.095 . . . . 0.0 109.055 -177.284 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.426 HD12 HG22 ' A' ' 121' ' ' ILE . 12.0 tp -83.45 143.93 29.93 Favored 'General case' 0 C--N 1.327 -0.386 0 O-C-N 124.474 1.109 . . . . 0.0 108.577 178.558 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . 0.415 ' SG ' HG22 ' A' ' 120' ' ' ILE . 71.5 m -65.68 -175.13 0.25 Allowed 'General case' 0 N--CA 1.453 -0.315 0 CA-C-O 122.888 1.327 . . . . 0.0 111.165 173.189 . . . . . . . . 2 2 . 1 . 009 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 18.6 p -131.78 96.33 3.92 Favored 'General case' 0 C--N 1.319 -0.728 0 N-CA-C 108.345 -0.983 . . . . 0.0 108.345 -177.905 . . . . . . . . 1 1 . 1 . 009 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.548 ' CE1' ' CH2' ' A' ' 4' ' ' TRP . 27.9 p-80 . . . . . 0 C--O 1.246 0.913 0 CA-C-O 115.346 -2.264 . . . . 0.0 112.86 172.697 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.935 ' HB3' ' HB3' ' A' ' 13' ' ' GLN . . . . . . . . 0 CA--C 1.514 -0.423 0 N-CA-C 108.918 -0.771 . . . . 0.0 108.918 . . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 7.5 p -67.15 152.21 9.82 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.619 0 O-C-N 124.204 0.94 . . . . 0.0 110.791 176.546 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.862 HG21 HD23 ' A' ' 10' ' ' LEU . 1.8 m -87.36 115.45 24.78 Favored 'General case' 0 N--CA 1.448 -0.568 0 C-N-CA 123.148 0.579 . . . . 0.0 111.071 178.935 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 14.5 m95 -83.1 140.58 32.56 Favored 'General case' 0 C--O 1.213 -0.858 0 N-CA-C 109.535 -0.543 . . . . 0.0 109.535 -179.904 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 m -124.55 133.84 53.17 Favored 'General case' 0 C--N 1.309 -1.155 0 O-C-N 120.478 -1.389 . . . . 0.0 108.787 -177.993 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.618 ' HB3' ' HB3' ' A' ' 122' ' ' ALA . 3.7 m -120.79 56.89 0.99 Allowed 'General case' 0 N--CA 1.447 -0.592 0 CA-C-O 118.215 -0.898 . . . . 0.0 109.273 179.728 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 39.64 60.62 1.73 Allowed Glycine 0 C--N 1.345 1.043 0 O-C-N 124.648 1.218 . . . . 0.0 112.088 -178.533 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 178.74 -81.57 0.06 OUTLIER Glycine 0 C--N 1.334 0.467 0 N-CA-C 110.881 -0.887 . . . . 0.0 110.881 -177.96 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 10.9 mt -123.97 160.11 28.32 Favored 'General case' 0 C--O 1.235 0.338 0 CA-C-O 121.45 0.643 . . . . 0.0 109.827 178.602 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.862 HD23 HG21 ' A' ' 3' ' ' THR . 9.0 mp -90.47 132.78 35.47 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 107.61 -1.256 . . . . 0.0 107.61 -177.78 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.669 ' CZ ' ' HB3' ' A' ' 106' ' ' ALA . 65.4 m-85 -116.43 91.08 3.48 Favored 'General case' 0 N--CA 1.433 -1.279 0 C-N-CA 127.826 2.45 . . . . 0.0 109.213 -175.838 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.01 127.02 28.42 Favored 'General case' 0 N--CA 1.441 -0.908 0 CA-C-O 117.52 -1.229 . . . . 0.0 108.514 179.456 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.935 ' HB3' ' HB3' ' A' ' 1' ' ' ALA . 0.0 OUTLIER -50.38 -50.58 51.05 Favored 'General case' 0 C--O 1.209 -1.063 0 CA-C-O 116.752 -1.594 . . . . 0.0 110.682 -179.227 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.418 ' O ' ' CB ' ' A' ' 18' ' ' SER . 11.2 t-20 -47.45 -38.48 13.66 Favored 'General case' 0 C--O 1.191 -2.011 0 O-C-N 124.633 1.208 . . . . 0.0 110.232 177.771 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -71.25 -51.43 24.62 Favored 'General case' 0 C--O 1.2 -1.52 0 CA-C-O 116.687 -1.625 . . . . 0.0 113.376 170.25 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.597 ' HB1' HD11 ' A' ' 120' ' ' ILE . . . -48.59 -34.63 11.91 Favored 'General case' 0 N--CA 1.444 -0.768 0 CA-C-N 121.583 1.992 . . . . 0.0 112.687 173.677 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 23.2 pt-20 -89.91 -44.04 10.17 Favored 'General case' 0 N--CA 1.435 -1.183 0 C-N-CA 123.659 0.784 . . . . 0.0 109.68 177.737 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.418 ' CB ' ' O ' ' A' ' 14' ' ' ASN . 30.8 t -64.58 -25.65 68.06 Favored 'General case' 0 C--O 1.205 -1.242 0 C-N-CA 126.492 1.917 . . . . 0.0 106.787 -177.438 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 7.3 t-20 -73.6 -53.37 10.64 Favored 'General case' 0 N--CA 1.429 -1.491 0 O-C-N 119.153 -2.217 . . . . 0.0 108.711 179.103 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -72.26 -12.47 61.17 Favored 'General case' 0 N--CA 1.451 -0.418 0 CA-C-O 122.08 0.943 . . . . 0.0 111.626 177.803 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 1.4 m170 -62.28 -50.76 70.4 Favored 'General case' 0 N--CA 1.441 -0.902 0 N-CA-C 107.471 -1.307 . . . . 0.0 107.471 -176.412 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -74.03 -41.28 62.05 Favored 'General case' 0 N--CA 1.443 -0.8 0 O-C-N 124.418 1.074 . . . . 0.0 110.091 179.934 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.706 ' HB2' ' CZ ' ' A' ' 83' ' ' PHE . . . -41.64 129.54 2.38 Favored Pre-proline 0 N--CA 1.445 -0.699 0 O-C-N 125.644 1.84 . . . . 0.0 111.332 178.384 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.486 ' HG2' ' CG2' ' A' ' 30' ' ' THR . 18.2 Cg_endo -73.03 126.57 11.33 Favored 'Trans proline' 0 N--CA 1.449 -1.135 0 C-N-CA 121.923 1.748 . . . . 0.0 109.573 -177.161 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.876 HD21 ' O ' ' A' ' 113' ' ' PRO . 4.1 tp -59.79 88.65 0.01 OUTLIER 'General case' 0 N--CA 1.45 -0.434 0 O-C-N 124.143 0.902 . . . . 0.0 111.19 178.861 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -175.88 167.12 3.08 Favored 'General case' 0 N--CA 1.445 -0.7 0 N-CA-C 109.366 -0.605 . . . . 0.0 109.366 -176.163 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.5 t0 -115.19 132.34 56.64 Favored 'General case' 0 CA--C 1.509 -0.626 0 CA-C-O 117.704 -1.141 . . . . 0.0 109.579 177.612 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 50.71 62.0 5.59 Favored Glycine 0 C--N 1.34 0.796 0 N-CA-C 108.254 -1.938 . . . . 0.0 108.254 172.136 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -151.55 35.68 0.57 Allowed 'General case' 0 CA--C 1.512 -0.489 0 CA-C-O 122.304 1.05 . . . . 0.0 110.685 -179.822 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.486 ' CG2' ' HG2' ' A' ' 24' ' ' PRO . 9.2 p -144.23 153.06 41.67 Favored 'General case' 0 CA--C 1.498 -1.042 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -175.65 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.425 ' CA ' ' HB3' ' A' ' 97' ' ' LYS . . . -36.64 -78.33 0.04 OUTLIER Glycine 0 C--N 1.34 0.776 0 O-C-N 124.307 1.005 . . . . 0.0 111.314 -178.92 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.462 ' O ' ' HE3' ' A' ' 100' ' ' LYS . 30.8 t -52.41 -61.52 2.23 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-O 117.681 -1.152 . . . . 0.0 110.669 177.921 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER 162.04 -51.86 0.0 OUTLIER 'General case' 0 C--O 1.218 -0.592 0 O-C-N 125.521 1.763 . . . . 0.0 110.421 179.124 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.518 ' CD2' ' HD3' ' A' ' 84' ' ' PRO . 61.6 m-85 -61.82 151.33 79.73 Favored Pre-proline 0 N--CA 1.43 -1.474 0 CA-C-O 117.13 -1.414 . . . . 0.0 111.511 -179.199 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.489 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 22.7 Cg_endo -73.76 164.41 87.48 Favored 'Cis proline' 0 N--CA 1.455 -0.772 0 C-N-CA 122.032 -2.07 . . . . 0.0 111.931 -3.453 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.5 OUTLIER -140.95 162.87 34.45 Favored 'General case' 0 CA--C 1.502 -0.892 0 CA-C-O 116.897 -1.525 . . . . 0.0 110.6 -178.345 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.728 ' CH2' HG22 ' A' ' 39' ' ' THR . 18.2 t90 -60.69 139.26 57.93 Favored 'General case' 0 N--CA 1.449 -0.513 0 O-C-N 124.143 0.902 . . . . 0.0 108.772 179.187 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.665 ' CE2' HG21 ' A' ' 109' ' ' ILE . 25.7 t80 -110.98 79.02 1.16 Allowed 'General case' 0 N--CA 1.426 -1.632 0 N-CA-C 105.934 -1.876 . . . . 0.0 105.934 -176.123 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.728 HG22 ' CH2' ' A' ' 37' ' ' TRP . 23.6 p -37.79 -34.57 0.11 Allowed 'General case' 0 C--O 1.214 -0.782 0 C-N-CA 124.265 1.026 . . . . 0.0 110.778 175.171 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.55 ' HB2' ' CD2' ' A' ' 38' ' ' PHE . 43.4 t30 57.63 19.25 5.28 Favored 'General case' 0 C--O 1.209 -1.068 0 N-CA-C 107.385 -1.339 . . . . 0.0 107.385 174.688 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.805 ' C ' HD23 ' A' ' 48' ' ' LEU . . . 112.49 -46.94 1.1 Allowed Glycine 0 N--CA 1.421 -2.364 0 O-C-N 118.682 -2.511 . . . . 0.0 112.353 -171.808 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.659 ' N ' HD23 ' A' ' 48' ' ' LEU . 58.2 m-85 -49.63 144.87 5.55 Favored 'General case' 0 N--CA 1.442 -0.829 0 C-N-CA 124.285 1.034 . . . . 0.0 110.372 -177.314 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.78 -35.79 26.21 Favored 'General case' 0 C--N 1.323 -0.568 0 CA-C-N 116.294 -0.412 . . . . 0.0 110.214 178.362 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . -164.13 -100.32 0.15 Allowed Glycine 0 N--CA 1.442 -0.906 0 N-CA-C 110.638 -0.985 . . . . 0.0 110.638 -179.648 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -85.89 175.98 8.33 Favored 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 118.111 -0.947 . . . . 0.0 109.778 179.653 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.422 ' O ' ' HD2' ' A' ' 66' ' ' PRO . . . 38.51 -156.93 0.01 OUTLIER Glycine 0 C--N 1.349 1.264 0 CA-C-O 123.14 1.411 . . . . 0.0 112.08 179.241 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.487 ' HA ' ' CE1' ' A' ' 42' ' ' TYR . 0.8 OUTLIER -65.11 -172.17 0.09 Allowed 'General case' 0 N--CA 1.444 -0.737 0 O-C-N 120.267 -1.726 . . . . 0.0 111.727 174.869 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.88 HD22 ' HB3' ' A' ' 52' ' ' ARG . 0.0 OUTLIER -87.93 174.76 4.84 Favored Pre-proline 0 N--CA 1.441 -0.924 0 O-C-N 120.51 -1.369 . . . . 0.0 109.109 -178.774 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -73.92 -175.7 2.26 Favored 'Trans proline' 0 N--CA 1.45 -1.081 0 C-N-CA 122.335 2.023 . . . . 0.0 111.734 178.305 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.4 tttt -67.47 94.89 0.43 Allowed 'General case' 0 N--CA 1.45 -0.468 0 O-C-N 121.134 -0.979 . . . . 0.0 109.751 177.57 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 115.47 91.3 1.73 Allowed Glycine 0 CA--C 1.5 -0.866 0 CA-C-O 118.807 -0.996 . . . . 0.0 110.885 179.255 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.88 ' HB3' HD22 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -177.11 155.94 1.22 Allowed 'General case' 0 CA--C 1.512 -0.489 0 C-N-CA 123.767 0.827 . . . . 0.0 110.58 177.661 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 4.1 m -141.33 98.31 6.66 Favored Pre-proline 0 C--N 1.327 -0.39 0 O-C-N 124.374 1.046 . . . . 0.0 110.763 -178.536 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 20.2 Cg_endo -71.23 177.46 6.57 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 122.24 1.96 . . . . 0.0 112.024 179.061 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.41 ' CG2' ' HB2' ' A' ' 133' ' ' LEU . 5.4 mt -97.96 136.64 28.12 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.487 0 N-CA-C 108.492 -0.929 . . . . 0.0 108.492 -179.228 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . 0.543 ' O ' HD22 ' A' ' 133' ' ' LEU . 0.1 OUTLIER -91.43 155.25 18.59 Favored 'General case' 0 CA--C 1.51 -0.564 0 N-CA-C 109.285 -0.635 . . . . 0.0 109.285 177.697 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.606 ' CE2' HD13 ' A' ' 133' ' ' LEU . 9.4 m-85 -140.26 -47.72 0.44 Allowed 'General case' 0 N--CA 1.446 -0.647 0 C-N-CA 123.765 0.826 . . . . 0.0 111.046 -179.985 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 119.73 -3.72 13.27 Favored Glycine 0 C--N 1.334 0.442 0 CA-C-N 116.284 -0.416 . . . . 0.0 112.148 -177.852 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -95.73 134.73 38.32 Favored 'General case' 0 CA--C 1.501 -0.925 0 CA-C-O 118.096 -0.954 . . . . 0.0 108.708 -179.138 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 13.7 t -72.15 -5.33 34.77 Favored 'General case' 0 C--O 1.221 -0.428 0 O-C-N 124.971 1.419 . . . . 0.0 111.581 177.21 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.683 ' HB2' HG21 ' A' ' 111' ' ' THR . 0.0 OUTLIER -91.92 -51.0 5.42 Favored 'General case' 0 N--CA 1.437 -1.093 0 N-CA-C 107.039 -1.467 . . . . 0.0 107.039 -177.398 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.812 ' HA ' HD11 ' A' ' 80' ' ' LEU . 1.9 m -75.15 -37.52 61.32 Favored 'General case' 0 N--CA 1.443 -0.791 0 N-CA-C 108.27 -1.011 . . . . 0.0 108.27 -178.423 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -59.91 -41.63 92.13 Favored 'General case' 0 C--N 1.343 0.305 0 CA-C-O 121.927 0.87 . . . . 0.0 109.857 176.861 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.9 OUTLIER -49.41 160.69 0.53 Allowed Pre-proline 0 N--CA 1.439 -1.024 0 CA-C-O 122.672 1.225 . . . . 0.0 110.177 179.953 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 19.8 Cg_endo -75.21 144.84 30.04 Favored 'Trans proline' 0 N--CA 1.441 -1.592 0 C-N-CA 120.99 1.126 . . . . 0.0 113.231 175.115 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.514 ' HG3' ' CD2' ' A' ' 42' ' ' TYR . 21.0 Cg_endo -75.25 168.75 23.97 Favored 'Trans proline' 0 N--CA 1.45 -1.085 0 C-N-CA 123.584 2.856 . . . . 0.0 111.443 178.786 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.1 tptt -132.22 52.18 2.09 Favored 'General case' 0 C--O 1.207 -1.17 0 CA-C-O 117.683 -1.151 . . . . 0.0 108.899 -178.419 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.454 ' CE1' ' O ' ' A' ' 70' ' ' LYS . 49.0 t-80 -83.84 158.56 21.63 Favored 'General case' 0 C--O 1.216 -0.672 0 CA-C-N 119.048 0.84 . . . . 0.0 110.011 179.074 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -175.71 -36.23 0.01 OUTLIER 'General case' 0 C--N 1.328 -0.338 0 C-N-CA 123.6 0.76 . . . . 0.0 109.658 173.455 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . 0.454 ' O ' ' CE1' ' A' ' 68' ' ' HIS . 0.0 OUTLIER -81.39 -171.51 3.32 Favored 'General case' 0 C--O 1.212 -0.909 0 N-CA-C 112.138 0.422 . . . . 0.0 112.138 178.389 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.1 t0 -82.69 36.34 0.49 Allowed 'General case' 0 C--N 1.315 -0.928 0 CA-C-O 122.038 0.923 . . . . 0.0 111.827 177.067 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.427 ' O ' ' CE2' ' A' ' 79' ' ' TYR . . . 159.82 -83.67 0.13 Allowed Glycine 0 N--CA 1.44 -1.06 0 O-C-N 120.009 -1.682 . . . . 0.0 111.051 -177.045 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.442 ' OD1' ' CE1' ' A' ' 79' ' ' TYR . 0.5 OUTLIER -143.73 75.89 1.49 Allowed 'General case' 0 N--CA 1.438 -1.06 0 CA-C-O 117.436 -1.269 . . . . 0.0 108.548 179.366 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . 0.414 ' CA ' ' HB2' ' A' ' 70' ' ' LYS . . . -33.52 -94.89 0.01 OUTLIER Glycine 0 N--CA 1.446 -0.696 0 CA-C-N 119.517 1.053 . . . . 0.0 114.719 176.168 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.2 mttm -85.16 -108.88 0.05 OUTLIER 'General case' 0 C--O 1.216 -0.685 0 C-N-CA 120.703 -0.399 . . . . 0.0 110.436 176.795 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.605 HG23 ' O ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -101.55 21.8 13.72 Favored 'General case' 0 C--N 1.325 -0.463 0 C-N-CA 123.892 0.877 . . . . 0.0 111.046 -179.949 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.435 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 5.6 m-20 -30.25 104.56 0.03 OUTLIER 'General case' 0 C--O 1.19 -2.035 0 C-N-CA 124.292 1.037 . . . . 0.0 111.576 -177.529 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.456 ' CD2' ' H ' ' A' ' 78' ' ' HIS . 0.5 OUTLIER -80.76 10.69 4.59 Favored 'General case' 0 C--N 1.314 -0.951 0 O-C-N 118.081 -2.887 . . . . 0.0 110.824 -177.206 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.862 ' CZ ' HD21 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -38.37 141.01 0.27 Allowed 'General case' 0 N--CA 1.436 -1.167 0 N-CA-C 115.65 1.722 . . . . 0.0 115.65 172.948 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.812 HD11 ' HA ' ' A' ' 62' ' ' CYS . 0.2 OUTLIER -76.68 158.49 30.98 Favored 'General case' 0 C--N 1.317 -0.811 0 O-C-N 120.101 -1.624 . . . . 0.0 110.237 178.291 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.862 HD21 ' CZ ' ' A' ' 79' ' ' TYR . 1.3 mt -140.31 133.75 29.98 Favored 'General case' 0 N--CA 1.445 -0.712 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 179.721 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 6.3 pm0 -101.65 151.69 21.71 Favored 'General case' 0 N--CA 1.437 -1.117 0 CA-C-O 122.489 1.138 . . . . 0.0 108.906 -178.549 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.706 ' CZ ' ' HB2' ' A' ' 23' ' ' ALA . 7.8 t80 -141.84 132.44 12.92 Favored Pre-proline 0 N--CA 1.44 -0.969 0 O-C-N 121.33 -0.856 . . . . 0.0 111.989 -179.11 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.518 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 18.6 Cg_endo -74.47 93.74 0.92 Allowed 'Trans proline' 0 N--CA 1.449 -1.145 0 C-N-CA 123.657 2.905 . . . . 0.0 110.264 -177.933 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 3.3 t -93.34 119.33 32.35 Favored 'General case' 0 N--CA 1.443 -0.821 0 CA-C-O 122.437 1.113 . . . . 0.0 111.028 179.547 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.645 ' CD2' ' CE1' ' A' ' 90' ' ' HIS . 25.1 m-85 -84.43 151.83 59.82 Favored Pre-proline 0 N--CA 1.438 -1.067 0 O-C-N 121.005 -1.059 . . . . 0.0 111.029 -179.591 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 19.3 Cg_endo -78.06 -42.46 0.24 Allowed 'Trans proline' 0 CA--C 1.503 -1.073 0 C-N-CA 122.291 1.994 . . . . 0.0 112.718 179.582 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -42.9 -33.33 0.76 Allowed 'General case' 0 C--N 1.348 0.533 0 O-C-N 126.032 2.082 . . . . 0.0 110.161 176.273 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 99.92 16.34 28.56 Favored Glycine 0 N--CA 1.432 -1.6 0 N-CA-C 109.188 -1.565 . . . . 0.0 109.188 178.541 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.645 ' CE1' ' CD2' ' A' ' 86' ' ' PHE . 2.0 p-80 -87.93 131.16 34.7 Favored 'General case' 0 N--CA 1.438 -1.048 0 N-CA-C 108.018 -1.104 . . . . 0.0 108.018 -179.61 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -70.82 100.67 1.96 Allowed 'General case' 0 C--N 1.321 -0.66 0 N-CA-C 108.565 -0.902 . . . . 0.0 108.565 176.18 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.483 ' O ' ' CD2' ' A' ' 94' ' ' PHE . 19.9 t80 -35.77 140.74 0.1 Allowed 'General case' 0 C--O 1.205 -1.271 0 CA-C-O 122.051 0.929 . . . . 0.0 112.172 177.473 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.406 ' CE ' ' HB2' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -77.91 61.69 2.57 Favored 'General case' 0 C--N 1.315 -0.892 0 O-C-N 119.032 -2.293 . . . . 0.0 109.418 178.648 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.483 ' CD2' ' O ' ' A' ' 92' ' ' TYR . 30.4 p90 -76.07 4.13 9.08 Favored 'General case' 0 N--CA 1.439 -1.025 0 C-N-CA 124.077 0.951 . . . . 0.0 111.832 177.016 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.2 t0 -104.45 -33.3 8.64 Favored 'General case' 0 N--CA 1.45 -0.425 0 CA-C-O 122.578 1.18 . . . . 0.0 109.242 -179.641 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 14.3 m -98.54 95.79 7.53 Favored 'General case' 0 CA--C 1.506 -0.725 0 O-C-N 120.554 -1.341 . . . . 0.0 107.915 -179.138 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.425 ' HB3' ' CA ' ' A' ' 31' ' ' GLY . 0.1 OUTLIER -73.48 -35.39 65.67 Favored 'General case' 0 C--O 1.22 -0.448 0 N-CA-C 109.605 -0.517 . . . . 0.0 109.605 177.27 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.415 ' HA ' ' HA ' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -119.56 105.77 43.21 Favored Pre-proline 0 N--CA 1.437 -1.121 0 O-C-N 120.006 -1.684 . . . . 0.0 109.451 -179.355 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.415 ' HA ' ' HA ' ' A' ' 98' ' ' LYS . 24.1 Cg_endo -73.88 172.14 63.0 Favored 'Cis proline' 0 C--O 1.213 -0.737 0 O-C-N 124.416 1.745 . . . . 0.0 112.039 -1.84 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.462 ' HE3' ' O ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -118.2 127.32 53.64 Favored 'General case' 0 CA--C 1.511 -0.54 0 C-N-CA 123.408 0.683 . . . . 0.0 109.544 -178.798 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.406 ' HB2' ' CE ' ' A' ' 93' ' ' LYS . 9.2 tp10 -82.34 149.76 27.57 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.857 1.348 . . . . 0.0 110.218 178.927 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -51.31 139.25 26.57 Favored Pre-proline 0 N--CA 1.43 -1.448 0 CA-C-O 122.364 1.078 . . . . 0.0 112.546 172.258 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -73.61 -164.22 0.19 Allowed 'Trans proline' 0 N--CA 1.449 -1.12 0 C-N-CA 121.689 1.593 . . . . 0.0 111.885 177.741 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -140.14 158.94 26.02 Favored Glycine 0 N--CA 1.441 -0.986 0 O-C-N 121.338 -0.851 . . . . 0.0 112.368 177.038 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -74.88 -62.56 0.03 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.878 0 C-N-CA 122.471 2.114 . . . . 0.0 110.867 179.558 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.669 ' HB3' ' CZ ' ' A' ' 11' ' ' TYR . . . -67.57 133.88 50.23 Favored 'General case' 0 N--CA 1.436 -1.174 0 O-C-N 123.868 0.73 . . . . 0.0 110.488 179.017 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.42 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 0.0 OUTLIER -140.33 147.03 39.25 Favored 'General case' 0 CA--C 1.498 -1.039 0 CA-C-O 117.206 -1.378 . . . . 0.0 111.51 178.766 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.525 ' C ' HD12 ' A' ' 109' ' ' ILE . 3.2 p -83.24 120.14 33.95 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.676 0 C-N-CA 124.221 1.008 . . . . 0.0 110.985 177.775 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.665 HG21 ' CE2' ' A' ' 38' ' ' PHE . 1.7 mp -105.84 124.35 60.91 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.582 0 N-CA-C 106.372 -1.714 . . . . 0.0 106.372 -175.975 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.553 ' C ' HD23 ' A' ' 80' ' ' LEU . 19.3 p90 -142.27 164.2 30.78 Favored 'General case' 0 N--CA 1.442 -0.838 0 CA-C-O 121.661 0.743 . . . . 0.0 111.074 179.894 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.683 HG21 ' HB2' ' A' ' 61' ' ' ASP . 1.6 p -91.88 163.67 13.95 Favored 'General case' 0 CA--C 1.503 -0.847 0 N-CA-C 109.599 -0.519 . . . . 0.0 109.599 -177.804 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.553 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.2 OUTLIER -117.04 152.22 48.52 Favored Pre-proline 0 N--CA 1.434 -1.226 0 C-N-CA 123.292 0.637 . . . . 0.0 110.646 -179.72 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.876 ' O ' HD21 ' A' ' 25' ' ' LEU . 19.1 Cg_endo -73.48 -51.68 0.16 OUTLIER 'Cis proline' 0 CA--C 1.51 -0.717 0 C-N-CA 122.252 -1.978 . . . . 0.0 109.484 -5.441 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 53.2 t-20 -41.64 111.69 0.25 Allowed 'General case' 0 N--CA 1.438 -1.064 0 CA-C-O 113.612 -3.089 . . . . 0.0 110.012 -179.661 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.733 ' CE ' HD13 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -65.76 68.89 0.05 OUTLIER 'General case' 0 CA--C 1.508 -0.669 0 O-C-N 127.12 2.763 . . . . 0.0 108.562 -178.707 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.578 ' O ' HG12 ' A' ' 116' ' ' VAL . 24.2 t -74.29 64.28 0.13 Allowed 'Isoleucine or valine' 0 N--CA 1.445 -0.68 0 N-CA-C 106.028 -1.842 . . . . 0.0 106.028 -177.623 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.605 ' CZ ' ' NE2' ' A' ' 13' ' ' GLN . 2.0 t80 -36.71 124.65 0.85 Allowed 'General case' 0 N--CA 1.432 -1.347 0 O-C-N 120.61 -1.306 . . . . 0.0 108.946 178.949 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . 0.568 ' HB3' ' CD2' ' A' ' 57' ' ' PHE . 0.1 OUTLIER -101.41 -38.23 8.1 Favored 'General case' 0 N--CA 1.439 -1.008 0 O-C-N 123.836 0.71 . . . . 0.0 109.383 177.29 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.551 ' HA2' ' CZ ' ' A' ' 117' ' ' PHE . . . 158.68 -159.9 30.61 Favored Glycine 0 N--CA 1.444 -0.79 0 N-CA-C 111.209 -0.756 . . . . 0.0 111.209 -178.602 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.634 HG22 ' SG ' ' A' ' 134' ' ' CYS . 3.4 mp -117.91 145.4 23.86 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.349 0 CA-C-O 117.383 -1.294 . . . . 0.0 107.947 -178.12 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.537 HD13 ' CE1' ' A' ' 38' ' ' PHE . 6.6 pt -110.27 158.5 10.51 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.944 0 CA-C-N 120.959 1.708 . . . . 0.0 109.101 178.008 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.618 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . . . 177.89 159.01 0.46 Allowed 'General case' 0 N--CA 1.44 -0.946 0 C-N-CA 124.063 0.945 . . . . 0.0 109.648 -179.95 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.503 ' CE1' ' CD2' ' A' ' 131' ' ' LEU . 0.3 OUTLIER -91.11 96.04 10.39 Favored 'General case' 0 N--CA 1.442 -0.841 0 N-CA-C 108.863 -0.792 . . . . 0.0 108.863 -178.407 . . . . . . . . 3 3 . 1 . 010 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.2 p -103.32 43.98 1.05 Allowed 'General case' 0 C--N 1.316 -0.872 0 CA-C-O 121.706 0.765 . . . . 0.0 109.027 -177.008 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.6 tptt -105.78 -24.13 12.56 Favored 'General case' 0 C--O 1.221 -0.423 0 O-C-N 121.387 -0.821 . . . . 0.0 110.831 177.312 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.0 tm-20 -175.34 -70.95 0.01 OUTLIER 'General case' 0 C--O 1.223 -0.32 0 O-C-N 124.152 0.908 . . . . 0.0 110.831 178.404 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.4 p-10 -136.38 -55.87 0.75 Allowed 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 107.909 -1.145 . . . . 0.0 107.909 -177.426 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.7 OUTLIER -163.67 77.85 0.4 Allowed 'General case' 0 N--CA 1.44 -0.937 0 CA-C-O 121.859 0.837 . . . . 0.0 110.796 -178.191 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -112.17 -102.66 2.63 Favored Glycine 0 C--N 1.332 0.324 0 N-CA-C 110.788 -0.925 . . . . 0.0 110.788 -179.774 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.0 OUTLIER -91.99 147.76 22.72 Favored 'General case' 0 CA--C 1.511 -0.546 0 O-C-N 121.251 -1.146 . . . . 0.0 110.844 -179.86 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.503 ' CD2' ' CE1' ' A' ' 123' ' ' HIS . 17.2 mt -83.43 145.77 28.79 Favored 'General case' 0 N--CA 1.449 -0.521 0 CA-C-O 121.989 0.899 . . . . 0.0 110.975 178.007 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 11.4 ptpt -157.09 169.57 24.49 Favored 'General case' 0 CA--C 1.505 -0.786 0 CA-C-O 118.521 -0.752 . . . . 0.0 109.975 -177.091 . . . . . . . . 1 1 . 1 . 010 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.606 HD13 ' CE2' ' A' ' 57' ' ' PHE . 9.7 tp -83.99 139.71 32.37 Favored 'General case' 0 C--N 1.321 -0.666 0 N-CA-C 108.55 -0.907 . . . . 0.0 108.55 179.17 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . 0.634 ' SG ' HG22 ' A' ' 120' ' ' ILE . 72.1 m -58.98 -174.37 0.02 OUTLIER 'General case' 0 N--CA 1.441 -0.913 0 CA-C-O 124.124 1.916 . . . . 0.0 108.594 177.389 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -167.38 120.85 0.96 Allowed 'General case' 0 C--N 1.314 -0.949 0 O-C-N 120.057 -1.652 . . . . 0.0 108.575 -179.916 . . . . . . . . 2 2 . 1 . 010 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 1.8 m80 . . . . . 0 C--O 1.253 1.255 0 CA-C-O 115.143 -2.36 . . . . 0.0 111.847 177.212 . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.7 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 . . . . . . . . . 0 0 . 1 . 011 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.446 HG11 ' HD2' ' A' ' 136' ' ' HIS . 5.2 p -169.91 131.22 0.23 Allowed 'Isoleucine or valine' 0 C--O 1.234 0.237 0 N-CA-C 107.64 -1.245 . . . . 0.0 107.64 179.088 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.811 HG23 HD23 ' A' ' 10' ' ' LEU . 0.9 OUTLIER -85.65 117.54 24.6 Favored 'General case' 0 C--N 1.323 -0.57 0 CA-C-N 116.011 -0.54 . . . . 0.0 109.693 177.468 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.601 ' CH2' ' CE1' ' A' ' 136' ' ' HIS . 26.9 m95 -85.02 140.76 30.78 Favored 'General case' 0 N--CA 1.447 -0.58 0 N-CA-C 109.547 -0.538 . . . . 0.0 109.547 179.036 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -136.05 132.87 36.78 Favored 'General case' 0 C--N 1.316 -0.87 0 N-CA-C 108.356 -0.979 . . . . 0.0 108.356 -176.908 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.676 ' SG ' ' HB3' ' A' ' 122' ' ' ALA . 0.5 OUTLIER -119.05 69.39 0.81 Allowed 'General case' 0 N--CA 1.452 -0.359 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.651 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 34.79 86.65 0.01 OUTLIER Glycine 0 CA--C 1.53 0.983 0 C-N-CA 124.037 0.827 . . . . 0.0 113.648 -179.479 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 147.78 -74.05 0.29 Allowed Glycine 0 N--CA 1.462 0.403 0 N-CA-C 110.464 -1.054 . . . . 0.0 110.464 -176.855 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.441 HD13 ' HG3' ' A' ' 87' ' ' PRO . 5.7 mt -131.16 160.18 35.53 Favored 'General case' 0 C--O 1.237 0.427 0 N-CA-C 109.246 -0.65 . . . . 0.0 109.246 178.243 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.811 HD23 HG23 ' A' ' 3' ' ' THR . 0.0 OUTLIER -102.27 154.74 18.76 Favored 'General case' 0 C--O 1.218 -0.597 0 CA-C-N 114.863 -1.062 . . . . 0.0 110.442 178.116 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.638 ' CZ ' ' HB3' ' A' ' 106' ' ' ALA . 30.6 m-85 -134.59 108.84 8.28 Favored 'General case' 0 C--O 1.239 0.512 0 N-CA-C 108.471 -0.937 . . . . 0.0 108.471 -178.277 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -55.89 120.2 7.02 Favored 'General case' 0 N--CA 1.453 -0.292 0 N-CA-C 109.075 -0.713 . . . . 0.0 109.075 177.649 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.493 ' HB2' ' CD1' ' A' ' 4' ' ' TRP . 8.4 tp-100 -54.8 -42.01 71.28 Favored 'General case' 0 CA--C 1.503 -0.846 0 C-N-CA 119.959 -0.697 . . . . 0.0 112.387 178.822 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 3.4 t-20 -50.35 -26.05 4.49 Favored 'General case' 0 C--N 1.328 -0.352 0 O-C-N 124.029 0.831 . . . . 0.0 112.306 177.379 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 1.2 mttp -96.36 -34.25 11.63 Favored 'General case' 0 C--O 1.219 -0.503 0 C-N-CA 124.569 1.148 . . . . 0.0 112.49 170.957 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.02 -39.52 69.2 Favored 'General case' 0 C--N 1.317 -0.83 0 CA-C-N 120.406 1.457 . . . . 0.0 111.851 176.31 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.4 pt-20 -87.38 -44.56 11.27 Favored 'General case' 0 C--N 1.331 -0.201 0 C-N-CA 122.962 0.505 . . . . 0.0 110.204 175.125 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.2 t -69.21 -57.67 5.06 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-N 118.959 0.799 . . . . 0.0 112.292 -177.982 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.529 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 3.9 t-20 -44.89 -30.97 1.1 Allowed 'General case' 0 N--CA 1.468 0.438 0 N-CA-C 112.548 0.573 . . . . 0.0 112.548 170.939 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.432 ' O ' ' HB3' ' A' ' 23' ' ' ALA . 1.5 p -83.64 -33.34 25.3 Favored 'General case' 0 CA--C 1.514 -0.427 0 N-CA-C 113.073 0.768 . . . . 0.0 113.073 175.56 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 13.7 m170 -47.84 -36.79 12.53 Favored 'General case' 0 N--CA 1.472 0.667 0 C-N-CA 124.037 0.935 . . . . 0.0 109.919 179.561 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.529 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.1 OUTLIER -70.17 -47.96 59.36 Favored 'General case' 0 CA--C 1.518 -0.252 0 C-N-CA 124.577 1.151 . . . . 0.0 110.573 177.87 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.507 ' HB1' ' HG3' ' A' ' 35' ' ' PRO . . . -39.61 127.21 1.46 Allowed Pre-proline 0 CA--C 1.537 0.447 0 O-C-N 124.602 1.189 . . . . 0.0 110.606 176.364 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.568 ' HG2' HG22 ' A' ' 30' ' ' THR . 18.7 Cg_endo -72.79 124.69 9.9 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 121.546 1.497 . . . . 0.0 109.096 -177.774 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.726 HD21 ' O ' ' A' ' 113' ' ' PRO . 3.8 tp -60.78 94.36 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.373 0 C-N-CA 123.542 0.737 . . . . 0.0 111.291 178.416 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 179.89 160.35 0.84 Allowed 'General case' 0 C--N 1.329 -0.324 0 CA-C-N 115.714 -0.675 . . . . 0.0 109.35 -174.949 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -99.86 116.18 31.33 Favored 'General case' 0 CA--C 1.51 -0.567 0 C-N-CA 123.826 0.85 . . . . 0.0 108.898 177.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 50.51 72.47 0.49 Allowed Glycine 0 CA--C 1.528 0.873 0 O-C-N 124.394 1.059 . . . . 0.0 112.426 176.481 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -145.17 22.03 1.55 Allowed 'General case' 0 N--CA 1.473 0.708 0 O-C-N 122.429 -0.453 . . . . 0.0 112.033 -179.856 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.568 HG22 ' HG2' ' A' ' 24' ' ' PRO . 33.5 p -121.91 156.8 32.58 Favored 'General case' 0 C--N 1.32 -0.71 0 N-CA-C 108.268 -1.012 . . . . 0.0 108.268 -176.471 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -43.68 -52.01 6.63 Favored Glycine 0 C--N 1.332 0.337 0 CA-C-N 116.003 -0.544 . . . . 0.0 112.989 -178.792 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 12.2 t -68.03 -79.48 0.05 Allowed 'General case' 0 CA--C 1.518 -0.259 0 CA-C-O 119.306 -0.378 . . . . 0.0 111.235 173.726 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 89.1 p -178.42 -59.05 0.01 OUTLIER 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 124.803 1.241 . . . . 0.0 109.83 -178.863 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.534 ' CE1' ' HB3' ' A' ' 103' ' ' PRO . 81.6 m-85 -63.57 148.95 93.22 Favored Pre-proline 0 CA--C 1.552 1.022 0 C-N-CA 123.303 0.641 . . . . 0.0 112.375 -176.54 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.507 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 25.2 Cg_endo -74.9 169.77 73.56 Favored 'Cis proline' 0 N--CA 1.455 -0.736 0 O-C-N 123.524 1.276 . . . . 0.0 112.116 1.347 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.753 ' C ' HD23 ' A' ' 81' ' ' LEU . 1.4 p80 -142.5 169.22 17.98 Favored 'General case' 0 CA--C 1.505 -0.77 0 N-CA-C 109.538 -0.541 . . . . 0.0 109.538 -177.29 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.899 ' CH2' HG22 ' A' ' 39' ' ' THR . 20.5 t90 -71.65 129.22 38.16 Favored 'General case' 0 C--N 1.326 -0.447 0 N-CA-C 108.734 -0.839 . . . . 0.0 108.734 178.399 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.517 ' CZ ' HD13 ' A' ' 121' ' ' ILE . 33.9 t80 -99.48 82.74 2.7 Favored 'General case' 0 N--CA 1.441 -0.89 0 N-CA-C 105.869 -1.901 . . . . 0.0 105.869 179.331 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.899 HG22 ' CH2' ' A' ' 37' ' ' TRP . 41.6 p -39.51 -33.5 0.17 Allowed 'General case' 0 CA--C 1.503 -0.845 0 CA-C-N 114.337 -1.301 . . . . 0.0 110.815 170.905 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.499 ' HB2' ' CE2' ' A' ' 38' ' ' PHE . 59.0 t30 55.63 20.13 3.7 Favored 'General case' 0 N--CA 1.474 0.733 0 CA-C-O 123.558 1.646 . . . . 0.0 112.125 -179.966 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.464 ' C ' HD23 ' A' ' 48' ' ' LEU . . . 110.08 -44.52 1.48 Allowed Glycine 0 N--CA 1.436 -1.331 0 CA-C-O 116.039 -2.534 . . . . 0.0 113.661 -170.959 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.518 ' CE2' ' HD3' ' A' ' 66' ' ' PRO . 76.9 m-85 -45.94 150.99 0.5 Allowed 'General case' 0 C--N 1.343 0.296 0 C-N-CA 125.779 1.631 . . . . 0.0 110.666 -178.728 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -81.4 -37.73 27.67 Favored 'General case' 0 C--N 1.324 -0.529 0 CA-C-N 115.907 -0.588 . . . . 0.0 111.049 178.052 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.436 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -164.29 -77.66 0.03 OUTLIER Glycine 0 C--N 1.335 0.503 0 N-CA-C 111.189 -0.765 . . . . 0.0 111.189 -178.38 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -113.22 -62.78 1.54 Allowed 'General case' 0 C--N 1.329 -0.315 0 C-N-CA 123.289 0.636 . . . . 0.0 111.377 -178.303 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.6 -169.85 0.11 Allowed Glycine 0 C--N 1.342 0.892 0 C-N-CA 124.408 1.004 . . . . 0.0 111.135 177.809 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 3.9 mtpt -59.53 -169.49 0.01 OUTLIER 'General case' 0 CA--C 1.538 0.506 0 CA-C-O 123.279 1.514 . . . . 0.0 111.701 176.728 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.631 ' H ' HD12 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -93.18 176.58 2.44 Favored Pre-proline 0 C--N 1.318 -0.783 0 CA-C-N 114.802 -1.09 . . . . 0.0 110.309 -178.091 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -70.83 158.85 54.43 Favored 'Trans proline' 0 N--CA 1.444 -1.386 0 O-C-N 123.807 1.425 . . . . 0.0 110.967 178.276 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 1.4 ttpp -64.71 97.23 0.21 Allowed 'General case' 0 C--N 1.33 -0.241 0 CA-C-N 115.713 -0.676 . . . . 0.0 110.263 176.39 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 119.19 40.12 0.65 Allowed Glycine 0 N--CA 1.464 0.509 0 CA-C-N 115.643 -0.708 . . . . 0.0 111.853 -177.208 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.451 ' NE ' ' HA2' ' A' ' 41' ' ' GLY . 0.2 OUTLIER -122.07 159.79 26.34 Favored 'General case' 0 CA--C 1.513 -0.471 0 C-N-CA 122.837 0.455 . . . . 0.0 110.703 175.761 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 53.3 m -136.03 98.9 11.42 Favored Pre-proline 0 C--N 1.329 -0.286 0 CA-C-N 114.719 -1.128 . . . . 0.0 109.621 179.938 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 20.7 Cg_endo -72.37 179.19 5.28 Favored 'Trans proline' 0 C--N 1.353 0.786 0 C-N-CA 122.668 2.245 . . . . 0.0 111.275 177.191 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 6.8 mt -107.17 140.48 25.23 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.585 0 N-CA-C 108.508 -0.923 . . . . 0.0 108.508 -179.441 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -95.89 146.45 24.57 Favored 'General case' 0 N--CA 1.455 -0.218 0 CA-C-O 121.533 0.682 . . . . 0.0 109.621 176.669 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.568 ' CD1' ' HB3' ' A' ' 118' ' ' CYS . 24.0 m-85 -128.59 -50.14 1.27 Allowed 'General case' 0 C--N 1.328 -0.361 0 C-N-CA 124.263 1.025 . . . . 0.0 110.77 179.633 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 117.28 -3.18 18.57 Favored Glycine 0 C--N 1.337 0.634 0 C-N-CA 123.742 0.687 . . . . 0.0 112.657 -175.135 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -97.98 133.33 42.6 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-N 117.759 0.779 . . . . 0.0 109.818 177.381 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 46.3 t -69.4 -6.09 27.79 Favored 'General case' 0 N--CA 1.474 0.772 0 O-C-N 124.749 1.281 . . . . 0.0 111.551 176.773 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -89.48 -57.16 2.98 Favored 'General case' 0 CA--C 1.517 -0.318 0 O-C-N 120.651 -1.28 . . . . 0.0 109.367 -178.58 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.502 ' SG ' HD21 ' A' ' 80' ' ' LEU . 2.1 t -68.9 -25.91 64.83 Favored 'General case' 0 N--CA 1.457 -0.107 0 O-C-N 124.492 1.12 . . . . 0.0 110.806 176.522 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 10.7 t0 -70.86 -38.45 73.14 Favored 'General case' 0 C--O 1.236 0.353 0 CA-C-O 121.367 0.603 . . . . 0.0 110.618 174.576 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.408 ' HD2' ' ND1' ' A' ' 78' ' ' HIS . 0.0 OUTLIER -55.44 158.16 6.05 Favored Pre-proline 0 CA--C 1.537 0.443 0 CA-C-O 122.163 0.982 . . . . 0.0 111.745 179.787 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 20.1 Cg_endo -70.78 140.85 39.74 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 120.309 0.673 . . . . 0.0 113.029 175.751 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.518 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 19.3 Cg_endo -71.77 172.26 14.83 Favored 'Trans proline' 0 N--CA 1.448 -1.172 0 C-N-CA 122.73 2.287 . . . . 0.0 111.514 177.896 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -134.18 54.67 1.93 Allowed 'General case' 0 C--N 1.321 -0.643 0 CA-C-N 115.59 -0.732 . . . . 0.0 109.899 178.721 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.441 ' CE1' ' O ' ' A' ' 69' ' ' SER . 49.9 t-80 -77.95 156.44 30.24 Favored 'General case' 0 N--CA 1.476 0.873 0 CA-C-O 121.669 0.747 . . . . 0.0 110.249 -178.804 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.441 ' O ' ' CE1' ' A' ' 68' ' ' HIS . 0.2 OUTLIER -142.95 -166.02 2.2 Favored 'General case' 0 C--N 1.325 -0.48 0 O-C-N 121.251 -0.906 . . . . 0.0 110.568 179.047 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -83.6 72.51 10.3 Favored 'General case' 0 C--O 1.219 -0.535 0 O-C-N 121.894 -0.504 . . . . 0.0 110.647 176.619 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -178.58 -41.37 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.699 0 CA-C-O 121.61 0.719 . . . . 0.0 110.563 179.462 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.409 ' O ' ' CE2' ' A' ' 79' ' ' TYR . . . 118.73 -48.18 0.96 Allowed Glycine 0 CA--C 1.499 -0.948 0 CA-C-N 115.014 -0.994 . . . . 0.0 111.206 -177.149 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.426 ' ND2' ' CZ ' ' A' ' 112' ' ' TYR . 2.0 t-20 -147.56 85.17 1.57 Allowed 'General case' 0 N--CA 1.438 -1.069 0 N-CA-C 107.344 -1.354 . . . . 0.0 107.344 179.083 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -71.07 -119.35 0.05 OUTLIER Glycine 0 CA--C 1.529 0.909 0 CA-C-O 122.036 0.798 . . . . 0.0 111.807 177.119 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 20.6 mttt -52.79 -87.77 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.675 0 O-C-N 121.066 -1.255 . . . . 0.0 112.717 178.211 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.531 HG23 ' O ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -123.54 19.05 9.63 Favored 'General case' 0 CA--C 1.513 -0.474 0 CA-C-N 115.792 -0.64 . . . . 0.0 111.014 177.623 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.496 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 6.5 m-20 -32.18 105.18 0.03 OUTLIER 'General case' 0 CA--C 1.504 -0.815 0 C-N-CA 124.898 1.279 . . . . 0.0 109.15 -176.123 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.503 ' CD2' ' H ' ' A' ' 78' ' ' HIS . 3.2 p80 -88.42 18.43 4.51 Favored 'General case' 0 N--CA 1.474 0.765 0 N-CA-C 109.697 -0.483 . . . . 0.0 109.697 -175.987 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.964 ' CZ ' HD11 ' A' ' 81' ' ' LEU . 0.4 OUTLIER -40.15 135.25 1.42 Allowed 'General case' 0 N--CA 1.439 -1.016 0 C-N-CA 125.419 1.488 . . . . 0.0 110.948 173.804 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.687 HD23 ' C ' ' A' ' 110' ' ' TYR . 0.4 OUTLIER -75.45 155.37 36.34 Favored 'General case' 0 C--N 1.322 -0.594 0 CA-C-N 115.029 -0.987 . . . . 0.0 109.851 176.113 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.964 HD11 ' CZ ' ' A' ' 79' ' ' TYR . 1.7 mp -140.69 150.49 43.54 Favored 'General case' 0 C--N 1.321 -0.662 0 CA-C-O 120.883 0.373 . . . . 0.0 110.147 176.484 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.485 ' CB ' ' CD1' ' A' ' 109' ' ' ILE . 0.4 OUTLIER -115.76 157.53 24.2 Favored 'General case' 0 C--O 1.24 0.578 0 CA-C-O 122.009 0.909 . . . . 0.0 110.627 -179.699 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.493 ' HB3' HG12 ' A' ' 108' ' ' VAL . 30.3 t80 -139.99 133.76 15.46 Favored Pre-proline 0 CA--C 1.532 0.27 0 CA-C-O 118.698 -0.668 . . . . 0.0 112.204 -178.452 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.555 ' HA ' ' HG2' ' A' ' 107' ' ' ARG . 17.8 Cg_endo -70.03 87.71 0.58 Allowed 'Trans proline' 0 CA--C 1.505 -0.956 0 C-N-CA 123.937 3.091 . . . . 0.0 110.72 -174.706 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.64 HG22 ' HA ' ' A' ' 107' ' ' ARG . 2.7 t -83.5 129.02 34.96 Favored 'General case' 0 C--N 1.328 -0.359 0 O-C-N 124.237 0.961 . . . . 0.0 110.902 -179.865 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.648 ' CD1' ' CD1' ' A' ' 92' ' ' TYR . 4.6 m-85 -96.54 152.34 38.55 Favored Pre-proline 0 C--O 1.237 0.395 0 C-N-CA 122.796 0.439 . . . . 0.0 110.203 -178.95 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . 0.441 ' HG3' HD13 ' A' ' 9' ' ' LEU . 18.8 Cg_endo -73.07 -47.74 0.31 Allowed 'Trans proline' 0 N--CA 1.447 -1.213 0 O-C-N 124.047 1.551 . . . . 0.0 112.266 179.426 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -42.74 -41.08 3.05 Favored 'General case' 0 C--O 1.233 0.207 0 CA-C-O 123.07 1.414 . . . . 0.0 110.278 179.47 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 94.85 18.0 36.17 Favored Glycine 0 N--CA 1.443 -0.872 0 CA-C-N 114.48 -1.236 . . . . 0.0 110.146 -179.739 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.437 ' O ' ' CE1' ' A' ' 92' ' ' TYR . 1.8 p-80 -86.69 147.48 25.86 Favored 'General case' 0 C--O 1.216 -0.663 0 CA-C-N 118.061 0.931 . . . . 0.0 109.601 176.526 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.5 t70 -63.92 139.82 58.81 Favored 'General case' 0 N--CA 1.479 1.001 0 CA-C-N 118.642 0.655 . . . . 0.0 111.902 174.525 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.648 ' CD1' ' CD1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -96.18 146.97 24.23 Favored 'General case' 0 C--N 1.328 -0.345 0 N-CA-C 107.743 -1.206 . . . . 0.0 107.743 -174.608 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -83.21 69.05 9.85 Favored 'General case' 0 C--N 1.32 -0.696 0 O-C-N 121.371 -0.83 . . . . 0.0 110.08 175.478 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.441 ' CD2' ' HZ ' ' A' ' 83' ' ' PHE . 25.7 p90 -83.55 -23.58 31.96 Favored 'General case' 0 C--N 1.327 -0.397 0 CA-C-N 115.571 -0.74 . . . . 0.0 111.113 177.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 5.0 t0 -91.17 -23.74 20.15 Favored 'General case' 0 N--CA 1.466 0.368 0 CA-C-O 123.012 1.387 . . . . 0.0 110.924 179.464 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -86.15 108.9 18.53 Favored 'General case' 0 CA--C 1.517 -0.325 0 O-C-N 120.61 -1.306 . . . . 0.0 108.575 179.936 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.97 -48.2 82.69 Favored 'General case' 0 C--O 1.239 0.541 0 CA-C-O 121.609 0.719 . . . . 0.0 111.067 178.602 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.438 ' HA ' ' HA ' ' A' ' 99' ' ' PRO . 0.3 OUTLIER -139.03 128.39 14.24 Favored Pre-proline 0 CA--C 1.543 0.7 0 CA-C-N 114.508 -1.223 . . . . 0.0 110.233 -178.995 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.438 ' HA ' ' HA ' ' A' ' 98' ' ' LYS . 25.9 Cg_endo -69.78 176.3 33.19 Favored 'Cis proline' 0 N--CA 1.459 -0.522 0 C-N-CA 122.789 -1.754 . . . . 0.0 111.527 -5.126 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -140.72 122.83 15.68 Favored 'General case' 0 C--N 1.323 -0.569 0 C-N-CA 124.005 0.922 . . . . 0.0 109.092 178.803 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 6.1 tp10 -87.6 162.32 17.22 Favored 'General case' 0 C--N 1.325 -0.499 0 O-C-N 125.47 1.731 . . . . 0.0 110.006 178.17 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -50.53 154.49 2.22 Favored Pre-proline 0 C--O 1.222 -0.382 0 CA-C-N 115.54 -0.755 . . . . 0.0 111.116 177.646 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.534 ' HB3' ' CE1' ' A' ' 34' ' ' TYR . 20.5 Cg_endo -73.7 -87.39 0.0 OUTLIER 'Trans proline' 0 N--CA 1.451 -0.977 0 C-N-CA 121.096 1.197 . . . . 0.0 111.912 178.227 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 148.7 159.9 8.78 Favored Glycine 0 CA--C 1.524 0.654 0 O-C-N 121.146 -0.971 . . . . 0.0 110.905 -178.815 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -76.64 -73.17 0.01 OUTLIER 'Trans proline' 0 N--CA 1.454 -0.814 0 C-N-CA 122.725 2.284 . . . . 0.0 110.949 179.892 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.638 ' HB3' ' CZ ' ' A' ' 11' ' ' TYR . . . -62.26 151.42 36.39 Favored 'General case' 0 N--CA 1.442 -0.865 0 O-C-N 123.915 0.759 . . . . 0.0 110.105 178.969 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.64 ' HA ' HG22 ' A' ' 85' ' ' THR . 7.8 mtm-85 -152.7 142.74 22.27 Favored 'General case' 0 CA--C 1.513 -0.453 0 CA-C-N 114.935 -1.03 . . . . 0.0 110.983 -178.769 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.493 HG12 ' HB3' ' A' ' 83' ' ' PHE . 4.8 p -82.09 124.61 39.33 Favored 'Isoleucine or valine' 0 C--N 1.328 -0.328 0 O-C-N 124.207 0.942 . . . . 0.0 109.477 178.725 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.616 ' CG2' HD22 ' A' ' 80' ' ' LEU . 6.1 mm -104.65 142.0 18.92 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.722 0 CA-C-N 116.014 -0.539 . . . . 0.0 109.87 -179.444 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.687 ' C ' HD23 ' A' ' 80' ' ' LEU . 9.6 p90 -163.73 147.71 10.3 Favored 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 122.271 1.034 . . . . 0.0 111.711 -178.386 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 9.6 p -83.6 169.74 15.07 Favored 'General case' 0 C--O 1.238 0.486 0 CA-C-N 115.421 -0.808 . . . . 0.0 109.388 -178.966 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.588 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.6 OUTLIER -111.37 154.61 43.65 Favored Pre-proline 0 CA--C 1.552 1.035 0 CA-C-N 115.567 -0.742 . . . . 0.0 111.295 177.812 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.726 ' O ' HD21 ' A' ' 25' ' ' LEU . 18.8 Cg_endo -73.65 -56.92 0.14 OUTLIER 'Cis proline' 0 CA--C 1.504 -1.012 0 C-N-CA 123.724 -1.365 . . . . 0.0 110.466 -6.746 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.512 ' O ' HG23 ' A' ' 116' ' ' VAL . 1.1 m-20 -43.79 116.62 1.0 Allowed 'General case' 0 N--CA 1.448 -0.551 0 O-C-N 123.812 0.695 . . . . 0.0 109.352 178.233 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.561 ' HE2' HD22 ' A' ' 25' ' ' LEU . 0.0 OUTLIER -65.39 79.67 0.06 Allowed 'General case' 0 CA--C 1.513 -0.464 0 N-CA-C 108.251 -1.018 . . . . 0.0 108.251 -179.001 . . . . . . . . 3 3 . 1 . 011 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.512 HG23 ' O ' ' A' ' 114' ' ' ASN . 91.7 t -73.63 75.95 0.35 Allowed 'Isoleucine or valine' 0 CA--C 1.515 -0.384 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 -177.039 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.436 ' CZ ' ' NE2' ' A' ' 13' ' ' GLN . 40.4 t80 -37.91 103.91 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.649 0 C-N-CA 125.808 1.643 . . . . 0.0 109.432 -179.199 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . 0.568 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 10.9 m -83.25 -44.61 14.78 Favored 'General case' 0 N--CA 1.447 -0.604 0 N-CA-C 108.632 -0.877 . . . . 0.0 108.632 -178.188 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 157.12 -147.71 16.36 Favored Glycine 0 N--CA 1.442 -0.906 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 179.451 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.49 HG13 ' CG ' ' A' ' 4' ' ' TRP . 1.2 mm -127.88 140.45 49.11 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.803 0 N-CA-C 107.642 -1.244 . . . . 0.0 107.642 -176.889 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.93 HG22 HD12 ' A' ' 133' ' ' LEU . 8.9 pt -129.05 155.24 40.97 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.972 0 N-CA-C 108.353 -0.98 . . . . 0.0 108.353 -177.952 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.676 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . . . -174.91 153.21 1.65 Allowed 'General case' 0 C--N 1.329 -0.306 0 CA-C-O 122.407 1.098 . . . . 0.0 109.255 178.242 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.519 ' CD2' HD13 ' A' ' 131' ' ' LEU . 3.7 m-70 -90.57 92.46 8.86 Favored 'General case' 0 C--O 1.223 -0.323 0 N-CA-C 108.866 -0.79 . . . . 0.0 108.866 -177.743 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.597 HG22 ' HD2' ' A' ' 132' ' ' LYS . 2.0 t -97.55 43.32 1.07 Allowed 'General case' 0 N--CA 1.476 0.852 0 CA-C-O 122.661 1.22 . . . . 0.0 110.829 -179.705 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 7.5 ttpt -104.89 -27.42 11.73 Favored 'General case' 0 C--O 1.221 -0.397 0 CA-C-N 115.547 -0.751 . . . . 0.0 110.534 178.413 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.3 OUTLIER -172.09 -65.15 0.02 OUTLIER 'General case' 0 C--N 1.33 -0.261 0 O-C-N 124.281 0.988 . . . . 0.0 110.683 179.37 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 24.1 t30 -153.95 -47.56 0.09 Allowed 'General case' 0 C--O 1.233 0.234 0 CA-C-O 122.354 1.074 . . . . 0.0 109.864 178.991 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.0 OUTLIER -157.4 76.23 0.82 Allowed 'General case' 0 N--CA 1.45 -0.46 0 CA-C-N 115.559 -0.746 . . . . 0.0 110.539 -177.974 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -125.39 -106.21 1.57 Allowed Glycine 0 CA--C 1.519 0.328 0 N-CA-C 110.051 -1.22 . . . . 0.0 110.051 179.054 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -81.94 143.41 31.66 Favored 'General case' 0 C--N 1.327 -0.393 0 O-C-N 122.084 -0.656 . . . . 0.0 110.727 -179.301 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.535 HD21 HD12 ' A' ' 121' ' ' ILE . 5.2 tp -100.0 139.29 35.88 Favored 'General case' 0 C--O 1.224 -0.244 0 CA-C-O 120.861 0.362 . . . . 0.0 110.503 177.999 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.597 ' HD2' HG22 ' A' ' 124' ' ' THR . 4.2 ptpt -148.04 169.75 19.27 Favored 'General case' 0 CA--C 1.514 -0.419 0 N-CA-C 109.199 -0.667 . . . . 0.0 109.199 -179.929 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.93 HD12 HG22 ' A' ' 121' ' ' ILE . 4.0 tp -84.14 148.14 26.95 Favored 'General case' 0 C--O 1.235 0.296 0 O-C-N 124.31 1.007 . . . . 0.0 109.167 178.286 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . 0.459 ' SG ' HG22 ' A' ' 120' ' ' ILE . 72.2 m -67.26 -174.54 0.38 Allowed 'General case' 0 CA--C 1.531 0.214 0 CA-C-O 122.316 1.055 . . . . 0.0 109.95 175.131 . . . . . . . . 2 2 . 1 . 011 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 15.2 m -129.04 95.29 4.03 Favored 'General case' 0 C--N 1.327 -0.405 0 N-CA-C 108.54 -0.911 . . . . 0.0 108.54 -177.971 . . . . . . . . 1 1 . 1 . 011 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.601 ' CE1' ' CH2' ' A' ' 4' ' ' TRP . 24.5 p-80 . . . . . 0 C--N 1.328 -0.337 0 O-C-N 123.711 0.632 . . . . 0.0 110.928 176.814 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.504 -0.799 0 CA-C-O 116.48 -1.724 . . . . 0.0 107.786 . . . . . . . . . 0 0 . 1 . 012 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.0 p -40.25 119.87 0.19 Allowed 'Isoleucine or valine' 0 CA--C 1.533 0.302 0 O-C-N 125.439 1.712 . . . . 0.0 110.791 178.637 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.45 ' CG2' ' HB3' ' A' ' 10' ' ' LEU . 3.7 m -86.71 111.56 20.81 Favored 'General case' 0 CA--C 1.505 -0.782 0 N-CA-C 108.529 -0.915 . . . . 0.0 108.529 -176.283 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 24.8 m95 -77.29 142.7 39.32 Favored 'General case' 0 N--CA 1.446 -0.641 0 C-N-CA 123.247 0.619 . . . . 0.0 110.011 178.114 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -140.01 135.82 33.08 Favored 'General case' 0 CA--C 1.496 -1.114 0 N-CA-C 108.281 -1.007 . . . . 0.0 108.281 -179.007 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.665 ' SG ' ' HB3' ' A' ' 122' ' ' ALA . 0.8 OUTLIER -116.24 60.76 0.72 Allowed 'General case' 0 N--CA 1.449 -0.49 0 CA-C-N 115.496 -0.774 . . . . 0.0 110.594 177.114 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 39.22 72.27 0.22 Allowed Glycine 0 CA--C 1.53 0.985 0 O-C-N 124.018 0.824 . . . . 0.0 112.688 -178.346 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 168.38 -77.46 0.11 Allowed Glycine 0 C--O 1.224 -0.49 0 N-CA-C 111.076 -0.81 . . . . 0.0 111.076 -177.206 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 16.9 mt -126.17 162.43 25.4 Favored 'General case' 0 C--O 1.239 0.536 0 CA-C-O 121.749 0.785 . . . . 0.0 109.908 178.177 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.617 HD22 ' H ' ' A' ' 10' ' ' LEU . 0.2 OUTLIER -89.91 165.23 14.21 Favored 'General case' 0 CA--C 1.508 -0.66 0 CA-C-N 115.012 -0.995 . . . . 0.0 109.086 -177.242 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 46.6 m-85 -156.1 82.95 1.0 Allowed 'General case' 0 C--N 1.324 -0.535 0 N-CA-C 108.131 -1.063 . . . . 0.0 108.131 -171.362 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -53.46 125.76 19.1 Favored 'General case' 0 N--CA 1.445 -0.717 0 N-CA-C 107.904 -1.147 . . . . 0.0 107.904 179.324 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.546 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 7.2 tp-100 -59.43 -21.4 59.96 Favored 'General case' 0 C--O 1.217 -0.656 0 C-N-CA 118.996 -1.081 . . . . 0.0 113.776 176.528 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -63.16 -24.67 67.99 Favored 'General case' 0 N--CA 1.442 -0.864 0 N-CA-C 114.497 1.295 . . . . 0.0 114.497 172.81 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.401 ' O ' ' HB2' ' A' ' 19' ' ' ASN . 6.8 mttp -101.53 -30.46 11.38 Favored 'General case' 0 C--O 1.201 -1.467 0 CA-C-O 114.038 -2.887 . . . . 0.0 111.023 174.998 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -54.42 -66.0 0.48 Allowed 'General case' 0 C--N 1.328 -0.362 0 CA-C-N 122.212 2.278 . . . . 0.0 112.204 176.477 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 26.4 pt-20 -61.27 -44.98 96.35 Favored 'General case' 0 N--CA 1.442 -0.831 0 CA-C-O 117.88 -1.057 . . . . 0.0 109.449 176.683 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 46.0 t -57.54 -47.86 80.88 Favored 'General case' 0 C--O 1.212 -0.909 0 CA-C-N 119.801 1.182 . . . . 0.0 109.003 -176.437 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.463 ' OD1' ' HA ' ' A' ' 85' ' ' THR . 5.0 t-20 -47.7 -37.1 12.36 Favored 'General case' 0 N--CA 1.442 -0.834 0 O-C-N 121.064 -1.023 . . . . 0.0 112.302 174.333 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.9 OUTLIER -79.99 -29.46 39.49 Favored 'General case' 0 N--CA 1.449 -0.519 0 N-CA-C 114.853 1.427 . . . . 0.0 114.853 172.736 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 17.9 m170 -53.19 -39.91 64.01 Favored 'General case' 0 N--CA 1.456 -0.161 0 C-N-CA 125.696 1.598 . . . . 0.0 110.539 176.403 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.447 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -82.16 -49.92 9.6 Favored 'General case' 0 N--CA 1.441 -0.914 0 CA-C-O 117.733 -1.127 . . . . 0.0 110.232 178.922 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.645 ' HB2' ' CZ ' ' A' ' 83' ' ' PHE . . . -42.15 136.63 2.23 Favored Pre-proline 0 N--CA 1.448 -0.57 0 O-C-N 125.504 1.753 . . . . 0.0 112.446 177.511 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.655 ' HG2' HG22 ' A' ' 30' ' ' THR . 19.1 Cg_endo -73.01 123.3 8.78 Favored 'Trans proline' 0 N--CA 1.447 -1.214 0 C-N-CA 121.722 1.615 . . . . 0.0 109.228 -176.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.665 HD13 ' HE2' ' A' ' 115' ' ' LYS . 7.0 tp -59.62 103.07 0.17 Allowed 'General case' 0 N--CA 1.449 -0.487 0 CA-C-N 115.688 -0.687 . . . . 0.0 110.853 179.55 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.644 ' O ' HD22 ' A' ' 81' ' ' LEU . 0.3 OUTLIER -179.83 176.96 0.72 Allowed 'General case' 0 C--N 1.328 -0.351 0 CA-C-O 121.803 0.811 . . . . 0.0 110.5 -175.577 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.49 ' HB2' ' CE1' ' A' ' 79' ' ' TYR . 1.3 t0 -110.94 83.87 1.83 Allowed 'General case' 0 C--N 1.327 -0.402 0 N-CA-C 107.622 -1.251 . . . . 0.0 107.622 179.52 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 70.38 81.18 0.26 Allowed Glycine 0 N--CA 1.444 -0.833 0 N-CA-C 109.572 -1.411 . . . . 0.0 109.572 173.547 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -149.47 40.3 0.84 Allowed 'General case' 0 CA--C 1.509 -0.62 0 O-C-N 121.852 -0.793 . . . . 0.0 111.972 179.617 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.655 HG22 ' HG2' ' A' ' 24' ' ' PRO . 17.7 p -128.2 152.22 48.32 Favored 'General case' 0 CA--C 1.502 -0.873 0 N-CA-C 108.231 -1.026 . . . . 0.0 108.231 -175.01 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -42.45 -49.25 5.76 Favored Glycine 0 C--N 1.334 0.47 0 CA-C-O 119.629 -0.539 . . . . 0.0 112.562 -179.373 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -67.81 -78.31 0.06 Allowed 'General case' 0 N--CA 1.452 -0.357 0 O-C-N 123.792 0.348 . . . . 0.0 111.478 174.014 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 79.3 p -177.06 -65.77 0.01 OUTLIER 'General case' 0 C--O 1.22 -0.466 0 C-N-CA 125.121 1.368 . . . . 0.0 110.161 -179.953 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.421 ' HA ' ' C ' ' A' ' 35' ' ' PRO . 90.7 m-85 -63.3 150.9 88.35 Favored Pre-proline 0 N--CA 1.43 -1.46 0 C-N-CA 125.498 1.519 . . . . 0.0 111.95 -176.771 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.989 ' HB2' HD13 ' A' ' 81' ' ' LEU . 17.2 Cg_endo -75.98 160.31 95.86 Favored 'Cis proline' 0 N--CA 1.449 -1.108 0 C-N-CA 122.621 -1.824 . . . . 0.0 110.957 2.244 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.6 OUTLIER -135.75 166.12 24.0 Favored 'General case' 0 CA--C 1.509 -0.609 0 CA-C-O 118.197 -0.906 . . . . 0.0 109.181 179.775 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.933 ' CH2' HG22 ' A' ' 39' ' ' THR . 21.8 t90 -62.66 152.09 36.34 Favored 'General case' 0 N--CA 1.444 -0.756 0 N-CA-C 108.546 -0.909 . . . . 0.0 108.546 175.882 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.497 ' CZ ' HD13 ' A' ' 121' ' ' ILE . 18.5 t80 -128.78 78.27 1.84 Allowed 'General case' 0 N--CA 1.425 -1.7 0 N-CA-C 105.169 -2.16 . . . . 0.0 105.169 -173.204 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.933 HG22 ' CH2' ' A' ' 37' ' ' TRP . 73.1 p -39.24 -35.68 0.27 Allowed 'General case' 0 C--O 1.212 -0.899 0 C-N-CA 124.25 1.02 . . . . 0.0 110.179 173.3 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.425 ' HB2' ' CD2' ' A' ' 38' ' ' PHE . 44.6 t30 57.04 19.6 4.81 Favored 'General case' 0 CA--C 1.538 0.507 0 CA-C-O 123.306 1.527 . . . . 0.0 110.023 176.929 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.655 ' C ' HD23 ' A' ' 48' ' ' LEU . . . 107.68 -40.8 2.39 Favored Glycine 0 N--CA 1.428 -1.846 0 CA-C-O 116.194 -2.448 . . . . 0.0 115.208 -169.457 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.496 ' CE2' ' HD3' ' A' ' 66' ' ' PRO . 77.0 m-85 -45.85 153.75 0.27 Allowed 'General case' 0 C--N 1.339 0.145 0 CA-C-N 119.385 1.592 . . . . 0.0 112.18 176.338 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -81.98 -36.38 27.95 Favored 'General case' 0 C--N 1.326 -0.439 0 CA-C-O 121.764 0.792 . . . . 0.0 111.496 177.909 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.531 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -175.18 -63.6 0.05 OUTLIER Glycine 0 C--N 1.337 0.595 0 C-N-CA 124.513 1.054 . . . . 0.0 111.337 -178.584 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -117.88 -68.15 0.94 Allowed 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.373 0.606 . . . . 0.0 111.277 -179.075 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -57.13 -173.86 0.25 Allowed Glycine 0 C--N 1.341 0.839 0 N-CA-C 111.002 -0.839 . . . . 0.0 111.002 178.764 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.526 ' HD2' HD12 ' A' ' 48' ' ' LEU . 0.1 OUTLIER -55.97 -174.04 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.66 0 CA-C-O 124.874 2.273 . . . . 0.0 113.336 174.108 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.655 HD23 ' C ' ' A' ' 41' ' ' GLY . 0.0 OUTLIER -80.6 163.58 55.73 Favored Pre-proline 0 C--N 1.313 -1.016 0 O-C-N 119.837 -1.789 . . . . 0.0 110.723 -179.66 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -71.18 160.14 49.95 Favored 'Trans proline' 0 N--CA 1.446 -1.27 0 C-N-CA 122.06 1.84 . . . . 0.0 109.764 178.38 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 7.5 ttpt -50.95 99.04 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.469 0 C-N-CA 123.987 0.915 . . . . 0.0 110.324 177.082 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 104.92 85.64 1.86 Allowed Glycine 0 C--O 1.227 -0.316 0 CA-C-N 116.387 -0.37 . . . . 0.0 112.652 -174.569 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -166.02 165.21 18.09 Favored 'General case' 0 CA--C 1.517 -0.318 0 C-N-CA 124.205 1.002 . . . . 0.0 111.361 174.82 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 93.5 m -138.46 96.05 9.93 Favored Pre-proline 0 C--N 1.331 -0.227 0 CA-C-N 116.008 -0.542 . . . . 0.0 110.023 -177.944 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.53 ' HB3' HD21 ' A' ' 48' ' ' LEU . 18.4 Cg_endo -72.49 145.6 42.72 Favored 'Trans proline' 0 N--CA 1.452 -0.958 0 C-N-CA 122.355 2.036 . . . . 0.0 110.672 -179.883 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.484 HD12 HG21 ' A' ' 121' ' ' ILE . 7.1 mt -73.94 119.74 21.72 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.456 0 N-CA-C 108.338 -0.986 . . . . 0.0 108.338 -179.258 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 5.6 tppt? -81.5 135.36 35.6 Favored 'General case' 0 C--N 1.33 -0.265 0 N-CA-C 108.898 -0.778 . . . . 0.0 108.898 177.819 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.58 ' CD1' ' HB3' ' A' ' 118' ' ' CYS . 28.6 m-85 -113.55 -52.09 2.77 Favored 'General case' 0 C--N 1.327 -0.374 0 C-N-CA 124.276 1.031 . . . . 0.0 110.587 179.119 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 121.16 -3.1 11.5 Favored Glycine 0 C--O 1.223 -0.554 0 C-N-CA 123.642 0.639 . . . . 0.0 112.85 -175.07 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 16.2 mttt -101.87 130.37 48.33 Favored 'General case' 0 CA--C 1.502 -0.903 0 CA-C-N 118.173 0.987 . . . . 0.0 109.26 177.169 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 28.1 t -63.55 -12.2 30.61 Favored 'General case' 0 C--O 1.223 -0.307 0 O-C-N 124.665 1.228 . . . . 0.0 111.581 175.292 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 5.2 m-20 -86.99 -47.79 8.66 Favored 'General case' 0 N--CA 1.451 -0.413 0 C-N-CA 124.867 1.267 . . . . 0.0 110.615 178.697 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 71.6 m -74.68 -10.59 59.68 Favored 'General case' 0 N--CA 1.454 -0.23 0 O-C-N 123.967 0.792 . . . . 0.0 112.731 173.984 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.6 t70 -93.24 -40.12 10.61 Favored 'General case' 0 CA--C 1.507 -0.674 0 C-N-CA 124.795 1.238 . . . . 0.0 110.151 176.513 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -48.48 158.77 0.58 Allowed Pre-proline 0 CA--C 1.539 0.53 0 CA-C-O 121.827 0.822 . . . . 0.0 111.825 179.724 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 22.3 Cg_endo -70.76 132.94 22.69 Favored 'Trans proline' 0 N--CA 1.442 -1.534 0 C-N-CA 120.823 1.015 . . . . 0.0 113.336 174.802 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.496 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 17.8 Cg_endo -71.45 170.78 17.61 Favored 'Trans proline' 0 N--CA 1.446 -1.301 0 C-N-CA 123.404 2.736 . . . . 0.0 111.057 178.709 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.8 tptt -124.46 53.0 1.47 Allowed 'General case' 0 C--O 1.205 -1.243 0 O-C-N 121.417 -0.802 . . . . 0.0 108.954 178.061 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.475 ' CD2' ' CG ' ' A' ' 37' ' ' TRP . 52.3 t-80 -78.89 161.0 27.03 Favored 'General case' 0 C--N 1.326 -0.451 0 O-C-N 119.333 -2.104 . . . . 0.0 111.744 178.869 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -171.78 -163.93 0.29 Allowed 'General case' 0 CA--C 1.504 -0.812 0 O-C-N 117.813 -3.054 . . . . 0.0 109.396 175.292 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -70.31 53.66 0.14 Allowed 'General case' 0 C--O 1.215 -0.723 0 N-CA-C 113.381 0.882 . . . . 0.0 113.381 172.164 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . 0.402 ' O ' ' C ' ' A' ' 72' ' ' GLY . 3.5 m-20 -177.49 74.48 0.02 OUTLIER 'General case' 0 CA--C 1.507 -0.684 0 N-CA-C 106.208 -1.775 . . . . 0.0 106.208 -178.634 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.424 ' O ' ' CE2' ' A' ' 79' ' ' TYR . . . -11.68 -70.27 0.01 OUTLIER Glycine 0 C--O 1.219 -0.79 0 C-N-CA 125.175 1.369 . . . . 0.0 114.305 178.827 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 18.3 t30 -121.96 78.61 1.49 Allowed 'General case' 0 CA--C 1.546 0.827 0 C-N-CA 124.924 1.29 . . . . 0.0 112.68 165.192 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -69.13 -98.8 0.04 OUTLIER Glycine 0 CA--C 1.521 0.436 0 CA-C-O 122.74 1.189 . . . . 0.0 111.546 179.457 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 18.0 mttt -72.12 -102.57 0.01 OUTLIER 'General case' 0 C--O 1.222 -0.38 0 CA-C-O 122.827 1.299 . . . . 0.0 111.059 176.779 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.496 HG23 ' O ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -112.29 14.75 20.51 Favored 'General case' 0 C--N 1.323 -0.547 0 O-C-N 121.104 -0.997 . . . . 0.0 110.844 178.87 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 96.4 m-20 -31.72 100.21 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.561 0 C-N-CA 124.514 1.126 . . . . 0.0 112.202 -178.04 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.433 ' CD2' ' H ' ' A' ' 78' ' ' HIS . 6.1 p80 -87.7 45.45 1.28 Allowed 'General case' 0 CA--C 1.516 -0.329 0 O-C-N 119.942 -1.724 . . . . 0.0 108.174 -172.388 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.49 ' CE1' ' HB2' ' A' ' 27' ' ' ASP . 40.7 p90 -71.07 135.52 47.78 Favored 'General case' 0 N--CA 1.44 -0.953 0 C-N-CA 124.42 1.088 . . . . 0.0 110.398 -178.922 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.464 ' HG ' HG22 ' A' ' 111' ' ' THR . 0.3 OUTLIER -71.5 138.2 48.75 Favored 'General case' 0 C--O 1.218 -0.57 0 N-CA-C 109.117 -0.697 . . . . 0.0 109.117 176.327 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.989 HD13 ' HB2' ' A' ' 35' ' ' PRO . 0.4 OUTLIER -130.54 141.92 50.47 Favored 'General case' 0 C--N 1.319 -0.738 0 N-CA-C 106.853 -1.536 . . . . 0.0 106.853 176.432 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.0 pm0 -104.03 167.69 9.6 Favored 'General case' 0 N--CA 1.434 -1.228 0 CA-C-O 121.974 0.893 . . . . 0.0 112.628 174.563 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.645 ' CZ ' ' HB2' ' A' ' 23' ' ' ALA . 31.9 t80 -154.31 139.33 11.83 Favored Pre-proline 0 C--O 1.225 -0.209 0 O-C-N 120.974 -1.079 . . . . 0.0 113.368 178.636 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.519 ' HD2' ' CD1' ' A' ' 83' ' ' PHE . 19.3 Cg_endo -74.49 94.89 0.92 Allowed 'Trans proline' 0 N--CA 1.452 -0.913 0 C-N-CA 124.346 3.364 . . . . 0.0 110.832 -175.321 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.463 ' HA ' ' OD1' ' A' ' 19' ' ' ASN . 6.3 t -98.86 105.24 17.37 Favored 'General case' 0 CA--C 1.508 -0.64 0 O-C-N 124.879 1.362 . . . . 0.0 112.577 -179.438 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.526 ' CE1' ' CD1' ' A' ' 92' ' ' TYR . 56.4 m-85 -82.35 159.55 64.38 Favored Pre-proline 0 N--CA 1.446 -0.632 0 CA-C-N 115.543 -0.753 . . . . 0.0 111.321 -179.414 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 13.8 Cg_endo -76.55 -36.28 1.75 Allowed 'Trans proline' 0 CA--C 1.498 -1.309 0 C-N-CA 122.283 1.989 . . . . 0.0 112.973 178.438 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.5 m-20 -45.87 -31.14 1.98 Allowed 'General case' 0 N--CA 1.468 0.439 0 O-C-N 125.016 1.448 . . . . 0.0 110.406 176.974 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.15 17.69 68.87 Favored Glycine 0 N--CA 1.438 -1.193 0 N-CA-C 111.195 -0.762 . . . . 0.0 111.195 177.374 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 2.6 p-80 -82.66 140.99 32.83 Favored 'General case' 0 N--CA 1.439 -0.978 0 N-CA-C 108.447 -0.946 . . . . 0.0 108.447 178.399 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 19.9 t0 -72.33 85.63 1.09 Allowed 'General case' 0 C--N 1.324 -0.537 0 N-CA-C 108.249 -1.019 . . . . 0.0 108.249 175.369 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.526 ' CD1' ' CE1' ' A' ' 86' ' ' PHE . 70.8 t80 -40.82 151.91 0.05 Allowed 'General case' 0 C--O 1.22 -0.472 0 CA-C-O 122.655 1.217 . . . . 0.0 111.57 -179.357 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -80.71 64.99 5.69 Favored 'General case' 0 C--N 1.314 -0.972 0 O-C-N 119.153 -2.217 . . . . 0.0 110.541 177.211 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.477 ' CD2' ' HZ ' ' A' ' 83' ' ' PHE . 33.2 p90 -82.2 -12.27 58.21 Favored 'General case' 0 N--CA 1.448 -0.566 0 CA-C-O 118.17 -0.919 . . . . 0.0 110.732 178.678 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 30.7 t0 -97.88 -30.91 12.48 Favored 'General case' 0 C--N 1.331 -0.236 0 CA-C-O 123.782 1.753 . . . . 0.0 110.485 179.658 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 69.2 m -80.3 108.92 14.31 Favored 'General case' 0 N--CA 1.449 -0.498 0 O-C-N 119.662 -1.899 . . . . 0.0 109.492 178.917 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -58.25 -48.56 80.04 Favored 'General case' 0 CA--C 1.516 -0.345 0 CA-C-O 121.611 0.72 . . . . 0.0 111.135 178.231 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.432 ' HA ' ' HA ' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -137.81 125.25 13.81 Favored Pre-proline 0 N--CA 1.438 -1.058 0 CA-C-N 114.62 -1.173 . . . . 0.0 110.105 -175.729 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.432 ' HA ' ' HA ' ' A' ' 98' ' ' LYS . 25.3 Cg_endo -71.75 175.02 44.07 Favored 'Cis proline' 0 N--CA 1.457 -0.651 0 C-N-CA 122.819 -1.742 . . . . 0.0 110.84 -3.471 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -136.85 130.12 31.29 Favored 'General case' 0 C--N 1.326 -0.454 0 C-N-CA 123.919 0.888 . . . . 0.0 109.49 178.409 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.465 ' HB3' ' CE1' ' A' ' 92' ' ' TYR . 0.4 OUTLIER -78.86 -177.99 5.79 Favored 'General case' 0 C--O 1.238 0.479 0 O-C-N 125.59 1.806 . . . . 0.0 112.863 177.061 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.6 OUTLIER -76.74 152.36 82.91 Favored Pre-proline 0 N--CA 1.451 -0.425 0 N-CA-C 113.423 0.897 . . . . 0.0 113.423 172.18 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 25.9 Cg_endo -69.92 -165.07 0.15 Allowed 'Trans proline' 0 N--CA 1.452 -0.943 0 C-N-CA 122.372 2.048 . . . . 0.0 112.688 175.568 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -131.52 158.19 22.67 Favored Glycine 0 CA--C 1.526 0.772 0 O-C-N 121.43 -0.794 . . . . 0.0 112.799 176.565 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -76.02 -42.78 0.37 Allowed 'Trans proline' 0 N--CA 1.455 -0.789 0 C-N-CA 122.394 2.063 . . . . 0.0 111.313 178.244 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.897 ' HB1' ' CG2' ' A' ' 120' ' ' ILE . . . -92.72 145.56 24.32 Favored 'General case' 0 N--CA 1.442 -0.872 0 C-N-CA 123.23 0.612 . . . . 0.0 110.709 177.069 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.491 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 4.4 mtm-85 -145.4 149.5 34.85 Favored 'General case' 0 CA--C 1.495 -1.136 0 CA-C-O 117.104 -1.427 . . . . 0.0 111.597 177.875 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.644 HG23 ' CD1' ' A' ' 117' ' ' PHE . 2.3 p -83.65 110.43 18.41 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.537 0 O-C-N 124.136 0.898 . . . . 0.0 110.434 178.641 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.411 HG12 ' CE2' ' A' ' 38' ' ' PHE . 1.7 mp -95.93 125.06 48.83 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.104 0 N-CA-C 105.689 -1.967 . . . . 0.0 105.689 -174.735 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.615 ' CZ ' HD11 ' A' ' 81' ' ' LEU . 8.6 p90 -146.23 154.97 42.34 Favored 'General case' 0 C--N 1.321 -0.67 0 CA-C-O 121.782 0.801 . . . . 0.0 109.061 -179.864 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.464 HG22 ' HG ' ' A' ' 80' ' ' LEU . 1.8 p -91.79 164.8 13.57 Favored 'General case' 0 C--N 1.317 -0.817 0 O-C-N 121.931 -0.48 . . . . 0.0 109.734 -179.88 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.511 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -110.88 155.77 41.84 Favored Pre-proline 0 CA--C 1.544 0.729 0 O-C-N 121.759 -0.588 . . . . 0.0 110.911 179.18 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.511 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 19.3 Cg_endo -73.18 -50.17 0.2 OUTLIER 'Cis proline' 0 CA--C 1.5 -1.188 0 C-N-CA 123.544 -1.44 . . . . 0.0 111.099 -8.249 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.541 ' HB3' HG23 ' A' ' 116' ' ' VAL . 1.4 m-20 -46.32 110.51 0.28 Allowed 'General case' 0 CA--C 1.501 -0.912 0 CA-C-O 115.999 -1.953 . . . . 0.0 108.846 178.295 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.665 ' HE2' HD13 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -67.71 68.36 0.1 Allowed 'General case' 0 CA--C 1.511 -0.549 0 O-C-N 125.904 2.003 . . . . 0.0 108.154 -178.49 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.541 HG23 ' HB3' ' A' ' 114' ' ' ASN . 72.0 t -73.66 71.43 0.24 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.577 0 N-CA-C 105.358 -2.089 . . . . 0.0 105.358 -177.763 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.644 ' CD1' HG23 ' A' ' 108' ' ' VAL . 29.9 t80 -39.44 116.44 0.61 Allowed 'General case' 0 N--CA 1.441 -0.88 0 C-N-CA 125.832 1.653 . . . . 0.0 109.352 179.597 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . 0.58 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 4.6 m -89.09 -46.55 8.75 Favored 'General case' 0 N--CA 1.436 -1.133 0 N-CA-C 108.494 -0.928 . . . . 0.0 108.494 -178.978 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.598 ' HA2' ' CZ ' ' A' ' 117' ' ' PHE . . . 155.08 -171.62 33.34 Favored Glycine 0 N--CA 1.448 -0.565 0 N-CA-C 111.545 -0.622 . . . . 0.0 111.545 -179.235 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.897 ' CG2' ' HB1' ' A' ' 106' ' ' ALA . 2.8 mp -109.65 129.69 64.06 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.269 0 N-CA-C 107.531 -1.285 . . . . 0.0 107.531 -177.847 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.716 HG22 HD12 ' A' ' 133' ' ' LEU . 8.9 pt -102.55 155.42 5.09 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.093 0 CA-C-N 119.535 1.061 . . . . 0.0 108.318 -179.515 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.665 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . . . -175.51 157.98 2.18 Favored 'General case' 0 C--N 1.324 -0.518 0 CA-C-O 122.879 1.324 . . . . 0.0 110.07 175.561 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.495 ' CE1' ' HG ' ' A' ' 131' ' ' LEU . 4.0 m-70 -89.8 94.31 9.78 Favored 'General case' 0 N--CA 1.447 -0.579 0 O-C-N 121.31 -0.869 . . . . 0.0 108.69 -177.221 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.492 ' O ' HG23 ' A' ' 124' ' ' THR . 1.4 t -97.06 37.87 1.28 Allowed 'General case' 0 N--CA 1.474 0.734 0 CA-C-O 123.643 1.687 . . . . 0.0 111.808 179.993 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.5 ttpp -102.86 -28.21 12.19 Favored 'General case' 0 C--O 1.219 -0.517 0 O-C-N 120.519 -1.363 . . . . 0.0 111.313 179.024 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 1.3 tm-20 -172.35 -68.1 0.02 OUTLIER 'General case' 0 C--O 1.219 -0.517 0 O-C-N 124.145 0.903 . . . . 0.0 109.954 178.084 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -155.3 -44.85 0.08 Allowed 'General case' 0 N--CA 1.454 -0.264 0 C-N-CA 124.056 0.942 . . . . 0.0 110.649 -179.832 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 4.7 tt0 -153.3 79.56 1.18 Allowed 'General case' 0 N--CA 1.446 -0.646 0 C-N-CA 124.671 1.189 . . . . 0.0 109.106 -179.884 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -129.58 -104.8 1.13 Allowed Glycine 0 N--CA 1.459 0.212 0 N-CA-C 110.197 -1.161 . . . . 0.0 110.197 176.496 . . . . . . . . 1 1 . 1 . 012 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -89.14 150.92 22.48 Favored 'General case' 0 CA--C 1.509 -0.61 0 O-C-N 121.845 -0.797 . . . . 0.0 111.055 -179.984 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.563 HD23 ' H ' ' A' ' 132' ' ' LYS . 0.5 OUTLIER -103.23 145.91 29.23 Favored 'General case' 0 C--N 1.325 -0.482 0 CA-C-O 121.226 0.536 . . . . 0.0 109.633 178.051 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.563 ' H ' HD23 ' A' ' 131' ' ' LEU . 0.1 OUTLIER -154.65 169.84 22.94 Favored 'General case' 0 CA--C 1.507 -0.684 0 C-N-CA 125.318 1.447 . . . . 0.0 109.931 179.464 . . . . . . . . 3 3 . 1 . 012 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.716 HD12 HG22 ' A' ' 121' ' ' ILE . 7.2 tp -83.8 147.46 27.57 Favored 'General case' 0 C--N 1.324 -0.527 0 N-CA-C 108.176 -1.046 . . . . 0.0 108.176 176.612 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . 0.574 ' SG ' HG22 ' A' ' 120' ' ' ILE . 99.5 m -60.18 -177.67 0.07 Allowed 'General case' 0 N--CA 1.45 -0.474 0 CA-C-O 123.708 1.718 . . . . 0.0 109.985 176.219 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -162.96 109.43 1.18 Allowed 'General case' 0 C--N 1.319 -0.746 0 O-C-N 120.588 -1.32 . . . . 0.0 107.475 -177.916 . . . . . . . . 2 2 . 1 . 012 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 0.2 OUTLIER . . . . . 0 C--O 1.254 1.303 0 CA-C-O 115.335 -2.269 . . . . 0.0 111.438 174.227 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.488 1.473 0 N-CA-C 108.352 -0.981 . . . . 0.0 108.352 . . . . . . . . . 0 0 . 1 . 013 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 4.1 p -67.26 139.94 20.16 Favored 'Isoleucine or valine' 0 C--O 1.237 0.425 0 N-CA-C 108.344 -0.984 . . . . 0.0 108.344 178.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.408 HG23 ' HA ' ' A' ' 12' ' ' ASN . 2.5 m -98.78 118.34 35.3 Favored 'General case' 0 C--N 1.317 -0.812 0 C-N-CA 124.26 1.024 . . . . 0.0 108.944 -176.219 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.413 ' CE2' ' ND1' ' A' ' 136' ' ' HIS . 28.6 m95 -82.35 137.07 34.87 Favored 'General case' 0 CA--C 1.506 -0.716 0 O-C-N 120.851 -1.156 . . . . 0.0 109.024 -172.833 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -127.14 132.12 50.62 Favored 'General case' 0 CA--C 1.504 -0.808 0 CA-C-O 122.115 0.959 . . . . 0.0 108.43 -176.265 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.482 ' SG ' ' HB3' ' A' ' 122' ' ' ALA . 0.0 OUTLIER -121.6 66.68 0.89 Allowed 'General case' 0 N--CA 1.45 -0.43 0 CA-C-N 115.08 -0.964 . . . . 0.0 112.707 176.919 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 42.44 56.2 4.21 Favored Glycine 0 N--CA 1.471 1.019 0 O-C-N 124.061 0.851 . . . . 0.0 113.28 -176.673 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -168.36 -88.69 0.07 OUTLIER Glycine 0 C--O 1.226 -0.387 0 N-CA-C 111.162 -0.775 . . . . 0.0 111.162 -175.607 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 32.5 mt -132.14 165.16 24.7 Favored 'General case' 0 C--O 1.233 0.205 0 C-N-CA 125.304 1.441 . . . . 0.0 109.983 177.592 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -90.83 111.04 22.27 Favored 'General case' 0 C--O 1.223 -0.336 0 C-N-CA 124.48 1.112 . . . . 0.0 110.137 179.197 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . . . . . . . . . 84.4 m-85 -89.64 111.2 22.09 Favored 'General case' 0 C--O 1.238 0.485 0 C-N-CA 130.635 3.574 . . . . 0.0 109.067 -179.801 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.408 ' HA ' HG23 ' A' ' 3' ' ' THR . 0.1 OUTLIER -54.6 122.16 10.0 Favored 'General case' 0 C--O 1.22 -0.458 0 N-CA-C 108.769 -0.826 . . . . 0.0 108.769 176.374 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.447 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 6.9 tp-100 -55.12 -48.33 73.78 Favored 'General case' 0 C--O 1.215 -0.739 0 C-N-CA 118.754 -1.178 . . . . 0.0 113.227 177.482 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.2 t-20 -48.94 -37.21 19.33 Favored 'General case' 0 C--O 1.204 -1.301 0 N-CA-C 114.175 1.176 . . . . 0.0 114.175 173.903 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 7.5 mttp -71.61 -42.08 68.11 Favored 'General case' 0 C--O 1.21 -1.021 0 CA-C-O 116.369 -1.777 . . . . 0.0 113.132 167.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.528 ' HA ' HG21 ' A' ' 85' ' ' THR . . . -51.98 -48.27 64.45 Favored 'General case' 0 C--N 1.313 -1.02 0 CA-C-N 122.828 2.558 . . . . 0.0 113.475 172.984 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 8.7 pt-20 -74.5 -47.79 31.06 Favored 'General case' 0 CA--C 1.541 0.622 0 CA-C-N 119.0 0.818 . . . . 0.0 111.753 172.048 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 38.0 t -66.55 -55.73 14.09 Favored 'General case' 0 N--CA 1.481 1.098 0 O-C-N 119.738 -1.851 . . . . 0.0 112.301 -175.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.5 t-20 -40.5 -46.15 2.4 Favored 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 124.711 1.205 . . . . 0.0 110.894 169.474 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.435 ' O ' ' HB3' ' A' ' 23' ' ' ALA . 0.1 OUTLIER -76.16 -28.87 57.54 Favored 'General case' 0 N--CA 1.471 0.604 0 C-N-CA 126.976 2.11 . . . . 0.0 116.437 174.981 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 7.7 m170 -54.68 -35.6 63.74 Favored 'General case' 0 N--CA 1.483 1.191 0 C-N-CA 127.802 2.441 . . . . 0.0 111.037 177.572 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -75.91 -42.6 48.51 Favored 'General case' 0 N--CA 1.451 -0.379 0 C-N-CA 126.569 1.948 . . . . 0.0 112.506 174.325 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.596 ' HB1' ' HG3' ' A' ' 35' ' ' PRO . . . -45.65 127.6 6.54 Favored Pre-proline 0 CA--C 1.542 0.638 0 C-N-CA 127.318 2.247 . . . . 0.0 111.844 175.037 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -66.28 146.66 81.7 Favored 'Trans proline' 0 N--CA 1.445 -1.346 0 C-N-CA 122.833 2.355 . . . . 0.0 111.272 -175.44 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.535 HD13 ' CE2' ' A' ' 112' ' ' TYR . 0.6 OUTLIER -79.72 94.57 5.76 Favored 'General case' 0 CA--C 1.535 0.369 0 CA-C-N 115.943 -0.571 . . . . 0.0 111.613 -179.781 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 1.6 m 179.78 167.96 1.2 Allowed 'General case' 0 C--N 1.328 -0.348 0 C-N-CA 125.711 1.604 . . . . 0.0 110.665 -174.926 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.453 ' HA ' ' HA ' ' A' ' 36' ' ' HIS . 0.3 OUTLIER -108.71 118.29 36.41 Favored 'General case' 0 CA--C 1.51 -0.594 0 C-N-CA 125.988 1.715 . . . . 0.0 109.169 175.12 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 55.27 62.39 6.34 Favored Glycine 0 CA--C 1.522 0.495 0 O-C-N 123.663 0.602 . . . . 0.0 112.713 171.233 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.1 mmtt -145.73 20.68 1.48 Allowed 'General case' 0 N--CA 1.481 1.115 0 C-N-CA 125.755 1.622 . . . . 0.0 115.243 -176.306 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 45.2 p -118.42 158.3 25.56 Favored 'General case' 0 C--N 1.318 -0.782 0 C-N-CA 125.715 1.606 . . . . 0.0 108.513 179.335 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.45 ' HA3' ' O ' ' A' ' 95' ' ' ASP . . . -50.52 -55.01 18.46 Favored Glycine 0 CA--C 1.504 -0.596 0 N-CA-C 116.222 1.249 . . . . 0.0 116.222 -177.02 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 13.5 t -62.72 -62.06 1.99 Allowed 'General case' 0 N--CA 1.444 -0.738 0 CA-C-O 116.695 -1.621 . . . . 0.0 112.896 171.057 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 160.22 -42.15 0.0 OUTLIER 'General case' 0 N--CA 1.495 1.78 0 C-N-CA 131.427 3.891 . . . . 0.0 115.963 178.478 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.511 ' CD2' ' HD3' ' A' ' 84' ' ' PRO . 86.0 m-85 -78.47 147.32 71.67 Favored Pre-proline 0 CA--C 1.547 0.859 0 C-N-CA 125.182 1.393 . . . . 0.0 113.999 -177.954 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.596 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 35.1 Cg_endo -71.84 162.28 89.64 Favored 'Cis proline' 0 N--CA 1.441 -1.603 0 CA-C-N 120.626 1.259 . . . . 0.0 110.609 -2.725 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.453 ' HA ' ' HA ' ' A' ' 27' ' ' ASP . 1.6 p80 -139.36 173.65 11.33 Favored 'General case' 0 C--N 1.316 -0.848 0 CA-C-N 113.16 -1.836 . . . . 0.0 108.068 -177.14 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.82 ' CH2' HG22 ' A' ' 39' ' ' THR . 19.7 t90 -75.96 138.47 40.99 Favored 'General case' 0 N--CA 1.443 -0.791 0 CA-C-O 123.222 1.487 . . . . 0.0 110.78 173.298 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.48 ' CE2' HG21 ' A' ' 109' ' ' ILE . 28.4 t80 -106.89 91.83 3.83 Favored 'General case' 0 N--CA 1.419 -1.994 0 C-N-CA 130.297 3.439 . . . . 0.0 104.688 177.712 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.82 HG22 ' CH2' ' A' ' 37' ' ' TRP . 80.4 p -41.47 -37.98 1.18 Allowed 'General case' 0 N--CA 1.471 0.616 0 CA-C-N 112.794 -2.003 . . . . 0.0 111.851 164.162 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.466 ' HA ' ' CZ ' ' A' ' 38' ' ' PHE . 65.8 t30 59.31 17.12 5.53 Favored 'General case' 0 C--O 1.213 -0.842 0 CA-C-N 118.901 0.773 . . . . 0.0 111.995 179.986 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.482 ' HA2' ' NE ' ' A' ' 52' ' ' ARG . . . 107.38 -43.3 1.72 Allowed Glycine 0 N--CA 1.44 -1.085 0 CA-C-O 115.132 -3.038 . . . . 0.0 114.62 -166.01 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 89.2 m-85 -45.94 154.85 0.21 Allowed 'General case' 0 N--CA 1.481 1.096 0 C-N-CA 128.789 2.836 . . . . 0.0 111.667 178.032 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 1.7 m-20 -82.04 -34.7 29.39 Favored 'General case' 0 N--CA 1.478 0.973 0 N-CA-C 113.437 0.903 . . . . 0.0 113.437 178.282 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.538 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -175.95 -68.38 0.06 OUTLIER Glycine 0 CA--C 1.528 0.848 0 C-N-CA 126.199 1.856 . . . . 0.0 113.036 -175.815 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . 0.414 ' OD2' ' HE2' ' A' ' 67' ' ' LYS . 0.1 OUTLIER -118.78 -62.73 1.49 Allowed 'General case' 0 N--CA 1.476 0.866 0 C-N-CA 127.188 2.195 . . . . 0.0 113.955 -176.322 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -64.39 -168.54 1.59 Allowed Glycine 0 N--CA 1.446 -0.651 0 C-N-CA 125.732 1.635 . . . . 0.0 111.021 178.12 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 43.8 pttt -59.06 -172.15 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.728 0 CA-C-O 124.696 2.189 . . . . 0.0 113.631 173.342 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.601 ' H ' HD12 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -87.41 170.02 12.97 Favored Pre-proline 0 C--N 1.316 -0.852 0 CA-C-N 114.333 -1.303 . . . . 0.0 111.947 -177.755 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -62.59 164.68 17.59 Favored 'Trans proline' 0 N--CA 1.44 -1.662 0 CA-C-O 123.093 1.205 . . . . 0.0 109.955 177.26 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.13 102.06 0.12 Allowed 'General case' 0 C--O 1.218 -0.58 0 O-C-N 120.307 -1.495 . . . . 0.0 110.695 170.333 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.08 78.35 1.4 Allowed Glycine 0 N--CA 1.466 0.638 0 N-CA-C 111.213 -0.755 . . . . 0.0 111.213 -176.756 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.482 ' NE ' ' HA2' ' A' ' 41' ' ' GLY . 0.4 OUTLIER -148.93 154.48 39.48 Favored 'General case' 0 CA--C 1.516 -0.352 0 C-N-CA 124.303 1.041 . . . . 0.0 109.96 170.974 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 28.9 m -124.72 101.46 33.2 Favored Pre-proline 0 CA--C 1.543 0.686 0 C-N-CA 125.087 1.355 . . . . 0.0 108.882 175.829 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.533 ' HG3' HD21 ' A' ' 48' ' ' LEU . 32.5 Cg_endo -69.22 148.9 69.6 Favored 'Trans proline' 0 N--CA 1.444 -1.437 0 C-N-CA 123.316 2.677 . . . . 0.0 111.078 172.518 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 4.5 mt -61.19 118.38 3.73 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.434 0 N-CA-C 106.813 -1.551 . . . . 0.0 106.813 175.378 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 2.0 tppt? -86.52 132.29 33.96 Favored 'General case' 0 C--N 1.332 -0.179 0 O-C-N 121.611 -0.681 . . . . 0.0 109.516 174.111 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.57 ' CD1' ' HB3' ' A' ' 118' ' ' CYS . 7.9 m-85 -114.84 -36.32 4.52 Favored 'General case' 0 N--CA 1.474 0.753 0 C-N-CA 126.518 1.927 . . . . 0.0 112.495 178.409 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.47 0.42 55.59 Favored Glycine 0 N--CA 1.474 1.221 0 C-N-CA 125.494 1.521 . . . . 0.0 114.114 -172.847 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -100.45 134.78 42.88 Favored 'General case' 0 CA--C 1.506 -0.726 0 C-N-CA 123.939 0.896 . . . . 0.0 111.299 175.315 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 79.6 p -68.91 -8.78 47.43 Favored 'General case' 0 N--CA 1.469 0.485 0 C-N-CA 124.092 0.957 . . . . 0.0 113.502 176.939 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.708 ' HB2' HG21 ' A' ' 111' ' ' THR . 0.0 OUTLIER -84.03 -52.3 6.42 Favored 'General case' 0 N--CA 1.47 0.575 0 C-N-CA 126.926 2.09 . . . . 0.0 108.977 176.091 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.438 ' HB2' ' CD2' ' A' ' 57' ' ' PHE . 3.7 m -78.75 -15.49 58.38 Favored 'General case' 0 CA--C 1.534 0.355 0 N-CA-C 113.603 0.964 . . . . 0.0 113.603 -179.28 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 25.9 t0 -86.05 -30.8 22.35 Favored 'General case' 0 N--CA 1.471 0.579 0 C-N-CA 127.212 2.205 . . . . 0.0 111.977 167.888 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -55.43 153.86 13.3 Favored Pre-proline 0 CA--C 1.536 0.43 0 CA-C-N 119.463 1.029 . . . . 0.0 113.76 179.111 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 20.0 Cg_endo -67.11 136.85 42.21 Favored 'Trans proline' 0 CA--C 1.553 1.43 0 C-N-CA 120.363 0.709 . . . . 0.0 111.789 173.628 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.449 ' HB3' ' HA ' ' A' ' 79' ' ' TYR . 19.6 Cg_endo -67.09 174.76 6.46 Favored 'Trans proline' 0 N--CA 1.459 -0.539 1 C-N-CA 125.428 4.085 . . . . 0.0 113.225 175.421 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . 0.414 ' HE2' ' OD2' ' A' ' 45' ' ' ASP 0.355 4.2 mmtt -133.9 41.21 3.03 Favored 'General case' 0 N--CA 1.482 1.147 0 N-CA-C 116.073 1.879 . . . . 0.0 116.073 178.35 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.536 ' HA ' ' OD2' ' A' ' 77' ' ' ASP 0.312 56.3 t-80 -58.32 152.3 17.8 Favored 'General case' 0 C--O 1.218 -0.564 0 CA-C-O 124.798 2.237 . . . . 0.0 114.284 -177.527 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -148.56 -172.13 4.02 Favored 'General case' 0 CA--C 1.512 -0.51 0 O-C-N 119.777 -1.827 . . . . 0.0 111.026 179.147 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -79.02 69.79 5.25 Favored 'General case' 0 C--O 1.213 -0.821 0 O-C-N 121.151 -0.968 . . . . 0.0 112.002 172.626 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -170.03 -45.43 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.598 0 C-N-CA 124.158 0.983 . . . . 0.0 111.887 -179.738 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 133.98 -66.75 0.56 Allowed Glycine 0 C--O 1.204 -1.738 0 N-CA-C 108.95 -1.66 . . . . 0.0 108.95 -179.148 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.501 ' H ' ' ND2' ' A' ' 73' ' ' ASN . 0.1 OUTLIER -107.48 -3.24 19.65 Favored 'General case' 0 N--CA 1.48 1.049 0 C-N-CA 130.311 3.444 . . . . 0.0 113.417 -176.411 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 34.4 -122.13 0.42 Allowed Glycine 0 C--O 1.221 -0.712 0 C-N-CA 128.282 2.849 . . . . 0.0 113.783 -176.63 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 24.4 mttt -69.72 -79.02 0.06 Allowed 'General case' 0 N--CA 1.472 0.65 0 N-CA-C 115.209 1.559 . . . . 0.0 115.209 167.716 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.6 OUTLIER -123.45 11.22 9.26 Favored 'General case' 0 CA--C 1.504 -0.799 0 CA-C-O 116.676 -1.63 . . . . 0.0 111.957 -179.791 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.536 ' OD2' ' HA ' ' A' ' 68' ' ' HIS . 58.1 t0 -17.78 94.53 0.01 OUTLIER 'General case' 0 C--O 1.214 -0.792 0 C-N-CA 126.689 1.996 . . . . 0.0 114.293 -171.867 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.43 ' CD2' ' H ' ' A' ' 78' ' ' HIS . 19.2 p80 -84.32 11.47 8.32 Favored 'General case' 0 C--N 1.316 -0.865 0 N-CA-C 114.31 1.226 . . . . 0.0 114.31 -172.87 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.843 ' CZ ' HD21 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -43.87 162.42 0.02 OUTLIER 'General case' 0 N--CA 1.443 -0.776 0 C-N-CA 126.684 1.994 . . . . 0.0 113.223 169.372 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 1.0 OUTLIER -83.02 150.45 26.34 Favored 'General case' 0 N--CA 1.427 -1.585 0 CA-C-N 113.236 -1.802 . . . . 0.0 110.441 169.641 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.843 HD21 ' CZ ' ' A' ' 79' ' ' TYR . 1.6 mt -132.42 130.47 40.65 Favored 'General case' 0 CA--C 1.51 -0.563 0 C-N-CA 123.743 0.817 . . . . 0.0 109.218 173.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -94.06 155.19 17.23 Favored 'General case' 0 N--CA 1.443 -0.787 0 C-N-CA 123.734 0.814 . . . . 0.0 112.088 176.955 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.463 ' HZ ' ' CE2' ' A' ' 94' ' ' PHE . 59.8 t80 -149.05 127.16 5.82 Favored Pre-proline 0 CA--C 1.551 1.004 0 N-CA-C 114.021 1.119 . . . . 0.0 114.021 179.146 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.511 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 23.4 Cg_endo -71.59 94.78 0.69 Allowed 'Trans proline' 0 N--CA 1.45 -1.065 1 C-N-CA 126.062 4.508 . . . . 0.0 110.119 -176.093 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.528 HG21 ' HA ' ' A' ' 16' ' ' ALA . 6.2 t -94.49 114.3 26.28 Favored 'General case' 0 C--N 1.323 -0.565 0 CA-C-N 113.233 -1.803 . . . . 0.0 110.127 178.719 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 82.0 m-85 -82.31 154.25 69.15 Favored Pre-proline 0 CA--C 1.54 0.581 0 CA-C-N 115.854 -0.612 . . . . 0.0 112.136 178.268 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 24.3 Cg_endo -73.31 -35.12 5.28 Favored 'Trans proline' 0 N--CA 1.453 -0.872 0 C-N-CA 122.953 2.435 . . . . 0.0 115.204 177.943 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -50.79 -30.95 15.47 Favored 'General case' 0 N--CA 1.484 1.265 0 C-N-CA 128.182 2.593 . . . . 0.0 110.983 175.082 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 82.27 11.53 82.08 Favored Glycine 0 CA--C 1.499 -0.955 0 CA-C-N 114.568 -1.197 . . . . 0.0 115.067 177.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . 0.255 5.2 p-80 -62.36 132.37 52.38 Favored 'General case' 0 N--CA 1.43 -1.434 0 N-CA-C 106.096 -1.816 . . . . 0.0 106.096 171.834 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 12.1 t70 -56.76 99.51 0.04 OUTLIER 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 105.788 -1.93 . . . . 0.0 105.788 157.359 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 8.8 t80 -47.07 137.02 8.06 Favored 'General case' 0 N--CA 1.436 -1.153 0 O-C-N 118.823 -2.423 . . . . 0.0 108.484 169.021 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -75.36 59.01 1.02 Allowed 'General case' 0 C--N 1.324 -0.536 0 O-C-N 120.786 -1.196 . . . . 0.0 112.326 171.26 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.463 ' CE2' ' HZ ' ' A' ' 83' ' ' PHE . 32.6 p90 -71.72 -29.43 64.54 Favored 'General case' 0 C--O 1.219 -0.506 0 C-N-CA 124.794 1.237 . . . . 0.0 112.644 173.884 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.45 ' O ' ' HA3' ' A' ' 31' ' ' GLY . 1.1 t70 -75.65 -38.9 58.46 Favored 'General case' 0 N--CA 1.476 0.835 0 C-N-CA 126.527 1.931 . . . . 0.0 111.402 175.764 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.3 t -77.75 107.76 10.49 Favored 'General case' 0 C--N 1.33 -0.248 0 O-C-N 121.33 -0.856 . . . . 0.0 109.046 -176.315 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 21.5 pttt -60.35 -41.17 93.09 Favored 'General case' 0 N--CA 1.477 0.886 0 CA-C-O 122.593 1.187 . . . . 0.0 114.109 178.655 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -145.24 131.13 9.54 Favored Pre-proline 0 CA--C 1.537 0.468 0 CA-C-N 114.174 -1.376 . . . . 0.0 110.837 178.913 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 37.0 Cg_endo -67.67 165.21 70.39 Favored 'Cis proline' 0 N--CA 1.455 -0.771 0 O-C-N 123.283 1.149 . . . . 0.0 110.349 -11.102 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -124.37 148.5 47.49 Favored 'General case' 0 C--N 1.325 -0.476 0 C-N-CA 125.484 1.513 . . . . 0.0 107.712 177.681 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 10.9 tp10 -96.14 171.0 8.88 Favored 'General case' 0 C--N 1.319 -0.761 0 O-C-N 124.014 0.821 . . . . 0.0 109.577 169.2 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -46.5 152.17 0.91 Allowed Pre-proline 0 CA--C 1.543 0.708 0 C-N-CA 127.424 2.29 . . . . 0.0 111.865 168.038 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 38.2 Cg_endo -72.74 -84.77 0.0 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.336 0 C-N-CA 123.107 2.538 . . . . 0.0 112.284 176.972 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 138.48 146.07 4.93 Favored Glycine 0 CA--C 1.526 0.776 0 N-CA-C 110.069 -1.213 . . . . 0.0 110.069 -178.605 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 23.9 Cg_endo -76.62 -67.5 0.02 OUTLIER 'Trans proline' 0 N--CA 1.451 -1.0 0 C-N-CA 124.062 3.175 . . . . 0.0 112.162 179.905 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.405 ' HA ' ' HB2' ' A' ' 122' ' ' ALA . . . -68.99 132.16 46.23 Favored 'General case' 0 N--CA 1.449 -0.502 0 CA-C-O 123.125 1.44 . . . . 0.0 111.658 176.172 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -137.68 152.12 48.95 Favored 'General case' 0 C--N 1.32 -0.678 0 CA-C-N 113.615 -1.63 . . . . 0.0 110.194 -177.99 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.418 ' CG1' ' HB3' ' A' ' 83' ' ' PHE . 2.5 p -87.54 116.62 30.04 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.642 0 C-N-CA 125.247 1.419 . . . . 0.0 109.438 175.928 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.48 HG21 ' CE2' ' A' ' 38' ' ' PHE . 1.6 mp -104.22 115.64 46.52 Favored 'Isoleucine or valine' 0 C--N 1.317 -0.81 0 N-CA-C 104.877 -2.268 . . . . 0.0 104.877 -178.582 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . . . . . . . . . 10.2 p90 -126.81 156.22 41.63 Favored 'General case' 0 N--CA 1.438 -1.066 0 CA-C-N 114.48 -1.236 . . . . 0.0 108.467 177.245 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.708 HG21 ' HB2' ' A' ' 61' ' ' ASP . 3.2 p -82.98 166.48 18.79 Favored 'General case' 0 CA--C 1.505 -0.783 0 C-N-CA 124.844 1.258 . . . . 0.0 111.277 177.225 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.535 ' CE2' HD13 ' A' ' 25' ' ' LEU 0.276 8.7 t80 -109.94 158.49 34.86 Favored Pre-proline 0 CA--C 1.544 0.748 0 O-C-N 120.962 -1.086 . . . . 0.0 112.33 176.333 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.525 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 18.9 Cg_endo -69.01 -41.9 0.81 Allowed 'Cis proline' 0 C--N 1.348 0.516 0 N-CA-C 114.794 1.036 . . . . 0.0 114.794 -21.544 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.469 ' HB3' HG23 ' A' ' 116' ' ' VAL . 1.3 t-20 -50.37 106.48 0.12 Allowed 'General case' 0 CA--C 1.519 -0.241 0 C-N-CA 125.528 1.531 . . . . 0.0 108.92 170.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.503 ' HE2' HD21 ' A' ' 25' ' ' LEU . 2.3 mtmt -67.12 65.41 0.06 Allowed 'General case' 0 C--N 1.339 0.111 0 C-N-CA 127.959 2.503 . . . . 0.0 108.792 177.431 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.469 HG23 ' HB3' ' A' ' 114' ' ' ASN . 47.3 t -72.93 86.54 0.45 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.586 0 N-CA-C 103.254 -2.869 . . . . 0.0 103.254 175.951 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.451 ' CZ ' ' HA2' ' A' ' 119' ' ' GLY . 37.8 t80 -46.12 103.8 0.04 OUTLIER 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 129.142 2.977 . . . . 0.0 109.427 176.933 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . 0.57 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 22.4 m -80.21 -41.7 24.68 Favored 'General case' 0 N--CA 1.449 -0.492 0 CA-C-O 122.884 1.326 . . . . 0.0 110.447 -176.056 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.451 ' HA2' ' CZ ' ' A' ' 117' ' ' PHE . . . 159.44 -154.22 25.28 Favored Glycine 0 N--CA 1.433 -1.552 0 CA-C-N 113.651 -1.613 . . . . 0.0 110.09 -178.555 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.424 HD11 ' CB ' ' A' ' 16' ' ' ALA . 1.3 mm -123.08 147.99 27.12 Favored 'Isoleucine or valine' 0 N--CA 1.439 -1.016 0 N-CA-C 105.208 -2.145 . . . . 0.0 105.208 -179.092 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.418 HG12 ' CD1' ' A' ' 109' ' ' ILE . 4.3 pt -136.99 151.65 27.5 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.987 0 O-C-N 119.851 -1.781 . . . . 0.0 109.175 179.397 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.482 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . . . -166.14 159.68 15.5 Favored 'General case' 0 C--N 1.324 -0.5 0 CA-C-O 121.742 0.782 . . . . 0.0 110.355 176.747 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.428 ' CD2' HD13 ' A' ' 131' ' ' LEU . 32.9 m-70 -90.09 91.2 8.45 Favored 'General case' 0 C--O 1.221 -0.42 0 CA-C-N 115.579 -0.737 . . . . 0.0 110.673 -178.46 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.453 HG22 ' HD3' ' A' ' 132' ' ' LYS . 2.0 t -92.29 33.33 1.1 Allowed 'General case' 0 N--CA 1.491 1.588 0 CA-C-O 123.25 1.5 . . . . 0.0 112.944 -179.079 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -94.93 -33.95 12.58 Favored 'General case' 0 C--N 1.325 -0.477 0 O-C-N 120.905 -1.122 . . . . 0.0 112.019 179.69 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -170.73 -78.86 0.01 OUTLIER 'General case' 0 CA--C 1.544 0.745 0 C-N-CA 125.628 1.571 . . . . 0.0 109.566 -178.393 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.8 p30 -127.59 -58.65 1.24 Allowed 'General case' 0 CA--C 1.537 0.449 0 C-N-CA 129.28 3.032 . . . . 0.0 110.435 -176.9 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.3 mt-30 -160.95 74.73 0.51 Allowed 'General case' 0 CA--C 1.538 0.495 0 C-N-CA 126.671 1.988 . . . . 0.0 112.176 -176.226 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -122.4 -106.92 1.91 Allowed Glycine 0 N--CA 1.468 0.783 0 O-C-N 121.346 -0.846 . . . . 0.0 112.369 177.172 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -63.99 154.66 33.44 Favored 'General case' 0 C--N 1.323 -0.56 0 O-C-N 121.735 -0.862 . . . . 0.0 112.235 177.362 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.428 HD13 ' CD2' ' A' ' 123' ' ' HIS . 7.4 tp -125.59 135.06 51.79 Favored 'General case' 0 N--CA 1.449 -0.521 0 C-N-CA 124.925 1.29 . . . . 0.0 110.532 -178.271 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.453 ' HD3' HG22 ' A' ' 124' ' ' THR . 0.8 OUTLIER -147.35 166.42 27.18 Favored 'General case' 0 C--N 1.324 -0.506 0 CA-C-N 114.48 -1.236 . . . . 0.0 109.057 -177.416 . . . . . . . . 3 3 . 1 . 013 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . . . . . . . . . 14.7 tp -77.4 141.67 39.67 Favored 'General case' 0 C--N 1.324 -0.534 0 CA-C-N 114.962 -1.017 . . . . 0.0 109.036 173.946 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . 0.419 ' SG ' HG22 ' A' ' 120' ' ' ILE . 34.9 m -70.56 176.78 3.86 Favored 'General case' 0 C--N 1.325 -0.499 0 C-N-CA 126.448 1.899 . . . . 0.0 111.243 169.686 . . . . . . . . 2 2 . 1 . 013 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 92.5 p -142.37 100.45 3.7 Favored 'General case' 0 C--N 1.317 -0.819 0 N-CA-C 105.284 -2.117 . . . . 0.0 105.284 -177.866 . . . . . . . . 1 1 . 1 . 013 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.413 ' ND1' ' CE2' ' A' ' 4' ' ' TRP . 0.5 OUTLIER . . . . . 0 C--O 1.246 0.921 0 CA-C-O 114.972 -2.442 . . . . 0.0 114.671 165.022 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.472 ' H2 ' ' H ' ' A' ' 14' ' ' ASN . . . . . . . . 0 CA--C 1.51 -0.561 0 CA-C-O 118.061 -0.971 . . . . 0.0 109.214 . . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.655 HG22 ' HB2' ' A' ' 136' ' ' HIS . 11.0 p -51.56 136.64 11.0 Favored 'Isoleucine or valine' 0 N--CA 1.449 -0.485 0 O-C-N 124.583 1.177 . . . . 0.0 109.145 -178.871 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.55 HG21 HD23 ' A' ' 10' ' ' LEU . 1.1 m -84.46 112.38 20.33 Favored 'General case' 0 N--CA 1.439 -0.99 0 CA-C-O 121.546 0.688 . . . . 0.0 110.008 179.926 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.497 ' CG ' HG13 ' A' ' 120' ' ' ILE . 27.5 m95 -78.44 138.08 38.3 Favored 'General case' 0 N--CA 1.43 -1.462 0 C-N-CA 123.877 0.871 . . . . 0.0 111.248 175.089 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.2 m -120.16 120.52 36.43 Favored 'General case' 0 CA--C 1.499 -1.013 0 N-CA-C 109.541 -0.54 . . . . 0.0 109.541 -177.679 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.876 ' HB3' ' HB3' ' A' ' 122' ' ' ALA . 55.6 m -106.88 51.89 0.73 Allowed 'General case' 0 N--CA 1.448 -0.526 0 CA-C-N 116.397 -0.365 . . . . 0.0 110.581 178.916 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.743 ' HA3' HG21 ' A' ' 124' ' ' THR . . . 45.46 48.06 11.79 Favored Glycine 0 C--O 1.218 -0.863 0 O-C-N 123.951 0.782 . . . . 0.0 111.974 -176.964 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -162.2 -80.97 0.04 OUTLIER Glycine 0 C--O 1.225 -0.407 0 N-CA-C 110.472 -1.051 . . . . 0.0 110.472 -177.52 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 1.6 mt -127.39 163.91 23.01 Favored 'General case' 0 N--CA 1.451 -0.422 0 CA-C-O 121.148 0.499 . . . . 0.0 110.008 177.684 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.55 HD23 HG21 ' A' ' 3' ' ' THR . 9.2 mp -85.55 133.78 34.05 Favored 'General case' 0 N--CA 1.443 -0.8 0 CA-C-N 115.65 -0.704 . . . . 0.0 109.144 -179.353 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.504 ' CE2' ' CB ' ' A' ' 106' ' ' ALA . 64.5 m-85 -122.89 110.37 15.34 Favored 'General case' 0 N--CA 1.445 -0.705 0 C-N-CA 124.41 1.084 . . . . 0.0 110.17 -175.321 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.5 t30 -65.74 119.16 10.7 Favored 'General case' 0 N--CA 1.444 -0.751 0 O-C-N 120.335 -1.478 . . . . 0.0 108.517 -179.996 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.462 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 7.0 tp-100 -48.47 -42.46 32.77 Favored 'General case' 0 C--O 1.197 -1.687 0 CA-C-N 118.542 0.61 . . . . 0.0 111.518 179.491 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.472 ' H ' ' H2 ' ' A' ' 1' ' ' ALA . 21.2 t30 -48.8 -48.36 41.43 Favored 'General case' 0 C--O 1.189 -2.087 0 CA-C-N 117.785 0.266 . . . . 0.0 111.106 175.875 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 9.7 mttt -67.28 -34.94 78.45 Favored 'General case' 0 C--O 1.196 -1.742 0 O-C-N 120.641 -1.287 . . . . 0.0 112.502 171.277 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.37 -45.1 80.68 Favored 'General case' 0 C--N 1.31 -1.132 0 CA-C-N 121.337 1.88 . . . . 0.0 113.106 172.904 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.401 ' O ' ' CD2' ' A' ' 21' ' ' HIS . 4.2 pt-20 -85.94 -37.8 18.67 Favored 'General case' 0 C--O 1.206 -1.197 0 CA-C-O 118.575 -0.726 . . . . 0.0 109.14 178.733 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.4 ' CB ' ' O ' ' A' ' 14' ' ' ASN . 47.8 t -71.75 -61.29 1.83 Allowed 'General case' 0 CA--C 1.5 -0.947 0 C-N-CA 126.6 1.96 . . . . 0.0 108.819 -177.037 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.51 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 8.7 t-20 -40.97 -35.93 0.59 Allowed 'General case' 0 N--CA 1.445 -0.68 0 CA-C-N 119.285 0.948 . . . . 0.0 112.555 173.311 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.421 ' O ' ' HB3' ' A' ' 23' ' ' ALA . 0.2 OUTLIER -81.61 -37.96 26.77 Favored 'General case' 0 N--CA 1.439 -0.985 0 N-CA-C 114.383 1.253 . . . . 0.0 114.383 174.228 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.401 ' CD2' ' O ' ' A' ' 17' ' ' GLU . 5.5 m170 -44.09 -39.2 4.07 Favored 'General case' 0 N--CA 1.442 -0.83 0 C-N-CA 126.436 1.894 . . . . 0.0 109.518 178.652 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.51 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -73.41 -49.09 28.9 Favored 'General case' 0 N--CA 1.436 -1.161 0 CA-C-O 118.435 -0.793 . . . . 0.0 112.1 175.77 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.585 ' HB1' ' HG3' ' A' ' 35' ' ' PRO . . . -35.64 129.77 0.57 Allowed Pre-proline 0 N--CA 1.439 -1.006 0 O-C-N 124.634 1.209 . . . . 0.0 112.566 174.076 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.703 ' HG2' HG22 ' A' ' 30' ' ' THR . 19.4 Cg_endo -73.4 124.23 9.26 Favored 'Trans proline' 0 N--CA 1.442 -1.54 0 C-N-CA 121.898 1.732 . . . . 0.0 109.707 -176.86 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.753 HD13 ' HE2' ' A' ' 115' ' ' LYS . 5.4 tp -60.44 95.45 0.04 OUTLIER 'General case' 0 N--CA 1.449 -0.51 0 C-N-CA 123.103 0.561 . . . . 0.0 110.925 179.48 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.477 ' O ' HD22 ' A' ' 81' ' ' LEU . 0.4 OUTLIER 179.13 173.07 0.8 Allowed 'General case' 0 C--N 1.324 -0.523 0 C-N-CA 123.322 0.649 . . . . 0.0 110.445 -176.745 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -109.25 119.37 39.28 Favored 'General case' 0 CA--C 1.511 -0.53 0 C-N-CA 124.101 0.961 . . . . 0.0 109.934 179.095 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 45.98 64.06 2.62 Favored Glycine 0 C--O 1.225 -0.413 0 C-N-CA 120.865 -0.683 . . . . 0.0 112.209 177.94 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . 0.421 ' CD ' ' HB2' ' A' ' 26' ' ' SER . 3.0 ptmt -127.5 8.51 6.47 Favored 'General case' 0 CA--C 1.511 -0.543 0 O-C-N 122.247 -0.56 . . . . 0.0 111.463 179.102 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.703 HG22 ' HG2' ' A' ' 24' ' ' PRO . 8.1 p -115.06 152.45 32.47 Favored 'General case' 0 CA--C 1.508 -0.668 0 N-CA-C 107.941 -1.133 . . . . 0.0 107.941 -174.055 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -39.37 -59.16 1.92 Allowed Glycine 0 C--N 1.335 0.493 0 O-C-N 124.001 0.813 . . . . 0.0 112.544 179.978 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 29.7 t -62.46 -63.3 1.27 Allowed 'General case' 0 N--CA 1.441 -0.895 0 CA-C-O 116.273 -1.822 . . . . 0.0 111.166 176.042 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 159.63 -57.85 0.0 OUTLIER 'General case' 0 C--O 1.221 -0.418 0 O-C-N 126.085 2.115 . . . . 0.0 109.537 179.099 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.526 ' CD2' ' HD3' ' A' ' 84' ' ' PRO . 55.3 m-85 -55.8 145.09 53.8 Favored Pre-proline 0 N--CA 1.434 -1.229 0 N-CA-C 113.608 0.966 . . . . 0.0 113.608 179.234 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.585 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 22.5 Cg_endo -74.4 163.4 90.4 Favored 'Cis proline' 0 N--CA 1.447 -1.221 0 C-N-CA 122.822 -1.741 . . . . 0.0 111.428 -1.87 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.773 ' C ' HD23 ' A' ' 81' ' ' LEU . 1.5 p80 -137.22 175.1 9.91 Favored 'General case' 0 C--O 1.212 -0.914 0 O-C-N 120.981 -1.074 . . . . 0.0 110.339 -177.148 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.838 ' CZ3' HG22 ' A' ' 39' ' ' THR . 21.0 t90 -75.15 130.83 39.87 Favored 'General case' 0 N--CA 1.448 -0.556 0 N-CA-C 108.836 -0.802 . . . . 0.0 108.836 179.486 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.545 ' CE1' ' CD1' ' A' ' 121' ' ' ILE . 42.2 t80 -101.81 77.74 1.75 Allowed 'General case' 0 N--CA 1.427 -1.608 0 C-N-CA 126.009 1.724 . . . . 0.0 107.309 -178.975 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.838 HG22 ' CZ3' ' A' ' 37' ' ' TRP . 64.0 p -39.63 -31.78 0.11 Allowed 'General case' 0 C--O 1.215 -0.716 0 C-N-CA 124.297 1.039 . . . . 0.0 110.694 175.458 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.414 ' HB2' ' CD2' ' A' ' 38' ' ' PHE . 43.7 t30 60.47 14.08 4.57 Favored 'General case' 0 N--CA 1.447 -0.604 0 CA-C-O 122.861 1.315 . . . . 0.0 109.147 177.693 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.529 ' C ' HD23 ' A' ' 48' ' ' LEU . . . 116.3 -40.3 2.44 Favored Glycine 0 N--CA 1.423 -2.178 0 O-C-N 119.556 -1.965 . . . . 0.0 111.875 -174.312 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.734 ' N ' HD23 ' A' ' 48' ' ' LEU . 65.0 m-85 -49.54 156.12 0.69 Allowed 'General case' 0 N--CA 1.448 -0.547 0 C-N-CA 124.732 1.213 . . . . 0.0 110.392 -178.214 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -83.37 -39.4 20.74 Favored 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 120.138 -0.625 . . . . 0.0 110.576 178.08 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.416 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -162.41 -76.67 0.03 OUTLIER Glycine 0 C--N 1.339 0.741 0 C-N-CA 123.715 0.674 . . . . 0.0 111.623 -179.577 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -114.0 -63.81 1.4 Allowed 'General case' 0 CA--C 1.509 -0.62 0 C-N-CA 122.514 0.326 . . . . 0.0 110.959 -179.598 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.12 -168.25 0.07 OUTLIER Glycine 0 C--N 1.353 1.513 0 O-C-N 124.274 0.983 . . . . 0.0 111.119 178.588 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -56.1 -164.43 0.0 OUTLIER 'General case' 0 CA--C 1.543 0.683 0 CA-C-O 124.62 2.152 . . . . 0.0 111.987 176.101 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.734 HD23 ' N ' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -105.9 178.04 1.21 Allowed Pre-proline 0 N--CA 1.433 -1.311 0 O-C-N 119.647 -1.908 . . . . 0.0 110.568 -179.478 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . 0.403 ' CD ' ' CB ' ' A' ' 48' ' ' LEU . 23.9 Cg_endo -73.01 177.61 7.54 Favored 'Trans proline' 0 N--CA 1.444 -1.416 0 C-N-CA 122.138 1.892 . . . . 0.0 111.685 178.396 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 2.8 tttm -83.83 102.0 12.03 Favored 'General case' 0 N--CA 1.444 -0.767 0 O-C-N 120.955 -1.091 . . . . 0.0 109.87 177.74 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 117.96 65.12 0.32 Allowed Glycine 0 C--O 1.223 -0.577 0 N-CA-C 111.187 -0.765 . . . . 0.0 111.187 179.384 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.726 ' CD ' HD13 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -153.23 176.3 12.11 Favored 'General case' 0 CA--C 1.51 -0.574 0 C-N-CA 123.066 0.547 . . . . 0.0 110.625 178.72 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.9 m -154.24 107.0 2.43 Favored Pre-proline 0 C--O 1.215 -0.711 0 CA-C-O 119.032 -0.509 . . . . 0.0 111.786 173.75 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -71.26 174.4 10.82 Favored 'Trans proline' 0 N--CA 1.451 -0.997 0 C-N-CA 121.879 1.719 . . . . 0.0 111.783 178.809 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.506 HD12 HG21 ' A' ' 121' ' ' ILE . 4.1 mt -95.11 132.95 37.67 Favored 'Isoleucine or valine' 0 N--CA 1.445 -0.699 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -179.514 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -100.2 136.68 39.72 Favored 'General case' 0 N--CA 1.447 -0.588 0 N-CA-C 109.282 -0.636 . . . . 0.0 109.282 178.227 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.446 ' CD1' HD13 ' A' ' 133' ' ' LEU . 8.2 m-85 -121.94 -52.99 1.97 Allowed 'General case' 0 CA--C 1.514 -0.423 0 C-N-CA 123.098 0.559 . . . . 0.0 109.959 -179.273 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 126.45 -6.37 7.57 Favored Glycine 0 C--N 1.333 0.407 0 C-N-CA 123.654 0.645 . . . . 0.0 112.285 -176.884 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.73 131.52 37.05 Favored 'General case' 0 CA--C 1.5 -0.975 0 CA-C-O 118.087 -0.958 . . . . 0.0 109.207 178.749 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 87.5 p -67.05 -7.53 23.48 Favored 'General case' 0 C--O 1.22 -0.496 0 O-C-N 125.056 1.473 . . . . 0.0 111.532 176.984 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.467 ' HB2' HG11 ' A' ' 116' ' ' VAL . 9.5 m-20 -89.64 -56.88 3.07 Favored 'General case' 0 N--CA 1.438 -1.043 0 C-N-CA 124.42 1.088 . . . . 0.0 109.629 179.341 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 68.6 m -69.64 -20.29 63.6 Favored 'General case' 0 N--CA 1.448 -0.569 0 O-C-N 123.859 0.724 . . . . 0.0 110.364 177.522 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 11.0 t70 -78.46 -41.77 31.79 Favored 'General case' 0 N--CA 1.449 -0.501 0 C-N-CA 123.321 0.648 . . . . 0.0 110.674 176.599 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.418 ' HD2' ' ND1' ' A' ' 78' ' ' HIS . 0.0 OUTLIER -50.7 159.8 0.87 Allowed Pre-proline 0 N--CA 1.443 -0.809 0 CA-C-O 121.503 0.668 . . . . 0.0 110.832 179.699 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.413 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 28.3 Cg_endo -72.01 136.88 28.14 Favored 'Trans proline' 0 N--CA 1.439 -1.695 0 C-N-CA 121.521 1.481 . . . . 0.0 114.264 173.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.535 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 19.0 Cg_endo -72.29 170.06 20.08 Favored 'Trans proline' 0 N--CA 1.445 -1.379 0 C-N-CA 122.786 2.324 . . . . 0.0 111.236 178.943 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -128.87 53.28 1.87 Allowed 'General case' 0 C--O 1.2 -1.514 0 CA-C-O 118.166 -0.921 . . . . 0.0 110.596 178.468 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.432 ' CE1' ' O ' ' A' ' 69' ' ' SER . 46.7 t-80 -76.87 165.72 24.31 Favored 'General case' 0 C--N 1.324 -0.517 0 CA-C-N 119.468 1.031 . . . . 0.0 111.061 -179.91 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.432 ' O ' ' CE1' ' A' ' 68' ' ' HIS . 0.2 OUTLIER -157.55 -165.29 1.74 Allowed 'General case' 0 N--CA 1.448 -0.53 0 O-C-N 121.17 -0.956 . . . . 0.0 110.962 177.194 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.85 75.01 10.4 Favored 'General case' 0 N--CA 1.445 -0.676 0 O-C-N 120.174 -1.579 . . . . 0.0 111.332 176.67 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -177.46 -45.25 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.549 0 C-N-CA 123.291 0.636 . . . . 0.0 109.881 179.124 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.482 ' O ' ' CE2' ' A' ' 79' ' ' TYR . . . 122.92 -50.89 0.82 Allowed Glycine 0 N--CA 1.438 -1.203 0 CA-C-O 118.636 -1.091 . . . . 0.0 111.632 -176.888 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 7.2 t30 -151.54 82.97 1.3 Allowed 'General case' 0 N--CA 1.438 -1.075 0 CA-C-N 118.603 1.202 . . . . 0.0 107.962 178.116 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.03 -115.96 0.01 OUTLIER Glycine 0 C--O 1.222 -0.616 0 CA-C-O 123.083 1.38 . . . . 0.0 111.451 179.941 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 8.0 mttp -60.39 -98.37 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.46 0 O-C-N 119.681 -2.07 . . . . 0.0 110.648 178.052 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.57 HG23 ' O ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -109.37 16.1 22.59 Favored 'General case' 0 N--CA 1.447 -0.581 0 O-C-N 120.633 -1.292 . . . . 0.0 110.833 179.717 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.488 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 5.7 m-20 -29.31 103.44 0.02 OUTLIER 'General case' 0 C--O 1.203 -1.364 0 C-N-CA 124.807 1.243 . . . . 0.0 110.85 -177.958 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.574 ' CD2' ' H ' ' A' ' 78' ' ' HIS . 3.5 p80 -85.74 14.19 6.19 Favored 'General case' 0 CA--C 1.513 -0.447 0 O-C-N 121.39 -0.819 . . . . 0.0 110.209 -176.9 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.999 ' CZ ' HD11 ' A' ' 81' ' ' LEU . 0.3 OUTLIER -35.84 132.29 0.49 Allowed 'General case' 0 N--CA 1.426 -1.645 0 C-N-CA 124.911 1.285 . . . . 0.0 113.795 173.071 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.675 HD23 ' O ' ' A' ' 110' ' ' TYR . 0.4 OUTLIER -74.05 154.99 38.99 Favored 'General case' 0 CA--C 1.507 -0.677 0 CA-C-O 118.346 -0.835 . . . . 0.0 109.034 179.376 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.999 HD11 ' CZ ' ' A' ' 79' ' ' TYR . 1.2 mp -142.34 143.34 32.7 Favored 'General case' 0 N--CA 1.446 -0.664 0 C-N-CA 123.956 0.902 . . . . 0.0 109.647 178.322 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.495 ' CB ' ' CD1' ' A' ' 109' ' ' ILE . 0.2 OUTLIER -108.93 162.78 13.89 Favored 'General case' 0 N--CA 1.438 -1.046 0 CA-C-O 122.186 0.994 . . . . 0.0 111.233 179.464 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.552 ' CZ ' ' HB2' ' A' ' 23' ' ' ALA . 38.0 t80 -150.64 126.33 4.95 Favored Pre-proline 0 N--CA 1.443 -0.801 0 CA-C-N 115.626 -0.716 . . . . 0.0 112.312 -179.489 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.526 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 21.5 Cg_endo -71.98 101.35 1.19 Allowed 'Trans proline' 0 N--CA 1.446 -1.292 0 C-N-CA 123.764 2.976 . . . . 0.0 111.01 -179.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -101.01 114.88 29.21 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-O 121.943 0.877 . . . . 0.0 110.661 179.884 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 64.6 m-85 -81.4 160.96 63.69 Favored Pre-proline 0 N--CA 1.442 -0.868 0 O-C-N 121.423 -0.798 . . . . 0.0 112.483 178.478 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 18.7 Cg_endo -76.67 -41.61 0.41 Allowed 'Trans proline' 0 CA--C 1.497 -1.358 0 C-N-CA 122.496 2.131 . . . . 0.0 112.962 179.071 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.1 m-20 -45.09 -30.99 1.21 Allowed 'General case' 0 C--N 1.349 0.574 0 O-C-N 125.052 1.47 . . . . 0.0 110.021 177.895 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 89.66 -4.08 83.57 Favored Glycine 0 N--CA 1.427 -1.964 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 177.228 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 5.2 p-80 -61.53 127.73 32.9 Favored 'General case' 0 N--CA 1.435 -1.175 0 N-CA-C 108.462 -0.94 . . . . 0.0 108.462 178.733 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.7 t70 -61.02 93.29 0.03 OUTLIER 'General case' 0 C--N 1.327 -0.377 0 N-CA-C 108.559 -0.904 . . . . 0.0 108.559 176.879 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.498 ' CD2' ' HB3' ' A' ' 94' ' ' PHE . 7.1 t80 -38.32 143.3 0.14 Allowed 'General case' 0 C--O 1.212 -0.92 0 CA-C-O 121.994 0.902 . . . . 0.0 110.813 179.572 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 12.2 ptpt -78.49 62.04 3.01 Favored 'General case' 0 C--N 1.318 -0.796 0 O-C-N 119.712 -1.867 . . . . 0.0 110.368 176.911 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.498 ' HB3' ' CD2' ' A' ' 92' ' ' TYR . 30.6 p90 -80.84 -8.34 59.68 Favored 'General case' 0 N--CA 1.437 -1.098 0 C-N-CA 123.372 0.669 . . . . 0.0 111.299 177.641 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 8.5 t70 -97.21 -32.63 11.83 Favored 'General case' 0 C--N 1.327 -0.405 0 CA-C-O 122.095 0.95 . . . . 0.0 110.179 178.972 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 19.8 m -81.85 107.1 14.3 Favored 'General case' 0 N--CA 1.443 -0.8 0 O-C-N 121.181 -0.95 . . . . 0.0 108.731 -178.485 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.5 ptpt -59.31 -48.8 80.26 Favored 'General case' 0 C--O 1.224 -0.286 0 N-CA-C 109.378 -0.601 . . . . 0.0 109.378 179.312 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 3.6 pttt -142.66 128.42 10.42 Favored Pre-proline 0 N--CA 1.431 -1.415 0 C-N-CA 124.208 1.003 . . . . 0.0 109.64 -176.371 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -71.25 176.92 34.72 Favored 'Cis proline' 0 N--CA 1.454 -0.822 0 C-N-CA 122.682 -1.799 . . . . 0.0 111.421 -3.827 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -140.4 146.52 38.46 Favored 'General case' 0 CA--C 1.517 -0.325 0 C-N-CA 122.953 0.501 . . . . 0.0 110.172 177.985 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.2 tm-20 -99.62 165.06 11.8 Favored 'General case' 0 C--N 1.319 -0.76 0 O-C-N 123.939 0.774 . . . . 0.0 110.776 178.725 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 2.8 t30 -57.45 153.42 28.4 Favored Pre-proline 0 N--CA 1.439 -1.013 0 CA-C-N 115.968 -0.56 . . . . 0.0 111.528 177.595 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 23.7 Cg_endo -74.12 -164.69 0.22 Allowed 'Trans proline' 0 N--CA 1.449 -1.102 0 C-N-CA 122.453 2.102 . . . . 0.0 111.468 177.413 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -132.89 157.8 22.8 Favored Glycine 0 N--CA 1.444 -0.782 0 O-C-N 121.342 -0.848 . . . . 0.0 112.643 178.241 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -74.92 -64.36 0.03 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.086 0 C-N-CA 122.474 2.116 . . . . 0.0 110.101 179.407 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.821 ' HA ' ' HB2' ' A' ' 122' ' ' ALA . . . -69.39 141.43 54.14 Favored 'General case' 0 N--CA 1.441 -0.883 0 O-C-N 123.502 0.501 . . . . 0.0 111.017 179.212 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 5.2 mtm-85 -142.86 143.86 32.26 Favored 'General case' 0 N--CA 1.442 -0.852 0 O-C-N 124.257 0.973 . . . . 0.0 111.204 -179.799 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.441 ' CG1' ' HB3' ' A' ' 83' ' ' PHE . 4.8 p -83.39 124.67 39.8 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.404 0 O-C-N 124.016 0.823 . . . . 0.0 110.377 178.823 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.638 ' CG2' HD22 ' A' ' 80' ' ' LEU . 6.2 mm -103.91 140.44 22.05 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.914 0 N-CA-C 109.971 -0.381 . . . . 0.0 109.971 -179.336 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.675 ' O ' HD23 ' A' ' 80' ' ' LEU . 9.9 p90 -164.21 152.05 12.43 Favored 'General case' 0 N--CA 1.439 -1.02 0 CA-C-O 122.53 1.157 . . . . 0.0 111.287 -178.543 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 5.6 p -89.64 166.76 13.41 Favored 'General case' 0 C--N 1.319 -0.725 0 O-C-N 121.593 -0.692 . . . . 0.0 109.204 -178.255 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.578 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -110.95 153.8 43.65 Favored Pre-proline 0 N--CA 1.438 -1.029 0 C-N-CA 122.971 0.508 . . . . 0.0 111.168 179.263 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.578 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 19.5 Cg_endo -73.78 -55.28 0.14 OUTLIER 'Cis proline' 0 CA--C 1.501 -1.134 0 C-N-CA 123.001 -1.666 . . . . 0.0 109.759 -5.677 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.451 ' O ' HG23 ' A' ' 116' ' ' VAL . 2.3 t-20 -44.18 113.67 0.56 Allowed 'General case' 0 CA--C 1.5 -0.976 0 CA-C-O 115.653 -2.117 . . . . 0.0 109.823 179.88 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.753 ' HE2' HD13 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -63.24 78.61 0.02 OUTLIER 'General case' 0 CA--C 1.508 -0.663 0 O-C-N 125.529 1.768 . . . . 0.0 108.64 -178.3 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.467 HG11 ' HB2' ' A' ' 61' ' ' ASP . 77.6 t -73.54 72.11 0.25 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.823 0 N-CA-C 106.142 -1.799 . . . . 0.0 106.142 -176.011 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.462 ' CZ ' ' NE2' ' A' ' 13' ' ' GLN . 42.0 t80 -37.46 104.96 0.03 OUTLIER 'General case' 0 N--CA 1.437 -1.094 0 C-N-CA 125.647 1.579 . . . . 0.0 110.15 -178.791 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . 0.528 ' SG ' HD21 ' A' ' 80' ' ' LEU . 5.7 m -82.72 -44.68 15.35 Favored 'General case' 0 N--CA 1.438 -1.063 0 N-CA-C 107.818 -1.179 . . . . 0.0 107.818 -178.184 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 158.03 -145.71 12.22 Favored Glycine 0 N--CA 1.44 -1.09 0 N-CA-C 110.216 -1.154 . . . . 0.0 110.216 179.782 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.497 HG13 ' CG ' ' A' ' 4' ' ' TRP . 1.1 mm -127.43 145.7 34.43 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.212 0 N-CA-C 107.153 -1.425 . . . . 0.0 107.153 -175.528 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.656 HG13 HD23 ' A' ' 131' ' ' LEU . 5.7 pt -137.39 151.93 27.01 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.937 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 -177.717 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.876 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . . . 177.87 129.55 0.06 Allowed 'General case' 0 N--CA 1.447 -0.605 0 CA-C-O 122.088 0.947 . . . . 0.0 109.711 -178.719 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.461 ' H ' ' CD2' ' A' ' 123' ' ' HIS . 0.4 OUTLIER -88.75 95.35 10.24 Favored 'General case' 0 N--CA 1.441 -0.881 0 O-C-N 121.431 -0.793 . . . . 0.0 110.583 179.594 . . . . . . . . 3 3 . 1 . 014 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.743 HG21 ' HA3' ' A' ' 7' ' ' GLY . 1.1 t -98.19 31.82 2.64 Favored 'General case' 0 C--N 1.319 -0.741 0 CA-C-O 123.729 1.728 . . . . 0.0 112.221 179.678 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 70.1 tttt -84.32 -44.56 13.69 Favored 'General case' 0 N--CA 1.444 -0.728 0 CA-C-O 116.688 -1.625 . . . . 0.0 110.063 -178.642 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER 169.86 -81.49 0.0 OUTLIER 'General case' 0 C--O 1.223 -0.313 0 O-C-N 126.013 2.071 . . . . 0.0 110.889 178.99 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.3 t30 -159.81 29.85 0.18 Allowed 'General case' 0 N--CA 1.44 -0.973 0 C-N-CA 124.387 1.075 . . . . 0.0 110.665 -178.344 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.5 mt-30 -171.8 89.72 0.11 Allowed 'General case' 0 N--CA 1.444 -0.744 0 CA-C-O 122.671 1.224 . . . . 0.0 110.267 -177.953 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 166.8 105.48 0.18 Allowed Glycine 0 CA--C 1.483 -1.933 0 CA-C-O 115.254 -2.97 . . . . 0.0 107.902 179.044 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -35.99 146.32 0.03 OUTLIER 'General case' 0 C--O 1.24 0.558 0 CA-C-N 119.494 1.647 . . . . 0.0 112.659 177.419 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.656 HD23 HG13 ' A' ' 121' ' ' ILE . 8.4 mp -57.45 148.25 24.0 Favored 'General case' 0 N--CA 1.447 -0.615 0 N-CA-C 108.402 -0.962 . . . . 0.0 108.402 -175.704 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 1.2 pttt -123.56 149.96 44.63 Favored 'General case' 0 CA--C 1.501 -0.924 0 CA-C-O 118.263 -0.875 . . . . 0.0 108.779 -177.764 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.468 ' HB2' ' CG2' ' A' ' 55' ' ' ILE . 9.0 tp -61.56 127.7 32.71 Favored 'General case' 0 N--CA 1.453 -0.3 0 O-C-N 124.798 1.311 . . . . 0.0 109.1 179.613 . . . . . . . . 2 2 . 1 . 014 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 35.2 m -67.19 -174.36 0.36 Allowed 'General case' 0 N--CA 1.436 -1.156 0 CA-C-O 122.707 1.242 . . . . 0.0 109.39 177.612 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 66.3 m -151.1 101.33 2.86 Favored 'General case' 0 C--N 1.322 -0.613 0 O-C-N 121.468 -0.77 . . . . 0.0 109.354 -179.35 . . . . . . . . 1 1 . 1 . 014 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.655 ' HB2' HG22 ' A' ' 2' ' ' VAL . 0.4 OUTLIER . . . . . 0 C--O 1.247 0.969 0 CA-C-O 116.527 -1.702 . . . . 0.0 113.313 175.131 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.478 0.945 0 N-CA-C 107.846 -1.168 . . . . 0.0 107.846 . . . . . . . . . 0 0 . 1 . 015 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.611 HG22 ' HB2' ' A' ' 136' ' ' HIS . 9.1 p -119.66 135.52 59.74 Favored 'Isoleucine or valine' 0 C--O 1.237 0.441 0 C-N-CA 124.2 1.0 . . . . 0.0 109.564 177.037 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 14.9 m -90.09 115.38 27.31 Favored 'General case' 0 C--N 1.319 -0.744 0 N-CA-C 108.53 -0.915 . . . . 0.0 108.53 -176.537 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.509 ' CE2' ' CD2' ' A' ' 136' ' ' HIS . 23.3 m95 -78.23 142.28 38.0 Favored 'General case' 0 C--O 1.215 -0.725 0 O-C-N 121.676 -0.64 . . . . 0.0 110.671 -179.908 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 1.0 OUTLIER -140.66 141.74 35.01 Favored 'General case' 0 CA--C 1.499 -1.008 0 N-CA-C 107.664 -1.236 . . . . 0.0 107.664 -177.361 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.613 ' SG ' ' HB3' ' A' ' 122' ' ' ALA . 0.1 OUTLIER -119.67 -79.14 0.6 Allowed 'General case' 0 C--O 1.218 -0.598 0 O-C-N 124.467 1.104 . . . . 0.0 111.034 176.916 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -74.32 -87.45 0.23 Allowed Glycine 0 C--O 1.219 -0.804 0 N-CA-C 110.283 -1.127 . . . . 0.0 110.283 -179.125 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -143.67 12.61 2.2 Favored Glycine 0 C--O 1.221 -0.662 0 O-C-N 121.573 -0.957 . . . . 0.0 111.704 178.293 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 22.4 mt -113.9 155.49 25.68 Favored 'General case' 0 C--O 1.235 0.325 0 CA-C-N 117.824 0.812 . . . . 0.0 109.581 178.925 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 7.4 mp -106.78 133.37 51.54 Favored 'General case' 0 C--O 1.218 -0.588 0 N-CA-C 108.789 -0.819 . . . . 0.0 108.789 -175.668 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.606 ' CZ ' ' HB3' ' A' ' 106' ' ' ALA . 60.8 m-85 -124.58 91.4 3.44 Favored 'General case' 0 C--N 1.321 -0.671 0 C-N-CA 125.749 1.62 . . . . 0.0 106.992 -170.349 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -53.48 121.07 6.95 Favored 'General case' 0 N--CA 1.447 -0.624 0 CA-C-O 117.708 -1.139 . . . . 0.0 108.745 179.095 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.498 ' NE2' ' CE1' ' A' ' 117' ' ' PHE . 1.2 tt0 -52.24 -50.78 61.35 Favored 'General case' 0 CA--C 1.498 -1.029 0 CA-C-O 117.243 -1.361 . . . . 0.0 111.173 -179.392 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 16.6 t-20 -50.42 -36.84 34.87 Favored 'General case' 0 C--O 1.194 -1.825 0 O-C-N 125.42 1.7 . . . . 0.0 110.615 178.75 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 4.4 mttp -71.59 -51.01 25.61 Favored 'General case' 0 C--O 1.212 -0.917 0 CA-C-O 116.526 -1.702 . . . . 0.0 115.428 166.893 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -47.86 -35.11 9.79 Favored 'General case' 0 C--O 1.211 -0.936 0 CA-C-N 121.653 2.024 . . . . 0.0 113.024 171.949 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.443 ' O ' ' CD2' ' A' ' 21' ' ' HIS . 16.0 pt-20 -88.32 -40.81 13.31 Favored 'General case' 0 C--O 1.205 -1.285 0 C-N-CA 125.76 1.624 . . . . 0.0 110.471 172.139 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 20.4 t -77.0 -59.12 2.91 Favored 'General case' 0 CA--C 1.501 -0.912 0 O-C-N 117.217 -3.427 . . . . 0.0 108.123 -172.488 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.534 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -45.38 -32.31 2.03 Favored 'General case' 0 CA--C 1.545 0.76 0 N-CA-C 115.367 1.617 . . . . 0.0 115.367 167.215 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.492 ' HB3' HG11 ' A' ' 108' ' ' VAL . 54.5 p -83.74 -24.56 31.1 Favored 'General case' 0 C--O 1.216 -0.691 0 N-CA-C 114.603 1.334 . . . . 0.0 114.603 173.049 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.443 ' CD2' ' O ' ' A' ' 17' ' ' GLU . 10.0 m170 -55.98 -37.91 69.72 Favored 'General case' 0 CA--C 1.515 -0.367 0 C-N-CA 126.504 1.922 . . . . 0.0 108.701 178.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.534 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.1 OUTLIER -71.02 -44.45 65.85 Favored 'General case' 0 N--CA 1.441 -0.883 0 CA-C-O 117.15 -1.405 . . . . 0.0 110.178 178.899 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.598 ' HB1' ' HG3' ' A' ' 35' ' ' PRO . . . -39.99 126.04 1.62 Allowed Pre-proline 0 CA--C 1.549 0.934 0 O-C-N 126.058 2.099 . . . . 0.0 111.287 176.098 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.751 ' HG2' HG22 ' A' ' 30' ' ' THR . 13.5 Cg_endo -72.67 123.41 9.0 Favored 'Trans proline' 0 N--CA 1.445 -1.38 0 C-N-CA 122.433 2.089 . . . . 0.0 107.804 -175.972 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.65 HD13 ' HE2' ' A' ' 115' ' ' LYS . 3.4 tp -60.51 87.85 0.02 OUTLIER 'General case' 0 CA--C 1.507 -0.704 0 C-N-CA 124.514 1.126 . . . . 0.0 112.414 178.39 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 4.4 m -174.53 148.96 1.23 Allowed 'General case' 0 C--N 1.327 -0.402 0 C-N-CA 124.993 1.317 . . . . 0.0 109.95 -171.581 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.407 ' HB3' ' HA3' ' A' ' 72' ' ' GLY . 0.0 OUTLIER -86.81 113.71 22.86 Favored 'General case' 0 CA--C 1.508 -0.655 0 C-N-CA 124.136 0.974 . . . . 0.0 110.176 176.362 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 54.03 72.41 0.55 Allowed Glycine 0 CA--C 1.525 0.669 0 C-N-CA 119.402 -1.38 . . . . 0.0 111.996 177.189 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -141.04 21.41 2.27 Favored 'General case' 0 CA--C 1.504 -0.813 0 O-C-N 121.438 -1.036 . . . . 0.0 112.724 177.951 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.751 HG22 ' HG2' ' A' ' 24' ' ' PRO . 10.7 p -129.57 152.07 49.49 Favored 'General case' 0 CA--C 1.493 -1.231 0 N-CA-C 106.248 -1.76 . . . . 0.0 106.248 -171.693 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -38.43 -66.87 0.58 Allowed Glycine 0 N--CA 1.442 -0.919 0 O-C-N 124.502 1.126 . . . . 0.0 112.858 178.392 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.42 ' HA ' ' CE ' ' A' ' 100' ' ' LYS . 24.2 t -52.77 -65.46 0.55 Allowed 'General case' 0 CA--C 1.492 -1.28 0 CA-C-O 114.994 -2.431 . . . . 0.0 113.07 173.803 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 160.87 -53.18 0.0 OUTLIER 'General case' 0 C--O 1.219 -0.552 0 O-C-N 127.626 3.079 . . . . 0.0 109.507 178.611 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.533 ' CE2' ' CE1' ' A' ' 36' ' ' HIS . 50.9 m-85 -61.46 147.05 88.61 Favored Pre-proline 0 N--CA 1.439 -1.008 0 N-CA-C 114.775 1.398 . . . . 0.0 114.775 -179.386 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.598 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 23.2 Cg_endo -74.55 150.53 95.66 Favored 'Cis proline' 0 N--CA 1.443 -1.477 0 C-N-CA 123.457 -1.476 . . . . 0.0 109.6 0.772 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.533 ' CE1' ' CE2' ' A' ' 34' ' ' TYR . 0.4 OUTLIER -126.72 160.64 30.21 Favored 'General case' 0 CA--C 1.499 -1.008 0 CA-C-O 117.062 -1.447 . . . . 0.0 109.003 179.242 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.918 ' CH2' HG22 ' A' ' 39' ' ' THR . 22.1 t90 -58.45 148.8 26.92 Favored 'General case' 0 N--CA 1.464 0.242 0 O-C-N 124.763 1.289 . . . . 0.0 109.184 177.527 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.501 ' CZ ' HD13 ' A' ' 121' ' ' ILE . 10.8 t80 -129.22 78.36 1.85 Allowed 'General case' 0 N--CA 1.435 -1.221 0 N-CA-C 103.711 -2.7 . . . . 0.0 103.711 -170.711 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.918 HG22 ' CH2' ' A' ' 37' ' ' TRP . 44.7 p -39.15 -34.96 0.2 Allowed 'General case' 0 C--O 1.204 -1.31 0 C-N-CA 124.81 1.244 . . . . 0.0 110.117 173.855 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 56.7 t30 66.86 11.98 8.62 Favored 'General case' 0 CA--C 1.545 0.78 0 C-N-CA 125.683 1.593 . . . . 0.0 110.523 178.799 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 108.15 -6.83 34.76 Favored Glycine 0 CA--C 1.537 1.451 0 O-C-N 120.96 -1.088 . . . . 0.0 114.687 -170.066 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.695 ' CE1' HD11 ' A' ' 48' ' ' LEU . 6.1 m-85 -78.26 168.51 19.73 Favored 'General case' 0 CA--C 1.515 -0.378 0 C-N-CA 124.472 1.109 . . . . 0.0 109.782 -178.298 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -87.11 -37.36 17.46 Favored 'General case' 0 C--N 1.324 -0.542 0 CA-C-N 115.746 -0.661 . . . . 0.0 111.748 175.973 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.58 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . 176.43 -60.31 0.1 Allowed Glycine 0 CA--C 1.506 -0.469 0 C-N-CA 124.179 0.895 . . . . 0.0 112.881 -177.784 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -115.85 -63.11 1.5 Allowed 'General case' 0 C--N 1.327 -0.396 0 CA-C-O 122.716 1.246 . . . . 0.0 110.819 179.125 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -59.24 165.89 8.95 Favored Glycine 0 C--N 1.339 0.728 0 N-CA-C 109.706 -1.358 . . . . 0.0 109.706 177.872 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.56 ' HA ' ' CE2' ' A' ' 42' ' ' TYR . 0.0 OUTLIER -59.2 -168.97 0.01 OUTLIER 'General case' 0 CA--C 1.535 0.375 0 CA-C-O 123.288 1.518 . . . . 0.0 111.325 178.082 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.695 HD11 ' CE1' ' A' ' 42' ' ' TYR . 4.7 mp -77.14 152.12 81.85 Favored Pre-proline 0 N--CA 1.43 -1.458 0 O-C-N 120.472 -1.392 . . . . 0.0 110.833 179.238 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -72.17 170.43 19.1 Favored 'Trans proline' 0 N--CA 1.445 -1.336 0 C-N-CA 122.539 2.159 . . . . 0.0 110.792 179.0 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -58.92 100.43 0.07 Allowed 'General case' 0 CA--C 1.54 0.577 0 O-C-N 121.619 -0.676 . . . . 0.0 109.378 176.338 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 114.75 56.48 0.37 Allowed Glycine 0 CA--C 1.51 -0.252 0 O-C-N 121.684 -0.635 . . . . 0.0 111.552 -177.844 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.429 ' CB ' ' HB3' ' A' ' 48' ' ' LEU . 0.1 OUTLIER -150.36 165.52 32.82 Favored 'General case' 0 N--CA 1.445 -0.692 0 CA-C-O 118.573 -0.727 . . . . 0.0 112.454 174.214 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 54.1 m -145.02 97.29 4.86 Favored Pre-proline 0 C--O 1.233 0.21 0 O-C-N 125.338 1.649 . . . . 0.0 110.276 -176.807 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.507 ' HG3' HD13 ' A' ' 48' ' ' LEU . 20.4 Cg_endo -72.47 148.09 47.65 Favored 'Trans proline' 0 N--CA 1.455 -0.777 0 C-N-CA 122.878 2.385 . . . . 0.0 110.88 179.764 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.438 HD12 HG21 ' A' ' 121' ' ' ILE . 6.7 mt -69.18 120.97 17.61 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.414 0 N-CA-C 107.585 -1.265 . . . . 0.0 107.585 -177.877 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.6 tppt? -83.03 135.24 34.92 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 120.897 -1.127 . . . . 0.0 108.652 177.805 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.61 ' CE1' HD13 ' A' ' 133' ' ' LEU . 7.9 m-85 -118.44 -51.61 2.4 Favored 'General case' 0 CA--C 1.513 -0.451 0 C-N-CA 123.786 0.834 . . . . 0.0 109.858 -178.982 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 122.32 -4.51 10.3 Favored Glycine 0 C--O 1.222 -0.613 0 CA-C-O 119.35 -0.695 . . . . 0.0 112.831 -175.282 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.435 ' HD3' ' CG1' ' A' ' 116' ' ' VAL . 1.6 mtpt -96.5 139.03 33.2 Favored 'General case' 0 CA--C 1.501 -0.91 0 CA-C-N 118.399 1.1 . . . . 0.0 110.553 175.832 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 23.2 t -74.77 -1.71 23.27 Favored 'General case' 0 C--O 1.222 -0.351 0 O-C-N 124.771 1.294 . . . . 0.0 111.961 175.027 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 7.0 m-20 -87.95 -54.16 4.37 Favored 'General case' 0 CA--C 1.516 -0.364 0 O-C-N 120.793 -1.192 . . . . 0.0 108.709 179.919 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.585 ' HA ' HD11 ' A' ' 80' ' ' LEU . 2.7 m -75.47 -32.38 60.57 Favored 'General case' 0 N--CA 1.45 -0.438 0 O-C-N 124.028 0.83 . . . . 0.0 109.426 -178.845 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 44.1 t0 -62.88 -39.17 93.66 Favored 'General case' 0 N--CA 1.469 0.494 0 CA-C-O 122.556 1.169 . . . . 0.0 110.811 173.056 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.467 ' HD3' ' CE1' ' A' ' 78' ' ' HIS . 0.0 OUTLIER -53.64 160.01 2.21 Favored Pre-proline 0 N--CA 1.444 -0.749 0 O-C-N 120.973 -1.079 . . . . 0.0 112.621 178.78 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 28.4 Cg_endo -70.32 133.87 25.53 Favored 'Trans proline' 0 N--CA 1.438 -1.79 0 N-CA-C 114.697 0.999 . . . . 0.0 114.697 172.202 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.475 ' HD2' ' CD2' ' A' ' 42' ' ' TYR . 21.1 Cg_endo -70.46 168.92 21.07 Favored 'Trans proline' 0 N--CA 1.439 -1.685 0 C-N-CA 124.115 3.21 . . . . 0.0 111.238 176.665 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.9 tptt -128.05 51.75 1.94 Allowed 'General case' 0 C--O 1.199 -1.583 0 CA-C-N 115.02 -0.991 . . . . 0.0 108.826 177.808 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 55.9 t-80 -75.66 168.82 19.3 Favored 'General case' 0 N--CA 1.474 0.745 0 O-C-N 119.921 -1.737 . . . . 0.0 110.972 178.395 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 24.0 p -161.67 -156.82 0.45 Allowed 'General case' 0 C--O 1.222 -0.375 0 O-C-N 120.994 -1.066 . . . . 0.0 111.846 174.317 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.11 70.88 9.13 Favored 'General case' 0 C--O 1.215 -0.719 0 O-C-N 120.67 -1.269 . . . . 0.0 112.739 172.315 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -176.08 -40.78 0.01 OUTLIER 'General case' 0 N--CA 1.47 0.551 0 CA-C-O 121.88 0.848 . . . . 0.0 109.701 177.483 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.407 ' HA3' ' HB3' ' A' ' 27' ' ' ASP . . . 108.67 -57.82 0.42 Allowed Glycine 0 C--O 1.212 -1.219 0 CA-C-O 118.389 -1.228 . . . . 0.0 111.761 -175.658 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -135.05 67.92 1.48 Allowed 'General case' 0 C--N 1.319 -0.734 0 N-CA-C 105.529 -2.026 . . . . 0.0 105.529 -173.445 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.47 -119.24 0.01 OUTLIER Glycine 0 CA--C 1.529 0.93 0 CA-C-O 122.411 1.006 . . . . 0.0 113.001 177.801 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 15.7 mttt -63.79 -99.3 0.0 OUTLIER 'General case' 0 CA--C 1.539 0.528 0 O-C-N 119.32 -2.282 . . . . 0.0 112.156 176.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.474 HG23 ' O ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -105.46 12.45 31.43 Favored 'General case' 0 C--N 1.317 -0.841 0 O-C-N 119.453 -2.03 . . . . 0.0 110.547 178.433 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.463 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 21.1 m-20 -29.66 105.83 0.03 OUTLIER 'General case' 0 C--O 1.201 -1.498 0 C-N-CA 126.234 1.813 . . . . 0.0 110.41 -176.479 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.626 ' CD2' ' H ' ' A' ' 78' ' ' HIS . 2.3 p80 -86.21 14.02 7.07 Favored 'General case' 0 N--CA 1.469 0.502 0 CA-C-N 120.144 1.338 . . . . 0.0 110.082 -175.357 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.898 ' CZ ' HD11 ' A' ' 81' ' ' LEU . 0.4 OUTLIER -32.55 132.2 0.14 Allowed 'General case' 0 N--CA 1.439 -1.018 0 C-N-CA 126.015 1.726 . . . . 0.0 112.887 170.428 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.585 HD11 ' HA ' ' A' ' 62' ' ' CYS . 0.2 OUTLIER -75.61 155.53 35.8 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 121.015 -1.053 . . . . 0.0 109.067 178.238 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.898 HD11 ' CZ ' ' A' ' 79' ' ' TYR . 1.7 mp -141.81 134.36 28.28 Favored 'General case' 0 CA--C 1.508 -0.649 0 CA-C-N 118.874 0.761 . . . . 0.0 109.354 176.835 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.451 ' CB ' ' CD1' ' A' ' 109' ' ' ILE . 1.7 pm0 -103.13 154.56 19.17 Favored 'General case' 0 N--CA 1.442 -0.864 0 CA-C-O 122.842 1.306 . . . . 0.0 110.78 179.396 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.478 ' HZ ' ' CD2' ' A' ' 94' ' ' PHE . 37.8 t80 -141.79 138.82 17.5 Favored Pre-proline 0 C--O 1.218 -0.559 0 O-C-N 121.265 -0.897 . . . . 0.0 112.853 -179.662 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.506 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 14.6 Cg_endo -72.15 88.35 0.84 Allowed 'Trans proline' 0 CA--C 1.485 -1.942 0 C-N-CA 124.658 3.572 . . . . 0.0 109.341 -173.29 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 9.7 t -80.11 116.62 20.32 Favored 'General case' 0 N--CA 1.448 -0.533 0 C-N-CA 123.674 0.789 . . . . 0.0 111.769 179.613 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.506 ' CD1' ' CE1' ' A' ' 92' ' ' TYR . 7.8 m-85 -84.65 159.09 58.88 Favored Pre-proline 0 C--N 1.318 -0.777 0 O-C-N 120.406 -1.434 . . . . 0.0 110.701 -179.556 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -76.42 -45.29 0.21 Allowed 'Trans proline' 0 N--CA 1.446 -1.291 0 C-N-CA 122.252 1.968 . . . . 0.0 111.544 178.766 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -53.62 -28.75 34.47 Favored 'General case' 0 N--CA 1.473 0.7 0 CA-C-O 124.108 1.909 . . . . 0.0 110.229 177.275 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.73 -9.5 51.1 Favored Glycine 0 N--CA 1.436 -1.354 0 CA-C-O 116.458 -2.301 . . . . 0.0 112.133 -177.434 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 2.4 p-80 -50.53 138.91 16.74 Favored 'General case' 0 C--O 1.209 -1.041 0 CA-C-O 116.805 -1.569 . . . . 0.0 107.887 178.609 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 3.0 t70 -62.1 143.51 56.57 Favored 'General case' 0 N--CA 1.472 0.653 0 CA-C-N 120.88 1.673 . . . . 0.0 111.644 175.782 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.506 ' CE1' ' CD1' ' A' ' 86' ' ' PHE . 0.1 OUTLIER -98.01 155.08 17.28 Favored 'General case' 0 C--O 1.215 -0.756 0 N-CA-C 107.022 -1.473 . . . . 0.0 107.022 -174.159 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -81.73 55.11 2.59 Favored 'General case' 0 C--N 1.314 -0.935 0 O-C-N 118.515 -2.615 . . . . 0.0 111.053 172.18 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.478 ' CD2' ' HZ ' ' A' ' 83' ' ' PHE . 40.0 p90 -69.24 -26.74 64.94 Favored 'General case' 0 N--CA 1.436 -1.16 0 CA-C-O 117.828 -1.082 . . . . 0.0 110.877 175.412 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 15.8 t70 -90.09 -21.05 22.48 Favored 'General case' 0 N--CA 1.47 0.526 0 CA-C-N 119.956 1.253 . . . . 0.0 111.442 179.234 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.7 m -108.77 101.05 10.21 Favored 'General case' 0 CA--C 1.496 -1.108 0 N-CA-C 106.919 -1.512 . . . . 0.0 106.919 -178.747 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -69.26 -29.57 67.5 Favored 'General case' 0 N--CA 1.465 0.284 0 CA-C-O 121.896 0.855 . . . . 0.0 110.234 175.969 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 1.6 mttm -125.75 113.38 24.85 Favored Pre-proline 0 N--CA 1.444 -0.745 0 CA-C-O 117.654 -1.165 . . . . 0.0 109.276 -179.888 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 17.8 Cg_endo -70.29 173.36 46.84 Favored 'Cis proline' 0 C--N 1.356 0.926 0 O-C-N 124.44 1.758 . . . . 0.0 110.521 -3.556 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.42 ' CE ' ' HA ' ' A' ' 32' ' ' SER . 0.5 OUTLIER -130.39 145.99 51.89 Favored 'General case' 0 CA--C 1.507 -0.705 0 C-N-CA 125.293 1.437 . . . . 0.0 110.021 177.863 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -110.07 175.19 5.53 Favored 'General case' 0 C--O 1.243 0.733 0 O-C-N 125.751 1.907 . . . . 0.0 109.122 -177.869 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.2 t30 -76.49 139.83 67.9 Favored Pre-proline 0 N--CA 1.442 -0.849 0 CA-C-N 114.927 -1.033 . . . . 0.0 111.916 176.626 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 28.2 Cg_endo -72.74 -165.61 0.24 Allowed 'Trans proline' 0 N--CA 1.45 -1.066 0 C-N-CA 122.523 2.149 . . . . 0.0 111.899 175.612 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -136.3 163.89 25.11 Favored Glycine 0 CA--C 1.525 0.679 0 O-C-N 120.853 -1.154 . . . . 0.0 112.891 176.236 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -76.62 -50.12 0.11 Allowed 'Trans proline' 0 N--CA 1.454 -0.845 0 C-N-CA 122.464 2.109 . . . . 0.0 110.898 178.846 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.606 ' HB3' ' CZ ' ' A' ' 11' ' ' TYR . . . -75.29 142.51 43.27 Favored 'General case' 0 CA--C 1.51 -0.563 0 O-C-N 121.903 -0.498 . . . . 0.0 110.465 177.331 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.491 ' HG2' ' HA ' ' A' ' 84' ' ' PRO . 3.6 mtm-85 -143.81 145.69 32.53 Favored 'General case' 0 CA--C 1.5 -0.968 0 CA-C-O 117.721 -1.133 . . . . 0.0 112.415 178.32 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.492 HG11 ' HB3' ' A' ' 20' ' ' SER . 5.3 p -79.15 124.98 38.2 Favored 'Isoleucine or valine' 0 CA--C 1.513 -0.476 0 O-C-N 124.176 0.922 . . . . 0.0 110.62 177.769 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.524 HG12 HG23 ' A' ' 121' ' ' ILE . 4.4 mm -103.99 141.38 19.74 Favored 'Isoleucine or valine' 0 CA--C 1.496 -1.127 0 C-N-CA 123.914 0.886 . . . . 0.0 109.718 -179.086 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.502 ' O ' HD23 ' A' ' 80' ' ' LEU . 10.4 p90 -166.01 152.48 9.41 Favored 'General case' 0 N--CA 1.442 -0.843 0 CA-C-O 122.891 1.329 . . . . 0.0 110.034 -178.161 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.7 p -89.79 167.68 12.68 Favored 'General case' 0 CA--C 1.502 -0.894 0 CA-C-N 115.064 -0.971 . . . . 0.0 109.062 -178.905 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.588 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.3 OUTLIER -108.46 153.83 41.86 Favored Pre-proline 0 CA--C 1.552 1.031 0 O-C-N 123.534 0.521 . . . . 0.0 111.341 177.182 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.588 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 14.1 Cg_endo -75.81 -55.27 0.14 OUTLIER 'Cis proline' 0 CA--C 1.49 -1.706 0 N-CA-C 107.998 -1.578 . . . . 0.0 107.998 -5.681 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 29.0 t-20 -44.17 112.24 0.38 Allowed 'General case' 0 CA--C 1.506 -0.746 0 CA-C-O 116.279 -1.82 . . . . 0.0 109.713 179.898 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.65 ' HE2' HD13 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -66.44 76.17 0.1 Allowed 'General case' 0 CA--C 1.505 -0.755 0 C-N-CA 124.797 1.239 . . . . 0.0 107.985 -177.666 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.435 ' CG1' ' HD3' ' A' ' 59' ' ' LYS . 54.8 t -75.83 72.03 0.39 Allowed 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 N-CA-C 105.643 -1.984 . . . . 0.0 105.643 -176.255 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.56 ' CE1' ' HA2' ' A' ' 119' ' ' GLY . 7.6 t80 -39.08 111.17 0.17 Allowed 'General case' 0 N--CA 1.444 -0.735 0 C-N-CA 126.321 1.848 . . . . 0.0 106.84 -178.819 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . 0.548 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 0.1 OUTLIER -91.25 -22.78 20.41 Favored 'General case' 0 N--CA 1.436 -1.15 0 C-N-CA 121.126 -0.23 . . . . 0.0 110.405 175.974 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.56 ' HA2' ' CE1' ' A' ' 117' ' ' PHE . . . 134.82 -170.31 22.86 Favored Glycine 0 CA--C 1.496 -1.148 0 C-N-CA 123.621 0.629 . . . . 0.0 112.1 -176.636 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.539 HG21 ' HB1' ' A' ' 106' ' ' ALA . 3.4 mp -107.67 151.53 9.66 Favored 'Isoleucine or valine' 0 CA--C 1.498 -1.034 0 N-CA-C 106.41 -1.7 . . . . 0.0 106.41 -179.274 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.72 HG22 HD12 ' A' ' 133' ' ' LEU . 9.9 pt -120.94 154.72 24.5 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.621 0 N-CA-C 108.062 -1.088 . . . . 0.0 108.062 177.327 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.613 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . . . -174.34 157.97 2.83 Favored 'General case' 0 C--N 1.325 -0.475 0 CA-C-O 123.644 1.688 . . . . 0.0 110.069 175.117 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.452 ' CE1' ' HG ' ' A' ' 131' ' ' LEU . 7.2 m-70 -90.57 95.78 10.33 Favored 'General case' 0 C--O 1.219 -0.547 0 O-C-N 120.717 -1.239 . . . . 0.0 108.457 -176.339 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.639 HG22 ' HD2' ' A' ' 132' ' ' LYS . 1.3 t -96.85 36.53 1.39 Allowed 'General case' 0 N--CA 1.475 0.807 0 CA-C-O 124.391 2.043 . . . . 0.0 111.328 -179.492 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 1.5 tptt -101.53 -28.69 12.4 Favored 'General case' 0 C--O 1.217 -0.632 0 O-C-N 119.153 -2.217 . . . . 0.0 111.214 178.075 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -171.06 -66.18 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.57 0 O-C-N 123.62 0.575 . . . . 0.0 110.079 177.671 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 0.7 OUTLIER -155.59 -44.77 0.08 Allowed 'General case' 0 N--CA 1.453 -0.279 0 CA-C-O 122.096 0.951 . . . . 0.0 110.194 179.348 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 6.7 tt0 -153.55 79.1 1.15 Allowed 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 125.167 1.387 . . . . 0.0 109.269 -178.936 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -130.49 -103.54 1.0 Allowed Glycine 0 N--CA 1.463 0.486 0 O-C-N 120.399 -1.438 . . . . 0.0 109.723 176.814 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -90.25 150.57 21.9 Favored 'General case' 0 C--N 1.323 -0.577 0 O-C-N 120.99 -1.3 . . . . 0.0 110.701 -178.812 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.561 HD23 ' H ' ' A' ' 132' ' ' LYS . 0.6 OUTLIER -104.96 146.46 29.0 Favored 'General case' 0 C--N 1.324 -0.511 0 CA-C-N 118.941 0.791 . . . . 0.0 109.246 179.445 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.639 ' HD2' HG22 ' A' ' 124' ' ' THR . 0.0 OUTLIER -151.96 168.35 25.49 Favored 'General case' 0 C--N 1.321 -0.654 0 C-N-CA 125.412 1.485 . . . . 0.0 109.759 -179.9 . . . . . . . . 3 3 . 1 . 015 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.72 HD12 HG22 ' A' ' 121' ' ' ILE . 10.4 tp -84.41 141.44 30.83 Favored 'General case' 0 C--N 1.325 -0.49 0 O-C-N 124.656 1.223 . . . . 0.0 108.387 177.245 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . 0.537 ' SG ' HG22 ' A' ' 120' ' ' ILE . 79.4 m -60.64 -179.42 0.12 Allowed 'General case' 0 N--CA 1.45 -0.47 0 CA-C-O 123.264 1.507 . . . . 0.0 110.312 174.889 . . . . . . . . 2 2 . 1 . 015 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 13.2 m -159.06 87.79 0.87 Allowed 'General case' 0 C--N 1.314 -0.937 0 N-CA-C 104.002 -2.592 . . . . 0.0 104.002 -176.993 . . . . . . . . 1 1 . 1 . 015 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.611 ' HB2' HG22 ' A' ' 2' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.257 1.48 0 CA-C-O 114.024 -2.893 . . . . 0.0 114.756 167.939 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.514 -0.412 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 . . . . . . . . . 0 0 . 1 . 016 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 8.7 p -84.19 146.73 6.38 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.412 0 CA-C-O 121.611 0.719 . . . . 0.0 109.974 177.733 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 3.9 m -88.04 114.49 24.71 Favored 'General case' 0 C--N 1.323 -0.582 0 C-N-CA 123.665 0.786 . . . . 0.0 109.368 -178.927 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.515 ' CE2' ' CD2' ' A' ' 136' ' ' HIS . 19.5 m95 -79.01 144.32 34.81 Favored 'General case' 0 N--CA 1.447 -0.594 0 N-CA-C 109.249 -0.649 . . . . 0.0 109.249 179.052 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -138.61 134.35 33.65 Favored 'General case' 0 C--N 1.323 -0.577 0 N-CA-C 108.607 -0.886 . . . . 0.0 108.607 -178.426 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.617 ' SG ' ' HB3' ' A' ' 122' ' ' ALA . 0.1 OUTLIER -118.78 -84.19 0.65 Allowed 'General case' 0 N--CA 1.451 -0.406 0 CA-C-O 121.42 0.628 . . . . 0.0 110.374 176.911 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . 0.46 ' O ' HD12 ' A' ' 9' ' ' LEU . . . -92.85 75.1 1.26 Allowed Glycine 0 C--O 1.217 -0.927 0 CA-C-O 117.564 -1.687 . . . . 0.0 111.813 -177.447 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 45.9 27.5 2.4 Favored Glycine 0 N--CA 1.473 1.145 0 CA-C-N 118.96 1.38 . . . . 0.0 113.948 -175.885 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.46 HD12 ' O ' ' A' ' 7' ' ' GLY . 2.6 mt -129.98 149.17 51.82 Favored 'General case' 0 N--CA 1.449 -0.504 0 N-CA-C 107.662 -1.236 . . . . 0.0 107.662 -174.912 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.584 HD22 ' H ' ' A' ' 10' ' ' LEU . 0.1 OUTLIER -100.42 155.15 17.98 Favored 'General case' 0 C--N 1.324 -0.539 0 O-C-N 124.487 1.117 . . . . 0.0 108.102 -173.826 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.775 ' CZ ' ' HB3' ' A' ' 106' ' ' ALA . 50.7 m-85 -158.72 86.03 0.84 Allowed 'General case' 0 N--CA 1.447 -0.61 0 CA-C-O 122.181 0.991 . . . . 0.0 108.872 -172.463 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -54.99 125.22 19.5 Favored 'General case' 0 CA--C 1.509 -0.62 0 CA-C-O 117.058 -1.449 . . . . 0.0 108.727 -179.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.54 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 0.8 OUTLIER -49.74 -35.07 20.88 Favored 'General case' 0 C--O 1.222 -0.393 0 CA-C-N 119.106 0.866 . . . . 0.0 111.271 178.585 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.404 ' O ' ' CB ' ' A' ' 18' ' ' SER . 8.4 t-20 -61.07 -44.91 96.65 Favored 'General case' 0 C--O 1.204 -1.317 0 CA-C-N 116.167 -0.469 . . . . 0.0 111.41 175.95 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -72.4 -42.88 64.67 Favored 'General case' 0 C--O 1.207 -1.15 0 CA-C-O 117.736 -1.126 . . . . 0.0 111.899 173.73 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -52.09 -39.8 60.3 Favored 'General case' 0 C--N 1.322 -0.625 0 CA-C-N 119.893 1.224 . . . . 0.0 111.422 176.521 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 10.2 pt-20 -85.81 -47.91 9.27 Favored 'General case' 0 N--CA 1.441 -0.88 0 CA-C-O 117.907 -1.044 . . . . 0.0 110.387 176.099 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.404 ' CB ' ' O ' ' A' ' 14' ' ' ASN . 29.0 t -64.39 -59.42 4.38 Favored 'General case' 0 CA--C 1.499 -0.992 0 C-N-CA 125.982 1.713 . . . . 0.0 107.948 -173.368 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.471 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 13.4 t-20 -38.07 -40.51 0.49 Allowed 'General case' 0 N--CA 1.453 -0.286 0 CA-C-N 118.919 0.782 . . . . 0.0 112.362 172.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -78.6 -38.2 40.53 Favored 'General case' 0 C--O 1.218 -0.602 0 N-CA-C 114.869 1.433 . . . . 0.0 114.869 174.52 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 10.3 m170 -43.55 -36.04 1.93 Allowed 'General case' 0 C--N 1.34 0.191 0 C-N-CA 126.25 1.82 . . . . 0.0 109.87 178.037 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.471 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.1 OUTLIER -74.8 -52.0 12.59 Favored 'General case' 0 N--CA 1.44 -0.958 0 C-N-CA 124.318 1.047 . . . . 0.0 111.105 177.226 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.442 ' HB1' ' HG3' ' A' ' 35' ' ' PRO . . . -37.58 126.08 0.92 Allowed Pre-proline 0 CA--C 1.544 0.722 0 O-C-N 124.967 1.417 . . . . 0.0 111.629 174.826 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.637 ' HG2' HG22 ' A' ' 30' ' ' THR . 19.2 Cg_endo -73.09 132.18 17.77 Favored 'Trans proline' 0 N--CA 1.445 -1.343 0 C-N-CA 122.033 1.822 . . . . 0.0 110.125 -178.088 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.644 HD13 ' HE2' ' A' ' 115' ' ' LYS . 7.3 tp -59.79 112.42 1.83 Allowed 'General case' 0 N--CA 1.445 -0.676 0 CA-C-N 115.435 -0.802 . . . . 0.0 110.561 179.017 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 179.71 149.98 0.33 Allowed 'General case' 0 CA--C 1.516 -0.347 0 C-N-CA 122.617 0.367 . . . . 0.0 111.193 -178.715 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.549 ' HB2' ' CE2' ' A' ' 79' ' ' TYR . 4.2 t0 -86.86 78.99 8.93 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 122.024 0.916 . . . . 0.0 108.62 -179.378 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . 0.44 ' N ' ' HA ' ' A' ' 36' ' ' HIS . . . 68.38 76.93 0.4 Allowed Glycine 0 N--CA 1.451 -0.333 0 N-CA-C 110.346 -1.102 . . . . 0.0 110.346 177.019 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -152.13 40.55 0.63 Allowed 'General case' 0 CA--C 1.516 -0.354 0 CA-C-O 122.342 1.068 . . . . 0.0 111.876 178.503 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.637 HG22 ' HG2' ' A' ' 24' ' ' PRO . 8.4 p -121.32 159.1 26.76 Favored 'General case' 0 C--N 1.312 -1.054 0 N-CA-C 108.377 -0.972 . . . . 0.0 108.377 -176.665 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -37.66 -77.81 0.05 OUTLIER Glycine 0 C--N 1.333 0.407 0 C-N-CA 125.145 1.355 . . . . 0.0 111.846 -178.607 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.417 ' OG ' ' HE2' ' A' ' 100' ' ' LYS . 18.0 t -55.24 -57.11 13.15 Favored 'General case' 0 CA--C 1.511 -0.543 0 CA-C-O 118.203 -0.903 . . . . 0.0 111.137 177.493 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER 161.1 -51.16 0.0 OUTLIER 'General case' 0 CA--C 1.51 -0.568 0 O-C-N 124.859 1.35 . . . . 0.0 111.44 178.191 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.426 ' CD1' ' HD3' ' A' ' 84' ' ' PRO . 90.2 m-85 -69.53 147.36 96.71 Favored Pre-proline 0 N--CA 1.444 -0.775 0 O-C-N 124.089 0.868 . . . . 0.0 112.915 178.591 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.597 ' CB ' HD21 ' A' ' 81' ' ' LEU . 28.4 Cg_endo -77.42 179.3 31.66 Favored 'Cis proline' 0 N--CA 1.446 -1.314 0 C-N-CA 122.359 -1.934 . . . . 0.0 112.426 2.572 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.44 ' HA ' ' N ' ' A' ' 28' ' ' GLY . 0.5 OUTLIER -154.29 167.58 29.47 Favored 'General case' 0 CA--C 1.506 -0.72 0 CA-C-O 118.322 -0.847 . . . . 0.0 110.972 -179.87 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.908 ' CH2' HG22 ' A' ' 39' ' ' THR . 17.9 t90 -61.74 152.23 31.76 Favored 'General case' 0 C--N 1.322 -0.623 0 CA-C-O 122.183 0.992 . . . . 0.0 109.546 175.638 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.48 ' CE2' ' HB2' ' A' ' 40' ' ' ASN . 8.7 t80 -125.27 84.46 2.28 Favored 'General case' 0 N--CA 1.432 -1.344 0 N-CA-C 105.682 -1.97 . . . . 0.0 105.682 -175.411 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.908 HG22 ' CH2' ' A' ' 37' ' ' TRP . 62.3 p -38.67 -36.4 0.25 Allowed 'General case' 0 C--O 1.214 -0.784 0 CA-C-N 115.063 -0.971 . . . . 0.0 110.234 173.372 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.48 ' HB2' ' CE2' ' A' ' 38' ' ' PHE . 51.3 t30 55.07 21.15 3.65 Favored 'General case' 0 CA--C 1.528 0.106 0 CA-C-O 122.697 1.237 . . . . 0.0 110.849 177.816 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.594 ' HA3' HD23 ' A' ' 48' ' ' LEU . . . 106.9 -40.08 2.64 Favored Glycine 0 N--CA 1.423 -2.186 0 CA-C-O 118.504 -1.164 . . . . 0.0 114.431 -171.038 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.496 ' CE2' ' HD3' ' A' ' 66' ' ' PRO . 76.1 m-85 -48.72 155.42 0.57 Allowed 'General case' 0 N--CA 1.452 -0.348 0 CA-C-N 118.998 1.399 . . . . 0.0 111.761 177.492 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.44 -36.29 22.45 Favored 'General case' 0 C--N 1.327 -0.408 0 CA-C-O 121.376 0.608 . . . . 0.0 110.796 178.428 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.512 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -172.21 -61.87 0.04 OUTLIER Glycine 0 C--N 1.335 0.498 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -178.864 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -123.33 -64.19 1.18 Allowed 'General case' 0 CA--C 1.508 -0.665 0 C-N-CA 122.542 0.337 . . . . 0.0 110.891 -178.515 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -55.64 -174.13 0.14 Allowed Glycine 0 C--N 1.345 1.043 0 C-N-CA 124.435 1.016 . . . . 0.0 110.676 178.703 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -59.99 -166.28 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.557 0 CA-C-O 123.793 1.759 . . . . 0.0 110.687 178.581 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.736 ' H ' HD12 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -94.31 170.17 8.65 Favored Pre-proline 0 C--N 1.312 -1.034 0 O-C-N 120.995 -1.066 . . . . 0.0 110.217 -178.518 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.1 Cg_endo -71.64 158.18 54.12 Favored 'Trans proline' 0 N--CA 1.441 -1.582 0 C-N-CA 121.913 1.742 . . . . 0.0 111.062 178.539 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -62.28 97.59 0.09 Allowed 'General case' 0 N--CA 1.455 -0.209 0 CA-C-N 115.996 -0.547 . . . . 0.0 109.983 177.459 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 119.85 39.31 0.66 Allowed Glycine 0 C--O 1.227 -0.283 0 CA-C-O 119.476 -0.624 . . . . 0.0 111.952 -176.914 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.47 ' HG2' ' CA ' ' A' ' 41' ' ' GLY . 0.0 OUTLIER -122.63 161.81 23.09 Favored 'General case' 0 CA--C 1.511 -0.524 0 CA-C-N 117.759 0.779 . . . . 0.0 111.283 177.103 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 26.0 m -139.74 98.32 7.91 Favored Pre-proline 0 C--N 1.328 -0.357 0 O-C-N 124.265 0.978 . . . . 0.0 110.054 -178.773 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 20.5 Cg_endo -72.06 161.19 45.47 Favored 'Trans proline' 0 N--CA 1.45 -1.062 0 C-N-CA 122.052 1.835 . . . . 0.0 111.674 178.747 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.448 HD12 HG21 ' A' ' 121' ' ' ILE . 6.9 mt -85.43 121.47 37.17 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.43 0 N-CA-C 107.753 -1.202 . . . . 0.0 107.753 -178.81 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.66 135.07 35.13 Favored 'General case' 0 C--N 1.329 -0.299 0 N-CA-C 108.654 -0.869 . . . . 0.0 108.654 177.542 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.582 ' CE1' HD13 ' A' ' 133' ' ' LEU . 15.1 m-85 -118.3 -51.87 2.4 Favored 'General case' 0 C--N 1.326 -0.415 0 C-N-CA 123.354 0.661 . . . . 0.0 110.617 179.361 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 122.42 -2.09 10.4 Favored Glycine 0 C--O 1.226 -0.366 0 CA-C-N 115.638 -0.71 . . . . 0.0 112.302 -176.938 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 33.9 mmtt -100.0 141.61 32.58 Favored 'General case' 0 CA--C 1.507 -0.706 0 CA-C-N 117.567 0.683 . . . . 0.0 110.195 177.241 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 44.9 t -76.22 -2.06 29.48 Favored 'General case' 0 C--O 1.221 -0.429 0 O-C-N 124.66 1.225 . . . . 0.0 111.226 176.522 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.618 ' OD2' HG11 ' A' ' 116' ' ' VAL . 0.7 OUTLIER -87.83 -55.56 3.72 Favored 'General case' 0 CA--C 1.512 -0.511 0 O-C-N 120.876 -1.14 . . . . 0.0 109.075 -179.196 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.738 ' HA ' HD11 ' A' ' 80' ' ' LEU . 2.0 m -74.38 -31.77 62.49 Favored 'General case' 0 N--CA 1.448 -0.552 0 O-C-N 124.586 1.179 . . . . 0.0 109.383 -179.57 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 30.4 t0 -64.89 -38.24 90.3 Favored 'General case' 0 C--O 1.232 0.165 0 CA-C-O 122.279 1.037 . . . . 0.0 110.586 175.053 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -54.12 160.1 2.57 Favored Pre-proline 0 N--CA 1.445 -0.676 0 O-C-N 121.179 -0.95 . . . . 0.0 112.251 179.304 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.4 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 22.2 Cg_endo -71.2 140.62 37.73 Favored 'Trans proline' 0 N--CA 1.441 -1.586 0 C-N-CA 120.326 0.684 . . . . 0.0 113.422 175.629 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.496 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 22.9 Cg_endo -73.1 170.3 20.14 Favored 'Trans proline' 0 N--CA 1.446 -1.307 0 C-N-CA 123.542 2.828 . . . . 0.0 111.415 177.949 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.9 tptp -136.15 57.38 1.78 Allowed 'General case' 0 C--O 1.214 -0.789 0 N-CA-C 108.504 -0.924 . . . . 0.0 108.504 -178.913 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 43.8 t-80 -74.0 154.95 39.07 Favored 'General case' 0 CA--C 1.543 0.685 0 CA-C-O 124.486 2.089 . . . . 0.0 113.09 175.285 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -142.07 -172.08 3.5 Favored 'General case' 0 C--N 1.322 -0.598 0 O-C-N 118.677 -2.514 . . . . 0.0 110.411 178.2 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -85.26 69.48 10.74 Favored 'General case' 0 N--CA 1.45 -0.44 0 O-C-N 121.947 -0.471 . . . . 0.0 111.042 176.717 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -177.76 -42.68 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.46 0 O-C-N 123.555 0.535 . . . . 0.0 110.112 179.365 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.507 ' CA ' ' HB3' ' A' ' 27' ' ' ASP . . . 124.98 -78.95 0.37 Allowed Glycine 0 N--CA 1.441 -0.967 0 CA-C-N 115.189 -0.914 . . . . 0.0 112.727 -179.688 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 9.2 p-10 -118.86 58.66 0.84 Allowed 'General case' 0 N--CA 1.449 -0.488 0 C-N-CA 124.236 1.015 . . . . 0.0 108.956 178.353 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -57.28 -105.58 0.01 OUTLIER Glycine 0 CA--C 1.525 0.701 0 CA-C-O 121.661 0.589 . . . . 0.0 112.695 -179.831 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 22.1 mttt -60.97 -96.32 0.0 OUTLIER 'General case' 0 C--O 1.222 -0.384 0 O-C-N 121.197 -1.178 . . . . 0.0 111.259 177.393 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.583 HG23 ' O ' ' A' ' 76' ' ' THR . 0.6 OUTLIER -126.63 26.88 6.2 Favored 'General case' 0 CA--C 1.511 -0.527 0 O-C-N 121.645 -0.659 . . . . 0.0 111.086 178.902 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.476 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 1.9 m-20 -34.49 106.23 0.04 OUTLIER 'General case' 0 C--O 1.216 -0.689 0 C-N-CA 124.597 1.159 . . . . 0.0 109.91 -176.732 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.461 ' CD2' ' H ' ' A' ' 78' ' ' HIS . 0.4 OUTLIER -84.19 19.49 1.83 Allowed 'General case' 0 C--N 1.328 -0.354 0 O-C-N 121.142 -0.974 . . . . 0.0 110.63 -177.37 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.549 ' CE2' ' HB2' ' A' ' 27' ' ' ASP . 22.9 p90 -48.49 135.46 14.19 Favored 'General case' 0 N--CA 1.439 -0.997 0 C-N-CA 124.695 1.198 . . . . 0.0 110.818 177.933 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.738 HD11 ' HA ' ' A' ' 62' ' ' CYS . 0.2 OUTLIER -76.07 137.24 40.05 Favored 'General case' 0 N--CA 1.451 -0.392 0 N-CA-C 108.214 -1.032 . . . . 0.0 108.214 178.431 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.85 HD22 ' CZ ' ' A' ' 110' ' ' TYR . 0.3 OUTLIER -123.91 148.76 46.58 Favored 'General case' 0 C--N 1.317 -0.807 0 N-CA-C 108.63 -0.878 . . . . 0.0 108.63 177.132 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 2.1 pm0 -115.16 163.45 15.63 Favored 'General case' 0 N--CA 1.444 -0.764 0 CA-C-N 115.725 -0.671 . . . . 0.0 112.134 176.965 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.508 ' CD1' ' HD2' ' A' ' 84' ' ' PRO . 40.2 t80 -152.61 133.93 8.19 Favored Pre-proline 0 CA--C 1.534 0.352 0 N-CA-C 113.119 0.785 . . . . 0.0 113.119 -178.981 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.508 ' HD2' ' CD1' ' A' ' 83' ' ' PHE . 17.8 Cg_endo -72.27 104.3 1.66 Allowed 'Trans proline' 0 N--CA 1.446 -1.299 0 C-N-CA 123.345 2.697 . . . . 0.0 110.626 -176.573 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.426 ' HA ' ' OD1' ' A' ' 19' ' ' ASN . 1.6 t -105.92 108.36 19.83 Favored 'General case' 0 CA--C 1.5 -0.947 0 O-C-N 124.356 1.035 . . . . 0.0 110.136 -178.773 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.438 ' CD2' ' NE2' ' A' ' 90' ' ' HIS . 1.4 m-85 -85.29 161.25 52.45 Favored Pre-proline 0 C--N 1.319 -0.739 0 CA-C-O 121.138 0.494 . . . . 0.0 111.372 -179.407 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -76.33 -41.23 0.49 Allowed 'Trans proline' 0 CA--C 1.496 -1.395 0 C-N-CA 121.871 1.714 . . . . 0.0 112.711 179.555 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -39.54 -31.13 0.08 Allowed 'General case' 0 N--CA 1.469 0.497 0 O-C-N 124.989 1.431 . . . . 0.0 111.363 175.176 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 91.58 -9.96 75.85 Favored Glycine 0 N--CA 1.43 -1.76 0 C-N-CA 124.749 1.166 . . . . 0.0 111.892 179.234 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.438 ' NE2' ' CD2' ' A' ' 86' ' ' PHE . 0.5 OUTLIER -57.63 143.8 39.97 Favored 'General case' 0 N--CA 1.442 -0.855 0 CA-C-O 122.712 1.244 . . . . 0.0 109.089 177.447 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 6.5 t70 -88.6 122.54 32.16 Favored 'General case' 0 C--N 1.317 -0.827 0 N-CA-C 108.416 -0.957 . . . . 0.0 108.416 174.827 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 4.6 t80 -48.11 170.02 0.02 OUTLIER 'General case' 0 C--O 1.214 -0.78 0 CA-C-O 123.213 1.482 . . . . 0.0 113.614 175.761 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -99.86 60.83 1.1 Allowed 'General case' 0 C--N 1.321 -0.634 0 O-C-N 119.371 -2.081 . . . . 0.0 107.33 -176.937 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.415 ' CD2' ' HZ ' ' A' ' 83' ' ' PHE . 7.3 p90 -81.12 14.91 2.09 Favored 'General case' 0 C--N 1.324 -0.531 0 O-C-N 121.742 -0.599 . . . . 0.0 112.1 177.417 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 14.1 t70 -108.46 -31.41 7.82 Favored 'General case' 0 C--N 1.327 -0.403 0 CA-C-O 121.458 0.647 . . . . 0.0 109.982 -179.608 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.8 m -113.87 116.09 28.75 Favored 'General case' 0 CA--C 1.507 -0.682 0 C-N-CA 123.175 0.59 . . . . 0.0 109.474 -179.589 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.8 pttm -58.33 -45.48 88.02 Favored 'General case' 0 CA--C 1.514 -0.414 0 CA-C-N 116.142 -0.481 . . . . 0.0 111.058 177.741 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.419 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 9.7 ttmt -142.07 131.9 12.47 Favored Pre-proline 0 N--CA 1.442 -0.87 0 CA-C-O 118.424 -0.798 . . . . 0.0 109.948 -179.138 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.419 ' C ' ' HA ' ' A' ' 98' ' ' LYS . 30.9 Cg_endo -70.25 175.37 38.41 Favored 'Cis proline' 0 N--CA 1.456 -0.724 0 O-C-N 124.769 1.931 . . . . 0.0 112.256 -4.437 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.417 ' HE2' ' OG ' ' A' ' 32' ' ' SER . 0.0 OUTLIER -145.18 147.54 32.58 Favored 'General case' 0 C--N 1.326 -0.434 0 N-CA-C 109.807 -0.442 . . . . 0.0 109.807 177.765 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.2 tt0 -84.86 175.87 8.85 Favored 'General case' 0 C--N 1.323 -0.567 0 CA-C-O 121.24 0.543 . . . . 0.0 111.276 179.738 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 25.8 t-20 -73.13 140.67 80.36 Favored Pre-proline 0 CA--C 1.545 0.754 0 O-C-N 121.469 -0.769 . . . . 0.0 111.361 175.258 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -70.26 -161.85 0.09 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.95 0 C-N-CA 122.47 2.114 . . . . 0.0 113.356 175.431 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -137.83 158.08 24.49 Favored Glycine 0 CA--C 1.523 0.592 0 O-C-N 120.948 -1.095 . . . . 0.0 111.625 176.485 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -74.4 -41.03 0.95 Allowed 'Trans proline' 0 N--CA 1.45 -1.051 0 C-N-CA 122.242 1.962 . . . . 0.0 111.374 179.184 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.775 ' HB3' ' CZ ' ' A' ' 11' ' ' TYR . . . -90.28 138.23 31.7 Favored 'General case' 0 N--CA 1.445 -0.693 0 CA-C-O 121.082 0.467 . . . . 0.0 110.03 177.739 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.463 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 0.0 OUTLIER -139.32 151.82 46.71 Favored 'General case' 0 C--O 1.213 -0.845 0 CA-C-O 117.916 -1.04 . . . . 0.0 111.483 177.753 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.517 ' C ' HD12 ' A' ' 109' ' ' ILE . 3.3 p -82.62 120.71 34.56 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.467 0 C-N-CA 123.958 0.903 . . . . 0.0 110.584 177.403 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.517 HD12 ' C ' ' A' ' 108' ' ' VAL . 1.7 mp -108.16 120.49 59.61 Favored 'Isoleucine or valine' 0 CA--C 1.509 -0.628 0 N-CA-C 107.287 -1.375 . . . . 0.0 107.287 -176.756 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.85 ' CZ ' HD22 ' A' ' 81' ' ' LEU . 5.8 p90 -140.92 152.42 45.01 Favored 'General case' 0 N--CA 1.444 -0.733 0 CA-C-O 122.733 1.254 . . . . 0.0 110.149 -178.853 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.44 HG22 HD21 ' A' ' 80' ' ' LEU . 3.0 p -84.33 160.88 20.6 Favored 'General case' 0 C--N 1.321 -0.672 0 CA-C-N 115.047 -0.979 . . . . 0.0 109.788 -179.547 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.56 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.3 OUTLIER -113.01 152.83 45.26 Favored Pre-proline 0 CA--C 1.545 0.758 0 CA-C-O 120.464 0.173 . . . . 0.0 110.927 179.506 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.56 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 19.3 Cg_endo -74.25 -50.03 0.2 Allowed 'Cis proline' 0 CA--C 1.499 -1.261 0 C-N-CA 123.462 -1.474 . . . . 0.0 111.043 -5.021 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 32.6 t-20 -44.39 106.57 0.07 Allowed 'General case' 0 CA--C 1.512 -0.516 0 O-C-N 125.03 1.456 . . . . 0.0 108.801 178.582 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.644 ' HE2' HD13 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -67.88 68.56 0.11 Allowed 'General case' 0 CA--C 1.514 -0.42 0 C-N-CA 124.322 1.049 . . . . 0.0 108.811 -178.828 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.618 HG11 ' OD2' ' A' ' 61' ' ' ASP . 24.2 t -73.87 73.32 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.446 -0.628 0 N-CA-C 105.356 -2.09 . . . . 0.0 105.356 -177.787 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.561 ' CE1' ' HA2' ' A' ' 119' ' ' GLY . 4.6 t80 -37.26 117.1 0.51 Allowed 'General case' 0 N--CA 1.438 -1.039 0 C-N-CA 124.65 1.18 . . . . 0.0 108.139 179.132 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . 0.563 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -97.15 -34.08 11.26 Favored 'General case' 0 N--CA 1.439 -0.976 0 CA-C-N 115.936 -0.575 . . . . 0.0 109.744 177.328 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.561 ' HA2' ' CE1' ' A' ' 117' ' ' PHE . . . 146.25 -175.09 25.9 Favored Glycine 0 N--CA 1.446 -0.664 0 C-N-CA 123.484 0.564 . . . . 0.0 111.708 -178.375 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.711 HG21 ' HB1' ' A' ' 106' ' ' ALA . 3.3 mp -103.66 149.38 7.63 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.745 0 N-CA-C 108.041 -1.096 . . . . 0.0 108.041 -179.185 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.448 HG21 HD12 ' A' ' 55' ' ' ILE . 5.3 pt -122.16 151.85 26.03 Favored 'Isoleucine or valine' 0 C--N 1.313 -0.982 0 N-CA-C 108.361 -0.977 . . . . 0.0 108.361 178.873 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.617 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . . . -176.65 132.55 0.21 Allowed 'General case' 0 C--N 1.326 -0.418 0 CA-C-O 122.558 1.171 . . . . 0.0 109.504 178.204 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.457 ' H ' ' CD2' ' A' ' 123' ' ' HIS . 0.3 OUTLIER -88.17 94.83 9.94 Favored 'General case' 0 C--N 1.325 -0.461 0 O-C-N 121.079 -1.013 . . . . 0.0 110.687 179.188 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.504 ' O ' HG23 ' A' ' 124' ' ' THR . 1.1 t -98.48 33.19 2.3 Favored 'General case' 0 C--N 1.321 -0.641 0 CA-C-O 123.154 1.454 . . . . 0.0 111.306 179.71 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 2.4 tttt -84.32 -46.42 11.8 Favored 'General case' 0 C--O 1.215 -0.728 0 CA-C-O 117.866 -1.064 . . . . 0.0 109.709 179.168 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.8 OUTLIER 172.74 -82.39 0.0 OUTLIER 'General case' 0 C--O 1.224 -0.244 0 C-N-CA 124.592 1.157 . . . . 0.0 110.371 -179.988 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.4 t-20 -157.99 25.64 0.26 Allowed 'General case' 0 N--CA 1.448 -0.531 0 C-N-CA 124.483 1.113 . . . . 0.0 110.704 -178.568 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.3 OUTLIER -170.82 88.56 0.12 Allowed 'General case' 0 N--CA 1.446 -0.66 0 CA-C-O 122.069 0.938 . . . . 0.0 110.599 -177.631 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 167.94 104.15 0.17 Allowed Glycine 0 CA--C 1.491 -1.421 0 CA-C-O 116.04 -2.533 . . . . 0.0 107.134 179.266 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 6.5 mt-10 -33.02 139.23 0.05 Allowed 'General case' 0 C--O 1.238 0.461 0 C-N-CA 125.686 1.595 . . . . 0.0 112.35 177.878 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.421 HD23 ' HA ' ' A' ' 122' ' ' ALA . 0.3 OUTLIER -56.94 156.01 7.32 Favored 'General case' 0 N--CA 1.446 -0.643 0 CA-C-N 114.818 -1.083 . . . . 0.0 110.185 -177.632 . . . . . . . . 3 3 . 1 . 016 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -132.87 153.37 51.39 Favored 'General case' 0 CA--C 1.502 -0.885 0 N-CA-C 108.468 -0.938 . . . . 0.0 108.468 -176.905 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.582 HD13 ' CE1' ' A' ' 57' ' ' PHE . 9.9 tp -59.63 129.64 42.9 Favored 'General case' 0 N--CA 1.449 -0.51 0 O-C-N 125.141 1.526 . . . . 0.0 107.42 -179.77 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . 0.59 ' SG ' HG22 ' A' ' 120' ' ' ILE . 79.9 m -58.64 -177.22 0.03 OUTLIER 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 125.031 1.457 . . . . 0.0 109.313 178.204 . . . . . . . . 2 2 . 1 . 016 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 1.2 m -152.22 81.6 1.25 Allowed 'General case' 0 CA--C 1.5 -0.944 0 N-CA-C 106.131 -1.803 . . . . 0.0 106.131 -176.8 . . . . . . . . 1 1 . 1 . 016 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.515 ' CD2' ' CE2' ' A' ' 4' ' ' TRP . 0.0 OUTLIER . . . . . 0 C--O 1.242 0.692 0 CA-C-O 116.021 -1.942 . . . . 0.0 112.546 173.35 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.486 1.373 0 CA-C-O 116.258 -1.829 . . . . 0.0 107.827 . . . . . . . . . 0 0 . 1 . 017 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.484 HG11 ' CD2' ' A' ' 136' ' ' HIS . 0.4 OUTLIER 77.87 148.3 0.01 OUTLIER 'Isoleucine or valine' 0 N--CA 1.465 0.294 0 C-N-CA 125.191 1.396 . . . . 0.0 109.155 -177.185 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.827 HG21 HD23 ' A' ' 10' ' ' LEU . 9.3 m -101.9 105.14 15.91 Favored 'General case' 0 C--N 1.313 -1.013 0 O-C-N 121.584 -0.698 . . . . 0.0 109.373 -176.864 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 20.3 m95 -73.81 141.97 46.17 Favored 'General case' 0 C--O 1.217 -0.615 0 C-N-CA 124.202 1.001 . . . . 0.0 108.628 -178.258 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -135.23 144.33 46.84 Favored 'General case' 0 C--N 1.32 -0.685 0 N-CA-C 108.144 -1.058 . . . . 0.0 108.144 -179.339 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.607 ' SG ' ' HB3' ' A' ' 122' ' ' ALA . 0.8 OUTLIER -124.47 30.68 5.94 Favored 'General case' 0 C--N 1.325 -0.48 0 C-N-CA 123.324 0.65 . . . . 0.0 112.571 175.404 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 153.08 -96.78 0.17 Allowed Glycine 0 C--O 1.223 -0.539 0 N-CA-C 111.267 -0.733 . . . . 0.0 111.267 -179.762 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -118.45 -4.48 13.58 Favored Glycine 0 N--CA 1.468 0.802 0 C-N-CA 123.649 0.642 . . . . 0.0 113.862 176.135 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.422 ' H ' HD12 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -104.53 133.38 49.49 Favored 'General case' 0 CA--C 1.517 -0.301 0 N-CA-C 107.661 -1.237 . . . . 0.0 107.661 -176.894 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.827 HD23 HG21 ' A' ' 3' ' ' THR . 4.8 mp -94.25 164.81 12.88 Favored 'General case' 0 C--O 1.221 -0.426 0 O-C-N 125.373 1.67 . . . . 0.0 110.4 -179.569 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.479 ' H ' HG22 ' A' ' 3' ' ' THR . 41.3 m-85 -157.62 84.19 0.9 Allowed 'General case' 0 C--N 1.327 -0.381 0 C-N-CA 125.086 1.354 . . . . 0.0 108.548 -170.956 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -54.33 122.85 11.25 Favored 'General case' 0 C--O 1.218 -0.57 0 N-CA-C 107.363 -1.347 . . . . 0.0 107.363 -179.129 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.544 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 0.7 OUTLIER -52.08 -48.56 64.62 Favored 'General case' 0 C--O 1.212 -0.915 0 CA-C-N 119.753 1.16 . . . . 0.0 111.876 -179.163 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.4 t-20 -48.0 -34.98 10.16 Favored 'General case' 0 C--O 1.207 -1.169 0 O-C-N 124.455 1.097 . . . . 0.0 111.548 176.331 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -76.38 -55.7 5.31 Favored 'General case' 0 C--O 1.202 -1.429 0 CA-C-O 114.991 -2.433 . . . . 0.0 114.262 168.187 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -43.38 -37.96 2.53 Favored 'General case' 0 CA--C 1.538 0.487 0 CA-C-N 122.274 2.306 . . . . 0.0 113.89 173.264 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.8 pt-20 -82.16 -53.11 6.34 Favored 'General case' 0 N--CA 1.45 -0.446 0 CA-C-O 117.136 -1.411 . . . . 0.0 110.54 172.999 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 34.8 t -57.77 -22.3 46.25 Favored 'General case' 0 C--O 1.218 -0.593 0 CA-C-N 119.923 1.238 . . . . 0.0 109.466 -177.787 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.451 ' ND2' ' CE1' ' A' ' 83' ' ' PHE . 0.1 OUTLIER -75.39 -46.31 33.71 Favored 'General case' 0 N--CA 1.433 -1.304 0 O-C-N 120.277 -1.514 . . . . 0.0 110.596 176.351 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -70.38 -6.31 34.54 Favored 'General case' 0 CA--C 1.537 0.448 0 C-N-CA 124.311 1.044 . . . . 0.0 112.405 173.854 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 20.0 m170 -73.55 -43.32 60.17 Favored 'General case' 0 C--O 1.222 -0.379 0 O-C-N 120.017 -1.677 . . . . 0.0 110.758 -179.79 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -81.89 -35.17 29.51 Favored 'General case' 0 C--O 1.22 -0.5 0 C-N-CA 123.636 0.775 . . . . 0.0 111.304 178.862 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.733 ' HB1' ' HG3' ' A' ' 35' ' ' PRO . . . -42.92 125.65 3.2 Favored Pre-proline 0 N--CA 1.442 -0.833 0 O-C-N 125.11 1.506 . . . . 0.0 112.706 177.463 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.46 ' HG2' ' CG2' ' A' ' 30' ' ' THR . 19.3 Cg_endo -72.87 127.01 11.81 Favored 'Trans proline' 0 N--CA 1.446 -1.322 0 C-N-CA 122.327 2.018 . . . . 0.0 108.589 -175.419 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.562 HD23 ' CE2' ' A' ' 112' ' ' TYR . 0.9 OUTLIER -63.49 111.15 2.21 Favored 'General case' 0 N--CA 1.449 -0.504 0 C-N-CA 123.519 0.728 . . . . 0.0 109.244 178.877 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . 0.707 ' O ' HD12 ' A' ' 81' ' ' LEU . 0.2 OUTLIER -176.46 175.29 1.79 Allowed 'General case' 0 C--O 1.209 -1.034 0 C-N-CA 123.815 0.846 . . . . 0.0 111.552 -179.421 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.458 ' HB3' ' CA ' ' A' ' 72' ' ' GLY . 3.5 t0 -115.54 85.55 2.3 Favored 'General case' 0 C--N 1.318 -0.775 0 N-CA-C 105.835 -1.913 . . . . 0.0 105.835 176.799 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 74.68 71.42 1.13 Allowed Glycine 0 C--O 1.226 -0.381 0 N-CA-C 110.146 -1.181 . . . . 0.0 110.146 174.261 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -150.79 51.42 0.86 Allowed 'General case' 0 N--CA 1.471 0.616 0 CA-C-O 122.942 1.353 . . . . 0.0 112.583 179.139 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.539 HG21 ' HD2' ' A' ' 35' ' ' PRO . 0.8 OUTLIER -137.5 149.02 46.48 Favored 'General case' 0 C--N 1.308 -1.23 0 N-CA-C 107.63 -1.248 . . . . 0.0 107.63 -173.356 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -41.07 -69.93 0.46 Allowed Glycine 0 CA--C 1.509 -0.33 0 O-C-N 124.829 1.331 . . . . 0.0 113.59 -175.826 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 47.2 t -56.65 -53.29 59.4 Favored 'General case' 0 CA--C 1.515 -0.374 0 CA-C-O 116.344 -1.788 . . . . 0.0 111.727 175.306 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 155.65 -34.91 0.01 OUTLIER 'General case' 0 N--CA 1.478 0.961 0 C-N-CA 127.653 2.381 . . . . 0.0 112.178 177.318 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.462 ' CE1' ' CZ ' ' A' ' 107' ' ' ARG . 92.7 m-85 -85.24 144.16 40.49 Favored Pre-proline 0 CA--C 1.544 0.713 0 N-CA-C 115.027 1.491 . . . . 0.0 115.027 178.203 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.733 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 40.8 Cg_endo -80.95 174.93 44.88 Favored 'Cis proline' 0 N--CA 1.435 -1.914 0 C-N-CA 122.628 -1.822 . . . . 0.0 112.199 5.149 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.404 ' O ' ' HG ' ' A' ' 81' ' ' LEU . 0.3 OUTLIER -149.89 165.76 31.61 Favored 'General case' 0 CA--C 1.502 -0.871 0 CA-C-O 117.587 -1.197 . . . . 0.0 110.694 -175.585 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.65 ' CH2' HG22 ' A' ' 39' ' ' THR . 19.9 t90 -70.87 146.06 49.86 Favored 'General case' 0 C--O 1.24 0.586 0 C-N-CA 118.686 -1.205 . . . . 0.0 111.107 173.349 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . . . . . . . . . 9.9 t80 -114.46 85.73 2.29 Favored 'General case' 0 N--CA 1.44 -0.973 0 N-CA-C 104.026 -2.583 . . . . 0.0 104.026 -176.845 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.65 HG22 ' CH2' ' A' ' 37' ' ' TRP . 60.5 p -36.63 -41.39 0.3 Allowed 'General case' 0 C--O 1.212 -0.892 0 CA-C-N 114.275 -1.33 . . . . 0.0 110.914 169.701 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . . . . . . . . . 57.4 t30 58.31 20.19 7.02 Favored 'General case' 0 N--CA 1.468 0.464 0 CA-C-O 122.972 1.368 . . . . 0.0 111.224 178.514 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 107.37 -39.81 2.75 Favored Glycine 0 N--CA 1.436 -1.345 0 CA-C-O 118.425 -1.208 . . . . 0.0 114.181 -168.988 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.421 ' CE2' ' HD3' ' A' ' 66' ' ' PRO . 86.9 m-85 -53.85 147.4 12.09 Favored 'General case' 0 N--CA 1.463 0.195 0 CA-C-N 118.574 1.187 . . . . 0.0 110.392 -178.966 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -82.04 -36.77 27.39 Favored 'General case' 0 N--CA 1.472 0.651 0 CA-C-O 122.216 1.008 . . . . 0.0 111.516 179.065 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 179.59 -56.89 0.08 OUTLIER Glycine 0 C--N 1.332 0.36 0 C-N-CA 124.995 1.284 . . . . 0.0 110.833 -178.722 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 8.5 m-20 -78.84 -156.93 0.11 Allowed 'General case' 0 N--CA 1.444 -0.759 0 CA-C-O 123.434 1.587 . . . . 0.0 110.861 179.504 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . 0.481 ' CA ' ' HB2' ' A' ' 65' ' ' PRO . . . -88.59 44.26 3.15 Favored Glycine 0 N--CA 1.442 -0.934 0 CA-C-O 118.347 -1.252 . . . . 0.0 114.562 174.344 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.2 mtpt -146.21 160.62 41.73 Favored 'General case' 0 N--CA 1.465 0.31 0 C-N-CA 125.12 1.368 . . . . 0.0 110.233 -179.936 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . . . . . . . . . 1.1 mp -125.99 155.8 72.68 Favored Pre-proline 0 C--O 1.241 0.621 0 CA-C-N 115.639 -0.71 . . . . 0.0 110.931 -177.911 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 19.5 Cg_endo -71.2 158.22 55.32 Favored 'Trans proline' 0 N--CA 1.45 -1.071 0 C-N-CA 122.045 1.83 . . . . 0.0 110.011 179.556 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -52.81 105.79 0.14 Allowed 'General case' 0 CA--C 1.537 0.454 0 C-N-CA 123.536 0.734 . . . . 0.0 109.214 176.161 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 96.32 61.09 0.98 Allowed Glycine 0 N--CA 1.465 0.585 0 O-C-N 121.574 -0.704 . . . . 0.0 112.237 -176.643 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . . . . . . . . . 2.8 tpm_? -134.79 151.61 51.09 Favored 'General case' 0 CA--C 1.51 -0.588 0 O-C-N 122.083 -0.657 . . . . 0.0 111.117 174.396 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 2.6 m -147.97 103.98 3.62 Favored Pre-proline 0 C--N 1.325 -0.479 0 O-C-N 124.181 0.926 . . . . 0.0 109.285 -179.487 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -71.16 154.82 61.91 Favored 'Trans proline' 0 N--CA 1.445 -1.33 0 C-N-CA 122.459 2.106 . . . . 0.0 110.867 176.262 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.548 HD12 HG21 ' A' ' 121' ' ' ILE . 12.0 mt -63.91 123.83 17.46 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.566 0 N-CA-C 108.311 -0.996 . . . . 0.0 108.311 178.734 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -83.06 135.25 34.91 Favored 'General case' 0 C--N 1.328 -0.368 0 N-CA-C 108.872 -0.788 . . . . 0.0 108.872 177.949 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.577 ' CD1' ' HB3' ' A' ' 118' ' ' CYS . 21.7 m-85 -116.27 -33.58 4.93 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 124.458 1.103 . . . . 0.0 110.754 179.621 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.06 -2.38 56.65 Favored Glycine 0 CA--C 1.525 0.707 0 O-C-N 121.558 -0.713 . . . . 0.0 113.406 -174.583 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -98.65 132.95 43.64 Favored 'General case' 0 CA--C 1.498 -1.056 0 CA-C-N 118.086 0.943 . . . . 0.0 109.875 176.923 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -64.82 -13.94 57.57 Favored 'General case' 0 C--O 1.217 -0.645 0 O-C-N 124.535 1.147 . . . . 0.0 112.222 177.191 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.433 ' HB2' HG11 ' A' ' 116' ' ' VAL . 0.1 OUTLIER -86.88 -49.67 7.23 Favored 'General case' 0 CA--C 1.516 -0.354 0 C-N-CA 125.295 1.438 . . . . 0.0 110.106 178.438 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.45 ' HB3' ' CD2' ' A' ' 57' ' ' PHE . 79.4 m -74.89 -9.9 58.98 Favored 'General case' 0 C--O 1.222 -0.361 0 O-C-N 124.015 0.822 . . . . 0.0 112.906 174.711 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 18.3 t0 -92.67 -41.39 10.2 Favored 'General case' 0 N--CA 1.467 0.413 0 C-N-CA 125.308 1.443 . . . . 0.0 109.224 176.468 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.14 157.26 1.55 Allowed Pre-proline 0 N--CA 1.45 -0.462 0 CA-C-O 122.189 0.995 . . . . 0.0 111.552 -177.738 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.481 ' HB2' ' CA ' ' A' ' 46' ' ' GLY . 26.7 Cg_endo -69.75 132.44 23.36 Favored 'Trans proline' 0 N--CA 1.43 -2.224 0 N-CA-C 114.193 0.805 . . . . 0.0 114.193 174.354 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.421 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 29.1 Cg_endo -69.39 168.11 22.01 Favored 'Trans proline' 0 N--CA 1.433 -2.066 0 C-N-CA 123.691 2.928 . . . . 0.0 111.129 175.814 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 2.4 tptt -127.99 123.31 34.46 Favored 'General case' 0 CA--C 1.507 -0.675 0 CA-C-O 115.472 -2.204 . . . . 0.0 105.101 176.148 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 14.1 t-80 -107.37 164.18 12.41 Favored 'General case' 0 CA--C 1.538 0.5 0 O-C-N 127.528 3.017 . . . . 0.0 110.888 171.92 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -154.06 175.53 13.31 Favored 'General case' 0 C--N 1.325 -0.463 0 CA-C-O 122.406 1.098 . . . . 0.0 109.633 -178.982 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -84.21 48.7 1.52 Allowed 'General case' 0 C--O 1.218 -0.594 0 O-C-N 121.568 -0.707 . . . . 0.0 112.3 175.19 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -161.64 22.14 0.12 Allowed 'General case' 0 N--CA 1.473 0.685 0 CA-C-O 122.614 1.197 . . . . 0.0 112.23 -178.691 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.458 ' CA ' ' HB3' ' A' ' 27' ' ' ASP . . . 73.92 -63.73 1.98 Allowed Glycine 0 CA--C 1.538 1.48 0 O-C-N 120.793 -1.192 . . . . 0.0 112.897 -169.911 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 16.0 t30 -108.08 -98.65 0.37 Allowed 'General case' 0 C--O 1.207 -1.145 0 N-CA-C 106.525 -1.657 . . . . 0.0 106.525 175.001 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 123.52 -157.93 18.04 Favored Glycine 0 C--O 1.222 -0.65 0 O-C-N 119.795 -1.815 . . . . 0.0 110.644 -168.154 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 3.9 mttp -50.54 -84.29 0.01 OUTLIER 'General case' 0 N--CA 1.477 0.89 0 C-N-CA 123.919 0.888 . . . . 0.0 113.268 -179.728 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.427 HG23 ' O ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -117.61 9.55 13.16 Favored 'General case' 0 C--N 1.323 -0.572 0 CA-C-O 118.554 -0.736 . . . . 0.0 111.879 175.6 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.422 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 0.4 OUTLIER -26.2 97.95 0.01 OUTLIER 'General case' 0 C--O 1.211 -0.958 0 C-N-CA 126.671 1.988 . . . . 0.0 112.1 -179.325 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.467 ' CD2' ' H ' ' A' ' 78' ' ' HIS . 6.0 p80 -89.12 69.4 8.34 Favored 'General case' 0 CA--C 1.506 -0.721 0 O-C-N 119.446 -2.034 . . . . 0.0 107.326 -170.076 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.424 ' HB2' ' CD1' ' A' ' 37' ' ' TRP . 35.9 p90 -92.84 135.55 34.03 Favored 'General case' 0 C--N 1.324 -0.539 0 C-N-CA 124.674 1.189 . . . . 0.0 109.575 -177.274 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . . . . . . . . . 0.4 OUTLIER -73.47 127.96 34.15 Favored 'General case' 0 C--O 1.213 -0.86 0 N-CA-C 108.52 -0.918 . . . . 0.0 108.52 175.292 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.921 HD22 ' CZ ' ' A' ' 110' ' ' TYR . 0.1 OUTLIER -115.08 146.08 41.67 Favored 'General case' 0 C--N 1.323 -0.548 0 N-CA-C 108.585 -0.895 . . . . 0.0 108.585 174.965 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -106.83 161.73 14.43 Favored 'General case' 0 C--O 1.242 0.68 0 CA-C-O 122.355 1.074 . . . . 0.0 112.214 173.995 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.451 ' CE1' ' ND2' ' A' ' 19' ' ' ASN . 9.1 t80 -153.95 140.23 12.68 Favored Pre-proline 0 C--N 1.328 -0.368 0 O-C-N 121.444 -0.785 . . . . 0.0 112.715 179.703 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.408 ' HA ' ' HG2' ' A' ' 107' ' ' ARG . 20.1 Cg_endo -70.99 95.72 0.67 Allowed 'Trans proline' 0 N--CA 1.458 -0.564 0 C-N-CA 124.366 3.378 . . . . 0.0 112.844 179.96 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 14.8 t -101.54 104.49 15.39 Favored 'General case' 0 C--N 1.326 -0.447 0 CA-C-O 122.436 1.112 . . . . 0.0 110.347 -177.169 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 37.9 m-85 -80.61 160.87 66.07 Favored Pre-proline 0 C--N 1.32 -0.681 0 O-C-N 121.099 -1.001 . . . . 0.0 111.932 -179.569 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 12.2 Cg_endo -76.39 -35.05 2.38 Favored 'Trans proline' 0 N--CA 1.452 -0.914 0 C-N-CA 122.194 1.929 . . . . 0.0 113.664 177.098 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 2.0 m-20 -43.02 -31.61 0.55 Allowed 'General case' 0 N--CA 1.475 0.781 0 O-C-N 125.213 1.57 . . . . 0.0 110.868 174.589 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 80.71 15.81 76.91 Favored Glycine 0 N--CA 1.443 -0.893 0 CA-C-N 115.574 -0.739 . . . . 0.0 111.5 178.379 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 1.6 p-80 -81.62 160.74 23.7 Favored 'General case' 0 N--CA 1.445 -0.722 0 CA-C-O 121.36 0.6 . . . . 0.0 109.824 177.42 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 17.7 t70 -97.11 92.28 5.97 Favored 'General case' 0 C--N 1.319 -0.729 0 N-CA-C 108.066 -1.087 . . . . 0.0 108.066 174.223 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.506 ' CE2' ' HB3' ' A' ' 101' ' ' GLU . 0.0 OUTLIER -47.57 162.52 0.07 Allowed 'General case' 0 C--O 1.223 -0.303 0 CA-C-O 123.105 1.431 . . . . 0.0 113.194 175.68 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -87.18 59.1 5.39 Favored 'General case' 0 C--N 1.319 -0.759 0 O-C-N 120.026 -1.671 . . . . 0.0 110.899 177.531 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . . . . . . . . . 43.7 p90 -75.09 -16.47 60.56 Favored 'General case' 0 C--N 1.324 -0.526 0 CA-C-N 115.369 -0.832 . . . . 0.0 112.755 175.303 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 6.4 t0 -92.66 -23.25 19.03 Favored 'General case' 0 N--CA 1.469 0.48 0 CA-C-O 123.873 1.797 . . . . 0.0 111.478 179.355 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.4 OUTLIER -87.51 109.82 19.88 Favored 'General case' 0 CA--C 1.513 -0.458 0 O-C-N 119.892 -1.755 . . . . 0.0 109.131 177.871 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 7.2 ptpt -59.45 -46.55 88.45 Favored 'General case' 0 CA--C 1.516 -0.334 0 CA-C-O 121.354 0.597 . . . . 0.0 112.109 176.932 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.401 ' HA ' ' HA ' ' A' ' 99' ' ' PRO . 1.1 mtmt -141.52 127.22 11.0 Favored Pre-proline 0 N--CA 1.444 -0.75 0 CA-C-N 115.26 -0.882 . . . . 0.0 110.107 -178.151 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.401 ' HA ' ' HA ' ' A' ' 98' ' ' LYS . 28.5 Cg_endo -70.5 173.04 48.9 Favored 'Cis proline' 0 N--CA 1.456 -0.714 0 C-N-CA 123.288 -1.547 . . . . 0.0 110.951 -5.018 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -130.47 149.62 52.06 Favored 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 123.526 0.73 . . . . 0.0 109.243 177.443 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . 0.506 ' HB3' ' CE2' ' A' ' 92' ' ' TYR . 2.9 tt0 -100.91 176.72 5.18 Favored 'General case' 0 C--N 1.316 -0.889 0 O-C-N 123.938 0.774 . . . . 0.0 111.773 176.437 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -83.14 126.34 72.47 Favored Pre-proline 0 CA--C 1.541 0.631 0 N-CA-C 112.469 0.544 . . . . 0.0 112.469 179.059 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.419 ' HB3' ' CE2' ' A' ' 34' ' ' TYR . 31.7 Cg_endo -67.6 -166.32 0.13 Allowed 'Trans proline' 0 N--CA 1.452 -0.94 0 CA-C-O 123.371 1.321 . . . . 0.0 113.226 176.407 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -139.42 173.04 22.97 Favored Glycine 0 CA--C 1.523 0.558 0 O-C-N 121.02 -1.05 . . . . 0.0 112.679 176.277 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -75.05 -57.92 0.05 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.97 0 C-N-CA 123.017 2.478 . . . . 0.0 111.101 178.786 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.459 ' CB ' ' CE2' ' A' ' 11' ' ' TYR . . . -60.87 133.38 56.04 Favored 'General case' 0 N--CA 1.443 -0.81 0 CA-C-O 120.979 0.419 . . . . 0.0 111.155 177.879 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.476 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 6.8 mtm-85 -147.35 149.48 32.88 Favored 'General case' 0 CA--C 1.497 -1.084 0 CA-C-O 117.194 -1.384 . . . . 0.0 110.522 179.5 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.469 ' C ' HD12 ' A' ' 109' ' ' ILE . 2.8 p -81.86 118.92 30.44 Favored 'Isoleucine or valine' 0 N--CA 1.472 0.665 0 O-C-N 124.434 1.084 . . . . 0.0 110.493 175.414 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.469 HD12 ' C ' ' A' ' 108' ' ' VAL . 1.8 mp -108.07 117.51 53.81 Favored 'Isoleucine or valine' 0 CA--C 1.508 -0.662 0 N-CA-C 106.047 -1.834 . . . . 0.0 106.047 -177.656 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.921 ' CZ ' HD22 ' A' ' 81' ' ' LEU . 8.0 p90 -134.1 153.21 51.96 Favored 'General case' 0 N--CA 1.447 -0.621 0 O-C-N 124.252 0.97 . . . . 0.0 109.56 -179.857 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.8 p -84.28 162.72 20.01 Favored 'General case' 0 C--N 1.319 -0.732 0 CA-C-N 116.211 -0.449 . . . . 0.0 110.231 178.195 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.562 ' CE2' HD23 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -110.06 154.87 42.52 Favored Pre-proline 0 CA--C 1.548 0.884 0 O-C-N 122.014 -0.429 . . . . 0.0 110.61 178.747 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.496 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 17.9 Cg_endo -74.15 -48.81 0.25 Allowed 'Cis proline' 0 CA--C 1.509 -0.749 0 C-N-CA 123.934 -1.278 . . . . 0.0 111.515 -8.987 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 5.9 t-20 -45.8 107.77 0.11 Allowed 'General case' 0 N--CA 1.451 -0.393 0 CA-C-O 117.62 -1.181 . . . . 0.0 108.895 175.496 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.445 ' HE2' HD13 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -67.84 68.46 0.11 Allowed 'General case' 0 CA--C 1.512 -0.509 0 C-N-CA 125.711 1.604 . . . . 0.0 108.09 -179.4 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.433 HG11 ' HB2' ' A' ' 61' ' ' ASP . 18.0 t -73.19 78.89 0.37 Allowed 'Isoleucine or valine' 0 CA--C 1.51 -0.576 0 N-CA-C 102.992 -2.966 . . . . 0.0 102.992 -179.934 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.544 ' CZ ' ' NE2' ' A' ' 13' ' ' GLN . 5.2 t80 -37.82 118.9 0.71 Allowed 'General case' 0 N--CA 1.443 -0.791 0 C-N-CA 125.339 1.456 . . . . 0.0 108.93 176.548 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . 0.577 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 7.3 m -95.22 -45.31 7.23 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-O 121.763 0.792 . . . . 0.0 109.304 179.367 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.519 ' HA2' ' CE1' ' A' ' 117' ' ' PHE . . . 156.16 -166.55 33.13 Favored Glycine 0 N--CA 1.445 -0.709 0 N-CA-C 110.85 -0.9 . . . . 0.0 110.85 -178.713 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.592 HG22 ' SG ' ' A' ' 134' ' ' CYS . 3.0 mp -117.03 132.67 66.12 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.343 0 N-CA-C 106.383 -1.71 . . . . 0.0 106.383 -178.275 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.774 HG22 HD12 ' A' ' 133' ' ' LEU . 10.2 pt -108.44 154.62 9.64 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.692 0 N-CA-C 108.591 -0.892 . . . . 0.0 108.591 179.947 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.607 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . . . -170.75 157.1 5.44 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-O 121.733 0.778 . . . . 0.0 110.637 175.449 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.439 ' CE1' ' HG ' ' A' ' 131' ' ' LEU . 8.3 m-70 -90.42 89.88 7.79 Favored 'General case' 0 C--N 1.325 -0.463 0 N-CA-C 109.154 -0.684 . . . . 0.0 109.154 -175.756 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.539 HG22 ' HD3' ' A' ' 132' ' ' LYS . 1.5 t -95.6 40.16 1.12 Allowed 'General case' 0 N--CA 1.483 1.22 0 CA-C-O 124.032 1.873 . . . . 0.0 111.02 -179.21 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 7.6 tptm -103.09 -28.47 11.94 Favored 'General case' 0 C--O 1.221 -0.432 0 O-C-N 120.193 -1.567 . . . . 0.0 111.358 177.998 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -171.45 -65.75 0.02 OUTLIER 'General case' 0 C--O 1.222 -0.369 0 O-C-N 124.076 0.86 . . . . 0.0 110.57 177.665 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 14.9 t-20 -152.8 -46.01 0.1 Allowed 'General case' 0 C--N 1.332 -0.181 0 CA-C-O 122.985 1.374 . . . . 0.0 110.87 178.571 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.1 OUTLIER -157.0 75.56 0.83 Allowed 'General case' 0 N--CA 1.449 -0.517 0 CA-C-O 121.986 0.898 . . . . 0.0 110.835 -178.431 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -129.73 -107.26 1.24 Allowed Glycine 0 N--CA 1.462 0.398 0 N-CA-C 109.951 -1.26 . . . . 0.0 109.951 178.691 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -76.57 151.37 36.32 Favored 'General case' 0 C--N 1.324 -0.508 0 O-C-N 122.23 -0.571 . . . . 0.0 111.296 179.649 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.538 HD23 ' H ' ' A' ' 132' ' ' LYS . 0.6 OUTLIER -110.87 146.09 37.1 Favored 'General case' 0 C--N 1.325 -0.495 0 N-CA-C 109.036 -0.727 . . . . 0.0 109.036 177.689 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.539 ' HD3' HG22 ' A' ' 124' ' ' THR . 0.0 OUTLIER -154.2 170.06 22.13 Favored 'General case' 0 C--N 1.322 -0.617 0 C-N-CA 125.196 1.398 . . . . 0.0 110.093 177.743 . . . . . . . . 3 3 . 1 . 017 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.774 HD12 HG22 ' A' ' 121' ' ' ILE . 6.0 tp -81.33 146.18 30.49 Favored 'General case' 0 C--O 1.24 0.604 0 N-CA-C 108.787 -0.82 . . . . 0.0 108.787 175.894 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . 0.592 ' SG ' HG22 ' A' ' 120' ' ' ILE . 87.2 m -61.4 175.01 0.63 Allowed 'General case' 0 C--N 1.321 -0.635 0 CA-C-O 123.488 1.613 . . . . 0.0 109.614 172.241 . . . . . . . . 2 2 . 1 . 017 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 72.0 m -161.4 90.99 0.83 Allowed 'General case' 0 C--N 1.313 -1.001 0 N-CA-C 104.198 -2.519 . . . . 0.0 104.198 -175.188 . . . . . . . . 1 1 . 1 . 017 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.484 ' CD2' HG11 ' A' ' 2' ' ' VAL . 0.4 OUTLIER . . . . . 0 N--CA 1.474 0.726 0 CA-C-O 115.656 -2.116 . . . . 0.0 115.305 169.631 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.508 -0.657 0 N-CA-C 108.137 -1.06 . . . . 0.0 108.137 . . . . . . . . . 0 0 . 1 . 018 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 5.6 p -106.8 141.94 20.82 Favored 'Isoleucine or valine' 0 C--N 1.323 -0.552 0 N-CA-C 108.65 -0.87 . . . . 0.0 108.65 -179.256 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.599 HG21 HD22 ' A' ' 10' ' ' LEU . 0.9 OUTLIER -85.59 112.25 20.8 Favored 'General case' 0 C--N 1.32 -0.698 0 O-C-N 121.907 -0.496 . . . . 0.0 110.469 178.504 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.471 ' CG ' HG13 ' A' ' 120' ' ' ILE . 29.9 m95 -79.13 139.16 38.11 Favored 'General case' 0 N--CA 1.44 -0.966 0 C-N-CA 123.091 0.556 . . . . 0.0 110.951 176.54 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.447 ' OG1' HD23 ' A' ' 10' ' ' LEU . 0.9 OUTLIER -121.36 124.66 45.07 Favored 'General case' 0 CA--C 1.499 -0.989 0 N-CA-C 108.865 -0.791 . . . . 0.0 108.865 -177.81 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.673 ' HB3' ' HB3' ' A' ' 122' ' ' ALA . 13.6 m -113.65 40.68 2.35 Favored 'General case' 0 N--CA 1.451 -0.38 0 CA-C-O 121.267 0.556 . . . . 0.0 110.912 177.598 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 138.05 -94.84 0.22 Allowed Glycine 0 C--O 1.223 -0.574 0 N-CA-C 111.298 -0.721 . . . . 0.0 111.298 -179.138 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.545 ' C ' HD13 ' A' ' 9' ' ' LEU . . . -123.79 1.62 9.3 Favored Glycine 0 N--CA 1.463 0.434 0 C-N-CA 123.074 0.369 . . . . 0.0 112.803 177.393 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.623 ' N ' HD13 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -107.8 140.44 40.88 Favored 'General case' 0 N--CA 1.443 -0.824 0 N-CA-C 106.236 -1.764 . . . . 0.0 106.236 -173.428 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.599 HD22 HG21 ' A' ' 3' ' ' THR . 17.1 mt -106.07 121.01 43.27 Favored 'General case' 0 N--CA 1.446 -0.657 0 O-C-N 124.258 0.974 . . . . 0.0 109.311 -177.48 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.526 ' CE2' ' CB ' ' A' ' 106' ' ' ALA . 61.2 m-85 -116.06 99.94 7.61 Favored 'General case' 0 N--CA 1.445 -0.68 0 C-N-CA 124.966 1.307 . . . . 0.0 108.968 -175.137 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 9.7 t-20 -56.26 122.28 11.42 Favored 'General case' 0 N--CA 1.437 -1.12 0 CA-C-O 118.234 -0.889 . . . . 0.0 108.982 179.657 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.495 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 6.1 tp-100 -50.09 -46.97 53.92 Favored 'General case' 0 C--O 1.21 -0.987 0 O-C-N 123.978 0.799 . . . . 0.0 112.105 179.835 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . 0.402 ' O ' ' CB ' ' A' ' 18' ' ' SER . 5.5 t-20 -50.07 -41.54 48.22 Favored 'General case' 0 C--O 1.201 -1.482 0 O-C-N 123.211 0.319 . . . . 0.0 110.975 176.541 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -70.12 -37.12 75.23 Favored 'General case' 0 C--O 1.204 -1.302 0 CA-C-O 116.916 -1.516 . . . . 0.0 113.076 170.429 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -56.04 -44.95 79.28 Favored 'General case' 0 C--N 1.309 -1.162 0 CA-C-N 121.813 2.097 . . . . 0.0 113.151 172.847 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.434 ' O ' ' CD2' ' A' ' 21' ' ' HIS . 5.1 pt-20 -82.52 -37.67 24.9 Favored 'General case' 0 C--O 1.211 -0.927 0 C-N-CA 123.203 0.601 . . . . 0.0 109.715 176.836 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . 0.402 ' CB ' ' O ' ' A' ' 14' ' ' ASN . 28.8 t -73.98 -60.02 2.45 Favored 'General case' 0 CA--C 1.505 -0.777 0 O-C-N 119.751 -1.843 . . . . 0.0 109.521 -176.422 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.474 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 12.1 t-20 -40.75 -37.4 0.75 Allowed 'General case' 0 N--CA 1.447 -0.62 0 C-N-CA 124.543 1.137 . . . . 0.0 112.359 172.127 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.565 ' HB3' HG11 ' A' ' 108' ' ' VAL . 1.0 OUTLIER -82.52 -36.45 26.36 Favored 'General case' 0 N--CA 1.44 -0.953 0 N-CA-C 114.046 1.128 . . . . 0.0 114.046 174.561 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.434 ' CD2' ' O ' ' A' ' 17' ' ' GLU . 4.4 m170 -45.76 -38.56 7.19 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 126.288 1.835 . . . . 0.0 110.133 178.563 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.474 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -72.05 -47.43 51.65 Favored 'General case' 0 N--CA 1.44 -0.93 0 C-N-CA 123.826 0.85 . . . . 0.0 112.145 175.793 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.725 ' HB1' ' HG3' ' A' ' 35' ' ' PRO . . . -37.88 130.25 0.94 Allowed Pre-proline 0 N--CA 1.443 -0.785 0 O-C-N 124.762 1.289 . . . . 0.0 112.079 174.165 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.724 ' HG2' HG22 ' A' ' 30' ' ' THR . 16.4 Cg_endo -73.31 124.48 9.49 Favored 'Trans proline' 0 N--CA 1.45 -1.044 0 C-N-CA 121.836 1.691 . . . . 0.0 108.939 -176.381 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.626 HD13 ' HE2' ' A' ' 115' ' ' LYS . 3.9 tp -60.94 93.27 0.03 OUTLIER 'General case' 0 N--CA 1.445 -0.706 0 C-N-CA 123.635 0.774 . . . . 0.0 111.227 179.367 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 178.55 155.0 0.4 Allowed 'General case' 0 N--CA 1.449 -0.475 0 C-N-CA 122.957 0.503 . . . . 0.0 110.092 -174.032 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -95.77 123.18 39.22 Favored 'General case' 0 CA--C 1.508 -0.642 0 C-N-CA 123.973 0.909 . . . . 0.0 109.006 178.825 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 48.04 70.25 0.78 Allowed Glycine 0 C--N 1.335 0.482 0 CA-C-O 122.104 0.835 . . . . 0.0 111.895 176.602 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -149.09 30.18 0.79 Allowed 'General case' 0 CA--C 1.51 -0.58 0 O-C-N 121.831 -0.805 . . . . 0.0 111.962 179.562 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.724 HG22 ' HG2' ' A' ' 24' ' ' PRO . 36.4 p -127.52 147.23 50.32 Favored 'General case' 0 CA--C 1.504 -0.826 0 N-CA-C 108.182 -1.044 . . . . 0.0 108.182 -175.859 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -41.23 -55.35 3.62 Favored Glycine 0 N--CA 1.448 -0.556 0 O-C-N 123.981 0.8 . . . . 0.0 112.082 -178.928 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 29.2 t -67.37 -70.64 0.24 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-O 118.803 -0.618 . . . . 0.0 111.474 175.183 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 13.1 p 176.03 -57.66 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.414 0 C-N-CA 124.306 1.042 . . . . 0.0 112.85 179.769 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . . . . . . . . . 78.5 m-85 -67.48 151.55 97.05 Favored Pre-proline 0 N--CA 1.427 -1.609 0 C-N-CA 124.131 0.972 . . . . 0.0 112.066 178.583 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.725 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 24.5 Cg_endo -74.62 164.06 89.0 Favored 'Cis proline' 0 N--CA 1.455 -0.74 0 C-N-CA 123.144 -1.607 . . . . 0.0 111.103 -1.536 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.421 ' CD2' ' HG2' ' A' ' 82' ' ' GLU . 0.3 OUTLIER -143.17 161.4 38.32 Favored 'General case' 0 CA--C 1.503 -0.855 0 CA-C-O 117.474 -1.251 . . . . 0.0 109.662 -179.034 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.959 ' CH2' HG22 ' A' ' 39' ' ' THR . 13.7 t90 -59.33 138.67 57.55 Favored 'General case' 0 N--CA 1.446 -0.629 0 O-C-N 124.937 1.398 . . . . 0.0 110.137 177.827 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.538 ' CZ ' HD13 ' A' ' 121' ' ' ILE . 9.8 t80 -109.13 85.83 2.17 Favored 'General case' 0 N--CA 1.423 -1.782 0 N-CA-C 105.592 -2.003 . . . . 0.0 105.592 -176.018 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.959 HG22 ' CH2' ' A' ' 37' ' ' TRP . 20.1 p -38.69 -34.6 0.15 Allowed 'General case' 0 CA--C 1.495 -1.138 0 CA-C-N 115.303 -0.862 . . . . 0.0 110.653 170.745 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.484 ' HB2' ' CE2' ' A' ' 38' ' ' PHE . 62.9 t30 53.8 22.58 3.29 Favored 'General case' 0 N--CA 1.45 -0.437 0 CA-C-N 120.854 1.661 . . . . 0.0 111.625 177.675 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.738 ' C ' HD23 ' A' ' 48' ' ' LEU . . . 104.27 -44.28 1.51 Allowed Glycine 0 N--CA 1.419 -2.488 0 CA-C-O 117.26 -1.855 . . . . 0.0 115.218 -168.578 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.506 ' CE2' ' HD3' ' A' ' 66' ' ' PRO . 84.8 m-85 -43.34 151.1 0.17 Allowed 'General case' 0 N--CA 1.451 -0.406 0 C-N-CA 125.691 1.597 . . . . 0.0 112.279 176.294 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -82.82 -36.39 25.58 Favored 'General case' 0 C--N 1.328 -0.361 0 CA-C-O 121.326 0.584 . . . . 0.0 111.884 177.894 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.52 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -165.3 -77.63 0.03 OUTLIER Glycine 0 C--N 1.34 0.794 0 C-N-CA 124.459 1.028 . . . . 0.0 111.846 -179.078 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -109.41 -67.98 0.95 Allowed 'General case' 0 CA--C 1.513 -0.459 0 C-N-CA 123.521 0.728 . . . . 0.0 111.029 -179.245 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.23 -170.71 0.11 Allowed Glycine 0 C--N 1.348 1.233 0 C-N-CA 124.436 1.017 . . . . 0.0 110.967 178.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -58.77 -167.64 0.01 OUTLIER 'General case' 0 CA--C 1.542 0.656 0 CA-C-O 124.296 1.998 . . . . 0.0 111.703 177.356 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.738 HD23 ' C ' ' A' ' 41' ' ' GLY . 0.0 OUTLIER -86.78 163.47 40.96 Favored Pre-proline 0 N--CA 1.44 -0.968 0 O-C-N 120.139 -1.601 . . . . 0.0 110.566 -179.354 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.8 Cg_endo -71.83 171.51 16.39 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 122.067 1.844 . . . . 0.0 111.077 178.056 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 10.3 tttt -58.79 96.44 0.03 OUTLIER 'General case' 0 N--CA 1.45 -0.465 0 CA-C-N 115.841 -0.618 . . . . 0.0 110.196 177.131 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 108.33 88.4 1.97 Allowed Glycine 0 N--CA 1.447 -0.59 0 N-CA-C 111.895 -0.482 . . . . 0.0 111.895 -177.533 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.507 ' HB3' HD22 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -166.55 163.75 17.02 Favored 'General case' 0 CA--C 1.513 -0.478 0 C-N-CA 123.795 0.838 . . . . 0.0 111.557 176.283 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 97.7 m -143.6 95.07 5.94 Favored Pre-proline 0 C--O 1.236 0.389 0 O-C-N 124.33 1.019 . . . . 0.0 109.604 -176.882 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -72.98 169.75 21.43 Favored 'Trans proline' 0 N--CA 1.456 -0.716 0 C-N-CA 122.529 2.153 . . . . 0.0 110.901 -179.756 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.405 ' CG2' ' HB2' ' A' ' 133' ' ' LEU . 6.4 mt -99.58 134.22 39.61 Favored 'Isoleucine or valine' 0 N--CA 1.446 -0.631 0 N-CA-C 108.238 -1.023 . . . . 0.0 108.238 -178.2 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -86.09 157.6 20.01 Favored 'General case' 0 N--CA 1.449 -0.5 0 CA-C-O 121.107 0.479 . . . . 0.0 110.182 176.7 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.432 ' CD1' ' HB3' ' A' ' 118' ' ' CYS . 26.2 m-85 -140.65 -46.85 0.41 Allowed 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 123.805 0.842 . . . . 0.0 111.036 178.233 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 112.57 -4.42 26.29 Favored Glycine 0 C--N 1.338 0.664 0 C-N-CA 123.523 0.582 . . . . 0.0 113.057 -175.104 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -95.91 134.84 38.42 Favored 'General case' 0 CA--C 1.503 -0.839 0 CA-C-O 117.859 -1.067 . . . . 0.0 110.388 176.982 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 20.1 t -69.23 -6.36 28.68 Favored 'General case' 0 C--O 1.225 -0.222 0 O-C-N 125.127 1.517 . . . . 0.0 111.538 176.617 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -89.69 -56.88 3.07 Favored 'General case' 0 N--CA 1.446 -0.674 0 O-C-N 120.289 -1.507 . . . . 0.0 109.614 -179.45 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . . . . . . . . . 27.7 m -70.99 -18.06 62.62 Favored 'General case' 0 N--CA 1.45 -0.447 0 O-C-N 123.789 0.68 . . . . 0.0 110.688 177.218 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.6 t70 -80.28 -41.0 25.79 Favored 'General case' 0 CA--C 1.514 -0.413 0 C-N-CA 123.678 0.791 . . . . 0.0 111.515 174.806 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -52.04 158.97 1.57 Allowed Pre-proline 0 N--CA 1.444 -0.766 0 CA-C-O 122.282 1.039 . . . . 0.0 111.033 179.404 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 25.2 Cg_endo -71.02 136.21 29.17 Favored 'Trans proline' 0 N--CA 1.444 -1.395 0 C-N-CA 121.003 1.135 . . . . 0.0 113.673 174.149 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.506 ' HD3' ' CE2' ' A' ' 42' ' ' TYR . 19.2 Cg_endo -72.54 171.34 17.35 Favored 'Trans proline' 0 N--CA 1.446 -1.287 0 C-N-CA 122.957 2.438 . . . . 0.0 111.015 178.581 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.4 tptt -128.41 49.93 2.14 Favored 'General case' 0 C--O 1.212 -0.9 0 CA-C-N 115.475 -0.784 . . . . 0.0 109.936 178.545 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.442 ' CE1' ' CE3' ' A' ' 37' ' ' TRP . 56.2 t-80 -77.13 161.25 28.39 Favored 'General case' 0 C--N 1.326 -0.418 0 O-C-N 120.132 -1.605 . . . . 0.0 112.126 -179.691 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.2 OUTLIER -161.56 177.89 9.6 Favored 'General case' 0 CA--C 1.502 -0.896 0 O-C-N 118.787 -2.445 . . . . 0.0 108.178 176.878 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 6.2 pttp -64.68 74.22 0.04 OUTLIER 'General case' 0 N--CA 1.448 -0.572 0 C-N-CA 124.858 1.263 . . . . 0.0 111.724 175.379 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER 179.56 -47.58 0.01 OUTLIER 'General case' 0 C--N 1.323 -0.566 0 C-N-CA 125.524 1.53 . . . . 0.0 110.294 -176.322 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 113.31 -71.89 0.22 Allowed Glycine 0 CA--C 1.488 -1.621 0 CA-C-O 118.805 -0.997 . . . . 0.0 112.157 -177.541 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.7 p-10 -128.81 64.33 1.45 Allowed 'General case' 0 N--CA 1.441 -0.878 0 C-N-CA 125.934 1.694 . . . . 0.0 107.803 -177.731 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -59.56 -110.63 0.01 OUTLIER Glycine 0 C--N 1.334 0.454 0 CA-C-O 122.391 0.995 . . . . 0.0 112.543 178.817 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 4.5 mttp -63.22 -98.4 0.0 OUTLIER 'General case' 0 C--O 1.222 -0.372 0 O-C-N 119.792 -2.005 . . . . 0.0 111.75 177.562 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.54 HG23 ' O ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -114.23 15.93 18.06 Favored 'General case' 0 CA--C 1.51 -0.593 0 O-C-N 120.608 -1.307 . . . . 0.0 111.082 178.239 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.475 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 29.0 m-20 -30.5 107.5 0.04 OUTLIER 'General case' 0 N--CA 1.441 -0.901 0 C-N-CA 124.787 1.235 . . . . 0.0 110.16 -177.236 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.557 ' CD2' ' H ' ' A' ' 78' ' ' HIS . 2.8 p80 -87.43 14.52 7.94 Favored 'General case' 0 CA--C 1.511 -0.524 0 O-C-N 121.654 -0.654 . . . . 0.0 110.561 -177.068 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.529 ' HB2' ' CD1' ' A' ' 37' ' ' TRP . 14.9 p90 -39.51 137.34 0.83 Allowed 'General case' 0 N--CA 1.429 -1.514 0 C-N-CA 125.592 1.557 . . . . 0.0 110.715 176.973 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.669 HD22 ' CG2' ' A' ' 109' ' ' ILE . 0.3 OUTLIER -71.88 157.87 37.07 Favored 'General case' 0 N--CA 1.448 -0.548 0 C-N-CA 120.414 -0.514 . . . . 0.0 110.622 177.244 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.514 HD21 ' CE2' ' A' ' 79' ' ' TYR . 5.5 mp -139.67 120.77 14.7 Favored 'General case' 0 CA--C 1.501 -0.925 0 N-CA-C 108.685 -0.858 . . . . 0.0 108.685 -177.903 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.497 ' CB ' ' CD1' ' A' ' 109' ' ' ILE . 0.5 OUTLIER -92.36 152.68 19.63 Favored 'General case' 0 N--CA 1.439 -1.017 0 CA-C-O 122.259 1.028 . . . . 0.0 111.585 178.723 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.505 ' CZ ' ' HB2' ' A' ' 23' ' ' ALA . 12.6 t80 -145.23 134.05 11.04 Favored Pre-proline 0 N--CA 1.444 -0.762 0 CA-C-N 115.581 -0.736 . . . . 0.0 112.583 179.963 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -74.62 112.92 3.67 Favored 'Trans proline' 0 N--CA 1.453 -0.907 0 C-N-CA 122.959 2.44 . . . . 0.0 110.188 -177.672 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.6 t -104.73 110.45 22.78 Favored 'General case' 0 N--CA 1.447 -0.605 0 O-C-N 124.323 1.014 . . . . 0.0 110.079 -179.304 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.438 ' CE1' ' HB2' ' A' ' 92' ' ' TYR . 70.1 m-85 -82.02 157.92 68.05 Favored Pre-proline 0 N--CA 1.445 -0.69 0 O-C-N 121.424 -0.797 . . . . 0.0 112.25 178.85 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 17.0 Cg_endo -76.63 -42.25 0.36 Allowed 'Trans proline' 0 CA--C 1.501 -1.15 0 C-N-CA 122.555 2.17 . . . . 0.0 112.332 179.561 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -44.69 -30.92 1.02 Allowed 'General case' 0 C--N 1.353 0.731 0 CA-C-O 122.159 0.98 . . . . 0.0 110.855 176.688 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 85.23 8.77 81.06 Favored Glycine 0 N--CA 1.434 -1.47 0 N-CA-C 110.371 -1.092 . . . . 0.0 110.371 177.279 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 4.2 p-80 -73.84 128.38 35.36 Favored 'General case' 0 N--CA 1.439 -0.996 0 N-CA-C 108.171 -1.048 . . . . 0.0 108.171 178.58 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -61.36 93.15 0.03 OUTLIER 'General case' 0 N--CA 1.431 -1.424 0 C-N-CA 123.601 0.76 . . . . 0.0 109.76 173.286 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.47 ' O ' ' CD2' ' A' ' 94' ' ' PHE . 12.9 t80 -39.7 144.58 0.17 Allowed 'General case' 0 N--CA 1.442 -0.847 0 CA-C-O 121.967 0.889 . . . . 0.0 111.19 179.569 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -77.38 57.31 1.49 Allowed 'General case' 0 N--CA 1.444 -0.739 0 O-C-N 120.011 -1.68 . . . . 0.0 109.988 176.666 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.47 ' CD2' ' O ' ' A' ' 92' ' ' TYR . 34.3 p90 -71.19 -9.91 58.88 Favored 'General case' 0 N--CA 1.439 -1.018 0 C-N-CA 124.085 0.954 . . . . 0.0 112.168 175.711 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 13.3 t0 -89.7 -36.41 15.23 Favored 'General case' 0 N--CA 1.452 -0.371 0 CA-C-O 123.131 1.443 . . . . 0.0 110.451 -179.97 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 4.9 m -84.46 111.29 19.34 Favored 'General case' 0 N--CA 1.441 -0.904 0 O-C-N 120.341 -1.474 . . . . 0.0 109.394 179.513 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 11.0 ptpt -58.75 -47.92 82.99 Favored 'General case' 0 CA--C 1.508 -0.636 0 CA-C-O 120.945 0.403 . . . . 0.0 111.235 178.3 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.403 ' HA ' ' HA ' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -143.18 130.51 10.84 Favored Pre-proline 0 N--CA 1.432 -1.346 0 C-N-CA 123.78 0.832 . . . . 0.0 109.378 -177.312 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.403 ' HA ' ' HA ' ' A' ' 98' ' ' LYS . 24.7 Cg_endo -70.1 175.44 37.65 Favored 'Cis proline' 0 N--CA 1.455 -0.739 0 C-N-CA 122.284 -1.965 . . . . 0.0 111.007 -6.484 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.43 147.03 42.86 Favored 'General case' 0 CA--C 1.514 -0.424 0 CA-C-N 115.937 -0.574 . . . . 0.0 109.902 178.313 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.1 tp10 -87.94 173.41 8.93 Favored 'General case' 0 C--O 1.24 0.591 0 O-C-N 123.837 0.711 . . . . 0.0 112.133 177.211 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.3 m-20 -72.5 143.03 84.73 Favored Pre-proline 0 N--CA 1.442 -0.853 0 CA-C-O 118.117 -0.944 . . . . 0.0 111.165 177.295 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 26.2 Cg_endo -73.15 -164.8 0.21 Allowed 'Trans proline' 0 N--CA 1.457 -0.627 0 C-N-CA 123.266 2.644 . . . . 0.0 111.739 176.327 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -140.97 164.5 26.44 Favored Glycine 0 N--CA 1.44 -1.046 0 O-C-N 121.581 -0.7 . . . . 0.0 112.478 177.359 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 18.6 Cg_endo -75.39 -60.24 0.04 OUTLIER 'Trans proline' 0 N--CA 1.452 -0.963 0 C-N-CA 122.692 2.262 . . . . 0.0 110.481 179.127 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.779 ' HA ' ' HB2' ' A' ' 122' ' ' ALA . . . -63.31 139.83 58.81 Favored 'General case' 0 N--CA 1.438 -1.031 0 O-C-N 123.689 0.618 . . . . 0.0 111.62 178.206 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 1.5 mtm-85 -143.14 143.48 31.83 Favored 'General case' 0 N--CA 1.442 -0.857 0 CA-C-N 115.428 -0.806 . . . . 0.0 111.307 -179.503 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.565 HG11 ' HB3' ' A' ' 20' ' ' SER . 7.0 p -83.14 124.13 39.27 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.414 0 O-C-N 123.92 0.762 . . . . 0.0 110.479 178.789 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.669 ' CG2' HD22 ' A' ' 80' ' ' LEU . 6.3 mm -106.23 140.91 22.8 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.892 0 C-N-CA 122.823 0.449 . . . . 0.0 110.157 -179.231 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.621 ' C ' HD23 ' A' ' 80' ' ' LEU . 9.7 p90 -165.48 153.1 10.83 Favored 'General case' 0 N--CA 1.434 -1.233 0 CA-C-O 122.042 0.925 . . . . 0.0 110.483 -177.413 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.4 p -88.8 165.53 14.62 Favored 'General case' 0 C--N 1.324 -0.536 0 CA-C-N 115.676 -0.693 . . . . 0.0 109.776 -178.907 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.547 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.2 OUTLIER -111.29 154.09 43.79 Favored Pre-proline 0 CA--C 1.549 0.929 0 C-N-CA 122.184 0.193 . . . . 0.0 111.368 178.761 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.547 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 19.0 Cg_endo -73.87 -52.85 0.16 OUTLIER 'Cis proline' 0 CA--C 1.499 -1.256 0 C-N-CA 123.525 -1.448 . . . . 0.0 109.708 -6.883 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 10.2 t30 -43.24 110.93 0.22 Allowed 'General case' 0 N--CA 1.439 -1.01 0 CA-C-O 117.628 -1.177 . . . . 0.0 109.914 178.761 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.626 ' HE2' HD13 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -66.96 72.45 0.1 Allowed 'General case' 0 CA--C 1.51 -0.585 0 C-N-CA 124.429 1.092 . . . . 0.0 108.519 -178.116 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.433 ' O ' HG12 ' A' ' 116' ' ' VAL . 36.9 t -72.32 77.4 0.28 Allowed 'Isoleucine or valine' 0 N--CA 1.441 -0.912 0 N-CA-C 105.596 -2.001 . . . . 0.0 105.596 -176.919 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.495 ' CZ ' ' NE2' ' A' ' 13' ' ' GLN . 41.5 t80 -39.57 107.1 0.06 Allowed 'General case' 0 N--CA 1.435 -1.219 0 C-N-CA 126.002 1.721 . . . . 0.0 110.034 -179.635 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . 0.474 ' SG ' HD21 ' A' ' 80' ' ' LEU . 10.2 m -81.94 -46.13 14.47 Favored 'General case' 0 N--CA 1.436 -1.175 0 N-CA-C 108.288 -1.004 . . . . 0.0 108.288 -178.113 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.428 ' HA2' ' CZ ' ' A' ' 117' ' ' PHE . . . 160.4 -147.73 15.03 Favored Glycine 0 N--CA 1.441 -0.998 0 N-CA-C 110.203 -1.159 . . . . 0.0 110.203 -179.571 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.471 HG13 ' CG ' ' A' ' 4' ' ' TRP . 1.2 mm -128.64 138.94 53.23 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.929 0 N-CA-C 106.537 -1.653 . . . . 0.0 106.537 -175.682 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.63 HD12 HD22 ' A' ' 131' ' ' LEU . 7.6 pt -130.0 154.94 41.13 Favored 'Isoleucine or valine' 0 C--N 1.31 -1.114 0 N-CA-C 108.511 -0.922 . . . . 0.0 108.511 -177.922 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.779 ' HB2' ' HA ' ' A' ' 106' ' ' ALA . . . -178.89 159.68 1.05 Allowed 'General case' 0 N--CA 1.445 -0.72 0 CA-C-O 121.794 0.807 . . . . 0.0 109.714 179.109 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.492 ' CE1' ' HG ' ' A' ' 131' ' ' LEU . 1.4 m-70 -91.2 93.05 8.93 Favored 'General case' 0 N--CA 1.448 -0.574 0 N-CA-C 109.222 -0.659 . . . . 0.0 109.222 -178.867 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.753 HG22 ' HD3' ' A' ' 132' ' ' LYS . 1.8 t -97.71 39.97 1.19 Allowed 'General case' 0 N--CA 1.469 0.516 0 CA-C-O 123.376 1.56 . . . . 0.0 111.395 -179.924 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 8.0 tttm -103.75 -26.97 12.53 Favored 'General case' 0 C--O 1.221 -0.412 0 O-C-N 120.812 -1.18 . . . . 0.0 111.432 178.597 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.7 OUTLIER -169.53 -64.06 0.02 OUTLIER 'General case' 0 C--O 1.223 -0.292 0 O-C-N 124.296 0.998 . . . . 0.0 110.853 177.838 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 42.8 t30 -153.62 -46.84 0.09 Allowed 'General case' 0 N--CA 1.452 -0.336 0 CA-C-O 123.303 1.525 . . . . 0.0 110.586 178.454 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -157.58 75.59 0.79 Allowed 'General case' 0 N--CA 1.442 -0.853 0 CA-C-O 122.381 1.086 . . . . 0.0 110.913 -178.679 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -118.98 -105.89 2.21 Favored Glycine 0 C--N 1.334 0.425 0 O-C-N 121.186 -0.946 . . . . 0.0 110.982 178.84 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 2.3 mt-10 -85.59 156.78 20.58 Favored 'General case' 0 CA--C 1.516 -0.341 0 O-C-N 122.157 -0.613 . . . . 0.0 111.648 179.245 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.63 HD22 HD12 ' A' ' 121' ' ' ILE . 0.5 OUTLIER -105.95 141.99 36.42 Favored 'General case' 0 C--N 1.327 -0.387 0 N-CA-C 109.635 -0.506 . . . . 0.0 109.635 178.208 . . . . . . . . 3 3 . 1 . 018 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.753 ' HD3' HG22 ' A' ' 124' ' ' THR . 2.5 ptmt -149.13 172.54 14.64 Favored 'General case' 0 CA--C 1.509 -0.615 0 C-N-CA 123.466 0.707 . . . . 0.0 109.712 179.173 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.537 HD12 HG22 ' A' ' 121' ' ' ILE . 11.6 tp -86.76 136.25 33.07 Favored 'General case' 0 C--O 1.241 0.631 0 CA-C-O 121.646 0.736 . . . . 0.0 109.448 177.678 . . . . . . . . 2 2 . 1 . 018 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 50.7 m -66.02 -179.61 0.76 Allowed 'General case' 0 N--CA 1.443 -0.79 0 C-N-CA 124.152 0.981 . . . . 0.0 109.389 175.627 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 68.4 m -159.44 92.08 1.04 Allowed 'General case' 0 CA--C 1.506 -0.722 0 N-CA-C 105.663 -1.977 . . . . 0.0 105.663 -178.17 . . . . . . . . 1 1 . 1 . 018 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER . . . . . 0 C--O 1.257 1.496 0 CA-C-O 113.965 -2.921 . . . . 0.0 113.682 170.493 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.622 ' HB1' ' HB3' ' A' ' 13' ' ' GLN . . . . . . . . 0 N--CA 1.474 0.761 0 N-CA-C 107.814 -1.18 . . . . 0.0 107.814 . . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 11.5 p -89.69 159.06 2.91 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.426 0 O-C-N 123.85 0.719 . . . . 0.0 109.92 178.209 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.937 HG21 HD23 ' A' ' 10' ' ' LEU . 5.9 m -94.79 107.78 19.8 Favored 'General case' 0 C--N 1.321 -0.658 0 C-N-CA 123.634 0.774 . . . . 0.0 110.62 178.984 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 20.4 m95 -78.57 141.42 38.11 Favored 'General case' 0 N--CA 1.449 -0.499 0 C-N-CA 124.005 0.922 . . . . 0.0 108.879 179.416 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -132.63 138.09 47.24 Favored 'General case' 0 CA--C 1.498 -1.053 0 N-CA-C 109.5 -0.555 . . . . 0.0 109.5 179.916 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.659 ' SG ' ' HB3' ' A' ' 122' ' ' ALA . 0.5 OUTLIER -121.63 64.53 0.9 Allowed 'General case' 0 N--CA 1.445 -0.713 0 CA-C-N 114.838 -1.073 . . . . 0.0 108.674 177.834 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 37.6 75.03 0.09 OUTLIER Glycine 0 CA--C 1.53 1.004 0 C-N-CA 124.851 1.215 . . . . 0.0 114.104 178.803 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 159.87 -75.03 0.2 Allowed Glycine 0 C--O 1.226 -0.404 0 N-CA-C 111.144 -0.782 . . . . 0.0 111.144 -175.346 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 74.2 mt -126.69 159.91 32.3 Favored 'General case' 0 C--O 1.238 0.49 0 CA-C-O 122.12 0.962 . . . . 0.0 110.34 177.337 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.937 HD23 HG21 ' A' ' 3' ' ' THR . 9.9 mp -87.96 167.48 13.68 Favored 'General case' 0 C--O 1.22 -0.497 0 CA-C-N 114.458 -1.246 . . . . 0.0 109.143 179.284 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.656 ' CZ ' ' HB3' ' A' ' 106' ' ' ALA . 65.4 m-85 -156.09 87.17 1.05 Allowed 'General case' 0 C--N 1.323 -0.568 0 C-N-CA 125.276 1.43 . . . . 0.0 108.386 -173.175 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.8 OUTLIER -53.47 120.11 5.69 Favored 'General case' 0 C--O 1.224 -0.26 0 CA-C-O 117.832 -1.08 . . . . 0.0 108.457 177.814 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.622 ' HB3' ' HB1' ' A' ' 1' ' ' ALA . 0.9 OUTLIER -49.27 -43.77 43.31 Favored 'General case' 0 C--O 1.212 -0.876 0 CA-C-N 119.865 1.211 . . . . 0.0 111.629 178.842 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.4 t-20 -48.89 -42.37 36.57 Favored 'General case' 0 C--O 1.201 -1.462 0 CA-C-N 117.779 0.263 . . . . 0.0 111.187 176.087 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.47 -44.36 62.42 Favored 'General case' 0 C--O 1.21 -1.026 0 O-C-N 120.416 -1.427 . . . . 0.0 112.644 169.602 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.503 ' HB1' HD11 ' A' ' 120' ' ' ILE . . . -52.11 -38.49 57.58 Favored 'General case' 0 C--N 1.315 -0.926 0 CA-C-N 121.4 1.909 . . . . 0.0 112.907 175.379 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.3 pt-20 -86.06 -48.89 8.23 Favored 'General case' 0 C--O 1.21 -1.022 0 CA-C-O 117.51 -1.234 . . . . 0.0 108.971 175.66 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 31.2 t -69.45 -57.88 4.69 Favored 'General case' 0 CA--C 1.504 -0.797 0 C-N-CA 126.599 1.96 . . . . 0.0 109.483 -173.173 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.445 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 0.5 OUTLIER -42.17 -36.6 1.23 Allowed 'General case' 0 C--O 1.217 -0.627 0 CA-C-N 119.536 1.062 . . . . 0.0 110.745 169.664 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.448 ' O ' ' HB3' ' A' ' 23' ' ' ALA . 1.4 p -83.53 -29.74 27.66 Favored 'General case' 0 C--O 1.218 -0.564 0 N-CA-C 114.911 1.449 . . . . 0.0 114.911 176.161 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 14.0 m170 -50.31 -35.67 28.47 Favored 'General case' 0 C--O 1.222 -0.351 0 C-N-CA 126.696 1.999 . . . . 0.0 109.826 178.532 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.445 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.1 OUTLIER -71.59 -49.54 39.37 Favored 'General case' 0 N--CA 1.445 -0.694 0 C-N-CA 125.43 1.492 . . . . 0.0 111.193 175.946 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.719 ' HB1' ' HG3' ' A' ' 35' ' ' PRO . . . -39.39 123.15 1.38 Allowed Pre-proline 0 C--O 1.239 0.529 0 O-C-N 124.867 1.355 . . . . 0.0 111.807 174.852 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.536 ' HG2' HG22 ' A' ' 30' ' ' THR . 18.1 Cg_endo -70.76 126.37 12.57 Favored 'Trans proline' 0 N--CA 1.445 -1.366 0 C-N-CA 122.083 1.855 . . . . 0.0 108.868 -177.044 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.863 HD21 ' O ' ' A' ' 113' ' ' PRO . 4.9 tp -62.91 94.54 0.07 Allowed 'General case' 0 N--CA 1.453 -0.282 0 C-N-CA 123.449 0.7 . . . . 0.0 112.219 178.959 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 3.1 m 179.98 153.64 0.52 Allowed 'General case' 0 C--N 1.329 -0.312 0 C-N-CA 125.082 1.353 . . . . 0.0 110.163 -173.022 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 0.0 OUTLIER -92.61 119.16 31.77 Favored 'General case' 0 N--CA 1.469 0.516 0 C-N-CA 125.436 1.494 . . . . 0.0 109.367 176.235 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 49.86 69.69 0.99 Allowed Glycine 0 CA--C 1.525 0.708 0 CA-C-O 122.189 0.883 . . . . 0.0 112.476 174.347 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.5 mtpt -145.95 22.89 1.39 Allowed 'General case' 0 N--CA 1.471 0.575 0 N-CA-C 113.143 0.794 . . . . 0.0 113.143 -178.549 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.536 HG22 ' HG2' ' A' ' 24' ' ' PRO . 33.6 p -123.45 150.97 43.18 Favored 'General case' 0 C--N 1.321 -0.653 0 C-N-CA 124.398 1.079 . . . . 0.0 108.693 -177.169 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -38.65 -63.44 1.01 Allowed Glycine 0 CA--C 1.522 0.477 0 C-N-CA 124.705 1.145 . . . . 0.0 113.712 178.448 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.415 ' HB3' ' HA ' ' A' ' 94' ' ' PHE . 44.1 t -63.64 -59.4 4.65 Favored 'General case' 0 C--N 1.331 -0.204 0 CA-C-O 118.312 -0.851 . . . . 0.0 112.071 174.497 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.0 m 158.9 -48.61 0.0 OUTLIER 'General case' 0 N--CA 1.476 0.861 0 C-N-CA 126.872 2.069 . . . . 0.0 112.17 179.605 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.535 ' CD2' ' HD3' ' A' ' 84' ' ' PRO . 63.3 m-85 -64.48 145.54 98.43 Favored Pre-proline 0 CA--C 1.542 0.643 0 CA-C-O 117.801 -1.095 . . . . 0.0 112.909 -179.956 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.719 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 28.6 Cg_endo -73.35 158.53 98.38 Favored 'Cis proline' 0 N--CA 1.448 -1.198 0 C-N-CA 123.577 -1.426 . . . . 0.0 111.137 -4.132 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.808 ' C ' HD23 ' A' ' 81' ' ' LEU . 2.1 p80 -137.19 170.56 15.88 Favored 'General case' 0 CA--C 1.506 -0.744 0 CA-C-N 114.713 -1.131 . . . . 0.0 109.565 -176.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.906 ' CH2' HG22 ' A' ' 39' ' ' THR . 22.7 t90 -71.56 148.03 47.07 Favored 'General case' 0 C--N 1.325 -0.474 0 CA-C-O 121.99 0.9 . . . . 0.0 109.243 179.685 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.517 ' CE2' ' HB2' ' A' ' 40' ' ' ASN . 27.5 t80 -124.31 78.24 1.64 Allowed 'General case' 0 N--CA 1.435 -1.182 0 C-N-CA 127.11 2.164 . . . . 0.0 106.003 -177.71 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.906 HG22 ' CH2' ' A' ' 37' ' ' TRP . 77.0 p -37.04 -39.91 0.26 Allowed 'General case' 0 C--O 1.218 -0.571 0 C-N-CA 124.421 1.088 . . . . 0.0 111.6 171.911 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.517 ' HB2' ' CE2' ' A' ' 38' ' ' PHE . 46.0 t30 59.69 16.06 5.19 Favored 'General case' 0 CA--C 1.536 0.427 0 CA-C-O 122.428 1.109 . . . . 0.0 110.907 178.678 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.545 ' C ' HD23 ' A' ' 48' ' ' LEU . . . 115.11 -40.89 2.31 Favored Glycine 0 N--CA 1.44 -1.049 0 CA-C-O 117.435 -1.758 . . . . 0.0 111.619 -172.7 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.442 ' CD1' ' HD2' ' A' ' 66' ' ' PRO . 76.2 m-85 -49.34 159.53 0.31 Allowed 'General case' 0 CA--C 1.535 0.386 0 CA-C-N 119.202 1.501 . . . . 0.0 112.295 -179.627 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -84.25 -35.82 23.14 Favored 'General case' 0 N--CA 1.469 0.479 0 CA-C-O 122.589 1.185 . . . . 0.0 111.317 179.89 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.465 ' HA2' ' CZ2' ' A' ' 37' ' ' TRP . . . 145.04 -31.44 1.73 Allowed Glycine 0 C--O 1.218 -0.863 0 C-N-CA 125.185 1.374 . . . . 0.0 111.586 -176.701 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -80.9 -54.28 5.72 Favored 'General case' 0 C--N 1.324 -0.539 0 CA-C-N 119.049 1.425 . . . . 0.0 111.575 -179.555 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . 157.23 33.13 0.02 OUTLIER Glycine 0 C--N 1.336 0.541 0 O-C-N 124.309 1.006 . . . . 0.0 112.748 -177.642 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 29.2 mttt -142.07 159.8 41.51 Favored 'General case' 0 CA--C 1.507 -0.7 0 C-N-CA 124.36 1.064 . . . . 0.0 109.088 178.846 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.545 HD23 ' C ' ' A' ' 41' ' ' GLY . 3.8 mt -108.01 147.96 36.52 Favored Pre-proline 0 N--CA 1.446 -0.657 0 O-C-N 124.429 1.081 . . . . 0.0 110.613 -179.406 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 23.3 Cg_endo -72.62 177.66 7.23 Favored 'Trans proline' 0 N--CA 1.446 -1.3 0 C-N-CA 124.251 3.301 . . . . 0.0 111.278 -179.065 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.9 ttpt -76.94 102.69 6.5 Favored 'General case' 0 C--N 1.33 -0.259 0 O-C-N 120.575 -1.328 . . . . 0.0 109.938 175.05 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 99.3 83.69 1.75 Allowed Glycine 0 C--O 1.222 -0.653 0 O-C-N 124.216 0.948 . . . . 0.0 110.945 177.55 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.452 ' CG ' HD22 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -163.2 172.91 14.09 Favored 'General case' 0 N--CA 1.465 0.278 0 C-N-CA 124.444 1.097 . . . . 0.0 110.056 178.803 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 8.9 m -152.79 107.93 2.7 Favored Pre-proline 0 C--N 1.327 -0.384 0 O-C-N 123.635 0.585 . . . . 0.0 110.77 174.0 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 27.6 Cg_endo -70.79 145.89 52.36 Favored 'Trans proline' 0 N--CA 1.452 -0.936 0 C-N-CA 122.288 1.992 . . . . 0.0 111.166 177.012 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.508 HD12 HG21 ' A' ' 121' ' ' ILE . 16.9 mt -70.42 119.96 17.45 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.439 0 N-CA-C 108.194 -1.039 . . . . 0.0 108.194 179.147 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 3.8 tttt -84.01 132.67 34.72 Favored 'General case' 0 C--N 1.329 -0.321 0 N-CA-C 109.478 -0.564 . . . . 0.0 109.478 176.574 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.574 ' CD1' ' HB3' ' A' ' 118' ' ' CYS . 10.9 m-85 -114.54 -53.51 2.65 Favored 'General case' 0 C--N 1.329 -0.316 0 C-N-CA 124.818 1.247 . . . . 0.0 111.273 -179.626 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 121.28 -6.31 10.84 Favored Glycine 0 CA--C 1.526 0.732 0 C-N-CA 124.587 1.089 . . . . 0.0 113.21 -176.444 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.3 OUTLIER -91.92 131.07 37.51 Favored 'General case' 0 CA--C 1.509 -0.621 0 O-C-N 121.606 -0.938 . . . . 0.0 110.233 177.188 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 32.3 t -68.77 -2.43 9.38 Favored 'General case' 0 CA--C 1.539 0.53 0 O-C-N 124.891 1.369 . . . . 0.0 111.802 176.456 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.466 ' OD2' HG11 ' A' ' 116' ' ' VAL . 0.5 OUTLIER -88.21 -54.06 4.39 Favored 'General case' 0 CA--C 1.518 -0.284 0 O-C-N 120.252 -1.53 . . . . 0.0 108.967 178.587 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.629 ' HB3' HD21 ' A' ' 80' ' ' LEU . 1.9 m -77.11 -34.27 56.81 Favored 'General case' 0 N--CA 1.452 -0.352 0 O-C-N 123.814 0.696 . . . . 0.0 110.422 -178.954 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 17.4 t0 -62.27 -37.66 86.34 Favored 'General case' 0 N--CA 1.466 0.331 0 C-N-CA 123.322 0.649 . . . . 0.0 111.186 173.874 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.35 159.6 1.11 Allowed Pre-proline 0 N--CA 1.448 -0.557 0 CA-C-O 121.485 0.659 . . . . 0.0 112.123 178.77 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 21.0 Cg_endo -68.73 120.62 7.52 Favored 'Trans proline' 0 N--CA 1.444 -1.392 0 C-N-CA 120.742 0.961 . . . . 0.0 111.573 174.455 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.442 ' HD2' ' CD1' ' A' ' 42' ' ' TYR . 25.4 Cg_endo -69.19 168.53 20.55 Favored 'Trans proline' 0 N--CA 1.447 -1.262 0 C-N-CA 124.233 3.289 . . . . 0.0 111.261 175.116 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 1.7 tptp -131.12 136.46 48.39 Favored 'General case' 0 C--O 1.211 -0.967 0 CA-C-O 118.042 -0.98 . . . . 0.0 108.43 176.902 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 13.5 t-80 -115.32 160.52 19.7 Favored 'General case' 0 C--N 1.32 -0.695 0 C-N-CA 125.516 1.527 . . . . 0.0 108.593 177.744 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -150.59 170.63 18.7 Favored 'General case' 0 C--N 1.322 -0.596 0 CA-C-N 114.788 -1.096 . . . . 0.0 110.735 179.359 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -86.93 60.61 6.32 Favored 'General case' 0 C--O 1.217 -0.613 0 C-N-CA 123.068 0.547 . . . . 0.0 111.406 177.639 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -175.16 -38.4 0.01 OUTLIER 'General case' 0 N--CA 1.473 0.678 0 C-N-CA 123.299 0.64 . . . . 0.0 110.967 -179.07 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 125.48 -67.18 0.53 Allowed Glycine 0 C--N 1.336 0.573 0 C-N-CA 125.071 1.319 . . . . 0.0 109.929 -178.106 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.3 p-10 -128.48 62.14 1.46 Allowed 'General case' 0 C--N 1.326 -0.448 0 C-N-CA 127.905 2.482 . . . . 0.0 107.925 -174.501 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -61.64 -104.35 0.01 OUTLIER Glycine 0 CA--C 1.529 0.926 0 CA-C-O 121.706 0.615 . . . . 0.0 112.299 176.99 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 10.2 mttt -65.42 -92.92 0.01 OUTLIER 'General case' 0 N--CA 1.471 0.599 0 O-C-N 120.736 -1.449 . . . . 0.0 112.009 177.763 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.484 HG23 ' O ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -128.62 14.4 6.49 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 121.553 -0.717 . . . . 0.0 110.877 178.282 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.448 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 47.1 m-20 -27.95 102.83 0.02 OUTLIER 'General case' 0 C--O 1.208 -1.098 0 C-N-CA 125.491 1.516 . . . . 0.0 111.564 -178.255 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.491 ' CD2' ' H ' ' A' ' 78' ' ' HIS . 5.6 p80 -94.59 65.34 3.13 Favored 'General case' 0 CA--C 1.505 -0.766 0 O-C-N 120.214 -1.554 . . . . 0.0 108.432 -170.268 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.898 ' CE2' HD11 ' A' ' 81' ' ' LEU . 13.7 p90 -93.97 141.75 28.16 Favored 'General case' 0 N--CA 1.444 -0.739 0 C-N-CA 124.523 1.129 . . . . 0.0 110.574 -176.471 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.629 HD21 ' HB3' ' A' ' 62' ' ' CYS . 0.3 OUTLIER -69.29 141.38 54.34 Favored 'General case' 0 C--O 1.216 -0.673 0 C-N-CA 119.694 -0.802 . . . . 0.0 110.496 173.895 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.898 HD11 ' CE2' ' A' ' 79' ' ' TYR . 0.8 OUTLIER -128.75 143.51 50.94 Favored 'General case' 0 C--N 1.323 -0.57 0 C-N-CA 124.69 1.196 . . . . 0.0 110.339 176.236 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -106.41 153.93 21.53 Favored 'General case' 0 N--CA 1.445 -0.71 0 CA-C-O 122.717 1.246 . . . . 0.0 111.426 177.874 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.703 ' CZ ' ' HB2' ' A' ' 23' ' ' ALA . 6.9 t80 -142.94 128.99 10.4 Favored Pre-proline 0 N--CA 1.45 -0.459 0 O-C-N 121.379 -0.826 . . . . 0.0 112.506 179.963 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.535 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 23.7 Cg_endo -72.45 93.94 0.76 Allowed 'Trans proline' 0 N--CA 1.446 -1.277 0 C-N-CA 124.091 3.194 . . . . 0.0 110.612 179.037 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 2.2 t -99.95 113.23 25.66 Favored 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 122.503 1.145 . . . . 0.0 109.939 179.242 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.433 ' CD2' ' NE2' ' A' ' 90' ' ' HIS . 43.6 m-85 -81.51 158.5 68.64 Favored Pre-proline 0 C--N 1.324 -0.517 0 O-C-N 121.466 -0.772 . . . . 0.0 111.996 179.177 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 13.2 Cg_endo -76.16 -39.27 0.89 Allowed 'Trans proline' 0 N--CA 1.453 -0.89 0 C-N-CA 122.257 1.971 . . . . 0.0 113.87 178.321 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 1.0 OUTLIER -40.43 -38.18 0.79 Allowed 'General case' 0 N--CA 1.471 0.603 0 O-C-N 125.145 1.528 . . . . 0.0 110.287 174.88 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 102.01 -7.58 55.03 Favored Glycine 0 N--CA 1.44 -1.062 0 C-N-CA 124.762 1.172 . . . . 0.0 112.716 -178.483 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.433 ' NE2' ' CD2' ' A' ' 86' ' ' PHE . 9.2 p-80 -62.75 123.56 18.75 Favored 'General case' 0 N--CA 1.446 -0.665 0 N-CA-C 108.056 -1.09 . . . . 0.0 108.056 177.75 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.3 t70 -62.64 117.04 5.72 Favored 'General case' 0 N--CA 1.443 -0.796 0 N-CA-C 108.45 -0.944 . . . . 0.0 108.45 171.585 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . . . . . . . . . 30.4 t80 -44.16 154.44 0.11 Allowed 'General case' 0 C--O 1.21 -0.994 0 CA-C-O 123.018 1.389 . . . . 0.0 112.689 172.489 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -90.51 66.53 6.34 Favored 'General case' 0 C--N 1.32 -0.693 0 O-C-N 119.149 -2.219 . . . . 0.0 109.926 177.896 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.433 ' CE1' ' HZ ' ' A' ' 83' ' ' PHE . 15.7 p90 -80.79 -6.46 58.56 Favored 'General case' 0 C--N 1.323 -0.578 0 N-CA-C 113.319 0.859 . . . . 0.0 113.319 174.705 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 1.8 m-20 -91.0 -38.35 12.88 Favored 'General case' 0 C--N 1.327 -0.407 0 CA-C-O 122.677 1.227 . . . . 0.0 110.696 -179.654 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 52.4 m -88.41 106.88 18.54 Favored 'General case' 0 CA--C 1.519 -0.243 0 O-C-N 121.346 -0.846 . . . . 0.0 109.202 179.141 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 9.7 ptpt -58.23 -46.48 85.84 Favored 'General case' 0 N--CA 1.469 0.514 0 CA-C-O 121.16 0.505 . . . . 0.0 111.309 177.487 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.426 ' HA ' ' HA ' ' A' ' 99' ' ' PRO . 0.0 OUTLIER -142.21 132.08 12.42 Favored Pre-proline 0 N--CA 1.444 -0.726 0 C-N-CA 125.065 1.346 . . . . 0.0 109.787 -178.858 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.426 ' HA ' ' HA ' ' A' ' 98' ' ' LYS . 29.0 Cg_endo -68.27 173.39 39.03 Favored 'Cis proline' 0 N--CA 1.459 -0.519 0 C-N-CA 123.06 -1.642 . . . . 0.0 110.505 -9.093 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.3 ptmm? -137.85 154.76 49.46 Favored 'General case' 0 C--N 1.328 -0.355 0 C-N-CA 123.56 0.744 . . . . 0.0 109.563 178.345 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 11.1 tt0 -98.11 171.07 8.47 Favored 'General case' 0 C--O 1.244 0.778 0 CA-C-O 122.159 0.981 . . . . 0.0 110.177 178.681 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 3.8 m-80 -53.66 143.56 38.09 Favored Pre-proline 0 N--CA 1.443 -0.777 0 CA-C-N 115.531 -0.759 . . . . 0.0 111.106 172.897 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 27.7 Cg_endo -73.88 -68.58 0.02 OUTLIER 'Trans proline' 0 N--CA 1.445 -1.344 0 C-N-CA 122.311 2.007 . . . . 0.0 110.688 176.496 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 124.63 152.81 8.41 Favored Glycine 0 CA--C 1.524 0.611 0 O-C-N 120.388 -1.445 . . . . 0.0 111.251 -178.661 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 18.0 Cg_endo -75.78 -56.52 0.06 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.775 0 C-N-CA 122.85 2.367 . . . . 0.0 111.115 179.985 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.656 ' HB3' ' CZ ' ' A' ' 11' ' ' TYR . . . -72.09 138.47 47.81 Favored 'General case' 0 N--CA 1.438 -1.049 0 O-C-N 123.369 0.418 . . . . 0.0 110.4 177.337 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.455 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 10.0 mtm-85 -144.43 149.28 35.77 Favored 'General case' 0 CA--C 1.503 -0.832 0 CA-C-O 118.073 -0.965 . . . . 0.0 110.429 177.864 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.443 ' CG1' ' HB3' ' A' ' 83' ' ' PHE . 3.1 p -83.92 114.26 24.15 Favored 'Isoleucine or valine' 0 C--N 1.324 -0.521 0 C-N-CA 125.145 1.378 . . . . 0.0 111.017 175.925 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.436 HG21 ' CE2' ' A' ' 38' ' ' PHE . 1.8 mp -101.43 120.68 51.35 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.611 0 N-CA-C 107.017 -1.475 . . . . 0.0 107.017 -176.973 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.424 ' CG ' ' HG2' ' A' ' 115' ' ' LYS . 17.6 p90 -138.19 162.47 34.18 Favored 'General case' 0 C--N 1.319 -0.731 0 CA-C-N 115.019 -0.991 . . . . 0.0 110.459 -178.849 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.5 p -91.52 161.94 14.75 Favored 'General case' 0 C--N 1.318 -0.775 0 C-N-CA 122.755 0.422 . . . . 0.0 110.886 -179.776 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.484 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.2 OUTLIER -110.64 154.96 42.93 Favored Pre-proline 0 CA--C 1.546 0.818 0 CA-C-N 118.216 0.462 . . . . 0.0 111.275 177.946 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.863 ' O ' HD21 ' A' ' 25' ' ' LEU . 18.9 Cg_endo -72.37 -54.28 0.15 OUTLIER 'Cis proline' 0 N--CA 1.454 -0.821 0 C-N-CA 123.689 -1.379 . . . . 0.0 108.771 -9.95 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 41.3 t-20 -40.18 108.45 0.09 Allowed 'General case' 0 N--CA 1.451 -0.415 0 CA-C-O 116.511 -1.709 . . . . 0.0 110.507 178.658 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.677 ' CE ' HD13 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -67.5 63.84 0.07 Allowed 'General case' 0 CA--C 1.517 -0.316 0 C-N-CA 126.455 1.902 . . . . 0.0 108.119 -178.223 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.466 HG11 ' OD2' ' A' ' 61' ' ' ASP . 35.9 t -73.34 75.52 0.32 Allowed 'Isoleucine or valine' 0 N--CA 1.444 -0.768 0 N-CA-C 103.712 -2.699 . . . . 0.0 103.712 178.937 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.533 ' CZ ' ' NE2' ' A' ' 13' ' ' GLN . 2.2 t80 -40.87 124.21 2.08 Favored 'General case' 0 N--CA 1.437 -1.111 0 C-N-CA 125.182 1.393 . . . . 0.0 107.714 174.361 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . 0.574 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 0.1 OUTLIER -100.64 -40.84 7.19 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-N 115.766 -0.652 . . . . 0.0 111.227 175.768 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.477 ' HA2' ' CZ ' ' A' ' 117' ' ' PHE . . . 160.31 -174.79 37.09 Favored Glycine 0 CA--C 1.505 -0.589 0 N-CA-C 110.583 -1.007 . . . . 0.0 110.583 -178.692 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.542 ' CG2' ' HB1' ' A' ' 106' ' ' ALA . 3.2 mp -106.06 145.34 14.1 Favored 'Isoleucine or valine' 0 CA--C 1.499 -1.004 0 N-CA-C 107.71 -1.218 . . . . 0.0 107.71 178.065 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.508 HG21 HD12 ' A' ' 55' ' ' ILE . 8.5 pt -119.78 152.71 22.47 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.8 0 N-CA-C 108.374 -0.972 . . . . 0.0 108.374 179.936 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.659 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . . . -174.99 125.54 0.27 Allowed 'General case' 0 C--N 1.326 -0.445 0 CA-C-O 122.964 1.364 . . . . 0.0 109.741 179.508 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.43 ' H ' ' CD2' ' A' ' 123' ' ' HIS . 0.4 OUTLIER -88.09 89.89 8.17 Favored 'General case' 0 C--N 1.322 -0.591 0 O-C-N 120.86 -1.15 . . . . 0.0 111.734 178.193 . . . . . . . . 3 3 . 1 . 019 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.401 HG21 ' O ' ' A' ' 6' ' ' CYS . 3.5 p -102.06 41.44 1.22 Allowed 'General case' 0 C--N 1.309 -1.17 0 C-N-CA 123.86 0.864 . . . . 0.0 109.83 -177.908 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 9.2 ttpt -93.02 -41.11 10.17 Favored 'General case' 0 C--O 1.218 -0.594 0 CA-C-O 116.638 -1.649 . . . . 0.0 111.559 177.277 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER 170.64 -85.28 0.0 OUTLIER 'General case' 0 C--O 1.223 -0.307 0 C-N-CA 126.758 2.023 . . . . 0.0 109.168 178.886 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.5 t30 -158.48 26.12 0.24 Allowed 'General case' 0 CA--C 1.53 0.206 0 C-N-CA 125.334 1.454 . . . . 0.0 111.768 -175.676 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -170.11 92.98 0.22 Allowed 'General case' 0 N--CA 1.452 -0.333 0 CA-C-O 123.095 1.426 . . . . 0.0 110.629 -175.104 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 163.54 109.73 0.23 Allowed Glycine 0 CA--C 1.494 -1.222 0 N-CA-C 106.442 -2.663 . . . . 0.0 106.442 178.659 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -37.49 143.89 0.09 Allowed 'General case' 0 C--O 1.24 0.581 0 CA-C-N 119.053 1.426 . . . . 0.0 112.465 175.078 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.497 ' H ' HD12 ' A' ' 131' ' ' LEU . 6.6 mp -54.41 144.54 20.54 Favored 'General case' 0 N--CA 1.443 -0.821 0 N-CA-C 108.201 -1.037 . . . . 0.0 108.201 -179.322 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -123.15 148.42 45.76 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 108.141 -1.059 . . . . 0.0 108.141 -178.979 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.477 HD13 ' CE1' ' A' ' 57' ' ' PHE . 9.7 tp -56.75 131.85 50.43 Favored 'General case' 0 N--CA 1.448 -0.527 0 O-C-N 125.415 1.697 . . . . 0.0 107.842 179.002 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . 0.539 ' SG ' HG22 ' A' ' 120' ' ' ILE . 71.3 m -58.54 178.0 0.12 Allowed 'General case' 0 N--CA 1.445 -0.697 0 C-N-CA 124.38 1.072 . . . . 0.0 109.554 174.585 . . . . . . . . 2 2 . 1 . 019 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 38.3 m -154.23 112.09 3.5 Favored 'General case' 0 C--N 1.321 -0.651 0 N-CA-C 107.575 -1.269 . . . . 0.0 107.575 -176.287 . . . . . . . . 1 1 . 1 . 019 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 0.3 OUTLIER . . . . . 0 C--O 1.255 1.343 0 CA-C-O 115.519 -2.182 . . . . 0.0 110.943 172.035 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.51 -0.581 0 N-CA-C 108.454 -0.943 . . . . 0.0 108.454 . . . . . . . . . 0 0 . 1 . 020 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.555 HG22 ' HB3' ' A' ' 136' ' ' HIS . 3.5 p -74.24 134.79 28.82 Favored 'Isoleucine or valine' 0 C--N 1.327 -0.406 0 CA-C-O 121.858 0.837 . . . . 0.0 109.487 179.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . . . . . . . . . 5.2 m -90.56 120.0 31.28 Favored 'General case' 0 C--N 1.316 -0.882 0 N-CA-C 108.566 -0.902 . . . . 0.0 108.566 -176.908 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.462 ' CG ' HG13 ' A' ' 120' ' ' ILE . 31.9 m95 -79.75 141.34 36.42 Favored 'General case' 0 N--CA 1.447 -0.606 0 N-CA-C 110.105 -0.331 . . . . 0.0 110.105 -179.263 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . . . . . . . . . 0.9 OUTLIER -134.01 129.6 36.36 Favored 'General case' 0 CA--C 1.504 -0.816 0 CA-C-O 122.366 1.079 . . . . 0.0 108.669 -176.856 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.78 ' SG ' ' HB3' ' A' ' 122' ' ' ALA . 0.0 OUTLIER -125.96 67.24 1.19 Allowed 'General case' 0 C--N 1.319 -0.741 0 N-CA-C 107.45 -1.315 . . . . 0.0 107.45 177.064 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 130.38 -98.36 0.41 Allowed Glycine 0 C--O 1.22 -0.741 0 N-CA-C 111.233 -0.747 . . . . 0.0 111.233 178.899 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -133.32 8.42 5.04 Favored Glycine 0 N--CA 1.464 0.512 0 C-N-CA 123.416 0.532 . . . . 0.0 112.4 178.101 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.497 HD13 ' OH ' ' A' ' 11' ' ' TYR . 0.0 OUTLIER -115.85 142.36 46.87 Favored 'General case' 0 CA--C 1.512 -0.483 0 N-CA-C 108.025 -1.102 . . . . 0.0 108.025 -176.754 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . . . . . . . . . 8.6 mp -110.21 125.92 53.58 Favored 'General case' 0 C--N 1.324 -0.532 0 N-CA-C 108.112 -1.07 . . . . 0.0 108.112 -175.07 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.52 ' CZ ' ' HB3' ' A' ' 106' ' ' ALA . 77.5 m-85 -117.04 103.5 10.31 Favored 'General case' 0 C--N 1.319 -0.733 0 C-N-CA 126.327 1.851 . . . . 0.0 108.2 -173.094 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 10.7 t-20 -55.18 121.47 8.9 Favored 'General case' 0 N--CA 1.445 -0.684 0 CA-C-O 118.113 -0.946 . . . . 0.0 108.991 178.809 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.533 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 5.9 tp-100 -51.33 -45.28 62.23 Favored 'General case' 0 C--O 1.206 -1.211 0 O-C-N 124.023 0.827 . . . . 0.0 111.881 179.672 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 5.2 t-20 -51.02 -40.83 59.13 Favored 'General case' 0 C--O 1.197 -1.697 0 CA-C-N 117.801 0.273 . . . . 0.0 111.309 176.102 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -70.86 -36.78 72.98 Favored 'General case' 0 C--O 1.199 -1.604 0 O-C-N 120.1 -1.625 . . . . 0.0 113.395 168.979 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -55.61 -40.96 72.78 Favored 'General case' 0 C--N 1.31 -1.113 0 CA-C-N 123.04 2.654 . . . . 0.0 113.871 171.705 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 3.5 pt-20 -86.45 -38.75 17.0 Favored 'General case' 0 C--O 1.206 -1.186 0 C-N-CA 123.622 0.769 . . . . 0.0 108.999 176.655 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 44.7 t -73.42 -58.74 3.1 Favored 'General case' 0 CA--C 1.502 -0.879 0 O-C-N 119.889 -1.757 . . . . 0.0 108.771 -176.469 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.476 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 7.6 t-20 -42.62 -36.13 1.3 Allowed 'General case' 0 C--N 1.329 -0.304 0 CA-C-N 119.624 1.102 . . . . 0.0 112.977 171.823 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.428 ' HB3' HG11 ' A' ' 108' ' ' VAL . 1.0 OUTLIER -82.27 -31.95 29.86 Favored 'General case' 0 C--O 1.221 -0.414 0 N-CA-C 114.635 1.346 . . . . 0.0 114.635 174.149 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 5.0 m170 -50.8 -39.33 52.57 Favored 'General case' 0 CA--C 1.513 -0.462 0 C-N-CA 126.204 1.802 . . . . 0.0 109.162 178.475 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.476 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -75.38 -45.7 37.56 Favored 'General case' 0 N--CA 1.44 -0.941 0 CA-C-O 117.388 -1.291 . . . . 0.0 110.689 177.844 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.723 ' HB1' ' HG3' ' A' ' 35' ' ' PRO . . . -40.4 135.15 1.49 Allowed Pre-proline 0 CA--C 1.543 0.706 0 O-C-N 125.609 1.818 . . . . 0.0 111.966 176.574 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.691 ' HG2' HG22 ' A' ' 30' ' ' THR . 18.5 Cg_endo -72.65 122.02 7.88 Favored 'Trans proline' 0 N--CA 1.447 -1.221 0 C-N-CA 122.067 1.845 . . . . 0.0 109.319 -176.953 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.676 HD13 ' HE2' ' A' ' 115' ' ' LYS . 5.2 tp -59.88 94.39 0.03 OUTLIER 'General case' 0 N--CA 1.451 -0.38 0 C-N-CA 123.311 0.644 . . . . 0.0 111.17 178.717 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -171.58 178.71 3.07 Favored 'General case' 0 C--N 1.325 -0.468 0 C-N-CA 123.312 0.645 . . . . 0.0 109.673 -176.444 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.407 ' HB2' ' CE2' ' A' ' 79' ' ' TYR . 2.7 t0 -116.45 89.25 3.07 Favored 'General case' 0 C--N 1.326 -0.424 0 C-N-CA 124.211 1.004 . . . . 0.0 109.673 177.413 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 71.86 78.69 0.46 Allowed Glycine 0 N--CA 1.443 -0.854 0 N-CA-C 109.737 -1.345 . . . . 0.0 109.737 176.397 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.1 mmtp -149.77 30.24 0.73 Allowed 'General case' 0 CA--C 1.513 -0.46 0 C-N-CA 123.355 0.662 . . . . 0.0 111.723 178.094 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.691 HG22 ' HG2' ' A' ' 24' ' ' PRO . 11.8 p -122.02 149.37 43.6 Favored 'General case' 0 CA--C 1.504 -0.816 0 N-CA-C 107.792 -1.188 . . . . 0.0 107.792 -175.116 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.4 ' C ' ' HA ' ' A' ' 97' ' ' LYS . . . -42.11 -52.62 4.94 Favored Glycine 0 C--N 1.332 0.353 0 O-C-N 123.814 0.696 . . . . 0.0 111.905 -179.181 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 7.5 t -67.75 -64.53 0.84 Allowed 'General case' 0 CA--C 1.503 -0.847 0 CA-C-O 116.266 -1.826 . . . . 0.0 112.303 174.237 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER 166.24 -59.39 0.0 OUTLIER 'General case' 0 N--CA 1.472 0.656 0 C-N-CA 126.334 1.854 . . . . 0.0 111.423 177.723 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.52 ' CD2' ' HD3' ' A' ' 84' ' ' PRO . 60.5 m-85 -62.99 147.52 94.17 Favored Pre-proline 0 N--CA 1.436 -1.162 0 N-CA-C 113.786 1.032 . . . . 0.0 113.786 179.119 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.723 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 21.0 Cg_endo -75.6 164.56 87.79 Favored 'Cis proline' 0 N--CA 1.453 -0.911 0 C-N-CA 123.232 -1.57 . . . . 0.0 111.6 0.483 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.466 ' CD2' ' CD2' ' A' ' 34' ' ' TYR . 1.3 p80 -140.08 173.64 11.31 Favored 'General case' 0 C--O 1.21 -1.012 0 CA-C-O 117.865 -1.064 . . . . 0.0 110.305 -177.491 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.948 ' CH2' HG22 ' A' ' 39' ' ' THR . 19.6 t90 -75.95 127.1 32.28 Favored 'General case' 0 C--N 1.318 -0.801 0 CA-C-N 119.441 1.018 . . . . 0.0 109.226 175.964 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.573 ' CZ ' ' HA ' ' A' ' 40' ' ' ASN . 34.6 t80 -97.38 86.69 3.94 Favored 'General case' 0 N--CA 1.427 -1.62 0 C-N-CA 125.928 1.691 . . . . 0.0 107.303 177.766 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.948 HG22 ' CH2' ' A' ' 37' ' ' TRP . 61.8 p -39.87 -35.1 0.32 Allowed 'General case' 0 CA--C 1.508 -0.67 0 C-N-CA 124.774 1.23 . . . . 0.0 111.042 173.603 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.573 ' HA ' ' CZ ' ' A' ' 38' ' ' PHE . 65.1 t30 69.19 8.77 7.01 Favored 'General case' 0 C--O 1.222 -0.381 0 C-N-CA 124.614 1.165 . . . . 0.0 110.376 177.757 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.461 ' CA ' ' HD3' ' A' ' 52' ' ' ARG . . . 112.7 -13.78 24.8 Favored Glycine 0 N--CA 1.428 -1.843 0 C-N-CA 124.741 1.162 . . . . 0.0 114.206 -172.563 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.621 ' CE1' HD11 ' A' ' 48' ' ' LEU . 16.0 m-85 -70.61 166.55 20.44 Favored 'General case' 0 N--CA 1.452 -0.369 0 C-N-CA 124.095 0.958 . . . . 0.0 110.682 179.69 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -85.01 -40.44 16.87 Favored 'General case' 0 C--N 1.325 -0.483 0 CA-C-N 115.768 -0.651 . . . . 0.0 110.992 176.671 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.575 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . 174.84 -49.63 0.13 Allowed Glycine 0 C--N 1.335 0.484 0 C-N-CA 124.354 0.978 . . . . 0.0 111.794 -178.013 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -125.01 -63.24 1.17 Allowed 'General case' 0 C--N 1.322 -0.595 0 CA-C-O 122.026 0.917 . . . . 0.0 109.505 -179.652 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.48 161.38 21.76 Favored Glycine 0 C--N 1.341 0.823 0 N-CA-C 110.352 -1.099 . . . . 0.0 110.352 179.863 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.585 ' HA ' ' CE2' ' A' ' 42' ' ' TYR . 19.5 mtmt -54.74 175.15 0.06 Allowed 'General case' 0 CA--C 1.528 0.119 0 CA-C-O 122.303 1.049 . . . . 0.0 112.339 176.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.635 ' H ' HD12 ' A' ' 48' ' ' LEU . 5.8 mp -56.76 153.72 21.01 Favored Pre-proline 0 N--CA 1.447 -0.618 0 O-C-N 121.658 -0.651 . . . . 0.0 111.381 178.296 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 19.2 Cg_endo -71.72 158.99 52.07 Favored 'Trans proline' 0 N--CA 1.448 -1.19 0 C-N-CA 121.88 1.72 . . . . 0.0 110.092 -179.536 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 5.9 tttt -55.52 98.35 0.02 OUTLIER 'General case' 0 CA--C 1.536 0.436 0 C-N-CA 123.145 0.578 . . . . 0.0 109.921 177.133 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.8 72.89 0.62 Allowed Glycine 0 C--O 1.228 -0.226 0 CA-C-O 119.503 -0.609 . . . . 0.0 112.686 -176.15 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.461 ' HD3' ' CA ' ' A' ' 41' ' ' GLY . 12.3 ttm180 -174.42 162.8 3.59 Favored 'General case' 0 CA--C 1.517 -0.312 0 C-N-CA 124.175 0.99 . . . . 0.0 110.448 175.786 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.3 m -136.52 110.34 9.6 Favored Pre-proline 0 C--O 1.208 -1.089 0 O-C-N 123.909 0.756 . . . . 0.0 110.87 178.625 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.527 ' HG3' HD13 ' A' ' 48' ' ' LEU . 24.9 Cg_endo -71.98 -178.72 3.33 Favored 'Trans proline' 0 N--CA 1.457 -0.673 0 C-N-CA 121.698 1.599 . . . . 0.0 112.232 177.592 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.456 HD11 ' O ' ' A' ' 131' ' ' LEU . 6.6 mt -95.42 114.17 31.45 Favored 'Isoleucine or valine' 0 CA--C 1.514 -0.428 0 N-CA-C 107.509 -1.293 . . . . 0.0 107.509 -178.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.61 135.46 35.55 Favored 'General case' 0 C--N 1.327 -0.403 0 O-C-N 120.954 -1.091 . . . . 0.0 108.635 177.277 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.49 ' CD2' ' HB3' ' A' ' 118' ' ' CYS . 4.7 m-85 -117.67 -52.4 2.45 Favored 'General case' 0 C--N 1.325 -0.483 0 C-N-CA 123.234 0.614 . . . . 0.0 109.795 179.958 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 134.15 -12.26 4.71 Favored Glycine 0 C--O 1.224 -0.513 0 C-N-CA 123.92 0.772 . . . . 0.0 112.418 -176.785 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -90.51 134.33 34.44 Favored 'General case' 0 CA--C 1.507 -0.699 0 CA-C-N 117.43 0.615 . . . . 0.0 109.481 177.816 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 87.8 p -75.93 2.72 11.79 Favored 'General case' 0 C--O 1.222 -0.372 0 O-C-N 124.362 1.039 . . . . 0.0 111.713 176.084 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 70.3 m-20 -89.11 -56.14 3.4 Favored 'General case' 0 C--O 1.217 -0.619 0 C-N-CA 124.867 1.267 . . . . 0.0 109.047 179.598 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.746 ' HB3' HD11 ' A' ' 80' ' ' LEU . 2.1 m -71.57 -29.97 65.33 Favored 'General case' 0 N--CA 1.449 -0.479 0 N-CA-C 110.242 -0.281 . . . . 0.0 110.242 178.849 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 31.7 t0 -66.66 -38.16 86.27 Favored 'General case' 0 C--N 1.34 0.154 0 CA-C-O 121.091 0.472 . . . . 0.0 110.909 175.259 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -51.84 164.18 0.58 Allowed Pre-proline 0 N--CA 1.447 -0.598 0 CA-C-O 122.156 0.979 . . . . 0.0 111.692 178.493 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 30.0 Cg_endo -69.85 126.54 13.37 Favored 'Trans proline' 0 N--CA 1.443 -1.48 0 C-N-CA 121.239 1.293 . . . . 0.0 114.499 172.594 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.463 ' CD ' ' CD2' ' A' ' 42' ' ' TYR . 21.5 Cg_endo -70.64 168.16 23.51 Favored 'Trans proline' 0 N--CA 1.444 -1.44 0 C-N-CA 124.099 3.2 . . . . 0.0 111.48 177.171 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 5.2 tptt -130.61 61.22 1.62 Allowed 'General case' 0 C--O 1.202 -1.397 0 CA-C-O 116.95 -1.5 . . . . 0.0 108.854 179.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 40.6 t-80 -75.58 164.97 25.78 Favored 'General case' 0 C--N 1.323 -0.584 0 CA-C-N 120.291 1.405 . . . . 0.0 111.029 178.737 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.9 -179.71 7.21 Favored 'General case' 0 C--N 1.323 -0.548 0 O-C-N 120.869 -1.144 . . . . 0.0 110.841 178.093 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -84.34 69.23 10.46 Favored 'General case' 0 C--O 1.211 -0.928 0 O-C-N 120.29 -1.506 . . . . 0.0 111.34 177.453 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -176.76 -41.98 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.485 0 O-C-N 123.772 0.67 . . . . 0.0 109.707 179.385 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.449 ' O ' ' CE2' ' A' ' 79' ' ' TYR . . . 138.11 -72.5 0.44 Allowed Glycine 0 C--O 1.21 -1.361 0 N-CA-C 110.168 -1.173 . . . . 0.0 110.168 -178.749 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.5 OUTLIER -140.72 72.85 1.4 Allowed 'General case' 0 N--CA 1.438 -1.064 0 O-C-N 121.872 -0.781 . . . . 0.0 109.865 179.24 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -60.47 -101.98 0.01 OUTLIER Glycine 0 C--O 1.221 -0.717 0 CA-C-O 119.736 -0.48 . . . . 0.0 112.47 178.353 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 14.9 mttt -52.42 -90.29 0.0 OUTLIER 'General case' 0 C--O 1.22 -0.457 0 CA-C-O 122.152 0.977 . . . . 0.0 111.25 179.371 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.533 HG23 ' O ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -134.47 20.66 3.64 Favored 'General case' 0 CA--C 1.5 -0.966 0 CA-C-O 117.765 -1.112 . . . . 0.0 111.192 178.586 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -20.54 90.1 0.01 OUTLIER 'General case' 0 C--O 1.211 -0.938 0 C-N-CA 125.424 1.49 . . . . 0.0 114.089 -177.461 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 28.4 p80 -92.22 29.45 1.66 Allowed 'General case' 0 N--CA 1.467 0.383 0 O-C-N 119.097 -2.252 . . . . 0.0 108.196 -170.1 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.967 ' CZ ' HD21 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -57.37 176.29 0.13 Allowed 'General case' 0 N--CA 1.428 -1.561 0 N-CA-C 115.073 1.508 . . . . 0.0 115.073 174.161 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.819 HD22 HG22 ' A' ' 109' ' ' ILE . 3.6 mt -95.84 154.99 16.94 Favored 'General case' 0 C--O 1.215 -0.758 0 CA-C-N 115.791 -0.64 . . . . 0.0 111.371 173.946 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.967 HD21 ' CZ ' ' A' ' 79' ' ' TYR . 2.1 mt -141.14 129.28 22.12 Favored 'General case' 0 CA--C 1.51 -0.578 0 N-CA-C 107.853 -1.166 . . . . 0.0 107.853 -177.96 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.495 ' CB ' ' CD1' ' A' ' 109' ' ' ILE . 0.2 OUTLIER -98.92 155.72 17.26 Favored 'General case' 0 N--CA 1.442 -0.835 0 CA-C-O 122.832 1.301 . . . . 0.0 111.543 178.66 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.451 ' HZ ' ' CD2' ' A' ' 94' ' ' PHE . 47.7 t80 -146.27 129.8 8.34 Favored Pre-proline 0 N--CA 1.452 -0.332 0 O-C-N 121.221 -0.924 . . . . 0.0 112.2 179.422 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.52 ' HD3' ' CD2' ' A' ' 34' ' ' TYR . 21.5 Cg_endo -71.96 106.02 1.93 Allowed 'Trans proline' 0 N--CA 1.445 -1.324 0 C-N-CA 124.531 3.487 . . . . 0.0 110.801 -179.462 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -105.94 114.99 29.46 Favored 'General case' 0 CA--C 1.513 -0.455 0 CA-C-N 114.903 -1.044 . . . . 0.0 109.937 -179.73 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.419 ' CE1' ' HB2' ' A' ' 92' ' ' TYR . 70.7 m-85 -82.17 158.02 67.52 Favored Pre-proline 0 N--CA 1.449 -0.515 0 O-C-N 121.775 -0.578 . . . . 0.0 111.818 178.916 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 16.0 Cg_endo -76.8 -38.88 0.77 Allowed 'Trans proline' 0 CA--C 1.498 -1.288 0 C-N-CA 122.467 2.112 . . . . 0.0 112.713 179.404 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 6.1 m-20 -44.92 -30.7 1.06 Allowed 'General case' 0 N--CA 1.469 0.497 0 O-C-N 125.342 1.651 . . . . 0.0 110.98 176.674 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 90.42 -8.48 79.73 Favored Glycine 0 N--CA 1.438 -1.216 0 N-CA-C 109.712 -1.355 . . . . 0.0 109.712 176.349 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.6 p-80 -59.71 129.25 41.0 Favored 'General case' 0 N--CA 1.442 -0.843 0 N-CA-C 107.872 -1.158 . . . . 0.0 107.872 178.072 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.8 t70 -62.68 96.58 0.09 Allowed 'General case' 0 C--N 1.324 -0.518 0 N-CA-C 107.785 -1.191 . . . . 0.0 107.785 175.483 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.492 ' CD2' ' HB3' ' A' ' 94' ' ' PHE . 7.0 t80 -37.82 142.34 0.16 Allowed 'General case' 0 C--O 1.212 -0.904 0 CA-C-O 121.843 0.83 . . . . 0.0 110.92 178.865 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . 0.423 ' HE2' ' O ' ' A' ' 99' ' ' PRO . 0.1 OUTLIER -77.43 57.29 1.5 Allowed 'General case' 0 C--N 1.314 -0.947 0 O-C-N 119.584 -1.947 . . . . 0.0 110.779 175.972 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.492 ' HB3' ' CD2' ' A' ' 92' ' ' TYR . 33.2 p90 -71.25 -9.26 57.82 Favored 'General case' 0 N--CA 1.443 -0.8 0 C-N-CA 124.319 1.048 . . . . 0.0 112.23 175.892 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 2.1 t70 -92.19 -37.27 12.81 Favored 'General case' 0 C--N 1.33 -0.253 0 CA-C-O 122.223 1.011 . . . . 0.0 109.709 -179.456 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.9 m -75.41 106.15 6.8 Favored 'General case' 0 CA--C 1.513 -0.464 0 O-C-N 121.266 -0.896 . . . . 0.0 108.968 -179.956 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . 0.4 ' HA ' ' C ' ' A' ' 31' ' ' GLY . 4.1 pttp -58.59 -49.91 75.76 Favored 'General case' 0 CA--C 1.519 -0.226 0 CA-C-O 121.882 0.848 . . . . 0.0 110.362 178.163 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.422 ' HA ' ' HA ' ' A' ' 99' ' ' PRO . 0.7 OUTLIER -145.54 126.06 7.27 Favored Pre-proline 0 N--CA 1.436 -1.146 0 CA-C-N 114.989 -1.005 . . . . 0.0 110.244 -176.612 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.423 ' O ' ' HE2' ' A' ' 93' ' ' LYS . 29.7 Cg_endo -70.11 175.96 35.58 Favored 'Cis proline' 0 N--CA 1.461 -0.397 0 O-C-N 124.419 1.747 . . . . 0.0 111.797 -4.686 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 15.3 tttm -141.95 132.34 25.12 Favored 'General case' 0 C--N 1.326 -0.445 0 C-N-CA 123.526 0.73 . . . . 0.0 109.069 178.252 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.2 tt0 -72.14 170.81 13.18 Favored 'General case' 0 C--O 1.237 0.442 0 O-C-N 124.747 1.279 . . . . 0.0 111.881 177.141 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -65.13 152.1 92.25 Favored Pre-proline 0 N--CA 1.445 -0.699 0 CA-C-N 115.449 -0.796 . . . . 0.0 111.442 177.863 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 26.8 Cg_endo -73.3 -164.83 0.21 Allowed 'Trans proline' 0 N--CA 1.454 -0.824 0 C-N-CA 122.734 2.289 . . . . 0.0 112.139 175.983 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -141.4 157.43 26.14 Favored Glycine 0 CA--C 1.522 0.494 0 O-C-N 121.353 -0.842 . . . . 0.0 112.438 177.403 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 19.1 Cg_endo -75.76 -67.56 0.02 OUTLIER 'Trans proline' 0 N--CA 1.453 -0.895 0 C-N-CA 122.868 2.379 . . . . 0.0 110.43 179.838 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.761 ' HA ' ' HB2' ' A' ' 122' ' ' ALA . . . -60.73 138.78 58.06 Favored 'General case' 0 N--CA 1.446 -0.634 0 O-C-N 123.9 0.75 . . . . 0.0 110.452 179.038 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 6.0 mtm-85 -144.1 144.07 31.43 Favored 'General case' 0 CA--C 1.508 -0.656 0 O-C-N 124.529 1.143 . . . . 0.0 111.148 -179.051 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.428 HG11 ' HB3' ' A' ' 20' ' ' SER . 4.3 p -82.52 123.95 38.86 Favored 'Isoleucine or valine' 0 C--N 1.325 -0.48 0 O-C-N 123.907 0.754 . . . . 0.0 110.595 179.032 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.819 HG22 HD22 ' A' ' 80' ' ' LEU . 7.0 mm -104.67 138.68 28.34 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.903 0 N-CA-C 110.018 -0.364 . . . . 0.0 110.018 -178.923 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.807 ' C ' HD23 ' A' ' 80' ' ' LEU . 12.6 p90 -165.52 155.19 12.62 Favored 'General case' 0 N--CA 1.444 -0.744 0 CA-C-O 121.801 0.81 . . . . 0.0 111.517 -178.188 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 16.9 p -91.2 160.86 15.33 Favored 'General case' 0 C--N 1.318 -0.773 0 N-CA-C 108.627 -0.879 . . . . 0.0 108.627 -175.918 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.524 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -107.79 155.79 39.23 Favored Pre-proline 0 C--N 1.318 -0.776 0 O-C-N 122.029 -0.419 . . . . 0.0 110.694 179.905 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.524 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 17.8 Cg_endo -73.32 -53.87 0.15 OUTLIER 'Cis proline' 0 CA--C 1.5 -1.176 0 C-N-CA 123.351 -1.521 . . . . 0.0 109.399 -7.429 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.571 ' O ' HG23 ' A' ' 116' ' ' VAL . 11.6 t30 -44.17 107.38 0.09 Allowed 'General case' 0 C--O 1.217 -0.642 0 CA-C-O 116.187 -1.864 . . . . 0.0 109.632 179.886 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.676 ' HE2' HD13 ' A' ' 25' ' ' LEU . 0.3 OUTLIER -62.35 85.37 0.02 OUTLIER 'General case' 0 CA--C 1.509 -0.627 0 O-C-N 124.568 1.168 . . . . 0.0 108.737 -176.099 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.571 HG23 ' O ' ' A' ' 114' ' ' ASN . 81.0 t -84.31 67.67 0.54 Allowed 'Isoleucine or valine' 0 CA--C 1.505 -0.756 0 N-CA-C 104.964 -2.235 . . . . 0.0 104.964 -173.692 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.576 ' CZ ' ' HA2' ' A' ' 119' ' ' GLY . 47.1 t80 -37.13 101.98 0.02 OUTLIER 'General case' 0 N--CA 1.45 -0.453 0 C-N-CA 125.225 1.41 . . . . 0.0 109.759 178.549 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . 0.49 ' HB3' ' CD2' ' A' ' 57' ' ' PHE . 0.0 OUTLIER -81.79 -24.62 35.86 Favored 'General case' 0 N--CA 1.442 -0.874 0 N-CA-C 109.641 -0.503 . . . . 0.0 109.641 178.997 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.576 ' HA2' ' CZ ' ' A' ' 117' ' ' PHE . . . 144.99 -147.42 18.58 Favored Glycine 0 N--CA 1.434 -1.435 0 N-CA-C 110.254 -1.138 . . . . 0.0 110.254 -178.724 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.462 HG13 ' CG ' ' A' ' 4' ' ' TRP . 1.1 mm -127.31 148.27 32.08 Favored 'Isoleucine or valine' 0 CA--C 1.492 -1.273 0 N-CA-C 106.354 -1.721 . . . . 0.0 106.354 -175.428 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.741 HD12 ' HB2' ' A' ' 131' ' ' LEU . 8.2 pt -136.23 154.99 34.14 Favored 'Isoleucine or valine' 0 C--N 1.318 -0.765 0 N-CA-C 108.139 -1.059 . . . . 0.0 108.139 -178.253 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.78 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . . . 179.25 131.43 0.08 Allowed 'General case' 0 C--N 1.323 -0.575 0 CA-C-O 122.145 0.974 . . . . 0.0 109.502 -179.976 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.457 ' CG ' HD12 ' A' ' 131' ' ' LEU . 0.5 OUTLIER -88.05 94.61 9.85 Favored 'General case' 0 C--N 1.321 -0.657 0 CA-C-O 122.372 1.082 . . . . 0.0 111.927 179.212 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.545 HG21 ' O ' ' A' ' 6' ' ' CYS . 1.3 p -103.84 42.21 1.21 Allowed 'General case' 0 C--N 1.305 -1.328 0 O-C-N 121.304 -0.872 . . . . 0.0 109.184 -176.7 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 15.0 tttt -95.72 -39.54 9.83 Favored 'General case' 0 C--O 1.211 -0.937 0 CA-C-O 115.328 -2.272 . . . . 0.0 111.117 178.009 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 2.8 mt-10 169.89 -86.38 0.0 OUTLIER 'General case' 0 C--O 1.218 -0.568 0 O-C-N 126.136 2.148 . . . . 0.0 108.749 178.606 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.1 m-20 -158.76 28.7 0.22 Allowed 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 127.055 2.142 . . . . 0.0 110.384 -176.633 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 0.8 OUTLIER -169.34 91.72 0.24 Allowed 'General case' 0 N--CA 1.448 -0.563 0 CA-C-O 122.829 1.3 . . . . 0.0 110.034 -177.646 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . 163.31 109.62 0.23 Allowed Glycine 0 CA--C 1.483 -1.965 0 CA-C-O 115.245 -2.975 . . . . 0.0 106.146 179.077 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.5 OUTLIER -35.44 151.73 0.01 OUTLIER 'General case' 0 CA--C 1.539 0.541 0 CA-C-N 119.877 1.839 . . . . 0.0 112.76 175.322 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.741 ' HB2' HD12 ' A' ' 121' ' ' ILE . 0.0 OUTLIER -59.79 154.93 17.14 Favored 'General case' 0 C--N 1.32 -0.713 0 O-C-N 121.037 -1.039 . . . . 0.0 108.642 -176.504 . . . . . . . . 3 3 . 1 . 020 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 3.8 ptmt -132.64 151.39 51.97 Favored 'General case' 0 CA--C 1.498 -1.021 0 N-CA-C 107.813 -1.18 . . . . 0.0 107.813 -178.248 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.465 HD13 ' CD2' ' A' ' 57' ' ' PHE . 13.4 tp -54.32 129.71 36.39 Favored 'General case' 0 C--N 1.327 -0.392 0 O-C-N 125.11 1.507 . . . . 0.0 108.339 -179.569 . . . . . . . . 2 2 . 1 . 020 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 76.4 m -66.57 -173.78 0.25 Allowed 'General case' 0 N--CA 1.439 -0.982 0 CA-C-O 124.363 2.03 . . . . 0.0 108.237 177.291 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 39.3 m -157.94 125.52 5.19 Favored 'General case' 0 C--N 1.302 -1.491 0 N-CA-C 102.819 -3.03 . . . . 0.0 102.819 -179.916 . . . . . . . . 1 1 . 1 . 020 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.555 ' HB3' HG22 ' A' ' 2' ' ' VAL . 2.4 m80 . . . . . 0 CA--C 1.575 1.923 0 N-CA-C 118.489 2.774 . . . . 0.0 118.489 175.091 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . 0.684 ' HB3' ' HB3' ' A' ' 13' ' ' GLN . . . . . . . . 0 N--CA 1.498 1.96 0 CA-C-O 116.669 -1.634 . . . . 0.0 107.644 . . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 14.3 p -41.51 142.82 0.3 Allowed 'Isoleucine or valine' 0 N--CA 1.48 1.066 0 CA-C-O 123.12 1.438 . . . . 0.0 112.774 169.752 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.442 HG21 HD12 ' A' ' 10' ' ' LEU . 6.4 m -93.37 111.25 22.85 Favored 'General case' 0 C--N 1.321 -0.664 0 N-CA-C 107.632 -1.248 . . . . 0.0 107.632 -173.089 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.414 ' CZ2' ' CD2' ' A' ' 136' ' ' HIS . 18.0 m95 -75.59 143.77 42.16 Favored 'General case' 0 CA--C 1.504 -0.789 0 N-CA-C 107.21 -1.404 . . . . 0.0 107.21 -178.557 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.537 ' OG1' HD13 ' A' ' 10' ' ' LEU . 1.9 m -145.88 153.25 40.65 Favored 'General case' 0 C--N 1.322 -0.606 0 N-CA-C 108.034 -1.099 . . . . 0.0 108.034 -179.975 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.608 ' CB ' ' HB3' ' A' ' 122' ' ' ALA . 0.8 OUTLIER -125.65 -84.64 0.63 Allowed 'General case' 0 N--CA 1.473 0.703 0 N-CA-C 113.955 1.094 . . . . 0.0 113.955 172.448 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -102.0 58.38 0.61 Allowed Glycine 0 N--CA 1.473 1.101 0 N-CA-C 110.789 -0.924 . . . . 0.0 110.789 -178.032 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 72.92 -3.31 29.02 Favored Glycine 0 N--CA 1.494 2.559 0 N-CA-C 117.681 1.832 . . . . 0.0 117.681 -171.331 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . 0.351 5.1 mt -94.73 132.61 39.3 Favored 'General case' 0 CA--C 1.545 0.778 0 C-N-CA 126.087 1.755 . . . . 0.0 108.405 -177.438 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.537 HD13 ' OG1' ' A' ' 5' ' ' THR . 4.4 mm? -99.29 151.86 20.57 Favored 'General case' 0 N--CA 1.476 0.854 0 C-N-CA 125.316 1.446 . . . . 0.0 110.102 -170.861 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.856 ' CZ ' ' HB3' ' A' ' 106' ' ' ALA . 40.9 m-85 -157.85 74.65 0.74 Allowed 'General case' 0 N--CA 1.47 0.549 0 N-CA-C 105.632 -1.988 . . . . 0.0 105.632 -168.017 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . 0.431 ' HA ' ' HA ' ' A' ' 3' ' ' THR . 0.2 OUTLIER -50.67 128.0 19.47 Favored 'General case' 0 N--CA 1.478 0.96 0 O-C-N 120.053 -1.655 . . . . 0.0 108.606 178.251 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.684 ' HB3' ' HB3' ' A' ' 1' ' ' ALA . 0.2 OUTLIER -44.66 -54.7 5.91 Favored 'General case' 0 N--CA 1.483 1.201 0 CA-C-O 117.682 -1.151 . . . . 0.0 111.841 178.179 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.0 t-20 -48.27 -51.2 26.76 Favored 'General case' 0 C--O 1.202 -1.403 0 O-C-N 124.235 0.959 . . . . 0.0 112.449 176.193 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -59.41 -35.64 74.36 Favored 'General case' 0 N--CA 1.486 1.365 0 CA-C-O 114.329 -2.748 . . . . 0.0 117.491 169.981 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.665 ' HB1' HD11 ' A' ' 120' ' ' ILE . . . -63.13 -68.33 0.35 Allowed 'General case' 0 N--CA 1.474 0.739 0 C-N-CA 127.518 2.327 . . . . 0.0 115.487 169.537 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 1.5 pt-20 -48.35 -42.0 30.17 Favored 'General case' 0 N--CA 1.488 1.456 0 CA-C-O 117.714 -1.136 . . . . 0.0 110.739 167.836 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 41.5 t -64.84 -53.09 52.25 Favored 'General case' 0 N--CA 1.494 1.726 0 C-N-CA 126.687 1.995 . . . . 0.0 110.418 -179.702 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 3.1 t-20 -44.98 -49.12 11.37 Favored 'General case' 0 N--CA 1.474 0.762 0 CA-C-N 119.189 0.904 . . . . 0.0 111.247 173.152 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.507 ' HB2' ' CE2' ' A' ' 110' ' ' TYR . 1.7 p -67.72 -32.65 73.42 Favored 'General case' 0 N--CA 1.474 0.738 0 N-CA-C 118.133 2.642 . . . . 0.0 118.133 172.933 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 11.0 m170 -58.64 -40.24 82.84 Favored 'General case' 0 N--CA 1.484 1.273 0 C-N-CA 127.535 2.334 . . . . 0.0 110.73 174.38 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -80.6 -44.76 18.41 Favored 'General case' 0 CA--C 1.511 -0.521 0 C-N-CA 125.28 1.432 . . . . 0.0 111.658 176.407 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.582 ' HB1' ' HG3' ' A' ' 35' ' ' PRO . . . -47.35 126.45 9.67 Favored Pre-proline 0 CA--C 1.552 1.041 0 O-C-N 125.527 1.767 . . . . 0.0 112.76 177.457 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . . . . . . . . . 24.1 Cg_endo -68.28 128.96 18.28 Favored 'Trans proline' 0 N--CA 1.439 -1.718 0 N-CA-C 107.596 -1.732 . . . . 0.0 107.596 -176.272 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.744 HD21 ' O ' ' A' ' 113' ' ' PRO . 4.6 tp -65.31 90.65 0.1 Allowed 'General case' 0 C--N 1.329 -0.307 0 C-N-CA 126.397 1.879 . . . . 0.0 112.505 178.138 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER 174.21 161.95 0.19 Allowed 'General case' 0 C--N 1.321 -0.662 0 C-N-CA 125.84 1.656 . . . . 0.0 108.786 -172.148 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.456 ' HA ' ' HA ' ' A' ' 36' ' ' HIS . 2.9 t70 -104.74 119.17 38.36 Favored 'General case' 0 CA--C 1.495 -1.171 0 C-N-CA 128.558 2.743 . . . . 0.0 108.425 -179.062 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 56.76 50.02 66.47 Favored Glycine 0 CA--C 1.531 1.044 0 C-N-CA 119.69 -1.243 . . . . 0.0 112.069 172.407 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -111.81 -3.57 14.89 Favored 'General case' 0 N--CA 1.488 1.47 0 C-N-CA 125.382 1.473 . . . . 0.0 114.344 176.119 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . . . . . . . . . 14.2 p -114.27 158.42 21.44 Favored 'General case' 0 C--N 1.317 -0.831 0 N-CA-C 107.075 -1.454 . . . . 0.0 107.075 -170.895 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -45.89 -55.08 7.55 Favored Glycine 0 N--CA 1.467 0.736 0 C-N-CA 124.331 0.967 . . . . 0.0 115.039 -178.745 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 30.4 t -57.52 -71.8 0.1 Allowed 'General case' 0 C--N 1.325 -0.461 0 N-CA-C 114.266 1.209 . . . . 0.0 114.266 165.64 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 1.5 m 161.44 -51.03 0.0 OUTLIER 'General case' 0 N--CA 1.484 1.256 0 C-N-CA 131.338 3.855 . . . . 0.0 110.929 -176.507 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.483 ' CE1' ' HG3' ' A' ' 103' ' ' PRO . 90.8 m-85 -57.38 147.72 57.36 Favored Pre-proline 0 CA--C 1.569 1.694 0 N-CA-C 112.847 0.684 . . . . 0.0 112.847 -174.038 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.582 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 19.6 Cg_endo -66.79 148.31 78.21 Favored 'Cis proline' 0 N--CA 1.428 -2.324 0 N-CA-C 106.784 -2.045 . . . . 0.0 106.784 -7.467 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.456 ' HA ' ' HA ' ' A' ' 27' ' ' ASP 0.27 0.3 OUTLIER -117.3 167.08 11.55 Favored 'General case' 0 C--N 1.303 -1.444 0 CA-C-N 113.736 -1.574 . . . . 0.0 107.393 174.927 . . . . . . . . 4 4 . 1 . 021 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.704 ' CH2' HG22 ' A' ' 39' ' ' THR . 11.1 t90 -64.03 133.17 52.6 Favored 'General case' 0 C--N 1.317 -0.846 0 CA-C-O 123.274 1.511 . . . . 0.0 112.329 168.768 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.482 ' CD2' ' HB2' ' A' ' 40' ' ' ASN . 18.0 t80 -98.7 89.98 4.55 Favored 'General case' 0 N--CA 1.439 -1.005 0 N-CA-C 102.995 -2.965 . . . . 0.0 102.995 -179.742 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.704 HG22 ' CH2' ' A' ' 37' ' ' TRP . 82.8 p -38.86 -41.52 0.75 Allowed 'General case' 0 CA--C 1.502 -0.887 0 CA-C-N 111.329 -2.669 . . . . 0.0 110.421 160.923 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.482 ' HB2' ' CD2' ' A' ' 38' ' ' PHE . 63.2 t30 57.36 25.09 10.84 Favored 'General case' 0 N--CA 1.489 1.499 0 CA-C-N 120.625 1.557 . . . . 0.0 112.09 178.316 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.753 ' C ' HD23 ' A' ' 48' ' ' LEU . . . 94.4 -39.35 2.92 Favored Glycine 0 CA--C 1.542 1.779 0 CA-C-O 113.723 -3.82 . . . . 0.0 117.846 -163.92 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . . . . . . . . . 81.9 m-85 -45.14 148.72 0.56 Allowed 'General case' 0 N--CA 1.499 2.007 0 C-N-CA 130.203 3.401 . . . . 0.0 111.687 173.853 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -83.68 -32.56 25.52 Favored 'General case' 0 N--CA 1.484 1.245 0 N-CA-C 115.34 1.607 . . . . 0.0 115.34 177.363 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.407 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -168.79 -81.95 0.05 OUTLIER Glycine 0 CA--C 1.527 0.841 0 C-N-CA 126.133 1.825 . . . . 0.0 111.82 -176.647 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -108.26 -63.95 1.27 Allowed 'General case' 0 N--CA 1.484 1.233 0 C-N-CA 127.337 2.255 . . . . 0.0 114.226 -178.307 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -60.52 -171.37 0.66 Allowed Glycine 0 C--O 1.222 -0.599 0 CA-C-N 114.54 -1.209 . . . . 0.0 111.989 177.012 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -57.55 -175.29 0.02 OUTLIER 'General case' 0 CA--C 1.547 0.838 0 CA-C-O 124.375 2.036 . . . . 0.0 115.151 170.441 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.753 HD23 ' C ' ' A' ' 41' ' ' GLY . 0.0 OUTLIER -74.7 160.04 81.84 Favored Pre-proline 0 C--N 1.312 -1.044 0 CA-C-N 114.338 -1.301 . . . . 0.0 110.56 -177.889 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 21.1 Cg_endo -62.03 168.72 8.58 Favored 'Trans proline' 0 N--CA 1.435 -1.967 0 CA-C-O 123.88 1.534 . . . . 0.0 110.119 171.306 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 6.5 ttpt -55.1 101.35 0.05 OUTLIER 'General case' 0 N--CA 1.478 0.971 0 C-N-CA 125.624 1.57 . . . . 0.0 111.665 170.222 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 94.37 90.24 1.67 Allowed Glycine 0 N--CA 1.474 1.203 0 N-CA-C 111.553 -0.619 . . . . 0.0 111.553 -173.822 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.446 ' CD ' ' HA2' ' A' ' 41' ' ' GLY . 0.0 OUTLIER -167.01 163.89 15.96 Favored 'General case' 0 N--CA 1.475 0.806 0 C-N-CA 126.463 1.905 . . . . 0.0 111.148 171.98 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 42.4 m -134.89 101.93 11.37 Favored Pre-proline 0 N--CA 1.478 0.972 0 N-CA-C 108.951 -0.759 . . . . 0.0 108.951 -178.325 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.497 ' HB3' HD21 ' A' ' 48' ' ' LEU . 29.8 Cg_endo -71.46 140.71 37.05 Favored 'Trans proline' 0 N--CA 1.43 -2.247 0 C-N-CA 122.155 1.903 . . . . 0.0 109.911 176.472 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . . . . . . . . . 3.0 mt -61.8 119.52 5.97 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.432 0 N-CA-C 105.206 -2.146 . . . . 0.0 105.206 172.294 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -85.65 143.88 28.16 Favored 'General case' 0 N--CA 1.469 0.518 0 CA-C-N 115.712 -0.676 . . . . 0.0 110.284 169.821 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.535 ' CD1' ' HB3' ' A' ' 118' ' ' CYS . 7.0 m-85 -124.68 -53.24 1.68 Allowed 'General case' 0 N--CA 1.482 1.147 0 C-N-CA 126.308 1.843 . . . . 0.0 111.044 179.514 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 122.43 -5.62 10.05 Favored Glycine 0 N--CA 1.476 1.345 0 C-N-CA 126.735 2.112 . . . . 0.0 114.929 -172.982 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -93.79 131.48 39.12 Favored 'General case' 0 CA--C 1.503 -0.865 0 C-N-CA 125.013 1.325 . . . . 0.0 110.765 172.622 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 92.0 p -67.89 2.78 1.8 Allowed 'General case' 0 N--CA 1.477 0.904 0 N-CA-C 114.677 1.362 . . . . 0.0 114.677 174.976 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . 0.486 ' OD2' HG11 ' A' ' 116' ' ' VAL . 0.4 OUTLIER -94.38 -55.19 3.25 Favored 'General case' 0 N--CA 1.464 0.253 0 C-N-CA 128.608 2.763 . . . . 0.0 108.201 -173.839 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.757 ' HA ' HD11 ' A' ' 80' ' ' LEU . 1.8 m -77.31 -26.32 52.12 Favored 'General case' 0 CA--C 1.537 0.451 0 C-N-CA 124.528 1.131 . . . . 0.0 113.077 175.148 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 15.7 t70 -72.32 -26.74 62.06 Favored 'General case' 0 N--CA 1.488 1.441 0 C-N-CA 126.274 1.829 . . . . 0.0 114.043 166.881 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -63.07 155.06 74.99 Favored Pre-proline 0 CA--C 1.539 0.52 0 O-C-N 120.247 -1.533 . . . . 0.0 114.32 175.412 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -63.85 129.55 25.04 Favored 'Trans proline' 0 CA--C 1.568 2.207 0 O-C-N 119.336 -0.929 . . . . 0.0 112.063 174.582 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.528 ' HB3' ' HA ' ' A' ' 79' ' ' TYR . 19.4 Cg_endo -65.75 177.43 2.87 Favored 'Trans proline' 0 N--CA 1.447 -1.253 1 C-N-CA 125.448 4.099 . . . . 0.0 111.146 176.587 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 3.4 tptt -132.75 53.0 2.04 Favored 'General case' 0 C--O 1.214 -0.767 0 O-C-N 120.331 -1.481 . . . . 0.0 110.309 170.649 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 46.3 t-80 -76.04 160.94 29.31 Favored 'General case' 0 N--CA 1.48 1.069 0 CA-C-O 123.315 1.531 . . . . 0.0 112.978 -178.819 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -148.74 -171.48 3.87 Favored 'General case' 0 N--CA 1.478 0.957 0 O-C-N 117.949 -2.969 . . . . 0.0 110.947 177.116 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.76 79.94 7.32 Favored 'General case' 0 C--O 1.213 -0.832 0 O-C-N 120.736 -1.227 . . . . 0.0 110.043 170.113 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -175.25 -44.21 0.01 OUTLIER 'General case' 0 N--CA 1.494 1.76 0 C-N-CA 126.022 1.729 . . . . 0.0 111.766 176.218 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 123.8 -63.61 0.55 Allowed Glycine 0 C--O 1.221 -0.691 0 N-CA-C 109.851 -1.3 . . . . 0.0 109.851 -176.287 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 2.8 t-20 -140.28 96.84 3.11 Favored 'General case' 0 CA--C 1.548 0.891 0 C-N-CA 128.165 2.586 . . . . 0.0 106.251 177.097 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -73.46 -99.21 0.08 OUTLIER Glycine 0 CA--C 1.536 1.353 0 N-CA-C 116.365 1.306 . . . . 0.0 116.365 170.444 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 23.9 mttt -75.33 -97.94 0.02 OUTLIER 'General case' 0 N--CA 1.491 1.588 0 O-C-N 120.164 -1.786 . . . . 0.0 114.313 172.913 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . . . . . . . . . 0.5 OUTLIER -109.52 12.8 24.28 Favored 'General case' 0 N--CA 1.492 1.639 0 O-C-N 120.838 -1.164 . . . . 0.0 111.025 178.518 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . . . . . . . . . 4.7 m-20 -23.16 95.06 0.01 OUTLIER 'General case' 0 C--O 1.215 -0.718 0 C-N-CA 129.449 3.099 . . . . 0.0 111.51 -171.783 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.406 ' CD2' ' H ' ' A' ' 78' ' ' HIS . 5.7 p80 -91.13 54.67 2.66 Favored 'General case' 0 N--CA 1.492 1.654 0 O-C-N 118.048 -2.907 . . . . 0.0 106.529 -163.172 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.528 ' HA ' ' HB3' ' A' ' 66' ' ' PRO . 39.8 p90 -85.53 148.33 26.0 Favored 'General case' 0 C--N 1.318 -0.801 0 N-CA-C 105.906 -1.887 . . . . 0.0 105.906 -172.439 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.757 HD11 ' HA ' ' A' ' 62' ' ' CYS . 0.9 OUTLIER -73.79 162.29 29.29 Favored 'General case' 0 C--O 1.217 -0.634 0 C-N-CA 116.817 -1.953 . . . . 0.0 112.951 168.455 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.445 ' HB2' ' CE1' ' A' ' 110' ' ' TYR . 4.1 mp -141.65 111.23 6.52 Favored 'General case' 0 CA--C 1.498 -1.04 0 CA-C-N 119.921 1.237 . . . . 0.0 111.701 179.003 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 3.2 pm0 -80.2 152.69 29.03 Favored 'General case' 0 C--O 1.238 0.488 0 C-N-CA 119.243 -0.983 . . . . 0.0 111.291 -178.145 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.556 ' CE2' ' HB2' ' A' ' 23' ' ' ALA . 3.0 t80 -142.02 133.86 13.44 Favored Pre-proline 0 CA--C 1.544 0.741 0 N-CA-C 114.067 1.136 . . . . 0.0 114.067 179.073 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.644 ' HG2' ' CD2' ' A' ' 92' ' ' TYR . 30.9 Cg_endo -71.9 87.37 0.85 Allowed 'Trans proline' 0 N--CA 1.454 -0.849 0 C-N-CA 124.633 3.555 . . . . 0.0 112.009 -177.29 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 6.4 t -89.89 96.73 10.82 Favored 'General case' 0 CA--C 1.508 -0.647 0 CA-C-N 114.316 -1.311 . . . . 0.0 110.592 -179.837 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . . . . . . . . . 51.5 m-85 -80.58 157.5 72.28 Favored Pre-proline 0 CA--C 1.552 1.052 0 O-C-N 120.963 -1.085 . . . . 0.0 112.407 179.695 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . 0.267 9.3 Cg_endo -71.59 -30.96 14.17 Favored 'Trans proline' 0 N--CA 1.451 -1.019 0 C-N-CA 122.171 1.914 . . . . 0.0 115.711 175.107 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 7.6 t70 -43.74 -35.81 2.0 Favored 'General case' 0 N--CA 1.499 2.001 0 C-N-CA 128.353 2.661 . . . . 0.0 109.899 174.931 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 88.71 7.85 70.86 Favored Glycine 0 C--N 1.328 0.106 0 N-CA-C 116.432 1.333 . . . . 0.0 116.432 -178.404 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 3.7 p-80 -71.59 128.52 36.08 Favored 'General case' 0 N--CA 1.439 -0.989 0 N-CA-C 106.346 -1.724 . . . . 0.0 106.346 174.442 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 31.0 t70 -64.54 110.4 2.3 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 104.965 -2.235 . . . . 0.0 104.965 163.033 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.644 ' CD2' ' HG2' ' A' ' 84' ' ' PRO . 9.3 t80 -39.3 142.15 0.28 Allowed 'General case' 0 CA--C 1.553 1.088 0 C-N-CA 126.735 2.014 . . . . 0.0 109.756 171.052 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -78.76 61.94 3.15 Favored 'General case' 0 C--N 1.323 -0.556 0 O-C-N 118.098 -2.877 . . . . 0.0 111.664 169.906 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.484 ' CD1' ' HZ ' ' A' ' 83' ' ' PHE . 11.9 p90 -70.93 -27.58 63.87 Favored 'General case' 0 C--O 1.221 -0.442 0 C-N-CA 124.775 1.23 . . . . 0.0 113.447 170.134 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 31.1 t70 -76.53 -42.47 42.97 Favored 'General case' 0 N--CA 1.486 1.358 0 C-N-CA 125.728 1.611 . . . . 0.0 111.633 -179.256 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 20.1 m -76.51 116.39 17.15 Favored 'General case' 0 N--CA 1.466 0.361 0 O-C-N 119.807 -1.808 . . . . 0.0 109.316 -179.935 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 5.1 pttt -56.81 -44.22 81.76 Favored 'General case' 0 N--CA 1.495 1.802 0 CA-C-O 123.534 1.635 . . . . 0.0 113.945 176.634 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 5.3 tttt -151.26 133.96 8.61 Favored Pre-proline 0 CA--C 1.549 0.931 0 C-N-CA 126.0 1.72 . . . . 0.0 111.938 179.831 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 36.0 Cg_endo -66.63 165.4 64.79 Favored 'Cis proline' 0 N--CA 1.45 -1.045 0 C-N-CA 124.013 -1.244 . . . . 0.0 110.022 -9.862 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 1.6 pttm -142.11 145.94 34.83 Favored 'General case' 0 C--N 1.323 -0.584 0 N-CA-C 105.62 -1.992 . . . . 0.0 105.62 176.265 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 2.8 tt0 -69.17 173.01 6.03 Favored 'General case' 0 N--CA 1.477 0.915 0 C-N-CA 124.205 1.002 . . . . 0.0 111.797 172.797 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 45.4 t30 -113.28 127.08 27.24 Favored Pre-proline 0 CA--C 1.556 1.175 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -178.258 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . 0.483 ' HG3' ' CE1' ' A' ' 34' ' ' TYR . 70.1 Cg_endo -74.35 -160.87 0.11 Allowed 'Trans proline' 0 CA--C 1.554 1.522 0 C-N-CA 125.217 3.945 . . . . 0.0 109.787 167.953 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . 112.49 -39.61 2.81 Favored Glycine 0 CA--C 1.545 1.96 0 CA-C-O 114.797 -3.224 . . . . 0.0 112.505 -162.344 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 34.6 Cg_endo -70.93 -163.67 0.13 Allowed 'Trans proline' 0 C--N 1.366 1.488 1 CA-C-N 125.577 4.689 . . . . 0.0 112.469 177.736 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.944 ' HB2' ' HB2' ' A' ' 122' ' ' ALA . . . -63.95 160.77 17.07 Favored 'General case' 0 N--CA 1.452 -0.358 0 CA-C-O 124.757 2.218 . . . . 0.0 113.052 169.451 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -144.74 151.95 39.65 Favored 'General case' 0 C--O 1.214 -0.799 0 CA-C-N 111.832 -2.44 . . . . 0.0 110.8 179.613 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . . . . . . . . . 3.7 p -87.8 120.84 37.53 Favored 'Isoleucine or valine' 0 N--CA 1.491 1.577 0 C-N-CA 127.13 2.172 . . . . 0.0 112.003 173.292 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.412 ' CG2' HD22 ' A' ' 80' ' ' LEU . 1.7 mp -112.1 127.32 69.36 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.886 0 N-CA-C 106.667 -1.605 . . . . 0.0 106.667 -171.644 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.507 ' CE2' ' HB2' ' A' ' 20' ' ' SER . 14.1 p90 -145.98 156.24 43.37 Favored 'General case' 0 C--N 1.309 -1.163 0 N-CA-C 107.479 -1.304 . . . . 0.0 107.479 -177.029 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.7 p -81.79 164.91 21.35 Favored 'General case' 0 N--CA 1.487 1.417 0 C-N-CA 124.196 0.999 . . . . 0.0 112.187 176.306 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.466 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.4 OUTLIER -109.8 158.89 33.63 Favored Pre-proline 0 CA--C 1.556 1.185 0 N-CA-C 112.667 0.618 . . . . 0.0 112.667 175.415 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.744 ' O ' HD21 ' A' ' 25' ' ' LEU . 19.8 Cg_endo -69.45 -52.73 0.16 OUTLIER 'Cis proline' 0 CA--C 1.501 -1.167 0 N-CA-C 108.915 -1.225 . . . . 0.0 108.915 -15.837 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.45 ' O ' HG23 ' A' ' 116' ' ' VAL . 28.6 t30 -43.69 108.88 0.12 Allowed 'General case' 0 CA--C 1.543 0.701 0 C-N-CA 123.931 0.892 . . . . 0.0 110.098 177.004 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.703 ' HE2' HD13 ' A' ' 25' ' ' LEU . 0.4 OUTLIER -67.54 75.05 0.17 Allowed 'General case' 0 N--CA 1.48 1.066 0 C-N-CA 127.99 2.516 . . . . 0.0 107.615 -179.344 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.486 HG11 ' OD2' ' A' ' 61' ' ' ASP . 72.0 t -85.06 78.45 1.48 Allowed 'Isoleucine or valine' 0 C--N 1.319 -0.749 0 N-CA-C 101.112 -3.662 . . . . 0.0 101.112 -175.983 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.486 ' CZ ' ' NE2' ' A' ' 13' ' ' GLN . 5.9 t80 -41.29 113.51 0.41 Allowed 'General case' 0 N--CA 1.44 -0.935 0 C-N-CA 129.071 2.948 . . . . 0.0 104.944 176.5 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . 0.535 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 0.1 OUTLIER -93.89 -37.95 11.46 Favored 'General case' 0 N--CA 1.441 -0.91 0 CA-C-O 122.101 0.953 . . . . 0.0 112.963 174.967 . . . . . . . . 3 3 . 1 . 021 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.564 ' HA3' HD11 ' A' ' 133' ' ' LEU . . . 163.72 -168.92 38.51 Favored Glycine 0 N--CA 1.445 -0.725 0 C-N-CA 125.32 1.438 . . . . 0.0 111.648 -179.601 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.665 HD11 ' HB1' ' A' ' 16' ' ' ALA . 1.3 mp -114.72 120.39 64.24 Favored 'Isoleucine or valine' 0 CA--C 1.49 -1.356 0 N-CA-C 103.119 -2.919 . . . . 0.0 103.119 176.411 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.582 HD12 ' HG ' ' A' ' 131' ' ' LEU . 8.4 pt -89.52 153.5 3.22 Favored 'Isoleucine or valine' 0 C--N 1.314 -0.953 0 CA-C-O 117.707 -1.139 . . . . 0.0 109.333 172.427 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.944 ' HB2' ' HB2' ' A' ' 106' ' ' ALA . . . -161.64 164.07 29.49 Favored 'General case' 0 N--CA 1.491 1.579 0 CA-C-N 121.484 1.947 . . . . 0.0 113.25 172.062 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.546 ' CD2' HD13 ' A' ' 131' ' ' LEU . 39.2 m-70 -89.33 91.68 8.85 Favored 'General case' 0 C--O 1.217 -0.656 0 C-N-CA 119.168 -1.013 . . . . 0.0 109.404 -176.001 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . . . . . . . . . 1.1 t -94.1 32.35 1.51 Allowed 'General case' 0 N--CA 1.502 2.148 0 CA-C-O 124.413 2.054 . . . . 0.0 112.661 -179.828 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.0 tptm -97.77 -33.53 11.24 Favored 'General case' 0 N--CA 1.475 0.824 0 CA-C-O 117.154 -1.403 . . . . 0.0 112.225 178.465 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -172.25 -68.45 0.02 OUTLIER 'General case' 0 N--CA 1.47 0.554 0 C-N-CA 125.655 1.582 . . . . 0.0 110.629 178.991 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 2.0 t-20 -150.91 -49.3 0.12 Allowed 'General case' 0 CA--C 1.545 0.772 0 C-N-CA 127.354 2.262 . . . . 0.0 111.908 -179.121 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 8.7 tt0 -149.22 82.23 1.42 Allowed 'General case' 0 N--CA 1.448 -0.549 0 C-N-CA 127.984 2.514 . . . . 0.0 108.314 -177.763 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -130.95 -114.43 1.64 Allowed Glycine 0 N--CA 1.473 1.155 0 N-CA-C 109.347 -1.501 . . . . 0.0 109.347 171.019 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.7 mm-40 -79.27 145.2 33.67 Favored 'General case' 0 C--N 1.308 -1.224 0 O-C-N 121.078 -1.248 . . . . 0.0 111.105 178.495 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.582 ' HG ' HD12 ' A' ' 121' ' ' ILE . 3.7 tp -104.89 126.34 51.86 Favored 'General case' 0 C--O 1.217 -0.605 0 C-N-CA 123.468 0.707 . . . . 0.0 110.999 175.479 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -136.65 168.54 19.3 Favored 'General case' 0 N--CA 1.477 0.879 0 C-N-CA 126.052 1.741 . . . . 0.0 110.531 -179.488 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.564 HD11 ' HA3' ' A' ' 119' ' ' GLY . 14.3 tp -71.99 142.67 49.37 Favored 'General case' 0 N--CA 1.479 1.016 0 CA-C-N 118.82 0.736 . . . . 0.0 110.325 175.668 . . . . . . . . 2 2 . 1 . 021 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 75.1 m -69.27 179.52 1.95 Allowed 'General case' 0 C--N 1.325 -0.477 0 CA-C-O 124.764 2.221 . . . . 0.0 113.05 165.875 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 96.9 p -146.01 89.15 1.86 Allowed 'General case' 0 C--N 1.316 -0.863 0 N-CA-C 105.101 -2.185 . . . . 0.0 105.101 -179.103 . . . . . . . . 1 1 . 1 . 021 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.414 ' CD2' ' CZ2' ' A' ' 4' ' ' TRP . 0.0 OUTLIER . . . . . 0 N--CA 1.487 1.415 0 CA-C-O 113.814 -2.993 . . . . 0.0 116.852 163.596 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.487 1.379 0 CA-C-O 114.717 -2.563 . . . . 0.0 108.642 . . . . . . . . . 0 0 . 1 . 022 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . . . . . . . . . 0.4 OUTLIER 61.71 110.27 0.03 OUTLIER 'Isoleucine or valine' 0 CA--C 1.534 0.349 0 CA-C-O 124.337 2.017 . . . . 0.0 109.825 177.985 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.679 HG21 HD22 ' A' ' 10' ' ' LEU . 0.9 OUTLIER -92.65 113.05 25.21 Favored 'General case' 0 C--N 1.312 -1.031 0 O-C-N 119.046 -2.284 . . . . 0.0 110.27 179.323 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . . . . . . . . . 25.6 m95 -77.93 141.04 39.27 Favored 'General case' 0 N--CA 1.444 -0.74 0 N-CA-C 109.448 -0.575 . . . . 0.0 109.448 177.345 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.401 ' OG1' HD23 ' A' ' 10' ' ' LEU . 0.9 OUTLIER -130.88 119.91 22.88 Favored 'General case' 0 C--N 1.321 -0.669 0 N-CA-C 108.56 -0.904 . . . . 0.0 108.56 -178.695 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.588 ' SG ' ' HB3' ' A' ' 122' ' ' ALA . 0.8 OUTLIER -98.33 52.31 1.03 Allowed 'General case' 0 C--N 1.33 -0.251 0 CA-C-N 115.894 -0.594 . . . . 0.0 111.593 176.49 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 42.88 49.73 6.13 Favored Glycine 0 CA--C 1.529 0.958 0 C-N-CA 123.395 0.521 . . . . 0.0 112.619 -175.478 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . -167.39 -82.89 0.05 OUTLIER Glycine 0 C--O 1.226 -0.396 0 N-CA-C 111.192 -0.763 . . . . 0.0 111.192 -176.804 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 85.3 mt -119.41 159.33 24.43 Favored 'General case' 0 C--O 1.236 0.371 0 CA-C-O 121.546 0.689 . . . . 0.0 110.205 177.617 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.679 HD22 HG21 ' A' ' 3' ' ' THR . 3.5 mt -82.99 165.47 19.64 Favored 'General case' 0 C--O 1.219 -0.544 0 CA-C-N 115.069 -0.969 . . . . 0.0 109.613 179.499 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.488 ' CZ ' ' HB3' ' A' ' 106' ' ' ALA . 55.7 m-85 -157.78 85.72 0.9 Allowed 'General case' 0 C--N 1.325 -0.467 0 N-CA-C 107.907 -1.146 . . . . 0.0 107.907 -174.337 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.2 OUTLIER -54.51 114.46 1.68 Allowed 'General case' 0 N--CA 1.447 -0.617 0 N-CA-C 107.882 -1.155 . . . . 0.0 107.882 177.231 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.51 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 8.1 tp-100 -51.16 -34.17 30.21 Favored 'General case' 0 CA--C 1.5 -0.945 0 N-CA-C 113.443 0.905 . . . . 0.0 113.443 -179.797 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 8.2 t-20 -43.26 -34.28 1.14 Allowed 'General case' 0 C--O 1.22 -0.472 0 O-C-N 124.969 1.418 . . . . 0.0 112.137 174.406 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . 0.426 ' CD ' ' HA2' ' A' ' 89' ' ' GLY . 0.0 OUTLIER -95.92 -51.32 4.51 Favored 'General case' 0 N--CA 1.43 -1.473 0 CA-C-O 116.182 -1.866 . . . . 0.0 113.341 171.843 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.691 ' HB1' HD11 ' A' ' 120' ' ' ILE . . . -42.42 -33.39 0.66 Allowed 'General case' 0 CA--C 1.546 0.815 0 CA-C-N 123.041 2.655 . . . . 0.0 114.021 174.863 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . . . . . . . . . 9.6 pt-20 -85.06 -49.25 8.44 Favored 'General case' 0 N--CA 1.443 -0.824 0 C-N-CA 124.49 1.116 . . . . 0.0 109.537 172.5 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 36.8 t -62.42 -43.62 98.39 Favored 'General case' 0 C--O 1.217 -0.656 0 O-C-N 119.796 -1.815 . . . . 0.0 110.482 -174.553 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . . . . . . . . . 1.8 t-20 -46.03 -38.66 8.11 Favored 'General case' 0 N--CA 1.44 -0.969 0 C-N-CA 125.901 1.68 . . . . 0.0 110.713 171.111 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . . . . . . . . . 4.9 p -79.32 -28.97 42.14 Favored 'General case' 0 N--CA 1.451 -0.381 0 C-N-CA 123.697 0.799 . . . . 0.0 112.554 176.25 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . . . . . . . . . 22.6 m170 -57.16 -44.11 83.14 Favored 'General case' 0 C--O 1.225 -0.222 0 C-N-CA 124.251 1.021 . . . . 0.0 110.886 176.866 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . . . . . . . . . 0.0 OUTLIER -78.77 -46.13 19.51 Favored 'General case' 0 N--CA 1.447 -0.6 0 CA-C-O 118.392 -0.814 . . . . 0.0 110.719 178.583 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.86 ' HB1' ' HG3' ' A' ' 35' ' ' PRO . . . -43.38 130.72 3.62 Favored Pre-proline 0 N--CA 1.447 -0.596 0 O-C-N 125.312 1.632 . . . . 0.0 111.434 178.611 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.438 ' HG2' ' CG2' ' A' ' 30' ' ' THR . 18.0 Cg_endo -71.08 122.87 9.16 Favored 'Trans proline' 0 N--CA 1.449 -1.131 0 C-N-CA 122.242 1.961 . . . . 0.0 108.908 -177.362 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.697 HD21 ' O ' ' A' ' 113' ' ' PRO . 2.0 tp -61.15 88.94 0.02 OUTLIER 'General case' 0 N--CA 1.451 -0.417 0 C-N-CA 124.425 1.09 . . . . 0.0 111.77 177.744 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -177.77 167.65 2.13 Favored 'General case' 0 C--N 1.323 -0.564 0 CA-C-N 115.553 -0.749 . . . . 0.0 109.448 -175.172 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.415 ' HA ' ' HA ' ' A' ' 36' ' ' HIS . 1.3 t70 -114.89 126.88 55.31 Favored 'General case' 0 CA--C 1.512 -0.494 0 C-N-CA 124.295 1.038 . . . . 0.0 110.112 179.756 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 56.09 55.51 28.9 Favored Glycine 0 CA--C 1.525 0.665 0 CA-C-O 122.348 0.971 . . . . 0.0 111.145 176.189 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 17.2 tttt -141.01 28.56 1.9 Allowed 'General case' 0 N--CA 1.469 0.512 0 CA-C-O 124.197 1.951 . . . . 0.0 112.068 -179.386 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.579 HG21 ' HD2' ' A' ' 35' ' ' PRO . 34.6 p -134.74 143.31 47.08 Favored 'General case' 0 C--N 1.309 -1.157 0 O-C-N 119.854 -1.779 . . . . 0.0 108.506 -174.836 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -40.03 -65.8 0.88 Allowed Glycine 0 C--N 1.332 0.349 0 C-N-CA 124.223 0.916 . . . . 0.0 113.543 -177.794 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 25.3 t -54.65 -61.56 2.23 Favored 'General case' 0 C--O 1.235 0.32 0 CA-C-O 117.567 -1.206 . . . . 0.0 111.281 172.914 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 6.0 p 159.45 -43.02 0.0 OUTLIER 'General case' 0 N--CA 1.471 0.584 0 O-C-N 125.637 1.836 . . . . 0.0 113.091 -178.584 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.589 ' CE2' ' CE1' ' A' ' 36' ' ' HIS . 62.2 m-85 -79.34 149.67 72.7 Favored Pre-proline 0 N--CA 1.442 -0.86 0 C-N-CA 124.88 1.272 . . . . 0.0 113.258 178.286 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.86 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 23.1 Cg_endo -74.26 157.93 99.09 Favored 'Cis proline' 0 N--CA 1.45 -1.037 0 C-N-CA 123.476 -1.468 . . . . 0.0 110.351 -1.118 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.589 ' CE1' ' CE2' ' A' ' 34' ' ' TYR . 0.3 OUTLIER -134.6 155.85 49.73 Favored 'General case' 0 C--N 1.321 -0.656 0 CA-C-N 113.649 -1.614 . . . . 0.0 109.01 179.125 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.885 ' CH2' HG22 ' A' ' 39' ' ' THR . 25.2 t90 -55.49 121.6 9.37 Favored 'General case' 0 N--CA 1.442 -0.845 0 CA-C-O 122.158 0.98 . . . . 0.0 110.724 174.134 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.538 ' CE2' HG21 ' A' ' 109' ' ' ILE . 41.7 t80 -92.77 85.86 5.34 Favored 'General case' 0 N--CA 1.429 -1.482 0 C-N-CA 126.997 2.119 . . . . 0.0 106.343 177.929 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.885 HG22 ' CH2' ' A' ' 37' ' ' TRP . 43.8 p -38.98 -36.45 0.28 Allowed 'General case' 0 C--O 1.221 -0.428 0 CA-C-N 114.973 -1.012 . . . . 0.0 111.505 171.533 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.48 ' HA ' ' CZ ' ' A' ' 38' ' ' PHE . 63.9 t30 66.45 9.93 6.89 Favored 'General case' 0 CA--C 1.529 0.159 0 CA-C-O 122.402 1.096 . . . . 0.0 111.687 -179.261 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . . . . . . . . . . . 113.21 -18.93 20.71 Favored Glycine 0 N--CA 1.433 -1.519 0 C-N-CA 124.874 1.226 . . . . 0.0 113.226 -171.824 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.605 ' CE1' HD11 ' A' ' 48' ' ' LEU . 11.4 m-85 -63.98 161.53 15.67 Favored 'General case' 0 C--N 1.329 -0.283 0 CA-C-N 118.647 1.223 . . . . 0.0 110.993 179.983 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -82.41 -41.88 19.32 Favored 'General case' 0 C--N 1.328 -0.347 0 CA-C-O 121.373 0.606 . . . . 0.0 111.287 176.047 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.558 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -173.33 -67.4 0.05 OUTLIER Glycine 0 C--N 1.339 0.696 0 C-N-CA 124.094 0.854 . . . . 0.0 112.497 -177.755 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -115.77 -63.21 1.48 Allowed 'General case' 0 C--N 1.327 -0.398 0 C-N-CA 124.003 0.921 . . . . 0.0 110.045 -179.782 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -58.12 162.49 9.74 Favored Glycine 0 C--N 1.341 0.827 0 N-CA-C 110.971 -0.851 . . . . 0.0 110.971 178.454 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.56 ' HA ' ' CE2' ' A' ' 42' ' ' TYR . 11.8 mtmt -56.6 173.36 0.19 Allowed 'General case' 0 C--N 1.334 -0.089 0 CA-C-O 121.59 0.709 . . . . 0.0 111.152 179.097 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.665 ' H ' HD12 ' A' ' 48' ' ' LEU . 5.7 mp -57.63 154.17 26.76 Favored Pre-proline 0 N--CA 1.446 -0.667 0 CA-C-N 116.127 -0.488 . . . . 0.0 110.708 -179.421 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -70.74 159.15 53.63 Favored 'Trans proline' 0 N--CA 1.45 -1.063 0 C-N-CA 121.692 1.595 . . . . 0.0 110.066 179.919 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 9.6 tttt -56.45 97.68 0.02 OUTLIER 'General case' 0 CA--C 1.537 0.443 0 C-N-CA 123.247 0.619 . . . . 0.0 110.081 176.137 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 117.83 60.26 0.29 Allowed Glycine 0 C--N 1.329 0.172 0 CA-C-N 116.443 -0.344 . . . . 0.0 112.629 -176.343 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.413 ' HG2' HD23 ' A' ' 48' ' ' LEU . 14.0 ttm180 -164.06 162.56 23.13 Favored 'General case' 0 CA--C 1.519 -0.237 0 C-N-CA 123.287 0.635 . . . . 0.0 110.606 175.194 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.9 m -139.08 109.33 7.62 Favored Pre-proline 0 C--N 1.326 -0.449 0 C-N-CA 123.196 0.598 . . . . 0.0 109.584 179.641 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.542 ' HG3' HD13 ' A' ' 48' ' ' LEU . 26.3 Cg_endo -72.86 177.16 8.01 Favored 'Trans proline' 0 N--CA 1.456 -0.722 0 C-N-CA 123.126 2.551 . . . . 0.0 111.129 177.287 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.47 HD12 HG21 ' A' ' 121' ' ' ILE . 6.5 mt -94.89 124.57 47.44 Favored 'Isoleucine or valine' 0 N--CA 1.447 -0.594 0 N-CA-C 107.658 -1.238 . . . . 0.0 107.658 -179.383 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -81.09 136.42 35.93 Favored 'General case' 0 N--CA 1.453 -0.307 0 N-CA-C 108.541 -0.911 . . . . 0.0 108.541 175.123 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.552 ' CD1' ' HB3' ' A' ' 118' ' ' CYS . 10.8 m-85 -118.89 -28.54 5.53 Favored 'General case' 0 C--N 1.328 -0.352 0 C-N-CA 123.717 0.807 . . . . 0.0 111.027 177.747 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 100.66 -3.66 56.23 Favored Glycine 0 CA--C 1.526 0.736 0 C-N-CA 123.883 0.754 . . . . 0.0 113.209 -175.046 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 1.3 mmpt? -97.88 127.82 44.07 Favored 'General case' 0 CA--C 1.508 -0.657 0 CA-C-N 117.695 0.748 . . . . 0.0 109.414 176.868 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -66.35 -11.69 52.54 Favored 'General case' 0 C--O 1.219 -0.51 0 O-C-N 124.893 1.371 . . . . 0.0 111.819 175.854 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -85.15 -46.87 10.69 Favored 'General case' 0 CA--C 1.515 -0.37 0 C-N-CA 125.637 1.575 . . . . 0.0 111.049 175.806 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.459 ' SG ' ' CE2' ' A' ' 57' ' ' PHE . 2.0 t -73.1 -16.63 61.46 Favored 'General case' 0 CA--C 1.536 0.407 0 O-C-N 123.956 0.785 . . . . 0.0 112.071 176.688 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 22.2 t70 -90.04 -34.66 15.87 Favored 'General case' 0 N--CA 1.453 -0.309 0 C-N-CA 124.387 1.075 . . . . 0.0 110.812 175.246 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.21 163.1 0.97 Allowed Pre-proline 0 N--CA 1.446 -0.629 0 CA-C-O 121.538 0.685 . . . . 0.0 112.157 179.838 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.463 ' HA ' ' CE2' ' A' ' 42' ' ' TYR . 24.6 Cg_endo -71.74 129.45 15.54 Favored 'Trans proline' 0 N--CA 1.44 -1.651 0 C-N-CA 121.144 1.229 . . . . 0.0 113.093 174.605 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.469 ' HD2' ' CD2' ' A' ' 42' ' ' TYR . 20.4 Cg_endo -68.46 167.59 22.05 Favored 'Trans proline' 0 N--CA 1.443 -1.498 0 C-N-CA 123.713 2.942 . . . . 0.0 111.206 176.701 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 10.3 tptt -126.75 66.16 1.26 Allowed 'General case' 0 C--O 1.223 -0.328 0 CA-C-N 115.895 -0.593 . . . . 0.0 109.787 177.423 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.409 ' CE1' ' O ' ' A' ' 69' ' ' SER . 41.7 t-80 -77.92 168.07 20.49 Favored 'General case' 0 C--N 1.328 -0.343 0 CA-C-O 121.498 0.666 . . . . 0.0 110.932 177.39 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.409 ' O ' ' CE1' ' A' ' 68' ' ' HIS . 1.5 p -141.47 173.79 11.17 Favored 'General case' 0 C--N 1.324 -0.536 0 O-C-N 121.232 -0.918 . . . . 0.0 111.429 176.782 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 5.5 mtpt -84.77 71.97 10.79 Favored 'General case' 0 C--O 1.219 -0.521 0 O-C-N 120.495 -1.378 . . . . 0.0 110.993 175.338 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -177.29 -43.07 0.01 OUTLIER 'General case' 0 N--CA 1.467 0.402 0 O-C-N 124.54 1.15 . . . . 0.0 111.014 178.509 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 161.71 -85.08 0.11 Allowed Glycine 0 N--CA 1.442 -0.912 0 N-CA-C 108.626 -1.79 . . . . 0.0 108.626 -178.801 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 1.5 p-10 -94.14 -98.27 0.15 Allowed 'General case' 0 C--N 1.316 -0.858 0 C-N-CA 124.424 1.089 . . . . 0.0 108.465 -178.171 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . 125.9 -162.92 20.02 Favored Glycine 0 N--CA 1.445 -0.706 0 C-N-CA 125.781 1.658 . . . . 0.0 110.614 -175.503 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 1.3 mttt -43.65 -81.49 0.01 OUTLIER 'General case' 0 C--O 1.218 -0.554 0 C-N-CA 125.118 1.367 . . . . 0.0 112.942 -179.678 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.525 HG23 ' O ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -117.96 14.53 14.17 Favored 'General case' 0 CA--C 1.51 -0.588 0 CA-C-O 116.062 -1.923 . . . . 0.0 111.856 176.01 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.471 ' OD2' ' CE1' ' A' ' 79' ' ' TYR . 11.6 p-10 -11.77 83.08 0.0 OUTLIER 'General case' 0 C--O 1.214 -0.793 0 CA-C-O 124.469 2.08 . . . . 0.0 115.685 179.08 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . . . . . . . . . 33.6 p80 -91.88 19.41 6.63 Favored 'General case' 0 C--N 1.324 -0.521 0 O-C-N 118.361 -2.712 . . . . 0.0 109.485 -170.531 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.942 ' CE1' HD11 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -52.91 179.12 0.02 OUTLIER 'General case' 0 N--CA 1.428 -1.542 0 C-N-CA 125.329 1.452 . . . . 0.0 113.987 175.229 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.496 HD21 HG22 ' A' ' 111' ' ' THR . 2.0 mt -100.63 154.34 18.67 Favored 'General case' 0 CA--C 1.504 -0.812 0 CA-C-O 118.444 -0.789 . . . . 0.0 110.869 173.871 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.942 HD11 ' CE1' ' A' ' 79' ' ' TYR . 2.6 mp -142.02 125.89 17.13 Favored 'General case' 0 C--N 1.325 -0.489 0 C-N-CA 123.901 0.881 . . . . 0.0 109.803 179.175 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . . . . . . . . . 1.3 pm0 -92.34 154.24 18.69 Favored 'General case' 0 N--CA 1.445 -0.676 0 CA-C-O 121.386 0.613 . . . . 0.0 109.832 -179.125 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.53 ' CD1' ' HD2' ' A' ' 84' ' ' PRO . 6.4 t80 -143.68 135.13 12.73 Favored Pre-proline 0 N--CA 1.45 -0.449 0 O-C-N 121.538 -0.726 . . . . 0.0 112.65 179.078 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.53 ' HD2' ' CD1' ' A' ' 83' ' ' PHE . 18.2 Cg_endo -73.33 99.72 1.15 Allowed 'Trans proline' 0 N--CA 1.451 -1.01 0 C-N-CA 123.988 3.125 . . . . 0.0 110.236 -177.374 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 1.4 t -95.93 108.12 20.46 Favored 'General case' 0 N--CA 1.447 -0.623 0 CA-C-N 115.226 -0.897 . . . . 0.0 109.743 -179.912 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.409 ' CE1' ' HB2' ' A' ' 92' ' ' TYR . 59.0 m-85 -83.36 150.82 61.31 Favored Pre-proline 0 C--O 1.241 0.638 0 CA-C-O 118.804 -0.617 . . . . 0.0 110.953 178.964 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 16.4 Cg_endo -75.72 -36.55 2.09 Favored 'Trans proline' 0 N--CA 1.455 -0.774 0 C-N-CA 123.311 2.674 . . . . 0.0 113.209 178.352 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.8 OUTLIER -41.42 -34.4 0.53 Allowed 'General case' 0 C--N 1.351 0.669 0 O-C-N 125.53 1.769 . . . . 0.0 111.079 176.186 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . 0.426 ' HA2' ' CD ' ' A' ' 15' ' ' LYS . . . 98.03 -4.91 61.13 Favored Glycine 0 N--CA 1.439 -1.143 0 N-CA-C 110.566 -1.014 . . . . 0.0 110.566 178.25 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . . . . . . . . . 1.8 p-80 -71.92 136.55 46.91 Favored 'General case' 0 N--CA 1.443 -0.777 0 CA-C-O 122.107 0.956 . . . . 0.0 108.813 177.501 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 7.7 t0 -75.45 104.2 5.91 Favored 'General case' 0 C--N 1.322 -0.599 0 N-CA-C 108.32 -0.993 . . . . 0.0 108.32 173.432 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.417 ' O ' ' CD2' ' A' ' 94' ' ' PHE . 8.3 t80 -37.84 145.41 0.07 Allowed 'General case' 0 N--CA 1.451 -0.389 0 CA-C-O 121.991 0.9 . . . . 0.0 111.884 177.131 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.2 OUTLIER -79.87 61.3 3.75 Favored 'General case' 0 C--N 1.322 -0.591 0 O-C-N 119.902 -1.749 . . . . 0.0 110.679 176.004 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.444 ' CD2' ' HZ ' ' A' ' 83' ' ' PHE . 43.6 p90 -75.56 1.88 13.16 Favored 'General case' 0 N--CA 1.448 -0.562 0 C-N-CA 124.325 1.05 . . . . 0.0 113.144 175.253 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 9.8 t70 -98.11 -41.16 8.06 Favored 'General case' 0 C--N 1.328 -0.357 0 C-N-CA 124.407 1.083 . . . . 0.0 110.305 178.853 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 18.8 m -87.09 110.61 20.22 Favored 'General case' 0 N--CA 1.451 -0.375 0 N-CA-C 108.597 -0.89 . . . . 0.0 108.597 -178.965 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 12.7 pttt -57.62 -49.13 77.46 Favored 'General case' 0 C--O 1.241 0.609 0 O-C-N 121.872 -0.518 . . . . 0.0 110.724 177.372 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . . . . . . . . . 13.1 mtmt -141.56 128.54 11.54 Favored Pre-proline 0 N--CA 1.444 -0.758 0 C-N-CA 125.383 1.473 . . . . 0.0 110.765 -177.265 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . . . . . . . . . 28.3 Cg_endo -71.34 173.57 49.49 Favored 'Cis proline' 0 CA--C 1.54 0.821 0 C-N-CA 122.934 -1.694 . . . . 0.0 110.955 -4.891 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.9 OUTLIER -141.99 142.4 32.94 Favored 'General case' 0 CA--C 1.518 -0.259 0 C-N-CA 123.895 0.878 . . . . 0.0 109.674 179.365 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 4.7 tt0 -80.82 175.59 10.55 Favored 'General case' 0 C--N 1.324 -0.5 0 O-C-N 124.613 1.195 . . . . 0.0 111.557 179.061 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 24.3 t-20 -73.61 140.39 78.51 Favored Pre-proline 0 N--CA 1.449 -0.522 0 CA-C-O 118.567 -0.73 . . . . 0.0 110.846 175.717 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 24.2 Cg_endo -70.23 -163.14 0.11 Allowed 'Trans proline' 0 CA--C 1.548 1.188 0 C-N-CA 124.001 3.134 . . . . 0.0 112.687 175.375 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -145.37 163.44 28.15 Favored Glycine 0 N--CA 1.446 -0.693 0 O-C-N 120.487 -1.383 . . . . 0.0 111.707 174.747 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 18.3 Cg_endo -75.43 -57.73 0.05 OUTLIER 'Trans proline' 0 N--CA 1.456 -0.733 0 C-N-CA 123.244 2.629 . . . . 0.0 110.829 178.689 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.734 ' HB1' ' CG2' ' A' ' 120' ' ' ILE . . . -63.64 135.72 56.97 Favored 'General case' 0 N--CA 1.438 -1.026 0 O-C-N 123.586 0.554 . . . . 0.0 110.589 178.045 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.479 ' O ' ' HA ' ' A' ' 120' ' ' ILE . 3.1 mtm-85 -141.7 143.94 33.82 Favored 'General case' 0 C--O 1.211 -0.95 0 CA-C-O 117.225 -1.369 . . . . 0.0 110.807 178.578 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.669 HG23 ' CD1' ' A' ' 117' ' ' PHE . 2.8 p -81.98 119.2 31.09 Favored 'Isoleucine or valine' 0 C--N 1.322 -0.63 0 C-N-CA 124.702 1.201 . . . . 0.0 110.104 176.904 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.538 HG21 ' CE2' ' A' ' 38' ' ' PHE . 1.8 mp -105.39 124.5 60.33 Favored 'Isoleucine or valine' 0 CA--C 1.505 -0.786 0 N-CA-C 106.52 -1.659 . . . . 0.0 106.52 -177.113 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.453 ' CG ' ' HG2' ' A' ' 115' ' ' LYS . 15.3 p90 -141.33 162.73 34.79 Favored 'General case' 0 C--N 1.316 -0.851 0 C-N-CA 123.192 0.597 . . . . 0.0 109.931 -179.42 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.496 HG22 HD21 ' A' ' 80' ' ' LEU . 1.2 p -95.34 165.11 12.54 Favored 'General case' 0 C--N 1.323 -0.56 0 N-CA-C 109.352 -0.61 . . . . 0.0 109.352 -177.83 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.585 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.6 OUTLIER -108.96 153.41 42.49 Favored Pre-proline 0 CA--C 1.54 0.593 0 O-C-N 122.121 -0.362 . . . . 0.0 111.442 177.454 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.697 ' O ' HD21 ' A' ' 25' ' ' LEU . 18.8 Cg_endo -74.44 -54.31 0.15 OUTLIER 'Cis proline' 0 N--CA 1.455 -0.769 0 C-N-CA 123.491 -1.462 . . . . 0.0 110.427 -7.803 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 1.6 m-20 -42.6 112.57 0.36 Allowed 'General case' 0 N--CA 1.444 -0.747 0 CA-C-O 116.544 -1.693 . . . . 0.0 110.061 175.89 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.619 ' HE2' HD13 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -64.93 71.42 0.03 OUTLIER 'General case' 0 CA--C 1.514 -0.423 0 O-C-N 125.621 1.825 . . . . 0.0 108.357 179.529 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.424 ' O ' HG12 ' A' ' 116' ' ' VAL . 18.0 t -74.55 75.67 0.41 Allowed 'Isoleucine or valine' 0 N--CA 1.447 -0.593 0 N-CA-C 104.576 -2.379 . . . . 0.0 104.576 -179.299 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.669 ' CD1' HG23 ' A' ' 108' ' ' VAL . 27.6 t80 -41.08 119.39 1.16 Allowed 'General case' 0 N--CA 1.437 -1.122 0 C-N-CA 125.217 1.407 . . . . 0.0 110.063 176.798 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . 0.552 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 5.5 m -95.15 -45.48 7.18 Favored 'General case' 0 N--CA 1.432 -1.36 0 CA-C-N 115.754 -0.657 . . . . 0.0 109.837 -178.937 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . 0.568 ' HA2' ' CZ ' ' A' ' 117' ' ' PHE . . . 157.64 177.95 31.23 Favored Glycine 0 N--CA 1.445 -0.761 0 CA-C-N 115.635 -0.711 . . . . 0.0 111.48 -179.841 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.734 ' CG2' ' HB1' ' A' ' 106' ' ' ALA . 2.7 mp -101.23 124.37 54.89 Favored 'Isoleucine or valine' 0 C--O 1.205 -1.289 0 N-CA-C 107.798 -1.186 . . . . 0.0 107.798 -178.586 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.686 HG22 HD12 ' A' ' 133' ' ' LEU . 7.5 pt -97.15 154.22 3.71 Favored 'Isoleucine or valine' 0 C--N 1.307 -1.27 0 CA-C-N 120.232 1.378 . . . . 0.0 109.024 -179.598 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.588 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . . . -173.8 156.25 2.8 Favored 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 122.468 1.128 . . . . 0.0 110.762 176.057 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.455 ' CE1' ' HG ' ' A' ' 131' ' ' LEU . 6.1 m-70 -90.03 93.0 9.22 Favored 'General case' 0 C--O 1.221 -0.445 0 O-C-N 121.338 -0.851 . . . . 0.0 109.095 -177.24 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.65 HG22 ' HD2' ' A' ' 132' ' ' LYS . 1.8 t -96.89 38.18 1.25 Allowed 'General case' 0 N--CA 1.475 0.822 0 CA-C-O 124.014 1.864 . . . . 0.0 110.995 -178.804 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.8 tptt -101.72 -30.32 11.39 Favored 'General case' 0 C--O 1.221 -0.414 0 O-C-N 119.739 -1.85 . . . . 0.0 110.919 178.5 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.6 OUTLIER -170.8 -68.61 0.02 OUTLIER 'General case' 0 C--O 1.222 -0.384 0 O-C-N 124.593 1.183 . . . . 0.0 110.419 -179.907 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 4.4 t30 -154.9 -44.53 0.08 Allowed 'General case' 0 N--CA 1.454 -0.265 0 CA-C-O 122.855 1.312 . . . . 0.0 111.001 179.304 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 6.4 tt0 -154.77 79.66 1.08 Allowed 'General case' 0 N--CA 1.446 -0.674 0 C-N-CA 124.526 1.13 . . . . 0.0 109.01 -179.219 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -131.31 -106.55 1.09 Allowed Glycine 0 N--CA 1.459 0.176 0 N-CA-C 110.459 -1.057 . . . . 0.0 110.459 175.865 . . . . . . . . 1 1 . 1 . 022 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.1 OUTLIER -85.37 150.43 24.74 Favored 'General case' 0 C--N 1.322 -0.627 0 O-C-N 121.435 -1.038 . . . . 0.0 111.18 -179.975 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.576 HD23 ' H ' ' A' ' 132' ' ' LYS . 0.6 OUTLIER -105.27 145.65 30.39 Favored 'General case' 0 C--N 1.325 -0.484 0 N-CA-C 109.079 -0.711 . . . . 0.0 109.079 179.657 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.65 ' HD2' HG22 ' A' ' 124' ' ' THR . 0.0 OUTLIER -152.14 168.54 24.98 Favored 'General case' 0 CA--C 1.513 -0.467 0 C-N-CA 125.535 1.534 . . . . 0.0 109.82 179.922 . . . . . . . . 3 3 . 1 . 022 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.686 HD12 HG22 ' A' ' 121' ' ' ILE . 7.4 tp -82.29 149.82 27.59 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.47 1.106 . . . . 0.0 108.728 175.243 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . 0.479 ' SG ' HG22 ' A' ' 120' ' ' ILE . 8.3 m -63.11 -175.72 0.11 Allowed 'General case' 0 N--CA 1.449 -0.509 0 CA-C-O 124.01 1.862 . . . . 0.0 108.525 176.096 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 0.0 OUTLIER -172.01 121.87 0.47 Allowed 'General case' 0 C--N 1.316 -0.868 0 O-C-N 120.482 -1.386 . . . . 0.0 107.601 -176.925 . . . . . . . . 2 2 . 1 . 022 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . . . . . . . . . 0.4 OUTLIER . . . . . 0 C--O 1.258 1.5 0 CA-C-O 113.472 -3.156 . . . . 0.0 110.493 172.617 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 C--O 1.219 -0.538 0 N-CA-C 108.583 -0.895 . . . . 0.0 108.583 . . . . . . . . . 0 0 . 1 . 023 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.672 HG22 ' HB2' ' A' ' 136' ' ' HIS . 1.8 p -123.85 122.73 65.36 Favored 'Isoleucine or valine' 0 N--CA 1.45 -0.47 0 N-CA-C 108.778 -0.823 . . . . 0.0 108.778 -179.093 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.449 HG21 ' HB3' ' A' ' 10' ' ' LEU . 2.9 m -86.83 119.75 27.39 Favored 'General case' 0 C--N 1.313 -0.989 0 CA-C-N 115.764 -0.653 . . . . 0.0 109.467 -177.434 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.474 ' CG ' HG13 ' A' ' 120' ' ' ILE . 28.8 m95 -79.98 139.63 36.93 Favored 'General case' 0 N--CA 1.441 -0.891 0 N-CA-C 109.815 -0.439 . . . . 0.0 109.815 179.956 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.862 ' OG1' HD13 ' A' ' 10' ' ' LEU . 0.9 OUTLIER -133.5 132.81 41.43 Favored 'General case' 0 CA--C 1.501 -0.905 0 N-CA-C 109.52 -0.548 . . . . 0.0 109.52 -178.36 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.71 ' SG ' ' HB3' ' A' ' 122' ' ' ALA . 0.1 OUTLIER -120.56 41.65 3.2 Favored 'General case' 0 N--CA 1.451 -0.423 0 CA-C-N 115.886 -0.597 . . . . 0.0 110.284 177.732 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . 148.31 -96.26 0.17 Allowed Glycine 0 C--O 1.222 -0.637 0 N-CA-C 111.001 -0.84 . . . . 0.0 111.001 -179.36 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . 0.599 ' C ' HD13 ' A' ' 9' ' ' LEU . . . -127.07 4.37 7.34 Favored Glycine 0 C--O 1.223 -0.593 0 N-CA-C 112.061 -0.416 . . . . 0.0 112.061 178.585 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.669 ' N ' HD13 ' A' ' 9' ' ' LEU . 0.0 OUTLIER -111.13 141.29 44.82 Favored 'General case' 0 CA--C 1.502 -0.883 0 N-CA-C 107.148 -1.427 . . . . 0.0 107.148 -173.083 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.862 HD13 ' OG1' ' A' ' 5' ' ' THR . 1.2 mm? -113.42 120.23 40.33 Favored 'General case' 0 N--CA 1.448 -0.531 0 N-CA-C 106.493 -1.669 . . . . 0.0 106.493 -171.808 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.575 ' CE2' ' CB ' ' A' ' 106' ' ' ALA . 63.4 m-85 -115.18 101.41 8.94 Favored 'General case' 0 N--CA 1.441 -0.884 0 C-N-CA 125.065 1.346 . . . . 0.0 109.595 -175.653 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.4 OUTLIER -57.62 120.94 9.21 Favored 'General case' 0 CA--C 1.504 -0.79 0 N-CA-C 108.126 -1.064 . . . . 0.0 108.126 179.984 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.513 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 6.8 tp-100 -46.49 -43.58 16.9 Favored 'General case' 0 C--O 1.2 -1.547 0 O-C-N 124.246 0.967 . . . . 0.0 111.498 179.591 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 7.0 t-20 -48.22 -49.22 33.89 Favored 'General case' 0 C--O 1.194 -1.821 0 CA-C-N 117.693 0.224 . . . . 0.0 110.768 176.474 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -67.46 -34.58 77.48 Favored 'General case' 0 C--O 1.195 -1.779 0 O-C-N 120.712 -1.242 . . . . 0.0 111.922 172.985 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . . . . . . . . . . . -58.0 -50.59 72.9 Favored 'General case' 0 C--N 1.311 -1.068 0 CA-C-N 121.1 1.773 . . . . 0.0 112.067 174.269 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.434 ' O ' ' CD2' ' A' ' 21' ' ' HIS . 3.6 pt-20 -78.5 -36.94 44.36 Favored 'General case' 0 C--O 1.207 -1.145 0 N-CA-C 109.153 -0.684 . . . . 0.0 109.153 178.754 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 43.2 t -71.37 -63.25 1.15 Allowed 'General case' 0 CA--C 1.503 -0.833 0 C-N-CA 125.463 1.505 . . . . 0.0 108.981 -177.863 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.503 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 10.4 t-20 -39.54 -37.92 0.54 Allowed 'General case' 0 N--CA 1.448 -0.542 0 C-N-CA 123.942 0.897 . . . . 0.0 111.768 174.771 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.428 ' O ' ' HB3' ' A' ' 23' ' ' ALA . 0.0 OUTLIER -80.2 -40.35 27.36 Favored 'General case' 0 N--CA 1.443 -0.801 0 O-C-N 124.757 1.286 . . . . 0.0 113.342 175.229 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.434 ' CD2' ' O ' ' A' ' 17' ' ' GLU . 4.6 m170 -42.44 -40.38 2.55 Favored 'General case' 0 N--CA 1.447 -0.577 0 C-N-CA 125.467 1.507 . . . . 0.0 109.611 178.442 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.503 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -71.16 -49.46 43.63 Favored 'General case' 0 N--CA 1.439 -1.023 0 CA-C-O 118.162 -0.923 . . . . 0.0 111.279 177.036 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.593 ' HB1' ' HG3' ' A' ' 35' ' ' PRO . . . -35.56 131.76 0.53 Allowed Pre-proline 0 N--CA 1.441 -0.902 0 O-C-N 125.067 1.479 . . . . 0.0 112.054 174.656 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.831 ' HG2' HG22 ' A' ' 30' ' ' THR . 18.9 Cg_endo -73.01 122.1 7.83 Favored 'Trans proline' 0 N--CA 1.446 -1.319 0 C-N-CA 122.24 1.96 . . . . 0.0 110.292 -178.115 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.634 HD13 ' HE2' ' A' ' 115' ' ' LYS . 3.3 tp -59.51 97.84 0.04 OUTLIER 'General case' 0 N--CA 1.447 -0.586 0 CA-C-N 116.256 -0.429 . . . . 0.0 110.658 179.057 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER -179.98 166.02 1.25 Allowed 'General case' 0 C--N 1.324 -0.516 0 O-C-N 123.548 0.53 . . . . 0.0 109.943 -177.699 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . . . . . . . . . 1.7 t0 -103.46 98.46 8.36 Favored 'General case' 0 C--N 1.326 -0.416 0 N-CA-C 109.363 -0.606 . . . . 0.0 109.363 178.531 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 66.83 79.19 0.22 Allowed Glycine 0 N--CA 1.447 -0.598 0 N-CA-C 110.248 -1.141 . . . . 0.0 110.248 177.714 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 1.4 mtpt -151.44 27.99 0.65 Allowed 'General case' 0 CA--C 1.513 -0.443 0 O-C-N 122.012 -0.699 . . . . 0.0 110.964 178.533 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.831 HG22 ' HG2' ' A' ' 24' ' ' PRO . 10.8 p -122.47 148.62 44.92 Favored 'General case' 0 CA--C 1.508 -0.642 0 N-CA-C 108.326 -0.99 . . . . 0.0 108.326 -175.753 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -39.72 -56.14 2.6 Favored Glycine 0 N--CA 1.448 -0.523 0 N-CA-C 111.752 -0.539 . . . . 0.0 111.752 -179.517 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 29.4 t -69.35 -60.14 2.54 Favored 'General case' 0 N--CA 1.439 -0.987 0 CA-C-O 116.909 -1.519 . . . . 0.0 111.354 176.958 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 0.5 OUTLIER 163.04 -56.7 0.0 OUTLIER 'General case' 0 C--O 1.223 -0.329 0 O-C-N 125.603 1.814 . . . . 0.0 110.77 178.136 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.557 ' CD1' ' HD3' ' A' ' 84' ' ' PRO . 69.1 m-85 -60.25 144.7 87.22 Favored Pre-proline 0 N--CA 1.437 -1.08 0 CA-C-O 118.051 -0.976 . . . . 0.0 113.127 178.849 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.593 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 25.0 Cg_endo -74.92 165.05 86.91 Favored 'Cis proline' 0 N--CA 1.452 -0.941 0 C-N-CA 122.361 -1.933 . . . . 0.0 112.027 -0.53 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.445 ' CD2' ' CD1' ' A' ' 34' ' ' TYR . 1.0 OUTLIER -139.42 168.21 20.33 Favored 'General case' 0 C--N 1.32 -0.695 0 O-C-N 121.546 -0.721 . . . . 0.0 110.308 -178.343 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.895 ' CZ3' HG22 ' A' ' 39' ' ' THR . 22.7 t90 -70.31 113.72 7.74 Favored 'General case' 0 C--N 1.325 -0.496 0 N-CA-C 108.593 -0.892 . . . . 0.0 108.593 179.094 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.436 ' CE1' ' HA ' ' A' ' 40' ' ' ASN . 8.5 t80 -84.71 79.44 9.6 Favored 'General case' 0 N--CA 1.427 -1.596 0 C-N-CA 124.888 1.275 . . . . 0.0 108.872 178.234 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.895 HG22 ' CZ3' ' A' ' 37' ' ' TRP . 60.6 p -36.51 -38.07 0.15 Allowed 'General case' 0 C--O 1.216 -0.677 0 C-N-CA 124.439 1.095 . . . . 0.0 110.596 176.9 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.436 ' HA ' ' CE1' ' A' ' 38' ' ' PHE . 65.2 t30 69.83 7.47 6.24 Favored 'General case' 0 N--CA 1.444 -0.75 0 C-N-CA 124.099 0.959 . . . . 0.0 108.599 176.992 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.459 ' C ' HD23 ' A' ' 48' ' ' LEU . . . 120.81 -35.37 3.72 Favored Glycine 0 N--CA 1.429 -1.811 0 CA-C-O 117.293 -1.837 . . . . 0.0 111.796 -175.705 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.665 ' N ' HD23 ' A' ' 48' ' ' LEU . 60.4 m-85 -51.42 173.13 0.03 OUTLIER 'General case' 0 N--CA 1.452 -0.353 0 CA-C-N 118.066 0.933 . . . . 0.0 110.424 -178.354 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -95.66 -43.01 8.11 Favored 'General case' 0 C--N 1.317 -0.825 0 N-CA-C 108.826 -0.805 . . . . 0.0 108.826 -179.169 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.535 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . -178.29 -52.2 0.07 OUTLIER Glycine 0 C--N 1.338 0.682 0 N-CA-C 111.381 -0.688 . . . . 0.0 111.381 -179.657 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -84.5 -90.74 0.09 Allowed 'General case' 0 C--O 1.217 -0.647 0 N-CA-C 108.373 -0.973 . . . . 0.0 108.373 -179.86 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -148.93 28.75 1.27 Allowed Glycine 0 N--CA 1.443 -0.862 0 O-C-N 120.898 -1.126 . . . . 0.0 110.616 -176.362 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 6.3 mttp -126.06 144.28 50.79 Favored 'General case' 0 CA--C 1.501 -0.92 0 CA-C-O 117.703 -1.141 . . . . 0.0 109.115 -177.695 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.665 HD23 ' N ' ' A' ' 42' ' ' TYR . 1.5 mt -106.46 159.12 30.91 Favored Pre-proline 0 C--N 1.319 -0.738 0 O-C-N 124.151 0.907 . . . . 0.0 109.26 -179.232 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 20.4 Cg_endo -73.54 -175.61 2.13 Favored 'Trans proline' 0 N--CA 1.444 -1.43 0 C-N-CA 122.954 2.436 . . . . 0.0 111.564 179.05 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 3.7 tptp -68.35 98.38 0.83 Allowed 'General case' 0 N--CA 1.445 -0.691 0 O-C-N 121.35 -0.844 . . . . 0.0 109.259 177.185 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 87.23 88.3 1.07 Allowed Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 110.779 -0.928 . . . . 0.0 110.779 179.042 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.415 ' HD2' ' HA2' ' A' ' 41' ' ' GLY . 0.0 OUTLIER -151.32 137.93 18.75 Favored 'General case' 0 N--CA 1.448 -0.533 0 CA-C-O 119.286 -0.387 . . . . 0.0 111.294 177.347 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 3.9 m -128.95 103.36 18.76 Favored Pre-proline 0 C--N 1.327 -0.392 0 O-C-N 124.629 1.206 . . . . 0.0 110.225 -178.56 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 20.3 Cg_endo -72.42 158.28 51.58 Favored 'Trans proline' 0 N--CA 1.448 -1.194 0 C-N-CA 122.226 1.95 . . . . 0.0 111.762 178.916 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.517 HD11 ' HG ' ' A' ' 131' ' ' LEU . 5.4 mt -77.41 123.41 33.99 Favored 'Isoleucine or valine' 0 N--CA 1.451 -0.397 0 N-CA-C 108.519 -0.919 . . . . 0.0 108.519 -179.023 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 1.0 OUTLIER -91.12 135.69 33.6 Favored 'General case' 0 N--CA 1.451 -0.412 0 N-CA-C 108.806 -0.812 . . . . 0.0 108.806 179.01 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.501 ' CD1' ' HB3' ' A' ' 118' ' ' CYS . 15.3 m-85 -114.74 -52.48 2.7 Favored 'General case' 0 N--CA 1.449 -0.482 0 CA-C-N 115.467 -0.788 . . . . 0.0 110.225 179.91 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 126.9 -5.57 7.4 Favored Glycine 0 C--O 1.223 -0.585 0 CA-C-N 115.964 -0.562 . . . . 0.0 111.853 -177.232 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -91.95 132.1 36.76 Favored 'General case' 0 CA--C 1.5 -0.978 0 CA-C-O 117.651 -1.166 . . . . 0.0 109.393 178.891 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 31.1 t -67.09 -9.78 43.07 Favored 'General case' 0 C--O 1.221 -0.439 0 O-C-N 125.034 1.459 . . . . 0.0 111.036 177.481 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 3.7 m-20 -92.15 -49.77 6.02 Favored 'General case' 0 N--CA 1.443 -0.794 0 C-N-CA 124.032 0.933 . . . . 0.0 108.887 -179.193 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.838 ' SG ' HD21 ' A' ' 80' ' ' LEU . 3.9 t -75.89 -6.61 51.65 Favored 'General case' 0 N--CA 1.45 -0.452 0 O-C-N 123.766 0.666 . . . . 0.0 111.214 175.988 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.9 t0 -99.94 -32.58 10.9 Favored 'General case' 0 N--CA 1.45 -0.443 0 C-N-CA 123.571 0.749 . . . . 0.0 110.165 177.987 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.531 ' HD3' ' CE1' ' A' ' 78' ' ' HIS . 0.0 OUTLIER -51.5 166.03 0.39 Allowed Pre-proline 0 N--CA 1.441 -0.89 0 CA-C-O 121.725 0.774 . . . . 0.0 111.018 179.913 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . 0.424 ' HA ' ' HD3' ' A' ' 66' ' ' PRO . 26.6 Cg_endo -72.11 135.24 24.7 Favored 'Trans proline' 0 N--CA 1.44 -1.645 0 C-N-CA 121.291 1.327 . . . . 0.0 113.865 174.959 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.424 ' HD3' ' HA ' ' A' ' 65' ' ' PRO . 20.3 Cg_endo -71.72 171.31 16.69 Favored 'Trans proline' 0 N--CA 1.449 -1.117 0 C-N-CA 122.529 2.153 . . . . 0.0 112.095 178.217 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 21.8 tptt -138.48 72.18 1.4 Allowed 'General case' 0 C--O 1.195 -1.813 0 CA-C-O 116.385 -1.769 . . . . 0.0 108.287 178.185 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.458 ' CD2' ' CD2' ' A' ' 37' ' ' TRP . 53.2 t-80 -79.4 159.36 27.11 Favored 'General case' 0 C--N 1.327 -0.401 0 CA-C-N 119.463 1.029 . . . . 0.0 110.603 178.207 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -145.31 -178.35 6.02 Favored 'General case' 0 N--CA 1.447 -0.581 0 CA-C-O 121.78 0.8 . . . . 0.0 110.011 -179.681 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -86.37 62.98 7.75 Favored 'General case' 0 C--O 1.209 -1.039 0 O-C-N 121.299 -0.875 . . . . 0.0 110.926 178.08 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.1 OUTLIER -177.6 -39.27 0.01 OUTLIER 'General case' 0 C--N 1.325 -0.474 0 N-CA-C 109.396 -0.594 . . . . 0.0 109.396 179.831 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . . . . . . . . . . . 129.82 -82.88 0.33 Allowed Glycine 0 C--O 1.207 -1.573 0 N-CA-C 110.624 -0.99 . . . . 0.0 110.624 -179.301 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.41 ' HA ' ' HB2' ' A' ' 77' ' ' ASP . 7.1 p-10 -115.88 53.17 0.86 Allowed 'General case' 0 C--N 1.313 -0.979 0 O-C-N 120.744 -1.445 . . . . 0.0 107.978 -177.762 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -55.8 -115.94 0.01 OUTLIER Glycine 0 C--O 1.217 -0.93 0 O-C-N 123.879 0.737 . . . . 0.0 111.9 178.172 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 7.9 mttm -42.73 -82.92 0.01 OUTLIER 'General case' 0 C--O 1.223 -0.311 0 O-C-N 121.443 -1.034 . . . . 0.0 110.894 179.946 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.633 HG23 ' O ' ' A' ' 76' ' ' THR . 0.6 OUTLIER -146.43 26.77 1.15 Allowed 'General case' 0 CA--C 1.507 -0.682 0 CA-C-N 116.069 -0.514 . . . . 0.0 111.164 178.203 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.475 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 0.8 OUTLIER -26.54 96.52 0.01 OUTLIER 'General case' 0 C--O 1.213 -0.827 0 C-N-CA 124.231 1.012 . . . . 0.0 112.331 -178.688 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.531 ' CE1' ' HD3' ' A' ' 64' ' ' ARG . 16.5 p80 -94.71 23.77 5.17 Favored 'General case' 0 CA--C 1.513 -0.478 0 N-CA-C 108.746 -0.835 . . . . 0.0 108.746 -173.756 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.656 ' CE1' HD11 ' A' ' 81' ' ' LEU . 0.0 OUTLIER -57.51 -177.25 0.02 OUTLIER 'General case' 0 N--CA 1.436 -1.136 0 N-CA-C 114.509 1.3 . . . . 0.0 114.509 174.889 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.838 HD21 ' SG ' ' A' ' 62' ' ' CYS . 0.4 OUTLIER -100.48 149.4 23.72 Favored 'General case' 0 N--CA 1.448 -0.544 0 CA-C-N 115.583 -0.735 . . . . 0.0 110.371 175.42 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.738 HD23 ' HA ' ' A' ' 37' ' ' TRP . 1.0 OUTLIER -138.42 118.92 13.83 Favored 'General case' 0 N--CA 1.449 -0.518 0 O-C-N 124.021 0.825 . . . . 0.0 108.873 -179.027 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.511 ' CB ' ' CD1' ' A' ' 109' ' ' ILE . 0.2 OUTLIER -87.68 163.12 16.71 Favored 'General case' 0 N--CA 1.444 -0.775 0 CA-C-O 122.238 1.018 . . . . 0.0 111.581 178.702 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.539 ' CZ ' ' HB2' ' A' ' 23' ' ' ALA . 50.9 t80 -153.11 122.13 3.22 Favored Pre-proline 0 N--CA 1.446 -0.634 0 CA-C-N 115.575 -0.739 . . . . 0.0 112.876 -179.424 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.557 ' HD3' ' CD1' ' A' ' 34' ' ' TYR . 18.2 Cg_endo -71.93 112.09 3.32 Favored 'Trans proline' 0 N--CA 1.447 -1.21 0 C-N-CA 123.506 2.804 . . . . 0.0 110.792 -177.946 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . . . . . . . . . 0.1 OUTLIER -113.78 121.22 43.39 Favored 'General case' 0 CA--C 1.51 -0.574 0 O-C-N 124.139 0.899 . . . . 0.0 110.268 -179.319 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.421 ' CE2' ' HB2' ' A' ' 92' ' ' TYR . 58.4 m-85 -82.11 157.7 68.13 Favored Pre-proline 0 N--CA 1.444 -0.76 0 N-CA-C 112.328 0.492 . . . . 0.0 112.328 178.725 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 19.7 Cg_endo -75.52 -37.95 1.58 Allowed 'Trans proline' 0 CA--C 1.5 -1.176 0 C-N-CA 122.392 2.061 . . . . 0.0 112.84 179.542 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -46.35 -30.82 2.26 Favored 'General case' 0 C--O 1.224 -0.285 0 C-N-CA 124.902 1.281 . . . . 0.0 108.786 -179.648 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 95.91 -9.94 68.2 Favored Glycine 0 N--CA 1.431 -1.662 0 N-CA-C 109.459 -1.457 . . . . 0.0 109.459 176.443 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.403 ' O ' ' CD2' ' A' ' 90' ' ' HIS . 4.1 p-80 -61.92 125.91 25.49 Favored 'General case' 0 N--CA 1.439 -1.021 0 N-CA-C 108.828 -0.804 . . . . 0.0 108.828 179.064 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 0.4 OUTLIER -60.98 97.22 0.06 Allowed 'General case' 0 N--CA 1.43 -1.431 0 C-N-CA 123.12 0.568 . . . . 0.0 110.234 176.121 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.531 ' CD2' ' HB3' ' A' ' 94' ' ' PHE . 6.2 t80 -36.25 140.49 0.13 Allowed 'General case' 0 N--CA 1.445 -0.708 0 CA-C-O 121.919 0.866 . . . . 0.0 111.285 179.541 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -77.51 59.79 1.98 Allowed 'General case' 0 N--CA 1.444 -0.772 0 O-C-N 120.227 -1.546 . . . . 0.0 110.156 177.465 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.531 ' HB3' ' CD2' ' A' ' 92' ' ' TYR . 28.2 p90 -77.27 -8.12 57.08 Favored 'General case' 0 N--CA 1.44 -0.951 0 C-N-CA 123.443 0.697 . . . . 0.0 111.633 177.67 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.9 OUTLIER -93.87 -33.33 13.56 Favored 'General case' 0 N--CA 1.448 -0.554 0 CA-C-O 122.166 0.984 . . . . 0.0 109.679 -179.624 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 0.1 OUTLIER -81.87 104.08 11.99 Favored 'General case' 0 N--CA 1.443 -0.812 0 O-C-N 121.236 -0.915 . . . . 0.0 108.987 179.907 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -59.7 -49.38 77.96 Favored 'General case' 0 CA--C 1.515 -0.381 0 CA-C-N 115.999 -0.546 . . . . 0.0 109.724 178.818 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.454 ' HA ' ' HA ' ' A' ' 99' ' ' PRO . 39.1 pttt -139.22 125.79 12.56 Favored Pre-proline 0 N--CA 1.435 -1.18 0 C-N-CA 123.633 0.773 . . . . 0.0 108.975 -176.833 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.454 ' HA ' ' HA ' ' A' ' 98' ' ' LYS . 24.0 Cg_endo -71.14 177.34 32.85 Favored 'Cis proline' 0 N--CA 1.457 -0.636 0 C-N-CA 122.376 -1.927 . . . . 0.0 111.469 -4.057 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.4 OUTLIER -132.9 144.88 50.46 Favored 'General case' 0 C--N 1.328 -0.365 0 C-N-CA 122.724 0.41 . . . . 0.0 109.988 177.48 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 5.4 tp10 -95.9 152.64 18.32 Favored 'General case' 0 C--N 1.319 -0.747 0 O-C-N 124.338 1.024 . . . . 0.0 110.366 177.53 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.5 m-80 -44.66 149.01 0.83 Allowed Pre-proline 0 N--CA 1.44 -0.948 0 O-C-N 123.926 0.766 . . . . 0.0 111.694 174.025 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 23.8 Cg_endo -73.14 -164.88 0.21 Allowed 'Trans proline' 0 N--CA 1.446 -1.317 0 C-N-CA 122.394 2.063 . . . . 0.0 111.557 178.155 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -139.12 157.18 24.8 Favored Glycine 0 N--CA 1.443 -0.9 0 O-C-N 121.955 -0.465 . . . . 0.0 112.206 177.856 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 17.9 Cg_endo -75.09 -75.91 0.01 OUTLIER 'Trans proline' 0 N--CA 1.45 -1.073 0 C-N-CA 122.806 2.338 . . . . 0.0 110.956 179.659 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.575 ' CB ' ' CE2' ' A' ' 11' ' ' TYR . . . -60.4 136.54 58.07 Favored 'General case' 0 N--CA 1.441 -0.922 0 O-C-N 123.434 0.459 . . . . 0.0 110.573 178.747 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.421 ' HG2' ' HA ' ' A' ' 84' ' ' PRO . 0.8 OUTLIER -141.71 146.98 36.71 Favored 'General case' 0 CA--C 1.507 -0.681 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.853 -178.607 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.431 ' CG1' ' HB3' ' A' ' 83' ' ' PHE . 6.6 p -83.03 125.76 40.06 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.679 0 O-C-N 123.719 0.637 . . . . 0.0 110.119 178.589 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.663 ' CG2' HD22 ' A' ' 80' ' ' LEU . 9.4 mm -104.62 140.87 21.43 Favored 'Isoleucine or valine' 0 CA--C 1.501 -0.92 0 CA-C-N 116.069 -0.514 . . . . 0.0 110.063 179.614 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.48 ' CG ' ' HG2' ' A' ' 115' ' ' LYS . 9.7 p90 -166.12 155.48 11.69 Favored 'General case' 0 N--CA 1.443 -0.808 0 CA-C-O 121.841 0.829 . . . . 0.0 110.38 -178.944 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 1.4 p -90.86 160.96 15.45 Favored 'General case' 0 C--N 1.32 -0.682 0 CA-C-N 115.651 -0.704 . . . . 0.0 109.93 -179.977 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.547 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -109.48 153.95 42.56 Favored Pre-proline 0 N--CA 1.44 -0.969 0 C-N-CA 123.055 0.542 . . . . 0.0 111.367 179.149 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.547 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 19.1 Cg_endo -73.29 -54.05 0.15 OUTLIER 'Cis proline' 0 CA--C 1.504 -1.007 0 C-N-CA 122.538 -1.859 . . . . 0.0 110.18 -5.434 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 58.2 t30 -42.36 107.36 0.08 Allowed 'General case' 0 N--CA 1.443 -0.789 0 CA-C-O 116.961 -1.495 . . . . 0.0 110.237 179.803 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.634 ' HE2' HD13 ' A' ' 25' ' ' LEU . 0.2 OUTLIER -64.44 76.6 0.04 OUTLIER 'General case' 0 CA--C 1.512 -0.493 0 O-C-N 125.061 1.476 . . . . 0.0 108.802 -177.621 . . . . . . . . 3 3 . 1 . 023 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.498 ' O ' HG12 ' A' ' 116' ' ' VAL . 38.1 t -75.95 74.23 0.46 Allowed 'Isoleucine or valine' 0 N--CA 1.443 -0.802 0 N-CA-C 106.057 -1.831 . . . . 0.0 106.057 -176.516 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.513 ' CZ ' ' NE2' ' A' ' 13' ' ' GLN . 39.1 t80 -36.35 105.97 0.04 OUTLIER 'General case' 0 N--CA 1.444 -0.727 0 C-N-CA 124.629 1.171 . . . . 0.0 110.55 179.606 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . 0.501 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 8.7 m -83.52 -46.27 12.63 Favored 'General case' 0 N--CA 1.438 -1.052 0 N-CA-C 108.089 -1.078 . . . . 0.0 108.089 -178.771 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 162.34 -144.96 10.15 Favored Glycine 0 N--CA 1.444 -0.784 0 N-CA-C 110.403 -1.079 . . . . 0.0 110.403 179.727 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.474 HG13 ' CG ' ' A' ' 4' ' ' TRP . 1.2 mm -128.72 144.67 37.34 Favored 'Isoleucine or valine' 0 CA--C 1.497 -1.091 0 N-CA-C 107.871 -1.159 . . . . 0.0 107.871 -176.519 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.773 HG22 HD12 ' A' ' 133' ' ' LEU . 8.6 pt -133.64 155.46 40.21 Favored 'Isoleucine or valine' 0 CA--C 1.506 -0.722 0 N-CA-C 108.19 -1.041 . . . . 0.0 108.19 -178.561 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.71 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . . . -171.93 148.83 2.35 Favored 'General case' 0 C--N 1.324 -0.524 0 CA-C-O 121.69 0.757 . . . . 0.0 109.953 177.711 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.708 ' CE1' HD22 ' A' ' 131' ' ' LEU . 5.1 m-70 -89.81 95.95 10.47 Favored 'General case' 0 N--CA 1.445 -0.678 0 N-CA-C 108.536 -0.912 . . . . 0.0 108.536 -176.922 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.7 HG22 ' HD3' ' A' ' 132' ' ' LYS . 3.0 t -98.16 41.13 1.14 Allowed 'General case' 0 C--N 1.326 -0.428 0 CA-C-O 122.349 1.071 . . . . 0.0 111.466 179.904 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 3.4 tptt -106.09 -27.55 11.04 Favored 'General case' 0 C--O 1.221 -0.42 0 O-C-N 121.563 -0.71 . . . . 0.0 110.477 178.921 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -173.07 -67.82 0.02 OUTLIER 'General case' 0 C--O 1.221 -0.408 0 CA-C-O 121.625 0.726 . . . . 0.0 110.617 178.39 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 42.6 t30 -155.54 -43.61 0.08 Allowed 'General case' 0 N--CA 1.448 -0.57 0 CA-C-O 122.64 1.21 . . . . 0.0 110.271 178.812 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 5.2 tt0 -154.41 78.59 1.09 Allowed 'General case' 0 N--CA 1.443 -0.805 0 CA-C-O 122.582 1.182 . . . . 0.0 109.45 -179.974 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -130.65 -104.19 1.02 Allowed Glycine 0 N--CA 1.452 -0.243 0 O-C-N 120.954 -1.091 . . . . 0.0 110.503 178.106 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 3.5 mt-10 -84.0 146.16 28.13 Favored 'General case' 0 CA--C 1.513 -0.473 0 O-C-N 122.197 -0.59 . . . . 0.0 110.871 -179.843 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.708 HD22 ' CE1' ' A' ' 123' ' ' HIS . 5.0 tp -111.33 137.32 49.23 Favored 'General case' 0 N--CA 1.447 -0.594 0 C-N-CA 122.826 0.451 . . . . 0.0 110.585 178.178 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.7 ' HD3' HG22 ' A' ' 124' ' ' THR . 6.9 ptmm? -140.34 171.94 13.44 Favored 'General case' 0 C--N 1.325 -0.488 0 CA-C-N 116.031 -0.531 . . . . 0.0 109.74 -179.527 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.773 HD12 HG22 ' A' ' 121' ' ' ILE . 6.0 tp -88.39 141.77 28.27 Favored 'General case' 0 C--N 1.326 -0.448 0 O-C-N 124.237 0.96 . . . . 0.0 109.244 178.866 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . 0.466 ' SG ' HG22 ' A' ' 120' ' ' ILE . 57.5 m -67.57 -176.1 0.58 Allowed 'General case' 0 N--CA 1.437 -1.094 0 CA-C-O 121.862 0.839 . . . . 0.0 109.307 177.494 . . . . . . . . 2 2 . 1 . 023 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 2.1 m -156.27 84.92 0.99 Allowed 'General case' 0 CA--C 1.511 -0.529 0 N-CA-C 107.668 -1.234 . . . . 0.0 107.668 -178.855 . . . . . . . . 1 1 . 1 . 023 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.672 ' HB2' HG22 ' A' ' 2' ' ' VAL . 0.0 OUTLIER . . . . . 0 C--O 1.258 1.543 0 CA-C-O 115.151 -2.357 . . . . 0.0 112.528 173.957 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 CA--C 1.505 -0.771 0 N-CA-C 108.622 -0.881 . . . . 0.0 108.622 . . . . . . . . . 0 0 . 1 . 024 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.65 HG13 ' CD2' ' A' ' 136' ' ' HIS . 7.6 p -104.44 167.99 2.61 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.678 0 O-C-N 123.973 0.796 . . . . 0.0 110.257 177.995 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.457 ' N ' HG22 ' A' ' 2' ' ' VAL . 2.4 m -85.94 109.13 18.54 Favored 'General case' 0 C--N 1.307 -1.281 0 C-N-CA 125.936 1.695 . . . . 0.0 110.962 -179.493 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.482 ' CD1' ' HB2' ' A' ' 13' ' ' GLN . 25.5 m95 -77.67 142.4 38.84 Favored 'General case' 0 N--CA 1.442 -0.863 0 O-C-N 121.709 -0.619 . . . . 0.0 110.164 179.546 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.419 ' OG1' HD13 ' A' ' 10' ' ' LEU . 0.9 OUTLIER -131.97 134.36 45.53 Favored 'General case' 0 CA--C 1.5 -0.943 0 C-N-CA 123.204 0.602 . . . . 0.0 110.117 -176.957 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.731 ' SG ' ' HB3' ' A' ' 122' ' ' ALA . 0.0 OUTLIER -134.07 -73.46 0.48 Allowed 'General case' 0 C--O 1.222 -0.393 0 N-CA-C 109.989 -0.374 . . . . 0.0 109.989 177.367 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -80.44 42.5 2.61 Favored Glycine 0 C--O 1.211 -1.281 0 CA-C-O 117.844 -1.531 . . . . 0.0 111.373 179.905 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 64.04 12.78 50.69 Favored Glycine 0 C--O 1.22 -0.751 0 CA-C-N 119.361 1.581 . . . . 0.0 111.756 -175.067 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . . . . . . . . . 0.8 OUTLIER -114.33 149.45 36.01 Favored 'General case' 0 CA--C 1.507 -0.677 0 N-CA-C 107.492 -1.299 . . . . 0.0 107.492 -176.119 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.419 HD13 ' OG1' ' A' ' 5' ' ' THR . 2.1 mm? -105.18 125.5 51.05 Favored 'General case' 0 CA--C 1.507 -0.692 0 N-CA-C 105.405 -2.072 . . . . 0.0 105.405 -172.169 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.658 ' CZ ' ' HB3' ' A' ' 106' ' ' ALA . 90.5 m-85 -120.27 106.96 12.41 Favored 'General case' 0 C--N 1.312 -1.041 0 C-N-CA 124.509 1.124 . . . . 0.0 108.015 -174.076 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 6.8 t-20 -54.19 116.28 2.52 Favored 'General case' 0 C--O 1.206 -1.187 0 N-CA-C 108.124 -1.065 . . . . 0.0 108.124 178.724 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.482 ' HB2' ' CD1' ' A' ' 4' ' ' TRP . 6.3 tp-100 -54.79 -45.46 74.32 Favored 'General case' 0 C--O 1.196 -1.757 0 CA-C-O 116.429 -1.748 . . . . 0.0 111.993 178.881 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 1.3 t-20 -51.0 -36.28 38.49 Favored 'General case' 0 C--O 1.189 -2.126 0 O-C-N 124.117 0.886 . . . . 0.0 110.242 175.843 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -75.59 -40.85 55.9 Favored 'General case' 0 C--O 1.197 -1.696 0 CA-C-N 121.765 2.075 . . . . 0.0 112.177 170.039 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.465 ' O ' HG11 ' A' ' 108' ' ' VAL . . . -52.1 -35.9 49.26 Favored 'General case' 0 C--N 1.303 -1.42 0 O-C-N 117.463 -3.273 . . . . 0.0 113.406 171.018 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.428 ' O ' ' CD2' ' A' ' 21' ' ' HIS . 0.9 OUTLIER -94.5 -38.43 10.91 Favored 'General case' 0 C--O 1.2 -1.506 0 CA-C-O 122.657 1.218 . . . . 0.0 108.009 178.275 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 26.1 t -73.22 -58.49 3.27 Favored 'General case' 0 C--O 1.201 -1.467 1 O-C-N 115.447 -4.533 . . . . 0.0 106.838 -177.306 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.525 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 1.3 t-20 -50.46 -27.92 7.37 Favored 'General case' 0 C--N 1.311 -1.076 0 O-C-N 117.733 -3.104 . . . . 0.0 113.391 173.167 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.519 ' HB3' HG11 ' A' ' 108' ' ' VAL . 24.0 p -86.98 -16.95 34.26 Favored 'General case' 0 N--CA 1.449 -0.495 0 O-C-N 123.629 0.581 . . . . 0.0 112.527 175.191 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.428 ' CD2' ' O ' ' A' ' 17' ' ' GLU . 7.5 m170 -66.19 -39.5 89.73 Favored 'General case' 0 C--O 1.215 -0.719 0 C-N-CA 124.973 1.309 . . . . 0.0 107.881 179.773 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.525 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.0 OUTLIER -75.47 -41.78 54.75 Favored 'General case' 0 N--CA 1.442 -0.828 0 CA-C-O 116.647 -1.644 . . . . 0.0 109.269 -178.519 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.883 ' HB1' ' HG3' ' A' ' 35' ' ' PRO . . . -40.31 130.07 1.7 Allowed Pre-proline 0 N--CA 1.443 -0.778 0 O-C-N 126.649 2.468 . . . . 0.0 111.943 177.764 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.458 ' HG2' ' CG2' ' A' ' 30' ' ' THR . 14.5 Cg_endo -72.73 115.02 4.18 Favored 'Trans proline' 0 N--CA 1.451 -1.013 0 C-N-CA 122.103 1.868 . . . . 0.0 109.83 -176.133 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.6 HD13 ' HE2' ' A' ' 115' ' ' LYS . 2.5 tp -56.14 100.28 0.04 OUTLIER 'General case' 0 CA--C 1.514 -0.428 0 C-N-CA 123.272 0.629 . . . . 0.0 111.225 178.711 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 0.6 OUTLIER -167.72 166.27 13.86 Favored 'General case' 0 C--N 1.325 -0.467 0 CA-C-O 121.788 0.804 . . . . 0.0 109.453 -177.195 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.492 ' HB2' ' CE1' ' A' ' 79' ' ' TYR . 5.8 t0 -100.42 73.3 1.65 Allowed 'General case' 0 CA--C 1.548 0.87 0 CA-C-O 124.048 1.88 . . . . 0.0 107.104 179.014 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 79.58 86.03 0.57 Allowed Glycine 0 N--CA 1.448 -0.503 0 O-C-N 118.816 -2.427 . . . . 0.0 109.36 176.504 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -151.14 33.52 0.58 Allowed 'General case' 0 CA--C 1.514 -0.425 0 O-C-N 121.205 -1.174 . . . . 0.0 111.23 177.204 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.474 HG21 ' HD2' ' A' ' 35' ' ' PRO . 55.3 p -129.73 143.85 51.01 Favored 'General case' 0 C--N 1.314 -0.941 0 N-CA-C 108.333 -0.988 . . . . 0.0 108.333 -175.927 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . . . . . . . . . . . -38.08 -67.79 0.48 Allowed Glycine 0 C--N 1.338 0.642 0 O-C-N 124.117 0.885 . . . . 0.0 112.979 -178.552 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . 0.461 ' HB3' ' HA ' ' A' ' 94' ' ' PHE . 32.2 t -51.86 -66.38 0.39 Allowed 'General case' 0 N--CA 1.44 -0.97 0 CA-C-O 115.744 -2.074 . . . . 0.0 110.554 174.328 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 3.2 p 167.44 -56.42 0.01 OUTLIER 'General case' 0 CA--C 1.514 -0.418 0 O-C-N 126.927 2.642 . . . . 0.0 111.256 179.895 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.528 ' CD1' ' HG3' ' A' ' 84' ' ' PRO . 32.3 m-85 -69.27 150.03 97.32 Favored Pre-proline 0 N--CA 1.429 -1.478 0 CA-C-O 116.494 -1.717 . . . . 0.0 112.708 178.995 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.883 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 37.5 Cg_endo -72.24 138.56 55.03 Favored 'Cis proline' 0 N--CA 1.442 -1.519 0 C-N-CA 121.281 -2.383 . . . . 0.0 112.264 -4.602 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . . . . . . . . . 0.7 OUTLIER -128.94 150.6 50.31 Favored 'General case' 0 CA--C 1.508 -0.635 0 CA-C-O 116.91 -1.519 . . . . 0.0 113.781 173.44 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.965 ' CH2' HG22 ' A' ' 39' ' ' THR . 19.1 t90 -44.42 151.85 0.23 Allowed 'General case' 0 C--O 1.237 0.428 0 CA-C-O 122.577 1.179 . . . . 0.0 110.872 176.305 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.522 ' CE1' ' HA ' ' A' ' 40' ' ' ASN . 3.0 t80 -127.87 79.64 1.91 Allowed 'General case' 0 N--CA 1.417 -2.089 0 N-CA-C 105.478 -2.045 . . . . 0.0 105.478 -172.921 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.965 HG22 ' CH2' ' A' ' 37' ' ' TRP . 38.1 p -36.96 -39.51 0.23 Allowed 'General case' 0 C--O 1.205 -1.288 0 C-N-CA 125.388 1.475 . . . . 0.0 110.506 173.773 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.522 ' HA ' ' CE1' ' A' ' 38' ' ' PHE . 43.5 t30 59.14 17.42 5.58 Favored 'General case' 0 C--O 1.206 -1.211 0 CA-C-N 120.426 1.466 . . . . 0.0 107.39 173.154 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.492 ' C ' HD23 ' A' ' 48' ' ' LEU . . . 113.09 -45.84 1.26 Allowed Glycine 0 N--CA 1.428 -1.851 0 O-C-N 118.716 -2.49 . . . . 0.0 113.321 -170.639 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.57 ' N ' HD23 ' A' ' 48' ' ' LEU . 83.3 m-85 -45.21 153.61 0.2 Allowed 'General case' 0 N--CA 1.452 -0.37 0 C-N-CA 124.318 1.047 . . . . 0.0 111.942 178.097 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.09 -36.38 24.92 Favored 'General case' 0 C--N 1.326 -0.429 0 CA-C-N 115.434 -0.803 . . . . 0.0 110.14 178.593 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . . . . . . . . . . . 126.56 42.16 0.3 Allowed Glycine 0 C--N 1.341 0.819 0 C-N-CA 123.922 0.773 . . . . 0.0 111.299 -177.296 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -146.64 -69.64 0.25 Allowed 'General case' 0 C--N 1.326 -0.444 0 CA-C-O 118.031 -0.985 . . . . 0.0 109.294 179.707 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -146.43 -73.49 0.02 OUTLIER Glycine 0 C--O 1.195 -2.287 0 N-CA-C 107.591 -2.204 . . . . 0.0 107.591 -176.192 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . . . . . . . . . 4.5 ptpt -100.96 -165.33 1.19 Allowed 'General case' 0 C--N 1.325 -0.496 0 CA-C-N 120.468 2.134 . . . . 0.0 110.35 178.638 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.713 ' H ' HD12 ' A' ' 48' ' ' LEU . 0.0 OUTLIER -113.35 174.12 2.49 Favored Pre-proline 0 N--CA 1.438 -1.041 0 C-N-CA 123.623 0.769 . . . . 0.0 110.028 -178.93 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.5 Cg_endo -74.27 156.91 46.22 Favored 'Trans proline' 0 N--CA 1.454 -0.802 0 C-N-CA 122.362 2.041 . . . . 0.0 110.855 179.426 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.7 OUTLIER -59.71 98.1 0.05 OUTLIER 'General case' 0 CA--C 1.536 0.441 0 N-CA-C 108.536 -0.913 . . . . 0.0 108.536 178.301 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 120.31 55.83 0.24 Allowed Glycine 0 CA--C 1.507 -0.442 0 CA-C-O 118.345 -1.253 . . . . 0.0 111.889 -178.318 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.418 ' HD2' ' HA2' ' A' ' 41' ' ' GLY . 1.3 mmt180 -149.79 143.07 25.15 Favored 'General case' 0 CA--C 1.508 -0.646 0 CA-C-N 117.671 0.735 . . . . 0.0 110.811 177.055 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 14.1 m -131.45 96.74 20.67 Favored Pre-proline 0 C--N 1.324 -0.531 0 O-C-N 124.318 1.011 . . . . 0.0 110.352 -178.628 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . 0.653 ' HG3' HD21 ' A' ' 48' ' ' LEU . 18.0 Cg_endo -72.36 173.23 13.44 Favored 'Trans proline' 0 N--CA 1.454 -0.8 0 C-N-CA 122.022 1.814 . . . . 0.0 111.723 179.267 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.524 HD11 ' HG ' ' A' ' 131' ' ' LEU . 8.4 mt -86.53 111.62 21.69 Favored 'Isoleucine or valine' 0 C--O 1.209 -1.076 0 N-CA-C 108.266 -1.013 . . . . 0.0 108.266 -176.348 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.6 OUTLIER -80.23 137.49 36.66 Favored 'General case' 0 C--N 1.324 -0.529 0 O-C-N 120.617 -1.302 . . . . 0.0 108.703 178.922 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.491 ' CG ' ' SG ' ' A' ' 118' ' ' CYS . 3.0 m-85 -118.5 -52.79 2.35 Favored 'General case' 0 CA--C 1.511 -0.551 0 CA-C-N 115.308 -0.86 . . . . 0.0 109.628 -179.999 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 128.73 -9.95 6.39 Favored Glycine 0 CA--C 1.524 0.6 0 C-N-CA 123.48 0.562 . . . . 0.0 111.722 -176.74 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . 0.425 ' CB ' ' HB3' ' A' ' 62' ' ' CYS . 15.2 mmtt -69.08 170.57 9.71 Favored 'General case' 0 C--O 1.197 -1.692 0 CA-C-O 118.217 -0.897 . . . . 0.0 111.127 177.16 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 1.4 m -101.69 -47.54 4.59 Favored 'General case' 0 C--O 1.19 -2.027 0 N-CA-C 108.318 -0.993 . . . . 0.0 108.318 179.596 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -73.29 -40.92 64.17 Favored 'General case' 0 C--O 1.219 -0.521 0 CA-C-N 120.888 1.676 . . . . 0.0 108.974 178.698 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.488 ' SG ' ' CD1' ' A' ' 57' ' ' PHE . 11.0 t -71.84 -14.58 62.0 Favored 'General case' 0 C--N 1.348 0.533 0 O-C-N 123.468 0.48 . . . . 0.0 110.138 178.198 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 8.8 t70 -95.62 -32.75 12.65 Favored 'General case' 0 N--CA 1.454 -0.268 0 N-CA-C 112.365 0.505 . . . . 0.0 112.365 174.693 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . . . . . . . . . 0.0 OUTLIER -53.94 168.36 0.43 Allowed Pre-proline 0 N--CA 1.429 -1.493 0 CA-C-O 122.349 1.071 . . . . 0.0 108.674 -177.635 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 30.3 Cg_endo -72.71 124.7 9.94 Favored 'Trans proline' 0 N--CA 1.438 -1.768 0 C-N-CA 121.068 1.179 . . . . 0.0 115.13 172.123 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.419 ' HD2' ' CD1' ' A' ' 42' ' ' TYR . 18.6 Cg_endo -72.04 164.15 36.55 Favored 'Trans proline' 0 CA--C 1.502 -1.111 0 C-N-CA 123.595 2.863 . . . . 0.0 111.802 179.614 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 8.2 tptt -126.06 130.38 51.02 Favored 'General case' 0 C--O 1.205 -1.273 0 CA-C-O 117.329 -1.319 . . . . 0.0 108.382 178.951 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . . . . . . . . . 41.4 t-80 -122.6 161.5 23.62 Favored 'General case' 0 C--N 1.322 -0.618 0 CA-C-N 119.226 0.921 . . . . 0.0 110.214 174.612 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . . . . . . . . . 0.3 OUTLIER -152.6 179.08 8.92 Favored 'General case' 0 C--N 1.317 -0.808 0 CA-C-N 116.015 -0.539 . . . . 0.0 110.2 179.223 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 3.8 mptt -84.82 69.18 10.69 Favored 'General case' 0 C--O 1.215 -0.757 0 O-C-N 121.828 -0.545 . . . . 0.0 111.422 177.146 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -176.94 -41.36 0.01 OUTLIER 'General case' 0 C--N 1.321 -0.649 0 N-CA-C 109.482 -0.562 . . . . 0.0 109.482 179.223 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.486 ' CA ' ' HB3' ' A' ' 27' ' ' ASP . . . 122.07 -63.9 0.51 Allowed Glycine 0 N--CA 1.442 -0.958 0 N-CA-C 110.987 -0.845 . . . . 0.0 110.987 -179.061 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . 0.408 ' ND2' ' N ' ' A' ' 73' ' ' ASN . 0.1 OUTLIER -133.98 56.74 1.83 Allowed 'General case' 0 CA--C 1.509 -0.603 0 N-CA-C 106.701 -1.592 . . . . 0.0 106.701 -173.06 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -58.96 -109.73 0.01 OUTLIER Glycine 0 C--O 1.215 -1.035 0 CA-C-O 121.998 0.777 . . . . 0.0 111.583 179.412 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 19.8 mttt -60.98 -98.82 0.0 OUTLIER 'General case' 0 C--O 1.214 -0.794 0 O-C-N 120.017 -1.872 . . . . 0.0 109.941 179.374 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.593 HG23 ' O ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -120.94 15.66 11.67 Favored 'General case' 0 CA--C 1.493 -1.226 0 O-C-N 119.331 -2.105 . . . . 0.0 110.611 -179.241 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.433 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 1.3 m-20 -24.3 95.56 0.01 OUTLIER 'General case' 0 C--O 1.197 -1.689 0 C-N-CA 126.768 2.027 . . . . 0.0 112.948 -176.615 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.5 ' CD2' ' H ' ' A' ' 78' ' ' HIS . 6.4 p80 -88.98 60.45 5.46 Favored 'General case' 0 CA--C 1.501 -0.917 0 N-CA-C 106.321 -1.733 . . . . 0.0 106.321 -167.929 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.578 ' HB2' ' CD1' ' A' ' 37' ' ' TRP . 52.0 p90 -91.11 136.78 32.85 Favored 'General case' 0 N--CA 1.44 -0.962 0 C-N-CA 124.672 1.189 . . . . 0.0 111.602 -178.446 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.669 HD23 ' O ' ' A' ' 110' ' ' TYR . 2.5 mt -67.31 128.88 38.06 Favored 'General case' 0 C--O 1.205 -1.281 0 CA-C-O 117.481 -1.247 . . . . 0.0 109.271 178.811 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.844 HD11 ' HB2' ' A' ' 35' ' ' PRO . 0.2 OUTLIER -121.28 135.03 55.17 Favored 'General case' 0 C--N 1.316 -0.861 0 CA-C-N 121.025 1.739 . . . . 0.0 107.329 178.608 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.562 ' N ' HD12 ' A' ' 81' ' ' LEU . 0.1 OUTLIER -101.56 166.09 10.89 Favored 'General case' 0 N--CA 1.436 -1.169 0 CA-C-O 123.168 1.461 . . . . 0.0 114.503 171.218 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.502 ' CD1' ' HD2' ' A' ' 84' ' ' PRO . 52.2 t80 -146.3 131.82 9.26 Favored Pre-proline 0 CA--C 1.498 -1.024 0 O-C-N 117.823 -3.048 . . . . 0.0 113.115 179.462 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.544 ' HA ' ' HG2' ' A' ' 107' ' ' ARG . 19.3 Cg_endo -72.98 106.18 2.1 Favored 'Trans proline' 0 CA--C 1.473 -2.554 0 C-N-CA 124.645 3.563 . . . . 0.0 110.583 -175.698 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.55 ' HA ' ' CZ ' ' A' ' 92' ' ' TYR . 0.6 OUTLIER -100.73 121.01 40.94 Favored 'General case' 0 CA--C 1.49 -1.332 0 O-C-N 125.613 1.82 . . . . 0.0 112.36 -179.306 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.597 ' CD1' ' CD1' ' A' ' 92' ' ' TYR . 13.8 m-85 -85.19 162.66 48.3 Favored Pre-proline 0 N--CA 1.44 -0.963 0 CA-C-N 120.475 1.489 . . . . 0.0 111.179 -179.423 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 15.6 Cg_endo -77.77 -44.34 0.18 Allowed 'Trans proline' 0 CA--C 1.516 -0.386 0 C-N-CA 122.161 1.907 . . . . 0.0 112.431 179.605 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -48.62 -26.4 2.23 Favored 'General case' 0 CA--C 1.544 0.729 0 O-C-N 125.279 1.612 . . . . 0.0 110.913 174.446 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 74.92 17.64 80.2 Favored Glycine 0 N--CA 1.431 -1.676 0 CA-C-O 117.39 -1.783 . . . . 0.0 109.706 179.592 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.419 ' O ' ' CE1' ' A' ' 92' ' ' TYR . 1.0 OUTLIER -82.74 147.52 28.39 Favored 'General case' 0 C--O 1.182 -2.454 0 CA-C-O 116.929 -1.51 . . . . 0.0 110.359 -179.593 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 8.6 t70 -62.09 134.39 56.54 Favored 'General case' 0 C--N 1.305 -1.34 0 CA-C-N 123.54 2.882 . . . . 0.0 111.831 176.173 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.597 ' CD1' ' CD1' ' A' ' 86' ' ' PHE . 0.2 OUTLIER -93.6 136.48 33.83 Favored 'General case' 0 C--O 1.202 -1.399 0 N-CA-C 105.595 -2.002 . . . . 0.0 105.595 -173.21 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -72.39 61.24 0.47 Allowed 'General case' 0 C--N 1.318 -0.778 0 O-C-N 119.769 -1.832 . . . . 0.0 111.029 175.075 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.49 ' CD2' ' HZ ' ' A' ' 83' ' ' PHE . 1.5 p90 -74.95 -23.96 58.39 Favored 'General case' 0 N--CA 1.426 -1.651 0 C-N-CA 126.401 1.88 . . . . 0.0 109.581 179.749 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . . . . . . . . . 0.5 OUTLIER -86.56 -31.49 21.19 Favored 'General case' 0 N--CA 1.451 -0.423 0 N-CA-C 107.835 -1.172 . . . . 0.0 107.835 -178.844 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 1.9 t -82.38 104.74 12.9 Favored 'General case' 0 N--CA 1.448 -0.538 0 N-CA-C 107.691 -1.225 . . . . 0.0 107.691 -177.61 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 32.6 pttt -58.27 -50.71 72.63 Favored 'General case' 0 C--O 1.227 -0.126 0 N-CA-C 107.931 -1.137 . . . . 0.0 107.931 179.241 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.425 ' HA ' ' HA ' ' A' ' 99' ' ' PRO . 4.4 mttp -137.41 124.88 14.04 Favored Pre-proline 0 N--CA 1.438 -1.027 0 C-N-CA 124.787 1.235 . . . . 0.0 109.095 -173.719 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.425 ' HA ' ' HA ' ' A' ' 98' ' ' LYS . 23.3 Cg_endo -73.26 175.01 47.31 Favored 'Cis proline' 0 CA--C 1.54 0.822 0 O-C-N 124.934 2.018 . . . . 0.0 111.564 -2.913 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . 0.413 ' HD2' ' HA ' ' A' ' 32' ' ' SER . 9.6 tttp -137.6 117.5 13.26 Favored 'General case' 0 C--O 1.22 -0.467 0 N-CA-C 109.308 -0.627 . . . . 0.0 109.308 179.152 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 14.3 tp10 -72.54 154.3 40.88 Favored 'General case' 0 C--O 1.253 1.243 0 O-C-N 124.62 1.2 . . . . 0.0 110.32 176.918 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 1.0 OUTLIER -48.43 124.55 11.73 Favored Pre-proline 0 N--CA 1.438 -1.07 0 C-N-CA 125.113 1.365 . . . . 0.0 112.105 172.758 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 25.8 Cg_endo -70.3 -164.95 0.15 Allowed 'Trans proline' 0 CA--C 1.54 0.818 0 C-N-CA 122.691 2.261 . . . . 0.0 112.125 177.681 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -134.73 158.66 23.59 Favored Glycine 0 N--CA 1.442 -0.927 0 CA-C-N 115.815 -0.63 . . . . 0.0 112.561 177.288 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . . . . . . . . . 18.4 Cg_endo -76.07 -61.76 0.03 OUTLIER 'Trans proline' 0 N--CA 1.455 -0.765 0 C-N-CA 122.72 2.28 . . . . 0.0 110.109 179.9 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.658 ' HB3' ' CZ ' ' A' ' 11' ' ' TYR . . . -58.78 133.34 55.88 Favored 'General case' 0 N--CA 1.432 -1.328 0 O-C-N 124.653 1.22 . . . . 0.0 111.938 178.015 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.544 ' HG2' ' HA ' ' A' ' 84' ' ' PRO . 0.0 OUTLIER -141.23 146.9 37.46 Favored 'General case' 0 CA--C 1.496 -1.11 0 O-C-N 124.632 1.208 . . . . 0.0 111.817 -178.489 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.519 HG11 ' HB3' ' A' ' 20' ' ' SER . 7.7 p -80.5 126.1 39.43 Favored 'Isoleucine or valine' 0 C--N 1.319 -0.756 0 CA-C-O 121.423 0.63 . . . . 0.0 110.407 178.839 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.558 ' CG2' HD22 ' A' ' 80' ' ' LEU . 24.5 mm -100.28 147.24 7.86 Favored 'Isoleucine or valine' 0 CA--C 1.493 -1.229 0 O-C-N 121.227 -0.921 . . . . 0.0 110.361 179.008 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.669 ' O ' HD23 ' A' ' 80' ' ' LEU . 11.4 p90 -176.76 148.14 0.66 Allowed 'General case' 0 N--CA 1.441 -0.906 0 CA-C-O 124.408 2.052 . . . . 0.0 110.131 -177.624 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . 0.409 HG22 ' HA ' ' A' ' 62' ' ' CYS . 7.0 p -81.55 167.69 19.02 Favored 'General case' 0 C--N 1.311 -1.075 0 O-C-N 120.207 -1.558 . . . . 0.0 108.947 -177.612 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.464 ' CD1' ' C ' ' A' ' 112' ' ' TYR . 0.1 OUTLIER -116.2 152.56 47.99 Favored Pre-proline 0 N--CA 1.432 -1.34 0 C-N-CA 123.938 0.895 . . . . 0.0 109.892 179.875 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.467 ' O ' HD21 ' A' ' 25' ' ' LEU . 15.6 Cg_endo -72.7 -44.03 0.61 Allowed 'Cis proline' 0 CA--C 1.516 -0.413 0 C-N-CA 122.076 -2.052 . . . . 0.0 109.378 -9.213 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . . . . . . . . . 43.4 m-20 -46.84 106.98 0.09 Allowed 'General case' 0 CA--C 1.49 -1.337 0 CA-C-O 113.631 -3.08 . . . . 0.0 109.816 -179.382 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.6 ' HE2' HD13 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -68.31 72.27 0.2 Allowed 'General case' 0 CA--C 1.501 -0.918 0 O-C-N 127.457 2.973 . . . . 0.0 107.03 -175.787 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.577 ' O ' HG12 ' A' ' 116' ' ' VAL . 14.6 t -74.08 70.16 0.24 Allowed 'Isoleucine or valine' 0 CA--C 1.511 -0.533 0 N-CA-C 104.876 -2.268 . . . . 0.0 104.876 -177.133 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.449 ' CZ ' ' NE2' ' A' ' 13' ' ' GLN . 54.6 t80 -37.17 100.8 0.02 OUTLIER 'General case' 0 N--CA 1.445 -0.703 0 C-N-CA 126.064 1.746 . . . . 0.0 110.732 178.831 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . 0.491 ' SG ' ' CG ' ' A' ' 57' ' ' PHE . 0.1 OUTLIER -81.43 -39.53 24.76 Favored 'General case' 0 N--CA 1.444 -0.744 0 N-CA-C 107.627 -1.249 . . . . 0.0 107.627 -178.235 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 159.82 -146.86 13.36 Favored Glycine 0 N--CA 1.441 -1.02 0 N-CA-C 110.065 -1.214 . . . . 0.0 110.065 -179.734 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.441 HG13 ' CG ' ' A' ' 4' ' ' TRP . 1.0 OUTLIER -129.61 149.0 33.22 Favored 'Isoleucine or valine' 0 CA--C 1.482 -1.672 0 N-CA-C 107.184 -1.413 . . . . 0.0 107.184 -172.923 . . . . . . . . 3 3 . 1 . 024 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.565 ' CD1' HD21 ' A' ' 131' ' ' LEU . 7.2 pt -138.23 154.69 28.26 Favored 'Isoleucine or valine' 0 C--N 1.311 -1.074 0 CA-C-N 120.304 1.411 . . . . 0.0 108.293 -178.177 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.731 ' HB3' ' SG ' ' A' ' 6' ' ' CYS . . . -172.31 151.77 2.61 Favored 'General case' 0 C--N 1.32 -0.685 0 CA-C-O 122.338 1.066 . . . . 0.0 110.021 176.867 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.473 ' CE1' HD13 ' A' ' 131' ' ' LEU . 2.2 m-70 -89.46 94.96 10.07 Favored 'General case' 0 N--CA 1.445 -0.681 0 O-C-N 120.996 -1.065 . . . . 0.0 108.278 -176.89 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.553 ' O ' HG23 ' A' ' 124' ' ' THR . 3.4 t -98.17 41.27 1.14 Allowed 'General case' 0 C--N 1.323 -0.573 0 CA-C-O 123.798 1.761 . . . . 0.0 110.611 -179.544 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 5.6 tttt -103.04 -26.44 13.06 Favored 'General case' 0 C--N 1.321 -0.662 0 O-C-N 119.072 -2.267 . . . . 0.0 111.183 177.866 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -170.28 -61.38 0.02 OUTLIER 'General case' 0 C--O 1.218 -0.593 0 O-C-N 123.633 0.583 . . . . 0.0 110.524 177.493 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.6 m-80 -156.03 -45.29 0.08 Allowed 'General case' 0 N--CA 1.456 -0.158 0 CA-C-O 122.499 1.142 . . . . 0.0 110.108 178.995 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 1.4 mt-30 -159.46 75.54 0.65 Allowed 'General case' 0 C--O 1.218 -0.575 0 CA-C-O 122.173 0.987 . . . . 0.0 110.523 -179.017 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -119.1 -101.89 2.01 Favored Glycine 0 N--CA 1.459 0.214 0 CA-C-O 122.578 1.099 . . . . 0.0 110.863 179.816 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 0.0 OUTLIER -92.84 140.45 29.49 Favored 'General case' 0 CA--C 1.506 -0.719 0 O-C-N 120.934 -1.333 . . . . 0.0 111.035 -179.317 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.565 HD21 ' CD1' ' A' ' 121' ' ' ILE . 6.0 tp -92.49 145.32 24.55 Favored 'General case' 0 C--N 1.323 -0.545 0 O-C-N 121.519 -0.738 . . . . 0.0 111.484 177.847 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.434 ' HD2' HG22 ' A' ' 124' ' ' THR . 9.2 ptpt -150.02 173.92 13.3 Favored 'General case' 0 C--N 1.321 -0.648 0 CA-C-O 117.448 -1.263 . . . . 0.0 110.608 179.111 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.481 HD12 HG22 ' A' ' 121' ' ' ILE . 12.2 tp -82.28 139.71 34.03 Favored 'General case' 0 C--N 1.322 -0.627 0 N-CA-C 108.48 -0.933 . . . . 0.0 108.48 -178.807 . . . . . . . . 2 2 . 1 . 024 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 73.3 m -67.28 -172.83 0.24 Allowed 'General case' 0 N--CA 1.439 -1.001 0 C-N-CA 124.072 0.949 . . . . 0.0 109.363 176.833 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 61.1 m -162.05 114.33 1.72 Allowed 'General case' 0 CA--C 1.505 -0.767 0 CA-C-O 117.056 -1.449 . . . . 0.0 107.835 -179.624 . . . . . . . . 1 1 . 1 . 024 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.65 ' CD2' HG13 ' A' ' 2' ' ' VAL . 2.4 m80 . . . . . 0 C--O 1.277 2.515 0 CA-C-O 113.525 -3.131 . . . . 0.0 113.22 176.206 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 1' ' ' ALA . . . . . . . . . . . . . . . . . . . . 0 N--CA 1.473 0.701 0 N-CA-C 109.389 -0.597 . . . . 0.0 109.389 . . . . . . . . . 0 0 . 1 . 025 nuclear nobuild full ' A' A ' 2' ' ' VAL . . . . . 0.468 HG13 ' HB2' ' A' ' 136' ' ' HIS . 5.1 p -50.46 149.57 0.82 Allowed 'Isoleucine or valine' 0 C--O 1.24 0.565 0 CA-C-O 121.271 0.557 . . . . 0.0 110.188 179.542 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 3' ' ' THR . . . . . 0.478 HG21 ' HB3' ' A' ' 10' ' ' LEU . 3.2 m -94.51 121.34 35.95 Favored 'General case' 0 C--N 1.314 -0.953 0 N-CA-C 108.43 -0.952 . . . . 0.0 108.43 -174.581 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 4' ' ' TRP . . . . . 0.45 ' CG ' HG13 ' A' ' 120' ' ' ILE . 24.2 m95 -79.36 140.53 37.45 Favored 'General case' 0 N--CA 1.445 -0.711 0 N-CA-C 109.264 -0.643 . . . . 0.0 109.264 -179.271 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 5' ' ' THR . . . . . 0.529 ' OG1' HD12 ' A' ' 10' ' ' LEU . 0.9 OUTLIER -128.56 134.48 48.64 Favored 'General case' 0 CA--C 1.504 -0.796 0 N-CA-C 108.908 -0.775 . . . . 0.0 108.908 -178.079 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 6' ' ' CYS . . . . . 0.734 ' HB3' ' HB3' ' A' ' 122' ' ' ALA . 8.4 m -123.1 -71.46 0.72 Allowed 'General case' 0 N--CA 1.449 -0.505 0 CA-C-N 115.888 -0.596 . . . . 0.0 110.689 178.868 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 7' ' ' GLY . . . . . . . . . . . . . . . -86.27 32.26 3.9 Favored Glycine 0 C--O 1.221 -0.685 0 CA-C-O 119.773 -0.459 . . . . 0.0 111.996 176.906 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 8' ' ' GLY . . . . . . . . . . . . . . . 82.53 -13.03 43.53 Favored Glycine 0 CA--C 1.529 0.955 0 CA-C-N 117.491 0.646 . . . . 0.0 112.854 -175.164 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 9' ' ' LEU . . . . . 0.424 HD13 ' OH ' ' A' ' 11' ' ' TYR . 0.2 OUTLIER -87.66 139.99 29.97 Favored 'General case' 0 N--CA 1.448 -0.555 0 N-CA-C 107.924 -1.139 . . . . 0.0 107.924 -177.685 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 10' ' ' LEU . . . . . 0.529 HD12 ' OG1' ' A' ' 5' ' ' THR . 5.0 mp -86.22 135.09 33.7 Favored 'General case' 0 C--N 1.326 -0.414 0 O-C-N 124.032 0.832 . . . . 0.0 109.455 -178.589 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 11' ' ' TYR . . . . . 0.533 ' CE2' ' CB ' ' A' ' 106' ' ' ALA . 60.4 m-85 -124.06 105.84 9.88 Favored 'General case' 0 CA--C 1.506 -0.717 0 C-N-CA 125.539 1.536 . . . . 0.0 109.554 -175.14 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 12' ' ' ASN . . . . . . . . . . . . . 0.1 OUTLIER -56.79 112.97 1.46 Allowed 'General case' 0 N--CA 1.441 -0.888 0 N-CA-C 108.732 -0.84 . . . . 0.0 108.732 -179.328 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 13' ' ' GLN . . . . . 0.455 ' NE2' ' CZ ' ' A' ' 117' ' ' PHE . 6.1 tp-100 -51.2 -48.68 61.94 Favored 'General case' 0 C--O 1.214 -0.792 0 C-N-CA 119.586 -0.846 . . . . 0.0 111.91 -179.024 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 14' ' ' ASN . . . . . . . . . . . . . 4.6 t-20 -49.2 -39.8 31.09 Favored 'General case' 0 C--O 1.197 -1.669 0 O-C-N 124.162 0.913 . . . . 0.0 111.263 176.862 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 15' ' ' LYS . . . . . . . . . . . . . 16.8 mttt -71.59 -38.89 70.84 Favored 'General case' 0 C--O 1.219 -0.549 0 CA-C-N 118.755 0.707 . . . . 0.0 112.904 171.217 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 16' ' ' ALA . . . . . 0.486 ' O ' HG11 ' A' ' 108' ' ' VAL . . . -53.67 -39.14 64.85 Favored 'General case' 0 C--O 1.215 -0.741 0 CA-C-N 119.87 1.213 . . . . 0.0 111.99 173.409 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 17' ' ' GLU . . . . . 0.456 ' O ' ' CD2' ' A' ' 21' ' ' HIS . 6.0 pt-20 -90.38 -38.78 13.09 Favored 'General case' 0 C--O 1.221 -0.431 0 C-N-CA 123.802 0.841 . . . . 0.0 110.809 176.228 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 18' ' ' SER . . . . . . . . . . . . . 40.7 t -75.05 -60.12 2.43 Favored 'General case' 0 CA--C 1.506 -0.747 0 O-C-N 119.716 -1.865 . . . . 0.0 109.557 -176.508 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 19' ' ' ASN . . . . . 0.535 ' HA ' ' CE1' ' A' ' 22' ' ' HIS . 0.1 OUTLIER -48.39 -29.45 4.02 Favored 'General case' 0 N--CA 1.445 -0.698 0 N-CA-C 113.043 0.757 . . . . 0.0 113.043 171.062 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 20' ' ' SER . . . . . 0.558 ' HB3' HG11 ' A' ' 108' ' ' VAL . 31.7 p -85.19 -24.66 27.8 Favored 'General case' 0 C--O 1.221 -0.432 0 N-CA-C 113.41 0.893 . . . . 0.0 113.41 175.413 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 21' ' ' HIS . . . . . 0.456 ' CD2' ' O ' ' A' ' 17' ' ' GLU . 10.2 m170 -57.13 -35.97 70.12 Favored 'General case' 0 C--O 1.222 -0.351 0 C-N-CA 124.156 0.982 . . . . 0.0 109.217 178.061 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 22' ' ' HIS . . . . . 0.535 ' CE1' ' HA ' ' A' ' 19' ' ' ASN . 0.1 OUTLIER -71.69 -42.13 67.8 Favored 'General case' 0 N--CA 1.445 -0.709 0 CA-C-O 118.566 -0.731 . . . . 0.0 110.138 179.901 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 23' ' ' ALA . . . . . 0.796 ' HB1' ' HG3' ' A' ' 35' ' ' PRO . . . -39.99 133.77 1.43 Allowed Pre-proline 0 N--CA 1.443 -0.793 0 O-C-N 125.189 1.555 . . . . 0.0 111.124 176.505 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 24' ' ' PRO . . . . . 0.732 ' HG2' HG22 ' A' ' 30' ' ' THR . 19.5 Cg_endo -72.61 119.36 6.06 Favored 'Trans proline' 0 N--CA 1.443 -1.442 0 C-N-CA 122.1 1.867 . . . . 0.0 108.55 -177.8 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 25' ' ' LEU . . . . . 0.526 HD22 ' HE2' ' A' ' 115' ' ' LYS . 3.4 tp -60.58 84.19 0.01 OUTLIER 'General case' 0 N--CA 1.455 -0.211 0 C-N-CA 124.284 1.033 . . . . 0.0 111.266 177.885 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 26' ' ' SER . . . . . . . . . . . . . 2.4 m -165.89 147.24 6.94 Favored 'General case' 0 C--N 1.325 -0.464 0 CA-C-N 115.943 -0.571 . . . . 0.0 110.291 -174.682 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 27' ' ' ASP . . . . . 0.48 ' HB3' ' CA ' ' A' ' 72' ' ' GLY . 2.7 t0 -78.89 85.66 4.84 Favored 'General case' 0 C--N 1.327 -0.376 0 N-CA-C 108.269 -1.011 . . . . 0.0 108.269 -178.843 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 28' ' ' GLY . . . . . . . . . . . . . . . 65.68 86.31 0.07 OUTLIER Glycine 0 N--CA 1.449 -0.453 0 N-CA-C 110.948 -0.861 . . . . 0.0 110.948 177.812 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 29' ' ' LYS . . . . . . . . . . . . . 5.2 mmtt -150.49 44.68 0.86 Allowed 'General case' 0 N--CA 1.47 0.537 0 CA-C-O 121.934 0.873 . . . . 0.0 111.615 178.749 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 30' ' ' THR . . . . . 0.732 HG22 ' HG2' ' A' ' 24' ' ' PRO . 12.2 p -130.64 -170.77 2.41 Favored 'General case' 0 C--N 1.321 -0.653 0 CA-C-N 115.083 -0.962 . . . . 0.0 109.55 -174.695 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 31' ' ' GLY . . . . . 0.403 ' HA3' ' O ' ' A' ' 95' ' ' ASP . . . -83.82 -55.23 2.86 Favored Glycine 0 N--CA 1.447 -0.602 0 C-N-CA 120.881 -0.676 . . . . 0.0 112.706 177.446 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 32' ' ' SER . . . . . . . . . . . . . 1.0 OUTLIER -76.05 9.56 2.4 Favored 'General case' 0 CA--C 1.514 -0.415 0 O-C-N 122.136 -0.626 . . . . 0.0 112.336 177.854 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 33' ' ' SER . . . . . . . . . . . . . 2.1 p 89.83 -58.45 0.02 OUTLIER 'General case' 0 CA--C 1.503 -0.855 0 C-N-CA 127.17 2.188 . . . . 0.0 109.258 -179.782 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 34' ' ' TYR . . . . . 0.491 ' CG ' ' HG3' ' A' ' 84' ' ' PRO . 85.9 m-85 -59.38 142.82 86.38 Favored Pre-proline 0 N--CA 1.437 -1.08 0 O-C-N 125.826 1.953 . . . . 0.0 112.768 -176.914 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 35' ' ' PRO . . . . . 0.796 ' HG3' ' HB1' ' A' ' 23' ' ' ALA . 36.0 Cg_endo -76.48 -172.69 11.47 Favored 'Cis proline' 0 N--CA 1.438 -1.764 0 C-N-CA 122.66 -1.808 . . . . 0.0 111.521 0.577 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 36' ' ' HIS . . . . . 0.429 ' CD2' ' N ' ' A' ' 36' ' ' HIS . 0.3 OUTLIER -159.62 159.75 33.5 Favored 'General case' 0 CA--C 1.502 -0.886 0 O-C-N 120.774 -1.204 . . . . 0.0 110.101 -178.68 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 37' ' ' TRP . . . . . 0.599 ' CD1' ' HB2' ' A' ' 79' ' ' TYR . 10.3 t90 -69.6 134.35 48.67 Favored 'General case' 0 C--O 1.243 0.753 0 CA-C-O 122.796 1.284 . . . . 0.0 110.044 175.458 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 38' ' ' PHE . . . . . 0.444 ' CZ ' ' HA ' ' A' ' 40' ' ' ASN . 14.0 t80 -97.63 97.59 9.16 Favored 'General case' 0 N--CA 1.433 -1.277 0 N-CA-C 105.766 -1.939 . . . . 0.0 105.766 178.939 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 39' ' ' THR . . . . . 0.438 ' HA ' ' CZ2' ' A' ' 37' ' ' TRP . 77.4 p -36.14 -35.18 0.07 Allowed 'General case' 0 C--O 1.208 -1.124 0 CA-C-N 114.89 -1.05 . . . . 0.0 110.873 173.489 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 40' ' ' ASN . . . . . 0.444 ' HA ' ' CZ ' ' A' ' 38' ' ' PHE . 4.1 t-20 65.97 11.65 7.87 Favored 'General case' 0 N--CA 1.446 -0.654 0 C-N-CA 123.926 0.89 . . . . 0.0 110.631 179.717 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 41' ' ' GLY . . . . . 0.487 ' HA3' HD23 ' A' ' 48' ' ' LEU . . . 97.7 4.08 58.12 Favored Glycine 0 CA--C 1.536 1.384 0 N-CA-C 114.364 0.506 . . . . 0.0 114.364 -169.939 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 42' ' ' TYR . . . . . 0.708 ' CE1' HD11 ' A' ' 48' ' ' LEU . 2.6 m-85 -99.0 165.61 11.67 Favored 'General case' 0 N--CA 1.447 -0.591 0 C-N-CA 124.103 0.961 . . . . 0.0 109.339 -177.456 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 43' ' ' ASP . . . . . . . . . . . . . 0.6 OUTLIER -83.3 -34.88 25.62 Favored 'General case' 0 C--N 1.324 -0.522 0 CA-C-N 115.693 -0.685 . . . . 0.0 111.625 176.911 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 44' ' ' GLY . . . . . 0.526 ' HA2' ' CH2' ' A' ' 37' ' ' TRP . . . 173.24 -62.3 0.13 Allowed Glycine 0 C--N 1.335 0.489 0 C-N-CA 124.008 0.813 . . . . 0.0 112.06 -178.285 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 45' ' ' ASP . . . . . . . . . . . . . 0.2 OUTLIER -111.42 -61.81 1.64 Allowed 'General case' 0 C--N 1.326 -0.453 0 CA-C-O 122.607 1.194 . . . . 0.0 110.356 179.671 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 46' ' ' GLY . . . . . . . . . . . . . . . -56.16 161.12 6.91 Favored Glycine 0 C--N 1.34 0.797 0 N-CA-C 109.738 -1.345 . . . . 0.0 109.738 179.228 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 47' ' ' LYS . . . . . 0.568 ' HA ' ' CD2' ' A' ' 42' ' ' TYR . 8.5 ptpt -56.98 -163.14 0.0 OUTLIER 'General case' 0 CA--C 1.541 0.612 0 CA-C-O 122.998 1.38 . . . . 0.0 112.033 175.732 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 48' ' ' LEU . . . . . 0.708 HD11 ' CE1' ' A' ' 42' ' ' TYR . 4.0 mp -81.35 155.25 71.87 Favored Pre-proline 0 N--CA 1.44 -0.931 0 O-C-N 121.068 -1.02 . . . . 0.0 111.041 178.107 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 49' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -71.2 159.4 52.14 Favored 'Trans proline' 0 N--CA 1.444 -1.394 0 C-N-CA 121.947 1.765 . . . . 0.0 110.266 178.45 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 50' ' ' LYS . . . . . . . . . . . . . 0.5 OUTLIER -53.11 97.77 0.02 OUTLIER 'General case' 0 CA--C 1.534 0.327 0 C-N-CA 123.263 0.625 . . . . 0.0 110.083 177.274 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 51' ' ' GLY . . . . . . . . . . . . . . . 112.26 79.19 0.95 Allowed Glycine 0 CA--C 1.517 0.191 0 CA-C-N 116.192 -0.458 . . . . 0.0 112.184 -176.146 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 52' ' ' ARG . . . . . 0.472 ' HD3' ' CA ' ' A' ' 41' ' ' GLY . 0.0 OUTLIER -174.83 157.31 2.42 Favored 'General case' 0 CA--C 1.519 -0.232 0 C-N-CA 123.891 0.876 . . . . 0.0 110.733 175.547 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 53' ' ' THR . . . . . . . . . . . . . 1.2 m -141.47 108.76 6.15 Favored Pre-proline 0 C--N 1.328 -0.347 0 O-C-N 123.972 0.795 . . . . 0.0 109.829 -179.91 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 54' ' ' PRO . . . . . . . . . . . . . 23.4 Cg_endo -72.53 179.12 5.43 Favored 'Trans proline' 0 N--CA 1.447 -1.226 0 C-N-CA 122.479 2.119 . . . . 0.0 111.619 177.338 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 55' ' ' ILE . . . . . 0.409 ' CG2' ' HB2' ' A' ' 133' ' ' LEU . 5.2 mt -90.16 124.76 42.96 Favored 'Isoleucine or valine' 0 C--N 1.326 -0.424 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -179.788 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 56' ' ' LYS . . . . . . . . . . . . . 0.1 OUTLIER -81.18 134.65 35.66 Favored 'General case' 0 N--CA 1.454 -0.244 0 N-CA-C 109.336 -0.616 . . . . 0.0 109.336 177.675 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 57' ' ' PHE . . . . . 0.521 ' CD1' ' HB3' ' A' ' 118' ' ' CYS . 40.1 m-85 -114.33 -47.83 2.91 Favored 'General case' 0 C--N 1.327 -0.407 0 C-N-CA 123.494 0.718 . . . . 0.0 110.642 179.43 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 58' ' ' GLY . . . . . . . . . . . . . . . 121.66 -1.81 11.12 Favored Glycine 0 C--O 1.223 -0.54 0 C-N-CA 123.767 0.698 . . . . 0.0 112.514 -176.36 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 59' ' ' LYS . . . . . . . . . . . . . 4.5 mttm -103.24 145.53 29.8 Favored 'General case' 0 CA--C 1.507 -0.688 0 CA-C-N 117.74 0.77 . . . . 0.0 109.588 177.537 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 60' ' ' SER . . . . . . . . . . . . . 30.4 t -79.13 -9.16 59.48 Favored 'General case' 0 C--O 1.222 -0.374 0 O-C-N 124.794 1.309 . . . . 0.0 111.309 176.784 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 61' ' ' ASP . . . . . . . . . . . . . 1.2 m-20 -89.04 -48.99 7.03 Favored 'General case' 0 CA--C 1.515 -0.375 0 C-N-CA 123.788 0.835 . . . . 0.0 109.797 179.995 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 62' ' ' CYS . . . . . 0.7 ' SG ' HD21 ' A' ' 80' ' ' LEU . 1.4 t -72.91 -17.04 61.54 Favored 'General case' 0 N--CA 1.451 -0.415 0 O-C-N 123.739 0.649 . . . . 0.0 111.814 175.871 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 63' ' ' ASP . . . . . . . . . . . . . 16.3 t0 -86.43 -33.13 20.52 Favored 'General case' 0 C--N 1.334 -0.091 0 CA-C-O 122.009 0.909 . . . . 0.0 111.295 174.422 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 64' ' ' ARG . . . . . 0.511 ' HD3' ' CE1' ' A' ' 78' ' ' HIS . 0.0 OUTLIER -57.27 158.99 9.09 Favored Pre-proline 0 N--CA 1.445 -0.691 0 O-C-N 121.369 -0.832 . . . . 0.0 111.343 179.492 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 65' ' ' PRO . . . . . . . . . . . . . 22.2 Cg_endo -71.14 140.09 36.86 Favored 'Trans proline' 0 N--CA 1.442 -1.5 0 C-N-CA 120.763 0.975 . . . . 0.0 113.74 174.365 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 66' ' ' PRO . . . . . 0.529 ' HD2' ' CD2' ' A' ' 42' ' ' TYR . 22.8 Cg_endo -70.77 169.88 19.13 Favored 'Trans proline' 0 N--CA 1.448 -1.191 0 C-N-CA 123.482 2.788 . . . . 0.0 112.238 177.058 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 67' ' ' LYS . . . . . . . . . . . . . 0.8 OUTLIER -133.37 49.95 2.26 Favored 'General case' 0 CA--C 1.517 -0.315 0 N-CA-C 112.263 0.468 . . . . 0.0 112.263 179.224 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 68' ' ' HIS . . . . . 0.483 ' HA ' ' OD2' ' A' ' 77' ' ' ASP . 25.1 t-80 -73.92 156.97 37.09 Favored 'General case' 0 C--O 1.22 -0.459 0 CA-C-N 115.403 -0.817 . . . . 0.0 111.588 -177.536 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 69' ' ' SER . . . . . 0.443 ' O ' ' CE1' ' A' ' 68' ' ' HIS . 1.5 p -148.22 -160.05 1.12 Allowed 'General case' 0 CA--C 1.52 -0.191 0 CA-C-O 122.287 1.041 . . . . 0.0 111.3 177.169 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 70' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -82.59 75.64 9.49 Favored 'General case' 0 C--O 1.217 -0.625 0 O-C-N 120.259 -1.526 . . . . 0.0 111.722 172.148 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 71' ' ' ASP . . . . . . . . . . . . . 0.3 OUTLIER -177.22 -44.59 0.01 OUTLIER 'General case' 0 N--CA 1.469 0.503 0 C-N-CA 123.271 0.628 . . . . 0.0 109.958 177.6 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 72' ' ' GLY . . . . . 0.48 ' CA ' ' HB3' ' A' ' 27' ' ' ASP . . . 109.17 -54.46 0.55 Allowed Glycine 0 C--O 1.212 -1.239 0 CA-C-N 115.182 -0.917 . . . . 0.0 112.912 -178.458 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 73' ' ' ASN . . . . . . . . . . . . . 0.9 OUTLIER -133.87 65.65 1.57 Allowed 'General case' 0 C--N 1.329 -0.302 0 N-CA-C 106.476 -1.676 . . . . 0.0 106.476 -179.574 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 74' ' ' GLY . . . . . . . . . . . . . . . -63.44 -126.63 0.01 OUTLIER Glycine 0 CA--C 1.525 0.718 0 CA-C-O 121.94 0.745 . . . . 0.0 111.492 179.447 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 75' ' ' LYS . . . . . . . . . . . . . 12.8 mttt -58.2 -92.66 0.0 OUTLIER 'General case' 0 C--O 1.221 -0.444 0 O-C-N 120.738 -1.448 . . . . 0.0 112.311 178.132 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 76' ' ' THR . . . . . 0.529 HG23 ' O ' ' A' ' 76' ' ' THR . 0.5 OUTLIER -115.86 15.99 16.27 Favored 'General case' 0 CA--C 1.509 -0.631 0 CA-C-O 118.307 -0.854 . . . . 0.0 110.427 177.473 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 77' ' ' ASP . . . . . 0.505 ' O ' ' CD1' ' A' ' 112' ' ' TYR . 20.1 t0 -29.11 102.06 0.02 OUTLIER 'General case' 0 C--O 1.212 -0.897 0 O-C-N 123.979 0.799 . . . . 0.0 110.99 -179.566 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 78' ' ' HIS . . . . . 0.511 ' CE1' ' HD3' ' A' ' 64' ' ' ARG . 5.7 p80 -87.55 64.18 7.98 Favored 'General case' 0 C--N 1.33 -0.253 0 N-CA-C 108.602 -0.888 . . . . 0.0 108.602 -176.016 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 79' ' ' TYR . . . . . 0.599 ' HB2' ' CD1' ' A' ' 37' ' ' TRP . 34.4 p90 -90.29 136.56 32.98 Favored 'General case' 0 N--CA 1.445 -0.709 0 C-N-CA 124.242 1.017 . . . . 0.0 109.527 -178.128 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 80' ' ' LEU . . . . . 0.7 HD21 ' SG ' ' A' ' 62' ' ' CYS . 0.3 OUTLIER -74.44 142.51 44.92 Favored 'General case' 0 C--O 1.216 -0.697 0 C-N-CA 119.758 -0.777 . . . . 0.0 109.225 176.22 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 81' ' ' LEU . . . . . 0.668 HD21 ' HB2' ' A' ' 35' ' ' PRO . 1.1 tt -134.66 144.07 47.62 Favored 'General case' 0 C--N 1.323 -0.574 0 N-CA-C 109.303 -0.628 . . . . 0.0 109.303 176.338 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 82' ' ' GLU . . . . . 0.508 ' HB2' HD11 ' A' ' 109' ' ' ILE . 6.1 pm0 -109.35 165.62 11.49 Favored 'General case' 0 N--CA 1.438 -1.052 0 C-N-CA 123.547 0.739 . . . . 0.0 111.429 -179.694 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 83' ' ' PHE . . . . . 0.605 ' HB3' HG12 ' A' ' 108' ' ' VAL . 36.7 t80 -148.93 135.23 10.12 Favored Pre-proline 0 C--N 1.329 -0.302 0 CA-C-O 117.795 -1.098 . . . . 0.0 112.444 -179.186 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 84' ' ' PRO . . . . . 0.565 ' HA ' ' HG2' ' A' ' 107' ' ' ARG . 19.1 Cg_endo -70.73 88.67 0.64 Allowed 'Trans proline' 0 CA--C 1.501 -1.152 0 C-N-CA 124.513 3.475 . . . . 0.0 110.679 -176.015 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 85' ' ' THR . . . . . 0.622 HG22 ' HA ' ' A' ' 107' ' ' ARG . 1.2 t -86.71 115.92 24.47 Favored 'General case' 0 N--CA 1.45 -0.443 0 O-C-N 124.411 1.07 . . . . 0.0 111.958 179.741 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 86' ' ' PHE . . . . . 0.617 ' CD1' ' CD1' ' A' ' 92' ' ' TYR . 18.2 m-85 -83.67 160.42 58.78 Favored Pre-proline 0 N--CA 1.45 -0.473 0 C-N-CA 123.193 0.597 . . . . 0.0 111.525 -179.877 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 87' ' ' PRO . . . . . . . . . . . . . 18.2 Cg_endo -75.05 -44.54 0.33 Allowed 'Trans proline' 0 N--CA 1.449 -1.141 0 C-N-CA 122.189 1.926 . . . . 0.0 111.748 179.041 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 88' ' ' ASP . . . . . . . . . . . . . 0.7 OUTLIER -52.21 -28.38 18.22 Favored 'General case' 0 C--O 1.234 0.288 0 CA-C-O 122.992 1.377 . . . . 0.0 110.031 177.89 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 89' ' ' GLY . . . . . . . . . . . . . . . 83.1 -14.14 40.53 Favored Glycine 0 N--CA 1.438 -1.227 0 CA-C-O 118.23 -1.317 . . . . 0.0 111.809 -179.023 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 90' ' ' HIS . . . . . 0.425 ' O ' ' CE1' ' A' ' 92' ' ' TYR . 1.6 p-80 -48.69 143.22 5.36 Favored 'General case' 0 C--O 1.213 -0.838 0 N-CA-C 108.726 -0.842 . . . . 0.0 108.726 178.425 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 91' ' ' ASP . . . . . . . . . . . . . 26.5 t70 -63.64 137.66 58.18 Favored 'General case' 0 C--N 1.322 -0.587 0 CA-C-O 121.793 0.806 . . . . 0.0 111.736 177.32 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 92' ' ' TYR . . . . . 0.617 ' CD1' ' CD1' ' A' ' 86' ' ' PHE . 0.0 OUTLIER -94.86 148.5 22.24 Favored 'General case' 0 C--N 1.321 -0.665 0 N-CA-C 107.702 -1.221 . . . . 0.0 107.702 -174.876 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 93' ' ' LYS . . . . . . . . . . . . . 15.0 ptpt -84.4 68.62 10.31 Favored 'General case' 0 C--N 1.321 -0.649 0 O-C-N 121.272 -0.893 . . . . 0.0 109.564 176.079 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 94' ' ' PHE . . . . . 0.422 ' CD2' ' O ' ' A' ' 92' ' ' TYR . 30.7 p90 -83.4 -16.15 46.99 Favored 'General case' 0 N--CA 1.445 -0.689 0 CA-C-N 115.814 -0.63 . . . . 0.0 111.583 177.465 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 95' ' ' ASP . . . . . 0.403 ' O ' ' HA3' ' A' ' 31' ' ' GLY . 0.4 OUTLIER -89.8 -30.87 17.68 Favored 'General case' 0 C--N 1.329 -0.324 0 C-N-CA 123.82 0.848 . . . . 0.0 110.448 178.55 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 96' ' ' SER . . . . . . . . . . . . . 2.0 t -90.91 110.29 21.52 Favored 'General case' 0 CA--C 1.508 -0.64 0 N-CA-C 108.168 -1.049 . . . . 0.0 108.168 -177.014 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 97' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -60.52 -46.1 91.38 Favored 'General case' 0 CA--C 1.508 -0.658 0 CA-C-O 120.958 0.409 . . . . 0.0 110.347 179.723 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 98' ' ' LYS . . . . . 0.427 ' HA ' ' C ' ' A' ' 99' ' ' PRO . 6.6 mttm -141.07 128.46 11.98 Favored Pre-proline 0 N--CA 1.438 -1.04 0 CA-C-N 115.327 -0.851 . . . . 0.0 109.962 -178.251 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 99' ' ' PRO . . . . . 0.427 ' C ' ' HA ' ' A' ' 98' ' ' LYS . 20.0 Cg_endo -70.05 176.86 31.71 Favored 'Cis proline' 0 N--CA 1.458 -0.602 0 O-C-N 124.579 1.831 . . . . 0.0 111.472 -3.802 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 100' ' ' LYS . . . . . . . . . . . . . 0.0 OUTLIER -138.03 152.34 48.76 Favored 'General case' 0 C--N 1.325 -0.461 0 C-N-CA 123.515 0.726 . . . . 0.0 109.891 177.731 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 101' ' ' GLU . . . . . . . . . . . . . 1.2 tp10 -104.13 146.37 28.84 Favored 'General case' 0 C--N 1.321 -0.656 0 O-C-N 124.327 1.017 . . . . 0.0 108.767 -179.875 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 102' ' ' ASN . . . . . . . . . . . . . 5.7 t30 -56.23 120.26 33.64 Favored Pre-proline 0 N--CA 1.445 -0.706 0 CA-C-O 118.095 -0.955 . . . . 0.0 110.792 177.353 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 103' ' ' PRO . . . . . . . . . . . . . 24.9 Cg_endo -71.6 -163.22 0.13 Allowed 'Trans proline' 0 N--CA 1.45 -1.069 0 C-N-CA 122.723 2.282 . . . . 0.0 111.753 178.303 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 104' ' ' GLY . . . . . . . . . . . . . . . -142.5 172.29 24.38 Favored Glycine 0 CA--C 1.524 0.645 0 O-C-N 121.414 -0.804 . . . . 0.0 112.113 177.187 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 105' ' ' PRO . . . . . 0.569 ' HB2' ' HB1' ' A' ' 122' ' ' ALA . 18.7 Cg_endo -74.03 -50.88 0.15 Allowed 'Trans proline' 0 N--CA 1.447 -1.26 0 C-N-CA 122.112 1.875 . . . . 0.0 110.542 178.925 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 106' ' ' ALA . . . . . 0.604 ' HA ' ' HB2' ' A' ' 122' ' ' ALA . . . -61.24 135.74 57.83 Favored 'General case' 0 CA--C 1.507 -0.704 0 O-C-N 123.645 0.591 . . . . 0.0 109.892 -179.155 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 107' ' ' ARG . . . . . 0.622 ' HA ' HG22 ' A' ' 85' ' ' THR . 9.4 mtm-85 -151.39 148.1 27.71 Favored 'General case' 0 N--CA 1.445 -0.719 0 O-C-N 124.224 0.952 . . . . 0.0 110.456 -179.085 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 108' ' ' VAL . . . . . 0.605 HG12 ' HB3' ' A' ' 83' ' ' PHE . 12.8 p -87.99 116.01 29.25 Favored 'Isoleucine or valine' 0 N--CA 1.468 0.439 0 O-C-N 124.354 1.034 . . . . 0.0 111.525 178.584 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 109' ' ' ILE . . . . . 0.655 ' CG2' HD22 ' A' ' 80' ' ' LEU . 1.4 mp -107.39 122.05 61.08 Favored 'Isoleucine or valine' 0 CA--C 1.502 -0.885 0 N-CA-C 105.818 -1.919 . . . . 0.0 105.818 -173.09 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 110' ' ' TYR . . . . . 0.465 ' CZ ' HD22 ' A' ' 81' ' ' LEU . 6.3 p90 -141.46 151.73 43.62 Favored 'General case' 0 N--CA 1.443 -0.823 0 CA-C-O 121.836 0.827 . . . . 0.0 109.711 -179.388 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 111' ' ' THR . . . . . . . . . . . . . 4.3 p -80.64 163.23 23.78 Favored 'General case' 0 C--N 1.32 -0.68 0 CA-C-N 115.236 -0.893 . . . . 0.0 109.639 178.421 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 112' ' ' TYR . . . . . 0.524 ' CG ' ' HA ' ' A' ' 113' ' ' PRO . 0.1 OUTLIER -111.9 154.73 44.04 Favored Pre-proline 0 CA--C 1.546 0.808 0 O-C-N 123.353 0.408 . . . . 0.0 110.893 178.86 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 113' ' ' PRO . . . . . 0.524 ' HA ' ' CG ' ' A' ' 112' ' ' TYR . 19.0 Cg_endo -74.16 -51.08 0.16 OUTLIER 'Cis proline' 0 CA--C 1.502 -1.094 0 C-N-CA 123.533 -1.444 . . . . 0.0 110.529 -5.956 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 114' ' ' ASN . . . . . 0.541 ' O ' HG23 ' A' ' 116' ' ' VAL . 43.8 t-20 -45.23 109.96 0.21 Allowed 'General case' 0 C--O 1.219 -0.549 0 N-CA-C 108.578 -0.897 . . . . 0.0 108.578 177.971 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 115' ' ' LYS . . . . . 0.526 ' HE2' HD22 ' A' ' 25' ' ' LEU . 0.1 OUTLIER -66.39 76.63 0.1 Allowed 'General case' 0 CA--C 1.512 -0.497 0 C-N-CA 123.675 0.79 . . . . 0.0 109.016 179.547 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 116' ' ' VAL . . . . . 0.541 HG23 ' O ' ' A' ' 114' ' ' ASN . 57.3 t -74.84 72.51 0.35 Allowed 'Isoleucine or valine' 0 N--CA 1.451 -0.419 0 N-CA-C 106.303 -1.74 . . . . 0.0 106.303 -176.188 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 117' ' ' PHE . . . . . 0.455 ' CZ ' ' NE2' ' A' ' 13' ' ' GLN . 59.8 t80 -34.02 104.95 0.03 OUTLIER 'General case' 0 N--CA 1.446 -0.673 0 C-N-CA 126.752 2.021 . . . . 0.0 109.22 -178.378 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 118' ' ' CYS . . . . . 0.521 ' HB3' ' CD1' ' A' ' 57' ' ' PHE . 14.6 m -84.84 -44.81 12.9 Favored 'General case' 0 N--CA 1.441 -0.91 0 N-CA-C 108.235 -1.024 . . . . 0.0 108.235 -177.683 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 119' ' ' GLY . . . . . . . . . . . . . . . 158.89 -151.03 21.94 Favored Glycine 0 N--CA 1.441 -1.02 0 N-CA-C 110.014 -1.234 . . . . 0.0 110.014 179.657 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 120' ' ' ILE . . . . . 0.45 HG13 ' CG ' ' A' ' 4' ' ' TRP . 1.1 mm -127.44 133.14 68.51 Favored 'Isoleucine or valine' 0 CA--C 1.504 -0.806 0 N-CA-C 107.001 -1.481 . . . . 0.0 107.001 -176.45 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 121' ' ' ILE . . . . . 0.661 HD12 HD21 ' A' ' 131' ' ' LEU . 6.4 pt -119.72 155.14 22.5 Favored 'Isoleucine or valine' 0 C--N 1.32 -0.691 0 N-CA-C 107.755 -1.202 . . . . 0.0 107.755 -177.327 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 122' ' ' ALA . . . . . 0.734 ' HB3' ' HB3' ' A' ' 6' ' ' CYS . . . -176.11 153.75 1.32 Allowed 'General case' 0 C--N 1.323 -0.545 0 CA-C-O 120.817 0.342 . . . . 0.0 110.249 178.635 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 123' ' ' HIS . . . . . 0.53 ' CD2' HD13 ' A' ' 131' ' ' LEU . 5.6 m-70 -90.23 97.56 11.26 Favored 'General case' 0 C--N 1.326 -0.442 0 N-CA-C 108.6 -0.889 . . . . 0.0 108.6 -176.922 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 124' ' ' THR . . . . . 0.668 HG22 ' HD3' ' A' ' 132' ' ' LYS . 1.7 t -97.27 40.84 1.13 Allowed 'General case' 0 N--CA 1.471 0.598 0 CA-C-O 123.169 1.462 . . . . 0.0 111.47 179.595 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 125' ' ' LYS . . . . . . . . . . . . . 12.7 tttm -105.02 -27.05 11.89 Favored 'General case' 0 C--O 1.219 -0.515 0 CA-C-N 115.28 -0.873 . . . . 0.0 111.118 178.229 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 126' ' ' GLU . . . . . . . . . . . . . 0.2 OUTLIER -172.82 -66.59 0.02 OUTLIER 'General case' 0 C--O 1.22 -0.469 0 O-C-N 123.934 0.771 . . . . 0.0 110.234 178.265 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 127' ' ' ASN . . . . . . . . . . . . . 1.1 m-20 -155.34 -44.22 0.08 Allowed 'General case' 0 N--CA 1.455 -0.188 0 CA-C-O 122.241 1.02 . . . . 0.0 110.782 179.514 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 128' ' ' GLN . . . . . . . . . . . . . 3.3 tt0 -155.39 79.64 1.03 Allowed 'General case' 0 N--CA 1.443 -0.804 0 C-N-CA 124.159 0.984 . . . . 0.0 109.414 -179.947 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 129' ' ' GLY . . . . . . . . . . . . . . . -130.06 -105.67 1.14 Allowed Glycine 0 C--N 1.329 0.193 0 N-CA-C 110.301 -1.12 . . . . 0.0 110.301 176.821 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 130' ' ' GLU . . . . . . . . . . . . . 1.9 mt-10 -83.66 143.07 30.32 Favored 'General case' 0 C--N 1.325 -0.474 0 O-C-N 122.439 -0.447 . . . . 0.0 111.352 179.774 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 131' ' ' LEU . . . . . 0.661 HD21 HD12 ' A' ' 121' ' ' ILE . 5.7 tp -99.12 145.75 26.84 Favored 'General case' 0 C--O 1.22 -0.448 0 CA-C-O 120.769 0.319 . . . . 0.0 111.066 177.506 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 132' ' ' LYS . . . . . 0.668 ' HD3' HG22 ' A' ' 124' ' ' THR . 0.0 OUTLIER -152.79 172.26 16.99 Favored 'General case' 0 C--N 1.325 -0.477 0 N-CA-C 109.466 -0.568 . . . . 0.0 109.466 -179.743 . . . . . . . . 3 3 . 1 . 025 nuclear nobuild full ' A' A ' 133' ' ' LEU . . . . . 0.409 ' HB2' ' CG2' ' A' ' 55' ' ' ILE . 14.9 tp -85.62 140.64 30.41 Favored 'General case' 0 C--O 1.244 0.765 0 O-C-N 123.886 0.741 . . . . 0.0 109.375 177.633 . . . . . . . . 2 2 . 1 . 025 nuclear nobuild full ' A' A ' 134' ' ' CYS . . . . . . . . . . . . . 60.8 m -68.71 -178.47 1.18 Allowed 'General case' 0 N--CA 1.449 -0.5 0 CA-C-N 114.738 -1.119 . . . . 0.0 109.786 175.954 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 135' ' ' SER . . . . . . . . . . . . . 73.6 m -148.62 100.27 3.09 Favored 'General case' 0 CA--C 1.506 -0.733 0 N-CA-C 106.606 -1.627 . . . . 0.0 106.606 -178.787 . . . . . . . . 1 1 . 1 . 025 nuclear nobuild full ' A' A ' 136' ' ' HIS . . . . . 0.468 ' HB2' HG13 ' A' ' 2' ' ' VAL . 0.3 OUTLIER . . . . . 0 C--O 1.248 0.981 0 CA-C-O 117.892 -1.051 . . . . 0.0 113.268 173.312 . . . . . . . . 2 2 . 1 stop_ save_